Citrus Sinensis ID: 011868
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 476 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RWC9 | 444 | CBL-interacting serine/th | yes | no | 0.911 | 0.977 | 0.658 | 1e-172 | |
| Q94C40 | 432 | CBL-interacting serine/th | no | no | 0.899 | 0.990 | 0.635 | 1e-168 | |
| Q9LGV5 | 461 | CBL-interacting protein k | yes | no | 0.918 | 0.947 | 0.615 | 1e-165 | |
| Q0D4B2 | 525 | CBL-interacting protein k | no | no | 0.894 | 0.811 | 0.628 | 1e-164 | |
| Q75L42 | 454 | CBL-interacting protein k | no | no | 0.892 | 0.936 | 0.602 | 1e-160 | |
| Q6ZLP5 | 450 | CBL-interacting protein k | no | no | 0.884 | 0.935 | 0.492 | 1e-127 | |
| Q2V452 | 441 | CBL-interacting serine/th | no | no | 0.871 | 0.941 | 0.483 | 1e-125 | |
| Q93VD3 | 482 | CBL-interacting serine/th | no | no | 0.869 | 0.858 | 0.485 | 1e-125 | |
| Q84VQ3 | 439 | CBL-interacting serine/th | no | no | 0.871 | 0.945 | 0.483 | 1e-123 | |
| Q2QY53 | 438 | CBL-interacting protein k | no | no | 0.857 | 0.931 | 0.483 | 1e-122 |
| >sp|Q8RWC9|CIPK1_ARATH CBL-interacting serine/threonine-protein kinase 1 OS=Arabidopsis thaliana GN=CIPK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 605 bits (1560), Expect = e-172, Method: Compositional matrix adjust.
Identities = 310/471 (65%), Positives = 369/471 (78%), Gaps = 37/471 (7%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
+K ++GMRLG+YELGRTLGEGNFGKVKFA+D SG FAVKI++K+RI L + QIKRE
Sbjct: 9 KKAEKGMRLGKYELGRTLGEGNFGKVKFAKDTVSGHSFAVKIIDKSRIADLNFSLQIKRE 68
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
I TLK+LKHP++VRLHEVLASK+KI MV+E VTGGELFD+I S G+L E +GRK+FQQLI
Sbjct: 69 IRTLKMLKHPHIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQLI 128
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
DG+SYCH+KGVFHRDLK LEN+LLD+
Sbjct: 129 DGISYCHSKGVFHRDLK-----------------------------------LENVLLDA 153
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
KG+IKI+DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA SDIWSCGVILYV
Sbjct: 154 KGHIKITDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAASDIWSCGVILYV 213
Query: 245 ILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304
ILTG LPFDDRNLAVLYQKI +GD +P+WLSPGA+ +++++L+PNPV RIT+ GIKA E
Sbjct: 214 ILTGCLPFDDRNLAVLYQKICKGDPPIPRWLSPGARTMIKRMLDPNPVTRITVVGIKASE 273
Query: 305 WFEQDYTPANP-DDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLS 363
WF+ +Y P+ P DDDEE++ D++AFS+ E+ S+ G+ SP +INAFQLIGMSS LDLS
Sbjct: 274 WFKLEYIPSIPDDDDEEEVDTDDDAFSIQELGSEEGKGSDSPTIINAFQLIGMSSFLDLS 333
Query: 364 GFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGS 423
GFFE+E+VSER+IRFTSN SAKDLLE+IE VTEMGF VQKK+ KL+ QE + QK
Sbjct: 334 GFFEQENVSERRIRFTSNSSAKDLLEKIETAVTEMGFSVQKKHAKLRVKQEERNQKGQVG 393
Query: 424 LSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGL-PPSQELLA 473
LSV AEVFEI PSL VVELRKSYGD +YRQL +L D+G P QE++
Sbjct: 394 LSVTAEVFEIKPSLNVVELRKSYGDSCLYRQLYERLLKDVGTSSPEQEIVT 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q94C40|CIPKH_ARATH CBL-interacting serine/threonine-protein kinase 17 OS=Arabidopsis thaliana GN=CIPK17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 591 bits (1523), Expect = e-168, Method: Compositional matrix adjust.
Identities = 296/466 (63%), Positives = 356/466 (76%), Gaps = 38/466 (8%)
Query: 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
+GMR+G+YELGRTLGEGN KVKFA D +G FA+KI+EK+ I L ++ QIKREI TL
Sbjct: 4 KGMRVGKYELGRTLGEGNSAKVKFAIDTLTGESFAIKIIEKSCITRLNVSFQIKREIRTL 63
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
K+LKHPN+VRLHEVLASK+KIYMVLE VTGG+LFD+I SKG+L E +GRK+FQQLIDGVS
Sbjct: 64 KVLKHPNIVRLHEVLASKTKIYMVLECVTGGDLFDRIVSKGKLSETQGRKMFQQLIDGVS 123
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
YCHNKGVFHRDLK LEN+LLD+KG+I
Sbjct: 124 YCHNKGVFHRDLK-----------------------------------LENVLLDAKGHI 148
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248
KI+DFGLSAL QH+R+DGLLHTTCGSPNYVAPEVLAN GYDGA SDIWSCGVILYVILTG
Sbjct: 149 KITDFGLSALSQHYREDGLLHTTCGSPNYVAPEVLANEGYDGAASDIWSCGVILYVILTG 208
Query: 249 YLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308
LPFDD NLAV+ +KIF+GD +P+W+S GA+ +++++L+PNPV R+TIAGIKA +WF+
Sbjct: 209 CLPFDDANLAVICRKIFKGDPPIPRWISLGAKTMIKRMLDPNPVTRVTIAGIKAHDWFKH 268
Query: 309 DYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEK 368
DYTP+N DDD++ + + F M E + ++P SP +INAFQLIGMSS LDLSGFFE
Sbjct: 269 DYTPSNYDDDDDVYLIQEDVFMMKEYEEE--KSPDSPTIINAFQLIGMSSFLDLSGFFET 326
Query: 369 EDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAA 428
E +SER+IRFTSN AKDLLE IE I TEMGF +QKK+ KLKA +E QK LSV A
Sbjct: 327 EKLSERQIRFTSNSLAKDLLENIETIFTEMGFCLQKKHAKLKAIKEESTQKRQCGLSVTA 386
Query: 429 EVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPS-QELLA 473
EVFEISPSL VVELRKS+GD ++Y+QL +L ++LG QELLA
Sbjct: 387 EVFEISPSLNVVELRKSHGDSSLYKQLYERLLNELGSSSQVQELLA 432
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LGV5|CIPK1_ORYSJ CBL-interacting protein kinase 1 OS=Oryza sativa subsp. japonica GN=CIPK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 582 bits (1499), Expect = e-165, Method: Compositional matrix adjust.
Identities = 296/481 (61%), Positives = 360/481 (74%), Gaps = 44/481 (9%)
Query: 1 MVIAEKKQEGMR---LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI 57
MV E + E R LGRYE+GRTLGEGNFGKVK+A+ L +G FA+KIL++N+I+ L+
Sbjct: 1 MVNGEAEAECTRASLLGRYEIGRTLGEGNFGKVKYARHLATGAHFAIKILDRNKILSLRF 60
Query: 58 TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR 117
DQI+REI TLKLLKHPNVVRLHEV ASK+KIYMVLEYV GGELFDKIA KG+L E EGR
Sbjct: 61 DDQIRREIGTLKLLKHPNVVRLHEVAASKTKIYMVLEYVNGGELFDKIAVKGKLSEHEGR 120
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177
+LFQQLID VSYCH+KGV+HRDLK
Sbjct: 121 RLFQQLIDAVSYCHDKGVYHRDLKP----------------------------------- 145
Query: 178 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 237
EN+L+D +GNIKISDFGLSALPQH +DGLLHTTCGSPNY+APEVL NRGYDG+ SDIWS
Sbjct: 146 ENVLVDRRGNIKISDFGLSALPQHLGNDGLLHTTCGSPNYIAPEVLQNRGYDGSLSDIWS 205
Query: 238 CGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI 297
CGVILYV+L GYLPFDDRNL VLYQKIF+GD ++PKWLSP A++LLR+ILEPNP+KRI I
Sbjct: 206 CGVILYVMLVGYLPFDDRNLVVLYQKIFKGDTQIPKWLSPSARDLLRRILEPNPMKRINI 265
Query: 298 AGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMS 357
AGIK EWF++DYTP P DD++D ++D+ + E + + P INAFQLIGM+
Sbjct: 266 AGIKEHEWFQKDYTPVVPYDDDDDNYLDS-VLPIKEQIDEAKQE--KPTHINAFQLIGMA 322
Query: 358 SCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKP 417
S LDLSGFFE+ED S+RKIRFTS HS KDL ++IE++VTEMGF+VQ+ N KLK + +
Sbjct: 323 SALDLSGFFEEEDASQRKIRFTSTHSPKDLFDKIENVVTEMGFQVQRGNSKLKVMKNGRG 382
Query: 418 QKSL---GSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLAT 474
K+L S V EV E+ PSLYVVEL+KS+GDP +YRQLC +LS +LG+ ++++ T
Sbjct: 383 SKNLRNPSSFLVCTEVVELGPSLYVVELKKSHGDPILYRQLCERLSDELGVCKTEQIQRT 442
Query: 475 E 475
E
Sbjct: 443 E 443
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4B2|CIPKL_ORYSJ CBL-interacting protein kinase 21 OS=Oryza sativa subsp. japonica GN=CIPK21 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 577 bits (1487), Expect = e-164, Method: Compositional matrix adjust.
Identities = 293/466 (62%), Positives = 348/466 (74%), Gaps = 40/466 (8%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
MR+G+YE+GR LGEG+FGKVK A+ D+G FA+KIL++ RI+ +KI +QIKREIATLK
Sbjct: 81 AMRMGKYEMGRALGEGHFGKVKLARHADTGAAFAIKILDRQRILAMKIDEQIKREIATLK 140
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
LLKHPNVVRLHEV ASK+KIYMVLEYV GGELFDKIA KG+L E EGRKLFQQL+D VSY
Sbjct: 141 LLKHPNVVRLHEVSASKTKIYMVLEYVNGGELFDKIALKGKLSEKEGRKLFQQLMDAVSY 200
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
CH KGV+HRDLK EN+L+D+KGNIK
Sbjct: 201 CHEKGVYHRDLKP-----------------------------------ENVLVDAKGNIK 225
Query: 190 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249
+SDFGLSALPQ+ R DGLLHTTCGSPNY+APEVL NRGYDG+ SDIWSCGVILYV+LTG
Sbjct: 226 VSDFGLSALPQNQRKDGLLHTTCGSPNYIAPEVLLNRGYDGSLSDIWSCGVILYVMLTGN 285
Query: 250 LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309
LPFDD+N VLYQKI +GD ++PKWLSPGAQ++LRKIL+PNP+ R+ I GI+A EWF QD
Sbjct: 286 LPFDDQNTVVLYQKILKGDARIPKWLSPGAQDILRKILDPNPITRLDITGIRAHEWFRQD 345
Query: 310 YTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKE 369
YTPA P DD++D + + M E + T + INAFQLIGMSSCLDLSGFFEKE
Sbjct: 346 YTPAMPFDDDDDNNISDGNLHMTE--NQDIETSPAISQINAFQLIGMSSCLDLSGFFEKE 403
Query: 370 DVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQ---EHKPQKSLGSLSV 426
DVSERKIRF SN+S L E+IE VTE GF+VQK +GKLK Q E + G+L +
Sbjct: 404 DVSERKIRFVSNYSPTSLFEKIESTVTEKGFQVQKNSGKLKVIQVCKEPANPRGHGNLLI 463
Query: 427 AAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELL 472
+AEVFEI+ SLYVVEL++S GD ++YRQLC LS DLG+ Q+LL
Sbjct: 464 SAEVFEINESLYVVELKRSSGDCSLYRQLCASLSEDLGICKRQQLL 509
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75L42|CIPKH_ORYSJ CBL-interacting protein kinase 17 OS=Oryza sativa subsp. japonica GN=CIPK17 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 565 bits (1456), Expect = e-160, Method: Compositional matrix adjust.
Identities = 279/463 (60%), Positives = 347/463 (74%), Gaps = 38/463 (8%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
LG YE+GRTLGEGNFGKVK+A+ L +G FAVKIL++ R++ L+ DQI+REIATLKLL+
Sbjct: 10 LGGYEMGRTLGEGNFGKVKYARHLATGGHFAVKILDRGRVVSLRAGDQIRREIATLKLLR 69
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HP+VVRLHEV ASK+KIYMVLE+V GGELF++IA KG+L E EGR+LFQQLIDGVSYCH+
Sbjct: 70 HPHVVRLHEVAASKTKIYMVLEFVNGGELFERIAVKGKLSEKEGRRLFQQLIDGVSYCHD 129
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
+GV+HRDLK EN+L+D KGNIKISD
Sbjct: 130 RGVYHRDLKP-----------------------------------ENVLVDQKGNIKISD 154
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
FGLSALPQH +DGLLHTTCGSPNY+APEVL N+GYDG+ SDIWSCGVILYV+L GYLPF
Sbjct: 155 FGLSALPQHLGNDGLLHTTCGSPNYIAPEVLQNKGYDGSLSDIWSCGVILYVMLIGYLPF 214
Query: 253 DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 312
DDRN+ VLYQKIF+GD ++PKWLS AQNLLR+ILEPNP+KRI +AGIK+ EWF++DY P
Sbjct: 215 DDRNIVVLYQKIFKGDTQIPKWLSHSAQNLLRRILEPNPMKRIDMAGIKSHEWFQKDYIP 274
Query: 313 ANP-DDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDV 371
P DDD+ED+ + ++ + G + INAFQLIGM+S LDLSGFFE E+V
Sbjct: 275 VLPYDDDDEDVQFGARLPAKEQINDEPGDK--NSHQINAFQLIGMASSLDLSGFFEDEEV 332
Query: 372 SERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVF 431
S+R+IRFTS H KD ++IE TE+GF+VQ+ + KLK + K K+ S V+AEVF
Sbjct: 333 SQRRIRFTSTHPPKDAFDKIESSATELGFQVQRGHSKLKLMRNCKGSKNPESFMVSAEVF 392
Query: 432 EISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLAT 474
E+ PS+ VVELRKS GDP +YRQLC ++SSD+G ++++ AT
Sbjct: 393 ELGPSVNVVELRKSNGDPALYRQLCERISSDMGARNTEQIFAT 435
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 456 bits (1172), Expect = e-127, Method: Compositional matrix adjust.
Identities = 233/473 (49%), Positives = 317/473 (67%), Gaps = 52/473 (10%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+GRYELGRTLGEG F KVKFA++ DSG A+KIL+K++++ K+ QIKREI+T+KL+
Sbjct: 9 RVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIKREISTMKLI 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPNV+R+HEV+ASK+KIY+V+E VTGGELFDKIAS+GRL+E + RK FQQLI+ V YCH
Sbjct: 69 RHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQLINAVDYCH 128
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
++GV+HRDLK EN+LLD+ G +K+S
Sbjct: 129 SRGVYHRDLKP-----------------------------------ENLLLDASGTLKVS 153
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
DFGLSAL Q R+DGLLHTTCG+PNYVAPEV+ N+GYDGA +D+WSCGVIL+V++ GYLP
Sbjct: 154 DFGLSALSQQVREDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILFVLMAGYLP 213
Query: 252 FDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311
F+D NL LY+KIF+ DF P W S A+ L++KIL+PNP RITIA + +EWF++ Y
Sbjct: 214 FEDSNLMSLYKKIFKADFSCPSWFSTSAKKLIKKILDPNPSTRITIAELINNEWFKKGYQ 273
Query: 312 PANPDDDEEDIFVD------NEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGF 365
P P + D+ +D NE+ ++ + R P ++NAF+LI S L+L
Sbjct: 274 P--PRFETADVNLDDINSIFNESGDQTQLVVE--RREERPSVMNAFELISTSQGLNLGTL 329
Query: 366 FEKEDVS--ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGS 423
FEK+ +R+ RF S A ++L +IE MGF VQK+N KLK E+ +K G
Sbjct: 330 FEKQSQGSVKRETRFASRLPANEILSKIEAAAGPMGFNVQKRNYKLKLQGENPGRK--GQ 387
Query: 424 LSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSS---DLGLPPSQELLA 473
L++A EVFE++PSLY+VELRKS GD + + + +S+ D+ P ++A
Sbjct: 388 LAIATEVFEVTPSLYMVELRKSNGDTLEFHKFYHNISNGLKDVMWKPESSIIA 440
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 447 bits (1151), Expect = e-125, Method: Compositional matrix adjust.
Identities = 225/465 (48%), Positives = 312/465 (67%), Gaps = 50/465 (10%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
++Q R+G+YE+GRT+GEG F KVKFA++ ++G P A+KIL+K +++ K+ +QI+REI
Sbjct: 4 RQQVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREI 63
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
AT+KL+KHPNVV+L+EV+ASK+KI+++LEYVTGGELFDKI + GR++E E R+ FQQLI
Sbjct: 64 ATMKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIH 123
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
V YCH++GV+HRDLK EN+LLDS
Sbjct: 124 AVDYCHSRGVYHRDLKP-----------------------------------ENLLLDSY 148
Query: 186 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245
GN+KISDFGLSAL Q RDDGLLHT+CG+PNYVAPEVL +RGYDGAT+D+WSCGV+LYV+
Sbjct: 149 GNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLNDRGYDGATADMWSCGVVLYVL 208
Query: 246 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 305
L GYLPFDD NL LY+KI G+F P WLS GA L+ +IL+PNP+ R+T + DEW
Sbjct: 209 LAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKLITRILDPNPMTRVTPQEVFEDEW 268
Query: 306 FEQDYTPA-------NPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSS 358
F++DY P + DD + +F D+E + E + P INAF++I MS
Sbjct: 269 FKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTE------KREEQPAAINAFEIISMSR 322
Query: 359 CLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQ 418
L+L F+ E +R+ R T A +++E+IE+ +GF VQKKN K++ +
Sbjct: 323 GLNLENLFDPEQEFKRETRITLRGGANEIIEKIEEAAKPLGFDVQKKNYKMRLENVKAGR 382
Query: 419 KSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 463
K G+L+VA E+F+++PSL++V++ KS GD + + KLS+ L
Sbjct: 383 K--GNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKLSNSL 425
|
Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 447 bits (1150), Expect = e-125, Method: Compositional matrix adjust.
Identities = 222/457 (48%), Positives = 305/457 (66%), Gaps = 43/457 (9%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+G+YELGRTLGEG F KVKFA+++++G A+K+++K +++ K+ QIKREI+T+KL+K
Sbjct: 28 VGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIK 87
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HPNV+R+ EV+ASK+KIY VLE+VTGGELFDKI+S GRL+E E RK FQQLI+ V YCH+
Sbjct: 88 HPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHS 147
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
+GV+HRDLK EN+LLD+ G +K+SD
Sbjct: 148 RGVYHRDLKP-----------------------------------ENLLLDANGALKVSD 172
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
FGLSALPQ R+DGLLHTTCG+PNYVAPEV+ N+GYDGA +D+WSCGVIL+V++ GYLPF
Sbjct: 173 FGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILFVLMAGYLPF 232
Query: 253 DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 312
+D NL LY+KIF+ +F P W S A+ L+++IL+PNP RIT A + +EWF++ Y
Sbjct: 233 EDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRILDPNPATRITFAEVIENEWFKKGYKA 292
Query: 313 -----ANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFE 367
A+ D+ D D+ S + V +P +NAF+LI S L+L FE
Sbjct: 293 PKFENADVSLDDVDAIFDDSGESKNLVVERREEGLKTPVTMNAFELISTSQGLNLGSLFE 352
Query: 368 KE-DVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSV 426
K+ + +RK RFTS SA +++ +IE MGF V+ N K+K T E +K G L+V
Sbjct: 353 KQMGLVKRKTRFTSKSSANEIVTKIEAAAAPMGFDVKTNNYKMKLTGEKSGRK--GQLAV 410
Query: 427 AAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 463
A EVF+++PSLY+VE+RKS GD + + L++ L
Sbjct: 411 ATEVFQVAPSLYMVEMRKSGGDTLEFHKFYKNLTTGL 447
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 442 bits (1136), Expect = e-123, Method: Compositional matrix adjust.
Identities = 219/453 (48%), Positives = 306/453 (67%), Gaps = 38/453 (8%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YE+G+TLG+G F KV+ A + ++G A+KIL+K +++ K+ +QI+REI T+KL+
Sbjct: 9 RVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICTMKLI 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
HPNVVRL+EVLASK+KIY+VLE+ TGGELFDKI GRL+E RK FQQLI+ V YCH
Sbjct: 69 NHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVDYCH 128
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
++GV+HRDLK EN+LLD++GN+K+S
Sbjct: 129 SRGVYHRDLKP-----------------------------------ENLLLDAQGNLKVS 153
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
DFGLSAL + R DGLLHT CG+PNY APEVL ++GYDGAT+D+WSCGVIL+V+L GYLP
Sbjct: 154 DFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQGYDGATADLWSCGVILFVLLAGYLP 213
Query: 252 FDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311
F+D NL LY+KI G++ P WLSPGA+NL+ +IL+PNP+ RITI + D WF+++Y
Sbjct: 214 FEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLIVRILDPNPMTRITIPEVLGDAWFKKNYK 273
Query: 312 PANPDDDEEDIFVDNEA-FSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKED 370
PA ++ EE D +A F E + P +NAF+LI MS LDL FE+E+
Sbjct: 274 PAVFEEKEEANLDDVDAVFKDSEEHHVTEKKEEQPTSMNAFELISMSRALDLGNLFEEEE 333
Query: 371 VSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEV 430
+R+ RF + +A DL+++IE+ +GF +QKKN K++ +K G+L VA E+
Sbjct: 334 GFKRETRFAAKGAANDLVQKIEEASKPLGFDIQKKNYKMRLENVTAGRK--GNLRVATEI 391
Query: 431 FEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 463
F++SPSL+++E+RK+ GD + + KLS+ L
Sbjct: 392 FQVSPSLHMIEVRKTKGDTLEFHKFYKKLSTSL 424
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 439 bits (1130), Expect = e-122, Method: Compositional matrix adjust.
Identities = 222/459 (48%), Positives = 304/459 (66%), Gaps = 51/459 (11%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YELGRT+GEG F KVKFA+D ++G P A+KIL+K +++ K+ +QIKREI+T+KL+
Sbjct: 9 RVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTMKLI 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
KHPNVVR++EV+ SK+KIY+VLEYVTGGELFD I + GR++E E R+ FQQLI+ V YCH
Sbjct: 69 KHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVDYCH 128
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
++GV+HRDLK EN+LLDS GN+K+S
Sbjct: 129 SRGVYHRDLKP-----------------------------------ENLLLDSYGNLKVS 153
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
DFGLSAL Q +DDGLLHTTCG+PNYVAPEVL ++GYDGA +D+WSCGVIL+V+L GYLP
Sbjct: 154 DFGLSALSQQIKDDGLLHTTCGTPNYVAPEVLEDQGYDGAMADLWSCGVILFVLLAGYLP 213
Query: 252 FDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311
F+D NL LY+KI +F P W S A+ LL +IL+PNP+ R+TI I DEWF++ Y
Sbjct: 214 FEDSNLMTLYKKISNAEFTFPPWTSFPAKRLLTRILDPNPMTRVTIPEILEDEWFKKGYK 273
Query: 312 PANPD-------DDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSG 364
D DD +F D+E + E + P +NAF+LI MS+ L+L
Sbjct: 274 RPEFDEKYDTTLDDVYAVFNDSEEHHVTEKKEE-------PEALNAFELISMSAGLNLGN 326
Query: 365 FFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSL 424
F+ E +R+ RFTS K+++ +IE+ +GF VQKKN KL+ + +K G+L
Sbjct: 327 LFDSEQEFKRETRFTSKCPPKEIVRKIEEAAKPLGFDVQKKNYKLRLEKVKAGRK--GNL 384
Query: 425 SVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 463
+VA E+ +++PSL++VE+RK+ GD + + LS L
Sbjct: 385 NVATEILQVAPSLHMVEVRKAKGDTLEFHKFYKNLSRTL 423
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 476 | ||||||
| 255556588 | 436 | CBL-interacting serine/threonine-protein | 0.905 | 0.988 | 0.751 | 0.0 | |
| 224110276 | 474 | predicted protein [Populus trichocarpa] | 0.903 | 0.907 | 0.748 | 0.0 | |
| 356548027 | 446 | PREDICTED: CBL-interacting serine/threon | 0.905 | 0.966 | 0.716 | 0.0 | |
| 363807952 | 448 | uncharacterized protein LOC100805710 [Gl | 0.905 | 0.962 | 0.699 | 0.0 | |
| 356530499 | 447 | PREDICTED: CBL-interacting serine/threon | 0.922 | 0.982 | 0.690 | 0.0 | |
| 357450323 | 465 | CBL-interacting protein kinase [Medicago | 0.894 | 0.916 | 0.717 | 0.0 | |
| 359477295 | 392 | PREDICTED: CBL-interacting serine/threon | 0.792 | 0.961 | 0.779 | 0.0 | |
| 297736814 | 391 | unnamed protein product [Vitis vinifera] | 0.789 | 0.961 | 0.776 | 0.0 | |
| 356558505 | 437 | PREDICTED: CBL-interacting serine/threon | 0.884 | 0.963 | 0.705 | 0.0 | |
| 357479181 | 446 | CBL-interacting protein kinase [Medicago | 0.888 | 0.948 | 0.679 | 1e-177 |
| >gi|255556588|ref|XP_002519328.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223541643|gb|EEF43192.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1870), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/471 (75%), Positives = 393/471 (83%), Gaps = 40/471 (8%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
++ + GMRLG YELGRTLGEGNFGKVK A+++DSGLPFAVKILEKNRIIHL I+DQI
Sbjct: 1 MVTHQHHNGMRLGNYELGRTLGEGNFGKVKLAKNIDSGLPFAVKILEKNRIIHLNISDQI 60
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV GGELFD+IASKG+L EA+GRKLFQ
Sbjct: 61 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVNGGELFDRIASKGKLPEAQGRKLFQ 120
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
QL+DGVSYCHNKGVFHRDLK LEN+L
Sbjct: 121 QLVDGVSYCHNKGVFHRDLK-----------------------------------LENVL 145
Query: 182 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241
+D+KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE+L+NRGYDGATSD WSCGVI
Sbjct: 146 VDAKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEILSNRGYDGATSDTWSCGVI 205
Query: 242 LYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301
LYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWLS GAQN++R+IL+PNPV RIT+A IK
Sbjct: 206 LYVILTGYLPFDDRNLAVLYQKIFKGDAQIPKWLSSGAQNMIRRILDPNPVTRITMADIK 265
Query: 302 ADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLD 361
+DEWF+QDYTPA EEDI +DNE FSMHE+P +G SP LINAFQLIGMSSCLD
Sbjct: 266 SDEWFKQDYTPA-----EEDIHIDNEGFSMHELPPEGESILRSPTLINAFQLIGMSSCLD 320
Query: 362 LSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSL 421
LSGFFEKEDVSERKIRFTSN S KDLL++IE+ TEMGFR+QKKNGKLK QE K Q+SL
Sbjct: 321 LSGFFEKEDVSERKIRFTSNRSMKDLLQKIEETATEMGFRIQKKNGKLKVVQERKEQRSL 380
Query: 422 GSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELL 472
GSLSVAAEVFEISPSL+VVEL+KS GDP+VYRQLC KLS+DL LP + LL
Sbjct: 381 GSLSVAAEVFEISPSLHVVELQKSNGDPSVYRQLCKKLSNDLRLPSDEGLL 431
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224110276|ref|XP_002315469.1| predicted protein [Populus trichocarpa] gi|116265922|gb|ABJ91209.1| CBL-interacting protein kinase 1 [Populus trichocarpa] gi|222864509|gb|EEF01640.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1861), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/466 (74%), Positives = 396/466 (84%), Gaps = 36/466 (7%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
GM+LG+YELGRTLGEGNFGKVK A+++++G PFAVKILEKNRII LKITDQIKREIATLK
Sbjct: 14 GMQLGKYELGRTLGEGNFGKVKLAKNIETGQPFAVKILEKNRIIDLKITDQIKREIATLK 73
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD+IASKG+L EAEGRK+FQQLIDGVSY
Sbjct: 74 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDRIASKGKLPEAEGRKMFQQLIDGVSY 133
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
CH+KGVFHRDLK LEN+L+D+KGNIK
Sbjct: 134 CHSKGVFHRDLK-----------------------------------LENVLVDAKGNIK 158
Query: 190 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249
ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE+L+NRGYDGATSDIWSCGVILYVILTGY
Sbjct: 159 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEILSNRGYDGATSDIWSCGVILYVILTGY 218
Query: 250 LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309
LPFDDRNLAVLYQKIF+GD ++PKWLSPGA+N++++IL+PNPV RIT A IKADEWF+ D
Sbjct: 219 LPFDDRNLAVLYQKIFKGDAQVPKWLSPGAKNMIKRILDPNPVTRITTADIKADEWFKLD 278
Query: 310 YTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKE 369
YTP + ++++D+++D+ AFS+ E PS+ G +P SP LINAFQLIGMSSCLDLSG FEKE
Sbjct: 279 YTPMDSAEEQDDVYIDDAAFSIQEAPSEDG-SPKSPNLINAFQLIGMSSCLDLSGLFEKE 337
Query: 370 DVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAE 429
DVSERKIRFTSNHS DLLE+IEDIVTEMGFRVQK+NG+ + QEH+ +KS GSLSVA E
Sbjct: 338 DVSERKIRFTSNHSMSDLLEKIEDIVTEMGFRVQKRNGRFQVIQEHRGKKSSGSLSVATE 397
Query: 430 VFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLATE 475
VFEISPSLYVVELRKSYGD + YRQLC KLS+DLG+P S LL TE
Sbjct: 398 VFEISPSLYVVELRKSYGDSSAYRQLCTKLSNDLGVPSSPGLLTTE 443
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356548027|ref|XP_003542405.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 682 bits (1759), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/469 (71%), Positives = 382/469 (81%), Gaps = 38/469 (8%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
++EGMRLG+YELGRTLGEGNFGKVKFA++ DSG FAVKI+EKN+I+ L IT+QIKREIA
Sbjct: 12 EREGMRLGKYELGRTLGEGNFGKVKFARNTDSGQAFAVKIIEKNKIVDLNITNQIKREIA 71
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
TLKLL+HPNVVRL+EVLASK+KIYMVLEYV GGELFD IASKG+L E E RKLFQQLIDG
Sbjct: 72 TLKLLRHPNVVRLYEVLASKTKIYMVLEYVNGGELFDIIASKGKLTEGECRKLFQQLIDG 131
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
VSYCH KGVFHRDLK LEN+L+D+KG
Sbjct: 132 VSYCHTKGVFHRDLK-----------------------------------LENVLVDNKG 156
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
NIK++DFGLSALPQH R+DGLLHTTCGSPNYVAPEVLAN+GYDGATSD WSCGVILYV L
Sbjct: 157 NIKVTDFGLSALPQHLREDGLLHTTCGSPNYVAPEVLANKGYDGATSDTWSCGVILYVSL 216
Query: 247 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
TGYLPFDDRNL VLYQKIF+GD ++PKWLSPGAQN++R+IL+PNP RIT+AGIK D WF
Sbjct: 217 TGYLPFDDRNLVVLYQKIFKGDAQIPKWLSPGAQNMIRRILDPNPETRITMAGIKEDPWF 276
Query: 307 EQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG-GRTPGSPPLINAFQLIGMSSCLDLSGF 365
++ Y PANP+D ED+ VDNEAFS HE P++ R GSP LINAFQLIGMSSCLDLSGF
Sbjct: 277 KKGYIPANPED--EDVHVDNEAFSSHEEPNEAEQRNSGSPTLINAFQLIGMSSCLDLSGF 334
Query: 366 FEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLS 425
FEKEDVSERKIRF S S KDL++RIED VTEM FRV+KKNGKLK +E+K K+LG LS
Sbjct: 335 FEKEDVSERKIRFASILSVKDLIDRIEDTVTEMEFRVEKKNGKLKVMRENKVHKTLGCLS 394
Query: 426 VAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLAT 474
V EVFEISPSLYVVELRKSYGD +VY+QLC KL +DLG+PP Q L+ +
Sbjct: 395 VVVEVFEISPSLYVVELRKSYGDGSVYKQLCKKLLNDLGVPPKQGLVRS 443
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363807952|ref|NP_001242199.1| uncharacterized protein LOC100805710 [Glycine max] gi|255644530|gb|ACU22768.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1727), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/469 (69%), Positives = 379/469 (80%), Gaps = 38/469 (8%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
++EGMRLG+Y+LGRTLGEGNFGKVKFA++ DSG FAVKI++KN I+ + IT+QI REIA
Sbjct: 14 EREGMRLGKYDLGRTLGEGNFGKVKFARNTDSGQAFAVKIIDKNTIVDINITNQIIREIA 73
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
TLKLL+HPNVVRL+EVLASK+KIYMVLEYV GGELFD IASKG+ E EGRKLFQQLIDG
Sbjct: 74 TLKLLRHPNVVRLYEVLASKTKIYMVLEYVNGGELFDIIASKGKHIEGEGRKLFQQLIDG 133
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
VSYCH KGVFHRDLK LEN+L+D+KG
Sbjct: 134 VSYCHTKGVFHRDLK-----------------------------------LENVLVDNKG 158
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
NIKI+DFGLSALPQH R+DGLLHTTCGSPNYVAPEVLAN+GYDGATSD WSCGVILYVIL
Sbjct: 159 NIKITDFGLSALPQHLREDGLLHTTCGSPNYVAPEVLANKGYDGATSDTWSCGVILYVIL 218
Query: 247 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
G+LPFDDRNL VLYQKIF+GD ++PKWL+PGA+N++R+IL+PNP RIT+AGIK D WF
Sbjct: 219 PGHLPFDDRNLVVLYQKIFKGDVQIPKWLTPGARNMIRRILDPNPETRITMAGIKEDPWF 278
Query: 307 EQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG-GRTPGSPPLINAFQLIGMSSCLDLSGF 365
++ Y P NP+D ED++VD EAFS+HE P++ R GSP LINAFQLIGMSSCLDLSGF
Sbjct: 279 KKGYIPVNPED--EDVYVDQEAFSIHEQPNEAEQRNSGSPSLINAFQLIGMSSCLDLSGF 336
Query: 366 FEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLS 425
FEKEDVSERKIRF SN S KDL+ERIED TEM FRV+KKNGKLK +E+K K+LG LS
Sbjct: 337 FEKEDVSERKIRFASNLSVKDLIERIEDTATEMEFRVEKKNGKLKVIRENKVHKTLGCLS 396
Query: 426 VAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLAT 474
V EVF IS SLYVVELRKSYGD +VY+QLCNKL +DLG+PP Q L+ +
Sbjct: 397 VVVEVFGISSSLYVVELRKSYGDGSVYKQLCNKLLNDLGIPPKQPLVRS 445
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356530499|ref|XP_003533818.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1725), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/475 (69%), Positives = 387/475 (81%), Gaps = 36/475 (7%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
+ K+++G+RLG+YELG+TLGEGNFGKVK A+D SG FAVKIL+K++II L DQIK
Sbjct: 6 LGRKEEQGVRLGKYELGKTLGEGNFGKVKLARDTHSGKLFAVKILDKSKIIDLNNIDQIK 65
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
REI+TLKLLKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKIASKG+L+EAEGRK+FQQ
Sbjct: 66 REISTLKLLKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKIASKGKLKEAEGRKIFQQ 125
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
LID VS+CHNKGVFHRDLK LEN+L+
Sbjct: 126 LIDCVSFCHNKGVFHRDLK-----------------------------------LENVLV 150
Query: 183 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242
D+KGNIKI+DF LSALPQHFR+DGLLHTTCGSPNYVAPE+LAN+GYDGATSDIWSCGVIL
Sbjct: 151 DAKGNIKITDFNLSALPQHFREDGLLHTTCGSPNYVAPEILANKGYDGATSDIWSCGVIL 210
Query: 243 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302
YVILTGYLPFDDRNLAVLYQKIF+G+ ++P+WLSPG+QN+++++L+ NP RIT+A IK
Sbjct: 211 YVILTGYLPFDDRNLAVLYQKIFKGEVQIPRWLSPGSQNIIKRMLDANPKTRITMAMIKE 270
Query: 303 DEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGR-TPGSPPLINAFQLIGMSSCLD 361
DEWF++ YTPANP+D+EE +++D+E FS+H+V + + P SP LINAFQLI MSS LD
Sbjct: 271 DEWFKEGYTPANPEDEEESVYIDDEDFSIHDVSHEADQGCPRSPTLINAFQLISMSSSLD 330
Query: 362 LSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSL 421
LSG FE+EDVSERKIRFTS HS KDL+ERIEDIVTEMGFRVQKKNG LK QE K QK
Sbjct: 331 LSGLFEQEDVSERKIRFTSIHSPKDLVERIEDIVTEMGFRVQKKNGMLKVIQEIKVQKCP 390
Query: 422 GSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLATEV 476
GS SV AEVFEISPSLYVVEL KS GD ++YRQLC KLS+DLG+ Q+L ++EV
Sbjct: 391 GSFSVEAEVFEISPSLYVVELSKSCGDASLYRQLCKKLSNDLGVHTRQQLGSSEV 445
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357450323|ref|XP_003595438.1| CBL-interacting protein kinase [Medicago truncatula] gi|355484486|gb|AES65689.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 661 bits (1705), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/463 (71%), Positives = 379/463 (81%), Gaps = 37/463 (7%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
+RLG+YELG+TLGEGNFGKVK A+D D G FAVKILEKN+I+ L TDQIKREI+TLKL
Sbjct: 15 VRLGKYELGKTLGEGNFGKVKLARDTDCGQFFAVKILEKNKIVDLNNTDQIKREISTLKL 74
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
LKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKI+SKG+L EA GRK+FQQLIDGVSYC
Sbjct: 75 LKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKISSKGKLTEAHGRKMFQQLIDGVSYC 134
Query: 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKI 190
HNKGVFHRDLK LEN+L+D+KGNIKI
Sbjct: 135 HNKGVFHRDLK-----------------------------------LENVLVDAKGNIKI 159
Query: 191 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250
+DF LSALPQH R DGLLHTTCGSPNYVAPE+LANRGYDGA SDIWSCGVILYVILTGYL
Sbjct: 160 TDFNLSALPQHCRADGLLHTTCGSPNYVAPEILANRGYDGAKSDIWSCGVILYVILTGYL 219
Query: 251 PFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310
PFDDRNLAVLYQKIF+ D ++P+WLSPGAQN+++KIL+PNP R+T+ IK DEWF++ Y
Sbjct: 220 PFDDRNLAVLYQKIFKADVQIPRWLSPGAQNIIKKILDPNPKTRVTMDMIKEDEWFKEGY 279
Query: 311 TPAN--PDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEK 368
PAN +++EED+F+D+EAFS+HEV DG ++P SP LINAFQLIGMSSCLDLSGFFE+
Sbjct: 280 NPANLEDEEEEEDVFIDDEAFSIHEVSLDGDQSPKSPALINAFQLIGMSSCLDLSGFFEQ 339
Query: 369 EDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAA 428
EDVSERKIRFTSNHS KDL E+IEDIV EMGF+V KKNGKLK QE K KSL SLSVAA
Sbjct: 340 EDVSERKIRFTSNHSPKDLTEKIEDIVIEMGFKVHKKNGKLKVIQEDKAHKSLDSLSVAA 399
Query: 429 EVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQEL 471
EVFE+ PSLYVVELRKSYGD +VYRQLC +LS+DLG+ E+
Sbjct: 400 EVFEVGPSLYVVELRKSYGDASVYRQLCKRLSNDLGIAEVAEV 442
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477295|ref|XP_002275061.2| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Vitis vinifera] gi|229609839|gb|ACQ83535.1| CBL-interacting protein kinase 19 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 660 bits (1704), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/412 (77%), Positives = 353/412 (85%), Gaps = 35/412 (8%)
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
IKREIATLKLLKHPNVVRLHEVLASK+KIYMVLEYVTGGELFD+IAS G+L EAEGRKLF
Sbjct: 14 IKREIATLKLLKHPNVVRLHEVLASKTKIYMVLEYVTGGELFDRIASNGKLSEAEGRKLF 73
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
QQLID VSYCHNKGVFHRDLK LEN+
Sbjct: 74 QQLIDAVSYCHNKGVFHRDLK-----------------------------------LENV 98
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240
L+DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE+LANRGYDG+TSDIWSCGV
Sbjct: 99 LVDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEILANRGYDGSTSDIWSCGV 158
Query: 241 ILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 300
ILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWLS GA+N++++IL+P P RIT+AGI
Sbjct: 159 ILYVILTGYLPFDDRNLAVLYQKIFKGDAQMPKWLSSGAKNIIKRILDPKPETRITMAGI 218
Query: 301 KADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCL 360
KADEWF+Q YTPA P+++EEDI VD+EAFS++EVP + ++PGSP LINAFQLIGMSSCL
Sbjct: 219 KADEWFKQQYTPAYPEEEEEDIHVDDEAFSIYEVPMEAKKSPGSPNLINAFQLIGMSSCL 278
Query: 361 DLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKS 420
DLSGFFEKEDVSERKIRFTSNH KDLLE+IEDIVTEMGFRV+KKNG+LK QEHK QKS
Sbjct: 279 DLSGFFEKEDVSERKIRFTSNHCPKDLLEKIEDIVTEMGFRVEKKNGRLKVMQEHKCQKS 338
Query: 421 LGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELL 472
GSLSVAAEVFEISPSLYVVELRKSYGD +VYRQLC KLSSDLG+P SQELL
Sbjct: 339 FGSLSVAAEVFEISPSLYVVELRKSYGDSSVYRQLCKKLSSDLGVPTSQELL 390
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297736814|emb|CBI26015.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 654 bits (1688), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/412 (77%), Positives = 352/412 (85%), Gaps = 36/412 (8%)
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
IKREIATLKLLKHPNVVRLHEVLASK+KIYMVLEYVTGGELFD+IAS G+L EAEGRKLF
Sbjct: 14 IKREIATLKLLKHPNVVRLHEVLASKTKIYMVLEYVTGGELFDRIASNGKLSEAEGRKLF 73
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
QQLID VSYCHNKGVFHRDLK LEN+
Sbjct: 74 QQLIDAVSYCHNKGVFHRDLK-----------------------------------LENV 98
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240
L+DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE+LANRGYDG+TSDIWSCGV
Sbjct: 99 LVDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEILANRGYDGSTSDIWSCGV 158
Query: 241 ILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 300
ILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWLS GA+N++++IL+P P RIT+AGI
Sbjct: 159 ILYVILTGYLPFDDRNLAVLYQKIFKGDAQMPKWLSSGAKNIIKRILDPKPETRITMAGI 218
Query: 301 KADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCL 360
KADEWF+Q YTPA P+++EEDI VD+EAFS++E P + ++PGSP LINAFQLIGMSSCL
Sbjct: 219 KADEWFKQQYTPAYPEEEEEDIHVDDEAFSIYE-PMEAKKSPGSPNLINAFQLIGMSSCL 277
Query: 361 DLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKS 420
DLSGFFEKEDVSERKIRFTSNH KDLLE+IEDIVTEMGFRV+KKNG+LK QEHK QKS
Sbjct: 278 DLSGFFEKEDVSERKIRFTSNHCPKDLLEKIEDIVTEMGFRVEKKNGRLKVMQEHKCQKS 337
Query: 421 LGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELL 472
GSLSVAAEVFEISPSLYVVELRKSYGD +VYRQLC KLSSDLG+P SQELL
Sbjct: 338 FGSLSVAAEVFEISPSLYVVELRKSYGDSSVYRQLCKKLSSDLGVPTSQELL 389
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558505|ref|XP_003547546.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 652 bits (1682), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/458 (70%), Positives = 375/458 (81%), Gaps = 37/458 (8%)
Query: 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
+GMRLG+YELG+TLGEGNFGKVK A+D SG FAVKIL+K++II L TDQIKREI TL
Sbjct: 12 QGMRLGKYELGKTLGEGNFGKVKLARDTHSGKLFAVKILDKSKIIDLNNTDQIKREIFTL 71
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
KLLKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKIASKG+L+EA GRK+FQQLID VS
Sbjct: 72 KLLKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKIASKGKLKEAVGRKIFQQLIDCVS 131
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
+CHNKGVFHRDLK LEN+L+D+KGNI
Sbjct: 132 FCHNKGVFHRDLK-----------------------------------LENVLVDAKGNI 156
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248
KI+DF LSALPQHFR DGLLHTTCGSPNYVAPE+LAN+GYDGATSDIWSCGVILYVILTG
Sbjct: 157 KITDFNLSALPQHFRADGLLHTTCGSPNYVAPEILANKGYDGATSDIWSCGVILYVILTG 216
Query: 249 YLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308
YLPFDDRNLAVLYQKI +G+ ++P+WLSPG+QN+++++L+ N RIT+A IK DEWF++
Sbjct: 217 YLPFDDRNLAVLYQKILKGEVQIPRWLSPGSQNIIKRMLDVNLKTRITMAMIKEDEWFKE 276
Query: 309 DYTPANPDDDEEDIFVDNEAFSMHEVPSDGGR-TPGSPPLINAFQLIGMSSCLDLSGFFE 367
Y+PANP+D+EE +++D E FS+H+V + + +P SP LINAFQLI MSS LDLSG FE
Sbjct: 277 GYSPANPEDEEESVYID-EDFSIHDVSLEADQGSPRSPTLINAFQLISMSSSLDLSGLFE 335
Query: 368 KEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVA 427
+EDVSERKIRFTS HS KDL+ER+EDIVTEMGFRVQKKNG LK QE K QK LG+LSVA
Sbjct: 336 QEDVSERKIRFTSIHSPKDLVERLEDIVTEMGFRVQKKNGMLKVVQEIKTQKCLGNLSVA 395
Query: 428 AEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGL 465
AEVFEISPSLYVVEL KS GD +VYRQLC KLS+DLG+
Sbjct: 396 AEVFEISPSLYVVELSKSCGDASVYRQLCKKLSNDLGV 433
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357479181|ref|XP_003609876.1| CBL-interacting protein kinase [Medicago truncatula] gi|355510931|gb|AES92073.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 627 bits (1618), Expect = e-177, Method: Compositional matrix adjust.
Identities = 312/459 (67%), Positives = 373/459 (81%), Gaps = 36/459 (7%)
Query: 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
EG+RLG+YELGR LGEGNFGKVKFA++ DSG P+A+KI++KN+II L IT+QIKREI L
Sbjct: 19 EGVRLGKYELGRILGEGNFGKVKFARNTDSGQPYAIKIIDKNKIIDLNITNQIKREICAL 78
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
KLL+HPNVV+L+EVLASK+KIYMVLEYVTG ELFDKIASKG+L E EGRKLFQQLIDGVS
Sbjct: 79 KLLRHPNVVKLYEVLASKTKIYMVLEYVTGEELFDKIASKGKLPEGEGRKLFQQLIDGVS 138
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
YCH+KGVFHRDLK LEN+L+D+KGN+
Sbjct: 139 YCHSKGVFHRDLK-----------------------------------LENVLVDAKGNL 163
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248
KI+DFGLSALPQ FR DGLLHTTCGS NYVAPE+LANRGY+GA+SD+WSCGVILYV+LTG
Sbjct: 164 KITDFGLSALPQQFRADGLLHTTCGSANYVAPEILANRGYNGASSDVWSCGVILYVVLTG 223
Query: 249 YLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308
+LPFDDRNLAVLYQK+ +GDF+ PKWLS GAQN++++IL+PNP RIT+A IK D WF++
Sbjct: 224 FLPFDDRNLAVLYQKVLKGDFQKPKWLSAGAQNIIKRILDPNPKTRITMAEIKEDLWFKE 283
Query: 309 DYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPL-INAFQLIGMSSCLDLSGFFE 367
Y A +D+E+ ++VD++AF++HE+ + ++ P+ INAFQLIGMSSCLDLSGFFE
Sbjct: 284 GYNQAYHEDEEDGVYVDDQAFNIHELSHEEEKSSSQSPIRINAFQLIGMSSCLDLSGFFE 343
Query: 368 KEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVA 427
KEDVSERKIRFT+N SAK L+E+IED VTEM FRVQKKNGK+K QE+K K+LGSLSV
Sbjct: 344 KEDVSERKIRFTANLSAKVLMEKIEDSVTEMEFRVQKKNGKMKVMQENKDHKTLGSLSVI 403
Query: 428 AEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLP 466
EVFEIS SLYVVELRK YGD +VYRQLC KL +DLG+P
Sbjct: 404 IEVFEISSSLYVVELRKCYGDASVYRQLCKKLLNDLGVP 442
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 476 | ||||||
| TAIR|locus:2090537 | 444 | CIPK1 "CBL-interacting protein | 0.626 | 0.671 | 0.703 | 1.2e-164 | |
| TAIR|locus:2007685 | 432 | CIPK17 "CBL-interacting protei | 0.623 | 0.687 | 0.66 | 3.9e-155 | |
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.602 | 0.636 | 0.489 | 2e-117 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.596 | 0.589 | 0.493 | 8.6e-117 | |
| TAIR|locus:1005716172 | 439 | CIPK26 "calcineurin B-like pro | 0.602 | 0.653 | 0.489 | 1.3e-115 | |
| TAIR|locus:2155233 | 446 | SOS2 "SALT OVERLY SENSITIVE 2" | 0.619 | 0.661 | 0.423 | 1.5e-106 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.613 | 0.656 | 0.424 | 1.5e-106 | |
| TAIR|locus:2181047 | 421 | CIPK15 "CBL-interacting protei | 0.567 | 0.641 | 0.455 | 7.6e-99 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.563 | 0.610 | 0.434 | 1.2e-98 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.573 | 0.619 | 0.423 | 4.2e-98 |
| TAIR|locus:2090537 CIPK1 "CBL-interacting protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1094 (390.2 bits), Expect = 1.2e-164, Sum P(2) = 1.2e-164
Identities = 211/300 (70%), Positives = 251/300 (83%)
Query: 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234
L+LEN+LLD+KG+IKI+DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA SD
Sbjct: 144 LKLENVLLDAKGHIKITDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAASD 203
Query: 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
IWSCGVILYVILTG LPFDDRNLAVLYQKI +GD +P+WLSPGA+ +++++L+PNPV R
Sbjct: 204 IWSCGVILYVILTGCLPFDDRNLAVLYQKICKGDPPIPRWLSPGARTMIKRMLDPNPVTR 263
Query: 295 ITIAGIKADEWFEQDYTPANPDDD-EEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQL 353
IT+ GIKA EWF+ +Y P+ PDDD EE++ D++AFS+ E+ S+ G+ SP +INAFQL
Sbjct: 264 ITVVGIKASEWFKLEYIPSIPDDDDEEEVDTDDDAFSIQELGSEEGKGSDSPTIINAFQL 323
Query: 354 IGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQ 413
IGMSS LDLSGFFE+E+VSER+IRFTSN SAKDLLE+IE VTEMGF VQKK+ KL+ Q
Sbjct: 324 IGMSSFLDLSGFFEQENVSERRIRFTSNSSAKDLLEKIETAVTEMGFSVQKKHAKLRVKQ 383
Query: 414 EHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLP-PSQELL 472
E + QK LSV AEVFEI PSL VVELRKSYGD +YRQL +L D+G P QE++
Sbjct: 384 EERNQKGQVGLSVTAEVFEIKPSLNVVELRKSYGDSCLYRQLYERLLKDVGTSSPEQEIV 443
|
|
| TAIR|locus:2007685 CIPK17 "CBL-interacting protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1016 (362.7 bits), Expect = 3.9e-155, Sum P(2) = 3.9e-155
Identities = 198/300 (66%), Positives = 242/300 (80%)
Query: 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234
L+LEN+LLD+KG+IKI+DFGLSAL QH+R+DGLLHTTCGSPNYVAPEVLAN GYDGA SD
Sbjct: 135 LKLENVLLDAKGHIKITDFGLSALSQHYREDGLLHTTCGSPNYVAPEVLANEGYDGAASD 194
Query: 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
IWSCGVILYVILTG LPFDD NLAV+ +KIF+GD +P+W+S GA+ +++++L+PNPV R
Sbjct: 195 IWSCGVILYVILTGCLPFDDANLAVICRKIFKGDPPIPRWISLGAKTMIKRMLDPNPVTR 254
Query: 295 ITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLI 354
+TIAGIKA +WF+ DYTP+N DDD++ + + F M E + ++P SP +INAFQLI
Sbjct: 255 VTIAGIKAHDWFKHDYTPSNYDDDDDVYLIQEDVFMMKEYEEE--KSPDSPTIINAFQLI 312
Query: 355 GMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQE 414
GMSS LDLSGFFE E +SER+IRFTSN AKDLLE IE I TEMGF +QKK+ KLKA +E
Sbjct: 313 GMSSFLDLSGFFETEKLSERQIRFTSNSLAKDLLENIETIFTEMGFCLQKKHAKLKAIKE 372
Query: 415 HKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPS-QELLA 473
QK LSV AEVFEISPSL VVELRKS+GD ++Y+QL +L ++LG QELLA
Sbjct: 373 ESTQKRQCGLSVTAEVFEISPSLNVVELRKSHGDSSLYKQLYERLLNELGSSSQVQELLA 432
|
|
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 715 (256.8 bits), Expect = 2.0e-117, Sum P(2) = 2.0e-117
Identities = 142/290 (48%), Positives = 196/290 (67%)
Query: 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234
L+ EN+LLDS GN+KISDFGLSAL Q RDDGLLHT+CG+PNYVAPEVL +RGYDGAT+D
Sbjct: 148 LKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLNDRGYDGATAD 207
Query: 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
+WSCGV+LYV+L GYLPFDD NL LY+KI G+F P WLS GA L+ +IL+PNP+ R
Sbjct: 208 MWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKLITRILDPNPMTR 267
Query: 295 ITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA-FSMHEVPSDGGRTPGSPPLINAFQL 353
+T + DEWF++DY P ++ ++ D +A F E + P INAF++
Sbjct: 268 VTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTEKREEQPAAINAFEI 327
Query: 354 IGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQ 413
I MS L+L F+ E +R+ R T A +++E+IE+ +GF VQKKN K++
Sbjct: 328 ISMSRGLNLENLFDPEQEFKRETRITLRGGANEIIEKIEEAAKPLGFDVQKKNYKMRLEN 387
Query: 414 EHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 463
+K G+L+VA E+F+++PSL++V++ KS GD + + KLS+ L
Sbjct: 388 VKAGRK--GNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKLSNSL 435
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 710 (255.0 bits), Expect = 8.6e-117, Sum P(2) = 8.6e-117
Identities = 147/298 (49%), Positives = 205/298 (68%)
Query: 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234
L+ EN+LLD+ G +K+SDFGLSALPQ R+DGLLHTTCG+PNYVAPEV+ N+GYDGA +D
Sbjct: 155 LKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKGYDGAKAD 214
Query: 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
+WSCGVIL+V++ GYLPF+D NL LY+KIF+ +F P W S A+ L+++IL+PNP R
Sbjct: 215 LWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRILDPNPATR 274
Query: 295 ITIAGIKADEWFEQDY-TPA--NPD---DDEEDIFVDN-EAFSMH-EVPSDGGRTPGSPP 346
IT A + +EWF++ Y P N D DD + IF D+ E+ ++ E +G +TP +
Sbjct: 275 ITFAEVIENEWFKKGYKAPKFENADVSLDDVDAIFDDSGESKNLVVERREEGLKTPVT-- 332
Query: 347 LINAFQLIGMSSCLDLSGFFEKE-DVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK 405
+NAF+LI S L+L FEK+ + +RK RFTS SA +++ +IE MGF V+
Sbjct: 333 -MNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAPMGFDVKTN 391
Query: 406 NGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 463
N K+K T E +K G L+VA EVF+++PSLY+VE+RKS GD + + L++ L
Sbjct: 392 NYKMKLTGEKSGRK--GQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYKNLTTGL 447
|
|
| TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 735 (263.8 bits), Expect = 1.3e-115, Sum P(2) = 1.3e-115
Identities = 142/290 (48%), Positives = 202/290 (69%)
Query: 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234
L+ EN+LLD++GN+K+SDFGLSAL + R DGLLHT CG+PNY APEVL ++GYDGAT+D
Sbjct: 137 LKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQGYDGATAD 196
Query: 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
+WSCGVIL+V+L GYLPF+D NL LY+KI G++ P WLSPGA+NL+ +IL+PNP+ R
Sbjct: 197 LWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLIVRILDPNPMTR 256
Query: 295 ITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA-FSMHEVPSDGGRTPGSPPLINAFQL 353
ITI + D WF+++Y PA ++ EE D +A F E + P +NAF+L
Sbjct: 257 ITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKKEEQPTSMNAFEL 316
Query: 354 IGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQ 413
I MS LDL FE+E+ +R+ RF + +A DL+++IE+ +GF +QKKN K++
Sbjct: 317 ISMSRALDLGNLFEEEEGFKRETRFAAKGAANDLVQKIEEASKPLGFDIQKKNYKMRLEN 376
Query: 414 EHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 463
+K G+L VA E+F++SPSL+++E+RK+ GD + + KLS+ L
Sbjct: 377 VTAGRK--GNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKLSTSL 424
|
|
| TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 621 (223.7 bits), Expect = 1.5e-106, Sum P(2) = 1.5e-106
Identities = 133/314 (42%), Positives = 194/314 (61%)
Query: 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234
L+ EN+LLD+ GN+K+SDFGLSALPQ + LL TTCG+PNYVAPEVL+ +GYDG+ +D
Sbjct: 135 LKPENLLLDTNGNLKVSDFGLSALPQEGVE--LLRTTCGTPNYVAPEVLSGQGYDGSAAD 192
Query: 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
IWSCGVIL+VIL GYLPF + +L LY+KI +F P W S + L+ +IL+PNP R
Sbjct: 193 IWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFLIHRILDPNPKTR 252
Query: 295 ITIAGIKADEWFEQDYTPANPDDDEE----DIFVDNEAFSMHEVPSDGGRTPGSPPLINA 350
I I GIK D WF +Y P ++EE DI + V + R P ++NA
Sbjct: 253 IQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENVERNDEGPLMMNA 312
Query: 351 FQLIGMSSCLDLSGFFEK-EDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKL 409
F++I +S L+LS F++ +D +R+ RF S +++ IE + MGF+ +N K
Sbjct: 313 FEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKT 372
Query: 410 KATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPT----VYRQLCNKLSSDL-- 463
+ E G L+V E++E++PSL++V++RK+ G+ Y++LC+KL + +
Sbjct: 373 RL--EGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLENIIWR 430
Query: 464 ---GLPPSQELLAT 474
G+P S E+L T
Sbjct: 431 ATEGIPKS-EILRT 443
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 1.5e-106, Sum P(2) = 1.5e-106
Identities = 130/306 (42%), Positives = 192/306 (62%)
Query: 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234
L+ EN+LLDS+GN+KISDFGLSALP+ + +L TTCG+PNYVAPEVL+++GY+GA +D
Sbjct: 133 LKPENLLLDSQGNLKISDFGLSALPE--QGVTILKTTCGTPNYVAPEVLSHKGYNGAVAD 190
Query: 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
IWSCGVILYV++ GYLPFD+ +L LY KI + +F P + + GA++L+ +IL+PNP R
Sbjct: 191 IWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLINRILDPNPETR 250
Query: 295 ITIAGIKADEWFEQDYTPANPDDDE----EDIFVDNEAFSMHEVPSDGGRTPGSPPLINA 350
ITIA I+ DEWF +DYTP D E +D++ + DG R G P +NA
Sbjct: 251 ITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYAQDGTRDTG-PLTLNA 309
Query: 351 FQLIGMSSCLDLSGFFEK-EDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKL 409
F LI +S L+L+ F++ +D + + RF S+ A +L +E + MGF+ +N K+
Sbjct: 310 FDLIILSQGLNLATLFDRGKDSMKHQTRFISHKPANVVLSSMEVVSQSMGFKTHIRNYKM 369
Query: 410 KATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPT----VYRQLCNKLSSDLGL 465
+ E SV EVF+++PS+ +V+++ + GD Y+ C+KL +
Sbjct: 370 RV--EGLSANKTSHFSVILEVFKVAPSILMVDIQNAAGDAEEYLKFYKTFCSKLDDIIWK 427
Query: 466 PPSQEL 471
PP +
Sbjct: 428 PPDASM 433
|
|
| TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 615 (221.5 bits), Expect = 7.6e-99, Sum P(2) = 7.6e-99
Identities = 128/281 (45%), Positives = 179/281 (63%)
Query: 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234
L+ EN+LLD GN+KISDFGLSAL R DGLLHTTCG+P YVAPEV++ GYDG +D
Sbjct: 135 LKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVAPEVISRNGYDGFKAD 194
Query: 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
+WSCGVIL+V+L GYLPF D NL LY+KI + + K P WL+PGA+ LL++IL+PNP R
Sbjct: 195 VWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGAKRLLKRILDPNPNTR 254
Query: 295 ITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLI 354
++ I WF + + EE+ VD EA + R +NAF++I
Sbjct: 255 VSTEKIMKSSWFRKGLQEEVKESVEEETEVDAEAEGNASAEKEKKRCIN----LNAFEII 310
Query: 355 GMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQE 414
+S+ DLSG FEK + E ++RFTSN A ++ E++ +I ++ +V+KK E
Sbjct: 311 SLSTGFDLSGLFEKGEEKE-EMRFTSNREASEITEKLVEIGKDLKMKVRKKE------HE 363
Query: 415 HKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQL 455
+ + S + V AEVFEI+PS ++V L+KS GD Y+++
Sbjct: 364 WRVKMSAEATVVEAEVFEIAPSYHMVVLKKSGGDTAEYKRV 404
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 611 (220.1 bits), Expect = 1.2e-98, Sum P(2) = 1.2e-98
Identities = 127/292 (43%), Positives = 185/292 (63%)
Query: 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234
L+ EN+LLD G++KISDFGLSAL + + DGLLHTTCG+P YVAPEV+ +GYDGA +D
Sbjct: 135 LKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYDGAKAD 194
Query: 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
+WSCGV+LYV+L G+LPF ++NL +Y+KI +G+FK P W P + LL +IL+PNP R
Sbjct: 195 VWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDPNPNSR 254
Query: 295 ITIAGIKADEWFEQDY----TPANPDDDEEDIFVDN--EAFSMHEVPSDGGRTPGSPPLI 348
I I I + WF++ + TP +P+ + D + + AFS+ P
Sbjct: 255 IKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFSV------------KPMSY 302
Query: 349 NAFQLIG-MSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG-FRVQKKN 406
NAF LI +S DLSG FEKE+ SE K FT+ AK+++ + E+I T F + K +
Sbjct: 303 NAFDLISSLSQGFDLSGLFEKEERSESK--FTTKKDAKEIVSKFEEIATSSERFNLTKSD 360
Query: 407 GKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNK 458
+K + + +K G L++ E+FE++ S ++VE +KS GD Y+Q C++
Sbjct: 361 VGVKMEDKREGRK--GHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQFCDR 410
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 607 (218.7 bits), Expect = 4.2e-98, Sum P(2) = 4.2e-98
Identities = 122/288 (42%), Positives = 180/288 (62%)
Query: 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234
L+ EN+LLD +GN+K++DFGLSA +H + DGLLHTTCG+P YVAPEV+ +GYDGA +D
Sbjct: 147 LKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKKGYDGAKAD 206
Query: 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
+WSCGVIL+V+L GYLPF D NL +Y+KI+RGDFK P WLS A+ L+ K+L+PNP R
Sbjct: 207 LWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKLLDPNPNTR 266
Query: 295 ITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA--FSMHEVPSDGGRTPGSPPLINAFQ 352
ITI + WF++ T + + I E F +H+ + +NAF
Sbjct: 267 ITIEKVMDSPWFKKQATRSRNEPVAATITTTEEDVDFLVHKSKEE-------TETLNAFH 319
Query: 353 LIGMSSCLDLSGFFEKEDVSE-RKIRFTSNHSAKDLLERIEDIVTEMG--FRVQKKNGKL 409
+I +S DLS FE++ E R++RF ++ A ++ +E+ +G F V+K ++
Sbjct: 320 IIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEE-AARVGNKFDVRKSESRV 378
Query: 410 KATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCN 457
+ + +K G L+V AE+F ++PS VVE++K +GD Y C+
Sbjct: 379 RIEGKQNGRK--GKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNFCS 424
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8RWC9 | CIPK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6581 | 0.9117 | 0.9774 | yes | no |
| Q9LGV5 | CIPK1_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6153 | 0.9180 | 0.9479 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 476 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-99 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-83 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-69 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-67 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-62 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-58 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-57 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-56 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-52 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-49 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-49 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-44 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-43 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-43 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-41 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-41 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-41 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-40 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-40 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 9e-40 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-40 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-39 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-39 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-39 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-39 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-39 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-38 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-38 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-38 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-38 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-38 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-37 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-37 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-37 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-37 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-37 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-37 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-36 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-36 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-35 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-35 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-35 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-35 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-35 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-34 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-34 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-34 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-34 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-33 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-32 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-32 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-32 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-31 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-31 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-30 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-30 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-29 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-29 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-29 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-29 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-28 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-28 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-28 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-27 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-27 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-27 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-26 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-26 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-25 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-25 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-24 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-24 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-24 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-24 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-24 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-24 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-23 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-23 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-23 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-23 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-23 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-23 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-23 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 1e-22 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-22 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-22 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-22 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-22 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-21 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-21 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-21 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-20 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-20 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-19 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-19 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-19 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-18 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-18 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-18 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-18 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-18 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-17 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-16 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-12 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-05 | |
| cd12120 | 95 | cd12120, AMPKA_C_like, C-terminal regulatory domai | 6e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.001 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.001 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 297 bits (762), Expect = 7e-99
Identities = 115/295 (38%), Positives = 162/295 (54%), Gaps = 45/295 (15%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
YE+ LGEG+FGKV A+D +G A+K+++K +I K ++I REI LK LKHPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK--KDRERILREIKILKKLKHPN 58
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+VRL++V + K+Y+V+EY GG+LFD + +GRL E E R +Q++ + Y H+KG+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
HRDLK ENILLD G++K++DFGL
Sbjct: 119 VHRDLK-----------------------------------PENILLDEDGHVKLADFGL 143
Query: 196 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 255
+ L T G+P Y+APEVL +GY A DIWS GVILY +LTG PF
Sbjct: 144 AR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA-VDIWSLGVILYELLTGKPPFPGD 199
Query: 256 -NLAVLYQKIFRGDFKLPKW---LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
L L++KI + P +SP A++L+RK+L +P KR+T +F
Sbjct: 200 DQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 257 bits (660), Expect = 2e-83
Identities = 107/298 (35%), Positives = 147/298 (49%), Gaps = 45/298 (15%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
YEL R LG G+FG V A+ +G AVKIL+K K +REI L+ L HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPN 59
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+VRL + K +Y+V+EY GG+LFD ++ G L E E +K+ Q++ G+ Y H+ G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
HRDLK ENILLD G +KI+DFGL
Sbjct: 120 IHRDLK-----------------------------------PENILLDENGVVKIADFGL 144
Query: 196 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 255
+ + + L T G+P Y+APEVL G D+WS GVILY +LTG PF
Sbjct: 145 AK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGE 202
Query: 256 NLA---VLYQKIFRGDFKLPKW----LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
N+ L ++I + + S A++L++K L +P KR T I WF
Sbjct: 203 NILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 1e-69
Identities = 101/288 (35%), Positives = 156/288 (54%), Gaps = 41/288 (14%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G+FGKV + D+G +A+K+L+K +II K + E L + HP +V+LH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
++ K+Y+VLEY GGELF ++ +GR E R +++ + Y H+ G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 142 VILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQH 201
ENILLD+ G+IK++DFGL+ +
Sbjct: 121 -----------------------------------PENILLDADGHIKLTDFGLAK--EL 143
Query: 202 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 261
+ +T CG+P Y+APEVL +GY G D WS GV+LY +LTG PF + +Y
Sbjct: 144 SSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY 202
Query: 262 QKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG---IKADEWF 306
+KI + + P++LSP A++L+ +L+ +P KR+ G IKA +F
Sbjct: 203 EKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 1e-67
Identities = 100/297 (33%), Positives = 153/297 (51%), Gaps = 46/297 (15%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E +TLG G+FG+V + SG +A+KIL K +I+ LK + + E L+ ++HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V L+ S +Y+V+EYV GGELF + GR E R Q++ + Y H+ +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
+RDLK EN+LLDS G IKI+DFG
Sbjct: 123 VYRDLK-----------------------------------PENLLLDSDGYIKITDFGF 147
Query: 196 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 255
+ R G +T CG+P Y+APE++ ++GY A D W+ G+++Y +L GY PF D
Sbjct: 148 AK-----RVKGRTYTLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAGYPPFFDD 201
Query: 256 NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFE 307
N +Y+KI G + P + SP A++L+R +L+ + KR+ + IK WF
Sbjct: 202 NPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 202 bits (517), Expect = 6e-62
Identities = 92/314 (29%), Positives = 149/314 (47%), Gaps = 59/314 (18%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
++ G+ +GEG+F V A++ ++ +A+KIL+K ++I K +K E L +L HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+++L+ + +Y VLEY GEL I G L E R +++ + Y H+KG
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
+ HRDLK P ENILLD +IKI+DFG
Sbjct: 123 IIHRDLK---------------------------P--------ENILLDKDMHIKITDFG 147
Query: 195 LS------ALPQHFRDDGLLHTT------------CGSPNYVAPEVLANRGYDGATSDIW 236
+ + P+ + D + G+ YV+PE+L N G +SD+W
Sbjct: 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLW 206
Query: 237 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 296
+ G I+Y +LTG PF N + +QKI + ++ P P A++L+ K+L +P R+
Sbjct: 207 ALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLG 266
Query: 297 IAG----IKADEWF 306
+ +KA +F
Sbjct: 267 VNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 1e-60
Identities = 96/282 (34%), Positives = 136/282 (48%), Gaps = 72/282 (25%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LGEG FG V A+D +G A+KI++K L +++ REI LK L HPN+V+L+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKLNHPNIVKLYG 58
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
V ++ +Y+V+EY GG L D + G+L E E ++ Q+++G+ Y H+ G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 141 KVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK-GNIKISDFGLSALP 199
K ENILLDS G +K++DFGLS
Sbjct: 119 K-----------------------------------PENILLDSDNGKVKLADFGLSK-- 141
Query: 200 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV 259
D LL T G+P Y+APEVL +GY SDIWS GVILY +
Sbjct: 142 LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------- 187
Query: 260 LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301
P ++L+RK+L+ +P KR + I
Sbjct: 188 -----------------PELKDLIRKMLQKDPEKRPSAKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 4e-58
Identities = 89/289 (30%), Positives = 140/289 (48%), Gaps = 42/289 (14%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ G LG G+FG V A D D+G AVK +E + ++ + ++REI L L+HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL-EALEREIRILSSLQHP 59
Query: 75 NVVRL--HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
N+VR E K+ + + LEYV+GG L + G+L E RK +Q+++G++Y H+
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
G+ HRD+K NIL+DS G +K++D
Sbjct: 120 NGIVHRDIK-----------------------------------GANILVDSDGVVKLAD 144
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
FG + + G+P ++APEV+ G +DIWS G + + TG P+
Sbjct: 145 FGCAKRLGDIETGEGTGSVRGTPYWMAPEVI-RGEEYGRAADIWSLGCTVIEMATGKPPW 203
Query: 253 DDRN--LAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIA 298
+ +A LY+ G+ ++P+ LS A++ LRK L +P KR T
Sbjct: 204 SELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTAD 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 188 bits (481), Expect = 7e-57
Identities = 94/295 (31%), Positives = 145/295 (49%), Gaps = 48/295 (16%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG G FG+V+ + FA+K ++K I+ + I E L+ HP +V+L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
K IYM++EY GGEL+ + +G E R ++ Y HN+G+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 142 VILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQH 201
P EN+LLDS G +K+ DFG + +
Sbjct: 121 ---------------------------P--------ENLLLDSNGYVKLVDFGFA---KK 142
Query: 202 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAV 259
+ T CG+P YVAPE++ N+GYD + D WS G++LY +LTG PF DD +
Sbjct: 143 LKSGQKTWTFCGTPEYVAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDEDPME 201
Query: 260 LYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFE 307
+Y I +G+ KL P ++ A++L++++L NP +R+ I IK +WF
Sbjct: 202 IYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 4e-56
Identities = 87/297 (29%), Positives = 139/297 (46%), Gaps = 56/297 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL------EKNRIIHLKITDQIKREIATL 68
+YE+ + +G+G+FGKV + G + +K + EK R + E+ L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-------EDALNEVKIL 53
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLI 124
K L HPN+++ +E K K+ +V+EY GG+L KI + + E + F QL
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
+ Y H++ + HRD+K +NI L S
Sbjct: 114 LALKYLHSRKILHRDIKP-----------------------------------QNIFLTS 138
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
G +K+ DFG+S + L T G+P Y++PE+ N+ Y+ SDIWS G +LY
Sbjct: 139 NGLVKLGDFGISKVLSS--TVDLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYE 195
Query: 245 ILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGI 300
+ T PF+ NL L KI +G + +P S +NL+ +L+ +P +R +IA I
Sbjct: 196 LCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 5e-52
Identities = 89/293 (30%), Positives = 148/293 (50%), Gaps = 41/293 (13%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
+ +L +E+G TLG G+FG+V+ A+ +G +A+K L+K I+ +K +
Sbjct: 7 FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVA 66
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
+E + L L HP +V + ++++Y +LE+V GGELF + GR + +
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE 126
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
L+ Y H+K + +RDLK P EN+LL
Sbjct: 127 LVLAFEYLHSKDIIYRDLK---------------------------P--------ENLLL 151
Query: 183 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242
D+KG++K++DFG + + T CG+P Y+APEV+ ++G+ A D W+ GV+L
Sbjct: 152 DNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAPEVIQSKGHGKAV-DWWTMGVLL 205
Query: 243 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
Y + GY PF D +Y+KI G K P W A++L++ +L+ + KR+
Sbjct: 206 YEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-49
Identities = 92/297 (30%), Positives = 151/297 (50%), Gaps = 46/297 (15%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
E +T+G G FG+V +D S +A+K++ +I LK + E LK + HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
++RL + +YM++EYV GGELF + + GR + G +++ + Y H+K +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
+RDLK P ENILLD +G+IK++DFG
Sbjct: 123 VYRDLK---------------------------P--------ENILLDKEGHIKLTDFGF 147
Query: 196 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 255
+ + RD T CG+P Y+APEV+ ++G++ A D W+ G+++Y +L GY PF D
Sbjct: 148 A---KKLRDR--TWTLCGTPEYLAPEVIQSKGHNKAV-DWWALGILIYEMLVGYPPFFDD 201
Query: 256 NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFE 307
N +Y+KI G + P+ L A++L++K+L + +R+ +K WF+
Sbjct: 202 NPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 4e-49
Identities = 88/294 (29%), Positives = 142/294 (48%), Gaps = 47/294 (15%)
Query: 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84
G +G+V A+ +G +A+K+++K +I DQ+ E L + P VV+L+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVIL 144
K +Y+V+EY+ GG+L + + G L E R +++ + Y H+ G+ HRDLK
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP-- 121
Query: 145 KSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL----PQ 200
+NIL+DS G++K++DFGLS + Q
Sbjct: 122 ---------------------------------DNILIDSNGHLKLTDFGLSKVGLVRRQ 148
Query: 201 HFRDDGLLHT--TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258
+D G+P+Y+APEV+ +G+ T D WS G ILY L G PF
Sbjct: 149 INLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPE 207
Query: 259 VLYQKIFRGDFKLPK--WLSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFE 307
++Q I G + P+ +S A +L+ K+L P+P KR+ +I IK +F+
Sbjct: 208 EIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 159 bits (402), Expect = 2e-44
Identities = 98/327 (29%), Positives = 149/327 (45%), Gaps = 62/327 (18%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP- 74
Y + R LGEG+FG+V A+D A+K+L K K ++ REI L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFD---KIASKGRLQEAEGRKLFQQLIDGVSYCH 131
N+V+L++ + +Y+V+EYV GG L D KI KG L E+E + Q++ + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN-IKI 190
+KG+ HRD+K ENILLD G +K+
Sbjct: 119 SKGIIHRDIK-----------------------------------PENILLDRDGRVVKL 143
Query: 191 SDFGLSAL----PQHFRDDGLLHTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGVILYV 244
DFGL+ L L T+ G+P Y+APEVL + Y ++SDIWS G+ LY
Sbjct: 144 IDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYE 203
Query: 245 ILTGYLPFDDRNLAVLYQKIFRG-------------DFKLPKWLSPGAQNLLRKILEPNP 291
+LTG PF+ + + + P+ +S A +LL+K+L +P
Sbjct: 204 LLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDP 263
Query: 292 VKRITIAGIKADEWFEQDYTPANPDDD 318
R++ + + + + D
Sbjct: 264 KNRLSSSSDLSHDLLAHLKLKESDLSD 290
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 3e-44
Identities = 82/288 (28%), Positives = 139/288 (48%), Gaps = 48/288 (16%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ +G+G FG+V A+ +G A+K+++ + ++I EI LK KHPN
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES---KEKKEKIINEIQILKKCKHPN 58
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
+V+ + K ++++V+E+ +GG L D + S + L E++ + ++L+ G+ Y H+ G
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
+ HRD+K NILL S G +K+ DFG
Sbjct: 119 IIHRDIKA-----------------------------------ANILLTSDGEVKLIDFG 143
Query: 195 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-D 253
LSA D +T G+P ++APEV+ + YD +DIWS G+ + G P+ +
Sbjct: 144 LSA---QLSDTKARNTMVGTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSE 199
Query: 254 DRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRITIA 298
+ L+ KI + P+ S ++ L+K L+ NP KR T
Sbjct: 200 LPPMKALF-KIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAE 246
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 3e-43
Identities = 92/280 (32%), Positives = 146/280 (52%), Gaps = 42/280 (15%)
Query: 20 RTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPN 75
+ LG+G +GKV + + D+G FA+K+L+K I+ + K T K E L+ +KHP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V L + K+Y++LEY++GGELF + +G E ++ + + H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
+RDLK P ENILLD++G++K++DFGL
Sbjct: 122 IYRDLK---------------------------P--------ENILLDAQGHVKLTDFGL 146
Query: 196 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 255
+ + + HT CG+ Y+APE+L G+ G D WS G ++Y +LTG PF
Sbjct: 147 CK--ESIHEGTVTHTFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAE 203
Query: 256 NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
N KI +G LP +L+P A++LL+K+L+ NP R+
Sbjct: 204 NRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 4e-43
Identities = 83/294 (28%), Positives = 132/294 (44%), Gaps = 42/294 (14%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y+LG +G G FG V +L++G A+K + +I + I +EI LK LKHP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+V+ + + +Y++LEY G L I G E+ Q++ G++Y H +G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
V HRD+K NIL G +K++DFG
Sbjct: 120 VIHRDIKA-----------------------------------ANILTTKDGVVKLADFG 144
Query: 195 LSALPQHFRDDGLLHTTC-GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253
++ D + G+P ++APEV+ G A SDIWS G + +LTG P+
Sbjct: 145 VA---TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIELLTGNPPYY 200
Query: 254 DRN-LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
D N +A L++ + LP+ +SP ++ L + + +P R T + W
Sbjct: 201 DLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-41
Identities = 108/359 (30%), Positives = 178/359 (49%), Gaps = 74/359 (20%)
Query: 20 RTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQI--KREIATLKLLKHP 74
+ LG+G+FGKV + + D+G +A+K+L+K LK+ D++ K E L + HP
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHP 58
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+V+LH ++ K+Y++L+++ GG+LF +++ + E + + +L + + H+ G
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
+ +RDLK P ENILLD +G+IK++DFG
Sbjct: 119 IIYRDLK---------------------------P--------ENILLDEEGHIKLTDFG 143
Query: 195 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254
LS + ++ CG+ Y+APEV+ RG+ + +D WS GV+++ +LTG LPF
Sbjct: 144 LSKESID--HEKKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQG 200
Query: 255 RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWF--- 306
++ I + +P++LSP AQ+LLR + + NP R+ + IK +F
Sbjct: 201 KDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260
Query: 307 ----------EQDYTPA--NPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQL 353
+ + PA PDD + D E S P D +PG PP NA QL
Sbjct: 261 DWNKLYRREIKPPFKPAVGRPDD---TFYFDPEFTS--RTPKD---SPGIPPSANAHQL 311
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-41
Identities = 90/277 (32%), Positives = 144/277 (51%), Gaps = 39/277 (14%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVR 78
+ LG+G+FGKV A+ + +AVK+L+K+ I+ + E L L KHP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH +K +++ V+EYV GG+L I GR E R +++ G+ + H +G+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK L+N+LLDS+G+IKI+DFG+
Sbjct: 121 DLK-----------------------------------LDNVLLDSEGHIKIADFGMCK- 144
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258
+ T CG+P+Y+APE+L+ + Y G D W+ GV+LY +L G PF+ +
Sbjct: 145 -EGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDED 202
Query: 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
L+Q I + + P+WLS A+++L+ L NP KR+
Sbjct: 203 ELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 4e-41
Identities = 80/283 (28%), Positives = 129/283 (45%), Gaps = 42/283 (14%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+EL R +G+G FGKV Q D+ FA+K + K + + + E L+ L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V L + +Y+V++ + GG+L ++ K + E + + +++ + Y H+KG+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
HRD+K P +NILLD +G++ I+DF +
Sbjct: 122 IHRDIK---------------------------P--------DNILLDEQGHVHITDFNI 146
Query: 196 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD-- 253
+ D L +T G+P Y+APEVL +GY D WS GV Y L G P+
Sbjct: 147 AT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGH 202
Query: 254 DRNLAVLYQKIF-RGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
R + + D P S A + + K+LE +P KR+
Sbjct: 203 SRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 4e-41
Identities = 86/297 (28%), Positives = 133/297 (44%), Gaps = 51/297 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
YE+ T+G+G+FG V+ + G K ++ + K Q+ E+ L+ LKHPN
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPN 60
Query: 76 VVRL--HEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSY 129
+VR + S +Y+V+EY GG+L I + ++E ++ QL+ +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 130 CHNKG-----VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
CHN+ V HRDLK P NI LD+
Sbjct: 121 CHNRSDPGNTVLHRDLK---------------------------P--------ANIFLDA 145
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
N+K+ DFGL+ + H D T G+P Y++PE L + YD SDIWS G ++Y
Sbjct: 146 NNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYE 202
Query: 245 ILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGI 300
+ PF RN L KI G F ++P S +++ +L +P KR + +
Sbjct: 203 LCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 4e-40
Identities = 84/276 (30%), Positives = 136/276 (49%), Gaps = 38/276 (13%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G FGKV ++ +G +A+KIL+K II E L+ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ ++ V+EY GGELF ++ + E R +++ + Y H+ V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 140 LKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALP 199
LK LEN++LD G+IKI+DFGL
Sbjct: 121 LK-----------------------------------LENLMLDKDGHIKITDFGLCK-- 143
Query: 200 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV 259
+ D + T CG+P Y+APEVL + Y G D W GV++Y ++ G LPF +++
Sbjct: 144 EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202
Query: 260 LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
L++ I + + P+ LSP A++LL +L+ +P +R+
Sbjct: 203 LFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 5e-40
Identities = 94/332 (28%), Positives = 138/332 (41%), Gaps = 111/332 (33%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLL 71
YE LGEG +G V A+D +G A+K +I + I REI+ LK L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKEL 55
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGE-----LFDKIASKGRLQEAEGRKLFQQLIDG 126
KHPN+V+L +V+ ++ K+Y+V EY + DK L + + QL+ G
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGP--LSPNLIKSIMYQLLRG 110
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
++YCH+ + HRDLK +NIL++ G
Sbjct: 111 LAYCHSHRILHRDLK-----------------------------------PQNILINRDG 135
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVL-ANRGYDGATSD 234
+K++DFGL+ G P Y APE+L ++ Y A D
Sbjct: 136 VLKLADFGLA-------------RAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAV-D 181
Query: 235 IWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR----------------GDFK--LPKW- 274
IWS G I ++TG F D + L+ KIF+ D+K PK+
Sbjct: 182 IWSVGCIFAEMITGKPLFPGDSEIDQLF-KIFQILGTPTEESWPGVTKLPDYKPTFPKFP 240
Query: 275 ----------LSPGAQNLLRKILEPNPVKRIT 296
L P +LL K+L+ NP KRI+
Sbjct: 241 PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 9e-40
Identities = 53/116 (45%), Positives = 76/116 (65%), Gaps = 3/116 (2%)
Query: 349 NAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN-G 407
NAF LI +SS LDLSG FE+ED +R+ RFTS A++++E++E+ ++GFRV+KK G
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKEG 60
Query: 408 KLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 463
+K E + G L+V+ EVFE++PSL VVE++KS GD Y + L L
Sbjct: 61 GVK--LEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPL 114
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 9e-40
Identities = 87/301 (28%), Positives = 137/301 (45%), Gaps = 48/301 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
R++ G +G G FGKV A +LD+G AVK ++ N K +I E+ L+LLK
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLK 57
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HPN+V+ + V + K+Y+ +EY +GG L + + L E R QL++G++Y H+
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
G+ HRD+K P NI LD G IK+ D
Sbjct: 118 HGIVHRDIK---------------------------P--------ANIFLDHNGVIKLGD 142
Query: 193 FGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG--ATSDIWSCGVILYVILTG 248
FG + + + G+P Y+APEV+ G +DIWS G ++ + TG
Sbjct: 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202
Query: 249 YLPFD--DRNLAVLYQKIFRGDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAGIKADE 304
P+ D +++ +P LSP ++ L + LE +P KR T + +
Sbjct: 203 KRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHP 262
Query: 305 W 305
+
Sbjct: 263 F 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 85/275 (30%), Positives = 139/275 (50%), Gaps = 39/275 (14%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLH 80
LG+G+FGKV A+ + +A+KIL+K+ II + E L L P + +LH
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
+ ++Y V+EYV GG+L I G+ +E ++ G+ + H+KG+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 141 KVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQ 200
K L+N++LD++G+IKI+DFG+ +
Sbjct: 128 K-----------------------------------LDNVMLDAEGHIKIADFGMCK--E 150
Query: 201 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL 260
+ T CG+P+Y+APE++A + Y G + D W+ GV+LY +L G PFD + L
Sbjct: 151 NIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
Query: 261 YQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
+Q I + PK LS A ++ + +L +P KR+
Sbjct: 210 FQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 97/302 (32%), Positives = 145/302 (48%), Gaps = 45/302 (14%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
+ +G+G+FGKV A+ G +AVK+L+K I+ K + I E L K LKHP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + K+Y VL+YV GGELF + + E R ++ + Y H+ + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK ENILLDS+G++ ++DFGL
Sbjct: 121 DLKP-----------------------------------ENILLDSQGHVVLTDFGLCK- 144
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258
+ + T CG+P Y+APEVL YD T D W G +LY +L G PF R+++
Sbjct: 145 -EGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVS 202
Query: 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD---YTPANP 315
+Y I +LP + A +LL +L + +R+ G KAD ++ ++P N
Sbjct: 203 QMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL---GAKADFLEIKNHVFFSPINW 259
Query: 316 DD 317
DD
Sbjct: 260 DD 261
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 91/309 (29%), Positives = 158/309 (51%), Gaps = 57/309 (18%)
Query: 16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
+EL R LG G +GKV + + D+G +A+K+L+K I+ K + + E L+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 72 KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
+ P +V LH + +K++++L+YV GGELF + + E+E R +++ + +
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKI 190
H G+ +RD+K LENILLDS+G++ +
Sbjct: 122 HQLGIIYRDIK-----------------------------------LENILLDSEGHVVL 146
Query: 191 SDFGLSAL---PQHFRDDGLLHTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGVILYVI 245
+DFGLS + R ++ CG+ Y+APEV+ + G+D A D WS GV+ + +
Sbjct: 147 TDFGLSKEFLAEEEER----AYSFCGTIEYMAPEVIRGGSGGHDKAV-DWWSLGVLTFEL 201
Query: 246 LTGYLPF---DDRNL-AVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG-- 299
LTG PF ++N + + ++I + PK +S A++ ++K+LE +P KR+ G
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGAD 261
Query: 300 -IKADEWFE 307
IK +F+
Sbjct: 262 EIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 85/286 (29%), Positives = 138/286 (48%), Gaps = 39/286 (13%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVR 78
+ LG+G+FGKV A+ + +A+K+L+K+ I+ D E L L KHP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH +K +++ V+EYV GG+L +I + E R ++ + + H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK L+NILLD++G+ K++DFG+
Sbjct: 121 DLK-----------------------------------LDNILLDAEGHCKLADFGMCK- 144
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258
+ + T CG+P+Y+APE+L Y G + D W+ GV++Y ++ G PF+ N
Sbjct: 145 -EGILNGVTTTTFCGTPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNED 202
Query: 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304
L++ I D P WLS A ++L+ + NP KR+ + E
Sbjct: 203 DLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGE 248
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 5e-39
Identities = 94/285 (32%), Positives = 137/285 (48%), Gaps = 42/285 (14%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
+ +G+G+FGKV A+ G +AVK+L+K I+ K I E L K +KHP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + K+Y VL+YV GGELF + + E R ++ + Y H+ + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK P ENILLDS+G++ ++DFGL
Sbjct: 121 DLK---------------------------P--------ENILLDSQGHVVLTDFGLCK- 144
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258
+ T CG+P Y+APEVL + YD T D W G +LY +L G PF R+ A
Sbjct: 145 -EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTA 202
Query: 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303
+Y I +L +S A++LL +L+ + KR+ G K D
Sbjct: 203 EMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRL---GAKDD 244
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 87/290 (30%), Positives = 144/290 (49%), Gaps = 42/290 (14%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVR 78
R LG+G+FGKV A+ +SG +AVK+L+K+ I+ + E L L + HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
L+ + +++ V+E+V GG+L I R EA R ++ + + H+KG+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK L+N+LLD +G+ K++DFG+
Sbjct: 121 DLK-----------------------------------LDNVLLDHEGHCKLADFGMCK- 144
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258
+ + T CG+P+Y+APE+L Y G + D W+ GV+LY +L G+ PF+ N
Sbjct: 145 -EGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENED 202
Query: 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR---ITIAGIKADEW 305
L++ I + P WLS A ++L+ + NP R +T+ G +A
Sbjct: 203 DLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 83/293 (28%), Positives = 135/293 (46%), Gaps = 56/293 (19%)
Query: 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVL 83
G FG V A+ +G FA+K+L+K+ +I +K E A + + P V +L+
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVI 143
SK +Y+V+EY+ GG+ I + G L E ++ +++ GV H +G+ HRD+K
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK-- 124
Query: 144 LKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSA---LPQ 200
P EN+L+D G++K++DFGLS +
Sbjct: 125 -------------------------P--------ENLLIDQTGHLKLTDFGLSRNGLENK 151
Query: 201 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL 260
F G+P+Y+APE + G D SD WS G +++ L GY PF +
Sbjct: 152 KF---------VGTPDYLAPETILGVGDDKM-SDWWSLGCVIFEFLFGYPPFHAETPDAV 201
Query: 261 YQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAG---IKADEWF 306
+ I P+ + SP A +L+ ++L +P KR+ G IK+ +F
Sbjct: 202 FDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 5e-38
Identities = 103/341 (30%), Positives = 158/341 (46%), Gaps = 54/341 (15%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVR 78
+ +G+G+FGKV A+ +AVK+L+K I+ K I E LK +KHP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + K+Y VL+Y+ GGELF + + E R ++ + Y H+ + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK ENILLDS+G+I ++DFGL
Sbjct: 121 DLKP-----------------------------------ENILLDSQGHIVLTDFGLCK- 144
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258
++ +G T CG+P Y+APEVL + YD T D W G +LY +L G PF RN A
Sbjct: 145 -ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTA 202
Query: 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-------------IAGIKADEW 305
+Y I +L ++ A++LL +L+ + KR+ + I D+
Sbjct: 203 EMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDL 262
Query: 306 FEQDYTPA-NPD-DDEEDIFVDNEAFSMHEVPSDGGRTPGS 344
+ TP NP+ D+ + F+ VP+ G++P S
Sbjct: 263 INKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQSPDS 303
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 6e-38
Identities = 90/288 (31%), Positives = 142/288 (49%), Gaps = 39/288 (13%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVR 78
+ LG+G+FGKV A+ + FA+K L+K+ ++ + E L L +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
L +K ++ V+EY+ GG+L I S GR EA R ++I G+ + H KG+ +R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK L+N+LLD G+IKI+DFG+
Sbjct: 121 DLK-----------------------------------LDNVLLDKDGHIKIADFGMCK- 144
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258
++ +G T CG+P+Y+APE+L + Y+ + D WS GV+LY +L G PF +
Sbjct: 145 -ENMNGEGKASTFCGTPDYIAPEILKGQKYNESV-DWWSFGVLLYEMLIGQSPFHGEDED 202
Query: 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
L+ I P+W+S A++ L K+ E +P KR+ + G F
Sbjct: 203 ELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPF 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 8e-38
Identities = 83/276 (30%), Positives = 136/276 (49%), Gaps = 38/276 (13%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G FGKV ++ +G +A+KIL K II E L+ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ ++ V+EY GGELF ++ + E R +++ + Y H++ V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 140 LKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALP 199
+K LEN++LD G+IKI+DFGL
Sbjct: 121 IK-----------------------------------LENLMLDKDGHIKITDFGLCK-- 143
Query: 200 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV 259
+ D + T CG+P Y+APEVL + Y G D W GV++Y ++ G LPF +++
Sbjct: 144 EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202
Query: 260 LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
L++ I + + P+ LSP A++LL +L+ +P +R+
Sbjct: 203 LFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 1e-37
Identities = 87/277 (31%), Positives = 144/277 (51%), Gaps = 43/277 (15%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH---LKITDQIKREIATLKLLKHPNVVR 78
LG+G+FGKV A+ + +A+KIL+K+ +I ++ T KR +A K P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD--KPPFLTQ 65
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + ++Y V+EYV GG+L I G+ +E + ++ G+ + H +G+ +R
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYR 125
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK L+N++LDS+G+IKI+DFG+
Sbjct: 126 DLK-----------------------------------LDNVMLDSEGHIKIADFGMCK- 149
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258
+H D T CG+P+Y+APE++A + Y G + D W+ GV+LY +L G PFD +
Sbjct: 150 -EHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDED 207
Query: 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
L+Q I + PK LS A ++ + ++ +P KR+
Sbjct: 208 ELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 1e-37
Identities = 89/276 (32%), Positives = 136/276 (49%), Gaps = 38/276 (13%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G FGKV ++ SG +A+KIL+K II E LK +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+K ++ V+EYV GGELF ++ + E R +++ + Y H+ + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 140 LKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALP 199
LK LEN++LD G+IKI+DFGL
Sbjct: 121 LK-----------------------------------LENLMLDKDGHIKITDFGLCK-- 143
Query: 200 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV 259
+ D + T CG+P Y+APEVL + Y G D W GV++Y ++ G LPF +++
Sbjct: 144 EGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202
Query: 260 LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
L++ I D K P+ LS A++LL +L +P KR+
Sbjct: 203 LFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 1e-37
Identities = 90/290 (31%), Positives = 136/290 (46%), Gaps = 42/290 (14%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKRE 64
K++ M+ + RTLG G+FG+V A + P A+K EK++II K D + E
Sbjct: 22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE 81
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L + HP V L+ +S +Y+VLE+V GGE F + R G Q++
Sbjct: 82 RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV 141
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
Y + + +RDLK EN+LLD
Sbjct: 142 LIFEYLQSLNIVYRDLKP-----------------------------------ENLLLDK 166
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
G IK++DFG + + D +T CG+P Y+APE+L N G+ G +D W+ G+ +Y
Sbjct: 167 DGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYE 220
Query: 245 ILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
IL G PF ++YQKI G PK+L ++L++K+L + KR
Sbjct: 221 ILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKR 270
|
Length = 340 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 98/367 (26%), Positives = 174/367 (47%), Gaps = 66/367 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
+EL + LG G +GKV + + D+G +A+K+L+K ++ K + + E L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 72 KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
+ P +V LH +++K++++L+YV+GGE+F + + E E R ++I + +
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKI 190
H G+ +RD+K LENILLDS+G++ +
Sbjct: 122 HKLGIVYRDIK-----------------------------------LENILLDSEGHVVL 146
Query: 191 SDFGLSALPQHF--RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248
+DFGLS + F + ++ CG+ Y+APE++ +G G D WS G++++ +LTG
Sbjct: 147 TDFGLS---KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
Query: 249 YLPFD---DRNL-AVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304
PF +RN + + ++I + D P ++ P AQ+LL K+L +P KR+ A E
Sbjct: 204 ASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASE 263
Query: 305 WFEQDY---------------TPANPD-DDEEDIFVDNEAFS-MHEVPSDGGRTPGSPPL 347
E + P P +E D+ E F+ + V S G P +
Sbjct: 264 IKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGTPPSGARV 323
Query: 348 INAFQLI 354
+ +
Sbjct: 324 FQGYSFV 330
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 91/290 (31%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G+FGKV + D+ +A+K + K I+ E L + P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
S K+Y+VL ++ GGELF + +GR + R +L+ + H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 142 VILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQH 201
ENILLD +G+I + DFGL L +
Sbjct: 121 P-----------------------------------ENILLDYQGHIALCDFGLCKL--N 143
Query: 202 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 261
+DD +T CG+P Y+APE+L GY A D W+ GV+LY +LTG PF D N+ +Y
Sbjct: 144 MKDDDKTNTFCGTPEYLAPELLLGHGYTKAV-DWWTLGVLLYEMLTGLPPFYDENVNEMY 202
Query: 262 QKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFEQ 308
+KI + + P A++LL +L +P +R+ G IK +F Q
Sbjct: 203 RKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 87/317 (27%), Positives = 138/317 (43%), Gaps = 73/317 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY++ +GEG G V A+D ++G A+K + R + I +Q REI L+ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVA-LRRLEGGIPNQALREIKALQACQHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNK 133
VV+L +V S +V+EY+ L + + + R L EA+ + + L+ GV+Y H
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
G+ HRDLK P N+L+ + G +KI+DF
Sbjct: 119 GIMHRDLK---------------------------P--------ANLLISADGVLKIADF 143
Query: 194 GLSALPQHFRDDGLLHT-TCGSPNYVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLP 251
GL+ L ++ L++ + Y APE+L R YD D+W+ G I +L G
Sbjct: 144 GLARL--FSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV-DLWAVGCIFAELLNGSPL 200
Query: 252 FDDRN--------LAVL---YQKIFRGDFKLPKW-------------------LSPGAQN 281
F N L ++ + G LP + SP A +
Sbjct: 201 FPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALD 260
Query: 282 LLRKILEPNPVKRITIA 298
LL+ +L +P KR++ A
Sbjct: 261 LLKGLLVYDPSKRLSAA 277
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 4e-36
Identities = 84/278 (30%), Positives = 144/278 (51%), Gaps = 45/278 (16%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPNVV 77
LG+G+FGKV A+ + +A+KIL+K+ +I D ++ + ++L K P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALSGKPPFLT 64
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
+LH + ++Y V+EYV GG+L +I GR +E ++ G+ + H+KG+ +
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIY 124
Query: 138 RDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSA 197
RDLK L+N++LDS+G+IKI+DFG+
Sbjct: 125 RDLK-----------------------------------LDNVMLDSEGHIKIADFGMCK 149
Query: 198 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL 257
++ D T CG+P+Y+APE++A + Y G + D W+ GV+LY +L G PF+ +
Sbjct: 150 --ENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDE 206
Query: 258 AVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
L+Q I + PK +S A + + ++ +P KR+
Sbjct: 207 DELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 7e-36
Identities = 84/277 (30%), Positives = 138/277 (49%), Gaps = 39/277 (14%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G FGKV ++ +G +A+KIL+K I+ E L+ +HP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHR 138
+ ++ V+EY GGELF ++ + E R +++ + Y H+ K V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK LEN++LD G+IKI+DFGL
Sbjct: 121 DLK-----------------------------------LENLMLDKDGHIKITDFGLCK- 144
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258
+ +D + T CG+P Y+APEVL + Y G D W GV++Y ++ G LPF +++
Sbjct: 145 -EGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHE 202
Query: 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
L++ I + + P+ LSP A++LL +L+ +P +R+
Sbjct: 203 KLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 84/291 (28%), Positives = 132/291 (45%), Gaps = 48/291 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLK 72
R+ G LG G+FG V +LD G FAVK L + + Q+++EIA L L+
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HPN+V+ + +Y+ LE V GG L + G E R +Q++ G+ Y H+
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
+ HRD+K NIL+D+ G +K++D
Sbjct: 121 RNTVHRDIKG-----------------------------------ANILVDTNGVVKLAD 145
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
FG++ + + + GSP ++APEV+A +G G +DIWS G + + TG P+
Sbjct: 146 FGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW 202
Query: 253 DDRNLAVLYQKIFR-GDFK----LPKWLSPGAQNLLRKILEPNPVKRITIA 298
+F+ G K +P LS A++ + K L+ +P R T A
Sbjct: 203 SQLE---GVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAA 250
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 60/293 (20%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLLK 72
E + LG+G+ G V + +G +A+K IH+ + Q+ RE+ TL+ +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKK------IHVDGDEEFRKQLLRELKTLRSCE 57
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
P VV+ + + +I +VLEY+ GG L D + G++ E + +Q++ G+ Y H
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 133 K-GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
K + HRD+K N+L++SKG +KI+
Sbjct: 118 KRHIIHRDIK-----------------------------------PSNLLINSKGEVKIA 142
Query: 192 DFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250
DFG+S L +T G+ Y++PE + +DIWS G+ L G
Sbjct: 143 DFGISKVLEN---TLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKF 198
Query: 251 PFDDRN---LAVLYQKIFRGDFKLPKW----LSPGAQNLLRKILEPNPVKRIT 296
PF L Q I G P SP ++ + L+ +P KR +
Sbjct: 199 PFLPPGQPSFFELMQAICDGP--PPSLPAEEFSPEFRDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 84/285 (29%), Positives = 138/285 (48%), Gaps = 43/285 (15%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHL-KITDQIKREIATLKLLKH 73
+ G+ LG+G FG+V D+D+G AVK + + K + ++ EI LK L+H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+V+ + L + + +EY+ GG + D++ + G L E RK +Q+++GV Y H+
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
+ HRD+K NIL DS GN+K+ DF
Sbjct: 124 MIVHRDIKG-----------------------------------ANILRDSAGNVKLGDF 148
Query: 194 GLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
G S Q G + + G+P +++PEV++ GY G +D+WS G + +LT P+
Sbjct: 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPW 207
Query: 253 DD-RNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRKILEPNPVKR 294
+ +A ++ KI + +LP +SP A+N LR+ N KR
Sbjct: 208 AEFEAMAAIF-KIATQPTNPQLPSHVSPDARNFLRRTFVENAKKR 251
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 3e-35
Identities = 83/284 (29%), Positives = 143/284 (50%), Gaps = 45/284 (15%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPN 75
+ LG+G+FGKV A+ + FA+K L+K+ ++ + D ++ + ++L +HP
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL---MDDDVECTMVEKRVLSLAWEHPF 57
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+ L+ +K ++ V+EY+ GG+L I S + ++I G+ + H+KG+
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI 117
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
+RDLK L+NILLD+ G+IKI+DFG+
Sbjct: 118 VYRDLK-----------------------------------LDNILLDTDGHIKIADFGM 142
Query: 196 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 255
++ D T CG+P+Y+APE+L + Y + D WS GV+LY +L G PF
Sbjct: 143 CK--ENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGH 199
Query: 256 NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 299
+ L+Q I + P+WL+ A+++L K+ P +R+ + G
Sbjct: 200 DEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKG 243
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 4e-35
Identities = 87/302 (28%), Positives = 161/302 (53%), Gaps = 52/302 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
+EL + LG G +GKV + + DSG +A+K+L+K I+ K T+ + E L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 72 KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
+ P +V LH + +K++++L+Y+ GGELF ++ + R +E E + +++ + +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKI 190
H G+ +RD+K LENILLDS G++ +
Sbjct: 122 HKLGIIYRDIK-----------------------------------LENILLDSNGHVVL 146
Query: 191 SDFGLSALPQHFRDDGL--LHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVIL 246
+DFGLS + F +D + ++ CG+ Y+AP+++ + G+D A D WS GV++Y +L
Sbjct: 147 TDFGLS---KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAV-DWWSMGVLMYELL 202
Query: 247 TGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302
TG PF + + A + ++I + + P+ +S A+++++++L +P KR+ A
Sbjct: 203 TGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDA 262
Query: 303 DE 304
DE
Sbjct: 263 DE 264
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 6e-35
Identities = 97/335 (28%), Positives = 142/335 (42%), Gaps = 92/335 (27%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKLL 71
YE +GEG +G+V A++ +G A+K K R+ + K IT REI L+ L
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK---KIRMENEKEGFPIT--AIREIKLLQKL 55
Query: 72 KHPNVVRLHEVLASKSK--IYMVLEYV----TGGELFDKIASKG-RLQEAEGRKLFQQLI 124
+HPN+VRL E++ SK K IYMV EY+ TG + S + E++ + +QL+
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLL 110
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
+G+ Y H+ G+ HRD+K NIL+++
Sbjct: 111 EGLQYLHSNGILHRDIKG-----------------------------------SNILINN 135
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGVIL 242
G +K++DFGL A P R+ + Y PE+L A R Y D+WS G IL
Sbjct: 136 DGVLKLADFGL-ARPYTKRNSADYTNRVITLWYRPPELLLGATR-YGPE-VDMWSVGCIL 192
Query: 243 YVILTGYLPFDDRNLAVLYQKIFR-----------GDFKLP------------------- 272
+ G F +KIF G KLP
Sbjct: 193 AELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFF 252
Query: 273 -KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
+ P A +LL K+L +P KRI+ E+F
Sbjct: 253 KHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 89/326 (27%), Positives = 144/326 (44%), Gaps = 69/326 (21%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+E+ + +G G FG+V +D D+G +A+K+L K+ +I ++ E L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
P +V+L+ + +Y+V+EY+ GG+L + + K E R +L+ + H
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
G HRD+K P +NIL+D+ G+IK++DF
Sbjct: 121 GFIHRDIK---------------------------P--------DNILIDADGHIKLADF 145
Query: 194 GLSA---------------LPQHFRDDGLLH------------TTCGSPNYVAPEVLANR 226
GL FRD+ L+ +T G+P+Y+APEVL
Sbjct: 146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT 205
Query: 227 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLP--KWLSPGAQNL 282
Y D WS GVILY +L G+ PF L Y KI ++ + P +SP A +L
Sbjct: 206 PYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDL 264
Query: 283 LRKILEPNPVKRITIA-GIKADEWFE 307
+ ++L P R+ IK+ +F+
Sbjct: 265 ICRLLCD-PEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 5e-34
Identities = 83/293 (28%), Positives = 148/293 (50%), Gaps = 46/293 (15%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPN 75
+ LG+G+FGKV A+ G FAVK L+K+ ++ I D ++ + ++L ++P
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL---IDDDVECTMVEKRVLALAWENPF 57
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+ L+ +K ++ V+E++ GG+L I KGR +++ G+ + H+KG+
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
+RDLK L+N++LD G+IKI+DFG+
Sbjct: 118 IYRDLK-----------------------------------LDNVMLDRDGHIKIADFGM 142
Query: 196 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 255
++ D T CG+P+Y+APE+L Y + D WS GV+LY +L G PF
Sbjct: 143 CK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV-DWWSFGVLLYEMLIGQSPFHGD 199
Query: 256 NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG-IKADEWFE 307
+ L++ I P+W++ ++++L K+ E +P +R+ + G I+ +F+
Sbjct: 200 DEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 6e-34
Identities = 85/303 (28%), Positives = 131/303 (43%), Gaps = 66/303 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD-----QIKR-----E 64
+++ + LG+G++G V + VK L N+ LK D Q +R E
Sbjct: 1 DFKVLKKLGKGSYGSV-----------YKVKRLSDNQFYALKEVDLGSMSQKEREDAVNE 49
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLF 120
I L + HPN++ E +K+ +V+EY G+L I + + E E ++F
Sbjct: 50 IRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIF 109
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
QL+ G+ H + + HRDLK NI
Sbjct: 110 IQLLRGLQALHEQKILHRDLK-----------------------------------SANI 134
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240
LL + +KI D G+S + + + T G+P+Y+APEV R Y SDIWS G
Sbjct: 135 LLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGC 189
Query: 241 ILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAG 299
+LY + T PF+ R++ L K+ RG + +P S QN +R +L+ P R
Sbjct: 190 LLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDK 249
Query: 300 IKA 302
I A
Sbjct: 250 ILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 6e-34
Identities = 101/347 (29%), Positives = 158/347 (45%), Gaps = 55/347 (15%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVR 78
+ +G+G+FGKV A+ G +AVK+L+K +++ K I E LK +KHP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + K+Y VL++V GGELF + + E R ++ + Y H+ + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK ENILLDS+G++ ++DFGL
Sbjct: 121 DLKP-----------------------------------ENILLDSQGHVVLTDFGLCKE 145
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258
D T CG+P Y+APEV+ + YD T D W G +LY +L G PF R++A
Sbjct: 146 GIAQSDTTT--TFCGTPEYLAPEVIRKQPYDN-TVDWWCLGAVLYEMLYGLPPFYCRDVA 202
Query: 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI----TIAGIKADEWFEQ-DYT-- 311
+Y I L S A ++L ++LE + +R+ I+ +FE +T
Sbjct: 203 EMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDL 262
Query: 312 -------PANPD-DDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINA 350
P NP+ + +DI + F+ VP + ++NA
Sbjct: 263 EQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSD-YSIVNA 308
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 73/263 (27%), Positives = 117/263 (44%), Gaps = 49/263 (18%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G +G+V A+ D+G A+K ++K+ + L + E L K +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
+Y+ +EYV GG+ + + G L E R ++ + V H G HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 142 VILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQH 201
P EN L+D+ G+IK++DFGLS
Sbjct: 129 ---------------------------P--------ENFLIDASGHIKLTDFGLSK---- 149
Query: 202 FRDDGLL---HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258
G++ ++ GSP+Y+APEVL +GYD T D WS G +LY L G+ PF
Sbjct: 150 ----GIVTYANSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPN 204
Query: 259 VLYQKI--FRGDFKLPKWLSPGA 279
++ + ++ + P + P
Sbjct: 205 ETWENLKYWKETLQRPVYDDPRF 227
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-33
Identities = 73/259 (28%), Positives = 108/259 (41%), Gaps = 48/259 (18%)
Query: 17 ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
ELG+ LGEG FG+V + AVK L K + + E + +K L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREE-FLEEASIMKKLS 59
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
HPN+VRL V +Y+V EY+ GG+L D + +L + ++ Q+ G+ Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
+K HRDL A R N L+ +KIS
Sbjct: 120 SKNFVHRDL-----------AA--------------R----------NCLVTENLVVKIS 144
Query: 192 DFGLSALPQHFRDDGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248
DFGLS + DD G ++APE L + + SD+WS GV+L+ I T G
Sbjct: 145 DFGLS--RDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSK-SDVWSFGVLLWEIFTLG 201
Query: 249 YLPFDDRNLAVLYQKIFRG 267
P+ + + + + G
Sbjct: 202 EQPYPGMSNEEVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 81/277 (29%), Positives = 127/277 (45%), Gaps = 42/277 (15%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI---KREIATLKLLKHPNVVR 78
LG G+FGKV A+ +G +A+K L+K II + + KR T +HP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
L ++ + V+EY GG+L I E ++ G+ Y H + +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK L+N+LLD++G +KI+DFGL
Sbjct: 126 DLK-----------------------------------LDNLLLDTEGFVKIADFGLCKE 150
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258
F D T CG+P ++APEVL Y A D W GV++Y +L G PF +
Sbjct: 151 GMGFGDR--TSTFCGTPEFLAPEVLTETSYTRAV-DWWGLGVLIYEMLVGESPFPGDDEE 207
Query: 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
++ I + + P++LS A +++R++L NP +R+
Sbjct: 208 EVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 73/292 (25%), Positives = 115/292 (39%), Gaps = 60/292 (20%)
Query: 17 ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
LG+ LGEG FG+V + + AVK L+++ ++ RE ++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKLD 59
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
HPNVV+L V + +Y+V+EY+ GG+L L++ + L+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDL------LSYLRKNRPKLSLSDLLSFALQIAR 113
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
G+ Y +K HRDL N L+
Sbjct: 114 GMEYLESKNFIHRDLA-----------------------------------ARNCLVGEN 138
Query: 186 GNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYV 244
+KISDFGLS + DD P ++APE L + SD+WS GV+L+
Sbjct: 139 LVVKISDFGLSR--DLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSK-SDVWSFGVLLWE 195
Query: 245 ILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKR 294
I T G P+ + + + + G P P +L+ + +P R
Sbjct: 196 IFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 98/352 (27%), Positives = 139/352 (39%), Gaps = 105/352 (29%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT-DQIK----REIATLK 69
RYE G+ LGEG + V A+D ++G A+K K ++ K D I REI L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIK---KIKLGERKEAKDGINFTALREIKLLQ 57
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVS 128
LKHPN++ L +V KS I +V E++ +L I K L A+ + + G+
Sbjct: 58 ELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
Y H+ + HRDLK P N+L+ S G +
Sbjct: 117 YLHSNWILHRDLK---------------------------P--------NNLLIASDGVL 141
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVLANRGYDGATSDIWS 237
K++DFGL+ + GSPN Y APE+L + G D+WS
Sbjct: 142 KLADFGLA-------------RSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWS 188
Query: 238 CGVILYVILTG--YLPFDD--RNLAVLYQKIFR-----------GDFKLPKWL----SPG 278
G I +L +LP D L KIF G LP ++ P
Sbjct: 189 VGCIFAELLLRVPFLPGDSDIDQLG----KIFEALGTPTEENWPGVTSLPDYVEFKPFPP 244
Query: 279 -------------AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 317
A +LL+++L NP KRIT +F D P P
Sbjct: 245 TPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQ 296
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 75/296 (25%), Positives = 117/296 (39%), Gaps = 67/296 (22%)
Query: 17 ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLK 69
LG+ LGEG FG+V + AVK L+++ QI+ RE ++
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-----ASEQQIEEFLREARIMR 56
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID--- 125
L HPN+V+L V + + +V+EY+ GG+L L++ ++L L+
Sbjct: 57 KLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDL------LDYLRKNRPKELSLSDLLSFAL 110
Query: 126 ----GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
G+ Y +K HRDL N L
Sbjct: 111 QIARGMEYLESKNFIHRDLA-----------------------------------ARNCL 135
Query: 182 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGV 240
+ +KISDFGLS + DD P ++APE L + SD+WS GV
Sbjct: 136 VGENLVVKISDFGLSR--DLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSK-SDVWSFGV 192
Query: 241 ILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKR 294
+L+ I T G P+ + A + + + +G P P L+ + +P R
Sbjct: 193 LLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 4e-32
Identities = 79/289 (27%), Positives = 139/289 (48%), Gaps = 42/289 (14%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y + +GEG+FGK + + G + +K + +++ K ++ ++E+A L +KHP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRL-QEAEGRKLFQQLIDGVSYCHN 132
N+V+ E +Y+V++Y GG+L+ KI A +G L E + F Q+ + + H+
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
+ + HRD+K +NI L G IK+ D
Sbjct: 120 RKILHRDIKS-----------------------------------QNIFLTKDGTIKLGD 144
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
FG++ + + L T G+P Y++PE+ NR Y+ SDIW+ G +LY + T F
Sbjct: 145 FGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNN-KSDIWALGCVLYEMCTLKHAF 201
Query: 253 DDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGI 300
+ N+ L KI RG + + S +NL+ ++ + NP R ++ I
Sbjct: 202 EAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 9e-32
Identities = 90/298 (30%), Positives = 131/298 (43%), Gaps = 61/298 (20%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILE------KNRIIHLKITDQIKREIATLKLLK 72
G +G G+FG V + SG AVK +E ++ + D + REIA LK L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H N+V+ + + LEYV GG + + + G +E R +Q++ G++Y HN
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
+G+ HRD+K NIL+D+KG IKISD
Sbjct: 125 RGIIHRDIKG-----------------------------------ANILVDNKGGIKISD 149
Query: 193 FGLSALPQHFRDDGLLHTTC--------GSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
FG+S + L T GS ++APEV+ Y DIWS G ++
Sbjct: 150 FGISKKLEA----NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKA-DIWSLGCLVVE 204
Query: 245 ILTGYLPFDDRNLAVLYQKIFR-GDFKLPKW---LSPGAQNLLRKILEPNPVKRITIA 298
+LTG PF D Q IF+ G+ P+ +S A + L K E + KR T A
Sbjct: 205 MLTGKHPFPDCT---QLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAA 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 79/298 (26%), Positives = 146/298 (48%), Gaps = 53/298 (17%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVR 78
R +G G++ KV + + +A+K+++K + + D ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH ++S+++ V+E+V+GG+L + + +L E R ++ +++ H +G+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK L+N+LLD++G+IK++D+G+
Sbjct: 121 DLK-----------------------------------LDNVLLDAEGHIKLTDYGMCK- 144
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLPFD---- 253
+ R T CG+PNY+APE+L RG D G + D W+ GV+++ ++ G PFD
Sbjct: 145 -EGIRPGDTTSTFCGTPNYIAPEIL--RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGM 201
Query: 254 ----DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
D+N L+Q I ++P+ LS A ++L+ L +P +R+ G F
Sbjct: 202 SDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERL---GCHPQTGF 256
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 81/322 (25%), Positives = 132/322 (40%), Gaps = 71/322 (22%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G+ G+V + +G FA+K+L+K +I ++ E L L HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
+ +++ + +V++Y GGELF + L E R +++ + Y H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 138 RDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLS- 196
RDLK P ENILL G+I +SDF LS
Sbjct: 127 RDLK---------------------------P--------ENILLHESGHIMLSDFDLSK 151
Query: 197 --ALPQHFRDDGLLHTTCGSPN------------------------YVAPEVLANRGYDG 230
+ L + S Y+APEV++ G+
Sbjct: 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS 211
Query: 231 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--WLSPGAQNLLRKILE 288
A D W+ G++LY +L G PF N + I + + P +S A++L+RK+L
Sbjct: 212 AV-DWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLV 270
Query: 289 PNPVKRITIAG----IKADEWF 306
+P KR+ IK +F
Sbjct: 271 KDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 83/294 (28%), Positives = 134/294 (45%), Gaps = 53/294 (18%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-------HLKITDQIKREIATLKLL 71
G +G+G +G+V A ++ +G AVK +E I + ++ EI TLK L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
H N+V+ ++ + + LEYV GG + + + GR +E R +Q+++G++Y H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
+KG+ HRDLK +N+L+D+ G KIS
Sbjct: 126 SKGILHRDLKA-----------------------------------DNLLVDADGICKIS 150
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGY 249
DFG+S D+ + GS ++APEV+ + +GY A DIWS G ++ + G
Sbjct: 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYS-AKVDIWSLGCVVLEMFAGR 209
Query: 250 LPF-DDRNLAVLYQKIFRGDFKLP------KWLSPGAQNLLRKILEPNPVKRIT 296
P+ D+ +A ++ K+ P LSP A + L NP R T
Sbjct: 210 RPWSDEEAIAAMF-KLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 85/314 (27%), Positives = 139/314 (44%), Gaps = 63/314 (20%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + + G +G V + ++ FA+K + K +I Q+ E L ++P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
VV + +K + MV+EYV GG+ + + G L R F + + + Y HN G+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
HRDLK P +N+L+ S G+IK++DFGL
Sbjct: 123 VHRDLK---------------------------P--------DNLLITSMGHIKLTDFGL 147
Query: 196 SAL-----------------PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 238
S + + F D + CG+P Y+APEV+ +GY G D W+
Sbjct: 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQV----CGTPEYIAPEVILRQGY-GKPVDWWAM 202
Query: 239 GVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW---LSPGAQNLLRKILEPNPVKRI 295
G+ILY L G +PF L+ ++ D + P+ L AQ+L+ ++L NP++R+
Sbjct: 203 GIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERL 262
Query: 296 TIAG---IKADEWF 306
G +K +F
Sbjct: 263 GTGGAFEVKQHRFF 276
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 80/298 (26%), Positives = 123/298 (41%), Gaps = 58/298 (19%)
Query: 20 RTLGEGNFGKVKFA---QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+ LGEG FG+V AVK L K + D +E +K L HPNV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKD-FLKEARVMKKLGHPNV 58
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLID-------GV 127
VRL V + +Y+VLEY+ GG+L D + + + + + L+ G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
Y +K HRDL A R N L+
Sbjct: 119 EYLASKKFVHRDL-----------AA--------------R----------NCLVGEDLV 143
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCG-SPN-YVAPEVLANRGYDGATSDIWSCGVILYVI 245
+KISDFGLS + DD T G P ++APE L + + SD+WS GV+L+ I
Sbjct: 144 VKISDFGLS--RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEI 200
Query: 246 LT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 300
T G P+ + + + + +G ++L P++ L+ + +P R T + +
Sbjct: 201 FTLGATPYPGLSNEEVLEYLRKG-YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 78/286 (27%), Positives = 141/286 (49%), Gaps = 48/286 (16%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
R +G G++ KV + + +A+K+++K + + D ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH ++S+++ V+EYV GG+L + + +L E R ++ ++Y H +G+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK L+N+LLDS+G+IK++D+G+
Sbjct: 121 DLK-----------------------------------LDNVLLDSEGHIKLTDYGMCK- 144
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD----- 253
+ R T CG+PNY+APE+L Y G + D W+ GV+++ ++ G PFD
Sbjct: 145 -EGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSS 202
Query: 254 ---DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
D+N L+Q I ++P+ LS A ++L+ L +P +R+
Sbjct: 203 DNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 83/283 (29%), Positives = 129/283 (45%), Gaps = 43/283 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y + R +GEG+FG+ Q ++S +A+K + + + ++E L +KHP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS--AVEDSRKEAVLLAKMKHP 58
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRL-QEAEGRKLFQQLIDGVSYCHN 132
N+V E + +Y+V+EY GG+L KI +G+L E + F Q+ GV + H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
K V HRD+K +NI L G +K+ D
Sbjct: 119 KRVLHRDIKS-----------------------------------KNIFLTQNGKVKLGD 143
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
FG + L T G+P YV PE+ N Y+ SDIWS G ILY + T PF
Sbjct: 144 FGSARLLTS--PGAYACTYVGTPYYVPPEIWENMPYNN-KSDIWSLGCILYELCTLKHPF 200
Query: 253 DDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKR 294
+ L K+ +G +K LP S ++L++++ + NP R
Sbjct: 201 QANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-29
Identities = 72/283 (25%), Positives = 128/283 (45%), Gaps = 44/283 (15%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ +G+G+FG V +A+K ++ +++ + + I E L L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSSY 60
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNK 133
++R +E K K+ +V+EY G+L + L E + + F Q++ G+++ H+K
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
+ HRD+K + N+ LD+ N+KI D
Sbjct: 121 KILHRDIKSL-----------------------------------NLFLDAYDNVKIGDL 145
Query: 194 GLSALPQHFRDDGLL-HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
G++ L D+ +T G+P Y++PE+ ++ Y+ SD+W+ GV+LY TG PF
Sbjct: 146 GVAKL---LSDNTNFANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPF 201
Query: 253 DDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKR 294
D N L KI RG F + + S L+ + L + +R
Sbjct: 202 DANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 78/318 (24%), Positives = 119/318 (37%), Gaps = 75/318 (23%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK---ILEKNRIIHLKITDQIKREIATLKL 70
+YE+ +GEG +G V ++ +G A+K E + + RE+ L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL----REVKVLRQ 56
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
L+H N+V L E K ++Y+V EYV L AS G L R QL+ ++YC
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKI 190
H+ + HRD+K P ENIL+ G +K+
Sbjct: 117 HSHNIIHRDIK---------------------------P--------ENILVSESGVLKL 141
Query: 191 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI--------- 241
DFG A R L + Y APE+L G D+W+ G I
Sbjct: 142 CDFGF-ARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200
Query: 242 ----------LYVILTGYLPFDDRNLAVLYQ-KIFRG------------DFKLPKWLSPG 278
LY+I P + + F G + + P +S
Sbjct: 201 LFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSP 260
Query: 279 AQNLLRKILEPNPVKRIT 296
A + L+ L +P +R+T
Sbjct: 261 ALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 82/279 (29%), Positives = 133/279 (47%), Gaps = 43/279 (15%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQI-KREIATLKLLKH-PNVVR 78
+G+G FG+V + D+ +A+K+L K I+ K + I +R I LL P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
L + S +Y+V +Y++GGELF + +GR E + +L+ + + H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK ENILLD+ G+I + DFGLS
Sbjct: 121 DLKP-----------------------------------ENILLDATGHIALCDFGLSK- 144
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNL 257
+ D+ +T CG+ Y+APEVL + +GY D WS GV+++ + G+ PF +
Sbjct: 145 -ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKHVDFWSLGVLVFEMCCGWSPFYAEDT 202
Query: 258 AVLYQKIFRGDFKLPK-WLSPGAQNLLRKILEPNPVKRI 295
+Y+ I G + PK LS + ++ +L NP R+
Sbjct: 203 QQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 76/283 (26%), Positives = 129/283 (45%), Gaps = 54/283 (19%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+GEG G+V A D +G A+K L K + I EI +K KHPN+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK------ELIINEILIMKDCKHPNIVDY 80
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
++ ++++V+EY+ GG L D I + R+ E + + ++++ G+ Y H++ V HR
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR 140
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
D+K +NILL G++K++DFG +A
Sbjct: 141 DIKS-----------------------------------DNILLSKDGSVKLADFGFAAQ 165
Query: 199 --PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDR 255
+ + ++ G+P ++APEV+ + Y DIWS G++ + G P +
Sbjct: 166 LTKEKSKR----NSVVGTPYWMAPEVIKRKDYGPKV-DIWSLGIMCIEMAEGEPPYLREP 220
Query: 256 NLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRIT 296
L L+ +G K P+ SP ++ L K L +P KR +
Sbjct: 221 PLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 82/289 (28%), Positives = 127/289 (43%), Gaps = 45/289 (15%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V Q +G +A K L+K R+ K E L+ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRD 139
+K + +V+ + GG+L I + G E R +F Q+I G+ + H + + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 140 LKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALP 199
LK P EN+LLD GN++ISD GL+
Sbjct: 121 LK---------------------------P--------ENVLLDDHGNVRISDLGLAV-- 143
Query: 200 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV 259
+ + G+P Y+APEVL YD + D ++ G LY ++ G PF R V
Sbjct: 144 -ELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKV 201
Query: 260 ----LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304
L ++ + P SP A++L +L+ +P KR+ G ADE
Sbjct: 202 EKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADE 250
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 74/284 (26%), Positives = 139/284 (48%), Gaps = 46/284 (16%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVR 78
R +G G++ KV + + +A+K+++K + + D ++ E + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + S++++V+EYV GG+L + + +L E R ++ +++ H +G+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK L+N+LLD+ G+IK++D+G+
Sbjct: 121 DLK-----------------------------------LDNVLLDADGHIKLTDYGMCK- 144
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD----- 253
+ T CG+PNY+APE+L Y G + D W+ GV+++ ++ G PFD
Sbjct: 145 -EGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDN 202
Query: 254 -DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
D N L+Q I ++P++LS A ++L+ L +P +R+
Sbjct: 203 PDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 86/335 (25%), Positives = 128/335 (38%), Gaps = 85/335 (25%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+T+G G FG+V + +D+ +A+K L K ++ +K E L + VV+L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ K +Y V++Y+ GG++ + G +E R +L + H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 140 LKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSA-- 197
+K P +NIL+D G+IK++DFGL
Sbjct: 127 IK---------------------------P--------DNILIDRDGHIKLTDFGLCTGF 151
Query: 198 ----------LPQHFRDDG-----------------------------LLHTTCGSPNYV 218
H R D L H+ G+PNY+
Sbjct: 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYI 211
Query: 219 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLPKW-- 274
APEVL GY D WS GVILY +L G PF A K+ + +P
Sbjct: 212 APEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAK 270
Query: 275 LSPGAQNLLRKILEPNPVKRI---TIAGIKADEWF 306
LS A +L+ + L R+ IKA +F
Sbjct: 271 LSREASDLILR-LCCGAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-28
Identities = 78/293 (26%), Positives = 122/293 (41%), Gaps = 44/293 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+YE R +G G FG V + +K + ++ + E LKLL HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHN 132
N++ +E + +V+EY GG L + I + L E F Q++ + + H
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI-KIS 191
K + HRDLK +NILLD + KI
Sbjct: 120 KLILHRDLKT-----------------------------------QNILLDKHKMVVKIG 144
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
DFG+S + +T G+P Y++PE+ + Y+ SDIW+ G +LY + +
Sbjct: 145 DFGISKI---LSSKSKAYTVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRA 200
Query: 252 FDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303
F+ NL L KI G F + SP + L+ +L +P KR ++ I A
Sbjct: 201 FEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 92/335 (27%), Positives = 150/335 (44%), Gaps = 80/335 (23%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + +G G FG+V+ Q D+G +A+K L K+ ++ + ++ E L +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
VV+L+ ++ +Y+++EY+ GG++ + K E E R + I + H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
HRD+K P +N+LLD+KG+IK+SDFGL
Sbjct: 123 IHRDIK---------------------------P--------DNLLLDAKGHIKLSDFGL 147
Query: 196 S-----------------ALPQHFRDD-------------------GLLHTTCGSPNYVA 219
ALP +F D L ++T G+P+Y+A
Sbjct: 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIA 207
Query: 220 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLPK--WL 275
PEV GY D WS GVI+Y +L GY PF N Y+KI ++ + P L
Sbjct: 208 PEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPL 266
Query: 276 SPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 307
SP A++L++++ +R+ G IK+ +F+
Sbjct: 267 SPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 82/315 (26%), Positives = 124/315 (39%), Gaps = 76/315 (24%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKH 73
Y+ +GEG +G V A+D +G A+K K ++ REI LK L H
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIK---KIKLRFESEGIPKTALREIKLLKELNH 57
Query: 74 PNVVRLHEVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
PN+++L +V K +Y+V E++ T K +G L E+ + QL+ G+++CH+
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHS 116
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
G+ HRDLK P EN+L++++G +K++D
Sbjct: 117 HGILHRDLK---------------------------P--------ENLLINTEGVLKLAD 141
Query: 193 FGLSALPQHFRDDGLLHTTCGSPN-YVAPEVLANRGYDGATSDIWSCGVILYVILTG--Y 249
FGL+ F +T Y APE+L DIWS G I +L+
Sbjct: 142 FGLARS---FGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPL 198
Query: 250 LPFDD-----------------RNLAVLYQKIFRGDFKLPKW-----------LSPGAQN 281
P F PK SP A +
Sbjct: 199 FPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALD 258
Query: 282 LLRKILEPNPVKRIT 296
LL ++L +P KRIT
Sbjct: 259 LLSQMLHYDPHKRIT 273
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 71/287 (24%), Positives = 124/287 (43%), Gaps = 47/287 (16%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVK---ILEKNRIIHLKITDQIKREIATLKLLKHPN 75
G+ LG G F A+D+ +G AVK + ++ + +++EI + L HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
++R+ S + +E++ GG + ++ G +EA +QL+ G+SY H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN-IKISDFG 194
HRD+K N+L+DS G ++I+DFG
Sbjct: 125 IHRDVKG-----------------------------------ANLLIDSTGQRLRIADFG 149
Query: 195 LSA-LPQHFRDDGLLH-TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
+A L G G+ ++APEVL Y G + D+WS G ++ + T P+
Sbjct: 150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPW 208
Query: 253 DDRNLAVLYQKIFR-----GDFKLPKWLSPGAQNLLRKILEPNPVKR 294
+ + IF+ +P+ LSPG +++ + LE P R
Sbjct: 209 NAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDR 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 73/285 (25%), Positives = 125/285 (43%), Gaps = 51/285 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+++ LGEG++G V A ++G A+K++ + +I +EI+ LK P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-----EIIKEISILKQCDSPY 59
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+V+ + + +++V+EY G + D KI +K L E E + Q + G+ Y H+
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSN 118
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
HRD+K NILL+ +G K++DF
Sbjct: 119 KKIHRDIKA-----------------------------------GNILLNEEGQAKLADF 143
Query: 194 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253
G+S Q +T G+P ++APEV+ GY+ DIWS G+ + G P+
Sbjct: 144 GVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKA-DIWSLGITAIEMAEGKPPYS 200
Query: 254 D----RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
D R + ++ K P+ SP + ++K L +P +R
Sbjct: 201 DIHPMRAIFMIPNKPPPT-LSDPEKWSPEFNDFVKKCLVKDPEER 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 83/294 (28%), Positives = 142/294 (48%), Gaps = 51/294 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RYE+ + +GEG+FGK+ A+ +K ++ ++ +K + K+E+ L +KHP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL--FQQLIDGVSYCHN 132
N+V ++++V+EY GG+L +I + + +E + L F Q+ G+ + H+
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI-KIS 191
+ + HRD+K +NI L G + K+
Sbjct: 120 RKILHRDIKS-----------------------------------QNIFLSKNGMVAKLG 144
Query: 192 DFGLSALPQHFRDDGLLHTTC-GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250
DFG++ + D L TC G+P Y++PE+ NR Y+ T DIWS G +LY + T
Sbjct: 145 DFGIA---RQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKT-DIWSLGCVLYELCTLKH 200
Query: 251 PFDDRNLAVLYQKIFRGDFKLPKWLSPG----AQNLLRKILEPNPVKRITIAGI 300
PF+ NL L KI +G F P +SP ++L+ ++ + +P R +I I
Sbjct: 201 PFEGNNLHQLVLKICQGYFA-P--ISPNFSRDLRSLISQLFKVSPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 91/353 (25%), Positives = 134/353 (37%), Gaps = 105/353 (29%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKL 70
+L YE+ LGEG FG+V A+ + +G A+K IL N IT REI LK
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL--REIKILKK 63
Query: 71 LKHPNVVRLHEVLASKSK--------IYMVLEYVT---GGELFDKIASKGRLQEAEGRKL 119
LKHPNVV L ++ + +YMV Y+ G L + +L E++ +
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP---SVKLTESQIKCY 120
Query: 120 FQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179
QL++G++Y H + HRD+K N
Sbjct: 121 MLQLLEGINYLHENHILHRDIKA-----------------------------------AN 145
Query: 180 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------------YVAPE-VLANR 226
IL+D++G +KI+DFGL+ + + G Y PE +L R
Sbjct: 146 ILIDNQGILKIADFGLA---RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER 202
Query: 227 GYDGATSDIWSCGVILYVILTG--YLP-FDDRNLAVLYQKIFR-----GDFKLPKWLS-P 277
Y A DIW G + + T L D + IF+ + P W S P
Sbjct: 203 RYTTAV-DIWGIGCVFAEMFTRRPILQGKSDIDQL---HLIFKLCGTPTEETWPGWRSLP 258
Query: 278 GAQN------------------------LLRKILEPNPVKRITIAGIKADEWF 306
G + LL K+L +P KR+T + +F
Sbjct: 259 GCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 88/301 (29%), Positives = 134/301 (44%), Gaps = 66/301 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--------EKNRIIHLKITDQIKREIA 66
+Y + R LG G G V A+ + G PFAVK++ +KNR + E+
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA---------QAEVC 83
Query: 67 TLKLLKHPNVVRLHEVLASK--------SKIYMVLEYVTGGELFDKIASKGR----LQEA 114
L ++V+ HE A K I +VL+Y G+L +I S+ + +E
Sbjct: 84 CLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREH 143
Query: 115 EGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174
E LF Q++ V + H+K + HRD+K
Sbjct: 144 EAGLLFIQVLLAVHHVHSKHMIHRDIKS-------------------------------- 171
Query: 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234
NILL S G +K+ DFG S + D + T CG+P YVAPE+ + Y +D
Sbjct: 172 ---ANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKAD 227
Query: 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVK 293
++S GV+LY +LT PFD N+ + K G + LP +SP Q ++ +L +P +
Sbjct: 228 MFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKR 287
Query: 294 R 294
R
Sbjct: 288 R 288
|
Length = 496 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-27
Identities = 81/297 (27%), Positives = 134/297 (45%), Gaps = 56/297 (18%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR---EIATLKLLKHPNVVR 78
LG+G FGKV AQ ++GL A KI I ++ ++++ EI L KHPN+V
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKI------IQIESEEELEDFMVEIDILSECKHPNIVG 66
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFH 137
L+E ++K+++++E+ GG L + R L E + R + +Q+++ +++ H+ V H
Sbjct: 67 LYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIH 126
Query: 138 RDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSA 197
RDLK NILL G++K++DFG+SA
Sbjct: 127 RDLKA-----------------------------------GNILLTLDGDVKLADFGVSA 151
Query: 198 LPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYVILTGYLPF 252
+ T G+P ++APEV+A + YD +DIWS G+ L + P
Sbjct: 152 KNKS--TLQKRDTFIGTPYWMAPEVVACETFKDNPYD-YKADIWSLGITLIELAQMEPPH 208
Query: 253 DDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
+ N + KI + + P S + L+ L +P R T A + +
Sbjct: 209 HELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 81/297 (27%), Positives = 131/297 (44%), Gaps = 48/297 (16%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
LG +++ + +G+G F V A L G A+K ++ ++ K +EI LK L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGEL---FDKIASKGRL-QEAEGRKLFQQLIDGVS 128
HPNV++ +++ +VLE G+L + RL E K F QL +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
+ H+K + HRD+K P N+ + + G +
Sbjct: 121 HMHSKRIMHRDIK---------------------------P--------ANVFITATGVV 145
Query: 189 KISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
K+ D GL + F H+ G+P Y++PE + GY+ SDIWS G +LY +
Sbjct: 146 KLGDLGLG---RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAA 201
Query: 248 GYLPF--DDRNLAVLYQKIFRGDFK-LPK-WLSPGAQNLLRKILEPNPVKRITIAGI 300
PF D NL L +KI + D+ LP S ++L+ + + P+P KR I+ +
Sbjct: 202 LQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 85/298 (28%), Positives = 135/298 (45%), Gaps = 64/298 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLK 69
YEL + +G G +G V A+D+ +G A+K++ K+ I++EI+ LK
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI--------KLEPGDDFEIIQQEISMLK 55
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVS 128
+HPN+V + K+++V+EY GG L D ++G L E + + ++ + G++
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
Y H G HRD+K NILL G++
Sbjct: 116 YLHETGKIHRDIKG-----------------------------------ANILLTEDGDV 140
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVI 245
K++DFG+SA Q + G+P ++APEV A GYDG DIW+ G+ +
Sbjct: 141 KLADFGVSA--QLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGK-CDIWALGITAIEL 197
Query: 246 LTGYLP-FDDRNLAVLYQKIFRGDFKLP------KWLSPGAQNLLRKILEPNPVKRIT 296
P FD + L+ I + +F P KW SP + ++K L +P KR T
Sbjct: 198 AELQPPMFDLHPMRALFL-ISKSNFPPPKLKDKEKW-SPVFHDFIKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 91/318 (28%), Positives = 135/318 (42%), Gaps = 94/318 (29%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ------IKREIATLKLLKHPN 75
+GEG +G V A+D +G A+K I L+ D+ I REI+ LK L HPN
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKK------IRLETEDEGVPSTAI-REISLLKELNHPN 59
Query: 76 VVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+VRL +V+ S++K+Y+V E++ + D G L + QL+ G++YCH+
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSH 118
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
V HRDLK P +N+L+D +G +K++DF
Sbjct: 119 RVLHRDLK---------------------------P--------QNLLIDREGALKLADF 143
Query: 194 GLSALPQHFRDDGL-----LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248
GL+ R G+ H + Y APE+L DIWS G I ++
Sbjct: 144 GLA------RAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR 196
Query: 249 YLPF-DDRNLAVLYQKIFR----------------GDFK--LPKW-----------LSPG 278
F D + L+ +IFR D+K PKW L
Sbjct: 197 RPLFPGDSEIDQLF-RIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDED 255
Query: 279 AQNLLRKILEPNPVKRIT 296
+LL K+L +P KRI+
Sbjct: 256 GLDLLSKMLVYDPAKRIS 273
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 79/279 (28%), Positives = 130/279 (46%), Gaps = 43/279 (15%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--EKNRIIHLKITDQIKREIATLKLLKH 73
+ LG+ LG G FG+V D D+G AVK + + + K + ++ EI LK L+H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 74 PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+V+ + L + K+ + +EY+ GG + D++ + G L E R+ +Q++ GVSY H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
+ + HRD+K NIL DS GN+K+
Sbjct: 124 SNMIVHRDIKG-----------------------------------ANILRDSAGNVKLG 148
Query: 192 DFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250
DFG S Q G + + G+P +++PEV++ GY G +D+WS + +LT
Sbjct: 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKP 207
Query: 251 PFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNLLRKIL 287
P+ + KI K LP +S ++ L++I
Sbjct: 208 PWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 90/326 (27%), Positives = 139/326 (42%), Gaps = 90/326 (27%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLLKHPNVV 77
LGEG + V ++ +G A+K IHL + REI+ +K LKH N+V
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKE------IHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 78 RLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
RLH+V+ +++K+ +V EY+ + D +G L + QL+ G+++CH V
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
HRDLK P +N+L++ +G +K++DFGL
Sbjct: 122 LHRDLK---------------------------P--------QNLLINKRGELKLADFGL 146
Query: 196 SALPQHFRDDGLLHTTCGSPN----YVAPEVL-ANRGYDGATS-DIWSCGVILYVILTGY 249
+ R G+ T + Y AP+VL +R Y +TS DIWS G I+ ++TG
Sbjct: 147 A------RAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY--STSIDIWSVGCIMAEMITGR 198
Query: 250 LPFDDRNLAVLYQKIFR-----------GDFKLPKW------------------LSPGAQ 280
F N KIFR G +LP++ P
Sbjct: 199 PLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGI 258
Query: 281 NLLRKILEPNPVKRITIAGIKADEWF 306
+LL ++L+ NP RI+ WF
Sbjct: 259 DLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 87/336 (25%), Positives = 131/336 (38%), Gaps = 110/336 (32%)
Query: 24 EGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-------REIATLKLLKHPNV 76
EG +G V A+D +G A+K LK+ + + REI L L+HPN+
Sbjct: 15 EGTYGVVYRARDKKTGEIVALK--------KLKMEKEKEGFPITSLREINILLKLQHPNI 66
Query: 77 VRLHEVLASKS--KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNK 133
V + EV+ + KIYMV+EYV +L + + K ++E + L QL+ GV++ H+
Sbjct: 67 VTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
+ HRDLK N+LL+++G +KI DF
Sbjct: 126 WILHRDLK-----------------------------------TSNLLLNNRGILKICDF 150
Query: 194 GLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVLANRGYDGATSDIWSCGVIL 242
GL+ R+ GSP Y APE+L D+WS G I
Sbjct: 151 GLA------RE-------YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIF 197
Query: 243 YVILTGYLPFDDRNLAVLYQKIFR-----------GDFKLPKW----------------- 274
+LT F ++ KIF+ G +LP
Sbjct: 198 AELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKF 257
Query: 275 ----LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
LS +LL ++L +P KRI+ +F
Sbjct: 258 PALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 66/245 (26%), Positives = 110/245 (44%), Gaps = 51/245 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLK 69
+ L +G+G+FG+V A D + A+K+ I L+ I D I++EI L
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV------IDLEEAEDEIED-IQQEIQFLS 54
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
+ P + + + SK+++++EY GG D + G+L E + ++++ G+ Y
Sbjct: 55 QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEY 113
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
H +G HRD+K NILL +G++K
Sbjct: 114 LHEEGKIHRDIK-----------------------------------AANILLSEEGDVK 138
Query: 190 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249
++DFG+S Q +T G+P ++APEV+ GYD +DIWS G+ + G
Sbjct: 139 LADFGVSG--QLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGE 195
Query: 250 LPFDD 254
P D
Sbjct: 196 PPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 77/276 (27%), Positives = 131/276 (47%), Gaps = 43/276 (15%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILE--KNRIIHLKITDQIKREIATLKLLKHPNV 76
G+ LG+G FG+V D+D+G A K ++ K ++ EI LK L+H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 77 VRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
V+ + L +++ + + +EY+ GG + D++ + G L E+ RK +Q+++G+SY H+
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
+ HRD+K NIL DS GN+K+ DFG
Sbjct: 127 IVHRDIKG-----------------------------------ANILRDSAGNVKLGDFG 151
Query: 195 LSALPQHFRDDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253
S Q G + + G+P +++PEV++ GY G +D+WS G + +LT P+
Sbjct: 152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWA 210
Query: 254 DRNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRKIL 287
+ KI + +LP +S A++ L I
Sbjct: 211 EYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 79/279 (28%), Positives = 135/279 (48%), Gaps = 43/279 (15%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN--RIIHLKITDQIKREIATLKLLKH 73
+ LG+ LG+G FG+V D D+G AVK ++ + K + ++ EI LK L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 74 PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+V+ + L + + + +E++ GG + D++ S G L E RK +Q+++GVSY H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
+ + HRD+K NIL DS GN+K+
Sbjct: 124 SNMIVHRDIKG-----------------------------------ANILRDSVGNVKLG 148
Query: 192 DFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250
DFG S Q G + + G+P +++PEV++ GY G +DIWS G + +LT
Sbjct: 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKP 207
Query: 251 PFDD-RNLAVLYQKIFR-GDFKLPKWLSPGAQNLLRKIL 287
P+ + +A +++ + + LP +S ++ L++I
Sbjct: 208 PWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 81/298 (27%), Positives = 129/298 (43%), Gaps = 60/298 (20%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKH 73
YEL +G G V A L + A+K LEK + D++++E+ + H
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS----VDELRKEVQAMSQCNH 58
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYC 130
PNVV+ + ++++V+ Y++GG L D + S G L EA + ++++ G+ Y
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKI 190
H+ G HRD+K NILL G++KI
Sbjct: 119 HSNGQIHRDIKA-----------------------------------GNILLGEDGSVKI 143
Query: 191 SDFGLSALPQHFRDDG-----LLHTTCGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYV 244
+DFG+SA D G + T G+P ++APEV+ GYD +DIWS G+
Sbjct: 144 ADFGVSAS---LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD-FKADIWSFGITAIE 199
Query: 245 ILTGYLPFDD-RNLAVLYQKIFRGDFKLP-----KWLSPGAQNLLRKILEPNPVKRIT 296
+ TG P+ + VL + L K S + ++ L+ +P KR T
Sbjct: 200 LATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 84/319 (26%), Positives = 138/319 (43%), Gaps = 76/319 (23%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+GEG +G V A++ +G A+K + + + I REI+ LK L HPN+V+L +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 66
Query: 82 VLASKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
V+ +++K+Y+V E++ + F + + + QL+ G+++CH+ V HRDL
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126
Query: 141 KVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQ 200
K P +N+L++++G IK++DFGL+
Sbjct: 127 K---------------------------P--------QNLLINTEGAIKLADFGLA---- 147
Query: 201 HFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDD 254
R G+ T Y APE+L Y DIWS G I ++T P D
Sbjct: 148 --RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205
Query: 255 ---------RNLAVLYQKIFRG-----DFK--LPKW-----------LSPGAQNLLRKIL 287
R L + ++ G D+K PKW L ++LL ++L
Sbjct: 206 EIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQML 265
Query: 288 EPNPVKRITIAGIKADEWF 306
+P KRI+ A +F
Sbjct: 266 HYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 86/317 (27%), Positives = 145/317 (45%), Gaps = 64/317 (20%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI----KREIA 66
M+ +++ + +G G FG+V+ + S +A+K+L K +I K +D +R+I
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI--KRSDSAFFWEERDI- 96
Query: 67 TLKLLKHPN---VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
+ H N +V+LH +YMV+EY+ GG+L + + S + E R ++
Sbjct: 97 ----MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEV 151
Query: 124 IDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD 183
+ + H+ G HRD+K P +N+LLD
Sbjct: 152 VLALDAIHSMGFIHRDVK---------------------------P--------DNMLLD 176
Query: 184 SKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVLANRGYD---GATSDIWSC 238
G++K++DFG +G++ T G+P+Y++PEVL ++G D G D WS
Sbjct: 177 KSGHLKLADFGTCM---KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 239 GVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLPK--WLSPGAQNLLRKILEPNPVK- 293
GV LY +L G PF +L Y KI + P +S A++L+ L V+
Sbjct: 234 GVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRL 293
Query: 294 -RITIAGIKADEWFEQD 309
R + IK+ +F+ D
Sbjct: 294 GRNGVDEIKSHPFFKND 310
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 66/239 (27%), Positives = 108/239 (45%), Gaps = 62/239 (25%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-REI-ATLKLLKH 73
Y++ + LG+G FG V A++ ++G A+K + K + + + + RE+ + KL +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWE--ECMNLREVKSLRKLNEH 57
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGR-LQEAEGRKLFQQLIDGVSYCH 131
PN+V+L EV ++Y V EY+ G L+ + KG+ E+ R + Q++ G+++ H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
G FHRDLK P EN+L+ +KI+
Sbjct: 117 KHGFFHRDLK---------------------------P--------ENLLVSGPEVVKIA 141
Query: 192 DFGLSALPQHFRDDGLLHTTCGSP--NYV------APEVLANRGYDGATSDIWSCGVIL 242
DFGL+ R P +YV APE+L + DIW+ G I+
Sbjct: 142 DFGLA------R-----EIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIM 189
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 95/347 (27%), Positives = 132/347 (38%), Gaps = 103/347 (29%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+TLG G FG+V A+ +D+ +A+K L K ++ +K E L + VVRL
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ K +Y V++Y+ GG++ + G E R +L V H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 140 LKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL---- 195
+K +NIL+D G+IK++DFGL
Sbjct: 127 IKP-----------------------------------DNILIDRDGHIKLTDFGLCTGF 151
Query: 196 -----SALPQ---HFRDDG---------------------------------LLHTTCGS 214
S Q H R D L H+ G+
Sbjct: 152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGT 211
Query: 215 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW 274
PNY+APEVL GY D WS GVILY +L G PF L Q K+ W
Sbjct: 212 PNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPF-------LAQTPLETQMKVINW 263
Query: 275 -----------LSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 307
LSP A +L+ K+ P R+ G IKA +F+
Sbjct: 264 QTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKAHPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 68/292 (23%), Positives = 124/292 (42%), Gaps = 50/292 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ L R LG G FG+V + + A+KIL+ + ++ ++E+ LK L+H +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQ---QDFQKEVQALKRLRHKH 63
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGR-LQEAEGRKLFQQLIDGVSYCHNK 133
++ L V + +Y++ E + G L + S +G+ L A + Q+ +G++Y +
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
HRDL NIL+ K++DF
Sbjct: 124 NSIHRDLAA-----------------------------------RNILVGEDLVCKVADF 148
Query: 194 GLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLP 251
GL+ L ++D L + P + APE A+ G SD+WS G++LY + T G +P
Sbjct: 149 GLARL---IKEDVYLSSDKKIPYKWTAPEA-ASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
Query: 252 FDDRNLAVLYQKIFRGDFKLPKWLS--PGAQNLLRKILEPNPVKRITIAGIK 301
+ N +Y +I G +++P ++ + P R + ++
Sbjct: 205 YPGMNNHEVYDQITAG-YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 86/294 (29%), Positives = 132/294 (44%), Gaps = 48/294 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI--TDQIKREIATLKLLK 72
RY L + LG+G+FG V +D + +K+L++ + L T Q +E L L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVS 128
HP +V+ H + ++ EY G +L K+ + L E + + F QL+ GV
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
Y H + + HRDLK +NI L K N+
Sbjct: 121 YMHQRRILHRDLKA-----------------------------------KNIFL--KNNL 143
Query: 189 -KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
KI DFG+S L D L T G+P Y++PE L ++GYD + SDIWS G ILY +
Sbjct: 144 LKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCC 200
Query: 248 GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGI 300
F+ +N + +I G LP+ S ++++ +L +P R + A I
Sbjct: 201 LAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-24
Identities = 77/270 (28%), Positives = 118/270 (43%), Gaps = 49/270 (18%)
Query: 37 DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL-HEVLASKSKIYMVLEY 95
+G A+K+L + + +RE A L HPN+V L A ++ V EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQ 155
V G L + +A+ G L E +L Q++D ++ HN+G+ HRDLK
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLK-------------- 106
Query: 156 VFLLTFLLMIVIRPWKFNVLQLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTT- 211
P +NI++ G + K+ DFG+ L RD + T
Sbjct: 107 -------------P--------QNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTR 145
Query: 212 ----CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFR 266
G+P Y APE L SD+++ G+I LTG ++A +LYQ++
Sbjct: 146 TTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSP 204
Query: 267 GDFKLPKWLS--PGAQNLLRKILEPNPVKR 294
D LP W++ P Q +LRK L +P +R
Sbjct: 205 VDVSLPPWIAGHPLGQ-VLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 87/328 (26%), Positives = 135/328 (41%), Gaps = 91/328 (27%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKH 73
+++ +GEG +G+V A+D D+G A+K K R+ + K I REI L+ L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQLNH 65
Query: 74 PNVVRLHEVLASKSK----------IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQ 122
N+V L E++ K Y+V EY+ +L + S E + +Q
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
L++G++YCH K HRD+K C NILL
Sbjct: 125 LLEGLNYCHKKNFLHRDIK-----C------------------------------SNILL 149
Query: 183 DSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDIWSCGVI 241
++KG IK++DFGL+ L + ++ +T + Y PE+L G D+WSCG I
Sbjct: 150 NNKGQIKLADFGLARL--YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 207
Query: 242 LYVILTGYLPFD-DRNLAVL--------------------------------YQKIFRGD 268
L + T F ++ LA L Y++ R +
Sbjct: 208 LGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE 267
Query: 269 FKLPKWLSPGAQNLLRKILEPNPVKRIT 296
F + A +LL +L +P KR T
Sbjct: 268 FSF---IPTPALDLLDHMLTLDPSKRCT 292
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 69/282 (24%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + +G G FG+V+ Q D+G +A+KIL K ++ + I+ E L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
VV++ K +Y+++E++ GG++ + K L E E + + + + H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
HRD+K +N+LLDSKG++K+SDFGL
Sbjct: 123 IHRDIKP-----------------------------------DNLLLDSKGHVKLSDFGL 147
Query: 196 S-----------------ALPQHFRDDG----------------LLHTTCGSPNYVAPEV 222
+LP F L +T G+P+Y+APEV
Sbjct: 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEV 207
Query: 223 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 264
GY+ D WS GVI+Y +L GY PF Y+K+
Sbjct: 208 FMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 98/359 (27%), Positives = 132/359 (36%), Gaps = 125/359 (34%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--------REIATLK 69
L R +GEG +G V A+D SG A+K K R D + REI L
Sbjct: 12 LNR-IGEGTYGIVYRARDTTSGEIVALK---KVR------MDNERDGIPISSLREITLLL 61
Query: 70 LLKHPNVVRLHEVLASKS--KIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLID 125
L+HPN+V L EV+ K I++V+EY L D + + E++ + L QL+
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLR 119
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
G+ Y H + HRDLKV N+LL K
Sbjct: 120 GLQYLHENFIIHRDLKV-----------------------------------SNLLLTDK 144
Query: 186 GNIKISDFGLS---ALPQHFRDDGLLHTTCGSPN-----YVAPEVL-ANRGYDGATSDIW 236
G +KI+DFGL+ LP +P Y APE+L Y A D+W
Sbjct: 145 GCLKIADFGLARTYGLPAKPM----------TPKVVTLWYRAPELLLGCTTYTTAI-DMW 193
Query: 237 SCGVILYVILTG--YLP-------------------------FDDRNLAVLYQKIFRGDF 269
+ G IL +L LP F D L G F
Sbjct: 194 AVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV--------GKF 245
Query: 270 KLPK-----------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 317
LPK WLS LL +L +P KR T +F++ P P+
Sbjct: 246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEM 304
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 69/282 (24%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + +G G FG+V+ Q D+G +A+KIL K ++ + I+ E L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
VV++ K +Y+++E++ GG++ + K L E + + + + H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
HRD+K +N+LLD+KG++K+SDFGL
Sbjct: 123 IHRDIKP-----------------------------------DNLLLDAKGHVKLSDFGL 147
Query: 196 -SALPQHFRDD--------------------------------GLLHTTCGSPNYVAPEV 222
+ L + R + L ++T G+P+Y+APEV
Sbjct: 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEV 207
Query: 223 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 264
GY+ D WS GVI+Y +L GY PF Y+K+
Sbjct: 208 FMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 72/303 (23%), Positives = 135/303 (44%), Gaps = 51/303 (16%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+++ +G G+FG+V+ ++ +G +A+K+++K+ ++ + + E L + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+ +L K +Y+V+EY GG+L + + + E + +L+ + H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
HRD I+P EN+L+D G+IK++DFG
Sbjct: 123 YVHRD---------------------------IKP--------ENVLIDRTGHIKLADFG 147
Query: 195 LSALPQHFRDDGLLHTT--CGSPNYVAPEVL-ANRGYDGATSDI----WSCGVILYVILT 247
+A + ++++ G+P+Y+APEVL G T + WS GVI Y ++
Sbjct: 148 SAA---RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY 204
Query: 248 GYLPFDDRNLAVLYQKI--FRGDFKLPKWL--SPGAQNLLRKILEPNPVKRITIAGIKAD 303
G PF + A Y I F+ K P+ S +L++ +L +R+ G+
Sbjct: 205 GRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLL-CGQKERLGYEGLCCH 263
Query: 304 EWF 306
+F
Sbjct: 264 PFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 76/294 (25%), Positives = 135/294 (45%), Gaps = 61/294 (20%)
Query: 15 RYELGR--TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IAT 67
R L +GEG+ G V A D +G AVK ++ + Q +RE +
Sbjct: 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD--------LRKQQRRELLFNEVVI 69
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
++ +HPN+V ++ ++++V+E++ GG L D I + R+ E + + ++ +
Sbjct: 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKAL 128
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
S+ H +GV HRD+K ++ILL S G
Sbjct: 129 SFLHAQGVIHRDIKS-----------------------------------DSILLTSDGR 153
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
+K+SDFG A Q ++ + G+P ++APEV++ Y G DIWS G+++ ++
Sbjct: 154 VKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVD 210
Query: 248 GYLP-FDDRNLAVLYQKIFRGD----FKLPKWLSPGAQNLLRKILEPNPVKRIT 296
G P F++ L + K R + K +SP ++ L ++L +P +R T
Sbjct: 211 GEPPYFNEPPLQAM--KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-23
Identities = 86/293 (29%), Positives = 131/293 (44%), Gaps = 58/293 (19%)
Query: 15 RYELGRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR-----EIATL 68
Y R LG+G FG+ + + D L V E ++L + +R EI L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSL---VVWKE----VNLTRLSEKERRDALNEIVIL 53
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAE--GRKLFQQLID 125
LL+HPN++ + + + + +EY GG L+DKI KG+L E E LFQ ++
Sbjct: 54 SLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ-IVS 112
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
VSY H G+ HRD+K + NI L
Sbjct: 113 AVSYIHKAGILHRDIKTL-----------------------------------NIFLTKA 137
Query: 186 GNIKISDFGLSALPQHFRDDGLLHTTC-GSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
G IK+ DFG+S + + + T G+P Y++PE+ Y+ SDIW+ G +LY
Sbjct: 138 GLIKLGDFGIS---KILGSEYSMAETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYE 193
Query: 245 ILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRIT 296
+LT FD N L KI +G++ + S +L+ +L+ +P KR T
Sbjct: 194 LLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 81/319 (25%), Positives = 143/319 (44%), Gaps = 50/319 (15%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
++ + ++ M+ Y++ + +G G FG+V+ + S +A+K+L K +I +
Sbjct: 31 IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
E + P VV+L +YMV+EY+ GG+L + + S + E +
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTA 149
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
+++ + H+ G+ HRD+K +N+L
Sbjct: 150 EVVLALDAIHSMGLIHRDVKP-----------------------------------DNML 174
Query: 182 LDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVLANRG---YDGATSDIW 236
LD G++K++DFG + G++ T G+P+Y++PEVL ++G Y G D W
Sbjct: 175 LDKHGHLKLADFGTC---MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 237 SCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLPK--WLSPGAQNLLRKILEPNPV 292
S GV L+ +L G PF +L Y KI + P+ +S A+NL+ L V
Sbjct: 232 SVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREV 291
Query: 293 K--RITIAGIKADEWFEQD 309
+ R + IK +F+ D
Sbjct: 292 RLGRNGVEEIKQHPFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 5e-23
Identities = 90/364 (24%), Positives = 134/364 (36%), Gaps = 102/364 (28%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKH 73
RYEL + +G G +G V A D +G A+K + + + L +I REI L+ L+H
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 74 PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
N++ L ++L S +Y+V E + +L I S L + + Q++ G+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
Y H+ V HRDLK P NIL++S ++
Sbjct: 118 YLHSANVIHRDLK---------------------------P--------SNILVNSNCDL 142
Query: 189 KISDFGLS--ALPQHFRDDGLLHTTCGSPNYV------APEV-LANRGYDGATSDIWSCG 239
KI DFGL+ P L YV APE+ L++ Y A DIWS G
Sbjct: 143 KICDFGLARGVDPDEDEKGFLTE-------YVVTRWYRAPELLLSSSRYTKAI-DIWSVG 194
Query: 240 VILYVILTGYLPFDDRNLAVLYQKIF-------------------------RGDFKLPKW 274
I +LT F R+ I
Sbjct: 195 CIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPL 254
Query: 275 ------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA----------NPDDD 318
SP A +LL K+L +P KRIT A + Q + P D
Sbjct: 255 SKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFD 314
Query: 319 EEDI 322
++++
Sbjct: 315 DDEL 318
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 7e-23
Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 53/299 (17%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
LG GN G V +G AVK + I+ I QI RE+ L P +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGF 64
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
+ + I + +EY+ GG L DKI +GR+ E K+ ++ G++Y H K +
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 137 HRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLS 196
HRD+K P NIL++S+G IK+ DFG+S
Sbjct: 124 HRDVK---------------------------P--------SNILVNSRGQIKLCDFGVS 148
Query: 197 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF---D 253
+ L T G+ +Y+APE + Y SDIWS G+ L + TG P+ +
Sbjct: 149 G----QLVNSLAKTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPEN 203
Query: 254 DRNLAV--LYQKIFRGDF-KLPK-WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308
D + L Q I +LP SP Q+ + L +P +R + + + ++
Sbjct: 204 DPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 8e-23
Identities = 71/243 (29%), Positives = 111/243 (45%), Gaps = 58/243 (23%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLK 72
G +EL +GEG +GKV A+ +G A+KI++ II + + IK E L K
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEE-IKEEYNILRKYSN 61
Query: 73 HPNVVRLHEVLASKS------KIYMVLEYVTGG---ELFDKIASKG-RLQEAEGRKLFQQ 122
HPN+ + K+ ++++V+E GG +L + KG RL+E + ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
+ G++Y H V HRD+K +NILL
Sbjct: 122 TLRGLAYLHENKVIHRDIKG-----------------------------------QNILL 146
Query: 183 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWS 237
+K+ DFG+SA Q G +T G+P ++APEV+A + YD A SD+WS
Sbjct: 147 TKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYD-ARSDVWS 203
Query: 238 CGV 240
G+
Sbjct: 204 LGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 1e-22
Identities = 29/58 (50%), Positives = 43/58 (74%), Gaps = 1/58 (1%)
Query: 348 INAFQLIGMSSCLDLSGFFEKEDVSERK-IRFTSNHSAKDLLERIEDIVTEMGFRVQK 404
+NAF LI +SS LDLSG FE+E S++K RFTS A +++ ++E+I E+GF+V+K
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 87/328 (26%), Positives = 138/328 (42%), Gaps = 100/328 (30%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-------REIAT 67
+YE +GEG +G V A++ ++ A+K +++ D + REI
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRLDDDDEGVPSSALREICL 52
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLID 125
LK LKH N+VRL++VL S K+ +V EY + FD + G + + QL+
Sbjct: 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFD--SCNGDIDPEIVKSFMFQLLK 110
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
G+++CH+ V HRDLK P +N+L++
Sbjct: 111 GLAFCHSHNVLHRDLK---------------------------P--------QNLLINKN 135
Query: 186 GNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----YVAPEVL-ANRGYDGATS-DIWSC 238
G +K++DFGL+ R G + C S Y P+VL + Y TS D+WS
Sbjct: 136 GELKLADFGLA------RAFG-IPVRCYSAEVVTLWYRPPDVLFGAKLYS--TSIDMWSA 186
Query: 239 GVILYVILTGYLP-FDDRNLAVLYQKIFR-----------GDFKLPKW------------ 274
G I + P F ++ ++IFR G KLP +
Sbjct: 187 GCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSL 246
Query: 275 ------LSPGAQNLLRKILEPNPVKRIT 296
L+ ++LL+ +L NPV+RI+
Sbjct: 247 VNVVPKLNSTGRDLLQNLLVCNPVQRIS 274
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 68/241 (28%), Positives = 112/241 (46%), Gaps = 49/241 (20%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
E +G G G V +G +A+K++ N ++ QI REI L+ + HPNV
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR--QICREIEILRDVNHPNV 134
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
V+ H++ +I ++LE++ GG L IA + L + + +Q++ G++Y H + +
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD-----VARQILSGIAYLHRRHI 189
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
HRD I+P N+L++S N+KI+DFG+
Sbjct: 190 VHRD---------------------------IKP--------SNLLINSAKNVKIADFGV 214
Query: 196 SALPQHFRDDGLLHTTCGSPNYVAPEVL---ANRG-YDGATSDIWSCGVILYVILTGYLP 251
S + D +++ G+ Y++PE + N G YDG DIWS GV + G P
Sbjct: 215 SRILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
Query: 252 F 252
F
Sbjct: 273 F 273
|
Length = 353 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-22
Identities = 73/278 (26%), Positives = 107/278 (38%), Gaps = 81/278 (29%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+TLG G FG+V A +D+ +A+K L K +++ +K E L + VV+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ K +Y V++Y+ GG++ + E R +L + H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 140 LKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL---- 195
+K +NIL+D G+IK++DFGL
Sbjct: 127 IKP-----------------------------------DNILIDLDGHIKLTDFGLCTGF 151
Query: 196 ------------------SALPQHFRDD-----------------------GLLHTTCGS 214
S P DD L H+ G+
Sbjct: 152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGT 211
Query: 215 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
PNY+APEVL +GY D WS GVIL+ +L G PF
Sbjct: 212 PNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 5e-22
Identities = 83/310 (26%), Positives = 136/310 (43%), Gaps = 50/310 (16%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
M+ YE+ + +G G FG+V+ + + +A+K+L K +I + E +
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
P VV+L +YMV+EY+ GG+L + + S + E R +++ +
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 158
Query: 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKI 190
H+ G HRD+K +N+LLD G++K+
Sbjct: 159 HSMGFIHRDVKP-----------------------------------DNMLLDKSGHLKL 183
Query: 191 SDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVI 245
+DFG +G++ T G+P+Y++PEVL ++G Y G D WS GV LY +
Sbjct: 184 ADFGTC---MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
Query: 246 LTGYLPFDDRNLAVLYQKIF--RGDFKLP--KWLSPGAQNLLRKILEPNPVK--RITIAG 299
L G PF +L Y KI + P +S A+NL+ L V+ R +
Sbjct: 241 LVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEE 300
Query: 300 IKADEWFEQD 309
IK +F+ D
Sbjct: 301 IKRHLFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 6e-22
Identities = 82/291 (28%), Positives = 126/291 (43%), Gaps = 45/291 (15%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R LG+G FG+V Q +G +A K LEK RI K E L+ + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
+K + +VL + GG+L I G EGR +F ++ G+ H + + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 138 RDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSA 197
RDLK ENILLD G+I+ISD GL+
Sbjct: 126 RDLKP-----------------------------------ENILLDDHGHIRISDLGLAV 150
Query: 198 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL 257
H + + G+ Y+APEV+ N Y + D W+ G +LY ++ G PF R
Sbjct: 151 ---HVPEGQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKK 206
Query: 258 AVLYQKIFR----GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304
+ +++ R + + SP A++L + +L +P +R+ G A E
Sbjct: 207 KIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGARE 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 7e-22
Identities = 94/304 (30%), Positives = 144/304 (47%), Gaps = 72/304 (23%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
LG+G +G V A+DL + + A+K I E++ + + EIA LKH N+V+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQY- 70
Query: 81 EVLASKS-----KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLF--QQLIDGVSYCHN 132
L S S KI+M E V GG L + SK G L++ E +F +Q+++G+ Y H+
Sbjct: 71 --LGSDSENGFFKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS-KGNIKIS 191
+ HRD+K +N+L+++ G +KIS
Sbjct: 127 NQIVHRDIKG-----------------------------------DNVLVNTYSGVVKIS 151
Query: 192 DFGLSALPQHFRDDGL---LHTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGVILYVIL 246
DFG S R G+ T G+ Y+APEV+ RGY GA +DIWS G + +
Sbjct: 152 DFGTSK-----RLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAPADIWSLGCTIVEMA 205
Query: 247 TGYLPFDDRNLAVLYQKIFR-GDFK----LPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301
TG PF + L +F+ G FK +P+ LS A+N + + EP+P KR + +
Sbjct: 206 TGKPPFIE--LGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263
Query: 302 ADEW 305
D +
Sbjct: 264 QDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 7e-22
Identities = 82/279 (29%), Positives = 124/279 (44%), Gaps = 47/279 (16%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILE---KNRIIHLKITDQIKREIATLKLLKHPN 75
G LG+G +G V + + G AVK +E N + K ++++ E+ LK LKH N
Sbjct: 5 GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V+ + I + +E+V GG + + G L E K +Q++DGV+Y HN V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG- 194
HRD+K N++L G IK+ DFG
Sbjct: 124 VHRDIKG-----------------------------------NNVMLMPNGIIKLIDFGC 148
Query: 195 ---LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
L+ + H +L + G+P ++APEV+ GY G SDIWS G ++ + TG P
Sbjct: 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPP 207
Query: 252 FD--DRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKIL 287
DR A+ Y RG +LP S A + + L
Sbjct: 208 LASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCL 246
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 76/317 (23%), Positives = 125/317 (39%), Gaps = 85/317 (26%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ +G+G FG+V+ Q D+G +A+K L K+ + +K E L P VV L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ +Y+++E++ GG+L + E R + + + H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 140 LKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL---- 195
I+P +NIL+D G+IK+SDFGL
Sbjct: 127 ---------------------------IKP--------DNILIDRGGHIKLSDFGLSTGF 151
Query: 196 ----------------SALPQHFRDDGLL-------------------------HTTCGS 214
S + + + ++T G+
Sbjct: 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGT 211
Query: 215 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLP 272
P+Y+APE+ +GY G D WS G I++ L G+ PF N Y+KI +R P
Sbjct: 212 PDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFP 270
Query: 273 K--WLSPGAQNLLRKIL 287
LS A++L+R+++
Sbjct: 271 DDIHLSVEAEDLIRRLI 287
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 80/291 (27%), Positives = 125/291 (42%), Gaps = 45/291 (15%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R LG+G FG+V Q +G +A K LEK RI K E L+ + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
+K + +VL + GG+L I + G E R +F ++ G+ H + + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 138 RDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSA 197
RDLK P ENILLD G+I+ISD GL+
Sbjct: 126 RDLK---------------------------P--------ENILLDDYGHIRISDLGLAV 150
Query: 198 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL 257
+ + G+ Y+APEV+ N Y + D W G ++Y ++ G PF R
Sbjct: 151 ---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
Query: 258 AVLYQKIFR----GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304
V +++ R + + S A+++ R++L +P R+ G A+E
Sbjct: 207 KVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEE 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 72/244 (29%), Positives = 111/244 (45%), Gaps = 53/244 (21%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--EKNRIIHLKITDQIKREIATLKLLKHP 74
EL R LGEG G V + ++G+ FA+K + + N + QI RE+ K K P
Sbjct: 5 ELSR-LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ----KQILRELEINKSCKSP 59
Query: 75 NVVRLHE--VLASKSKIYMVLEYVTGGEL---FDKIASKG-RLQEAEGRKLFQQLIDGVS 128
+V+ + + S S I + +EY GG L + K+ +G R+ E K+ + ++ G+S
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
Y H++ + HRD I+P NILL KG +
Sbjct: 120 YLHSRKIIHRD---------------------------IKP--------SNILLTRKGQV 144
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248
K+ DFG+S + L T G+ Y+APE + + Y TSD+WS G+ L +
Sbjct: 145 KLCDFGVSGELV----NSLAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQN 199
Query: 249 YLPF 252
PF
Sbjct: 200 RFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 92/357 (25%), Positives = 138/357 (38%), Gaps = 106/357 (29%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+YE+ +G G +G+V A+ + G +A+K + ++ + I+ REIA L+ LK
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 73 HPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLID 125
H NVV L EV + +Y++ +Y +L+ I A + + + + L Q+++
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL--- 182
GV Y H+ V HRDLK P NIL+
Sbjct: 120 GVHYLHSNWVLHRDLK---------------------------P--------ANILVMGE 144
Query: 183 -DSKGNIKISDFGL-----SALPQHFRDDGLLHTTCGSPNYVAPEV-LANRGYDGATSDI 235
+G +KI D GL + L D ++ T Y APE+ L R Y A DI
Sbjct: 145 GPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW----YRAPELLLGARHYTKAI-DI 199
Query: 236 WSCGVILYVILTGYLPF----DDRNLAVLYQ-----KIFR-------------------- 266
W+ G I +LT F + +Q +IF
Sbjct: 200 WAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYD 259
Query: 267 ---GDFK--------LPKW------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
DFK L KW +LLRK+LE +P KRIT +F
Sbjct: 260 TLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 87/325 (26%), Positives = 138/325 (42%), Gaps = 92/325 (28%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKL 70
YE +GEG +G V A+DL++G A+K + + ++++ REIA LK
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKK------VRVPLSEEGIPLSTLREIALLKQ 54
Query: 71 LK---HPNVVRLHEVLA-----SKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLF 120
L+ HPN+VRL +V + K+ +V E+V K G L + L
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLM 113
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
+QL+ GV + H+ + HRDLK P +NI
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLK---------------------------P--------QNI 138
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS-DIWSCG 239
L+ S G +KI+DFGL+ + + + L + + Y APEVL Y AT D+WS G
Sbjct: 139 LVTSDGQVKIADFGLARI---YSFEMALTSVVVTLWYRAPEVLLQSSY--ATPVDMWSVG 193
Query: 240 VILYVI---------------------LTGYLPFDD--RNLAVL---YQKIFRGDFK--L 271
I + + G ++ RN+++ + FK +
Sbjct: 194 CIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFV 253
Query: 272 PKWLSPGAQNLLRKILEPNPVKRIT 296
P+ + +LL+K+L NP KRI+
Sbjct: 254 PE-ICEEGLDLLKKMLTFNPHKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 90/359 (25%), Positives = 143/359 (39%), Gaps = 85/359 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ +G G +G+V A D +G A+K L + IH K T RE+ LK +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT---YRELRLLKHMD 72
Query: 73 HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V L +Y+V + G +L + + + +L + + L Q++ G
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ-KLSDDHIQFLVYQILRG 130
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ Y H+ G+ HRDLK P NI ++
Sbjct: 131 LKYIHSAGIIHRDLK---------------------------P--------SNIAVNEDC 155
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
+KI DFGL+ D + + Y APE++ N + T DIWS G I+ +L
Sbjct: 156 ELKILDFGLARHT-----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
Query: 247 TGYLPF------------------------------DDRNLAVLYQKIFRGDFK-LPKWL 275
TG F RN ++ + DFK +
Sbjct: 211 TGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGA 270
Query: 276 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN-PDDDEEDIFVDNEAFSMHE 333
+P A +LL K+L +P KRIT A A + + + P + P D ++ ++ E
Sbjct: 271 NPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAPPYDQSFESRDLTVDE 329
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 9e-21
Identities = 81/310 (26%), Positives = 133/310 (42%), Gaps = 75/310 (24%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
L R LG G FG+V + + AVK L+ + + +E +K L+H +V
Sbjct: 10 LERKLGAGQFGEV-WMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLV 64
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSY 129
+L+ V + + IY+V EY++ G L D L+ EG+KL QL+D G++Y
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
++ HRDL NIL+ K
Sbjct: 119 LESRNYIHRDLAA-----------------------------------RNILVGENLVCK 143
Query: 190 ISDFGLSALPQHFRDDGLLHTTCGSPNY----VAPEVLANRGYDGATSDIWSCGVILYVI 245
I+DFGL+ L DD +T + APE AN G SD+WS G++L I
Sbjct: 144 IADFGLARL---IEDD--EYTAREGAKFPIKWTAPEA-ANYGRFTIKSDVWSFGILLTEI 197
Query: 246 LT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA----QNLLRKILEPNPVKRITIAGI 300
+T G +P+ + +++ RG +++P+ P +L+ + + +P +R T +
Sbjct: 198 VTYGRVPYPGMTNREVLEQVERG-YRMPR--PPNCPEELYDLMLQCWDKDPEERPTFEYL 254
Query: 301 KADEWFEQDY 310
+ F +DY
Sbjct: 255 Q---SFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 85/317 (26%), Positives = 134/317 (42%), Gaps = 91/317 (28%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKLLKHPNV 76
+GEG +G V ++ +G A+K I L+ ++ REI+ LK L+HPN+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKK------IRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 77 VRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
V L +VL +S++Y++ E+++ + D + + + Q++ G+ +CH++
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
V HRDLK P +N+L+D+KG IK++DFG
Sbjct: 122 VLHRDLK---------------------------P--------QNLLIDNKGVIKLADFG 146
Query: 195 LSALPQHFRDDGL-----LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249
L+ R G+ H + Y APEVL DIWS G I + T
Sbjct: 147 LA------RAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
Query: 250 LPFD-DRNLAVLYQKIFR----------------GDFK--LPKW-----------LSPGA 279
F D + L+ +IFR D+K PKW L
Sbjct: 200 PLFHGDSEIDQLF-RIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDG 258
Query: 280 QNLLRKILEPNPVKRIT 296
+LL K+L +P KRI+
Sbjct: 259 LDLLEKMLIYDPAKRIS 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 73/284 (25%), Positives = 130/284 (45%), Gaps = 50/284 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ + +G G FG+V + ++ FA+KIL K ++ T + E L +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+ LH ++ +Y+V++Y GG+L ++ + RL E R +++ + H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
HRD+K +NIL+D G+I+++DFG
Sbjct: 123 YVHRDIKP-----------------------------------DNILMDMNGHIRLADFG 147
Query: 195 LSALPQHFRDDGLLHTTC--GSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTG 248
S L +DG + ++ G+P+Y++PE+L +G G D WS GV +Y +L G
Sbjct: 148 -SCL--KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
Query: 249 YLPFDDRNLAVLYQKIF--RGDFKLPKW---LSPGAQNLLRKIL 287
PF +L Y KI + F+ P +S A++L+R+++
Sbjct: 205 ETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 86/320 (26%), Positives = 132/320 (41%), Gaps = 83/320 (25%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL---EKNRIIHLKITDQIKREIATLKLL 71
+YE +GEG++G V ++ ++G A+K E + +I KI REI LK L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIA---LREIRMLKQL 57
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
KHPN+V L EV K K+++V EY L + + + E +K+ Q + V++CH
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
HRD+K P ENIL+ +G IK+
Sbjct: 118 KHNCIHRDVK---------------------------P--------ENILITKQGQIKLC 142
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPN-YVAPEVLANRGYDGATSDIWSCGVILYVILTG-- 248
DFG + + DD +T + Y APE+L G D+W+ G + +LTG
Sbjct: 143 DFGFARILTGPGDD---YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
Query: 249 -----------YLPFDDRNLAVLY---QKIFR-GDF-----------------KLPKWLS 276
YL + L L Q+IF F K P +S
Sbjct: 200 LWPGKSDVDQLYLI--RKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPN-IS 256
Query: 277 PGAQNLLRKILEPNPVKRIT 296
A + L+ L+ +P +R++
Sbjct: 257 SPALSFLKGCLQMDPTERLS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 78/292 (26%), Positives = 124/292 (42%), Gaps = 50/292 (17%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L + + + +G G F +V A L G+P A+K ++ ++ K +EI LK L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVS 128
HPNV++ + +++ +VLE G+L I K + E K F QL +
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
+ H++ V HRD+K N+ + + G +
Sbjct: 121 HMHSRRVMHRDIKP-----------------------------------ANVFITATGVV 145
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248
K+ D GL H+ G+P Y++PE + GY+ SDIWS G +LY +
Sbjct: 146 KLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAAL 202
Query: 249 YLPF--DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE----PNPVKR 294
PF D NL L +KI + D+ P S LR+++ P+P KR
Sbjct: 203 QSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 4e-20
Identities = 75/294 (25%), Positives = 133/294 (45%), Gaps = 53/294 (18%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-----LKL 70
Y R +G+G++G+V + G + +K L +L+ + +R+ A L
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKL------NLRNASRRERKAAEQEAQLLSQ 55
Query: 71 LKHPNVVRLHEVLASKS-KIYMVLEYVTGGELFDKIA-SKGRL-QEAEGRKLFQQLIDGV 127
LKHPN+V E + +Y+V+ + GG+L+ K+ KG+L E + + F Q+ +
Sbjct: 56 LKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
Y H K + HRDLK +N+ L
Sbjct: 116 QYLHEKHILHRDLKT-----------------------------------QNVFLTRTNI 140
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
IK+ D G++ + ++ D + T G+P Y++PE+ +N+ Y+ SD+W+ G +Y + T
Sbjct: 141 IKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMAT 197
Query: 248 GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGI 300
F+ +++ L +I G +PK SP L+ +L P KR ++ I
Sbjct: 198 LKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 7e-20
Identities = 77/283 (27%), Positives = 132/283 (46%), Gaps = 48/283 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RYE +G+G G V A D+ +G A+K + + ++ I EI +K LK+P
Sbjct: 23 RYE---KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL---IINEILVMKELKNP 76
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+V + ++++V+EY+ GG L D + ++ + EA+ + ++ + + + H
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
V HRD+K +N+LL G++K++DFG
Sbjct: 136 VIHRDIKS-----------------------------------DNVLLGMDGSVKLTDFG 160
Query: 195 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254
A Q + T G+P ++APEV+ + Y G DIWS G++ ++ G P+ +
Sbjct: 161 FCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLN 217
Query: 255 RN-LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKR 294
N L LY G +L P+ LSP ++ L + LE + KR
Sbjct: 218 ENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 9e-20
Identities = 87/295 (29%), Positives = 134/295 (45%), Gaps = 61/295 (20%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ---IKREIATLKLLK 72
YEL + +G G +G V A++L +G AVKI I L+ D I++EI +K K
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKI------IKLEPGDDFSLIQQEIFMVKECK 64
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H N+V S+ K+++ +EY GG L D G L E + + ++ + G++Y H+
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
KG HRD+K NILL G++K++D
Sbjct: 125 KGKMHRDIKG-----------------------------------ANILLTDNGDVKLAD 149
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGY 249
FG++A + + G+P ++APEV A N GY+ DIW+ G I + L
Sbjct: 150 FGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN-QLCDIWAVG-ITAIELAEL 205
Query: 250 LP--FDDRNLAVLYQKIFRGDFKLP------KWLSPGAQNLLRKILEPNPVKRIT 296
P FD + L+ + + +F+ P KW S N ++ L NP KR T
Sbjct: 206 QPPMFDLHPMRALFL-MSKSNFQPPKLKDKTKW-SSTFHNFVKISLTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 55/288 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IATLK 69
+Y +G+G G V A D+ +G A+K + + Q K+E I ++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIK--------QMNLQQQPKKELIINEILVMR 71
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
KHPN+V + ++++V+EY+ GG L D + ++ + E + + ++ + + +
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 130
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
H+ V HRD+K +NILL G++K
Sbjct: 131 LHSNQVIHRDIKS-----------------------------------DNILLGMDGSVK 155
Query: 190 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249
++DFG A Q + T G+P ++APEV+ + Y G DIWS G++ ++ G
Sbjct: 156 LTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGE 212
Query: 250 LPFDDRN-LAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKR 294
P+ + N L LY G + + P+ LS ++ L + LE + KR
Sbjct: 213 PPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 89/357 (24%), Positives = 138/357 (38%), Gaps = 92/357 (25%)
Query: 15 RYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----------- 62
RY G LGEG +GKV+ A D +G A+K ++ I + D+
Sbjct: 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL 68
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
RE+ + +KH N++ L +V I +V++ + +L + K RL E++ + + Q
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQ 127
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
+++G++ H HRDL P NI +
Sbjct: 128 ILNGLNVLHKWYFMHRDLS---------------------------P--------ANIFI 152
Query: 183 DSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPN---------YVAPEVL--ANRGY 228
+SKG KI+DFGL+ P + T Y APE+L A + Y
Sbjct: 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEK-Y 211
Query: 229 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RG------------------- 267
A D+WS G I +LTG F N +IF G
Sbjct: 212 HFAV-DMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEF 270
Query: 268 DFKLPKWLSPGAQN-------LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 317
+ PK L N LL+ +L+ NP++RI+ E+F+ D P +P
Sbjct: 271 TPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPCDPSQ 327
|
Length = 335 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 86/330 (26%), Positives = 136/330 (41%), Gaps = 83/330 (25%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL---EKNRIIHLKITDQIKREIATLKLL 71
+YE +GEG++G V + ++G A+K E ++++ KI REI LK L
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVK-KIA---MREIRMLKQL 57
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+H N+V L EV K ++Y+V E+V L D L E+ RK Q++ G+ +CH
Sbjct: 58 RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
+ + HRD I+P ENIL+ G +K+
Sbjct: 118 SHNIIHRD---------------------------IKP--------ENILVSQSGVVKLC 142
Query: 192 DFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248
DFG + A P D + + Y APE+L G DIW+ G ++ +LTG
Sbjct: 143 DFGFARTLAAPGEVYTDYV-----ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
Query: 249 --YLPFDDR------------NLAVLYQKIFRG------------------DFKLPKWLS 276
P D NL +Q+IF+ + + PK S
Sbjct: 198 EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKL-S 256
Query: 277 PGAQNLLRKILEPNPVKRITIAGIKADEWF 306
+L ++ L +P R + + + E+F
Sbjct: 257 GLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-19
Identities = 71/245 (28%), Positives = 109/245 (44%), Gaps = 51/245 (20%)
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL------QEAE 115
+ E+ L H +V+ + S K+ +++EY +GG+L +I K RL QE E
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRLKEHLPFQEYE 170
Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVL 175
LF Q++ + H++ + HRDLK
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKS--------------------------------- 197
Query: 176 QLENILLDSKGNIKISDFGLSALPQHFRDDGLL---HTTCGSPNYVAPEVLANRGYDGAT 232
NI L G IK+ DFG S + + D L + CG+P Y+APE+ + Y
Sbjct: 198 --ANIFLMPTGIIKLGDFGFS---KQYSDSVSLDVASSFCGTPYYLAPELWERKRYS-KK 251
Query: 233 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNP 291
+D+WS GVILY +LT + PF + + Q++ G + P +S G + LL +L NP
Sbjct: 252 ADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNP 311
Query: 292 VKRIT 296
R T
Sbjct: 312 ALRPT 316
|
Length = 478 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 3e-19
Identities = 82/304 (26%), Positives = 124/304 (40%), Gaps = 74/304 (24%)
Query: 22 LGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
LG+G+FG V+ + SG +P AVK L+ +++ I D +E A + L H N++R
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDHENLIR 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLIDGVSYCHNKGV 135
L+ V+ + + MV E G L D++ K L L Q+ +G+ Y +K
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
HRDL NILL S +KI DFGL
Sbjct: 119 IHRDLAA-----------------------------------RNILLASDDKVKIGDFGL 143
Query: 196 S-ALPQHFRDDGLLHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVIL 242
ALPQ +YV APE L R + A SD+W GV L
Sbjct: 144 MRALPQ------------NEDHYVMEEHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTL 190
Query: 243 YVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAG 299
+ + T G P+ + + + +KI + +L P+ N++ + NP R T A
Sbjct: 191 WEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAA 250
Query: 300 IKAD 303
++
Sbjct: 251 LREF 254
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 79/294 (26%), Positives = 124/294 (42%), Gaps = 46/294 (15%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L +++ + +G G F +V A L P A+K ++ ++ K +EI LK L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVS 128
HPNV++ + +++ +VLE G+L I K + E K F QL V
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
+ H++ V HRD+K N+ + + G +
Sbjct: 121 HMHSRRVMHRDIKP-----------------------------------ANVFITATGVV 145
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248
K+ D GL H+ G+P Y++PE + GY+ SDIWS G +LY +
Sbjct: 146 KLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAAL 202
Query: 249 YLPF--DDRNLAVLYQKIFRGDF-KLPK-WLSPGAQNLLRKILEPNPVKRITIA 298
PF D NL L QKI + D+ LP S + L+ + P+P +R I
Sbjct: 203 QSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIG 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 65/239 (27%), Positives = 100/239 (41%), Gaps = 52/239 (21%)
Query: 20 RTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LGEG+FGKV+ ++G AVK L + +D +REI L+ L H N
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSD-FEREIEILRTLDHEN 67
Query: 76 VVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----QQLIDGVSY 129
+V+ V + +++EY+ G L D + R ++ K Q+ G+ Y
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRLLLFSSQICKGMDY 124
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
++ HRDL NIL++S+ +K
Sbjct: 125 LGSQRYIHRDLA-----------------------------------ARNILVESEDLVK 149
Query: 190 ISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
ISDFGL+ + +D + SP + APE L + A SD+WS GV LY + T
Sbjct: 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 6e-19
Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 47/296 (15%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVR 78
+G G FG+V + D+G +A+K L+K RI + E L L+ P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
+ + K+ +L+ + GG+L ++ G EAE R ++I G+ + HN+ V +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK NILLD G+++ISD GL+
Sbjct: 122 DLKP-----------------------------------ANILLDEHGHVRISDLGLACD 146
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYVILTGYLPF---DD 254
+ H + G+ Y+APEVL YD +++D +S G +L+ +L G+ PF
Sbjct: 147 FSKKKP----HASVGTHGYMAPEVLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKT 201
Query: 255 RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310
++ + + +LP SP ++LL +L+ + +R+ G A E E +
Sbjct: 202 KDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 77/286 (26%), Positives = 135/286 (47%), Gaps = 61/286 (21%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IATLKLLKHPNV 76
+GEG+ G V A++ SG AVK+++ + Q +RE + ++ +H NV
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD--------LRKQQRRELLFNEVVIMRDYQHQNV 80
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
V +++ ++++++E++ GG L D I S+ RL E + + + ++ + Y H++GV
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVI 139
Query: 137 HRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLS 196
HRD+K ++ILL G +K+SDFG
Sbjct: 140 HRDIKS-----------------------------------DSILLTLDGRVKLSDFGFC 164
Query: 197 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDR 255
A Q +D + G+P ++APEV++ Y G DIWS G+++ ++ G P F D
Sbjct: 165 A--QISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDS 221
Query: 256 NLAVLYQKIFRGDFKLPKW-----LSPGAQNLLRKILEPNPVKRIT 296
+ + K R D PK +SP ++ L ++L P +R T
Sbjct: 222 PVQAM--KRLR-DSPPPKLKNAHKISPVLRDFLERMLTREPQERAT 264
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 85/327 (25%), Positives = 131/327 (40%), Gaps = 101/327 (30%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLK- 72
Y++ +GEG F +V AQ +G +A+K ++K H K +Q+ REI L+ L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 73 HPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGV 127
HPN++RL EVL + ++ +V E + L++ I KGR L E + QL+ +
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELI--KGRKRPLPEKRVKSYMYQLLKSL 113
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
+ H G+FHRD+K P ENIL+
Sbjct: 114 DHMHRNGIFHRDIK---------------------------P--------ENILIK-DDI 137
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYV---------APEVLANRGYDGATSDIWSC 238
+K++DFG S P Y APE L GY G DIW+
Sbjct: 138 LKLADFG-SC-----------RGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAV 185
Query: 239 GVILYVILTGYLPFDDRN------------------LAVLYQKIFRGDFKLPK------- 273
G + + IL+ + F N + ++K ++ P
Sbjct: 186 GCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLR 245
Query: 274 WL----SPGAQNLLRKILEPNPVKRIT 296
L S +LL+K+L +P +RIT
Sbjct: 246 KLLPNASAEGLDLLKKLLAYDPDERIT 272
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 9e-19
Identities = 76/295 (25%), Positives = 130/295 (44%), Gaps = 45/295 (15%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVR 78
+G G FG+V + D+G +A+K L+K RI + E L L+ P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
+ + K+ +L+ + GG+L ++ G E E R ++I G+ + HN+ V +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DLK NILLD G+++ISD GL+
Sbjct: 122 DLKP-----------------------------------ANILLDEHGHVRISDLGLACD 146
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF---DDR 255
+ H + G+ Y+APEVL +++D +S G +L+ +L G+ PF +
Sbjct: 147 FSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202
Query: 256 NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310
+ + + + +LP SP ++LL +L+ + KR+ G A E E +
Sbjct: 203 DKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 76/293 (25%), Positives = 133/293 (45%), Gaps = 56/293 (19%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR---EIATLKLLK 72
+E+ LG+G FGKV AQ+ ++G +L ++I K ++++ EI L
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETG------VLAAAKVIDTKSEEELEDYMVEIDILASCD 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCH 131
HPN+V+L + ++ +++++E+ GG + + R L E + R + +Q ++ ++Y H
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
+ HRDLK NIL G+IK++
Sbjct: 121 ENKIIHRDLKA-----------------------------------GNILFTLDGDIKLA 145
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL-----ANRGYDGATSDIWSCGVILYVIL 246
DFG+SA ++ R + G+P ++APEV+ +R YD +D+WS G+ L +
Sbjct: 146 DFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMA 202
Query: 247 TGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRIT 296
P + N + KI + + P S ++ L+K LE N R T
Sbjct: 203 QIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWT 255
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 74/290 (25%), Positives = 131/290 (45%), Gaps = 51/290 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+EL + +G G +G V A+++++G A+K++ ++ + +++EI +K KH N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V + K+++ +E+ GG L D G L E++ + ++ + G+ Y H+KG
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
HRD+K NILL G++K++DFG+
Sbjct: 128 MHRDIKG-----------------------------------ANILLTDNGHVKLADFGV 152
Query: 196 SALPQHFRDDGLLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLP-F 252
SA Q + G+P ++APEV A +G DIW+ G+ + P F
Sbjct: 153 SA--QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210
Query: 253 DDRNLAVLYQKIFRGDFKLP------KWLSPGAQNLLRKILEPNPVKRIT 296
D + L+ + + +F+ P KW S + ++ L NP KR T
Sbjct: 211 DLHPMRALFL-MTKSNFQPPKLKDKMKW-SNSFHHFVKMALTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 81/307 (26%), Positives = 138/307 (44%), Gaps = 54/307 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ + +G G FG+V + ++G +A+KIL K ++ T + E L
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKG 134
+ LH ++ +Y+V++Y GG+L ++ RL E R +++ + H G
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
HRD I+P +N+LLD G+I+++DFG
Sbjct: 123 YVHRD---------------------------IKP--------DNVLLDKNGHIRLADFG 147
Query: 195 LSALPQHFRDDGLLHTTC--GSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTG 248
S L DG + + G+P+Y++PE+L +G G D WS GV +Y +L G
Sbjct: 148 -SCL--RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
Query: 249 YLPFDDRNLAVLYQKI--FRGDFKLP---KWLSPGAQNLLRKILEPNPVKRITIAGI--- 300
PF +L Y KI + F+ P +S A++L+R+++ P R+ G+
Sbjct: 205 ETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQDF 263
Query: 301 KADEWFE 307
K +FE
Sbjct: 264 KDHPFFE 270
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 61/237 (25%)
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+PN ++L+ + + ++++Y+ G+LFD + +G+L EAE +K+ +QL++ ++ H
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD-SKGNIKI 190
+ H D+K LEN+L D +K I +
Sbjct: 127 KHNIIHNDIK-----------------------------------LENVLYDRAKDRIYL 151
Query: 191 SDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
D+GL P + DG L +Y +PE + YD + D W+ GV+ Y +LT
Sbjct: 152 CDYGLCKIIGTPSCY--DGTL-------DYFSPEKIKGHNYD-VSFDWWAVGVLTYELLT 201
Query: 248 GYLPFDDRN--------LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 296
G PF + L QK K +S A + ++ +L+ N R+T
Sbjct: 202 GKHPFKEDEDEELDLESLLKRQQK----KLPFIKNVSKNANDFVQSMLKYNINYRLT 254
|
Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 96/341 (28%), Positives = 140/341 (41%), Gaps = 97/341 (28%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKL 70
YE +GEG +GKV A+D ++G A+K K R L++ ++ REI+ L++
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTR---LEMDEEGIPPTALREISLLQM 56
Query: 71 LKH-PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGR-----LQEAEGRKL 119
L +VRL +V + K +Y+V EY+ +L + S GR L +
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 120 FQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179
QL+ GV++CH GV HRDLK P +N
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLK---------------------------P--------QN 140
Query: 180 ILLD-SKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 235
+L+D KG +KI+D GL ++P H + Y APEVL + DI
Sbjct: 141 LLVDKQKGLLKIADLGLGRAFSIPV----KSYTHEIV-TLWYRAPEVLLGSTHYSTPVDI 195
Query: 236 WSCGVILYVILTGYLPF-DDRNLAVLYQKIFR-----------GDFKL------PKW--- 274
WS G I + F D L L IF+ G KL P+W
Sbjct: 196 WSVGCIFAEMSRKQPLFPGDSELQQLL-HIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQ 254
Query: 275 --------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
LSP +LL+K+L +P KRI+ +F+
Sbjct: 255 DLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 73/250 (29%), Positives = 108/250 (43%), Gaps = 43/250 (17%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R LG+G FG+V Q +G +A K LEK RI K E L+ + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
+K + +VL + GG+L I + G E R LF +++ G+ H + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 138 RDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSA 197
RDLK ENILLD G+I+ISD GL+
Sbjct: 126 RDLKP-----------------------------------ENILLDDYGHIRISDLGLAV 150
Query: 198 -LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 256
+P+ + G+ Y+APEVL N+ Y + D W G ++Y ++ G PF R
Sbjct: 151 KIPE----GESIRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRK 205
Query: 257 LAVLYQKIFR 266
V +++ R
Sbjct: 206 EKVKREEVDR 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 66/248 (26%), Positives = 111/248 (44%), Gaps = 56/248 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKL 70
R EL +G G +G V + + +G A+KI I+L D I+RE+A L
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKI------INLDTPDDDVSDIQREVALLSQ 55
Query: 71 LKH---PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
L+ PN+ + + ++++++EY GG + + G + E + ++++ +
Sbjct: 56 LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVAL 114
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
Y H GV HRD+K NIL+ + GN
Sbjct: 115 KYIHKVGVIHRDIKA-----------------------------------ANILVTNTGN 139
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYVIL 246
+K+ DFG++AL T G+P ++APEV+ + YD +DIWS G+ +Y +
Sbjct: 140 VKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYD-TKADIWSLGITIYEMA 196
Query: 247 TGYLPFDD 254
TG P+ D
Sbjct: 197 TGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 74/294 (25%), Positives = 129/294 (43%), Gaps = 54/294 (18%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ LG+G FGKV A++ ++G A K++E L + EI L HP
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPY 70
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
+V+L K+++++E+ GG + + R L E + + + +Q+++ + Y H+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
+ HRDLK N+LL G+IK++DFG
Sbjct: 131 IIHRDLKA-----------------------------------GNVLLTLDGDIKLADFG 155
Query: 195 LSA--LPQHFRDDGLLHTTCGSPNYVAPEV-----LANRGYDGATSDIWSCGVILYVILT 247
+SA + R D + G+P ++APEV + + YD +DIWS G+ L +
Sbjct: 156 VSAKNVKTLQRRDSFI----GTPYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQ 210
Query: 248 GYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRITIA 298
P + N + KI + + P S ++ L+ L+ +P R + A
Sbjct: 211 IEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAA 264
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 3e-18
Identities = 67/237 (28%), Positives = 94/237 (39%), Gaps = 54/237 (22%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+G+GNFG V + L AVK LK + +E LK HPN+V+L
Sbjct: 1 EKIGKGNFGDV-YKGVLKGNTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKL 57
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLID---GVSYCHNKGV 135
V K IY+V+E V GG L + K RL +KL Q +D G+ Y +K
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV---KKLLQMSLDAAAGMEYLESKNC 114
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
HRDL N L+ +KISDFG+
Sbjct: 115 IHRDLAA-----------------------------------RNCLVGENNVLKISDFGM 139
Query: 196 SALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATSDIWSCGVILYVILTG 248
S + G+ + G + APE L N G + SD+WS G++L+ +
Sbjct: 140 S----REEEGGIYTVSDGLKQIPIKWTAPEAL-NYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 4e-18
Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 39/272 (14%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
RL YE+ + +G G FG+V + + F K + R + + Q+ E+ ++ L
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVNVMREL 69
Query: 72 KHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLID 125
KH N+VR + +K+ K+Y+++E+ G+L I G+++E + +QL+
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 126 GVSYCHN-------KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178
++YCHN + V HRDLK +FL T IR Q
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLK-----------PQNIFLSTG-----IRHIGKITAQAN 173
Query: 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIW 236
N L+ + KI DFGLS ++ + + H+ G+P Y +PE+L + + YD SD+W
Sbjct: 174 N--LNGRPIAKIGDFGLS---KNIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMW 227
Query: 237 SCGVILYVILTGYLPFDD-RNLAVLYQKIFRG 267
+ G I+Y + +G PF N + L ++ RG
Sbjct: 228 ALGCIIYELCSGKTPFHKANNFSQLISELKRG 259
|
Length = 1021 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 81/292 (27%), Positives = 125/292 (42%), Gaps = 47/292 (16%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R LG+G FG+V Q +G +A K LEK RI K E L+ + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
+K + +VL + GG+L I + G E R +F +L G+ + + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 138 RDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSA 197
RDLK ENILLD +G+I+ISD GL+
Sbjct: 126 RDLKP-----------------------------------ENILLDDRGHIRISDLGLAV 150
Query: 198 -LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 256
+P+ G + G+ Y+APEV+ N Y + D W G ++Y ++ G PF R
Sbjct: 151 QIPEGETVRGRV----GTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRK 205
Query: 257 LAVLYQKIFR----GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304
V +++ R + + S A+++ R +L NP +R+ G A
Sbjct: 206 ERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAG 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 7e-18
Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 35/172 (20%)
Query: 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84
G FGKV + ++ +AVK+++K +I+ + Q++ E L L K P +V L+ L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVIL 144
S + +Y+V+EY+ GG++ + G E K ++ + Y H G+ HRDLK
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK--- 131
Query: 145 KSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLS 196
P +N+L+ ++G+IK++DFGLS
Sbjct: 132 ------------------------P--------DNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 71/284 (25%), Positives = 127/284 (44%), Gaps = 50/284 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ + +G G FG+V + + +A+KIL K ++ T + E L
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+ LH ++ +Y+V++Y GG+L ++ + RL E R +++ + H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
HRD+K +N+LLD G+I+++DFG
Sbjct: 123 YVHRDIKP-----------------------------------DNVLLDMNGHIRLADFG 147
Query: 195 LSALPQHFRDDGLLHTTC--GSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTG 248
S L + DG + ++ G+P+Y++PE+L G G D WS GV +Y +L G
Sbjct: 148 -SCLKMN--QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
Query: 249 YLPFDDRNLAVLYQKIFRGD--FKLPKWL---SPGAQNLLRKIL 287
PF +L Y KI + F+ P + S A++L+++++
Sbjct: 205 ETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 78/289 (26%), Positives = 124/289 (42%), Gaps = 49/289 (16%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G GNFG+V + P AVK + LK + +E LK HPN+VRL
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLIG 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
V K IY+V+E V GG+ + ++G RL+ E ++ + G+ Y +K HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 141 KVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQ 200
N L+ K +KISDFG+S
Sbjct: 121 AA-----------------------------------RNCLVTEKNVLKISDFGMS---- 141
Query: 201 HFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR 255
+DG+ +T G + APE L N G + SD+WS G++L+ + G +P+ +
Sbjct: 142 REEEDGVYASTGGMKQIPVKWTAPEAL-NYGRYSSESDVWSFGILLWEAFSLGAVPYANL 200
Query: 256 NLAVLYQKIFRGDFKLPKWLSPGA-QNLLRKILEPNPVKRITIAGIKAD 303
+ + I +G L P A L+ + E +P +R + + + +
Sbjct: 201 SNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQE 249
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 70/286 (24%), Positives = 119/286 (41%), Gaps = 55/286 (19%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+LG T+G+G FG V G AVK L+ E + + L+HPN+
Sbjct: 9 KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKD----DSTAAQAFLAEASVMTTLRHPNL 62
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQ-QLIDGVSYCHNKG 134
V+L V+ + +Y+V EY+ G L D + S+GR + + F + +G+ Y K
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
HRDL N+L+ K+SDFG
Sbjct: 123 FVHRDLAA-----------------------------------RNVLVSEDLVAKVSDFG 147
Query: 195 LSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 252
L+ ++ + P + APE L + + SD+WS G++L+ I + G +P+
Sbjct: 148 LA------KEASQGQDSGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPY 200
Query: 253 DDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRIT 296
L + + +G +++ P+ P +++ E +P KR T
Sbjct: 201 PRIPLKDVVPHVEKG-YRMEAPEGCPPEVYKVMKDCWELDPAKRPT 245
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 3e-17
Identities = 72/288 (25%), Positives = 130/288 (45%), Gaps = 55/288 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
+Y +G+G G V A D+ +G A+K + + Q K+E+ ++L
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIK--------QMNLQQQPKKELIINEILVMR 71
Query: 72 --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
K+PN+V + ++++V+EY+ GG L D + ++ + E + + ++ + + +
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDF 130
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
H+ V HRD+K +NILL G++K
Sbjct: 131 LHSNQVIHRDIKS-----------------------------------DNILLGMDGSVK 155
Query: 190 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249
++DFG A Q + T G+P ++APEV+ + Y G DIWS G++ ++ G
Sbjct: 156 LTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGE 212
Query: 250 LPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKR 294
P+ + N L LY G +L P+ LS ++ L + LE + +R
Sbjct: 213 PPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 94/337 (27%), Positives = 143/337 (42%), Gaps = 95/337 (28%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLK 69
+YE +GEG +G V A+D + A+K I L+ D+ REI+ LK
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKK------IRLEQEDEGVPSTAIREISLLK 56
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----QLID 125
++H N+VRL +V+ S+ ++Y+V EY+ +L K A+ +L + Q++
Sbjct: 57 EMQHGNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILR 113
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
G++YCH+ V HRDLK P +N+L+D +
Sbjct: 114 GIAYCHSHRVLHRDLK---------------------------P--------QNLLIDRR 138
Query: 186 GN-IKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATSDIWSCGV 240
N +K++DFGL+ R G+ T Y APE+L + DIWS G
Sbjct: 139 TNALKLADFGLA------RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGC 192
Query: 241 ILYVILTGYLPF-DDRNLAVLYQKIFR----------------GDFK--LPKW------- 274
I ++ F D + L+ KIFR D+K PKW
Sbjct: 193 IFAEMVNQKPLFPGDSEIDELF-KIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLAT 251
Query: 275 ----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
L P +LL K+L +P KRIT E+F+
Sbjct: 252 VVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 66/244 (27%), Positives = 102/244 (41%), Gaps = 56/244 (22%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLK 72
+YE +G+G FG+V A+ + A+K +L +N IT REI L+LLK
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL--REIKILQLLK 69
Query: 73 HPNVVRLHEVLASKSK--------IYMVLEYVT---GGELFDKIASKGRLQEAEGRKLFQ 121
H NVV L E+ +K+ Y+V E+ G L +K + +E +K+ +
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNK---NVKFTLSEIKKVMK 126
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
L++G+ Y H + HRD+K NIL
Sbjct: 127 MLLNGLYYIHRNKILHRDMKA-----------------------------------ANIL 151
Query: 182 LDSKGNIKISDFGLS-ALPQHFRDDGLLHTT-CGSPNYVAPEVLAN-RGYDGATSDIWSC 238
+ G +K++DFGL+ A +T + Y PE+L R Y G D+W
Sbjct: 152 ITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDY-GPPIDMWGA 210
Query: 239 GVIL 242
G I+
Sbjct: 211 GCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 62/231 (26%), Positives = 110/231 (47%), Gaps = 42/231 (18%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+GEG+ G V A + +G AVK ++ + + + + E+ ++ H NVV ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
++++V+E++ GG L D I + R+ E + + ++ +SY HN+GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 142 VILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQH 201
++ILL S G IK+SDFG A Q
Sbjct: 146 S-----------------------------------DSILLTSDGRIKLSDFGFCA--QV 168
Query: 202 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
++ + G+P ++APEV++ Y G DIWS G+++ ++ G P+
Sbjct: 169 SKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 88/330 (26%), Positives = 129/330 (39%), Gaps = 88/330 (26%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY R LG G+ G V A D D AVK + +K REI ++ L H
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK---HALREIKIIRRLDH 61
Query: 74 PNVVRLHEVLASKSK--------------IYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
N+V+++EVL +Y+V EY+ + +G L E R
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLF 119
Query: 120 FQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179
QL+ G+ Y H+ V HRDLK VF+ T E+
Sbjct: 120 MYQLLRGLKYIHSANVLHRDLK-----------PANVFINT-----------------ED 151
Query: 180 ILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPE-VLANRGYDGATSDIWS 237
++L KI DFGL+ + H+ G L + Y +P +L+ Y A D+W+
Sbjct: 152 LVL------KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI-DMWA 204
Query: 238 CGVILYVILTGYLPF---------------------DDRN--LAVLYQKIFRGDFKLPKW 274
G I +LTG F +DRN L V+ + R D P+
Sbjct: 205 AGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFV-RNDGGEPRR 263
Query: 275 --------LSPGAQNLLRKILEPNPVKRIT 296
++P A + L +IL NP+ R+T
Sbjct: 264 PLRDLLPGVNPEALDFLEQILTFNPMDRLT 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 78/303 (25%), Positives = 127/303 (41%), Gaps = 55/303 (18%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPF-AVK-------ILEKNRIIHLKITDQIKREIAT 67
Y + LG G FG V + ++G A+K K++ K I E+
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 68 LK-LLKHPNVVRLHEVLASKSKIYMVLEYVTG---GELFDKIASKG-RLQEAEGRKLFQQ 122
+K L+HPN+VR ++ ++Y+V++ + G GE F+ + K R E +F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 123 LIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
++ + Y H K + HRDL P NI+
Sbjct: 122 MVLALRYLHKEKRIVHRDLT---------------------------P--------NNIM 146
Query: 182 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241
L + I+DFGL+ Q + L + G+ Y PE++ N Y G +D+W+ G I
Sbjct: 147 LGEDDKVTITDFGLAKQKQ---PESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCI 202
Query: 242 LYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWL-SPGAQNLLRKILEPNPVKRITIAG 299
LY + T PF N+ L KI ++ LP+ + S +++ L P+ R I
Sbjct: 203 LYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQ 262
Query: 300 IKA 302
+ A
Sbjct: 263 VSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 84/305 (27%), Positives = 135/305 (44%), Gaps = 64/305 (20%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HP 74
+E+ T+G+G +GKV + +G AVKIL+ IH I ++I+ E LK L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP---IH-DIDEEIEAEYNILKALSDHP 75
Query: 75 NVVRLHEVLASK-----SKIYMVLEYVTGGELFDKIASKGRLQEAEGRK------LFQQL 123
NVV+ + + K ++++VLE GG + D + KG L+ E + + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEA 133
Query: 124 IDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD 183
+ G+ + H HRD+K NILL
Sbjct: 134 LMGLQHLHVNKTIHRDVKG-----------------------------------NNILLT 158
Query: 184 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSC 238
++G +K+ DFG+SA R +T+ G+P ++APEV+A + YD A D+WS
Sbjct: 159 TEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYD-ARCDVWSL 215
Query: 239 GVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLRKILEPNPVKRI 295
G+ + G P D + KI R P+ S + +RK L + KR
Sbjct: 216 GITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRP 275
Query: 296 TIAGI 300
T++ +
Sbjct: 276 TVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.2 bits (197), Expect = 1e-16
Identities = 70/290 (24%), Positives = 132/290 (45%), Gaps = 59/290 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
+Y +G+G G V A D+ +G A++ + + Q K+E+ ++L
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMR 72
Query: 72 --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
K+PN+V + ++++V+EY+ GG L D + ++ + E + + ++ + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
H+ V HRD+K +NILL G++K
Sbjct: 132 LHSNQVIHRDIKS-----------------------------------DNILLGMDGSVK 156
Query: 190 ISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
++DFG A P+ + ++ G+P ++APEV+ + Y G DIWS G++ ++
Sbjct: 157 LTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIE 211
Query: 248 GYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKR 294
G P+ + N L LY G +L P+ LS ++ L + L+ + KR
Sbjct: 212 GEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 79/302 (26%), Positives = 125/302 (41%), Gaps = 55/302 (18%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V Q +G +A K L K R+ K + E L + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEA--EGRKLF--QQLIDGVSYCHNKGVFH 137
+K+ + +V+ + GG+L I + E R F Q+I G+ + H + + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 138 RDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSA 197
RDLK EN+LLD+ GN++ISD GL+
Sbjct: 121 RDLKP-----------------------------------ENVLLDNDGNVRISDLGLAV 145
Query: 198 LPQHFRDDGLLHTT--CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 255
+ DG T G+P ++APE+L YD + D ++ GV LY ++ PF R
Sbjct: 146 ELK----DGQSKTKGYAGTPGFMAPELLQGEEYDFSV-DYFALGVTLYEMIAARGPFRAR 200
Query: 256 NLAV----LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWF 306
V L Q+I P SP +++ +L +P KR+ G++ F
Sbjct: 201 GEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260
Query: 307 EQ 308
Sbjct: 261 RD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 89/339 (26%), Positives = 133/339 (39%), Gaps = 91/339 (26%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY++ +G+G++G V A D +G A+K + + H+ +I REI L+LL+HP
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHP 59
Query: 75 NVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
++V + ++ S+ IY+V E + +L I + L + QL+ + Y
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
H VFHRDLK P +NIL ++ +K
Sbjct: 119 IHTANVFHRDLK---------------------------P--------KNILANADCKLK 143
Query: 190 ISDFGLSALPQHFRDDGLLHTTCGSPNYV------APEVLANRGYDGATS--DIWSCGVI 241
I DFGL+ + F D T +YV APE L + T DIWS G I
Sbjct: 144 ICDFGLARV--AFNDTP---TAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCI 197
Query: 242 LYVILTGYLPFDDRNLAVLYQKIFRGDF--------------------------KLPKWL 275
+LTG F +N V++Q D K P
Sbjct: 198 FAEVLTGKPLFPGKN--VVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPF 255
Query: 276 S-------PGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
S P A LL ++L +P R T AD +F+
Sbjct: 256 SQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 77/280 (27%), Positives = 121/280 (43%), Gaps = 66/280 (23%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-K 72
+E+ T+G+G +GKV + G AVKIL+ + ++I+ E L+ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPN 77
Query: 73 HPNVVRLHEVL-----ASKSKIYMVLEYVTGG---ELFDKIASKG-RLQEAEGRKLFQQL 123
HPNVV+ + + ++++VLE GG EL + G RL EA +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 124 IDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD 183
+ G+ + HN + HRD+K NILL
Sbjct: 138 LLGLQHLHNNRIIHRDVKG-----------------------------------NNILLT 162
Query: 184 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSC 238
++G +K+ DFG+SA R +T+ G+P ++APEV+A + YD A D+WS
Sbjct: 163 TEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYD-ARCDVWSL 219
Query: 239 GVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKWLSP 277
G+ + G P FD + L FK+P+ P
Sbjct: 220 GITAIELGDGDPPLFDMHPVKTL--------FKIPRNPPP 251
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 79/299 (26%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 16 YELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
+E+ RT LG G +G+V L AVK L+++ + ++ +E A +
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 56
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLID 125
K +KHPN+V+L V + Y++ E++T G L D + R QE L Q+
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISS 115
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
+ Y K HRDL N L+
Sbjct: 116 AMEYLEKKNFIHRDLAA-----------------------------------RNCLVGEN 140
Query: 186 GNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYV 244
+K++DFGLS L D H P + APE LA + SD+W+ GV+L+
Sbjct: 141 HLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWE 197
Query: 245 ILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 300
I T G P+ +L+ +Y+ + +G +++ P+ P L+R + NP R + A I
Sbjct: 198 IATYGMSPYPGIDLSQVYELLEKG-YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 43/234 (18%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G+FG+V D + A+KI++ +I D I++EI L P + R +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYITRYYG 69
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
+K+++++EY+ GG D + G L+E + ++++ G+ Y H++ HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 142 VILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQH 201
N+LL +G++K++DFG++
Sbjct: 129 A-----------------------------------ANVLLSEQGDVKLADFGVAG---Q 150
Query: 202 FRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254
D + T G+P ++APEV+ YD +DIWS G+ + G P D
Sbjct: 151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 95/345 (27%), Positives = 143/345 (41%), Gaps = 87/345 (25%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ +G G +G V A D +GL AVK L + IIH K T RE+ LK +K
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 74
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V +Y+V ++ G +L + I +L + + L Q++ G
Sbjct: 75 HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 132
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ Y H+ + HRDLK N+ ++
Sbjct: 133 LKYIHSADIIHRDLKP-----------------------------------SNLAVNEDC 157
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
+KI DFGL+ +H D+ + + Y APE++ N + T DIWS G I+ +L
Sbjct: 158 ELKILDFGLA---RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212
Query: 247 TGYLPF------DDRNL---------AVLYQKIFRGDFK--------LPKW--------L 275
TG F D L A L +KI + +PK
Sbjct: 213 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 272
Query: 276 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 320
+P A +LL K+L + KRIT A A +F Q + +PDD+
Sbjct: 273 NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH---DPDDEPV 314
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 68/239 (28%), Positives = 106/239 (44%), Gaps = 54/239 (22%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+GNFG+V F L P AVK +++ LKI + E LK HPN+V+L
Sbjct: 3 LGKGNFGEV-FKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIG 59
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNKGVFHR 138
V + IY+V+E V GG+ + K E + ++L + +D G++Y +K HR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DL N L+ +KISDFG+S
Sbjct: 118 DLAA-----------------------------------RNCLVGENNVLKISDFGMSR- 141
Query: 199 PQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 252
++D ++++ G + APE L N G + SD+WS G++L+ + G P+
Sbjct: 142 ----QEDDGIYSSSGLKQIPIKWTAPEAL-NYGRYSSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 68/236 (28%), Positives = 104/236 (44%), Gaps = 46/236 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY + +G G FG V A+D +G A+K + K + + + RE+ LK L+H
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV-LAKRTYRELKLLKHLRHE 69
Query: 75 NVVRLHEVLASKSK-IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
N++ L ++ S + IY V E + G ++ + L++ + Q++ G+ Y H+
Sbjct: 70 NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
GV HRDLK P NIL++ ++KI DF
Sbjct: 128 GVVHRDLK---------------------------P--------SNILINENCDLKICDF 152
Query: 194 GLSALPQHFRDDGLLHTTCGSPNYVAPEV-LANRGYDGATSDIWSCGVILYVILTG 248
GL A Q + G + T Y APE+ L + YD DIWS G I +L G
Sbjct: 153 GL-ARIQDPQMTGYVSTR----YYRAPEIMLTWQKYDVEV-DIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 90/349 (25%), Positives = 135/349 (38%), Gaps = 85/349 (24%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY + +G G +G V A D +G A+K L + L + RE+ LK +KH
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKHE 74
Query: 75 NVVRLHEVLASKSKI------YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
NV+ L +V + Y+V+ ++ G K+ +L E + L Q++ G+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
Y H G+ HRDLK N+ ++ +
Sbjct: 133 YIHAAGIIHRDLKP-----------------------------------GNLAVNEDCEL 157
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248
KI DFGL+ + D + + Y APEV+ N + T DIWS G I+ +LTG
Sbjct: 158 KILDFGLAR-----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
Query: 249 YLPF------------------------------DDRNLAVLYQKIFRGDFK-LPKWLSP 277
F D +N + + DF+ L +P
Sbjct: 213 KPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANP 272
Query: 278 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ-----DYTPANPDDDEED 321
A N+L K+L + RIT A A +FE+ D T A P DD D
Sbjct: 273 LAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPYDDSFD 321
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 77/239 (32%), Positives = 111/239 (46%), Gaps = 57/239 (23%)
Query: 22 LGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
LG+GNFG V+ QD ++G AVK L+ + HL+ +REI LK L+H N+
Sbjct: 12 LGKGNFGSVELCRYDPLQD-NTGEVVAVKKLQHSTAEHLR---DFEREIEILKSLQHDNI 67
Query: 77 VRLHEVLASKSK--IYMVLEYVTGGELFDK-IASKGRLQEAEGRKLFQ---QLIDGVSYC 130
V+ V S + + +V+EY+ G L D + RL + RKL Q+ G+ Y
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL---DHRKLLLYASQICKGMEYL 124
Query: 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKI 190
+K HRDL AT NIL++S+ +KI
Sbjct: 125 GSKRYVHRDL-----------AT------------------------RNILVESENRVKI 149
Query: 191 SDFGLSA-LPQHFRDDGLLHTTCGSPNY-VAPEVLANRGYDGATSDIWSCGVILYVILT 247
DFGL+ LPQ ++ + SP + APE L + A SD+WS GV+LY + T
Sbjct: 150 GDFGLTKVLPQD-KEYYKVREPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 96/364 (26%), Positives = 145/364 (39%), Gaps = 100/364 (27%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY+ +GEG +G V A +G+ A+K + H + REI L+ KH
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP--FEHQTFCQRTLREIKILRRFKHE 63
Query: 75 NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
N++ + +++ S +Y+V E + +L+ I ++ L + Q++ G+ Y
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKY 121
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
H+ V HRDLK P N+LL++ ++K
Sbjct: 122 IHSANVLHRDLK---------------------------P--------SNLLLNTNCDLK 146
Query: 190 ISDFGL--SALPQHFRDDGLLHTTCGSPNYVAPEV-LANRGYDGATSDIWSCGVILYVIL 246
I DFGL A P+H G L + Y APE+ L ++GY A DIWS G IL +L
Sbjct: 147 ICDFGLARIADPEH-DHTGFLTEYVATRWYRAPEIMLNSKGYTKAI-DIWSVGCILAEML 204
Query: 247 TG--------Y---------------------------------LPFDDRNLAVLYQKIF 265
+ Y LPF + V + K+F
Sbjct: 205 SNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPK---VPWNKLF 261
Query: 266 RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD 325
P P A +LL K+L NP KRIT+ A + EQ + P++ EE D
Sbjct: 262 ------PN-ADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFD 314
Query: 326 NEAF 329
E F
Sbjct: 315 FELF 318
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 106/381 (27%), Positives = 147/381 (38%), Gaps = 118/381 (30%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---------R 63
L +YE+ + LG+G +G V A D + A+K KI D + R
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK----------KIFDAFRNATDAQRTFR 55
Query: 64 EIATLK-LLKHPNVVRLHEVL-ASKSK-IYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
EI L+ L HPN+V+L V+ A K IY+V EY+ +L I L++ R +
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-RANILEDVHKRYIM 113
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
QL+ + Y H+ V HRDLK P NI
Sbjct: 114 YQLLKALKYIHSGNVIHRDLK---------------------------P--------SNI 138
Query: 181 LLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVA------PEVL-ANRGYDGAT 232
LL+S +K++DFGL+ +L + + T +YVA PE+L + Y
Sbjct: 139 LLNSDCRVKLADFGLARSLSELEENPENPVLT----DYVATRWYRAPEILLGSTRYTKGV 194
Query: 233 SDIWSCGVILYVILTG-------------------------------YLPFDDRNLAVLY 261
D+WS G IL +L G PF L L
Sbjct: 195 -DMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLP 253
Query: 262 Q-KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA--NPDDD 318
D LPK S A +LL+K+L NP KR+T A+E E Y NP D+
Sbjct: 254 SRPRKPLDELLPK-ASDDALDLLKKLLVFNPNKRLT-----AEEALEHPYVAQFHNPSDE 307
Query: 319 E---EDI---FVDNEAFSMHE 333
I DN S+ E
Sbjct: 308 PVLPYPITIPLDDNVKLSVAE 328
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 75/242 (30%), Positives = 108/242 (44%), Gaps = 60/242 (24%)
Query: 20 RTLGEGNFGKVKF-----AQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
R LGEG+FGKV A D +G AVK L++ T K+EI LK L H
Sbjct: 10 RVLGEGHFGKVSLYCYDPAND-GTGEMVAVKTLKRECGQQN--TSGWKKEINILKTLYHE 66
Query: 75 NVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
N+V+ + + + +++EYV G L D + K +L A+ QQ+ +G++Y H+
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
+ HRDL N+LLD+ +KI D
Sbjct: 126 QHYIHRDLAA-----------------------------------RNVLLDNDRLVKIGD 150
Query: 193 FGLS-ALPQ-----HFRDDGLLHTTCGSPNY-VAPEVLANRGYDGATSDIWSCGVILYVI 245
FGL+ A+P+ R+DG SP + A E L + A SD+WS GV LY +
Sbjct: 151 FGLAKAVPEGHEYYRVREDG------DSPVFWYAVECLKENKFSYA-SDVWSFGVTLYEL 203
Query: 246 LT 247
LT
Sbjct: 204 LT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 65/240 (27%), Positives = 99/240 (41%), Gaps = 48/240 (20%)
Query: 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+ LG GNFG V L + AVK L++ I K + RE + + L HP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCI 58
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
VRL V + + +V+E G L + + + ++ ++L Q+ G++Y +K
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 137 HRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLS 196
HRDL N+LL ++ KISDFG+S
Sbjct: 118 HRDLAA-----------------------------------RNVLLVNRHQAKISDFGMS 142
Query: 197 -ALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 252
AL D TT G P + APE + + SD+WS GV L+ + G P+
Sbjct: 143 RAL--GAGSDYYRATTAGRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 45/208 (21%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
RE++ LK LKH N+V LH+++ ++ + +V EY+ +L + + G L K+F
Sbjct: 52 REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMF 110
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
QL+ G+SYCH + + HRDLK +N+L
Sbjct: 111 QLLRGLSYCHKRKILHRDLKP-----------------------------------QNLL 135
Query: 182 LDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 238
++ KG +K++DFGL+ ++P + ++ + Y P+VL D+W
Sbjct: 136 INEKGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPDVLLGSTEYSTPIDMWGV 190
Query: 239 GVILYVILTGYLPFDDRNLAVLYQKIFR 266
G ILY + TG F + IFR
Sbjct: 191 GCILYEMATGRPMFPGSTVKEELHLIFR 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 72/283 (25%), Positives = 131/283 (46%), Gaps = 51/283 (18%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+GEG+ G V A SG AVK ++ + + + + E+ ++ +H NVV ++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
++++V+E++ GG L D I + R+ E + + ++ +S H +GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 142 VILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQH 201
++ILL G +K+SDFG A Q
Sbjct: 144 S-----------------------------------DSILLTHDGRVKLSDFGFCA--QV 166
Query: 202 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVL 260
++ + G+P ++APE+++ Y G DIWS G+++ ++ G P F++ L +
Sbjct: 167 SKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 225
Query: 261 YQKIFRGDFKLPKW-----LSPGAQNLLRKILEPNPVKRITIA 298
K+ R + PK +SP + L ++L +P +R T A
Sbjct: 226 --KMIRDNLP-PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAA 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 68/240 (28%), Positives = 103/240 (42%), Gaps = 55/240 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLK- 72
+YE +G G +G V A+D SG A+K + + L ++ RE+A LK L+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLS--TVREVALLKRLEA 58
Query: 73 --HPNVVRLHEVLAS-----KSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQL 123
HPN+VRL +V A+ ++K+ +V E+V DK+ G L + L +Q
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQF 117
Query: 124 IDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD 183
+ G+ + H + HRDLK ENIL+
Sbjct: 118 LRGLDFLHANCIVHRDLKP-----------------------------------ENILVT 142
Query: 184 SKGNIKISDFGLSALPQ-HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242
S G +K++DFGL+ + ++ T Y APEVL Y D+WS G I
Sbjct: 143 SGGQVKLADFGLARIYSCQMALTPVVVTLW----YRAPEVLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 66/265 (24%), Positives = 109/265 (41%), Gaps = 63/265 (23%)
Query: 13 LGRYELGRTLGEGNFGKV---------------KFAQDLDSGLPFAVKILEKNRIIHLKI 57
L + + L G FGK+ + + G P +++ K +
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 58 TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV---LEYVTGGELFDK-IASKGRLQE 113
Q++ EI L L H N++++ E+L S++ YM+ ++ ++D+ K R
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 114 AEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173
+ R + +QL+ V Y H+K + HRD+K
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIK-------------------------------- 294
Query: 174 VLQLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 230
LENI L+ G I + DFG + + D G + T + +PE+LA GY
Sbjct: 295 ---LENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATN----SPEILAGDGYCE 347
Query: 231 ATSDIWSCGVILYVILT-GYLPFDD 254
T DIWSCG+IL +L+ + P D
Sbjct: 348 IT-DIWSCGLILLDMLSHDFCPIGD 371
|
Length = 501 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 75/316 (23%), Positives = 125/316 (39%), Gaps = 69/316 (21%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLLKHPNVV 77
LG+GN+G V +G+ A+K I L++ + QI E+ L P +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKE------IRLELDESKFNQIIMELDILHKAVSPYIV 62
Query: 78 RLHEVLASKSKIYMVLEYVTGG---ELFDKIASKGRLQEAEGRKLFQQLIDGVSYC---H 131
+ + +YM +EY+ G +L+ + + E R++ ++ G+ + H
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
N + HRD+K P N+L++ G +K+
Sbjct: 123 N--IIHRDVK---------------------------P--------TNVLVNGNGQVKLC 145
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA-----TSDIWSCGVILYVIL 246
DFG+S L T G +Y+APE + + G + SD+WS G+ + +
Sbjct: 146 DFGVSGN----LVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA 201
Query: 247 TGYLPFDDRNLAVLY---QKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302
G P+ A ++ I GD LP S AQ+ + K L P +R T A +
Sbjct: 202 LGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261
Query: 303 DEWFEQDYTPANPDDD 318
W + N D D
Sbjct: 262 HPWLVKY---KNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 62/285 (21%), Positives = 113/285 (39%), Gaps = 55/285 (19%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
+ LG G FG V + + A+K++ + + D E + L HPN+V
Sbjct: 8 FLKELGSGQFGVVHLGKWRGK-IDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLV 62
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
+L+ V + I++V EY+ G L + + KG+L + + + + Y + G
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 137 HRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLS 196
HRDL N L+ +K+SDFGL+
Sbjct: 123 HRDLAA-----------------------------------RNCLVGEDNVVKVSDFGLA 147
Query: 197 ALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 252
++ DD + G+ + PEV + + SD+WS GV+++ + + G +P+
Sbjct: 148 ---RYVLDDQYTSSQ-GTKFPVKWAPPEVF-DYSRFSSKSDVWSFGVLMWEVFSEGKMPY 202
Query: 253 DDR-NLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKR 294
+ N V+ + + G ++L PK ++ P R
Sbjct: 203 ERFSNSEVV-ESVSAG-YRLYRPKLAPTEVYTIMYSCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 83/302 (27%), Positives = 138/302 (45%), Gaps = 39/302 (12%)
Query: 18 LGRTLGEGNFGKV--KFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLL 71
LG+TLGEG FGKV A L G AVK+L++N ++ D + E LK +
Sbjct: 4 LGKTLGEGEFGKVVKATAFRL-KGRAGYTTVAVKMLKENAS-SSELRDLLS-EFNLLKQV 60
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
HP+V++L+ + + +++EY G L + L+E+ RK+ + +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSL------RSFLRES--RKVGPSYLGSDGNRN 112
Query: 132 NKGVFHRDLKVI----LKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
+ + + D + + L S +I+ +L + +V R L N+L+
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAE--MKLVHRD-----LAARNVLVAEGRK 165
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVI 245
+KISDFGLS + +D + + G ++A E L + Y SD+WS GV+L+ I
Sbjct: 166 MKISDFGLSR--DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEI 222
Query: 246 LT-GYLPFDD---RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301
+T G P+ L L + +R + P+ S NL+ + P KR T A I
Sbjct: 223 VTLGGNPYPGIAPERLFNLLKTGYRME--RPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280
Query: 302 AD 303
+
Sbjct: 281 KE 282
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 64/258 (24%), Positives = 116/258 (44%), Gaps = 52/258 (20%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G+FG+V D + A+KI++ +I D I++EI L P V + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYVTKYYG 69
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
+K+++++EY+ GG D + + G E + + ++++ G+ Y H++ HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 142 VILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQH 201
N+LL +G++K++DFG++
Sbjct: 129 A-----------------------------------ANVLLSEQGDVKLADFGVAG---Q 150
Query: 202 FRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAV 259
D + T G+P ++APEV+ YD + +DIWS G+ + G P D + + V
Sbjct: 151 LTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRV 209
Query: 260 LYQKIFRGDFKLPKWLSP 277
L F +PK P
Sbjct: 210 L--------FLIPKNNPP 219
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 74/309 (23%), Positives = 125/309 (40%), Gaps = 68/309 (22%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL----KITDQIKREIATLKLLKHPN 75
LG GN G V + + +G A K+ +H+ + QI RE+ + + P
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKV------VHIGAKSSVRKQILRELQIMHECRSPY 64
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK- 133
+V + +++ I M +E++ G L D+I K G + K+ +++G++Y +N
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
+ HRD+K P NIL++S+G IK+ DF
Sbjct: 124 RIMHRDIK---------------------------P--------SNILVNSRGQIKLCDF 148
Query: 194 GLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
G+S L D T G+ Y++PE + Y SD+WS G+ + + G PF
Sbjct: 149 GVSGELINSIAD-----TFVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPF 202
Query: 253 DDRN------------LAVLYQKIFRGDFKLPK-WLSPGAQNLLRKILEPNPVKRITIAG 299
N L +L Q + +LP ++ + L +P +R T
Sbjct: 203 AFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQ 262
Query: 300 IKADEWFEQ 308
+ A F Q
Sbjct: 263 LCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-14
Identities = 62/253 (24%), Positives = 117/253 (46%), Gaps = 50/253 (19%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG G FG VK+ + A+K++++ + D+ E + L H +V+L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQL 64
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
+ V + IY+V EY++ G L + + G R Q ++ ++ + + +G++Y +K HR
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DL N L+D +G +K+SDFGLS
Sbjct: 125 DLAA-----------------------------------RNCLVDDQGCVKVSDFGLS-- 147
Query: 199 PQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 254
++ DD ++ GS + PEVL + + SD+W+ GV+++ + + G +P++
Sbjct: 148 -RYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYER 204
Query: 255 RNLAVLYQKIFRG 267
N + +K+ +G
Sbjct: 205 FNNSETVEKVSQG 217
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 5e-14
Identities = 72/289 (24%), Positives = 121/289 (41%), Gaps = 55/289 (19%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-IKREIATLK 69
+ L + LG +GEG FG V + G AVK I +T Q E A +
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEYT--GQKVAVKN------IKCDVTAQAFLEETAVMT 54
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGV 127
L H N+VRL V+ +Y+V+E ++ G L + + ++GR + + + + +G+
Sbjct: 55 KLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
Y +K + HRDL NIL+ G
Sbjct: 114 EYLESKKLVHRDLAA-----------------------------------RNILVSEDGV 138
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
K+SDFGL+ + D+ L + APE L ++ + + SD+WS GV+L+ + +
Sbjct: 139 AKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKKFS-SKSDVWSYGVLLWEVFS 192
Query: 248 -GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKR 294
G P+ +L + + + +G + P+ L+ E P KR
Sbjct: 193 YGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 87/348 (25%), Positives = 137/348 (39%), Gaps = 86/348 (24%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-- 72
RYEL + LG+G +G V A++ ++ V I + + KI KR + LKLL+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKIL--AKRALRELKLLRHF 58
Query: 73 --HPNVVRLHE---VLASK-SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H N+ L++ V +++Y+ E + +L I S L +A + Q++ G
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCG 117
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ Y H+ V HRDLK P N+L+++
Sbjct: 118 LKYIHSANVLHRDLK---------------------------P--------GNLLVNADC 142
Query: 187 NIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV-LANRGYDGATSDIWSCGVILY 243
+KI DFGL+ + G + + Y APE+ L+ + Y A D+WS G IL
Sbjct: 143 ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAI-DVWSVGCILA 201
Query: 244 VILTGYLPFDDRN--------LAVL----------------YQKIFRGDFKLPK---WLS 276
+L F ++ L VL I K +
Sbjct: 202 ELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIF 261
Query: 277 PGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 320
P A +LL K+L +P KRI++ +E E Y D D+E
Sbjct: 262 PNANPLALDLLEKLLAFDPTKRISV-----EEALEHPYLAIWHDPDDE 304
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 61/243 (25%), Positives = 95/243 (39%), Gaps = 61/243 (25%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH----LKITDQIKREIATLKL 70
RY+ +G G +G V A D SG A+K +I H + + RE+ L+
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRH 60
Query: 71 LKHPNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
KH N++ + ++L +Y+V++ + +L I S L E R QL+ G
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ Y H+ V HRDLK P N+L++
Sbjct: 120 LKYIHSANVIHRDLK---------------------------P--------SNLLVNEDC 144
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------APEVL-ANRGYDGATSDIWSCG 239
++I DFG++ + T YV APE+L + Y A D+WS G
Sbjct: 145 ELRIGDFGMARGLSSSPTEHKYFMT----EYVATRWYRAPELLLSLPEYTTAI-DMWSVG 199
Query: 240 VIL 242
I
Sbjct: 200 CIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 66/254 (25%), Positives = 113/254 (44%), Gaps = 54/254 (21%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
G +EL +G G +G+V + + +G A+K+++ + ++IK EI LK H
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSH 71
Query: 74 -PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIA-SKGR-LQEAEGRKLFQQLI 124
N+ + KS ++++V+E+ G + D + +KG L+E + ++++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
G+++ H V HRD+K +N+LL
Sbjct: 132 RGLAHLHAHKVIHRDIKG-----------------------------------QNVLLTE 156
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT----SDIWSCGV 240
+K+ DFG+SA Q R G +T G+P ++APEV+A AT SDIWS G+
Sbjct: 157 NAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGI 214
Query: 241 ILYVILTGYLPFDD 254
+ G P D
Sbjct: 215 TAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 61/259 (23%), Positives = 102/259 (39%), Gaps = 68/259 (26%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
L R LG+G+FG V K + A+K + +N + +I + E + +K
Sbjct: 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMKEF 66
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--------KLFQ-- 121
+VVRL V+++ +V+E + G+L + S+ R + K Q
Sbjct: 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQMA 125
Query: 122 -QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
++ DG++Y K HRDL N
Sbjct: 126 AEIADGMAYLAAKKFVHRDLAA-----------------------------------RNC 150
Query: 181 LLDSKGNIKISDFGLSAL---PQHFRDDG--LLHTTCGSP-NYVAPEVLANRGYDGATSD 234
++ +KI DFG++ ++R G LL P ++APE L + G SD
Sbjct: 151 MVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL------PVRWMAPESLKD-GVFTTKSD 203
Query: 235 IWSCGVILYVILT-GYLPF 252
+WS GV+L+ + T P+
Sbjct: 204 VWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 8e-14
Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G+FG+V D + A+KI++ +I D I++EI L P V + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYVTKYYG 69
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
+K+++++EY+ GG D + G L E + + ++++ G+ Y H++ HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 142 VILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQH 201
N+LL G +K++DFG++
Sbjct: 129 A-----------------------------------ANVLLSEHGEVKLADFGVAG---Q 150
Query: 202 FRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254
D + T G+P ++APEV+ YD + +DIWS G+ + G P +
Sbjct: 151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSE 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 47/225 (20%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHPNVVR 78
R +G G+FG V FA+D+ + A+K + + + K D IK E+ L+ L+HPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK-EVRFLQKLRHPNTIQ 79
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
+ ++V+EY G K LQE E + + G++Y H+ + HR
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
D+K NILL G +K+ DFG +++
Sbjct: 140 DVKA-----------------------------------GNILLSEPGLVKLGDFGSASI 164
Query: 199 PQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGATSDIWSCGV 240
+ G+P ++APEV+ + G YDG D+WS G+
Sbjct: 165 MAP------ANXFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 69/236 (29%), Positives = 104/236 (44%), Gaps = 53/236 (22%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
LG GN G V SGL A K+ IHL+I +QI RE+ L P +V
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKL------IHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK-GV 135
+ S +I + +E++ GG L D++ K GR+ E K+ ++ G++Y K +
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKI 121
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
HRD+K P NIL++S+G IK+ DFG+
Sbjct: 122 MHRDVK---------------------------P--------SNILVNSRGEIKLCDFGV 146
Query: 196 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
S D + ++ G+ +Y++PE L Y SDIWS G+ L + G P
Sbjct: 147 SGQLI----DSMANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 48/261 (18%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V ++ AVK L+ + E +K L+H +
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKG 134
VRL+ V+ + IY++ EY+ G L D + S G++ + Q+ +G++Y K
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
HRDL+ NVL E+++ KI+DFG
Sbjct: 124 YIHRDLRAA-----------------------------NVLVSESLM------CKIADFG 148
Query: 195 LSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 252
L+ + + ++ P + APE + N G SD+WS G++LY I+T G +P+
Sbjct: 149 LARVIED--NEYTAREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
Query: 253 DDRNLAVLYQKIFRGDFKLPK 273
+ + + + RG +++P+
Sbjct: 206 PGMSNSDVMSALQRG-YRMPR 225
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 55/234 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN-RIIHLKITDQIKREIATLKLLKH 73
+ R +G G+FG V FA+D+ + A+K + + + + K D IK E+ L+ L+H
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK-EVRFLQQLRH 74
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
PN + + ++V+EY G ++ + K LQE E + + G++Y H
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
+ HRD+K NILL G +K++
Sbjct: 133 SHERIHRDIKA-----------------------------------GNILLTEPGTVKLA 157
Query: 192 DFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEV-LA-NRG-YDGATSDIWSCGV 240
DFG ++L P ++ G+P ++APEV LA + G YDG D+WS G+
Sbjct: 158 DFGSASLVSPA--------NSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 90/366 (24%), Positives = 147/366 (40%), Gaps = 99/366 (27%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ +G G +G V A D AVK L + +IH + T RE+ LK +K
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT---YRELRLLKHMK 72
Query: 73 HPNVVRLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V +++Y+V + G +L + I +L + + L QL+ G
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTN-LMGADL-NNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ Y H+ G+ HRDLK N+ ++
Sbjct: 131 LKYIHSAGIIHRDLKP-----------------------------------SNVAVNEDC 155
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
++I DFGL+ + D + + Y APE++ N + T DIWS G I+ +L
Sbjct: 156 ELRILDFGLAR-----QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
Query: 247 TG--YLPFDD------RNLAVL------------------------------YQKIFRGD 268
G P +D R + V+ +KIFRG
Sbjct: 211 KGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRG- 269
Query: 269 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN-PDDDEEDIFVDNE 327
+P A +LL K+L + KRI+ + A +F Q + P + P+ + D +N+
Sbjct: 270 ------ANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPYDESPENK 323
Query: 328 AFSMHE 333
++ E
Sbjct: 324 ERTIEE 329
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 71/255 (27%), Positives = 108/255 (42%), Gaps = 54/255 (21%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
LG GN G V SGL A K+ IHL+I +QI RE+ L P +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKL------IHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
+ S +I + +E++ GG L + GR+ E K+ +I G++Y K +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 126
Query: 137 HRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLS 196
HRD+K NIL++S+G IK+ DFG+S
Sbjct: 127 HRDVKP-----------------------------------SNILVNSRGEIKLCDFGVS 151
Query: 197 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF---D 253
D + ++ G+ +Y++PE L Y SDIWS G+ L + G P D
Sbjct: 152 GQ----LIDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPD 206
Query: 254 DRNLAVLYQKIFRGD 268
+ L +++ GD
Sbjct: 207 AKELELMFGCPVEGD 221
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 70/242 (28%), Positives = 104/242 (42%), Gaps = 58/242 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFA----VKILEKNRIIHLKITDQIKREIATLKL 70
+YE +GEG +GKV A+DL +G F V++ + L RE+A L+
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----REVAVLRH 57
Query: 71 LK---HPNVVRLHEVLA-----SKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLF 120
L+ HPNVVRL +V ++K+ +V E+V DK+ G E + +
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI-KDMM 116
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
QL+ G+ + H+ V HRDLK +NI
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKP-----------------------------------QNI 141
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240
L+ S G IK++DFGL+ + + L + + Y APEVL Y D+WS G
Sbjct: 142 LVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGC 197
Query: 241 IL 242
I
Sbjct: 198 IF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 97/363 (26%), Positives = 144/363 (39%), Gaps = 94/363 (25%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-TDQIKREIATLKLLKH 73
RY + +G G +G V A D +G A+K L +R +I + RE+ LK ++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHMQH 73
Query: 74 PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
NV+ L +V S Y+V+ Y+ KI L E + + L Q++ G+
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKVQYLVYQMLCGL 130
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
Y H+ G+ HRDLK N+ ++
Sbjct: 131 KYIHSAGIIHRDLKP-----------------------------------GNLAVNEDCE 155
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
+KI DFGL+ +H D + + Y APEV+ N + T DIWS G I+ +LT
Sbjct: 156 LKILDFGLA---RH--ADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210
Query: 248 GYLPFDDRN-LAVLYQ-----------------------------KIFRGDFKL--PKWL 275
G F ++ L L Q K R DF PK
Sbjct: 211 GKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPK-A 269
Query: 276 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ-----DYTPANPDDDEEDIFVDNEAFS 330
SP A +LL K+LE + KR+T +F+ + T P DD ++NE S
Sbjct: 270 SPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQPYDDS----LENEKLS 325
Query: 331 MHE 333
+ E
Sbjct: 326 VDE 328
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 66/254 (25%), Positives = 114/254 (44%), Gaps = 54/254 (21%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
G +EL +G G +G+V + + +G A+K+++ + ++IK+EI LK H
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 61
Query: 74 -PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIA-SKGR-LQEAEGRKLFQQLI 124
N+ + K+ ++++V+E+ G + D I +KG L+E + ++++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
G+S+ H V HRD+K +N+LL
Sbjct: 122 RGLSHLHQHKVIHRDIKG-----------------------------------QNVLLTE 146
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT----SDIWSCGV 240
+K+ DFG+SA Q R G +T G+P ++APEV+A AT SD+WS G+
Sbjct: 147 NAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 204
Query: 241 ILYVILTGYLPFDD 254
+ G P D
Sbjct: 205 TAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 45/224 (20%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R +G G+FG V FA+D+ + A+K + + + I +E+ L+ +KHPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ ++V+EY G K LQE E + + G++Y H+ + HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 140 LKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALP 199
+K NILL G +K++DFG +++
Sbjct: 151 IKA-----------------------------------GNILLTEPGQVKLADFGSASIA 175
Query: 200 QHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGATSDIWSCGV 240
++ G+P ++APEV+ + G YDG D+WS G+
Sbjct: 176 SP------ANSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGI 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 67/274 (24%), Positives = 113/274 (41%), Gaps = 62/274 (22%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLK 69
E + LG G FG V + G +P A+K+L + K +I E +
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMA 64
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELF-------DKIASKGRLQEAEGRKLFQQ 122
+ HP+VVRL + S S++ ++ + + G L D I S+ L Q
Sbjct: 65 SVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV------Q 117
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
+ G+SY K + HRDL N+L+
Sbjct: 118 IAKGMSYLEEKRLVHRDLAA-----------------------------------RNVLV 142
Query: 183 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGATSDIWSCGV 240
+ ++KI+DFGL+ L D+ H G P ++A E + +R Y SD+WS GV
Sbjct: 143 KTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGV 199
Query: 241 ILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
++ ++T G P++ + + +G+ +LP+
Sbjct: 200 TVWELMTFGAKPYEGIPAVEIPDLLEKGE-RLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 75/295 (25%), Positives = 126/295 (42%), Gaps = 52/295 (17%)
Query: 17 ELGRTLGEGNFGKVK---FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
LGR +GEG FG V + + + AVK + + ++ +E ++ H
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDH 66
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
P++V+L V+ +++ +++V+E GEL + +K L A QL ++Y +
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
K HRD I R N+L+ S +K+ D
Sbjct: 126 KRFVHRD-------------------------IAAR----------NVLVSSPDCVKLGD 150
Query: 193 FGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GY 249
FGLS ++ D+ + G P ++APE + R + A SD+W GV ++ IL G
Sbjct: 151 FGLS---RYLEDESYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGV 206
Query: 250 LPFDD-RNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302
PF +N V+ +I G+ +P P +L+ K +P KR +KA
Sbjct: 207 KPFQGVKNNDVI-GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 45/208 (21%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
RE++ LK LKH N+V LH+++ ++ + +V EY+ +L + G KLF
Sbjct: 53 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLF 111
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
QL+ G++YCH + V HRDLK +N+L
Sbjct: 112 QLLRGLNYCHRRKVLHRDLKP-----------------------------------QNLL 136
Query: 182 LDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 238
++ +G +K++DFGL+ ++P + ++ + Y P++L D+W
Sbjct: 137 INERGELKLADFGLARAKSIPTKTYSNEVV-----TLWYRPPDILLGSTDYSTQIDMWGV 191
Query: 239 GVILYVILTGYLPFDDRNLAVLYQKIFR 266
G I Y + TG F + IFR
Sbjct: 192 GCIFYEMSTGRPLFPGSTVEEQLHFIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 47/223 (21%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
+G G+FG V FA + + AVK + + + K D IK E+ L+ LKHPN +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIK-EVKFLQQLKHPNTIEYK 87
Query: 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
+ ++V+EY G K LQE E + + G++Y H+ + HRD+
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147
Query: 141 KVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQ 200
K NILL G +K++DFG ++
Sbjct: 148 KA-----------------------------------GNILLTEPGQVKLADFGSASKSS 172
Query: 201 HFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGATSDIWSCGV 240
++ G+P ++APEV+ + G YDG D+WS G+
Sbjct: 173 P------ANSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGI 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 73/265 (27%), Positives = 113/265 (42%), Gaps = 55/265 (20%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
LG GN G V Q SGL A K+ IHL+I +QI RE+ L P +V
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKL------IHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
+ S +I + +E++ GG L + R+ E K+ ++ G++Y K +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIM 126
Query: 137 HRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLS 196
HRD+K NIL++S+G IK+ DFG+S
Sbjct: 127 HRDVKP-----------------------------------SNILVNSRGEIKLCDFGVS 151
Query: 197 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF---D 253
D + ++ G+ +Y++PE L Y SDIWS G+ L + G P D
Sbjct: 152 GQ----LIDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPD 206
Query: 254 DRNL-AVLYQKIFRGDFKLPKWLSP 277
+ L A+ + + G+ P +SP
Sbjct: 207 AKELEAIFGRPVVDGEEGEPHSISP 231
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 61/247 (24%), Positives = 104/247 (42%), Gaps = 41/247 (16%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V Q ++G +A K L+K R+ E L+ + P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRD 139
SK+ + +V+ + GG+L I + G R + Q+ G+ + H+ + +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 140 LKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALP 199
+K EN+LLD +GN ++SD GL+
Sbjct: 121 MKP-----------------------------------ENVLLDDQGNCRLSDLGLAV-- 143
Query: 200 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV 259
+D + G+ Y+APE+L Y D ++ G +Y ++ G PF D V
Sbjct: 144 -ELKDGKTITQRAGTNGYMAPEILKEEPYSYPV-DWFAMGCSIYEMVAGRTPFKDHKEKV 201
Query: 260 LYQKIFR 266
+++ R
Sbjct: 202 AKEELKR 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-13
Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 39/255 (15%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ RY++ R +G+G G+V A D A+K + ++ + + + RE L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGEL-------FDKIASKGRLQEAEGRK----LFQ 121
HP +V ++ + + +Y + Y+ G L + K + L E +F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW---KFNVLQLE 178
++ + Y H+KGV HRDLK LL +VI W F L+ E
Sbjct: 121 KICATIEYVHSKGVLHRDLKP------------DNILLGLFGEVVILDWGAAIFKKLE-E 167
Query: 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS-DIWS 237
LLD + + + +P G+P+Y+APE L G + S DI++
Sbjct: 168 EDLLDIDVDERNICYSSMTIPGKI---------VGTPDYMAPERL--LGVPASESTDIYA 216
Query: 238 CGVILYVILTGYLPF 252
GVILY +LT P+
Sbjct: 217 LGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 8e-13
Identities = 77/310 (24%), Positives = 128/310 (41%), Gaps = 73/310 (23%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L R LG G FG+V + ++ P AVK L+ + E +K L+HP +
Sbjct: 9 QLLRKLGAGQFGEV-WEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
++L+ V + IY+V E + G L + LQ GR L QLID G++
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLE------YLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
Y + HRDL N+L+
Sbjct: 118 YLEAQNYIHRDLAA-----------------------------------RNVLVGENNIC 142
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVILYVI 245
K++DFGL+ + ++D + G+ + APE A SD+WS G++L I
Sbjct: 143 KVADFGLARV---IKED-IYEAREGAKFPIKWTAPEA-ALYNRFSIKSDVWSFGILLTEI 197
Query: 246 LT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL----EPNPVKRITIAGI 300
+T G +P+ A + Q++ +G +++P PG L I+ + +P R T +
Sbjct: 198 VTYGRMPYPGMTNAEVLQQVDQG-YRMPC--PPGCPKELYDIMLDCWKEDPDDRPTFETL 254
Query: 301 KADEWFEQDY 310
+ W +D+
Sbjct: 255 Q---WKLEDF 261
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 71/274 (25%), Positives = 115/274 (41%), Gaps = 74/274 (27%)
Query: 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIATLKLL 71
+ +G G FG+V + G + A+K L +K R+ L E + +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-------TEASIMGQF 62
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------ 125
HPN++RL V+ + ++ EY+ G L DK L+E +G+ QL+
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRGIA 116
Query: 126 -GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
G+ Y HRDL NIL++S
Sbjct: 117 SGMKYLSEMNYVHRDLAA-----------------------------------RNILVNS 141
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCG--SP-NYVAPEVLANRGYDGATSDIWSCGVI 241
K+SDFGLS + D +TT G P + APE +A R + A SD+WS G++
Sbjct: 142 NLVCKVSDFGLS---RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIV 197
Query: 242 LYVILT-GYLPFDD-RNLAVLYQKIFRGDFKLPK 273
++ +++ G P+ D N V+ + + G ++LP
Sbjct: 198 MWEVMSYGERPYWDMSNQDVI-KAVEDG-YRLPP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 66/291 (22%), Positives = 117/291 (40%), Gaps = 83/291 (28%)
Query: 29 KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88
KV D + F +K L K + + RE T+ PN+V LH+ + S+
Sbjct: 8 KVLLVMDTRTQQTFILKGLRK--------SSEYSRERLTIIPHCVPNMVCLHKYIVSEDS 59
Query: 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCH 148
+++VL++ GG+L+ I+ + E ++ +++ + H +G+ RDL
Sbjct: 60 VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLN------- 112
Query: 149 MRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLL 208
P NILLD +G+I+++ F + + +
Sbjct: 113 --------------------P--------NNILLDDRGHIQLTYFS------RWSE---V 135
Query: 209 HTTCGSPN----YVAPEVLANRGYDGATS------DIWSCGVILYVILTGYLPFDDRNLA 258
+C Y APEV G S D WS G IL+ +LTG
Sbjct: 136 EDSCDGEAVENMYCAPEV-------GGISEETEACDWWSLGAILFELLTG---------K 179
Query: 259 VLYQKIFRG-----DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304
L + G +P+W+S A++LL+++L+ NP +R+ ++
Sbjct: 180 TLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVED 230
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 57/202 (28%), Positives = 87/202 (43%), Gaps = 69/202 (34%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
RE + LK LKH N+V LH+++ +K + +V EY+ +L + G +LF
Sbjct: 52 REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLF 110
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
QL+ G++YCH + V HRDLK P +N+L
Sbjct: 111 QLLRGLAYCHQRRVLHRDLK---------------------------P--------QNLL 135
Query: 182 LDSKGNIKISDFGLS---ALPQH----------FR-DDGLLHTTCGSPNYVAPEVLANRG 227
+ +G +K++DFGL+ ++P +R D LL GS Y
Sbjct: 136 ISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLL----GSTEY---------- 181
Query: 228 YDGATS-DIWSCGVILYVILTG 248
+TS D+W G I Y + TG
Sbjct: 182 ---STSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 62/242 (25%), Positives = 100/242 (41%), Gaps = 49/242 (20%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
YE LGEG++ V + +G A+K++ T RE + LK LKH N
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFT--AIREASLLKGLKHAN 64
Query: 76 VVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+V LH+++ +K + +V EYV + DK G L + QL+ G+SY H +
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
+ HRDLK +N+L+ G +K++DF
Sbjct: 123 YILHRDLKP-----------------------------------QNLLISDTGELKLADF 147
Query: 194 GLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250
GL+ ++P H + ++ + Y P+VL D+W G I ++ G
Sbjct: 148 GLARAKSVPSHTYSNEVV-----TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVA 202
Query: 251 PF 252
F
Sbjct: 203 AF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 74/261 (28%), Positives = 112/261 (42%), Gaps = 72/261 (27%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLP-----FAVKILEKNRIIHLKITDQIKREIATLK 69
R LG+ LGEG FG+V A+ + P AVK+L+ + ++D + E+ +K
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVS-EMEMMK 70
Query: 70 LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------GRKLF 120
++ KH N++ L V + +Y+V+EY G L D + ++ E L
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 121 Q--------QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172
Q Q+ G+ + +K HRDL R
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAA-------R---------------------- 161
Query: 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRD----DGLLHTTCGS-P-NYVAPEVLANR 226
NVL E+ ++ KI+DFGL+ RD D TT G P ++APE L +R
Sbjct: 162 NVLVTEDHVM------KIADFGLA------RDIHHIDYYRKTTNGRLPVKWMAPEALFDR 209
Query: 227 GYDGATSDIWSCGVILYVILT 247
Y SD+WS GV+L+ I T
Sbjct: 210 VYT-HQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 75/245 (30%), Positives = 113/245 (46%), Gaps = 38/245 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQ--DLDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
R LG+ LGEG FG+V A+ LD P AVK+L K+ ++D I E+
Sbjct: 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 76
Query: 68 LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
+K++ KH N++ L +Y+++EY ASKG L+E L + G
Sbjct: 77 MKMIGKHKNIINLLGACTQDGPLYVIVEY----------ASKGNLREY----LRARRPPG 122
Query: 127 VSYCHNKGVFHRDLKVI--LKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
+ YC+N + L SC ++A +L + + L N+L+
Sbjct: 123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-------KKCIHRDLAARNVLVTE 175
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVIL 242
+KI+DFGL+ H D TT G ++APE L +R Y SD+WS GV+L
Sbjct: 176 DNVMKIADFGLARDIHHI--DYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLL 232
Query: 243 YVILT 247
+ I T
Sbjct: 233 WEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 45/208 (21%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-Q 121
RE++ LK LKH N+V LH+++ + + +V EY+ +L + G + K+F
Sbjct: 53 REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLY 111
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
Q++ G++YCH + V HRDLK +N+L
Sbjct: 112 QILRGLAYCHRRKVLHRDLKP-----------------------------------QNLL 136
Query: 182 LDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 238
++ +G +K++DFGL+ ++P + ++ + Y P+VL D+W
Sbjct: 137 INERGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPDVLLGSSEYSTQIDMWGV 191
Query: 239 GVILYVILTGYLPFDDRNLAVLYQKIFR 266
G I + + +G F + IFR
Sbjct: 192 GCIFFEMASGRPLFPGSTVEDELHLIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 79/313 (25%), Positives = 133/313 (42%), Gaps = 70/313 (22%)
Query: 20 RTLGEGNFGKVKFA----QDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHP 74
R LGEG+FGKV+ + ++G AVK L+ ++ H+ +K+EI L+ L H
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI---ADLKKEIEILRNLYHE 66
Query: 75 NVVRLHEVLASK--SKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCH 131
N+V+ + + I +++E++ G L + + +K ++ + K Q+ G+ Y
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
++ HRDL N+L++S+ +KI
Sbjct: 127 SRQYVHRDLAA-----------------------------------RNVLVESEHQVKIG 151
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNY-VAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250
DFGL+ + ++ + SP + APE L + A SD+WS GV LY +LT Y
Sbjct: 152 DFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLT-YC 209
Query: 251 PFDDRNLAVLYQKI--FRGDF---KLPKWLSPGAQ------------NLLRKILEPNPVK 293
+ + + + I G +L + L G + L+RK E P K
Sbjct: 210 DSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSK 269
Query: 294 RIT----IAGIKA 302
R T I G +A
Sbjct: 270 RTTFQNLIEGFEA 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 52/233 (22%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
Y + +TL G+ G+V A P +KI +K + E L+ + HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL---------IEAMLLQNVNHPS 118
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKG 134
V+R+ + L S + MVL + + +L+ + + L + + +Q+++G+ Y H +
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
+ HRD+K ENI ++ + I D G
Sbjct: 178 IIHRDVKT-----------------------------------ENIFINDVDQVCIGDLG 202
Query: 195 LSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
+ P GL G+ APEVLA Y+ + +DIWS G++L+ +L
Sbjct: 203 AAQFPVVAPAFLGL----AGTVETNAPEVLARDKYN-SKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 6e-12
Identities = 74/273 (27%), Positives = 116/273 (42%), Gaps = 61/273 (22%)
Query: 16 YELGRTLGEGNFGKVKFAQ---DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ LGR LG+G FG V+ AQ + S AVK+L K I ++ RE A +K
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 73 HPNVVRLHEV-LASKSK----IYMV-LEYVTGGELFDKIASKGRLQE----AEGRKLFQQ 122
HPNV++L V L S++K I MV L ++ G+L + R+ E + L +
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMS-RIGEEPFTLPLQTLVRF 118
Query: 123 LID---GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179
+ID G+ Y +K HRDL N
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAA-----------------------------------RN 143
Query: 180 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIW 236
+L+ + ++DFGLS + C S ++A E LA+ Y SD+W
Sbjct: 144 CMLNENMTVCVADFGLS---KKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVW 199
Query: 237 SCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 268
+ GV ++ I+T G P+ + +Y + +G+
Sbjct: 200 AFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 69/305 (22%), Positives = 123/305 (40%), Gaps = 59/305 (19%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
+ + +L +T+G+G FG V G AVK ++ + + E + +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMTQ 55
Query: 71 LKHPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---G 126
L+H N+V+L V+ K +Y+V EY+ G L D + S+GR G L + +D
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEA 114
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ Y HRDL N+L+
Sbjct: 115 MEYLEANNFVHRDLAA-----------------------------------RNVLVSEDN 139
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
K+SDFGL+ +D G L + APE L + + SD+WS G++L+ I
Sbjct: 140 VAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFS-TKSDVWSFGILLWEIY 193
Query: 247 T-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303
+ G +P+ L + ++ +G +K+ P P +++++ + R + ++
Sbjct: 194 SFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLR-- 250
Query: 304 EWFEQ 308
E E
Sbjct: 251 EQLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 73/307 (23%), Positives = 121/307 (39%), Gaps = 62/307 (20%)
Query: 18 LGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
LG+ LGEG FG V + +QD S L AVK ++ + + +I + + E A +K HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-SEAACMKDFDHP 61
Query: 75 NVVRLHEV---LASKSKI---YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID--- 125
NV++L V +S KI ++L ++ G+L + RL + Q L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS-RLGGLPEKLPLQTLLKFMV 120
Query: 126 ----GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
G+ Y N+ HRDL N +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAA-----------------------------------RNCM 145
Query: 182 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSC 238
L + ++DFGLS + + ++A E LA+R Y + SD+W+
Sbjct: 146 LREDMTVCVADFGLS---KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAF 201
Query: 239 GVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRIT 296
GV ++ I T G P+ +Y + G+ K P+ +L+ +P R T
Sbjct: 202 GVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPT 261
Query: 297 IAGIKAD 303
++
Sbjct: 262 FTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 77/316 (24%), Positives = 118/316 (37%), Gaps = 88/316 (27%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLLKHPNVV 77
LGEG++ V +G A+K+ I +K + + RE + LK LKH N+V
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKV------ISMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
LH+++ +K + V EY+ I G L R QL+ G++Y H + + H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126
Query: 138 RDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSA 197
RDLK +N+L+ G +K++DFGL+
Sbjct: 127 RDLKP-----------------------------------QNLLISYLGELKLADFGLA- 150
Query: 198 LPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253
R + T S Y P+VL + DIW G I +L G F
Sbjct: 151 -----RAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205
Query: 254 DRN------------LAVLYQKIFRGDFKLPKW-------------------LS--PGAQ 280
+ L V + + G KLP + LS P A+
Sbjct: 206 GVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAE 265
Query: 281 NLLRKILEPNPVKRIT 296
+L ++L P RI+
Sbjct: 266 DLASQMLMMFPKDRIS 281
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 71/294 (24%), Positives = 114/294 (38%), Gaps = 62/294 (21%)
Query: 21 TLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
TLG G FG+V K ++ VK L+K + +L+ + +RE+ + L H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLSHKN 69
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGR-------LQEAEGRKLFQQLIDG 126
VVRL + YM+LEY G+L F + L + L Q+ G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ + N HRDL A N L+ S+
Sbjct: 130 MDHLSNARFVHRDL-----------AA------------------------RNCLVSSQR 154
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVI 245
+K+S LS + + P ++APE + + SD+WS GV+++ +
Sbjct: 155 EVKVSLLSLSKDV--YNSEYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEV 211
Query: 246 LT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE----PNPVKR 294
T G LPF + + ++ G +LP + G + L K++ NP R
Sbjct: 212 FTQGELPFYGLSDEEVLNRLQAGKLELP--VPEGCPSRLYKLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 70/267 (26%), Positives = 115/267 (43%), Gaps = 61/267 (22%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V + A+K L++ + + E +K L+HP +
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
VRL+ V+ ++ IY++ EY+ G L D L+ EG KL +LID G++
Sbjct: 64 VRLYAVV-TQEPIYIITEYMENGSLVD------FLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
+ K HRDL+ NIL+
Sbjct: 117 FIERKNYIHRDLRA-----------------------------------ANILVSETLCC 141
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
KI+DFGL+ L + ++ P + APE + N G SD+WS G++L I+T
Sbjct: 142 KIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVT 198
Query: 248 -GYLPFDDRNLAVLYQKIFRGDFKLPK 273
G +P+ + Q + RG +++P+
Sbjct: 199 YGRIPYPGMTNPEVIQNLERG-YRMPR 224
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 58/254 (22%), Positives = 108/254 (42%), Gaps = 50/254 (19%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG G FG V + + + A+K + + + + E + L HP +V+L
Sbjct: 10 KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQL 64
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
+ V + +Y+V E++ G L + + + G+L + + Q + +G+ Y HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198
DL N L+ S G +K+SDFG++
Sbjct: 125 DLAA-----------------------------------RNCLVSSTGVVKVSDFGMT-- 147
Query: 199 PQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 254
++ DD ++ G+ + PEV Y + SD+WS GV+++ + T G +PF+
Sbjct: 148 -RYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEK 204
Query: 255 RNLAVLYQKIFRGD 268
++ + + I RG
Sbjct: 205 KSNYEVVEMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 57/236 (24%), Positives = 101/236 (42%), Gaps = 54/236 (22%)
Query: 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
LG GN G V A L + AVK++ + I +++ QI E+ L P ++ +
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 81 EVLASKSKIYMVLEYVTGGEL--FDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
+++I + E++ GG L + KI GR+ A ++ G++Y + +
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA--------VVKGLTYLWSLKIL 117
Query: 137 HRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLS 196
HRD+K P N+L++++G +K+ DFG+S
Sbjct: 118 HRDVK---------------------------P--------SNMLVNTRGQVKLCDFGVS 142
Query: 197 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
+ + T G+ Y+APE ++ Y G SD+WS G+ + G P+
Sbjct: 143 TQLV----NSIAKTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 63/252 (25%), Positives = 104/252 (41%), Gaps = 60/252 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIA 66
++ + +G G FG+V + G +P A+K L EK R L E +
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFL-------SEAS 57
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLI 124
+ HPN++ L V+ + +V EY+ G L D K G+ + + + +
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIA 116
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
G+ Y + G HRDL NIL++S
Sbjct: 117 SGMKYLSDMGYVHRDLAA-----------------------------------RNILVNS 141
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVI 241
K+SDFGLS + + D +TT G + APE +A R + A SD+WS G++
Sbjct: 142 NLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIV 198
Query: 242 LYVILT-GYLPF 252
++ +++ G P+
Sbjct: 199 MWEVMSYGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 59/257 (22%), Positives = 110/257 (42%), Gaps = 51/257 (19%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G G FG V L+ A+K + + + + E + L HP +V+L+
Sbjct: 12 IGSGQFGLVWLGYWLEKR-KVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYG 66
Query: 82 VLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
V +S I +V E++ G L D + A +G+ + + + +G++Y + V HRDL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 141 KVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQ 200
N L+ +K+SDFG++
Sbjct: 127 AA-----------------------------------RNCLVGENQVVKVSDFGMT---- 147
Query: 201 HFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 256
F D ++ G+ + +PEV + Y + SD+WS GV+++ + + G P+++R+
Sbjct: 148 RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRS 206
Query: 257 LAVLYQKIFRGDFKLPK 273
+ + + I G F+L K
Sbjct: 207 NSEVVETINAG-FRLYK 222
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 61/261 (23%), Positives = 112/261 (42%), Gaps = 49/261 (18%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V A + AVK ++ + E +K L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKG 134
V+LH V+ +K IY++ E++ G L D + S + + Q+ +G+++ +
Sbjct: 64 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
HRDL+ NIL+ + KI+DFG
Sbjct: 123 YIHRDLRA-----------------------------------ANILVSASLVCKIADFG 147
Query: 195 LSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 252
L+ + + ++ P + APE + N G SD+WS G++L I+T G +P+
Sbjct: 148 LARVIED--NEYTAREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPY 204
Query: 253 DDRNLAVLYQKIFRGDFKLPK 273
+ + + + RG +++P+
Sbjct: 205 PGMSNPEVIRALERG-YRMPR 224
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 57/230 (24%), Positives = 96/230 (41%), Gaps = 42/230 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
++E+ +GEG +G V + ++ A+K K+ + ++ + RE+ L+ LK
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
N+V L E + K+Y+V EYV EL +++ + G E + R QLI + +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN-GVPPE-KVRSYIYQLIKAIHWCHK 118
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
+ HRD+K EN+L+ +K+ D
Sbjct: 119 NDIVHRDIKP-----------------------------------ENLLISHNDVLKLCD 143
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242
FG + + + Y +PE+L Y G D+WS G IL
Sbjct: 144 FGFARNLSEGSNANYTEYV-ATRWYRSPELLLGAPY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 70/285 (24%), Positives = 113/285 (39%), Gaps = 43/285 (15%)
Query: 22 LGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
LG GNFG VK + S AVKIL KN + D++ RE ++ L +P +VR+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ ++S + +V+E G L + + E +L Q+ G+ Y HRD
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 140 LKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALP 199
L N+LL ++ KISDFGLS
Sbjct: 121 LAA-----------------------------------RNVLLVTQHYAKISDFGLSKAL 145
Query: 200 QHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNL 257
+ T P + APE + N + SD+WS GV+++ + G P+
Sbjct: 146 GADENYYKAKTHGKWPVKWYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204
Query: 258 AVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301
+ Q I G+ + P+ P +L++ +R A ++
Sbjct: 205 NEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVE 249
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 64/248 (25%), Positives = 99/248 (39%), Gaps = 53/248 (21%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
L RY+ + +G G G V A D G+ AVK L + H K + RE+ LK
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAK---RAYRELVLLKC 76
Query: 71 LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
+ H N++ L V + +Y+V+E + L I + L L Q++
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIHME--LDHERMSYLLYQML 133
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
G+ + H+ G+ HRDLK NI++ S
Sbjct: 134 CGIKHLHSAGIIHRDLKP-----------------------------------SNIVVKS 158
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
+KI DFGL+ + ++ + Y APEV+ GY DIWS G I+
Sbjct: 159 DCTLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGE 214
Query: 245 ILTGYLPF 252
++ G + F
Sbjct: 215 LVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 76/314 (24%), Positives = 120/314 (38%), Gaps = 79/314 (25%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLP------FAVKILEKNRIIHLKITDQIKREIATLKLL 71
L R LGEG FGKV F + P AVK L++ + +RE L
Sbjct: 9 LKRELGEGAFGKV-FLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNF 65
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--------------KGRLQEAEGR 117
+H N+V+ + V MV EY+ G+L + S G L ++
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177
++ Q+ G+ Y ++ HRDL AT
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDL-----------AT------------------------ 150
Query: 178 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-----CGSP----NYVAPEVLANRGY 228
N L+ +KI DFG+S RD ++TT G ++ PE + R +
Sbjct: 151 RNCLVGYDLVVKIGDFGMS------RD---VYTTDYYRVGGHTMLPIRWMPPESIMYRKF 201
Query: 229 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL-PKWLSPGAQNLLRKI 286
SD+WS GV+L+ I T G P+ + + + I +G P+ +++
Sbjct: 202 T-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGC 260
Query: 287 LEPNPVKRITIAGI 300
+ +P +RI I I
Sbjct: 261 WKRDPQQRINIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 72/290 (24%), Positives = 116/290 (40%), Gaps = 65/290 (22%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK--LLKH--PNVV 77
+G G G+V + +G AVK + + ++ KR + L L H P +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRT-----GNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNK-G 134
+ + + S +++ +E + DK+ +G + E K+ ++ + Y K G
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
V HRD+K P NILLD+ GN+K+ DFG
Sbjct: 136 VIHRDVK---------------------------P--------SNILLDASGNVKLCDFG 160
Query: 195 LSALPQHFRDDGLLHT-TCGSPNYVAPEVL----ANRGYDGATSDIWSCGVILYVILTGY 249
+S D T + G Y+APE + N YD +D+WS G+ L + TG
Sbjct: 161 ISG----RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYD-IRADVWSLGISLVELATGQ 215
Query: 250 LPFD--DRNLAVLYQKIFRGDF-KLP--KWLSPGAQNLLRKILEPNPVKR 294
P+ VL KI + + LP + SP + + L + KR
Sbjct: 216 FPYKNCKTEFEVL-TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKR 264
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 78/328 (23%), Positives = 124/328 (37%), Gaps = 107/328 (32%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEK---NRIIHLKITDQIKREIATLKLLKHPNVVR 78
+G G +G V A++ ++ A+K + NRI + REI L+ L H NV+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL----REIKLLRHLDHENVIA 68
Query: 79 LHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+ +++ + +Y+V E + +L I S L + + QL+ G+ Y H+
Sbjct: 69 IKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA 127
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
V HRDLK P N+LL++ ++KI DF
Sbjct: 128 NVLHRDLK---------------------------P--------SNLLLNANCDLKICDF 152
Query: 194 GLSALPQHFRDDGLLHTTCGSPN----------YVAPEVLANRGYDGATSDIWSCGVILY 243
GL+ TT + Y APE+L N D+WS G I
Sbjct: 153 GLA------------RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFA 200
Query: 244 VILTG--------YL------------PFDD--------------RNLAVLYQKIFRGDF 269
+L Y+ P ++ R+L ++ F F
Sbjct: 201 ELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLF 260
Query: 270 KLPKWLSPGAQNLLRKILEPNPVKRITI 297
P +P A +LL K+L +P KRIT+
Sbjct: 261 --PH-ANPLAIDLLEKMLVFDPSKRITV 285
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 49/197 (24%), Positives = 78/197 (39%), Gaps = 51/197 (25%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
REI LK + H ++ L KS + MV+ +LF + G L + + ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
L++ ++Y H +G+ HRD+K ENI L
Sbjct: 194 LLEALAYLHGRGIIHRDVK-----------------------------------TENIFL 218
Query: 183 DSKGNIKISDFGLSA-------LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 235
D N + DFG + PQ + G L T +PE+LA Y A +DI
Sbjct: 219 DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN-------SPELLALDPY-CAKTDI 270
Query: 236 WSCGVILYVILTGYLPF 252
WS G++L+ + +
Sbjct: 271 WSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 75/297 (25%), Positives = 121/297 (40%), Gaps = 61/297 (20%)
Query: 18 LGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
LG+TLGEG FG V + QD DS L AVK ++ ++ D + E +K HP
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQD-DSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHP 60
Query: 75 NVVRLHEVL--ASKSKIY----MVLEYVTGGE-----LFDKIASKGRLQEAEGR-KLFQQ 122
NV+RL V +S+ Y ++L ++ G+ L+ ++ + + K
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
+ G+ Y +K HRDL N +L
Sbjct: 121 IASGMEYLSSKSFIHRDLAA-----------------------------------RNCML 145
Query: 183 DSKGNIKISDFGLSAL---PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239
+ N+ ++DFGLS ++R + ++A E LA+R Y SD+WS G
Sbjct: 146 NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV---KWIAIESLADRVYT-TKSDVWSFG 201
Query: 240 VILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKR 294
V ++ I T G P+ + +Y + +G+ K P G +L+ NP R
Sbjct: 202 VTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDR 258
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 77/307 (25%), Positives = 128/307 (41%), Gaps = 68/307 (22%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V + + AVK L+ + + E +K L+H +
Sbjct: 9 QLIKKLGNGQFGEV-WMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
V+L+ V+ S+ IY+V EY++ G L D L++ EGR L L+D G++
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLD------FLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
Y HRDL+ NIL+
Sbjct: 117 YIERMNYIHRDLRS-----------------------------------ANILVGDGLVC 141
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVILYVI 245
KI+DFGL+ L + D G+ + APE A G SD+WS G++L +
Sbjct: 142 KIADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTEL 196
Query: 246 LT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303
+T G +P+ N + +++ RG P+ L+ + + +P +R T +++
Sbjct: 197 VTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS- 255
Query: 304 EWFEQDY 310
F +DY
Sbjct: 256 --FLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 72/310 (23%), Positives = 121/310 (39%), Gaps = 75/310 (24%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
G+TLG G FGKV A D+ + AVK+L+ H + + E+ +
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT--AHSSEREALMSELKIMS 93
Query: 70 LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLID 125
L H N+V L I ++ EY G+L + + K R L Q+
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAK 152
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
G+++ +K HRDL N+LL
Sbjct: 153 GMAFLASKNCIHRDLAA-----------------------------------RNVLLTHG 177
Query: 186 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------------APEVLANRGYDGATS 233
+KI DFGL+ RD +++ + NYV APE + N Y S
Sbjct: 178 KIVKICDFGLA------RD--IMNDS----NYVVKGNARLPVKWMAPESIFNCVYT-FES 224
Query: 234 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPN 290
D+WS G++L+ I + G P+ + + K+ + +++ P+ ++++ + +
Sbjct: 225 DVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDAD 284
Query: 291 PVKRITIAGI 300
P+KR T I
Sbjct: 285 PLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 66/243 (27%), Positives = 103/243 (42%), Gaps = 47/243 (19%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
E R +G G FG V D G A+K + N +L ++ RE+ L KH NV
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNV 61
Query: 77 VRLHEVLASK-----SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYC 130
+ ++L +IY+V E + +L I S L ++ K+F Q++ G+ Y
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLS-SDHVKVFLYQILRGLKYL 119
Query: 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKI 190
H+ G+ HRD+K P N+L++S +KI
Sbjct: 120 HSAGILHRDIK---------------------------P--------GNLLVNSNCVLKI 144
Query: 191 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL-ANRGYDGATSDIWSCGVILYVILTGY 249
DFGL+ + + + + + Y APE+L +R Y A DIWS G I +L
Sbjct: 145 CDFGLARV-EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAV-DIWSVGCIFAELLGRR 202
Query: 250 LPF 252
+ F
Sbjct: 203 ILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 37/119 (31%), Positives = 56/119 (47%), Gaps = 14/119 (11%)
Query: 213 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 272
G+P+Y+APE+L + + A D W+ GV L+ LTG PF+D ++Q I D P
Sbjct: 542 GTPDYLAPELLLGKPHGPAV-DWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 273 ---KWLSPGAQNLLRKILEPNPVKRITIAGIKAD------EWFEQDYTP----ANPDDD 318
+ LS AQN + +L +P KR + +K +W PDD+
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQNQTMPFIPQPDDE 659
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 62/256 (24%), Positives = 99/256 (38%), Gaps = 66/256 (25%)
Query: 22 LGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
LGEG FGKV + + S A+K L++N K+ + ++E + L+HPN+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--KVQQEFRQEAELMSDLQHPNI 70
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIAS----------------KGRLQEAEGRKLF 120
V L V + M+ EY+ G+L + + K L ++ +
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
Q+ G+ Y + HRDL A N
Sbjct: 131 IQIAAGMEYLSSHHFVHRDL-----------AA------------------------RNC 155
Query: 181 LLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 237
L+ +KISDFGLS ++R + + ++ PE + G SDIWS
Sbjct: 156 LVGEGLTVKISDFGLSRDIYSADYYR---VQSKSLLPVRWMPPEAILY-GKFTTESDIWS 211
Query: 238 CGVILYVILT-GYLPF 252
GV+L+ I + G P+
Sbjct: 212 FGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 68/269 (25%), Positives = 107/269 (39%), Gaps = 86/269 (31%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
R LG+ LGEG FG+V A+ D + AVK+L+ N + D I E+
Sbjct: 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLIS-EMEL 70
Query: 68 LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE------------- 113
+KL+ KH N++ L V + +Y+++EY A+KG L+E
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEY----------AAKGNLREFLRARRPPGPDYT 120
Query: 114 ------AEGRKLFQQLID-------GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160
E + F+ L+ G+ Y ++ HRDL
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA------------------ 162
Query: 161 FLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYV 218
N+L+ +KI+DFGL+ D T+ G ++
Sbjct: 163 -----------------RNVLVTEDNVMKIADFGLARGVHDI--DYYKKTSNGRLPVKWM 203
Query: 219 APEVLANRGYDGATSDIWSCGVILYVILT 247
APE L +R Y SD+WS G++++ I T
Sbjct: 204 APEALFDRVYT-HQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 70/253 (27%), Positives = 105/253 (41%), Gaps = 60/253 (23%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
L YE G +G G +G V A+ D +A+K +E I+ REIA L+
Sbjct: 1 LFEYE-GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-----GISMSACREIALLRE 54
Query: 71 LKHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI-------ASKGRLQEAEG--RKL 119
LKHPNV+ L +V S + K++++ +Y +L+ I A+K +Q G + L
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 120 FQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179
Q++DG+ Y H V HRDLK N
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKP-----------------------------------AN 138
Query: 180 ILL----DSKGNIKISDFGLSAL-PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234
IL+ +G +KI+D G + L + L + Y APE+L + D
Sbjct: 139 ILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAID 198
Query: 235 IWSCGVILYVILT 247
IW+ G I +LT
Sbjct: 199 IWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 71/253 (28%), Positives = 105/253 (41%), Gaps = 60/253 (23%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKL 70
L YE G +G G +G V A+ D +A+K +E I+ REIA L+
Sbjct: 1 LFEYE-GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-----GISMSACREIALLRE 54
Query: 71 LKHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI----ASKG-----RLQEAEGRKL 119
LKHPNV+ L +V S S K++++ +Y +L+ I ASK +L + + L
Sbjct: 55 LKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 120 FQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179
Q++DG+ Y H V HRDLK N
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKP-----------------------------------AN 138
Query: 180 ILL----DSKGNIKISDFGLSAL-PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234
IL+ +G +KI+D G + L + L + Y APE+L + D
Sbjct: 139 ILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAID 198
Query: 235 IWSCGVILYVILT 247
IW+ G I +LT
Sbjct: 199 IWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 92/355 (25%), Positives = 150/355 (42%), Gaps = 74/355 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
R LG+ LGEG FG+V A+ + + + AVK+L K+ ++D + E+
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLSDLVS-EMEM 70
Query: 68 LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
+K++ KH N++ L +Y+++EY ASKG L+E L + G
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEY----------ASKGNLREY----LRARRPPG 116
Query: 127 VSY----CH--NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
+ Y C + + +DL SC ++A +L + + L N+
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLV----SCAYQVARGMEYLAS-------QKCIHRDLAARNV 165
Query: 181 LLDSKGNIKISDFGLSALPQHFRD----DGLLHTTCGS--PNYVAPEVLANRGYDGATSD 234
L+ +KI+DFGL+ RD D TT G ++APE L +R Y SD
Sbjct: 166 LVTEDNVMKIADFGLA------RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSD 218
Query: 235 IWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPV 292
+WS GV+L+ I T G P+ + L++ + G P + ++R+ P
Sbjct: 219 VWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPS 278
Query: 293 KRITIAGI-----------KADEW------FEQDYTPANPDDDEEDIFVDNEAFS 330
+R T + DE+ FEQ Y+P PD D+ F+
Sbjct: 279 QRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQ-YSPGCPDSPSSCSSGDDSVFA 332
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 75/308 (24%), Positives = 111/308 (36%), Gaps = 70/308 (22%)
Query: 20 RTLGEGNFGKVKFAQDLD-----SG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
LG G FG+V D SG + AVK L K K + +E + H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNH 58
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG-----RKLFQQLID--- 125
PN+V+L V Y+++E + GG+L + R++ ++L +D
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAK 117
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
G Y HRDL N L+ K
Sbjct: 118 GCVYLEQMHFIHRDLAA-----------------------------------RNCLVSEK 142
Query: 186 GN-----IKISDFGL-----SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 235
G +KI DFGL + +GLL ++APE L + G SD+
Sbjct: 143 GYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV-----RWMAPESLLD-GKFTTQSDV 196
Query: 236 WSCGVILYVILT-GYLPFDDR-NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 293
WS GV+++ ILT G P+ N VL G + P+ L+ +P +
Sbjct: 197 WSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSE 256
Query: 294 RITIAGIK 301
R T I+
Sbjct: 257 RPTFDRIQ 264
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 32/80 (40%), Positives = 40/80 (50%), Gaps = 5/80 (6%)
Query: 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG--ATSDIW 236
NILLD GNIK+ DFG+S D G Y+APE + DG SD+W
Sbjct: 138 NILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVW 194
Query: 237 SCGVILYVILTGYLPFDDRN 256
S G+ LY + TG P+ N
Sbjct: 195 SLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 79/305 (25%), Positives = 125/305 (40%), Gaps = 72/305 (23%)
Query: 22 LGEGNFGKVKFAQDLDSGLPF--AVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
+GEGNFG+V A GL A+K+L++ + H +++ KL HPN++
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELE---VLCKLGHHPNII 66
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------------GRKLFQQL 123
L ++ +Y+ +EY G L D + K R+ E + ++L Q
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 124 ID---GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
D G+ Y K HRDL NVL EN+
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAA-----------------------------RNVLVGENL 156
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSC 238
KI+DFGLS + + + T G ++A E L Y SD+WS
Sbjct: 157 A------SKIADFGLSRGEEVY-----VKKTMGRLPVRWMAIESLNYSVYT-TKSDVWSF 204
Query: 239 GVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRI 295
GV+L+ I++ G P+ A LY+K+ +G +++ P+ L+R+ P +R
Sbjct: 205 GVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRMEKPRNCDDEVYELMRQCWRDRPYERP 263
Query: 296 TIAGI 300
A I
Sbjct: 264 PFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 68/272 (25%), Positives = 110/272 (40%), Gaps = 71/272 (26%)
Query: 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIATLKLL 71
+ +G G FG+V G + A+K L EK R L E + +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-------EASIMGQF 63
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------ 125
H N++RL V+ ++ EY+ G L DK L++ +G QL+
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKY-----LRDHDGEFSSYQLVGMLRGIA 117
Query: 126 -GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
G+ Y + HRDL NIL++S
Sbjct: 118 AGMKYLSDMNYVHRDLAA-----------------------------------RNILVNS 142
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVI 241
K+SDFGLS + + + +TT G + APE +A R + A SD+WS G++
Sbjct: 143 NLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIV 199
Query: 242 LYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 272
++ +++ G P+ D + + + I G F+LP
Sbjct: 200 MWEVMSFGERPYWDMSNHEVMKAINDG-FRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 9e-09
Identities = 66/268 (24%), Positives = 104/268 (38%), Gaps = 54/268 (20%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
+G G FGKV + G+ A V + E +E+ + L HPNV++
Sbjct: 3 IGNGWFGKV-LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ-----LIDGVSYCHNKGV 135
+VLE+ G+L + + S + +K Q + G+ + H
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF 121
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
H DL L N L + ++KI D+GL
Sbjct: 122 IHSDLA-----------------------------------LRNCQLTADLSVKIGDYGL 146
Query: 196 SALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGAT------SDIWSCGVILYVILT 247
AL Q + +D + C + P ++APE++ RG D S+IWS GV ++ + T
Sbjct: 147 -ALEQ-YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
Query: 248 -GYLPFDD-RNLAVLYQKIFRGDFKLPK 273
P+ D + VL Q + D KLPK
Sbjct: 205 AADQPYPDLSDEQVLKQVVREQDIKLPK 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 70/246 (28%), Positives = 113/246 (45%), Gaps = 46/246 (18%)
Query: 18 LGRTLGEGNFGKVKFAQDL--DSGLP-----FAVKILEKNRIIHLKITDQIKREIATLKL 70
LG+ LGEG FG+V A+ L D P AVK+L K+ ++D + E+ +K+
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 76
Query: 71 L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE--AEGRKLFQQLIDGV 127
+ KH N++ L +Y+++EY ASKG L+E R + +
Sbjct: 77 IGKHKNIINLLGACTQDGPLYVIVEY----------ASKGNLREYLRARRPPGMEYSYDI 126
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
+ ++ + +D L SC ++A +L + + L N+L+
Sbjct: 127 ARVPDEQMTFKD----LVSCTYQVARGMEYLAS-------QKCIHRDLAARNVLVTENNV 175
Query: 188 IKISDFGLSALPQHFRD----DGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVI 241
+KI+DFGL+ RD D TT G ++APE L +R Y SD+WS GV+
Sbjct: 176 MKIADFGLA------RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVL 228
Query: 242 LYVILT 247
++ I T
Sbjct: 229 MWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 75/304 (24%), Positives = 121/304 (39%), Gaps = 70/304 (23%)
Query: 22 LGEGNFGKVKFAQDLDSGLPF--AVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
+GEGNFG+V A+ GL A+K +++ ++ H +++ KL HPN++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE---VLCKLGHHPNII 59
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------------GRKLFQQL 123
L + +Y+ +EY G L D + K R+ E + ++L
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 124 ID---GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
D G+ Y K HRDL NI
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAA-----------------------------------RNI 143
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSC 238
L+ KI+DFGLS + + + T G ++A E L Y SD+WS
Sbjct: 144 LVGENYVAKIADFGLSRGQEVY-----VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSY 197
Query: 239 GVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRIT 296
GV+L+ I++ G P+ A LY+K+ +G + P +L+R+ P +R +
Sbjct: 198 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS 257
Query: 297 IAGI 300
A I
Sbjct: 258 FAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 66/249 (26%), Positives = 101/249 (40%), Gaps = 59/249 (23%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLLKHP 74
L R LGEG FGKV F + + P KIL + + + K RE L L+H
Sbjct: 9 LKRELGEGAFGKV-FLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 67
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------------RLQEAEGRKLFQ 121
++V+ + V + MV EY+ G+L + + G L +++ + Q
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
Q+ G+ Y ++ HRDL N L EN+L
Sbjct: 128 QIAAGMVYLASQHFVHRDLAT-----------------------------RNCLVGENLL 158
Query: 182 LDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 238
+KI DFG+S ++R G HT ++ PE + R + SD+WS
Sbjct: 159 ------VKIGDFGMSRDVYSTDYYRVGG--HTML-PIRWMPPESIMYRKFT-TESDVWSL 208
Query: 239 GVILYVILT 247
GV+L+ I T
Sbjct: 209 GVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 62/270 (22%), Positives = 108/270 (40%), Gaps = 69/270 (25%)
Query: 22 LGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHP 74
+G G FG+V + G + A+K L+ T++ +R E + + HP
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG------YTEKQRRDFLSEASIMGQFDHP 65
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------DGV 127
N++ L V+ + ++ E++ G L L++ +G+ QL+ G+
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGAL------DSFLRQNDGQFTVIQLVGMLRGIAAGM 119
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
Y HRDL NIL++S
Sbjct: 120 KYLSEMNYVHRDLAA-----------------------------------RNILVNSNLV 144
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVILYV 244
K+SDFGLS + D ++ G + APE +A R + A SD+WS G++++
Sbjct: 145 CKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWE 203
Query: 245 ILT-GYLPF-DDRNLAVLYQKIFRGDFKLP 272
+++ G P+ D N V+ D++LP
Sbjct: 204 VMSYGERPYWDMSNQDVI--NAIEQDYRLP 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 78/302 (25%), Positives = 118/302 (39%), Gaps = 66/302 (21%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLH 80
+GEGNFG+V A+ GL I E+ L KL HPN++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----------QQLID----- 125
+ +Y+ +EY G L D + K R+ E + QQL+
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 126 --GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD 183
G+ Y K HRDL NIL+
Sbjct: 134 ARGMDYLSQKQFIHRDLAA-----------------------------------RNILVG 158
Query: 184 SKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVI 241
KI+DFGLS + + + T G ++A E L Y SD+WS GV+
Sbjct: 159 ENYVAKIADFGLSRGQEVY-----VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVL 212
Query: 242 LYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ--NLLRKILEPNPVKRITIA 298
L+ I++ G P+ A LY+K+ +G ++L K L+ + +L+R+ P +R + A
Sbjct: 213 LWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFA 271
Query: 299 GI 300
I
Sbjct: 272 QI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 64/245 (26%), Positives = 98/245 (40%), Gaps = 67/245 (27%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
L RY+ + +G G G V A D +G A+K L + + H K + RE+ +KL
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAK---RAYRELVLMKL 71
Query: 71 LKHPNVVRLHEV------LASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQ 122
+ H N++ L V L +Y+V+E + ++ R+ L Q
Sbjct: 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQ 126
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
++ G+ + H+ G+ HRDLK P NI++
Sbjct: 127 MLCGIKHLHSAGIIHRDLK---------------------------P--------SNIVV 151
Query: 183 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----YVAPEVLANRGYDGATSDIWS 237
S +KI DFGL+ R G + +P Y APEV+ GY DIWS
Sbjct: 152 KSDCTLKILDFGLA------RTAG--TSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWS 202
Query: 238 CGVIL 242
G I+
Sbjct: 203 VGCIM 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 40/187 (21%), Positives = 76/187 (40%), Gaps = 40/187 (21%)
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
E L+ + HP++++L ++L Y T +L+ +A+K + + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERS 190
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
++ + Y H + HRD+K ENI +
Sbjct: 191 VLRAIQYLHENRIIHRDIKA-----------------------------------ENIFI 215
Query: 183 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242
+ G++ + DFG + P + + G+ APE+LA Y G DIWS G++L
Sbjct: 216 NHPGDVCLGDFGAACFPVDINANKY-YGWAGTIATNAPELLARDPY-GPAVDIWSAGIVL 273
Query: 243 YVILTGY 249
+ + T +
Sbjct: 274 FEMATCH 280
|
Length = 391 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 75/302 (24%), Positives = 130/302 (43%), Gaps = 68/302 (22%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V + + A+K L+ ++ + +E +K L+H +V L+
Sbjct: 14 LGQGCFGEV-WMGTWNGTTKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--KLFQ------QLIDGVSYCHNK 133
V+ S+ IY+V E++ G L D L+E +G+ KL Q Q+ DG++Y
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLD------FLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
HRDL+ N+L +N++ KI+DF
Sbjct: 122 NYIHRDLRAA-----------------------------NILVGDNLV------CKIADF 146
Query: 194 GLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GY 249
GL+ L + D G+ + APE A G SD+WS G++L ++T G
Sbjct: 147 GLARLIE----DNEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELVTKGR 201
Query: 250 LPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308
+P+ + +++ RG P+ L++ + +P +R T I++ F +
Sbjct: 202 VPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS---FLE 258
Query: 309 DY 310
DY
Sbjct: 259 DY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 64/254 (25%), Positives = 96/254 (37%), Gaps = 66/254 (25%)
Query: 18 LGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L R LGEG FGKV A+ + AVK L+ L +RE L L+
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQ 65
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELF----------------DKIASKGRLQEAEG 116
H ++V+ + V + MV EY+ G+L +KG L ++
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQ 176
+ Q+ G+ Y ++ HRDL
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLAT---------------------------------- 151
Query: 177 LENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 233
N L+ + +KI DFG+S ++R G HT ++ PE + R + S
Sbjct: 152 -RNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG--HTML-PIRWMPPESIMYRKFT-TES 206
Query: 234 DIWSCGVILYVILT 247
D+WS GVIL+ I T
Sbjct: 207 DVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 61/271 (22%), Positives = 90/271 (33%), Gaps = 85/271 (31%)
Query: 14 GRYELGRTLGEGNFGKVKFA-----QDLDSGLP-----------FAVKILEKNRIIHLKI 57
LGEG FG+V QD AVK+L + + +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 58 TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL---------FDKIASK 108
D +K E+ L L PN+ RL V + M++EY+ G+L +
Sbjct: 65 -DFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 109 GRLQEAEGRKLFQ--QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166
+ L+ Q+ G+ Y + HRDL AT
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDL-----------AT------------- 158
Query: 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAP--- 220
N L+ IKI+DFG+S ++R G P
Sbjct: 159 -----------RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG---------RAPLPIRW 198
Query: 221 ----EVLANRGYDGATSDIWSCGVILYVILT 247
VL + + SD+W+ GV L+ ILT
Sbjct: 199 MAWESVLLGK-FTTK-SDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 44/182 (24%), Positives = 78/182 (42%), Gaps = 40/182 (21%)
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKGR-LQEAEGRKLFQ 121
E L+ L HP V+ L +V +VL +Y + +L+ + ++ R L A+ + +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS--DLYTYLGARLRPLGLAQVTAVAR 267
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
QL+ + Y H +G+ HRD+K EN+L
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKT-----------------------------------ENVL 292
Query: 182 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241
++ +I + DFG + + + G+ + APEVLA Y + DIWS G++
Sbjct: 293 VNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLV 351
Query: 242 LY 243
++
Sbjct: 352 IF 353
|
Length = 461 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 77/307 (25%), Positives = 119/307 (38%), Gaps = 69/307 (22%)
Query: 22 LGEGNFGKVKFAQ------DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
LGEG FGKV A+ + D L AVK L++ +RE L +L+H +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKML-VAVKALKE---ASESARQDFQREAELLTVLQHQH 68
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQ---------- 121
+VR + V + MV EY+ G+L + S G L E Q
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 122 -QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
Q+ G+ Y + HRDL AT N
Sbjct: 129 SQIASGMVYLASLHFVHRDL-----------AT------------------------RNC 153
Query: 181 LLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 237
L+ +KI DFG+S ++R G T ++ PE + R + SDIWS
Sbjct: 154 LVGQGLVVKIGDFGMSRDIYSTDYYRVGG---RTMLPIRWMPPESILYRKFT-TESDIWS 209
Query: 238 CGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRI 295
GV+L+ I T G P+ + + I +G + + P+ P +++ + P +R+
Sbjct: 210 FGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRM 269
Query: 296 TIAGIKA 302
I I +
Sbjct: 270 VIKDIHS 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 49/229 (21%)
Query: 22 LGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
LG GNFG VK + + A+K+L+ + D++ RE + L +P +VR+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
V +++ + +V+E +GG L ++ K + + +L Q+ G+ Y K HR
Sbjct: 61 IGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLS-A 197
DL N+LL ++ KISDFGLS A
Sbjct: 120 DLAA-----------------------------------RNVLLVNQHYAKISDFGLSKA 144
Query: 198 LPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVILY 243
L DD + APE + R + + SD+WS G+ ++
Sbjct: 145 LGA---DDSYYKARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 77/294 (26%), Positives = 123/294 (41%), Gaps = 63/294 (21%)
Query: 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
R +G+G+FG V +DS + AVK L NRI L+ +Q +E +K HPNV
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 77 VRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHN 132
+ L + L S+ +VL Y+ G+L + I S+ +++ G L Q+ G+ Y +
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLAS 116
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
K HRDL N +LD +K++D
Sbjct: 117 KKFVHRDLAA-----------------------------------RNCMLDESFTVKVAD 141
Query: 193 FGLSALPQHFRD-------DGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYV 244
FGL+ RD HT P ++A E L + + SD+WS GV+L+
Sbjct: 142 FGLA------RDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWE 194
Query: 245 ILT-GYLPFDDRNLAVLYQKIFRGDFKL-PKWLSPGAQNLLRKILEPNPVKRIT 296
++T G P+ D + + + +G L P++ ++ P P R T
Sbjct: 195 LMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPT 248
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 40/137 (29%), Positives = 62/137 (45%), Gaps = 11/137 (8%)
Query: 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE----VLANRGYDGATSD 234
N+L++ G +K+ DFG+S + D G Y+APE L +GYD SD
Sbjct: 134 NVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYMAPERINPELNQKGYD-VKSD 189
Query: 235 IWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDFKLPK-WLSPGAQNLLRKILEPNP 291
+WS G+ + + TG P+D L Q + +LP SP Q+ + K L+ N
Sbjct: 190 VWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNY 249
Query: 292 VKRITIAGIKADEWFEQ 308
+R + +FE
Sbjct: 250 KERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 64/269 (23%), Positives = 94/269 (34%), Gaps = 82/269 (30%)
Query: 17 ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIA 66
L R LG G FG+V L AVK L E++ L E
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM-------EAL 61
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--------- 117
+ H N+VRL V + +++LE + GG+L K L+E R
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSLTM 115
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173
+ + G Y HRD I R
Sbjct: 116 KDLLFCARDVAKGCKYLEENHFIHRD-------------------------IAAR----- 145
Query: 174 VLQLENILLDSKGN---IKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANRG 227
N LL KG KI+DFG++ ++R G ++ PE + G
Sbjct: 146 -----NCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG---RAMLPIKWMPPEAFLD-G 196
Query: 228 YDGATSDIWSCGVILYVILT-GYLPFDDR 255
+ +D+WS GV+L+ I + GY+P+ R
Sbjct: 197 IFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 67/273 (24%), Positives = 104/273 (38%), Gaps = 82/273 (30%)
Query: 15 RYELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIKREIATLK 69
Y R +G+G FG+V A L PF AVK+L++ ++ Q RE A +
Sbjct: 8 EYV--RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ--REAALMA 63
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS---------------------- 107
HPN+V+L V A + ++ EY+ G+L + +
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 108 KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167
L E + +Q+ G++Y + HRDL AT
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL-----------AT-------------- 158
Query: 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------YVAPE 221
N L+ +KI+DFGLS R+ S N ++ PE
Sbjct: 159 ----------RNCLVGENMVVKIADFGLS------RNIYSADYYKASENDAIPIRWMPPE 202
Query: 222 -VLANRGYDGATSDIWSCGVILYVILT-GYLPF 252
+ NR Y SD+W+ GV+L+ I + G P+
Sbjct: 203 SIFYNR-YT-TESDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 53/252 (21%), Positives = 94/252 (37%), Gaps = 54/252 (21%)
Query: 17 ELGRTLGEGNFGK--VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
EL +G+ V A+ + AVK + + + +++EI T + L+HP
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLK-LLQQEIITSRQLQHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHN 132
N++ S++Y+V + G D + + L E + + +++ + Y H+
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
KG HR +K+ H ILL G + +S
Sbjct: 120 KGFIHRS----VKASH-------------------------------ILLSGDGKVVLS- 143
Query: 193 FGLSALPQHFRDDGLLHTTCGSP--------NYVAPEVLAN--RGYDGATSDIWSCGVIL 242
GL G +++PEVL +GY+ SDI+S G+
Sbjct: 144 -GLRYS-VSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYN-EKSDIYSVGITA 200
Query: 243 YVILTGYLPFDD 254
+ G++PF D
Sbjct: 201 CELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 74/319 (23%), Positives = 123/319 (38%), Gaps = 65/319 (20%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
L RY+ + +G G G V A D A+K L + H K + RE+ +K
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 72
Query: 71 LKHPNVVRLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
+ H N++ L V + +Y+V+E + L I + L L Q++
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQML 129
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
G+ + H+ G+ HRDLK NI++ S
Sbjct: 130 CGIKHLHSAGIIHRDLKP-----------------------------------SNIVVKS 154
Query: 185 KGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241
+KI DFGL+ R G ++ + Y APEV+ GY DIWS G I
Sbjct: 155 DCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCI 207
Query: 242 LYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 300
+ ++ + F R+ + K+ P+++ Q +R +E P AG+
Sbjct: 208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK-LQPTVRNYVENRP----KYAGL 262
Query: 301 KADEWFEQDYTPANPDDDE 319
+ F PA+ + ++
Sbjct: 263 TFPKLFPDSLFPADSEHNK 281
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 62/260 (23%), Positives = 100/260 (38%), Gaps = 53/260 (20%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
L RY+ + +G G G V A D A+K L + H K + RE+ +K
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
+ H N++ L V + + + EL D + E + + L Q++ G+
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
+ H+ G+ HRDLK NI++ S
Sbjct: 140 KHLHSAGIIHRDLKP-----------------------------------SNIVVKSDCT 164
Query: 188 IKISDFGLSALPQHFRDDG---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
+KI DFGL+ R G ++ + Y APEV+ GY DIWS G I+
Sbjct: 165 LKILDFGLA------RTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGE 217
Query: 245 ILTGYLPFDDRNLAVLYQKI 264
++ G + F + + K+
Sbjct: 218 MIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 62/260 (23%), Positives = 100/260 (38%), Gaps = 64/260 (24%)
Query: 15 RYELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
R L L EG FG++ + + VK + K+ +++T ++ E L
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV-KDHASEIQVTLLLQ-ESCLLYG 64
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG------RKLFQ--- 121
L H N++ + V + VL + RL EA ++L
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
Q+ G+SY H +GV H+D IA N +
Sbjct: 125 QIACGMSYLHKRGVIHKD-----------IAA------------------------RNCV 149
Query: 182 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------YVAPEVLANRGYDGATSDI 235
+D + +KI+D LS RD + C N ++A E L N+ Y A SD+
Sbjct: 150 IDEELQVKITDNALS------RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDV 202
Query: 236 WSCGVILYVILT-GYLPFDD 254
WS GV+L+ ++T G P+ +
Sbjct: 203 WSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 60/242 (24%), Positives = 100/242 (41%), Gaps = 49/242 (20%)
Query: 20 RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG G FG V + G +P A+K+L +N K +I E + + P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPY 70
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
V RL + + S + +V + + G L D + +K R+ + Q+ G+SY
Sbjct: 71 VCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
+ HRDL N+L+ S ++KI+DFG
Sbjct: 130 LVHRDLAA-----------------------------------RNVLVKSPNHVKITDFG 154
Query: 195 LSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLP 251
L+ L D+ H G ++A E + +R + SD+WS GV ++ ++T G P
Sbjct: 155 LARLLD--IDETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKP 211
Query: 252 FD 253
+D
Sbjct: 212 YD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 60/260 (23%), Positives = 97/260 (37%), Gaps = 74/260 (28%)
Query: 22 LGEGNFGKVKFAQDLDSGLP------FAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
LGE FGKV + L P A+K L+ + ++ K E L+HPN
Sbjct: 13 LGEDRFGKV-YKGHLFGTAPGEQTQAVAIKTLKDK--AEGPLREEFKHEAMMRSRLQHPN 69
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELF----------------DKIASKGRLQEAEGRKL 119
+V L V+ + + M+ Y + +L D K L+ A+ +
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 120 FQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179
Q+ G+ + + V H+DL N
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLAT-----------------------------------RN 154
Query: 180 ILLDSKGNIKISDFGLSALPQHFRD------DGLLHTTCGSPNYVAPEVLANRGYDGATS 233
+L+ K N+KISD GL FR+ L+ + +++PE + G S
Sbjct: 155 VLVFDKLNVKISDLGL------FREVYAADYYKLMGNSLLPIRWMSPEAIM-YGKFSIDS 207
Query: 234 DIWSCGVILYVILT-GYLPF 252
DIWS GV+L+ + + G P+
Sbjct: 208 DIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 65/272 (23%), Positives = 111/272 (40%), Gaps = 69/272 (25%)
Query: 18 LGRTLGEGNFGKV-KFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKR----EIATLKL 70
+ R LG G FG++ + L S LP A+ L +D+ +R E TL
Sbjct: 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG------CSDKQRRGFLAEALTLGQ 62
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
H N+VRL V+ + + +V EY++ G L L++ EG+ + QL+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGAL------DSFLRKHEGQLVAGQLMGMLPGL 116
Query: 126 --GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD 183
G+ Y G H+ L +L++
Sbjct: 117 ASGMKYLSEMGYVHKGLAA-----------------------------------HKVLVN 141
Query: 184 SKGNIKISDFGLSALPQHFRDDGLLHTTCG-SPN-YVAPEVLANRGYDGATSDIWSCGVI 241
S KIS F L + + + + T G SP + APE + + A SD+WS G++
Sbjct: 142 SDLVCKISGFR--RLQED-KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIV 197
Query: 242 LYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 272
++ +++ G P+ D + + + + G F+LP
Sbjct: 198 MWEVMSYGERPYWDMSGQDVIKAVEDG-FRLP 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 75/319 (23%), Positives = 127/319 (39%), Gaps = 67/319 (21%)
Query: 20 RTLGEGNFGKV--KFAQDLDSGLP---FAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
R LG+G+FG V A+D+ G AVK + ++ + +I + E + +K
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 69
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQLI 124
+VVRL V++ +V+E + G+L + S + + GR ++ ++
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
DG++Y + K HRDL N ++
Sbjct: 130 DGMAYLNAKKFVHRDLAA-----------------------------------RNCMVAH 154
Query: 185 KGNIKISDFGLSA---LPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239
+KI DFG++ ++R GLL ++APE L + G +SD+WS G
Sbjct: 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-----RWMAPESLKD-GVFTTSSDMWSFG 208
Query: 240 VILYVILT-GYLPFDD-RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI 297
V+L+ I + P+ N VL + G P +L+R + NP R T
Sbjct: 209 VVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTF 268
Query: 298 AGIKADEWFEQDYTPANPD 316
I + D P+ P+
Sbjct: 269 LEIV--NLLKDDLHPSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 56/242 (23%), Positives = 98/242 (40%), Gaps = 49/242 (20%)
Query: 20 RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG G FG V + G +P A+K L + K +I E + + +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE--ATSPKANKEILDEAYVMASVDNPH 70
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
V RL + + S + ++ + + G L D + K + Q+ G++Y +
Sbjct: 71 VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR 129
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
+ HRDL N+L+ + ++KI+DFG
Sbjct: 130 LVHRDLAA-----------------------------------RNVLVKTPQHVKITDFG 154
Query: 195 LSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLP 251
L+ L D+ H G ++A E + +R Y SD+WS GV ++ ++T G P
Sbjct: 155 LAKLLG--ADEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKP 211
Query: 252 FD 253
+D
Sbjct: 212 YD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 60/237 (25%), Positives = 101/237 (42%), Gaps = 52/237 (21%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V + + A+K L+ + + +E +K L+H +V+L+
Sbjct: 14 LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 82 VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
V+ S+ IY+V EY++ G L D K L+ + + Q+ G++Y HRD
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 140 LKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALP 199
L+ N+L EN++ K++DFGL+ L
Sbjct: 128 LRAA-----------------------------NILVGENLV------CKVADFGLARLI 152
Query: 200 QHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 252
+ D G+ + APE A G SD+WS G++L + T G +P+
Sbjct: 153 E----DNEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-05
Identities = 18/92 (19%), Positives = 36/92 (39%), Gaps = 2/92 (2%)
Query: 374 RKIRFTSNHSAKDLLERIEDIVTEMGFR--VQKKNGKLKATQEHKPQKSLGSLSVAAEVF 431
++ S ++ E I ++ G + N + + L S EV+
Sbjct: 4 WELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIEVY 63
Query: 432 EISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 463
E+ P L++V+ +K G + +L K+ L
Sbjct: 64 EVGPGLFMVDFKKKTGSTKTFTKLATKIQIKL 95
|
This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 61/248 (24%), Positives = 101/248 (40%), Gaps = 61/248 (24%)
Query: 20 RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG G FG V + G +P A+KIL N K + E + + HP+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPH 70
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----QLIDGVSYCH 131
+VRL V S + I +V + + G L D + ++ G +L Q+ G+ Y
Sbjct: 71 LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
+ + HRDL N+L+ S ++KI+
Sbjct: 127 ERRLVHRDLAA-----------------------------------RNVLVKSPNHVKIT 151
Query: 192 DFGLSAL-----PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
DFGL+ L ++ D G + ++A E + R + SD+WS GV ++ ++
Sbjct: 152 DFGLARLLEGDEKEYNADGGKMPI-----KWMALECIHYRKFT-HQSDVWSYGVTIWELM 205
Query: 247 T-GYLPFD 253
T G P+D
Sbjct: 206 TFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 68/248 (27%), Positives = 103/248 (41%), Gaps = 49/248 (19%)
Query: 22 LGEGNFGKVKFA-----QDLDS-GLPF----------AVKILEKNRIIHLKITDQIKREI 65
LGEG FG+V QDL + PF AVKIL + + + D +K E+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR-NDFLK-EV 70
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
L LK PN++RL V + + M+ EY+ G+L ++ S L + E
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPA 129
Query: 126 G----VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
+SY L ++IA+ +L + L V R L N L
Sbjct: 130 HCLPAISYS------------SLLHVALQIASGMKYLSS--LNFVHRD-----LATRNCL 170
Query: 182 LDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 238
+ IKI+DFG+S ++R G ++A E + + A SD+W+
Sbjct: 171 VGENLTIKIADFGMSRNLYAGDYYRIQG---RAVLPIRWMAWECILMGKFTTA-SDVWAF 226
Query: 239 GVILYVIL 246
GV L+ IL
Sbjct: 227 GVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 58/245 (23%), Positives = 100/245 (40%), Gaps = 44/245 (17%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKHP 74
E+GR G N V A+ +G V+I LE HLK ++ E+ +HP
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKA---LQNEVVLSHFFRHP 59
Query: 75 NVVRLHEVLASKSKIYMV---LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
N++ V + S ++++ + Y + L +G + EA + + G++Y H
Sbjct: 60 NIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLH 118
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
G HR+ +K+ H+ I+ + L+ L ++ L +K
Sbjct: 119 QNGYIHRN----IKASHILISGDGLVSLSGL---------SHLYSLVRNGQKAKVVYDFP 165
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGY 249
F S LP +++PE+L GY+ SDI+S G+ + TG
Sbjct: 166 QFSTSVLP-----------------WLSPELLRQDLYGYN-VKSDIYSVGITACELATGR 207
Query: 250 LPFDD 254
+PF D
Sbjct: 208 VPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 50/208 (24%), Positives = 74/208 (35%), Gaps = 63/208 (30%)
Query: 15 RYELGRTLGEGNFGKVKF------AQDLDSGLP--------FAVKILEKNRIIHLKITDQ 60
+ L LGEG FG+V A+ L G P AVK+L + + +
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARND 63
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG---------ELFDKIASKGRL 111
+EI + LK+PN++RL V S + M+ EY+ G E+ +
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 112 QEAEGRKLFQ---QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168
L Q+ G+ Y + HRDL AT
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDL-----------AT--------------- 157
Query: 169 PWKFNVLQLENILLDSKGNIKISDFGLS 196
N L+ + IKI+DFG+S
Sbjct: 158 ---------RNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 63/301 (20%), Positives = 116/301 (38%), Gaps = 71/301 (23%)
Query: 22 LGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
LGE FGK+ + +D A+K L+ I + + + ++E + + L HPN+V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAELHHPNIV 70
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKI-----------------ASKGRLQEAEGRKLF 120
L V+ + + M+ EY+ G+L + + K L + +
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
Q+ G+ Y + H+DL NI
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAA-----------------------------------RNI 155
Query: 181 LLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 237
L+ + ++KISD GLS ++R + + ++ PE + + + SDIWS
Sbjct: 156 LIGEQLHVKISDLGLSREIYSADYYR---VQPKSLLPIRWMPPEAIMYGKFS-SDSDIWS 211
Query: 238 CGVILYVI----LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 293
GV+L+ I L Y F ++ + + +K R + P +L+ + + P +
Sbjct: 212 FGVVLWEIFSFGLQPYYGFSNQEVIEMVRK--RQLLPCSEDCPPRMYSLMTECWQEGPSR 269
Query: 294 R 294
R
Sbjct: 270 R 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 35/163 (21%)
Query: 22 LGEGNFGKV---------KFAQD-------LDSGLPFAVKILEKNRIIHLKITDQIKREI 65
LGEG FG+V KF + + AVK+L ++ + + D +K EI
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR-NDFLK-EI 70
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG--------- 116
+ LK PN++RL V + + M+ EY+ G+L ++ S+ QEA
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEKADVVTISY 129
Query: 117 ---RKLFQQLIDGVSYCHNKGVFHRDLK----VILKSCHMRIA 152
+ Q+ G+ Y + HRDL ++ K+ ++IA
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIA 172
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 69/286 (24%), Positives = 100/286 (34%), Gaps = 76/286 (26%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
R +LG+ LG G FGKV A S AVK+L++ + K + LK
Sbjct: 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG-----ATASEYKALMTELK 62
Query: 70 LL----KHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASK------GRLQEAEGRK 118
+L H NVV L MV+ EY G L + + SK R + R+
Sbjct: 63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKRE 122
Query: 119 LFQQLIDGV---------SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169
+ Q+ S + + + L L + +
Sbjct: 123 MKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD-----VEEDEEGDELYKEPLTLEDLIS 177
Query: 170 WKFNV----------------LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 213
+ F V L NILL +KI DFGL+ RD
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RD------IYK 225
Query: 214 SPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT 247
P+YV APE + ++ Y SD+WS GV+L+ I +
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 57/271 (21%), Positives = 103/271 (38%), Gaps = 61/271 (22%)
Query: 22 LGEGNFGKVKFAQ-DLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+G G FGKV ++ D+G+ VK L+ N K ++ ++ ++L+HPN+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKAN--ASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V EY G+L ++ + Q +++ ++ GV++ H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
H DL L N L S +K+ D+G+
Sbjct: 121 LHSDLA-----------------------------------LRNCFLTSDLTVKVGDYGI 145
Query: 196 SALPQHFRDDGLL--HTTCGSPNYVAPEVLANRGYDGAT-------SDIWSCGVILYVIL 246
P +++D + C ++APE++ + G S++W+ GV L+ +
Sbjct: 146 G--PSRYKEDYIETEDDKCVPLRWLAPELVGEF-HGGLITAEQTKPSNVWALGVTLWELF 202
Query: 247 TG----YLPFDDRNLAVLYQKIFRGDFKLPK 273
Y DR VL I KL K
Sbjct: 203 ENAAQPYSHLSDRE--VLNHVIKDQQVKLFK 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 77/338 (22%), Positives = 125/338 (36%), Gaps = 86/338 (25%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
Y+LG +G G+FG V A +D+ A+K + L+ RE+ +K L H N
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-------LQDPQYKNRELLIMKNLNHIN 120
Query: 76 VVRLHEVLASKS------KIYM--VLEYV--TGGELFDKIASKGRLQEAEGRKLFQ-QLI 124
++ L + ++ I++ V+E++ T + A KL+ QL
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
++Y H+K + HRDLK +N+L+D
Sbjct: 181 RALAYIHSKFICHRDLKP-----------------------------------QNLLIDP 205
Query: 185 KGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243
+ +K+ DFG + + C S Y APE++ D+WS G I+
Sbjct: 206 NTHTLKLCDFG--SAKNLLAGQRSVSYIC-SRFYRAPELMLGATNYTTHIDLWSLGCIIA 262
Query: 244 VILTGYLPFDD--------RNLAVL--------------YQKIFRGDFK-------LPKW 274
++ GY F R + VL Y I D K PK
Sbjct: 263 EMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKG 322
Query: 275 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 312
A N + + L+ P+KR+ AD +F+ P
Sbjct: 323 TPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360
|
Length = 440 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 45/202 (22%), Positives = 76/202 (37%), Gaps = 49/202 (24%)
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQ 121
E+ KL HPN+V + +++++V ++ G D I + + E + Q
Sbjct: 49 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ 108
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
++ + Y H+ G HR +K +IL
Sbjct: 109 GVLKALDYIHHMGYVHRSVKA-----------------------------------SHIL 133
Query: 182 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-------VAPEVLAN--RGYDGAT 232
+ G + +S GL + L P Y ++PEVL +GYD A
Sbjct: 134 ISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AK 190
Query: 233 SDIWSCGVILYVILTGYLPFDD 254
SDI+S G+ + G++PF D
Sbjct: 191 SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 54/239 (22%), Positives = 92/239 (38%), Gaps = 54/239 (22%)
Query: 19 GRTLGEGNFGKVK---FAQDLDS-GLPFAVKILE--KNRIIHLKITDQIKREIATLKLLK 72
+ LG G FG V + + DS +P A+K ++ R +ITD + + L
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHM----LAMGSLD 67
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
H +VRL + S + +V + G L D + + L Q+ G+ Y
Sbjct: 68 HAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
+ HR+L NILL S ++I+
Sbjct: 127 EHRMVHRNLAA-----------------------------------RNILLKSDSIVQIA 151
Query: 192 DFGLSAL--PQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
DFG++ L P D ++ +P ++A E + Y SD+WS GV ++ +++
Sbjct: 152 DFGVADLLYPD---DKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 56/250 (22%), Positives = 102/250 (40%), Gaps = 63/250 (25%)
Query: 18 LGRTLGEGNFGKV--KFAQDLDSGLP---FAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ R LG+G+FG V A+ + P A+K + + + +I + E + +K
Sbjct: 10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEFN 67
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEG------RKLFQ---Q 122
+VVRL V++ +++E +T G+L + S + ++ +K+ Q +
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
+ DG++Y + HRDL N ++
Sbjct: 128 IADGMAYLNANKFVHRDLAA-----------------------------------RNCMV 152
Query: 183 DSKGNIKISDFGLS---ALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 237
+KI DFG++ ++R GLL +++PE L + G SD+WS
Sbjct: 153 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-----RWMSPESLKD-GVFTTYSDVWS 206
Query: 238 CGVILYVILT 247
GV+L+ I T
Sbjct: 207 FGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 476 | |||
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.45 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.04 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.96 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.91 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.82 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.79 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.65 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.56 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.47 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.45 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.45 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.38 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.27 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.22 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.21 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.2 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.18 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.08 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 98.04 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.97 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.91 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.82 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.79 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.69 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.64 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.49 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.45 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.42 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.38 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.36 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.18 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.18 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.14 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.12 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.9 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.76 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.48 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.42 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.33 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.32 | |
| PLN02236 | 344 | choline kinase | 96.11 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.83 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.37 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.34 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.04 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.48 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.45 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.35 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.67 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.39 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 91.62 | |
| PTZ00296 | 442 | choline kinase; Provisional | 90.47 |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-61 Score=489.77 Aligned_cols=266 Identities=55% Similarity=1.015 Sum_probs=248.3
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc-c-hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-H-LKITDQIKREIATLKLLK-HPNVVRLHEVLASK 86 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-~-~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~ 86 (476)
....++|++++.||+|+||+|++|.+..+|+.||+|++++.... . ......+.+|+.++++++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 47789999999999999999999999999999999988775322 1 134677889999999999 99999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
..+|+|||||.||+|++++...+++.|.+++.+|+||++|++|||++||+||||||
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~------------------------ 148 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKP------------------------ 148 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCH------------------------
Confidence 99999999999999999999989999999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCC-CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC-CCCccchhhhHhHHHHH
Q 011868 167 IRPWKFNVLQLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYV 244 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~-g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~sDvwSlGvil~e 244 (476)
||||+|.+ +++||+|||++.... ..+...++.||||.|+|||++.+.. |++.++|||||||+||.
T Consensus 149 -----------ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ 215 (370)
T KOG0583|consen 149 -----------ENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYV 215 (370)
T ss_pred -----------HHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHH
Confidence 99999999 999999999999754 3567889999999999999999988 99999999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHccCCCcCCCCChHHHhcCccccc-cCCC
Q 011868 245 ILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL-SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ-DYTP 312 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~-~~~~ 312 (476)
|++|+.||++.+...++.+|.++.+.+|.|+ |+++.+||++||.+||.+|+|+.+|+.||||+. +..+
T Consensus 216 ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~~~~~ 285 (370)
T KOG0583|consen 216 LLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKENPLP 285 (370)
T ss_pred HHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccCCCCC
Confidence 9999999999999999999999999999999 999999999999999999999999999999998 4433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-61 Score=493.71 Aligned_cols=265 Identities=37% Similarity=0.695 Sum_probs=252.6
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
-+|..++.||+|||++||.+++..+|+.||+|++.+.........+.+.+||+|++.|+|||||+++++|++.+++|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56999999999999999999999999999999999988888888999999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
|+|..++|..+++..++++|.+|+.|++||+.||.|||+++|+|||||
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLK-------------------------------- 145 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLK-------------------------------- 145 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccc--------------------------------
Confidence 999999999999988999999999999999999999999999999999
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+.|++++++.+|||+|||||+.... ++.+..|.||||.|.|||++.+.++. ..+||||+|||||.||+|++||+
T Consensus 146 ---LGNlfL~~~~~VKIgDFGLAt~le~--~~Erk~TlCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFe 219 (592)
T KOG0575|consen 146 ---LGNLFLNENMNVKIGDFGLATQLEY--DGERKKTLCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFE 219 (592)
T ss_pred ---hhheeecCcCcEEecccceeeeecC--cccccceecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcc
Confidence 5999999999999999999997654 44677899999999999999988885 88999999999999999999999
Q ss_pred CCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCCCCCCC
Q 011868 254 DRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 316 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~~~~~~ 316 (476)
..+..+.|.+|...++.+|..+|.++++||++||++||.+|||+++|+.|+||...+.|....
T Consensus 220 tk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 220 TKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred cchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 999999999999999999999999999999999999999999999999999998888776543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-62 Score=475.68 Aligned_cols=260 Identities=40% Similarity=0.736 Sum_probs=234.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchh----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
..+.|.+.++||+|+||.|.+|..+.||+.||||++.+....... -...+.+|+++|++|+|||||+++++|+...
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456799999999999999999999999999999999877544322 2345789999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
..|+||||+.||+|++.+..++.+.+...+.+++||+.|+.|||++||+||||||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKP------------------------- 304 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKP------------------------- 304 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCc-------------------------
Confidence 9999999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCC---CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCC--CccchhhhHhHHH
Q 011868 168 RPWKFNVLQLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD--GATSDIWSCGVIL 242 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~---g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~--~~~sDvwSlGvil 242 (476)
+|||+..+ ..+||+|||+|++.. ....+.|.||||.|.|||++.+.++. ..++|+||+||||
T Consensus 305 ----------eNILl~~~~e~~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvL 371 (475)
T KOG0615|consen 305 ----------ENILLSNDAEDCLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVL 371 (475)
T ss_pred ----------ceEEeccCCcceEEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceE
Confidence 99999876 689999999999743 57789999999999999999886643 4578999999999
Q ss_pred HHHhcCCCCCCCCcHHH-HHHHHHhCCCCC--CCC--CCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 243 YVILTGYLPFDDRNLAV-LYQKIFRGDFKL--PKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 243 ~elltG~~Pf~~~~~~~-~~~~i~~~~~~~--p~~--~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|.+++|.+||.+..... +.++|.++.+.+ |.| +|.++++||.+||..||++|||++++|+||||+..
T Consensus 372 fvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 372 FVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred EEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 99999999999877655 889999998775 344 89999999999999999999999999999999853
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-61 Score=492.31 Aligned_cols=262 Identities=48% Similarity=0.851 Sum_probs=249.9
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
-.+|-|+++++||.|+.|.|.+|++..||+.+|||++.+...........+.+||.+|+.+.||||+++||++++..++|
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 46889999999999999999999999999999999998875555556788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
+|.||++||+||+++..++++++.++.++|+||+.|+.|||..+|+||||||
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKp---------------------------- 140 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKP---------------------------- 140 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCc----------------------------
Confidence 9999999999999999999999999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+|+|||..+++||+|||+|.+- .++..+.|.||+|+|.|||++.+..|+|.++||||||||||.||||++
T Consensus 141 -------ENlLLd~~~nIKIADFGMAsLe---~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~L 210 (786)
T KOG0588|consen 141 -------ENLLLDVKNNIKIADFGMASLE---VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKL 210 (786)
T ss_pred -------hhhhhhcccCEeeeccceeecc---cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCC
Confidence 9999999999999999999863 357789999999999999999999999999999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 251 PFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
||++.|...++.++.+|.+.+|..+++++++||++||..||++|+|.++|++|||+....
T Consensus 211 PFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 211 PFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred CCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 999999999999999999999999999999999999999999999999999999997643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-57 Score=442.11 Aligned_cols=261 Identities=38% Similarity=0.714 Sum_probs=244.8
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
....+.|++.+.||+|+||+|++++.+.+++.+|+|++++......+..+....|..||..++||.||+++..|++..++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 46788999999999999999999999999999999999998877777789999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+|+||+.||+|+-.|++.+.++|..++.|+..|+.||.|||+.||+||||||
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKP--------------------------- 153 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKP--------------------------- 153 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCH---------------------------
Confidence 99999999999999999999999999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
||||+|.+|+++|+||||++.... .+..+++.|||+.|||||++.+.+|+ ..+|.|||||++|+|++|.
T Consensus 154 --------ENILLd~~GHi~LtDFgL~k~~~~--~~~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~ 222 (357)
T KOG0598|consen 154 --------ENILLDEQGHIKLTDFGLCKEDLK--DGDATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGK 222 (357)
T ss_pred --------HHeeecCCCcEEEeccccchhccc--CCCccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCC
Confidence 999999999999999999985332 44567789999999999999999997 8899999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHccCCCcCCCC----ChHHHhcCccccc
Q 011868 250 LPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRI----TIAGIKADEWFEQ 308 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~----s~~~il~~~~~~~ 308 (476)
+||.+.+...++++|.++... .|..+++++++||+++|..||.+|. .+.+|.+||||..
T Consensus 223 pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 223 PPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred CCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 999999999999999999944 5555999999999999999999996 6889999999964
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-57 Score=426.61 Aligned_cols=258 Identities=38% Similarity=0.749 Sum_probs=246.8
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
+..+++|+++++||.|+||.|.+++++.+|..+|+|++++......++.+...+|..+|+.+.||.++++++.+.+.+.+
T Consensus 40 ~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 40 PYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL 119 (355)
T ss_pred CcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence 37889999999999999999999999999999999999999888888899999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||++||+|+.++...+++++..++.|+.||+.|++|||+++|++|||||
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKP--------------------------- 172 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKP--------------------------- 172 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCCh---------------------------
Confidence 99999999999999999999999999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
||||+|.+|.+||+|||+|+.. ...+.+.||||.|+|||++..++|. .++|.|||||++|||++|+
T Consensus 173 --------ENiLlD~~G~iKitDFGFAK~v-----~~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~ 238 (355)
T KOG0616|consen 173 --------ENLLLDQNGHIKITDFGFAKRV-----SGRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGY 238 (355)
T ss_pred --------HHeeeccCCcEEEEeccceEEe-----cCcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCC
Confidence 9999999999999999999843 3458899999999999999999996 8899999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 250 LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
+||.+.+...+|++|..++..+|+.+++++++||+++|+.|-.+|. -..+|..||||+.
T Consensus 239 pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 239 PPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred CCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999999999999999999999999999999999999999994 5678999999984
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-56 Score=434.60 Aligned_cols=262 Identities=39% Similarity=0.652 Sum_probs=241.6
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
....+++|.+.+.||+|+||+||+|+++.++..||||.+.+... ..+..+.+..|+.+|+.++|||||.++|++..++.
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 35578999999999999999999999999999999999988764 55667889999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
+|||||||.||+|.++|...+.++|..++.++.||+.||++||+++|+||||||
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKP-------------------------- 137 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKP-------------------------- 137 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCc--------------------------
Confidence 999999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCC------CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHH
Q 011868 169 PWKFNVLQLENILLDSK------GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~------g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil 242 (476)
+|||++.. -.+||+|||+|+... ......+.||+|.|||||++....|+ .|+|+||+|+|+
T Consensus 138 ---------QNiLLs~~~~~~~~~~LKIADFGfAR~L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Il 204 (429)
T KOG0595|consen 138 ---------QNILLSTTARNDTSPVLKIADFGFARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTIL 204 (429)
T ss_pred ---------ceEEeccCCCCCCCceEEecccchhhhCC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHH
Confidence 99999875 458999999999654 46778899999999999999999998 899999999999
Q ss_pred HHHhcCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 243 YVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 243 ~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
|+|++|+.||+..+..+++..+.++.. .+|.++++.+.+|+...|+.+|..|.+..+-+.|+++....
T Consensus 205 yq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 205 YQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred HHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 999999999999999999998887753 35577899999999999999999999999999999887643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-56 Score=446.87 Aligned_cols=263 Identities=35% Similarity=0.642 Sum_probs=244.8
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~ 88 (476)
.....+|..++.||+|+|++|++|+++.+++.||||++.+.....++..+.+.+|-.+|.+| .||.|++||-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 56778999999999999999999999999999999999998887777788899999999999 79999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
+|+|+||+++|+|.++|..-+.|++..++.|+.||+.||+|||++|||||||||
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKP-------------------------- 202 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKP-------------------------- 202 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCCh--------------------------
Confidence 999999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC-----------CcccccccCCccccccccccCCCCCccchhhh
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD-----------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 237 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~-----------~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwS 237 (476)
||||+|+||++||+|||-|+.+...... ....+.+||..|++||+|....- +..+|||+
T Consensus 203 ---------ENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWA 272 (604)
T KOG0592|consen 203 ---------ENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWA 272 (604)
T ss_pred ---------hheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHH
Confidence 9999999999999999999976542111 11245789999999999877654 58999999
Q ss_pred HhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 238 CGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 238 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
||||||+|++|.+||.+.|.-.++++|...++.+|+.+++.+++||+++|..||.+|+|+.+|.+||||..
T Consensus 273 lGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 273 LGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred HHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999964
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-55 Score=423.11 Aligned_cols=260 Identities=29% Similarity=0.496 Sum_probs=235.9
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-E
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-K 88 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-~ 88 (476)
+...+..+.+..||+|+.|+||+++|+.|++.+|+|.+..+. ++...+++.+|+++++.++||+||.+|+.|..++ .
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 345567888899999999999999999999999999995543 5667899999999999999999999999999999 4
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
++++||||.||+|.+.+...++++|.....++.|++.||.|||+ ++|+||||||
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKP------------------------- 207 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKP------------------------- 207 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCH-------------------------
Confidence 99999999999999999888899999999999999999999996 8999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++..|.|||||||.++... .....+..||..|||||.+.+..|. .++||||||+.++|+.+
T Consensus 208 ----------sNlLvNskGeVKicDFGVS~~lv----nS~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~ 272 (364)
T KOG0581|consen 208 ----------SNLLVNSKGEVKICDFGVSGILV----NSIANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAI 272 (364)
T ss_pred ----------HHeeeccCCCEEeccccccHHhh----hhhcccccccccccChhhhcCCcCC-cccceecccHHHHHHhh
Confidence 99999999999999999998543 2367889999999999999999886 88999999999999999
Q ss_pred CCCCCCCC-----cHHHHHHHHHhCCC-CCCCC-CCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 248 GYLPFDDR-----NLAVLYQKIFRGDF-KLPKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 248 G~~Pf~~~-----~~~~~~~~i~~~~~-~~p~~-~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
|+.||... +..+++..|..+.. .+|.. +|+++++||..||++||.+|+|+.|+++|||+++...
T Consensus 273 GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 273 GRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred CCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 99999874 56688888888654 57776 9999999999999999999999999999999987543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-55 Score=427.57 Aligned_cols=259 Identities=44% Similarity=0.790 Sum_probs=245.6
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
.+|++.++||+|+||+|.+|.+...|+.||||.|+++...+....-.+.+||+||+.|+||||+.+|++|++.+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 58999999999999999999999999999999999998888777788999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||..+|+|.|++...+.+++.+++++|+||++|+.|||.++++|||||
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLK-------------------------------- 180 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLK-------------------------------- 180 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccc--------------------------------
Confidence 999999999999999999999999999999999999999999999999
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
++|||+|.|+++||+||||+.++. ....+.+.||+|.|.+||++.+..|.|+.+|-|||||+||.|+.|..||+
T Consensus 181 ---LENILLD~N~NiKIADFGLSNly~---~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD 254 (668)
T KOG0611|consen 181 ---LENILLDQNNNIKIADFGLSNLYA---DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD 254 (668)
T ss_pred ---hhheeecCCCCeeeeccchhhhhc---cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC
Confidence 499999999999999999999754 46789999999999999999999999999999999999999999999999
Q ss_pred CCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 254 DRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
|.+...+..+|..|.+.-|. -+.++.-||+.||..||.+|.|+++|..|=|++-.+.
T Consensus 255 G~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~ 311 (668)
T KOG0611|consen 255 GRDHKRLVRQISRGAYREPE-TPSDASGLIRWMLMVNPERRATIEDIASHWWVNWGYN 311 (668)
T ss_pred CchHHHHHHHhhcccccCCC-CCchHHHHHHHHHhcCcccchhHHHHhhhheeecccc
Confidence 99999999999999887765 4567899999999999999999999999988876654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-54 Score=431.28 Aligned_cols=262 Identities=34% Similarity=0.631 Sum_probs=238.5
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
.+.++.|++++.||+|+||.||+|+.+.||+.+|+|++++......+.+..++.|-.+|...++|+||+||-.|++...+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 56788999999999999999999999999999999999999888888889999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
||||||++||++..+|...+.|++..++.|+.+++.|++-+|+.|++||||||
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKP--------------------------- 269 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKP--------------------------- 269 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCCh---------------------------
Confidence 99999999999999999999999999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcc-------------------c-CC------------------------
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHF-------------------R-DD------------------------ 205 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~-------------------~-~~------------------------ 205 (476)
+|+|||..|++||+||||++..... . .+
T Consensus 270 --------dNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nr 341 (550)
T KOG0605|consen 270 --------DNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNR 341 (550)
T ss_pred --------hheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhh
Confidence 9999999999999999998642110 0 00
Q ss_pred -CcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCCCC--CCHHHH
Q 011868 206 -GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKW--LSPGAQ 280 (476)
Q Consensus 206 -~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~--~s~~~~ 280 (476)
......+|||.|||||++.+.+|. ..||.||||||+||||.|++||.+.++.+.+.+|.... +.+|.. +++++.
T Consensus 342 r~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~ 420 (550)
T KOG0605|consen 342 RQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAK 420 (550)
T ss_pred hhhhhcccCCccccchHHHhcCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHH
Confidence 011245799999999999999985 88999999999999999999999999999999998765 566654 789999
Q ss_pred HHHHHccCCCcCCCCC---hHHHhcCccccc
Q 011868 281 NLLRKILEPNPVKRIT---IAGIKADEWFEQ 308 (476)
Q Consensus 281 ~Li~~~L~~dP~~R~s---~~~il~~~~~~~ 308 (476)
+||.+||. ||.+|.- ++||.+||||+.
T Consensus 421 DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 421 DLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 99999999 9999985 899999999975
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-55 Score=399.76 Aligned_cols=258 Identities=39% Similarity=0.747 Sum_probs=235.0
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
--+.|++.+.||+|.|+.||++.+..||+.+|+|+++....... ..+.+.+|++|.+.|+||||+++++.+.+.+..|+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 34679999999999999999999999999999999987655433 46889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|+|++.|++|+.-|..+--++|..+..+++||+.||.|||.+||+|||+||
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP----------------------------- 138 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKP----------------------------- 138 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCCh-----------------------------
Confidence 999999999998887767799999999999999999999999999999997
Q ss_pred cccCCCCceEeCCC---CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 172 FNVLQLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 172 ~~~~~~~NiLl~~~---g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+|+|+.+. .-+||+|||+|.... .........|||.|||||++...+|. .++||||+|||||-|+.|
T Consensus 139 ------~nllLASK~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G 208 (355)
T KOG0033|consen 139 ------ENLLLASKAKGAAVKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVG 208 (355)
T ss_pred ------hheeeeeccCCCceeecccceEEEeC---CccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhC
Confidence 99999643 469999999998544 45566778999999999999999885 889999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCCCC--C--CCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFKLPK--W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~~p~--~--~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
++||.+.+...+|++|.++.+.+|. | +++++++||++||..||++|+|+.|+|+|||+.+.
T Consensus 209 ~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 209 YPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred CCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 9999999999999999999887654 4 89999999999999999999999999999999764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-53 Score=419.89 Aligned_cols=266 Identities=33% Similarity=0.533 Sum_probs=233.3
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SK 88 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~ 88 (476)
...+.|+.+++||+|+||.||+|++..+|+.||+|.++.+. ..++....+.|||.||++|+||||++|.++..+. +.
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 45567999999999999999999999999999999998776 3456678899999999999999999999998876 79
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
+|||+|||+. +|..++... -.|++.+++.|++||+.||+|||++||+|||||.
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~------------------------- 246 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKG------------------------- 246 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccc-------------------------
Confidence 9999999965 999888764 4899999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
.|||||.+|++||+|||||+++.... ...++..+-|.+|+|||.|.+..-++..+|+||+||||.||++
T Consensus 247 ----------SNiLidn~G~LKiaDFGLAr~y~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~ 315 (560)
T KOG0600|consen 247 ----------SNILIDNNGVLKIADFGLARFYTPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFL 315 (560)
T ss_pred ----------cceEEcCCCCEEeccccceeeccCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHc
Confidence 99999999999999999999876533 2346667789999999999998777899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCC----------CCCC-------------------CCCCHHHHHHHHHccCCCcCCCCChH
Q 011868 248 GYLPFDDRNLAVLYQKIFRGD----------FKLP-------------------KWLSPGAQNLLRKILEPNPVKRITIA 298 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~----------~~~p-------------------~~~s~~~~~Li~~~L~~dP~~R~s~~ 298 (476)
|++.|+|.+..+.+.+|++-. ..+| ..+++.+.+|+..||..||.+|.|+.
T Consensus 316 gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~ 395 (560)
T KOG0600|consen 316 GKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTAS 395 (560)
T ss_pred CCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHH
Confidence 999999999999998887521 0112 12578899999999999999999999
Q ss_pred HHhcCccccccCCCCC
Q 011868 299 GIKADEWFEQDYTPAN 314 (476)
Q Consensus 299 ~il~~~~~~~~~~~~~ 314 (476)
++|.++||.....+..
T Consensus 396 ~aL~seyF~t~p~~~~ 411 (560)
T KOG0600|consen 396 SALQSEYFTTEPLPCD 411 (560)
T ss_pred HHhcCcccccCCCCCC
Confidence 9999999955444433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-54 Score=403.03 Aligned_cols=249 Identities=32% Similarity=0.538 Sum_probs=224.9
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEE-EE-EeCC
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE-VL-ASKS 87 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~-~~-~~~~ 87 (476)
...+..|++.++||+|+||+||++++..+|..||.|.+.-+.. +.........|+.+|++|+|||||++++ .| ++..
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 3456679999999999999999999999999999999985543 4555788999999999999999999998 34 3444
Q ss_pred EEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--cC--cEeccCCcchhccchhhhHHHHHHH
Q 011868 88 KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHN--KG--VFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~--~g--ivHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
.+++|||||.+|+|...|+. ...++|..+|+++.|++.||.+||+ .. |+||||||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKP----------------- 156 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKP----------------- 156 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcc-----------------
Confidence 59999999999999999964 3579999999999999999999999 45 99999997
Q ss_pred HHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHh
Q 011868 160 TFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlG 239 (476)
.||+++.+|.+||+||||+++++. .....++.+|||.||+||++.+.+|+ .+|||||+|
T Consensus 157 ------------------aNIFl~~~gvvKLGDfGL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslG 215 (375)
T KOG0591|consen 157 ------------------ANIFLTANGVVKLGDFGLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLG 215 (375)
T ss_pred ------------------hheEEcCCCceeeccchhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHH
Confidence 999999999999999999998765 44567888999999999999999997 999999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC-CC-CCCCHHHHHHHHHccCCCcCCCCCh
Q 011868 240 VILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP-KWLSPGAQNLLRKILEPNPVKRITI 297 (476)
Q Consensus 240 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s~~~~~Li~~~L~~dP~~R~s~ 297 (476)
|++|||++-+.||.|.+...+..+|.+++++ +| ..+|.++..||..|+.+||.+||+.
T Consensus 216 CllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 216 CLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 9999999999999999999999999999986 67 6699999999999999999999986
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-52 Score=429.57 Aligned_cols=261 Identities=32% Similarity=0.624 Sum_probs=243.2
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS 87 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~ 87 (476)
....+.+|.+.+.||+|+||+|++|..+.+++.+|||+++|+.....+..+....|.+|+.... ||.++.++..|+++.
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4678889999999999999999999999999999999999999888888999999999999885 999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
++|+||||+.||++.. +...+.|++..++.|+..|+.||+|||++||+|||||
T Consensus 443 ~l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlK-------------------------- 495 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLK-------------------------- 495 (694)
T ss_pred eEEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecc--------------------------
Confidence 9999999999999544 3445789999999999999999999999999999999
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
++|||||.+|++||+|||+++-- ...+..+.|.||||.|||||++.+..|. ..+|.|||||+|||||.
T Consensus 496 ---------LdNiLLD~eGh~kiADFGlcKe~--m~~g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~ 563 (694)
T KOG0694|consen 496 ---------LDNLLLDTEGHVKIADFGLCKEG--MGQGDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLV 563 (694)
T ss_pred ---------hhheEEcccCcEEeccccccccc--CCCCCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHc
Confidence 59999999999999999999842 2245678999999999999999999996 88999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh-----HHHhcCccccc
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI-----AGIKADEWFEQ 308 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~-----~~il~~~~~~~ 308 (476)
|..||.|.+.++++..|...++.+|.|+|.++.++++++|..||.+|.-. ++|.+||||..
T Consensus 564 Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 564 GESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 99999999999999999999999999999999999999999999999964 78999999974
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-53 Score=387.37 Aligned_cols=263 Identities=35% Similarity=0.689 Sum_probs=248.4
Q ss_pred hccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011868 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (476)
Q Consensus 6 ~~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 85 (476)
.....+.+++|++++.||+|-||.||+|+...++-.||+|++.++.........++.+|++|.+.|+||||+++|++|.+
T Consensus 14 ~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 14 RATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred ccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 44567889999999999999999999999999999999999999887777778899999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHH
Q 011868 86 KSKIYMVLEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLL 163 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~ 163 (476)
+..+||++||+.+|+|+..+. ...++++..+..|+.|++.|+.|||..+|+||||||
T Consensus 94 ~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKp--------------------- 152 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKP--------------------- 152 (281)
T ss_pred cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCH---------------------
Confidence 999999999999999999998 556899999999999999999999999999999997
Q ss_pred hhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHH
Q 011868 164 MIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243 (476)
Q Consensus 164 ~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ 243 (476)
+|+|++.+|.+||+|||.+... +.....+.|||..|.+||...+..++ ..+|+|++|++.|
T Consensus 153 --------------enlLlg~~~~lkiAdfGwsV~~----p~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~y 213 (281)
T KOG0580|consen 153 --------------ENLLLGSAGELKIADFGWSVHA----PSNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCY 213 (281)
T ss_pred --------------HHhccCCCCCeeccCCCceeec----CCCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHH
Confidence 9999999999999999998742 24566789999999999999999997 8899999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 244 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 244 elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
|++.|.+||...+..+.|++|.+.++.+|..++.++.+||.+||..+|.+|.+..|++.|||...
T Consensus 214 eflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 214 EFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999865
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=414.03 Aligned_cols=261 Identities=34% Similarity=0.708 Sum_probs=238.8
Q ss_pred ccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 7 ~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
....+.+++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++..+
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred ccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 44567789999999999999999999999999999999999876443444567789999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
+..|+||||+.||+|.+.+...+.+++..++.++.||+.||+|||++||+||||||
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp------------------------ 146 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKP------------------------ 146 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCH------------------------
Confidence 99999999999999999999888999999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.+|.+||+|||++..... ...+.+||+.|+|||++.+..++ .++|||||||++|+|+
T Consensus 147 -----------~NIll~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell 209 (329)
T PTZ00263 147 -----------ENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFI 209 (329)
T ss_pred -----------HHEEECCCCCEEEeeccCceEcCC-----CcceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHH
Confidence 999999999999999999975322 23456899999999999888775 8999999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC-----hHHHhcCccccc
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 308 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-----~~~il~~~~~~~ 308 (476)
+|+.||.+.+....+.++..+..++|.++++.+.+||++||+.||.+|++ +++++.||||..
T Consensus 210 tg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 210 AGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred cCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 99999999988888999999999999999999999999999999999997 799999999975
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=422.34 Aligned_cols=259 Identities=31% Similarity=0.590 Sum_probs=241.7
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+++|-+.+.||+|+||.||+|+.+.+.+.||+|.+.+..- .++....+.+|++|++.++||||+.++++|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 4689999999999999999999999999999999988763 444578899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
.|||.| +|+.++..++.++|++++.+..|+++||.|||+++|.|||+||
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kP------------------------------ 128 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKP------------------------------ 128 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCc------------------------------
Confidence 999976 9999999999999999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
.|||++..|.+|+||||+|+.... +........|||.|||||++.+..|+ ..+|+||+|||+|||++|++||
T Consensus 129 -----qniLl~~~~~~KlcdFg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF 200 (808)
T KOG0597|consen 129 -----QNILLEKGGTLKLCDFGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPF 200 (808)
T ss_pred -----ceeeecCCCceeechhhhhhhccc--CceeeeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCc
Confidence 999999999999999999996543 45567778899999999999998887 8899999999999999999999
Q ss_pred CCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 253 DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
.......+...|.......|...|+.+.+|+..+|.+||.+|+|..+++.|||.+....
T Consensus 201 ~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 201 YARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred hHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhh
Confidence 99999999999999999999999999999999999999999999999999999876543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-52 Score=411.75 Aligned_cols=269 Identities=39% Similarity=0.667 Sum_probs=234.2
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccch-----------hHHHHHHHHHHHHHhCCCCCc
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----------KITDQIKREIATLKLLKHPNV 76 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~~~Ei~~l~~l~HpnI 76 (476)
.....+++|++++.||+|.||+|.+|++..+++.||||++.+...... .-.+.+.+||.+|++++||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 345678999999999999999999999999999999999976532110 113579999999999999999
Q ss_pred ceEEEEEEe--CCEEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhH
Q 011868 77 VRLHEVLAS--KSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIAT 153 (476)
Q Consensus 77 v~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~ 153 (476)
|+|+++..+ .+.+|||+|||..|.+...-. .++ +++.+++.|++.++.||+|||.+||+||||||
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKP----------- 238 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKP----------- 238 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccch-----------
Confidence 999999965 468999999999998865432 344 99999999999999999999999999999997
Q ss_pred HHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcc---cCCCcccccccCCcccccccccc---CC
Q 011868 154 LQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHF---RDDGLLHTTCGSPNYVAPEVLAN---RG 227 (476)
Q Consensus 154 ~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~---~~~~~~~~~~gt~~y~APE~l~~---~~ 227 (476)
.|+|++++|++||+|||.+..+... ..+..+....|||.|+|||...+ ..
T Consensus 239 ------------------------sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~ 294 (576)
T KOG0585|consen 239 ------------------------SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFS 294 (576)
T ss_pred ------------------------hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCcc
Confidence 9999999999999999998865322 12223455789999999999877 55
Q ss_pred CCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHccCCCcCCCCChHHHhcCcc
Q 011868 228 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEW 305 (476)
Q Consensus 228 ~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~ 305 (476)
+.+.+.||||+||+||.|+.|++||-+....+++.+|......+|.. +.+.+++||.+||.+||.+|+++.+|..|||
T Consensus 295 ~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 295 YSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred ccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 77899999999999999999999999999999999999999888866 7999999999999999999999999999999
Q ss_pred ccccCCC
Q 011868 306 FEQDYTP 312 (476)
Q Consensus 306 ~~~~~~~ 312 (476)
.......
T Consensus 375 vt~~g~~ 381 (576)
T KOG0585|consen 375 VTRDGDS 381 (576)
T ss_pred eccCCCC
Confidence 9876543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=393.53 Aligned_cols=256 Identities=28% Similarity=0.453 Sum_probs=221.9
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+++|+.+.++|+|+||.||+++++.||+.||||.+.... .+....+-..|||++|++++|||+|.++++|.....++||
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 468999999999999999999999999999999996543 3455567789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
+|||+. ++.+.++ ...+++++.++.|+.|++.|+.|||+++++||||||
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKP----------------------------- 129 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKP----------------------------- 129 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCCh-----------------------------
Confidence 999966 5555554 456799999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
||||++.+|.+||||||+|+.... .+...+..+.|.+|+|||.+.+...+|.++||||+||++.||++|.+.
T Consensus 130 ------ENILit~~gvvKLCDFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL 201 (396)
T KOG0593|consen 130 ------ENILITQNGVVKLCDFGFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPL 201 (396)
T ss_pred ------hheEEecCCcEEeccchhhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcC
Confidence 999999999999999999997654 345566778999999999999966668999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhC--------------C-----CCCC------------CCCCHHHHHHHHHccCCCcCCCCChHHH
Q 011868 252 FDDRNLAVLYQKIFRG--------------D-----FKLP------------KWLSPGAQNLLRKILEPNPVKRITIAGI 300 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~--------------~-----~~~p------------~~~s~~~~~Li~~~L~~dP~~R~s~~~i 300 (476)
|.|.+..+.+-.|.+. + ..+| +.++.-+.+|+.+||+.||++|++.+|+
T Consensus 202 ~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ql 281 (396)
T KOG0593|consen 202 WPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQL 281 (396)
T ss_pred CCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHH
Confidence 9998877666555431 1 0111 1256779999999999999999999999
Q ss_pred hcCcccc
Q 011868 301 KADEWFE 307 (476)
Q Consensus 301 l~~~~~~ 307 (476)
+.|++|.
T Consensus 282 l~H~yFd 288 (396)
T KOG0593|consen 282 LHHPYFD 288 (396)
T ss_pred hcChHHH
Confidence 9999993
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=402.88 Aligned_cols=261 Identities=34% Similarity=0.557 Sum_probs=224.0
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--KIY 90 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--~~~ 90 (476)
..+|..++.||+|+||.||++.+..+|...|||.+.... ... .+.+.+|+.+|++++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 456899999999999999999999999999999997763 222 678999999999999999999999755444 699
Q ss_pred EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+.|||++||+|.+++...+ ++++..++.|.+||+.||+|||++||+||||||
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~--------------------------- 145 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKP--------------------------- 145 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCccc---------------------------
Confidence 9999999999999998866 799999999999999999999999999999997
Q ss_pred cccccCCCCceEeCC-CCCEEEeccCCCCCCCcc-cCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 170 WKFNVLQLENILLDS-KGNIKISDFGLSALPQHF-RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~-~g~vkl~DFGla~~~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++. +|.+||+|||++...... ..........|||.|||||++......+.++||||+||++.||+|
T Consensus 146 --------~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T 217 (313)
T KOG0198|consen 146 --------ANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT 217 (313)
T ss_pred --------ceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC
Confidence 9999999 799999999999865531 112234567899999999999863333358999999999999999
Q ss_pred CCCCCCC-CcHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 248 GYLPFDD-RNLAVLYQKIFRGD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 248 G~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
|+.||.+ .......-++.... +.+|.++|++++++|++|+..||.+|||++++|.|||..+...
T Consensus 218 g~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 218 GKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 9999987 44444444444433 5789999999999999999999999999999999999987543
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=410.43 Aligned_cols=263 Identities=38% Similarity=0.686 Sum_probs=244.1
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
+..-|-|++.++||+|.|+.|.+|++..||+.||||++++...... ....+.+|+++|+.++|||||++|++..+...+
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence 4556779999999999999999999999999999999998875443 356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|||+|+=.||+|+|+|.. ..++.|+.+++||+||+.|+.|||+..+|||||||
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKP-------------------------- 146 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKP-------------------------- 146 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCc--------------------------
Confidence 999999999999999964 46799999999999999999999999999999997
Q ss_pred ccccccCCCCceEeC-CCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 169 PWKFNVLQLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~-~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|+.+- .-|-|||.|||++..+. .+..+.+.||+..|-|||++.+..|+.+++||||||||||-|++
T Consensus 147 ---------ENVVFFEKlGlVKLTDFGFSNkf~---PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVC 214 (864)
T KOG4717|consen 147 ---------ENVVFFEKLGLVKLTDFGFSNKFQ---PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVC 214 (864)
T ss_pred ---------ceeEEeeecCceEeeeccccccCC---CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHh
Confidence 898765 56999999999998544 46778999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
|++||+..|..+.+-+|..+.+..|..+|.++++||..||..||++|.|.++|..++|++....
T Consensus 215 Gq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 215 GQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred CCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 9999999999999999999999999999999999999999999999999999999999987544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=401.82 Aligned_cols=254 Identities=35% Similarity=0.664 Sum_probs=232.7
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||+|+||+||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997654333444677899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp------------------------------- 129 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKP------------------------------- 129 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCH-------------------------------
Confidence 9999999999998888899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+|||++.+|.+||+|||++..... ...+.+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.
T Consensus 130 ----~NIli~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~ 199 (291)
T cd05612 130 ----ENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFF 199 (291)
T ss_pred ----HHeEECCCCCEEEEecCcchhccC-----CcccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999875322 23356799999999999887775 88999999999999999999999
Q ss_pred CCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC-----hHHHhcCccccc
Q 011868 254 DRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 308 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-----~~~il~~~~~~~ 308 (476)
+.+....+..+..+...+|..+++.+.+||++||+.||.+|++ +++++.||||..
T Consensus 200 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 200 DDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 9998899999999999999999999999999999999999995 999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-51 Score=378.58 Aligned_cols=262 Identities=33% Similarity=0.474 Sum_probs=228.8
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
.+|...+.||+|+||.||+|++..||+.||||.++.... ..+......|||..|+.++||||+.++|+|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 579999999999999999999999999999999987653 4455678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 94 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
||++ .+|...|... ..++..+++.|+.|++.||+|||++.|+||||||
T Consensus 81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKP------------------------------ 129 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKP------------------------------ 129 (318)
T ss_pred Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCc------------------------------
Confidence 9995 5999998764 4799999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+|+|++++|.+||+|||+|+.+... .......+-|.+|+|||.+.+...++..+||||.|||+.||+-|.+.|
T Consensus 130 -----nNLLis~~g~lKiADFGLAr~f~~p--~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f 202 (318)
T KOG0659|consen 130 -----NNLLISSDGQLKIADFGLARFFGSP--NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF 202 (318)
T ss_pred -----cceEEcCCCcEEeecccchhccCCC--CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC
Confidence 9999999999999999999987653 233333478999999999999777789999999999999999999999
Q ss_pred CCCcHHHHHHHHHhCC--CC---------CC-----------------CCCCHHHHHHHHHccCCCcCCCCChHHHhcCc
Q 011868 253 DDRNLAVLYQKIFRGD--FK---------LP-----------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~~--~~---------~p-----------------~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~ 304 (476)
.|.+.-+....|+..- +. +| +..++++.+|+.+||..||.+|+|+.|+++|+
T Consensus 203 pG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 203 PGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred CCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 9999888888876521 10 11 11467899999999999999999999999999
Q ss_pred cccccCCCCC
Q 011868 305 WFEQDYTPAN 314 (476)
Q Consensus 305 ~~~~~~~~~~ 314 (476)
||.....|+.
T Consensus 283 yf~~~P~pt~ 292 (318)
T KOG0659|consen 283 YFKSLPLPTP 292 (318)
T ss_pred hhhcCCCCCC
Confidence 9997655543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-52 Score=385.35 Aligned_cols=257 Identities=37% Similarity=0.703 Sum_probs=232.5
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLK-HPNVVRLHEVLASK 86 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~ 86 (476)
..+|+-.+.||+|..+.|..+.++.+|+.+|+|++...... ..+..+.-.+|+.||+++. ||+|+++.|+|+++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 56788899999999999999999999999999999743221 2234456778999999995 99999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
.++++|+|+|+.|+|+|++.+...++|...+++++|+..|++|||.++|+||||||
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKp------------------------ 151 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKP------------------------ 151 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccCh------------------------
Confidence 99999999999999999999988999999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc------CCCCCccchhhhHhH
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN------RGYDGATSDIWSCGV 240 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~~~~~sDvwSlGv 240 (476)
+|||+|++.++||+|||+|+... .+..+...||||+|+|||.+.. .+| +..+|+|||||
T Consensus 152 -----------ENILlddn~~i~isDFGFa~~l~---~GekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GV 216 (411)
T KOG0599|consen 152 -----------ENILLDDNMNIKISDFGFACQLE---PGEKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGV 216 (411)
T ss_pred -----------hheeeccccceEEeccceeeccC---CchhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHH
Confidence 99999999999999999999654 4667889999999999999864 445 47799999999
Q ss_pred HHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC--CCC--CCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 241 ILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 241 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~--~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
|+|.|+.|.+||-......+++.|..|++.+ |.| +|...++||++||+.||.+|+|++++|+||||.+
T Consensus 217 ImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 217 IMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred HHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 9999999999999998999999999998765 666 7899999999999999999999999999999964
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=403.82 Aligned_cols=251 Identities=33% Similarity=0.629 Sum_probs=228.1
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 99 (476)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998764434444567889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCc
Q 011868 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179 (476)
Q Consensus 100 ~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~N 179 (476)
+|.+++...+.+++.+++.++.||+.||+|||++||+|||||| +|
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp-----------------------------------~N 125 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKL-----------------------------------EN 125 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCH-----------------------------------HH
Confidence 9999998888899999999999999999999999999999997 99
Q ss_pred eEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHH
Q 011868 180 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV 259 (476)
Q Consensus 180 iLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~ 259 (476)
||++.++.+||+|||+++.... ........+||+.|+|||++.+..+. .++||||+||++|+|++|+.||.+.+...
T Consensus 126 Ill~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~ 202 (323)
T cd05571 126 LMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202 (323)
T ss_pred EEECCCCCEEEeeCCCCccccc--CCCcccceecCccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHH
Confidence 9999999999999999874221 22334567899999999999888775 89999999999999999999999998888
Q ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 260 LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 260 ~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
.+..+..+...+|..+++++.+||++||+.||++|| ++.++++||||..
T Consensus 203 ~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 203 LFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 888888888899999999999999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-51 Score=406.47 Aligned_cols=260 Identities=30% Similarity=0.502 Sum_probs=226.6
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC-E
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS-K 88 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~-~ 88 (476)
..++||.++++||.|+||.||+|+...+|+.||||.+++... ..+ .-.-.||+..|++++ ||||++|.+++.+.. .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 456799999999999999999999999999999999976543 222 223468999999998 999999999998777 9
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
+|+||||| ..+|.+++..+ ..|++.+++.|+.||++||+|+|.+|++|||+||
T Consensus 85 L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKP------------------------- 138 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKP------------------------- 138 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCCh-------------------------
Confidence 99999999 56999999764 5799999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
||||+..+..+||+|||+|+-.. .....+..+.|.+|+|||++...++++.+.|||++|||++|+++
T Consensus 139 ----------ENiLi~~~~~iKiaDFGLARev~---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~s 205 (538)
T KOG0661|consen 139 ----------ENILISGNDVIKIADFGLAREVR---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYS 205 (538)
T ss_pred ----------hheEecccceeEecccccccccc---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHH
Confidence 99999999999999999999543 34456678899999999999999988899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhC-------------------CCCCC-----------CCCCHHHHHHHHHccCCCcCCCCCh
Q 011868 248 GYLPFDDRNLAVLYQKIFRG-------------------DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITI 297 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~-------------------~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~s~ 297 (476)
-++.|.|.+..+...+|..- .+.+| +..++++.+||.+||.+||.+|||+
T Consensus 206 LrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA 285 (538)
T KOG0661|consen 206 LRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTA 285 (538)
T ss_pred hcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccH
Confidence 99999999988777776531 12222 2268899999999999999999999
Q ss_pred HHHhcCccccccCC
Q 011868 298 AGIKADEWFEQDYT 311 (476)
Q Consensus 298 ~~il~~~~~~~~~~ 311 (476)
.|+++||||+....
T Consensus 286 ~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 286 SQALQHPFFQVGRA 299 (538)
T ss_pred HHHhcCcccccccc
Confidence 99999999986543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-50 Score=406.08 Aligned_cols=261 Identities=34% Similarity=0.621 Sum_probs=236.2
Q ss_pred ccCCccCcCEEEeceEeecCceEEEEEEECCCC-ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011868 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (476)
Q Consensus 7 ~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 85 (476)
+...+.+++|++.+.||+|+||.||+|.+..++ ..||+|.+.+...........+.+|+.+++.++||||+++++++.+
T Consensus 23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 102 (340)
T PTZ00426 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD 102 (340)
T ss_pred cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence 345667889999999999999999999876654 6899999976654444456778899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
.+..|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp----------------------- 159 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKP----------------------- 159 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCH-----------------------
Confidence 999999999999999999998888999999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+|||++.+|.+||+|||++..... ...+.+||+.|+|||++.+..++ .++||||+||++|+|
T Consensus 160 ------------~NILl~~~~~ikL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~el 221 (340)
T PTZ00426 160 ------------ENLLLDKDGFIKMTDFGFAKVVDT-----RTYTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEI 221 (340)
T ss_pred ------------HHEEECCCCCEEEecCCCCeecCC-----CcceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHH
Confidence 999999999999999999975322 23456899999999999887774 899999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
++|..||.+.+....+.++..+...+|..+++.+.++|++||+.||.+|+ +++++++||||..
T Consensus 222 l~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 222 LVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred hcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 99999999999888899999998889999999999999999999999995 8999999999975
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-50 Score=406.18 Aligned_cols=257 Identities=41% Similarity=0.763 Sum_probs=235.7
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~l 91 (476)
-..|++.+.||+|.||.||.++++.+|+.+|+|++.+...........+.+|+.+|+++. ||||+.++++|++...+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 347999999999999999999999999999999999887655445678999999999998 9999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||+|.||+|++.|... .+++..+..+++|++.|+.|||+.||+||||||
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKp----------------------------- 163 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKP----------------------------- 163 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCH-----------------------------
Confidence 99999999999999876 499999999999999999999999999999997
Q ss_pred cccCCCCceEeCCC----CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 172 FNVLQLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 172 ~~~~~~~NiLl~~~----g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|+|+... +.+|++|||+|..... ....++.||||.|+|||++...+|. ..+||||+||++|.|++
T Consensus 164 ------EN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~ 233 (382)
T KOG0032|consen 164 ------ENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLS 233 (382)
T ss_pred ------HHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhh
Confidence 99999643 5799999999996543 5678899999999999999988885 88999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCC--CC--CCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLP--KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p--~~--~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|..||.+.+....+.++..+++.++ .| +|..++++|++||..||.+|+|+.++|+|||+...
T Consensus 234 G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 234 GVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred CCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 9999999999999999999987654 33 78999999999999999999999999999998764
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-51 Score=414.87 Aligned_cols=265 Identities=43% Similarity=0.800 Sum_probs=250.2
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
.+...++.|.+.++||+|.|++|.+|++..++..||||++++....... ...+.+|+.+|+.++|||||+++.+..+..
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 5667889999999999999999999999999999999999988754443 455999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.+|+||||+.+|++++++...+++.+..++.+|.|+++|++|||+++|+|||||+
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~------------------------- 183 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKA------------------------- 183 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccch-------------------------
Confidence 9999999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||||+.+.++||+|||++..+. ......+.||+|.|.|||++.+..|+++.+|+||+|++||.|+.
T Consensus 184 ----------eNilL~~~mnikIaDfgfS~~~~---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~ 250 (596)
T KOG0586|consen 184 ----------ENILLDENMNIKIADFGFSTFFD---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVE 250 (596)
T ss_pred ----------hhcccccccceeeeccccceeec---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeee
Confidence 99999999999999999999765 36678999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
|.+||+|.+...+..+...+.+.+|-.++.++.+||+++|..+|.+|++.++|+.|.|....+.
T Consensus 251 GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 251 GSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred cccccCCcccccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 9999999999999999999999999999999999999999999999999999999999976543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=392.43 Aligned_cols=266 Identities=29% Similarity=0.502 Sum_probs=234.0
Q ss_pred hccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011868 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (476)
Q Consensus 6 ~~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 85 (476)
+..-....+.|++...||.|..++||+|+..-+++.||||+++.+.+.+. .+.+.+|+..|+.++||||++++..|..
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 44456677899999999999999999999999999999999998876443 7899999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHH
Q 011868 86 KSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLL 163 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~ 163 (476)
+..+|+||.||.+|++.+.+.. ...++|..+..+.++++.||.|||.+|-+|||||+
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKA--------------------- 154 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKA--------------------- 154 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceeccccc---------------------
Confidence 9999999999999999999976 34699999999999999999999999999999997
Q ss_pred hhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCC--cccccccCCcccccccccc--CCCCCccchhhhHh
Q 011868 164 MIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDG--LLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCG 239 (476)
Q Consensus 164 ~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~--~~~~~~~sDvwSlG 239 (476)
.|||++++|.|||+|||.+...-...... ...+..|||+|||||++.. .+|+ .|+||||||
T Consensus 155 --------------gnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfG 219 (516)
T KOG0582|consen 155 --------------GNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFG 219 (516)
T ss_pred --------------ccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhh
Confidence 99999999999999999876433222111 1266789999999999654 6786 999999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC----------CCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 240 VILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 240 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----------~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
++..||.+|..||....+..++..-.++.++.+. .++..++.+|..||+.||.+|||++++++|+||++.
T Consensus 220 ITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 220 ITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred HHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 9999999999999998888887777777766432 257789999999999999999999999999999763
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=396.66 Aligned_cols=250 Identities=36% Similarity=0.631 Sum_probs=226.8
Q ss_pred EeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 011868 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (476)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 101 (476)
||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999765433444467788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceE
Q 011868 102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181 (476)
Q Consensus 102 ~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiL 181 (476)
.+++...+++++..++.++.||+.||.|||++||+|||||| +|||
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp-----------------------------------~Nil 125 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKP-----------------------------------ENIL 125 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCH-----------------------------------HHeE
Confidence 99998888899999999999999999999999999999997 9999
Q ss_pred eCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHH
Q 011868 182 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 261 (476)
Q Consensus 182 l~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~ 261 (476)
++.+|.+||+|||+++.... ........+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+....+
T Consensus 126 i~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~ 202 (312)
T cd05585 126 LDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMY 202 (312)
T ss_pred ECCCCcEEEEECcccccCcc--CCCccccccCCcccCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHH
Confidence 99999999999999975322 22334567899999999999888775 8899999999999999999999999988899
Q ss_pred HHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC---ChHHHhcCcccccc
Q 011868 262 QKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQD 309 (476)
Q Consensus 262 ~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~---s~~~il~~~~~~~~ 309 (476)
..+......+|..+++++.+||.+||+.||.+|| ++.+++.||||.+.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 203 RKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 9999988899999999999999999999999997 57899999999763
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=396.98 Aligned_cols=251 Identities=35% Similarity=0.628 Sum_probs=227.3
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 99 (476)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++..++.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444445677889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCc
Q 011868 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179 (476)
Q Consensus 100 ~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~N 179 (476)
+|.+.+.....+++.+++.++.||+.||+|||++||+|||||| +|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp-----------------------------------~N 125 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKL-----------------------------------EN 125 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCH-----------------------------------HH
Confidence 9999998888899999999999999999999999999999997 99
Q ss_pred eEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHH
Q 011868 180 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV 259 (476)
Q Consensus 180 iLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~ 259 (476)
||++.++.+||+|||++..... ........+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+...
T Consensus 126 Ill~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~ 202 (328)
T cd05593 126 LMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202 (328)
T ss_pred eEECCCCcEEEecCcCCccCCC--cccccccccCCcCccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHH
Confidence 9999999999999999874221 12234456899999999999887775 89999999999999999999999988888
Q ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 260 LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 260 ~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
....+......+|..+++++.+||++||+.||.+|+ ++.++++||||..
T Consensus 203 ~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 203 LFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred HHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 888888888889999999999999999999999997 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-50 Score=386.89 Aligned_cols=262 Identities=31% Similarity=0.470 Sum_probs=225.3
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----CCEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-----KSKI 89 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~~~~ 89 (476)
+|...+.||+|+||.|+.|.++.+|+.||||.+... ..+.-..++..||+.+|+.++|+||+.+++++.. -+.+
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 455579999999999999999999999999998633 2345557889999999999999999999999865 3579
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+|+|++ +.+|...|..+..+++..++.++.||+.||.|+|+.+|+||||||
T Consensus 102 YiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKP--------------------------- 153 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKP--------------------------- 153 (359)
T ss_pred EEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccch---------------------------
Confidence 9999999 779999998877799999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
.|+|++.++.+||||||+|+..........++..+.|.+|.|||++....-++...||||+||||.||++|+
T Consensus 154 --------sNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gk 225 (359)
T KOG0660|consen 154 --------SNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGK 225 (359)
T ss_pred --------hheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCC
Confidence 999999999999999999997654434556677889999999999876554458999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhC-----------------------CCCCC--------CCCCHHHHHHHHHccCCCcCCCCChH
Q 011868 250 LPFDDRNLAVLYQKIFRG-----------------------DFKLP--------KWLSPGAQNLLRKILEPNPVKRITIA 298 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~-----------------------~~~~p--------~~~s~~~~~Li~~~L~~dP~~R~s~~ 298 (476)
+.|.|.+....+..|..- .+..| +..++.+.+|+.+||..||.+|+|++
T Consensus 226 plFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~ 305 (359)
T KOG0660|consen 226 PLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAE 305 (359)
T ss_pred CCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHH
Confidence 999998876666555421 11111 24789999999999999999999999
Q ss_pred HHhcCccccccCCCC
Q 011868 299 GIKADEWFEQDYTPA 313 (476)
Q Consensus 299 ~il~~~~~~~~~~~~ 313 (476)
|+|+|||+.....|.
T Consensus 306 eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 306 EALAHPYLAPYHDPE 320 (359)
T ss_pred HHhcChhhhhhcCCc
Confidence 999999998866554
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-49 Score=400.05 Aligned_cols=258 Identities=31% Similarity=0.555 Sum_probs=224.6
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998754444445677899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++||+|.+++...+++++.+++.++.|++.||+|||++||+||||||
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp------------------------------- 129 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKP------------------------------- 129 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCH-------------------------------
Confidence 9999999999998888999999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccC---------------------------------CCcccccccCCccccc
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRD---------------------------------DGLLHTTCGSPNYVAP 220 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~---------------------------------~~~~~~~~gt~~y~AP 220 (476)
+|||++.+|.+||+|||+++....... .....+.+||+.|+||
T Consensus 130 ----~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP 205 (363)
T cd05628 130 ----DNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAP 205 (363)
T ss_pred ----HHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCH
Confidence 999999999999999999875422100 0012346899999999
Q ss_pred cccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CCCCCCC--CCHHHHHHHHHccCCCcC---C
Q 011868 221 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPV---K 293 (476)
Q Consensus 221 E~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~--~s~~~~~Li~~~L~~dP~---~ 293 (476)
|++.+..++ .++|||||||++|+|++|+.||.+.+....+.++... ...+|++ +++++.+||.+|+. +|. .
T Consensus 206 E~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~ 283 (363)
T cd05628 206 EVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIG 283 (363)
T ss_pred HHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCC
Confidence 999888886 8999999999999999999999999888888888763 3445543 78999999999775 444 4
Q ss_pred CCChHHHhcCccccc
Q 011868 294 RITIAGIKADEWFEQ 308 (476)
Q Consensus 294 R~s~~~il~~~~~~~ 308 (476)
||++++|++||||..
T Consensus 284 r~~~~ei~~hp~f~~ 298 (363)
T cd05628 284 APGVEEIKTNPFFEG 298 (363)
T ss_pred CCCHHHHhCCCCCCC
Confidence 689999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=394.70 Aligned_cols=251 Identities=33% Similarity=0.631 Sum_probs=226.9
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 99 (476)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998764434444567888999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCc
Q 011868 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179 (476)
Q Consensus 100 ~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~N 179 (476)
+|.+++...+.+++..++.++.||+.||+|||++||+|||||| +|
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp-----------------------------------~N 125 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL-----------------------------------EN 125 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCH-----------------------------------HH
Confidence 9999998888899999999999999999999999999999997 99
Q ss_pred eEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHH
Q 011868 180 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV 259 (476)
Q Consensus 180 iLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~ 259 (476)
||++.++.+||+|||++..... ........+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+...
T Consensus 126 Ill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~ 202 (323)
T cd05595 126 LMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHER 202 (323)
T ss_pred EEEcCCCCEEecccHHhccccC--CCCccccccCCcCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999874221 22233456899999999999887775 89999999999999999999999988888
Q ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 260 LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 260 ~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
.+..+......+|..+++++.+||.+||+.||.+|+ ++.++++|+||..
T Consensus 203 ~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 203 LFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 888888888889999999999999999999999998 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=393.76 Aligned_cols=251 Identities=33% Similarity=0.638 Sum_probs=226.3
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876433344456778888888877 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
|+|.+++....++++..++.++.||+.||+|||++||+|||||| +
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp-----------------------------------~ 125 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKL-----------------------------------D 125 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCH-----------------------------------H
Confidence 99999998888899999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~ 258 (476)
|||++.++.+||+|||++..... ........+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+..
T Consensus 126 NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~ 202 (320)
T cd05590 126 NVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCGTPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENED 202 (320)
T ss_pred HeEECCCCcEEEeeCCCCeecCc--CCCcccccccCccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHH
Confidence 99999999999999999874321 22334556899999999999887775 8899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh------HHHhcCccccc
Q 011868 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI------AGIKADEWFEQ 308 (476)
Q Consensus 259 ~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~------~~il~~~~~~~ 308 (476)
.++..+..+...+|.++++++.+||++||+.||.+||++ ++++.||||..
T Consensus 203 ~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 203 DLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred HHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 999999999889999999999999999999999999998 89999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=391.50 Aligned_cols=256 Identities=33% Similarity=0.618 Sum_probs=229.9
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP-NVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~ 93 (476)
+|++.+.||+|+||.||+|++..+++.||||++.+...........+..|+.+++.++|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876443344467788899999999764 5889999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp------------------------------- 129 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKL------------------------------- 129 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCH-------------------------------
Confidence 9999999999998888899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.
T Consensus 130 ----~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~ 202 (324)
T cd05587 130 ----DNVMLDAEGHIKIADFGMCKENIF--GGKTTRTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFD 202 (324)
T ss_pred ----HHeEEcCCCCEEEeecCcceecCC--CCCceeeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCC
Confidence 999999999999999999874221 22234456899999999999887775 88999999999999999999999
Q ss_pred CCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh-----HHHhcCccccc
Q 011868 254 DRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI-----AGIKADEWFEQ 308 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~-----~~il~~~~~~~ 308 (476)
+.+....+..+......+|..+++++.++|++||+.||.+|++. +++++||||..
T Consensus 203 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 203 GEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred CCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 99988999999988888999999999999999999999999987 79999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=378.73 Aligned_cols=266 Identities=30% Similarity=0.412 Sum_probs=229.7
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSK 88 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~ 88 (476)
..++.|+.+..|++|+||.||+|+|+.|++.||+|.++.+. ....+.-.-.|||.+|.+++|||||.+-++... -+.
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 35678999999999999999999999999999999997665 445555677899999999999999999998864 357
Q ss_pred EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 89 IYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
+|+|||||+. +|..++..-+ +|+..+++.++.|+++|++|||.++|+||||||
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~------------------------- 205 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKT------------------------- 205 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccch-------------------------
Confidence 9999999965 9999997654 899999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|+|++..|.+||+|||+|+.+.. ....+...+-|.+|+|||.+.+..-++.+.|+||+|||+.||++
T Consensus 206 ----------SNLLm~~~G~lKiaDFGLAR~ygs--p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~ 273 (419)
T KOG0663|consen 206 ----------SNLLLSHKGILKIADFGLAREYGS--PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLT 273 (419)
T ss_pred ----------hheeeccCCcEEecccchhhhhcC--CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHh
Confidence 999999999999999999997655 23345666789999999999987766689999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCC-------------------CCCC------------CC-CCHHHHHHHHHccCCCcCCCC
Q 011868 248 GYLPFDDRNLAVLYQKIFRGD-------------------FKLP------------KW-LSPGAQNLLRKILEPNPVKRI 295 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~-------------------~~~p------------~~-~s~~~~~Li~~~L~~dP~~R~ 295 (476)
+++.|.|....+...+|++.- ..++ .. ++....+|+..+|..||.+|.
T Consensus 274 ~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~ 353 (419)
T KOG0663|consen 274 QKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRI 353 (419)
T ss_pred cCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccc
Confidence 999999999888888876521 1111 11 458899999999999999999
Q ss_pred ChHHHhcCccccccCCCCCC
Q 011868 296 TIAGIKADEWFEQDYTPANP 315 (476)
Q Consensus 296 s~~~il~~~~~~~~~~~~~~ 315 (476)
|+++.|.|+||.+...|..|
T Consensus 354 tA~~~L~h~~F~e~P~p~~P 373 (419)
T KOG0663|consen 354 TAEDGLKHEYFRETPLPIDP 373 (419)
T ss_pred cHHHhhcccccccCCCCCCh
Confidence 99999999999986665544
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=398.96 Aligned_cols=258 Identities=33% Similarity=0.616 Sum_probs=225.8
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998754434445677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp------------------------------- 129 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKP------------------------------- 129 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCH-------------------------------
Confidence 9999999999998888899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCC------------------------------------CcccccccCCcc
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDD------------------------------------GLLHTTCGSPNY 217 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~------------------------------------~~~~~~~gt~~y 217 (476)
+|||++.+|.+||+|||++......... ....+.+||+.|
T Consensus 130 ----~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 205 (364)
T cd05599 130 ----DNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDY 205 (364)
T ss_pred ----HHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccc
Confidence 9999999999999999998753221100 012245799999
Q ss_pred ccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCCC--CCCHHHHHHHHHccCCCcCC
Q 011868 218 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WLSPGAQNLLRKILEPNPVK 293 (476)
Q Consensus 218 ~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~Li~~~L~~dP~~ 293 (476)
+|||++.+.+++ .++|||||||++|+|++|..||.+.+....+..+.... ..+|. .+++++.+||++||. +|.+
T Consensus 206 ~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~ 283 (364)
T cd05599 206 IAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAER 283 (364)
T ss_pred cCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhh
Confidence 999999888775 89999999999999999999999988887777776543 33444 368999999999997 9999
Q ss_pred CCC---hHHHhcCccccc
Q 011868 294 RIT---IAGIKADEWFEQ 308 (476)
Q Consensus 294 R~s---~~~il~~~~~~~ 308 (476)
|++ +++++.||||+.
T Consensus 284 R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 284 RLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred cCCCCCHHHHhcCCCcCC
Confidence 998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=393.67 Aligned_cols=254 Identities=31% Similarity=0.536 Sum_probs=226.5
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||+|+||.||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998765434444677899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp------------------------------- 129 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKP------------------------------- 129 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCH-------------------------------
Confidence 9999999999998888899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+|||++.++.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.
T Consensus 130 ----~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~ 199 (333)
T cd05600 130 ----ENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFS 199 (333)
T ss_pred ----HHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCC
Confidence 999999999999999999975322 34566899999999999888775 88999999999999999999999
Q ss_pred CCcHHHHHHHHHhCC--CCCCC------CCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 254 DRNLAVLYQKIFRGD--FKLPK------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~--~~~p~------~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+.+....+..+.... ...|. .+++++.+||.+||..+|.+||+++++++||||..
T Consensus 200 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 200 GSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred CCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 988887777665432 22232 35899999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=392.34 Aligned_cols=251 Identities=34% Similarity=0.630 Sum_probs=226.7
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
+.||+|+||+||+|++..+++.||+|++.+...........+..|..+++.+ +||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544444456778899999876 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
|+|.+.+.....+++..++.++.||+.||.|||++||+|||||| +
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp-----------------------------------~ 125 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKL-----------------------------------D 125 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH-----------------------------------H
Confidence 99999998888899999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~ 258 (476)
|||++.+|.+||+|||++..... ........+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+..
T Consensus 126 Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~ 202 (321)
T cd05591 126 NILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCGTPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNED 202 (321)
T ss_pred HeEECCCCCEEEeecccceeccc--CCccccccccCccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999874322 22334556899999999999887775 8899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-------ChHHHhcCccccc
Q 011868 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-------TIAGIKADEWFEQ 308 (476)
Q Consensus 259 ~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-------s~~~il~~~~~~~ 308 (476)
..+..+..+...+|.++++++.+||.+||+.||++|+ +++++++||||..
T Consensus 203 ~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 203 DLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 9999999999899999999999999999999999999 8999999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=399.39 Aligned_cols=259 Identities=32% Similarity=0.533 Sum_probs=223.3
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
+.|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999998765445555678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++||+|.+++...+.+++..++.++.||+.||+|||+.||+||||||
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp------------------------------- 129 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKP------------------------------- 129 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcH-------------------------------
Confidence 9999999999998888899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccC---------------------------------------------CCcc
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRD---------------------------------------------DGLL 208 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~---------------------------------------------~~~~ 208 (476)
+|||++.+|.+||+|||++..+..... ....
T Consensus 130 ----~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (381)
T cd05626 130 ----DNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLA 205 (381)
T ss_pred ----HHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccccc
Confidence 999999999999999999864321000 0012
Q ss_pred cccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHh--CCCCCCC--CCCHHHHHHHH
Q 011868 209 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPK--WLSPGAQNLLR 284 (476)
Q Consensus 209 ~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~Li~ 284 (476)
.+.+||+.|+|||++.+..++ .++||||+||++|+|++|..||...+......++.. ....+|. .+++++.+||.
T Consensus 206 ~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~ 284 (381)
T cd05626 206 HSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLIT 284 (381)
T ss_pred ccccCCccccCHHHHcCCCCC-CccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHH
Confidence 346799999999999888775 889999999999999999999998887666666553 2344554 47999999999
Q ss_pred Hcc--CCCcCCCCChHHHhcCccccc
Q 011868 285 KIL--EPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 285 ~~L--~~dP~~R~s~~~il~~~~~~~ 308 (476)
+|+ ..+|..|++++++++||||..
T Consensus 285 ~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 285 KLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHccCcccccCCCCHHHHhcCcccCC
Confidence 955 455666999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=385.64 Aligned_cols=267 Identities=30% Similarity=0.493 Sum_probs=240.2
Q ss_pred ccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 7 ~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
+...+.++.|++++.||.|.-|+||+++...++..+|+|+++++.....+...++..|-+||+.++||.++.||..|+++
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 34566778899999999999999999999999999999999999887777788999999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 87 SKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
...|+|||||+||+|..+.+.+ +.|++..++.|+..++.||+|||-.|||+|||||
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKP---------------------- 207 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKP---------------------- 207 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCc----------------------
Confidence 9999999999999999998764 5799999999999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCc-----------------------------c-----c-------
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQH-----------------------------F-----R------- 203 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~-----------------------------~-----~------- 203 (476)
|||||-++|++.|+||-|+..... . .
T Consensus 208 -------------ENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~ 274 (459)
T KOG0610|consen 208 -------------ENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDE 274 (459)
T ss_pred -------------ceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccc
Confidence 999999999999999998743100 0 0
Q ss_pred -------------CCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC
Q 011868 204 -------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 270 (476)
Q Consensus 204 -------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 270 (476)
.+.+....+||-.|+|||++.+.+.. .++|+|+|||.+|||+.|..||.|.+..+.+.+|......
T Consensus 275 ~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~ 353 (459)
T KOG0610|consen 275 SASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK 353 (459)
T ss_pred cccccchhhhcCCCCccccccccccccccceeeecCCCC-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc
Confidence 00122345799999999999999985 8899999999999999999999999999999999999888
Q ss_pred CCCC--CCHHHHHHHHHccCCCcCCCCC----hHHHhcCcccccc
Q 011868 271 LPKW--LSPGAQNLLRKILEPNPVKRIT----IAGIKADEWFEQD 309 (476)
Q Consensus 271 ~p~~--~s~~~~~Li~~~L~~dP~~R~s----~~~il~~~~~~~~ 309 (476)
+|.. ++..+++||+++|.+||.+|.. +++|.+||||+.-
T Consensus 354 Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 354 FPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred CCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCC
Confidence 8854 6899999999999999999998 9999999999763
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=397.47 Aligned_cols=258 Identities=31% Similarity=0.540 Sum_probs=223.1
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997654334445677899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp------------------------------- 129 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKP------------------------------- 129 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH-------------------------------
Confidence 9999999999998888899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCC---------------------------------------------Ccc
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDD---------------------------------------------GLL 208 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~---------------------------------------------~~~ 208 (476)
+|||++.+|.+||+|||+++.+...... ...
T Consensus 130 ----~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (377)
T cd05629 130 ----DNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMA 205 (377)
T ss_pred ----HHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc
Confidence 9999999999999999999632210000 001
Q ss_pred cccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CCCCCCC--CCHHHHHHHH
Q 011868 209 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLR 284 (476)
Q Consensus 209 ~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~--~s~~~~~Li~ 284 (476)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+.++... ...+|.. +++++.+||.
T Consensus 206 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~ 284 (377)
T cd05629 206 YSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIR 284 (377)
T ss_pred cccCCCccccCHHHHccCCCC-CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHH
Confidence 135799999999999888775 8899999999999999999999998887777777653 3445553 7899999999
Q ss_pred HccCCCcCCC---CChHHHhcCccccc
Q 011868 285 KILEPNPVKR---ITIAGIKADEWFEQ 308 (476)
Q Consensus 285 ~~L~~dP~~R---~s~~~il~~~~~~~ 308 (476)
+||. +|.+| +|+.+++.||||..
T Consensus 285 ~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 285 RLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred HHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9998 67665 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=393.31 Aligned_cols=251 Identities=33% Similarity=0.635 Sum_probs=226.6
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 99 (476)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.....+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444444567788999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 100 ~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
+|.+++.....+++.+++.++.||+.||+|||+ .||+|||||| +
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp-----------------------------------~ 125 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL-----------------------------------E 125 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCC-----------------------------------C
Confidence 999999887889999999999999999999997 7999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~ 258 (476)
|||++.+|.+||+|||++..... ........+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..
T Consensus 126 NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~ 202 (325)
T cd05594 126 NLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHE 202 (325)
T ss_pred eEEECCCCCEEEecCCCCeecCC--CCcccccccCCcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHH
Confidence 99999999999999999874221 22234456899999999999887775 8999999999999999999999999888
Q ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 259 ~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
.....+......+|..+++++.+||.+||+.||++|+ ++.++++||||..
T Consensus 203 ~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 203 KLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred HHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 8888888888889999999999999999999999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=383.46 Aligned_cols=255 Identities=30% Similarity=0.447 Sum_probs=221.0
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
.|++.+.||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999986654333334567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 95 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|+++|+|.+.+... .++++..+..++.|++.||+|||++||+||||||
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp------------------------------ 130 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKP------------------------------ 130 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCH------------------------------
Confidence 99999999887542 3689999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+|||+++++.+||+|||++..... ........||+.|+|||++.+..++ .++||||+||++|+|++|+.||
T Consensus 131 -----~Nill~~~~~~kl~Dfg~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf 201 (285)
T cd05631 131 -----ENILLDDRGHIRISDLGLAVQIPE---GETVRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPF 201 (285)
T ss_pred -----HHEEECCCCCEEEeeCCCcEEcCC---CCeecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCC
Confidence 999999999999999999975322 2223456799999999999888775 8899999999999999999999
Q ss_pred CCCcHH----HHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC-----hHHHhcCccccc
Q 011868 253 DDRNLA----VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 308 (476)
Q Consensus 253 ~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-----~~~il~~~~~~~ 308 (476)
.+.+.. .....+......++..+++++.+||++||+.||.+||+ ++++++||||..
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 202 RKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred CCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 876532 33334444556677789999999999999999999997 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=383.00 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=215.1
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
.+++|++.+.||+|+||+||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++..++..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 46889999999999999999999999999999999975432 2224567899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
||||+. |+|.+++...+ .+++..++.++.||+.||+|||++||+||||||
T Consensus 81 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp---------------------------- 131 (288)
T cd07871 81 VFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKP---------------------------- 131 (288)
T ss_pred EEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH----------------------------
Confidence 999996 49999887544 589999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+|||++.++.+||+|||++..... .........||+.|+|||++.+....+.++||||+||++|+|++|+.
T Consensus 132 -------~Nil~~~~~~~kl~DfG~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~ 202 (288)
T cd07871 132 -------QNLLINEKGELKLADFGLARAKSV--PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP 202 (288)
T ss_pred -------HHEEECCCCCEEECcCcceeeccC--CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999875322 12233456789999999998764434588999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhCC-------------------CCCC-----------CCCCHHHHHHHHHccCCCcCCCCChHHH
Q 011868 251 PFDDRNLAVLYQKIFRGD-------------------FKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGI 300 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~-------------------~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~s~~~i 300 (476)
||.+.+.......+.... ..+| ..+++++.+||++||+.||.+|||++|+
T Consensus 203 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~ 282 (288)
T cd07871 203 MFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAA 282 (288)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence 999887665554443210 0111 2357889999999999999999999999
Q ss_pred hcCccc
Q 011868 301 KADEWF 306 (476)
Q Consensus 301 l~~~~~ 306 (476)
++||||
T Consensus 283 l~hp~f 288 (288)
T cd07871 283 LRHSYF 288 (288)
T ss_pred hcCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=389.60 Aligned_cols=254 Identities=30% Similarity=0.577 Sum_probs=225.8
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCEEEEE
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL---KLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l---~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999866433334456677777665 456799999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|||++||+|...+.. +.+++.+++.++.||+.||.|||++||+||||||
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp------------------------------ 129 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKL------------------------------ 129 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCH------------------------------
Confidence 999999999988754 5799999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||+++.+|.+||+|||++..... ......+.+||+.|+|||++.+..++ .++|||||||++|+|++|+.||
T Consensus 130 -----~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf 201 (324)
T cd05589 130 -----DNLLLDTEGFVKIADFGLCKEGMG--FGDRTSTFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPF 201 (324)
T ss_pred -----HHeEECCCCcEEeCcccCCccCCC--CCCcccccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCC
Confidence 999999999999999999874322 22334567899999999999887775 8899999999999999999999
Q ss_pred CCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 253 DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
.+.+....+..+..+...+|..+++.+.++|.+||+.||.+|| ++.++++||||..
T Consensus 202 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 202 PGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred CCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999888888898888889999999999999999999999999 6899999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=388.82 Aligned_cols=251 Identities=32% Similarity=0.628 Sum_probs=223.1
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
+.||+|+||+||+|++..+|+.||+|++++...........+..|..++... +||||+++++++..++.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999865432223345677788888755 899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
|+|.+++...+++++.++..++.||+.||+|||++||+|||||| +
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp-----------------------------------~ 125 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKL-----------------------------------D 125 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCH-----------------------------------H
Confidence 99999998888899999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~ 258 (476)
|||++.++.+||+|||++..... ........+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+..
T Consensus 126 Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~ 202 (316)
T cd05620 126 NVMLDRDGHIKIADFGMCKENVF--GDNRASTFCGTPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDED 202 (316)
T ss_pred HeEECCCCCEEeCccCCCeeccc--CCCceeccCCCcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999874221 22334567899999999999888775 8899999999999999999999998888
Q ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh-HHHhcCccccc
Q 011868 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI-AGIKADEWFEQ 308 (476)
Q Consensus 259 ~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~-~~il~~~~~~~ 308 (476)
.....+......+|.++++++.+||++||+.||.+||++ ++++.||||..
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 203 ELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 888888888888899999999999999999999999998 57999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=398.17 Aligned_cols=258 Identities=34% Similarity=0.558 Sum_probs=223.9
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.++..+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998765444455678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp------------------------------- 129 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKP------------------------------- 129 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH-------------------------------
Confidence 9999999999998878899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCccc---------------------------------------------CCCcc
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFR---------------------------------------------DDGLL 208 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~---------------------------------------------~~~~~ 208 (476)
+|||++.+|.+||+|||++..+.... .....
T Consensus 130 ----~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (382)
T cd05625 130 ----DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLA 205 (382)
T ss_pred ----HHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccc
Confidence 99999999999999999975321100 00012
Q ss_pred cccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCC--CCCCHHHHHHHH
Q 011868 209 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP--KWLSPGAQNLLR 284 (476)
Q Consensus 209 ~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~Li~ 284 (476)
.+.+||+.|+|||++.+.+|+ .++||||+||++|+|++|+.||.+.+......++.... ..+| ..+++++.+||.
T Consensus 206 ~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~ 284 (382)
T cd05625 206 HSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLII 284 (382)
T ss_pred cccccCcccCCHHHhcCCCCC-CeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHH
Confidence 345799999999999888886 89999999999999999999999988777766666532 3344 347999999999
Q ss_pred HccCCCcCCCCC---hHHHhcCccccc
Q 011868 285 KILEPNPVKRIT---IAGIKADEWFEQ 308 (476)
Q Consensus 285 ~~L~~dP~~R~s---~~~il~~~~~~~ 308 (476)
+|+ .||.+|++ +++++.||||..
T Consensus 285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 285 KLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 987 59999997 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=388.23 Aligned_cols=256 Identities=34% Similarity=0.615 Sum_probs=229.7
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
.|++.+.||+|+||+||+|++..+++.||+|++.+...........+..|..+++.+ .|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 489999999999999999999999999999999876433344456677788888887 5899999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++||+|.+.+...+.+++.++..++.||+.||+|||++||+||||||
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp------------------------------- 129 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKL------------------------------- 129 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCH-------------------------------
Confidence 9999999999998888899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+|||++.++.+||+|||++..... ........+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.
T Consensus 130 ----~Nill~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~ 202 (323)
T cd05616 130 ----DNVMLDSEGHIKIADFGMCKENMW--DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFE 202 (323)
T ss_pred ----HHeEECCCCcEEEccCCCceecCC--CCCccccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCC
Confidence 999999999999999999874321 12234467899999999999888775 89999999999999999999999
Q ss_pred CCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh-----HHHhcCccccc
Q 011868 254 DRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI-----AGIKADEWFEQ 308 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~-----~~il~~~~~~~ 308 (476)
+.+....+..+......+|..+++++.+|+.+||+.||.+|++. .+++.||||..
T Consensus 203 ~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 203 GEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred CCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 99999999999998888999999999999999999999999985 78999999964
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=394.50 Aligned_cols=258 Identities=33% Similarity=0.611 Sum_probs=228.5
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765434345677899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp------------------------------- 129 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKP------------------------------- 129 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH-------------------------------
Confidence 9999999999998888899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCccc---------------------------CCCcccccccCCccccccccccC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFR---------------------------DDGLLHTTCGSPNYVAPEVLANR 226 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~---------------------------~~~~~~~~~gt~~y~APE~l~~~ 226 (476)
+|||++.++.+||+|||++....... .........||+.|+|||++.+.
T Consensus 130 ----~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 205 (350)
T cd05573 130 ----DNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT 205 (350)
T ss_pred ----HHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence 99999999999999999998543321 00123456799999999999888
Q ss_pred CCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHh--CCCCCCCC--CCHHHHHHHHHccCCCcCCCCC-hHHHh
Q 011868 227 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKW--LSPGAQNLLRKILEPNPVKRIT-IAGIK 301 (476)
Q Consensus 227 ~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~s-~~~il 301 (476)
.++ .++|||||||++|+|++|+.||.+.+....+.++.. ....+|.. +++++.+||.+||. ||.+|++ +++++
T Consensus 206 ~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 206 PYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred CCC-CceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 775 899999999999999999999999888887777776 44455544 59999999999997 9999999 99999
Q ss_pred cCccccc
Q 011868 302 ADEWFEQ 308 (476)
Q Consensus 302 ~~~~~~~ 308 (476)
+||||..
T Consensus 284 ~hp~~~~ 290 (350)
T cd05573 284 SHPFFKG 290 (350)
T ss_pred cCCCcCC
Confidence 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=386.30 Aligned_cols=258 Identities=33% Similarity=0.622 Sum_probs=223.4
Q ss_pred CEEEeceEeecCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKI 89 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~ 89 (476)
+|++++.||+|+||+||+|++. .+++.||+|++.+.... .....+.+.+|+.+++.++ ||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 47899999999764322 2233567889999999995 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||++||+|.+++.....+++.+++.++.||+.||+|||++||+||||||
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp--------------------------- 133 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKL--------------------------- 133 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCH---------------------------
Confidence 99999999999999998888899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||++.+|.+||+|||+++..... ........+||+.|+|||++.+....+.++|||||||++|+|++|+
T Consensus 134 --------~Nili~~~~~~kl~DfG~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~ 204 (332)
T cd05614 134 --------ENILLDSEGHVVLTDFGLSKEFLSE-EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA 204 (332)
T ss_pred --------HHeEECCCCCEEEeeCcCCcccccc-CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCC
Confidence 9999999999999999999854321 1223345689999999999987654458899999999999999999
Q ss_pred CCCCCC----cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 250 LPFDDR----NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 250 ~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
.||... ....+...+.....++|..+++.+.+||.+||+.||++|| +++++++||||..
T Consensus 205 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 205 SPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999643 3345556677777788888999999999999999999999 7889999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=385.74 Aligned_cols=252 Identities=37% Similarity=0.673 Sum_probs=224.8
Q ss_pred eceEeecCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 19 GRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
++.||+|+||.||+|++. .+++.||+|++.+.... .......+.+|+.+|+.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 47889999999765321 22334567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
|++|++|.+.+...+.+++..+..++.||+.||+|||++||+||||||
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp-------------------------------- 128 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKP-------------------------------- 128 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH--------------------------------
Confidence 999999999998888899999999999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~ 254 (476)
+|||++.+|.+||+|||+++.... ........+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+
T Consensus 129 ---~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 129 ---ENILLDAQGHVKLTDFGLCKESIH--EGTVTHTFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred ---HHeEECCCCCEEEeeCcCCeeccc--CCCcccccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCC
Confidence 999999999999999999874221 22334556899999999999887775 889999999999999999999999
Q ss_pred CcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 255 RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 255 ~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
.+......++..+...+|..+++.+.+||++||+.||++|| ++++++.||||..
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 203 ENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred CCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 98888888999999999999999999999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=399.33 Aligned_cols=254 Identities=27% Similarity=0.525 Sum_probs=226.6
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
...|+...+||+|+.|.||.|....+++.||||.++...-.. .+-+.+|+.+|+..+|+|||.+++.|...+.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 457999999999999999999999999999999998765322 46789999999999999999999999888999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|||++||+|.|.+.. ..++|.++..++++++.||+|||.+||+|||||.
T Consensus 349 MEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKS------------------------------ 397 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKS------------------------------ 397 (550)
T ss_pred EeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeecccc------------------------------
Confidence 999999999998865 4699999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+|||++.+|.+||+|||++..... ......+.+|||+|||||++....| |+++||||||++++||+-|.+||
T Consensus 398 -----DnILL~~~g~vKltDFGFcaqi~~--~~~KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPY 469 (550)
T KOG0578|consen 398 -----DNILLTMDGSVKLTDFGFCAQISE--EQSKRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPY 469 (550)
T ss_pred -----ceeEeccCCcEEEeeeeeeecccc--ccCccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCc
Confidence 999999999999999999986554 2335567899999999999999988 59999999999999999999999
Q ss_pred CCCcHHHHHHHHHh-CC--CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 253 DDRNLAVLYQKIFR-GD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 253 ~~~~~~~~~~~i~~-~~--~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
-..++......|.. +. +..|+.+|+.+++|+.+||+.||.+|+++.++|+||||+.
T Consensus 470 lnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 470 LNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred cCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 87776555445444 33 3457779999999999999999999999999999999954
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=385.13 Aligned_cols=251 Identities=36% Similarity=0.695 Sum_probs=226.7
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444456778899999888 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
|+|.+.+...+++++.++..++.||+.||.|||++||+|||||| +
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp-----------------------------------~ 125 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKL-----------------------------------D 125 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCH-----------------------------------H
Confidence 99999998888899999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~ 258 (476)
||++++++.+||+|||++..... ........+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+..
T Consensus 126 Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~ 202 (318)
T cd05570 126 NVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCGTPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDED 202 (318)
T ss_pred HeEECCCCcEEecccCCCeecCc--CCCcccceecCccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHH
Confidence 99999999999999999864221 22234456899999999999888775 8899999999999999999999999888
Q ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh-----HHHhcCccccc
Q 011868 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI-----AGIKADEWFEQ 308 (476)
Q Consensus 259 ~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~-----~~il~~~~~~~ 308 (476)
..+..+......+|..+++.+.+||++||+.||.+|||+ .+++.||||..
T Consensus 203 ~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 203 ELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred HHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 888888888888899999999999999999999999999 99999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=397.81 Aligned_cols=258 Identities=32% Similarity=0.538 Sum_probs=222.6
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|+.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654333344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp------------------------------- 129 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKP------------------------------- 129 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCH-------------------------------
Confidence 9999999999998888899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccC-----------------------------------------CCcccccc
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRD-----------------------------------------DGLLHTTC 212 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-----------------------------------------~~~~~~~~ 212 (476)
+|||++.++.+||+|||+|..+..... .......+
T Consensus 130 ----~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (376)
T cd05598 130 ----DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLV 205 (376)
T ss_pred ----HHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccC
Confidence 999999999999999999853311000 00112457
Q ss_pred cCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCC--CCCCHHHHHHHHHccC
Q 011868 213 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP--KWLSPGAQNLLRKILE 288 (476)
Q Consensus 213 gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~Li~~~L~ 288 (476)
||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+......++.... ..+| ..+++++.+||.+|+
T Consensus 206 gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~- 283 (376)
T cd05598 206 GTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC- 283 (376)
T ss_pred CCccccCHHHHcCCCCC-cceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-
Confidence 99999999999888775 89999999999999999999999988776666665432 3333 357999999999977
Q ss_pred CCcCCCC---ChHHHhcCccccc
Q 011868 289 PNPVKRI---TIAGIKADEWFEQ 308 (476)
Q Consensus 289 ~dP~~R~---s~~~il~~~~~~~ 308 (476)
.+|.+|+ |+.++++||||..
T Consensus 284 ~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 284 CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred cCHhhcCCCCCHHHHhCCCCcCC
Confidence 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=380.50 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=214.5
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976532 2334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++++.+..+......+++..++.++.||+.||.|||+.||+||||||
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp------------------------------- 128 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKP------------------------------- 128 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH-------------------------------
Confidence 9999877766555556799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+||+++.++.+||+|||++....... ........||+.|+|||++.+..++ .++||||+||++|+|++|+.||.
T Consensus 129 ----~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~ 202 (287)
T cd07848 129 ----ENLLISHNDVLKLCDFGFARNLSEGS-NANYTEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFP 202 (287)
T ss_pred ----HHEEEcCCCcEEEeeccCcccccccc-cccccccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCC
Confidence 99999999999999999998643211 1223346799999999999887775 89999999999999999999998
Q ss_pred CCcHHHHHHHHHhCC-------------------CCCC-------------CCCCHHHHHHHHHccCCCcCCCCChHHHh
Q 011868 254 DRNLAVLYQKIFRGD-------------------FKLP-------------KWLSPGAQNLLRKILEPNPVKRITIAGIK 301 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~-------------------~~~p-------------~~~s~~~~~Li~~~L~~dP~~R~s~~~il 301 (476)
+.+.......+.... ...| ..+|+++.+||++||+.||.+|||+++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l 282 (287)
T cd07848 203 GESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282 (287)
T ss_pred CCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 876543332222110 0011 12678899999999999999999999999
Q ss_pred cCccc
Q 011868 302 ADEWF 306 (476)
Q Consensus 302 ~~~~~ 306 (476)
+||||
T Consensus 283 ~hp~f 287 (287)
T cd07848 283 NHPAF 287 (287)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=388.81 Aligned_cols=251 Identities=29% Similarity=0.594 Sum_probs=221.2
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
+.||+|+||+||+|++..+++.||+|++++...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876544444567788999999998 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
|+|.+++...+++++..++.++.||+.||+|||++||+|||||| +
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp-----------------------------------~ 125 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKL-----------------------------------D 125 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCH-----------------------------------H
Confidence 99999998878999999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCC---
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR--- 255 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~--- 255 (476)
||+++.++.+||+|||+++.... ......+.+||+.|+|||++.+..++ .++|+||+||++|+|++|+.||+..
T Consensus 126 Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~ 202 (329)
T cd05588 126 NVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMS 202 (329)
T ss_pred HeEECCCCCEEECcCcccccccc--CCCccccccCCccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCccccccc
Confidence 99999999999999999874211 22334567899999999999887775 8999999999999999999999631
Q ss_pred ------cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC------hHHHhcCccccc
Q 011868 256 ------NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT------IAGIKADEWFEQ 308 (476)
Q Consensus 256 ------~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s------~~~il~~~~~~~ 308 (476)
.....++.+......+|..+++.+.+||++||+.||.+|+| ++++++||||..
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 203 DNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 12335566777788899999999999999999999999997 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=386.61 Aligned_cols=251 Identities=35% Similarity=0.682 Sum_probs=222.5
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
+.||+|+||+||+|++..+++.||+|++.+...........+..|..++... +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999875433333445566777777654 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
|+|.+++...+++++.+++.++.||+.||+|||++||+|||||| +
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp-----------------------------------~ 125 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKL-----------------------------------D 125 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH-----------------------------------H
Confidence 99999998888899999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~ 258 (476)
|||++.++.+||+|||++..... ........+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+..
T Consensus 126 Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~ 202 (316)
T cd05592 126 NVLLDKDGHIKIADFGMCKENMN--GEGKASTFCGTPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDED 202 (316)
T ss_pred HeEECCCCCEEEccCcCCeECCC--CCCccccccCCccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999974322 12334566899999999999887775 8899999999999999999999999988
Q ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChH-HHhcCccccc
Q 011868 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIA-GIKADEWFEQ 308 (476)
Q Consensus 259 ~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~-~il~~~~~~~ 308 (476)
..+..+......+|.++++++.+||.+||+.||.+||++. +++.||||..
T Consensus 203 ~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 203 ELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 8888888888888999999999999999999999999875 7899999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-48 Score=385.26 Aligned_cols=251 Identities=33% Similarity=0.617 Sum_probs=222.6
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
+.||+|+||+||+|++..+++.||||++.+..............|..+++.. +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999875432233345667788888764 899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
|+|.+.+....++++.++..++.|++.||.|||++||+|||||| +
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp-----------------------------------~ 125 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKL-----------------------------------D 125 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCH-----------------------------------H
Confidence 99999998878899999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~ 258 (476)
|||++.++.+||+|||++..... ........+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+..
T Consensus 126 Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~ 202 (316)
T cd05619 126 NILLDTDGHIKIADFGMCKENML--GDAKTCTFCGTPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEE 202 (316)
T ss_pred HEEECCCCCEEEccCCcceECCC--CCCceeeecCCccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999874221 12234456899999999999887775 8999999999999999999999998888
Q ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChH-HHhcCccccc
Q 011868 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIA-GIKADEWFEQ 308 (476)
Q Consensus 259 ~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~-~il~~~~~~~ 308 (476)
..+..+......+|.+++.++.+||.+||+.||++||++. +++.||||..
T Consensus 203 ~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 203 ELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred HHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence 8888888877888899999999999999999999999996 8999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=377.18 Aligned_cols=265 Identities=33% Similarity=0.633 Sum_probs=246.1
Q ss_pred hccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011868 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (476)
Q Consensus 6 ~~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 85 (476)
+++..+.++.|+.++.||+|+||+|-+++.+.+|+.+|+|+++++-....+....-..|-++|+..+||.+..+.-.|++
T Consensus 160 ~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 160 KRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred cccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 34456688999999999999999999999999999999999998877666667778889999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
..++|+||||+.||+|+-.+.....+++..++.|-..|++||.|||+++|+.||||
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlK------------------------ 295 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLK------------------------ 295 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeech------------------------
Confidence 99999999999999999999888889999999999999999999999999999999
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
++|+|+|.+|++||+||||++-- ......+.+.||||.|+|||++....|. ..+|.|.+||++|||
T Consensus 296 -----------LENLlLDkDGHIKitDFGLCKE~--I~~g~t~kTFCGTPEYLAPEVleDnDYg-raVDWWG~GVVMYEM 361 (516)
T KOG0690|consen 296 -----------LENLLLDKDGHIKITDFGLCKEE--IKYGDTTKTFCGTPEYLAPEVLEDNDYG-RAVDWWGVGVVMYEM 361 (516)
T ss_pred -----------hhhheeccCCceEeeecccchhc--ccccceeccccCChhhcCchhhcccccc-ceeehhhhhHHHHHH
Confidence 49999999999999999999842 2345568899999999999999999884 899999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
++|++||...+...++..|..++..+|..++++++.|+..+|.+||.+|. .+.+|++|+||..
T Consensus 362 mCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 362 MCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 99999999999999999999999999999999999999999999999998 4789999999964
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=385.96 Aligned_cols=251 Identities=37% Similarity=0.632 Sum_probs=221.7
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++.+......|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999997654333333344555544 56889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
|+|.+++...+.+++..++.++.||+.||+|||++||+|||||| +
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp-----------------------------------~ 125 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKP-----------------------------------E 125 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCH-----------------------------------H
Confidence 99999998888899999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~ 258 (476)
|||++.+|.+||+|||++..... ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..
T Consensus 126 NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~ 202 (323)
T cd05575 126 NILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTA 202 (323)
T ss_pred HeEECCCCcEEEeccCCCccccc--CCCccccccCChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHH
Confidence 99999999999999999874321 22334456899999999999887775 8899999999999999999999999988
Q ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh----HHHhcCccccc
Q 011868 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI----AGIKADEWFEQ 308 (476)
Q Consensus 259 ~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~----~~il~~~~~~~ 308 (476)
..+..+......++..+++.+.++|++||+.||.+||++ .+++.||||..
T Consensus 203 ~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 203 EMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 899999888888888899999999999999999999998 59999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=392.66 Aligned_cols=263 Identities=29% Similarity=0.515 Sum_probs=228.3
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
..+..++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 45667899999999999999999999999999999999976543333345668899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp-------------------------- 170 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKP-------------------------- 170 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH--------------------------
Confidence 9999999999999998865 4699999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC---CCCccchhhhHhHHHHHH
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVI 245 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~sDvwSlGvil~el 245 (476)
+|||++.+|.+||+|||++...... ......+.+||+.|+|||++.+.. +.+.++|||||||++|+|
T Consensus 171 ---------~NILl~~~~~~kL~DfG~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyel 240 (370)
T cd05596 171 ---------DNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240 (370)
T ss_pred ---------HHEEEcCCCCEEEEeccceeeccCC-CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHH
Confidence 9999999999999999998754321 111234568999999999987542 335889999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCC--CCCCC--CCCHHHHHHHHHccCCCcCC--CCChHHHhcCccccc
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WLSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 308 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~Li~~~L~~dP~~--R~s~~~il~~~~~~~ 308 (476)
++|+.||.+.+....+.++.... ..+|. .+|.++.+||++||+.+|.+ |+|+++++.||||..
T Consensus 241 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 241 LVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 99999999998888888887643 44555 47999999999999999998 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=384.36 Aligned_cols=256 Identities=33% Similarity=0.618 Sum_probs=228.5
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 93 (476)
+|+..+.||+|+||+||+|++..+|+.||+|++.+...........+..|..+++.+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998754333344567788999998886 577889999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp------------------------------- 129 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKL------------------------------- 129 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH-------------------------------
Confidence 9999999999998888899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+|||++.++.+||+|||++..... ........+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.
T Consensus 130 ----~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~ 202 (323)
T cd05615 130 ----DNVMLDSEGHIKIADFGMCKEHMV--DGVTTRTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFD 202 (323)
T ss_pred ----HHeEECCCCCEEEeccccccccCC--CCccccCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCC
Confidence 999999999999999999874321 12234456799999999999887775 88999999999999999999999
Q ss_pred CCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh-----HHHhcCccccc
Q 011868 254 DRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI-----AGIKADEWFEQ 308 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~-----~~il~~~~~~~ 308 (476)
+.+....+..+......+|..+++++.+++.+||+.||.+|++. +++++||||..
T Consensus 203 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 203 GEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred CCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 99988889999988888999999999999999999999999984 68999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=380.72 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=211.2
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
.++|++.+.||+|+||+||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999975532 22235677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||+. ++|.+.+... +.+++..++.++.||+.||+|||++||+||||||
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp----------------------------- 131 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKP----------------------------- 131 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH-----------------------------
Confidence 99994 6888887653 5799999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+|||++.+|.+||+|||++..... ........+||+.|+|||++.+....+.++||||+||++|+|++|..|
T Consensus 132 ------~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 203 (303)
T cd07869 132 ------QNLLISDTGELKLADFGLARAKSV--PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203 (303)
T ss_pred ------HHEEECCCCCEEECCCCcceeccC--CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999874322 122334567899999999987655445889999999999999999999
Q ss_pred CCCCcH-HHHHHHHHh--CCC---------C------------CCC---------CCCHHHHHHHHHccCCCcCCCCChH
Q 011868 252 FDDRNL-AVLYQKIFR--GDF---------K------------LPK---------WLSPGAQNLLRKILEPNPVKRITIA 298 (476)
Q Consensus 252 f~~~~~-~~~~~~i~~--~~~---------~------------~p~---------~~s~~~~~Li~~~L~~dP~~R~s~~ 298 (476)
|.+... ......+.. +.. . .|. ..++++.+||++||+.||.+|||+.
T Consensus 204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~ 283 (303)
T cd07869 204 FPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQ 283 (303)
T ss_pred CCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHH
Confidence 987542 222222211 000 0 000 1356789999999999999999999
Q ss_pred HHhcCcccccc
Q 011868 299 GIKADEWFEQD 309 (476)
Q Consensus 299 ~il~~~~~~~~ 309 (476)
++++||||.+.
T Consensus 284 ~~l~h~~f~~~ 294 (303)
T cd07869 284 AALSHEYFSDL 294 (303)
T ss_pred HHhcCcccccC
Confidence 99999999763
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=385.15 Aligned_cols=251 Identities=30% Similarity=0.605 Sum_probs=220.5
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876544445567788999998877 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
|+|.+++...+++++..++.++.||+.||+|||++||+|||||| +
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp-----------------------------------~ 125 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL-----------------------------------D 125 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCH-----------------------------------H
Confidence 99999998888899999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCC----
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---- 254 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~---- 254 (476)
||+++.++.+||+|||+++.... ........+||+.|+|||++.+..++ .++|||||||++|+|++|+.||..
T Consensus 126 Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~ 202 (329)
T cd05618 126 NVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSS 202 (329)
T ss_pred HEEECCCCCEEEeeCCccccccC--CCCccccccCCccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCc
Confidence 99999999999999999874322 22234557899999999999888775 889999999999999999999952
Q ss_pred -----CcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC------hHHHhcCccccc
Q 011868 255 -----RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT------IAGIKADEWFEQ 308 (476)
Q Consensus 255 -----~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s------~~~il~~~~~~~ 308 (476)
.........+......+|..++..+.+||++||+.||.+||+ ++++++||||..
T Consensus 203 ~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 203 DNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred CCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 122345566777788899999999999999999999999998 579999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=383.83 Aligned_cols=251 Identities=34% Similarity=0.658 Sum_probs=223.9
Q ss_pred eceEeecCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011868 19 GRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 95 (476)
++.||+|+||+||++++. .+|+.||+|++.+.... ......+.+|+.++++++||||+++++++..++.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 367999999999999863 57899999999865422 22345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccC
Q 011868 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVL 175 (476)
Q Consensus 96 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 175 (476)
+++|+|.+++.....+++.+++.++.||+.||+|||++||+||||||
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp--------------------------------- 126 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKP--------------------------------- 126 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH---------------------------------
Confidence 99999999998878899999999999999999999999999999997
Q ss_pred CCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCC
Q 011868 176 QLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 255 (476)
Q Consensus 176 ~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~ 255 (476)
+||+++.++.+||+|||++..... ........+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.
T Consensus 127 --~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 127 --ENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred --HHeEECCCCcEEEeeccCCcccCC--CCCceecccCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCC
Confidence 999999999999999999875432 22334457899999999999887775 8899999999999999999999999
Q ss_pred cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC-----hHHHhcCccccc
Q 011868 256 NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 308 (476)
Q Consensus 256 ~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-----~~~il~~~~~~~ 308 (476)
+.......+......+|..+++.+.+||++||+.||.+||+ +++++.||||..
T Consensus 202 ~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 202 DRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred CHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 88888888888888899999999999999999999999999 777999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=391.45 Aligned_cols=258 Identities=31% Similarity=0.579 Sum_probs=225.1
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
+.|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++.+...+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998654444445678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp------------------------------- 129 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKP------------------------------- 129 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCH-------------------------------
Confidence 9999999999998888899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccC---------------------------------CCcccccccCCccccc
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRD---------------------------------DGLLHTTCGSPNYVAP 220 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~---------------------------------~~~~~~~~gt~~y~AP 220 (476)
+|||++.+|.+||+|||++........ .....+.+||+.|+||
T Consensus 130 ----~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 205 (360)
T cd05627 130 ----DNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAP 205 (360)
T ss_pred ----HHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCH
Confidence 999999999999999999874321100 0112245799999999
Q ss_pred cccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CCCCCCC--CCHHHHHHHHHccCCCcCCCCC
Q 011868 221 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRIT 296 (476)
Q Consensus 221 E~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~--~s~~~~~Li~~~L~~dP~~R~s 296 (476)
|++.+..++ .++|||||||++|+|++|+.||.+.+....+.++... ...+|.. +++++.+||.+|+. ||.+|++
T Consensus 206 E~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~ 283 (360)
T cd05627 206 EVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIG 283 (360)
T ss_pred HHHcCCCCC-CcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCC
Confidence 999888886 8899999999999999999999999888888877753 3444543 78999999999874 9999984
Q ss_pred ---hHHHhcCccccc
Q 011868 297 ---IAGIKADEWFEQ 308 (476)
Q Consensus 297 ---~~~il~~~~~~~ 308 (476)
++++++||||..
T Consensus 284 ~~~~~ei~~hp~f~~ 298 (360)
T cd05627 284 SNGVEEIKSHPFFEG 298 (360)
T ss_pred CCCHHHHhcCCCCCC
Confidence 799999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=373.88 Aligned_cols=260 Identities=32% Similarity=0.488 Sum_probs=224.7
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCC----
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKS---- 87 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~---- 87 (476)
+..|+.+++||+|+||+||+|+++.+|+.||+|.++.+.. .+.......+|+.+|+.++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~-~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE-EEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc-ccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 5668889999999999999999999999999999987653 2344567889999999999999 999999998877
Q ss_pred --EEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 88 --KIYMVLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 88 --~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
.+|+|+||+ .-+|..++.... .++...++.+++||+.||+|||++||+||||||
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKP------------------- 148 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKP------------------- 148 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCc-------------------
Confidence 899999999 569999997654 588899999999999999999999999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+|||++++|.+||+|||+|+.+.. .........+|.+|+|||++.+...++...||||+|||
T Consensus 149 ----------------QNlLi~~~G~lKlaDFGlAra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcI 210 (323)
T KOG0594|consen 149 ----------------QNLLISSSGVLKLADFGLARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCI 210 (323)
T ss_pred ----------------ceEEECCCCcEeeeccchHHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHH
Confidence 999999999999999999996543 23335567899999999999998666789999999999
Q ss_pred HHHHhcCCCCCCCCcHHHHHHHHHhC------------------CCCCCCC------------CCHHHHHHHHHccCCCc
Q 011868 242 LYVILTGYLPFDDRNLAVLYQKIFRG------------------DFKLPKW------------LSPGAQNLLRKILEPNP 291 (476)
Q Consensus 242 l~elltG~~Pf~~~~~~~~~~~i~~~------------------~~~~p~~------------~s~~~~~Li~~~L~~dP 291 (476)
++||++++..|.|.+..+...+|.+- +.++|.| .+++..+++.+||+.+|
T Consensus 211 faEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p 290 (323)
T KOG0594|consen 211 FAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDP 290 (323)
T ss_pred HHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCc
Confidence 99999999999999988777777641 1122322 23589999999999999
Q ss_pred CCCCChHHHhcCccccccCC
Q 011868 292 VKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 292 ~~R~s~~~il~~~~~~~~~~ 311 (476)
.+|.|+..++.||||.....
T Consensus 291 ~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 291 AKRISAKGALTHPYFSELPE 310 (323)
T ss_pred ccCcCHHHHhcChhhccccc
Confidence 99999999999999987543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=390.93 Aligned_cols=263 Identities=30% Similarity=0.527 Sum_probs=226.5
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
.....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 34556799999999999999999999999999999999976543333445678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
+|+||||++||+|.+++.. ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp-------------------------- 170 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKP-------------------------- 170 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCH--------------------------
Confidence 9999999999999999865 4699999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC---CCCccchhhhHhHHHHHH
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVI 245 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~sDvwSlGvil~el 245 (476)
+|||++++|.+||+|||++...... ......+.+||+.|+|||++.+.. +.+.++||||+||++|+|
T Consensus 171 ---------~NILl~~~~~~kL~DFG~a~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyel 240 (370)
T cd05621 171 ---------DNMLLDKHGHLKLADFGTCMKMDET-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240 (370)
T ss_pred ---------HHEEECCCCCEEEEecccceecccC-CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHH
Confidence 9999999999999999999854321 111234678999999999987643 345889999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCC--CCCCC--CCCHHHHHHHHHccCCCcCC--CCChHHHhcCccccc
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WLSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 308 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~Li~~~L~~dP~~--R~s~~~il~~~~~~~ 308 (476)
++|+.||.+.+....+.++.... +.+|. .+++.++++|.+||..+|.+ |+|++++++||||+.
T Consensus 241 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 241 LVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 99999999998888888887643 45555 36999999999999866654 899999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=385.86 Aligned_cols=252 Identities=30% Similarity=0.505 Sum_probs=217.3
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCce-EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS- 87 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~-vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~- 87 (476)
...+....+.+.||+|+||+||.|.. .|+. ||||++......... ...|.+|+.+|++++|||||++++++.+..
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34455667778899999999999985 4555 999999876544433 789999999999999999999999999887
Q ss_pred EEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC-cEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 88 KIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKG-VFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~al~yLH~~g-ivHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
..++||||+++|+|.+++.. ...++...+..++.||+.||.|||+++ |+||||||
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~---------------------- 171 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKS---------------------- 171 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccCh----------------------
Confidence 79999999999999999987 578999999999999999999999999 99999997
Q ss_pred hhccccccccCCCCceEeCCCC-CEEEeccCCCCCCCcccCCCcccccccCCccccccccc--cCCCCCccchhhhHhHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKG-NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVI 241 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g-~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~~sDvwSlGvi 241 (476)
+|+|++.++ ++||+|||+++...... .......||+.|||||++. +..|+ .|+||||||++
T Consensus 172 -------------~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIv 235 (362)
T KOG0192|consen 172 -------------DNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIV 235 (362)
T ss_pred -------------hhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHH
Confidence 999999998 99999999998543211 2333478999999999999 55776 99999999999
Q ss_pred HHHHhcCCCCCCCCcHHHHHHHHH-hC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 242 LYVILTGYLPFDDRNLAVLYQKIF-RG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 242 l~elltG~~Pf~~~~~~~~~~~i~-~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+|||+||..||.+.........+. .+ .+.+|..+++.+..||.+||+.||.+||++.+|+.
T Consensus 236 lWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 236 LWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 999999999999988765555544 33 35567889999999999999999999999999865
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=385.26 Aligned_cols=257 Identities=28% Similarity=0.534 Sum_probs=223.6
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||+|+||+||+|++..+|+.||+|++++...........+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765434445677899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 94 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp------------------------------ 130 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKP------------------------------ 130 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCch------------------------------
Confidence 999999999999775 6899999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc------CCCCCccchhhhHhHHHHHHh
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN------RGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.+|.+||+|||++....... .......+||+.|+|||++.. ..+ +.++|||||||++|+|+
T Consensus 131 -----~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~DiwslG~il~el~ 203 (330)
T cd05601 131 -----ENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPEVLTTMNGDGKGTY-GVECDWWSLGVIAYEMI 203 (330)
T ss_pred -----HheEECCCCCEEeccCCCCeECCCCC-ceeeecccCCccccCHHHhccccccccCCC-CCcceeecccceeeeec
Confidence 99999999999999999997543211 112334579999999999863 334 48899999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCC--CCCC--CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGD--FKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+|+.||.+.+....+.++.... ..+| ..+++++.+||++||+ ||.+|||++++++||||..
T Consensus 204 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 204 YGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999888877777776543 2333 3478999999999998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=383.15 Aligned_cols=251 Identities=35% Similarity=0.604 Sum_probs=221.4
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++..++..|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654333333455555654 57789999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
|+|..++...+++++.+++.++.||+.||+|||++||+|||||| +
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp-----------------------------------~ 125 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKP-----------------------------------E 125 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCH-----------------------------------H
Confidence 99999998888999999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~ 258 (476)
|||++.+|.+||+|||++..... ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..
T Consensus 126 NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~ 202 (325)
T cd05604 126 NILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVA 202 (325)
T ss_pred HeEECCCCCEEEeecCCcccCCC--CCCCcccccCChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHH
Confidence 99999999999999999874321 12234456899999999999888775 8899999999999999999999999888
Q ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh----HHHhcCccccc
Q 011868 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI----AGIKADEWFEQ 308 (476)
Q Consensus 259 ~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~----~~il~~~~~~~ 308 (476)
.++.++......+++..+..+.++|++||+.||.+||++ .+++.||||..
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 203 EMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred HHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 888888888877777899999999999999999999987 58999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=380.89 Aligned_cols=251 Identities=37% Similarity=0.627 Sum_probs=221.3
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|.. +++.++||||+++++++...+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998654333333445555554 67889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
|+|...+.....+++.+++.++.||+.||+|||++||+|||||| +
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp-----------------------------------~ 125 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKP-----------------------------------E 125 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCH-----------------------------------H
Confidence 99999998878899999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~ 258 (476)
||+++.+|.+||+|||+++.... ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..
T Consensus 126 NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~ 202 (321)
T cd05603 126 NILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCGTPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVS 202 (321)
T ss_pred HeEECCCCCEEEccCCCCccCCC--CCCccccccCCcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHH
Confidence 99999999999999999874221 22334456899999999999887775 7899999999999999999999999988
Q ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh----HHHhcCccccc
Q 011868 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI----AGIKADEWFEQ 308 (476)
Q Consensus 259 ~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~----~~il~~~~~~~ 308 (476)
..+..+......+|...+..+.++|.+||+.||.+|+++ .++++|+||..
T Consensus 203 ~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 203 QMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred HHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 888898888888888899999999999999999999976 49999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=385.08 Aligned_cols=250 Identities=32% Similarity=0.562 Sum_probs=219.2
Q ss_pred EeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
||+|+||+||+|++..+++.||+|++.+..............|..++... +||||+++++++.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765433333344556677777665 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
|+|.+.+...+.+++..++.++.||+.||+|||++||+|||||| +
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp-----------------------------------~ 125 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKP-----------------------------------E 125 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCH-----------------------------------H
Confidence 99999998888899999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~ 258 (476)
|||++.++.+||+|||++..... ........+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..
T Consensus 126 Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~ 203 (330)
T cd05586 126 NILLDATGHIALCDFGLSKANLT--DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ 203 (330)
T ss_pred HeEECCCCCEEEecCCcCcCCCC--CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH
Confidence 99999999999999999874322 2233456789999999999876553458899999999999999999999999988
Q ss_pred HHHHHHHhCCCCCCCC-CCHHHHHHHHHccCCCcCCCC----ChHHHhcCccccc
Q 011868 259 VLYQKIFRGDFKLPKW-LSPGAQNLLRKILEPNPVKRI----TIAGIKADEWFEQ 308 (476)
Q Consensus 259 ~~~~~i~~~~~~~p~~-~s~~~~~Li~~~L~~dP~~R~----s~~~il~~~~~~~ 308 (476)
..+..+..+...+|.. +++++.+||++||+.||.+|| +++++++||||..
T Consensus 204 ~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 204 QMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 8888888888777754 799999999999999999998 7899999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=380.55 Aligned_cols=256 Identities=30% Similarity=0.488 Sum_probs=210.5
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SKI 89 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~~ 89 (476)
+|++.+.||+|+||.||+|++..+|+.||||.+..... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 69999999999999999999999999999999875322 222345788999999999999999999988543 358
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||+ +++|.+.+.....+++..++.++.||+.||.|||++||+||||||
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp--------------------------- 131 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKP--------------------------- 131 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH---------------------------
Confidence 9999999 579999998878899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccC-CCcccccccCCcccccccccc--CCCCCccchhhhHhHHHHHHh
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~--~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.+|.+||+|||+++....... ........||+.|+|||++.+ ..+ +.++|||||||++|+|+
T Consensus 132 --------~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~ 202 (338)
T cd07859 132 --------KNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVL 202 (338)
T ss_pred --------HHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHH
Confidence 999999999999999999975322111 112245679999999999865 445 48899999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHh--------------------------CCCCCC-----CCCCHHHHHHHHHccCCCcCCCC
Q 011868 247 TGYLPFDDRNLAVLYQKIFR--------------------------GDFKLP-----KWLSPGAQNLLRKILEPNPVKRI 295 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~--------------------------~~~~~p-----~~~s~~~~~Li~~~L~~dP~~R~ 295 (476)
+|+.||.+.+.......+.. ...+.+ +..++.+.++|.+||+.||++||
T Consensus 203 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 282 (338)
T cd07859 203 TGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP 282 (338)
T ss_pred cCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCC
Confidence 99999987664332221110 000100 23678899999999999999999
Q ss_pred ChHHHhcCccccc
Q 011868 296 TIAGIKADEWFEQ 308 (476)
Q Consensus 296 s~~~il~~~~~~~ 308 (476)
|++++++||||+.
T Consensus 283 t~~e~l~hp~f~~ 295 (338)
T cd07859 283 TAEEALADPYFKG 295 (338)
T ss_pred CHHHHhcCchhhh
Confidence 9999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=380.10 Aligned_cols=251 Identities=29% Similarity=0.596 Sum_probs=220.9
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++.++ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876544445567788999999888 599999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
|+|.+++...+.+++..++.++.||+.||+|||++||+|||||| +
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp-----------------------------------~ 125 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKL-----------------------------------D 125 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH-----------------------------------H
Confidence 99999998878899999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCC---
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR--- 255 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~--- 255 (476)
|||++.++.+||+|||++..... ......+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||...
T Consensus 126 Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~ 202 (327)
T cd05617 126 NVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDN 202 (327)
T ss_pred HEEEeCCCCEEEeccccceeccC--CCCceecccCCcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCC
Confidence 99999999999999999874221 22334567899999999999887775 8999999999999999999999532
Q ss_pred ----cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC------hHHHhcCccccc
Q 011868 256 ----NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT------IAGIKADEWFEQ 308 (476)
Q Consensus 256 ----~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s------~~~il~~~~~~~ 308 (476)
.....+..+......+|..++..+.++|.+||+.||.+|++ +++++.||||..
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 203 PDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred cccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 23345666667777888899999999999999999999998 469999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=380.02 Aligned_cols=251 Identities=37% Similarity=0.632 Sum_probs=220.1
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHH-HHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei-~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|. .+++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999865432222233444444 457889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
|+|.+++...+.+++..++.++.||+.||+|||++||+|||||| +
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp-----------------------------------~ 125 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKP-----------------------------------E 125 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCH-----------------------------------H
Confidence 99999998888899999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~ 258 (476)
|||++.+|.+||+|||+++.... ........+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+..
T Consensus 126 Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~ 202 (325)
T cd05602 126 NILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTA 202 (325)
T ss_pred HeEECCCCCEEEccCCCCccccc--CCCCcccccCCccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999874322 22334567899999999999887775 8899999999999999999999999988
Q ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChH----HHhcCccccc
Q 011868 259 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIA----GIKADEWFEQ 308 (476)
Q Consensus 259 ~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~----~il~~~~~~~ 308 (476)
..+..+......+++.+++.+.++|.+||+.||.+|+++. ++++|+||..
T Consensus 203 ~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 203 EMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred HHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 8888888887788888999999999999999999999876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=370.78 Aligned_cols=255 Identities=29% Similarity=0.444 Sum_probs=220.6
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++.+..+..+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999976543333334567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 95 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|+.||+|.+.+... ..+++..+..++.|++.||.|||+.||+||||||
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp------------------------------ 130 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKP------------------------------ 130 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCH------------------------------
Confidence 99999999888653 4699999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||++++++.++|+|||++..... .......+|++.|+|||++.+..++ .++||||+||++|+|++|+.||
T Consensus 131 -----~Nil~~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf 201 (285)
T cd05605 131 -----ENILLDDYGHIRISDLGLAVEIPE---GETIRGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPF 201 (285)
T ss_pred -----HHEEECCCCCEEEeeCCCceecCC---CCccccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCC
Confidence 999999999999999999875432 2223445799999999999877765 7899999999999999999999
Q ss_pred CCCcHHH----HHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 253 DDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 253 ~~~~~~~----~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
.+.+... ....+......+|..+++.+.+||.+||+.||++|| +++++++||||..
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 202 RQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred CCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 8866533 233344445566777999999999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=376.76 Aligned_cols=256 Identities=29% Similarity=0.437 Sum_probs=219.9
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||.||+|++..+|..||+|++.... .......+.+|+.+++.++||||+++++++..++..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4678999999999999999999999999999999997653 33446789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~-givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
||||++||+|.+++.....+++..+..++.|++.||.|||+. +|+||||||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp---------------------------- 132 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKP---------------------------- 132 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCCh----------------------------
Confidence 999999999999998878899999999999999999999986 699999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+|||++.++.+||+|||++..... .......||+.|+|||++.+..++ .++|||||||++|+|++|+.
T Consensus 133 -------~Nil~~~~~~~kl~Dfg~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~ 200 (331)
T cd06649 133 -------SNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRY 200 (331)
T ss_pred -------hhEEEcCCCcEEEccCcccccccc----cccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCC
Confidence 999999999999999999875422 233456799999999999887775 89999999999999999999
Q ss_pred CCCCCcHHHHHHHHH----------------------------------------------hCC-CCCC-CCCCHHHHHH
Q 011868 251 PFDDRNLAVLYQKIF----------------------------------------------RGD-FKLP-KWLSPGAQNL 282 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~----------------------------------------------~~~-~~~p-~~~s~~~~~L 282 (476)
||...+...+...+. ... ...+ ..+++++.+|
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 280 (331)
T cd06649 201 PIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEF 280 (331)
T ss_pred CCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHH
Confidence 998766543322111 111 0111 2367899999
Q ss_pred HHHccCCCcCCCCChHHHhcCcccccc
Q 011868 283 LRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 283 i~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|.+||+.||++|||+.++++||||+..
T Consensus 281 i~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 281 VNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred HHHHccCCcccCCCHHHHhcChHHhhc
Confidence 999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=388.28 Aligned_cols=255 Identities=27% Similarity=0.450 Sum_probs=229.2
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
..|...+.||+|+||.||+|.+..+++.||+|+++.+.. ....+.+.+|+.+|..++++||.++|+.|..+..+|++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 358888999999999999999999999999999988763 334788999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
|||.||++.+.+..+..+.+..+..++++++.|+.|||.++.+|||||+
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKa------------------------------- 139 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKA------------------------------- 139 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccc-------------------------------
Confidence 9999999999999887779999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
.|||+..+|.+||+|||.+..... ......+.+|||.||||||+.+.+|+ .|+||||||++.+||.+|.+||.
T Consensus 140 ----anil~s~~g~vkl~DfgVa~ql~~--~~~rr~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s 212 (467)
T KOG0201|consen 140 ----ANILLSESGDVKLADFGVAGQLTN--TVKRRKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHS 212 (467)
T ss_pred ----cceeEeccCcEEEEecceeeeeec--hhhccccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCc
Confidence 999999999999999999985543 23334889999999999999988997 89999999999999999999999
Q ss_pred CCcHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 254 DRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+.+++.....|-+..+| +...+|+.+++||..||+.||+.|||+.++++|+|++.
T Consensus 213 ~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 213 KLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 88876555445444433 44568999999999999999999999999999999976
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=384.27 Aligned_cols=263 Identities=30% Similarity=0.523 Sum_probs=225.7
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
..+..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.....
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 45566899999999999999999999999999999999976543333445668899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
+|+||||++||+|.+++.. .++++..++.++.||+.||+|||++||+||||||
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp-------------------------- 170 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP-------------------------- 170 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH--------------------------
Confidence 9999999999999998865 4689999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC---CCCccchhhhHhHHHHHH
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVI 245 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~sDvwSlGvil~el 245 (476)
+|||++.+|.+||+|||++...... ......+.+||+.|+|||++.+.. ..+.++|||||||++|+|
T Consensus 171 ---------~NIll~~~~~ikL~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyel 240 (371)
T cd05622 171 ---------DNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240 (371)
T ss_pred ---------HHEEECCCCCEEEEeCCceeEcCcC-CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHH
Confidence 9999999999999999999754321 112234678999999999987543 235889999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCC--CCCCC--CCCHHHHHHHHHccCCCcCC--CCChHHHhcCccccc
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WLSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 308 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~Li~~~L~~dP~~--R~s~~~il~~~~~~~ 308 (476)
++|..||.+.+....+.++.... .++|. .+++.+.+||.+||..+|.+ |++++++++|+||..
T Consensus 241 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 241 LVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred HhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 99999999999888888887643 34443 58999999999999855543 789999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=370.80 Aligned_cols=249 Identities=29% Similarity=0.483 Sum_probs=215.1
Q ss_pred EeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 011868 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (476)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 101 (476)
||+|+||+||++.+..+++.||+|.+.+...........+..|+.+++.++||||+++++++..+...|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999766543444456778899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCC
Q 011868 102 FDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177 (476)
Q Consensus 102 ~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 177 (476)
.+.+.. ...+++..+..++.||+.||+|||++||+||||||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp----------------------------------- 125 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKP----------------------------------- 125 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH-----------------------------------
Confidence 888743 34699999999999999999999999999999997
Q ss_pred CceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcH
Q 011868 178 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL 257 (476)
Q Consensus 178 ~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~ 257 (476)
+||+++.++.+||+|||++...... ........||+.|+|||++.+..++ .++||||+||++|+|++|+.||.....
T Consensus 126 ~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~ 202 (280)
T cd05608 126 ENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYAGTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGE 202 (280)
T ss_pred HHEEECCCCCEEEeeCccceecCCC--CccccccCCCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999999998754321 2223456799999999999888775 889999999999999999999976542
Q ss_pred ----HHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 258 ----AVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 258 ----~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
......+......+|..+++.+.+++.+||+.||++|| +++++++||||+.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 203 KVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred chhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 23344455555667778999999999999999999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=370.77 Aligned_cols=259 Identities=25% Similarity=0.421 Sum_probs=215.9
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
.+++|++.+.||+|+||+||+|++..+++.||+|.+..... ......+.+|+.+++.++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 46789999999999999999999999999999999976542 2223567789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp---------------------------- 132 (309)
T cd07872 82 VFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKP---------------------------- 132 (309)
T ss_pred EEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH----------------------------
Confidence 999996 4888887654 4589999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+||+++.++.+||+|||++..... .........+|+.|+|||++.+....+.++||||+||++|+|++|+.
T Consensus 133 -------~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~ 203 (309)
T cd07872 133 -------QNLLINERGELKLADFGLARAKSV--PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRP 203 (309)
T ss_pred -------HHEEECCCCCEEECccccceecCC--CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999875322 12223345689999999998765444589999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhC-------------------CCCCC-----------CCCCHHHHHHHHHccCCCcCCCCChHHH
Q 011868 251 PFDDRNLAVLYQKIFRG-------------------DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGI 300 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~-------------------~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~s~~~i 300 (476)
||.+.+..+....+... ...+| ..+++++.+||.+||+.||.+|||++++
T Consensus 204 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 283 (309)
T cd07872 204 LFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEA 283 (309)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHH
Confidence 99887765444333221 01111 2367899999999999999999999999
Q ss_pred hcCccccccC
Q 011868 301 KADEWFEQDY 310 (476)
Q Consensus 301 l~~~~~~~~~ 310 (476)
+.||||....
T Consensus 284 l~h~~~~~~~ 293 (309)
T cd07872 284 MKHAYFRSLG 293 (309)
T ss_pred hcChhhhhcc
Confidence 9999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=374.94 Aligned_cols=259 Identities=29% Similarity=0.535 Sum_probs=220.1
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654334444567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 94 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
||++||+|.+++.. ...+++.+++.++.||+.||+|||++||+||||||
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp------------------------------ 130 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKP------------------------------ 130 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCH------------------------------
Confidence 99999999999976 45799999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc----CCCCCccchhhhHhHHHHHHhcC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~sDvwSlGvil~elltG 248 (476)
+|||++.+|.+||+|||++....... .......+||+.|+|||++.. ....+.++||||+||++|+|++|
T Consensus 131 -----~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g 204 (331)
T cd05597 131 -----DNVLLDKNGHIRLADFGSCLRLLADG-TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204 (331)
T ss_pred -----HHEEECCCCCEEEEECCceeecCCCC-CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhC
Confidence 99999999999999999986433211 112233579999999999863 23345789999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCC--CCCC---CCCCHHHHHHHHHccCCCcCC--CCChHHHhcCccccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGD--FKLP---KWLSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 308 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~~~~Li~~~L~~dP~~--R~s~~~il~~~~~~~ 308 (476)
+.||.+.+....+.++.... ..+| ..+++++++||++||..++.+ |+++++++.||||..
T Consensus 205 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 205 ETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred CCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 99999988887777776543 3333 347899999999998765544 889999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=379.01 Aligned_cols=258 Identities=28% Similarity=0.445 Sum_probs=216.5
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
...++.|+.++.||+|+||+||+|++..+++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 445778999999999999999999999999999999996543 334457899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||+.+|+|.+. ...++..+..++.||+.||+|||++||+||||||
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp--------------------------- 196 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKP--------------------------- 196 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCH---------------------------
Confidence 999999999998653 3467888899999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc----CCCCCccchhhhHhHHHHHH
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~sDvwSlGvil~el 245 (476)
+|||++.++.+||+|||++...... ........||+.|+|||++.. ..+.+.++|||||||++|+|
T Consensus 197 --------~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el 266 (353)
T PLN00034 197 --------SNLLINSAKNVKIADFGVSRILAQT--MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEF 266 (353)
T ss_pred --------HHEEEcCCCCEEEcccccceecccc--cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHH
Confidence 9999999999999999999854321 122345679999999998743 34555789999999999999
Q ss_pred hcCCCCCCCCcHH---HHHHHHH-hCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 246 LTGYLPFDDRNLA---VLYQKIF-RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 246 ltG~~Pf~~~~~~---~~~~~i~-~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
++|+.||...... .....+. ......+..+++++.+||.+||+.||++|||+.++++||||....
T Consensus 267 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 267 YLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 9999999744322 2222222 223445667899999999999999999999999999999998754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=361.35 Aligned_cols=255 Identities=35% Similarity=0.650 Sum_probs=223.8
Q ss_pred cCCccCcCEEEe-ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe
Q 011868 8 QEGMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS 85 (476)
Q Consensus 8 ~~~~~~~~Y~i~-~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~ 85 (476)
++....+.|.+- +.||-|-.|+|..+.++.||+.+|+|++.. ....++|++++-+.+ |||||.++|+|++
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 444566778886 469999999999999999999999999843 256788999988875 9999999999864
Q ss_pred ----CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHH
Q 011868 86 ----KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 86 ----~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
...+.+|||.++||+|+..|+.++ .|+|.++..+++||..|+.|||+.+|.||||||
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKp----------------- 189 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKP----------------- 189 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCCh-----------------
Confidence 456788999999999999998876 499999999999999999999999999999997
Q ss_pred HHHHhhhccccccccCCCCceEeCC---CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhh
Q 011868 160 TFLLMIVIRPWKFNVLQLENILLDS---KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 236 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl~~---~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvw 236 (476)
||+|... |..+||+|||+|+.... ...+.+.|-||.|+|||++...+|+ ..+|+|
T Consensus 190 ------------------ENLLyt~t~~na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKyd-kscdmw 247 (400)
T KOG0604|consen 190 ------------------ENLLYTTTSPNAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMW 247 (400)
T ss_pred ------------------hheeeecCCCCcceEecccccccccCC---CccccCCcccccccCHHHhCchhcC-CCCCcc
Confidence 9999975 45799999999995432 4568899999999999999989987 789999
Q ss_pred hHhHHHHHHhcCCCCCCCCcH----HHHHHHHHhCCCCCC--CC--CCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 237 SCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLP--KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 237 SlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p--~~--~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
|+|||+|.|++|++||..... ..+..+|..+.+.|| +| +|..++++|+++|..+|.+|.|+++++.|||+.+
T Consensus 248 SlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 248 SLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred chhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 999999999999999976553 466788999988876 44 7999999999999999999999999999999976
Q ss_pred c
Q 011868 309 D 309 (476)
Q Consensus 309 ~ 309 (476)
.
T Consensus 328 ~ 328 (400)
T KOG0604|consen 328 Y 328 (400)
T ss_pred c
Confidence 4
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=383.24 Aligned_cols=258 Identities=30% Similarity=0.514 Sum_probs=237.9
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK-IY 90 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~-~~ 90 (476)
.+++|..++++|+|+||.+++.+++..++.+++|.+....... ...+...+|+.+++++.|||||.+.+.|..++. .|
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 4688999999999999999999999999999999998876543 335688999999999999999999999988888 99
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|||+||+||+|.+.|... .-++++.+..+|.|++.|+.|||+++|+|||||+
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~-------------------------- 134 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKC-------------------------- 134 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchh--------------------------
Confidence 999999999999999764 3599999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
.||+++.++.|||+|||+|+.... ......+..|||.||.||++.+..|. .|+|||||||++|||++-
T Consensus 135 ---------~Nifltk~~~VkLgDfGlaK~l~~--~~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~l 202 (426)
T KOG0589|consen 135 ---------ANIFLTKDKKVKLGDFGLAKILNP--EDSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTL 202 (426)
T ss_pred ---------hhhhccccCceeecchhhhhhcCC--chhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhc
Confidence 999999999999999999997654 33477889999999999999999995 999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+.+|.+.+...+..+|.++. .+.|..++.+++.||..||..+|..||++.++|.+|.+..
T Consensus 203 k~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 203 KPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 99999999999999999988 6788999999999999999999999999999999988764
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=382.59 Aligned_cols=254 Identities=20% Similarity=0.324 Sum_probs=210.4
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
+...++|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++..+...
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 4556789999999999999999999999999999996532 3467899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+|||++ +++|.+++.....+++.+++.++.||+.||+|||++||+||||||
T Consensus 159 ~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP--------------------------- 210 (391)
T PHA03212 159 CLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKA--------------------------- 210 (391)
T ss_pred EEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh---------------------------
Confidence 9999999 579999998878899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||++.++.+||+|||+|...... ........+||+.|+|||++.+..++ .++||||+||++|+|++|+
T Consensus 211 --------~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~ 280 (391)
T PHA03212 211 --------ENIFINHPGDVCLGDFGAACFPVDI-NANKYYGWAGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCH 280 (391)
T ss_pred --------HhEEEcCCCCEEEEeCCcccccccc-cccccccccCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCC
Confidence 9999999999999999999753321 12233456899999999999887775 8999999999999999999
Q ss_pred CCCCCCc-------HHHHHHHHH--------------------------hCCC----CCCC-----CCCHHHHHHHHHcc
Q 011868 250 LPFDDRN-------LAVLYQKIF--------------------------RGDF----KLPK-----WLSPGAQNLLRKIL 287 (476)
Q Consensus 250 ~Pf~~~~-------~~~~~~~i~--------------------------~~~~----~~p~-----~~s~~~~~Li~~~L 287 (476)
.||-+.. .......+. .... ..|. .++.++.+||.+||
T Consensus 281 ~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL 360 (391)
T PHA03212 281 DSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKML 360 (391)
T ss_pred CCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHh
Confidence 8864321 111111111 1100 1111 14568999999999
Q ss_pred CCCcCCCCChHHHhcCccccccC
Q 011868 288 EPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 288 ~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
+.||.+|||++++++||||....
T Consensus 361 ~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 361 AFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred cCChhhCCCHHHHhcChhhccCC
Confidence 99999999999999999997643
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=389.98 Aligned_cols=252 Identities=26% Similarity=0.376 Sum_probs=207.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~----- 86 (476)
..++|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3457999999999999999999999999999999886542 2345799999999999999999987432
Q ss_pred ---CEEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHH
Q 011868 87 ---SKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 87 ---~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
..+|+||||++ ++|.+.+. ....+++..++.++.||+.||+|||++||+||||||
T Consensus 137 ~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp----------------- 198 (440)
T PTZ00036 137 EKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKP----------------- 198 (440)
T ss_pred CCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCH-----------------
Confidence 25779999996 47777664 345799999999999999999999999999999997
Q ss_pred HHHHhhhccccccccCCCCceEeCCCC-CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhH
Q 011868 160 TFLLMIVIRPWKFNVLQLENILLDSKG-NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 238 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl~~~g-~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSl 238 (476)
+|||++.++ .+||+|||+|+.... .......+||+.|+|||++.+....+.++||||+
T Consensus 199 ------------------~NILl~~~~~~vkL~DFGla~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 257 (440)
T PTZ00036 199 ------------------QNLLIDPNTHTLKLCDFGSAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSL 257 (440)
T ss_pred ------------------HHEEEcCCCCceeeeccccchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHH
Confidence 999999765 699999999985432 2233456789999999998765434589999999
Q ss_pred hHHHHHHhcCCCCCCCCcHHHHHHHHHhC-----------------CC------------CCCCCCCHHHHHHHHHccCC
Q 011868 239 GVILYVILTGYLPFDDRNLAVLYQKIFRG-----------------DF------------KLPKWLSPGAQNLLRKILEP 289 (476)
Q Consensus 239 Gvil~elltG~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~~Li~~~L~~ 289 (476)
||++|+|++|++||.+.+....+.++.+. .. .+|...++++.+||.+||+.
T Consensus 258 Gvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~ 337 (440)
T PTZ00036 258 GCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKY 337 (440)
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCC
Confidence 99999999999999988765554444321 01 12345678999999999999
Q ss_pred CcCCCCChHHHhcCcccccc
Q 011868 290 NPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 290 dP~~R~s~~~il~~~~~~~~ 309 (476)
||.+|||+.++++||||...
T Consensus 338 dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 338 EPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred ChhHCcCHHHHhCChhHHhh
Confidence 99999999999999999753
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=390.89 Aligned_cols=258 Identities=29% Similarity=0.445 Sum_probs=226.0
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCC-CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
....|.+.+.||+|+||.||+|.+..+ ++.||+|.+... .......+.+|+.+|+.++||||+++++++...+..|
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 344599999999999999999998877 788999987544 2334567888999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 91 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
+||||++||+|.+.+.. ..++++.++..++.||+.||.|||++||+||||||
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp------------------------ 197 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKS------------------------ 197 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCH------------------------
Confidence 99999999999987753 34699999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.++.+||+|||+++............+.+||+.|+|||++.+..+. .++||||+||++|+|+
T Consensus 198 -----------~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~ 265 (478)
T PTZ00267 198 -----------ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELL 265 (478)
T ss_pred -----------HhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHH
Confidence 9999999999999999999865432222334567899999999999887775 8899999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+|+.||.+.+...++..+..+.. ++|..+++++.+||.+||+.||++||++++++.|+|++.
T Consensus 266 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 266 TLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99999999888888888777655 356678999999999999999999999999999999864
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=376.57 Aligned_cols=259 Identities=29% Similarity=0.458 Sum_probs=213.3
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--- 87 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--- 87 (476)
..+++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 357899999999999999999999999999999999975532 3334567889999999999999999999986443
Q ss_pred ---EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 88 ---KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 88 ---~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
.+|+||||+. ++|.+.+. ..+++..+..++.||+.||+|||++||+||||||
T Consensus 97 ~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp---------------------- 151 (359)
T cd07876 97 EFQDVYLVMELMD-ANLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP---------------------- 151 (359)
T ss_pred ccceeEEEEeCCC-cCHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH----------------------
Confidence 5799999995 46777664 3589999999999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+||+++.+|.+||+|||++.... .........||+.|+|||++.+..++ .++|||||||++|+
T Consensus 152 -------------~NIl~~~~~~~kl~Dfg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~e 214 (359)
T cd07876 152 -------------SNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGE 214 (359)
T ss_pred -------------HHEEECCCCCEEEecCCCccccc---cCccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHH
Confidence 99999999999999999997432 22234456789999999999888875 88999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHHh----------------------CCCC---------CCC-----------CCCHHHHHH
Q 011868 245 ILTGYLPFDDRNLAVLYQKIFR----------------------GDFK---------LPK-----------WLSPGAQNL 282 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~~i~~----------------------~~~~---------~p~-----------~~s~~~~~L 282 (476)
|++|+.||.+.+....+..+.. .... +|. ..++.+.+|
T Consensus 215 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 294 (359)
T cd07876 215 LVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDL 294 (359)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHH
Confidence 9999999987765433222211 1111 111 135789999
Q ss_pred HHHccCCCcCCCCChHHHhcCccccccCCC
Q 011868 283 LRKILEPNPVKRITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 283 i~~~L~~dP~~R~s~~~il~~~~~~~~~~~ 312 (476)
|.+||+.||++|||++|+++||||...+.+
T Consensus 295 i~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 295 LSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=392.88 Aligned_cols=260 Identities=33% Similarity=0.540 Sum_probs=227.9
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---- 87 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~---- 87 (476)
.-++|++.+.||+|+||+||+|++..+|+.||||++..... .......+.+|+.++..++|+||+++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 44799999999999999999999999999999999977653 3344567889999999999999999998775332
Q ss_pred ----EEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHH
Q 011868 88 ----KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 88 ----~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
.+++||||+++|+|.+.+.. ...+++..++.++.|++.||.|||++||+||||||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP----------------- 171 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKS----------------- 171 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCH-----------------
Confidence 47899999999999998864 24699999999999999999999999999999997
Q ss_pred HHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHh
Q 011868 160 TFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlG 239 (476)
+|||++.++.+||+|||+++............+.+||+.|+|||++.+..++ .++||||||
T Consensus 172 ------------------~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlG 232 (496)
T PTZ00283 172 ------------------ANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLG 232 (496)
T ss_pred ------------------HHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHH
Confidence 9999999999999999999865433233344567899999999999887775 899999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 240 VILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 240 vil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
|++|+|++|+.||.+.+....+.++..+.. ++|..+++++.+||.+||+.||.+||++.++++|||++.
T Consensus 233 vilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 233 VLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999988888887776654 467889999999999999999999999999999999864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=364.34 Aligned_cols=252 Identities=31% Similarity=0.430 Sum_probs=209.2
Q ss_pred cCEEEeceEeecCceEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEE-----
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLA----- 84 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~----- 84 (476)
.+|++.+.||+|+||+||+|++.. +++.||+|.+...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999864 5788999998754422 22334566788877766 6999999999985
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHH
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFL 162 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~ 162 (476)
....+|+||||+. ++|.+++... ..+++.+++.++.||+.||.|||++||+||||||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp-------------------- 138 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP-------------------- 138 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCH--------------------
Confidence 3456899999995 6999988653 4589999999999999999999999999999997
Q ss_pred HhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHH
Q 011868 163 LMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242 (476)
Q Consensus 163 ~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil 242 (476)
+|||++.++.+||+|||++..... ........||+.|+|||++.+..++ .++||||+||++
T Consensus 139 ---------------~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il 199 (290)
T cd07862 139 ---------------QNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIF 199 (290)
T ss_pred ---------------HHEEEcCCCCEEEccccceEeccC---CcccccccccccccChHHHhCCCCC-CccchHHHHHHH
Confidence 999999999999999999975432 2334456799999999999877775 889999999999
Q ss_pred HHHhcCCCCCCCCcHHHHHHHHHhCCC-C--------------------------CCCCCCHHHHHHHHHccCCCcCCCC
Q 011868 243 YVILTGYLPFDDRNLAVLYQKIFRGDF-K--------------------------LPKWLSPGAQNLLRKILEPNPVKRI 295 (476)
Q Consensus 243 ~elltG~~Pf~~~~~~~~~~~i~~~~~-~--------------------------~p~~~s~~~~~Li~~~L~~dP~~R~ 295 (476)
|+|++|++||.+.+....+.++..... + ..+.+++.+.+||.+||+.||++||
T Consensus 200 ~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 279 (290)
T cd07862 200 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 279 (290)
T ss_pred HHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcC
Confidence 999999999998887766666543210 0 1124678889999999999999999
Q ss_pred ChHHHhcCccc
Q 011868 296 TIAGIKADEWF 306 (476)
Q Consensus 296 s~~~il~~~~~ 306 (476)
|+.++++||||
T Consensus 280 s~~~~l~hp~f 290 (290)
T cd07862 280 SAYSALSHPYF 290 (290)
T ss_pred CHHHHhcCCCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=363.19 Aligned_cols=254 Identities=38% Similarity=0.738 Sum_probs=231.7
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||+|+||.||+|.+..+++.||+|++........+..+.+.+|+.++++++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997665444455678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||+++++|.+++...+.+++..+..++.||+.||+|||++|++||||+|
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p------------------------------- 129 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKP------------------------------- 129 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH-------------------------------
Confidence 9999999999998888899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
.||+++.+|.+||+|||++...... ....+|++.|+|||.+.+..++ .++||||||+++|+|++|+.||.
T Consensus 130 ----~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~ 199 (290)
T cd05580 130 ----ENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFF 199 (290)
T ss_pred ----HHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999998854321 3456799999999998777664 88999999999999999999999
Q ss_pred CCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 254 DRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
..+......++..+..++|..+++.+.++|.+||..||.+|+ +++++++||||..
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 200 DDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 888777888888888889999999999999999999999999 9999999999965
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=379.60 Aligned_cols=257 Identities=28% Similarity=0.422 Sum_probs=216.4
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KI 89 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----~~ 89 (476)
.|++.+.||+|+||+||+|.+..+|+.||||.+.... ........+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4789999999999999999999999999999986542 22333567889999999999999999999998776 89
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||+. ++|.+.+.....+++..++.++.||+.||+|||++||+||||||
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp--------------------------- 131 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKP--------------------------- 131 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh---------------------------
Confidence 99999995 68999888778899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||++.++.+||+|||+++..... .........+|+.|+|||++.+....+.++||||+||++|+|++|+
T Consensus 132 --------~Nili~~~~~~kL~Dfg~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 202 (372)
T cd07853 132 --------GNLLVNSNCVLKICDFGLARVEEPD-ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202 (372)
T ss_pred --------HHEEECCCCCEEeccccceeecccC-ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCC
Confidence 9999999999999999999754321 1222334568999999999987654458899999999999999999
Q ss_pred CCCCCCcHHHHHHHHHh-----------------------CCC---------CCCCCCCHHHHHHHHHccCCCcCCCCCh
Q 011868 250 LPFDDRNLAVLYQKIFR-----------------------GDF---------KLPKWLSPGAQNLLRKILEPNPVKRITI 297 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~-----------------------~~~---------~~p~~~s~~~~~Li~~~L~~dP~~R~s~ 297 (476)
.||.+.+.......+.. ... .+....++++.+||.+||+.||.+|||+
T Consensus 203 ~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~ 282 (372)
T cd07853 203 ILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA 282 (372)
T ss_pred CCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH
Confidence 99998776555444322 111 1223467899999999999999999999
Q ss_pred HHHhcCcccccc
Q 011868 298 AGIKADEWFEQD 309 (476)
Q Consensus 298 ~~il~~~~~~~~ 309 (476)
.++++||||...
T Consensus 283 ~e~l~hp~~~~~ 294 (372)
T cd07853 283 ADALAHPYLDEG 294 (372)
T ss_pred HHHhcCHhhCCC
Confidence 999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=371.44 Aligned_cols=259 Identities=28% Similarity=0.508 Sum_probs=220.8
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||+|+||+||++++..+++.||+|++.+...........+.+|+.+++.++|+||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997644333344566889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 94 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp------------------------------ 130 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKP------------------------------ 130 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCH------------------------------
Confidence 99999999999976 46799999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc----CCCCCccchhhhHhHHHHHHhcC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~sDvwSlGvil~elltG 248 (476)
+|||++.++.+||+|||++...... ........+||+.|+|||++.. ....+.++|||||||++|+|++|
T Consensus 131 -----~Nili~~~~~~kL~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g 204 (332)
T cd05623 131 -----DNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204 (332)
T ss_pred -----HHEEECCCCCEEEeecchheecccC-CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcC
Confidence 9999999999999999998743221 1112234679999999999863 22335889999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCC--CCCCC---CCCHHHHHHHHHccCCCcCC--CCChHHHhcCccccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGD--FKLPK---WLSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 308 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~~~~Li~~~L~~dP~~--R~s~~~il~~~~~~~ 308 (476)
+.||.+.+....+.++.... .++|. .+++++.+||++||..+|.+ |++++++++||||..
T Consensus 205 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 205 ETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred CCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 99999998888888887653 23333 47999999999999766554 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=371.75 Aligned_cols=258 Identities=28% Similarity=0.502 Sum_probs=220.9
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||+|+||+||++++..+++.||+|++.+...........+.+|+.+++.++|+||+++++++..++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997644333344566889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 94 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
||++||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp------------------------------ 130 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKP------------------------------ 130 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCch------------------------------
Confidence 99999999999976 46799999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc-----CCCCCccchhhhHhHHHHHHhc
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.+|.+||+|||++....... .......+||+.|+|||++.+ ..+ +.++||||+||++|+|++
T Consensus 131 -----~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwSlGvil~ell~ 203 (331)
T cd05624 131 -----DNVLLDMNGHIRLADFGSCLKMNQDG-TVQSSVAVGTPDYISPEILQAMEDGMGKY-GPECDWWSLGVCMYEMLY 203 (331)
T ss_pred -----HHEEEcCCCCEEEEeccceeeccCCC-ceeeccccCCcccCCHHHHhccccCCCCC-CCcccEEeeehhhhhhhh
Confidence 99999999999999999987543211 112234679999999999865 234 478999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCC--CCCCC---CCCHHHHHHHHHccCCCcCC--CCChHHHhcCccccc
Q 011868 248 GYLPFDDRNLAVLYQKIFRGD--FKLPK---WLSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 308 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~~~~Li~~~L~~dP~~--R~s~~~il~~~~~~~ 308 (476)
|+.||.+.+....+.++.... +++|. .+++++.+||.+||..++.+ |++++++++||||..
T Consensus 204 g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 204 GETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred CCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999988888887776643 33443 36899999999999976655 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=370.01 Aligned_cols=257 Identities=29% Similarity=0.440 Sum_probs=218.0
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.++||+|+||.||+|.+..++..+|+|++.... .......+.+|+.+++.++||||+++++++..++.+|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3578999999999999999999999999999999987653 33345779999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~-givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
||||++||+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp---------------------------- 132 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP---------------------------- 132 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCh----------------------------
Confidence 999999999999998878899999999999999999999985 799999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+|||++.+|.+||+|||++..... ......+||+.|+|||++.+..++ .++||||+||++|+|++|+.
T Consensus 133 -------~Nili~~~~~~kL~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~ 200 (333)
T cd06650 133 -------SNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRY 200 (333)
T ss_pred -------hhEEEcCCCCEEEeeCCcchhhhh----hccccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCC
Confidence 999999999999999999874322 223345799999999999877665 88999999999999999999
Q ss_pred CCCCCcHHHHHHH--------------------------------------------HHhCC-CCCC-CCCCHHHHHHHH
Q 011868 251 PFDDRNLAVLYQK--------------------------------------------IFRGD-FKLP-KWLSPGAQNLLR 284 (476)
Q Consensus 251 Pf~~~~~~~~~~~--------------------------------------------i~~~~-~~~p-~~~s~~~~~Li~ 284 (476)
||........... +.... ...+ ..+++++.+||.
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 280 (333)
T cd06650 201 PIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVN 280 (333)
T ss_pred CCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHH
Confidence 9986554332211 11111 1111 136788999999
Q ss_pred HccCCCcCCCCChHHHhcCccccccC
Q 011868 285 KILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 285 ~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
+||+.||++|||+.+++.||||+...
T Consensus 281 ~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 281 KCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred HhccCCcccCcCHHHHhhCHHHhcCc
Confidence 99999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=353.51 Aligned_cols=257 Identities=32% Similarity=0.529 Sum_probs=222.1
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
+.|++.+.||+|++|.||.|.+..+++.||+|.+....... ......+.+|+.+++.++||||+++++++..+...|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987553221 2234678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||++|++|.+.+...+.+++..++.++.|++.||.|||+.|++||||||
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p----------------------------- 132 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKG----------------------------- 132 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH-----------------------------
Confidence 999999999999998878899999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCC-CcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+||++++++.++|+|||++......... .......|+..|+|||++.+..++ .++||||+||++|+|++|+.
T Consensus 133 ------~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~ 205 (263)
T cd06625 133 ------ANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKP 205 (263)
T ss_pred ------HHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCC
Confidence 9999999999999999998754322111 111345688999999999887764 89999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 251 PFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
||...+......++... ...+|..+++.+.++|++||..+|.+|||+.++++|+||
T Consensus 206 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 206 PWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 99887666555554433 345677789999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=373.57 Aligned_cols=258 Identities=28% Similarity=0.421 Sum_probs=214.2
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~----- 86 (476)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 46899999999999999999999999999999999975432 233356788999999999999999999987543
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 87 -~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
..+|+||||+. ++|.+.+.. .+++..++.++.|++.||+|||++||+||||||
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp----------------------- 154 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP----------------------- 154 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCH-----------------------
Confidence 46899999995 578777753 588999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+|||++.++.+||+|||+++.... ........||+.|+|||++.+..++ .++|||||||++|+|
T Consensus 155 ------------~NIll~~~~~~kL~DfG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el 218 (364)
T cd07875 155 ------------SNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEM 218 (364)
T ss_pred ------------HHEEECCCCcEEEEeCCCccccCC---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHH
Confidence 999999999999999999975322 2233456799999999999888775 889999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCC----------------------CC--------------C------CCCCCHHHHHHH
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGD----------------------FK--------------L------PKWLSPGAQNLL 283 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~----------------------~~--------------~------p~~~s~~~~~Li 283 (476)
++|+.||.+.+....+.++...- .. + +...++.+++||
T Consensus 219 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 298 (364)
T cd07875 219 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298 (364)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHH
Confidence 99999999877665555443210 00 0 011346789999
Q ss_pred HHccCCCcCCCCChHHHhcCccccccCCC
Q 011868 284 RKILEPNPVKRITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 284 ~~~L~~dP~~R~s~~~il~~~~~~~~~~~ 312 (476)
.+||+.||.+|||++++++||||...+.+
T Consensus 299 ~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 327 (364)
T cd07875 299 SKMLVIDASKRISVDEALQHPYINVWYDP 327 (364)
T ss_pred HHhcCcCcccCCCHHHHhcCcccccccCc
Confidence 99999999999999999999999865544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=387.35 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=206.6
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC------CCcceEEEEEEeC
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH------PNVVRLHEVLASK 86 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H------pnIv~l~~~~~~~ 86 (476)
.++|++.+.||+|+||+||+|.+..+++.||||+++... ........|+.+++.++| ++++++++++..+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 478999999999999999999999999999999996532 223456678887777755 4588999988754
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 87 -~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
.++|+|||++ |++|.+++...+.+++.+++.++.||+.||+|||+ .||+||||||
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP---------------------- 260 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKP---------------------- 260 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCH----------------------
Confidence 5799999999 88999999887889999999999999999999998 5999999997
Q ss_pred hhccccccccCCCCceEeCCCC----------------CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCC
Q 011868 165 IVIRPWKFNVLQLENILLDSKG----------------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 228 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g----------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 228 (476)
+|||++.++ .+||+|||++... .......+||+.|+|||++.+..|
T Consensus 261 -------------~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~ 322 (467)
T PTZ00284 261 -------------ENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGW 322 (467)
T ss_pred -------------HHEEEecCCcccccccccccCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCC
Confidence 999998766 4999999988632 122345789999999999998888
Q ss_pred CCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----------------------------C-------
Q 011868 229 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----------------------------K------- 273 (476)
Q Consensus 229 ~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----------------------------~------- 273 (476)
. .++|||||||++|||++|+.||++.+.......+......+| .
T Consensus 323 ~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (467)
T PTZ00284 323 M-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIAR 401 (467)
T ss_pred C-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhc
Confidence 5 889999999999999999999988775544333322110000 0
Q ss_pred -------CCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 274 -------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 274 -------~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
..++.+.+||++||+.||.+|||++|+++||||.+.+.
T Consensus 402 ~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 402 ARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred ccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 01356789999999999999999999999999987543
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=372.04 Aligned_cols=259 Identities=28% Similarity=0.437 Sum_probs=213.4
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK---- 86 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~---- 86 (476)
..+++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 457899999999999999999999999999999999975432 333456788999999999999999999998643
Q ss_pred --CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 87 --SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
...|+||||+. ++|.+.+.. .+++..++.++.|++.||+|||++||+||||||
T Consensus 93 ~~~~~~lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp---------------------- 147 (355)
T cd07874 93 EFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP---------------------- 147 (355)
T ss_pred ccceeEEEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh----------------------
Confidence 35799999995 477777653 589999999999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+|||++.++.+||+|||+++.... ........||+.|+|||++.+..++ .++|||||||++|+
T Consensus 148 -------------~Nill~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~e 210 (355)
T cd07874 148 -------------SNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGE 210 (355)
T ss_pred -------------HHEEECCCCCEEEeeCcccccCCC---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHH
Confidence 999999999999999999975322 2233456799999999999888775 88999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHHhC----------------------C-----CC---------------CCCCCCHHHHHH
Q 011868 245 ILTGYLPFDDRNLAVLYQKIFRG----------------------D-----FK---------------LPKWLSPGAQNL 282 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~~i~~~----------------------~-----~~---------------~p~~~s~~~~~L 282 (476)
|++|+.||.+.+....+..+... . .. .+...+.++.+|
T Consensus 211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 290 (355)
T cd07874 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290 (355)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHH
Confidence 99999999887654433322110 0 00 011135678999
Q ss_pred HHHccCCCcCCCCChHHHhcCccccccCCC
Q 011868 283 LRKILEPNPVKRITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 283 i~~~L~~dP~~R~s~~~il~~~~~~~~~~~ 312 (476)
|.+||+.||.+|||+.|+++||||...+.+
T Consensus 291 i~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 291 LSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred HHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=355.73 Aligned_cols=252 Identities=37% Similarity=0.665 Sum_probs=214.7
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 95 (476)
|++++.||+|+||+||+|++..+++.||+|++........ ......+|+.+++.++||||+++++++......|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999987753222 233445699999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccC
Q 011868 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVL 175 (476)
Q Consensus 96 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 175 (476)
+.+++|.+++.....+++.++..++.||+.||++||+.||+||||||
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp--------------------------------- 126 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKP--------------------------------- 126 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSG---------------------------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc---------------------------------
Confidence 99999999998778899999999999999999999999999999997
Q ss_pred CCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccc-cCCCCCccchhhhHhHHHHHHhcCCCCCCC
Q 011868 176 QLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-NRGYDGATSDIWSCGVILYVILTGYLPFDD 254 (476)
Q Consensus 176 ~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~~sDvwSlGvil~elltG~~Pf~~ 254 (476)
+||++++++.++|+|||.+.... ..........+++.|+|||++. +..+ +.++||||||+++|+|++|..||..
T Consensus 127 --~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~~~~p~~~ 201 (260)
T PF00069_consen 127 --ENILLDENGEVKLIDFGSSVKLS--ENNENFNPFVGTPEYMAPEVLQQGKKY-TRKSDIWSLGIILYELLTGKLPFEE 201 (260)
T ss_dssp --GGEEESTTSEEEESSGTTTEEST--STTSEBSSSSSSGGGSCHHHHTTTSSB-STHHHHHHHHHHHHHHHHSSSSSTT
T ss_pred --ccccccccccccccccccccccc--ccccccccccccccccccccccccccc-ccccccccccccccccccccccccc
Confidence 99999999999999999987421 1233455678999999999987 4444 5899999999999999999999998
Q ss_pred Cc---HHHHHHHHHhCCCCCCC----CCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 255 RN---LAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 255 ~~---~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
.+ ......+........+. ..++.+.++|.+||+.||++|||+.++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 202 SNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp SSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 73 33344443332222111 124899999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=361.02 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=216.0
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
..+++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++...+..|
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 357899999999999999999999999999999999975532 222456778999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+||||+. ++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||
T Consensus 81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp--------------------------- 132 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKP--------------------------- 132 (301)
T ss_pred EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCH---------------------------
Confidence 9999996 589888865 35689999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+||+++.++.+||+|||++..... .........+++.|+|||++.+....+.++||||+||++|+|++|+
T Consensus 133 --------~Nil~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 202 (301)
T cd07873 133 --------QNLLINERGELKLADFGLARAKSI--PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202 (301)
T ss_pred --------HHEEECCCCcEEECcCcchhccCC--CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999875322 1222334567899999999876554458899999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhC-------------------CCCCC-----------CCCCHHHHHHHHHccCCCcCCCCChHH
Q 011868 250 LPFDDRNLAVLYQKIFRG-------------------DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAG 299 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~-------------------~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~s~~~ 299 (476)
.||.+.+.......+... ....| ..+++.+.+||.+||+.||.+|||+++
T Consensus 203 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~e 282 (301)
T cd07873 203 PLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEE 282 (301)
T ss_pred CCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 999987765444333211 01111 236788999999999999999999999
Q ss_pred HhcCccccc
Q 011868 300 IKADEWFEQ 308 (476)
Q Consensus 300 il~~~~~~~ 308 (476)
+++||||..
T Consensus 283 il~h~~f~~ 291 (301)
T cd07873 283 AMKHPYFHC 291 (301)
T ss_pred HhcCccccc
Confidence 999999965
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=359.88 Aligned_cols=255 Identities=30% Similarity=0.449 Sum_probs=216.9
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++.+...+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999976654444445667889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 95 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|++|++|.+++... ..+++.++..++.|++.||.|||+.||+||||||
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp------------------------------ 130 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKP------------------------------ 130 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCH------------------------------
Confidence 99999999988643 3599999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||+++.++.++|+|||++..... ........||+.|+|||++.+..++ .++||||+||++|+|++|+.||
T Consensus 131 -----~Nil~~~~~~~~l~Dfg~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf 201 (285)
T cd05630 131 -----ENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPF 201 (285)
T ss_pred -----HHEEECCCCCEEEeeccceeecCC---CccccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCC
Confidence 999999999999999999875322 1222345799999999999887775 8899999999999999999999
Q ss_pred CCCcHH---HHHHHH-HhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC-----hHHHhcCccccc
Q 011868 253 DDRNLA---VLYQKI-FRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 308 (476)
Q Consensus 253 ~~~~~~---~~~~~i-~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-----~~~il~~~~~~~ 308 (476)
.+.... ...... .......+..+++++.+||++||+.||.+||| ++++++||||+.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 202 QQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred CCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 865421 112222 12223456678999999999999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=359.14 Aligned_cols=251 Identities=31% Similarity=0.432 Sum_probs=207.5
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----C
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLAS-----K 86 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~-----~ 86 (476)
+|++.+.||+|+||+||+|++..+++.||+|.+..... .......+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 69999999999999999999999999999999875432 222234566777777766 69999999998864 3
Q ss_pred CEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 87 SKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
..+++||||+. ++|.+++... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp---------------------- 136 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKP---------------------- 136 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH----------------------
Confidence 46899999996 5898888653 3589999999999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+||+++.++.+||+|||++..... ........||+.|+|||++.+..++ .++||||+||++|+
T Consensus 137 -------------~Nili~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~ 199 (288)
T cd07863 137 -------------ENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAE 199 (288)
T ss_pred -------------HHEEECCCCCEEECccCccccccC---cccCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHH
Confidence 999999999999999999986432 2223445789999999999887775 89999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHHhCC-----------CC----------------CCCCCCHHHHHHHHHccCCCcCCCCCh
Q 011868 245 ILTGYLPFDDRNLAVLYQKIFRGD-----------FK----------------LPKWLSPGAQNLLRKILEPNPVKRITI 297 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~~i~~~~-----------~~----------------~p~~~s~~~~~Li~~~L~~dP~~R~s~ 297 (476)
|++|++||.+.+....+.++.... .. ..+.++..+.+||.+||+.||.+|||+
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 279 (288)
T cd07863 200 MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISA 279 (288)
T ss_pred HHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCH
Confidence 999999998877665555543210 00 112357788999999999999999999
Q ss_pred HHHhcCccc
Q 011868 298 AGIKADEWF 306 (476)
Q Consensus 298 ~~il~~~~~ 306 (476)
.+++.||||
T Consensus 280 ~~~l~hp~f 288 (288)
T cd07863 280 FRALQHPFF 288 (288)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=370.77 Aligned_cols=256 Identities=29% Similarity=0.431 Sum_probs=212.4
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~----- 86 (476)
..++|++.+.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34689999999999999999999999999999999975432 223346678999999999999999999988543
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 87 -~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
...|++|+++ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp----------------------- 146 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKP----------------------- 146 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCh-----------------------
Confidence 4579999998 8899887754 5799999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||+++.++.+||+|||++..... .....+||+.|+|||++.+....+.++|||||||++|+|
T Consensus 147 ------------~Nil~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 209 (343)
T cd07878 147 ------------SNVAVNEDCELRILDFGLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred ------------hhEEECCCCCEEEcCCccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHH
Confidence 999999999999999999985322 234567999999999988754445899999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCC-----------------------CCCC--------CCCCHHHHHHHHHccCCCcCCC
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGD-----------------------FKLP--------KWLSPGAQNLLRKILEPNPVKR 294 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~-----------------------~~~p--------~~~s~~~~~Li~~~L~~dP~~R 294 (476)
++|+.||.+.+.......+.... ...| ...++.+.+||.+||+.||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R 289 (343)
T cd07878 210 LKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKR 289 (343)
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhC
Confidence 99999998876554444332210 0011 2356778999999999999999
Q ss_pred CChHHHhcCccccccC
Q 011868 295 ITIAGIKADEWFEQDY 310 (476)
Q Consensus 295 ~s~~~il~~~~~~~~~ 310 (476)
||+.++++||||.+..
T Consensus 290 ~s~~ell~hp~~~~~~ 305 (343)
T cd07878 290 ISASEALAHPYFSQYH 305 (343)
T ss_pred CCHHHHhcCcchhccC
Confidence 9999999999998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=369.56 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=207.1
Q ss_pred cCcCEEEeceEeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~ 85 (476)
..++|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 3468999999999999999999752 356789999997543 233356789999999999 89999999998865
Q ss_pred C-CEEEEEEeccCCCChHHHHHhc--------------------------------------------------------
Q 011868 86 K-SKIYMVLEYVTGGELFDKIASK-------------------------------------------------------- 108 (476)
Q Consensus 86 ~-~~~~lV~E~~~gg~L~~~l~~~-------------------------------------------------------- 108 (476)
. +.+|+||||+++|+|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 4689999999999999998642
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEe
Q 011868 109 ------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182 (476)
Q Consensus 109 ------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl 182 (476)
.++++.++..++.||+.||+|||++||+|||||| +|||+
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp-----------------------------------~Nil~ 207 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAA-----------------------------------RNILL 207 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCcc-----------------------------------ceEEE
Confidence 2477888999999999999999999999999997 99999
Q ss_pred CCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHH-H
Q 011868 183 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV-L 260 (476)
Q Consensus 183 ~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~-~ 260 (476)
+.++.+||+|||+++............+..+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+..... .
T Consensus 208 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~ 286 (338)
T cd05102 208 SENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEF 286 (338)
T ss_pred cCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHH
Confidence 99999999999999754321111122334567899999999887775 89999999999999997 999998865433 3
Q ss_pred HHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 261 YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 261 ~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
...+..+ ....|...++.+.+||.+||+.||.+|||+.++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 287 CQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 3333333 23456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=356.58 Aligned_cols=256 Identities=29% Similarity=0.444 Sum_probs=220.2
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++.+..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48888999999999999999999999999999977654444445667889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 95 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|+.+++|.+.+... .++++..+..++.|++.||.|||+.||+||||||
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp------------------------------ 130 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKP------------------------------ 130 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCH------------------------------
Confidence 99999999888643 3699999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||++++++.+||+|||++..... ........|++.|+|||++.+..++ .++|+||+||++|+|++|..||
T Consensus 131 -----~Nili~~~~~~kl~Dfg~~~~~~~---~~~~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~ 201 (285)
T cd05632 131 -----ENILLDDYGHIRISDLGLAVKIPE---GESIRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPF 201 (285)
T ss_pred -----HHEEECCCCCEEEecCCcceecCC---CCcccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCC
Confidence 999999999999999999874322 1223445799999999999877775 8899999999999999999999
Q ss_pred CCCcHHHH----HHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC-----hHHHhcCcccccc
Q 011868 253 DDRNLAVL----YQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQD 309 (476)
Q Consensus 253 ~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-----~~~il~~~~~~~~ 309 (476)
.+...... ...+......++..+++.+.+|+.+||+.||++||+ +.+++.|+||...
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 202 RGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred CCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 87665433 233344444566778999999999999999999999 8899999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=359.75 Aligned_cols=252 Identities=31% Similarity=0.481 Sum_probs=214.3
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KI 89 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----~~ 89 (476)
.|+-.+.+|.|+||.||.|....+++.||||.+-.+. +.-.+|..+|++++|||||++.-+|.... ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 5889999999999999999999999999999886553 23347999999999999999999885432 34
Q ss_pred EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 90 YMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
.+||||++. +|.+.+.. +.+++.-.++-|+.||.+||.|||+.||+||||||
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKP----------------------- 153 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKP----------------------- 153 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCCh-----------------------
Confidence 579999964 99998874 56899999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCC-CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~-g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
.|+|+|.+ |.+||||||.|+.... +....+...|..|+|||.+.+...++.+.||||+|||+.|
T Consensus 154 ------------qNlLvD~~tg~LKicDFGSAK~L~~---~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aE 218 (364)
T KOG0658|consen 154 ------------QNLLVDPDTGVLKICDFGSAKVLVK---GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAE 218 (364)
T ss_pred ------------heEEEcCCCCeEEeccCCcceeecc---CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHH
Confidence 99999976 9999999999997654 3333566779999999999997766799999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHHhC-----------------CCCC------------CCCCCHHHHHHHHHccCCCcCCCC
Q 011868 245 ILTGYLPFDDRNLAVLYQKIFRG-----------------DFKL------------PKWLSPGAQNLLRKILEPNPVKRI 295 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~~i~~~-----------------~~~~------------p~~~s~~~~~Li~~~L~~dP~~R~ 295 (476)
|+-|++.|.|.+...+...|.+- +..+ ....++++.+|+.++|..+|.+|.
T Consensus 219 Ll~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~ 298 (364)
T KOG0658|consen 219 LLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL 298 (364)
T ss_pred HhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC
Confidence 99999999999887777666531 1111 123689999999999999999999
Q ss_pred ChHHHhcCccccccCCC
Q 011868 296 TIAGIKADEWFEQDYTP 312 (476)
Q Consensus 296 s~~~il~~~~~~~~~~~ 312 (476)
++.|+++||||..-..+
T Consensus 299 ~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 299 SALEALAHPFFDELRDP 315 (364)
T ss_pred CHHHHhcchhhHHhhCc
Confidence 99999999999875444
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=372.50 Aligned_cols=244 Identities=29% Similarity=0.461 Sum_probs=212.6
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 95 (476)
+.+++.||+|.||+||+|... ....||+|.+...... .+.|.+|+.+|++|+|+|||++++++..+..+||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 445788999999999999973 3447999999765322 36778999999999999999999999998899999999
Q ss_pred cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 96 VTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 96 ~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
++.|+|.+++.. .+.+...+...++.||++||+||+++++|||||-+
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAA------------------------------- 331 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAA------------------------------- 331 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhh-------------------------------
Confidence 999999999986 45799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 252 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf 252 (476)
.||||++++.+||+|||||+..... .-.......-...|.|||.+....++ .+||||||||+||||+| |+.||
T Consensus 332 ----RNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py 405 (468)
T KOG0197|consen 332 ----RNILVDEDLVVKISDFGLARLIGDD-EYTASEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPY 405 (468)
T ss_pred ----hheeeccCceEEEcccccccccCCC-ceeecCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCC
Confidence 9999999999999999999943321 10111122234689999999988886 89999999999999999 99999
Q ss_pred CCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHh
Q 011868 253 DDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il 301 (476)
.+.+..+..+.+.+| .++.|..+++++.+++..||+.+|++|||++.+.
T Consensus 406 ~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 406 PGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 999999999999887 5788999999999999999999999999999664
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=347.75 Aligned_cols=253 Identities=28% Similarity=0.546 Sum_probs=220.2
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIYMVL 93 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lV~ 93 (476)
+|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+.+|+.++++++|||++++++.+.. +..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 59999999999999999999999999999999976542 23335678999999999999999999998764 45789999
Q ss_pred eccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 94 EYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 94 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||+++++|.+.+.. ...+++.+++.++.|++.|++|||+.|++||||||
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p----------------------------- 130 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKT----------------------------- 130 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCc-----------------------------
Confidence 99999999999875 34589999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||+++.++.++|+|||++..... .........|++.|+|||++.+..++ .++|+||+||++|+|++|+.|
T Consensus 131 ------~nil~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~ 201 (257)
T cd08223 131 ------QNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHA 201 (257)
T ss_pred ------hhEEEecCCcEEEecccceEEecc--cCCccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCC
Confidence 999999999999999999875432 12233456789999999999887775 889999999999999999999
Q ss_pred CCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 252 FDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
|...+.......+..+.. ..+..+++.+.++|.+||+.||.+|||+.++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 202 FNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred CCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 998877766666666554 4566789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=356.25 Aligned_cols=248 Identities=26% Similarity=0.439 Sum_probs=209.2
Q ss_pred EeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 011868 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (476)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 101 (476)
||+|+||+||++++..+|+.||+|.+.............+..|+.+++.++||||+++++++..+...|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765433323344566799999999999999999999999999999999999999
Q ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCc
Q 011868 102 FDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179 (476)
Q Consensus 102 ~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~N 179 (476)
.+.+... ..+++..+..++.||+.||+|||+.||+|||||| +|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp-----------------------------------~N 125 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKP-----------------------------------EN 125 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCCh-----------------------------------Hh
Confidence 9888543 3588999999999999999999999999999997 99
Q ss_pred eEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcH--
Q 011868 180 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-- 257 (476)
Q Consensus 180 iLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~-- 257 (476)
|+++.++.++|+|||++..... ........||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+...
T Consensus 126 ili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~~~~ 201 (277)
T cd05607 126 VLLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHKEKV 201 (277)
T ss_pred EEEcCCCCEEEeeceeeeecCC---CceeeccCCCCCccCHHHHccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCcchh
Confidence 9999999999999999875432 2223345799999999999887765 899999999999999999999976432
Q ss_pred --HHHHHHHHhCCCCCC-CCCCHHHHHHHHHccCCCcCCCCCh----HHHhcCccccc
Q 011868 258 --AVLYQKIFRGDFKLP-KWLSPGAQNLLRKILEPNPVKRITI----AGIKADEWFEQ 308 (476)
Q Consensus 258 --~~~~~~i~~~~~~~p-~~~s~~~~~Li~~~L~~dP~~R~s~----~~il~~~~~~~ 308 (476)
..............+ ..+++++.+||++||+.||.+||++ ++++.||||+.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 202 AKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred hHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 233444444444433 3589999999999999999999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=348.57 Aligned_cols=256 Identities=34% Similarity=0.523 Sum_probs=220.6
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccc------hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH------LKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
+|.+...||+|+||.||+|.+..+++.||+|.+....... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5888999999999999999998899999999987543221 2234678999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
.|+||||+++++|.+++...+.+++..++.++.|++.||+|||++|++||||||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p-------------------------- 134 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKG-------------------------- 134 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCH--------------------------
Confidence 999999999999999998878899999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC----CCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+||+++.++.++|+|||++........ ........|++.|+|||.+.+..++ .++|+||+||++|+
T Consensus 135 ---------~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~ 204 (267)
T cd06628 135 ---------ANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVE 204 (267)
T ss_pred ---------HHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHH
Confidence 999999999999999999886542111 1112234688999999999877775 78999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 245 ILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
|++|+.||.+.+......++... ...+|..++..+.++|++||++||.+||++.++++||||
T Consensus 205 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 205 MLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 99999999887665554444443 345667789999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=357.50 Aligned_cols=254 Identities=30% Similarity=0.450 Sum_probs=216.3
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||+|+||.||+|.+..++..+|+|.+.... ......++.+|+.+++.++||||+++++++..++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999987542 3344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
||++|++|.+++...+++++..++.++.|++.||.|||+ .+++||||||
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p------------------------------ 128 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKP------------------------------ 128 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCCh------------------------------
Confidence 999999999999888889999999999999999999998 5999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+|||++.++.+||+|||++.... .....+.+|++.|+|||++.+..+. .++|+||+||++|+|++|+.||
T Consensus 129 -----~nil~~~~~~~~l~dfg~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~ 198 (308)
T cd06615 129 -----SNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPI 198 (308)
T ss_pred -----HHEEEecCCcEEEccCCCccccc----ccccccCCCCcCccChhHhcCCCCC-ccchHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999987432 2223456799999999998776664 8899999999999999999999
Q ss_pred CCCcHHHHHHHHHhC-------------------------------------CCCCCC-CCCHHHHHHHHHccCCCcCCC
Q 011868 253 DDRNLAVLYQKIFRG-------------------------------------DFKLPK-WLSPGAQNLLRKILEPNPVKR 294 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~-------------------------------------~~~~p~-~~s~~~~~Li~~~L~~dP~~R 294 (476)
...+.......+... ....|. .+++++.+||.+||..||++|
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 278 (308)
T cd06615 199 PPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKER 278 (308)
T ss_pred CCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhC
Confidence 765543332222110 011111 267889999999999999999
Q ss_pred CChHHHhcCcccccc
Q 011868 295 ITIAGIKADEWFEQD 309 (476)
Q Consensus 295 ~s~~~il~~~~~~~~ 309 (476)
||+.++++||||...
T Consensus 279 pt~~~ll~~~~~~~~ 293 (308)
T cd06615 279 ADLKELTKHPFIKRA 293 (308)
T ss_pred cCHHHHhcChhhhhc
Confidence 999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=376.28 Aligned_cols=248 Identities=32% Similarity=0.443 Sum_probs=216.0
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-C-----CCcceEEEEEEeCCE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H-----PNVVRLHEVLASKSK 88 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-H-----pnIv~l~~~~~~~~~ 88 (476)
+|++.+.||+|+||.|-+|.|..|++.||||+++.. .....+...|+.+|..++ | -|+|+++|+|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 899999999999999999999999999999999764 355788899999999997 4 379999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 89 IYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
.|||+|++ +-+|.++++.+ .+++...++.++.||+.||.+||+.||||.||||
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKP------------------------ 317 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKP------------------------ 317 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCh------------------------
Confidence 99999999 67999999875 4799999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCC--CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 167 IRPWKFNVLQLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~--g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
|||||.+. ..+||+|||.|+.. .....+.+-+..|+|||++.+.+|+ .+.||||||||++|
T Consensus 318 -----------ENILL~~~~r~~vKVIDFGSSc~~-----~q~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAE 380 (586)
T KOG0667|consen 318 -----------ENILLKDPKRSRIKVIDFGSSCFE-----SQRVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAE 380 (586)
T ss_pred -----------hheeeccCCcCceeEEeccccccc-----CCcceeeeeccccccchhhccCCCC-CccceeehhhhHHh
Confidence 99999754 47999999999853 2334488899999999999999997 88999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHHhCC----------------------------------------------------CCCC
Q 011868 245 ILTGYLPFDDRNLAVLYQKIFRGD----------------------------------------------------FKLP 272 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~~i~~~~----------------------------------------------------~~~p 272 (476)
|++|.+.|.|.+..+++..|..-. ...|
T Consensus 381 L~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P 460 (586)
T KOG0667|consen 381 LFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGP 460 (586)
T ss_pred HhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCC
Confidence 999999999999887776664200 0011
Q ss_pred CC-----------CCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 273 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 273 ~~-----------~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
.. -...+.++|.+||.+||.+|+|+.++++|||+..
T Consensus 461 ~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 461 PGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred CCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence 00 1234799999999999999999999999999974
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=343.72 Aligned_cols=253 Identities=28% Similarity=0.480 Sum_probs=223.3
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
.|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999999765432 3346778999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 95 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|++|++|.+++... ..+++..++.++.|++.||.|||+.|++||||||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~------------------------------ 129 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKS------------------------------ 129 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCc------------------------------
Confidence 99999999999764 5789999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||+++.++.++|+|||++...... .......+|++.|+|||++.+..++ .++|+|||||++|+|++|+.||
T Consensus 130 -----~nili~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~ 201 (256)
T cd08529 130 -----LNLFLDAYDNVKIGDLGVAKLLSDN--TNFANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPF 201 (256)
T ss_pred -----ceEEEeCCCCEEEcccccceeccCc--cchhhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCC
Confidence 9999999999999999998854331 2223445789999999999887765 8899999999999999999999
Q ss_pred CCCcHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 253 DDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
...+......++..+..+ ++..+++++.++|.+||+.+|++||++.+++.|||+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 202 DANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 988877777777766544 445688999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=359.15 Aligned_cols=247 Identities=32% Similarity=0.469 Sum_probs=195.6
Q ss_pred eceEeecCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEe
Q 011868 19 GRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIYMVLE 94 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E 94 (476)
+++||+|+||+||+|++. .+++.||+|.+..... ...+.+|+.+++.++||||+++++++.. +..+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 578999999999999965 4678999999865431 3457789999999999999999999854 467899999
Q ss_pred ccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 95 YVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 95 ~~~gg~L~~~l~~~---------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
|+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp----------------------- 136 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKP----------------------- 136 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCH-----------------------
Confidence 99 56888887532 2589999999999999999999999999999997
Q ss_pred hccccccccCCCCceEe----CCCCCEEEeccCCCCCCCccc-CCCcccccccCCccccccccccCCCCCccchhhhHhH
Q 011868 166 VIRPWKFNVLQLENILL----DSKGNIKISDFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl----~~~g~vkl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGv 240 (476)
+|||+ +.++.+||+|||+++...... ........+||+.|+|||++.+....+.++||||+||
T Consensus 137 ------------~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 204 (317)
T cd07868 137 ------------ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 204 (317)
T ss_pred ------------HHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHH
Confidence 99999 456899999999998654321 1223345689999999999987654458899999999
Q ss_pred HHHHHhcCCCCCCCCcHH---------HHHHHHHhC----------------------------CCCC----------CC
Q 011868 241 ILYVILTGYLPFDDRNLA---------VLYQKIFRG----------------------------DFKL----------PK 273 (476)
Q Consensus 241 il~elltG~~Pf~~~~~~---------~~~~~i~~~----------------------------~~~~----------p~ 273 (476)
++|+|++|++||.+.+.. ..+.++... .... ..
T Consensus 205 il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (317)
T cd07868 205 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 284 (317)
T ss_pred HHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCC
Confidence 999999999999754321 111111110 0000 01
Q ss_pred CCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 274 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 274 ~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
..++.+.+||++||+.||.+|||++|+++||||
T Consensus 285 ~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 285 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 135678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=350.83 Aligned_cols=253 Identities=30% Similarity=0.452 Sum_probs=209.5
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999999865432 22335678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 95 YVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 95 ~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|+. ++|.+++... ..+++.+++.++.||+.||+|||++|++||||||
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p----------------------------- 129 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKP----------------------------- 129 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCH-----------------------------
Confidence 996 6888888542 4689999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||+++.+|.+||+|||++..... .........+++.|+|||++.+....+.++|||||||++|+|++|+.|
T Consensus 130 ------~nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~ 201 (285)
T cd07861 130 ------QNLLIDNKGVIKLADFGLARAFGI--PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPL 201 (285)
T ss_pred ------HHEEEcCCCcEEECcccceeecCC--CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999999999874322 112223346789999999987654445889999999999999999999
Q ss_pred CCCCcHHHHHHHHHhC------------------CC-----------CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 252 FDDRNLAVLYQKIFRG------------------DF-----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~------------------~~-----------~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|.+.+.......+... .. .....+++++.+||++||+.||.+|||+.+++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 202 FHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 9876643322221110 00 012236889999999999999999999999999
Q ss_pred Cccc
Q 011868 303 DEWF 306 (476)
Q Consensus 303 ~~~~ 306 (476)
||||
T Consensus 282 ~~~~ 285 (285)
T cd07861 282 HPYF 285 (285)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=356.08 Aligned_cols=259 Identities=31% Similarity=0.526 Sum_probs=226.6
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 37999999999999999999999999999999998765444345678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 94 EYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 94 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||+.|++|.+++... ..+++..++.++.|++.||+|||++|++||||||
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp----------------------------- 131 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKP----------------------------- 131 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCCh-----------------------------
Confidence 999999999998753 5799999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccC---------------------------CCcccccccCCccccccccc
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRD---------------------------DGLLHTTCGSPNYVAPEVLA 224 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~---------------------------~~~~~~~~gt~~y~APE~l~ 224 (476)
+||+++.++.++|+|||++........ ........||..|+|||++.
T Consensus 132 ------~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 205 (316)
T cd05574 132 ------ENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS 205 (316)
T ss_pred ------HHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc
Confidence 999999999999999999875432110 00112346889999999998
Q ss_pred cCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHccCCCcCCCCC----hH
Q 011868 225 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRIT----IA 298 (476)
Q Consensus 225 ~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~s----~~ 298 (476)
+..++ .++|||||||++|+|++|..||.+.+....+..+......++.. .++.+.++|.+||..||++||| ++
T Consensus 206 ~~~~~-~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 206 GDGHG-SAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCCCC-chHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 77764 88999999999999999999999888877777777666666554 6899999999999999999999 99
Q ss_pred HHhcCccccc
Q 011868 299 GIKADEWFEQ 308 (476)
Q Consensus 299 ~il~~~~~~~ 308 (476)
+++.||||+.
T Consensus 285 ~ll~~~~~~~ 294 (316)
T cd05574 285 EIKQHPFFRG 294 (316)
T ss_pred HHHcCchhhc
Confidence 9999999975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=352.48 Aligned_cols=255 Identities=31% Similarity=0.468 Sum_probs=221.1
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||.|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++||||+++++.+..+...|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 5699999999999999999999889999999998654 3334577889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 94 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
||+++++|.+++... ..+++.+++.++.|++.||.|||++||+||||||
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p------------------------------ 131 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKA------------------------------ 131 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCh------------------------------
Confidence 999999999998763 5799999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc-----CCCCCccchhhhHhHHHHHHhc
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++.++|+|||++...... ........|++.|+|||++.. ..+ +.++|+||+||++|+|++
T Consensus 132 -----~nili~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~-~~~sDi~slG~il~~l~~ 203 (280)
T cd06611 132 -----GNILLTLDGDVKLADFGVSAKNKST--LQKRDTFIGTPYWMAPEVVACETFKDNPY-DYKADIWSLGITLIELAQ 203 (280)
T ss_pred -----hhEEECCCCCEEEccCccchhhccc--ccccceeecchhhcCHHHHhhcccCCCCC-CccccHHHHHHHHHHHHh
Confidence 9999999999999999998753321 222334578999999999753 223 468999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|+.||.+.+......++..+.. ..|..++.++.++|.+||+.||.+||+++++++||||...
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 204 MEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred CCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 9999998877766666666543 3456688999999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=354.05 Aligned_cols=253 Identities=29% Similarity=0.476 Sum_probs=209.8
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||+|+||+||+|++..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+....|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 69999999999999999999999999999999976432 22334567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 95 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
|+. ++|.+.+.. .+++++..++.++.||+.||.|||++||+||||||
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~------------------------------- 127 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKP------------------------------- 127 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH-------------------------------
Confidence 996 588887764 56799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC-
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF- 252 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf- 252 (476)
+||+++.++.+||+|||++..... .........+++.|+|||++.+....+.++||||+||++|+|++|..||
T Consensus 128 ----~nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 128 ----QNLLINKNGELKLADFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred ----HHEEEcCCCcEEECccchhhccCC--CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 999999999999999999875432 1122334567899999999877654458899999999999999988885
Q ss_pred CCCcHHHHHHHHHhCC-------------------C----------CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 253 DDRNLAVLYQKIFRGD-------------------F----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~~-------------------~----------~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
.+.+....+..+.... . ...+.+++++.+||++||+.||.+|||+++++.|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 202 PGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 5555444444332210 0 0112367899999999999999999999999999
Q ss_pred ccc
Q 011868 304 EWF 306 (476)
Q Consensus 304 ~~~ 306 (476)
|||
T Consensus 282 ~~f 284 (284)
T cd07839 282 PYF 284 (284)
T ss_pred CCC
Confidence 997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=348.98 Aligned_cols=256 Identities=31% Similarity=0.585 Sum_probs=222.7
Q ss_pred EEEe-ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 011868 16 YELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 16 Y~i~-~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 93 (476)
|.+. +.||+|+|+.|--+....+|..||||++++.. .....++.+|++++..++ |+||++++++|+++.++||||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 5554 56999999999999999999999999999874 334678999999999995 999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
|-+.||+|...|.....|+|.+|.++.+.|++||.|||.+||.||||||
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKP------------------------------- 204 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKP------------------------------- 204 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCc-------------------------------
Confidence 9999999999999989999999999999999999999999999999997
Q ss_pred cCCCCceEeCCCC---CEEEeccCCCCCCCcc-----cCCCcccccccCCcccccccccc----CCCCCccchhhhHhHH
Q 011868 174 VLQLENILLDSKG---NIKISDFGLSALPQHF-----RDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVI 241 (476)
Q Consensus 174 ~~~~~NiLl~~~g---~vkl~DFGla~~~~~~-----~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~sDvwSlGvi 241 (476)
+|||-..-. -+|||||.|..-.... .....+-++||+..|||||+..- ..++..++|.||||||
T Consensus 205 ----ENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvI 280 (463)
T KOG0607|consen 205 ----ENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVI 280 (463)
T ss_pred ----cceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHH
Confidence 999986554 4899999988643221 12334567899999999998642 2233489999999999
Q ss_pred HHHHhcCCCCCCCC---------------cHHHHHHHHHhCCCCCCCC----CCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 242 LYVILTGYLPFDDR---------------NLAVLYQKIFRGDFKLPKW----LSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 242 l~elltG~~Pf~~~---------------~~~~~~~~i~~~~~~~p~~----~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
||.||+|++||.|. -...++..|..|.+.+|.. +|.++++||+.+|..||.+|.++.++++
T Consensus 281 lYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 281 LYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 99999999999762 1456788899999999953 8999999999999999999999999999
Q ss_pred Ccccccc
Q 011868 303 DEWFEQD 309 (476)
Q Consensus 303 ~~~~~~~ 309 (476)
|||+...
T Consensus 361 hPw~~~~ 367 (463)
T KOG0607|consen 361 HPWVQRC 367 (463)
T ss_pred Ccccccc
Confidence 9999753
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=370.29 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=208.5
Q ss_pred CcCEEEeceEeecCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
-.+|++++.||+|+||.||+|... .++..||+|.+... ....+|+.+|+.++||||+++++++......|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 457999999999999999999754 35688999988543 23457999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
+|||++ +++|.+++.....+++.+++.++.||+.||.|||++||+||||||
T Consensus 163 lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp---------------------------- 213 (392)
T PHA03207 163 MVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKT---------------------------- 213 (392)
T ss_pred EEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCH----------------------------
Confidence 999999 579999997778899999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+|||++.++.+||+|||++................||+.|+|||++.+..|+ .++||||+||++|+|++|+.
T Consensus 214 -------~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~ 285 (392)
T PHA03207 214 -------ENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNV 285 (392)
T ss_pred -------HHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCC
Confidence 9999999999999999999754432222233456799999999999888775 88999999999999999999
Q ss_pred CCCCCcH---HHHHHHHHh----C-------------------------CCCCCC-----CCCHHHHHHHHHccCCCcCC
Q 011868 251 PFDDRNL---AVLYQKIFR----G-------------------------DFKLPK-----WLSPGAQNLLRKILEPNPVK 293 (476)
Q Consensus 251 Pf~~~~~---~~~~~~i~~----~-------------------------~~~~p~-----~~s~~~~~Li~~~L~~dP~~ 293 (476)
||.+.+. ...+..+.+ . .+..|. .++.++.++|++||..||++
T Consensus 286 pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 365 (392)
T PHA03207 286 TLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEF 365 (392)
T ss_pred CCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhh
Confidence 9976432 111111111 0 011121 24668899999999999999
Q ss_pred CCChHHHhcCcccccc
Q 011868 294 RITIAGIKADEWFEQD 309 (476)
Q Consensus 294 R~s~~~il~~~~~~~~ 309 (476)
|||+.++++||||.+.
T Consensus 366 Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 366 RPSAQDILSLPLFTKE 381 (392)
T ss_pred CCCHHHHhhCchhhcc
Confidence 9999999999999763
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=348.02 Aligned_cols=253 Identities=32% Similarity=0.561 Sum_probs=224.2
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 59999999999999999999998999999999987655454557889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
|+.|++|.+++....++++.++..++.||+.||.|||++|++|+||||
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~-------------------------------- 128 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKP-------------------------------- 128 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH--------------------------------
Confidence 999999999998777899999999999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~ 254 (476)
+||++++++.++|+|||++..... ........|+..|+|||++.+..+. .++|+||+||++|+|++|..||..
T Consensus 129 ---~nil~~~~~~~~l~d~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~ 201 (258)
T cd05578 129 ---DNILLDEQGHVHITDFNIATKVTP---DTLTTSTSGTPGYMAPEVLCRQGYS-VAVDWWSLGVTAYECLRGKRPYRG 201 (258)
T ss_pred ---HHeEEcCCCCEEEeecccccccCC---CccccccCCChhhcCHHHHcccCCC-CcccchhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999875432 2233456789999999999877764 889999999999999999999987
Q ss_pred CcH---HHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh--HHHhcCccc
Q 011868 255 RNL---AVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI--AGIKADEWF 306 (476)
Q Consensus 255 ~~~---~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~--~~il~~~~~ 306 (476)
.+. ..............|..+++.+.++|++||+.||.+||++ .++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 202 HSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred CCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 763 3333333335566777889999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=352.85 Aligned_cols=259 Identities=32% Similarity=0.582 Sum_probs=224.1
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999997664333444567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p------------------------------- 129 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKP------------------------------- 129 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCch-------------------------------
Confidence 9999999999998888899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCccc-------------CCCcccccccCCccccccccccCCCCCccchhhhHhH
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFR-------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~-------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGv 240 (476)
+||+++.+|.+||+|||+++...... .........|+..|+|||.+.+..+ +.++|+|||||
T Consensus 130 ----~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~ 204 (305)
T cd05609 130 ----DNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGI 204 (305)
T ss_pred ----HHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHH
Confidence 99999999999999999986321000 0001123468889999999887766 48999999999
Q ss_pred HHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC---CCCHHHHHHHHHccCCCcCCCCC---hHHHhcCccccc
Q 011868 241 ILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK---WLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 308 (476)
Q Consensus 241 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~---~~s~~~~~Li~~~L~~dP~~R~s---~~~il~~~~~~~ 308 (476)
++|+|++|..||.+.+.......+..+....|. .+++++.++|.+||+.||++||+ +.++++||||..
T Consensus 205 vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 205 ILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 999999999999988888878777766544433 47889999999999999999998 788999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=348.68 Aligned_cols=255 Identities=28% Similarity=0.443 Sum_probs=213.0
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 579999999999999999999998999999999865432 2223456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++++.|...+.....+++.+++.++.||+.||+|||++|++||||||
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p------------------------------- 128 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKP------------------------------- 128 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCh-------------------------------
Confidence 9999988888776667899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+||+++.++.+||+|||++...... ........++..|+|||++.+....+.++||||+||++|+|++|..||.
T Consensus 129 ----~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~ 202 (286)
T cd07847 129 ----ENILITKQGQIKLCDFGFARILTGP--GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202 (286)
T ss_pred ----hhEEEcCCCcEEECccccceecCCC--cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999864331 1122345688999999998765444588999999999999999999998
Q ss_pred CCcHHHHHHHHHhC-------------------CCCCC------------CCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 254 DRNLAVLYQKIFRG-------------------DFKLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 254 ~~~~~~~~~~i~~~-------------------~~~~p------------~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+.+..+....+... ....| ..++..+.+||.+||+.||++|||+.+++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 203 GKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 77654333222110 00001 235788999999999999999999999999
Q ss_pred Cccc
Q 011868 303 DEWF 306 (476)
Q Consensus 303 ~~~~ 306 (476)
||||
T Consensus 283 ~~~f 286 (286)
T cd07847 283 HPYF 286 (286)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=348.19 Aligned_cols=253 Identities=30% Similarity=0.450 Sum_probs=213.6
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++..+..+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3457999999999999999999999999999999997543 1224568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||+++++|.+.+...+++++.++..++.|++.||.|||+.||+||||||
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p----------------------------- 134 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKG----------------------------- 134 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCH-----------------------------
Confidence 999999999999998778899999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc---CCCCCccchhhhHhHHHHHHhcC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~sDvwSlGvil~elltG 248 (476)
+||+++.++.+||+|||++..... .........|++.|+|||.+.. ..+ +.++|+||+||++|+|++|
T Consensus 135 ------~nill~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~~~~Dvws~G~il~el~~g 205 (267)
T cd06646 135 ------ANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPEVAAVEKNGGY-NQLCDIWAVGITAIELAEL 205 (267)
T ss_pred ------HHEEECCCCCEEECcCccceeecc--cccccCccccCccccCHhHcccccCCCC-cchhhHHHHHHHHHHHHhC
Confidence 999999999999999999975432 1122234578999999998753 334 4789999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCCC-----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 305 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~ 305 (476)
+.||...+.......+....+..+ ..++..+.+||++||+.||++|||++++++|+|
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 206 QPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999976654433333333332222 236789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=389.57 Aligned_cols=267 Identities=28% Similarity=0.467 Sum_probs=220.1
Q ss_pred ccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-
Q 011868 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS- 85 (476)
Q Consensus 7 ~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~- 85 (476)
..+...+++|++++.||+|+||+||+|.+..+++.||+|++..... .......+..|+.+|+.++||||++++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3456778999999999999999999999999999999999976543 33345788999999999999999999998854
Q ss_pred -CCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-------CcEeccCCcchhccchhhhH
Q 011868 86 -KSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK-------GVFHRDLKVILKSCHMRIAT 153 (476)
Q Consensus 86 -~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~-------givHrDiKp~~~~~~~~~~~ 153 (476)
...+|+||||+++|+|.++|.. .+.+++..++.++.||+.||+|||+. +|+||||||
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKP----------- 153 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKP----------- 153 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcH-----------
Confidence 4679999999999999999864 25799999999999999999999985 499999997
Q ss_pred HHHHHHHHHHhhhccccccccCCCCceEeCC-----------------CCCEEEeccCCCCCCCcccCCCcccccccCCc
Q 011868 154 LQVFLLTFLLMIVIRPWKFNVLQLENILLDS-----------------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 216 (476)
Q Consensus 154 ~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~-----------------~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 216 (476)
+|||++. .+.+||+|||++..... .......+||+.
T Consensus 154 ------------------------eNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~ 206 (1021)
T PTZ00266 154 ------------------------QNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPY 206 (1021)
T ss_pred ------------------------HHeEeecCccccccccccccccCCCCceEEccCCccccccc---cccccccCCCcc
Confidence 9999964 34599999999985432 233455689999
Q ss_pred cccccccccC-CCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHccCCCcCCC
Q 011868 217 YVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-KWLSPGAQNLLRKILEPNPVKR 294 (476)
Q Consensus 217 y~APE~l~~~-~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-~~~s~~~~~Li~~~L~~dP~~R 294 (476)
|+|||++.+. ...+.++||||||||||+|++|..||...+..............+| ...++++.+||..||+.+|.+|
T Consensus 207 YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeR 286 (1021)
T PTZ00266 207 YWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKER 286 (1021)
T ss_pred ccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHC
Confidence 9999998653 2235889999999999999999999986654433333333333333 4478999999999999999999
Q ss_pred CChHHHhcCccccccCCC
Q 011868 295 ITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 295 ~s~~~il~~~~~~~~~~~ 312 (476)
|++.+++.|+|+.....+
T Consensus 287 PSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 287 PSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred cCHHHHhccHHHhhcCCC
Confidence 999999999999865443
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=343.04 Aligned_cols=253 Identities=30% Similarity=0.594 Sum_probs=222.6
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||+|+||+||++.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 69999999999999999999999999999999976433 23335688999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 95 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|+++++|.+.+... ..+++.++..++.|++.|+.|||++|++|+||+|
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~------------------------------ 129 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKS------------------------------ 129 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCH------------------------------
Confidence 99999999998753 3589999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||+++.++.++|+|||++...... ........|++.|+|||++.+..++ .++|+|||||++|+|++|+.||
T Consensus 130 -----~nil~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~ 201 (256)
T cd08218 130 -----QNIFLTKDGTIKLGDFGIARVLNST--VELARTCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAF 201 (256)
T ss_pred -----HHEEEcCCCCEEEeeccceeecCcc--hhhhhhccCCccccCHHHhCCCCCC-CccchhHHHHHHHHHHcCCCCc
Confidence 9999999999999999999754331 1122345688999999998877664 7899999999999999999999
Q ss_pred CCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 253 DDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
...+.......+..+.. +.|..++.++.++|.+||+.+|++||++.++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 202 EAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred cCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 98888777777766654 3567789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=351.29 Aligned_cols=257 Identities=25% Similarity=0.452 Sum_probs=219.9
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
-...+|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++.+......|
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 345689999999999999999999999999999999976542 22467889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
+||||++|++|.+++.. ..+++.++..++.|++.||+|||+.||+||||||
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp---------------------------- 144 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS---------------------------- 144 (296)
T ss_pred EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH----------------------------
Confidence 99999999999998865 4689999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+||+++.++.+||+|||++..... .........|++.|+|||.+.+..++ .++|||||||++|+|++|+.
T Consensus 145 -------~Nill~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~ 214 (296)
T cd06654 145 -------DNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEP 214 (296)
T ss_pred -------HHEEEcCCCCEEECccccchhccc--cccccCcccCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCC
Confidence 999999999999999999875332 11223345789999999998877664 89999999999999999999
Q ss_pred CCCCCcHHHHHHHHHh-CC--CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 251 PFDDRNLAVLYQKIFR-GD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~-~~--~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
||...+.......+.. .. .+.|..+++.+.+||.+||..||++|||+.+++.||||...
T Consensus 215 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 215 PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred CCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 9988775443333322 22 23455688999999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=374.24 Aligned_cols=249 Identities=31% Similarity=0.555 Sum_probs=219.1
Q ss_pred eEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCC
Q 011868 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGE 100 (476)
Q Consensus 21 ~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~ 100 (476)
.||+|+||+||-|+|..|...+|||.+.... .....-+..||.+++.++|.|||++++.+..++++-+.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 5999999999999999999999999996542 3345678899999999999999999999999999999999999999
Q ss_pred hHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCC
Q 011868 101 LFDKIASK-GRL--QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177 (476)
Q Consensus 101 L~~~l~~~-~~l--~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 177 (476)
|.+++.+. +++ .|.++-.|.+||+.||.|||++.|||||||-
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKG----------------------------------- 703 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKG----------------------------------- 703 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccC-----------------------------------
Confidence 99999875 677 7899999999999999999999999999997
Q ss_pred CceEeCC-CCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc--CCCCCccchhhhHhHHHHHHhcCCCCCCC
Q 011868 178 ENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD 254 (476)
Q Consensus 178 ~NiLl~~-~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~sDvwSlGvil~elltG~~Pf~~ 254 (476)
+|+|++. .|.+||+|||-++.... -...+.+..||..|||||++.. .+| |.++|||||||++.||.||++||..
T Consensus 704 DNVLvNTySGvlKISDFGTsKRLAg--inP~TETFTGTLQYMAPEvIDqG~RGY-G~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 704 DNVLVNTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDQGPRGY-GKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred CcEEEeeccceEEecccccchhhcc--CCccccccccchhhhChHhhccCCcCC-CchhhhhhccceeEeeccCCCCeee
Confidence 9999975 69999999999886443 3456778899999999999975 345 6999999999999999999999965
Q ss_pred Cc--HHHHHH-HHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 255 RN--LAVLYQ-KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 255 ~~--~~~~~~-~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
.. ...+++ -+.+..+++|..+|.+++++|.+|+.+||.+||++.++|.+||++...
T Consensus 781 lgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 781 LGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred cCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 33 233333 345667889999999999999999999999999999999999998763
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=348.25 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=214.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||.||+|++..+++.||+|.++... ......+.+|+.+++.++||||+++++.+...+..|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 3458999999999999999999999999999999987553 2234568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||+++++|.+++...+.+++.+++.++.|++.|+.|||++|++||||||
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp----------------------------- 134 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKG----------------------------- 134 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH-----------------------------
Confidence 999999999999998888999999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccc---cCCCCCccchhhhHhHHHHHHhcC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~sDvwSlGvil~elltG 248 (476)
+||+++.++.+||+|||++..... .........|++.|+|||++. ...+ +.++|+||+||++|+|++|
T Consensus 135 ------~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~ 205 (267)
T cd06645 135 ------ANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAEL 205 (267)
T ss_pred ------HHEEECCCCCEEECcceeeeEccC--cccccccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcC
Confidence 999999999999999999874322 112223457999999999974 3335 4789999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCCC-----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 305 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~ 305 (476)
..||...................+ ..++..+.++|.+||..||++|||++++++|||
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 206 QPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999976554443333333333222 136788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=344.81 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=217.2
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc---chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
+|++.+.||+|+||+||+|.+ .+++.+|+|.+...... .......+.+|+.+++.++|+||+++++++......|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999987 57889999998754321 22334678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||++|++|.+++...+++++..++.++.|++.||+|||+.||+|+||||
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p----------------------------- 130 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKG----------------------------- 130 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCH-----------------------------
Confidence 999999999999998878899999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCccc----CCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFR----DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~----~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||++++++.++|+|||++....... .........|+..|+|||++.+..++ .++|||||||++|+|++
T Consensus 131 ------~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~ 203 (265)
T cd06631 131 ------NNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMAT 203 (265)
T ss_pred ------HhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHh
Confidence 99999999999999999987532111 11223345689999999999887775 88999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhC---CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 248 GYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
|..||...+.......+... ..+.|..++.++.++|++||+.+|.+||++.+++.||||
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 204 GKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999876654443333332 234566789999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=351.28 Aligned_cols=263 Identities=32% Similarity=0.435 Sum_probs=220.3
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+|++.+.||+|+||.||+|.+..+|+.||||.+...... .......+.+|+.+++.++|+||+++++++.+....|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999765432 123345678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||+ +++|.+++.... .+++..++.++.||+.||.|||++|++||||||
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p----------------------------- 130 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKP----------------------------- 130 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCh-----------------------------
Confidence 9999 999999998765 799999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||+++.+|.++|+|||++...... ........+++.|+|||.+.+....+.++||||+||++|+|++|.+|
T Consensus 131 ------~nill~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~ 202 (298)
T cd07841 131 ------NNLLIASDGVLKLADFGLARSFGSP--NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPF 202 (298)
T ss_pred ------hhEEEcCCCCEEEccceeeeeccCC--CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcc
Confidence 9999999999999999999754331 12233345788999999986654445889999999999999999999
Q ss_pred CCCCcHHHHHHHHHhCCC-----------------------C-----CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 252 FDDRNLAVLYQKIFRGDF-----------------------K-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~~~-----------------------~-----~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|.+.+....+.++..... . .....+..+.++|.+||++||++|||+.+++.|
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 203 LPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 988776555544432100 0 012246789999999999999999999999999
Q ss_pred ccccccCCCCCC
Q 011868 304 EWFEQDYTPANP 315 (476)
Q Consensus 304 ~~~~~~~~~~~~ 315 (476)
+||.....+..+
T Consensus 283 ~~~~~~~~~~~~ 294 (298)
T cd07841 283 PYFSNDPAPTPP 294 (298)
T ss_pred ccccCCCCCCCC
Confidence 999987766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=348.07 Aligned_cols=253 Identities=28% Similarity=0.476 Sum_probs=217.4
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 95 (476)
|++.+.||+|+||+||+|.+..++..+|+|.+.... ......+.+|+.+++.++||||+++++++......|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 788999999999999999999999999999986542 33456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 96 VTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 96 ~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
+++++|...+.. ..++++..++.++.|++.||.|||+.|++||||||
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp-------------------------------- 131 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKA-------------------------------- 131 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCc--------------------------------
Confidence 999999988764 45799999999999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc-----CCCCCccchhhhHhHHHHHHhcCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+||+++.++.+||+|||++..... .........|++.|+|||++.. ..+ +.++||||+||++|+|++|.
T Consensus 132 ---~nili~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~ 205 (282)
T cd06643 132 ---GNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIE 205 (282)
T ss_pred ---ccEEEccCCCEEEccccccccccc--cccccccccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCC
Confidence 999999999999999999875322 1122344578999999999842 234 37899999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 250 LPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
.||...+.......+.... ...|..++.++.+||.+||+.||.+||+++++++||||...
T Consensus 206 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 206 PPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred CCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 9998877666655555443 23455688999999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=350.07 Aligned_cols=255 Identities=27% Similarity=0.468 Sum_probs=220.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
...+|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.....+|+
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 44579999999999999999999999999999999875432 235678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|+||+++++|.+++.. ..+++.++..++.|++.||+|||++|++||||||
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p----------------------------- 143 (296)
T cd06655 94 VMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKS----------------------------- 143 (296)
T ss_pred EEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH-----------------------------
Confidence 9999999999998865 4699999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||+++.++.+||+|||++...... ........|++.|+|||.+.+..+. .++|||||||++|+|++|+.|
T Consensus 144 ------~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~p 214 (296)
T cd06655 144 ------DNVLLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPP 214 (296)
T ss_pred ------HHEEECCCCCEEEccCccchhcccc--cccCCCcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999998754321 1223345789999999998877775 889999999999999999999
Q ss_pred CCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 252 FDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
|.+.+.......+.... ...|..+++.+.++|++||..||.+|||+.+++.||||..
T Consensus 215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 215 YLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred CCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 99887655444444332 2345568899999999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=347.65 Aligned_cols=255 Identities=26% Similarity=0.464 Sum_probs=222.8
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||.|+||.||+|++..+++.||+|++.... .......+.+|+.+++.++||||+++++++..+...|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47999999999999999999999999999999997653 2333567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||+++++|.+++... ++++..++.++.|++.|+.|||++|++||||+|
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p------------------------------- 126 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKA------------------------------- 126 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH-------------------------------
Confidence 999999999998764 899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+||++++++.++|+|||+++...... .......|++.|+|||++.+..++ .++||||+||++|+|++|+.||.
T Consensus 127 ----~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~ 199 (274)
T cd06609 127 ----ANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLS 199 (274)
T ss_pred ----HHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcc
Confidence 99999999999999999998654321 223445788999999999887765 89999999999999999999998
Q ss_pred CCcHHHHHHHHHhCCC-CCCCC-CCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 254 DRNLAVLYQKIFRGDF-KLPKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~~-~~p~~-~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
..+.......+..... ..+.. +++++.+++.+||..||++|||++++++||||...
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 200 DLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred cCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 8776666555555433 34444 78999999999999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=349.39 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=219.1
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCC-----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 85 (476)
+.+++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 45678999999999999999999976555 689999986543 33445779999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccch
Q 011868 86 KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHM 149 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~ 149 (476)
....|++|||+++++|.+++... ..+++.+++.++.|++.||.|||++|++||||||
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp------- 152 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAA------- 152 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccc-------
Confidence 99999999999999999999754 4578899999999999999999999999999997
Q ss_pred hhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCC
Q 011868 150 RIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 229 (476)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 229 (476)
+||++++++.+||+|||++................+++.|+|||.+.+..++
T Consensus 153 ----------------------------~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (283)
T cd05048 153 ----------------------------RNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT 204 (283)
T ss_pred ----------------------------ceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc
Confidence 9999999999999999998754321111223345678899999998877775
Q ss_pred CccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 230 GATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 230 ~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
.++|||||||++|+|++ |..||.+.+..+....+..+. .+.|..+++++.+|+.+||+.||.+||++.+|+++
T Consensus 205 -~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 205 -TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred -hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 89999999999999998 999999988888877776654 34567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=343.26 Aligned_cols=256 Identities=29% Similarity=0.478 Sum_probs=220.4
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||.|+||+||+|....++..+|+|++....... ....+.+|+.+++.++|+||+++++.+......|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999997654322 4678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 94 EYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 94 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
|+++|++|.+++... ..+++..++.++.|++.||+|||++|++||||||
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p---------------------------- 130 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKA---------------------------- 130 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH----------------------------
Confidence 999999999999763 4589999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC--CcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+||++++++.++|+|||++......... .......|+..|+|||++......+.++|+|||||++|+|++|
T Consensus 131 -------~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g 203 (267)
T cd06610 131 -------GNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG 203 (267)
T ss_pred -------HhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhC
Confidence 9999999999999999998765432221 1234457899999999987763335889999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCC-CC-----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFK-LP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~-~p-----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
+.||...+....+.+......+ ++ ..+++.+.+++.+||+.||++|||+++++.||||
T Consensus 204 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 204 AAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred CCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 9999887776666665554332 22 2467899999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=348.23 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=218.1
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
-+.|++++.||+|+||.||+|++..+++.||+|.+... .......+.+|+.+++.++||||+++++.+..++..|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 35699999999999999999999999999999998654 334467788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||++|++|...+.. ...+++..++.++.|++.|++|||++|++||||||
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp----------------------------- 138 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA----------------------------- 138 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCc-----------------------------
Confidence 999999999887754 45799999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc-----CCCCCccchhhhHhHHHHHHh
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~sDvwSlGvil~ell 246 (476)
+||+++.++.+||+|||++..... .........+++.|+|||++.+ ..+ +.++|||||||++|+|+
T Consensus 139 ------~Nili~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el~ 209 (292)
T cd06644 139 ------GNVLLTLDGDIKLADFGVSAKNVK--TLQRRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMA 209 (292)
T ss_pred ------ceEEEcCCCCEEEccCccceeccc--cccccceecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHHh
Confidence 999999999999999999874322 1112234568899999999853 223 47899999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+|..||...+....+.++..... ..+..++.++.++|.+||..||++||+++++++||||..
T Consensus 210 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 210 QIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred cCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 99999988776666655554432 235567889999999999999999999999999999964
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=346.50 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=211.2
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||+|+||.||+|.+..+++.||+|++..+. .......+.+|+.++++++||||+++++.+......++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 6889999999999999999999999999999997653 23345678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
|+++++|..+ ..+++..+..++.|++.||+|||+.||+|+||||
T Consensus 80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp-------------------------------- 123 (279)
T cd06619 80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKP-------------------------------- 123 (279)
T ss_pred cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCH--------------------------------
Confidence 9999998654 3588999999999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~ 254 (476)
+||+++.++.++|+|||++..... ......+||+.|+|||++.+..++ .++|+||+||++|+|++|+.||..
T Consensus 124 ---~Nill~~~~~~~l~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 124 ---SNMLVNTRGQVKLCDFGVSTQLVN----SIAKTYVGTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred ---HHEEECCCCCEEEeeCCcceeccc----ccccCCCCChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchh
Confidence 999999999999999999974322 233456899999999999887775 899999999999999999999965
Q ss_pred CcH-------HHHHHHHHhCCC-CC-CCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 255 RNL-------AVLYQKIFRGDF-KL-PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 255 ~~~-------~~~~~~i~~~~~-~~-p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
... ......+..... .. ....++++.++|.+||+.||.+||++++++.||||...
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 196 IQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred hcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 321 122222222222 22 23478899999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=343.66 Aligned_cols=248 Identities=36% Similarity=0.695 Sum_probs=221.0
Q ss_pred EeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 011868 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (476)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 101 (476)
||.|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+..+...|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999989999999999876544445567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceE
Q 011868 102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181 (476)
Q Consensus 102 ~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiL 181 (476)
.+++.....+++..+..++.||+.||+|||++|++|+|||| +||+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~-----------------------------------~nil 125 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKP-----------------------------------ENLL 125 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCH-----------------------------------HHEE
Confidence 99998877899999999999999999999999999999997 9999
Q ss_pred eCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCc--HHH
Q 011868 182 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAV 259 (476)
Q Consensus 182 l~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~--~~~ 259 (476)
++.++.++|+|||++...... .......|++.|+|||.+.+..++ .++|+||+||++|+|++|..||.... ...
T Consensus 126 v~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 201 (262)
T cd05572 126 LDSNGYVKLVDFGFAKKLKSG---QKTWTFCGTPEYVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPME 201 (262)
T ss_pred EcCCCCEEEeeCCcccccCcc---cccccccCCcCccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH
Confidence 999999999999999854321 123445789999999998877775 88999999999999999999998776 666
Q ss_pred HHHHHH--hCCCCCCCCCCHHHHHHHHHccCCCcCCCCC-----hHHHhcCccccc
Q 011868 260 LYQKIF--RGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 308 (476)
Q Consensus 260 ~~~~i~--~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-----~~~il~~~~~~~ 308 (476)
.+.++. .....+|...++++.++|.+||+.||.+||+ ++++++||||+.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 202 IYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred HHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 677766 4456677778999999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=345.27 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=211.3
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe------C
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS------K 86 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~------~ 86 (476)
+.|++.+.||+|+||+||+|.+..+++.||+|.+.... .....+.+|+.+++++ +||||+++++++.. .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 57999999999999999999999999999999997543 1245788999999998 69999999999865 3
Q ss_pred CEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 87 SKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
..+|+||||+.+++|.+++... ..+++..+..++.|++.|++|||++||+||||||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~---------------------- 139 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKG---------------------- 139 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCH----------------------
Confidence 4689999999999999998763 3689999999999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc-----CCCCCccchhhhHh
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCG 239 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~sDvwSlG 239 (476)
+||++++++.+||+|||++..... .........|++.|+|||++.+ ..+ +.++||||+|
T Consensus 140 -------------~nili~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG 203 (272)
T cd06637 140 -------------QNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLG 203 (272)
T ss_pred -------------HHEEECCCCCEEEccCCCceeccc--ccccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHH
Confidence 999999999999999999875432 1223345679999999999863 234 4789999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 240 VILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 240 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
|++|+|++|..||...........+...... .+..++.++.+||.+||..||.+|||+.+++.||||
T Consensus 204 v~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 204 ITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 9999999999999876655444444333221 234478899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=349.68 Aligned_cols=241 Identities=19% Similarity=0.262 Sum_probs=210.2
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEec
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKIYMVLEY 95 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E~ 95 (476)
..||+|+++.||+|.. +|+.||||.+.+.........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999986 789999999987654444456788999999999999999999999876 4578999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 96 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
++||+|.+++.....+++.....++.|++.||.|||+ .+++||||||
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp-------------------------------- 151 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTS-------------------------------- 151 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCCh--------------------------------
Confidence 9999999999887889999999999999999999998 4999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc--CCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+|||+++++.+||+|||+++.... ......||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||
T Consensus 152 ---~nill~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf 222 (283)
T PHA02988 152 ---VSFLVTENYKLKIICHGLEKILSS-----PPFKNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPF 222 (283)
T ss_pred ---hhEEECCCCcEEEcccchHhhhcc-----ccccccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCC
Confidence 999999999999999999875322 1234568999999999876 455 48999999999999999999999
Q ss_pred CCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 253 DDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
.+.+...++..+... .+++|..+++.+.+||.+||+.||.+|||+++++..
T Consensus 223 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 223 ENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred CCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 998888888877554 345566789999999999999999999999999753
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=357.52 Aligned_cols=254 Identities=22% Similarity=0.392 Sum_probs=207.7
Q ss_pred EeceEeec--CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011868 18 LGRTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 18 i~~~LG~G--~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 95 (476)
++++||+| +|++||++.+..+|+.||+|.++.... .......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56889999 789999999999999999999976543 234467788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 96 VTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 96 ~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
+++|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp------------------------------- 129 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKA------------------------------- 129 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCh-------------------------------
Confidence 999999999865 34699999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccC-----CCcccccccCCccccccccccC--CCCCccchhhhHhHHHHHHh
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~--~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.++.++++|||.+........ ........++..|+|||++.+. .+ +.++||||+||++|+|+
T Consensus 130 ----~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~ 204 (327)
T cd08227 130 ----SHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELA 204 (327)
T ss_pred ----hhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHH
Confidence 999999999999999986543211110 0112234577889999998763 45 48899999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCCCC----------------------------------------------CCCCCCHHHH
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGDFK----------------------------------------------LPKWLSPGAQ 280 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~~~----------------------------------------------~p~~~s~~~~ 280 (476)
+|+.||.+............+..+ ....+++.+.
T Consensus 205 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (327)
T cd08227 205 NGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFH 284 (327)
T ss_pred HCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHH
Confidence 999999876544333322221110 1112467899
Q ss_pred HHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 281 NLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 281 ~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+||++||+.||.+|||++++++||||++
T Consensus 285 ~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 285 HFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred HHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 9999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=344.10 Aligned_cols=257 Identities=31% Similarity=0.500 Sum_probs=215.7
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccc-------hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-------LKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
+|.+.+.||.|+||+||+|.+..+|+.||+|.+....... ....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 6899999999999999999998899999999986432111 112456889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.+++||||+++++|.+++...+++++..++.++.||+.||.|||++|++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~------------------------- 136 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKA------------------------- 136 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCCh-------------------------
Confidence 9999999999999999998878899999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC-CCCccchhhhHhHHHHHHh
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~sDvwSlGvil~ell 246 (476)
+||+++.++.++|+|||++................|+..|+|||++.... ..+.++|+||||+++|+|+
T Consensus 137 ----------~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~ 206 (272)
T cd06629 137 ----------DNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF 206 (272)
T ss_pred ----------hhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHH
Confidence 99999999999999999997543322222234456899999999987654 2348899999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhC--CCCCCC----CCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 247 TGYLPFDDRNLAVLYQKIFRG--DFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~--~~~~p~----~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
+|..||...+.......+... ...++. .++..+.++|.+||.++|.+|||++++++|||+
T Consensus 207 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 207 AGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred hCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 999999766654444333322 223333 358899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=345.66 Aligned_cols=255 Identities=32% Similarity=0.487 Sum_probs=216.0
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 69999999999999999999999999999999976542 23345788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 95 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
|+ +++|.+++.. ...+++.+++.++.||+.||+|||+.|++|+||||
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p------------------------------- 127 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKP------------------------------- 127 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCH-------------------------------
Confidence 99 9999999864 45799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+||+++.++.++|+|||++....... ........|+..|+|||.+.+....+.++||||+||++|+|++|.+||.
T Consensus 128 ----~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 202 (286)
T cd07832 128 ----ANLLISADGVLKIADFGLARLFSEEE-PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202 (286)
T ss_pred ----HHEEEcCCCcEEEeeeeecccccCCC-CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence 99999999999999999998654321 1223445789999999998766554689999999999999999999998
Q ss_pred CCcHHHHHHHHHhCC-------------------CCC-----------CCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 254 DRNLAVLYQKIFRGD-------------------FKL-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~-------------------~~~-----------p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+.+....+..+...- ..+ .+..+..+.+||++||+.||.+|||+++++.|
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 203 GENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 877655444433210 000 12356889999999999999999999999999
Q ss_pred cccc
Q 011868 304 EWFE 307 (476)
Q Consensus 304 ~~~~ 307 (476)
|||.
T Consensus 283 ~~~~ 286 (286)
T cd07832 283 PYFT 286 (286)
T ss_pred cCcC
Confidence 9984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=350.90 Aligned_cols=264 Identities=31% Similarity=0.450 Sum_probs=218.1
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SK 88 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~ 88 (476)
..+++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.++++++|+||+++++++... +.
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 357899999999999999999999999999999999875532 222234567899999999999999999998754 56
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
+|+||||+. ++|.+.+.. ...+++.+++.++.||+.||+|||+.|++||||||
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p------------------------- 136 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKV------------------------- 136 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH-------------------------
Confidence 899999995 588888765 35799999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++.+||+|||++...... ........+++.|+|||++.+....+.++||||+||++|+|++
T Consensus 137 ----------~nil~~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~ 204 (309)
T cd07845 137 ----------SNLLLTDKGCLKIADFGLARTYGLP--AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA 204 (309)
T ss_pred ----------HHEEECCCCCEEECccceeeecCCc--cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHh
Confidence 9999999999999999999854331 1222333468899999998765444588999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhC-------------------CCCCC-----------CCCCHHHHHHHHHccCCCcCCCCCh
Q 011868 248 GYLPFDDRNLAVLYQKIFRG-------------------DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITI 297 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~-------------------~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~s~ 297 (476)
|+.||.+.+....+..+... .+..+ .+.++.+.+||.+||++||.+|||+
T Consensus 205 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~ 284 (309)
T cd07845 205 HKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATA 284 (309)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCH
Confidence 99999988877666555431 11111 2358889999999999999999999
Q ss_pred HHHhcCccccccCCCC
Q 011868 298 AGIKADEWFEQDYTPA 313 (476)
Q Consensus 298 ~~il~~~~~~~~~~~~ 313 (476)
++++.||||.....+.
T Consensus 285 ~~il~h~~f~~~~~~~ 300 (309)
T cd07845 285 EEALESSYFKEKPLPC 300 (309)
T ss_pred HHHhcChhhccCCCCC
Confidence 9999999998766553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=349.75 Aligned_cols=255 Identities=29% Similarity=0.423 Sum_probs=214.7
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+.... ....+.+.+|+.+++.++||||+++++++..+...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4799999999999999999999889999999998664422 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++++.|.+.......+++.+++.++.||+.||+|||+.|++||||+|
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p------------------------------- 128 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKP------------------------------- 128 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCH-------------------------------
Confidence 9999998888776666799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+||++++++.++|+|||++...... ........++..|+|||++.+....+.++||||+||++|+|++|+.||.
T Consensus 129 ----~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~ 202 (286)
T cd07846 129 ----ENILVSQSGVVKLCDFGFARTLAAP--GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202 (286)
T ss_pred ----HHEEECCCCcEEEEeeeeeeeccCC--ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999998754321 2223345688999999998765545588999999999999999999998
Q ss_pred CCcHHHHHHHHHhCC-------------------CC------------CCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 254 DRNLAVLYQKIFRGD-------------------FK------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~-------------------~~------------~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+.+.......+.... .. .++.++..+.+|+.+||+.||.+||++.++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 203 GDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 766544333322100 00 12346788999999999999999999999999
Q ss_pred Cccc
Q 011868 303 DEWF 306 (476)
Q Consensus 303 ~~~~ 306 (476)
||||
T Consensus 283 ~~~~ 286 (286)
T cd07846 283 HEFF 286 (286)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=338.83 Aligned_cols=253 Identities=30% Similarity=0.503 Sum_probs=223.8
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||.|+||.||.+++..+++.+++|.+..... +......+.+|+.++++++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 69999999999999999999999999999999876543 23445778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 95 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|+++++|.+.+... ..+++.++..++.|++.||+|||+.|++||||||
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p------------------------------ 129 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKT------------------------------ 129 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCh------------------------------
Confidence 99999999999764 4689999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||+++.++.+||+|||++...... ........|++.|+|||++.+..++ .++|+||+||++|+|++|..||
T Consensus 130 -----~ni~~~~~~~~kl~d~~~~~~~~~~--~~~~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~ 201 (256)
T cd08221 130 -----LNIFLTKAGLIKLGDFGISKILGSE--YSMAETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTF 201 (256)
T ss_pred -----HhEEEeCCCCEEECcCcceEEcccc--cccccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCC
Confidence 9999999999999999998754331 1133456789999999998877664 7899999999999999999999
Q ss_pred CCCcHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 253 DDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
...+.......+..+.++ .+..++..+.++|.+||..||.+||++.++++|+|+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 202 DATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred CCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 998888887777766544 345678999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=341.51 Aligned_cols=256 Identities=29% Similarity=0.499 Sum_probs=215.8
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIY 90 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~ 90 (476)
.|++.+.||+|+||.||+|.+..++..||+|.+..... ...+....+.+|+.+++.++||||+++++++.. ...+|
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 68999999999999999999999999999999875432 123345678999999999999999999998865 46789
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
++|||+++++|.+.+...+.+++...+.++.|++.||+|||++||+||||||
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p---------------------------- 134 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKG---------------------------- 134 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH----------------------------
Confidence 9999999999999998877899999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCccc-CCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+||+++.++.+||+|||++....... .........++..|+|||++.+..++ .++||||+||++|+|++|+
T Consensus 135 -------~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~ 206 (266)
T cd06651 135 -------ANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEK 206 (266)
T ss_pred -------HHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCC
Confidence 99999999999999999987543211 11222345688999999999877665 8899999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccc
Q 011868 250 LPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~ 307 (476)
.||...+......++... ...+|..+++.+.++| +||..+|++||++++++.||||+
T Consensus 207 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 207 PPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 999877654444433322 3445677889999999 57778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=347.19 Aligned_cols=257 Identities=27% Similarity=0.447 Sum_probs=218.5
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++++.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.++++++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47999999999999999999998899999999986542 3333578889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 94 EYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 94 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
||++|++|..++... ..+++..++.++.||+.||.|||+ .||+||||||
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p--------------------------- 131 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKP--------------------------- 131 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCH---------------------------
Confidence 999999999888763 379999999999999999999997 5999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCC-----CCccchhhhHhHHHHH
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY-----DGATSDIWSCGVILYV 244 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-----~~~~sDvwSlGvil~e 244 (476)
+||+++.++.+||+|||++.... .....+..|++.|+|||++.+... .+.++|+||+||++|+
T Consensus 132 --------~nil~~~~~~~~l~dfg~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~ 199 (286)
T cd06622 132 --------TNVLVNGNGQVKLCDFGVSGNLV----ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILE 199 (286)
T ss_pred --------HHEEECCCCCEEEeecCCccccc----CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHH
Confidence 99999999999999999987432 223345678999999999865432 2478999999999999
Q ss_pred HhcCCCCCCCCcHHHHHH---HHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 245 ILTGYLPFDDRNLAVLYQ---KIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~---~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
|++|+.||...+....+. .+..+. ..+|..+++++.++|.+||+.+|++||++++++.||||.....
T Consensus 200 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 200 MALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred HHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 999999997765544333 233332 3466678999999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=338.93 Aligned_cols=249 Identities=33% Similarity=0.574 Sum_probs=218.5
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||+|+||.||++.+..+++.||+|.++... .....+.+.+|+.+++.++||||+++++.+...+.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999987543 23346788899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 95 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p------------------------------ 128 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKS------------------------------ 128 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCc------------------------------
Confidence 99999999988642 4589999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||+++.++.++|+|||++...... ........|++.|+|||++.+..++ .++|+||+|+++|+|++|..||
T Consensus 129 -----~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~p~ 200 (255)
T cd08219 129 -----KNIFLTQNGKVKLGDFGSARLLTSP--GAYACTYVGTPYYVPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPF 200 (255)
T ss_pred -----ceEEECCCCcEEEcccCcceeeccc--ccccccccCCccccCHHHHccCCcC-chhhhhhhchhheehhhccCCC
Confidence 9999999999999999998754321 2223345689999999998877764 8899999999999999999999
Q ss_pred CCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 253 DDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
...+.......+..+.. +.|..++..+.+||.+||+.||.+|||+.+++.-
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 201 QANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 98888777777766654 3567789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=364.62 Aligned_cols=253 Identities=25% Similarity=0.416 Sum_probs=209.1
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~ 85 (476)
..++|++++.||+|+||.||+|++..+ +..||+|++.... .......+.+|+.+++.+ +||||+++++.+..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 355899999999999999999986443 4579999997653 233356788999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc---------------------------------------------------------
Q 011868 86 KSKIYMVLEYVTGGELFDKIASK--------------------------------------------------------- 108 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~--------------------------------------------------------- 108 (476)
.+..|+||||+++|+|.+++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 99999999999999999988542
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccC
Q 011868 109 -------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVL 175 (476)
Q Consensus 109 -------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 175 (476)
.++++.+++.++.||+.||+|||++||+||||||
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp--------------------------------- 240 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAA--------------------------------- 240 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCch---------------------------------
Confidence 2478889999999999999999999999999997
Q ss_pred CCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCCCCCC
Q 011868 176 QLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 254 (476)
Q Consensus 176 ~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~ 254 (476)
+|||++.++.+||+|||+++............+..+++.|+|||++.+..++ .++||||+||++|+|++ |+.||..
T Consensus 241 --~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~ 317 (374)
T cd05106 241 --RNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPG 317 (374)
T ss_pred --heEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999754321111112233456789999999877775 89999999999999997 9999987
Q ss_pred CcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 255 RNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 255 ~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
......+.+.... ....|...++++.++|.+||+.||.+|||+.++++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 318 ILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6554444343333 34466778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=345.94 Aligned_cols=257 Identities=34% Similarity=0.639 Sum_probs=229.3
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV 92 (476)
++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++...+..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998755444455678899999999998 99999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|||+.+++|.+++...+.+++.+++.++.|++.||.|||+.|++|+||||
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~------------------------------ 130 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKP------------------------------ 130 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCH------------------------------
Confidence 99999999999998888899999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccC------------------CCcccccccCCccccccccccCCCCCccch
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRD------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSD 234 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~sD 234 (476)
+||+++.+|.++|+|||++........ ........|+..|+|||++....+ +.++|
T Consensus 131 -----~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~D 204 (280)
T cd05581 131 -----ENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSD 204 (280)
T ss_pred -----HHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC-Chhhh
Confidence 999999999999999999886543211 022234467899999999877665 48899
Q ss_pred hhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh----HHHhcCccc
Q 011868 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI----AGIKADEWF 306 (476)
Q Consensus 235 vwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~----~~il~~~~~ 306 (476)
+||+||+++++++|+.||...+....+..+......+|..+++.+.++|.+||+.||.+|||+ +++++||||
T Consensus 205 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 205 LWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 999999999999999999988877777777777888888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=338.55 Aligned_cols=251 Identities=31% Similarity=0.493 Sum_probs=217.3
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... .....+.+|+.+++.++||||+++++.+.....+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 579999999999999999999988999999999976532 24678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 94 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
||+.+++|.+++... .++++.+++.++.|++.||+|||++|++||||||
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p------------------------------ 129 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKG------------------------------ 129 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCh------------------------------
Confidence 999999999998775 7899999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccC---CCCCccchhhhHhHHHHHHhcCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~~~~~sDvwSlGvil~elltG~ 249 (476)
+||+++.++.+||+|||++...... ........++..|+|||.+.+. .++ .++|+|||||++|+|++|.
T Consensus 130 -----~ni~i~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~ 201 (262)
T cd06613 130 -----ANILLTEDGDVKLADFGVSAQLTAT--IAKRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQ 201 (262)
T ss_pred -----hhEEECCCCCEEECccccchhhhhh--hhccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCC
Confidence 9999999999999999998754321 1123345789999999998766 565 7899999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCCCCC-----CCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcc
Q 011868 250 LPFDDRNLAVLYQKIFRGDFKL-----PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 305 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~~~~-----p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~ 305 (476)
.||.+.+.......+....+.. +..++.++.++|++||..||.+|||+.+++.|+|
T Consensus 202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 202 PPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred CCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 9998877655444444443222 2335788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=349.80 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=206.6
Q ss_pred cCcCEEEeceEeecCceEEEEEEECC----------------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLD----------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn 75 (476)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++++++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 45789999999999999999998532 34579999987643 2334567999999999999999
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCChHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcE
Q 011868 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVF 136 (476)
Q Consensus 76 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------------------~~l~~~~~~~~~~qi~~al~yLH~~giv 136 (476)
|+++++++...+..|+||||+++|+|.+++... ..+++.++..++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999999999999999999999999998643 1367788999999999999999999999
Q ss_pred eccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCc
Q 011868 137 HRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 216 (476)
Q Consensus 137 HrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 216 (476)
|||||| +|||++.++.+||+|||+++...............++..
T Consensus 161 H~dlkp-----------------------------------~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~ 205 (304)
T cd05096 161 HRDLAT-----------------------------------RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR 205 (304)
T ss_pred ccCcch-----------------------------------hheEEcCCccEEECCCccceecccCceeEecCcCCCCcc
Confidence 999997 999999999999999999975432111112334456889
Q ss_pred cccccccccCCCCCccchhhhHhHHHHHHhc--CCCCCCCCcHHHHHHHHHh---C-----CCCCCCCCCHHHHHHHHHc
Q 011868 217 YVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLAVLYQKIFR---G-----DFKLPKWLSPGAQNLLRKI 286 (476)
Q Consensus 217 y~APE~l~~~~~~~~~sDvwSlGvil~ellt--G~~Pf~~~~~~~~~~~i~~---~-----~~~~p~~~s~~~~~Li~~~ 286 (476)
|+|||++.+..++ .++|||||||++|+|++ +..||.+.+.......+.. . ....|+.+++.+.+||.+|
T Consensus 206 y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 284 (304)
T cd05096 206 WMAWECILMGKFT-TASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQC 284 (304)
T ss_pred ccCHHHHhcCCCC-chhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHH
Confidence 9999998877765 89999999999999986 6788987665554443321 1 1223556789999999999
Q ss_pred cCCCcCCCCChHHHhc
Q 011868 287 LEPNPVKRITIAGIKA 302 (476)
Q Consensus 287 L~~dP~~R~s~~~il~ 302 (476)
|+.||.+|||+.+|.+
T Consensus 285 l~~~p~~RPs~~~i~~ 300 (304)
T cd05096 285 WSRDCRERPSFSDIHA 300 (304)
T ss_pred ccCCchhCcCHHHHHH
Confidence 9999999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=368.75 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=205.5
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
..+|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++++||||+++++++...+..|+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999996422 3356899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||++ .++|.+++... ..+++.+++.++.||+.||.|||++||+||||||
T Consensus 239 ~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP----------------------------- 288 (461)
T PHA03211 239 LPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKT----------------------------- 288 (461)
T ss_pred EEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCH-----------------------------
Confidence 9999 57898888653 4699999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+|||++.++.+||+|||+++..............+||+.|+|||++.+..++ .++|||||||+||||++|..|
T Consensus 289 ------~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~ 361 (461)
T PHA03211 289 ------ENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTAS 361 (461)
T ss_pred ------HHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999865432222223356799999999999888775 899999999999999998765
Q ss_pred CCC-C-------cHHHHHHHHHhCCC-----------------------------CCCCC-----CCHHHHHHHHHccCC
Q 011868 252 FDD-R-------NLAVLYQKIFRGDF-----------------------------KLPKW-----LSPGAQNLLRKILEP 289 (476)
Q Consensus 252 f~~-~-------~~~~~~~~i~~~~~-----------------------------~~p~~-----~s~~~~~Li~~~L~~ 289 (476)
+-. . ....+.+.+..... ..+.| +++.+.+||.+||+.
T Consensus 362 lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 441 (461)
T PHA03211 362 LFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTF 441 (461)
T ss_pred cccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHccc
Confidence 422 1 12223322222111 01111 456899999999999
Q ss_pred CcCCCCChHHHhcCccccc
Q 011868 290 NPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 290 dP~~R~s~~~il~~~~~~~ 308 (476)
||.+|||+.|+|+||||+.
T Consensus 442 DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 442 DGARRPSAAELLRLPLFQS 460 (461)
T ss_pred ChhhCcCHHHHhhCcccCC
Confidence 9999999999999999974
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=345.65 Aligned_cols=249 Identities=30% Similarity=0.467 Sum_probs=206.2
Q ss_pred eEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh---CCCCCcceEEEEEEeCCEEEEEEeccC
Q 011868 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL---LKHPNVVRLHEVLASKSKIYMVLEYVT 97 (476)
Q Consensus 21 ~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~---l~HpnIv~l~~~~~~~~~~~lV~E~~~ 97 (476)
.||+|+||.||+|.+..+++.||+|.+.+.............+|..+++. .+||||+.+++.+..++..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999976543322223334455544444 479999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCC
Q 011868 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177 (476)
Q Consensus 98 gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 177 (476)
|++|.+++...+.+++.++..++.|++.||+|||+.||+||||||
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp----------------------------------- 125 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKP----------------------------------- 125 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCH-----------------------------------
Confidence 999999998888899999999999999999999999999999997
Q ss_pred CceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcH
Q 011868 178 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL 257 (476)
Q Consensus 178 ~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~ 257 (476)
+||++++++.++|+|||++..... .......||+.|+|||.+.+....+.++||||+||++|+|++|..||.+...
T Consensus 126 ~Nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 126 ANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred HHEEECCCCCEEEccCCcceeccc----cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 999999999999999999874322 1223457999999999986433334889999999999999999999975432
Q ss_pred ---HHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 258 ---AVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 258 ---~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
.............+|..+++++.++|.+||+.||++|+ |++++++||||+.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 202 KDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred cCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 22222233344567778999999999999999999999 6999999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=336.80 Aligned_cols=252 Identities=31% Similarity=0.510 Sum_probs=220.8
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||+|+||.||+|.+..+++.+|+|.+..... .......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 69999999999999999999999999999999976543 23346789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 95 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|++|++|.+++... ..+++..+..++.|++.|++|||++|++||||||
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~------------------------------ 129 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKT------------------------------ 129 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH------------------------------
Confidence 99999999999763 3589999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCC-CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 173 NVLQLENILLDSKG-NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 173 ~~~~~~NiLl~~~g-~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||+++.++ .+||+|||++..... ........|++.|+|||.+.+..++ .++||||+||++|+|++|..|
T Consensus 130 -----~nil~~~~~~~~~l~d~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~~~~~ 200 (256)
T cd08220 130 -----QNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRA 200 (256)
T ss_pred -----HHEEEcCCCCEEEEccCCCceecCC---CccccccccCCcccCchhccCCCCC-cccchHHHHHHHHHHHhCCCC
Confidence 999998654 589999999985432 2223345689999999998877664 889999999999999999999
Q ss_pred CCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 252 FDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
|.+.+......++.... .+++..+++++.++|.+||+.||.+|||+.++++||||
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 201 FEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred cccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 99888777776666554 34667789999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=342.90 Aligned_cols=257 Identities=27% Similarity=0.472 Sum_probs=217.2
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc---chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
+|+..+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588999999999999999999999999999999754321 12345789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||++|++|.+.+...+++++..++.++.||+.||.|||++|++||||||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~----------------------------- 131 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKG----------------------------- 131 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH-----------------------------
Confidence 999999999999998878899999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCC-CEEEeccCCCCCCCcccC--CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 172 FNVLQLENILLDSKG-NIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g-~vkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+||+++.++ .+||+|||++........ ........|+..|+|||++.+..++ .++|+||+||++|+|++|
T Consensus 132 ------~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g 204 (268)
T cd06630 132 ------ANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATA 204 (268)
T ss_pred ------HHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhC
Confidence 999998876 599999999875433211 1112345688999999998877765 889999999999999999
Q ss_pred CCCCCCCcHHHHHHHH---H--hCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccc
Q 011868 249 YLPFDDRNLAVLYQKI---F--RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i---~--~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~ 307 (476)
..||...+.......+ . ......|..+++++.+++.+||+.||++|||+.++++||||.
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 205 KPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999765432222222 1 223456677899999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=341.56 Aligned_cols=252 Identities=22% Similarity=0.322 Sum_probs=213.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
...+|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 4567999999999999999999864 356789999997653 23345678999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.|+||||+++|+|.+++... ..+++.+++.++.||+.||+|||++|++||||||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp------------------------- 135 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAA------------------------- 135 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccH-------------------------
Confidence 99999999999999998763 5799999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++.+|++|||.+...... .........++..|+|||++.+..++ .++||||+||++|++++
T Consensus 136 ----------~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~ 203 (266)
T cd05064 136 ----------HKVLVNSDLVCKISGFRRLQEDKSE-AIYTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMS 203 (266)
T ss_pred ----------hhEEEcCCCcEEECCCccccccccc-chhcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhc
Confidence 9999999999999999987643211 01111223456789999999887775 89999999999999775
Q ss_pred -CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 248 -GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 248 -G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|..||.+.+.......+..+ ..+.|..++..+.+++.+||+.+|.+|||+++|++
T Consensus 204 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 204 YGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 99999988877777776655 34566778999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=344.64 Aligned_cols=249 Identities=29% Similarity=0.455 Sum_probs=209.6
Q ss_pred eEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHH---HHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011868 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI---ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (476)
Q Consensus 21 ~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei---~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 97 (476)
.||+|+||.||+|.+..+++.||+|.+.+...........+..|. .+++...||||+++++.+......|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999999875433222222333443 34455679999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCC
Q 011868 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177 (476)
Q Consensus 98 gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 177 (476)
||+|.+++...+.+++.+++.++.|++.||+|||+++|+||||||
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p----------------------------------- 125 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKP----------------------------------- 125 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCH-----------------------------------
Confidence 999999998878899999999999999999999999999999997
Q ss_pred CceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCC--
Q 011868 178 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-- 255 (476)
Q Consensus 178 ~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~-- 255 (476)
+||+++.++.+||+|||++..... ......+|+..|+|||++.+....+.++||||+||++|+|++|+.||.+.
T Consensus 126 ~nili~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~ 201 (278)
T cd05606 126 ANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (278)
T ss_pred HHEEECCCCCEEEccCcCccccCc----cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999999875432 22345679999999999875433348899999999999999999999876
Q ss_pred -cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 256 -NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 256 -~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
........+......+|..+++++.++|.+||..||.+|| ++.++++||||..
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 202 KDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred cchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 3334444455556677777899999999999999999999 9999999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.61 Aligned_cols=257 Identities=31% Similarity=0.500 Sum_probs=216.3
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKI 89 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~ 89 (476)
.+|++.+.||+|+||+||.|.+..+|..||||.+..... ........+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 479999999999999999999999999999999864321 122345788999999999999999999998865 3578
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|++|||++|++|.+++.....+++..+..++.|++.||+|||++|++|+||||
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p--------------------------- 134 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKG--------------------------- 134 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCH---------------------------
Confidence 89999999999999998777899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCccc-CCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+||+++.++.++|+|||++....... .........|+..|+|||++.+..++ .++|||||||++|+|++|
T Consensus 135 --------~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g 205 (265)
T cd06652 135 --------ANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYG-RKADIWSVGCTVVEMLTE 205 (265)
T ss_pred --------HHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCC-cchhHHHHHHHHHHHhhC
Confidence 99999999999999999987543211 11123445689999999999877764 889999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccc
Q 011868 249 YLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~ 307 (476)
+.||.+.+......++... ....|...+..+.++|++||. +|++||++++++.|||+.
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 206 KPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred CCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999876655444444332 233566688899999999995 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=349.20 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=218.6
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
...+|++++.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++......|+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 34789999999999999999999999999999999975432 224678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||++|++|.+++.. ..+++.++..++.|++.||.|||+.|++||||||
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p----------------------------- 143 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKS----------------------------- 143 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH-----------------------------
Confidence 9999999999998865 5689999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||+++.++.++|+|||++...... ........|++.|+|||.+.+..+. .++|+||+||++|+|++|..|
T Consensus 144 ------~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slGvil~~l~tg~~p 214 (297)
T cd06656 144 ------DNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPP 214 (297)
T ss_pred ------HHEEECCCCCEEECcCccceEccCC--ccCcCcccCCccccCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999998754321 1223345789999999999877764 889999999999999999999
Q ss_pred CCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 252 FDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|.+.+.......+.... ...|..+++.+.+||.+||+.||++||++++++.||||...
T Consensus 215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 215 YLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred CCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 98766543322222221 22455688899999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=389.64 Aligned_cols=262 Identities=29% Similarity=0.513 Sum_probs=233.5
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
.+.-+.|++++.||+|+||.|.+++++.|++.||+|++.+-..........|..|-.+|..-+.+-|+.++-.|.++.++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 45567899999999999999999999999999999999886555444567899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||++||+|..++...+++++..|+.|+..|+.||.-+|+.|+|||||||
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKP--------------------------- 203 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKP--------------------------- 203 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCc---------------------------
Confidence 99999999999999998877999999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc----CCCCCccchhhhHhHHHHHH
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~sDvwSlGvil~el 245 (476)
+|+|+|.+|++||+|||.+--.... +.-...+.+|||-|.+||++.. .+.+|..||.||+||++|||
T Consensus 204 --------DNvLld~~GHikLADFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEM 274 (1317)
T KOG0612|consen 204 --------DNVLLDKSGHIKLADFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEM 274 (1317)
T ss_pred --------ceeEecccCcEeeccchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHH
Confidence 9999999999999999977643321 2234567789999999999963 25568999999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHccCCCcCCCCC---hHHHhcCccccc
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRG--DFKLP--KWLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 308 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~Li~~~L~~dP~~R~s---~~~il~~~~~~~ 308 (476)
+.|..||...+....|.+|... .+.|| ..+|+++++||.+++. +|..|.. ++++..||||..
T Consensus 275 lyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 275 LYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred HcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence 9999999999999999999876 57788 4589999999999985 5778887 999999999975
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=336.32 Aligned_cols=253 Identities=33% Similarity=0.568 Sum_probs=221.2
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSKIYMV 92 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~--~~~~~~lV 92 (476)
+|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++. .....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999976543 3344577889999999999999999999875 34578999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hcCcEeccCCcchhccchhhhHHHHHHHHHHH
Q 011868 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCH-----NKGVFHRDLKVILKSCHMRIATLQVFLLTFLL 163 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH-----~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~ 163 (476)
|||+++++|.+++.. ..++++..++.++.||+.||+||| +.+++||||||
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p--------------------- 138 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKP--------------------- 138 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCH---------------------
Confidence 999999999999865 357999999999999999999999 89999999997
Q ss_pred hhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHH
Q 011868 164 MIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243 (476)
Q Consensus 164 ~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ 243 (476)
+||++++++.+||+|||++...... ........|++.|+|||++.+..++ .++|+||||+++|
T Consensus 139 --------------~nili~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~ 201 (265)
T cd08217 139 --------------ANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIY 201 (265)
T ss_pred --------------HHEEEecCCCEEEecccccccccCC--cccccccccCCCccChhhhcCCCCC-chhHHHHHHHHHH
Confidence 9999999999999999999865432 1113445789999999998877664 8899999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 244 VILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 244 elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
+|++|+.||...+.......+..+.. .+|..+++.+.+++.+||+.+|++|||+.+|++|||+
T Consensus 202 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 202 ELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999998887777777776654 3566789999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=370.99 Aligned_cols=253 Identities=28% Similarity=0.449 Sum_probs=226.5
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
-|+|+..||.|+||+||+|.++.++-..|.|+|... +.+..+.+.-||.||..++||+|++|++.|..++.+|+..|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 588999999999999999999999999999999654 34557888899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 95 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||.||-....+.. ...+++.+++-+++|++.||.|||+++|+|||||+
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKA------------------------------- 158 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKA------------------------------- 158 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccc-------------------------------
Confidence 9999998887765 45799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc-----CCCCCccchhhhHhHHHHHHhcC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~sDvwSlGvil~elltG 248 (476)
.|||++-+|.++|+|||.+.-... ......+..|||+|||||++.. .+|+ .++||||||++|.+|..+
T Consensus 159 ----GNiL~TldGdirLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqi 231 (1187)
T KOG0579|consen 159 ----GNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQI 231 (1187)
T ss_pred ----cceEEEecCcEeeecccccccchh--HHhhhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhcc
Confidence 999999999999999999863221 2223456789999999999764 5676 899999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
.+|-..-+++..+-+|.+.+++ -|..++..+.+++.+||.+||..||+++++++|||+..
T Consensus 232 EPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 232 EPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred CCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 9999999999999999887765 47778999999999999999999999999999999974
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=344.86 Aligned_cols=253 Identities=29% Similarity=0.452 Sum_probs=210.8
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++++.||.|++|.||+|++..+|+.||||.+..... .......+.+|+.++++++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999875432 22334678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 95 ~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|+. ++|.+++.. ...+++..++.++.|++.||+|||+.|++||||+|
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p------------------------------ 128 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP------------------------------ 128 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH------------------------------
Confidence 995 689888865 35689999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||+++.++.+||+|||++...... ........+++.|+|||++.+....+.++|||||||++|+|+||+.||
T Consensus 129 -----~nill~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~ 201 (284)
T cd07860 129 -----QNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201 (284)
T ss_pred -----HHEEECCCCCEEEeeccchhhcccC--ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999998754321 122334467899999999877665558899999999999999999999
Q ss_pred CCCcHHHHHHHHHhCC------------------CCC-----------CCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 253 DDRNLAVLYQKIFRGD------------------FKL-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~~------------------~~~-----------p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
.+.+......++.... ..+ .+.+++++.++|.+||+.||++|||+++++.|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 202 PGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 8776543333222110 011 12367889999999999999999999999999
Q ss_pred ccc
Q 011868 304 EWF 306 (476)
Q Consensus 304 ~~~ 306 (476)
|||
T Consensus 282 ~~f 284 (284)
T cd07860 282 PFF 284 (284)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=336.51 Aligned_cols=255 Identities=33% Similarity=0.549 Sum_probs=217.9
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++|+||+++++++......++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999889999999999876532 3457889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
|+++++|.+++.....+++..++.++.|++.||.|||+.||+||||+|
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~-------------------------------- 127 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKP-------------------------------- 127 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCH--------------------------------
Confidence 999999999998877799999999999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCcccCCC--cccccccCCccccccccccCC---CCCccchhhhHhHHHHHHhcCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDG--LLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~---~~~~~sDvwSlGvil~elltG~ 249 (476)
+||++++++.+||+|||++.......... ......+++.|+|||++.+.. + +.++||||+||++|+|++|+
T Consensus 128 ---~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~~~~Dv~s~G~il~~l~~g~ 203 (264)
T cd06626 128 ---ANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH-GRAADIWSLGCVVLEMATGK 203 (264)
T ss_pred ---HHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCC-CcccchHHHHHHHHHHHhCC
Confidence 99999999999999999988654321111 122457889999999987655 4 48899999999999999999
Q ss_pred CCCCCCcH-HHHHHHHHh-CCCCCCCCC--CHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 250 LPFDDRNL-AVLYQKIFR-GDFKLPKWL--SPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 250 ~Pf~~~~~-~~~~~~i~~-~~~~~p~~~--s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
.||..... ......+.. ....+|.+. ++.+.++|.+||+.||.+|||+.+++.|||+
T Consensus 204 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 204 RPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred CCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99976532 222222222 234456554 8999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=346.71 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=209.5
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-- 87 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-- 87 (476)
...+++|++.++||+|+||.||+|.+..+++.||||.+..... .......+.+|+.++++++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 4467899999999999999999999999999999999865432 2223345678999999999999999999986543
Q ss_pred ------EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 88 ------KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 88 ------~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
..|+||||+. ++|.+.+... ..+++.+++.++.||+.||.|||++|++||||||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p------------------ 147 (310)
T cd07865 87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKA------------------ 147 (310)
T ss_pred ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH------------------
Confidence 4699999995 5888887654 3789999999999999999999999999999997
Q ss_pred HHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC--CcccccccCCccccccccccCCCCCccchhhhH
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 238 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSl 238 (476)
+||+++.++.+||+|||++......... .......++..|+|||.+.+....+.++||||+
T Consensus 148 -----------------~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 210 (310)
T cd07865 148 -----------------ANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGA 210 (310)
T ss_pred -----------------HHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHH
Confidence 9999999999999999999755332111 122345678899999998765434588999999
Q ss_pred hHHHHHHhcCCCCCCCCcHHHHHHHHHh--CC-----------------CCCC-------------CCCCHHHHHHHHHc
Q 011868 239 GVILYVILTGYLPFDDRNLAVLYQKIFR--GD-----------------FKLP-------------KWLSPGAQNLLRKI 286 (476)
Q Consensus 239 Gvil~elltG~~Pf~~~~~~~~~~~i~~--~~-----------------~~~p-------------~~~s~~~~~Li~~~ 286 (476)
||++|+|++|+.||.+.+.......+.. +. ..+| ...++.+.+||.+|
T Consensus 211 G~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~ 290 (310)
T cd07865 211 GCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKL 290 (310)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHH
Confidence 9999999999999988765443332221 00 0011 11356788999999
Q ss_pred cCCCcCCCCChHHHhcCccc
Q 011868 287 LEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 287 L~~dP~~R~s~~~il~~~~~ 306 (476)
|..||.+|||++++++||||
T Consensus 291 l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 291 LVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hcCChhhccCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=344.68 Aligned_cols=248 Identities=31% Similarity=0.497 Sum_probs=213.4
Q ss_pred EeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 011868 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (476)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 101 (476)
||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765433333455677899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCc
Q 011868 102 FDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179 (476)
Q Consensus 102 ~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~N 179 (476)
.+++.... .+++.+++.++.|++.||.|||+.|++||||+| +|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p-----------------------------------~N 125 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKP-----------------------------------EN 125 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH-----------------------------------HH
Confidence 99997655 799999999999999999999999999999997 99
Q ss_pred eEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcH--
Q 011868 180 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-- 257 (476)
Q Consensus 180 iLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~-- 257 (476)
|++++++.+||+|||++..... ........++..|+|||++.+..++ .++||||+||++|+|++|+.||...+.
T Consensus 126 il~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~ 201 (277)
T cd05577 126 VLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKV 201 (277)
T ss_pred EEECCCCCEEEccCcchhhhcc---CCccccccCCCCcCCHHHhcCCCCC-chhhhHHHHHHHHHHhhCCCCCCCCcccc
Confidence 9999999999999999875432 2223345688899999998877764 889999999999999999999977643
Q ss_pred --HHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 258 --AVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 258 --~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
..+...+.......|..+++.+.++|.+||+.||.+|| ++.+++.||||..
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 202 EKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred cHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 23333444445566777899999999999999999999 8888999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=343.62 Aligned_cols=256 Identities=29% Similarity=0.469 Sum_probs=215.6
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .......+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 579999999999999999999999999999999875432 2334578899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++++.+..+......+++.+++.++.||+.|+.|||++|++||||+|
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~------------------------------- 128 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKP------------------------------- 128 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH-------------------------------
Confidence 9998877776666667799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+||++++++.+||+|||++........ .......+++.|+|||++.+....+.++||||+||++|+|++|+.||.
T Consensus 129 ----~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 203 (288)
T cd07833 129 ----ENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203 (288)
T ss_pred ----HHeEECCCCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999886543221 133446788999999999887334589999999999999999999998
Q ss_pred CCcHHHHHHHHHhC---------------------CC-----------CCCCCCCHHHHHHHHHccCCCcCCCCChHHHh
Q 011868 254 DRNLAVLYQKIFRG---------------------DF-----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301 (476)
Q Consensus 254 ~~~~~~~~~~i~~~---------------------~~-----------~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il 301 (476)
+.+.......+... .+ .+|..+++++.+||++||..||++|||+++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 283 (288)
T cd07833 204 GDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283 (288)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHh
Confidence 76654433322110 00 12334588999999999999999999999999
Q ss_pred cCccc
Q 011868 302 ADEWF 306 (476)
Q Consensus 302 ~~~~~ 306 (476)
+||||
T Consensus 284 ~~~~f 288 (288)
T cd07833 284 QHPYF 288 (288)
T ss_pred cCCCC
Confidence 99997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=358.76 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=202.1
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
....+|++++.||+|+||.||+|++..+++.||+|+..+.. ...|+.+++.++||||+++++++......|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 34457999999999999999999999999999999854332 346899999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+||||+ .++|.+++.. ..++++.+++.++.||+.||.|||++||+||||||
T Consensus 134 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp--------------------------- 185 (357)
T PHA03209 134 MVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKT--------------------------- 185 (357)
T ss_pred EEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH---------------------------
Confidence 999999 5688888865 45799999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC-
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG- 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG- 248 (476)
+|||++.++.+||+|||++..... ........||+.|+|||++.+..++ .++||||+||++|+|+++
T Consensus 186 --------~Nill~~~~~~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~ 253 (357)
T PHA03209 186 --------ENIFINDVDQVCIGDLGAAQFPVV---APAFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYP 253 (357)
T ss_pred --------HHEEECCCCCEEEecCcccccccc---CcccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcC
Confidence 999999999999999999974322 2223456799999999999888775 899999999999999984
Q ss_pred CCCCCCCcHH----------HHHHHHHhC---CCCCC------------------------------CCCCHHHHHHHHH
Q 011868 249 YLPFDDRNLA----------VLYQKIFRG---DFKLP------------------------------KWLSPGAQNLLRK 285 (476)
Q Consensus 249 ~~Pf~~~~~~----------~~~~~i~~~---~~~~p------------------------------~~~s~~~~~Li~~ 285 (476)
..+|...... .+...+... ...+| ..++.++.+||.+
T Consensus 254 ~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 333 (357)
T PHA03209 254 STIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHK 333 (357)
T ss_pred CccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHH
Confidence 4445432210 111111100 00111 1246677889999
Q ss_pred ccCCCcCCCCChHHHhcCccccc
Q 011868 286 ILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 286 ~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
||+.||.+|||+.|+++||||++
T Consensus 334 mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 334 MLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHcCCcccCcCHHHHhcCchhcc
Confidence 99999999999999999999975
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=344.66 Aligned_cols=259 Identities=27% Similarity=0.430 Sum_probs=220.9
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
+..++|++.+.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++.+.....+|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 35678999999999999999999999999999999987543 3344678999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+||||+++++|.+++...+.+++..++.++.|++.||.|||+ .|++||||||
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p--------------------------- 132 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKP--------------------------- 132 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCH---------------------------
Confidence 999999999999999887789999999999999999999997 5999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+||+++.++.++|+|||++..... ......+|+..|+|||++.+..++ .++|+||+||++|+|++|+
T Consensus 133 --------~nil~~~~~~~~l~d~gl~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~ 199 (284)
T cd06620 133 --------SNILVNSRGQIKLCDFGVSGELIN----SIADTFVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGK 199 (284)
T ss_pred --------HHEEECCCCcEEEccCCcccchhh----hccCccccCcccCCHHHHccCCCC-ccchHHHHHHHHHHHHhCC
Confidence 999999999999999999864321 223346799999999998777664 8899999999999999999
Q ss_pred CCCCCCcHH-----------HHHHHHHhCC-CCCCCC-CCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 250 LPFDDRNLA-----------VLYQKIFRGD-FKLPKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 250 ~Pf~~~~~~-----------~~~~~i~~~~-~~~p~~-~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
.||...+.. .....+.... ..++.. ++..+.+||.+||+.||.+|||++++++|+||.+...
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 200 FPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred CCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 999865431 2333343332 223333 7789999999999999999999999999999977543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=343.53 Aligned_cols=255 Identities=30% Similarity=0.483 Sum_probs=207.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
.+++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.++...|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 46789999999999999999999988999999999875432 1223456789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
||||+. ++|.+++... ..+++..++.++.|++.||.|||++||+||||||
T Consensus 81 v~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p---------------------------- 131 (291)
T cd07844 81 VFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKP---------------------------- 131 (291)
T ss_pred EEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCH----------------------------
Confidence 999996 5999988653 4689999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+||+++.+|.+||+|||++...... ........++..|+|||++.+....+.++||||+||++|+|++|+.
T Consensus 132 -------~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~ 202 (291)
T cd07844 132 -------QNLLISERGELKLADFGLARAKSVP--SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRP 202 (291)
T ss_pred -------HHEEEcCCCCEEECccccccccCCC--CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999998743211 1112233578899999998764434588999999999999999999
Q ss_pred CCCCCc-HHHHHHHHHhC---------------------CCCC---------CCCCC--HHHHHHHHHccCCCcCCCCCh
Q 011868 251 PFDDRN-LAVLYQKIFRG---------------------DFKL---------PKWLS--PGAQNLLRKILEPNPVKRITI 297 (476)
Q Consensus 251 Pf~~~~-~~~~~~~i~~~---------------------~~~~---------p~~~s--~~~~~Li~~~L~~dP~~R~s~ 297 (476)
||.+.. .......+... .... ...++ +.+.++|.+||+.||.+|||+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~ 282 (291)
T cd07844 203 LFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA 282 (291)
T ss_pred CCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCH
Confidence 997765 22322222110 0000 01233 788999999999999999999
Q ss_pred HHHhcCccc
Q 011868 298 AGIKADEWF 306 (476)
Q Consensus 298 ~~il~~~~~ 306 (476)
.+++.||||
T Consensus 283 ~e~l~~~~f 291 (291)
T cd07844 283 AEAMKHPYF 291 (291)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=354.91 Aligned_cols=258 Identities=29% Similarity=0.458 Sum_probs=213.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~----- 86 (476)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 46789999999999999999999999999999999865432 333456778899999999999999999988643
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 87 -~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
...|+||||+. ++|.+.+... +++..++.++.|++.||+|||++||+||||||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp----------------------- 146 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP----------------------- 146 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH-----------------------
Confidence 35799999995 5888887653 99999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||+++.++.+||+|||++..... ........|++.|+|||++.+..++ .++|||||||++|+|
T Consensus 147 ------------~Nil~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l 210 (353)
T cd07850 147 ------------SNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEM 210 (353)
T ss_pred ------------HHEEECCCCCEEEccCccceeCCC---CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHH
Confidence 999999999999999999975322 2223445789999999999888775 889999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCC----------------------C-----C---------C-------CCCCCHHHHHH
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGD----------------------F-----K---------L-------PKWLSPGAQNL 282 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~----------------------~-----~---------~-------p~~~s~~~~~L 282 (476)
++|+.||.+.+....+.++...- . + + +...++.+.+|
T Consensus 211 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 290 (353)
T cd07850 211 IRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDL 290 (353)
T ss_pred HHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHH
Confidence 99999998776544443332100 0 0 0 11235578999
Q ss_pred HHHccCCCcCCCCChHHHhcCccccccCCC
Q 011868 283 LRKILEPNPVKRITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 283 i~~~L~~dP~~R~s~~~il~~~~~~~~~~~ 312 (476)
|.+||+.||++|||+.+++.||||..++.+
T Consensus 291 i~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 291 LSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred HHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 999999999999999999999999987764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=339.99 Aligned_cols=254 Identities=30% Similarity=0.447 Sum_probs=213.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC---
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS--- 87 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~--- 87 (476)
..++|++.+.||+|++|.||+|.+..+++.+|+|++..... ....+.+|+.+++++ .||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 35899999999999999999999998999999999876531 246789999999999 6999999999997644
Q ss_pred ---EEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 88 ---KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 88 ---~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
.+|+||||+++++|.+++.. +..+++..++.++.|++.||.|||+.|++||||+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p------------------ 141 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKG------------------ 141 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCH------------------
Confidence 58999999999999998864 35799999999999999999999999999999997
Q ss_pred HHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC----CCCccchhh
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----YDGATSDIW 236 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~~~sDvw 236 (476)
+||+++.++.+||+|||++..... .........|++.|+|||++.... ..+.++|||
T Consensus 142 -----------------~ni~~~~~~~~~l~d~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~ 202 (275)
T cd06608 142 -----------------QNILLTKNAEVKLVDFGVSAQLDS--TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVW 202 (275)
T ss_pred -----------------HHEEEccCCeEEECCCccceeccc--chhhhcCccccccccCHhHhcccccccCCccccccHH
Confidence 999999999999999999875332 122234567899999999875422 224789999
Q ss_pred hHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 237 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 237 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
||||++|+|++|+.||...+......++..... ..+..+++.+.+||.+||..||++|||+.++++|||+
T Consensus 203 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 203 SLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 999999999999999987665555555554432 2233467899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.57 Aligned_cols=254 Identities=33% Similarity=0.513 Sum_probs=218.9
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+|+..+.||+|+||+||+|.+..+++.||+|.+..... ...+..+.+.+|+.+++.++||||+++++++......|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 58889999999999999999988999999999875432 1233457899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|||+++++|.+++.....+++..+..++.||+.|++|||+.|++|+||+|
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~------------------------------ 130 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKG------------------------------ 130 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH------------------------------
Confidence 99999999999998877899999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||+++.++.+||+|||++...... .......|++.|+|||.+......+.++|+||+||++|+|++|+.||
T Consensus 131 -----~ni~~~~~~~~kl~d~~~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf 202 (258)
T cd06632 131 -----ANILVDTNGVVKLADFGMAKQVVEF---SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW 202 (258)
T ss_pred -----HHEEECCCCCEEEccCccceecccc---ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence 9999999999999999998754321 12345678999999999876652348899999999999999999999
Q ss_pred CCCcHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 253 DDRNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 253 ~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
..........++.. ....+|..+++.+.+++++||+.+|.+||++.+++.|||+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 203 SQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 87665444444433 2334567789999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=360.89 Aligned_cols=253 Identities=28% Similarity=0.443 Sum_probs=208.0
Q ss_pred CcCEEEeceEeecCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~ 86 (476)
.++|+++++||+|+||+||+|+. ..++..||||+++... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45899999999999999999974 3467789999996543 223356788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC---------------------------------------------------------
Q 011868 87 SKIYMVLEYVTGGELFDKIASKG--------------------------------------------------------- 109 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~--------------------------------------------------------- 109 (476)
+..|+||||++||+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886421
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 110 ------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 110 ------------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
.+++..+..++.||+.||+|||++||+||||||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp----------------------------- 242 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAA----------------------------- 242 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCch-----------------------------
Confidence 477888999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYL 250 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~ 250 (476)
+|||++.++.+||+|||+++...............++..|+|||++.+..++ .++|||||||++|+|++ |..
T Consensus 243 ------~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~ 315 (375)
T cd05104 243 ------RNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSS 315 (375)
T ss_pred ------hhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCC
Confidence 9999999999999999999754322111112233456789999999887775 89999999999999998 999
Q ss_pred CCCCCcHHH-HHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 251 PFDDRNLAV-LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 251 Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
||.+..... ....+..+ ....|...+.++.+||.+||+.||++|||+.++++.
T Consensus 316 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 316 PYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 998765443 33333333 233456678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=351.70 Aligned_cols=261 Identities=35% Similarity=0.624 Sum_probs=238.7
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~ 88 (476)
.++...|..+..||+|+||+|.+|..+.+.+.+|||+++++-....+..+--..|-++|... +-|.+++++.+|++-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 56677899999999999999999999999999999999988776666566666788888877 47889999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
+|+||||+.||+|.-.|++-+++.|..|..|+..|+-||-|||++||+.||||
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLK--------------------------- 477 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLK--------------------------- 477 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeecc---------------------------
Confidence 99999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
++|+++|.+|++||+|||+++- ....+..+.+.||||.|+|||++...+| +..+|.||+||+||||+.|
T Consensus 478 --------LDNvmLd~eGHiKi~DFGmcKE--ni~~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaG 546 (683)
T KOG0696|consen 478 --------LDNVMLDSEGHIKIADFGMCKE--NIFDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAG 546 (683)
T ss_pred --------ccceEeccCCceEeeecccccc--cccCCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcC
Confidence 4999999999999999999983 2234556788999999999999998888 5889999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh-----HHHhcCccccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI-----AGIKADEWFEQ 308 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~-----~~il~~~~~~~ 308 (476)
++||+|.+..++++.|...+..+|..+|.++.++....|.+.|.+|... .+|..||||..
T Consensus 547 QpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 547 QPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred CCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 9999999999999999999999999999999999999999999999753 56999999964
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=337.43 Aligned_cols=251 Identities=27% Similarity=0.456 Sum_probs=216.6
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+|+.+++.++||||+++++++......|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 367999999999999999999998889999999986542 157899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
+||+.+++|.+++.. ...+++..++.++.|++.|+.|||+.|++||||+|
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~----------------------------- 127 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKA----------------------------- 127 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCc-----------------------------
Confidence 999999999999875 45789999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||+++.++.+||+|||++...... ........|+..|+|||++.+..++ .++||||+||++|+|++|+.|
T Consensus 128 ------~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p 198 (256)
T cd06612 128 ------GNILLNEEGQAKLADFGVSGQLTDT--MAKRNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPP 198 (256)
T ss_pred ------ceEEECCCCcEEEcccccchhcccC--ccccccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999998854331 1123345588999999999887775 889999999999999999999
Q ss_pred CCCCcHHHHHHHHHhC---CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 252 FDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
|...+.......+... ....+..++..+.++|.+||+.||++|||+.+++.||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 199 YSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 9876654433333222 223345578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=337.64 Aligned_cols=253 Identities=30% Similarity=0.490 Sum_probs=214.9
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+++|++.+.||+|+||.||+|++..+++.||||.+........+....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 47899999999999999999999999999999998765444555567789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|||+++++|.+++.. ...+++..+..++.||+.||+|||++|++||||||
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~-------------------------- 134 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKP-------------------------- 134 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCH--------------------------
Confidence 999999999988853 34589999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+||+++.++.++|+|||++...... ........|++.|+|||.+.+..++ .++|+||+||++|+|++|
T Consensus 135 ---------~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g 202 (267)
T cd08228 135 ---------ANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred ---------HHEEEcCCCCEEECccccceeccch--hHHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcC
Confidence 9999999999999999998864331 1223345789999999999887775 889999999999999999
Q ss_pred CCCCCCCc--HHHHHHHHHhCCCC-C-CCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 249 YLPFDDRN--LAVLYQKIFRGDFK-L-PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 249 ~~Pf~~~~--~~~~~~~i~~~~~~-~-p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+.||.... .......+.....+ . +...+..+.++|.+||+.+|++||++.++++.
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 203 QSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred CCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 99996653 23444454443322 2 23577899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=338.60 Aligned_cols=251 Identities=34% Similarity=0.631 Sum_probs=221.8
Q ss_pred EeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 011868 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (476)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 101 (476)
||.|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++.+......|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999889999999999776544445567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceE
Q 011868 102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181 (476)
Q Consensus 102 ~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiL 181 (476)
.+++...+.+++..+..++.||+.||+|||++|++||||+| +||+
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~-----------------------------------~nil 125 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP-----------------------------------DNIL 125 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCH-----------------------------------HHeE
Confidence 99998877899999999999999999999999999999997 9999
Q ss_pred eCCCCCEEEeccCCCCCCCcccC------CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCC
Q 011868 182 LDSKGNIKISDFGLSALPQHFRD------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 255 (476)
Q Consensus 182 l~~~g~vkl~DFGla~~~~~~~~------~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~ 255 (476)
++.++.++|+|||++........ ........++..|+|||.+.+..+ +.++|||||||++|+|++|..||...
T Consensus 126 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 126 IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred EcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999875432111 112334568899999999887765 48899999999999999999999988
Q ss_pred cHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHccCCCcCCCCCh---HHHhcCccccc
Q 011868 256 NLAVLYQKIFRGDFKLPKWL--SPGAQNLLRKILEPNPVKRITI---AGIKADEWFEQ 308 (476)
Q Consensus 256 ~~~~~~~~i~~~~~~~p~~~--s~~~~~Li~~~L~~dP~~R~s~---~~il~~~~~~~ 308 (476)
+....+..+..+....|... ++.+.++|++||+.+|.+|||+ .+++.||||+.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 205 TPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 88888888877777777665 8999999999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=342.06 Aligned_cols=253 Identities=27% Similarity=0.383 Sum_probs=216.1
Q ss_pred cCcCEEEeceEeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
..++|.+.+.||+|+||.||+|.+.. +++.||+|.+.... ..+....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 45689999999999999999998743 46789999987553 233457899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASK--------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIA 152 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~--------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~ 152 (476)
...|+||||++|++|.+++... ..+++.++..++.|++.|+.|||++|++||||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp---------- 150 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLAT---------- 150 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecccccc----------
Confidence 9999999999999999999753 2478899999999999999999999999999997
Q ss_pred HHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCcc
Q 011868 153 TLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 232 (476)
Q Consensus 153 ~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~ 232 (476)
+||+++.++.+||+|||++................+++.|+|||++.+..++ .+
T Consensus 151 -------------------------~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~ 204 (280)
T cd05049 151 -------------------------RNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TE 204 (280)
T ss_pred -------------------------ceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hh
Confidence 9999999999999999998743221111122334567899999999887775 88
Q ss_pred chhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 233 SDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 233 sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+|||||||++|+|++ |..||.+.+.......+..+... .|..++..+.+++++||+.||++||++.+++.
T Consensus 205 ~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 205 SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999999999999998 99999888888777777766554 45668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=354.24 Aligned_cols=260 Identities=30% Similarity=0.473 Sum_probs=232.4
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
.+..+.|+.-+.||+|+||+|+-++...||+.+|.|.+.+.+...........+|-.+|.+++.+.||.+--.|++.+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 45667899999999999999999999999999999999888766555566788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 90 YMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
|+||..|+||+|.-.|.+-+ .|++..++.|+.+|+.||++||+.+||.||+||
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKP------------------------- 315 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKP------------------------- 315 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCCh-------------------------
Confidence 99999999999988887654 799999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||+|+.|+++|+|.|||.-+. ........+||.+|||||++.+..|+ ...|.||+||++|+|+.
T Consensus 316 ----------eNILLDd~GhvRISDLGLAvei~---~g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~ 381 (591)
T KOG0986|consen 316 ----------ENILLDDHGHVRISDLGLAVEIP---EGKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIA 381 (591)
T ss_pred ----------hheeeccCCCeEeeccceEEecC---CCCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHc
Confidence 99999999999999999998543 34445556999999999999999986 78999999999999999
Q ss_pred CCCCCCCCc----HHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 248 GYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 248 G~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
|+.||.... .+++-+.+......+|..+|+++++|.+.+|+.||.+|. .++++.+||||+.
T Consensus 382 G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 382 GHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred ccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 999997643 235556677777788999999999999999999999987 5678999999986
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=341.00 Aligned_cols=255 Identities=23% Similarity=0.372 Sum_probs=215.3
Q ss_pred ccCcCEEEeceEeecCceEEEEEEEC----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
+.+..|++.+.||+|+||+||+|... .++..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 45788999999999999999999853 456789999987543 233456789999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccch
Q 011868 87 SKIYMVLEYVTGGELFDKIASK-----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHM 149 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~-----------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~ 149 (476)
...|+||||+++++|.+++... ..+++.++..++.|++.||+|||++|++||||||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp------- 152 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAA------- 152 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhcccc-------
Confidence 9999999999999999998532 2478889999999999999999999999999997
Q ss_pred hhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCC
Q 011868 150 RIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 229 (476)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 229 (476)
+||++++++.+||+|||+++...............++..|+|||++.+..++
T Consensus 153 ----------------------------~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (283)
T cd05090 153 ----------------------------RNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS 204 (283)
T ss_pred ----------------------------ceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCC
Confidence 9999999999999999999754322111223344567789999998877664
Q ss_pred CccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 230 GATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 230 ~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
.++|||||||++|+|++ |..||.+.+.......+.... .+.|..+++.+.+++.+||+.||.+||++.+|+++
T Consensus 205 -~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 205 -SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred -chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 89999999999999998 999998887766666665543 45667789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=344.78 Aligned_cols=256 Identities=32% Similarity=0.444 Sum_probs=214.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI 89 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~ 89 (476)
.+++|++.+.||+|+||.||+|.+..+++.+|+|.++.... .......+.+|+.++++++||||+++++++... ...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc-cccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 45689999999999999999999998999999999975542 233345678899999999999999999998877 899
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||+. ++|.+.+... ..+++.+++.++.||+.||+|||+.|++||||||
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p-------------------------- 134 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKT-------------------------- 134 (293)
T ss_pred EEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCH--------------------------
Confidence 99999996 5999988764 3599999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+||+++.++.+||+|||++...... ........+++.|+|||.+.+....+.++|+||+||++|+|++|
T Consensus 135 ---------~nili~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 203 (293)
T cd07843 135 ---------SNLLLNNRGILKICDFGLAREYGSP--LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203 (293)
T ss_pred ---------HHEEECCCCcEEEeecCceeeccCC--ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhC
Confidence 9999999999999999998854331 12233456789999999987665445889999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCC-------------------------------CCCCCC-CCHHHHHHHHHccCCCcCCCCC
Q 011868 249 YLPFDDRNLAVLYQKIFRGD-------------------------------FKLPKW-LSPGAQNLLRKILEPNPVKRIT 296 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~-------------------------------~~~p~~-~s~~~~~Li~~~L~~dP~~R~s 296 (476)
..||...+....+.++.... ..++.. +++.+.++|++||+.||++|||
T Consensus 204 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t 283 (293)
T cd07843 204 KPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283 (293)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC
Confidence 99998877665554443210 012222 5888999999999999999999
Q ss_pred hHHHhcCccc
Q 011868 297 IAGIKADEWF 306 (476)
Q Consensus 297 ~~~il~~~~~ 306 (476)
+.|++.||||
T Consensus 284 ~~ell~~~~f 293 (293)
T cd07843 284 AEDALKHPYF 293 (293)
T ss_pred HHHHhcCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=348.93 Aligned_cols=247 Identities=32% Similarity=0.466 Sum_probs=193.8
Q ss_pred eceEeecCceEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEe
Q 011868 19 GRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSKIYMVLE 94 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~--~~~~~~lV~E 94 (476)
+.+||+|+||+||+|++.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. .+...|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4689999999999999654 668899999865431 346788999999999999999999884 4568899999
Q ss_pred ccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 95 YVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 95 ~~~gg~L~~~l~~~---------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
|+. ++|.+.+... ..+++..++.++.||+.||.|||+.||+||||||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp----------------------- 136 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKP----------------------- 136 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCH-----------------------
Confidence 995 5888877421 2588999999999999999999999999999997
Q ss_pred hccccccccCCCCceEe----CCCCCEEEeccCCCCCCCccc-CCCcccccccCCccccccccccCCCCCccchhhhHhH
Q 011868 166 VIRPWKFNVLQLENILL----DSKGNIKISDFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl----~~~g~vkl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGv 240 (476)
+|||+ +.++.+||+|||+++...... .........||+.|+|||++.+....+.++||||+||
T Consensus 137 ------------~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ 204 (317)
T cd07867 137 ------------ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 204 (317)
T ss_pred ------------HHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHH
Confidence 99999 566899999999998653321 1122345678999999999877554468899999999
Q ss_pred HHHHHhcCCCCCCCCcHH---------HHHHHHHhC----------------------------CC----------CCCC
Q 011868 241 ILYVILTGYLPFDDRNLA---------VLYQKIFRG----------------------------DF----------KLPK 273 (476)
Q Consensus 241 il~elltG~~Pf~~~~~~---------~~~~~i~~~----------------------------~~----------~~p~ 273 (476)
++|+|+||++||...+.. ....++... .. ....
T Consensus 205 il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (317)
T cd07867 205 IFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKV 284 (317)
T ss_pred HHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccC
Confidence 999999999999754321 111111100 00 0011
Q ss_pred CCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 274 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 274 ~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
..+..+.+||.+||+.||.+|||++|+++||||
T Consensus 285 ~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 285 KPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 235668899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=339.66 Aligned_cols=255 Identities=28% Similarity=0.414 Sum_probs=213.5
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC----
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK---- 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~---- 86 (476)
..++|++.+.||+|+||.||+|.+..+++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 4678999999999999999999999999999999986542 2245678899999999 799999999998643
Q ss_pred -CEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 87 -SKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 87 -~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
+..|+||||++|++|.+++.. ...+++..++.++.|++.||+|||+.|++||||||
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp------------------- 156 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKG------------------- 156 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH-------------------
Confidence 468999999999999998753 35789999999999999999999999999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC----CCCccchhhh
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----YDGATSDIWS 237 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~~~sDvwS 237 (476)
+||+++.++.+||+|||++...... ........|+..|+|||++.... ..+.++||||
T Consensus 157 ----------------~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s 218 (291)
T cd06639 157 ----------------NNILLTTEGGVKLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWS 218 (291)
T ss_pred ----------------HHEEEcCCCCEEEeecccchhcccc--cccccCccCCccccChhhhcCCCCcccccCCccchHH
Confidence 9999999999999999998754321 11223457899999999976432 1247899999
Q ss_pred HhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccc
Q 011868 238 CGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307 (476)
Q Consensus 238 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~ 307 (476)
+||++|+|++|+.||...+.......+..... ..+...+..+.+||.+||+.||++||++.++++||||+
T Consensus 219 lGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 219 LGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 99999999999999988776555555544422 23445778899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=340.57 Aligned_cols=252 Identities=31% Similarity=0.486 Sum_probs=211.7
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||.|++|+||+|++..+|+.||||.+..... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 59999999999999999999999999999999976532 2224567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 95 YVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 95 ~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|+.+ +|.+++... ..+++..+..++.|++.||+|||+.|++||||||
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p----------------------------- 128 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKP----------------------------- 128 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCH-----------------------------
Confidence 9974 888888653 3689999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||++++++.++|+|||++...... ........+++.|+|||++.+....+.++|||||||++|+|++|+.|
T Consensus 129 ------~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~ 200 (284)
T cd07836 129 ------QNLLINKRGELKLADFGLARAFGIP--VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPL 200 (284)
T ss_pred ------HHEEECCCCcEEEeecchhhhhcCC--ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999754321 11223456789999999987655445889999999999999999999
Q ss_pred CCCCcHHHHHHHHHhCC------------------CC-----------CCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 252 FDDRNLAVLYQKIFRGD------------------FK-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~~------------------~~-----------~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|.+.+....+.++.... .. +.+..++.+.++|.+||+.||.+||++.++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 201 FPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 99877665554443210 00 11235788999999999999999999999999
Q ss_pred Cccc
Q 011868 303 DEWF 306 (476)
Q Consensus 303 ~~~~ 306 (476)
||||
T Consensus 281 ~~~f 284 (284)
T cd07836 281 HPWF 284 (284)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=339.53 Aligned_cols=254 Identities=30% Similarity=0.469 Sum_probs=218.6
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++.+...+..|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468899999999999999999999999999999976542 244577899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 94 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||+.+++|.+++... ..+++..+..++.|++.|++|||+ .|++||||||
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~----------------------------- 129 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKP----------------------------- 129 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCH-----------------------------
Confidence 999999999999765 789999999999999999999999 9999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||+++.++.++|+|||++..... .......|+..|+|||.+.+..++ .++||||+||++|+|++|..|
T Consensus 130 ------~ni~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p 198 (265)
T cd06605 130 ------SNILVNSRGQIKLCDFGVSGQLVN----SLAKTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFP 198 (265)
T ss_pred ------HHEEECCCCCEEEeecccchhhHH----HHhhcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999874422 112226789999999999887775 889999999999999999999
Q ss_pred CCCC-----cHHHHHHHHHhCC-CCCCCC-CCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 252 FDDR-----NLAVLYQKIFRGD-FKLPKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 252 f~~~-----~~~~~~~~i~~~~-~~~p~~-~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|... ........+.... ...+.. +++++.++|.+||..||.+|||+.+++.||||+..
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 199 YPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred CCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 9764 2333444444433 234444 88999999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=341.13 Aligned_cols=253 Identities=27% Similarity=0.421 Sum_probs=210.6
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-----
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS----- 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~----- 85 (476)
..+.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 4478999999999999999999999999999999986542 2246788899999998 69999999999842
Q ss_pred -CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHH
Q 011868 86 -KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFL 162 (476)
Q Consensus 86 -~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~ 162 (476)
...+|++|||+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~-------------------- 149 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKG-------------------- 149 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH--------------------
Confidence 46789999999999999998653 4588999999999999999999999999999997
Q ss_pred HhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc-----CCCCCccchhhh
Q 011868 163 LMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWS 237 (476)
Q Consensus 163 ~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~sDvwS 237 (476)
+||+++.++.++|+|||++..... .........|++.|+|||++.. ..++ .++|+||
T Consensus 150 ---------------~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~-~~~Dvws 211 (282)
T cd06636 150 ---------------QNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYD-YRSDIWS 211 (282)
T ss_pred ---------------HHEEECCCCCEEEeeCcchhhhhc--cccCCCcccccccccCHhhcCcccCcCcCCC-cccchhH
Confidence 999999999999999999875432 1122345678999999999863 3353 7899999
Q ss_pred HhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-C-CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 238 CGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-K-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 238 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~-~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
|||++|+|++|..||...........+..... . .+..+++.+.+||++||+.||.+|||+.+|+.||||
T Consensus 212 lG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 212 LGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 99999999999999977655443333333221 1 223478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=339.90 Aligned_cols=256 Identities=26% Similarity=0.493 Sum_probs=217.8
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~l 91 (476)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++ |||++++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5888999999999999999999999999999987543 2333567889999999997 9999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p----------------------------- 129 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKA----------------------------- 129 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCH-----------------------------
Confidence 9999999999999865 4799999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||+++.++.++|+|||++...... ........|+..|+|||.+.+....+.++|+|||||++|+|++|..|
T Consensus 130 ------~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p 201 (277)
T cd06917 130 ------ANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201 (277)
T ss_pred ------HHEEEcCCCCEEEccCCceeecCCC--ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999998754332 22234457899999999987654445899999999999999999999
Q ss_pred CCCCcHHHHHHHHHhCC-CCCCCC-CCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 252 FDDRNLAVLYQKIFRGD-FKLPKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~~-~~~p~~-~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
|.+.+.......+.... ..++.. ++.++.+++.+||+.||++||++.+++.|+||++..
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 202 YSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred CCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 98876655444333322 223332 788999999999999999999999999999997644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=349.65 Aligned_cols=259 Identities=31% Similarity=0.471 Sum_probs=210.2
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK 88 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~ 88 (476)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 68999999999999999999999999999999986432 223456788899999999999999999987544 35
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
.|+||||+. ++|.+.+.. .++++..++.++.|++.||+|||++||+||||||
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp-------------------------- 134 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKP-------------------------- 134 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH--------------------------
Confidence 899999995 588887754 5799999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++.+||+|||++........ .......+||+.|+|||++.+....+.++||||+||++|+|++
T Consensus 135 ---------~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~ 205 (336)
T cd07849 135 ---------SNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205 (336)
T ss_pred ---------HHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999999999875432211 1122345789999999987654434588999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHh---------------C-----------CCC-----CCCCCCHHHHHHHHHccCCCcCCCCC
Q 011868 248 GYLPFDDRNLAVLYQKIFR---------------G-----------DFK-----LPKWLSPGAQNLLRKILEPNPVKRIT 296 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~---------------~-----------~~~-----~p~~~s~~~~~Li~~~L~~dP~~R~s 296 (476)
|+.||.+.+.......+.. . ... ..+..++++.++|.+||+.||.+|||
T Consensus 206 G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 285 (336)
T cd07849 206 NRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT 285 (336)
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC
Confidence 9999987654332222111 0 000 01235788999999999999999999
Q ss_pred hHHHhcCccccccCC
Q 011868 297 IAGIKADEWFEQDYT 311 (476)
Q Consensus 297 ~~~il~~~~~~~~~~ 311 (476)
+.+++.||||++...
T Consensus 286 ~~e~l~hp~~~~~~~ 300 (336)
T cd07849 286 VEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHhcCccccccCC
Confidence 999999999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=341.18 Aligned_cols=255 Identities=24% Similarity=0.439 Sum_probs=219.6
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
..|+..+.||.|+||.||.|.+..++..||+|++.... .......+.+|+.+++.++||||+++++++..+...|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46888999999999999999998899999999987653 2334578999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||++|++|.+++.. +++++.++..++.|++.||+|||+.+++|+||+|
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p------------------------------- 129 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKA------------------------------- 129 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCCh-------------------------------
Confidence 99999999998865 5799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+||+++.++.++|+|||++...... ........++..|+|||++.+..++ .++|+|||||++|+|++|..||.
T Consensus 130 ----~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06640 130 ----ANVLLSEQGDVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred ----hhEEEcCCCCEEEcccccceeccCC--ccccccccCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCC
Confidence 9999999999999999999754321 1122334688899999998877664 88999999999999999999998
Q ss_pred CCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 254 DRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
+.+.......+.... ...+..++..+.++|.+||+.+|++||++.++++|+||...
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 203 DMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred CcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 877665555443332 23445578899999999999999999999999999999654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=340.27 Aligned_cols=254 Identities=28% Similarity=0.413 Sum_probs=205.9
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+..... ......+.+|+.+++.++|+||+++++++..+...|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 3679999999999999999999999999999999975532 22234677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||+. ++|.+.+.. ...+++.+++.++.|++.||.|||+.||+||||||
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp----------------------------- 131 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKP----------------------------- 131 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh-----------------------------
Confidence 99995 677777654 35688999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||+++.++.+||+|||+++..... ........+++.|+|||++.+....+.++|||||||++|+|++|..|
T Consensus 132 ------~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~ 203 (291)
T cd07870 132 ------QNLLISYLGELKLADFGLARAKSIP--SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA 203 (291)
T ss_pred ------HHEEEcCCCcEEEeccccccccCCC--CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999998753321 12233456789999999987644334789999999999999999999
Q ss_pred CCCCcHH-HHHHHHHhC----------------C-----C--CCCC---------CCCHHHHHHHHHccCCCcCCCCChH
Q 011868 252 FDDRNLA-VLYQKIFRG----------------D-----F--KLPK---------WLSPGAQNLLRKILEPNPVKRITIA 298 (476)
Q Consensus 252 f~~~~~~-~~~~~i~~~----------------~-----~--~~p~---------~~s~~~~~Li~~~L~~dP~~R~s~~ 298 (476)
|.+.+.. +...++... . . ..+. ..++.+.+++.+||+.||.+|||+.
T Consensus 204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~ 283 (291)
T cd07870 204 FPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQ 283 (291)
T ss_pred CCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHH
Confidence 9865532 222222110 0 0 0000 1256889999999999999999999
Q ss_pred HHhcCccc
Q 011868 299 GIKADEWF 306 (476)
Q Consensus 299 ~il~~~~~ 306 (476)
+++.||||
T Consensus 284 ~~l~h~~~ 291 (291)
T cd07870 284 DALLHPYF 291 (291)
T ss_pred HHhcCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=341.37 Aligned_cols=255 Identities=32% Similarity=0.442 Sum_probs=209.2
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE----
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK---- 88 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~---- 88 (476)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999865432 2233467888999999995 6999999999877665
Q ss_pred -EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHH
Q 011868 89 -IYMVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFL 162 (476)
Q Consensus 89 -~~lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~ 162 (476)
.|+||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~-------------------- 138 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKP-------------------- 138 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCh--------------------
Confidence 8999999975 898888642 3589999999999999999999999999999997
Q ss_pred HhhhccccccccCCCCceEeCC-CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 163 LMIVIRPWKFNVLQLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 163 ~~~~~~p~~~~~~~~~NiLl~~-~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+||+++. ++.+||+|||++...... ........+++.|+|||++.+....+.++||||+||+
T Consensus 139 ---------------~nil~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 201 (295)
T cd07837 139 ---------------QNLLVDKQKGLLKIADLGLGRAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCI 201 (295)
T ss_pred ---------------HHEEEecCCCeEEEeecccceecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHH
Confidence 9999998 899999999998754221 1122334578899999998764444589999999999
Q ss_pred HHHHhcCCCCCCCCcHHHHHHHHHhCCC-----------------CCC-----------CCCCHHHHHHHHHccCCCcCC
Q 011868 242 LYVILTGYLPFDDRNLAVLYQKIFRGDF-----------------KLP-----------KWLSPGAQNLLRKILEPNPVK 293 (476)
Q Consensus 242 l~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~~p-----------~~~s~~~~~Li~~~L~~dP~~ 293 (476)
+|+|++|..||.+.+....+.++..... ..| +.+++.+.++|.+||++||.+
T Consensus 202 l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 281 (295)
T cd07837 202 FAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAK 281 (295)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhh
Confidence 9999999999988776554444332100 001 236888999999999999999
Q ss_pred CCChHHHhcCcccc
Q 011868 294 RITIAGIKADEWFE 307 (476)
Q Consensus 294 R~s~~~il~~~~~~ 307 (476)
|||+.+++.||||+
T Consensus 282 R~~~~eil~~~~~~ 295 (295)
T cd07837 282 RISAKAALTHPYFD 295 (295)
T ss_pred cCCHHHHhcCCCcC
Confidence 99999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=339.41 Aligned_cols=249 Identities=31% Similarity=0.501 Sum_probs=206.2
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEEEEE
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK--SKIYMV 92 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~--~~~~lV 92 (476)
|++.+.||+|+||.||+|.+..+++.||+|.+.+... ... .....+|+.+++++. ||||+++++++.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999999876432 112 233457888898885 99999999999887 899999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||+. ++|.+.+... ..+++.+++.++.|++.||+|||+.|++||||||
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p----------------------------- 128 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKP----------------------------- 128 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCH-----------------------------
Confidence 99996 5888888653 5789999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||+++. +.+||+|||++..... ........+++.|+|||++...++.+.++||||+||++|+|++|..|
T Consensus 129 ------~ni~l~~-~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p 198 (282)
T cd07831 129 ------ENILIKD-DILKLADFGSCRGIYS---KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPL 198 (282)
T ss_pred ------HHEEEcC-CCeEEEeccccccccc---CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcC
Confidence 9999999 9999999999975432 12223346889999999876655556899999999999999999999
Q ss_pred CCCCcHHHHHHHHHhC------------------CCCCC-----------CCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 252 FDDRNLAVLYQKIFRG------------------DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~------------------~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|.+.+.......+... .+.+| ..++..+.++|.+||++||++|||+++++.
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 199 FPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 9887765544443221 11111 235789999999999999999999999999
Q ss_pred Cccc
Q 011868 303 DEWF 306 (476)
Q Consensus 303 ~~~~ 306 (476)
||||
T Consensus 279 ~~~~ 282 (282)
T cd07831 279 HPYF 282 (282)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=339.90 Aligned_cols=254 Identities=30% Similarity=0.465 Sum_probs=211.0
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE-----
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA----- 84 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~----- 84 (476)
...++|++.+.||+|+||+||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 35679999999999999999999999999999999886432 1235678899999999 6999999999873
Q ss_pred eCCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 85 SKSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
.....|+||||++|++|.+.+.. ...+++..++.++.|++.||.|||+.+++||||||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp------------------ 152 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKG------------------ 152 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCH------------------
Confidence 34679999999999999988752 34689999999999999999999999999999997
Q ss_pred HHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc-----CCCCCccchh
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDI 235 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~sDv 235 (476)
+||+++.++.+||+|||++..... .........|++.|+|||++.. ..+ +.++||
T Consensus 153 -----------------~nili~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv 212 (286)
T cd06638 153 -----------------NNILLTTEGGVKLVDFGVSAQLTS--TRLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDV 212 (286)
T ss_pred -----------------HhEEECCCCCEEEccCCceeeccc--CCCccccccCCCcccChhhhchhhhccccc-cchhhh
Confidence 999999999999999999875432 1122334579999999999853 234 478999
Q ss_pred hhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 236 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 236 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
||+||++|+|++|+.||...+......++.... ...|..++..+.+||.+||+.||++|||+.++++|+||
T Consensus 213 ~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 213 WSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred hhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 999999999999999998776544443333322 12345578899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=335.51 Aligned_cols=247 Identities=32% Similarity=0.586 Sum_probs=210.5
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~-l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..+ ....+||||+++++++..++.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999999999999999976543222223344555544 4455899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
++|.+++...+.+++..+..++.|++.||.|||+.|++||||+| +
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p-----------------------------------~ 126 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKP-----------------------------------E 126 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH-----------------------------------H
Confidence 99999998878899999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~ 258 (476)
||++++++.+||+|||++..... .....|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+..
T Consensus 127 nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 199 (260)
T cd05611 127 NLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPD 199 (260)
T ss_pred HeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHH
Confidence 99999999999999999874322 234568899999999887765 48999999999999999999999988887
Q ss_pred HHHHHHHhCCCCC----CCCCCHHHHHHHHHccCCCcCCCCC---hHHHhcCccccc
Q 011868 259 VLYQKIFRGDFKL----PKWLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 308 (476)
Q Consensus 259 ~~~~~i~~~~~~~----p~~~s~~~~~Li~~~L~~dP~~R~s---~~~il~~~~~~~ 308 (476)
..+..+....... +..+++++.++|.+||+.||++||+ +++++.||||..
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 200 AVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred HHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 7777766554433 3357899999999999999999995 579999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=345.87 Aligned_cols=255 Identities=21% Similarity=0.323 Sum_probs=212.9
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCce----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 85 (476)
.+...+|++.+.||+|+||+||+|.+..+++. ||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 34567899999999999999999998666654 8999986442 33445778899999999999999999999876
Q ss_pred CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 86 KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
. ..++++||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp---------------------- 137 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAA---------------------- 137 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccch----------------------
Confidence 4 578999999999999999764 4688999999999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+|||++.++.+||+|||+++...............++..|+|||++.+..++ .++|||||||++|+
T Consensus 138 -------------~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~e 203 (316)
T cd05108 138 -------------RNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWE 203 (316)
T ss_pred -------------hheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHH
Confidence 9999999999999999999865432211112223456789999999887775 89999999999999
Q ss_pred Hhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 245 ILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 245 llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|++ |..||.+.....+...+..+ ..+.|..++.++.+++.+||..||.+|||+.+++.+
T Consensus 204 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 204 LMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 997 99999987766655444333 345567789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=340.05 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=214.4
Q ss_pred cCcCEEEeceEeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
...+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ......+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4567999999999999999999853 345679999986542 33456799999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhH
Q 011868 87 SKIYMVLEYVTGGELFDKIASKG-------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIAT 153 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~-------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~ 153 (476)
+.+|+||||+++++|.+++...+ .+++.+++.++.|++.||+|||++|++||||||
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp----------- 148 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT----------- 148 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCc-----------
Confidence 99999999999999999996533 489999999999999999999999999999997
Q ss_pred HHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccc
Q 011868 154 LQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 233 (476)
Q Consensus 154 ~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~s 233 (476)
+||++++++.+||+|||++................+++.|+|||++.+..++ .++
T Consensus 149 ------------------------~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~s 203 (288)
T cd05093 149 ------------------------RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TES 203 (288)
T ss_pred ------------------------ceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chh
Confidence 9999999999999999999754321111122334467899999999877665 899
Q ss_pred hhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 234 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 234 DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|||||||++|+|++ |..||.+.+.......+..+.. ..+..+++++.+|+.+||+.||.+|||+.++++
T Consensus 204 DiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 204 DVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999999999998 9999998888777788877653 456668899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=337.94 Aligned_cols=253 Identities=22% Similarity=0.310 Sum_probs=211.3
Q ss_pred CcCEEEeceEeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
-++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4679999999999999999998642 45679999986543 2233567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHH
Q 011868 88 KIYMVLEYVTGGELFDKIASKG----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVF 157 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~ 157 (476)
..|+||||+++++|.+++.... .++...+..++.|++.||+|||+.|++||||||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp--------------- 147 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAA--------------- 147 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcch---------------
Confidence 9999999999999999986532 356788899999999999999999999999997
Q ss_pred HHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhh
Q 011868 158 LLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 237 (476)
Q Consensus 158 ~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwS 237 (476)
+||++++++.++|+|||++................+++.|+|||++.+..++ .++||||
T Consensus 148 --------------------~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s 206 (277)
T cd05062 148 --------------------RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWS 206 (277)
T ss_pred --------------------heEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcC-chhHHHH
Confidence 9999999999999999998743221111111233567889999998877664 8899999
Q ss_pred HhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 238 CGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 238 lGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|||++|+|++ |..||.+.+.......+.... ...|...++.+.++|.+||+.||++|||+.+++.+
T Consensus 207 lG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 207 FGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999 799999888777776666554 35667788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=347.80 Aligned_cols=250 Identities=28% Similarity=0.465 Sum_probs=221.2
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 95 (476)
|+++.+||+|+||.||+|.++.+|+.+|||.+..+. ....+.+||+||++++.|++|++|+.|.....+|+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 778999999999999999999999999999986553 267889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 96 VTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 96 ~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
|-.|++.|.+.. ++++++.++..+++.-+.||+|||...-+|||||+
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKA-------------------------------- 157 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKA-------------------------------- 157 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhccc--------------------------------
Confidence 988999999864 56899999999999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~ 254 (476)
.|||++.+|..||+|||.|..... .-....++.|||.|||||++..-+|+ .++||||||++..||.-|++||.+
T Consensus 158 ---GNILLNT~G~AKLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsD 231 (502)
T KOG0574|consen 158 ---GNILLNTDGIAKLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSD 231 (502)
T ss_pred ---ccEEEcccchhhhhhccccchhhh--hHHhhCccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCccc
Confidence 999999999999999999975432 12235678999999999999999998 889999999999999999999988
Q ss_pred CcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 255 RNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 255 ~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
-.++...-.|-... +.-|+.+|.++.++|++||.++|++|.|+.++++|||.+.
T Consensus 232 IHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 232 IHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred ccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence 77654433332222 2346668999999999999999999999999999999875
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=360.87 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=224.6
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
.|.-++.||+|+||.||.|++..+.+.||||.+........+....+.+|+..|++++|||++.+.++|--+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 36667899999999999999999999999999987665566667889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 95 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
|| -|+-.|++.- .+++.+.++..|..+.+.||+|||+.+.+|||||+
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKA------------------------------- 154 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKA------------------------------- 154 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccc-------------------------------
Confidence 99 5688888864 56899999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc---CCCCCccchhhhHhHHHHHHhcCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
.|||+++.|.|||+|||.|.+.. ...+.+|||+||||||+.. ..|+ -++||||||++..||.-.++
T Consensus 155 ----GNILLse~g~VKLaDFGSAsi~~------PAnsFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkP 223 (948)
T KOG0577|consen 155 ----GNILLSEPGLVKLADFGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKP 223 (948)
T ss_pred ----cceEecCCCeeeeccccchhhcC------chhcccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCC
Confidence 99999999999999999998643 3567899999999999853 5576 68999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhCCCC-CC-CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 251 PFDDRNLAVLYQKIFRGDFK-LP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~~~-~p-~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
|+-.+|.+..+..|.+++.| ++ +.+|..+++||..||++-|..|||.++++.|+|......
T Consensus 224 PlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 224 PLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred CccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 99888888777777776644 33 347899999999999999999999999999999865443
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=344.17 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=218.4
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
..|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 34566778999999999999998899999999986543 233567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||+++++|.+++.. +++++.+++.++.||+.||+|||++||+||||||
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp------------------------------- 146 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS------------------------------- 146 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCH-------------------------------
Confidence 99999999998754 5799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+||+++.++.++|+|||++..... .........|++.|+|||.+.+..++ .++||||+||++|+|++|+.||.
T Consensus 147 ----~Nill~~~~~~kL~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 147 ----DSILLTSDGRIKLSDFGFCAQVSK--EVPKRKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred ----HHEEEcCCCCEEEccCcchhhccc--ccccCceeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999875332 12223446789999999998877775 78999999999999999999998
Q ss_pred CCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCCC
Q 011868 254 DRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~~ 312 (476)
+.+.......+.... .+.+...+..+.++|.+||..||.+|||++++++||||.....|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 220 NEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred CCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 877665555544332 12223478899999999999999999999999999999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=344.16 Aligned_cols=256 Identities=32% Similarity=0.479 Sum_probs=207.3
Q ss_pred CEEEeceEeecCceEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIY 90 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~ 90 (476)
+|++.++||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 69999999999999999999988 8999999999874322334456788999999999999999999999888 8899
Q ss_pred EEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 91 MVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
+||||+. ++|.+.+... ..+++..++.++.||+.||.|||+.||+||||||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp----------------------- 136 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKP----------------------- 136 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCH-----------------------
Confidence 9999995 5787776432 3689999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCC----CCCEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhhHhH
Q 011868 166 VIRPWKFNVLQLENILLDS----KGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~----~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGv 240 (476)
+||+++. ++.+||+|||++........ .......++|+.|+|||++.+....+.++|||||||
T Consensus 137 ------------~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 204 (316)
T cd07842 137 ------------ANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGC 204 (316)
T ss_pred ------------HHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHH
Confidence 9999999 99999999999986533221 112334578999999999876544458899999999
Q ss_pred HHHHHhcCCCCCCCCcHHH---------HHHHHHh--------------------------CCCCCC-----------CC
Q 011868 241 ILYVILTGYLPFDDRNLAV---------LYQKIFR--------------------------GDFKLP-----------KW 274 (476)
Q Consensus 241 il~elltG~~Pf~~~~~~~---------~~~~i~~--------------------------~~~~~p-----------~~ 274 (476)
++|+|++|+.||.+.+... ....+.. ....++ ..
T Consensus 205 ~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (316)
T cd07842 205 IFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKK 284 (316)
T ss_pred HHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccC
Confidence 9999999999997654321 0111000 001111 14
Q ss_pred CCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 275 LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 275 ~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
.++.+.++|.+||+.||++|||+.+++.||||
T Consensus 285 ~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 285 PDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 66789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=332.64 Aligned_cols=253 Identities=30% Similarity=0.579 Sum_probs=218.4
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||+|+||.||+|.+..+|..||+|.+..... .....+.+.+|+.+++.++|+||+++++.+......|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 68999999999999999999999999999999976532 22335678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+++||||||
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~------------------------------ 129 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKS------------------------------ 129 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCH------------------------------
Confidence 999999999987543 579999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCC-EEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 173 NVLQLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~-vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||++++++. +||+|||.+..... .........|++.|+|||++.+..++ .++|+||+||++|+|++|..|
T Consensus 130 -----~nil~~~~~~~~~l~d~~~~~~~~~--~~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p 201 (257)
T cd08225 130 -----QNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHP 201 (257)
T ss_pred -----HHEEEcCCCCeEEecccccchhccC--CcccccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCC
Confidence 9999998864 69999999875432 12223345689999999998777665 889999999999999999999
Q ss_pred CCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 252 FDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
|...+.......+..+.. +.+..++.++.++|.+||..+|++|||+.++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 202 FEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 998877766666555443 3445678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=333.79 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=214.9
Q ss_pred CcCEEEeceEeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
.++|++.+.||+|+||+||+|.+..+ ...||||.++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46799999999999999999998654 4579999987543 333456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||+++++|.+++... +.+++.++..++.|++.|++|||++||+||||||
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p-------------------------- 134 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAA-------------------------- 134 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCc--------------------------
Confidence 9999999999999998653 4799999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT- 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt- 247 (476)
+||++++++.++|+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++
T Consensus 135 ---------~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~ 204 (266)
T cd05033 135 ---------RNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSY 204 (266)
T ss_pred ---------ceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHcc
Confidence 9999999999999999999865421111112223456789999998877775 88999999999999998
Q ss_pred CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 248 GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|..||...........+..+ ..+.+..+++.+.+|+.+||+.+|++||++.+++++
T Consensus 205 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 205 GERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999887777776666654 345566789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=343.09 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=217.7
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
..|+..+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++..+...|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 35778889999999999999998899999999987543 2234578999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||+++++|.+++.. +.+++..++.++.|++.|+.|||++|++|+||+|
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p------------------------------- 129 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKA------------------------------- 129 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCCh-------------------------------
Confidence 99999999998864 5799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+||++++++.++|+|||++...... ........|+..|+|||++.+..++ .++|+|||||++|+|++|+.||.
T Consensus 130 ----~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06642 130 ----ANVLLSEQGDVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred ----heEEEeCCCCEEEccccccccccCc--chhhhcccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999998754321 1122334688999999999887765 88999999999999999999998
Q ss_pred CCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 254 DRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
..+.......+.... ...+...+.++.++|.+||+.+|++|||+.++++||||...
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 203 DLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred ccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 766555444443332 23445578899999999999999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=338.56 Aligned_cols=252 Identities=32% Similarity=0.473 Sum_probs=210.7
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 95 (476)
|++.+.||.|++|+||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.+....|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999976532 223346688899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 96 VTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 96 ~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
+ +++|.+++.... .+++..+..++.|++.||+|||+++++||||+|
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p------------------------------- 127 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKP------------------------------- 127 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCH-------------------------------
Confidence 9 569999987655 699999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+||+++.++.++|+|||++...... ........+++.|+|||++.+....+.++||||+||++|+|++|+.||.
T Consensus 128 ----~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 201 (283)
T cd07835 128 ----QNLLIDREGALKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201 (283)
T ss_pred ----HHEEEcCCCcEEEeecccccccCCC--ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999754321 1122334578999999988765444588999999999999999999998
Q ss_pred CCcHHHHHHHHHhCC--------------------C---------CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCc
Q 011868 254 DRNLAVLYQKIFRGD--------------------F---------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~--------------------~---------~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~ 304 (476)
+.+......++.+.. + .....+++.+.++|.+||++||.+|||+++++.||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 281 (283)
T cd07835 202 GDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHP 281 (283)
T ss_pred CCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCC
Confidence 776544433332210 0 01234678899999999999999999999999999
Q ss_pred cc
Q 011868 305 WF 306 (476)
Q Consensus 305 ~~ 306 (476)
||
T Consensus 282 ~~ 283 (283)
T cd07835 282 YF 283 (283)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=331.59 Aligned_cols=255 Identities=29% Similarity=0.493 Sum_probs=221.8
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|++.+.||+|++|.||+|++..+++.||+|++..... ......+.+|+..++.++||||+++++++......|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 368999999999999999999999999999999976542 144678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
||+++++|.+++.....+++..+..++.|++.|++|||+ .|++||||+|
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~------------------------------ 128 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKP------------------------------ 128 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCH------------------------------
Confidence 999999999999887889999999999999999999999 9999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||+++.++.++|+|||++...... ........++..|+|||.+.+..+ +.++|+||||+++|+|++|..||
T Consensus 129 -----~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~ 200 (264)
T cd06623 129 -----SNLLINSKGEVKIADFGISKVLENT--LDQCNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPF 200 (264)
T ss_pred -----HHEEECCCCCEEEccCccceecccC--CCcccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999998854331 122235568899999999877765 48899999999999999999999
Q ss_pred CCC---cHHHHHHHHHhCC-CCCCCC-CCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 253 DDR---NLAVLYQKIFRGD-FKLPKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 253 ~~~---~~~~~~~~i~~~~-~~~p~~-~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
... ........+.... ...+.. ++..+.++|.+||.++|++|||+.+++.|||++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 201 LPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred ccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 876 3444455554432 344555 7899999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=336.26 Aligned_cols=255 Identities=24% Similarity=0.431 Sum_probs=219.8
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
-|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++.+..+...|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 3778899999999999999998899999999986543 23345788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
|+.+++|.+++.. ..+++..+..++.|++.|+.|||+.|++|+||||
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p-------------------------------- 129 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKA-------------------------------- 129 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCH--------------------------------
Confidence 9999999998864 5799999999999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~ 254 (476)
.||+++.++.++|+|||++...... ........|+..|+|||.+.+..++ .++|+||+||++|+|++|..||..
T Consensus 130 ---~Ni~i~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 130 ---ANVLLSEHGEVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred ---HhEEECCCCCEEEeecccceecccc--hhhhccccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCc
Confidence 9999999999999999998754321 1122345688999999998776664 789999999999999999999987
Q ss_pred CcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 255 RNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 255 ~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
.+.......+.... ..++..++.++.++|.+||+.+|.+||++.++++||||.+..
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 204 LHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred cchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence 77665555554443 335667889999999999999999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=331.62 Aligned_cols=245 Identities=28% Similarity=0.442 Sum_probs=205.4
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 99 (476)
+.||+|+||.||+|++..+++.||+|.+.... ..+....+.+|+.+++.++||||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999998899999999886442 3444678999999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 100 ELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 100 ~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
+|.+++... ..+++.+++.++.|++.||+|||++|++|||||| +
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p-----------------------------------~ 123 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAA-----------------------------------R 123 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccch-----------------------------------h
Confidence 999999754 4689999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCCCCCCCcH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNL 257 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~ 257 (476)
||+++.++.+||+|||++................++..|+|||.+.+..+. .++|||||||++|+|++ |..||...+.
T Consensus 124 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~ 202 (252)
T cd05084 124 NCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSN 202 (252)
T ss_pred eEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence 999999999999999998743221000001111234579999998877764 88999999999999998 9999987776
Q ss_pred HHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 258 AVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 258 ~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
......+... ..+.|..++..+.+|+.+||+.||++|||+.++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 203 QQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6555555443 34566678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=340.91 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=216.5
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
...+|++.+.||+|+||+||+|.+..+++.||+|.+........+....+.+|+.+++.++||||+++++++......|+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 34569999999999999999999988999999999875543344445678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
||||+. |++.+.+.. ...+++..+..++.||+.||.|||+.||+||||+|
T Consensus 93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p---------------------------- 143 (307)
T cd06607 93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKA---------------------------- 143 (307)
T ss_pred EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCc----------------------------
Confidence 999996 577777653 45799999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc---CCCCCccchhhhHhHHHHHHhc
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++.+||+|||++..... .....|++.|+|||++.+ ..+ +.++||||+||++|+|++
T Consensus 144 -------~nIl~~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~-~~~sDv~s~G~il~el~t 209 (307)
T cd06607 144 -------GNILLTEPGTVKLADFGSASLVSP------ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAE 209 (307)
T ss_pred -------ccEEECCCCCEEEeecCcceecCC------CCCccCCccccCceeeeccCCCCC-CcccchHHHHHHHHHHHc
Confidence 999999999999999999874322 234568899999998752 334 478999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCC-CCC-CCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 248 GYLPFDDRNLAVLYQKIFRGD-FKL-PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~-~~~-p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
|+.||.+.+.......+.... ... +..++..+.++|.+||..||++||++.+++.||||....
T Consensus 210 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 210 RKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred CCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 999998877665544444332 222 234688999999999999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=343.06 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=212.0
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCce--EEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~ 86 (476)
...+++|++.+.||+|+||.||+|.+..++.. +|+|.+.... .......+.+|+.++.++ +||||+++++++..+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 46788999999999999999999998877764 5777664322 334457888999999999 899999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMR 150 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~ 150 (476)
+.+|+||||+++++|.+++...+ .+++.+++.++.||+.|++|||++|++||||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp-------- 152 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA-------- 152 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccch--------
Confidence 99999999999999999996432 478999999999999999999999999999997
Q ss_pred hhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCC
Q 011868 151 IATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 230 (476)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 230 (476)
+|||++.++.+||+|||++....... ......++..|+|||++.+..++
T Consensus 153 ---------------------------~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~- 201 (303)
T cd05088 153 ---------------------------RNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYT- 201 (303)
T ss_pred ---------------------------heEEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCc-
Confidence 99999999999999999986322111 11112346689999998776664
Q ss_pred ccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 231 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 231 ~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
.++|||||||++|+|+| |..||.+.+....+..+..+ ....|..+++++.+||.+||+.+|++||++++++.+
T Consensus 202 ~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 202 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88999999999999998 99999988877777666544 233455678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=338.69 Aligned_cols=246 Identities=27% Similarity=0.482 Sum_probs=206.0
Q ss_pred cCcCEEEeceE--eecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 011868 12 RLGRYELGRTL--GEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (476)
Q Consensus 12 ~~~~Y~i~~~L--G~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~ 88 (476)
..++|++.+.+ |+|+||.||++++..++..+|+|++....... .|+.....+ +||||+++++.+...+.
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 45678888776 99999999999999999999999987543211 122222223 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
.|+||||++|++|.+++.....+++.+++.++.|++.||.|||+.|++||||||
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p-------------------------- 137 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL-------------------------- 137 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH--------------------------
Confidence 999999999999999998877899999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCC-CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 169 PWKFNVLQLENILLDSKG-NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g-~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++ .++|+|||++..... .....|+..|+|||++.+..++ .++||||+||++|+|++
T Consensus 138 ---------~nil~~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~ 201 (267)
T PHA03390 138 ---------ENVLYDRAKDRIYLCDYGLCKIIGT------PSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLT 201 (267)
T ss_pred ---------HHEEEeCCCCeEEEecCccceecCC------CccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHH
Confidence 999999998 999999999874321 1234689999999999887775 88999999999999999
Q ss_pred CCCCCCCCcHHHH----HHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC-hHHHhcCcccc
Q 011868 248 GYLPFDDRNLAVL----YQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-IAGIKADEWFE 307 (476)
Q Consensus 248 G~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-~~~il~~~~~~ 307 (476)
|+.||........ .........+.++.+++.+.+||.+||+.||.+||+ ++++++||||+
T Consensus 202 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 202 GKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred CCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 9999986543321 122223344556678999999999999999999996 69999999996
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=339.02 Aligned_cols=258 Identities=30% Similarity=0.442 Sum_probs=211.9
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+++|++.+.||+|++|+||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++......|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 4789999999999999999999998999999999865432 223346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 93 LEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
|||+. ++|.+.+.... .+++..++.++.||+.||+|||++|++||||||
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p---------------------------- 130 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKP---------------------------- 130 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCc----------------------------
Confidence 99995 58888876543 357889999999999999999999999999997
Q ss_pred ccccCCCCceEeCC-CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 171 KFNVLQLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 171 ~~~~~~~~NiLl~~-~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+||+++. ++.+||+|||++...... ........|++.|+|||++.+....+.++||||+||++|+|++|+
T Consensus 131 -------~nill~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~ 201 (294)
T PLN00009 131 -------QNLLIDRRTNALKLADFGLARAFGIP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201 (294)
T ss_pred -------ceEEEECCCCEEEEcccccccccCCC--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999985 457999999999753321 112234467899999999876544458899999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCC--C---------------------C------CCCCCCHHHHHHHHHccCCCcCCCCChHHH
Q 011868 250 LPFDDRNLAVLYQKIFRGD--F---------------------K------LPKWLSPGAQNLLRKILEPNPVKRITIAGI 300 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~--~---------------------~------~p~~~s~~~~~Li~~~L~~dP~~R~s~~~i 300 (476)
.||...+......++.... . . ..+.+++.+.++|.+||+.||.+||++.++
T Consensus 202 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~ 281 (294)
T PLN00009 202 PLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA 281 (294)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHH
Confidence 9998776654444432210 0 0 113367889999999999999999999999
Q ss_pred hcCcccccc
Q 011868 301 KADEWFEQD 309 (476)
Q Consensus 301 l~~~~~~~~ 309 (476)
+.||||...
T Consensus 282 l~~~~~~~~ 290 (294)
T PLN00009 282 LEHEYFKDL 290 (294)
T ss_pred hcCchHhHH
Confidence 999999753
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=328.35 Aligned_cols=253 Identities=34% Similarity=0.595 Sum_probs=223.8
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+++++.++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 69999999999999999999998999999999976543 23446778999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 95 YVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 95 ~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
|+++++|.+.+... ..+++.++..++.|++.||.|||++|++|+||+|
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~---------------------------- 131 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKP---------------------------- 131 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCCh----------------------------
Confidence 99999999999763 6799999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+||+++.++.++|+|||++....... .......|++.|+|||.+.+..+. .++|+||+|+++|+|++|..
T Consensus 132 -------~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~ 201 (258)
T cd08215 132 -------QNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKH 201 (258)
T ss_pred -------HHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCC
Confidence 99999999999999999998654321 234456789999999998877765 78999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 251 PFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
||...+............ .++|..++..+.+++.+||..+|++|||+.+++.||||
T Consensus 202 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 202 PFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 998888777776666554 34566789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=336.66 Aligned_cols=255 Identities=26% Similarity=0.450 Sum_probs=219.2
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
.|.-.+.||+|++|.||+|.+..+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 3555579999999999999998999999999986442 2234668899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
|++|++|.+++.. +++++.++..++.|++.||+|||++|++||||||
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p-------------------------------- 143 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKS-------------------------------- 143 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCh--------------------------------
Confidence 9999999999877 6799999999999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~ 254 (476)
+||+++.++.++|+|||++...... ........|++.|+|||.+.+..++ .++||||+||++|+|++|+.||.+
T Consensus 144 ---~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 144 ---DSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred ---hhEEEcCCCcEEEcccccchhhccC--CcccccccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcC
Confidence 9999999999999999988743321 1122345689999999998877765 889999999999999999999988
Q ss_pred CcHHHHHHHHHhCCCCC---CCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 255 RNLAVLYQKIFRGDFKL---PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 255 ~~~~~~~~~i~~~~~~~---p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
.+......++.....+. +..+++.+.++|++||+.||++|||+.++++||||.+...
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 218 EPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred CCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 87777766666553322 2337889999999999999999999999999999987554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=335.98 Aligned_cols=255 Identities=24% Similarity=0.418 Sum_probs=207.3
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~-l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
++|++.+.||+|+||.||+|++..+|+.||+|.++...... . ...+..|+.+ ++.++||||+++++++..++..|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-E-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-H-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999997654222 2 3445556654 6777899999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~-givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
|||++ |+|.+.+.. ...+++..++.++.||+.||+|||++ +++||||||
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp------------------------- 132 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKP------------------------- 132 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCH-------------------------
Confidence 99995 688777653 34689999999999999999999997 999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc----CCCCCccchhhhHhHHHH
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILY 243 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~sDvwSlGvil~ 243 (476)
+||+++.++.+||+|||++..... ........|+..|+|||++.+ ..+ +.++|+||+||++|
T Consensus 133 ----------~nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~ 198 (283)
T cd06617 133 ----------SNVLINRNGQVKLCDFGISGYLVD---SVAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMI 198 (283)
T ss_pred ----------HHEEECCCCCEEEeeccccccccc---ccccccccCCccccChhhcCCccccccc-CccccchhhHHHHH
Confidence 999999999999999999875432 112233568899999998865 233 47899999999999
Q ss_pred HHhcCCCCCCCCc-HHHHHHHHHhC-CCCCC-CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 244 VILTGYLPFDDRN-LAVLYQKIFRG-DFKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 244 elltG~~Pf~~~~-~~~~~~~i~~~-~~~~p-~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
+|++|+.||.... .......+..+ ...+| ..++.++.++|.+||..+|++||++.+++.||||....
T Consensus 199 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 199 ELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999997532 22333333333 33344 34789999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=335.26 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=214.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
..++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 456899999999999999999997643 4789999986543 233356788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHH
Q 011868 87 SKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQV 156 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~ 156 (476)
...|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p-------------- 147 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAA-------------- 147 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCh--------------
Confidence 9999999999999999998642 2367889999999999999999999999999997
Q ss_pred HHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhh
Q 011868 157 FLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 236 (476)
Q Consensus 157 ~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvw 236 (476)
+||+++.++.+||+|||+++...............++..|+|||.+.+..++ .++|||
T Consensus 148 ---------------------~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~ 205 (277)
T cd05032 148 ---------------------RNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TKSDVW 205 (277)
T ss_pred ---------------------heEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCC-cccchH
Confidence 9999999999999999998754322111223345578899999998777664 889999
Q ss_pred hHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 237 SCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 237 SlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
||||++|+|++ |..||.+.+.......+..+ ..+.|..++..+.++|.+||+.+|++|||+.++++
T Consensus 206 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 206 SFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999998 99999988877777666654 34567778999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=339.80 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=217.1
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 85 (476)
+.+.+|++.+.||+|+||+||+|.+..+ +..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3466799999999999999999987543 5789999997543 33345778999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccch
Q 011868 86 KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHM 149 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~ 149 (476)
....++++||+.+++|.+++... ..+++..+..++.|++.||+|||++||+||||||
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp------- 152 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLAT------- 152 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccch-------
Confidence 99999999999999999998531 3478889999999999999999999999999997
Q ss_pred hhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCC
Q 011868 150 RIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 229 (476)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 229 (476)
+||++++++.+||+|||+++...............+++.|+|||++.+..++
T Consensus 153 ----------------------------~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (283)
T cd05091 153 ----------------------------RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS 204 (283)
T ss_pred ----------------------------hheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCC
Confidence 9999999999999999998754322222223344567899999998777664
Q ss_pred CccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 230 GATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 230 ~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
.++||||+||++|+|++ |..||.+.+.......+..+.. +.|..+++.+.+|+.+||+.+|.+||++++|++.
T Consensus 205 -~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 205 -IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred -cchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 88999999999999998 9999998888888888777654 4577799999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=348.59 Aligned_cols=262 Identities=27% Similarity=0.406 Sum_probs=215.1
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKI 89 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~ 89 (476)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999876432 22335678889999999999999999998753 3578
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp--------------------------- 135 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKP--------------------------- 135 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH---------------------------
Confidence 99999994 69999998777899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccC--CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.+|.+||+|||++........ ........|+..|+|||.+.+....+.++||||+||++|+|++
T Consensus 136 --------~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~ 207 (334)
T cd07855 136 --------SNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLG 207 (334)
T ss_pred --------HHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHc
Confidence 999999999999999999875432111 1122345789999999998764434588999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhC--------------------------CCCC-----CCCCCHHHHHHHHHccCCCcCCCCC
Q 011868 248 GYLPFDDRNLAVLYQKIFRG--------------------------DFKL-----PKWLSPGAQNLLRKILEPNPVKRIT 296 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~--------------------------~~~~-----p~~~s~~~~~Li~~~L~~dP~~R~s 296 (476)
|+.||.+.+.......+... .... .+..++++.++|.+||+.||.+|||
T Consensus 208 g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 287 (334)
T cd07855 208 RRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT 287 (334)
T ss_pred CCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC
Confidence 99999887654332221110 0011 1336889999999999999999999
Q ss_pred hHHHhcCccccccCCC
Q 011868 297 IAGIKADEWFEQDYTP 312 (476)
Q Consensus 297 ~~~il~~~~~~~~~~~ 312 (476)
+++++.||||.+...+
T Consensus 288 ~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 288 VEQALQHPFLAQYHDP 303 (334)
T ss_pred HHHHHhChhhhhccCC
Confidence 9999999999875544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=336.45 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=212.8
Q ss_pred cCcCEEEeceEeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34679999999999999999999876 77899999886543 223346788999999999999999999999988
Q ss_pred CEEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHH
Q 011868 87 SKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~-------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
...|+||||++|++|.+++...+ .+++.++..++.||+.|++|||++|++||||||
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp----------------- 144 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAA----------------- 144 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccch-----------------
Confidence 99999999999999999997643 489999999999999999999999999999997
Q ss_pred HHHHhhhccccccccCCCCceEeCCCC---CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhh
Q 011868 160 TFLLMIVIRPWKFNVLQLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 236 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl~~~g---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvw 236 (476)
+||+++.++ .+||+|||+++...............+++.|+|||++.+..++ .++|||
T Consensus 145 ------------------~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diw 205 (277)
T cd05036 145 ------------------RNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVW 205 (277)
T ss_pred ------------------heEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHH
Confidence 999998765 5999999999854221111111222345689999999877775 899999
Q ss_pred hHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 237 SCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 237 SlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
||||++|+|++ |..||.+.+.......+... ....|..++..+.+++.+||+.||++|||+.++++|
T Consensus 206 slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 206 SFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999997 99999988777666655443 345667789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=309.44 Aligned_cols=257 Identities=31% Similarity=0.489 Sum_probs=221.6
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
.+|.-.++||+|+||+|++|++..+++.||+|.++.+. .++.......+||.+|+.++|.|||+++++..++..+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 46777889999999999999999999999999998765 34455678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 94 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
||| ..+|..+..+ ++.++.+.++.++.|++.|+.|||++++.|||+||
T Consensus 81 e~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkp------------------------------ 129 (292)
T KOG0662|consen 81 EFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKP------------------------------ 129 (292)
T ss_pred HHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCc------------------------------
Confidence 999 5688888765 56799999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLP 251 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~P 251 (476)
+|+|++.+|.+|++|||+|+.+.- ........+-|.+|.+|.++.+.+.++...|+||.|||+.|+.. |++.
T Consensus 130 -----qnllin~ngelkladfglarafgi--pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl 202 (292)
T KOG0662|consen 130 -----QNLLINRNGELKLADFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_pred -----ceEEeccCCcEEecccchhhhcCC--ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence 999999999999999999986543 22233445678999999999998877788999999999999986 9999
Q ss_pred CCCCcHHHHHHHHHhCC--C---------CCC------------------CCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 252 FDDRNLAVLYQKIFRGD--F---------KLP------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~~--~---------~~p------------------~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|.|.+..+...+|+..- + .+| +.++..-++|++++|.-+|.+|++++.+++
T Consensus 203 fpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 203 FPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 99999988888887521 1 011 113445689999999999999999999999
Q ss_pred Ccccccc
Q 011868 303 DEWFEQD 309 (476)
Q Consensus 303 ~~~~~~~ 309 (476)
||||...
T Consensus 283 hpyf~d~ 289 (292)
T KOG0662|consen 283 HPYFSDF 289 (292)
T ss_pred Ccccccc
Confidence 9999753
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=359.97 Aligned_cols=261 Identities=32% Similarity=0.616 Sum_probs=243.7
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
..+.+...+++.+||-|+||.|=++........+|+|++++....+.+..+.+..|-.||..++.|.||++|-.|.+...
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 35667788999999999999999998755555699999999988888888999999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
+|+.||-|-||+|+..+..++.|++.+++.|+..++.|++|||++||+.|||||
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKP-------------------------- 548 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKP-------------------------- 548 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCCh--------------------------
Confidence 999999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+|+++|.+|.+||.|||+|+.. .....+.|.||||.|+|||++.+++.+ ..+|.||||+++|||++|
T Consensus 549 ---------ENllLd~~Gy~KLVDFGFAKki---~~g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G 615 (732)
T KOG0614|consen 549 ---------ENLLLDNRGYLKLVDFGFAKKI---GSGRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTG 615 (732)
T ss_pred ---------hheeeccCCceEEeehhhHHHh---ccCCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcC
Confidence 9999999999999999999854 346778899999999999999999998 889999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCC-----hHHHhcCccccc
Q 011868 249 YLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 308 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-----~~~il~~~~~~~ 308 (476)
.+||.+.+++..|..|.++ ...+|..++..+.+||+++...+|.+|.. +.+|.+|.||..
T Consensus 616 ~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 616 SPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred CCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 9999999999999999997 46789999999999999999999999986 889999999964
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=337.17 Aligned_cols=259 Identities=24% Similarity=0.330 Sum_probs=214.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
..++|++.+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34689999999999999999997542 34589999986543 223345678899999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHH
Q 011868 87 SKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQV 156 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~ 156 (476)
...|+||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp-------------- 147 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAA-------------- 147 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCCh--------------
Confidence 9999999999999999999642 2346678899999999999999999999999997
Q ss_pred HHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhh
Q 011868 157 FLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 236 (476)
Q Consensus 157 ~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvw 236 (476)
+||++++++.+||+|||+++...............++..|+|||.+.+..++ .++|+|
T Consensus 148 ---------------------~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dvw 205 (288)
T cd05061 148 ---------------------RNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TSSDMW 205 (288)
T ss_pred ---------------------heEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCC-hHhHHH
Confidence 9999999999999999998754321111112223457789999998877664 899999
Q ss_pred hHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc------Cccccc
Q 011868 237 SCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA------DEWFEQ 308 (476)
Q Consensus 237 SlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~------~~~~~~ 308 (476)
||||++|+|++ |..||.+.+.......+..+. .+.+...++.+.+++.+||+.||++|||+.++++ ||||..
T Consensus 206 slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 206 SFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 99999999998 899999888777777666553 4556778899999999999999999999999986 777753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=340.91 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=214.2
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE 81 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~ 81 (476)
....++|.+++.||+|+||.||+|++.. ++..+|+|.+..+. .......+.+|+.+++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4455899999999999999999998643 23579999997653 233356788899999999 7999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchh
Q 011868 82 VLASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILK 145 (476)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~ 145 (476)
++...+..|+||||+++|+|.+++... ..++..++..++.|++.||+|||++|++||||||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp--- 168 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA--- 168 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH---
Confidence 999999999999999999999999753 2478899999999999999999999999999997
Q ss_pred ccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc
Q 011868 146 SCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 225 (476)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 225 (476)
+||+++.++.+||+|||++................+++.|+|||++.+
T Consensus 169 --------------------------------~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (307)
T cd05098 169 --------------------------------RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 216 (307)
T ss_pred --------------------------------HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc
Confidence 999999999999999999875432111111122234578999999987
Q ss_pred CCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 226 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 226 ~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
..++ .++|||||||++|+|++ |..||.+.+.......+.... .+.|..++.++.+||.+||..+|.+|||+.+++++
T Consensus 217 ~~~~-~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 217 RIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CCCC-cHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7665 88999999999999998 999999888777776665554 35667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=331.53 Aligned_cols=251 Identities=27% Similarity=0.421 Sum_probs=215.4
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
....|++.+.||+|+||.||+|.+..+++.||+|.+..+. .....+.+|+.+++.++||||+++++++..+..+++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 4567999999999999999999999999999999986542 224678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+|||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp--------------------------- 132 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA--------------------------- 132 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCc---------------------------
Confidence 99999999999998653 3589999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
+||++++++.+||+|||++........ .......++..|+|||.+.+..++ .++|||||||++|+|++ |
T Consensus 133 --------~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g 202 (263)
T cd05052 133 --------RNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYG 202 (263)
T ss_pred --------ceEEEcCCCcEEeCCCcccccccccee-eccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCC
Confidence 999999999999999999975432111 111122345689999998877775 78999999999999998 9
Q ss_pred CCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 249 YLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
..||.+.+.......+..+ ....|..+++++.++|.+||+.||++|||+.++++.
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 203 MSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred CCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 9999988887777776654 445677789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=334.42 Aligned_cols=252 Identities=30% Similarity=0.505 Sum_probs=214.2
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+++|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++++..++..|++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 47899999999999999999999899999999988765444444557889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|||++|++|.+++.. ...+++.+++.++.||+.||.|||++|++|+||||
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p-------------------------- 134 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKP-------------------------- 134 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH--------------------------
Confidence 999999999998863 34689999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+||+++.++.++|+|||++...... .......+|++.|+|||++.+..++ .++|+|||||++|+|++|
T Consensus 135 ---------~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g 202 (267)
T cd08229 135 ---------ANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred ---------HHEEEcCCCCEEECcchhhhccccC--CcccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhC
Confidence 9999999999999999998754331 2223456789999999999887775 789999999999999999
Q ss_pred CCCCCCCcH--HHHHHHHHhCCCC-C-CCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 249 YLPFDDRNL--AVLYQKIFRGDFK-L-PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 249 ~~Pf~~~~~--~~~~~~i~~~~~~-~-p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
..||.+... ......+.....+ . +..+++.+.++|.+||+.||++|||+.+|+.
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 203 QSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred CCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 999976543 3444444433322 2 2458889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=341.85 Aligned_cols=258 Identities=26% Similarity=0.467 Sum_probs=219.2
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
.-|+....||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++.+..+...|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 346667789999999999999988999999999865432 22467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
||+++++|.+.+.. ..+++.+++.++.|++.||+|||++|++||||||
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p------------------------------- 145 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS------------------------------- 145 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH-------------------------------
Confidence 99999999987754 5799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+||+++.++.+||+|||++..... ........+|++.|+|||++.+..++ .++||||+||++|+|++|+.||.
T Consensus 146 ----~Nill~~~~~~kL~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~ 218 (297)
T cd06659 146 ----DSILLTLDGRVKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYF 218 (297)
T ss_pred ----HHeEEccCCcEEEeechhHhhccc--ccccccceecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999874332 11223446799999999999877764 88999999999999999999998
Q ss_pred CCcHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCCCC
Q 011868 254 DRNLAVLYQKIFRGDFK---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 313 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~~~---~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~~~ 313 (476)
..+.......+...... .+..+++.+.++|++||+.+|.+||+++++++||||.+...+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~ 281 (297)
T cd06659 219 SDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPE 281 (297)
T ss_pred CCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcc
Confidence 87766655555443222 2345788999999999999999999999999999998765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=346.70 Aligned_cols=258 Identities=27% Similarity=0.403 Sum_probs=213.2
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----S 87 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~ 87 (476)
..+|.+.+.||+|+||+||+|++..+++.||||.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3589999999999999999999999999999999875432 222345677899999999999999999987644 3
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
..|+||||+ +++|.+.+...+++++..++.++.|++.||.|||++|++||||||
T Consensus 83 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp------------------------- 136 (337)
T cd07858 83 DVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKP------------------------- 136 (337)
T ss_pred cEEEEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCH-------------------------
Confidence 589999999 579999998878899999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++.+||+|||++...... ........++..|+|||++.+....+.++||||+||++|+|++
T Consensus 137 ----------~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 204 (337)
T cd07858 137 ----------SNLLLNANCDLKICDFGLARTTSEK--GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG 204 (337)
T ss_pred ----------HHEEEcCCCCEEECcCccccccCCC--cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHc
Confidence 9999999999999999999854321 1233455789999999998764334589999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhC----------------------------CC---CCCCCCCHHHHHHHHHccCCCcCCCCC
Q 011868 248 GYLPFDDRNLAVLYQKIFRG----------------------------DF---KLPKWLSPGAQNLLRKILEPNPVKRIT 296 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~----------------------------~~---~~p~~~s~~~~~Li~~~L~~dP~~R~s 296 (476)
|+.||.+.+....+..+... .. ...+.+++.+.+||++||+.||.+|||
T Consensus 205 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps 284 (337)
T cd07858 205 RKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT 284 (337)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC
Confidence 99999877644333222110 00 012347889999999999999999999
Q ss_pred hHHHhcCcccccc
Q 011868 297 IAGIKADEWFEQD 309 (476)
Q Consensus 297 ~~~il~~~~~~~~ 309 (476)
++++++||||...
T Consensus 285 ~~ell~h~~~~~~ 297 (337)
T cd07858 285 VEEALAHPYLASL 297 (337)
T ss_pred HHHHHcCcchhhh
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=329.57 Aligned_cols=247 Identities=40% Similarity=0.746 Sum_probs=223.1
Q ss_pred EeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 011868 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (476)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 101 (476)
||+|+||.||.+.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+..+...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999889999999999877554444567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceE
Q 011868 102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181 (476)
Q Consensus 102 ~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiL 181 (476)
.+++.....+++..+..++.|++.|+.|||+.+++|+|||| +||+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p-----------------------------------~ni~ 125 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKP-----------------------------------ENIL 125 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCc-----------------------------------ceEE
Confidence 99998877899999999999999999999999999999997 9999
Q ss_pred eCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHH
Q 011868 182 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 261 (476)
Q Consensus 182 l~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~ 261 (476)
++.++.++|+|||++...... ........|+..|+|||.+.+..++ .++|+||||+++|+|++|..||...+.....
T Consensus 126 ~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~ 202 (250)
T cd05123 126 LDADGHIKLTDFGLAKELSSE--GSRTNTFCGTPEYLAPEVLLGKGYG-KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY 202 (250)
T ss_pred EcCCCcEEEeecCcceecccC--CCcccCCcCCccccChHHhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 999999999999998754321 1234456789999999998777664 7899999999999999999999888877788
Q ss_pred HHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh---HHHhcCccc
Q 011868 262 QKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI---AGIKADEWF 306 (476)
Q Consensus 262 ~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~---~~il~~~~~ 306 (476)
..+.....++|...+..+.++|++||..||++||++ ++++.||||
T Consensus 203 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 203 EKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 888888888888899999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=329.56 Aligned_cols=252 Identities=31% Similarity=0.510 Sum_probs=214.8
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+++|++.+.||+|+||.||+|.+..+|+.||+|.++............+.+|+.++++++|+||+++++.+...+..++|
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 47899999999999999999999889999999998754444444567899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|||+++++|.+++.. ...+++.+++.++.|++.||.|||+.|++||||||
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p-------------------------- 134 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKP-------------------------- 134 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcCh--------------------------
Confidence 999999999998864 34589999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+||+++.++.++|+|||++...... ........|++.|+|||.+.+..++ .++|+||+||++|+|++|
T Consensus 135 ---------~nil~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g 202 (267)
T cd08224 135 ---------ANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred ---------hhEEECCCCcEEEeccceeeeccCC--CcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHC
Confidence 9999999999999999998754321 2223445789999999999887775 889999999999999999
Q ss_pred CCCCCCCc--HHHHHHHHHhCCC-CCCC-CCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 249 YLPFDDRN--LAVLYQKIFRGDF-KLPK-WLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 249 ~~Pf~~~~--~~~~~~~i~~~~~-~~p~-~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+.||.... .......+..+.. +.|. .++..+.++|.+||..+|++|||+.+|+.
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 203 QSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred CCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99996543 3344445444433 3444 67889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=344.99 Aligned_cols=255 Identities=31% Similarity=0.412 Sum_probs=213.3
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----- 87 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----- 87 (476)
-++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467999999999999999999999999999999986543 23333567889999999999999999999987553
Q ss_pred -EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 88 -KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 88 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
.+|+||||+ |++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp------------------------ 146 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKP------------------------ 146 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH------------------------
Confidence 469999999 7899888764 5799999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+||+++.++.+||+|||++..... ......+++.|+|||++.+....+.++|+||+||++|+|+
T Consensus 147 -----------~Nill~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~ 210 (343)
T cd07880 147 -----------GNLAVNEDCELKILDFGLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210 (343)
T ss_pred -----------HHEEEcCCCCEEEeeccccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999999999875322 2234567899999999876443458899999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCCCC-------------------------------CCCCCCHHHHHHHHHccCCCcCCCC
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGDFK-------------------------------LPKWLSPGAQNLLRKILEPNPVKRI 295 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~~~-------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~ 295 (476)
+|+.||.+.+....+.++...... ....+++.+.++|.+||+.||++||
T Consensus 211 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 290 (343)
T cd07880 211 TGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI 290 (343)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCC
Confidence 999999887655444443321110 1235788899999999999999999
Q ss_pred ChHHHhcCccccccC
Q 011868 296 TIAGIKADEWFEQDY 310 (476)
Q Consensus 296 s~~~il~~~~~~~~~ 310 (476)
|+.+++.||||+...
T Consensus 291 t~~~~l~~~~~~~~~ 305 (343)
T cd07880 291 TAAEALAHPYFEEFH 305 (343)
T ss_pred CHHHHhcCccHhhhc
Confidence 999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=357.09 Aligned_cols=234 Identities=26% Similarity=0.435 Sum_probs=207.6
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
++-||.|+.|.||+|+ ..++.||||.++. .-..+|.-|++|+||||+.+.++|.....+|||||||..
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 4569999999999999 4678899998742 223588999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
|.|...+.....+.......+..+|+.||.|||.++|+|||||. -
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKS-----------------------------------P 241 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKS-----------------------------------P 241 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCC-----------------------------------C
Confidence 99999999999999999999999999999999999999999997 8
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 258 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~ 258 (476)
|||++.+..|||+|||-++.... ....-..+||..|||||++.+.+-. .|+|||||||||||||||..||.+-+..
T Consensus 242 NiLIs~~d~VKIsDFGTS~e~~~---~STkMSFaGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdss 317 (904)
T KOG4721|consen 242 NILISYDDVVKISDFGTSKELSD---KSTKMSFAGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSS 317 (904)
T ss_pred ceEeeccceEEeccccchHhhhh---hhhhhhhhhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchh
Confidence 99999999999999999885432 3445578999999999999988775 9999999999999999999999887766
Q ss_pred HHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 259 VLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 259 ~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
.+..-+..+ .++.|..++..++-||+.||+..|..||++.+|+.|
T Consensus 318 AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 318 AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred eeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 544333332 357789999999999999999999999999999988
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=329.51 Aligned_cols=248 Identities=25% Similarity=0.426 Sum_probs=211.3
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
.++|++.+.||+|+||.||+|... .+..+|+|.+...... ...+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 467999999999999999999874 5667999988654321 35688899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||++||+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p----------------------------- 128 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAA----------------------------- 128 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCc-----------------------------
Confidence 999999999999875 35689999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYL 250 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~ 250 (476)
+||+++.++.+||+|||+++...... ........++..|+|||++.+..+. .++||||+||++|+|++ |+.
T Consensus 129 ------~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~ 200 (256)
T cd05114 129 ------RNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKM 200 (256)
T ss_pred ------ceEEEcCCCeEEECCCCCccccCCCc-eeccCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCC
Confidence 99999999999999999987532211 1111122355689999998877775 88999999999999999 999
Q ss_pred CCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 251 PFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
||...+.......+..+.. ..|...+..+.+++.+||+.||.+|||++++++
T Consensus 201 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 201 PFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999888888887776543 346667889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=325.88 Aligned_cols=255 Identities=33% Similarity=0.533 Sum_probs=220.5
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIYMV 92 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~lV 92 (476)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999889999999999766432 34467899999999999999999999999988 899999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|||+++++|.+++.....+++.+++.++.|++.||+|||+.|++|+||+|
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p------------------------------ 129 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKG------------------------------ 129 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCH------------------------------
Confidence 99999999999998877899999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||+++.++.++|+|||.+................++..|+|||.+.+..++ .++||||+|+++|+|++|..||
T Consensus 130 -----~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~ 203 (260)
T cd06606 130 -----ANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG-RAADIWSLGCTVIEMATGKPPW 203 (260)
T ss_pred -----HHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999998865432211123456789999999998777654 8899999999999999999999
Q ss_pred CCCc-HHHHHHHHHh--CCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 253 DDRN-LAVLYQKIFR--GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 253 ~~~~-~~~~~~~i~~--~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
...+ .......+.. .....|...++.+.++|.+||..||.+||++.+++.||||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 204 SELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 8765 3333333332 3345677789999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.78 Aligned_cols=246 Identities=29% Similarity=0.421 Sum_probs=215.3
Q ss_pred ceEeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011868 20 RTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 96 (476)
+.||+|+||.||+|.+... +..||+|++...... .....+.+|+.+++.++|+||+++++++.....+|+||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4799999999999998766 899999999766432 24678999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 97 TGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 97 ~gg~L~~~l~~~---------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
++++|.+++... ..+++.+++.++.|++.||+|||++|++||||||
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p------------------------- 133 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAA------------------------- 133 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCc-------------------------
Confidence 999999999875 7899999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++.+||+|||.+................+++.|+|||.+....++ .++|||||||++|+|++
T Consensus 134 ----------~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~ 202 (262)
T cd00192 134 ----------RNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFT-SKSDVWSFGVLLWEIFT 202 (262)
T ss_pred ----------ceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcc-hhhccHHHHHHHHHHHh
Confidence 9999999999999999999865432211223445678899999998877664 88999999999999999
Q ss_pred -CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 248 -GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 248 -G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|..||.+.+.......+..+ ....|..+++++.+++.+||+.||.+|||+.+++++
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 203 LGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 69999998888777777654 345677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=325.45 Aligned_cols=253 Identities=32% Similarity=0.541 Sum_probs=222.0
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.++++++|||++++++++.+.+..|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 58999999999999999999988999999999977643 22446789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
|+++++|.+++...+.+++..++.++.|++.|+.|||+.||+||||||
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p-------------------------------- 127 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKA-------------------------------- 127 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCH--------------------------------
Confidence 999999999998878899999999999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~ 254 (476)
+||+++.++.++|+|||++...... ........|+..|+|||.+.+..+ +.++||||+|+++|+|++|..||..
T Consensus 128 ---~ni~i~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 128 ---ANILTTKDGVVKLADFGVATKLNDV--SKDDASVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred ---HHEEECCCCCEEEeccccceecCCC--cccccccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999865432 112344578999999999877665 4889999999999999999999987
Q ss_pred CcHHHHHHHHH-hCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 255 RNLAVLYQKIF-RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 255 ~~~~~~~~~i~-~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
.+......+.. .....+|..+++.+.++|.+||..+|++|||+.+++.||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 202 LNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 76554444443 33445677789999999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=331.03 Aligned_cols=249 Identities=31% Similarity=0.486 Sum_probs=208.0
Q ss_pred EeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011868 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (476)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 97 (476)
....||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..|+||||++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 3458999999999999998999999999986543 2335678999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 98 GGELFDKIASK-GRL--QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 98 gg~L~~~l~~~-~~l--~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
+++|.+.+... ..+ ++..+..++.||+.||+|||++||+||||||
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p-------------------------------- 136 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKG-------------------------------- 136 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCH--------------------------------
Confidence 99999999764 455 8889999999999999999999999999997
Q ss_pred CCCCceEeCC-CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC-CCCccchhhhHhHHHHHHhcCCCCC
Q 011868 175 LQLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 175 ~~~~NiLl~~-~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||+++. ++.++|+|||++..... .........|++.|+|||++.+.. ..+.++|+||+||++|+|++|+.||
T Consensus 137 ---~nil~~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~ 211 (268)
T cd06624 137 ---DNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211 (268)
T ss_pred ---HHEEEcCCCCeEEEecchhheeccc--CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCC
Confidence 9999986 67999999999875432 122233446899999999986533 2348899999999999999999999
Q ss_pred CCCcHH--HHHHH-HHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 253 DDRNLA--VLYQK-IFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 253 ~~~~~~--~~~~~-i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
...... ..... .......+|..+++++.+++++||+.+|.+|||+.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 212 IELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 764322 22221 2233445677889999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=332.73 Aligned_cols=251 Identities=27% Similarity=0.375 Sum_probs=209.8
Q ss_pred EEEeceEeecCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE----
Q 011868 16 YELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK---- 88 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~---- 88 (476)
|++++.||+|+||.||.|.... ++..||+|.+..+.. .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 6788999999999999998754 347899999976542 23345789999999999999999999998865443
Q ss_pred --EEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 89 --IYMVLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 89 --~~lV~E~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
.+++|||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp------------------ 141 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAA------------------ 141 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch------------------
Confidence 79999999999999988432 3689999999999999999999999999999997
Q ss_pred HHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhH
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGv 240 (476)
+||++++++.+||+|||+++...............++..|+|||.+.+..++ .++|||||||
T Consensus 142 -----------------~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~SlG~ 203 (273)
T cd05035 142 -----------------RNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGV 203 (273)
T ss_pred -----------------heEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCC-cccchHHHHH
Confidence 9999999999999999999854322111112223456789999998777664 8999999999
Q ss_pred HHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 241 ILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 241 il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
++|+|++ |..||.+.+....+..+..+ ....|..+++.+.++|.+||+.||++|||+.+++++
T Consensus 204 il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 204 TMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999 99999988877777776655 345677799999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=337.19 Aligned_cols=256 Identities=29% Similarity=0.457 Sum_probs=215.7
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL 83 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~ 83 (476)
....++|++.+.||+|+||.||+|..... ...+|+|.+.... .......+.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34556899999999999999999997643 3789999987643 233356788999999999 799999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhcc
Q 011868 84 ASKSKIYMVLEYVTGGELFDKIAS----------------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSC 147 (476)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~l~~----------------~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~ 147 (476)
..++.+|++|||+++|+|.+++.. ...+++..+..++.|++.||+|||+.||+||||||
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp----- 160 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAA----- 160 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccce-----
Confidence 999999999999999999999854 24688999999999999999999999999999997
Q ss_pred chhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC
Q 011868 148 HMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 227 (476)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 227 (476)
+||+++.++.+||+|||++................++..|+|||++.+..
T Consensus 161 ------------------------------~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 210 (293)
T cd05053 161 ------------------------------RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV 210 (293)
T ss_pred ------------------------------eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC
Confidence 99999999999999999998644321111122233567899999987777
Q ss_pred CCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 228 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 228 ~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
++ .++|||||||++|+|++ |..||.+.+....+..+..+. ...|...+..+.+|+.+||..||++|||+.+++++
T Consensus 211 ~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 211 YT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred cC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 75 88999999999999997 999999888777777666553 34566788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=328.32 Aligned_cols=256 Identities=30% Similarity=0.492 Sum_probs=217.2
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI 89 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~ 89 (476)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... ........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 369999999999999999999999999999999864321 1233457899999999999999999999998653 568
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+++|||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||||
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p--------------------------- 134 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKG--------------------------- 134 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCH---------------------------
Confidence 99999999999999998877899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+||+++.++.++|+|||+++....... ........|+..|+|||++.+..++ .++|+|||||++|+|++|
T Consensus 135 --------~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g 205 (264)
T cd06653 135 --------ANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTE 205 (264)
T ss_pred --------HHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhC
Confidence 999999999999999999985432111 1122345689999999999887765 889999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 249 YLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
+.||.+........++... ...+|..+++.+.++|.+||+ +|.+||++.+++.|||.
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 206 KPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred CCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999887665555554433 234677899999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=339.40 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=218.2
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+......|+
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 4579999999999999999999998899999999986443 2234678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|+||+++++|.+++.. ..+++.++..++.|++.|+.|||++|++||||||
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p----------------------------- 143 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS----------------------------- 143 (293)
T ss_pred EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCH-----------------------------
Confidence 9999999999998865 4689999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||+++.++.+||+|||++...... ........|++.|+|||.+.+..++ .++|+|||||++|+|++|+.|
T Consensus 144 ------~Nili~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~ll~~ll~g~~p 214 (293)
T cd06647 144 ------DNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPP 214 (293)
T ss_pred ------HHEEEcCCCCEEEccCcceeccccc--ccccccccCChhhcCchhhccCCCC-chhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999998754332 1223345689999999998877664 789999999999999999999
Q ss_pred CCCCcHHHHHHHHHhC-CC--CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 252 FDDRNLAVLYQKIFRG-DF--KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~-~~--~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
|...+.......+... .. ..+..++..+.++|++||..+|++||++++++.|+||....
T Consensus 215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 215 YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred CCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 9877654433333222 22 22344678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=345.31 Aligned_cols=256 Identities=30% Similarity=0.429 Sum_probs=209.3
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-------
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------- 86 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------- 86 (476)
++|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 789999999999999999999999999999999876542 3356788999999999999999999876543
Q ss_pred -------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHH
Q 011868 87 -------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 87 -------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
...|+||||+. ++|.+.+.. +++++..++.++.||+.||.|||+.||+||||||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp----------------- 142 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKP----------------- 142 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH-----------------
Confidence 35899999996 589888754 5799999999999999999999999999999997
Q ss_pred HHHHhhhccccccccCCCCceEeCC-CCCEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhh
Q 011868 160 TFLLMIVIRPWKFNVLQLENILLDS-KGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 237 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl~~-~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwS 237 (476)
+||+++. ++.+||+|||++........ ........|+..|+|||++.+....+.++||||
T Consensus 143 ------------------~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwS 204 (342)
T cd07854 143 ------------------ANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 204 (342)
T ss_pred ------------------HHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHH
Confidence 9999984 56789999999975432111 112233468899999998766444458899999
Q ss_pred HhHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-------------------------C-----CCCCCCCHHHHHHHHHcc
Q 011868 238 CGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------------------F-----KLPKWLSPGAQNLLRKIL 287 (476)
Q Consensus 238 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------------------~-----~~p~~~s~~~~~Li~~~L 287 (476)
+||++|+|++|+.||.+.+.......+.... . .+.+.++.++.+||++||
T Consensus 205 lGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 284 (342)
T cd07854 205 AGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQIL 284 (342)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHh
Confidence 9999999999999998877654444332210 0 011246788999999999
Q ss_pred CCCcCCCCChHHHhcCcccccc
Q 011868 288 EPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 288 ~~dP~~R~s~~~il~~~~~~~~ 309 (476)
+.||.+|||+.+++.||||+..
T Consensus 285 ~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 285 TFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred CCCchhccCHHHHhCCCccccc
Confidence 9999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=348.04 Aligned_cols=252 Identities=27% Similarity=0.412 Sum_probs=206.4
Q ss_pred cCEEEeceEeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-C
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS-K 86 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~-~ 86 (476)
++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++++ +||||+++++++.. +
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 48999999999999999999743 345789999987543 223356788899999999 79999999998754 4
Q ss_pred CEEEEEEeccCCCChHHHHHhc----------------------------------------------------------
Q 011868 87 SKIYMVLEYVTGGELFDKIASK---------------------------------------------------------- 108 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~---------------------------------------------------------- 108 (476)
..+|++|||+++++|.+++...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 6789999999999999988542
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCC
Q 011868 109 ---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185 (476)
Q Consensus 109 ---~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~ 185 (476)
.++++..+..++.||+.||+|||++||+|||||| +||+++.+
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp-----------------------------------~Nill~~~ 209 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAA-----------------------------------RNILLSEN 209 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc-----------------------------------ceEEEeCC
Confidence 2578999999999999999999999999999997 99999999
Q ss_pred CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHH-
Q 011868 186 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK- 263 (476)
Q Consensus 186 g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~- 263 (476)
+.+||+|||++................++..|+|||++.+..++ .++||||+||++|+|++ |..||.+....+.+..
T Consensus 210 ~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~ 288 (337)
T cd05054 210 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR 288 (337)
T ss_pred CcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH
Confidence 99999999999864322111122334567789999999888886 88999999999999998 9999987654333333
Q ss_pred HHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 264 IFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 264 i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+..+ ....|...++++.+++.+||+.+|++||+++++++|
T Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 289 LKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3332 233456688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=336.66 Aligned_cols=254 Identities=23% Similarity=0.300 Sum_probs=212.4
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCC----------------ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG----------------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~----------------~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hp 74 (476)
...++|++++.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+++.++||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDP 79 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCC
Confidence 34678999999999999999999876543 568999987654 234467899999999999999
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcc
Q 011868 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVI 143 (476)
Q Consensus 75 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~ 143 (476)
||+++++++..++..+++|||+.+++|.+++.... .+++..++.++.|++.||+|||++|++||||||
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp- 158 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT- 158 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch-
Confidence 99999999999999999999999999999997654 689999999999999999999999999999997
Q ss_pred hhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccc
Q 011868 144 LKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 223 (476)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 223 (476)
+||+++.++.++|+|||++................+++.|+|||++
T Consensus 159 ----------------------------------~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 204 (296)
T cd05051 159 ----------------------------------RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV 204 (296)
T ss_pred ----------------------------------hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh
Confidence 9999999999999999998754322111223345577899999998
Q ss_pred ccCCCCCccchhhhHhHHHHHHhc--CCCCCCCCcHHHHHHHHHhC--------CCCCCCCCCHHHHHHHHHccCCCcCC
Q 011868 224 ANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLAVLYQKIFRG--------DFKLPKWLSPGAQNLLRKILEPNPVK 293 (476)
Q Consensus 224 ~~~~~~~~~sDvwSlGvil~ellt--G~~Pf~~~~~~~~~~~i~~~--------~~~~p~~~s~~~~~Li~~~L~~dP~~ 293 (476)
.+..+. .++|||||||++|+|++ |..||...+........... ..+.|..++.++.++|.+||+.||.+
T Consensus 205 ~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 283 (296)
T cd05051 205 LLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEED 283 (296)
T ss_pred hcCCCC-ccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhc
Confidence 876664 89999999999999998 88899877666655554432 12344557889999999999999999
Q ss_pred CCChHHHhc
Q 011868 294 RITIAGIKA 302 (476)
Q Consensus 294 R~s~~~il~ 302 (476)
|||+.+++.
T Consensus 284 Rpt~~el~~ 292 (296)
T cd05051 284 RPTFREIHL 292 (296)
T ss_pred CCCHHHHHH
Confidence 999999954
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=351.43 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=211.8
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~l 91 (476)
-..|++.++||+||.++||++.... ...||+|.+.... .+....+-+.+||..|.+|+ |.+|++|||+-..++.+|+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 3479999999999999999999744 4456666554333 25566789999999999995 9999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 92 VLEYVTGGELFDKIASKGRL-QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l-~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
||||= ..+|...|...... +....+.|..|++.|+.++|..||||-||||
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKP---------------------------- 488 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKP---------------------------- 488 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCc----------------------------
Confidence 99987 56999999876654 3468899999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCC----------CccchhhhHhH
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD----------GATSDIWSCGV 240 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~----------~~~sDvwSlGv 240 (476)
.|+|+- .|.+||+|||+|.........-...+.+||+.|||||.+....+. +.++|||||||
T Consensus 489 -------ANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGC 560 (677)
T KOG0596|consen 489 -------ANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGC 560 (677)
T ss_pred -------ccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhh
Confidence 888874 589999999999976654444456678999999999998754433 57899999999
Q ss_pred HHHHHhcCCCCCCCCc-HHHHHHHHHhCC--CCCCCCCCHH-HHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 241 ILYVILTGYLPFDDRN-LAVLYQKIFRGD--FKLPKWLSPG-AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 241 il~elltG~~Pf~~~~-~~~~~~~i~~~~--~~~p~~~s~~-~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
|||+|+.|++||..-. .-..+..|...+ .++|..-+.. +.++++.||..||++|||+.++|+|||+....
T Consensus 561 ILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 561 ILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred HHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence 9999999999996532 334445555543 3566544444 99999999999999999999999999997543
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=374.28 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=209.9
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+++|++++.||+|+||.||+|.+..+|+.||+|++..+........+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 58999999999999999999999999999999999765444445567899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 93 LEYVTGGELFDKIASK-----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~-----------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
|||++||+|.+++... .+++...+..++.||+.||+|||++||+||||||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKP------------------- 141 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKP------------------- 141 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCch-------------------
Confidence 9999999999988641 2356677889999999999999999999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC----------------CCcccccccCCcccccccccc
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD----------------DGLLHTTCGSPNYVAPEVLAN 225 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~----------------~~~~~~~~gt~~y~APE~l~~ 225 (476)
+||+++.+|.+||+|||++........ .......+||+.|+|||++.+
T Consensus 142 ----------------eNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g 205 (932)
T PRK13184 142 ----------------DNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205 (932)
T ss_pred ----------------heEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC
Confidence 999999999999999999986521100 011123579999999999988
Q ss_pred CCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHH-HhCCCCC--CCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 226 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI-FRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 226 ~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i-~~~~~~~--p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
..++ .++||||+||++|+|+||..||...+........ ....... ...+++.+.+++.+||+.||++|++..+.+.
T Consensus 206 ~~~S-~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 206 VPAS-ESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred CCCC-cHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 7775 8999999999999999999999876554332221 1111111 2347889999999999999999987666544
Q ss_pred C
Q 011868 303 D 303 (476)
Q Consensus 303 ~ 303 (476)
+
T Consensus 285 ~ 285 (932)
T PRK13184 285 Q 285 (932)
T ss_pred H
Confidence 3
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.70 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=213.9
Q ss_pred ccCcCEEEeceEeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 85 (476)
...++|.+.+.||+|+||.||+|.+. .++..+|+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 35678999999999999999999853 345679999886443 2334678999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccch
Q 011868 86 KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHM 149 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~ 149 (476)
....++||||+++++|.+++... +.+++..++.++.||+.|++|||++||+||||||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp------- 151 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLAT------- 151 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCc-------
Confidence 99999999999999999999653 2388999999999999999999999999999997
Q ss_pred hhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCC
Q 011868 150 RIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 229 (476)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 229 (476)
+||+++.++.++|+|||++................|++.|+|||++.+..++
T Consensus 152 ----------------------------~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 203 (291)
T cd05094 152 ----------------------------RNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT 203 (291)
T ss_pred ----------------------------ceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC
Confidence 9999999999999999999754321111122344578899999998887775
Q ss_pred CccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 230 GATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 230 ~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
.++|||||||++|+|++ |..||...+.......+..+... .+..++..+.+++.+||+.||.+|||+.++++
T Consensus 204 -~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 204 -TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred -chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 88999999999999998 99999888877777777665543 45567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=334.61 Aligned_cols=259 Identities=32% Similarity=0.592 Sum_probs=219.6
Q ss_pred CEEEeceEeecCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~ 89 (476)
.|++.+.||+|+||.||+|.+. .+|+.||+|++...... .....+.+.+|+.+++.+ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999975 47899999999764322 223356788999999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||+++++|.+++....++++..+..++.|++.||.|||+.|++||||||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p--------------------------- 133 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKL--------------------------- 133 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH---------------------------
Confidence 99999999999999998888899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccC-CCCCccchhhhHhHHHHHHhcC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~sDvwSlGvil~elltG 248 (476)
+|||++.++.+||+|||++...... .........|+..|+|||.+.+. ...+.++||||+||++|+|++|
T Consensus 134 --------~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g 204 (290)
T cd05613 134 --------ENILLDSNGHVVLTDFGLSKEFHED-EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204 (290)
T ss_pred --------HHeEECCCCCEEEeeCccceecccc-cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcC
Confidence 9999999999999999999754321 12223456789999999998653 2334789999999999999999
Q ss_pred CCCCCCCc----HHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCcccccc
Q 011868 249 YLPFDDRN----LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQD 309 (476)
Q Consensus 249 ~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~~ 309 (476)
..||...+ ...+...+.....++|..+++.+.+++++||+.||++|| ++++++.||||...
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 205 ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred CCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 99997432 334445555566677788999999999999999999997 88999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=333.09 Aligned_cols=255 Identities=29% Similarity=0.458 Sum_probs=212.1
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIYM 91 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~l 91 (476)
++|+..+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++.. .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 57999999999999999999999999999999997653 22345778999999999999999999998854 347899
Q ss_pred EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 92 VLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
||||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~------------------------- 133 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKP------------------------- 133 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH-------------------------
Confidence 9999999999887653 34689999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++.++|+|||++..... .......++..|+|||.+.+..++ .++|||||||++|+|++
T Consensus 134 ----------~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~ 198 (287)
T cd06621 134 ----------SNILLTRKGQVKLCDFGVSGELVN----SLAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQ 198 (287)
T ss_pred ----------HHEEEecCCeEEEeeccccccccc----cccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHh
Confidence 999999999999999999874322 122345688899999998877775 78999999999999999
Q ss_pred CCCCCCCCc-----HHHHHHHHHhCC-CCCC------CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 248 GYLPFDDRN-----LAVLYQKIFRGD-FKLP------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 248 G~~Pf~~~~-----~~~~~~~i~~~~-~~~p------~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
|..||.... .......+.... ..++ ..+++.+.++|.+||+.||.+|||+.+++.||||....
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 199 NRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 999998652 233334433322 1111 12467899999999999999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=351.49 Aligned_cols=251 Identities=34% Similarity=0.655 Sum_probs=220.8
Q ss_pred EEEe--ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 16 YELG--RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 16 Y~i~--~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
|+|. +.||.|.||+||-|+++.+|+.||||+|++.+... +...++++|+.||+.+.||.||.+--.|++..++++||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 5553 68999999999999999999999999999988644 44589999999999999999999999999999999999
Q ss_pred eccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 94 EYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 94 E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|-+ .|+..+.|- ..+++++...+.++.||+.||.|||..+|+|.||||
T Consensus 643 EKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKP----------------------------- 692 (888)
T KOG4236|consen 643 EKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKP----------------------------- 692 (888)
T ss_pred hhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCc-----------------------------
Confidence 999 567777664 357999999999999999999999999999999997
Q ss_pred cccCCCCceEeCCC---CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 172 FNVLQLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 172 ~~~~~~~NiLl~~~---g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
||+|+.+. -.+||||||+|++.. +.....+++|||.|+|||++.+++|. ..-|+||.|||+|.-++|
T Consensus 693 ------ENVLLas~~~FPQvKlCDFGfARiIg---EksFRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSG 762 (888)
T KOG4236|consen 693 ------ENVLLASASPFPQVKLCDFGFARIIG---EKSFRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSG 762 (888)
T ss_pred ------hheeeccCCCCCceeeccccceeecc---hhhhhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecc
Confidence 99999765 379999999999754 35566788999999999999999997 678999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCCC--CC--CCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFKLP--KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~~p--~~--~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
..||... +++-.+|....+-+| +| +++.+.+||..+|+..=.+|.|++..+.|||++..
T Consensus 763 TFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 763 TFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred cccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 9999643 355566666665544 34 89999999999999999999999999999999763
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.69 Aligned_cols=251 Identities=27% Similarity=0.380 Sum_probs=208.1
Q ss_pred EEEeceEeecCceEEEEEEECCCCc--eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------C
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------S 87 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------~ 87 (476)
|.+++.||+|+||.||+|++..++. .||+|.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3578899999999999999877765 699999875432 334467889999999999999999999986432 3
Q ss_pred EEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 88 KIYMVLEYVTGGELFDKIAS------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~------~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
..+++|||+.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp------------------- 140 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAA------------------- 140 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccch-------------------
Confidence 57899999999999988742 23488999999999999999999999999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+|||+++++.+||+|||+++...............+++.|+|||++.+..++ .++|||||||+
T Consensus 141 ----------------~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~i 203 (272)
T cd05075 141 ----------------RNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT-TKSDVWSFGVT 203 (272)
T ss_pred ----------------hheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcC-hHHHHHHHHHH
Confidence 9999999999999999999864321111112233467789999998877775 89999999999
Q ss_pred HHHHhc-CCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 242 LYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 242 l~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+|+|++ |+.||.+......+..+..+.. +.+..++..+.++|.+||+.||++|||+++++++
T Consensus 204 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 204 MWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999 8999998887777777776543 4566688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.20 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=208.1
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~ 85 (476)
.-++|++++.||+|+||.||+|.+... +..||||++.... .......+.+|+.+|+++. ||||+++++++..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 356788999999999999999987433 3469999996543 2333567999999999996 9999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc---------------------------------------------------------
Q 011868 86 KSKIYMVLEYVTGGELFDKIASK--------------------------------------------------------- 108 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~--------------------------------------------------------- 108 (476)
.+.+|+||||+++|+|.+++...
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 99999999999999999988542
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccch
Q 011868 109 ---------------------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHM 149 (476)
Q Consensus 109 ---------------------------------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~ 149 (476)
..+++.++..++.||+.||+|||+.||+||||||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp------- 265 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAA------- 265 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh-------
Confidence 1377888899999999999999999999999997
Q ss_pred hhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCC
Q 011868 150 RIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 229 (476)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 229 (476)
+|||++.++.+||+|||+++...............+++.|+|||++.+..++
T Consensus 266 ----------------------------~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 317 (400)
T cd05105 266 ----------------------------RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT 317 (400)
T ss_pred ----------------------------HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC
Confidence 9999999999999999999754322111222334577899999999887775
Q ss_pred CccchhhhHhHHHHHHhc-CCCCCCCCcHH-HHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 230 GATSDIWSCGVILYVILT-GYLPFDDRNLA-VLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 230 ~~~sDvwSlGvil~ellt-G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
.++|||||||++|+|++ |..||.+.... ..+..+..+ ..+.+..+++++.++|.+||+.||++|||+.++.+
T Consensus 318 -~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 318 -TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred -chhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 89999999999999997 99999876543 333444433 24456678899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=359.45 Aligned_cols=244 Identities=36% Similarity=0.603 Sum_probs=216.5
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~ 90 (476)
....|++...+|.|+||.|..+.+..+++..++|++.+.. .+..+|+.++... +||||+++++++....+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 4567999999999999999999999999999999997762 3345678777666 6999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
+|||++.|+.+.+.+.....+. .++..+++||+.|+.|||++|++||||||
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp---------------------------- 443 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKP---------------------------- 443 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCCh----------------------------
Confidence 9999999999999998766555 88889999999999999999999999997
Q ss_pred ccccCCCCceEe-CCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 171 KFNVLQLENILL-DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 171 ~~~~~~~~NiLl-~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||+ ++.|+++|+|||.++.... ...+.|-|..|+|||++...+|+ .+||+||||++||+||+|+
T Consensus 444 -------~NIL~~~~~g~lrltyFG~a~~~~~-----~~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~ 510 (612)
T KOG0603|consen 444 -------GNILLDGSAGHLRLTYFGFWSELER-----SCDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGR 510 (612)
T ss_pred -------hheeecCCCCcEEEEEechhhhCch-----hhcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCC
Confidence 99999 5899999999999985432 25677899999999999988897 9999999999999999999
Q ss_pred CCCCCCcHH-HHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 250 LPFDDRNLA-VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 250 ~Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
.||...... ++..++..+.+. .++|.++++||++||+.||.+|+++.++..|||+
T Consensus 511 tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 511 TLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred CccccCCchHHHHHhhcCCccc--cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 999865544 666666665544 8899999999999999999999999999999999
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=333.09 Aligned_cols=266 Identities=32% Similarity=0.470 Sum_probs=217.3
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS- 85 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~- 85 (476)
..+..|+++..||+|+||.||+|.-.+++ +.+|||.++.+. ..........||+.++|.++|||++.+..+|-+
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~k-d~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEK-DGTGISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccC-CCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 44668999999999999999999655443 378999997654 234556789999999999999999999999876
Q ss_pred CCEEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 86 KSKIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
+..+|+++||++. +|+..|.- ...++...++.++.||++|+.|||++.|+||||||
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKP------------------ 160 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKP------------------ 160 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCc------------------
Confidence 8899999999965 99998853 23689999999999999999999999999999997
Q ss_pred HHHhhhccccccccCCCCceEeCCC----CCEEEeccCCCCCCCccc-CCCcccccccCCccccccccccCCCCCccchh
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSK----GNIKISDFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 235 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~----g~vkl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDv 235 (476)
.|||+..+ |.|||+|||+++.+...- .-.....++-|.+|+|||.+.+...++.+.||
T Consensus 161 -----------------aNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDv 223 (438)
T KOG0666|consen 161 -----------------ANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDV 223 (438)
T ss_pred -----------------ceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhh
Confidence 99999887 899999999999865421 11223456779999999999998877799999
Q ss_pred hhHhHHHHHHhcCCCCCCCCc---------HHHHHHHHHhC--CC---------CCCCC---------------------
Q 011868 236 WSCGVILYVILTGYLPFDDRN---------LAVLYQKIFRG--DF---------KLPKW--------------------- 274 (476)
Q Consensus 236 wSlGvil~elltG~~Pf~~~~---------~~~~~~~i~~~--~~---------~~p~~--------------------- 274 (476)
||.|||+.||+|-.+.|.+.. ..+...+|+.- .+ .+|++
T Consensus 224 WAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~ 303 (438)
T KOG0666|consen 224 WAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYY 303 (438)
T ss_pred HHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHH
Confidence 999999999999999987632 12334444431 00 12222
Q ss_pred -----CCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCCCC
Q 011868 275 -----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 313 (476)
Q Consensus 275 -----~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~~~ 313 (476)
-++.+.+|+.+||+.||.+|+|++++++|+||..+..|.
T Consensus 304 ~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lpp 347 (438)
T KOG0666|consen 304 HKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLPP 347 (438)
T ss_pred HHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCCC
Confidence 256699999999999999999999999999999886663
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=343.90 Aligned_cols=261 Identities=33% Similarity=0.440 Sum_probs=219.6
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KI 89 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----~~ 89 (476)
+|++.+.||.|+||.||+|++..+++.||||.+.... ........+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6999999999999999999998899999999987643 22334578999999999999999999999987765 78
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|++|||+. ++|.+.+....++++..++.++.||+.||+|||++||+||||||
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp--------------------------- 131 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKP--------------------------- 131 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH---------------------------
Confidence 99999996 58999998877899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+||+++.++.++|+|||++........ ........+++.|+|||++.+....+.++|+||+||++|+|++|
T Consensus 132 --------~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g 203 (330)
T cd07834 132 --------SNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203 (330)
T ss_pred --------HHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcC
Confidence 999999999999999999986543211 11234456899999999998773335899999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCC-------------------------------CCCCCCHHHHHHHHHccCCCcCCCCCh
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFK-------------------------------LPKWLSPGAQNLLRKILEPNPVKRITI 297 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~-------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~s~ 297 (476)
+.||.+.+....+..+...... ..+.+++.+.++|++||+.||.+|||+
T Consensus 204 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 283 (330)
T cd07834 204 KPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA 283 (330)
T ss_pred CCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCH
Confidence 9999988876665554432110 112357889999999999999999999
Q ss_pred HHHhcCccccccCCC
Q 011868 298 AGIKADEWFEQDYTP 312 (476)
Q Consensus 298 ~~il~~~~~~~~~~~ 312 (476)
++++.||||.....+
T Consensus 284 ~~ll~~~~~~~~~~~ 298 (330)
T cd07834 284 DEALAHPYLAQLHDP 298 (330)
T ss_pred HHHHhCccHHhhccc
Confidence 999999999875443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=345.60 Aligned_cols=258 Identities=30% Similarity=0.422 Sum_probs=215.8
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE---
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK--- 88 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~--- 88 (476)
.-++|++.+.||+|+||.||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4568999999999999999999999999999999986543 223345678889999999999999999998765544
Q ss_pred ---EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 89 ---IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 89 ---~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
.|+|+||+ +++|.+++.. .++++..++.++.|++.||+|||+.||+||||||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp----------------------- 146 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKP----------------------- 146 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH-----------------------
Confidence 89999999 7799998875 5799999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||+++.++.+||+|||++..... ......+++.|+|||++.+....+.++||||+||++|+|
T Consensus 147 ------------~Nill~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~el 209 (343)
T cd07851 147 ------------SNIAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred ------------HHeEECCCCCEEEccccccccccc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHH
Confidence 999999999999999999975422 234457889999999987644445899999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCCCC-------------------------------CCCCCCHHHHHHHHHccCCCcCCC
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGDFK-------------------------------LPKWLSPGAQNLLRKILEPNPVKR 294 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~~~-------------------------------~p~~~s~~~~~Li~~~L~~dP~~R 294 (476)
++|+.||.+.+....+..+...... .....++.+.++|++||+.||++|
T Consensus 210 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~R 289 (343)
T cd07851 210 LTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKR 289 (343)
T ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhC
Confidence 9999999887766555544331100 012358899999999999999999
Q ss_pred CChHHHhcCccccccCCC
Q 011868 295 ITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 295 ~s~~~il~~~~~~~~~~~ 312 (476)
||+.+++.||||.+...+
T Consensus 290 pt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 290 ITAAEALAHPYLAEYHDP 307 (343)
T ss_pred CCHHHHhcCCCccccCCC
Confidence 999999999999875443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=332.49 Aligned_cols=253 Identities=32% Similarity=0.502 Sum_probs=212.6
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEE
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIYMVL 93 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 93 (476)
|++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999998764 2334456788999999999999999999999888 8999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 94 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
||++ ++|.+.+... ..+++.+++.++.||+.||+|||+.|++|+||||
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p------------------------------ 128 (287)
T cd07840 80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKG------------------------------ 128 (287)
T ss_pred cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcH------------------------------
Confidence 9996 5898888765 5799999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||++++++.+||+|||++........ .......++..|+|||.+.+....+.++|||||||++|+|++|+.||
T Consensus 129 -----~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~ 202 (287)
T cd07840 129 -----SNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202 (287)
T ss_pred -----HHeEEcCCCCEEEccccceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999985543221 12334567889999998776544458999999999999999999999
Q ss_pred CCCcHHHHHHHHHhCCC-----------------------C--------CCCCCCHHHHHHHHHccCCCcCCCCChHHHh
Q 011868 253 DDRNLAVLYQKIFRGDF-----------------------K--------LPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~~~-----------------------~--------~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il 301 (476)
...+.......+..... . +...+++.+.++|++||..||.+||++.+++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l 282 (287)
T cd07840 203 QGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQAL 282 (287)
T ss_pred CCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 88776655554433110 0 0111378899999999999999999999999
Q ss_pred cCccc
Q 011868 302 ADEWF 306 (476)
Q Consensus 302 ~~~~~ 306 (476)
.||||
T Consensus 283 ~~~~~ 287 (287)
T cd07840 283 QHEYF 287 (287)
T ss_pred hCcCC
Confidence 99997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=336.16 Aligned_cols=259 Identities=25% Similarity=0.437 Sum_probs=217.7
Q ss_pred ccCCccCcCEEEeceEeecCceEEEEEEEC-------CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcce
Q 011868 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVR 78 (476)
Q Consensus 7 ~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~ 78 (476)
+.-.+..++|++.+.||+|+||.||+|++. ..+..||+|.+.... .......+.+|+.+++.+ +||||++
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~ 85 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 85 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchh
Confidence 445677789999999999999999999753 234579999986543 233357789999999999 7999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCc
Q 011868 79 LHEVLASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKV 142 (476)
Q Consensus 79 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp 142 (476)
+++++......|+||||+.+|+|.+++... ..++..++..++.||+.||.|||++|++||||||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 999999999999999999999999999753 2477888999999999999999999999999997
Q ss_pred chhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccc
Q 011868 143 ILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 222 (476)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~ 222 (476)
+||+++.++.+||+|||+++...............+++.|+|||+
T Consensus 166 -----------------------------------~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 210 (304)
T cd05101 166 -----------------------------------RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEA 210 (304)
T ss_pred -----------------------------------ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchh
Confidence 999999999999999999985433222222233456788999999
Q ss_pred cccCCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHH
Q 011868 223 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 300 (476)
Q Consensus 223 l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~i 300 (476)
+.+..++ .++|||||||++|+|++ |..||.+.+...+...+..+. ...|..++..+.+||.+||+.+|++|||+.++
T Consensus 211 ~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 289 (304)
T cd05101 211 LFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289 (304)
T ss_pred hccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 9887775 88999999999999998 899999888888777776543 34566688999999999999999999999999
Q ss_pred hcC
Q 011868 301 KAD 303 (476)
Q Consensus 301 l~~ 303 (476)
++.
T Consensus 290 l~~ 292 (304)
T cd05101 290 VED 292 (304)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=327.95 Aligned_cols=245 Identities=26% Similarity=0.378 Sum_probs=206.8
Q ss_pred ceEeecCceEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011868 20 RTLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 97 (476)
++||+|+||+||+|.. ..++..+|+|++.... .+....+.+.+|+.+++.++||||+++++++.. ...++||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCC
Confidence 3689999999999964 4578899999986543 234456789999999999999999999998864 46789999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCC
Q 011868 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177 (476)
Q Consensus 98 gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 177 (476)
+|+|.+++.....+++..+..++.|++.||+|||++||+||||||
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp----------------------------------- 123 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAA----------------------------------- 123 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccch-----------------------------------
Confidence 999999998777899999999999999999999999999999997
Q ss_pred CceEeCCCCCEEEeccCCCCCCCcccCC-CcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCCCCCCC
Q 011868 178 ENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR 255 (476)
Q Consensus 178 ~NiLl~~~g~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~ 255 (476)
.||+++.++.+||+|||++......... .......+++.|+|||.+....++ .++|+|||||++|+|++ |..||.+.
T Consensus 124 ~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 124 RNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS-SKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred hhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999754321110 011223346799999998766664 78999999999999998 99999988
Q ss_pred cHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 256 NLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 256 ~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+.......+..+. .+.|..+++++.++|.+||+.||++||++++|..
T Consensus 203 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 203 KGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 8777777776654 4567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=331.13 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=211.8
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
+...+|++.+.||+|+||+||+|.+..+|+ .||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 456789999999999999999999877776 48999986543 334457789999999999999999999998754
Q ss_pred CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
..+++|||+++|+|.+.+.. .+.+++.++..++.|++.||+|||++||+||||||
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp----------------------- 137 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAA----------------------- 137 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecccccc-----------------------
Confidence 57899999999999999976 35699999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+|||+++++.+||+|||+++...............+++.|+|||++.+..++ .++|||||||++|||
T Consensus 138 ------------~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el 204 (279)
T cd05109 138 ------------RNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWEL 204 (279)
T ss_pred ------------ceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHH
Confidence 9999999999999999999865432111112223356789999999887775 889999999999999
Q ss_pred hc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 246 LT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 246 lt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
++ |..||...........+..+. .+.+..++.++.++|.+||+.||++||++.+++.
T Consensus 205 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 205 MTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 98 999998877666665555543 3456678999999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=369.97 Aligned_cols=151 Identities=31% Similarity=0.589 Sum_probs=141.2
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
.+++|+++++||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.....+|+
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 36899999999999999999999999999999999987665556667889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP----------------------------- 132 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKP----------------------------- 132 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccH-----------------------------
Confidence 999999999999998777899999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSA 197 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~ 197 (476)
+|||++.++.+||+|||+++
T Consensus 133 ------~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 133 ------DNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred ------HHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=341.74 Aligned_cols=264 Identities=30% Similarity=0.393 Sum_probs=215.9
Q ss_pred CcCEEE-eceEeecCceEEEEEEECCCCceEEEEEeecccccchh-----------HHHHHHHHHHHHHhCCCCCcceEE
Q 011868 13 LGRYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----------ITDQIKREIATLKLLKHPNVVRLH 80 (476)
Q Consensus 13 ~~~Y~i-~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~-----------~~~~~~~Ei~~l~~l~HpnIv~l~ 80 (476)
-++|.. .+.||+|+||+||+|.+..+++.||||.+......... ....+.+|+.+++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 457865 46799999999999999999999999998654322100 112577899999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 81 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
+++......|+||||+. |+|.+.+.....+++..+..++.|++.||.|||+.|++||||||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~------------------ 147 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSP------------------ 147 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccH------------------
Confidence 99999999999999996 69999998877899999999999999999999999999999997
Q ss_pred HHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcc------------cCCCcccccccCCccccccccccCCC
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHF------------RDDGLLHTTCGSPNYVAPEVLANRGY 228 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~------------~~~~~~~~~~gt~~y~APE~l~~~~~ 228 (476)
+||+++.++.+||+|||++...... ..........+++.|+|||.+.+...
T Consensus 148 -----------------~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 210 (335)
T PTZ00024 148 -----------------ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEK 210 (335)
T ss_pred -----------------HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCC
Confidence 9999999999999999998754310 01112233457889999999876554
Q ss_pred CCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--C-------------------C-------CCCCCCHHHH
Q 011868 229 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--F-------------------K-------LPKWLSPGAQ 280 (476)
Q Consensus 229 ~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~-------------------~-------~p~~~s~~~~ 280 (476)
.+.++|+||+||++|+|++|..||.+.+....+..+.... . . .....+..+.
T Consensus 211 ~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (335)
T PTZ00024 211 YHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAI 290 (335)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHH
Confidence 4688999999999999999999999887665555443210 0 0 0123578899
Q ss_pred HHHHHccCCCcCCCCChHHHhcCccccccCCC
Q 011868 281 NLLRKILEPNPVKRITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 281 ~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~~ 312 (476)
++|.+||+.||++|||+++++.||||.....+
T Consensus 291 ~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 291 DLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 99999999999999999999999999876444
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=334.80 Aligned_cols=250 Identities=28% Similarity=0.426 Sum_probs=210.6
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCc--eEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~ 89 (476)
+++|++.+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++++ +||||+++++++...+.+
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 4789999999999999999999877665 46888876322 233356789999999999 799999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhH
Q 011868 90 YMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIAT 153 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~ 153 (476)
|+||||+++++|.+++... ..+++.+++.++.|++.||+|||++||+||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp----------- 147 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAA----------- 147 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCc-----------
Confidence 9999999999999999653 2488899999999999999999999999999997
Q ss_pred HHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccc
Q 011868 154 LQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 233 (476)
Q Consensus 154 ~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~s 233 (476)
+|||++.++.+||+|||++....... .......+..|+|||++.+..++ .++
T Consensus 148 ------------------------~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~ 199 (297)
T cd05089 148 ------------------------RNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYT-TKS 199 (297)
T ss_pred ------------------------ceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCC-chh
Confidence 99999999999999999986422110 11112234579999998877775 889
Q ss_pred hhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 234 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 234 DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|||||||++|+|++ |..||.+.+......++..+. ...|..+++.+.+||.+||+.||.+|||++++++.
T Consensus 200 DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 200 DVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999997 999999988887777776553 34566789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=342.78 Aligned_cols=257 Identities=31% Similarity=0.446 Sum_probs=211.4
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------ 86 (476)
-++|++.+.||+|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 3789999999999999999999999999999999976432 223356788999999999999999999988643
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
...|++++++ |++|.+.+.. ..+++..++.++.|++.||+|||++||+||||||
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp------------------------ 148 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKP------------------------ 148 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCh------------------------
Confidence 3478999988 8899887764 4699999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+||+++.++.+||+|||++.... .......|++.|+|||++.+....+.++||||+||++|+|+
T Consensus 149 -----------~NIll~~~~~~kl~dfg~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~ 212 (345)
T cd07877 149 -----------SNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212 (345)
T ss_pred -----------HHEEEcCCCCEEEeccccccccc-----ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999987432 22334578999999999876443458899999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCCC-----------------------CCC--------CCCCHHHHHHHHHccCCCcCCCC
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGDF-----------------------KLP--------KWLSPGAQNLLRKILEPNPVKRI 295 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~~-----------------------~~p--------~~~s~~~~~Li~~~L~~dP~~R~ 295 (476)
+|+.||.+.+.......+..... ..| ...++++.+||.+||+.||.+||
T Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 292 (345)
T cd07877 213 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 292 (345)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC
Confidence 99999987665444333322110 001 12578899999999999999999
Q ss_pred ChHHHhcCccccccCCC
Q 011868 296 TIAGIKADEWFEQDYTP 312 (476)
Q Consensus 296 s~~~il~~~~~~~~~~~ 312 (476)
|+.+++.||||.+...+
T Consensus 293 t~~e~l~h~~f~~~~~~ 309 (345)
T cd07877 293 TAAQALAHAYFAQYHDP 309 (345)
T ss_pred CHHHHhcChhhhhcCCC
Confidence 99999999999875443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=336.00 Aligned_cols=255 Identities=26% Similarity=0.413 Sum_probs=212.2
Q ss_pred CccCcCEEEeceEeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL 83 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~ 83 (476)
....++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 456678999999999999999999852 345689999987543 233457789999999999 799999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 84 ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
...+..|+||||+++|+|.+++.... .+++.++..++.|++.||+|||++||+||||||
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp------------------- 169 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAA------------------- 169 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhcc-------------------
Confidence 99999999999999999999997543 389999999999999999999999999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+||+++.++.+||+|||++................+++.|+|||++.+..++ .++||||+||+
T Consensus 170 ----------------~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvi 232 (302)
T cd05055 170 ----------------RNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIL 232 (302)
T ss_pred ----------------ceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHH
Confidence 9999999999999999999854332111112233467889999998877775 88999999999
Q ss_pred HHHHhc-CCCCCCCCcHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 242 LYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 242 l~ellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+|+|++ |..||.+.+....+.+..... ...|...++.+.+++.+||+++|++|||+.++++
T Consensus 233 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 233 LWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999998 999998877655444444332 2345668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.38 Aligned_cols=248 Identities=26% Similarity=0.426 Sum_probs=214.2
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
-..|++++.||.|+||.||+|.+.. +..+|+|++.... ......+.+|+.+++.++||||+++++++......|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3569999999999999999999976 8899999987653 22356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 93 LEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
|||+++++|.+++... ..+++.+++.++.||+.||.|||++|++||||||
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~---------------------------- 132 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAA---------------------------- 132 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCc----------------------------
Confidence 9999999999999753 4689999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GY 249 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~ 249 (476)
+||++++++.+||+|||++...... ........++..|+|||++.+..+. .++|||||||++|+|++ |+
T Consensus 133 -------~nilv~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~ 202 (261)
T cd05148 133 -------RNILVGEDLVCKVADFGLARLIKED--VYLSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQ 202 (261)
T ss_pred -------ceEEEcCCceEEEccccchhhcCCc--cccccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCC
Confidence 9999999999999999999754321 1112234467789999998877665 88999999999999998 89
Q ss_pred CCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 250 LPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
.||.+.+....+..+..+ ..+.|..+++.+.++|.+||+.||.+|||+.++++
T Consensus 203 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 203 VPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999988877777776654 34556778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=337.10 Aligned_cols=259 Identities=30% Similarity=0.450 Sum_probs=209.5
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK---- 86 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~---- 86 (476)
..+++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 347899999999999999999999999999999999875432 222234677899999999999999999987433
Q ss_pred ----CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 87 ----SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 87 ----~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
..+|+||||+. ++|...+.. ...+++.+++.++.||++||+|||++||+||||||
T Consensus 84 ~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p------------------- 143 (311)
T cd07866 84 KRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKA------------------- 143 (311)
T ss_pred cccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH-------------------
Confidence 35799999995 577777754 34799999999999999999999999999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC---------CcccccccCCccccccccccCCCCCcc
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD---------GLLHTTCGSPNYVAPEVLANRGYDGAT 232 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~---------~~~~~~~gt~~y~APE~l~~~~~~~~~ 232 (476)
+||++++++.+||+|||++......... .......|++.|+|||++.+....+.+
T Consensus 144 ----------------~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 207 (311)
T cd07866 144 ----------------ANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA 207 (311)
T ss_pred ----------------HHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCch
Confidence 9999999999999999999754322110 112234678899999998765444588
Q ss_pred chhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC-----------------------CC-------CCCCHHHHHH
Q 011868 233 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----------------------LP-------KWLSPGAQNL 282 (476)
Q Consensus 233 sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------------~p-------~~~s~~~~~L 282 (476)
+||||+||++|+|++|+.||.+.+.......+...... .+ ..+++.+.++
T Consensus 208 ~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (311)
T cd07866 208 VDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDL 287 (311)
T ss_pred hHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHH
Confidence 99999999999999999999988876655554331100 00 1244678999
Q ss_pred HHHccCCCcCCCCChHHHhcCccc
Q 011868 283 LRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 283 i~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
|.+||+.||.+|||+.+++.||||
T Consensus 288 i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 288 LSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHcccCcccCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=336.73 Aligned_cols=256 Identities=27% Similarity=0.437 Sum_probs=213.9
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE 81 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~ 81 (476)
....++|.+++.||+|+||.||+|++.. .+..||+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3455789999999999999999998642 34579999987543 233456788999999999 6999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchh
Q 011868 82 VLASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILK 145 (476)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~ 145 (476)
++...+.+|++|||+++|+|.+++... ..++..++..++.||+.||.|||++|++||||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp--- 162 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA--- 162 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc---
Confidence 999999999999999999999999653 2488899999999999999999999999999997
Q ss_pred ccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc
Q 011868 146 SCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 225 (476)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 225 (476)
+||+++.++.+||+|||+++...............++..|+|||++.+
T Consensus 163 --------------------------------~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 210 (314)
T cd05099 163 --------------------------------RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD 210 (314)
T ss_pred --------------------------------eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc
Confidence 999999999999999999985432211111222234568999999887
Q ss_pred CCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 226 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 226 ~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
..++ .++|||||||++|+|++ |..||.+.+....+..+..+. ...|..++.++.++|.+||+.||++|||+.++++.
T Consensus 211 ~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 211 RVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred CCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7665 88999999999999999 999999888877777776654 34566788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=332.24 Aligned_cols=252 Identities=28% Similarity=0.407 Sum_probs=212.6
Q ss_pred cCcCEEEeceEeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
...+|++.++||+|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4567899999999999999999743 356789999886542 34457899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKG---------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRI 151 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~---------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~ 151 (476)
...|++|||+++++|.+++.... .+++..++.++.||+.|++|||++|++||||||
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp--------- 150 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLAT--------- 150 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccH---------
Confidence 99999999999999999987542 488999999999999999999999999999997
Q ss_pred hHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCc
Q 011868 152 ATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 231 (476)
Q Consensus 152 ~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~ 231 (476)
+||++++++.+||+|||++................+++.|+|||++.+..++ .
T Consensus 151 --------------------------~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~ 203 (280)
T cd05092 151 --------------------------RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-T 203 (280)
T ss_pred --------------------------hhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-c
Confidence 9999999999999999998743221111112233457889999998887775 8
Q ss_pred cchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 232 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 232 ~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
++|||||||++|+|++ |..||...+.......+..+. ...|..+++.+.++|.+||+.||.+||+++++++
T Consensus 204 ~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 204 ESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 8999999999999998 999998877777776666553 4556778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=365.29 Aligned_cols=247 Identities=32% Similarity=0.550 Sum_probs=207.7
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEE-EEe---C---
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEV-LAS---K--- 86 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~-~~~---~--- 86 (476)
+++|.+.|.+|||+.||+|++...|..||+|++-.. ++...+.+.+||.+|++|+ |+|||.++|. ... +
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 578889999999999999999888899999998655 4556789999999999997 9999999993 321 1
Q ss_pred CEEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeccCCcchhccchhhhHHHHHHHHHH
Q 011868 87 SKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKVILKSCHMRIATLQVFLLTFL 162 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~al~yLH~~g--ivHrDiKp~~~~~~~~~~~~~~~~~~~~ 162 (476)
-.++|.||||.||.|.|++.. ..+|+|.++.+||.|++.||++||..+ |+|||||-
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKi-------------------- 174 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKI-------------------- 174 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhh--------------------
Confidence 257899999999999999974 357999999999999999999999987 99999996
Q ss_pred HhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCC--c-----ccccccCCccccccccc---cCCCCCcc
Q 011868 163 LMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDG--L-----LHTTCGSPNYVAPEVLA---NRGYDGAT 232 (476)
Q Consensus 163 ~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~--~-----~~~~~gt~~y~APE~l~---~~~~~~~~ 232 (476)
|||||+.+|+.||||||-|+-........ . .-....|+-|+|||++. +.+. +.|
T Consensus 175 ---------------ENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eK 238 (738)
T KOG1989|consen 175 ---------------ENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEK 238 (738)
T ss_pred ---------------hheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cch
Confidence 99999999999999999987432221100 0 01234789999999874 4445 599
Q ss_pred chhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHccCCCcCCCCChHHHhcCc
Q 011868 233 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAGIKADE 304 (476)
Q Consensus 233 sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~ 304 (476)
+|||+|||+||-|+....||++... ..|..+.+.+|+ .++..+.+||+.||++||.+||++.|++.+-
T Consensus 239 sDIWALGclLYkLCy~t~PFe~sg~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 239 SDIWALGCLLYKLCYFTTPFEESGK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred hHHHHHHHHHHHHHHhCCCcCcCcc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 9999999999999999999987633 256778888775 5899999999999999999999999988653
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=342.19 Aligned_cols=263 Identities=31% Similarity=0.422 Sum_probs=214.8
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC--
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK-- 86 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~-- 86 (476)
....++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 3456789999999999999999999988999999998865422 222345677899999999 999999999988643
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
...|+||||+. ++|.+.+... .+++..++.++.||+.||+|||+.||+||||||
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p------------------------ 135 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKP------------------------ 135 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH------------------------
Confidence 46899999996 5999988765 789999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC---CcccccccCCccccccccccCCCCCccchhhhHhHHHH
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD---GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ 243 (476)
+||+++.+|.+||+|||++......... .......||+.|+|||++.+....+.++|||||||++|
T Consensus 136 -----------~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~ 204 (337)
T cd07852 136 -----------SNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILG 204 (337)
T ss_pred -----------HHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHH
Confidence 9999999999999999999865332211 23334568999999999876554458899999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHHhCC---------------------------C----CCCCCCCHHHHHHHHHccCCCcC
Q 011868 244 VILTGYLPFDDRNLAVLYQKIFRGD---------------------------F----KLPKWLSPGAQNLLRKILEPNPV 292 (476)
Q Consensus 244 elltG~~Pf~~~~~~~~~~~i~~~~---------------------------~----~~p~~~s~~~~~Li~~~L~~dP~ 292 (476)
+|++|+.||.+........++.... . ...+.++.++.++|.+||+.||+
T Consensus 205 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~ 284 (337)
T cd07852 205 EMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPN 284 (337)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcc
Confidence 9999999998766544333322110 0 01122688999999999999999
Q ss_pred CCCChHHHhcCccccccC
Q 011868 293 KRITIAGIKADEWFEQDY 310 (476)
Q Consensus 293 ~R~s~~~il~~~~~~~~~ 310 (476)
+|||+.++++|||+.+..
T Consensus 285 ~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 285 KRLTAEEALEHPYVAQFH 302 (337)
T ss_pred cccCHHHHhhChhhhhhc
Confidence 999999999999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=331.89 Aligned_cols=248 Identities=34% Similarity=0.532 Sum_probs=206.0
Q ss_pred EEeceEeecCceEEEEEEEC----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 17 ELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
.+.+.||.|+||.||+|... ..+..|+||++.... ..+..+.+.+|+..+++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999987 356789999995432 344478899999999999999999999999988889999
Q ss_pred EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 93 LEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
|||+++|+|.+++... ..+++.+...++.||+.||.|||+++++||||++
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~---------------------------- 131 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSP---------------------------- 131 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SG----------------------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc----------------------------
Confidence 9999999999999876 6899999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GY 249 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~ 249 (476)
.||++++++.+||+|||++................+...|+|||.+.+..++ .++||||||+++|||++ |+
T Consensus 132 -------~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~ksDVysfG~~l~ei~~~~~ 203 (259)
T PF07714_consen 132 -------SNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYT-KKSDVYSFGMLLYEILTLGK 203 (259)
T ss_dssp -------GGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEES-HHHHHHHHHHHHHHHHTTSS
T ss_pred -------cccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccc
Confidence 9999999999999999999754221111222344577899999998887764 89999999999999999 78
Q ss_pred CCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 250 LPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
.||.+.+...+..++.++. .+.|..++..+.++|.+||..||.+|||+.+|++
T Consensus 204 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 204 FPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp GTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ccccccccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999988888888876654 3456678999999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=326.16 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=210.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ....+.+|+.++++++||||+++++++...+..|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 3467999999999999999999974 567899999865432 14668899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 92 VLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
||||+++++|.+++.... .+++.++..++.|++.|+.|||+.|++||||||
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p--------------------------- 131 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAA--------------------------- 131 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCc---------------------------
Confidence 999999999999997643 699999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
+||++++++.+||+|||++........ .......++..|+|||++.+..++ .++|||||||++|+|++ |
T Consensus 132 --------~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g 201 (261)
T cd05068 132 --------RNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIKWTAPEAALYNRFS-IKSDVWSFGILLTEIVTYG 201 (261)
T ss_pred --------ceEEEcCCCCEEECCcceEEEccCCcc-cccCCCcCceeccCccccccCCCC-chhhHHHHHHHHHHHHhcC
Confidence 999999999999999999985432110 011112234579999998877765 88999999999999999 9
Q ss_pred CCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 249 YLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+.||.+.+.......+... ..+.+...+..+.+++.+||+.||.+||++.+++.
T Consensus 202 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 202 RMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 9999988877777666544 23456668899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=327.49 Aligned_cols=253 Identities=22% Similarity=0.368 Sum_probs=213.0
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
..+.|++.+.||+|+||.||+|.+..+++ .||||.+.... .......+.+|+.+++.++||||+++++++..+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 35679999999999999999999877665 59999986543 34446789999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.|+||||+++++|.+++.. .+.+++.+++.++.|++.||.|||++|++||||||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p------------------------- 134 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAA------------------------- 134 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCh-------------------------
Confidence 9999999999999999875 35689999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccc---cCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC---GSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~---gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+||+++.++.+||+|||++................ ++..|+|||.+.+..++ .++||||+||++|+
T Consensus 135 ----------~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e 203 (269)
T cd05065 135 ----------RNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWE 203 (269)
T ss_pred ----------heEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHH
Confidence 99999999999999999987543321111111111 24579999999877775 78999999999999
Q ss_pred Hhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 245 ILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 245 llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|++ |..||.+.+.......+... ..+.+..++..+.+++.+||..+|.+||++.+++.
T Consensus 204 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 204 VMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 886 99999888777776666543 23455668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=326.52 Aligned_cols=250 Identities=25% Similarity=0.413 Sum_probs=210.8
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
...++|+++++||+|+||.||+|.+ .++..||+|.+..... ..+.+.+|+.+++.++||||+++++.+...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 3467899999999999999999997 4567799998865431 2467899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
++|||+++++|.+++.. ...++....+.++.|++.||+|||+.|++||||||
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p-------------------------- 131 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRA-------------------------- 131 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccch--------------------------
Confidence 99999999999999865 34688999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT- 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt- 247 (476)
+||+++.++.+||+|||++....... ........++..|+|||++.+..++ .++|||||||++|+|++
T Consensus 132 ---------~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~t~ 200 (261)
T cd05072 132 ---------ANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTY 200 (261)
T ss_pred ---------hhEEecCCCcEEECCCccceecCCCc-eeccCCCccceecCCHHHhccCCCC-hhhhhhhhHHHHHHHHcc
Confidence 99999999999999999998643211 1111223456789999998777664 78999999999999998
Q ss_pred CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 248 GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|..||.+.+.......+... ..+.+..++.++.+++.+||..||++|||++++..
T Consensus 201 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 201 GKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999888777666666544 23344557899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=326.45 Aligned_cols=249 Identities=24% Similarity=0.413 Sum_probs=210.4
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
.++|++.+.||+|+||+||+|... .+..+|+|.+..... ..+.+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 467999999999999999999874 455699999875432 135688999999999999999999999988899999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||+.+|+|.+++... ..+++.+++.++.||+.||+|||+.|++||||||
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p----------------------------- 128 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAA----------------------------- 128 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCc-----------------------------
Confidence 9999999999999763 4689999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYL 250 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~ 250 (476)
.||+++.++.+||+|||+++....... .......++..|+|||++.+..++ .++|||||||++|+|++ |..
T Consensus 129 ------~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~ 200 (256)
T cd05113 129 ------RNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKM 200 (256)
T ss_pred ------ceEEEcCCCCEEECCCccceecCCCce-eecCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCC
Confidence 999999999999999999875422110 011122355689999999877665 78999999999999998 999
Q ss_pred CCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 251 PFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
||...+.......+..+.. ..+...++.+.+++.+||+.||.+|||+.+++.+
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 201 PYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 9998887777777766543 3456678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=332.73 Aligned_cols=250 Identities=29% Similarity=0.394 Sum_probs=210.1
Q ss_pred CEEEeceEeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+..++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 23579999886543 223357789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchh
Q 011868 90 YMVLEYVTGGELFDKIASK------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILK 145 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~ 145 (476)
|++|||+.+++|.+++... .++++.++..++.|++.||+|||++|++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp--- 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA--- 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh---
Confidence 9999999999999988642 2478899999999999999999999999999997
Q ss_pred ccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc
Q 011868 146 SCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 225 (476)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 225 (476)
+||++++++.+||+|||+++...............++..|+|||++.+
T Consensus 156 --------------------------------~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 203 (290)
T cd05045 156 --------------------------------RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD 203 (290)
T ss_pred --------------------------------heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc
Confidence 999999999999999999975432211111233456778999999877
Q ss_pred CCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 226 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 226 ~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
..++ .++|||||||++|+|++ |..||.+.....+...+... ..+.|..++.++.+++.+||+.||.+||++.++++
T Consensus 204 ~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 204 HIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 7665 88999999999999998 99999988877766665543 34456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=335.12 Aligned_cols=259 Identities=30% Similarity=0.494 Sum_probs=211.6
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-- 87 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-- 87 (476)
....++|++.+.||+|+||.||+|.+..+|+.||+|.++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 3457889999999999999999999999999999999976532 2223456788999999999999999999987654
Q ss_pred --------EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHH
Q 011868 88 --------KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFL 158 (476)
Q Consensus 88 --------~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~ 158 (476)
.+|+|+||+++ ++.+.+... ..+++.+++.++.||+.||+|||+.||+||||||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p---------------- 144 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKC---------------- 144 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH----------------
Confidence 79999999975 777777653 4699999999999999999999999999999997
Q ss_pred HHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhH
Q 011868 159 LTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 238 (476)
Q Consensus 159 ~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSl 238 (476)
+||++++++.+||+|||++........ .......++..|+|||++.+....+.++||||+
T Consensus 145 -------------------~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 204 (302)
T cd07864 145 -------------------SNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 204 (302)
T ss_pred -------------------HHEEECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHH
Confidence 999999999999999999985433211 122234568899999988765444588999999
Q ss_pred hHHHHHHhcCCCCCCCCcHHHHHHHHHhC---CCC---------------------------CCCCCCHHHHHHHHHccC
Q 011868 239 GVILYVILTGYLPFDDRNLAVLYQKIFRG---DFK---------------------------LPKWLSPGAQNLLRKILE 288 (476)
Q Consensus 239 Gvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~---------------------------~p~~~s~~~~~Li~~~L~ 288 (476)
||++|+|++|+.||...+....+..+... ..+ ....+++.+.++|.+||+
T Consensus 205 G~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 284 (302)
T cd07864 205 GCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLT 284 (302)
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHcc
Confidence 99999999999999877665544443321 000 011367899999999999
Q ss_pred CCcCCCCChHHHhcCccc
Q 011868 289 PNPVKRITIAGIKADEWF 306 (476)
Q Consensus 289 ~dP~~R~s~~~il~~~~~ 306 (476)
.||.+|||+.+++.||||
T Consensus 285 ~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 285 LDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CChhhCCCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=329.57 Aligned_cols=254 Identities=20% Similarity=0.313 Sum_probs=209.6
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCce----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
...++|++.+.||+|+||+||+|.+..+++. ||+|.+.... .......+..|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~- 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG- 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence 4567899999999999999999998777764 6777764332 22334678889999999999999999998754
Q ss_pred CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
...++++||+++|+|.+++.. .+.+++..+..++.||+.||+|||++|++||||||
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp----------------------- 137 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAA----------------------- 137 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCc-----------------------
Confidence 567899999999999999975 45789999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||+++.++.+||+|||+++...............++..|+|||++.+..++ .++|||||||++|+|
T Consensus 138 ------------~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el 204 (279)
T cd05111 138 ------------RNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEM 204 (279)
T ss_pred ------------ceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHH
Confidence 9999999999999999999854322212223345577899999999877775 899999999999999
Q ss_pred hc-CCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 246 LT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 246 lt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
++ |..||.+.........+..+.. +.|..++.++.+++.+||..||.+|||+.++++.
T Consensus 205 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 205 MSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 98 9999998876665555554443 3455578899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=331.95 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=213.6
Q ss_pred cCcCEEEeceEeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45689999999999999999998743 67899999987543 234457799999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcch
Q 011868 87 SKIYMVLEYVTGGELFDKIASK----------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVIL 144 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~----------------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~ 144 (476)
...|++|||+++|+|.+++... ..+++.+++.++.||+.||+|||++|++||||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p-- 158 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT-- 158 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH--
Confidence 9999999999999999999642 2478888999999999999999999999999997
Q ss_pred hccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccc
Q 011868 145 KSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 224 (476)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 224 (476)
+||+++.++.++|+|||++................++..|+|||++.
T Consensus 159 ---------------------------------~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (288)
T cd05050 159 ---------------------------------RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF 205 (288)
T ss_pred ---------------------------------hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHh
Confidence 99999999999999999987432211111122234567899999988
Q ss_pred cCCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 225 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 225 ~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+..++ .++|||||||++|+|++ |..||.+.+.......+..+.. +.|..+++++.+||.+||+.||++|||+.++++
T Consensus 206 ~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 206 YNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred cCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77775 88999999999999997 9999988888777777766654 356678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=326.48 Aligned_cols=249 Identities=23% Similarity=0.424 Sum_probs=209.7
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
..+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 346899999999999999999875 566899999865432 135678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||++|++|.+++.. ...+++..++.++.||+.|++|||++|++||||||
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p----------------------------- 128 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAA----------------------------- 128 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccH-----------------------------
Confidence 999999999999875 34689999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYL 250 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~ 250 (476)
+||+++.++.+||+|||+++...... ........++..|+|||.+.+..++ .++|||||||++|+|++ |..
T Consensus 129 ------~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~ 200 (256)
T cd05059 129 ------RNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKM 200 (256)
T ss_pred ------hhEEECCCCcEEECCcccceeccccc-ccccCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCC
Confidence 99999999999999999987532110 0011112234579999999887775 78999999999999999 899
Q ss_pred CCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 251 PFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
||...+.......+... ....|...++.+.+++.+||..+|++|||+.++++.
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 201 PYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99887777776666554 345566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=333.71 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=214.0
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
.|...++||+|+||+||+|++..+|+.||+|.+.............+.+|+.+++.++|||++++++++......|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 47778899999999999999999999999999976544344445678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 95 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
|+. |+|.+.+.. ..++++.++..++.||+.|+.|||++|++||||||
T Consensus 102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p------------------------------- 149 (313)
T cd06633 102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA------------------------------- 149 (313)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCh-------------------------------
Confidence 995 578777754 45799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc---CCCCCccchhhhHhHHHHHHhcCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+||+++.++.+||+|||++... .......|+..|+|||++.. ..+ +.++|||||||++|+|++|..
T Consensus 150 ----~nili~~~~~~kL~dfg~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~sDv~slGvil~el~~g~~ 218 (313)
T cd06633 150 ----GNILLTEPGQVKLADFGSASKS------SPANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKP 218 (313)
T ss_pred ----hhEEECCCCCEEEeecCCCccc------CCCCCccccccccChhhccccCCCCC-CchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999998632 12234578999999999842 334 478999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhCCCC-C-CCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 251 PFDDRNLAVLYQKIFRGDFK-L-PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~~~-~-p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
||.+.+......++.....+ . ...++..+.+||.+||+.+|.+||++.+++.||||...
T Consensus 219 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 219 PLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred CCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 99887766555555444332 1 23467889999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=323.88 Aligned_cols=251 Identities=32% Similarity=0.533 Sum_probs=221.1
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|++.+.||+|+||.||++.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 589999999999999999999999999999999765432 2335677889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 95 YVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 95 ~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
|+++++|.+++.. ...+++..++.++.|++.||+|||+.|++||||+|
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~---------------------------- 131 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKS---------------------------- 131 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCc----------------------------
Confidence 9999999998865 35689999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+||+++.++.+||+|||++...... ......|++.|+|||.+.+..++ .++|+||+|+++|+|++|+.
T Consensus 132 -------~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~ 199 (256)
T cd08530 132 -------ANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAP 199 (256)
T ss_pred -------ceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999865432 33345689999999999877765 78999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 251 PFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
||...+.......+....++ .+..++.++.++|.+||+.+|.+|||+.++++||++
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 200 PFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 99998877776666665543 556688999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=319.00 Aligned_cols=249 Identities=32% Similarity=0.528 Sum_probs=214.9
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
.|++.+.||+|++|.||+|.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++......|+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999988999999999976542 346789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 95 YVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 95 ~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
|++|++|.+++... ..+++..+..++.|++.|+.|||++|++||||+|
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p------------------------------- 126 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKA------------------------------- 126 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCH-------------------------------
Confidence 99999999998775 5799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+||+++.++.++|+|||.+....... ......|+..|+|||.+.+..+ +.++|+||+|+++|+|++|+.||.
T Consensus 127 ----~ni~i~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~ 198 (253)
T cd05122 127 ----ANILLTSDGEVKLIDFGLSAQLSDTK---ARNTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYS 198 (253)
T ss_pred ----HHEEEccCCeEEEeeccccccccccc---cccceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999987543321 1345678999999999887765 488999999999999999999998
Q ss_pred CCcHHHHHHHHHhC-CCCCCCC--CCHHHHHHHHHccCCCcCCCCChHHHhcCcc
Q 011868 254 DRNLAVLYQKIFRG-DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEW 305 (476)
Q Consensus 254 ~~~~~~~~~~i~~~-~~~~p~~--~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~ 305 (476)
..+.......+... ....+.. ++..+.++|.+||+.||++|||+.+++.|||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 199 ELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 87544433333322 2223322 4889999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=334.70 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=216.2
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
.|+..+.||+|+||.||+|++..++..||+|.+........+....+.+|+.+++.++|||++++++++..+...|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 48889999999999999999999999999999976544445556789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 95 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
|+. |+|.+.+.. ..++++.++..++.|++.||.|||++||+||||+|
T Consensus 106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p------------------------------- 153 (317)
T cd06635 106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA------------------------------- 153 (317)
T ss_pred CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCc-------------------------------
Confidence 996 478777754 56799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc--CCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||+++.++.+||+|||++..... .....|++.|+|||++.. .+..+.++||||+||++|+|++|+.|
T Consensus 154 ----~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p 223 (317)
T cd06635 154 ----GNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223 (317)
T ss_pred ----ccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999874322 234578999999999742 22234789999999999999999999
Q ss_pred CCCCcHHHHHHHHHhCCCC-C-CCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 252 FDDRNLAVLYQKIFRGDFK-L-PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~~~~-~-p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|.+.+.......+.....+ . +..+++.+.++|.+||+.+|.+||++.++++|+|+...
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 224 LFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred CCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 9887766666666554432 2 33478899999999999999999999999999999654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=330.61 Aligned_cols=255 Identities=29% Similarity=0.478 Sum_probs=220.6
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
....|++.+.||+|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||+++++.+......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45679999999999999999999988899999999976542 35678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
++||++|++|.+++.... .+++..+..++.|++.||+|||+.|++|+||||
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p---------------------------- 144 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKS---------------------------- 144 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCh----------------------------
Confidence 999999999999998765 899999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+||+++.++.++|+|||++...... ........+++.|+|||++.+..++ .++|+||+||++|+|++|+.
T Consensus 145 -------~ni~i~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~ 214 (286)
T cd06614 145 -------DNILLSKDGSVKLADFGFAAQLTKE--KSKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEP 214 (286)
T ss_pred -------hhEEEcCCCCEEECccchhhhhccc--hhhhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCC
Confidence 9999999999999999988643321 1122345688999999998877765 88999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhCCC-CC--CCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 251 PFDDRNLAVLYQKIFRGDF-KL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~~-~~--p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
||...+.......+..... .. +..++..+.++|.+||+.+|.+|||+.+++.|+||.+
T Consensus 215 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 215 PYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred CCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 9988776655554443332 22 2337889999999999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=342.21 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=206.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~ 85 (476)
..++|++.+.||+|+||+||+|.+ ..+++.||||+++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 456899999999999999999984 3567899999997543 223356788999999999 68999999998764
Q ss_pred -CCEEEEEEeccCCCChHHHHHhc--------------------------------------------------------
Q 011868 86 -KSKIYMVLEYVTGGELFDKIASK-------------------------------------------------------- 108 (476)
Q Consensus 86 -~~~~~lV~E~~~gg~L~~~l~~~-------------------------------------------------------- 108 (476)
....|+||||+++|+|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 45689999999999999998642
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCC
Q 011868 109 -----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177 (476)
Q Consensus 109 -----------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 177 (476)
..++..++..++.||+.||+|||++||+||||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp----------------------------------- 207 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAA----------------------------------- 207 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCcc-----------------------------------
Confidence 1367788899999999999999999999999997
Q ss_pred CceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCCCCCCCc
Q 011868 178 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 256 (476)
Q Consensus 178 ~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~ 256 (476)
+||+++.++.+||+|||++.............+..+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+..
T Consensus 208 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 208 RNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred CeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 9999999999999999999754321111122234466789999998887775 88999999999999997 999998765
Q ss_pred HH-HHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 257 LA-VLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 257 ~~-~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
.. .....+..+ ..+.|.+.++++.+++.+||+.||++|||+.++++|
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 287 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 33 233333333 345677789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=325.65 Aligned_cols=252 Identities=23% Similarity=0.393 Sum_probs=211.5
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
.++|++.+.||+|+||.||+|.+..++. .+|+|.++... .......+.+|+.+++.++||||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999865543 79999986543 233457889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||+++++|.+++... +.+++.++..++.|++.|++|||++|++||||||
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp-------------------------- 134 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAA-------------------------- 134 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhch--------------------------
Confidence 9999999999999999764 4689999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCC-cccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++ .++|+|||||++|++++
T Consensus 135 ---------~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~ell~ 204 (267)
T cd05066 135 ---------RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMS 204 (267)
T ss_pred ---------hcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccC-chhhhHHHHHHHHHHhc
Confidence 99999999999999999998654321111 11112235689999999877764 89999999999999886
Q ss_pred -CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 248 -GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 248 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|..||.+.+.......+.++. .+.+..+++.+.+++.+||+.+|.+||++.++++
T Consensus 205 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 205 YGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 999998877766666666542 3444557899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=332.82 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=205.9
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCC--------------ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcce
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSG--------------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~--------------~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~ 78 (476)
.++|++.+.||+|+||.||+|++..++ ..||+|.+.... .......+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 468999999999999999999875432 358999987543 2344567999999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhc
Q 011868 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKG------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKS 146 (476)
Q Consensus 79 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~ 146 (476)
+++++......|+||||+.+++|.+++.... .+++..+..++.|++.||+|||++|++||||||
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp---- 157 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT---- 157 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh----
Confidence 9999999999999999999999999985431 367889999999999999999999999999997
Q ss_pred cchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccC
Q 011868 147 CHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 226 (476)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 226 (476)
+||+++.++.+||+|||++................+++.|+|||++.+.
T Consensus 158 -------------------------------~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 206 (295)
T cd05097 158 -------------------------------RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG 206 (295)
T ss_pred -------------------------------hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC
Confidence 9999999999999999998753221111122334457799999998877
Q ss_pred CCCCccchhhhHhHHHHHHhc--CCCCCCCCcHHHHHHHHHh-----C---CCCCCCCCCHHHHHHHHHccCCCcCCCCC
Q 011868 227 GYDGATSDIWSCGVILYVILT--GYLPFDDRNLAVLYQKIFR-----G---DFKLPKWLSPGAQNLLRKILEPNPVKRIT 296 (476)
Q Consensus 227 ~~~~~~sDvwSlGvil~ellt--G~~Pf~~~~~~~~~~~i~~-----~---~~~~p~~~s~~~~~Li~~~L~~dP~~R~s 296 (476)
.++ .++|||||||++|+|++ |..||...+.......+.. . ....++.+++.+.+||.+||+.||++|||
T Consensus 207 ~~~-~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs 285 (295)
T cd05097 207 KFT-TASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT 285 (295)
T ss_pred CcC-chhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcC
Confidence 764 89999999999999988 7789987766554443321 1 12234557899999999999999999999
Q ss_pred hHHHhc
Q 011868 297 IAGIKA 302 (476)
Q Consensus 297 ~~~il~ 302 (476)
+++|++
T Consensus 286 ~~~i~~ 291 (295)
T cd05097 286 FNKIHH 291 (295)
T ss_pred HHHHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=339.70 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=204.6
Q ss_pred ceEeec--CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011868 20 RTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (476)
Q Consensus 20 ~~LG~G--~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 97 (476)
..||+| +||+||+|++..+|+.||+|++..... ..+..+.+.+|+.+++.++||||+++++++...+..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 999999999999999999999976543 23445789999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccC
Q 011868 98 GGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVL 175 (476)
Q Consensus 98 gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 175 (476)
+++|.+++... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp--------------------------------- 129 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKA--------------------------------- 129 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH---------------------------------
Confidence 99999998763 3589999999999999999999999999999997
Q ss_pred CCCceEeCCCCCEEEeccCCCCCCCcccCC-C----cccccccCCccccccccccC--CCCCccchhhhHhHHHHHHhcC
Q 011868 176 QLENILLDSKGNIKISDFGLSALPQHFRDD-G----LLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 176 ~~~NiLl~~~g~vkl~DFGla~~~~~~~~~-~----~~~~~~gt~~y~APE~l~~~--~~~~~~sDvwSlGvil~elltG 248 (476)
+||+++.++.++++|||.+......... . ......++..|+|||++.+. .+ +.++||||+||++|+|++|
T Consensus 130 --~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~~l~el~~g 206 (328)
T cd08226 130 --SHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGY-NVKSDIYSVGITACELATG 206 (328)
T ss_pred --HHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCC-CchhhHHHHHHHHHHHHhC
Confidence 9999999999999999865422111000 0 01112356789999998764 34 4889999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCC-----------------------------------------------CCCCCCHHHHH
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFK-----------------------------------------------LPKWLSPGAQN 281 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~-----------------------------------------------~p~~~s~~~~~ 281 (476)
+.||.+................ .+..+++.+.+
T Consensus 207 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (328)
T cd08226 207 RVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQN 286 (328)
T ss_pred CCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHH
Confidence 9999876654443333222110 11225678999
Q ss_pred HHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 282 LLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 282 Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
||++||+.||++|||++++++||||....
T Consensus 287 li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 287 LVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred HHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 99999999999999999999999997644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=332.61 Aligned_cols=254 Identities=25% Similarity=0.371 Sum_probs=207.2
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~l 91 (476)
.+.|+..+.||+|+||.||++.+..+++.||+|.+..... ......+.+|+.++.++. ||||+++++++..+...|+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 4567788899999999999999999999999999876542 233567889999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 92 VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 92 V~E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~al~yLH~~-givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
+|||+. +++.++.. ....+++..+..++.|++.||+|||+. |++||||||
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp----------------------- 136 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKP----------------------- 136 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCH-----------------------
Confidence 999985 46555332 235799999999999999999999975 999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccC---CCCCccchhhhHhHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVIL 242 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~~~~~sDvwSlGvil 242 (476)
+||+++.++.+||+|||++..... ........|++.|+|||++.+. .+ +.++||||+||++
T Consensus 137 ------------~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~Di~slG~il 200 (288)
T cd06616 137 ------------SNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSARDGY-DVRSDVWSLGITL 200 (288)
T ss_pred ------------HHEEEccCCcEEEeecchhHHhcc---CCccccccCccCccCHHHhccccccCC-cchhhhhHHHHHH
Confidence 999999999999999999874322 1222344689999999998776 34 4889999999999
Q ss_pred HHHhcCCCCCCCCcH-HHHHHHHHhCCC-CCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 243 YVILTGYLPFDDRNL-AVLYQKIFRGDF-KLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 243 ~elltG~~Pf~~~~~-~~~~~~i~~~~~-~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
|+|++|+.||...+. .....++..+.. ..+ ..+++++.+||.+||+.||++|||++++++||||..
T Consensus 201 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 201 YEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred HHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 999999999976542 122223322222 222 237889999999999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=332.37 Aligned_cols=255 Identities=26% Similarity=0.435 Sum_probs=215.3
Q ss_pred EEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011868 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (476)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 96 (476)
+-..+||+|+||.||+|.+..+++.||||.+.... ......+.+|+.+++.++|+||+++++.+......|+||||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 33467999999999999999999999999885432 233567899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCC
Q 011868 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQ 176 (476)
Q Consensus 97 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 176 (476)
++++|.+++.. .++++..++.++.|++.||+|||+.|++||||||
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p---------------------------------- 144 (292)
T cd06657 100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS---------------------------------- 144 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH----------------------------------
Confidence 99999987754 5789999999999999999999999999999997
Q ss_pred CCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCc
Q 011868 177 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 256 (476)
Q Consensus 177 ~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~ 256 (476)
+||+++.++.++|+|||++...... ........|++.|+|||.+.+..+. .++|+||+||++|+|++|..||.+.+
T Consensus 145 -~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 145 -DSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred -HHEEECCCCCEEEcccccceecccc--cccccccccCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999988643321 1122345689999999998776664 88999999999999999999998877
Q ss_pred HHHHHHHHHhCC---CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCCCC
Q 011868 257 LAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 313 (476)
Q Consensus 257 ~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~~~ 313 (476)
.......+.... ......+++.+.++|.+||+.||.+||++.+++.||||.+...|.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 221 PLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred HHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence 665554443322 222344788999999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=336.48 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=210.4
Q ss_pred CEEEeceEeecCceEEEEEEECCC--CceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CC
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS----KS 87 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~----~~ 87 (476)
+|++.+.||+|+||.||+|++..+ +..||+|.+..... .......+.+|+.+++++ .||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999887 89999999865321 222356778899999999 59999999997543 24
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.+|++|||+ +++|.+.+....++++..++.++.||+.||+|||+.||+||||||
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp------------------------- 133 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKP------------------------- 133 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH-------------------------
Confidence 688999999 469999998878899999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC--CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||+++.++.+||+|||++........ ........||+.|+|||++.+....+.++||||+||++|+|
T Consensus 134 ----------~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l 203 (332)
T cd07857 134 ----------GNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203 (332)
T ss_pred ----------HHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999999975432211 11233457899999999876643334889999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhC-------------------------C---CCC---CCCCCHHHHHHHHHccCCCcCCC
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRG-------------------------D---FKL---PKWLSPGAQNLLRKILEPNPVKR 294 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~-------------------------~---~~~---p~~~s~~~~~Li~~~L~~dP~~R 294 (476)
++|..||.+.+.......+... . ..+ ....+..+.+||.+||+.||.+|
T Consensus 204 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 283 (332)
T cd07857 204 LGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKR 283 (332)
T ss_pred HhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccC
Confidence 9999999876644333322211 0 001 12257889999999999999999
Q ss_pred CChHHHhcCccccccCCC
Q 011868 295 ITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 295 ~s~~~il~~~~~~~~~~~ 312 (476)
||+.+++.|||+.+...+
T Consensus 284 ~t~~~ll~~~~~~~~~~~ 301 (332)
T cd07857 284 ISVEEALEHPYLAIWHDP 301 (332)
T ss_pred CCHHHHhcChhhhhhcCc
Confidence 999999999999876443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=325.35 Aligned_cols=247 Identities=25% Similarity=0.390 Sum_probs=207.6
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
.++|++.++||+|+||.||+|++..+ ..||+|++..... ....+.+|+.+++.++||||+++++++. ....|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 46899999999999999999998655 4599999975432 1357889999999999999999999875 4568999
Q ss_pred EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 93 LEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.|++||||||
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p---------------------------- 130 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA---------------------------- 130 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCc----------------------------
Confidence 9999999999999753 3589999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GY 249 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~ 249 (476)
+||+++.++.+||+|||++....... ........++..|+|||++.+..++ .++||||+||++|+|++ |.
T Consensus 131 -------~Nill~~~~~~~L~dfg~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~ 201 (262)
T cd05071 131 -------ANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGR 201 (262)
T ss_pred -------ccEEEcCCCcEEeccCCceeeccccc-cccccCCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCC
Confidence 99999999999999999997543211 1112234567789999998777775 88999999999999999 99
Q ss_pred CCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 250 LPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
.||.+.+.......+..+. .+.+..++..+.++|.+||+.||++||++.++++
T Consensus 202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 202 VPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 9998887777666665442 3445668899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=337.32 Aligned_cols=257 Identities=26% Similarity=0.439 Sum_probs=214.1
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCC-------CceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDS-------GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE 81 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~ 81 (476)
.+...+|++++.||+|+||.||+|++... +..||+|.+.... .......+.+|+.+++++ +||||+++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 34445899999999999999999986432 2368999886542 333457899999999999 7999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchh
Q 011868 82 VLASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILK 145 (476)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~ 145 (476)
++...+..|++|||+++|+|.+++... ..++..++..++.|++.||+|||++|++||||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp--- 162 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA--- 162 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc---
Confidence 999999999999999999999998753 2477888999999999999999999999999997
Q ss_pred ccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc
Q 011868 146 SCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 225 (476)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 225 (476)
+||+++.++.+||+|||+++...............++..|+|||++.+
T Consensus 163 --------------------------------~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 210 (334)
T cd05100 163 --------------------------------RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD 210 (334)
T ss_pred --------------------------------ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc
Confidence 999999999999999999975432211111222334568999999988
Q ss_pred CCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 226 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 226 ~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
..++ .++|||||||++|+|++ |..||.+.+.......+..+. .+.|..++.++.+||.+||+.+|.+|||+.+++.+
T Consensus 211 ~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 211 RVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7775 88999999999999998 999999988888777776543 34566788999999999999999999999999886
Q ss_pred c
Q 011868 304 E 304 (476)
Q Consensus 304 ~ 304 (476)
-
T Consensus 290 l 290 (334)
T cd05100 290 L 290 (334)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=325.76 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=214.3
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
...++|++.+.||+|+||+||+|.+..+|+ .||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 345789999999999999999999876665 58999887654 23345778999999999999999999999987
Q ss_pred CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
...++||||+++|+|.+++... ..+++..+..++.||+.||+|||++|++||||||
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p----------------------- 137 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAA----------------------- 137 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCc-----------------------
Confidence 7899999999999999999764 4699999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||+++.++.+||+|||+++...............++..|+|||.+....++ .++|+|||||++|++
T Consensus 138 ------------~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el 204 (279)
T cd05057 138 ------------RNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWEL 204 (279)
T ss_pred ------------ceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHH
Confidence 9999999999999999999864421111111222345789999998777665 889999999999999
Q ss_pred hc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 246 LT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 246 lt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
++ |..||.+.+...+...+..+. .+.|...+..+.+++.+||..||..|||+.++++
T Consensus 205 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 205 MTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred hcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 98 999999988877777776653 4566678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=324.32 Aligned_cols=248 Identities=26% Similarity=0.400 Sum_probs=209.0
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||.||+|.+. .+..||+|.+..... . ...+.+|+.++++++||||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-S---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-C---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 4568999999999999999999874 566799999876442 1 356889999999999999999999875 456899
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+|||+++++|.+++... ..+++.+++.++.|++.||+|||++|++||||||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p--------------------------- 130 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRS--------------------------- 130 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCcc---------------------------
Confidence 99999999999998753 3589999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
+||++++++.++|+|||++....... ........++..|+|||++.+..++ .++|+|||||++|+|++ |
T Consensus 131 --------~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~g 200 (260)
T cd05070 131 --------ANILVGDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKG 200 (260)
T ss_pred --------ceEEEeCCceEEeCCceeeeeccCcc-cccccCCCCCccccChHHHhcCCCc-chhhhHHHHHHHHHHHhcC
Confidence 99999999999999999997543211 1111223356689999998776664 88999999999999999 9
Q ss_pred CCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 249 YLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
..||.+.+.......+..+ ..+.|...+..+.+|+.+||.+||++|||++++.+
T Consensus 201 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 201 RVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999988877777776654 44567778999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=338.54 Aligned_cols=253 Identities=31% Similarity=0.444 Sum_probs=208.3
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------ 86 (476)
.++|.+.+.||+|+||.||+|++..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3689999999999999999999999999999999876432 223346688999999999999999999998654
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
..+|+||||+. .+|.+.+ ...+++..++.++.|++.||+|||+.|++||||||
T Consensus 93 ~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp------------------------ 145 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKP------------------------ 145 (342)
T ss_pred ceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH------------------------
Confidence 35799999995 4776655 34699999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+||+++.++.+||+|||++..... ......+++.|+|||++.+....+.++||||+||++|+|+
T Consensus 146 -----------~NIll~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~ 209 (342)
T cd07879 146 -----------GNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209 (342)
T ss_pred -----------HHEEECCCCCEEEeeCCCCcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHH
Confidence 999999999999999999874321 2234568899999999876443458899999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCC-----------------------CCCC--------CCCCHHHHHHHHHccCCCcCCCC
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGD-----------------------FKLP--------KWLSPGAQNLLRKILEPNPVKRI 295 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~-----------------------~~~p--------~~~s~~~~~Li~~~L~~dP~~R~ 295 (476)
+|+.||.+.+....+..+.... ...+ +..++.+.+||++||+.||.+||
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 289 (342)
T cd07879 210 TGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL 289 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc
Confidence 9999999877655444433210 0001 23577899999999999999999
Q ss_pred ChHHHhcCcccccc
Q 011868 296 TIAGIKADEWFEQD 309 (476)
Q Consensus 296 s~~~il~~~~~~~~ 309 (476)
++++++.||||...
T Consensus 290 ~~~e~l~h~~f~~~ 303 (342)
T cd07879 290 TATEALEHPYFDSF 303 (342)
T ss_pred CHHHHhcCcchhhc
Confidence 99999999999764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=322.56 Aligned_cols=244 Identities=25% Similarity=0.471 Sum_probs=208.6
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-ASKSKI 89 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-~~~~~~ 89 (476)
+.+.+|++.+.||+|+||.||+|.. .|..||+|.+.... ..+.+.+|+.++++++|+|++++++++ ..++..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 4567899999999999999999975 47889999986432 246788999999999999999999975 455679
Q ss_pred EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 90 YMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
|++|||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp------------------------- 130 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA------------------------- 130 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccch-------------------------
Confidence 99999999999999987643 488999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++.+||+|||++..... ......++..|+|||++.+..++ .++|||||||++|+|++
T Consensus 131 ----------~nil~~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~ 194 (256)
T cd05082 131 ----------RNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYS 194 (256)
T ss_pred ----------heEEEcCCCcEEecCCccceeccc-----cCCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHh
Confidence 999999999999999999874322 12234456789999998877775 88999999999999997
Q ss_pred -CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 248 -GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 248 -G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|+.||...+.......+..+ ....+..+++.+.++|.+||+.||++|||+.++++
T Consensus 195 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 195 FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999988877777766554 23456678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=324.61 Aligned_cols=264 Identities=30% Similarity=0.605 Sum_probs=239.6
Q ss_pred hccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 011868 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (476)
Q Consensus 6 ~~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~ 84 (476)
+.+.++.+..|++++.||+|+|++|.+++.++|.+.+|+|+++++-..+.+..+.++.|-.+...- +||.+|-++.+|.
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 455677888999999999999999999999999999999999998877777788899998888776 6999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
++.++++|.||++||+|.-.++.+.+++++.|+.|...|+.||.|||++||+.||||
T Consensus 322 tesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlk----------------------- 378 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLK----------------------- 378 (593)
T ss_pred ccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeecc-----------------------
Confidence 999999999999999999889888999999999999999999999999999999999
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
++|+|+|..|++||+|+|+.+- ...+...+.+.||||.|.|||++.+..| +..+|.|+|||+++|
T Consensus 379 ------------ldnvlldaeghikltdygmcke--~l~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfe 443 (593)
T KOG0695|consen 379 ------------LDNVLLDAEGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFE 443 (593)
T ss_pred ------------ccceEEccCCceeecccchhhc--CCCCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHH
Confidence 4999999999999999999873 3345667889999999999999999988 589999999999999
Q ss_pred HhcCCCCCCC-------C-cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC------ChHHHhcCcccc
Q 011868 245 ILTGYLPFDD-------R-NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI------TIAGIKADEWFE 307 (476)
Q Consensus 245 lltG~~Pf~~-------~-~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~------s~~~il~~~~~~ 307 (476)
|++|+.||+- . +...+++-|...+..+|..+|-.+..+++..|++||..|. .+.++..|+||.
T Consensus 444 mmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr 520 (593)
T KOG0695|consen 444 MMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR 520 (593)
T ss_pred HHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence 9999999952 2 2345677888889999999999999999999999999986 468899999996
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=382.33 Aligned_cols=259 Identities=33% Similarity=0.527 Sum_probs=225.1
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
||+-+.+||.|.||+||.|.+..+|+..|+|-+.-.... .+....+.+|..++..++|||+|++|++-..+...||.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 577788999999999999999999999999988755433 4556889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
||.||+|.+.++..+-.+|...+.|..|++.|++|||++|||||||||
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~-------------------------------- 1362 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKP-------------------------------- 1362 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCc--------------------------------
Confidence 999999999999877788999999999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCccc--CCCcccccccCCccccccccccCC--CCCccchhhhHhHHHHHHhcCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFR--DDGLLHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~--~~~~~sDvwSlGvil~elltG~~ 250 (476)
+||+++.+|.+|++|||.|....... -.+......|||.|||||++.+.. -.+-++||||+|||..||+||+.
T Consensus 1363 ---aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkr 1439 (1509)
T KOG4645|consen 1363 ---ANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKR 1439 (1509)
T ss_pred ---cceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCC
Confidence 99999999999999999987543321 123345678999999999997643 22467999999999999999999
Q ss_pred CCCCCc--HHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 251 PFDDRN--LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 251 Pf~~~~--~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
||..-+ ...+|.-.....+++|..+|++.+++|..||..||++|.++.|++.|.|-+..
T Consensus 1440 PW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1440 PWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred chhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 997654 34555555555678999999999999999999999999999999999886543
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=358.37 Aligned_cols=260 Identities=28% Similarity=0.404 Sum_probs=197.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCC-CceEEEEE--------------eecccccchhHHHHHHHHHHHHHhCCCCCc
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDS-GLPFAVKI--------------LEKNRIIHLKITDQIKREIATLKLLKHPNV 76 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~-~~~vAvK~--------------i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI 76 (476)
.+++|++++.||+|+||+||++..... +..++.|. +.+...........+.+|+.+|+.++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 457899999999999999999876432 22222221 111111122345678899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhh
Q 011868 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRI 151 (476)
Q Consensus 77 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~ 151 (476)
+++++++...+..|+|++++ +++|.+++... ......+++.++.||+.||+|||++||+||||||
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP--------- 295 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKL--------- 295 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCH---------
Confidence 99999999999999999999 56888877542 2345677889999999999999999999999997
Q ss_pred hHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCc
Q 011868 152 ATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 231 (476)
Q Consensus 152 ~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~ 231 (476)
+|||++.+|.+||+|||++....... .......+||+.|+|||++.+..++ .
T Consensus 296 --------------------------~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~ 347 (501)
T PHA03210 296 --------------------------ENIFLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYC-E 347 (501)
T ss_pred --------------------------HHEEECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCC-c
Confidence 99999999999999999998653311 1223356899999999999888875 8
Q ss_pred cchhhhHhHHHHHHhcCCC-CCCCC--cHHHHHHHHHhC----CCCCC----------------------------CCCC
Q 011868 232 TSDIWSCGVILYVILTGYL-PFDDR--NLAVLYQKIFRG----DFKLP----------------------------KWLS 276 (476)
Q Consensus 232 ~sDvwSlGvil~elltG~~-Pf~~~--~~~~~~~~i~~~----~~~~p----------------------------~~~s 276 (476)
++|||||||++|+|++|.. ||.+. +....+.++... ...+| ..++
T Consensus 348 ~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 427 (501)
T PHA03210 348 ITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLP 427 (501)
T ss_pred HHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCC
Confidence 8999999999999999875 44332 222222221110 00011 1145
Q ss_pred HHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 277 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 277 ~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
.++.++|.+||+.||.+|||+.|+++||||...
T Consensus 428 ~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 428 ADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred hHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 678889999999999999999999999999763
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=333.79 Aligned_cols=259 Identities=31% Similarity=0.455 Sum_probs=211.8
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIY 90 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~ 90 (476)
.-++|++.+.||.|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++.++||||+++++++.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 34689999999999999999999999999999999865432 22335678899999999999999999999865 56789
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
++|||+ +++|.+.+.. .++++..+..++.||++||+|||+.||+||||||
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p---------------------------- 136 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKP---------------------------- 136 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH----------------------------
Confidence 999999 6789887754 5689999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
.||++++++.+||+|||++.... .......+++.|+|||++.+....+.++||||+||++|+|++|+.
T Consensus 137 -------~Nili~~~~~~~l~dfg~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~ 204 (328)
T cd07856 137 -------SNILINENCDLKICDFGLARIQD-----PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204 (328)
T ss_pred -------HHEeECCCCCEEeCccccccccC-----CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999987432 122345678899999998663333589999999999999999999
Q ss_pred CCCCCcHHHHHHHHHh--------------------------CCCCCC-----CCCCHHHHHHHHHccCCCcCCCCChHH
Q 011868 251 PFDDRNLAVLYQKIFR--------------------------GDFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAG 299 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~--------------------------~~~~~p-----~~~s~~~~~Li~~~L~~dP~~R~s~~~ 299 (476)
||.+.+....+..+.. ...+.| +.+++.+.++|++||+.+|.+|||+++
T Consensus 205 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~e 284 (328)
T cd07856 205 LFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284 (328)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 9987664322211110 000111 246789999999999999999999999
Q ss_pred HhcCccccccCCCC
Q 011868 300 IKADEWFEQDYTPA 313 (476)
Q Consensus 300 il~~~~~~~~~~~~ 313 (476)
++.||||...-.+.
T Consensus 285 ll~~~~~~~~~~~~ 298 (328)
T cd07856 285 ALAHPYLAPYHDPT 298 (328)
T ss_pred HhcCCccccccCCc
Confidence 99999998765553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=332.82 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=214.1
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
-..|+..+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++|+|++++++++......|+|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34588899999999999999999999999999998754333344456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||+. |+|.+.+.. ..++++.++..++.|++.||.|||++|++||||||
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p----------------------------- 143 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA----------------------------- 143 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH-----------------------------
Confidence 99996 588777653 45689999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc---CCCCCccchhhhHhHHHHHHhcC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~sDvwSlGvil~elltG 248 (476)
+||+++.++.+||+|||++..... .....|++.|+|||++.+ ..+ +.++|||||||++|+|++|
T Consensus 144 ------~nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g 210 (308)
T cd06634 144 ------GNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAER 210 (308)
T ss_pred ------HhEEECCCCcEEECCcccceeecC------cccccCCccccCHHHHhhcccCCC-CcccchHHHHHHHHHHHcC
Confidence 999999999999999999874322 234568899999999753 334 4789999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCC-C-CCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFK-L-PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~-~-p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
..||.+.+.......+.....+ . +..++..+.+||++||+.+|.+||++++++.|||+...
T Consensus 211 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 211 KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred CCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999877655544444444332 2 33578899999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=330.32 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=205.7
Q ss_pred CcCEEEeceEeecCceEEEEEEECC----------------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLD----------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI 76 (476)
.++|++.+.||+|+||+||++.+.. ++..||+|++.... .......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4579999999999999999986432 34579999987543 33345789999999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchh
Q 011868 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILK 145 (476)
Q Consensus 77 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~ 145 (476)
+++++++...+..|+||||+++++|.+++.... .+++.++..++.|++.||+|||+.|++||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp--- 158 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT--- 158 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh---
Confidence 999999999999999999999999999986532 367789999999999999999999999999997
Q ss_pred ccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc
Q 011868 146 SCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 225 (476)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 225 (476)
+||+++.++.++|+|||++................+++.|+|||+..+
T Consensus 159 --------------------------------~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 206 (296)
T cd05095 159 --------------------------------RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL 206 (296)
T ss_pred --------------------------------heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc
Confidence 999999999999999999975432111112223445678999998877
Q ss_pred CCCCCccchhhhHhHHHHHHhc--CCCCCCCCcHHHHHHHHHh--------CCCCCCCCCCHHHHHHHHHccCCCcCCCC
Q 011868 226 RGYDGATSDIWSCGVILYVILT--GYLPFDDRNLAVLYQKIFR--------GDFKLPKWLSPGAQNLLRKILEPNPVKRI 295 (476)
Q Consensus 226 ~~~~~~~sDvwSlGvil~ellt--G~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~Li~~~L~~dP~~R~ 295 (476)
..+. .++|||||||++|+|++ |..||...+.......... ...+.|..+++.+.+|+.+||+.||.+||
T Consensus 207 ~~~~-~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 285 (296)
T cd05095 207 GKFT-TASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP 285 (296)
T ss_pred CCcc-chhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCC
Confidence 7664 89999999999999998 8899987665554433211 12344566889999999999999999999
Q ss_pred ChHHHhc
Q 011868 296 TIAGIKA 302 (476)
Q Consensus 296 s~~~il~ 302 (476)
++.+|++
T Consensus 286 ~~~~i~~ 292 (296)
T cd05095 286 SFQEIHA 292 (296)
T ss_pred CHHHHHH
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=321.56 Aligned_cols=244 Identities=26% Similarity=0.397 Sum_probs=205.7
Q ss_pred ceEeecCceEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011868 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 96 (476)
++||+|+||.||+|....++ ..||+|.+...... .....+.+|+.+++.++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 47999999999999876554 78999999766432 345788999999999999999999998764 4689999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCC
Q 011868 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQ 176 (476)
Q Consensus 97 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 176 (476)
++|+|.+++.....+++..+..++.|++.||+|||++|++||||||
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p---------------------------------- 123 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAA---------------------------------- 123 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCccc----------------------------------
Confidence 9999999998877899999999999999999999999999999997
Q ss_pred CCceEeCCCCCEEEeccCCCCCCCcccCCC-cccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCCCCCC
Q 011868 177 LENILLDSKGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 254 (476)
Q Consensus 177 ~~NiLl~~~g~vkl~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~ 254 (476)
+||+++.++.+||+|||+++......... ......++..|+|||.+.+..++ .++|||||||++|+|++ |..||..
T Consensus 124 -~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~ 201 (257)
T cd05060 124 -RNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGE 201 (257)
T ss_pred -ceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999998553311110 01112235679999998877765 89999999999999998 9999988
Q ss_pred CcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 255 RNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 255 ~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
.+.......+.... .+.|..+++.+.++|.+||..||.+||++.++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 202 MKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 88777766665553 3566778999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=346.04 Aligned_cols=256 Identities=27% Similarity=0.382 Sum_probs=210.2
Q ss_pred CccCcCEEEeceEeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVL 83 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~ 83 (476)
.+..++|.++++||+|+||.||+|++. .++..||+|+++... .......+.+|+.+|.++. ||||+++++++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 344567899999999999999999853 355789999997643 2233457889999999997 99999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhcC------------------------------------------------------
Q 011868 84 ASKSKIYMVLEYVTGGELFDKIASKG------------------------------------------------------ 109 (476)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~l~~~~------------------------------------------------------ 109 (476)
...+..|+||||+.+|+|.+++...+
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999999999999986431
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchh
Q 011868 110 --------------------------------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILK 145 (476)
Q Consensus 110 --------------------------------------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~ 145 (476)
.+++..+..++.||+.||+|||+.||+||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp--- 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA--- 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc---
Confidence 356778889999999999999999999999997
Q ss_pred ccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc
Q 011868 146 SCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 225 (476)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 225 (476)
+|||+++++.+||+|||+++...............+++.|+|||++.+
T Consensus 268 --------------------------------~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 315 (401)
T cd05107 268 --------------------------------RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN 315 (401)
T ss_pred --------------------------------ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC
Confidence 999999999999999999985432111112233467889999999987
Q ss_pred CCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHH-HHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 226 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK-IFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 226 ~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~-i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
..+. .++|||||||++|||++ |..||........... +..+ ....|..++.++.+|+.+||..+|.+||++.+|+.
T Consensus 316 ~~~~-~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 316 NLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred CCCC-cHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7664 88999999999999998 9999987655444333 3333 24456778999999999999999999999999986
Q ss_pred C
Q 011868 303 D 303 (476)
Q Consensus 303 ~ 303 (476)
.
T Consensus 395 ~ 395 (401)
T cd05107 395 L 395 (401)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=326.56 Aligned_cols=250 Identities=33% Similarity=0.463 Sum_probs=208.1
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCE----
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLASKSK---- 88 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~~~~---- 88 (476)
|++.+.||+|+||.||+|++..+++.||+|.+..... .......+.+|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7899999999999999999988899999999975442 223345667788887766 59999999999987776
Q ss_pred -EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 89 -IYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 89 -~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
+|++|||+. ++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~----------------------- 135 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKP----------------------- 135 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCh-----------------------
Confidence 999999996 58998887643 589999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||+++.++.+||+|||++..... ........+++.|+|||++.+..+. .++|+||+||++|+|
T Consensus 136 ------------~nili~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l 199 (287)
T cd07838 136 ------------QNILVTSDGQVKIADFGLARIYSF---EMALTSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAEL 199 (287)
T ss_pred ------------hhEEEccCCCEEEeccCcceeccC---CcccccccccccccChHHhccCCCC-CcchhhhHHHHHHHH
Confidence 999999999999999999875432 2222344578999999999887765 889999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCC-----CC-----------C-----------CCCCCHHHHHHHHHccCCCcCCCCChH
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGD-----FK-----------L-----------PKWLSPGAQNLLRKILEPNPVKRITIA 298 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~-----~~-----------~-----------p~~~s~~~~~Li~~~L~~dP~~R~s~~ 298 (476)
++|..||.+.+..+.+.++.... .. + ...+++.+.++|.+||+.||++||++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~ 279 (287)
T cd07838 200 FRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAF 279 (287)
T ss_pred HhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHH
Confidence 99999999888776666554310 00 0 012457789999999999999999999
Q ss_pred HHhcCccc
Q 011868 299 GIKADEWF 306 (476)
Q Consensus 299 ~il~~~~~ 306 (476)
+++.||||
T Consensus 280 ~il~~~~~ 287 (287)
T cd07838 280 EALQHPYF 287 (287)
T ss_pred HHhcCcCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=325.76 Aligned_cols=253 Identities=32% Similarity=0.533 Sum_probs=214.5
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
||.+.+.||+|+||+||++.+..++..+++|+++..... .......+.+|+.+++.++||||+++++++......|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999888888888877643321 122245677899999999999999999999988999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|||+++++|.+.+.. ...+++.+++.++.|++.|+.|||+.|++|+||||
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~-------------------------- 134 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKA-------------------------- 134 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCCh--------------------------
Confidence 999999999988853 35699999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+||+++. +.+||+|||++..... .........|++.|+|||.+.+..++ .++|+||+|+++|+|++|
T Consensus 135 ---------~nili~~-~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~ 201 (260)
T cd08222 135 ---------KNIFLKN-NLLKIGDFGVSRLLMG--SCDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCL 201 (260)
T ss_pred ---------hheEeec-CCEeecccCceeecCC--CcccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhC
Confidence 9999975 6799999999875432 22233455689999999998777775 789999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
..||.+.+......++..+.. ..|..++.++.++|.+||+.||++||++.++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 202 AHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred CCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 999988777666666655543 3456688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=325.31 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=211.5
Q ss_pred cCcCEEEeceEeecCceEEEEEEECC----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-C
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLD----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-K 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~ 86 (476)
..++|++.+.||+|+||.||.|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 45789999999999999999999865 36889999986442 44456788999999999999999999998765 5
Q ss_pred CEEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHH
Q 011868 87 SKIYMVLEYVTGGELFDKIASK--------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFL 158 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~--------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~ 158 (476)
...++++||+++++|.+++... ..+++.++..++.|++.||+|||++|++||||||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p---------------- 145 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAA---------------- 145 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCH----------------
Confidence 6789999999999999998653 3589999999999999999999999999999997
Q ss_pred HHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhH
Q 011868 159 LTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 238 (476)
Q Consensus 159 ~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSl 238 (476)
+||++++++.+||+|||+++...............++..|+|||++.+..++ .++|||||
T Consensus 146 -------------------~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~sl 205 (280)
T cd05043 146 -------------------RNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS-SASDVWSF 205 (280)
T ss_pred -------------------hhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCC-chhhHHHh
Confidence 9999999999999999999754321111111223456789999999877775 88999999
Q ss_pred hHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 239 GVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 239 Gvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
||++|++++ |+.||.+.+...+...+..+. ...+..+++++.+++.+||..||++|||+.++++
T Consensus 206 G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 206 GVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999 999999887777666655542 2345567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=320.88 Aligned_cols=245 Identities=28% Similarity=0.506 Sum_probs=212.1
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
+....|++.+.||.|+||.||+|.. .|+.||+|.+..... ...++.+|+.+++.++|+||+++++++......|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 3567899999999999999999986 488999999976532 3577899999999999999999999999899999
Q ss_pred EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 91 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p-------------------------- 130 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAA-------------------------- 130 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhccc--------------------------
Confidence 9999999999999997655 699999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT- 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt- 247 (476)
+||+++.++.+||+|||++...... .....++..|+|||.+....+. .++|||||||++|+|++
T Consensus 131 ---------~Nili~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~ape~~~~~~~~-~~~Di~slG~il~~l~~~ 195 (256)
T cd05039 131 ---------RNVLVSEDLVAKVSDFGLAKEASQG-----QDSGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSF 195 (256)
T ss_pred ---------ceEEEeCCCCEEEcccccccccccc-----cccCCCcccccCchhhcCCcCC-cHHHHHHHHHHHHHHHhc
Confidence 9999999999999999999854211 1123345689999998776664 78999999999999997
Q ss_pred CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 248 GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|+.||...+.......+..+ ....|..+++.+.++|.+||..+|++|||+.++++
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 196 GRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 99999888777766665544 33456678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=327.89 Aligned_cols=259 Identities=32% Similarity=0.589 Sum_probs=217.3
Q ss_pred CEEEeceEeecCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~ 89 (476)
+|++.+.||+|+||.||+|++. .+++.||||.+.+.... .......+.+|+.+++.+ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999999754322 223356788999999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||+.+|+|.+.+.....+++..++.++.|++.||+|||+.|++||||||
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p--------------------------- 133 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKL--------------------------- 133 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH---------------------------
Confidence 99999999999999998777899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC-CCCccchhhhHhHHHHHHhcC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~sDvwSlGvil~elltG 248 (476)
.||+++.++.++|+|||++...... ........+|+..|+|||.+.+.. ..+.++|+||+|+++|+|++|
T Consensus 134 --------~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg 204 (288)
T cd05583 134 --------ENILLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204 (288)
T ss_pred --------HHeEECCCCCEEEEECccccccccc-cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhC
Confidence 9999999999999999998754331 112223456899999999986643 234789999999999999999
Q ss_pred CCCCCCCc----HHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC---hHHHhcCcccccc
Q 011868 249 YLPFDDRN----LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQD 309 (476)
Q Consensus 249 ~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s---~~~il~~~~~~~~ 309 (476)
..||...+ .......+.....+.|..+++.+.++|.+||+.||++||| +.++++||||+..
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 205 ASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred CCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 99996432 2344455566667778889999999999999999999998 4677999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=321.78 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=211.6
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
.+.|+..+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 4578999999999999999999876654 79999986543 233456789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||+++++|.+++... +.+++.++..++.|++.|++|||+.|++||||||
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp-------------------------- 135 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAA-------------------------- 135 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccch--------------------------
Confidence 9999999999999998753 5789999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcc-cccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLL-HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~-~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++.+||+|||++............ .....++.|+|||++.+..++ .++|||||||++|+|++
T Consensus 136 ---------~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~ 205 (268)
T cd05063 136 ---------RNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMS 205 (268)
T ss_pred ---------hhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHh
Confidence 9999999999999999998754332111111 112234579999998877775 88999999999999997
Q ss_pred -CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 248 -GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 248 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|+.||...+.......+..+. .+.+...+..+.+++.+||+.+|++||++.++++
T Consensus 206 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 206 FGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 999998877777777666542 3344557899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=321.28 Aligned_cols=243 Identities=26% Similarity=0.395 Sum_probs=203.3
Q ss_pred eEeecCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 21 TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 21 ~LG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
.||+|+||.||+|... .++..||+|++.... .....+.+.+|+.++++++||||+++++++.. ...|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999765 445679999986553 33445779999999999999999999998864 578999999999
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCC
Q 011868 99 GELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177 (476)
Q Consensus 99 g~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 177 (476)
++|.+++.. ...+++.++..++.||+.||+|||++|++||||||
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp----------------------------------- 123 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAA----------------------------------- 123 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccch-----------------------------------
Confidence 999999875 45799999999999999999999999999999997
Q ss_pred CceEeCCCCCEEEeccCCCCCCCcccCCC-cccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCCCCCCC
Q 011868 178 ENILLDSKGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR 255 (476)
Q Consensus 178 ~NiLl~~~g~vkl~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~ 255 (476)
+||+++.++.+||+|||++.......... ......+++.|+|||++....++ .++|||||||++|+|++ |..||.+.
T Consensus 124 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~ 202 (257)
T cd05115 124 RNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKM 202 (257)
T ss_pred heEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCC-chhhHHHHHHHHHHHhcCCCCCcCcC
Confidence 99999999999999999997543211111 11112335789999998877664 88999999999999996 99999988
Q ss_pred cHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 256 NLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 256 ~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
........+..+. ...|...++++.++|.+||..||++||++.++.+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 203 KGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8777776666543 4567778999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.06 Aligned_cols=250 Identities=30% Similarity=0.476 Sum_probs=208.1
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 94 (476)
|++.+.||+|++|+||+|.+..+++.||||.+...... .......+|+..+++++ ||||+++++++..++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78899999999999999999889999999998654321 11234567999999999 9999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|+ +|+|.+.+.... .+++.++..++.|++.||.|||++|++|+||+|
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~------------------------------ 127 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKP------------------------------ 127 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCh------------------------------
Confidence 99 889999887754 789999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
.||+++.++.++|+|||++..... ........|+..|+|||++.+....+.++|+||||+++|+|++|+.||
T Consensus 128 -----~ni~i~~~~~~~l~d~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~ 199 (283)
T cd07830 128 -----ENLLVSGPEVVKIADFGLAREIRS---RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199 (283)
T ss_pred -----hhEEEcCCCCEEEeecccceeccC---CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc
Confidence 999999999999999999975432 122234568899999999865444458899999999999999999999
Q ss_pred CCCcHHHHHHHHHhCC-------------------CC-----------CCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 253 DDRNLAVLYQKIFRGD-------------------FK-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~~-------------------~~-----------~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
.+.+....+.++...- .. .....++.+.++|++||+.||.+|||+.+++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 200 PGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred CCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 8876655444332110 00 01123678999999999999999999999999
Q ss_pred Cccc
Q 011868 303 DEWF 306 (476)
Q Consensus 303 ~~~~ 306 (476)
||||
T Consensus 280 ~~~~ 283 (283)
T cd07830 280 HPYF 283 (283)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=320.08 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=212.2
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
+..++|++.+.||+|+||.||+|.+. +++.||||.+..... ....+.+|+.+++.++||||+++++++......|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 34578999999999999999999974 567899999875432 1467889999999999999999999999989999
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
+||||+++++|.+++... ..+++.++..++.|++.|+.|||++|++||||||
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p-------------------------- 131 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAA-------------------------- 131 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcch--------------------------
Confidence 999999999999999764 3689999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT- 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt- 247 (476)
+||++++++.+||+|||++....... ........++..|+|||.+.+..+ +.++|+||+||++|+|++
T Consensus 132 ---------~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~ 200 (261)
T cd05034 132 ---------RNILVGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTY 200 (261)
T ss_pred ---------heEEEcCCCCEEECccccceeccchh-hhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhC
Confidence 99999999999999999987543211 011112234578999999887766 488999999999999998
Q ss_pred CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 248 GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|+.||.+.+......++..+ ..+.|...+.++.+++.+||+.||++||+++++.+
T Consensus 201 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 201 GRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99999988877777777654 34456667899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=320.86 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=206.7
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
.++|++.+.||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. ....|++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 46799999999999999999997554 4699998865432 2356888999999999999999999885 4568999
Q ss_pred EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 93 LEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
|||+.+++|.+++... ..+++..+..++.|++.||+|||+.|++||||||
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~---------------------------- 130 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRA---------------------------- 130 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCc----------------------------
Confidence 9999999999999753 3488999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GY 249 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~ 249 (476)
+||++++++.++|+|||++....... ........++..|+|||.+.+..++ .++||||+||++|+|++ |.
T Consensus 131 -------~Nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~~l~el~t~g~ 201 (260)
T cd05069 131 -------ANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGR 201 (260)
T ss_pred -------ceEEEcCCCeEEECCCccceEccCCc-ccccCCCccchhhCCHHHhccCCcC-hHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999997543211 1111223456789999998776664 88999999999999999 99
Q ss_pred CCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 250 LPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
.||.+.+......++... ..+.|...+..+.+++++||+.||.+||+++++++
T Consensus 202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 202 VPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 999988877776666554 33456678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=320.54 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=208.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
.-++|+++++||+|+||.||+|.. .+++.||+|.+..... ....+.+|+.+++.++||||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 346799999999999999999986 4678899999875542 1457889999999999999999999874 457899
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+|||+.+++|.+++... ..+++.++..++.|++.||+|||+.|++||||||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p--------------------------- 130 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRA--------------------------- 130 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccH---------------------------
Confidence 99999999999998653 4689999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
+||+++.++.++|+|||++....... ........++..|+|||++....+. .++|||||||++|+|++ |
T Consensus 131 --------~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~el~~~g 200 (260)
T cd05067 131 --------ANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTYG 200 (260)
T ss_pred --------HhEEEcCCCCEEEccCcceeecCCCC-cccccCCcccccccCHHHhccCCcC-cccchHHHHHHHHHHHhCC
Confidence 99999999999999999997543211 1111233456789999998777664 88999999999999999 9
Q ss_pred CCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 249 YLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+.||.+.+.......+..+ ..+.+...+.++.++|.+||+.+|++|||+++++.
T Consensus 201 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 201 RIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999988877766666544 23456668889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=327.27 Aligned_cols=263 Identities=23% Similarity=0.356 Sum_probs=213.4
Q ss_pred hccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 011868 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (476)
Q Consensus 6 ~~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~ 84 (476)
.......++.|++.+.||+|+||+||+|.+..+++.||||.+.+... ......+.+|+.++.+. .||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred ceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 34456788999999999999999999999988899999999976532 22245566777766666 4999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHHHHHHHHHH
Q 011868 85 SKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFL 162 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~~~~~~~~~ 162 (476)
.....|++|||+ ++.|.+.+.. ...+++..+..++.|++.||+|||+ .||+||||+|
T Consensus 85 ~~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p-------------------- 143 (296)
T cd06618 85 TDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKP-------------------- 143 (296)
T ss_pred cCCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcH--------------------
Confidence 999999999999 4577777654 4579999999999999999999997 5999999997
Q ss_pred HhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC---CCCccchhhhHh
Q 011868 163 LMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCG 239 (476)
Q Consensus 163 ~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~sDvwSlG 239 (476)
+||++++++.+||+|||++..... ........+++.|+|||.+.+.. ..+.++||||||
T Consensus 144 ---------------~nill~~~~~~kL~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG 205 (296)
T cd06618 144 ---------------SNILLDASGNVKLCDFGISGRLVD---SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLG 205 (296)
T ss_pred ---------------HHEEEcCCCCEEECccccchhccC---CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHH
Confidence 999999999999999999875432 11223345788999999987543 124789999999
Q ss_pred HHHHHHhcCCCCCCCCcH-HHHHHHHHhCCC-CCCC--CCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 240 VILYVILTGYLPFDDRNL-AVLYQKIFRGDF-KLPK--WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 240 vil~elltG~~Pf~~~~~-~~~~~~i~~~~~-~~p~--~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|++|+|++|+.||..... ...+.++..... ..+. .++.++.+||.+||+.||.+||++++++.||||...
T Consensus 206 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 206 ISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred HHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 999999999999976433 344444444432 2232 368899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=344.64 Aligned_cols=248 Identities=29% Similarity=0.470 Sum_probs=214.2
Q ss_pred EEEeceEeecCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
-.+.++||+|+||+||+|+....+ ..||||..+.+..........+.+|+++|+.++|||||++||+...+..+|+
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i 238 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML 238 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence 345689999999999999976542 2389999976444456667899999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
|||+|+||+|.+++...+ .++..+...++.|.+.||+|||+++++||||-+
T Consensus 239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAA---------------------------- 290 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAA---------------------------- 290 (474)
T ss_pred EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhH----------------------------
Confidence 999999999999998876 499999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCccc-ccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLH-TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~-~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
.|+|++.++.+||+|||+++.-... .... ...-...|+|||.+....|+ .++||||+||++||+++ |
T Consensus 291 -------RNcL~~~~~~vKISDFGLs~~~~~~---~~~~~~~klPirWLAPEtl~~~~~s-~kTDV~sfGV~~~Eif~~g 359 (474)
T KOG0194|consen 291 -------RNCLYSKKGVVKISDFGLSRAGSQY---VMKKFLKKLPIRWLAPETLNTGIFS-FKTDVWSFGVLLWEIFENG 359 (474)
T ss_pred -------HHheecCCCeEEeCccccccCCcce---eeccccccCcceecChhhhccCccc-cccchhheeeeEEeeeccC
Confidence 9999999999999999998843211 1111 11245699999999888775 89999999999999999 8
Q ss_pred CCCCCCCcHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDF--KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
..||.+.+..+...+|....+ +.|...+..+..++.+||..||++|||+.++.+
T Consensus 360 ~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 360 AEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 999999999999999966554 456667888999999999999999999999865
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=323.32 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=213.4
Q ss_pred CcCEEEeceEeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
..+|++.+.||+|+||+||+|+... +.+.||+|.+.... .......+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4679999999999999999999653 35679999886543 2334678999999999999999999999999989
Q ss_pred EEEEEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHH
Q 011868 88 KIYMVLEYVTGGELFDKIASKG---------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFL 158 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~ 158 (476)
..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+.||+||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp---------------- 145 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAA---------------- 145 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCcc----------------
Confidence 9999999999999999997655 689999999999999999999999999999997
Q ss_pred HHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhH
Q 011868 159 LTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 238 (476)
Q Consensus 159 ~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSl 238 (476)
+||+++.++.++++|||++...... .........++..|+|||.+.+..+. .++|||||
T Consensus 146 -------------------~Nili~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~sl 204 (275)
T cd05046 146 -------------------RNCLVSSQREVKVSLLSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSF 204 (275)
T ss_pred -------------------ceEEEeCCCcEEEcccccccccCcc-cccccCCceeEEeecChhhhccCCCC-chhhHHHH
Confidence 9999999999999999998743211 11122334567889999998776664 88999999
Q ss_pred hHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 239 GVILYVILT-GYLPFDDRNLAVLYQKIFRGDF--KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 239 Gvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
||++|+|++ |..||.+.........+..+.. +.+..++..+.+++.+||+.||.+|||+.++++.
T Consensus 205 G~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 205 GVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 999999998 8999988777777766665543 3455688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=325.87 Aligned_cols=252 Identities=34% Similarity=0.513 Sum_probs=212.1
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 95 (476)
|++.+.||+|+||.||+|++..+++.||+|++.... ........+.+|+.+++.++|+||+++++++......|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999997654 2333456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 96 VTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 96 ~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
+. ++|.+++... ..+++..++.++.|++.||+|||++||+||||+|
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~-------------------------------- 126 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKP-------------------------------- 126 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCh--------------------------------
Confidence 96 5999999875 5799999999999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~ 254 (476)
+||++++++.++|+|||++...... ........++..|+|||.+.+....+.++||||+||++|+|++|+.||.+
T Consensus 127 ---~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 201 (282)
T cd07829 127 ---QNILINRDGVLKLADFGLARAFGIP--LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG 201 (282)
T ss_pred ---heEEEcCCCCEEEecCCcccccCCC--ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999998754331 11233345678999999987763445889999999999999999999988
Q ss_pred CcHHHHHHHHHhC------------------CCCCC-----------CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcc
Q 011868 255 RNLAVLYQKIFRG------------------DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 305 (476)
Q Consensus 255 ~~~~~~~~~i~~~------------------~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~ 305 (476)
.+....+.++... ...++ +..+..+.++|++||..||.+||++++++.|||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 202 DSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281 (282)
T ss_pred ccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence 7765554443321 00111 124778999999999999999999999999999
Q ss_pred c
Q 011868 306 F 306 (476)
Q Consensus 306 ~ 306 (476)
|
T Consensus 282 ~ 282 (282)
T cd07829 282 F 282 (282)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=324.74 Aligned_cols=239 Identities=23% Similarity=0.301 Sum_probs=198.8
Q ss_pred ceEeecCceEEEEEEECCCCc-------eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 20 RTLGEGNFGKVKFAQDLDSGL-------PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~-------~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+.||+|+||.||+|.+..++. .||+|.+.... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 469999999999999865443 48999886442 33456788999999999999999999999998999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||+.||+||||||
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp----------------------------- 128 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCA----------------------------- 128 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc-----------------------------
Confidence 99999999999997644 589999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCC--------EEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHH
Q 011868 172 FNVLQLENILLDSKGN--------IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~--------vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ 243 (476)
+||+++.++. ++++|||++.... ......+++.|+|||++.+....+.++||||+||++|
T Consensus 129 ------~nili~~~~~~~~~~~~~~~l~d~g~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~ 196 (258)
T cd05078 129 ------KNVLLIREEDRKTGNPPFIKLSDPGISITVL------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLW 196 (258)
T ss_pred ------ceEEEecccccccCCCceEEecccccccccC------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHH
Confidence 9999987765 6999999987432 1234568899999999987544458899999999999
Q ss_pred HHhcC-CCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 244 VILTG-YLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 244 elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+|++| ..||...+..... ........+|...+.++.+||.+||+.||++|||++++++.
T Consensus 197 ~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 197 EIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHcCCCCChhhccHHHHH-HHHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99998 5777665544432 23344556777778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=317.38 Aligned_cols=248 Identities=28% Similarity=0.438 Sum_probs=212.3
Q ss_pred EEEeceEeecCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
+++.+.||.|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+++.++|+||+++++++...+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 357889999999999999998766 899999996553 22246789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 92 VLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+|||+++++|.+.+..... +++.++..++.|++.|++|||+.|++||||||
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~--------------------------- 131 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAA--------------------------- 131 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeeccccc---------------------------
Confidence 9999999999999976544 99999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
+||++++++.++|+|||++.......... .....+++.|+|||.+.+..+ +.++||||+||++|+|++ |
T Consensus 132 --------~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g 201 (258)
T smart00219 132 --------RNCLVGENLVVKISDFGLSRDLYDDDYYK-KKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLG 201 (258)
T ss_pred --------ceEEEccCCeEEEcccCCceecccccccc-cccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCC
Confidence 99999999999999999997544321111 111237789999999866656 489999999999999998 8
Q ss_pred CCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 249 YLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+.||...+.......+.... ...+..++.++.+++.+||..||++|||+.++++
T Consensus 202 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 202 ESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 99999888877777776654 3456678999999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=326.10 Aligned_cols=252 Identities=33% Similarity=0.495 Sum_probs=211.2
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 95 (476)
|++.+.||+|++|.||+|.+..+++.+|+|.+..... .......+.+|+.+++.++||||+++++++......|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999988999999999876542 223457888999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 96 VTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 96 ~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
+.+ +|.+.+.. ...+++.+++.++.||+.||.|||+.||+|+||||
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p-------------------------------- 126 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKP-------------------------------- 126 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCH--------------------------------
Confidence 965 88888866 35899999999999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~ 254 (476)
+||+++.++.++|+|||.+....... .......++..|+|||.+.+....+.++|+||+||++|+|++|+.||.+
T Consensus 127 ---~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 201 (283)
T cd05118 127 ---ENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG 201 (283)
T ss_pred ---HHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999987543321 1223345888999999987763335899999999999999999999988
Q ss_pred CcHHHHHHHHHhCC-------------------CC-----------CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCc
Q 011868 255 RNLAVLYQKIFRGD-------------------FK-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304 (476)
Q Consensus 255 ~~~~~~~~~i~~~~-------------------~~-----------~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~ 304 (476)
.+..+...++...- .. ..+.++.++.++|.+||++||.+||++.+++.||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~ 281 (283)
T cd05118 202 KSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP 281 (283)
T ss_pred CCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCC
Confidence 77655544432210 00 1123678899999999999999999999999999
Q ss_pred cc
Q 011868 305 WF 306 (476)
Q Consensus 305 ~~ 306 (476)
||
T Consensus 282 ~~ 283 (283)
T cd05118 282 YF 283 (283)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=321.93 Aligned_cols=243 Identities=28% Similarity=0.434 Sum_probs=203.0
Q ss_pred ceEeecCceEEEEEEECCCCc--eEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecc
Q 011868 20 RTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYV 96 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 96 (476)
+.||+|+||.||+|++..++. .+|+|.+.... .......+.+|+.+++++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999987775 46888876432 233456788999999999 7999999999999999999999999
Q ss_pred CCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 97 TGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 97 ~gg~L~~~l~~~~----------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
++|+|.+++.... .+++.+++.++.|++.||+|||+.|++||||||
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp------------------ 140 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA------------------ 140 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccc------------------
Confidence 9999999986532 478999999999999999999999999999997
Q ss_pred HHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhH
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGv 240 (476)
+||++++++.+||+|||++...... ........+..|+|||++....++ .++|||||||
T Consensus 141 -----------------~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~ 199 (270)
T cd05047 141 -----------------RNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGV 199 (270)
T ss_pred -----------------ceEEEcCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHccCCCC-chhhHHHHHH
Confidence 9999999999999999998632211 011122345679999998777665 8899999999
Q ss_pred HHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 241 ILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 241 il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
++|+|++ |..||.+.+....+..+..+ ..+.+..++.++.+|+.+||+.||.+|||++++++.
T Consensus 200 il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 200 LLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred HHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 9999997 99999888877777766554 234566688999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=323.49 Aligned_cols=250 Identities=29% Similarity=0.387 Sum_probs=200.7
Q ss_pred cCE-EEeceEeecCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--C
Q 011868 14 GRY-ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--K 86 (476)
Q Consensus 14 ~~Y-~i~~~LG~G~fg~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~ 86 (476)
+|| ++.+.||+|+||+||++. ...++..||+|++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 466 999999999999998865 33578899999997653 22335678899999999999999999998765 3
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
...|+||||+++++|.+++.. ..+++.+++.++.|++.||.|||++||+||||||
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp------------------------ 135 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAA------------------------ 135 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCh------------------------
Confidence 468999999999999999876 4699999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC-CcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||++++++.+||+|||++......... .......++..|+|||.+.+..++ .++|||||||++|+|
T Consensus 136 -----------~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~el 203 (283)
T cd05080 136 -----------RNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTLYEL 203 (283)
T ss_pred -----------heEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCC-cccccHHHHHHHHHH
Confidence 9999999999999999999854321111 111223466789999998777664 899999999999999
Q ss_pred hcCCCCCCCCcHH--HHH-------------HHHHh-CCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 246 LTGYLPFDDRNLA--VLY-------------QKIFR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 246 ltG~~Pf~~~~~~--~~~-------------~~i~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
++|..||...... ... ..+.. ...+.|..++..+.+++.+||+.||++|||+++++.
T Consensus 204 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 204 LTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred HhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999998654321 100 01111 122345667899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=357.11 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=216.4
Q ss_pred cCcCEEEeceEeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
..+.-+..+.||+|+||+||+|+-.. ....||||.++... +.....+|+||++++..++|||||+|+|+|..+
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 34456778899999999999998543 34679999997664 444678999999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKG--------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIA 152 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~--------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~ 152 (476)
+.+|+|+||+..|||.++|...+ +++..+...++.||+.||+||-++.+|||||-+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLAT---------- 631 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLAT---------- 631 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhh----------
Confidence 99999999999999999996421 288899999999999999999999999999997
Q ss_pred HHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCcc
Q 011868 153 TLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 232 (476)
Q Consensus 153 ~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~ 232 (476)
.|.||.++-.|||+||||++..=...--.......-...|||||.+...+|+ .+
T Consensus 632 -------------------------RNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-te 685 (774)
T KOG1026|consen 632 -------------------------RNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TE 685 (774)
T ss_pred -------------------------hhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-ch
Confidence 9999999999999999999832110000111122235699999999999996 88
Q ss_pred chhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHh
Q 011868 233 SDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301 (476)
Q Consensus 233 sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il 301 (476)
|||||+||+|||+++ |..||.+...++..+.|..+. .+.|+.+++++.+|+..||+.+|++||++.+|-
T Consensus 686 SDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 686 SDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred hhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 999999999999998 999999999999999988876 577899999999999999999999999999983
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=314.82 Aligned_cols=244 Identities=26% Similarity=0.425 Sum_probs=205.0
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 99 (476)
+.||+|+||.||+|.. .++..||+|.+.... .......+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 4689999999999986 468899999986553 2333457889999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 100 ELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 100 ~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
+|.+++... ..+++..+..++.|++.||.|||++|++|||||| +
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p-----------------------------------~ 122 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA-----------------------------------R 122 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCh-----------------------------------h
Confidence 999998653 4689999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCCCCCCCcH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNL 257 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~ 257 (476)
||+++.++.+||+|||++....... ........++..|+|||++.+..+. .++||||+||++|+|++ |..||.+.+.
T Consensus 123 nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~~~~~g~~p~~~~~~ 200 (250)
T cd05085 123 NCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQIPIKWTAPEALNYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTN 200 (250)
T ss_pred eEEEcCCCeEEECCCccceeccccc-cccCCCCCCcccccCHHHhccCCCC-chhHHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 9999999999999999987432210 1111122446789999998777664 88999999999999998 9999998877
Q ss_pred HHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 258 AVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 258 ~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
......+..+. ...|..+++.+.+++.+||..+|++||++.++++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 201 QQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 76666665542 34566789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=316.48 Aligned_cols=244 Identities=27% Similarity=0.385 Sum_probs=206.5
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 99 (476)
+.||+|+||.||+|.+.. ++.||+|.+..... ......+.+|+.+++.++||||+++++++......|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999877 99999999876542 234578999999999999999999999999999999999999999
Q ss_pred ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCC
Q 011868 100 ELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178 (476)
Q Consensus 100 ~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 178 (476)
+|.+++.. ...+++..+..++.|++.|++|||++|++|||||| +
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p-----------------------------------~ 122 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAA-----------------------------------R 122 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCc-----------------------------------c
Confidence 99999965 34689999999999999999999999999999997 9
Q ss_pred ceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCCCCCCCcH
Q 011868 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNL 257 (476)
Q Consensus 179 NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~ 257 (476)
||+++.++.+||+|||++................++..|+|||.+.+..+. .++|+|||||++|+|++ |..||.+...
T Consensus 123 nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~i~~~l~t~~~~p~~~~~~ 201 (251)
T cd05041 123 NCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSN 201 (251)
T ss_pred eEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCC-cchhHHHHHHHHHHHHhccCCCCccCCH
Confidence 999999999999999999754321111111222345679999998777664 89999999999999999 8999988777
Q ss_pred HHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 258 AVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 258 ~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
......+... ..+.|...+..+.++|.+||..+|++|||+.++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 202 QQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 6666666544 34456678899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=317.95 Aligned_cols=244 Identities=29% Similarity=0.459 Sum_probs=206.6
Q ss_pred ceEeecCceEEEEEEECC-CCc--eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011868 20 RTLGEGNFGKVKFAQDLD-SGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 96 (476)
+.||+|++|.||+|.+.. ++. .||||.+...... ...+.+.+|+.++++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999765 333 6999999776532 556889999999999999999999999988 8999999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 97 TGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 97 ~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
++++|.+.+.... .+++..++.++.|++.||+|||++|++||||||
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p-------------------------------- 125 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAA-------------------------------- 125 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCc--------------------------------
Confidence 9999999997654 689999999999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCcccCC-CcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 252 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf 252 (476)
+||+++.++.+||+|||++......... .......++..|+|||.+.+..++ .++|||||||++|+|++ |..||
T Consensus 126 ---~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~ 201 (257)
T cd05040 126 ---RNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPW 201 (257)
T ss_pred ---ccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999865331111 111234577899999998877775 78999999999999998 99999
Q ss_pred CCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 253 DDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
...+.......+... ....|...+..+.+++.+||+.+|++|||+.++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 202 AGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 888777776666543 23345567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=320.26 Aligned_cols=252 Identities=26% Similarity=0.407 Sum_probs=210.1
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
.-.+|.+.+.||+|+||.||+|.+..+ ...||||...... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 345799999999999999999987544 3569999886543 23446789999999999999999999999875 45
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++|++||||||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p------------------------- 135 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAA------------------------- 135 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCh-------------------------
Confidence 78999999999999999764 3689999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++.+||+|||++....... ........+++.|+|||.+....+. .++|||||||++|+|++
T Consensus 136 ----------~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~ 203 (270)
T cd05056 136 ----------RNVLVSSPDCVKLGDFGLSRYLEDES-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILM 203 (270)
T ss_pred ----------heEEEecCCCeEEccCceeeeccccc-ceecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHH
Confidence 99999999999999999987543211 0111122345689999998777765 88999999999999986
Q ss_pred -CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 248 -GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 248 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|..||.+.+......++..+. .+.|..+++.+.++|.+||..+|.+|||+.+++..
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 204 LGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999888777666666543 45677789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=316.53 Aligned_cols=249 Identities=24% Similarity=0.415 Sum_probs=211.1
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 457999999999999999999874 5778999998654321 35688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||+++++|.+++... +.+++..++.++.|++.|++|||++|++||||||
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p----------------------------- 128 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAA----------------------------- 128 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccc-----------------------------
Confidence 9999999999998754 5689999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYL 250 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~ 250 (476)
+||+++.++.+||+|||++....... ........++..|+|||++.+..+. .++|||||||++|+|++ |+.
T Consensus 129 ------~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~ 200 (256)
T cd05112 129 ------RNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKT 200 (256)
T ss_pred ------ceEEEcCCCeEEECCCcceeecccCc-ccccCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCC
Confidence 99999999999999999987432210 1111223356789999998877765 78999999999999998 999
Q ss_pred CCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 251 PFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
||...+.......+..+. ...|...+..+.+|+.+||+.+|++|||+.++++.
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 201 PYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 999888777777776553 33456678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=344.04 Aligned_cols=259 Identities=32% Similarity=0.514 Sum_probs=223.7
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
=.-|..++.||-|+||+|.+++...|...||+|.+++........+..++.|-.||..-+.+-||+||-.|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 34588899999999999999999999999999999988877777788899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|||++||++..+|-..+-|+|+.|+.|+..+.+|+++.|..|++||||||
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKP------------------------------ 757 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKP------------------------------ 757 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCc------------------------------
Confidence 99999999999999889999999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccC----------------------------------------CCcccccc
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRD----------------------------------------DGLLHTTC 212 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~----------------------------------------~~~~~~~~ 212 (476)
+|||||.+|++||+||||++-+....+ ....+..+
T Consensus 758 -----DNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslv 832 (1034)
T KOG0608|consen 758 -----DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLV 832 (1034)
T ss_pred -----cceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhc
Confidence 999999999999999999876432110 01123557
Q ss_pred cCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHh--CC--CCCCCCCCHHHHHHHHHccC
Q 011868 213 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GD--FKLPKWLSPGAQNLLRKILE 288 (476)
Q Consensus 213 gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~--~~~p~~~s~~~~~Li~~~L~ 288 (476)
||+.|+|||++...+|. ..||.||.|||||||+.|++||...+......++.. .- ++.-..+|+++.+||.++.
T Consensus 833 gt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc- 910 (1034)
T KOG0608|consen 833 GTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC- 910 (1034)
T ss_pred CCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-
Confidence 99999999999999996 889999999999999999999988776555444433 22 3333568999999998866
Q ss_pred CCcCCCC---ChHHHhcCccccc
Q 011868 289 PNPVKRI---TIAGIKADEWFEQ 308 (476)
Q Consensus 289 ~dP~~R~---s~~~il~~~~~~~ 308 (476)
-+++.|. -++++.+||||+.
T Consensus 911 ~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 911 CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred cChhhhhcccchhhhhcCccccc
Confidence 4566776 4677999999974
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=323.77 Aligned_cols=238 Identities=25% Similarity=0.320 Sum_probs=195.1
Q ss_pred eEeecCceEEEEEEECC------------------------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 011868 21 TLGEGNFGKVKFAQDLD------------------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76 (476)
Q Consensus 21 ~LG~G~fg~V~~a~~~~------------------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI 76 (476)
.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 69999999999997432 22458999886542 2335678889999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHH
Q 011868 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQ 155 (476)
Q Consensus 77 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~ 155 (476)
+++++++......|+||||+++|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp------------- 145 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCA------------- 145 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCc-------------
Confidence 9999999999999999999999999998865 46789999999999999999999999999999997
Q ss_pred HHHHHHHHhhhccccccccCCCCceEeCCCC-------CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCC
Q 011868 156 VFLLTFLLMIVIRPWKFNVLQLENILLDSKG-------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 228 (476)
Q Consensus 156 ~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g-------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 228 (476)
+||+++.++ .+|++|||++..... .....++..|+|||.+.+...
T Consensus 146 ----------------------~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~ 197 (274)
T cd05076 146 ----------------------KNILLARLGLAEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNS 197 (274)
T ss_pred ----------------------ccEEEeccCcccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCC
Confidence 999998654 389999998863211 123457889999999876443
Q ss_pred CCccchhhhHhHHHHHHh-cCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 229 DGATSDIWSCGVILYVIL-TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 229 ~~~~sDvwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
.+.++|||||||++|+|+ +|..||.+........ ........|...++.+.++|.+||+.+|++|||+.+++++
T Consensus 198 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 198 LSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 458999999999999985 7999998766544322 3333445566677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=346.08 Aligned_cols=249 Identities=25% Similarity=0.419 Sum_probs=215.2
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
.+...++..||+|.||+||+|++- | .||||+++.+.. ..+..+.|++|+..+++-+|.||+-+.+++...+. .+|
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred HHHhhccceeccccccceeecccc--c-ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 345678899999999999999863 3 599999987765 44578999999999999999999999999998877 999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
+.+|+|.+|..++.. ..+|...+.+.|++||+.||.|||.++|+|||||.
T Consensus 466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKS----------------------------- 516 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKS----------------------------- 516 (678)
T ss_pred ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccc-----------------------------
Confidence 999999999999975 35799999999999999999999999999999998
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc---CCCCCccchhhhHhHHHHHHhcC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~sDvwSlGvil~elltG 248 (476)
.||++.+++.|||+||||+++.............-|...|||||++.. ..| +..+|||||||++|||+||
T Consensus 517 ------nNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg 589 (678)
T KOG0193|consen 517 ------NNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTG 589 (678)
T ss_pred ------cceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhC
Confidence 999999999999999999987655444555667789999999999874 345 4889999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFK-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
..||...+.+.+.-.+.+|... .-..++.++++|+..||..+|++||++.+|+.
T Consensus 590 ~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 590 ELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 9999987777776666666332 22346679999999999999999999999987
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=319.82 Aligned_cols=245 Identities=23% Similarity=0.303 Sum_probs=193.6
Q ss_pred ceEeecCceEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011868 20 RTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 97 (476)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 469999999999996432 44578888875443 23335678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 98 GGELFDKIASKG-----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 98 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
+|+|.+++.... ..++..++.++.||+.||+|||++||+||||||
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp------------------------------ 128 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLAL------------------------------ 128 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccH------------------------------
Confidence 999999997642 246788899999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccC------CCCCccchhhhHhHHHHHHh
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR------GYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~------~~~~~~sDvwSlGvil~ell 246 (476)
+|||+++++.+||+|||++................+++.|+|||++... ...+.++||||+||++|+|+
T Consensus 129 -----~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 203 (269)
T cd05042 129 -----RNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203 (269)
T ss_pred -----hheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHH
Confidence 9999999999999999998643211100111233456789999997532 12357899999999999999
Q ss_pred c-CCCCCCCCcHHHHHHHHHh-CCCC-----CCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 247 T-GYLPFDDRNLAVLYQKIFR-GDFK-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 247 t-G~~Pf~~~~~~~~~~~i~~-~~~~-----~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+ |..||..........++.. ...+ .+..+++.+.+++..|+ .||++|||++++++
T Consensus 204 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 204 TAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred hCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 9 8999988766555544433 3222 23357888999999999 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=319.38 Aligned_cols=239 Identities=23% Similarity=0.303 Sum_probs=195.3
Q ss_pred ceEeecCceEEEEEEECC------------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 20 RTLGEGNFGKVKFAQDLD------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
+.||+|+||.||+|.... ....||+|.+.... ......+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998432 23368999876542 334567888999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
..++||||+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp------------------------ 133 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCT------------------------ 133 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCc------------------------
Confidence 99999999999999888865 35699999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCC-------EEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHh
Q 011868 167 IRPWKFNVLQLENILLDSKGN-------IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~-------vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlG 239 (476)
+|||++.++. ++++|||++..... .....|+..|+|||++......+.++||||||
T Consensus 134 -----------~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 196 (262)
T cd05077 134 -----------KNILLAREGIDGECGPFIKLSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFG 196 (262)
T ss_pred -----------ccEEEecCCccCCCCceeEeCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHH
Confidence 9999987764 89999999874321 22356888999999987544445889999999
Q ss_pred HHHHHHh-cCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 240 VILYVIL-TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 240 vil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|++|+|+ +|..||.+....... .............++++.+||.+||+.||.+||++.+|+.+
T Consensus 197 ~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 197 TTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 9999998 599999876654432 23334444444456889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=325.65 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=210.0
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
...++|+..+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 455789999999999999999999877776 47888886543 233345788999999999999999999998754
Q ss_pred CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
..++++||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp----------------------- 137 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAA----------------------- 137 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeecccccc-----------------------
Confidence 467999999999999998764 3689999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||+++.++.+||+|||+++...............++..|+|||++.+..++ .++|||||||++|+|
T Consensus 138 ------------~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el 204 (303)
T cd05110 138 ------------RNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWEL 204 (303)
T ss_pred ------------ceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHH
Confidence 9999999999999999999865432211122334567899999998877765 889999999999999
Q ss_pred hc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 246 LT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 246 lt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
++ |..||.+.........+..+. ++.+...+..+.+++.+||..+|++||+++++++.
T Consensus 205 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 205 MTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 97 999998876655554444332 34456678899999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=329.40 Aligned_cols=248 Identities=22% Similarity=0.370 Sum_probs=198.9
Q ss_pred CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHHH
Q 011868 26 NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI 105 (476)
Q Consensus 26 ~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l 105 (476)
++|.||++++..+++.||||++..... .......+.+|+.+++.++||||+++++++......|++|||+++|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 445666677777999999999976532 3344678999999999999999999999999999999999999999999998
Q ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeC
Q 011868 106 ASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD 183 (476)
Q Consensus 106 ~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~ 183 (476)
... ..+++..+..++.|++.||+|||++||+|||||| +||+++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~-----------------------------------~Nili~ 135 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKA-----------------------------------SHILLS 135 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCc-----------------------------------ceEEEe
Confidence 753 4689999999999999999999999999999997 999999
Q ss_pred CCCCEEEeccCCCCCCCcccC-----CCcccccccCCccccccccccC--CCCCccchhhhHhHHHHHHhcCCCCCCCCc
Q 011868 184 SKGNIKISDFGLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRN 256 (476)
Q Consensus 184 ~~g~vkl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~--~~~~~~sDvwSlGvil~elltG~~Pf~~~~ 256 (476)
.+|.+||+|||.+........ ........++..|+|||++.+. .+ +.++|+||+||++|+|++|..||.+.+
T Consensus 136 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 136 GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred cCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999998864321111 1112334578899999998763 45 478999999999999999999998765
Q ss_pred HHHHHHHHHhCCC----------------------------------CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 257 LAVLYQKIFRGDF----------------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 257 ~~~~~~~i~~~~~----------------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
..........+.. ..+..+++++.+||++||+.||++|||++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 215 ATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred HHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 4333221111110 011123567899999999999999999999999
Q ss_pred CccccccC
Q 011868 303 DEWFEQDY 310 (476)
Q Consensus 303 ~~~~~~~~ 310 (476)
||||++..
T Consensus 295 ~p~~~~~~ 302 (314)
T cd08216 295 HSFFKQCK 302 (314)
T ss_pred CchHhhhc
Confidence 99998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=312.07 Aligned_cols=253 Identities=27% Similarity=0.420 Sum_probs=206.5
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-----eCC
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-----SKS 87 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~~ 87 (476)
-.||++.+.||+|||+.||++++..+++.+|+|.+.... .+..+...+|+...++++|||+++++++.. ...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 358999999999999999999999999999999997664 334688999999999999999999988763 334
Q ss_pred EEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC--cEeccCCcchhccchhhhHHHHHHHHH
Q 011868 88 KIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~al~yLH~~g--ivHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
..|++++|...|+|.+.+... .-++|.+...++.+|++||++||+.. .+||||||
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP------------------- 157 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKP------------------- 157 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCc-------------------
Confidence 699999999999999999752 36999999999999999999999998 99999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCc-------ccccccCCccccccccccCCCC--Ccc
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGL-------LHTTCGSPNYVAPEVLANRGYD--GAT 232 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~-------~~~~~gt~~y~APE~l~~~~~~--~~~ 232 (476)
.|||+.+.+.++|.|||.++...-.-.++. ...-..|..|+|||.+.-+.+. +.+
T Consensus 158 ----------------~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~er 221 (302)
T KOG2345|consen 158 ----------------ANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITER 221 (302)
T ss_pred ----------------ceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccc
Confidence 999999999999999999875432111110 0122468899999998644322 588
Q ss_pred chhhhHhHHHHHHhcCCCCCCCCcH--HHHHHHHHhCCCCCCCC--CCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 233 SDIWSCGVILYVILTGYLPFDDRNL--AVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 233 sDvwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+|||||||+||+|+.|..||+..-. ..+.-.+..+++.+|.. +|+.+.+||..||+.||.+||++.+++.+
T Consensus 222 tDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 222 TDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 9999999999999999999953211 11112234455666644 89999999999999999999999999865
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=313.08 Aligned_cols=257 Identities=24% Similarity=0.393 Sum_probs=213.4
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKI 89 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~ 89 (476)
..++..+.+..||.|+.|.||+++.+.+|...|||.+.+.. +.+..+++.+.+.++.+.. .|+||+.+++|..+...
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 44556677888999999999999999999999999998765 3444577777887776664 89999999999999999
Q ss_pred EEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 90 YMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
++.||.+ +.-+..++. -.++++|..+-++...+++||.||.. +||+|||+||
T Consensus 167 ~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKP------------------------- 220 (391)
T KOG0983|consen 167 FICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKP------------------------- 220 (391)
T ss_pred HHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCc-------------------------
Confidence 9999998 323333333 24689999999999999999999997 5999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc---CCCCCccchhhhHhHHHHH
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~sDvwSlGvil~e 244 (476)
+|||+|+.|++|+||||++...-. ........|.+.|||||.+.- ..|+ .++||||||+.++|
T Consensus 221 ----------SNILlDe~GniKlCDFGIsGrlvd---SkAhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlve 286 (391)
T KOG0983|consen 221 ----------SNILLDERGNIKLCDFGISGRLVD---SKAHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVE 286 (391)
T ss_pred ----------cceEEccCCCEEeecccccceeec---ccccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhh
Confidence 999999999999999999975432 222234579999999999863 4576 88999999999999
Q ss_pred HhcCCCCCCCCcH-HHHHHHHHhCCCCC-CC--CCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 245 ILTGYLPFDDRNL-AVLYQKIFRGDFKL-PK--WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 245 lltG~~Pf~~~~~-~~~~~~i~~~~~~~-p~--~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|.||+.||.+.+. -+.+.++.+.+++. |. .+|+.+.+|+..||++|+.+||...++|+|||+...
T Consensus 287 LaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 287 LATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred hhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 9999999998654 36677777766543 32 289999999999999999999999999999998764
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=318.21 Aligned_cols=245 Identities=20% Similarity=0.259 Sum_probs=194.0
Q ss_pred ceEeecCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011868 20 RTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 97 (476)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++++.+....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999854 3567899999876542 2234578899999999999999999999999899999999999
Q ss_pred CCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 98 GGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 98 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
+|+|.+++... ...++..++.++.|++.|++|||+.|++||||||
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp------------------------------ 128 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLAL------------------------------ 128 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCc------------------------------
Confidence 99999998643 2456778889999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC------CCCccchhhhHhHHHHHHh
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG------YDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~------~~~~~sDvwSlGvil~ell 246 (476)
+||+++.++.+||+|||++................|++.|+|||++.+.. ..+.++||||+||++|+|+
T Consensus 129 -----~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 203 (269)
T cd05087 129 -----RNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203 (269)
T ss_pred -----ceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHH
Confidence 99999999999999999987432211111122346788999999986432 1247899999999999999
Q ss_pred c-CCCCCCCCcHHHHHHHHHh-CCCCC-----CCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 247 T-GYLPFDDRNLAVLYQKIFR-GDFKL-----PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 247 t-G~~Pf~~~~~~~~~~~i~~-~~~~~-----p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+ |+.||...+.......... ..... ....++.+.+++++|+ .+|++|||+++|..
T Consensus 204 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 204 ELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred hCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6 9999987665554433322 22222 2236788999999999 68999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=320.18 Aligned_cols=264 Identities=28% Similarity=0.448 Sum_probs=220.2
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------ 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------ 85 (476)
..+.|+-..++|+|.||+||+|+...+|+.||+|++-.+. +.+.+-....+|+.+|..++|+|++.++++|.+
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 4568888999999999999999999999999998764432 244556678899999999999999999998843
Q ss_pred --CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHH
Q 011868 86 --KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFL 162 (476)
Q Consensus 86 --~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~ 162 (476)
...+|+|+++|+. +|+.++... .+++..+++.++.++++||.|+|++.|+|||+||
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKa-------------------- 152 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKA-------------------- 152 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccH--------------------
Confidence 3459999999954 999988654 5899999999999999999999999999999997
Q ss_pred HhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC--CCcccccccCCccccccccccCCCCCccchhhhHhH
Q 011868 163 LMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240 (476)
Q Consensus 163 ~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGv 240 (476)
+|+|++.+|.+||+|||+++.++.... .......+-|.+|++||.+.+..-++++.|||..||
T Consensus 153 ---------------aNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgC 217 (376)
T KOG0669|consen 153 ---------------ANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGC 217 (376)
T ss_pred ---------------hhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHH
Confidence 999999999999999999986654322 223344567999999999999877789999999999
Q ss_pred HHHHHhcCCCCCCCCcHHHHHHHHHh--CCC--------------------CCCCC-------------CCHHHHHHHHH
Q 011868 241 ILYVILTGYLPFDDRNLAVLYQKIFR--GDF--------------------KLPKW-------------LSPGAQNLLRK 285 (476)
Q Consensus 241 il~elltG~~Pf~~~~~~~~~~~i~~--~~~--------------------~~p~~-------------~s~~~~~Li~~ 285 (476)
|+.+|+||.+.|++.+.......|.. |.. ++|.. -++++.+|+.+
T Consensus 218 imaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ 297 (376)
T KOG0669|consen 218 IMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEK 297 (376)
T ss_pred HHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHH
Confidence 99999999999999887666555532 111 11111 25689999999
Q ss_pred ccCCCcCCCCChHHHhcCccccccCCC
Q 011868 286 ILEPNPVKRITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 286 ~L~~dP~~R~s~~~il~~~~~~~~~~~ 312 (476)
+|..||.+|+++++++.|.||.++..|
T Consensus 298 ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 298 LLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred HhccCcccCcchHhhhchhhhhcCCcc
Confidence 999999999999999999999887655
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=316.72 Aligned_cols=229 Identities=28% Similarity=0.449 Sum_probs=194.4
Q ss_pred cCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHH
Q 011868 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDK 104 (476)
Q Consensus 25 G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 104 (476)
|.||+||+|++..+++.||+|.+.+.. ...+|...+....||||+++++++......|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999997643 223344555556799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCC
Q 011868 105 IASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184 (476)
Q Consensus 105 l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~ 184 (476)
+....++++..+..++.|++.||+|||++||+|||||| +||+++.
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp-----------------------------------~Nil~~~ 120 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNP-----------------------------------NNILLDD 120 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH-----------------------------------HHEEEcC
Confidence 98777899999999999999999999999999999997 9999999
Q ss_pred CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHH
Q 011868 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 264 (476)
Q Consensus 185 ~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i 264 (476)
++.++++|||++..... ......++..|+|||.+.+..++ .++|+||+||++|+|++|+.||....... .
T Consensus 121 ~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~~~~~~~~~~----~ 190 (237)
T cd05576 121 RGHIQLTYFSRWSEVED-----SCDGEAVENMYCAPEVGGISEET-EACDWWSLGAILFELLTGKTLVECHPSGI----N 190 (237)
T ss_pred CCCEEEecccchhcccc-----ccccCCcCccccCCcccCCCCCC-chhhHHHHHHHHHHHHHCcchhhcCchhc----c
Confidence 99999999998764322 12334567889999998777664 88999999999999999999886432210 0
Q ss_pred HhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh-----HHHhcCccc
Q 011868 265 FRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI-----AGIKADEWF 306 (476)
Q Consensus 265 ~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~-----~~il~~~~~ 306 (476)
......+|.++++.+.++|.+||+.||++||++ ++++.||||
T Consensus 191 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 191 THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 112345788899999999999999999999996 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.16 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=202.7
Q ss_pred CEEEeceEeecCceEEEEEEE----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CE
Q 011868 15 RYELGRTLGEGNFGKVKFAQD----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SK 88 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~ 88 (476)
-|++++.||+|+||.||+|+. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 378999999999999999974 4578899999986543 334457899999999999999999999998765 57
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.|+||||++|++|.+++... ..+++.++..++.||+.||+|||++|++||||||
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp------------------------- 137 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAA------------------------- 137 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccch-------------------------
Confidence 89999999999999998654 3689999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC-CcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+||+++.++.+||+|||++......... .......|+..|+|||++.+..++ .++||||+||++|+|+
T Consensus 138 ----------~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ell 206 (284)
T cd05079 138 ----------RNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELL 206 (284)
T ss_pred ----------heEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhh
Confidence 9999999999999999999864332111 112345577889999998877665 8899999999999999
Q ss_pred cCCCCCCCCc---------------HHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 247 TGYLPFDDRN---------------LAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 247 tG~~Pf~~~~---------------~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
++..|+.... .......+..+ ..+.+..+++.+.+||.+||+.||++|||+.+++.+
T Consensus 207 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 207 TYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9877653211 01111111111 233455688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=315.11 Aligned_cols=242 Identities=27% Similarity=0.488 Sum_probs=205.8
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
.+.+|++.+.||+|+||.||++. .+++.||+|.+.... ....+.+|+.+++.++||||+++++++..+ ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 46789999999999999999886 578899999986542 245788999999999999999999998765 4799
Q ss_pred EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 92 VLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+|||+++++|.+++.... .+++..+..++.|++.|+.|||++|++||||||
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p--------------------------- 128 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAA--------------------------- 128 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCc---------------------------
Confidence 999999999999997643 589999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
+||+++.++.+||+|||++..... .......+..|+|||.+.+..++ .++|+||+||++|+|++ |
T Consensus 129 --------~nili~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~el~~~g 194 (254)
T cd05083 129 --------RNILVSEDGVAKVSDFGLARVGSM-----GVDNSKLPVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYG 194 (254)
T ss_pred --------ceEEEcCCCcEEECCCccceeccc-----cCCCCCCCceecCHHHhccCCcC-chhhHHHHHHHHHHHHhCC
Confidence 999999999999999999874321 11223345789999998776664 88999999999999997 9
Q ss_pred CCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 249 YLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+.||.+.+.......+.++. ...+..+++.+.+++.+||+.+|.+||++++++.
T Consensus 195 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 195 RAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999888777766665543 3345568899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=313.93 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=207.4
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||.||+|.+ ..+..+|+|.+.... .....+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 457899999999999999999986 456679999886532 224678899999999999999999999887 77899
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+|||+++++|.+++... ..++...+..++.|++.||.|||+.|++||||||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p--------------------------- 130 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA--------------------------- 130 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCc---------------------------
Confidence 99999999999999753 3578889999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
+||+++.++.+||+|||++....... ........++..|+|||++....++ .++|+|||||++|++++ |
T Consensus 131 --------~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~t~g 200 (260)
T cd05073 131 --------ANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYG 200 (260)
T ss_pred --------ceEEEcCCCcEEECCCcceeeccCCC-cccccCCcccccccCHhHhccCCcC-ccccchHHHHHHHHHHhcC
Confidence 99999999999999999987543211 1111223456789999998776664 78999999999999998 9
Q ss_pred CCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 249 YLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
..||.+.+.......+..+. .+.+...+.++.+++.+||+.||++||++.++++
T Consensus 201 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 201 RIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 99999887776666665542 3445668899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=314.41 Aligned_cols=246 Identities=26% Similarity=0.382 Sum_probs=200.8
Q ss_pred ceEeecCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEEEEec
Q 011868 20 RTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SKSKIYMVLEY 95 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-~~~~~~lV~E~ 95 (476)
+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.+++.++||||+++++++. .++..|++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998653 34579999885432 3334578889999999999999999999765 45678999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 96 VTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 96 ~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
+.+|+|.+++... ...++..+..++.|++.||.|||+.|++||||||
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~-------------------------------- 126 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAA-------------------------------- 126 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCc--------------------------------
Confidence 9999999999764 3567788889999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCccc--CCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLP 251 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~P 251 (476)
+|||+++++.+||+|||+++...... .........+++.|+|||.+.+..++ .++|||||||++|+|++ |.+|
T Consensus 127 ---~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~ 202 (262)
T cd05058 127 ---RNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPP 202 (262)
T ss_pred ---ceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999987432211 00111233467789999998877775 89999999999999999 6778
Q ss_pred CCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 252 FDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|...+.......+..+. ...|..+++.+.+++.+||+.+|++||++.+++..
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 203 YPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 88877777666666554 33456678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=327.63 Aligned_cols=252 Identities=30% Similarity=0.463 Sum_probs=208.6
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-C-CC----cceEEEEEEe
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H-PN----VVRLHEVLAS 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-H-pn----Iv~l~~~~~~ 85 (476)
.-+||+++.+||+|+||+|-.+.|..++..||||+++.-. ...+...-|+.+|+++. + |+ ++.+.++|+.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 4579999999999999999999999999999999996542 33466777999999994 2 33 8889999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHH
Q 011868 86 KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLL 163 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~ 163 (476)
.+++|+|+|.+ |.++++.+..++ +++..+++.+.+||+.+|+|||+.+++|-||||
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKP--------------------- 220 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKP--------------------- 220 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCCh---------------------
Confidence 99999999999 889999998764 799999999999999999999999999999997
Q ss_pred hhhccccccccCCCCceEeCC--------------------CCCEEEeccCCCCCCCcccCCCcccccccCCcccccccc
Q 011868 164 MIVIRPWKFNVLQLENILLDS--------------------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 223 (476)
Q Consensus 164 ~~~~~p~~~~~~~~~NiLl~~--------------------~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 223 (476)
||||+.+ +..++|+|||.|+.... .-.+.+.|..|+|||++
T Consensus 221 --------------ENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEVi 281 (415)
T KOG0671|consen 221 --------------ENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVI 281 (415)
T ss_pred --------------heEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchhe
Confidence 9998832 23589999999985322 23677899999999999
Q ss_pred ccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHH---HHHHHHhC------------------CCCCCCC--------
Q 011868 224 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV---LYQKIFRG------------------DFKLPKW-------- 274 (476)
Q Consensus 224 ~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~---~~~~i~~~------------------~~~~p~~-------- 274 (476)
.+-+|+ .+|||||+||||+||++|...|+..+..+ +.++|... ....|+.
T Consensus 282 LgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~ 360 (415)
T KOG0671|consen 282 LGLGWS-QPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKY 360 (415)
T ss_pred eccCcC-CccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchh
Confidence 999996 89999999999999999999998765333 33444321 1111111
Q ss_pred -----------------CCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 275 -----------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 275 -----------------~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
-..++.+||++||..||.+|+|+.|++.||||+..
T Consensus 361 v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 361 VFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred hhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 01247899999999999999999999999999753
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=318.31 Aligned_cols=245 Identities=27% Similarity=0.395 Sum_probs=203.9
Q ss_pred ceEeecCceEEEEEEECCCC------ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 20 RTLGEGNFGKVKFAQDLDSG------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
+.||+|+||.||+|++.... +.+|+|.+.+.. .......+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46899999999999976443 689999886543 2233567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 94 EYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 94 E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
||+++++|.+++... ..+++.++..++.|++.|++|||+.+++|+||||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p------------------------ 134 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAA------------------------ 134 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCCh------------------------
Confidence 999999999999642 3478899999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCC-----CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 167 IRPWKFNVLQLENILLDSKG-----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g-----~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+||+++.++ .++|+|||++................++..|+|||++.+..+ +.++|||||||+
T Consensus 135 -----------~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i 202 (269)
T cd05044 135 -----------RNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVL 202 (269)
T ss_pred -----------heEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHH
Confidence 999999888 899999999874322111111223356789999999987776 489999999999
Q ss_pred HHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 242 LYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 242 l~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+|+|++ |..||...+.......+..+ .+..+..+++.+.++|.+||..+|.+||+++++++
T Consensus 203 l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 203 MWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999998 99999887776666665543 34566778999999999999999999999999865
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=316.49 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=207.2
Q ss_pred EEEeceEeecCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 011868 16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----- 87 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----- 87 (476)
|.+.+.||+|+||.||+|... .+++.||||++..+.. .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999854 3678999999976542 3334677899999999999999999999885432
Q ss_pred -EEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 88 -KIYMVLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 88 -~~~lV~E~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
..++++||+.+|+|.+++... ..+++..++.++.|++.|++|||+.||+||||||
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp------------------ 141 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAA------------------ 141 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccch------------------
Confidence 347899999999998887432 2478999999999999999999999999999997
Q ss_pred HHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhH
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGv 240 (476)
+||+++.++.+||+|||+++...............+++.|++||.+.+..++ .++|||||||
T Consensus 142 -----------------~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~ 203 (273)
T cd05074 142 -----------------RNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGV 203 (273)
T ss_pred -----------------hhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHH
Confidence 9999999999999999998854321111112233456789999998877765 7899999999
Q ss_pred HHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 241 ILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 241 il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
++|+|++ |+.||.+.+....+..+..+. ...+...++.+.+++.+||+.+|++|||+.+++..
T Consensus 204 il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 204 TMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999 999999888777777666543 44566788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=316.48 Aligned_cols=251 Identities=26% Similarity=0.413 Sum_probs=200.5
Q ss_pred cCEEEeceEeecCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 011868 14 GRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KS 87 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~ 87 (476)
.+|++.+.||+|+||.||+|. +..++..||+|.+.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 479999999999999999997 44678899999986542 3345788999999999999999999998743 34
Q ss_pred EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
.+|+||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp------------------------ 136 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLAT------------------------ 136 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCH------------------------
Confidence 689999999999999999753 4689999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCc-ccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||++++++.+||+|||++........... .....++..|+|||++.+..+. .++||||+||++|+|
T Consensus 137 -----------~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el 204 (284)
T cd05081 137 -----------RNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYEL 204 (284)
T ss_pred -----------hhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcC-hHHHHHHHHHHHHHH
Confidence 999999999999999999986433111101 1112234569999998877664 889999999999999
Q ss_pred hcCCCCCCCCcHHHH---------------HHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 246 LTGYLPFDDRNLAVL---------------YQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~---------------~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
++|..|+........ ...+... .++.+..++.++.+||.+||..+|++|||+.++++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 205 FTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred hhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 998877644321100 0111111 233455688999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=313.20 Aligned_cols=250 Identities=30% Similarity=0.507 Sum_probs=210.7
Q ss_pred CEEEeceEeecCceEEEEEEECC-CCceEEEEEeecccc-------cchhHHHHHHHHHHHHHh-CCCCCcceEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRI-------IHLKITDQIKREIATLKL-LKHPNVVRLHEVLAS 85 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~-~~~~vAvK~i~~~~~-------~~~~~~~~~~~Ei~~l~~-l~HpnIv~l~~~~~~ 85 (476)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.++++ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999887 788999998864321 122334567788888875 799999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 86 KSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
++..|++|||++|++|.+++.. ...+++..++.++.|++.||.|||+ .|++||||||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~------------------ 142 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTP------------------ 142 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCH------------------
Confidence 9999999999999999988743 3469999999999999999999996 7899999997
Q ss_pred HHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhH
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGv 240 (476)
+||+++.++.+||+|||++..... ........|+..|+|||.+.+..+ +.++|+||||+
T Consensus 143 -----------------~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ 201 (269)
T cd08528 143 -----------------NNIMLGEDDKVTITDFGLAKQKQP---ESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGC 201 (269)
T ss_pred -----------------HHEEECCCCcEEEecccceeeccc---ccccccccCcccCcChhhhcCCCC-chHHHHHHHHH
Confidence 999999999999999999985433 113445678999999999987666 58999999999
Q ss_pred HHHHHhcCCCCCCCCcHHHHHHHHHhCCCC-CC-CCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 241 ILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP-KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 241 il~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
++|+|++|+.||...+.......+...... .+ ..+++.+.++|.+||+.||++||++.++.++
T Consensus 202 ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 202 ILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999999999888777666666655443 22 2578999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=313.58 Aligned_cols=245 Identities=20% Similarity=0.315 Sum_probs=194.4
Q ss_pred ceEeecCceEEEEEEECCC--CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011868 20 RTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 97 (476)
+.||+|+||+||+|....+ ...+++|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 4699999999999975332 3456677765443 23346789999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 98 GGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 98 gg~L~~~l~~~----~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
+|+|.+++... ..+++..++.++.||+.||+|||+.+++||||||
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp------------------------------- 127 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLAL------------------------------- 127 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCcc-------------------------------
Confidence 99999999753 2466778889999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC------CCCccchhhhHhHHHHHHhc
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG------YDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~------~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.++.+||+|||++...............+|+..|+|||++.... ..+.++|||||||++|+|++
T Consensus 128 ----~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 203 (268)
T cd05086 128 ----RNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFE 203 (268)
T ss_pred ----ceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHh
Confidence 99999999999999999986321111111223457889999999975321 12468999999999999996
Q ss_pred -CCCCCCCCcHHHHHHHHHhCC-C-----CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 248 -GYLPFDDRNLAVLYQKIFRGD-F-----KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 248 -G~~Pf~~~~~~~~~~~i~~~~-~-----~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|..||...+....+.++..+. . ..+..+++.+.+++..|| .+|++||+++++++
T Consensus 204 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 204 NAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 688998777766666554432 2 233447889999999999 67999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=328.71 Aligned_cols=247 Identities=30% Similarity=0.423 Sum_probs=196.4
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-KIYMV 92 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-~~~lV 92 (476)
+.|.-...||+|+||.||+|.. .+|..||||.+....... ..+|.+|+.++.+++|||+|+|+|+|.+.+ ..+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 3566678999999999999996 455899999876554221 355999999999999999999999999888 59999
Q ss_pred EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhc---CcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 93 LEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNK---GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~---givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
+||+++|+|.+.+.... ++++.+..+|+.+++.||+|||+. .|+||||||
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKs------------------------- 205 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKS------------------------- 205 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCH-------------------------
Confidence 99999999999998654 899999999999999999999985 399999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCccccc-ccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~-~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
.|||||++.+.||+|||+|+..... .....+. .||.+|+|||.+..... +.|+|||||||+|.||+
T Consensus 206 ----------sNILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllEli 272 (361)
T KOG1187|consen 206 ----------SNILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELI 272 (361)
T ss_pred ----------HHeeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHH
Confidence 9999999999999999999753321 2222222 89999999999877555 48999999999999999
Q ss_pred cCCCCCCCCc------HHHHHHH-HHhCC------CCCC-CCCC--HH---HHHHHHHccCCCcCCCCChHHHhc
Q 011868 247 TGYLPFDDRN------LAVLYQK-IFRGD------FKLP-KWLS--PG---AQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 247 tG~~Pf~~~~------~~~~~~~-i~~~~------~~~p-~~~s--~~---~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
||+.|.+... ....... +..+. ..+. ...+ .. +..+..+|++.+|..||++.++.+
T Consensus 273 tgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 273 TGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred hCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 9999887532 1222111 22221 1121 2223 22 556778999999999999999754
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=339.79 Aligned_cols=255 Identities=27% Similarity=0.504 Sum_probs=220.3
Q ss_pred CcCEEE-eceEeecCceEEEEEEECCCCceEEEEEeeccc-ccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE--
Q 011868 13 LGRYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR-IIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK-- 88 (476)
Q Consensus 13 ~~~Y~i-~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~-- 88 (476)
-|||-- ...||+|+|-+||+|.|..+|-.||--.+.... ...++..+++..|+.+|+.|+||||+++|+.+.+...
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 344432 357999999999999999999999865544322 2245557899999999999999999999999976654
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~--givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
+.+|+|++.+|+|..|+...++++...++.|++||+.||.|||++ -|+|||||.
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKC------------------------ 173 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKC------------------------ 173 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCcccccccc------------------------
Confidence 889999999999999999999999999999999999999999998 699999997
Q ss_pred ccccccccCCCCceEeCCC-CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 167 IRPWKFNVLQLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~-g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||+++.+ |.|||+|+|||++... .....+.|||.|||||++. ..|+ ..+||||||+.+.||
T Consensus 174 -----------DNIFinG~~G~VKIGDLGLAtl~r~----s~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEM 236 (632)
T KOG0584|consen 174 -----------DNIFVNGNLGEVKIGDLGLATLLRK----SHAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEM 236 (632)
T ss_pred -----------ceEEEcCCcCceeecchhHHHHhhc----cccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHH
Confidence 99999865 9999999999996543 3344589999999999876 6787 899999999999999
Q ss_pred hcCCCCCCC-CcHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 246 LTGYLPFDD-RNLAVLYQKIFRGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 246 ltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
+|+.+||.. .+...+|+++..|.-| +..--+|+++++|.+||.. ...|+|+.++|.||||..+
T Consensus 237 vT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 237 VTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 999999965 6788999999988654 3344589999999999999 9999999999999999875
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=312.10 Aligned_cols=236 Identities=22% Similarity=0.256 Sum_probs=194.3
Q ss_pred ceEeecCceEEEEEEECCCC----------ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 20 RTLGEGNFGKVKFAQDLDSG----------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~----------~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
+.||+|+||.||+|.+..++ ..+++|++.... .. ...+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46999999999999998776 358888775443 11 5778899999999999999999999887 778
Q ss_pred EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||+++|+|.+++.... .++...+..++.||+.||+|||++||+||||||
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp-------------------------- 129 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCG-------------------------- 129 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCcc--------------------------
Confidence 99999999999999998655 799999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCC-------CEEEeccCCCCCCCcccCCCcccccccCCccccccccccC-CCCCccchhhhHhH
Q 011868 169 PWKFNVLQLENILLDSKG-------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGV 240 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g-------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~sDvwSlGv 240 (476)
+||+++.++ .+||+|||++..... .....++..|+|||++.+. ...+.++|||||||
T Consensus 130 ---------~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 194 (259)
T cd05037 130 ---------KNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGT 194 (259)
T ss_pred ---------ceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHH
Confidence 999999888 799999999874322 2234577889999998776 23358899999999
Q ss_pred HHHHHhc-CCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 241 ILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 241 il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
++|+|++ |..||...+......... .....|......+.++|.+||..+|.+|||+.++++
T Consensus 195 ~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 195 TLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999999 688887765433333222 222233333488999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=354.16 Aligned_cols=250 Identities=27% Similarity=0.407 Sum_probs=214.6
Q ss_pred CcCEEEeceEeecCceEEEEEEECCC-Cc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDS-GL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~-~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
..+-++.+.||+|+||.||.|..... |. .||||.+.+.. +......|.+|..+|+.++||||+++++++-+.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 44677889999999999999986543 32 38888887654 5566789999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 88 KIYMVLEYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
..++++|||+||+|..+|+.. ..++..+...++.||+.|+.||+++++|||||-+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAa------------------ 830 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAA------------------ 830 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhh------------------
Confidence 999999999999999999764 3588999999999999999999999999999997
Q ss_pred HHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCC-ccccc-ccCCccccccccccCCCCCccchhhhH
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDG-LLHTT-CGSPNYVAPEVLANRGYDGATSDIWSC 238 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~-~~~~~-~gt~~y~APE~l~~~~~~~~~sDvwSl 238 (476)
.|.||++...+||+|||+|+..- +.+- ..+.. .-...|||||.+....+. .|+|||||
T Consensus 831 -----------------RNCLL~~~r~VKIaDFGlArDiy--~~~yyr~~~~a~lPvkWm~PEsl~d~iFt-skSDvWsF 890 (1025)
T KOG1095|consen 831 -----------------RNCLLDERRVVKIADFGLARDIY--DKDYYRKHGEAMLPVKWMPPESLKDGIFT-SKSDVWSF 890 (1025)
T ss_pred -----------------hheeecccCcEEEcccchhHhhh--hchheeccCccccceecCCHHHHhhcccc-cccchhhh
Confidence 99999999999999999999221 1111 11111 223599999999987775 89999999
Q ss_pred hHHHHHHhc-CCCCCCCCcHHHHHH-HHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 239 GVILYVILT-GYLPFDDRNLAVLYQ-KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 239 Gvil~ellt-G~~Pf~~~~~~~~~~-~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
||++||++| |..||.+.+..++.. -...+.++.|..++..+.++|..||+.+|++||++..|++
T Consensus 891 GVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 891 GVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 999999999 999999988777666 5556678889999999999999999999999999999987
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=312.81 Aligned_cols=251 Identities=27% Similarity=0.414 Sum_probs=204.1
Q ss_pred cCEEEeceEeecCceEEEEEEEC----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KS 87 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~ 87 (476)
..|++.+.||+|+||.||+|... .+++.||+|++...... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 56888999999999999999854 35889999999765422 346789999999999999999999999877 56
Q ss_pred EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
..|++|||+++++|.+++.... .+++..+..++.||+.||+|||+.|++||||||
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p------------------------ 137 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAA------------------------ 137 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH------------------------
Confidence 7999999999999999997643 699999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC-CcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||+++.++.++|+|||++......... .......++..|+|||.+.+..+. .++|||||||++|+|
T Consensus 138 -----------~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el 205 (284)
T cd05038 138 -----------RNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYEL 205 (284)
T ss_pred -----------HhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhhee
Confidence 9999999999999999999865421111 111123455679999998777664 889999999999999
Q ss_pred hcCCCCCCCCcHHH---------------HHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 246 LTGYLPFDDRNLAV---------------LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 246 ltG~~Pf~~~~~~~---------------~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
++|..||....... ....+... ..+.+..++.++.+|+.+||+.||++|||+.++++
T Consensus 206 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 206 FTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred eccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99999986543211 11122211 23345567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=355.02 Aligned_cols=254 Identities=33% Similarity=0.547 Sum_probs=208.3
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-------
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------- 85 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------- 85 (476)
+..|+.++.||+||||.||+++++-+|+.||||.|.... +......+.+|+..|.+|+|||||++|..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 456788899999999999999999999999999997664 44556889999999999999999998653310
Q ss_pred --------------------------------------------------------------------------------
Q 011868 86 -------------------------------------------------------------------------------- 85 (476)
Q Consensus 86 -------------------------------------------------------------------------------- 85 (476)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CEEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHh
Q 011868 86 ------------------------K--------SKIYMVLEYVTGGELFDKIASKGRL-QEAEGRKLFQQLIDGVSYCHN 132 (476)
Q Consensus 86 ------------------------~--------~~~~lV~E~~~gg~L~~~l~~~~~l-~~~~~~~~~~qi~~al~yLH~ 132 (476)
+ ..+|+-||||+...|.+++..+... ....+|++|+||+.||+|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 1268999999888888877766544 478899999999999999999
Q ss_pred cCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCC----c-------
Q 011868 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQ----H------- 201 (476)
Q Consensus 133 ~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~----~------- 201 (476)
+||+|||||| .||++|+++.|||+|||+|+... .
T Consensus 716 ~giIHRDLKP-----------------------------------~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~ 760 (1351)
T KOG1035|consen 716 QGIIHRDLKP-----------------------------------RNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSF 760 (1351)
T ss_pred CceeeccCCc-----------------------------------ceeEEcCCCCeeecccccchhhhhhhhhHhhccCc
Confidence 9999999997 99999999999999999998621 0
Q ss_pred -----ccCCCcccccccCCccccccccccCC---CCCccchhhhHhHHHHHHhcCCCCCCC-CcHHHHHHHHHhCCCCCC
Q 011868 202 -----FRDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLP 272 (476)
Q Consensus 202 -----~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~sDvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~p 272 (476)
...+...+..+||.-|+|||++.+.. |+ .|+|||||||||+||+. ||.- +........+.++..+.|
T Consensus 761 ~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn-~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~ 836 (1351)
T KOG1035|consen 761 STNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN-SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP 836 (1351)
T ss_pred cccccCCCCcccccccceeeeecHHHhccccccccc-chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC
Confidence 01122445678999999999998755 65 99999999999999984 5642 334456667777777766
Q ss_pred CC----CCHHHHHHHHHccCCCcCCCCChHHHhcCcccc
Q 011868 273 KW----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307 (476)
Q Consensus 273 ~~----~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~ 307 (476)
.. --+.-..+|++||+.||.+|||+.|+|++.||.
T Consensus 837 ~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 837 ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 33 235678999999999999999999999999986
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=313.08 Aligned_cols=254 Identities=13% Similarity=0.145 Sum_probs=194.1
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCC---CceEEEEEeecccccc--hhH------HHHHHHHHHHHHhCCCCCcceE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIH--LKI------TDQIKREIATLKLLKHPNVVRL 79 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~--~~~------~~~~~~Ei~~l~~l~HpnIv~l 79 (476)
..-++|++.+.||+|+||+||+|.+..+ +..+|+|+........ +.. ......+...++.+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3446899999999999999999998777 6778888654332110 000 0112233445667789999999
Q ss_pred EEEEEeCC----EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHH
Q 011868 80 HEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQ 155 (476)
Q Consensus 80 ~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~ 155 (476)
++++.... ..|++|+++ ..++.+.+......++..++.++.|++.||+|||+.||+||||||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp------------- 154 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKP------------- 154 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH-------------
Confidence 99765443 457889988 457777776655678999999999999999999999999999997
Q ss_pred HHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC-----CCcccccccCCccccccccccCCCCC
Q 011868 156 VFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDG 230 (476)
Q Consensus 156 ~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~ 230 (476)
+|||++.++.++|+|||+|+.+..... ........||+.|+|||++.+..++
T Consensus 155 ----------------------~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~- 211 (294)
T PHA02882 155 ----------------------ENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT- 211 (294)
T ss_pred ----------------------HHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC-
Confidence 999999999999999999975432111 1122334799999999999888775
Q ss_pred ccchhhhHhHHHHHHhcCCCCCCCCcH-H--------HHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHh
Q 011868 231 ATSDIWSCGVILYVILTGYLPFDDRNL-A--------VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301 (476)
Q Consensus 231 ~~sDvwSlGvil~elltG~~Pf~~~~~-~--------~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il 301 (476)
.++||||+||++|+|++|..||.+.+. . ....++..+...++ ..++.+.+++..|+..+|++||++++++
T Consensus 212 ~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~rp~~~~l~ 290 (294)
T PHA02882 212 RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIK-NANKFIYDFIECVTKLSYEEKPDYDALI 290 (294)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhccC-CCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence 899999999999999999999987632 1 12233444444333 4678999999999999999999999987
Q ss_pred c
Q 011868 302 A 302 (476)
Q Consensus 302 ~ 302 (476)
+
T Consensus 291 ~ 291 (294)
T PHA02882 291 K 291 (294)
T ss_pred H
Confidence 5
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.26 Aligned_cols=258 Identities=27% Similarity=0.432 Sum_probs=225.4
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE----
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA---- 84 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~---- 84 (476)
.-.-+.|++.+++|.|++|+||+++++.+++..|+||++... +..+++..|..+|+.. .|||++.+|++|.
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 345578999999999999999999999999999999997664 2346788899999988 5999999999985
Q ss_pred -eCCEEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 85 -SKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 85 -~~~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
.++.+|||||||.||+..|+++. ..++.|+.+..|++.++.|+.+||++.++|||||-
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG------------------- 151 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKG------------------- 151 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccC-------------------
Confidence 35689999999999999999975 45799999999999999999999999999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc-----CCCCCccchhh
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIW 236 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~sDvw 236 (476)
.|||++.+|.|||+|||.+..... ......+..|||.|||||++.. ..|+ ..+|+|
T Consensus 152 ----------------~NiLLT~e~~VKLvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~W 212 (953)
T KOG0587|consen 152 ----------------QNVLLTENAEVKLVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLW 212 (953)
T ss_pred ----------------ceEEEeccCcEEEeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcc-cccchh
Confidence 999999999999999999985544 3456678899999999999975 3354 789999
Q ss_pred hHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 237 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 237 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|||++..||-.|.+|+.++.+...+-+|-+..++ -|..++.++.++|..||.+|-.+||+..+++.|||+...
T Consensus 213 sLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 213 SLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred hccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 9999999999999999999988777666655433 356689999999999999999999999999999999743
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=333.80 Aligned_cols=242 Identities=35% Similarity=0.538 Sum_probs=199.7
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS------ 87 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------ 87 (476)
+.|..-+.||+|+||.||+++++.+|+.||||.+++.. ...-.+...+|+++|++++|||||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 56888899999999999999999999999999998765 3344788999999999999999999999865443
Q ss_pred EEEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 88 KIYMVLEYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
...+|||||.||+|+..+++. .++++.+...+...+..||.|||++||+||||||
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP---------------------- 148 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKP---------------------- 148 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCC----------------------
Confidence 468999999999999999753 4799999999999999999999999999999997
Q ss_pred hhccccccccCCCCceEeC--CCC--CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhH
Q 011868 165 IVIRPWKFNVLQLENILLD--SKG--NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~--~~g--~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGv 240 (476)
.||++- ++| ..||+|||.|+-.+ ++....+..||+.|.+||++...++++..+|.||+||
T Consensus 149 -------------~NIvl~~Gedgq~IyKLtDfG~Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gv 212 (732)
T KOG4250|consen 149 -------------GNIVLQIGEDGQSIYKLTDFGAARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGV 212 (732)
T ss_pred -------------CcEEEeecCCCceEEeeecccccccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhh
Confidence 999984 334 47999999999654 4567888999999999999986566679999999999
Q ss_pred HHHHHhcCCCCCCCC-----cHHHHHHHHHhC--------------------CCCCCCCCCHH----HHHHHHHccCCCc
Q 011868 241 ILYVILTGYLPFDDR-----NLAVLYQKIFRG--------------------DFKLPKWLSPG----AQNLLRKILEPNP 291 (476)
Q Consensus 241 il~elltG~~Pf~~~-----~~~~~~~~i~~~--------------------~~~~p~~~s~~----~~~Li~~~L~~dP 291 (476)
++|++.||..||--. +...++..+.+. .+|+|...++. +...+..+|..||
T Consensus 213 tlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~ 292 (732)
T KOG4250|consen 213 TLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNP 292 (732)
T ss_pred HHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhH
Confidence 999999999999432 222333333221 12344445544 4567788899999
Q ss_pred CCCC
Q 011868 292 VKRI 295 (476)
Q Consensus 292 ~~R~ 295 (476)
.+|.
T Consensus 293 ~~~~ 296 (732)
T KOG4250|consen 293 RKRG 296 (732)
T ss_pred HHhC
Confidence 9998
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=315.05 Aligned_cols=263 Identities=30% Similarity=0.435 Sum_probs=218.2
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccch----hHHHHHHHHHHHHHhCCCCCcceEEEEEEe-C
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL----KITDQIKREIATLKLLKHPNVVRLHEVLAS-K 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~ 86 (476)
.-.+|-++..||+|+|++||+|.|....+.||+|+-..+..+.. +..+...+|..|.+.|+||.||++||+|.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 45689999999999999999999999999999999765543322 234568899999999999999999999964 4
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--GVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~--givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
..+|-|+|||+|.+|.-++....-+++.+|+.|+.||++||.||.+. -|+|-||||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKP---------------------- 598 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKP---------------------- 598 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCC----------------------
Confidence 57899999999999999999988999999999999999999999986 699999997
Q ss_pred hhccccccccCCCCceEeCC---CCCEEEeccCCCCCCCcccCC-----CcccccccCCcccccccccc---CCCCCccc
Q 011868 165 IVIRPWKFNVLQLENILLDS---KGNIKISDFGLSALPQHFRDD-----GLLHTTCGSPNYVAPEVLAN---RGYDGATS 233 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~---~g~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~---~~~~~~~s 233 (476)
.|||+-+ -|.+||+||||+++++....+ ..+....||.+|++||.+.- .+-.+.++
T Consensus 599 -------------gNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKV 665 (775)
T KOG1151|consen 599 -------------GNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKV 665 (775)
T ss_pred -------------ccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccce
Confidence 8999853 478999999999987653222 24556789999999998753 22335899
Q ss_pred hhhhHhHHHHHHhcCCCCCCCCc-HHHHHHH--HHhC-CCCCC--CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccc
Q 011868 234 DIWSCGVILYVILTGYLPFDDRN-LAVLYQK--IFRG-DFKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307 (476)
Q Consensus 234 DvwSlGvil~elltG~~Pf~~~~-~~~~~~~--i~~~-~~~~p--~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~ 307 (476)
||||+|||+|.++.|+.||.... ..++++. |.+. +..|| +.+++++.++|++||+..-..|+...++..||+|.
T Consensus 666 DVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 666 DVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred eeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 99999999999999999997653 2333332 3332 23344 55899999999999999999999999999999997
Q ss_pred cc
Q 011868 308 QD 309 (476)
Q Consensus 308 ~~ 309 (476)
..
T Consensus 746 Ph 747 (775)
T KOG1151|consen 746 PH 747 (775)
T ss_pred ch
Confidence 53
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=331.74 Aligned_cols=258 Identities=21% Similarity=0.292 Sum_probs=182.4
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECCC----CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEE-
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDS----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV- 82 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~- 82 (476)
......++|++.+.||+|+||+||+|++..+ +..||+|.+..... .+....| .++...+.++..+...
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~ 198 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGF 198 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhh
Confidence 3456788999999999999999999999888 99999998754321 1111111 1222222333222221
Q ss_pred -----EEeCCEEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCcEe
Q 011868 83 -----LASKSKIYMVLEYVTGGELFDKIASKGR--------------------LQEAEGRKLFQQLIDGVSYCHNKGVFH 137 (476)
Q Consensus 83 -----~~~~~~~~lV~E~~~gg~L~~~l~~~~~--------------------l~~~~~~~~~~qi~~al~yLH~~givH 137 (476)
...+..+|+||||+.+++|.+++..... .....++.++.||+.||+|||++||+|
T Consensus 199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH 278 (566)
T PLN03225 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH 278 (566)
T ss_pred hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 2456689999999999999998865321 123456789999999999999999999
Q ss_pred ccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCC-CCCEEEeccCCCCCCCcccCCCcccccccCCc
Q 011868 138 RDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 216 (476)
Q Consensus 138 rDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~-~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 216 (476)
||||| +|||++. ++.+||+|||+|+..... ........+||+.
T Consensus 279 RDLKP-----------------------------------~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~ 322 (566)
T PLN03225 279 RDVKP-----------------------------------QNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPR 322 (566)
T ss_pred CcCCH-----------------------------------HHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCC
Confidence 99997 9999986 689999999999854321 1223456789999
Q ss_pred cccccccccCCCC---------------------CccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC----
Q 011868 217 YVAPEVLANRGYD---------------------GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL---- 271 (476)
Q Consensus 217 y~APE~l~~~~~~---------------------~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---- 271 (476)
|+|||++...... ..++||||+||+||||+++..|++.. .......+.......
T Consensus 323 Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~ 401 (566)
T PLN03225 323 YAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWR 401 (566)
T ss_pred ccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHH
Confidence 9999976432211 24569999999999999988776432 112222222111111
Q ss_pred -----------------CCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 272 -----------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 272 -----------------p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
....+....+||.+||+.||.+|||++++++||||...
T Consensus 402 ~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 402 KLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDRE 456 (566)
T ss_pred HhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCC
Confidence 11123345689999999999999999999999999764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=288.98 Aligned_cols=240 Identities=45% Similarity=0.785 Sum_probs=209.6
Q ss_pred CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHHH
Q 011868 26 NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI 105 (476)
Q Consensus 26 ~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l 105 (476)
+||.||+|.+..+|+.+|+|++........ .+.+.+|+..+++++|+||+++++++......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999988899999999976543221 578999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCC
Q 011868 106 ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185 (476)
Q Consensus 106 ~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~ 185 (476)
.....++...++.++.|++.++.|||+.|++|+||+| .||+++++
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~-----------------------------------~ni~~~~~ 123 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKP-----------------------------------ENILLDED 123 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCH-----------------------------------HHeEECCC
Confidence 8766699999999999999999999999999999997 99999999
Q ss_pred CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCC-CcHHHHHHHH
Q 011868 186 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKI 264 (476)
Q Consensus 186 g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~-~~~~~~~~~i 264 (476)
+.++|+|||.+..... ........++..|+|||.+.+..++ .++||||+|+++|+|++|..||.. .+........
T Consensus 124 ~~~~l~d~~~~~~~~~---~~~~~~~~~~~~~~~pE~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~ 199 (244)
T smart00220 124 GHVKLADFGLARQLDP---GGLLTTFVGTPEYMAPEVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI 199 (244)
T ss_pred CcEEEccccceeeecc---ccccccccCCcCCCCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 9999999999985433 1134456788999999998877775 799999999999999999999987 5666666666
Q ss_pred HhCCCCCCCC---CCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 265 FRGDFKLPKW---LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 265 ~~~~~~~p~~---~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
.......+.. ++.++.+++.+||..||++||++.++++||||
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 200 GKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred hccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 6555544332 88899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=287.92 Aligned_cols=251 Identities=25% Similarity=0.472 Sum_probs=207.0
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK--SK 88 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~--~~ 88 (476)
..++|++++++|+|.||+|+.|.+..+++.++||+++... .+.+++|+.||+.|+ ||||++++++..+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 4568999999999999999999999999999999997553 578999999999997 99999999998654 45
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
..||+||+.+.+...+- ..++.-+++.|+.|++.||.|||++||+|||+||
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKP-------------------------- 160 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKP-------------------------- 160 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCc--------------------------
Confidence 78999999887765544 3488999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCC-CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 169 PWKFNVLQLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~-g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
.|+++|.. -.++|+|+|||.++.. .......+.+..|--||.+.........-|+|||||+|..|++
T Consensus 161 ---------hNvmIdh~~rkLrlIDWGLAEFYHp---~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miF 228 (338)
T KOG0668|consen 161 ---------HNVMIDHELRKLRLIDWGLAEFYHP---GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 228 (338)
T ss_pred ---------ceeeechhhceeeeeecchHhhcCC---CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHh
Confidence 99999964 5799999999997654 3334556778899999999876544578999999999999999
Q ss_pred CCCCC-CCCcHHHHHHHHHh-------------CCCCCC-------------CC-----------CCHHHHHHHHHccCC
Q 011868 248 GYLPF-DDRNLAVLYQKIFR-------------GDFKLP-------------KW-----------LSPGAQNLLRKILEP 289 (476)
Q Consensus 248 G~~Pf-~~~~~~~~~~~i~~-------------~~~~~p-------------~~-----------~s~~~~~Li~~~L~~ 289 (476)
.+-|| .|.+..+.+-+|.+ -...++ +| .++++.+|+.++|..
T Consensus 229 rkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrY 308 (338)
T KOG0668|consen 229 RKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRY 308 (338)
T ss_pred ccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhh
Confidence 98886 45444444433321 111111 11 479999999999999
Q ss_pred CcCCCCChHHHhcCcccccc
Q 011868 290 NPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 290 dP~~R~s~~~il~~~~~~~~ 309 (476)
|-++|+|+.|++.||||..-
T Consensus 309 DHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 309 DHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred ccccccchHHHhcCchHHHH
Confidence 99999999999999999753
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.52 Aligned_cols=244 Identities=28% Similarity=0.434 Sum_probs=208.3
Q ss_pred EEeceEeecCceEEEEEEECC--CCc--eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 17 ELGRTLGEGNFGKVKFAQDLD--SGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~--~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
++.+.||.|-||.||.|.... .|+ -||||.-+.+. ..+..+.|..|..+|+.++||||+++++++.. ...|+|
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 345679999999999998643 333 58888887654 34447899999999999999999999999975 468999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||+++-|+|..+++.+ ..++......|+.||..||+|||+.+.|||||-.
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAa----------------------------- 519 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAA----------------------------- 519 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhh-----------------------------
Confidence 9999999999999865 4799999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccc--cccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~--~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
.|||+.+...+||+||||++..+. +...+. ..-...|||||.+.-..++ .+||||-|||.+||++. |
T Consensus 520 ------RNiLVsSp~CVKLaDFGLSR~~ed---~~yYkaS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lG 589 (974)
T KOG4257|consen 520 ------RNILVSSPQCVKLADFGLSRYLED---DAYYKASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLG 589 (974)
T ss_pred ------hheeecCcceeeecccchhhhccc---cchhhccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhc
Confidence 999999999999999999997654 222222 2234589999998877775 78999999999999987 9
Q ss_pred CCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 249 YLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
..||.|-...+....+.+| .++.|+.++|.+..|+.+||..+|.+||++.+|.+
T Consensus 590 vkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 590 VKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred CCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 9999997776666666666 47899999999999999999999999999988754
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.55 Aligned_cols=254 Identities=30% Similarity=0.434 Sum_probs=216.9
Q ss_pred cCEEEeceEeecCceEEEEEEECC-CC--ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLD-SG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~-~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
++..+.++||+|.||.||.|.... +| -.||||.++.+.... ..+.|.+|+.+|-+|+|||+++||++..+ ..+.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 455677899999999999998765 33 358999997765322 57899999999999999999999999887 7788
Q ss_pred EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
+|||++++|+|.+.+.. ...|.......|+.||+.||.||.++++|||||-+
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAA-------------------------- 240 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAA-------------------------- 240 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhh--------------------------
Confidence 99999999999999976 34688899999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCc-ccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
.|+|+.....||||||||.+......+--. .....-...|+|||.+....++ .+||||++||++|||++
T Consensus 241 ---------RNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFt 310 (1039)
T KOG0199|consen 241 ---------RNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFT 310 (1039)
T ss_pred ---------hhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhc
Confidence 999999999999999999986544221111 1122234589999999998886 88999999999999999
Q ss_pred -CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 248 -GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 248 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
|..||.|.+...++++|-.++ ++-|+.++.++.+++..||..+|++|||+..|.+.-++
T Consensus 311 yGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 311 YGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred cCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 999999999999999887653 67789999999999999999999999999999755443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=296.82 Aligned_cols=257 Identities=28% Similarity=0.440 Sum_probs=215.6
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~----- 86 (476)
...||.-++.+|.|+- .|-.|-|..++++||+|.+.... ......++..+|..++..+.|+||++++.+|.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 3457888999999998 78889999999999999987663 3444578899999999999999999999999643
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 87 -~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
...|+||||+ .++|.+.+. -.++...++.++.|++.|++|||+.||+||||||
T Consensus 93 ~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkP----------------------- 146 (369)
T KOG0665|consen 93 FQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKP----------------------- 146 (369)
T ss_pred HHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCc-----------------------
Confidence 3589999999 569988887 3588999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||++..++.+||.|||+|+.-. .+-.++..+.|..|.|||++.+.+|. +.+||||+|||+.||
T Consensus 147 ------------snivv~~~~~lKi~dfg~ar~e~---~~~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEl 210 (369)
T KOG0665|consen 147 ------------SNIVVNSDCTLKILDFGLARTED---TDFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEL 210 (369)
T ss_pred ------------ccceecchhheeeccchhhcccC---cccccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHH
Confidence 99999999999999999998422 22356667899999999999999975 889999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCC---------------------------CC----CCCC-----------CCHHHHHHH
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGD---------------------------FK----LPKW-----------LSPGAQNLL 283 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~---------------------------~~----~p~~-----------~s~~~~~Li 283 (476)
++|...|.|.+.-+.+.++...- +. +|.+ -+..+++|+
T Consensus 211 i~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll 290 (369)
T KOG0665|consen 211 ILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLL 290 (369)
T ss_pred hhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHH
Confidence 99999999987666665553210 01 1211 134689999
Q ss_pred HHccCCCcCCCCChHHHhcCccccccCCC
Q 011868 284 RKILEPNPVKRITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 284 ~~~L~~dP~~R~s~~~il~~~~~~~~~~~ 312 (476)
.+||..||++|+|++++|+|||++-++.+
T Consensus 291 ~~MLvi~pe~Risv~daL~HPY~~vw~~~ 319 (369)
T KOG0665|consen 291 SKMLVIDPEKRISVDDALRHPYIKVWYDP 319 (369)
T ss_pred HHhhccChhhcccHHHHhcCCeeeeeccc
Confidence 99999999999999999999999966543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=293.03 Aligned_cols=251 Identities=26% Similarity=0.397 Sum_probs=207.4
Q ss_pred EEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEec
Q 011868 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 95 (476)
+-...||.|+||+|++-.++.+|+..|||.|+.... .....++..|.....+- +.||||++|+....++..|+.||+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 345679999999999999999999999999987753 44467888888865554 689999999999999999999999
Q ss_pred cCCCChHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 96 VTGGELFDKI-----ASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 96 ~~gg~L~~~l-----~~~~~l~~~~~~~~~~qi~~al~yLH~~-givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+ .-+|..+- ..+..++|...-.+....+.||.||... +|+|||+||
T Consensus 145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKP--------------------------- 196 (361)
T KOG1006|consen 145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKP--------------------------- 196 (361)
T ss_pred H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCCh---------------------------
Confidence 9 44654332 2346799999999999999999999974 999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc--CCCCCccchhhhHhHHHHHHhc
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||+|..|.+||||||++..... .-....-.|..+|||||.+.. .+|+ .+|||||||++|||+.|
T Consensus 197 --------SNILldr~G~vKLCDFGIcGqLv~---SiAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAt 264 (361)
T KOG1006|consen 197 --------SNILLDRHGDVKLCDFGICGQLVD---SIAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVAT 264 (361)
T ss_pred --------hheEEecCCCEeeecccchHhHHH---HHHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeec
Confidence 999999999999999999874321 112233468999999999864 4676 89999999999999999
Q ss_pred CCCCCCCCc-HHHHHHHHHhCCCCC---CCC---CCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 248 GYLPFDDRN-LAVLYQKIFRGDFKL---PKW---LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 248 G~~Pf~~~~-~~~~~~~i~~~~~~~---p~~---~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|..||.+-+ ..+...++..++++. +.. ++..+..+|..||.+|-..||...+++.+||+...
T Consensus 265 G~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 265 GNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred CCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 999997654 345556666777653 333 78999999999999999999999999999998754
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=321.66 Aligned_cols=252 Identities=24% Similarity=0.407 Sum_probs=221.0
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
.+--.|.+.||.|.||+|++|+.+..|+ .||||.++... .++....|..|+.||-+++||||++|-++.......
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 3456788999999999999999887664 69999998765 456678999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
.+|.|||++|+|..+|.. +++|+..+...+++.|++||.||-+.|.|||||-+
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAA-------------------------- 759 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAA-------------------------- 759 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhh--------------------------
Confidence 999999999999999975 47899999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCccccccc--CCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g--t~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
.|||++.+-.+|++||||+++.+... .....+.-| ...|.|||.+...++. .+|||||+||++||.+
T Consensus 760 ---------RNILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVm 828 (996)
T KOG0196|consen 760 ---------RNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVM 828 (996)
T ss_pred ---------hheeeccceEEEeccccceeecccCC-CccccccCCccceeecChhHhhhcccC-chhhccccceEEEEec
Confidence 99999999999999999999775532 122222223 3599999999999886 7899999999999988
Q ss_pred c-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 247 T-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 247 t-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+ |..||-+.+..+....|.++ .++.|-.++..+..|+..||++|-.+||.++||+++
T Consensus 829 SyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 829 SYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred ccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 7 99999888888888888776 466777899999999999999999999999999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=313.74 Aligned_cols=265 Identities=19% Similarity=0.242 Sum_probs=192.2
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEEC----------------CCCceEEEEEeecccccch-h----------HHHHH
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDL----------------DSGLPFAVKILEKNRIIHL-K----------ITDQI 61 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~----------------~~~~~vAvK~i~~~~~~~~-~----------~~~~~ 61 (476)
..+..++|++.++||+|+||.||+|... ..++.||||.+........ + ..+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 3467889999999999999999999752 2456799999865421100 0 11223
Q ss_pred HHHHHHHHhCCCCCc-----ceEEEEEEe--------CCEEEEEEeccCCCChHHHHHhc--------------------
Q 011868 62 KREIATLKLLKHPNV-----VRLHEVLAS--------KSKIYMVLEYVTGGELFDKIASK-------------------- 108 (476)
Q Consensus 62 ~~Ei~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~l~~~-------------------- 108 (476)
..|+..+.+++|.++ ++++++|.. ++..|+||||+++++|.+++...
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 447777777776654 666776643 35689999999999999988632
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCC
Q 011868 109 ----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184 (476)
Q Consensus 109 ----~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~ 184 (476)
..+++..++.++.|++.||.|||+.+|+|||||| +|||++.
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp-----------------------------------~NILl~~ 344 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKP-----------------------------------ENLLVTV 344 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCch-----------------------------------HhEEECC
Confidence 1235677889999999999999999999999997 9999999
Q ss_pred CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCC--------------------C-CccchhhhHhHHHH
Q 011868 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY--------------------D-GATSDIWSCGVILY 243 (476)
Q Consensus 185 ~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~--------------------~-~~~sDvwSlGvil~ 243 (476)
++.+||+|||++....... ........+|+.|+|||++..... . ..+.||||+||++|
T Consensus 345 ~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~ 423 (507)
T PLN03224 345 DGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLM 423 (507)
T ss_pred CCcEEEEeCcCccccccCC-ccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHH
Confidence 9999999999997433211 111112234899999999864321 1 12479999999999
Q ss_pred HHhcCCC-CCCCCcH-----------HHHHHHHHhCCCCCC--CCCCHHHHHHHHHccCCCc---CCCCChHHHhcCccc
Q 011868 244 VILTGYL-PFDDRNL-----------AVLYQKIFRGDFKLP--KWLSPGAQNLLRKILEPNP---VKRITIAGIKADEWF 306 (476)
Q Consensus 244 elltG~~-Pf~~~~~-----------~~~~~~i~~~~~~~p--~~~s~~~~~Li~~~L~~dP---~~R~s~~~il~~~~~ 306 (476)
+|++|.. ||.+... ...+..+....+.++ ...++.+.+|+.+||..+| .+|+|++|+|+||||
T Consensus 424 em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 424 QMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred HHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 9999886 7754221 111122222333343 4478999999999999876 689999999999999
Q ss_pred ccc
Q 011868 307 EQD 309 (476)
Q Consensus 307 ~~~ 309 (476)
...
T Consensus 504 ~~~ 506 (507)
T PLN03224 504 LPE 506 (507)
T ss_pred CCC
Confidence 653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.95 Aligned_cols=252 Identities=28% Similarity=0.404 Sum_probs=211.6
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC------CCCcceEEEEEEe
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK------HPNVVRLHEVLAS 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~------HpnIv~l~~~~~~ 85 (476)
.=++|.+....|+|-||+|-.|.|...|..||||||..+. -+...=.+|+++|++|. --|+++++-.|..
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 3458999999999999999999999999999999998764 33566778999999995 3579999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHH
Q 011868 86 KSKIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFL 162 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~ 162 (476)
.+++|||+|.+ ..+|.+.+..-+ ++....++.|+.|+..||..|...||+|.||||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKP-------------------- 564 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKP-------------------- 564 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCc--------------------
Confidence 99999999999 679999997643 699999999999999999999999999999997
Q ss_pred HhhhccccccccCCCCceEeCCC-CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 163 LMIVIRPWKFNVLQLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 163 ~~~~~~p~~~~~~~~~NiLl~~~-g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+|||+++. ..+||||||.|..... .-.....-+..|.|||++.+..|+ ...|+||+||.
T Consensus 565 ---------------DNiLVNE~k~iLKLCDfGSA~~~~e----neitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgct 624 (752)
T KOG0670|consen 565 ---------------DNILVNESKNILKLCDFGSASFASE----NEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCT 624 (752)
T ss_pred ---------------cceEeccCcceeeeccCcccccccc----ccccHHHHHHhccCcceeecCccc-CCccceeecee
Confidence 99999976 5689999999874332 223334456799999999999998 88999999999
Q ss_pred HHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCC-----------------------------------------------
Q 011868 242 LYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW----------------------------------------------- 274 (476)
Q Consensus 242 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~----------------------------------------------- 274 (476)
||||+||+..|+|.+...++........++|..
T Consensus 625 LYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~ 704 (752)
T KOG0670|consen 625 LYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSE 704 (752)
T ss_pred eEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHH
Confidence 999999999999987666654443322222211
Q ss_pred ------C-------CHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 275 ------L-------SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 275 ------~-------s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+ -.++.+|+.+||..||++|.|+.|+|+||||..
T Consensus 705 l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 705 LIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 0 135889999999999999999999999999864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=300.04 Aligned_cols=291 Identities=25% Similarity=0.347 Sum_probs=209.5
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-----C---CCcceEEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----H---PNVVRLHEV 82 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-----H---pnIv~l~~~ 82 (476)
..-+||.+.++||+|.|++||+|.|.++.+.||+|+++... ...+....||.+|+.++ | .+||+|+|.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 33479999999999999999999999999999999997653 33577889999999984 3 359999999
Q ss_pred EE----eCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CcEeccCCcchhccchh---hh
Q 011868 83 LA----SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMR---IA 152 (476)
Q Consensus 83 ~~----~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~-givHrDiKp~~~~~~~~---~~ 152 (476)
|. +..++|+|+|++ |-+|..+|... ..++...++.|++||+.||.|||.. ||+|-||||.|+...+- .+
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~ 229 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPA 229 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchh
Confidence 95 456999999999 88999999754 4799999999999999999999985 99999999998765554 11
Q ss_pred HHHHHHHHHHHh-------------------------------------------hh-------cc-----------cc-
Q 011868 153 TLQVFLLTFLLM-------------------------------------------IV-------IR-----------PW- 170 (476)
Q Consensus 153 ~~~~~~~~~~~~-------------------------------------------~~-------~~-----------p~- 170 (476)
.+...+...... .. +. |.
T Consensus 230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~ 309 (590)
T KOG1290|consen 230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI 309 (590)
T ss_pred hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence 111111100000 00 00 00
Q ss_pred cccc----------------------------------------------------CCC-------CceEe-------CC
Q 011868 171 KFNV----------------------------------------------------LQL-------ENILL-------DS 184 (476)
Q Consensus 171 ~~~~----------------------------------------------------~~~-------~NiLl-------~~ 184 (476)
+... ..| .|.++ ..
T Consensus 310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~ 389 (590)
T KOG1290|consen 310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC 389 (590)
T ss_pred CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence 1110 000 01111 01
Q ss_pred CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCC---c---HH
Q 011868 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---N---LA 258 (476)
Q Consensus 185 ~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~---~---~~ 258 (476)
+-.+||+|||-|+.... ....-.-|..|+||||+.+.+|. ..+||||++|++|||+||.+.|+-. + .+
T Consensus 390 di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~-~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE 463 (590)
T KOG1290|consen 390 DIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYS-TSADIWSTACMAFELATGDYLFEPHSGENYSRDE 463 (590)
T ss_pred ceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCC-CchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence 23589999999995322 22334678999999999999996 8899999999999999999999531 1 11
Q ss_pred HHHHHHH------------hCC------------------------------CCCCCCCCHHHHHHHHHccCCCcCCCCC
Q 011868 259 VLYQKIF------------RGD------------------------------FKLPKWLSPGAQNLLRKILEPNPVKRIT 296 (476)
Q Consensus 259 ~~~~~i~------------~~~------------------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~s 296 (476)
+-...|. .|. +.++..-..++.+++.-||+.+|.+|||
T Consensus 464 DHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t 543 (590)
T KOG1290|consen 464 DHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT 543 (590)
T ss_pred HHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence 1111111 111 1122222456889999999999999999
Q ss_pred hHHHhcCccccccCCC
Q 011868 297 IAGIKADEWFEQDYTP 312 (476)
Q Consensus 297 ~~~il~~~~~~~~~~~ 312 (476)
+.++++|||+.....+
T Consensus 544 A~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 544 AAQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHHhcCccccCCCCC
Confidence 9999999999875544
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.99 Aligned_cols=241 Identities=28% Similarity=0.463 Sum_probs=212.5
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 95 (476)
..+.++||-|.||.||.|..+.-...||||.++.+.+ ..++|..|+.+|+.++|||+|+|+++|..+..+|||.||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 4556889999999999999988888999999976542 268899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 96 VTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 96 ~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
|..|+|.+++.... .++.-....++.||.+||+||..++++||||-+
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAA------------------------------- 393 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAA------------------------------- 393 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhh-------------------------------
Confidence 99999999998654 466677788899999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCccccccc---CCccccccccccCCCCCccchhhhHhHHHHHHhc-CC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG---SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GY 249 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g---t~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~ 249 (476)
.|.|+.++..|||+||||++++... ....-.| ...|.|||-+.-..+. .|+|||+|||+|||+.| |.
T Consensus 394 ----RNCLVgEnhiVKvADFGLsRlMtgD----TYTAHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGM 464 (1157)
T KOG4278|consen 394 ----RNCLVGENHIVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGM 464 (1157)
T ss_pred ----hhccccccceEEeeccchhhhhcCC----ceecccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCC
Confidence 9999999999999999999975431 1111222 4589999999888885 89999999999999998 99
Q ss_pred CCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHH
Q 011868 250 LPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 300 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~i 300 (476)
.||.|-+....|....++ .+.-|..+++...+|++.||+++|.+||++++|
T Consensus 465 sPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 465 SPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred CCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 999999999888877665 466789999999999999999999999999998
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=294.53 Aligned_cols=256 Identities=28% Similarity=0.415 Sum_probs=212.8
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EEE
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KIY 90 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----~~~ 90 (476)
.+--+.||.|+||.||.+.|..+|+.||+|.+..-. .+.-..+.+.+|+.+|..++|.|++..+|+..... .+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345678999999999999999999999999885432 23333578899999999999999999999875443 478
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
+++|++ ..+|...|.+...++.+.++-+..||+.||.|||+.||.||||||
T Consensus 134 V~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKP---------------------------- 184 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKP---------------------------- 184 (449)
T ss_pred HHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCC----------------------------
Confidence 899999 569999988888999999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
.|+|+++|..+||||||+|+.-+.. +...+...+-|-+|+|||++.+...++.+.||||.|||+.||+..+.
T Consensus 185 -------GNLLVNSNCvLKICDFGLARvee~d-~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrI 256 (449)
T KOG0664|consen 185 -------GNLLVNSNCILKICDFGLARTWDQR-DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKI 256 (449)
T ss_pred -------ccEEeccCceEEecccccccccchh-hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhh
Confidence 9999999999999999999975432 23344555678999999999997766789999999999999999999
Q ss_pred CCCCCcHHHHHHHHHh-----------------------CCCCCCC-----------CCCHHHHHHHHHccCCCcCCCCC
Q 011868 251 PFDDRNLAVLYQKIFR-----------------------GDFKLPK-----------WLSPGAQNLLRKILEPNPVKRIT 296 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~-----------------------~~~~~p~-----------~~s~~~~~Li~~~L~~dP~~R~s 296 (476)
.|+..++...++.|.. +....|. .-..+..+++.++|.+||.+|++
T Consensus 257 LFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris 336 (449)
T KOG0664|consen 257 LFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS 336 (449)
T ss_pred hhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc
Confidence 9998877666555432 1112221 22356889999999999999999
Q ss_pred hHHHhcCcccccc
Q 011868 297 IAGIKADEWFEQD 309 (476)
Q Consensus 297 ~~~il~~~~~~~~ 309 (476)
.++.+.|+++...
T Consensus 337 ~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 337 VEEALQHRYLEEG 349 (449)
T ss_pred Hhhhccccccccc
Confidence 9999999998654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.16 Aligned_cols=250 Identities=25% Similarity=0.393 Sum_probs=207.2
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
.+..++++||+|-||+|.++.- ..+..||||+++.+... .....|.+||++|.+|+||||+.++++|..++.+|+|+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 3567889999999999999985 45799999999877633 33689999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 94 EYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||+++|+|.+++.... .+.-....+++.||++||+||.+.++|||||.+
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~----------------------------- 665 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLAT----------------------------- 665 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccc-----------------------------
Confidence 9999999999997642 234455567999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc--CC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GY 249 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt--G~ 249 (476)
.|+|+|.++++||+|||+++..=....-......+-...|||||.+...+++ .+||+|+||+++||+++ ..
T Consensus 666 ------rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e 738 (807)
T KOG1094|consen 666 ------RNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCRE 738 (807)
T ss_pred ------cceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhh
Confidence 9999999999999999999832211111122233456799999999988886 88999999999999765 89
Q ss_pred CCCCCCcHHHHHHHHH---hCC-----CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 250 LPFDDRNLAVLYQKIF---RGD-----FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~---~~~-----~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
.||...+.+...+... ... +..|.-++..+.+||.+||..|-.+|||++++-.
T Consensus 739 ~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 739 QPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 9998877766555432 221 3457779999999999999999999999999843
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.13 Aligned_cols=207 Identities=33% Similarity=0.604 Sum_probs=186.8
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHH-----HHHHHHHHHHhCC---CCCcceEE
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD-----QIKREIATLKLLK---HPNVVRLH 80 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~-----~~~~Ei~~l~~l~---HpnIv~l~ 80 (476)
+...+..|...+.||.|+||+||+|.++.+...|+||.|.+++.......+ .+-.||+||..++ |+||++++
T Consensus 556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence 345677899999999999999999999999999999999988754333222 3567999999997 99999999
Q ss_pred EEEEeCCEEEEEEecc-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHH
Q 011868 81 EVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 81 ~~~~~~~~~~lV~E~~-~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
++|++++.+||+||-- +|-+|+++|.-...++|.+++.+|+|++.|+++||++||+|||||-
T Consensus 636 dfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikd----------------- 698 (772)
T KOG1152|consen 636 DFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKD----------------- 698 (772)
T ss_pred heeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceeccccc-----------------
Confidence 9999999999999976 5679999999989999999999999999999999999999999996
Q ss_pred HHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHh
Q 011868 160 TFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlG 239 (476)
||++++.+|.+||+|||.|... ..+...+.+||..|.|||++.+..|-|.+-|||++|
T Consensus 699 ------------------envivd~~g~~klidfgsaa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalg 756 (772)
T KOG1152|consen 699 ------------------ENVIVDSNGFVKLIDFGSAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALG 756 (772)
T ss_pred ------------------ccEEEecCCeEEEeeccchhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhh
Confidence 9999999999999999998753 345677889999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCC
Q 011868 240 VILYVILTGYLPFDD 254 (476)
Q Consensus 240 vil~elltG~~Pf~~ 254 (476)
++||.++....||.+
T Consensus 757 illytivykenpyyn 771 (772)
T KOG1152|consen 757 ILLYTIVYKENPYYN 771 (772)
T ss_pred heeeEEEeccCCCcC
Confidence 999999999999853
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=335.49 Aligned_cols=236 Identities=23% Similarity=0.334 Sum_probs=187.5
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
.|...+.||+|+||.||+|++..++..||||.+..... ...+|+.++++++||||+++++++.+....|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 35566789999999999999988999999999864321 12346889999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH---NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH---~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|+++|+|.+++. .+++.++..++.|++.||+||| +.+|+||||||
T Consensus 764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp----------------------------- 811 (968)
T PLN00113 764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP----------------------------- 811 (968)
T ss_pred CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCH-----------------------------
Confidence 999999999995 3889999999999999999999 66999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||+++.++..++. ||.+.... ...+..||+.|+|||++.+..++ .++||||+||++|||+||+.|
T Consensus 812 ------~Nil~~~~~~~~~~-~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p 877 (968)
T PLN00113 812 ------EKIIIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSP 877 (968)
T ss_pred ------HhEEECCCCceEEE-eccccccc------cCCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCC
Confidence 99999999988876 66654321 11234689999999999887775 899999999999999999999
Q ss_pred CCCCc-----HHHHHHHHHhC-------CCCC------CCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 252 FDDRN-----LAVLYQKIFRG-------DFKL------PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 252 f~~~~-----~~~~~~~i~~~-------~~~~------p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|+... ........... +... +.....++.+++.+||+.||++|||+.++++.
T Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 878 ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 95432 11111111100 0001 11112356789999999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=308.63 Aligned_cols=257 Identities=30% Similarity=0.452 Sum_probs=223.4
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
--++|++++.+|.|+||.||+|+|+.+++..|+|+++.+.. +...-+..|+-+++.++||||+.+++.|-.+...|+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 45689999999999999999999999999999999987653 235678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
+||||-||+|.+.-.--+++++.++....+..+.|++|||++|-+|||||-
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKG----------------------------- 140 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKG----------------------------- 140 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccc-----------------------------
Confidence 999999999999877778999999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccc---cCCCCCccchhhhHhHHHHHHhcC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~sDvwSlGvil~elltG 248 (476)
.|||+++.|.+|++|||.+..+.. .-.......|||+|||||+.. ..+|. ..||||++|+...|+---
T Consensus 141 ------anilltd~gDvklaDfgvsaqita--ti~KrksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eL 211 (829)
T KOG0576|consen 141 ------ANILLTDEGDVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGEL 211 (829)
T ss_pred ------cceeecccCceeecccCchhhhhh--hhhhhhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhc
Confidence 899999999999999999874332 223345678999999999863 45665 899999999999999888
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCCC-----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
++|--+..++.....+.+..+..| ..+++.+.+|++.+|.++|++|||++-+|.|||..+.
T Consensus 212 qpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 212 QPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred CCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 888666666666656666655544 3378899999999999999999999999999998653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.19 Aligned_cols=243 Identities=31% Similarity=0.433 Sum_probs=195.7
Q ss_pred eceEeecCceE-EEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEecc
Q 011868 19 GRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYV 96 (476)
Q Consensus 19 ~~~LG~G~fg~-V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 96 (476)
.+.+|.|+-|+ ||+|. ..|+.||||.+-.+ ..+...+||..|+.-+ |||||++|+.-.++++.|++.|+|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35689999986 78888 47889999987443 2567889999999984 999999999999999999999999
Q ss_pred CCCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 97 TGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 97 ~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
..+|.|+++..+. ......+....|+++||++||+.+|+||||||
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkP------------------------------ 634 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKP------------------------------ 634 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCC------------------------------
Confidence 5699999987411 11245678899999999999999999999997
Q ss_pred ccCCCCceEeCC---CC--CEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 173 NVLQLENILLDS---KG--NIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 173 ~~~~~~NiLl~~---~g--~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
.|||++. ++ .++|+|||+++....... -....+..||-+|+|||++....-. .++||+|+||++|+.+
T Consensus 635 -----QNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvl 708 (903)
T KOG1027|consen 635 -----QNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVL 708 (903)
T ss_pred -----ceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEe
Confidence 9999976 34 689999999986544221 2235567899999999999877664 6899999999999999
Q ss_pred c-CCCCCCCCcHHHHHHHHHhCCCCCCC---CCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 247 T-GYLPFDDRNLAVLYQKIFRGDFKLPK---WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 247 t-G~~Pf~~~~~~~~~~~i~~~~~~~p~---~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+ |..||.+.-. .-..|..+.+.+.. .-..++.+||.+|++++|..||++.++|.||+|=.
T Consensus 709 tgG~HpFGd~~~--R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 709 TGGSHPFGDSLE--RQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred cCCccCCCchHH--hhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 9 5999965432 22356666654321 11128999999999999999999999999999943
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.68 Aligned_cols=247 Identities=29% Similarity=0.473 Sum_probs=207.9
Q ss_pred EEeceEeecCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 011868 17 ELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (476)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~ 88 (476)
.+.+.||+|+||+|++|.-.. ....||||.+..... ....+.+..|+.+|+.+ .||||+.+.+.+..++.
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 566699999999999997431 145799999976653 25578999999999999 59999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhh
Q 011868 89 IYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIA 152 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~ 152 (476)
+++|+||+..|+|.+++...+ .++..+...+..||+.|++||++.+++||||-.
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAa---------- 446 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAA---------- 446 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhh----------
Confidence 999999999999999997654 388899999999999999999999999999997
Q ss_pred HHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCccccccc--CCccccccccccCCCCC
Q 011868 153 TLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG--SPNYVAPEVLANRGYDG 230 (476)
Q Consensus 153 ~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~g--t~~y~APE~l~~~~~~~ 230 (476)
.|||+..+..+||+|||+|+....... .......| ...|||||.+....|+
T Consensus 447 -------------------------RNVLi~~~~~~kIaDFGlar~~~~~~~-y~~~~~~~~LP~kWmApEsl~~~~ft- 499 (609)
T KOG0200|consen 447 -------------------------RNVLITKNKVIKIADFGLARDHYNKDY-YRTKSSAGTLPVKWMAPESLFDRVFT- 499 (609)
T ss_pred -------------------------hhEEecCCCEEEEccccceeccCCCCc-eEecCCCCccceeecCHHHhccCccc-
Confidence 999999999999999999984322111 01111222 2359999999997775
Q ss_pred ccchhhhHhHHHHHHhc-CCCCCCCCc-HHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 231 ATSDIWSCGVILYVILT-GYLPFDDRN-LAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 231 ~~sDvwSlGvil~ellt-G~~Pf~~~~-~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
.++||||+||+|||++| |..||.+.. ..++++.+..|. ...|..+++++.++++.||+.+|++||++.++..
T Consensus 500 ~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 500 SKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred ccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 89999999999999999 999999855 556677777764 4789999999999999999999999999999864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=280.28 Aligned_cols=245 Identities=27% Similarity=0.443 Sum_probs=191.2
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHH--hCCCCCcceEEEEEEeC----C
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK--LLKHPNVVRLHEVLASK----S 87 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~--~l~HpnIv~l~~~~~~~----~ 87 (476)
.+-++.+.||+|.||+||+|+. .|+.||||++.... .....||.+|.+ .|+|+||+.+++.-..+ .
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 4678899999999999999985 69999999996543 355666766665 55999999998764322 3
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CcEeccCCcchhccchhhhHHHHHHH
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~--------givHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
.+|||.+|.+.|+|+|++.. ..++.+.+.+++..+++||+|||.. .|+|||||.
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS----------------- 344 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS----------------- 344 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc-----------------
Confidence 68999999999999999987 6799999999999999999999943 599999997
Q ss_pred HHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC--CCcccccccCCccccccccccCC----CCC-cc
Q 011868 160 TFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANRG----YDG-AT 232 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~----~~~-~~ 232 (476)
.|||+..+|...|+|+|||-..++..+ +-..+..+||..|||||++...- +++ ..
T Consensus 345 ------------------KNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ 406 (513)
T KOG2052|consen 345 ------------------KNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKR 406 (513)
T ss_pred ------------------ccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhH
Confidence 999999999999999999986654321 23456789999999999986521 111 45
Q ss_pred chhhhHhHHHHHHhcC----------CCCCCC-----CcHHHHHHHHH--hCCCCCCC-CCCH----HHHHHHHHccCCC
Q 011868 233 SDIWSCGVILYVILTG----------YLPFDD-----RNLAVLYQKIF--RGDFKLPK-WLSP----GAQNLLRKILEPN 290 (476)
Q Consensus 233 sDvwSlGvil~elltG----------~~Pf~~-----~~~~~~~~~i~--~~~~~~p~-~~s~----~~~~Li~~~L~~d 290 (476)
+||||||.|+||+... ++||.+ ++.+++.+-+. +-.+.+|. |-+. .+.+|++.||..|
T Consensus 407 ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~N 486 (513)
T KOG2052|consen 407 ADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYAN 486 (513)
T ss_pred HHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCC
Confidence 8999999999998652 778864 34444443332 23344554 4333 3567899999999
Q ss_pred cCCCCChHHHhc
Q 011868 291 PVKRITIAGIKA 302 (476)
Q Consensus 291 P~~R~s~~~il~ 302 (476)
|.-|.|+--|.+
T Consensus 487 p~aRltALriKK 498 (513)
T KOG2052|consen 487 PAARLTALRIKK 498 (513)
T ss_pred chhhhHHHHHHH
Confidence 999999876644
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=293.60 Aligned_cols=247 Identities=24% Similarity=0.367 Sum_probs=212.5
Q ss_pred EEeceEeecCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 17 ELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+..++||+|+||+||+|...-.|+ +||||++.... ..+....+.+|+.+|.+++|||+++|++++.... +-||
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 345689999999999998765554 68999887654 3444688999999999999999999999997765 7899
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
++|+++|.|.|+++. ++++.......|..||++||.|||.++++||||-+
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaa----------------------------- 826 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAA----------------------------- 826 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhh-----------------------------
Confidence 999999999999975 46799999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYL 250 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~ 250 (476)
.|+|+.+-..+||.|||+|+........-....-.-.+.|||=|.+....|. .++||||+||++||++| |..
T Consensus 827 ------RNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~ 899 (1177)
T KOG1025|consen 827 ------RNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAK 899 (1177)
T ss_pred ------hheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCC
Confidence 9999999999999999999987664332222223345799999999888886 88999999999999998 999
Q ss_pred CCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 251 PFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|+++....++-..+..++ ++.|+.++-++.-++.+||..|+..||+++++.+
T Consensus 900 Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 900 PYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 999999888877776654 6778899999999999999999999999998753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=277.05 Aligned_cols=247 Identities=24% Similarity=0.353 Sum_probs=195.2
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCcceEEEEEEeCC-
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--KHPNVVRLHEVLASKS- 87 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l--~HpnIv~l~~~~~~~~- 87 (476)
..+...++.+.+|+|.||+||+|+. +++.||||++.... ...+.+|-.|.+.. +|+||+++++.-.-..
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 4466788899999999999999984 56999999996543 45677776666654 7999999998764333
Q ss_pred ---EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---------CcEeccCCcchhccchhhhHHH
Q 011868 88 ---KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---------GVFHRDLKVILKSCHMRIATLQ 155 (476)
Q Consensus 88 ---~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~---------givHrDiKp~~~~~~~~~~~~~ 155 (476)
.++||++|.+.|+|.+++.. ..+++....+++..++.||+|||+. .|+|||||.
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkS------------- 344 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKS------------- 344 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccc-------------
Confidence 79999999999999999976 4699999999999999999999953 599999998
Q ss_pred HHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCC-----C
Q 011868 156 VFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-----G 230 (476)
Q Consensus 156 ~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-----~ 230 (476)
.|||+.+|+...|+|||||..+......+.....+||..|||||++.+.--- -
T Consensus 345 ----------------------kNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Af 402 (534)
T KOG3653|consen 345 ----------------------KNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAF 402 (534)
T ss_pred ----------------------cceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHH
Confidence 9999999999999999999988766556666778999999999998763211 1
Q ss_pred ccchhhhHhHHHHHHhcCC------------CCCC-----CCcHHHHHHHHHh--CCCCCCCC-----CCHHHHHHHHHc
Q 011868 231 ATSDIWSCGVILYVILTGY------------LPFD-----DRNLAVLYQKIFR--GDFKLPKW-----LSPGAQNLLRKI 286 (476)
Q Consensus 231 ~~sDvwSlGvil~elltG~------------~Pf~-----~~~~~~~~~~i~~--~~~~~p~~-----~s~~~~~Li~~~ 286 (476)
.+.||||+|.|||||++.. .||+ .++.+++...+.+ ..+.+|.. --..+.+.+..|
T Consensus 403 kr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeC 482 (534)
T KOG3653|consen 403 KRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEEC 482 (534)
T ss_pred HHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHH
Confidence 3589999999999998842 3343 1333444443333 33445533 234588999999
Q ss_pred cCCCcCCCCChHHHh
Q 011868 287 LEPNPVKRITIAGIK 301 (476)
Q Consensus 287 L~~dP~~R~s~~~il 301 (476)
|+.||+-|.|+.=+.
T Consensus 483 WDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 483 WDHDAEARLTAGCVE 497 (534)
T ss_pred cCCchhhhhhhHHHH
Confidence 999999999986543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=276.93 Aligned_cols=254 Identities=29% Similarity=0.436 Sum_probs=202.8
Q ss_pred cCcCEEEeceEeecCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS 87 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~ 87 (476)
....|.++.+||.|+|+.||+|.+.. .++.||+|.+..... ...+.+|+++|..+. +.||+++.+++..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34569999999999999999999877 789999999876542 467999999999995 999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
..++||||++..+..++... ++..+++.|++.++.||.++|.+||+||||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKp------------------------- 160 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKP------------------------- 160 (418)
T ss_pred eeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCc-------------------------
Confidence 99999999999888887754 78999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCC-CCEEEeccCCCCCCCccc-------------------------------CCC---------
Q 011868 168 RPWKFNVLQLENILLDSK-GNIKISDFGLSALPQHFR-------------------------------DDG--------- 206 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~-g~vkl~DFGla~~~~~~~-------------------------------~~~--------- 206 (476)
.|+|.+.. +.-.|+|||+|...+... ..+
T Consensus 161 ----------sNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r 230 (418)
T KOG1167|consen 161 ----------SNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGR 230 (418)
T ss_pred ----------cccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCc
Confidence 99999854 778899999997211000 000
Q ss_pred --cccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCc-H----HHHH--------HHH--HhCC-
Q 011868 207 --LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-L----AVLY--------QKI--FRGD- 268 (476)
Q Consensus 207 --~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~-~----~~~~--------~~i--~~~~- 268 (476)
.--...||++|.|||++...+-.++++||||.|||+.-+++++.||-... . .++. .+. ..+.
T Consensus 231 ~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~ 310 (418)
T KOG1167|consen 231 PSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRI 310 (418)
T ss_pred cceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCce
Confidence 00123599999999999988877889999999999999999999983211 0 0000 000 0000
Q ss_pred --------------------------CC----------CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 269 --------------------------FK----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 269 --------------------------~~----------~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
.+ .-+.++..+.+|+.+||..||.+|+|++++|.||||..
T Consensus 311 ~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 311 LLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 00 00114558999999999999999999999999999974
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=261.14 Aligned_cols=253 Identities=28% Similarity=0.460 Sum_probs=200.9
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEE-EEeCCEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEV-LASKSKI 89 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~-~~~~~~~ 89 (476)
..+.|.|.+.||+|-||++.+++++.+...+++|.+.+... ....|.+|...--.|. |.||+.-|++ |++.+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 34679999999999999999999999999999999987643 2577888887766664 9999998886 5777888
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
.++|||++.|+|.+.+.. .++.|...+.++.|+++|++|+|+.++||||||.
T Consensus 98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~--------------------------- 149 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKA--------------------------- 149 (378)
T ss_pred EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhccccc---------------------------
Confidence 899999999999998866 5699999999999999999999999999999996
Q ss_pred cccccCCCCceEeC--CCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc---CCCC-CccchhhhHhHHHH
Q 011868 170 WKFNVLQLENILLD--SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN---RGYD-GATSDIWSCGVILY 243 (476)
Q Consensus 170 ~~~~~~~~~NiLl~--~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~-~~~sDvwSlGvil~ 243 (476)
+|||+- +...+||||||+++- .+...+..--+..|.|||+... ..+. .+.+|+|.||+|+|
T Consensus 150 --------eNiLif~~df~rvKlcDFG~t~k-----~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f 216 (378)
T KOG1345|consen 150 --------ENILIFDADFYRVKLCDFGLTRK-----VGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFF 216 (378)
T ss_pred --------ceEEEecCCccEEEeeecccccc-----cCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeee
Confidence 999984 335899999999873 2223334446778999998643 2221 35689999999999
Q ss_pred HHhcCCCCCCCCcHH----HHHHHHHhC-CCCCCCC---CCHHHHHHHHHccCCCcCCC---CChHHHhcCcccccc
Q 011868 244 VILTGYLPFDDRNLA----VLYQKIFRG-DFKLPKW---LSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQD 309 (476)
Q Consensus 244 elltG~~Pf~~~~~~----~~~~~i~~~-~~~~p~~---~s~~~~~Li~~~L~~dP~~R---~s~~~il~~~~~~~~ 309 (476)
.++||.+||+..... ..+.+..++ .+..|.. +++.+..+.++-|.++|++| -++.......|....
T Consensus 217 ~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 217 YCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred eeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 999999999753322 222333333 3445543 78999999999999999999 455556677887654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-31 Score=248.81 Aligned_cols=220 Identities=45% Similarity=0.747 Sum_probs=188.0
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 95 (476)
|++.+.||.|++|.||++.+..+++.+|+|.+...... .....+.+|+..++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999888999999999765422 2467899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 96 VTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 96 ~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
+++++|.+.+..... +++..+..++.|++.++.+||+.|++|+||+|
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~-------------------------------- 126 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKP-------------------------------- 126 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH--------------------------------
Confidence 999999999987666 89999999999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccc-ccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l-~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
.|++++.++.++|+|||++....... ........++..|++||.+ ....+. .++|+||||+++++|++|+.||.
T Consensus 127 ---~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 127 ---ENILLGMDGLVKLADFGLARFIHRDL-AALLKTVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ---HHEEEcCCCCEEEeeCceeeEecCcc-cccccceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCcc
Confidence 99999999999999999988654321 1123456788999999998 445554 68999999999999999999998
Q ss_pred C-Cc-HHHHHHHHHhCCCCCCCC
Q 011868 254 D-RN-LAVLYQKIFRGDFKLPKW 274 (476)
Q Consensus 254 ~-~~-~~~~~~~i~~~~~~~p~~ 274 (476)
+ .+ ...+.+.+..+.+...+|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~ 224 (225)
T smart00221 202 GEGEFTSLLSDVWSFGVPLLWEW 224 (225)
T ss_pred ccchhHHHHHHHHhcCCcccccc
Confidence 8 44 447777787776554443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-31 Score=243.01 Aligned_cols=213 Identities=45% Similarity=0.787 Sum_probs=186.2
Q ss_pred EeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 011868 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (476)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 101 (476)
||+|++|.||++.+..+++.+++|++....... ....+.+|+..++.++|++|+++++++......+++||++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997664221 347899999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCce
Q 011868 102 FDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180 (476)
Q Consensus 102 ~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~Ni 180 (476)
.+++... ..++...++.++.|++.++.+||+.|++|+||+| .||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~-----------------------------------~ni 123 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP-----------------------------------ENI 123 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH-----------------------------------hhE
Confidence 9999765 4799999999999999999999999999999997 999
Q ss_pred EeCC-CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHH
Q 011868 181 LLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV 259 (476)
Q Consensus 181 Ll~~-~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~ 259 (476)
+++. ++.++|+|||.+........ ......+...|++||.+......+.++|+||+|+++++|
T Consensus 124 ~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------- 187 (215)
T cd00180 124 LLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------- 187 (215)
T ss_pred EEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------
Confidence 9999 89999999999975432110 233456888999999987762335889999999999999
Q ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCc
Q 011868 260 LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304 (476)
Q Consensus 260 ~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~ 304 (476)
..+.+++.+|++.||++||++.++++++
T Consensus 188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 6788999999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=244.75 Aligned_cols=210 Identities=24% Similarity=0.428 Sum_probs=173.2
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEe
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
..-+..||+|+||.|=+-++..+|...|+|.+...- +.....++.+|+.+..+. .+|.+|.+|+.+..++.+|+.||
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 344678999999999999999999999999997653 344467788898877665 69999999999999999999999
Q ss_pred ccCCCChHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 95 YVTGGELFDK----IASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 95 ~~~gg~L~~~----l~~~~~l~~~~~~~~~~qi~~al~yLH~~-givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
.+ ..+|..+ +..++.++|...-+++..++.||.|||++ .++|||+||
T Consensus 126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKP--------------------------- 177 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKP--------------------------- 177 (282)
T ss_pred Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCc---------------------------
Confidence 99 4466443 33456799999999999999999999986 999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccc-cccCCcccccccccc----CCCCCccchhhhHhHHHHH
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT-TCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~-~~gt~~y~APE~l~~----~~~~~~~sDvwSlGvil~e 244 (476)
.|||++.+|++|+||||++.... ++...+ -.|...|||||.+.. .+|+ .+|||||||+++.|
T Consensus 178 --------sNiLIn~~GqVKiCDFGIsG~L~----dSiAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiE 244 (282)
T KOG0984|consen 178 --------SNILINYDGQVKICDFGISGYLV----DSIAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIE 244 (282)
T ss_pred --------ceEEEccCCcEEEcccccceeeh----hhhHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhh
Confidence 99999999999999999997543 233333 568899999998753 4675 89999999999999
Q ss_pred HhcCCCCCCC-CcHHHHHHHHHhCC
Q 011868 245 ILTGYLPFDD-RNLAVLYQKIFRGD 268 (476)
Q Consensus 245 lltG~~Pf~~-~~~~~~~~~i~~~~ 268 (476)
|.+++.||+. .++-+++.++....
T Consensus 245 lA~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 245 MAILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred hhhccccccccCCHHHHHHHHhcCC
Confidence 9999999975 34556666666543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=288.87 Aligned_cols=260 Identities=32% Similarity=0.540 Sum_probs=210.6
Q ss_pred cCE-EEeceEeecCceEEEEEEECCCCceEEEEEeecc--cccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 14 GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN--RIIH-LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 14 ~~Y-~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~--~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
.+| ...+.+|.|++|.|+.+......+.++.|..... .... ......+..|..+-..++|||++...+.+......
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 445 4567899999999988888777776777755421 1112 22223377888889999999998887777666666
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+-+||||++ +|+..+...+.++..++..++.||+.||+|+|+.||.|||+|+
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~--------------------------- 448 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKL--------------------------- 448 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCcc---------------------------
Confidence 666999999 9999999888999999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC--CcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|++++.+|.+||+|||.+.++....+. ......+|+.+|+|||++.+..|+....||||+|+|++.|++
T Consensus 449 --------enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~ 520 (601)
T KOG0590|consen 449 --------ENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL 520 (601)
T ss_pred --------ccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec
Confidence 9999999999999999999987665444 556778999999999999999999999999999999999999
Q ss_pred CCCCCCCCcHHHHH--HHH-------HhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 248 GYLPFDDRNLAVLY--QKI-------FRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 248 G~~Pf~~~~~~~~~--~~i-------~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|+.||......+.. ... ..+...+-..++...+.+|.+||++||.+|+|+++|++++||+.-
T Consensus 521 ~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 521 GRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred CCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 99999765443221 111 111112223467889999999999999999999999999999863
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=293.38 Aligned_cols=200 Identities=16% Similarity=0.210 Sum_probs=148.8
Q ss_pred hCCC-CCcceEEEEE-------EeCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccC
Q 011868 70 LLKH-PNVVRLHEVL-------ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140 (476)
Q Consensus 70 ~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDi 140 (476)
.++| +||.+++++| .....++++||++ +++|.+++.. ...+++.+++.+++||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4456 6888888877 2334678889988 6799999975 346999999999999999999999999999999
Q ss_pred CcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCC-------------------CCEEEeccCCCCCCCc
Q 011868 141 KVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK-------------------GNIKISDFGLSALPQH 201 (476)
Q Consensus 141 Kp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~-------------------g~vkl~DFGla~~~~~ 201 (476)
|| +|||++.. +.+|++|||+++....
T Consensus 107 KP-----------------------------------~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~ 151 (793)
T PLN00181 107 RP-----------------------------------SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEI 151 (793)
T ss_pred Cc-----------------------------------hhEEEcccCcEEEeeccccCcccccccCccccccccccccccc
Confidence 97 99999654 4556666666653211
Q ss_pred ccC--------------CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhC
Q 011868 202 FRD--------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 267 (476)
Q Consensus 202 ~~~--------------~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 267 (476)
... .......+||+.|||||++.+..|. .++|||||||+||||++|..|+..... ....+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~ 228 (793)
T PLN00181 152 LSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSN-CASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR 228 (793)
T ss_pred ccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCC-chhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh
Confidence 000 0001124689999999999888884 899999999999999999999764321 11222111
Q ss_pred CCC-CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 268 DFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 268 ~~~-~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
..+ .+....+...+++.+||++||.+||++.++++||||..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 229 VLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred hcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 111 11113466789999999999999999999999999975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=240.65 Aligned_cols=252 Identities=20% Similarity=0.239 Sum_probs=207.2
Q ss_pred CcCEEEeceEeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-C
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-K 86 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~ 86 (476)
-.|+++...+-+|+||.||.|.... +.+.|-+|.++... +.-....+..|...+.-..|||+..+.+++.. .
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 3467888889999999999996442 33456777765432 34456788999999999999999999998754 4
Q ss_pred CEEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHH
Q 011868 87 SKIYMVLEYVTGGELFDKIASK--------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFL 158 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~--------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~ 158 (476)
...++++.+..-|+|..++... ..++-.+...++.|++.|++|||++||+|.||-+
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAa---------------- 424 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAA---------------- 424 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhh----------------
Confidence 5788899999889999988722 1366777888999999999999999999999997
Q ss_pred HHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhH
Q 011868 159 LTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 238 (476)
Q Consensus 159 ~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSl 238 (476)
.|.++|+.-++||+|=.+++..-...-......-.....||+||.+.+..|+ ..+|+|||
T Consensus 425 -------------------RNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsf 484 (563)
T KOG1024|consen 425 -------------------RNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSF 484 (563)
T ss_pred -------------------hcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHH
Confidence 9999999999999999999854322211122222345789999999999886 88999999
Q ss_pred hHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 239 GVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 239 Gvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
||++|||+| |+.||..-++.++...+.+|. ..-|-++++++..++.-||..+|++||+++|+..
T Consensus 485 GVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 485 GVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 999999999 999999999999988888774 4568889999999999999999999999999754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-27 Score=229.51 Aligned_cols=256 Identities=38% Similarity=0.624 Sum_probs=213.6
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEEe
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP-NVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~E 94 (476)
|.+.+.||.|+||.||++.+. ..+|+|.+.............+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999986 78999999877644434578899999999999988 79999999988888999999
Q ss_pred ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 95 YVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
++.++++.+.+.... .+++.....++.|++.++.|+|+.|++|||+||
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp----------------------------- 129 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKP----------------------------- 129 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH-----------------------------
Confidence 999999997777654 799999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCC-CEEEeccCCCCCCCcccCC----CcccccccCCccccccccccC--CCCCccchhhhHhHHHHH
Q 011868 172 FNVLQLENILLDSKG-NIKISDFGLSALPQHFRDD----GLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYV 244 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g-~vkl~DFGla~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~--~~~~~~sDvwSlGvil~e 244 (476)
+||+++..+ .++++|||++......... ......+||+.|+|||.+.+. .+.....|+||+|+++++
T Consensus 130 ------~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~ 203 (384)
T COG0515 130 ------ENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYE 203 (384)
T ss_pred ------HHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHH
Confidence 999999998 7999999999854332211 135677899999999999873 344588999999999999
Q ss_pred HhcCCCCCCCCcH----HHHHHHHHhCCCC-CCCCCC--------HHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 245 ILTGYLPFDDRNL----AVLYQKIFRGDFK-LPKWLS--------PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 245 lltG~~Pf~~~~~----~~~~~~i~~~~~~-~p~~~s--------~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
+++|..||..... ......+.....+ ...... ..+.+++.+++..+|..|.+..+...++|....
T Consensus 204 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 204 LLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred HHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 9999999987763 4555555555443 222222 478999999999999999999998888766543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=223.25 Aligned_cols=159 Identities=23% Similarity=0.284 Sum_probs=129.6
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCC
Q 011868 99 GELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177 (476)
Q Consensus 99 g~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 177 (476)
|+|.+++.. ..++++.+++.++.||+.||+|||+++ ||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp----------------------------------- 39 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KS----------------------------------- 39 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------Cc-----------------------------------
Confidence 689999986 456999999999999999999999998 86
Q ss_pred CceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcH
Q 011868 178 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL 257 (476)
Q Consensus 178 ~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~ 257 (476)
+|||++.++.+|+ ||++..... ....||+.|||||++.+..|+ .++||||+||++|+|++|+.||.....
T Consensus 40 ~Nil~~~~~~~~~--fG~~~~~~~-------~~~~g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~ 109 (176)
T smart00750 40 GNILLTWDGLLKL--DGSVAFKTP-------EQSRVDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERE 109 (176)
T ss_pred ccEeEcCccceee--ccceEeecc-------ccCCCcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccch
Confidence 9999999999999 999875432 123689999999999888885 899999999999999999999976543
Q ss_pred -HHHHHHHHhCCCCC-------CCCCCH--HHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 258 -AVLYQKIFRGDFKL-------PKWLSP--GAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 258 -~~~~~~i~~~~~~~-------p~~~s~--~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
...+..+.....+. +..++. .+.++|.+||..||.+||++.+++.|+|+..
T Consensus 110 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 110 LSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred hcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 23333333322111 122333 6999999999999999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=236.94 Aligned_cols=172 Identities=22% Similarity=0.168 Sum_probs=135.8
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECC-CCceEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCcce-EEEEE
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVR-LHEVL 83 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~-l~~~~ 83 (476)
+.....++|++.+.||+|+||+||+|++.. +++.||||.+..... ........+.+|+.+|+.++|+||+. +++.
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 345567899999999999999999999876 678889998753311 12234567999999999999999985 5542
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccC-CcchhccchhhhHHHHHHHHHH
Q 011868 84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL-KVILKSCHMRIATLQVFLLTFL 162 (476)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDi-Kp~~~~~~~~~~~~~~~~~~~~ 162 (476)
+..|+||||++|++|.. +. +.. ...++.|++.||.|||++||+|||| ||
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP-------------------- 140 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKP-------------------- 140 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCc--------------------
Confidence 45899999999999963 21 111 1468899999999999999999999 97
Q ss_pred HhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCc------ccccccCCcccccccccc
Q 011868 163 LMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGL------LHTTCGSPNYVAPEVLAN 225 (476)
Q Consensus 163 ~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~------~~~~~gt~~y~APE~l~~ 225 (476)
+|||++.++.+||+|||+|+.......... ..+.++++.|+|||.+..
T Consensus 141 ---------------~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 141 ---------------QNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ---------------ceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999999999999999999986644321111 246678999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=252.72 Aligned_cols=239 Identities=33% Similarity=0.621 Sum_probs=208.1
Q ss_pred eEeecCceEEEEEEE---CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEecc
Q 011868 21 TLGEGNFGKVKFAQD---LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYV 96 (476)
Q Consensus 21 ~LG~G~fg~V~~a~~---~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 96 (476)
.+|+|+||+|++++. ...|..+|+|+..+......... ....|-.++..++ ||.+++++..++.++..|+++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999997653 35678899999987654333222 5666778888886 999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCC
Q 011868 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQ 176 (476)
Q Consensus 97 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 176 (476)
.||+|+..+.....+.+...+.+...++.|++++|+.||+|||+|+
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~---------------------------------- 125 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKL---------------------------------- 125 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccc----------------------------------
Confidence 9999999998877899999999999999999999999999999996
Q ss_pred CCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCc
Q 011868 177 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 256 (476)
Q Consensus 177 ~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~ 256 (476)
+||+++.+|++++.|||+++..-.. ...|||..|||||++. +.. ..+|.||+|++.++|+||..||.+
T Consensus 126 -enilld~~Ghi~~tdfglske~v~~------~~~cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~-- 193 (612)
T KOG0603|consen 126 -ENVLLLLEGHIKLTDFGLSKEAVKE------KIACGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG-- 193 (612)
T ss_pred -cceeecccCccccCCchhhhHhHhh------hhcccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch--
Confidence 9999999999999999999853221 1229999999999987 444 679999999999999999999987
Q ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh-----HHHhcCccccc
Q 011868 257 LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI-----AGIKADEWFEQ 308 (476)
Q Consensus 257 ~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~-----~~il~~~~~~~ 308 (476)
+....|.+.++.+|..++..+++++..++..+|.+|.-. .++++|++|..
T Consensus 194 --~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 194 --DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred --HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence 677888888999999999999999999999999999854 68999999965
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-24 Score=219.38 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=194.0
Q ss_pred CEEEeceEeecCceEEEEEEECCCC-ceEEEEEeecccccchhHHHHHHHHHHHHHhCCC----CCcceEEEEE-EeCCE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKH----PNVVRLHEVL-ASKSK 88 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H----pnIv~l~~~~-~~~~~ 88 (476)
+|.+.+.||+|+||.||++.+..++ ..+|+|......... ...+..|+.++..+.. +++..+++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987765 678999876543211 1268889999998873 6899999999 57889
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 89 IYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
.|+||+++ |.+|.++.... +.++..++..++.|++.+|+++|+.|++||||||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp------------------------ 150 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKP------------------------ 150 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCH------------------------
Confidence 99999999 99999987543 5899999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCC-----CCEEEeccCCCCCCCcccCCC-------c-ccccccCCccccccccccCCCCCccc
Q 011868 167 IRPWKFNVLQLENILLDSK-----GNIKISDFGLSALPQHFRDDG-------L-LHTTCGSPNYVAPEVLANRGYDGATS 233 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~-----g~vkl~DFGla~~~~~~~~~~-------~-~~~~~gt~~y~APE~l~~~~~~~~~s 233 (476)
+|+.+... -.+.|.|||+++.+....... . .....||..|+++.+..+... +.+.
T Consensus 151 -----------~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~D 218 (322)
T KOG1164|consen 151 -----------ENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRD 218 (322)
T ss_pred -----------HHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCch
Confidence 99999765 359999999998433211111 1 123459999999999887766 5899
Q ss_pred hhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHH---hCCC-C-CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 234 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIF---RGDF-K-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 234 DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~~-~-~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|+||++.++.+++.|.+||.+........+.. .... . +....+..+..+...+-..+...+|....+...
T Consensus 219 Dles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 219 DLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 99999999999999999997765332222222 1111 1 223345677777777777899999988877654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=199.37 Aligned_cols=249 Identities=21% Similarity=0.290 Sum_probs=197.6
Q ss_pred hccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEE
Q 011868 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLA 84 (476)
Q Consensus 6 ~~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~ 84 (476)
...+-++.++|.++++||.|+||.+|+|....+|+.||||+=.+.. . ..++..|..+.+.+++ ..|..+..+..
T Consensus 7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~----hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-K----HPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-C----CcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 3455678899999999999999999999999999999999754321 1 3578889999999975 78888888888
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHH
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLL 163 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~ 163 (476)
++..-.+|||++ |.+|.+++.-. ..++..++.-++-|++.-++|+|.++++||||||
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKP--------------------- 139 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKP--------------------- 139 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCc---------------------
Confidence 889999999999 99999988643 5799999999999999999999999999999997
Q ss_pred hhhccccccccCCCCceEeCCC---CCEEEeccCCCCCCCcccCCC-----cccccccCCccccccccccCCCCCccchh
Q 011868 164 MIVIRPWKFNVLQLENILLDSK---GNIKISDFGLSALPQHFRDDG-----LLHTTCGSPNYVAPEVLANRGYDGATSDI 235 (476)
Q Consensus 164 ~~~~~p~~~~~~~~~NiLl~~~---g~vkl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~sDv 235 (476)
+|.|..-+ ..+.++|||+|+.+....... .-....||..|.+--...+... +.+-|+
T Consensus 140 --------------dNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDm 204 (341)
T KOG1163|consen 140 --------------DNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDM 204 (341)
T ss_pred --------------cceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhh
Confidence 99998643 468999999999765433221 2234569999998776665443 367899
Q ss_pred hhHhHHHHHHhcCCCCCCCCcH---HHHHHHHHhCCCCCC-----CCCCHHHHHHHHHccCCCcCCCCC
Q 011868 236 WSCGVILYVILTGYLPFDDRNL---AVLYQKIFRGDFKLP-----KWLSPGAQNLLRKILEPNPVKRIT 296 (476)
Q Consensus 236 wSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p-----~~~s~~~~~Li~~~L~~dP~~R~s 296 (476)
=|+|.+|.++.-|.+||++-.. ...+++|.......| ..++.++...+.-|-..--++-|.
T Consensus 205 eSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 205 ESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred hhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 9999999999999999998654 456677777666544 336677777777665544444454
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-25 Score=237.59 Aligned_cols=220 Identities=31% Similarity=0.597 Sum_probs=176.0
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
-..|+.++++-.|+||.||+.+|+.+.+.+|+| ++++.. .+++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn---ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN---ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc---cccccCCccee---------------
Confidence 457999999999999999999999999999995 444321 1111 23333344443
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|+-...+..-++++... +.+++|||+.||+|||+||
T Consensus 136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkp------------------------------ 171 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKP------------------------------ 171 (1205)
T ss_pred ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCC------------------------------
Confidence 45555565555666554 7799999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCccc-------------CCCcccccccCCccccccccccCCCCCccchhhhHh
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFR-------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~-------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlG 239 (476)
+|++++.-|++|+.|||+++.--... ..-.-...||||.|.|||++..++| |.++|+|++|
T Consensus 172 -----dnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamG 245 (1205)
T KOG0606|consen 172 -----DNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMG 245 (1205)
T ss_pred -----CcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHH
Confidence 99999999999999999987421110 0112345699999999999999999 5999999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCC---CCHHHHHHHHHccCCCcCCCC---ChHHHhcCccccc
Q 011868 240 VILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW---LSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQ 308 (476)
Q Consensus 240 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~---~s~~~~~Li~~~L~~dP~~R~---s~~~il~~~~~~~ 308 (476)
+|+|+.+-|..||.+.+.++++.+.......+|+. ..++++++|.++|+.+|..|. .+-++.+|+||..
T Consensus 246 iIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 246 IILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred HHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 99999999999999999999999998888777754 688999999999999999996 4567899999964
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=203.03 Aligned_cols=249 Identities=20% Similarity=0.358 Sum_probs=202.4
Q ss_pred ccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 7 ~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
++.++.++...+..+|.+...|+.|+|+. .|..+++|++.... ......+.|..|...|+.+.||||+.+++.|.+.
T Consensus 183 r~~gid~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~-~t~risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 183 RYTGIDVSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVRE-VTARISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred cccCcchhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhh-cchhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 45577777888899999999999999985 45567889886554 3455678899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhc-CcEeccCCcchhccchhhhHHHHHHHHHHH
Q 011868 87 SKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMRIATLQVFLLTFLL 163 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~-givHrDiKp~~~~~~~~~~~~~~~~~~~~~ 163 (476)
.++.++..|++.|+|+..+.... -.+..++.+++..++.|++|||+. .++-|
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr------------------------- 314 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPR------------------------- 314 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhh-------------------------
Confidence 99999999999999999998754 367889999999999999999985 23222
Q ss_pred hhhccccccccCCCCceEeCCCCCEEEe--ccCCCCCCCcccCCCcccccccCCccccccccccCCCC--CccchhhhHh
Q 011868 164 MIVIRPWKFNVLQLENILLDSKGNIKIS--DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD--GATSDIWSCG 239 (476)
Q Consensus 164 ~~~~~p~~~~~~~~~NiLl~~~g~vkl~--DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~--~~~sDvwSlG 239 (476)
+.+.-..+++|++-+.+|+ |--++- ... .....|.||+||.+...+-+ -..+|+|||.
T Consensus 315 ---------~~lns~hvmidedltarismad~kfsf-----qe~----gr~y~pawmspealqrkped~n~raadmwsfa 376 (448)
T KOG0195|consen 315 ---------FYLNSKHVMIDEDLTARISMADTKFSF-----QEV----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFA 376 (448)
T ss_pred ---------hhcccceEEecchhhhheecccceeee-----ecc----ccccCcccCCHHHHhcCchhcchhhhhHHHHH
Confidence 1222378999999876665 322221 111 23457899999999876544 3469999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHh
Q 011868 240 VILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301 (476)
Q Consensus 240 vil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il 301 (476)
+++|||.|...||.+-..++.-.+|.-.. ..+|+.+++....|+.-|++.||.+||.+++|.
T Consensus 377 illwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 377 ILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999998888888776553 468999999999999999999999999998864
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=198.94 Aligned_cols=174 Identities=14% Similarity=0.196 Sum_probs=136.0
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHH------HHHHHHHHHhCCCCCcceEEEEEEe
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ------IKREIATLKLLKHPNVVRLHEVLAS 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~------~~~Ei~~l~~l~HpnIv~l~~~~~~ 85 (476)
.-++|++.+.||.|+||.||++.+ ++..+|||++.......+..... +.+|+..+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 357999999999999999999765 46689999997655444443333 6899999999999999999998653
Q ss_pred C--------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHH
Q 011868 86 K--------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVF 157 (476)
Q Consensus 86 ~--------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~ 157 (476)
. +..+++|||++|.+|.+.. .+++. ...|++.++..||+.|++|||+||
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp--------------- 163 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHK--------------- 163 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCCh---------------
Confidence 3 3589999999999998763 23332 456999999999999999999997
Q ss_pred HHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhh
Q 011868 158 LLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 237 (476)
Q Consensus 158 ~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwS 237 (476)
.|++++.+| ++|+|||.+......... ...+....|. .++|+||
T Consensus 164 --------------------~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~-~~~di~~ 207 (232)
T PRK10359 164 --------------------GNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYG-IKNEIKD 207 (232)
T ss_pred --------------------HHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhc-ccccccc
Confidence 999999999 999999988743221100 1133455676 7899999
Q ss_pred HhHHHHHHh
Q 011868 238 CGVILYVIL 246 (476)
Q Consensus 238 lGvil~ell 246 (476)
||+++..+.
T Consensus 208 lg~~~~~~~ 216 (232)
T PRK10359 208 LGYYLLIYK 216 (232)
T ss_pred eeEeehHHH
Confidence 999887553
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-23 Score=195.92 Aligned_cols=213 Identities=23% Similarity=0.373 Sum_probs=179.8
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV 92 (476)
-.|+++++||+|+||..++|.+.-++++||||.=.... .+.++..|....+.|. .++|...|-+....-+-.||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 37999999999999999999999999999999754322 1578889999999885 79999999988888888999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||++ |.+|.|++.-. .+|+..++.-++.|++.-++|+|++.+|.|||||
T Consensus 103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKP----------------------------- 152 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKP----------------------------- 152 (449)
T ss_pred hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCc-----------------------------
Confidence 9999 99999988754 5799999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCC-----CEEEeccCCCCCCCcccCCC-----cccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 172 FNVLQLENILLDSKG-----NIKISDFGLSALPQHFRDDG-----LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g-----~vkl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+|+||..-+ .+.++|||+|+.+....... ......||..||+--...+..-+ .+-|+=|||-+
T Consensus 153 ------dNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHv 225 (449)
T KOG1165|consen 153 ------DNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHV 225 (449)
T ss_pred ------cceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhh
Confidence 999997543 58999999999765532211 12345799999998887776654 78999999999
Q ss_pred HHHHhcCCCCCCC---CcHHHHHHHHHhCC
Q 011868 242 LYVILTGYLPFDD---RNLAVLYQKIFRGD 268 (476)
Q Consensus 242 l~elltG~~Pf~~---~~~~~~~~~i~~~~ 268 (476)
+.+.|-|.+||+| .+....|++|-...
T Consensus 226 FmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 226 FMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred hhhhccCCCccccccCcchHHHHHHhcccc
Confidence 9999999999987 45567788886544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=195.53 Aligned_cols=141 Identities=21% Similarity=0.284 Sum_probs=112.9
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecccccchh-----------------------HHHHHHHHHHHHHhCCCCC
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----------------------ITDQIKREIATLKLLKHPN 75 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~-----------------------~~~~~~~Ei~~l~~l~Hpn 75 (476)
...||+|+||.||+|.+. +|+.||||+++........ ......+|+.+++.+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999765321111 0123456999999998887
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCcEeccCCcchhccchhhhHH
Q 011868 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKVILKSCHMRIATL 154 (476)
Q Consensus 76 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yL-H~~givHrDiKp~~~~~~~~~~~~ 154 (476)
+.....+.... .|+||||++|+++...+...+++++.++..++.|++.+|.|+ |+.||+||||||
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP------------ 146 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSE------------ 146 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCH------------
Confidence 75444332222 389999999888776654557899999999999999999999 699999999997
Q ss_pred HHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCC
Q 011868 155 QVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198 (476)
Q Consensus 155 ~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~ 198 (476)
+|||++ ++.++|+|||+|..
T Consensus 147 -----------------------~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 147 -----------------------YNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred -----------------------HHEEEE-CCcEEEEEcccccc
Confidence 999998 58899999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-25 Score=237.03 Aligned_cols=260 Identities=33% Similarity=0.538 Sum_probs=220.1
Q ss_pred CcCEEEeceEeecCceEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~ 90 (476)
...|.+.+.||+|+|+.|-++.... +...+|+|.+.... ........+..|..+-+.+. |+|++.+++.....+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 6679999999999999998887643 44567777765443 23445677888999999997 999999999999999999
Q ss_pred EEEeccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 91 MVLEYVTGGELFDKI-ASKG-RLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 91 lV~E~~~gg~L~~~l-~~~~-~l~~~~~~~~~~qi~~al~yLH-~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
++++|..|+++++.+ .... ..+...+..++.|+..++.|+| ..++.||||||
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP------------------------- 152 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKP------------------------- 152 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCC-------------------------
Confidence 999999999999999 6655 7889999999999999999999 99999999997
Q ss_pred cccccccCCCCceEeCCCC-CEEEeccCCCCCCCc-ccCCCccccccc-CCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 168 RPWKFNVLQLENILLDSKG-NIKISDFGLSALPQH-FRDDGLLHTTCG-SPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g-~vkl~DFGla~~~~~-~~~~~~~~~~~g-t~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+|.+++..+ .++++|||+|+.+.. ..........|| ++.|+|||...+..|.+...|+||+|+++..
T Consensus 153 ----------~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~ 222 (601)
T KOG0590|consen 153 ----------SNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSA 222 (601)
T ss_pred ----------ccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccc
Confidence 999999999 999999999998776 444556777899 9999999999998888999999999999999
Q ss_pred HhcCCCCCCCCcHHHHH-HH-HHh-CC--CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 245 ILTGYLPFDDRNLAVLY-QK-IFR-GD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~-~~-i~~-~~--~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+++|..||......... .. +.. .. ......++..+.+++.+++..+|..|.+.+++..++|+..
T Consensus 223 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 223 MLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 99999999876544322 11 111 11 2233448899999999999999999999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=188.52 Aligned_cols=144 Identities=23% Similarity=0.283 Sum_probs=115.6
Q ss_pred EeceEeecCceEEEEEEECCCCceEEEEEeecccccch----------------------h-HHHHHHHHHHHHHhCCCC
Q 011868 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL----------------------K-ITDQIKREIATLKLLKHP 74 (476)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~----------------------~-~~~~~~~Ei~~l~~l~Hp 74 (476)
+.+.||+|+||+||+|.+. +|+.||||+++....... . ....+.+|...+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999986 899999999986532100 0 022356899999999999
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhH
Q 011868 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIAT 153 (476)
Q Consensus 75 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~ 153 (476)
+|.....+.... .|+||||++|+++........++++.++..++.|++.++.++|+ .||+||||||
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP----------- 146 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSE----------- 146 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCh-----------
Confidence 886554443332 48999999888665543345678999999999999999999999 9999999997
Q ss_pred HHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCC
Q 011868 154 LQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQ 200 (476)
Q Consensus 154 ~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~ 200 (476)
+||+++ ++.++|+|||++....
T Consensus 147 ------------------------~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 147 ------------------------YNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred ------------------------hhEEEE-CCCEEEEEcccceecC
Confidence 999999 8999999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-23 Score=199.68 Aligned_cols=234 Identities=26% Similarity=0.370 Sum_probs=156.0
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC----------CCcceEEEEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH----------PNVVRLHEVLA 84 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H----------pnIv~l~~~~~ 84 (476)
.+..++.||.|+++.||.++|..||+.+|+|++...........+.+++|.-....+.+ -.++.-+|...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46678899999999999999999999999999876654445557888888877766543 23333344332
Q ss_pred e---------C---C-----EEEEEEeccCCCChHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHhcCcEeccC
Q 011868 85 S---------K---S-----KIYMVLEYVTGGELFDKIAS---KGR----LQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140 (476)
Q Consensus 85 ~---------~---~-----~~~lV~E~~~gg~L~~~l~~---~~~----l~~~~~~~~~~qi~~al~yLH~~givHrDi 140 (476)
- . . ..+++|+-+ -++|.+.+.. ... +.......+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 1 1 236788888 5688877642 222 222233456699999999999999999999
Q ss_pred CcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccc
Q 011868 141 KVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 220 (476)
Q Consensus 141 Kp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 220 (476)
+| +|++++.+|.++|+||+..... +........+..|.+|
T Consensus 172 ~~-----------------------------------~nfll~~~G~v~Lg~F~~~~r~-----g~~~~~~~~~~~~~PP 211 (288)
T PF14531_consen 172 KP-----------------------------------ENFLLDQDGGVFLGDFSSLVRA-----GTRYRCSEFPVAFTPP 211 (288)
T ss_dssp SG-----------------------------------GGEEE-TTS-EEE--GGGEEET-----TEEEEGGGS-TTTS-H
T ss_pred ce-----------------------------------eeEEEcCCCCEEEcChHHHeec-----CceeeccCCCcccCCh
Confidence 97 9999999999999999866521 1122213455789999
Q ss_pred cccccC--------CCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcC
Q 011868 221 EVLANR--------GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPV 292 (476)
Q Consensus 221 E~l~~~--------~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~ 292 (476)
|..... .+ +.+.|.|+||+++|.|+||..||........... .+..-..++..++.||+.+|+.||.
T Consensus 212 e~~~~~~~~~~~~~~~-t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~ 286 (288)
T PF14531_consen 212 ELESCAGQFGQNNAPY-TFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPE 286 (288)
T ss_dssp HHHHHHTSCHHSEEEE--HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGG
T ss_pred hhhhhhcccCccccee-eeccCHHHHHHHHHHHHHccCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcc
Confidence 987543 23 4778999999999999999999987654322211 2222226888999999999999999
Q ss_pred CC
Q 011868 293 KR 294 (476)
Q Consensus 293 ~R 294 (476)
+|
T Consensus 287 ~R 288 (288)
T PF14531_consen 287 DR 288 (288)
T ss_dssp GS
T ss_pred cC
Confidence 88
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-23 Score=226.54 Aligned_cols=246 Identities=28% Similarity=0.391 Sum_probs=185.9
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeeccc-ccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR-IIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
.|...+.||.+.|=+|.+|++ ..|. |+||++-+.. ..+.+...+..+|++ ....+|||++++.-+...+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 788899999999999999997 4565 9999987654 223333445555666 66678999999998888888899999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
+|+. -+|+|++..+.-+..-+.+.|+.||+.||.-||..||+|||||.
T Consensus 101 qyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKs------------------------------- 148 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKS------------------------------- 148 (1431)
T ss_pred HHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCcccccccc-------------------------------
Confidence 9995 59999998877788999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCC--CCcccCCC---cccccccCCccccccccccCC---------C-CCccchhhhH
Q 011868 174 VLQLENILLDSKGNIKISDFGLSAL--PQHFRDDG---LLHTTCGSPNYVAPEVLANRG---------Y-DGATSDIWSC 238 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~--~~~~~~~~---~~~~~~gt~~y~APE~l~~~~---------~-~~~~sDvwSl 238 (476)
||||+++=+.+.|+||.--+- ..+.++.. ...|...-..|.|||.+.... . -.++.||||+
T Consensus 149 ----ENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~ 224 (1431)
T KOG1240|consen 149 ----ENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSA 224 (1431)
T ss_pred ----ceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhh
Confidence 999999999999999975431 11111111 111222334899999886522 1 2467899999
Q ss_pred hHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 239 GVILYVILT-GYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 239 Gvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
||++.||++ |++||.-. .++.. ..+... +..--+..+++||..|++.||++|.++++.|+.
T Consensus 225 GCViaELf~Eg~PlF~LS---QL~aY-r~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 225 GCVIAELFLEGRPLFTLS---QLLAY-RSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hHHHHHHHhcCCCcccHH---HHHhH-hccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 999999998 89999532 12111 111111 111235689999999999999999999999876
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-22 Score=197.30 Aligned_cols=257 Identities=25% Similarity=0.417 Sum_probs=182.2
Q ss_pred hccCCccCcCEEEeceEeecCceEEEEEEECCC-----------------------------------CceEEEEEeecc
Q 011868 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDS-----------------------------------GLPFAVKILEKN 50 (476)
Q Consensus 6 ~~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~-----------------------------------~~~vAvK~i~~~ 50 (476)
+.-.+.+++.|++++.||+|.-+.||.|+.... .-+.|||++-.-
T Consensus 149 r~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~ 228 (598)
T KOG4158|consen 149 RIDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNF 228 (598)
T ss_pred hhhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccc
Confidence 344467888999999999999999998864321 113577765322
Q ss_pred ccc--chhHHHHHHHHHH------HH--------Hh--------CCCCCcceEEEEEEe---------------------
Q 011868 51 RII--HLKITDQIKREIA------TL--------KL--------LKHPNVVRLHEVLAS--------------------- 85 (476)
Q Consensus 51 ~~~--~~~~~~~~~~Ei~------~l--------~~--------l~HpnIv~l~~~~~~--------------------- 85 (476)
... +..+.+.+.+|.. .+ +. -+|||||++...|.+
T Consensus 229 ~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~ 308 (598)
T KOG4158|consen 229 EHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWY 308 (598)
T ss_pred ccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceec
Confidence 211 2223344444421 11 11 259999999887732
Q ss_pred ------CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHH
Q 011868 86 ------KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 86 ------~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
...+|+||.-.+ .+|.+++..+. .+....+-++.|+++|+.|||.+||.|||+|.
T Consensus 309 p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKS----------------- 369 (598)
T KOG4158|consen 309 PSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKS----------------- 369 (598)
T ss_pred ccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccc-----------------
Confidence 236899999884 59999998754 67778888999999999999999999999997
Q ss_pred HHHHhhhccccccccCCCCceEe--CCCC--CEEEeccCCCCCCCcc----cCCCcccccccCCccccccccccCC----
Q 011868 160 TFLLMIVIRPWKFNVLQLENILL--DSKG--NIKISDFGLSALPQHF----RDDGLLHTTCGSPNYVAPEVLANRG---- 227 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl--~~~g--~vkl~DFGla~~~~~~----~~~~~~~~~~gt~~y~APE~l~~~~---- 227 (476)
+|||+ |+|+ .+.|+|||.+-..+.. .-.+..-..-|.-.-||||+....+
T Consensus 370 ------------------DNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 370 ------------------DNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred ------------------cceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99998 4444 4889999976532210 0011122335778899999975421
Q ss_pred -CCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHH-HHh-CCCCCCCCCCHHHHHHHHHccCCCcCCCCChHH
Q 011868 228 -YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK-IFR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 299 (476)
Q Consensus 228 -~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~-i~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~ 299 (476)
.+-.|+|.|++|.+.||+++...||.+...+.+-.. ..+ .-+.+|+.+++.+++|+..+|+.||++|++..-
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 223689999999999999999999988543322111 112 234578889999999999999999999998653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9e-22 Score=182.69 Aligned_cols=191 Identities=18% Similarity=0.195 Sum_probs=142.8
Q ss_pred EEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhH-HHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 011868 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-TDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~-~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 94 (476)
.+...|++|+||+|+++.. .+.+++.+.+.......... ...+.+|+.+|+++. |++|++++++ ...|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4678999999999998874 77888888776554322222 225889999999995 5889999886 34699999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccC-CcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL-KVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDi-Kp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
|+.|.+|.+.+.. . ...++.|++.+|+++|++||+|||| ||
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp------------------------------- 120 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKE------------------------------- 120 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCc-------------------------------
Confidence 9999998754321 1 2357899999999999999999999 55
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCC----C-------cccccccCCccccccccccC-CCCCccchhhhHhHH
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDD----G-------LLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVI 241 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~----~-------~~~~~~gt~~y~APE~l~~~-~~~~~~sDvwSlGvi 241 (476)
+|||++.+|.++|+|||+|........- . ..+...+++.|++|+...-- ..+-...+.++.|+-
T Consensus 121 ----~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~ 196 (218)
T PRK12274 121 ----ANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKP 196 (218)
T ss_pred ----ceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcch
Confidence 9999999999999999999854431110 0 01223478899999864321 111255788899999
Q ss_pred HHHHhcCCCCCCCC
Q 011868 242 LYVILTGYLPFDDR 255 (476)
Q Consensus 242 l~elltG~~Pf~~~ 255 (476)
+|.++|+..|+-+.
T Consensus 197 ~~~~~~~~~~~~~~ 210 (218)
T PRK12274 197 VYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHhccCCcccc
Confidence 99999999997544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-20 Score=175.97 Aligned_cols=134 Identities=18% Similarity=0.222 Sum_probs=108.4
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCC---EEE
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-----KHPNVVRLHEVLASKS---KIY 90 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~l~~~~~~~~---~~~ 90 (476)
.+.||+|+||.||. ++.++.. +||++..... ...+.+.+|+.+++.+ +||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 7777766 6999876432 2356799999999999 5799999999998873 434
Q ss_pred -EEEec--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 91 -MVLEY--VTGGELFDKIASKGRLQEAEGRKLFQQLIDGV-SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 91 -lV~E~--~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al-~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
+|||| +.+|+|.+++.. +.+++. ..++.|++.++ +|||+++|+||||||
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp------------------------ 133 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKP------------------------ 133 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCH------------------------
Confidence 78999 557999999976 457666 35688888877 999999999999997
Q ss_pred ccccccccCCCCceEeCC----CCCEEEeccCCC
Q 011868 167 IRPWKFNVLQLENILLDS----KGNIKISDFGLS 196 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~----~g~vkl~DFGla 196 (476)
+|||++. ++.++|+||+.+
T Consensus 134 -----------~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 134 -----------QNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred -----------HHEEEeccCCCCCcEEEEECCCC
Confidence 9999974 347999995544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-20 Score=178.32 Aligned_cols=144 Identities=22% Similarity=0.251 Sum_probs=115.9
Q ss_pred CEEEeceEeecCceEEEEEE-ECCCCceEEEEEeecccccch---------------------hHHHHHHHHHHHHHhCC
Q 011868 15 RYELGRTLGEGNFGKVKFAQ-DLDSGLPFAVKILEKNRIIHL---------------------KITDQIKREIATLKLLK 72 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~-~~~~~~~vAvK~i~~~~~~~~---------------------~~~~~~~~Ei~~l~~l~ 72 (476)
-|++.+.||+|+||.||+|. +..+|+.||+|+++....... .....+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37899999999999999999 667999999999975431100 01234678999999997
Q ss_pred CC--CcceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC-cEeccCCcchhccch
Q 011868 73 HP--NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG-VFHRDLKVILKSCHM 149 (476)
Q Consensus 73 Hp--nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g-ivHrDiKp~~~~~~~ 149 (476)
+. .+.++++. ...|+||||+.|++|.........+...++..++.||+.++.+||+.| |+||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp------- 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSE------- 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCCh-------
Confidence 53 34455543 235899999999888776544556777788899999999999999999 99999997
Q ss_pred hhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCC
Q 011868 150 RIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198 (476)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~ 198 (476)
+||+++ ++.++|+|||.+..
T Consensus 178 ----------------------------~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 178 ----------------------------YNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred ----------------------------hhEEEE-CCCEEEEEChhhhc
Confidence 999999 88999999999874
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.5e-20 Score=203.49 Aligned_cols=239 Identities=19% Similarity=0.273 Sum_probs=182.2
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
+...+|.|.+.||+|+||+||.|.+.. |+.||+|+=+....+.-.+-.++...+. ++ --+.|..+...+.-.+.-+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~--~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQ--MLPSIMHISSAHVFQNASV 770 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hh--hhcchHHHHHHHccCCcce
Confidence 344579999999999999999999866 9999999976665444333344433332 11 1355666666666666778
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
||+||.+.|+|.++++..+.+++..+..+..|++.-|++||..+|||+||||
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKP---------------------------- 822 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKP---------------------------- 822 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCc----------------------------
Confidence 9999999999999999888999999999999999999999999999999997
Q ss_pred ccccCCCCceEeCC-------CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHH
Q 011868 171 KFNVLQLENILLDS-------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243 (476)
Q Consensus 171 ~~~~~~~~NiLl~~-------~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ 243 (476)
+|.||.. +-.++|+|||-|-.+.-+.+.......++|-.+--+|...++.|. ..+|.|.++.+++
T Consensus 823 -------DNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h 894 (974)
T KOG1166|consen 823 -------DNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVH 894 (974)
T ss_pred -------ceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHH
Confidence 9999842 345999999999866666666677888999999999999999996 8899999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHHhCC-----CCCCCCCCH-HHHHHHHHccCCCcCCCCChHHH
Q 011868 244 VILTGYLPFDDRNLAVLYQKIFRGD-----FKLPKWLSP-GAQNLLRKILEPNPVKRITIAGI 300 (476)
Q Consensus 244 elltG~~Pf~~~~~~~~~~~i~~~~-----~~~p~~~s~-~~~~Li~~~L~~dP~~R~s~~~i 300 (476)
.||+|++-= ...+. ..++..+.. -..+++..+|+.|-..=|.+.++
T Consensus 895 ~mLFG~y~q-----------~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 895 VMLFGKYME-----------VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred HHHHHHHHH-----------hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHH
Confidence 999998431 12211 113333333 34578888888444444444443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-18 Score=164.51 Aligned_cols=137 Identities=24% Similarity=0.368 Sum_probs=115.5
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+.||+|++|.||+|.. .|..|++|+.......... ....+.+|+.+++.+.|++|.....++......+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999986 7788999987543322111 12467889999999999998877777777778899999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
|++|++|.+.+..... ....++.|++.+|.++|+.|++|||++|
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p-------------------------------- 123 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTT-------------------------------- 123 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCc--------------------------------
Confidence 9999999998865322 7888999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSAL 198 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~ 198 (476)
.|||++ ++.++|+|||++..
T Consensus 124 ---~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 124 ---SNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred ---ccEEEE-CCCEEEEECCcccC
Confidence 999999 88999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=161.36 Aligned_cols=133 Identities=21% Similarity=0.280 Sum_probs=108.2
Q ss_pred eEeecCceEEEEEEECCCCceEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011868 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----KITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 21 ~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 95 (476)
.||+|+||+||+|. .+|..|++|.......... ....++.+|+.+++.++|+++....-++......++||||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 48999999999998 4678899998654322111 1235678999999999988765555555566677999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccC
Q 011868 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVL 175 (476)
Q Consensus 96 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 175 (476)
++|++|.+.+..... .++.|++.+|.+||+.|++|||++|
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~--------------------------------- 118 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTT--------------------------------- 118 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCc---------------------------------
Confidence 999999988754321 7899999999999999999999997
Q ss_pred CCCceEeCCCCCEEEeccCCCCC
Q 011868 176 QLENILLDSKGNIKISDFGLSAL 198 (476)
Q Consensus 176 ~~~NiLl~~~g~vkl~DFGla~~ 198 (476)
.||+++ ++.++++|||++..
T Consensus 119 --~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 119 --SNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred --ceEEEE-CCcEEEEECCCCcC
Confidence 999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=179.67 Aligned_cols=200 Identities=28% Similarity=0.425 Sum_probs=157.6
Q ss_pred HHhCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCc-EeccCCcchh
Q 011868 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGV-FHRDLKVILK 145 (476)
Q Consensus 68 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~gi-vHrDiKp~~~ 145 (476)
|+.+.|.|+.++++.+.+....+.|.+||..|+|.|.+.. .-+++.--...+++.|+.||+|||+..| +|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s--- 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKS--- 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecc---
Confidence 4678899999999999999999999999999999999976 3467777788899999999999999755 9999997
Q ss_pred ccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc
Q 011868 146 SCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 225 (476)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 225 (476)
.|.++|....+||+|||+.............+...-...|.|||.+..
T Consensus 78 --------------------------------~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~ 125 (484)
T KOG1023|consen 78 --------------------------------SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRG 125 (484)
T ss_pred --------------------------------ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcc
Confidence 999999999999999999886532111111222223468999999877
Q ss_pred CCC------CCccchhhhHhHHHHHHhcCCCCCCCCc----HHHHHHHHHh-CCCCC-CC-----CCCHHHHHHHHHccC
Q 011868 226 RGY------DGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFR-GDFKL-PK-----WLSPGAQNLLRKILE 288 (476)
Q Consensus 226 ~~~------~~~~sDvwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~-~~~~~-p~-----~~s~~~~~Li~~~L~ 288 (476)
... -+.++||||+|++++|+++...||+..+ ..++..++.+ +..++ |. ...+++..+++.||.
T Consensus 126 ~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~ 205 (484)
T KOG1023|consen 126 ALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWE 205 (484)
T ss_pred cccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcc
Confidence 422 2466999999999999999999997633 2345555555 33222 21 245579999999999
Q ss_pred CCcCCCCChHHHhc
Q 011868 289 PNPVKRITIAGIKA 302 (476)
Q Consensus 289 ~dP~~R~s~~~il~ 302 (476)
.+|..||+++++..
T Consensus 206 e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 206 EIPEKRPSIEQIRS 219 (484)
T ss_pred cChhhCccHHHHHh
Confidence 99999999999754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-19 Score=184.87 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=173.9
Q ss_pred CcCEEEeceEeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEE-------E
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE-------V 82 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~-------~ 82 (476)
.+.+.+.+..+.++++.+...+...+ .+.++.|..+.+.. .......+++-.+....|-+..-+.+ .
T Consensus 243 ~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~---~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~ 319 (516)
T KOG1033|consen 243 SGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL---CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFES 319 (516)
T ss_pred cccccccccccccccCCchhhhhcccchhhhhccchhhhccch---hhhhhhhhhhhheeccccCCcccccCCCCchhhh
Confidence 44566677777777777765554333 45555555443331 12334455555555555444333333 1
Q ss_pred EE-----eCCEEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHH
Q 011868 83 LA-----SKSKIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATL 154 (476)
Q Consensus 83 ~~-----~~~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~ 154 (476)
.. ....+|+.|++|.-.+|.++|..+. ..+......++.|++.|++| +|.+|||+||
T Consensus 320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp------------ 384 (516)
T KOG1033|consen 320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKP------------ 384 (516)
T ss_pred ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccc------------
Confidence 11 1235899999999999999997543 46677888999999999999 9999999997
Q ss_pred HHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCccc----CCCcccccccCCccccccccccCCCCC
Q 011868 155 QVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFR----DDGLLHTTCGSPNYVAPEVLANRGYDG 230 (476)
Q Consensus 155 ~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~----~~~~~~~~~gt~~y~APE~l~~~~~~~ 230 (476)
.||+...++.+||.|||+.+...... .........||++||+||.+.+..|.
T Consensus 385 -----------------------~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~- 440 (516)
T KOG1033|consen 385 -----------------------SNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS- 440 (516)
T ss_pred -----------------------cccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-
Confidence 99999999999999999988654422 11234556899999999999999996
Q ss_pred ccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 231 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 231 ~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~-~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
.++||||||+||+||+. =..+|. ....+..+..+.++..-+ -.|.-..|+.+||.+.|.+||++.+.-.|.|.
T Consensus 441 ~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 441 EKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 99999999999999997 333331 122333444454442122 23556799999999999999988777777664
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=160.47 Aligned_cols=138 Identities=25% Similarity=0.356 Sum_probs=109.8
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccch-------------------hHHHHHHHHHHHHHhCCCCC-
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-------------------KITDQIKREIATLKLLKHPN- 75 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~-------------------~~~~~~~~Ei~~l~~l~Hpn- 75 (476)
|.+.+.||+|+||.||+|.. .+|+.||||+++.....-. .......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 88899999999999999987 4899999999875431000 01124678999999998774
Q ss_pred -cceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHH
Q 011868 76 -VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATL 154 (476)
Q Consensus 76 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~ 154 (476)
+...++. ...++||||++|++|..... ......++.|++.++.++|+.||+||||||
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p------------ 153 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSE------------ 153 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCc------------
Confidence 4444442 34689999999998876532 134667899999999999999999999997
Q ss_pred HHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCC
Q 011868 155 QVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALP 199 (476)
Q Consensus 155 ~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~ 199 (476)
+||++++++.++|+|||++...
T Consensus 154 -----------------------~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 154 -----------------------FNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred -----------------------ccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=177.45 Aligned_cols=138 Identities=21% Similarity=0.271 Sum_probs=111.6
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccc-----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
.|...+.||+|+||+||+|.... ..+++|+........ ......+.+|+.+++.++|++++....++......
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 45667899999999999998643 344555432221111 11235688999999999999999887777777778
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
++||||++|++|.+.+. ....++.|++.+|.|||+.|++||||||
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp--------------------------- 456 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTT--------------------------- 456 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCCh---------------------------
Confidence 99999999999999875 4567899999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSAL 198 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~ 198 (476)
+|||+ .++.++|+|||+++.
T Consensus 457 --------~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 457 --------SNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred --------HHEEE-ECCcEEEEeCccccc
Confidence 99999 678999999999984
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=152.94 Aligned_cols=137 Identities=27% Similarity=0.395 Sum_probs=100.7
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHH---------------------HHHHHHHHHhCCCCC--
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ---------------------IKREIATLKLLKHPN-- 75 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~---------------------~~~Ei~~l~~l~Hpn-- 75 (476)
.+.||+|+||+||+|.+. +|+.||||++............. ...|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999986 89999999987643221111111 145666676665443
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCChHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhH
Q 011868 76 VVRLHEVLASKSKIYMVLEYVTGGELFDK-IASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIAT 153 (476)
Q Consensus 76 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~-l~~~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~ 153 (476)
+.+.++. ...++||||++|+.+... +... .. ..+++.++.|++.++.++|. .||+||||||
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p----------- 143 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSE----------- 143 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCCh-----------
Confidence 5555543 236899999998544321 2111 11 16788999999999999999 9999999997
Q ss_pred HHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCC
Q 011868 154 LQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198 (476)
Q Consensus 154 ~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~ 198 (476)
+||+++ ++.++|+|||.+..
T Consensus 144 ------------------------~Nili~-~~~~~liDfg~a~~ 163 (187)
T cd05119 144 ------------------------YNILVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred ------------------------hhEEEE-CCcEEEEECccccc
Confidence 999999 99999999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.7e-16 Score=148.61 Aligned_cols=137 Identities=23% Similarity=0.372 Sum_probs=105.6
Q ss_pred ceEe-ecCceEEEEEEECCCCceEEEEEeecccc----------cchhHHHHHHHHHHHHHhCCCCCc--ceEEEEEEeC
Q 011868 20 RTLG-EGNFGKVKFAQDLDSGLPFAVKILEKNRI----------IHLKITDQIKREIATLKLLKHPNV--VRLHEVLASK 86 (476)
Q Consensus 20 ~~LG-~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----------~~~~~~~~~~~Ei~~l~~l~HpnI--v~l~~~~~~~ 86 (476)
..|| .|+.|+||.+.. .+..++||.+..... .+......+.+|+.+++.+.|++| +..+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888888875 477899998864321 011223568899999999998885 6777764332
Q ss_pred -C---EEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 87 -S---KIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 87 -~---~~~lV~E~~~g-g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
. ..++|||+++| .+|.+++.. .++++.. +.||+.+|.+||++||+||||||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp------------------- 170 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNA------------------- 170 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCc-------------------
Confidence 2 23599999997 688888754 4566543 57899999999999999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCC
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~ 198 (476)
+|||++.++.++|+|||.+..
T Consensus 171 ----------------~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 171 ----------------HNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred ----------------hhEEEcCCCCEEEEECCCccc
Confidence 999999999999999998874
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-16 Score=138.42 Aligned_cols=132 Identities=23% Similarity=0.281 Sum_probs=113.0
Q ss_pred EeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEec
Q 011868 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~~~~lV~E~ 95 (476)
+++.||+|.++.||++... +..+++|....... ...+.+|+.+++.++| .++++++.+....+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4678999999999999974 37899999865432 4578899999999976 5899999998888889999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---CcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 96 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~---givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
+.|+++... +......++.+++.+++++|.. +++|+|++|
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~------------------------------ 117 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHP------------------------------ 117 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCc------------------------------
Confidence 988877543 5566777899999999999985 799999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSAL 198 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~ 198 (476)
+|++++..+.++++|||++..
T Consensus 118 -----~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 118 -----GNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred -----ceEEEECCcEEEEEecccccC
Confidence 999999999999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-17 Score=178.90 Aligned_cols=265 Identities=26% Similarity=0.407 Sum_probs=213.9
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
....+.+.+.+-+-+|+++.+..+.-..+|...++|+..+.........+....+-.++-..+||-++...-.+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 45677888999999999999999998888888888877655433332233444444333334456666554445566789
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+|+++|+.|++|...+...+..+++-++.+...+..+.+|||+..+.|||++|
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p--------------------------- 932 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKP--------------------------- 932 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccc---------------------------
Confidence 99999999999999999888899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCc----------------------cc-------CCCcccccccCCccccc
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQH----------------------FR-------DDGLLHTTCGSPNYVAP 220 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~----------------------~~-------~~~~~~~~~gt~~y~AP 220 (476)
.|+|...+|..+++|||....... .. +....+...||+.|.+|
T Consensus 933 --------~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laP 1004 (1205)
T KOG0606|consen 933 --------DSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAP 1004 (1205)
T ss_pred --------cchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCC
Confidence 999999999999999984321100 00 00123456799999999
Q ss_pred cccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC---CCCCHHHHHHHHHccCCCcCCCCCh
Q 011868 221 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP---KWLSPGAQNLLRKILEPNPVKRITI 297 (476)
Q Consensus 221 E~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~Li~~~L~~dP~~R~s~ 297 (476)
|.+.+... +..+|+|+.|+++++.++|..||........++.|.....+.| ...++.+++++.++|..+|.+|..+
T Consensus 1005 e~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1005 EILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred cccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCc
Confidence 99988776 4789999999999999999999999999999999999887765 4479999999999999999999998
Q ss_pred H---HHhcCccccccC
Q 011868 298 A---GIKADEWFEQDY 310 (476)
Q Consensus 298 ~---~il~~~~~~~~~ 310 (476)
. +...|++|+...
T Consensus 1084 ~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred ccccccccCCccCCCC
Confidence 8 899999997643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-14 Score=150.91 Aligned_cols=254 Identities=20% Similarity=0.220 Sum_probs=192.2
Q ss_pred CEEEeceEee--cCceEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 011868 15 RYELGRTLGE--GNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKI 89 (476)
Q Consensus 15 ~Y~i~~~LG~--G~fg~V~~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~ 89 (476)
.+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.-.. .......=.+|+...+.++ |+|.++.+..++..+..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccCCcc
Confidence 4667788999 99999999998 78899999997432211 1112234456777777774 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 90 YMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLID----GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~----al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
|+-+|+| |.+|.++...... +++..++.++.+..+ ||.++|+.+++|-|+||
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp---------------------- 250 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKP---------------------- 250 (524)
T ss_pred eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccch----------------------
Confidence 9999999 6788888876554 899999999999999 99999999999999997
Q ss_pred hhccccccccCCCCceEeCCC-CCEEEeccCCCCCCCcccCCC---cccccccCCccccccccccCCCCCccchhhhHhH
Q 011868 165 IVIRPWKFNVLQLENILLDSK-GNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~-g~vkl~DFGla~~~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGv 240 (476)
+||+...+ ...+++|||+........-.. ......|..-|++||+..+- .+...|++|+|.
T Consensus 251 -------------~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~e 315 (524)
T KOG0601|consen 251 -------------ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGE 315 (524)
T ss_pred -------------hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhh
Confidence 99999999 889999999987554322111 11233678899999986543 357899999999
Q ss_pred HHHHHhcCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 241 ILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 241 il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
++.+-.+|..+....-...+ ..+.+. ..++-...+.++...+..|++.+|-.|++.+.+++|++...
T Consensus 316 v~l~~~l~~~~~~~g~~~~W-~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 316 VILEAILGSHLPSVGKNSSW-SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhHhhHhhcccccCCCCCCc-cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 99998887766543211000 001111 11122234667777999999999999999999999998864
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.3e-14 Score=153.60 Aligned_cols=145 Identities=24% Similarity=0.377 Sum_probs=101.8
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc--------------------------c-h----hHHHH-
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--------------------------H-L----KITDQ- 60 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--------------------------~-~----~~~~~- 60 (476)
+..|+. +.||.|++|+||.|+...+|+.||||+++..-.. + . +..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 7899999999999999878999999999754200 0 0 11122
Q ss_pred -----HHHHHHHHHhCC----CCCcceEEEEEE-eCCEEEEEEeccCCCChHHH--HHhcC----CCCHHHHHHHHHHHH
Q 011868 61 -----IKREIATLKLLK----HPNVVRLHEVLA-SKSKIYMVLEYVTGGELFDK--IASKG----RLQEAEGRKLFQQLI 124 (476)
Q Consensus 61 -----~~~Ei~~l~~l~----HpnIv~l~~~~~-~~~~~~lV~E~~~gg~L~~~--l~~~~----~l~~~~~~~~~~qi~ 124 (476)
+.+|+..+.+++ +.+.+.+-.++. ..+..+|||||+.|+++.+. +...+ .+.+..+..++.|+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 344555554442 333344333332 24567899999999999774 33322 355666666777765
Q ss_pred HHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCC----CEEEeccCCCCCCC
Q 011868 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG----NIKISDFGLSALPQ 200 (476)
Q Consensus 125 ~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g----~vkl~DFGla~~~~ 200 (476)
..|++|+|+|| .||+++.+| .++++|||++...+
T Consensus 278 -------~~GffHaDpHP-----------------------------------GNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RDGFFHADMHP-----------------------------------GNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hCCeeeCCCCh-----------------------------------HHeEEecCCCCCCeEEEEecceEEECC
Confidence 48999999997 999999988 99999999987543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.7e-13 Score=143.09 Aligned_cols=142 Identities=25% Similarity=0.318 Sum_probs=97.8
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccc---------------------------hhH----HH------HHH
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH---------------------------LKI----TD------QIK 62 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~---------------------------~~~----~~------~~~ 62 (476)
+.||.|++|.||+|+. .+|+.||||+.+...... ... .. .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999996 579999999986532100 000 00 245
Q ss_pred HHHHHHHhCC----CCCcceEEEEE-EeCCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhcCc
Q 011868 63 REIATLKLLK----HPNVVRLHEVL-ASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLID-GVSYCHNKGV 135 (476)
Q Consensus 63 ~Ei~~l~~l~----HpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~-al~yLH~~gi 135 (476)
+|+..+.+++ |.+-+.+-.++ ...+..++||||++|++|.+..... ... ....++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 5666666552 22222222222 2234579999999999998876432 122 23345566665 4788899999
Q ss_pred EeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCC
Q 011868 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQ 200 (476)
Q Consensus 136 vHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~ 200 (476)
+|+|+|| .||+++.+|.++++|||++....
T Consensus 279 ~H~D~hP-----------------------------------gNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHP-----------------------------------GNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCc-----------------------------------ccEEECCCCcEEEEeCCCeeECC
Confidence 9999997 99999999999999999997544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.4e-12 Score=136.76 Aligned_cols=188 Identities=19% Similarity=0.318 Sum_probs=140.3
Q ss_pred CcCEEEeceEeecCceEEE-EEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVK-FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~-~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
.--|++ ...+-++.+ +| -|.-+.++.+|.|...+.... .......+-+.-|+.++||||+++++.++.++.+|+
T Consensus 12 ~fpY~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~yl 86 (690)
T KOG1243|consen 12 QFPYDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYL 86 (690)
T ss_pred cCCccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEE
Confidence 334666 333333333 34 355567889999999876542 446778889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
|+|.+ ..|..++.. ++.......+.||+.||-|||+ .+++|++|.-
T Consensus 87 vTErV--~Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~---------------------------- 133 (690)
T KOG1243|consen 87 VTERV--RPLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCK---------------------------- 133 (690)
T ss_pred Eeecc--ccHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEee----------------------------
Confidence 99999 477777765 3466777789999999999985 6899999995
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
..++++..|..||++|-++...+.... ..+...---.|..|+.+....+ ..|.|-|||++++++.|..
T Consensus 134 -------~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~~---s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 134 -------DSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSEW---SIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred -------eeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcccc---chhhhhHHHHHHHHhCccc
Confidence 899999999999999988864433221 1111222234666775543333 3699999999999999943
|
|
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.45 E-value=9e-14 Score=102.92 Aligned_cols=61 Identities=46% Similarity=0.853 Sum_probs=48.4
Q ss_pred CCCcccchhhhccccccccCCCCccccc--cccceeeeecCCHHHHHHHHHHHHHhcCeEEEe
Q 011868 344 SPPLINAFQLIGMSSCLDLSGFFEKEDV--SERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK 404 (476)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~ 404 (476)
+|..+|||++|++|+|+|||++|+.... .++.+||+|..++++|+++||++++.+|++|++
T Consensus 1 ~p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 1 KPKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp --EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CCccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 3678999999999999999999987543 467899999999999999999999999999975
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.5e-12 Score=117.80 Aligned_cols=127 Identities=18% Similarity=0.234 Sum_probs=97.0
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccC
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYVT 97 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~ 97 (476)
++.|+.|.++.||+++. .+..|++|+...... ....+.+|+.+++.+.+.++ .+++.+.. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 46789999999999985 478899998754421 12356789999999875554 45555443 33579999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCc-----EeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV-----FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 98 gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~gi-----vHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|.++.+. ......++.+++.+|+.||+.++ +|+|++|
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~------------------------------ 116 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLP------------------------------ 116 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCc------------------------------
Confidence 9887643 11123457899999999999885 9999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSA 197 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~ 197 (476)
.||+++ ++.++++|||.+.
T Consensus 117 -----~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 117 -----GNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred -----CcEEEE-CCeEEEEeccccc
Confidence 999999 6789999999886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=7.5e-12 Score=116.11 Aligned_cols=142 Identities=16% Similarity=0.218 Sum_probs=104.1
Q ss_pred eceEeecCceEEEEEEECC------CCceEEEEEeecccc-------------------cchhHHHH----HHHHHHHHH
Q 011868 19 GRTLGEGNFGKVKFAQDLD------SGLPFAVKILEKNRI-------------------IHLKITDQ----IKREIATLK 69 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~------~~~~vAvK~i~~~~~-------------------~~~~~~~~----~~~Ei~~l~ 69 (476)
...||.|-=+.||.|.... .+..+|||+.+.... ...+.... ..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998643 357899998753211 00111223 348999999
Q ss_pred hCCC--CCcceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCcEeccCCcchhc
Q 011868 70 LLKH--PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKVILKS 146 (476)
Q Consensus 70 ~l~H--pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yL-H~~givHrDiKp~~~~ 146 (476)
++.. -++.+++++ ..-++||||+.+..+..-...+..+++.++..++.|++.+|..| |+.|++|+||++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~---- 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSE---- 153 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCH----
Confidence 9953 567777765 45689999996654432222233566677888899999999999 899999999997
Q ss_pred cchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCC
Q 011868 147 CHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQ 200 (476)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~ 200 (476)
.|||++ +|.+.|+|||.|...+
T Consensus 154 -------------------------------~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 -------------------------------YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred -------------------------------HHEEEE-CCcEEEEECCCceeCC
Confidence 999996 5789999999887443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.8e-13 Score=138.81 Aligned_cols=256 Identities=21% Similarity=0.190 Sum_probs=192.0
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEEC-CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~ 86 (476)
.....++|..+..||.|.|+.|+..... .++..|++|.+.+........ ..-..|+.+...+ .|.+++..+..+...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 3445678899999999999999987644 678899999887665433322 2234577777666 599999998888888
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
...|+=-|||+++++...+....-+.+...++...|++.++.++|+..++|+|+||
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~p------------------------ 394 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKP------------------------ 394 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccc------------------------
Confidence 88889999999999877765444688899999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCC-CCEEEeccCCCCCCCcccCCCcccccccCCccc-cccccccCCCCCccchhhhHhHHHHH
Q 011868 167 IRPWKFNVLQLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV-APEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~-g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~-APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
.||++..+ +..++.|||.++.+.. ......++-++. .+|++........++|++|||.-+.+
T Consensus 395 -----------sni~i~~~~~~~~~~~~~~~t~~~~-----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e 458 (524)
T KOG0601|consen 395 -----------SNILISNDGFFSKLGDFGCWTRLAF-----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDE 458 (524)
T ss_pred -----------cceeeccchhhhhccccccccccce-----ecccccccccccccchhhccccccccccccccccccccc
Confidence 99999886 7889999999873111 011112233444 35555544444589999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 245 ILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
.++|...=... .....+..+..+..+....++..+...++.+++..|+.+.++..|.=|..
T Consensus 459 ~~~~~~ls~~~---~~~~~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 459 AITGSPLSESG---VQSLTIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred cccCcccCccc---ccceeeecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 99987542211 12234455655655555688899999999999999999999887765543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.6e-11 Score=118.64 Aligned_cols=202 Identities=19% Similarity=0.271 Sum_probs=139.2
Q ss_pred HHhCCCCCcceEEEEEEe-----CCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc--CcE
Q 011868 68 LKLLKHPNVVRLHEVLAS-----KSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK--GVF 136 (476)
Q Consensus 68 l~~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~--giv 136 (476)
|-.+.|.||++++.++.+ ..+..++.||+..|+|.++|+. ...+.....++++.||++||.|||+. -|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 334469999999988754 4468899999999999999964 34688889999999999999999986 699
Q ss_pred eccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC--CCcccccccC
Q 011868 137 HRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS 214 (476)
Q Consensus 137 HrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~--~~~~~~~~gt 214 (476)
|+++.- +.|++..+|-+|+.---......+... ..-.....|-
T Consensus 201 hgnlTc-----------------------------------~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~ 245 (458)
T KOG1266|consen 201 HGNLTC-----------------------------------DTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSL 245 (458)
T ss_pred cCCcch-----------------------------------hheeecCCceEEecccCccccchhhhhhhHhhhhccccC
Confidence 999985 889999999888863222211111111 1112223467
Q ss_pred CccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC-CCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCC
Q 011868 215 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 293 (476)
Q Consensus 215 ~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 293 (476)
++|.|||.=....- ..++|||++|....+|..+..-- .+.+....-..+...-+-+. .+.-+.+|.+||+..|..
T Consensus 246 ~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~ 321 (458)
T KOG1266|consen 246 PGFSAPESGTTTNT-TGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNG 321 (458)
T ss_pred CccccCCcCccccc-ccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCC
Confidence 89999996332333 35799999999999998876542 22211111111111111111 122357899999999999
Q ss_pred CCChHHHhcCccccc
Q 011868 294 RITIAGIKADEWFEQ 308 (476)
Q Consensus 294 R~s~~~il~~~~~~~ 308 (476)
||++..++.||.+-.
T Consensus 322 rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 322 RPDARLLLFHPLLFE 336 (458)
T ss_pred CcchhhhhcCceeee
Confidence 999999999997643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.7e-10 Score=102.02 Aligned_cols=134 Identities=25% Similarity=0.326 Sum_probs=99.5
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHH-----HHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT-----DQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~-----~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
..+++|+=+.+|.+.. -|..+++|.=.+...-+++.. .+..+|+.++++++--.|.-.+-+..+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 3578999999998853 455577775433333333332 456789999999975555444444445566779999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
|++|..|.+.+... ...+++.+-.-+.-||..||+|+||.+
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTt-------------------------------- 120 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTT-------------------------------- 120 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCcc--------------------------------
Confidence 99998888888764 244666777778899999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSAL 198 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~ 198 (476)
+||++.+.+ +.++||||+.+
T Consensus 121 ---sNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 121 ---SNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ---ceEEEeCCc-EEEEECCcccc
Confidence 999997765 99999999984
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=2e-10 Score=108.25 Aligned_cols=175 Identities=17% Similarity=0.185 Sum_probs=114.2
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeC---CEEEEEEe
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASK---SKIYMVLE 94 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~---~~~~lV~E 94 (476)
+.||.|..+.||++... +|+.+++|+....... .....+.+|+.+++.+.+ .++.+++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 57899999999999863 4688999997654321 124678899999999975 4467788877654 36789999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHH--------------
Q 011868 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT-------------- 160 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~-------------- 160 (476)
|++|.++.+.+.. ..+++.+...++.+++.+|..||+...-.-.+................+...
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999988776532 4688889999999999999999986432111100000000000000000000
Q ss_pred ---HHHhh----hccccccccCCCCceEeCC--CCCEEEeccCCCCC
Q 011868 161 ---FLLMI----VIRPWKFNVLQLENILLDS--KGNIKISDFGLSAL 198 (476)
Q Consensus 161 ---~~~~~----~~~p~~~~~~~~~NiLl~~--~g~vkl~DFGla~~ 198 (476)
+.... ...-.-|..+.+.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 00000 0112346678899999998 56789999998873
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.4e-09 Score=94.79 Aligned_cols=144 Identities=22% Similarity=0.254 Sum_probs=107.8
Q ss_pred EeceEeecCceEEEEEEECCCCceEEEEEeecccccchhH-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-----TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~-----~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
....+-+|+=+.|+.+. ..|+...||.=.....-++.. ..+.++|+.+|.++.--.|.-..-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 56788999999999887 578888888543333223222 34678899999999766666555556566667889
Q ss_pred EeccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 93 LEYVTG-GELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 93 ~E~~~g-g~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|||++| .++.+++... ..........++++|-..+.-||.++|+|+||.+
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTT--------------------------- 141 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTT--------------------------- 141 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccc---------------------------
Confidence 999977 4777877653 2233333378899999999999999999999998
Q ss_pred cccccCCCCceEeCCCC---CEEEeccCCCCC
Q 011868 170 WKFNVLQLENILLDSKG---NIKISDFGLSAL 198 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g---~vkl~DFGla~~ 198 (476)
+||++..+| .+.++|||++..
T Consensus 142 --------SNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 142 --------SNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred --------cceEEecCCCcCceEEEeecchhc
Confidence 999997665 358999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.1e-09 Score=107.20 Aligned_cols=212 Identities=20% Similarity=0.212 Sum_probs=155.7
Q ss_pred CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEeccCC-CC
Q 011868 26 NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKIYMVLEYVTG-GE 100 (476)
Q Consensus 26 ~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~g-g~ 100 (476)
--.+.|++....+|..|++|.++-.+....+ ....-+++++++.|+|||++.++|.. +..+++|++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 3457899999899999999999655443332 23345678899999999999999863 4579999999986 57
Q ss_pred hHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 101 LFDKIAS---------------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 101 L~~~l~~---------------~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
|.++-.. +.+.+|...|.|+.||..||.++|+.|+.-+-|.+
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~----------------------- 421 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDL----------------------- 421 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccH-----------------------
Confidence 7776522 22578899999999999999999999998888885
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
.+||++.+.+++|+.-|+.-+..... + |-+.+. .+-|.=.||.++..|
T Consensus 422 ------------~kIlv~G~~RIriS~C~i~Dvl~~d~---------~-------~~le~~----Qq~D~~~lG~ll~aL 469 (655)
T KOG3741|consen 422 ------------KKILVTGKMRIRISGCGIMDVLQEDP---------T-------EPLESQ----QQNDLRDLGLLLLAL 469 (655)
T ss_pred ------------hHeEeeCcceEEEecccceeeecCCC---------C-------cchhHH----hhhhHHHHHHHHHHH
Confidence 99999999999999877765433211 0 112221 346888999999999
Q ss_pred hcCCCC-CCCCcHHHH-HHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 246 LTGYLP-FDDRNLAVL-YQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 246 ltG~~P-f~~~~~~~~-~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
.||..- +........ ...| -..+|.+++++|.-+...++.. -++.+++.+
T Consensus 470 At~~~ns~~~d~~~~s~~~~I-------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 470 ATGTENSNRTDSTQSSHLTRI-------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hhcccccccccchHHHHHHHh-------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 999633 111111111 2222 2347889999999999999887 788888765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.2e-09 Score=96.67 Aligned_cols=126 Identities=29% Similarity=0.399 Sum_probs=84.0
Q ss_pred EEEEEEECCCCceEEEEEeecccc-----------------------cchhHHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 011868 29 KVKFAQDLDSGLPFAVKILEKNRI-----------------------IHLKITDQIKREIATLKLLKHP--NVVRLHEVL 83 (476)
Q Consensus 29 ~V~~a~~~~~~~~vAvK~i~~~~~-----------------------~~~~~~~~~~~Ei~~l~~l~Hp--nIv~l~~~~ 83 (476)
.||.|.. ..|..+|||+.+.... ...-......+|...|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899987 5788999998753210 0011124578899999999765 567777653
Q ss_pred EeCCEEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 84 ASKSKIYMVLEYVT--GGELFDKIASKGRLQEAEGRKLFQQLIDGVSY-CHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 84 ~~~~~~~lV~E~~~--gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~y-LH~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
.-++||||+. |..+..+... .++......++.+++..+.. +|..||+|+||.+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~------------------ 135 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSE------------------ 135 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-ST------------------
T ss_pred ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCCh------------------
Confidence 2369999997 5555443322 23355677788889886665 5799999999997
Q ss_pred HHHhhhccccccccCCCCceEeCCCCCEEEeccCCCC
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSA 197 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~ 197 (476)
.|||++++ .+.++|||.+.
T Consensus 136 -----------------~NIlv~~~-~~~iIDf~qav 154 (188)
T PF01163_consen 136 -----------------YNILVDDG-KVYIIDFGQAV 154 (188)
T ss_dssp -----------------TSEEEETT-CEEE--GTTEE
T ss_pred -----------------hhEEeecc-eEEEEecCcce
Confidence 89999887 99999999876
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.8e-08 Score=97.15 Aligned_cols=132 Identities=16% Similarity=0.104 Sum_probs=94.1
Q ss_pred EEEEEEECCCCceEEEEEeecccccc---h-----hHHHHHHHHHHHHHhCCCCCc--ceEEEEEEe-----CCEEEEEE
Q 011868 29 KVKFAQDLDSGLPFAVKILEKNRIIH---L-----KITDQIKREIATLKLLKHPNV--VRLHEVLAS-----KSKIYMVL 93 (476)
Q Consensus 29 ~V~~a~~~~~~~~vAvK~i~~~~~~~---~-----~~~~~~~~Ei~~l~~l~HpnI--v~l~~~~~~-----~~~~~lV~ 93 (476)
.|.... ..|+.|.||......... . .-...+.+|...+.++..-+| +.+..+.+. ...-++||
T Consensus 37 rvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 344443 367789999663322100 0 001147899999988854333 344444432 23578999
Q ss_pred eccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 94 EYVTGG-ELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 94 E~~~gg-~L~~~l~~--~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
|++++. +|.+++.. ..+.++.....++.+++..+.-||..||+|+|+++
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~---------------------------- 166 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYI---------------------------- 166 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCCh----------------------------
Confidence 999876 78888753 34567778889999999999999999999999997
Q ss_pred ccccCCCCceEeCC-------CCCEEEeccCCCC
Q 011868 171 KFNVLQLENILLDS-------KGNIKISDFGLSA 197 (476)
Q Consensus 171 ~~~~~~~~NiLl~~-------~g~vkl~DFGla~ 197 (476)
.|||++. ++.+.++||+.+.
T Consensus 167 -------~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 167 -------CHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred -------hhEEEeccccCCCCCceEEEEECCccc
Confidence 9999975 4679999999885
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.8e-10 Score=116.75 Aligned_cols=154 Identities=23% Similarity=0.359 Sum_probs=115.7
Q ss_pred HHHHHHHHHHhc-CcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCC
Q 011868 122 QLIDGVSYCHNK-GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQ 200 (476)
Q Consensus 122 qi~~al~yLH~~-givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~ 200 (476)
+.+.|+.|+|+. ++||+.|.| ++|.++.+|..||+.|+++....
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p-----------------------------------~~i~~na~~~wkl~Gf~f~v~~~ 151 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQP-----------------------------------EAIVVNANGDWKLAGFSFCVNAN 151 (700)
T ss_pred cccchhhhhccCcceeecccch-----------------------------------hheeeccCcceeeccchhhhccC
Confidence 344899999975 999999997 99999999999999999876433
Q ss_pred cccC------CCccc-ccccCCccccccccccCCCCCccchhhhHhHHHHHHh-cCCCCCCCCcHHHHHHHHHh----CC
Q 011868 201 HFRD------DGLLH-TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL-TGYLPFDDRNLAVLYQKIFR----GD 268 (476)
Q Consensus 201 ~~~~------~~~~~-~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~----~~ 268 (476)
.... +.... -..-...|.|||.+.... .+.++|++|+||++|.+. .|+..+...+....+..-.. +.
T Consensus 152 ~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~-~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~ 230 (700)
T KOG2137|consen 152 GPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT-NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGA 230 (700)
T ss_pred CCCccccccCCCCCChhhccCcccccchhhcccc-ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccc
Confidence 2100 00011 111345899999988744 358899999999999999 67777776654444433221 12
Q ss_pred CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 269 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 269 ~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
+.....+++++++=+.++|..++..||++..++..|||.....
T Consensus 231 ~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~ 273 (700)
T KOG2137|consen 231 FGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGL 273 (700)
T ss_pred ccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCchh
Confidence 3355778999999999999999999999999999999987543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.6e-08 Score=95.28 Aligned_cols=137 Identities=26% Similarity=0.365 Sum_probs=105.1
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccc-----------------cc--hhHHHHHHHHHHHHHhCCCC--
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-----------------IH--LKITDQIKREIATLKLLKHP-- 74 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-----------------~~--~~~~~~~~~Ei~~l~~l~Hp-- 74 (476)
+.++.+||-|-=|.||.|.+ ..|.++|||.-+.... .+ .-.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 34678999999999999997 4799999997543211 00 01123578899999999755
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHH
Q 011868 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATL 154 (476)
Q Consensus 75 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~ 154 (476)
.+.+.+++ +.-.+||||++|-.|... +++...+..++..|+.-+.-+-..|++|+|+.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSe------------ 230 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSE------------ 230 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCch------------
Confidence 78887775 456899999998777542 234566666777777777777789999999996
Q ss_pred HHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCC
Q 011868 155 QVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSA 197 (476)
Q Consensus 155 ~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~ 197 (476)
-||+++++|.+.++||--+.
T Consensus 231 -----------------------fNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 231 -----------------------FNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred -----------------------heEEEecCCCEEEEeCcccc
Confidence 89999999999999998665
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1e-07 Score=95.63 Aligned_cols=234 Identities=18% Similarity=0.208 Sum_probs=150.0
Q ss_pred EeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE------EEeCC-EE
Q 011868 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV------LASKS-KI 89 (476)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~------~~~~~-~~ 89 (476)
.++.||+|+-+.+|-.-. -+ ..+.|+..+..... ..+ .+..|... .||-+-.-+.+ ...++ .+
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~-d~VAKIYh~Pppa~---~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VR-DQVAKIYHAPPPAA---QAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecch--hh-chhheeecCCCchH---HHH---HHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 467899999999994331 12 23458887654211 111 12223333 56654431111 11222 37
Q ss_pred EEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHH
Q 011868 90 YMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFL 162 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~-------~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~ 162 (476)
-+.|..++|..--..+.+ .....+.-+.+..+.|+++.+.||+.|-+-+|+++
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~-------------------- 145 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQ-------------------- 145 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCc--------------------
Confidence 788999988643333321 12366778889999999999999999999999996
Q ss_pred HhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccc-----cCCCCCccchhhh
Q 011868 163 LMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWS 237 (476)
Q Consensus 163 ~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~sDvwS 237 (476)
+|+|+++++.+.|.|=..-.+ ..++....-.+|.+.|.+||.-. +..- ....|.|.
T Consensus 146 ---------------~~~lVsd~~~V~LVdsDsfqi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FG 206 (637)
T COG4248 146 ---------------NSFLVSDDSKVVLVDSDSFQI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFG 206 (637)
T ss_pred ---------------cceeeecCceEEEEcccceee---ccCCceEecccCccccCCHHHhccccccccCC-Cccccchh
Confidence 999999999999986432221 11333444567999999999744 2222 25689999
Q ss_pred HhHHHHHHhcC-CCCCCCCcHH----HHHH-HHHhCC-----------CCCC---CC--CCHHHHHHHHHccCC--CcCC
Q 011868 238 CGVILYVILTG-YLPFDDRNLA----VLYQ-KIFRGD-----------FKLP---KW--LSPGAQNLLRKILEP--NPVK 293 (476)
Q Consensus 238 lGvil~elltG-~~Pf~~~~~~----~~~~-~i~~~~-----------~~~p---~~--~s~~~~~Li~~~L~~--dP~~ 293 (476)
||+++++++.| +.||.|-... .-++ .|..+. .+.| +| +++++..|..+|+.. +|.-
T Consensus 207 LavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~ 286 (637)
T COG4248 207 LAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATP 286 (637)
T ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCC
Confidence 99999999986 9999763210 0011 222221 1222 12 688999999999975 4668
Q ss_pred CCChHH
Q 011868 294 RITIAG 299 (476)
Q Consensus 294 R~s~~~ 299 (476)
|||++.
T Consensus 287 RP~a~a 292 (637)
T COG4248 287 RPTAKA 292 (637)
T ss_pred CCCHHH
Confidence 999764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.65 E-value=4e-07 Score=85.67 Aligned_cols=105 Identities=23% Similarity=0.380 Sum_probs=85.3
Q ss_pred HHHHHHHHHHHhCCCCC--cceEEEEEEeC----CEEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 011868 59 DQIKREIATLKLLKHPN--VVRLHEVLASK----SKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131 (476)
Q Consensus 59 ~~~~~Ei~~l~~l~Hpn--Iv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH 131 (476)
....+|...+..+..-+ +++.+.+.+.. ...++|+|+++|. +|.+.+......+......++.+++..++-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 46788988888885433 45556655542 2458999999884 79998876555778888999999999999999
Q ss_pred hcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCC---CEEEeccCCCCC
Q 011868 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG---NIKISDFGLSAL 198 (476)
Q Consensus 132 ~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g---~vkl~DFGla~~ 198 (476)
.+||+|+|+++ .|||++.++ .+.++||+-+..
T Consensus 136 ~~gi~H~Dl~~-----------------------------------~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNP-----------------------------------SNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCc-----------------------------------ccEEEeCCCCceeEEEEcchhcee
Confidence 99999999997 999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=9e-07 Score=82.71 Aligned_cols=137 Identities=17% Similarity=0.171 Sum_probs=100.0
Q ss_pred eecCceEEEEEEECCCCceEEEEEeecccccc---hhHHHHHHHHHHHHHhCCCCC--cceEEEEEE-e----CCEEEEE
Q 011868 23 GEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH---LKITDQIKREIATLKLLKHPN--VVRLHEVLA-S----KSKIYMV 92 (476)
Q Consensus 23 G~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~~~-~----~~~~~lV 92 (476)
|+||-|-|+.... .|+.+=+|.-.....-+ +--...|.+|+..|+.+..-+ +.++. ++. . .-.-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 5689999987663 45568888754111101 223578999999999996433 44444 222 1 1246899
Q ss_pred EeccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 93 LEYVTG-GELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 93 ~E~~~g-g~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+|-+.| -+|.+++... .+.++.....++.+++..+.-||+.|+.|+|+.+
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~--------------------------- 156 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYV--------------------------- 156 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCH---------------------------
Confidence 997754 5888887552 3567888889999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCC--EEEeccCCCC
Q 011868 170 WKFNVLQLENILLDSKGN--IKISDFGLSA 197 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~--vkl~DFGla~ 197 (476)
.||+++.+|. ++++||.-++
T Consensus 157 --------khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 157 --------RHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred --------hheeecCCCCeeEEEEEhhccc
Confidence 9999997777 9999998665
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.2e-06 Score=82.14 Aligned_cols=140 Identities=18% Similarity=0.248 Sum_probs=92.5
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHH------HHHHHHHHHHhCCCCC---cceEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD------QIKREIATLKLLKHPN---VVRLHEV 82 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~------~~~~Ei~~l~~l~Hpn---Iv~l~~~ 82 (476)
.-++|.+.+.+-......|.+-. ..|+.+++|..+......+.... ...+++..+.+++..+ ...++-+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 34678888888887777776655 56788999987654321111111 1344555555554333 3333333
Q ss_pred EE-----eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHH
Q 011868 83 LA-----SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVF 157 (476)
Q Consensus 83 ~~-----~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~ 157 (476)
.+ -....+++|||++|.+|.+... +++. +...+++++.-+|+.|++|+|.+|
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hp--------------- 163 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHP--------------- 163 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCc---------------
Confidence 22 1234568999999988876532 3332 445677889999999999999997
Q ss_pred HHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCC
Q 011868 158 LLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSA 197 (476)
Q Consensus 158 ~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~ 197 (476)
.|++++.++ ++++||+..+
T Consensus 164 --------------------gNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 164 --------------------GNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred --------------------CcEEEECCc-EEEEECcccc
Confidence 999998655 9999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.3e-08 Score=106.50 Aligned_cols=239 Identities=19% Similarity=0.193 Sum_probs=160.0
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEEe
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~E 94 (476)
|...+.+++|+++++++++...+...+ .+.+... ....-++++|.+++||| .+..++-++.+...+++|+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 556678899999999999977666655 6666332 34455888999999999 7777777788889999999
Q ss_pred ccCCC-ChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 95 YVTGG-ELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 95 ~~~gg-~L~~~l~-~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
++.++ +..+.+. ..-.+.+-+.....+.-..+++++|+.--+|||
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d--------------------------------- 361 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD--------------------------------- 361 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc---------------------------------
Confidence 99777 2222111 111233334444556666788999987666764
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
||+.. ++..|..||+....... .....+..+|+.++|||+.....++ .+.|.||+|+-..+|--|-+|-
T Consensus 362 ------~~l~s-~~~~~~~~~~v~~~L~~---~~~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 362 ------NILGS-EEEVKLLDFAVPPQLTR---TMKPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ------ccccc-ccccccccccCCcccCc---ccccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCC
Confidence 34433 37789999998774432 2235667899999999999998887 6789999998777777777775
Q ss_pred CCCcHHHHHHHHHhCCCCCC------CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 253 DDRNLAVLYQKIFRGDFKLP------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~~~~~p------~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
..+-. ....+-.+. ..| .|-...-.++...|+..-|-.|+....++.|.+|+...
T Consensus 431 ~~P~~--~~~~~g~~p-~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 431 SSPPA--VLPMIGNGP-NSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred CCCcc--ccCCCCCCC-CccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 33110 000000000 000 11111112467789999999999999988888886543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.6e-06 Score=80.84 Aligned_cols=139 Identities=19% Similarity=0.225 Sum_probs=98.8
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchh---------------------HHHHHHHHHHHHHhCC--CCCc
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---------------------ITDQIKREIATLKLLK--HPNV 76 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~---------------------~~~~~~~Ei~~l~~l~--HpnI 76 (476)
..|..|-=+.||+|.. ..+..+|+|+.......-.. ......+|..-|+++. +=.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3667777889999985 67899999998643221111 0123567888888884 4556
Q ss_pred ceEEEEEEeCCEEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHH
Q 011868 77 VRLHEVLASKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATL 154 (476)
Q Consensus 77 v~l~~~~~~~~~~~lV~E~~~gg-~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~ 154 (476)
.+-+.+.. -.|||||+... .-.-.|. ..++...++..+..+++..+.-|-. .|+||+||..
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSE------------ 195 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSE------------ 195 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchh------------
Confidence 66666543 46899999432 1111221 1245555899999999999998877 8999999996
Q ss_pred HHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCC
Q 011868 155 QVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQ 200 (476)
Q Consensus 155 ~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~ 200 (476)
-|||+. +|.+.++|||-|....
T Consensus 196 -----------------------yNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 196 -----------------------YNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -----------------------hheEEE-CCeEEEEECccccccC
Confidence 899999 8999999999887543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.9e-06 Score=78.89 Aligned_cols=164 Identities=12% Similarity=0.120 Sum_probs=100.9
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEEEEEEeccC
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEVLASKSKIYMVLEYVT 97 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~ 97 (476)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-+ +.+.+++.+..+..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 47899999999973 25567889875432 1355789999999986433 5778888888888899999998
Q ss_pred CCC-hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchh--ccchh-----hhHHHHHHHHHHHhhhcc-
Q 011868 98 GGE-LFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILK--SCHMR-----IATLQVFLLTFLLMIVIR- 168 (476)
Q Consensus 98 gg~-L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~--~~~~~-----~~~~~~~~~~~~~~~~~~- 168 (476)
|.+ +...+ ..+......+..+++..+.-||+..+-...+..... ...+. ..........+.......
T Consensus 78 G~~~~~~~~----~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 78 GKRSFSRII----SDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred Cccchhhhh----cCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 864 32222 234455566788888888888875332222110000 00000 000011111111111111
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCC
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSA 197 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~ 197 (476)
-.-|+.+.|.|+++++++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 123677889999999988 9999999886
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=3.1e-06 Score=89.69 Aligned_cols=137 Identities=24% Similarity=0.343 Sum_probs=90.3
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccc---------------------------cchhHHH----------HHH
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI---------------------------IHLKITD----------QIK 62 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---------------------------~~~~~~~----------~~~ 62 (476)
.-|+.++-|.||.|+. .+|+.||||+.+.+-. .-.+..+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5688999999999997 5699999998643210 0001111 245
Q ss_pred HHHHHHHhCC-----CCCcceEEEEEEeCCEEEEEEeccCCCChHHHH--HhcCCCCH-----HHHHHHHHHHHHHHHHH
Q 011868 63 REIATLKLLK-----HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI--ASKGRLQE-----AEGRKLFQQLIDGVSYC 130 (476)
Q Consensus 63 ~Ei~~l~~l~-----HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l--~~~~~l~~-----~~~~~~~~qi~~al~yL 130 (476)
+|...+.+++ .|++.--.=+.+-.+.-.|+|||+.|-.+.+.. .. .+++. .-+..++.|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~------- 281 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQL------- 281 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHH-------
Confidence 5666666653 233221111223345678999999998888874 33 34442 2233333333
Q ss_pred HhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCC
Q 011868 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQ 200 (476)
Q Consensus 131 H~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~ 200 (476)
=..|++|.|.+| .||+++.+|.+.+.|||+....+
T Consensus 282 ~~dgffHaDpHp-----------------------------------GNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 282 LRDGFFHADPHP-----------------------------------GNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HhcCccccCCCc-----------------------------------cceEEecCCcEEEEcCcceecCC
Confidence 237999999997 99999999999999999987543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.22 E-value=9.4e-06 Score=90.78 Aligned_cols=208 Identities=18% Similarity=0.207 Sum_probs=144.8
Q ss_pred HHHHHHHHHHHhCCCCCcceEEEEEEeCCE----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011868 59 DQIKREIATLKLLKHPNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (476)
Q Consensus 59 ~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~----~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g 134 (476)
.....|...+....|+|++.++.+...+.. ..+..++|..-++.+.+..-+..+..+++.+..+++.|++|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 345567778888899999999998754432 2345678999999999998889999999999999999999999986
Q ss_pred cEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEe--ccCCCCCCCcccCCCcccccc
Q 011868 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS--DFGLSALPQHFRDDGLLHTTC 212 (476)
Q Consensus 135 ivHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~--DFGla~~~~~~~~~~~~~~~~ 212 (476)
..|.=+... + -.+-..+..+.+.++ ||+.+..... ........
T Consensus 307 l~~v~L~~s--------~------------------------~~~~~~~~e~~~~~sl~~~~ss~~l~d---~~~~~~~~ 351 (1351)
T KOG1035|consen 307 LEHVVLSAS--------S------------------------SKESTVDGEGVVAISLSDFDSSKPLPD---NEKSFSDL 351 (1351)
T ss_pred cceeEEecc--------c------------------------ccccccCccceeecchhhhcccccCCC---cccchhhc
Confidence 555544320 0 013344556667776 8887764332 22223334
Q ss_pred cCCccccccccccCCCC-CccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCc
Q 011868 213 GSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNP 291 (476)
Q Consensus 213 gt~~y~APE~l~~~~~~-~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP 291 (476)
-+..|.|||......+. +...|+|.+|..+..+..|..+-... ...... ++........++..+|+.-++
T Consensus 352 ~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~---~~~~~~------l~~~~~~~~~d~~~~~~~~~~ 422 (1351)
T KOG1035|consen 352 LAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS---AVPVSL------LDVLSTSELLDALPKCLDEDS 422 (1351)
T ss_pred CccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc---cchhhh------hccccchhhhhhhhhhcchhh
Confidence 45677888887665554 12369999999999999876552111 000011 111122267889999999999
Q ss_pred CCCCChHHHhcCccccccC
Q 011868 292 VKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 292 ~~R~s~~~il~~~~~~~~~ 310 (476)
++|+++.+++.|+|.....
T Consensus 423 ~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 423 EERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhccchhhhhhchhccccc
Confidence 9999999999999986543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.4e-05 Score=76.90 Aligned_cols=99 Identities=18% Similarity=0.197 Sum_probs=70.2
Q ss_pred eEeecCc-eEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 21 TLGEGNF-GKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 21 ~LG~G~f-g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
.|..|.. +.||.... .+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3444444 88998874 34678889875432 345778999998884 44566888888777778999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~ 133 (476)
.++..... ..+...++.|+...+.-||+.
T Consensus 77 ~~l~~~~~------~~~~~~~~~~l~~~l~~lH~i 105 (244)
T cd05150 77 VPAAALWE------ELEPERLVDALAEALRRLHAL 105 (244)
T ss_pred ccHhHhhc------ccCHHHHHHHHHHHHHHHhcC
Confidence 87754321 122345788889999999975
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.9e-05 Score=74.54 Aligned_cols=102 Identities=24% Similarity=0.302 Sum_probs=73.8
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC--CcceEEEEE---EeCCEEEEEE
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP--NVVRLHEVL---ASKSKIYMVL 93 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hp--nIv~l~~~~---~~~~~~~lV~ 93 (476)
++.|+.|..+.||+..... ..+++|..... .....+.+|..+++.+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4689999999999998744 48999986443 3357788999999888533 356676644 3344689999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~ 133 (476)
++++|.++.. ..+......++.+++..+..||+.
T Consensus 75 ~~i~g~~~~~------~~~~~~~~~~~~~~~~~l~~lh~~ 108 (239)
T PF01636_consen 75 EYIPGRPLDD------ELSPEQRPELLRQLGRALAQLHQV 108 (239)
T ss_dssp EEESSEEHHH------TSTHHHHHHHHHHHHHHHHHHHHS
T ss_pred EEeccccccc------cccccccccccccchhhhhhcccc
Confidence 9999988876 355666666777777777777765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.3e-05 Score=72.43 Aligned_cols=129 Identities=18% Similarity=0.242 Sum_probs=93.8
Q ss_pred EeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEEecc
Q 011868 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV-RLHEVLASKSKIYMVLEYV 96 (476)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~~~~~~~~~~~lV~E~~ 96 (476)
+.+.||+|++|.||++.. .|..+|+|+-+.+. ....+..|+++|..+.-.++. ++|.+-. .++.|||+
T Consensus 26 v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i 94 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYI 94 (201)
T ss_pred hhhhhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhh
Confidence 356799999999999984 56689999876553 257899999999999877765 4555533 34559999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCC
Q 011868 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQ 176 (476)
Q Consensus 97 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 176 (476)
.|.+|.+.-... + ++-...++.+---|-..||-|+.|.-
T Consensus 95 ~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~---------------------------------- 133 (201)
T COG2112 95 DGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSR---------------------------------- 133 (201)
T ss_pred cCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcC----------------------------------
Confidence 998887654321 2 22233455665556678999999985
Q ss_pred CCceEeCCCCCEEEeccCCCCC
Q 011868 177 LENILLDSKGNIKISDFGLSAL 198 (476)
Q Consensus 177 ~~NiLl~~~g~vkl~DFGla~~ 198 (476)
|...++.+++.+.|+||--|++
T Consensus 134 ~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 134 PWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred CceeEEecCCcEEEEEccchhh
Confidence 4666666666999999998874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.6e-05 Score=86.30 Aligned_cols=111 Identities=14% Similarity=0.279 Sum_probs=80.9
Q ss_pred eceEeecCceEEEEEEECCCC--ceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCc--ceEEEEEEeC---CEEE
Q 011868 19 GRTLGEGNFGKVKFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNV--VRLHEVLASK---SKIY 90 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnI--v~l~~~~~~~---~~~~ 90 (476)
++.|+.|.+..+|+......+ ..+++|+....... .....+.+|+.+|+.+. |+++ .+++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 577899999999998764332 46778876543211 12357889999999995 6665 7888887654 4689
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~ 133 (476)
+||||++|..+.+.. -..++..+...+..|++.+|..||+.
T Consensus 121 lVME~v~G~~~~~~~--~~~~~~~~r~~l~~~l~~~La~LH~v 161 (822)
T PLN02876 121 YIMEYLEGRIFVDPK--LPGVAPERRRAIYRATAKVLAALHSA 161 (822)
T ss_pred EEEEecCCcccCCcc--CCCCCHHHHHHHHHHHHHHHHHHhCC
Confidence 999999886544311 12456778888999999999999985
|
|
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.6e-05 Score=55.81 Aligned_cols=43 Identities=28% Similarity=0.554 Sum_probs=38.3
Q ss_pred CceEEEEEEEEEc-CceEEEEEEecCCChhhHHHHHHHHHhhcC
Q 011868 422 GSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQLCNKLSSDLG 464 (476)
Q Consensus 422 ~~l~~~~ev~~~~-~~~~lVe~~k~~Gd~lef~~~~~~l~~~L~ 464 (476)
..+.|.+||+++. ++++.|+|+|.+||.+.|+++|.+|...|+
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~il~~l~ 46 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSKILNELR 46 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHHHHHHTT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHHHHHHcc
Confidence 5688999999998 899999999999999999999999988875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=4e-05 Score=81.18 Aligned_cols=141 Identities=22% Similarity=0.225 Sum_probs=89.7
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccc----------------------------hhHHH------HHHHHH
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH----------------------------LKITD------QIKREI 65 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~----------------------------~~~~~------~~~~Ei 65 (476)
+.||.-+.|.|++|+.+ +|+.||||+-+..-... .+..+ .|.+|+
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 57999999999999975 59999999854321000 00001 244455
Q ss_pred HHHHhC----CCCC------cceEEEEEEeCCEEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011868 66 ATLKLL----KHPN------VVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (476)
Q Consensus 66 ~~l~~l----~Hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~al~yLH~~g 134 (476)
+-..++ .|-+ |.++|-.+ .....|+|||++|..+.|.-. ....++...+.....+...-+ +=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHhcC
Confidence 444333 4555 45554433 345789999999988866532 123566664443333332222 22358
Q ss_pred cEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCC----CCCEEEeccCCCCCCC
Q 011868 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS----KGNIKISDFGLSALPQ 200 (476)
Q Consensus 135 ivHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~----~g~vkl~DFGla~~~~ 200 (476)
++|.|=+| .||+++. ++.+.+-|||+....+
T Consensus 322 ffHaDPHP-----------------------------------GNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 FFHADPHP-----------------------------------GNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CccCCCCC-----------------------------------CcEEEecCCCCCccEEEEccccccccc
Confidence 99999997 9999984 6789999999988544
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00016 Score=67.27 Aligned_cols=114 Identities=23% Similarity=0.283 Sum_probs=80.3
Q ss_pred cCEEEeceEeecCc-eEEEEEEECCCCceEEEEEeec---cc-------ccc-h-------hHHHHHHHHHHHHHhCC--
Q 011868 14 GRYELGRTLGEGNF-GKVKFAQDLDSGLPFAVKILEK---NR-------IIH-L-------KITDQIKREIATLKLLK-- 72 (476)
Q Consensus 14 ~~Y~i~~~LG~G~f-g~V~~a~~~~~~~~vAvK~i~~---~~-------~~~-~-------~~~~~~~~Ei~~l~~l~-- 72 (476)
..++.++.||.|+- |.||+++ ..|+.+|+|++.. .. ... . ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57899999999999 9999998 5788999999321 00 000 0 12345778888777664
Q ss_pred -CCCc--ceEEEEEEeC------------------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 011868 73 -HPNV--VRLHEVLASK------------------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131 (476)
Q Consensus 73 -HpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH 131 (476)
+.++ ++.+++..-. ....||.||++... .++.. =+.+|.+-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence 5566 8999987322 12467888776543 22333 3567888889999
Q ss_pred hcCcEeccCCc
Q 011868 132 NKGVFHRDLKV 142 (476)
Q Consensus 132 ~~givHrDiKp 142 (476)
..||+-+|+++
T Consensus 182 k~gI~~~Dv~~ 192 (207)
T PF13095_consen 182 KLGIVPRDVKP 192 (207)
T ss_pred HCCeeeccCcc
Confidence 99999999996
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.0005 Score=64.17 Aligned_cols=115 Identities=21% Similarity=0.223 Sum_probs=82.6
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccc-------------cchhHHHHHHHHHHHHHhCC------CCCcceEE
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-------------IHLKITDQIKREIATLKLLK------HPNVVRLH 80 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-------------~~~~~~~~~~~Ei~~l~~l~------HpnIv~l~ 80 (476)
..||+|+.-.|| .|+ ......||++..... ......++..+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy--~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCY--QHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEE--ECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 568999999999 443 344578899876650 01122466777877776666 78899999
Q ss_pred EEEEeCCEEEEEEeccCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCc
Q 011868 81 EVLASKSKIYMVLEYVTG------GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKV 142 (476)
Q Consensus 81 ~~~~~~~~~~lV~E~~~g------g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp 142 (476)
|+.+++.-.-+|+|.+.+ .+|.+++.. +.+++ .. ...+-.-.+||-+.+|+.+|++|
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~ 146 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNP 146 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCc
Confidence 999999989999998643 357777754 45666 33 33344556788899999999997
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00013 Score=69.97 Aligned_cols=99 Identities=12% Similarity=0.053 Sum_probs=63.8
Q ss_pred eceEeecCce-EEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC---CcceEEEEEEeC---CEEEE
Q 011868 19 GRTLGEGNFG-KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP---NVVRLHEVLASK---SKIYM 91 (476)
Q Consensus 19 ~~~LG~G~fg-~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hp---nIv~l~~~~~~~---~~~~l 91 (476)
++.++.|+.. .||... ..+++|+..... ....+.+|..+++.+... .+.++++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567777776 488652 247778754321 245789999999988632 345555544332 24589
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g 134 (476)
+|++++|.++.+.. ++ ....+..+++..+.-||+..
T Consensus 72 l~~~i~G~~l~~~~-----~~--~~~~l~~~la~~l~~LH~i~ 107 (235)
T cd05155 72 VYRWLEGETATAAA-----LS--DPSEFAEDLADFLAALRQID 107 (235)
T ss_pred EEEeecCCCCCccc-----cC--CHHHHHHHHHHHHHHHhCCC
Confidence 99999998885531 11 22357788888888899753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.69 E-value=2.6e-06 Score=96.87 Aligned_cols=206 Identities=18% Similarity=0.126 Sum_probs=141.5
Q ss_pred HHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh
Q 011868 59 DQIKREIATLKLLKHPNVVRLHEVLA--SKSKIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHN 132 (476)
Q Consensus 59 ~~~~~Ei~~l~~l~HpnIv~l~~~~~--~~~~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~al~yLH~ 132 (476)
+....|..-++...|+++...+.-.. +....|.+++|+.+|.+++.|-.+ ..+.+.-+.....+.+.+..-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 33444555566678999887766553 334578999999999999998653 234445555555665888888886
Q ss_pred c-C----cEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCc
Q 011868 133 K-G----VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGL 207 (476)
Q Consensus 133 ~-g----ivHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~ 207 (476)
. + .+|+++|+ -|.++..+-++|+.++|+.+...+ ....
T Consensus 1354 ~tnlg~T~v~~~Lkf-----------------------------------~lpmIVtny~v~~gk~gLdKIknp--~~sf 1396 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKF-----------------------------------TLPMIVTNYNVKLGKGGLDKIKNP--VLSF 1396 (2724)
T ss_pred cccCCccchhhhhhh-----------------------------------hccceecCCcccccccccccccCc--hHhh
Confidence 4 2 68899996 899999999999999999984322 2334
Q ss_pred ccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCC------CCCCCCCCHHHHH
Q 011868 208 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------FKLPKWLSPGAQN 281 (476)
Q Consensus 208 ~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------~~~p~~~s~~~~~ 281 (476)
.....+++.|++|++...-.+. .++|+|+.|+-+|++..|..+|- ...+.+.++. +..+.-.+.++-.
T Consensus 1397 ~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs~~n~~fi-----~flq~~Lkgiidn~tf~sIe~l~pgdaNv 1470 (2724)
T KOG1826|consen 1397 FGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRSDGNAYFI-----FFLQPALKGIIDNHTFFSIEKLKPGDANV 1470 (2724)
T ss_pred hhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHhcccHHHH-----HHHHHHHcCcccccccccccccCCCcccH
Confidence 5566788999999988777775 66999999999999999887763 2223333322 2233333444444
Q ss_pred HHHHccCCCcCCCCChHHHhcCcccc
Q 011868 282 LLRKILEPNPVKRITIAGIKADEWFE 307 (476)
Q Consensus 282 Li~~~L~~dP~~R~s~~~il~~~~~~ 307 (476)
....+|-..-..||.-...+.-+.+.
T Consensus 1471 e~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1471 EALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHHHHHHHhhhcchhhhhccccccc
Confidence 44555555556777766666655553
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.64 E-value=4.5e-05 Score=75.02 Aligned_cols=136 Identities=21% Similarity=0.288 Sum_probs=98.8
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc-----------------chh--HHHHHHHHHHHHHhCC-C-C
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----------------HLK--ITDQIKREIATLKLLK-H-P 74 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-----------------~~~--~~~~~~~Ei~~l~~l~-H-p 74 (476)
|.++.+||-|-=+.||.+.+ ..|.+.++|+-+..+.. ++- ..-...+|...|+.|. | -
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 67889999999999999987 67889999975432210 000 0123567888998884 3 2
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHH
Q 011868 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATL 154 (476)
Q Consensus 75 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~ 154 (476)
-+.+.+++ ++-|+|||++.|-.|...-. ...+..+...++.-+--|-.+|++|+|.+-
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNE------------ 230 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNE------------ 230 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccch------------
Confidence 35566654 45789999999877755321 223344566677777788899999999994
Q ss_pred HHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCC
Q 011868 155 QVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSA 197 (476)
Q Consensus 155 ~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~ 197 (476)
-||++++++.++++||--..
T Consensus 231 -----------------------FNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 231 -----------------------FNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred -----------------------heeEEecCCCEEEeechHhh
Confidence 89999999999999997443
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0014 Score=62.44 Aligned_cols=100 Identities=14% Similarity=0.195 Sum_probs=62.3
Q ss_pred eceEeecCceEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEEecc
Q 011868 19 GRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP-NVVRLHEVLASKSKIYMVLEYV 96 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~E~~ 96 (476)
++.|..|-...+|+..... .++.|++|+..... . ..-...+|+.+++.+... -.++++..+. + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~--~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT--E--LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc--c--ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4568888888999887533 35789999775432 1 112345799999988543 3445554432 2 3799999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011868 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (476)
Q Consensus 97 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g 134 (476)
+|.++..... . ...++.+++..|+-||+..
T Consensus 75 ~G~~l~~~~~-----~---~~~~~~~la~~l~~lH~~~ 104 (235)
T cd05157 75 PGRTLEPEDL-----R---NPKIYRLIARELAKLHSIK 104 (235)
T ss_pred CCCcCCHHHc-----c---ChHHHHHHHHHHHHHhccc
Confidence 9876643211 0 1224566777777777654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0028 Score=65.49 Aligned_cols=87 Identities=20% Similarity=0.163 Sum_probs=58.7
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecccc---cc-hhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI---IH-LKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~-~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~l 91 (476)
.+.||.|.+..||.+.+...++.|+||.-..... .. .-..++...|.+.|+.+. ..++++++.+- ....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 4689999999999999854446899998531100 00 112467788888888873 35677887773 355789
Q ss_pred EEeccCCCC-hHHHHHh
Q 011868 92 VLEYVTGGE-LFDKIAS 107 (476)
Q Consensus 92 V~E~~~gg~-L~~~l~~ 107 (476)
|||++++.. +.+.+..
T Consensus 109 VME~L~~~~~lr~~Ll~ 125 (401)
T PRK09550 109 VMEDLSDHKILRKGLID 125 (401)
T ss_pred EEecCCCccHHHHHHhc
Confidence 999998755 3344433
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0011 Score=65.59 Aligned_cols=76 Identities=17% Similarity=0.167 Sum_probs=51.6
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCEEE
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEV------LASKSKIY 90 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~------~~~~~~~~ 90 (476)
.+.|..|....+|+... .+..+++|+.... . ...+..|+.+++.+.+.+ +.+++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56788888889998863 3457899987541 1 356777888888885332 4454432 23345678
Q ss_pred EEEeccCCCChH
Q 011868 91 MVLEYVTGGELF 102 (476)
Q Consensus 91 lV~E~~~gg~L~ 102 (476)
+++++++|.++.
T Consensus 91 ~l~~~i~G~~~~ 102 (296)
T cd05153 91 ALVEFLAGEHLT 102 (296)
T ss_pred EEEEeCCCCCCC
Confidence 999999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00076 Score=65.43 Aligned_cols=160 Identities=15% Similarity=0.138 Sum_probs=85.8
Q ss_pred eEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccCCC
Q 011868 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYVTGG 99 (476)
Q Consensus 21 ~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~gg 99 (476)
.+..|-.+.+|+.. .+++.+++|+..... ....-...+|..+++.+...++ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 45678888999886 456788899754331 1111135779999999864333 44444432 36899999986
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcE--eccCCcchhcc--chhhh-HHHHHHH--HHHHhhhc----c
Q 011868 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF--HRDLKVILKSC--HMRIA-TLQVFLL--TFLLMIVI----R 168 (476)
Q Consensus 100 ~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~giv--HrDiKp~~~~~--~~~~~-~~~~~~~--~~~~~~~~----~ 168 (476)
.+...- +. ......+++..|.-||+.... ..+++.....- .+... ....... ........ +
T Consensus 74 ~~~~~~-----~~---~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (256)
T TIGR02721 74 VITLDQ-----FV---ALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLP 145 (256)
T ss_pred cccccc-----cc---CchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCC
Confidence 654310 00 012456778888888876431 11111000000 00000 0000000 00000100 0
Q ss_pred -ccccccCCCCceEeCCCCCEEEeccCCCCC
Q 011868 169 -PWKFNVLQLENILLDSKGNIKISDFGLSAL 198 (476)
Q Consensus 169 -p~~~~~~~~~NiLl~~~g~vkl~DFGla~~ 198 (476)
-.-|+++.+.||++++++ +.|+||..|..
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 124566778999999887 78999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0026 Score=63.48 Aligned_cols=81 Identities=16% Similarity=0.181 Sum_probs=50.9
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEE------EEe
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEV------LAS 85 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~------~~~ 85 (476)
+...-.+.++.|....+|+... .+| .+++|+..... . ...+..|+.+++.|...+ +.+++.. ...
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred CCceeccccCCccccceEEEEe-CCC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 3344466788888889998864 344 57889875432 1 244566777777774322 4444432 123
Q ss_pred CCEEEEEEeccCCCCh
Q 011868 86 KSKIYMVLEYVTGGEL 101 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L 101 (476)
.+..+++++|++|.++
T Consensus 95 ~g~~~~l~e~i~G~~~ 110 (307)
T TIGR00938 95 AGKPACLVEFLQGLSV 110 (307)
T ss_pred CCeEEEEEEeCCCCCC
Confidence 4678999999988654
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0014 Score=68.21 Aligned_cols=162 Identities=22% Similarity=0.256 Sum_probs=105.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEEeC-CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcE
Q 011868 58 TDQIKREIATLKLLKHPNVVRLHEVLASK-SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136 (476)
Q Consensus 58 ~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~giv 136 (476)
..++.-...+++.+.|+|...++++.... .+..+|||++ +.+|.+.+..+. +-..... +
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~ 85 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------A 85 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------c
Confidence 35666778899999999999999987644 4578899999 779999876542 2111110 2
Q ss_pred eccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCc
Q 011868 137 HRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 216 (476)
Q Consensus 137 HrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 216 (476)
||=+- -|++. .+| -++. .
T Consensus 86 ~~~~~------------------------------------~~~~~-------~td-~~~t-------~----------- 103 (725)
T KOG1093|consen 86 HGVLH------------------------------------LNIIY-------ITD-HFLT-------K----------- 103 (725)
T ss_pred cccce------------------------------------ehhhh-------ccc-cccc-------c-----------
Confidence 33111 23322 223 1111 0
Q ss_pred cccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC------------CCCCCCHHHHHHHH
Q 011868 217 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------------LPKWLSPGAQNLLR 284 (476)
Q Consensus 217 y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------~p~~~s~~~~~Li~ 284 (476)
| |- ..++|+||||+|.|+.++.-|...|......+....+.+-... +-..++....++..
T Consensus 104 ~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~ 175 (725)
T KOG1093|consen 104 Y--PS------PIGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLK 175 (725)
T ss_pred C--CC------CCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhc
Confidence 0 10 1124899999999999999998887665544444433322111 01124667788999
Q ss_pred HccCCCcCCCCChHHHhcCcccccc
Q 011868 285 KILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 285 ~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
+|+-..|..||...++++++-|...
T Consensus 176 ~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 176 KCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred cCCccccccccchhHHhcCccHHHH
Confidence 9999999999999999999888654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0015 Score=60.41 Aligned_cols=98 Identities=19% Similarity=0.262 Sum_probs=78.6
Q ss_pred HHHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---cC
Q 011868 62 KREIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDK---IASKGRLQEAEGRKLFQQLIDGVSYCHN---KG 134 (476)
Q Consensus 62 ~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~---l~~~~~l~~~~~~~~~~qi~~al~yLH~---~g 134 (476)
..|.-+++.+.+ +++++++|.| ++ ++|.||...+++... +..-...++....+++.|++..++++++ ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C---G~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC---GR-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC---CC-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999976 6999999998 23 568899977766421 1111346789999999999999999997 35
Q ss_pred cEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCC
Q 011868 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198 (476)
Q Consensus 135 ivHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~ 198 (476)
+.--|++| +|+-++++|.+|++|...+..
T Consensus 83 ~~lcDv~~-----------------------------------~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSP-----------------------------------DNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecch-----------------------------------HHeEEeCCCcEEEEechhcch
Confidence 88899997 999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.009 Score=59.81 Aligned_cols=75 Identities=12% Similarity=0.138 Sum_probs=45.7
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEE------EEEeCCEEE
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHE------VLASKSKIY 90 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~------~~~~~~~~~ 90 (476)
.+.|+.|....+|.... .+| .+++|++. .. . ...+..|+.+++.|...+ +.+.+. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~-~~--~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFE-RL--T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEe-CCC-cEEEEEec-cC--C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 45677888889998874 334 68999875 21 1 234445666666653212 333332 123356789
Q ss_pred EEEeccCCCCh
Q 011868 91 MVLEYVTGGEL 101 (476)
Q Consensus 91 lV~E~~~gg~L 101 (476)
++++|++|..+
T Consensus 99 ~l~~~l~G~~~ 109 (319)
T PRK05231 99 AIVTFLEGKWP 109 (319)
T ss_pred EEEEecCCCCC
Confidence 99999998754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0038 Score=62.05 Aligned_cols=101 Identities=12% Similarity=0.107 Sum_probs=65.0
Q ss_pred eceEeecCceEEEEEEECC------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEE
Q 011868 19 GRTLGEGNFGKVKFAQDLD------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKIYM 91 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~~~~l 91 (476)
++.|..|-...||+..... +++.+++|+..... .......+|..+++.+...+ ..+++..+. + .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence 3456677777888887532 25789999975432 11345678888888886433 345555553 2 35
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~gi 135 (476)
|+||++|..+...... . ...+.+++..|+.||+...
T Consensus 75 v~e~i~G~~l~~~~~~----~----~~~~~~ia~~L~~lH~~~~ 110 (302)
T cd05156 75 IEEFIPSRTLTTEELR----D----PDISAEIARRMAKLHSIVV 110 (302)
T ss_pred hhheeCCCcCCHhHcC----C----cHHHHHHHHHHHHhhCCCC
Confidence 8999998776543111 0 2356788889999998643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0087 Score=59.55 Aligned_cols=104 Identities=13% Similarity=0.114 Sum_probs=76.5
Q ss_pred EeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC---CCcceEEEEEEe---CCEEEE
Q 011868 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVRLHEVLAS---KSKIYM 91 (476)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H---pnIv~l~~~~~~---~~~~~l 91 (476)
-.+.||.|..+.||.... .++ .+.+|..+... ....+.+|...|+.+.- -.+.++++++.. .+..++
T Consensus 18 ~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYD-SQG-NPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEc-CCC-CEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 356799999999998864 233 57778753311 13578999999999853 368888887754 467899
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~ 133 (476)
|||+++|+++.+. ..+......+..+++.+++-||+.
T Consensus 91 VmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 91 LLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred EEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 9999999888761 134455667788899999999984
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.014 Score=58.93 Aligned_cols=142 Identities=23% Similarity=0.334 Sum_probs=96.5
Q ss_pred EeceEeecCceEEEEEEECCCCceEEEEEeecccc----------------------cchhHH-HHHHHHHHHHHhCCCC
Q 011868 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI----------------------IHLKIT-DQIKREIATLKLLKHP 74 (476)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----------------------~~~~~~-~~~~~Ei~~l~~l~Hp 74 (476)
|-..|..|-=+.||.|.. .+|..+|||+.+.+-. ...++. -...+|++-|+++...
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445788888899999986 6788899998743210 011111 2356789999998765
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCCh--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhh
Q 011868 75 NVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRI 151 (476)
Q Consensus 75 nIv~l~~~~~~~~~~~lV~E~~~gg~L--~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~ 151 (476)
.|.-.--+.. ..-.|||+|+ |++= .-.| .+..++...+..+..|++.-+.-|-+ .++||.||.-
T Consensus 227 GIP~PePIlL--k~hVLVM~Fl-Grdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSE--------- 293 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFL-GRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSE--------- 293 (520)
T ss_pred CCCCCCceee--ecceEeeeec-cCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhh---------
Confidence 5432111111 1246899999 4332 2222 23568889999999999999888754 6999999993
Q ss_pred hHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCC
Q 011868 152 ATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQ 200 (476)
Q Consensus 152 ~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~ 200 (476)
-|+|+ .+|.+.|+|-+-+.-..
T Consensus 294 --------------------------fN~Ly-hdG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 294 --------------------------FNLLY-HDGKLYIIDVSQSVEHD 315 (520)
T ss_pred --------------------------hhheE-ECCEEEEEEccccccCC
Confidence 57665 67899999998776433
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.032 Score=56.72 Aligned_cols=84 Identities=19% Similarity=0.159 Sum_probs=52.5
Q ss_pred eEeecCceEEEEEEECCCCceEEEEEeecc-cc--cc-hhHHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEEE
Q 011868 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKN-RI--IH-LKITDQIKREIATLKLLK--HP-NVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 21 ~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~--~~-~~~~~~~~~Ei~~l~~l~--Hp-nIv~l~~~~~~~~~~~lV~ 93 (476)
.+|.|...-||++.+...++.|+||.-..- +. .+ +-..++..-|...|+... -| .++++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997544468999964210 10 00 112456667888888774 34 46666554 334556899
Q ss_pred eccCCCC-hHHHHH
Q 011868 94 EYVTGGE-LFDKIA 106 (476)
Q Consensus 94 E~~~gg~-L~~~l~ 106 (476)
|+++... |...+.
T Consensus 80 EdL~~~~ilR~~Li 93 (370)
T TIGR01767 80 EDLSHHKIARKGLI 93 (370)
T ss_pred hhCccchHHHHHHH
Confidence 9995533 334443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.025 Score=56.61 Aligned_cols=172 Identities=17% Similarity=0.154 Sum_probs=99.2
Q ss_pred EEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCC--EEEEE
Q 011868 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKS--KIYMV 92 (476)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~--~~~lV 92 (476)
.+++..-.|....+|...+ +++.+++. ... ............+|..+++.+.- --+...+++|..+. ..|.|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred ceeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 4444554444445666654 37788888 332 12233446778889999988743 33445566665554 77999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHH-HHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHH---Hh----
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFL---LM---- 164 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~-qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~---~~---- 164 (476)
|+|++|..+.+.+. +.....+++. .++..|+-||+-.-+++ .+.-.-..........+...+. .+
T Consensus 104 ~~~veGe~~~~~~~-----~~~~~~~~~~~~l~~~La~LH~ida~~~--~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~ 176 (321)
T COG3173 104 MEWVEGEVVWSALP-----PESLGRQFALDALADFLAELHSIDAAGL--PDPGKPNAYRGRQLARWDDEYRRAKKELGGR 176 (321)
T ss_pred EEEecceeccCcCC-----cccchHHHHHHHHHHHHHHHhCCCCcCC--CCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence 99998865544332 2222234444 88889999997542111 1100000012222333333331 11
Q ss_pred -----------hhccc-------cccccCCCCceEeCCCCCEEEeccCCCCCC
Q 011868 165 -----------IVIRP-------WKFNVLQLENILLDSKGNIKISDFGLSALP 199 (476)
Q Consensus 165 -----------~~~~p-------~~~~~~~~~NiLl~~~g~vkl~DFGla~~~ 199 (476)
....| +-|+.+.+.|++++.++-+-|.||+++.+-
T Consensus 177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 11223 456678889999999988999999999863
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.045 Score=54.40 Aligned_cols=64 Identities=17% Similarity=0.331 Sum_probs=39.2
Q ss_pred EEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC--CcceEEEE------EEeCCEEEEEEeccCCCC
Q 011868 29 KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP--NVVRLHEV------LASKSKIYMVLEYVTGGE 100 (476)
Q Consensus 29 ~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hp--nIv~l~~~------~~~~~~~~lV~E~~~gg~ 100 (476)
.||+... ..| .+++|++... ...+..|+..+..|... .+++++.. ...++..|++++|++|.+
T Consensus 11 ~v~~v~t-~~g-~~~LK~~~~~-------~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~ 81 (313)
T TIGR02906 11 NVYKVET-DSG-NKCLKKINYP-------PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGRE 81 (313)
T ss_pred cEEEEEe-CCC-CeEEEEcCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcC
Confidence 4888763 334 6899987532 23455567777766433 34444432 233567899999999865
Q ss_pred h
Q 011868 101 L 101 (476)
Q Consensus 101 L 101 (476)
+
T Consensus 82 ~ 82 (313)
T TIGR02906 82 C 82 (313)
T ss_pred C
Confidence 4
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.029 Score=55.16 Aligned_cols=101 Identities=18% Similarity=0.257 Sum_probs=56.9
Q ss_pred eecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-C-CC-cceEEEEEEeCCEEEEEEeccCCC
Q 011868 23 GEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H-PN-VVRLHEVLASKSKIYMVLEYVTGG 99 (476)
Q Consensus 23 G~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-H-pn-Iv~l~~~~~~~~~~~lV~E~~~gg 99 (476)
++|-...|+...+ ..|..+++|.-... .....+.+|..+|+.+. | |- +.++. +.. .-+++|+++.|.
T Consensus 20 ~~g~~~~v~~i~~-~~g~~~VlR~p~~~-----~~~~~l~rE~~vL~~L~~~l~vpvP~~~--~~~--~~~~~y~~i~G~ 89 (276)
T cd05152 20 ESGLDFQVVFAKD-TDGVPWVLRIPRRP-----DVSERAAAEKRVLALVRKHLPVQVPDWR--VHT--PELIAYPKLPGV 89 (276)
T ss_pred CCcceeEEEEEEc-CCCCeEEEEecCCH-----HHHHHHHHHHHHHHHHHhcCCCCCCcee--eec--CceEEEeccCCC
Confidence 4444455665532 45778898876432 22466899999999985 3 21 22222 111 235678888876
Q ss_pred ChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhc
Q 011868 100 ELFDKIASKG-----RLQEAEGRKLFQQLIDGVSYCHNK 133 (476)
Q Consensus 100 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~yLH~~ 133 (476)
.+...-...+ ..+......++.|++..|.-||+.
T Consensus 90 p~~~~~~~~~~~~~~~~~~~~~~~la~~la~~La~LH~i 128 (276)
T cd05152 90 PAATIDPEIGEYVWNFDHKNPPEVFIESLAKALAELHSI 128 (276)
T ss_pred cccccCcccccceecccCCCcCHHHHHHHHHHHHHHhCC
Confidence 6533210000 000123345788899999999964
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.044 Score=55.75 Aligned_cols=76 Identities=18% Similarity=0.090 Sum_probs=48.9
Q ss_pred eceEeecCceEEEEEEECC----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEE
Q 011868 19 GRTLGEGNFGKVKFAQDLD----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVL 93 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lV~ 93 (476)
+..|-.|-...+|++.... +++.|++|+..... ....+ ..+|..+++.+..-++ .++++.+.. + .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEE
Confidence 4456668888999986432 34689999875432 12222 3779999999864444 356666533 2 579
Q ss_pred eccCCCChH
Q 011868 94 EYVTGGELF 102 (476)
Q Consensus 94 E~~~gg~L~ 102 (476)
+|++|.+|.
T Consensus 113 efi~g~~l~ 121 (344)
T PLN02236 113 EFIHARTLS 121 (344)
T ss_pred EeeCCCCCC
Confidence 999776653
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.059 Score=54.46 Aligned_cols=104 Identities=13% Similarity=0.240 Sum_probs=63.1
Q ss_pred CEEEeceEeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIY 90 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~ 90 (476)
..++ +.|..|=...+|+...... +..|.+|+..... . ..-...+|..+++.+..-++ .++++++. .+
T Consensus 16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G--- 86 (330)
T PLN02421 16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---D-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG--- 86 (330)
T ss_pred ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---C-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence 3443 4555577788998864332 3478999875432 1 12234678999999975555 45666553 33
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~gi 135 (476)
+|.+|++|..|... .+.. ...+.+|+..|..||+..+
T Consensus 87 ~i~~fi~g~~l~~~-----~l~~---~~~~~~ia~~L~~lH~~~~ 123 (330)
T PLN02421 87 MIQSFINARTLTPS-----DMRK---PKVAAEIAKELRRLHQVEI 123 (330)
T ss_pred EeehhhcCCCCChH-----HCCC---HHHHHHHHHHHHHHhCCCC
Confidence 48899977655211 1111 1256678888889998654
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.077 Score=52.52 Aligned_cols=74 Identities=18% Similarity=0.230 Sum_probs=49.4
Q ss_pred EeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEe
Q 011868 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~lV~E 94 (476)
-.+.++.|..+.+|... .+++.+-||+-.... ...+..|..-|+.|. --.+.+++.+....+.-|||||
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 35678999999999877 778889999876322 356888999888884 3457789998887777899999
Q ss_pred ccCCC
Q 011868 95 YVTGG 99 (476)
Q Consensus 95 ~~~gg 99 (476)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 99776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.12 Score=53.13 Aligned_cols=85 Identities=20% Similarity=0.177 Sum_probs=55.0
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEee----cccccchhHHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEE
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILE----KNRIIHLKITDQIKREIATLKLLK--HP-NVVRLHEVLASKSKIYM 91 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~----~~~~~~~~~~~~~~~Ei~~l~~l~--Hp-nIv~l~~~~~~~~~~~l 91 (476)
.+.||.|.-.-||++.+...++.|+||.-. ..... .-..++..-|..+|+... -| .++++|.+ ++....+
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~sw-pL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~ 110 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEF-KLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCC 110 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCC-CCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhH
Confidence 678999999999999984446679999642 11111 112467778888888874 34 46666654 3345678
Q ss_pred EEeccCCC-ChHHHHH
Q 011868 92 VLEYVTGG-ELFDKIA 106 (476)
Q Consensus 92 V~E~~~gg-~L~~~l~ 106 (476)
|||+++.. .|.+.+.
T Consensus 111 vMEdL~~~~ilR~~Li 126 (409)
T PRK12396 111 VMEDLSDHTILRTALI 126 (409)
T ss_pred HHHhCcccHHHHHHHH
Confidence 99998543 2444443
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.19 Score=51.91 Aligned_cols=99 Identities=15% Similarity=0.152 Sum_probs=59.9
Q ss_pred eceEeecCceEEEEEEECCC-Cce-----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEE
Q 011868 19 GRTLGEGNFGKVKFAQDLDS-GLP-----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKIYM 91 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~-~~~-----vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~~~~l 91 (476)
++.|..|-...+|++..... +.. |.+.+... .....-.-.+|+.+++.+...+ -.++++.+.. ++
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~ 126 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT 126 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence 44666688889998875332 222 34433211 1122233467999999997554 4566666642 68
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~ 133 (476)
+.||++|.+|...- +. -..+..+|+..|+-+|+.
T Consensus 127 l~efIeGr~l~~~d-----l~---~p~~~~~IA~~La~lH~~ 160 (383)
T PTZ00384 127 IQEWVEGNTMGIDS-----LQ---NLSVLTGIASSLAKFHKR 160 (383)
T ss_pred EEEEeccccCChhH-----hc---CHHHHHHHHHHHHHHhcc
Confidence 99999886553211 00 123567788899999985
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.62 Score=46.46 Aligned_cols=65 Identities=20% Similarity=0.298 Sum_probs=38.8
Q ss_pred CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEE------EEEeCCEEEEEEecc
Q 011868 26 NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHE------VLASKSKIYMVLEYV 96 (476)
Q Consensus 26 ~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~------~~~~~~~~~lV~E~~ 96 (476)
.-+.||+..- .+| .+++|.+... .+.+...+.++..+. -+++++++. +...++..|++|+++
T Consensus 18 ~~~~v~~v~T-~~G-~~~Lk~~~~~-------~~~l~~~~~~~~~L~~~G~~~~~~~~~t~~G~~~~~~~~~~~~L~~wi 88 (309)
T TIGR02904 18 VTGKLFKVYT-DQG-VFALKKLYAD-------RNTIESFVSQIQVLSEKGFSRIVPVYPTKDGSYYLFHGHFLYYLMPWL 88 (309)
T ss_pred ccCcEEEEEe-CCC-CEEEEEeccc-------hHhHHHHHHHHHHHHHcCCCcCCceeecCCCCeeeEECCEEEEEeCCc
Confidence 3568898763 444 6899998632 223334444455553 345566643 223456679999999
Q ss_pred CCC
Q 011868 97 TGG 99 (476)
Q Consensus 97 ~gg 99 (476)
+|.
T Consensus 89 ~G~ 91 (309)
T TIGR02904 89 DIE 91 (309)
T ss_pred ccc
Confidence 874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.11 Score=52.55 Aligned_cols=71 Identities=31% Similarity=0.426 Sum_probs=55.5
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~-givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
...|++|++- |+++.- + .--..+++..++.+.++-++-+... ..-|||+.
T Consensus 299 ~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt------------------------ 349 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLT------------------------ 349 (488)
T ss_pred eEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCccccccc------------------------
Confidence 3567788877 655532 2 2244678888999988888877765 78999999
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCC
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~ 198 (476)
..|||++ +|++-|+||-+++.
T Consensus 350 -----------~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 350 -----------LDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred -----------ccceeee-cCceEEEEeeeeec
Confidence 4999999 99999999999984
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.35 E-value=0.13 Score=48.21 Aligned_cols=142 Identities=18% Similarity=0.201 Sum_probs=68.5
Q ss_pred CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHH
Q 011868 39 GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR 117 (476)
Q Consensus 39 ~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~ 117 (476)
++.|.|++..... +..-...+|..+++.+..-++ .++++.+.+ + .|.+|+.|.+|...- +. -.
T Consensus 2 ~~~~~~Ri~g~~t----~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~-g---~v~e~i~g~~l~~~~-----~~---~~ 65 (211)
T PF01633_consen 2 PEKYLVRIPGEGT----ENFIDRENENEALKLLSEAGLGPKIIYFFEN-G---RVEEFIEGRTLSPED-----FR---NP 65 (211)
T ss_dssp TSEEEEEEEESCG----CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT-E---EEEE--SSEE--CGG-----GG---SH
T ss_pred CCEEEEEeCCCCc----ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC-C---cEEEEecccccChhh-----cc---Ch
Confidence 4578888886542 224566789999998865444 556665432 2 466999765542210 11 12
Q ss_pred HHHHHHHHHHHHHHhcCcEeccCCcchhccch------------------------hhhHHHHHHHHHHHhhhc----cc
Q 011868 118 KLFQQLIDGVSYCHNKGVFHRDLKVILKSCHM------------------------RIATLQVFLLTFLLMIVI----RP 169 (476)
Q Consensus 118 ~~~~qi~~al~yLH~~givHrDiKp~~~~~~~------------------------~~~~~~~~~~~~~~~~~~----~p 169 (476)
.++..|+..|+-||+..+-..+-++ .....+ .................. .-
T Consensus 66 ~~~~~iA~~l~~lH~~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v 144 (211)
T PF01633_consen 66 EILKRIAKLLAKLHSIPISPNSKKP-DLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLV 144 (211)
T ss_dssp HHHHHHHHHHHHHHTHHHTTSSSS--HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEE
T ss_pred HHHHHHHHHHHHHhhcccccccCcc-hHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCce
Confidence 3556677778888875540000010 000000 000011111111111101 13
Q ss_pred cccccCCCCceEe-CCCCCEEEeccCCCC
Q 011868 170 WKFNVLQLENILL-DSKGNIKISDFGLSA 197 (476)
Q Consensus 170 ~~~~~~~~~NiLl-~~~g~vkl~DFGla~ 197 (476)
.-|+.+.+.|||+ +.++.++++||..|.
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHh
Confidence 3467788899999 889999999999886
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.67 E-value=1.7 Score=43.70 Aligned_cols=70 Identities=19% Similarity=0.106 Sum_probs=43.1
Q ss_pred CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEE---E--EEEeCCEEEEEEeccCC
Q 011868 26 NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLH---E--VLASKSKIYMVLEYVTG 98 (476)
Q Consensus 26 ~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~---~--~~~~~~~~~lV~E~~~g 98 (476)
.-..||.... .+|..+++|+.+.... ....+..|+..+..+.... ++... + +...++..+.++++++|
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 4457888764 4567899998864431 2456777888887774211 22211 1 22335678889999987
Q ss_pred CC
Q 011868 99 GE 100 (476)
Q Consensus 99 g~ 100 (476)
..
T Consensus 112 ~~ 113 (325)
T PRK11768 112 RA 113 (325)
T ss_pred CC
Confidence 64
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.39 E-value=0.31 Score=46.16 Aligned_cols=101 Identities=17% Similarity=0.175 Sum_probs=64.8
Q ss_pred eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHH
Q 011868 41 PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120 (476)
Q Consensus 41 ~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~ 120 (476)
+..+|.+......-. ..-+..+.+++.++. .|+++..= +.-.+-++.|+|--... ... .++
T Consensus 87 ~L~lKKi~slp~~~~--~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~~-N~i 147 (308)
T PF07387_consen 87 PLFLKKIRSLPCCIN--DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NFS-NFI 147 (308)
T ss_pred hhhhhhccCCCcccc--hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------chh-HHH
Confidence 345666655443311 234577788887764 67777632 34456789999932111 011 111
Q ss_pred HHHHHHHHHHHh--cCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCC
Q 011868 121 QQLIDGVSYCHN--KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195 (476)
Q Consensus 121 ~qi~~al~yLH~--~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGl 195 (476)
..=+.+|.-.|+ .+.+|+|-.| +||+-|..|.+||.|=+.
T Consensus 148 ~agi~~L~~fH~~~~~~lHGD~np-----------------------------------~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 148 TAGIKDLMDFHSENQHCLHGDCNP-----------------------------------DNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHhHHHHHHhhccCCCeecCCCCh-----------------------------------hheeecCCCCEEecChhh
Confidence 112567788894 4799999997 999999999999998663
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.76 E-value=2 Score=50.03 Aligned_cols=77 Identities=17% Similarity=0.246 Sum_probs=43.9
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-------CCCcceEE-----EEEEe-C
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-------HPNVVRLH-----EVLAS-K 86 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-------HpnIv~l~-----~~~~~-~ 86 (476)
+.|+ |..-.+|+... .+|..+++|+.+... . ...+..|...|..|. -|.+++-. ..... +
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~--~---~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~ 103 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSE--P---RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD 103 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCcc--c---hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence 4564 45677888874 567789999997542 1 233444555555442 22333211 11111 2
Q ss_pred C--EEEEEEeccCCCChHH
Q 011868 87 S--KIYMVLEYVTGGELFD 103 (476)
Q Consensus 87 ~--~~~lV~E~~~gg~L~~ 103 (476)
+ +.+.+++|++|..+.+
T Consensus 104 G~~~~vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 104 GEPRLLRLLSWLPGTPLAE 122 (1013)
T ss_pred CceEEEEEEeccCCCcHHh
Confidence 2 5677899999977654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=91.62 E-value=0.041 Score=57.49 Aligned_cols=72 Identities=26% Similarity=0.421 Sum_probs=59.8
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 85 (476)
..+.++.+..+|.|+||+|+.+.+...+..+|||.|.... .........+|+..+.++.|++++++...+..
T Consensus 47 ~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn--~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~ 118 (516)
T KOG1033|consen 47 EANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKN--REESRSRVLREVSSLAEFEHPGIKRYFHAWYE 118 (516)
T ss_pred hhccccccccccccCccccCCccccccchhhHHHHhcccc--hhhhhhhhhccccchhhhcccchhhheeceec
Confidence 4567889999999999999999998888899999987554 33345778899999999999999998776643
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.47 E-value=3.2 Score=43.67 Aligned_cols=100 Identities=11% Similarity=0.040 Sum_probs=62.1
Q ss_pred EeceEeecCceEEEEEEECC--------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCE
Q 011868 18 LGRTLGEGNFGKVKFAQDLD--------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV-RLHEVLASKSK 88 (476)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~~~~~~~~~ 88 (476)
-++.|..|-.-.+|++.... .++.|.+++.-... ... -...+|..+++.+..-+|. ++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~---- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DEL-YNPISEFEVYKTMSKYRIAPQLLNTFS---- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---cce-eCHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence 35567777777888887432 25678999875432 222 2456788888888655554 5665553
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~ 133 (476)
-+.|.||++|..|...- +.. .....+++..|+-||+.
T Consensus 181 gg~I~efi~g~~l~~~d-----l~~---~~~~~~iA~~L~~lH~~ 217 (442)
T PTZ00296 181 GGRIEEWLYGDPLRIDD-----LKN---PSILIGIANVLGKFHTL 217 (442)
T ss_pred CCEEEEeeCCccCCHHH-----cCC---HHHHHHHHHHHHHHhcc
Confidence 24578999886543211 111 13566788888888876
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 476 | ||||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-70 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-69 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-68 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-66 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-66 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-66 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-65 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-62 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-61 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-60 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-59 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-59 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-59 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-59 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-58 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-58 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-58 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-57 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-56 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-52 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-52 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-51 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-51 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-50 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-47 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-43 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-43 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-43 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-42 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-42 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-42 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-42 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-42 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-42 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-41 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-41 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-41 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-41 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-41 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-41 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-41 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-41 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-41 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-41 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-41 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-41 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-41 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-41 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-41 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-41 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-40 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-40 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-40 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-40 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-40 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-40 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-40 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-40 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-40 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-40 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-40 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-40 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-40 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-39 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-39 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-39 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-39 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-39 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-39 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-39 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-39 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-39 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-39 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-39 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-39 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-39 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-39 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-39 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-39 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-39 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-39 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-38 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-38 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-38 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-38 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-38 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-38 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-38 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-38 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-38 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-38 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-38 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-38 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-38 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-38 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-38 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-38 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-38 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-38 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-38 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-38 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-38 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-38 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-38 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-38 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-38 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-38 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-37 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-37 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-37 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-37 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-37 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-37 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-37 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-37 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-37 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-37 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-37 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-37 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-37 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-37 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-37 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-37 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-37 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-37 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-37 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-37 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-37 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-37 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-37 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-37 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-37 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-37 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-37 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-37 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-37 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-37 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-37 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-37 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-37 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-37 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-37 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-37 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-37 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-37 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-37 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-37 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-36 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-36 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-36 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-36 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-36 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-36 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-36 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-36 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-36 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-36 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-36 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-36 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-36 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-36 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-36 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-36 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-36 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-36 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-36 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-36 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-36 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-36 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-35 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-35 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-35 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-35 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-34 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-34 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-34 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-34 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-34 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-34 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-34 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-34 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-34 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-34 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-33 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-33 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-33 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-33 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-33 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-33 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-33 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-33 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-33 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-33 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-33 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-33 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-33 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-33 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-33 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-33 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-33 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-33 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-32 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-32 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-32 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-32 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-32 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-32 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-32 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-32 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-32 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-32 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-32 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-32 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-32 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-32 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-32 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-32 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-32 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-32 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-31 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-31 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-31 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-31 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-31 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-31 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-31 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-31 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-31 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-31 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-31 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-31 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-31 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-31 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-31 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-31 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-31 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-31 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-31 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-31 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-31 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-31 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-31 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-31 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-31 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-31 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-31 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-31 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-31 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-31 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-31 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-31 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-31 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-31 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-31 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-31 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-30 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-30 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-30 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-30 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-30 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-30 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-30 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-29 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-29 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-29 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-29 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-29 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-28 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-28 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-28 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-28 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-26 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-26 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-26 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-26 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-26 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-26 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-25 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-25 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-25 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-25 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-24 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-24 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-24 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-24 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-24 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-24 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-24 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-24 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-24 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-24 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-24 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-24 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-24 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-24 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-24 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-24 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-24 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-24 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-24 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-24 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-24 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-24 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-24 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-24 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-24 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-24 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-23 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-23 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-23 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-21 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-21 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-21 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-21 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-21 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-21 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-21 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-21 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-21 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-21 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-21 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-21 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-21 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-21 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-21 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-21 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-21 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-20 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-20 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-20 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-19 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-19 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-19 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-19 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-19 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-18 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-18 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-18 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-18 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-18 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-18 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-17 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-17 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-17 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-15 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-15 | ||
| 2ehb_D | 143 | The Structure Of The C-Terminal Domain Of The Prote | 2e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-15 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-13 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-06 | ||
| 2zfd_B | 123 | The Crystal Structure Of Plant Specific Calcium Bin | 6e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-04 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 8e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-04 |
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2ZFD|B Chain B, The Crystal Structure Of Plant Specific Calcium Binding Protein Atcbl2 In Complex With The Regulatory Domain Of Atcipk14 Length = 123 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 468 bits (1205), Expect = e-163
Identities = 158/507 (31%), Positives = 232/507 (45%), Gaps = 97/507 (19%)
Query: 1 MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
M +K +++G Y LG TLG G FGKVK + +G AVKIL + +I L + +
Sbjct: 3 MAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK 62
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
I+REI LKL +HP++++L++V+++ S I+MV+EYV+GGELFD I GRL E E R+LF
Sbjct: 63 IRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF 122
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
QQ++ GV YCH V HRDLK EN+
Sbjct: 123 QQILSGVDYCHRHMVVHRDLK-----------------------------------PENV 147
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240
LLD+ N KI+DFGLS + D L T+CGSPNY APEV++ R Y G DIWS GV
Sbjct: 148 LLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGV 204
Query: 241 ILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 300
ILY +L G LPFDD ++ L++KI G F P++L+P +LL+ +L+ +P+KR TI I
Sbjct: 205 ILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDI 264
Query: 301 KADEWFEQDYTP--ANPDDDEEDIFVDNEA---------FSMHEVPSDGGRTPGSPPLIN 349
+ EWF+QD D +D+EA S EV S PL
Sbjct: 265 REHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAV 324
Query: 350 AFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKL 409
A+ LI + + S +H + ER+ +V E +
Sbjct: 325 AYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELN 384
Query: 410 KATQEHKPQKS------------------------------------------------L 421
+H+ +
Sbjct: 385 PQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS 444
Query: 422 GSLSVAAEVFEISPSLYVVELRKSYGD 448
++ +++++ Y+++ R +
Sbjct: 445 TFSKMSLQLYQVDSRTYLLDFRSIDDE 471
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 459 bits (1183), Expect = e-161
Identities = 117/380 (30%), Positives = 174/380 (45%), Gaps = 53/380 (13%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
RY+ + +G GNFG + +D + AVK +E+ I + ++REI + L
Sbjct: 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSL 73
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPN+VR EV+ + + + +++EY +GGEL+++I + GR E E R FQQL+ GVSYCH
Sbjct: 74 RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK--GNIK 189
+ + HRDLK LEN LLD +K
Sbjct: 134 SMQICHRDLK-----------------------------------LENTLLDGSPAPRLK 158
Query: 190 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249
I DFG S +T G+P Y+APEVL + YDG +D+WSCGV LYV+L G
Sbjct: 159 ICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
Query: 250 LPFDDRNLAVLYQK----IFRGDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAGIKAD 303
PF+D Y+K I + +P +SP +L+ +I +P RI+I IK
Sbjct: 216 YPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275
Query: 304 EWFEQDYTP--ANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLD 361
WF ++ N + + + P + N M+ LD
Sbjct: 276 SWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLD 335
Query: 362 LSGFFEKEDVSERKIRFTSN 381
L + D SE +I S+
Sbjct: 336 LDDDMDDFD-SESEIDIDSS 354
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 454 bits (1171), Expect = e-160
Identities = 132/309 (42%), Positives = 182/309 (58%), Gaps = 38/309 (12%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
K +++G Y LG TLG G FGKVK + +G AVKIL + +I L + +IKR
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
EI LKL +HP++++L++V+++ + +MV+EYV+GGELFD I GR++E E R+LFQQ+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 124 IDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD 183
+ V YCH V HRDLK EN+LLD
Sbjct: 121 LSAVDYCHRHMVVHRDLK-----------------------------------PENVLLD 145
Query: 184 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243
+ N KI+DFGLS + D L T+CGSPNY APEV++ R Y G DIWSCGVILY
Sbjct: 146 AHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILY 202
Query: 244 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303
+L G LPFDD ++ L++KI G F +P++L+ LL +L+ +P+KR TI I+
Sbjct: 203 ALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262
Query: 304 EWFEQDYTP 312
EWF+QD
Sbjct: 263 EWFKQDLPS 271
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 448 bits (1155), Expect = e-157
Identities = 108/344 (31%), Positives = 163/344 (47%), Gaps = 49/344 (14%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ ++L +TLGEG +G+V+ A + + AVKI++ R + + IK+EI K+L
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H NVV+ + + Y+ LEY +GGELFD+I + E + ++ F QL+ GV Y H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
G+ HRD+K EN+LLD + N+KISD
Sbjct: 124 IGITHRDIK-----------------------------------PENLLLDERDNLKISD 148
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
FGL+ + ++ + LL+ CG+ YVAPE+L R + D+WSCG++L +L G LP+
Sbjct: 149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208
Query: 253 DD-RNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309
D + Y L W + LL KIL NP RITI IK D W+ +
Sbjct: 209 DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268
Query: 310 YTP--------ANPDDDEEDIFVDNEAFSMHEVPSDGG-RTPGS 344
+ + F + ++ P + RTPGS
Sbjct: 269 LKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGS 312
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 449 bits (1156), Expect = e-157
Identities = 122/325 (37%), Positives = 184/325 (56%), Gaps = 40/325 (12%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
+G Y + TLGEG+FGKVK A + A+K + + + + +++REI+
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
LKLL+HP++++L++V+ + + I MV+EY GGELFD I K R+ E EGR+ FQQ+I
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ YCH + HRDLK EN+LLD
Sbjct: 121 IEYCHRHKIVHRDLK-----------------------------------PENLLLDDNL 145
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
N+KI+DFGLS + D L T+CGSPNY APEV+ + Y G D+WSCG++LYV+L
Sbjct: 146 NVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVML 202
Query: 247 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
G LPFDD + L++K+ + +P +LSPGAQ+L+R+++ +P++RITI I+ D WF
Sbjct: 203 VGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
Query: 307 EQDYT-PANPDDDEEDIFVDNEAFS 330
+ P ++ + + D+ S
Sbjct: 263 NVNLPDYLRPMEEVQGSYADSRIVS 287
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 446 bits (1149), Expect = e-157
Identities = 101/301 (33%), Positives = 150/301 (49%), Gaps = 40/301 (13%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ ++L +TLGEG +G+V+ A + + AVKI++ R + + IK+EI K+L
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H NVV+ + + Y+ LEY +GGELFD+I + E + ++ F QL+ GV Y H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
G+ HRD+K EN+LLD + N+KISD
Sbjct: 124 IGITHRDIK-----------------------------------PENLLLDERDNLKISD 148
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
FGL+ + ++ + LL+ CG+ YVAPE+L R + D+WSCG++L +L G LP+
Sbjct: 149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208
Query: 253 DD-RNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309
D + Y L W + LL KIL NP RITI IK D W+ +
Sbjct: 209 DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268
Query: 310 Y 310
Sbjct: 269 L 269
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 445 bits (1148), Expect = e-157
Identities = 104/324 (32%), Positives = 159/324 (49%), Gaps = 48/324 (14%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQIKREIATLKL 70
+G+Y +G LGEG++GKVK D ++ AVKIL+K ++ + +K+EI L+
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 71 LKHPNVVRLHEVL--ASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDG 126
L+H NV++L +VL K K+YMV+EY G E+ D + + R + F QLIDG
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDG 121
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ Y H++G+ H+D+K N+LL + G
Sbjct: 122 LEYLHSQGIVHKDIK-----------------------------------PGNLLLTTGG 146
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYVI 245
+KIS G++ F D T+ GSP + PE+ + G DIWS GV LY I
Sbjct: 147 TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNI 206
Query: 246 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 305
TG PF+ N+ L++ I +G + +P P +LL+ +LE P KR +I I+ W
Sbjct: 207 TTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266
Query: 306 FEQDYTPAN------PDDDEEDIF 323
F + + PA P D +D +
Sbjct: 267 FRKKHPPAEAPVPIPPSPDTKDRW 290
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 432 bits (1113), Expect = e-151
Identities = 94/311 (30%), Positives = 145/311 (46%), Gaps = 38/311 (12%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
I E + RY GR LG+G F K D D+ FA KI+ K+ ++ +++
Sbjct: 4 IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS 63
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
EI+ + L H +VV H +++VLE L + + L E E R +Q
Sbjct: 64 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 123
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
++ G Y H V HRDLK L N+ L
Sbjct: 124 IVLGCQYLHRNRVIHRDLK-----------------------------------LGNLFL 148
Query: 183 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242
+ +KI DFGL+ ++ D CG+PNY+APEVL+ +G+ D+WS G I+
Sbjct: 149 NEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIM 205
Query: 243 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302
Y +L G PF+ L Y +I + ++ +PK ++P A +L++K+L+ +P R TI +
Sbjct: 206 YTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265
Query: 303 DEWFEQDYTPA 313
DE+F Y PA
Sbjct: 266 DEFFTSGYIPA 276
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 430 bits (1109), Expect = e-150
Identities = 94/311 (30%), Positives = 145/311 (46%), Gaps = 38/311 (12%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
I E + RY GR LG+G F K D D+ FA KI+ K+ ++ +++
Sbjct: 30 IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS 89
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
EI+ + L H +VV H +++VLE L + + L E E R +Q
Sbjct: 90 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 149
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
++ G Y H V HRDLK L N+ L
Sbjct: 150 IVLGCQYLHRNRVIHRDLK-----------------------------------LGNLFL 174
Query: 183 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242
+ +KI DFGL+ ++ D CG+PNY+APEVL+ +G+ D+WS G I+
Sbjct: 175 NEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIM 231
Query: 243 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302
Y +L G PF+ L Y +I + ++ +PK ++P A +L++K+L+ +P R TI +
Sbjct: 232 YTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291
Query: 303 DEWFEQDYTPA 313
DE+F Y PA
Sbjct: 292 DEFFTSGYIPA 302
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 424 bits (1093), Expect = e-148
Identities = 115/318 (36%), Positives = 177/318 (55%), Gaps = 39/318 (12%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
IA E +G Y L +T+G+GNF KVK A+ + +G A+KI++K ++ + ++
Sbjct: 4 IASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-QKLF 62
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
RE+ +K+L HPN+V+L EV+ ++ +Y+++EY +GGE+FD + + GR++E E R F+Q
Sbjct: 63 REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ 122
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
++ V YCH K + HRDLK EN+LL
Sbjct: 123 IVSAVQYCHQKRIVHRDLK-----------------------------------AENLLL 147
Query: 183 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242
D+ NIKI+DFG S F G L CG+P Y APE+ + YDG D+WS GVIL
Sbjct: 148 DADMNIKIADFGFSNE---FTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204
Query: 243 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302
Y +++G LPFD +NL L +++ RG +++P ++S +NLL++ L NP+KR T+ I
Sbjct: 205 YTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
Query: 303 DEWFEQDYTPANPDDDEE 320
D W + E
Sbjct: 265 DRWINAGHEEDELKPFVE 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 419 bits (1080), Expect = e-147
Identities = 82/309 (26%), Positives = 152/309 (49%), Gaps = 39/309 (12%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
G ++ +++G LG+G+F V A+ + +GL A+K+++K + + +++ E+
Sbjct: 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVS 128
LKHP+++ L+ + +Y+VLE GE+ + ++ E E R Q+I G+
Sbjct: 67 QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
Y H+ G+ HRDL L N+LL NI
Sbjct: 127 YLHSHGILHRDLT-----------------------------------LSNLLLTRNMNI 151
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248
KI+DFGL+ + +T CG+PNY++PE+ + G SD+WS G + Y +L G
Sbjct: 152 KIADFGLATQLKM--PHEKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIG 208
Query: 249 YLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308
PFD + K+ D+++P +LS A++L+ ++L NP R++++ + + +
Sbjct: 209 RPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268
Query: 309 DYTPANPDD 317
+ + + D+
Sbjct: 269 NSSTKSKDE 277
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 413 bits (1063), Expect = e-144
Identities = 95/333 (28%), Positives = 154/333 (46%), Gaps = 67/333 (20%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT------ 58
+ ++L +Y L +G+G++G VK A + + +A+K+L K ++I
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 59 -----------------DQIKREIATLKLLKHPNVVRLHEVL--ASKSKIYMVLEYVTGG 99
+Q+ +EIA LK L HPNVV+L EVL ++ +YMV E V G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLL 159
+ + + + L E + R FQ LI G+ Y H + + HRD+K
Sbjct: 124 PVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK------------------ 164
Query: 160 TFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 219
P N+L+ G+IKI+DFG+S + D LL T G+P ++A
Sbjct: 165 ---------P--------SNLLVGEDGHIKIADFGVSNEFK--GSDALLSNTVGTPAFMA 205
Query: 220 PEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--L 275
PE L+ + + G D+W+ GV LY + G PF D + L+ KI + P +
Sbjct: 206 PESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDI 265
Query: 276 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308
+ ++L+ ++L+ NP RI + IK W +
Sbjct: 266 AEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 409 bits (1054), Expect = e-143
Identities = 88/313 (28%), Positives = 154/313 (49%), Gaps = 40/313 (12%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
+AE + + +++GR LG+G FG V A++ + A+K+L K+++ + Q++
Sbjct: 3 LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
REI L+HPN++R++ + +IY++LE+ GEL+ ++ GR E ++
Sbjct: 63 REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
L D + YCH + V HRD+K EN+L+
Sbjct: 123 LADALHYCHERKVIHRDIK-----------------------------------PENLLM 147
Query: 183 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242
KG +KI+DFG S R T CG+ +Y+ PE++ + +D D+W GV+
Sbjct: 148 GYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLC 202
Query: 243 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302
Y L G PFD + +++I D K P +LS G+++L+ K+L +P +R+ + G+
Sbjct: 203 YEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262
Query: 303 DEWFEQDYTPANP 315
W + + P
Sbjct: 263 HPWVKANSRRVLP 275
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 402 bits (1036), Expect = e-139
Identities = 84/347 (24%), Positives = 140/347 (40%), Gaps = 50/347 (14%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---- 59
EG +Y LG G FG V A D + VK ++K +++ +
Sbjct: 14 GLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKL 73
Query: 60 -QIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE-YVTGGELFDKIASKGRLQEAEGR 117
++ EIA L ++H N++++ ++ ++ +V+E + +G +LF I RL E
Sbjct: 74 GKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177
+F+QL+ V Y K + HRD+K
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIK-----------------------------------D 158
Query: 178 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 237
ENI++ IK+ DFG +A L +T CG+ Y APEVL Y G ++WS
Sbjct: 159 ENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWS 215
Query: 238 CGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI 297
GV LY ++ PF + ++ P +S +L+ +L+P P +R T+
Sbjct: 216 LGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTL 269
Query: 298 AGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGS 344
+ D W Q A+ +E E+ + + G S
Sbjct: 270 EKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLS 316
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 400 bits (1030), Expect = e-139
Identities = 87/316 (27%), Positives = 152/316 (48%), Gaps = 40/316 (12%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
K+ L +E+GR LG+G FG V A++ S A+K+L K ++ + Q++RE+
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
L+HPN++RL+ +++Y++LEY G ++ ++ + E +L +
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+SYCH+K V HRD+K EN+LL S G
Sbjct: 122 LSYCHSKRVIHRDIK-----------------------------------PENLLLGSAG 146
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
+KI+DFG S R CG+ +Y+ PE++ R +D D+WS GV+ Y L
Sbjct: 147 ELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFL 201
Query: 247 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
G PF+ Y++I R +F P +++ GA++L+ ++L+ NP +R + + W
Sbjct: 202 VGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261
Query: 307 EQDYTPANPDDDEEDI 322
+ + + ++E
Sbjct: 262 TANSSKPSNCQNKESA 277
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 394 bits (1014), Expect = e-136
Identities = 86/327 (26%), Positives = 133/327 (40%), Gaps = 54/327 (16%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--- 60
K Y LG LG+G FG V L L A+K++ +NR++
Sbjct: 21 PGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT 80
Query: 61 IKREIATLKLL----KHPNVVRLHEVLASKSKIYMVLEY-VTGGELFDKIASKGRLQEAE 115
E+A L + HP V+RL + ++ +VLE + +LFD I KG L E
Sbjct: 81 CPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP 140
Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVL 175
R F Q++ + +CH++GV HRD+K
Sbjct: 141 SRCFFGQVVAAIQHCHSRGVVHRDIK---------------------------------- 166
Query: 176 QLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234
ENIL+D + G K+ DFG AL D G+ Y PE ++ Y +
Sbjct: 167 -DENILIDLRRGCAKLIDFGSGALLH----DEPYTDFDGTRVYSPPEWISRHQYHALPAT 221
Query: 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
+WS G++LY ++ G +PF+ Q+I + P +SP L+R+ L P P R
Sbjct: 222 VWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSPDCCALIRRCLAPKPSSR 275
Query: 295 ITIAGIKADEWFEQDYTPANPDDDEED 321
++ I D W + + +
Sbjct: 276 PSLEEILLDPWMQTPAEDVPLNPSKGG 302
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 392 bits (1010), Expect = e-135
Identities = 89/326 (27%), Positives = 140/326 (42%), Gaps = 52/326 (15%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI---IHLKITD 59
+A K++ +Y++G LG G FG V + LP A+K +EK+RI L
Sbjct: 32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 91
Query: 60 QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
++ E+ LK + V+RL + ++LE +LFD I +G LQE
Sbjct: 92 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 151
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQ 176
R F Q+++ V +CHN GV HRD+K
Sbjct: 152 RSFFWQVLEAVRHCHNCGVLHRDIK----------------------------------- 176
Query: 177 LENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 235
ENIL+D +G +K+ DFG AL + D + G+ Y PE + Y G ++ +
Sbjct: 177 DENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAV 232
Query: 236 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
WS G++LY ++ G +PF+ ++I RG + +S Q+L+R L P R
Sbjct: 233 WSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 286
Query: 296 TIAGIKADEWFEQDYTPANPDDDEED 321
T I+ W + P +
Sbjct: 287 TFEEIQNHPWMQDVLLPQETAEIHLH 312
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 372 bits (957), Expect = e-127
Identities = 74/359 (20%), Positives = 132/359 (36%), Gaps = 85/359 (23%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--------- 56
K++ + Y + RTL +G F K+ + +A+K EK+ + +
Sbjct: 23 VKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 57 -----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL 111
D K E+ + +K+ + ++ + ++Y++ EY+ + L
Sbjct: 81 ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 112 Q--------EAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFL 162
+ + + +++ SY HN K + HRD+K
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK--------------------- 179
Query: 163 LMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 222
NIL+D G +K+SDFG S + D + + G+ ++ PE
Sbjct: 180 --------------PSNILMDKNGRVKLSDFGESE----YMVDKKIKGSRGTYEFMPPEF 221
Query: 223 LANRG-YDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLP-------- 272
+N Y+GA DIWS G+ LYV+ +PF +L L+ I + + P
Sbjct: 222 FSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLY 281
Query: 273 -----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 320
+LS + L+ L NP +RIT EW + +E
Sbjct: 282 PLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKE 340
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = e-105
Identities = 99/318 (31%), Positives = 146/318 (45%), Gaps = 54/318 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLK 69
Y + +TLG G G+VK A + + A+KI+ K + ++ EI LK
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
L HP ++++ ++ Y+VLE + GGELFDK+ RL+EA + F Q++ V Y
Sbjct: 71 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG--- 186
H G+ HRDLK P EN+LL S+
Sbjct: 130 LHENGIIHRDLK---------------------------P--------ENVLLSSQEEDC 154
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS--DIWSCGVILYV 244
IKI+DFG S + + L+ T CG+P Y+APEVL + G G D WS GVIL++
Sbjct: 155 LIKITDFGHS---KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 211
Query: 245 ILTGYLPFDDRNL-AVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAG 299
L+GY PF + L +I G +F W +S A +L++K+L +P R T
Sbjct: 212 CLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 271
Query: 300 IKADEWFEQDYTPANPDD 317
W + + D
Sbjct: 272 ALRHPWLQDEDMKRKFQD 289
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-103
Identities = 97/310 (31%), Positives = 154/310 (49%), Gaps = 51/310 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y L T+G G++G+VK A + + A K + K ++ D+ K+EI +K L HP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIMKSLDHP 66
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N++RL+E + IY+V+E TGGELF+++ K +E++ ++ + ++ V+YCH
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG---NIKIS 191
V HRDLK EN L + +K+
Sbjct: 127 VAHRDLK-----------------------------------PENFLFLTDSPDSPLKLI 151
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
DFGL+A F+ ++ T G+P YV+P+VL Y G D WS GV++YV+L GY P
Sbjct: 152 DFGLAA---RFKPGKMMRTKVGTPYYVSPQVL-EGLY-GPECDEWSAGVMMYVLLCGYPP 206
Query: 252 FDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
F + + KI G F W +SP A++L+R++L +P +RIT EWF
Sbjct: 207 FSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF- 265
Query: 308 QDYTPANPDD 317
+ ++P +
Sbjct: 266 EKQLSSSPRN 275
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 307 bits (790), Expect = e-103
Identities = 101/315 (32%), Positives = 157/315 (49%), Gaps = 47/315 (14%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y++ LG+G F V+ +GL FA KI+ ++ +++RE + L+HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHP 65
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+VRLH+ + +S Y+V + VTGGELF+ I ++ EA+ QQ+++ ++YCH+ G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN---IKIS 191
+ HR+LK P EN+LL SK +K++
Sbjct: 126 IVHRNLK---------------------------P--------ENLLLASKAKGAAVKLA 150
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
DFGL+ D H G+P Y++PEVL Y DIW+CGVILY++L GY P
Sbjct: 151 DFGLA---IEVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPP 206
Query: 252 FDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
F D + LY +I G D+ P+W ++P A++L+ +L NP KRIT W
Sbjct: 207 FWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266
Query: 308 QDYTPANPDDDEEDI 322
A+ ++ +
Sbjct: 267 NRERVASAIHRQDTV 281
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = e-101
Identities = 98/318 (30%), Positives = 146/318 (45%), Gaps = 54/318 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLK 69
Y + +TLG G G+VK A + + A++I+ K + ++ EI LK
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
L HP ++++ ++ Y+VLE + GGELFDK+ RL+EA + F Q++ V Y
Sbjct: 196 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG--- 186
H G+ HRDLK EN+LL S+
Sbjct: 255 LHENGIIHRDLK-----------------------------------PENVLLSSQEEDC 279
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS--DIWSCGVILYV 244
IKI+DFG S + + L+ T CG+P Y+APEVL + G G D WS GVIL++
Sbjct: 280 LIKITDFGHS---KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 336
Query: 245 ILTGYLPF-DDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAG 299
L+GY PF + R L +I G +F W +S A +L++K+L +P R T
Sbjct: 337 CLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 396
Query: 300 IKADEWFEQDYTPANPDD 317
W + + D
Sbjct: 397 ALRHPWLQDEDMKRKFQD 414
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = e-101
Identities = 90/310 (29%), Positives = 142/310 (45%), Gaps = 55/310 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-----IHLKITDQIKREIATLK 69
+Y+ +G G V+ +G FAVKI+E ++ + +RE L+
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 70 LLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
+ HP+++ L + S S +++V + + GELFD + K L E E R + + L++ VS
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
+ H + HRDLK P ENILLD I
Sbjct: 215 FLHANNIVHRDLK---------------------------P--------ENILLDDNMQI 239
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL------ANRGYDGATSDIWSCGVIL 242
++SDFG S H L CG+P Y+APE+L + GY G D+W+CGVIL
Sbjct: 240 RLSDFGFSC---HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVIL 295
Query: 243 YVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIA 298
+ +L G PF R ++ + I G F P+W S ++L+ ++L+ +P R+T
Sbjct: 296 FTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAE 355
Query: 299 GIKADEWFEQ 308
+FE+
Sbjct: 356 QALQHPFFER 365
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = e-100
Identities = 87/318 (27%), Positives = 135/318 (42%), Gaps = 56/318 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD------QIKREIATL 68
YE LG G V+ + +AVKI++ + +E+ L
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 69 KLLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
+ + HPN+++L + + + ++V + + GELFD + K L E E RK+ + L++ +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
H + HRDLK P ENILLD N
Sbjct: 138 CALHKLNIVHRDLK---------------------------P--------ENILLDDDMN 162
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA------NRGYDGATSDIWSCGVI 241
IK++DFG S L CG+P+Y+APE++ + GY G D+WS GVI
Sbjct: 163 IKLTDFGFS---CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVI 218
Query: 242 LYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITI 297
+Y +L G PF R ++ + I G F P+W S ++L+ + L P KR T
Sbjct: 219 MYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA 278
Query: 298 AGIKADEWFEQDYTPANP 315
A +F+Q
Sbjct: 279 EEALAHPFFQQYVVEEVR 296
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 303 bits (778), Expect = e-100
Identities = 101/313 (32%), Positives = 155/313 (49%), Gaps = 47/313 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y++ LG+G F V+ +GL FA KI+ ++ ++RE + L+HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHP 88
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+VRLH+ + +S Y+V + VTGGELF+ I ++ EA+ QQ+++ ++YCH+ G
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN---IKIS 191
+ HR+LK P EN+LL SK +K++
Sbjct: 149 IVHRNLK---------------------------P--------ENLLLASKAKGAAVKLA 173
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
DFGL+ D H G+P Y++PEVL Y DIW+CGVILY++L GY P
Sbjct: 174 DFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPP 229
Query: 252 FDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
F D + LY +I G D+ P+W ++P A++L+ +L NP KRIT W
Sbjct: 230 FWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289
Query: 308 QDYTPANPDDDEE 320
A+ ++
Sbjct: 290 NRERVASAIHRQD 302
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = 2e-99
Identities = 95/312 (30%), Positives = 147/312 (47%), Gaps = 50/312 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ LG G F +V + +G FA+K ++K+ ++ EIA LK +KH
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHE 66
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+V L ++ S + Y+V++ V+GGELFD+I +G E + + QQ++ V Y H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG---NIKIS 191
+ HRDLK EN+L + I I+
Sbjct: 127 IVHRDLK-----------------------------------PENLLYLTPEENSKIMIT 151
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
DFGLS +G++ T CG+P YVAPEVLA + Y D WS GVI Y++L GY P
Sbjct: 152 DFGLS----KMEQNGIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPP 206
Query: 252 FDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
F + + L++KI G +F+ P W +S A++ + +LE +P +R T + W +
Sbjct: 207 FYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266
Query: 308 QDYTPANPDDDE 319
+
Sbjct: 267 GNTALHRDIYPS 278
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 2e-98
Identities = 94/304 (30%), Positives = 142/304 (46%), Gaps = 52/304 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ R LG G FG V ++ SGL +K + K+R +QI+ EI LK L HP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAEIEVLKSLDHP 80
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYC 130
N++++ EV +Y+V+E GGEL ++I S L E +L +Q+++ ++Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK---GN 187
H++ V H+DLK ENIL
Sbjct: 141 HSQHVVHKDLK-----------------------------------PENILFQDTSPHSP 165
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
IKI DFGL+ F+ D G+ Y+APEV R DIWS GV++Y +LT
Sbjct: 166 IKIIDFGLAE---LFKSDEHSTNAAGTALYMAPEVF-KRDVTFKC-DIWSAGVVMYFLLT 220
Query: 248 GYLPFDDRNLAVLYQKIFRGDFKL---PKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304
G LPF +L + QK + + L+P A +LL+++L +P +R + A + E
Sbjct: 221 GCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280
Query: 305 WFEQ 308
WF+Q
Sbjct: 281 WFKQ 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 5e-98
Identities = 72/325 (22%), Positives = 124/325 (38%), Gaps = 71/325 (21%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E LG+G FG+V A++ +A+K + + I E+ L L H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQY 63
Query: 76 VVRLHEV-------------LASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQ 121
VVR + + KS +++ +EY G L+D I S+ Q E +LF+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
Q+++ +SY H++G+ HRDLK NI
Sbjct: 124 QILEALSYIHSQGIIHRDLK-----------------------------------PMNIF 148
Query: 182 LDSKGNIKISDFGLSALPQH------------FRDDGLLHTTCGSPNYVAPEVLANRGYD 229
+D N+KI DFGL+ L + G+ YVA EVL G+
Sbjct: 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY 208
Query: 230 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL----SPGAQNLLRK 285
D++S G+I + ++ Y + +K+ + P + ++R
Sbjct: 209 NEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRL 266
Query: 286 ILEPNPVKRITIAGIKADEWFEQDY 310
+++ +P KR + W +
Sbjct: 267 LIDHDPNKRPGARTLLNSGWLPVKH 291
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 2e-97
Identities = 104/302 (34%), Positives = 155/302 (51%), Gaps = 48/302 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY + LG+G+FG+V +D + +AVK++ K + K T I RE+ LK L HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+++L E+L S Y+V E TGGELFD+I + R E + ++ +Q+ G++Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG---NIKIS 191
+ HRDLK ENILL+SK +IKI
Sbjct: 142 IVHRDLK-----------------------------------PENILLESKEKDCDIKII 166
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
DFGLS F+ + + G+ Y+APEVL YD D+WS GVILY++L+G P
Sbjct: 167 DFGLST---CFQQNTKMKDRIGTAYYIAPEVL-RGTYDEK-CDVWSAGVILYILLSGTPP 221
Query: 252 FDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
F +N + +++ G F LP+W +S A++L+RK+L +P RIT W +
Sbjct: 222 FYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281
Query: 308 QD 309
+
Sbjct: 282 KY 283
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 4e-96
Identities = 104/314 (33%), Positives = 157/314 (50%), Gaps = 48/314 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y+L LG+G F V+ + +G +A I+ ++ ++RE +LLKHP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKHP 70
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+VRLH+ ++ + Y++ + VTGGELF+ I ++ EA+ QQ+++ V +CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN---IKIS 191
V HR+LK P EN+LL SK +K++
Sbjct: 131 VVHRNLK---------------------------P--------ENLLLASKLKGAAVKLA 155
Query: 192 DFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250
DFGL+ + G+P Y++PEVL Y G D+W+CGVILY++L GY
Sbjct: 156 DFGLAI---EVEGEQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYP 211
Query: 251 PFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
PF D + LYQ+I G DF P+W ++P A++L+ K+L NP KRIT A W
Sbjct: 212 PFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271
Query: 307 EQDYTPANPDDDEE 320
T A+ +E
Sbjct: 272 SHRSTVASCMHRQE 285
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 5e-95
Identities = 67/315 (21%), Positives = 124/315 (39%), Gaps = 54/315 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + + +G G KV + + +A+K + + + D + EIA L L+
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 86
Query: 75 N--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+ ++RL++ + IYMV+E +L + K + E + ++ +++ V H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
G+ H DLK N L+ G +K+ D
Sbjct: 146 HGIVHSDLK-----------------------------------PANFLIV-DGMLKLID 169
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD----------GATSDIWSCGVIL 242
FG++ Q + + G+ NY+ PE + + SD+WS G IL
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 243 YVILTGYLPFDDR--NLAVLYQKI-FRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 299
Y + G PF ++ L+ I + + P Q++L+ L+ +P +RI+I
Sbjct: 230 YYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 289
Query: 300 IKADEWFEQDYTPAN 314
+ A + + P N
Sbjct: 290 LLAHPYVQIQTHPVN 304
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 285 bits (733), Expect = 2e-94
Identities = 89/306 (29%), Positives = 143/306 (46%), Gaps = 50/306 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
YE+G LG G F V+ + +G +A K ++K R+ ++I+RE+ L+ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPN++ LH++ +K+ + ++LE V+GGELFD +A K L E E + +Q++DGV Y H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK----GN 187
+K + H DLK P ENI+L K
Sbjct: 126 SKRIAHFDLK---------------------------P--------ENIMLLDKNVPNPR 150
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
IK+ DFG++ G+P +VAPE++ D+WS GVI Y++L+
Sbjct: 151 IKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEA-DMWSIGVITYILLS 206
Query: 248 GYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKAD 303
G PF I DF + S A++ +R++L +P +R+TIA
Sbjct: 207 GASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266
Query: 304 EWFEQD 309
W +
Sbjct: 267 SWIKAI 272
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 5e-94
Identities = 104/311 (33%), Positives = 156/311 (50%), Gaps = 48/311 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY + LG+G+FG+V +D + +AVK++ K + K T I RE+ LK L HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+++L E+L S Y+V E TGGELFD+I + R E + ++ +Q+ G++Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG---NIKIS 191
+ HRDLK ENILL+SK +IKI
Sbjct: 142 IVHRDLK-----------------------------------PENILLESKEKDCDIKII 166
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
DFGLS F+ + + G+ Y+APEVL Y D+WS GVILY++L+G P
Sbjct: 167 DFGLS---TCFQQNTKMKDRIGTAYYIAPEVL-RGTY-DEKCDVWSAGVILYILLSGTPP 221
Query: 252 FDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
F +N + +++ G F LP+W +S A++L+RK+L +P RIT W +
Sbjct: 222 FYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281
Query: 308 QDYTPANPDDD 318
+ + D
Sbjct: 282 KYSSETPTISD 292
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 8e-94
Identities = 94/323 (29%), Positives = 147/323 (45%), Gaps = 50/323 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
Y++G LG G F VK ++ +GL +A K ++K + ++I+RE++ L+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
HPN++ LH+V +++ + ++LE V+GGELFD +A K L E E +Q++DGV+Y H
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK----GN 187
K + H DLK P ENI+L K +
Sbjct: 133 TKKIAHFDLK---------------------------P--------ENIMLLDKNIPIPH 157
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
IK+ DFGL+ D G+P +VAPE++ D+WS GVI Y++L+
Sbjct: 158 IKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA-DMWSIGVITYILLS 213
Query: 248 GYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKAD 303
G PF I DF + S A++ +RK+L KR+TI
Sbjct: 214 GASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 304 EWFEQDYTPANPDDDEEDIFVDN 326
W T E + ++N
Sbjct: 274 PWITPVDTQQAMVRRESVVNLEN 296
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 9e-94
Identities = 93/323 (28%), Positives = 146/323 (45%), Gaps = 50/323 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT---DQIKREIATLKLL 71
Y++G LG G F VK ++ +GL +A K ++K + + ++I+RE++ L+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
H NV+ LH+V +++ + ++LE V+GGELFD +A K L E E +Q++DGV+Y H
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK----GN 187
K + H DLK P ENI+L K +
Sbjct: 133 TKKIAHFDLK---------------------------P--------ENIMLLDKNIPIPH 157
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
IK+ DFGL+ D G+P +VAPE++ D+WS GVI Y++L+
Sbjct: 158 IKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA-DMWSIGVITYILLS 213
Query: 248 GYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKAD 303
G PF I DF + S A++ +RK+L KR+TI
Sbjct: 214 GASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 304 EWFEQDYTPANPDDDEEDIFVDN 326
W E + ++N
Sbjct: 274 PWITPVDNQQAMVRRESVVNLEN 296
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 1e-93
Identities = 90/347 (25%), Positives = 138/347 (39%), Gaps = 88/347 (25%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--IKREIATLKLLK 72
+Y L +G+G++G V+ A + + A+KI+ KN+I + D IK E+ +K L
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ-------------------- 112
HPN+ RL+EV + I +V+E GG L DK+
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 113 --------------------EAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIA 152
E + +Q+ + Y HN+G+ HRD+K
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIK----------- 195
Query: 153 TLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN--IKISDFGLSAL--PQHFRDDGLL 208
EN L + + IK+ DFGLS + + +
Sbjct: 196 ------------------------PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM 231
Query: 209 HTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 266
T G+P +VAPEVL N Y D WS GV+L+++L G +PF N A ++
Sbjct: 232 TTKAGTPYFVAPEVLNTTNESYGPKC-DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN 290
Query: 267 G--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309
F+ P + LSP A++LL +L N +R W Q
Sbjct: 291 KKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 2e-93
Identities = 88/319 (27%), Positives = 147/319 (46%), Gaps = 53/319 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--IKREIATLKLLK 72
YEL +G+G F V+ + ++G FAVKI++ + +KRE + +LK
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ----EAEGRKLFQQLIDGVS 128
HP++V L E +S +YMV E++ G +L +I + EA +Q+++ +
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN- 187
YCH+ + HRD+K P +LL SK N
Sbjct: 145 YCHDNNIIHRDVK---------------------------P--------HCVLLASKENS 169
Query: 188 --IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245
+K+ FG++ Q + G+P+++APEV+ Y G D+W CGVIL+++
Sbjct: 170 APVKLGGFGVAI--QLGESGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFIL 226
Query: 246 LTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIK 301
L+G LPF L++ I +G +W +S A++L+R++L +P +RIT+
Sbjct: 227 LSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEAL 285
Query: 302 ADEWF-EQDYTPANPDDDE 319
W E+D E
Sbjct: 286 NHPWLKERDRYAYKIHLPE 304
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 2e-93
Identities = 95/313 (30%), Positives = 147/313 (46%), Gaps = 53/313 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+E+ LG G V + + P+A+K+L+K ++ EI L L HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-----VDKKIVRTEIGVLLRLSHP 108
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+++L E+ + ++I +VLE VTGGELFD+I KG E + +Q+++ V+Y H G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG---NIKIS 191
+ HRDLK P EN+L + +KI+
Sbjct: 169 IVHRDLK---------------------------P--------ENLLYATPAPDAPLKIA 193
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
DFGLS + L+ T CG+P Y APE+L Y G D+WS G+I Y++L G+ P
Sbjct: 194 DFGLS---KIVEHQVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEP 249
Query: 252 F-DDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
F D+R ++++I F P W +S A++L+RK++ +P KR+T W
Sbjct: 250 FYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309
Query: 307 EQDYTPANPDDDE 319
D
Sbjct: 310 -TGKAANFVHMDT 321
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 3e-93
Identities = 94/327 (28%), Positives = 152/327 (46%), Gaps = 57/327 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----------DQIKRE 64
Y R LG G +G+V ++ + A+K+++K++ + + ++I E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
I+ LK L HPN+++L +V K Y+V E+ GGELF++I ++ + E + + +Q++
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
G+ Y H + HRD+K ENILL++
Sbjct: 157 SGICYLHKHNIVHRDIK-----------------------------------PENILLEN 181
Query: 185 KG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241
K NIKI DFGLS F D L G+ Y+APEVL + Y D+WSCGVI
Sbjct: 182 KNSLLNIKIVDFGLS---SFFSKDYKLRDRLGTAYYIAPEVL-KKKY-NEKCDVWSCGVI 236
Query: 242 LYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITI 297
+Y++L GY PF +N + +K+ +G F W +S A+ L++ +L + KR T
Sbjct: 237 MYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA 296
Query: 298 AGIKADEWFEQDYTPANPDDDEEDIFV 324
W ++ N D +
Sbjct: 297 EEALNSRWIKKYANNINKSDQKTLCGA 323
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 290 bits (743), Expect = 4e-93
Identities = 104/317 (32%), Positives = 158/317 (49%), Gaps = 47/317 (14%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY+ R LG+G+FG+V +D +G AVK++ K ++ + + RE+ LK L HP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+++L+E K Y+V E TGGELFD+I S+ R E + ++ +Q++ G++Y H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG---NIKIS 191
+ HRDLK EN+LL+SK NI+I
Sbjct: 147 IVHRDLK-----------------------------------PENLLLESKSKDANIRII 171
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
DFGLS HF + G+ Y+APEVL + Y D+WS GVILY++L+G P
Sbjct: 172 DFGLS---THFEASKKMKDKIGTAYYIAPEVL-HGTY-DEKCDVWSTGVILYILLSGCPP 226
Query: 252 FDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
F+ N + +K+ +G F+LP+W +S A++L+RK+L P RI+ EW +
Sbjct: 227 FNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 286
Query: 308 QDYTPANPDDDEEDIFV 324
D
Sbjct: 287 TYTKEQISVDVPSLDNA 303
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 4e-93
Identities = 72/344 (20%), Positives = 116/344 (33%), Gaps = 85/344 (24%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ L LG+G V + +G FA+K+ L+ D RE LK L H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNH 66
Query: 74 PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVS 128
N+V+L + + +++E+ G L+ + L E+E + + ++ G++
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL----DS 184
+ G+ HR++K NI+ D
Sbjct: 127 HLRENGIVHRNIK-----------------------------------PGNIMRVIGEDG 151
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-------GATSDIWS 237
+ K++DFG + DD + G+ Y+ P++ GAT D+WS
Sbjct: 152 QSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS 208
Query: 238 CGVILYVILTGYLPFDD----RNLAVLYQKIFRG-------------------DFKLPKW 274
GV Y TG LPF R + KI G +P
Sbjct: 209 IGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS 268
Query: 275 --LSPGAQN----LLRKILEPNPVKRITIAGIKADEWFEQDYTP 312
LS G Q +L ILE + K A+
Sbjct: 269 CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGN 312
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 4e-92
Identities = 92/323 (28%), Positives = 146/323 (45%), Gaps = 50/323 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT---DQIKREIATLKLL 71
Y+ G LG G F VK ++ +GL +A K ++K R + + I+RE++ LK +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPNV+ LHEV +K+ + ++LE V GGELFD +A K L E E + +Q+++GV Y H
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK----GN 187
+ + H DLK P ENI+L +
Sbjct: 132 SLQIAHFDLK---------------------------P--------ENIMLLDRNVPKPR 156
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
IKI DFGL+ G+P +VAPE++ D+WS GVI Y++L+
Sbjct: 157 IKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA-DMWSIGVITYILLS 212
Query: 248 GYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKAD 303
G PF + +F+ + S A++ +R++L +P KR+TI
Sbjct: 213 GASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 304 EWFEQDYTPANPDDDEEDIFVDN 326
W + T + ++
Sbjct: 273 PWIKPKDTQQALSRKASAVNMEK 295
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 2e-91
Identities = 91/311 (29%), Positives = 153/311 (49%), Gaps = 48/311 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y+ + LG G +G+V +D + + A+KI+ K + + + E+A LKLL HP
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHP 96
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+++L++ K Y+V+E GGELFD+I + + E + + +Q++ GV+Y H
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG---NIKIS 191
+ HRDLK EN+LL+SK IKI
Sbjct: 157 IVHRDLK-----------------------------------PENLLLESKEKDALIKIV 181
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
DFGLS F + + G+ Y+APEVL + Y D+WS GVIL+++L GY P
Sbjct: 182 DFGLS---AVFENQKKMKERLGTAYYIAPEVL-RKKY-DEKCDVWSIGVILFILLAGYPP 236
Query: 252 FDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
F + + +K+ +G F P+W +S GA++L++++L+ + +RI+ W +
Sbjct: 237 FGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296
Query: 308 QDYTPANPDDD 318
+ + +
Sbjct: 297 EMCSKKESGIE 307
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 2e-91
Identities = 67/321 (20%), Positives = 124/321 (38%), Gaps = 54/321 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
Y + + +G G KV + + +A+K + + + D + EIA L L+
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQ 113
Query: 74 PN--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+ ++RL++ + IYMV+E +L + K + E + ++ +++ V H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
G+ H DLK N L+ G +K+
Sbjct: 173 QHGIVHSDLK-----------------------------------PANFLIV-DGMLKLI 196
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD----------GATSDIWSCGVI 241
DFG++ Q + + G+ NY+ PE + + SD+WS G I
Sbjct: 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256
Query: 242 LYVILTGYLPFDDR--NLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIA 298
LY + G PF ++ L+ I + + P Q++L+ L+ +P +RI+I
Sbjct: 257 LYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 316
Query: 299 GIKADEWFEQDYTPANPDDDE 319
+ A + + P N
Sbjct: 317 ELLAHPYVQIQTHPVNQMAKG 337
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 3e-91
Identities = 67/320 (20%), Positives = 124/320 (38%), Gaps = 54/320 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + + +G G KV + + +A+K + + + D + EIA L L+
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 67
Query: 75 N--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+ ++RL++ + IYMV+E +L + K + E + ++ +++ V H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
G+ H DLK N L+ G +K+ D
Sbjct: 127 HGIVHSDLK-----------------------------------PANFLIV-DGMLKLID 150
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD----------GATSDIWSCGVIL 242
FG++ Q + + G+ NY+ PE + + SD+WS G IL
Sbjct: 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210
Query: 243 YVILTGYLPFDDR--NLAVLYQKI-FRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 299
Y + G PF ++ L+ I + + P Q++L+ L+ +P +RI+I
Sbjct: 211 YYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 270
Query: 300 IKADEWFEQDYTPANPDDDE 319
+ A + + P N
Sbjct: 271 LLAHPYVQIQTHPVNQMAKG 290
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 3e-91
Identities = 90/490 (18%), Positives = 146/490 (29%), Gaps = 94/490 (19%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
G +E+ LG G FG V D+G A+K + K ++ EI +K L
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKL 69
Query: 72 KHPNVVRLHEVLASKSKI------YMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQ 122
HPNVV EV K+ + +EY GG+L + L+E R L
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
+ + Y H + HRDLK ENI+L
Sbjct: 130 ISSALRYLHENRIIHRDLK-----------------------------------PENIVL 154
Query: 183 DSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239
KI D G + + L G+ Y+APE+L + Y T D WS G
Sbjct: 155 QPGPQRLIHKIIDLGYA---KELDQGELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFG 210
Query: 240 VILYVILTGYLPFDDRNLAVLYQKI--------------------FRGDFKLPKWLSPGA 279
+ + +TG+ PF V + F P LS
Sbjct: 211 TLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGIL 270
Query: 280 QNL----LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVP 335
L+ +L + +R T F+ + + +H P
Sbjct: 271 AGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA--LDSILSLKLLSVMNMVS-GRVHTYP 327
Query: 336 SDGGRTPGSPPLINAFQLIGMSSCLDLSG--FFEKEDVSERKIRFTSNHSAKDLLERIED 393
L N + + + + ++ + + + +
Sbjct: 328 VTENEN-----LQNLKSWLQQDTGIPEEEQELLQASGLALNSAQPLTQYVIDCTVIDGRQ 382
Query: 394 IVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYR 453
++ F + + SV+ + + L LR+ +G
Sbjct: 383 GEGDLIFLFDNRKTVYEPQISLPAH----PESVSIVLQDPKRPLTYTHLRRVWGQIW--- 435
Query: 454 QLCNKLSSDL 463
Q L D
Sbjct: 436 QTIRALKEDC 445
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 3e-91
Identities = 96/319 (30%), Positives = 142/319 (44%), Gaps = 57/319 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
YE+ +G G++ K + + FAVKI++K++ EI L + +H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQH 75
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
PN++ L +V +Y+V E + GGEL DKI + E E + + V Y H +
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG----NIK 189
GV HRDLK P NIL + +I+
Sbjct: 136 GVVHRDLK---------------------------P--------SNILYVDESGNPESIR 160
Query: 190 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249
I DFG + Q ++GLL T C + N+VAPEVL +GYD A DIWS GV+LY +LTGY
Sbjct: 161 ICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGY 217
Query: 250 LPFD---DRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKA 302
PF D + +I G W +S A++L+ K+L +P +R+T A +
Sbjct: 218 TPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277
Query: 303 DEWFEQDYTPANPDDDEED 321
W + +D
Sbjct: 278 HPWIVHWDQLPQYQLNRQD 296
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 1e-90
Identities = 70/347 (20%), Positives = 117/347 (33%), Gaps = 90/347 (25%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
+ + L LG+G V + +G FA+K+ L+ D RE
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFE 59
Query: 67 TLKLLKHPNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQ 121
LK L H N+V+L + + +++E+ G L+ + L E+E + +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
++ G+++ G+ HR++K NI+
Sbjct: 120 DVVGGMNHLRENGIVHRNIK-----------------------------------PGNIM 144
Query: 182 L----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-------G 230
D + K++DFG + DD + G+ Y+ P++ G
Sbjct: 145 RVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYG 201
Query: 231 ATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRGDF----------------- 269
AT D+WS GV Y TG LPF R + KI G
Sbjct: 202 ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDW 261
Query: 270 --------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308
L + L +L ILE + K D++F +
Sbjct: 262 SGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF-----DQFFAE 303
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 2e-89
Identities = 67/309 (21%), Positives = 126/309 (40%), Gaps = 50/309 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y + LG G FG V + S + K ++ +K+EI+ L + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
N++ LHE S ++ M+ E+++G ++F++I + L E E Q+ + + + H+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN--IKIS 191
+ H D++ P ENI+ ++ + IKI
Sbjct: 122 NIGHFDIR---------------------------P--------ENIIYQTRRSSTIKII 146
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
+FG + + + +P Y APEV + AT D+WS G ++YV+L+G P
Sbjct: 147 EFGQA---RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT-DMWSLGTLVYVLLSGINP 202
Query: 252 FDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
F + + I F + +S A + + ++L R+T + W +
Sbjct: 203 FLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262
Query: 308 QDYTPANPD 316
Q +
Sbjct: 263 QKIERVSTK 271
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 4e-89
Identities = 102/333 (30%), Positives = 159/333 (47%), Gaps = 63/333 (18%)
Query: 15 RYELG---RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
Y+L + LGEG+F + S FAVKI+ K ++EI LKL
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLC 62
Query: 72 K-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
+ HPN+V+LHEV + ++V+E + GGELF++I K E E + ++L+ VS+
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG---N 187
H+ GV HRDLK P EN+L +
Sbjct: 123 HDVGVVHRDLK---------------------------P--------ENLLFTDENDNLE 147
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
IKI DFG + L D+ L T C + +Y APE+L GYD + D+WS GVILY +L+
Sbjct: 148 IKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLS 204
Query: 248 GYLPFDDRN-------LAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRIT 296
G +PF + + +KI +G F+ W +S A++L++ +L +P KR+
Sbjct: 205 GQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK 264
Query: 297 IAGIKADEWFEQD-YTPANPDDDEEDIFVDNEA 328
++G++ +EW + +NP + + A
Sbjct: 265 MSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAA 297
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 1e-87
Identities = 95/317 (29%), Positives = 140/317 (44%), Gaps = 52/317 (16%)
Query: 15 RYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
Y L + LG G F V+ +G +A K L+K R + I EIA L+L K
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAVLELAKS 87
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYC 130
P V+ LHEV + S+I ++LEY GGE+F + + E + +L +Q+++GV Y
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK---GN 187
H + H DLK P +NILL S G+
Sbjct: 148 HQNNIVHLDLK---------------------------P--------QNILLSSIYPLGD 172
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
IKI DFG+S + L G+P Y+APE+L AT D+W+ G+I Y++LT
Sbjct: 173 IKIVDFGMS---RKIGHACELREIMGTPEYLAPEILNYDPITTAT-DMWNIGIIAYMLLT 228
Query: 248 GYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKAD 303
PF + Y I + D+ + +S A + ++ +L NP KR T +
Sbjct: 229 HTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288
Query: 304 EWFEQDYTPANPDDDEE 320
W Q + N EE
Sbjct: 289 SWL-QQWDFENLFHPEE 304
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 3e-87
Identities = 93/335 (27%), Positives = 139/335 (41%), Gaps = 74/335 (22%)
Query: 15 RYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
Y+L LGEG +V+ +L + +AVKI+EK I ++ RE+ L +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQG 69
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H NV+ L E + + Y+V E + GG + I + E E + Q + + + HN
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN---IK 189
KG+ HRDLK P ENIL + +K
Sbjct: 130 KGIAHRDLK---------------------------P--------ENILCEHPNQVSPVK 154
Query: 190 ISDFGLSAL-----PQHFRDDGLLHTTCGSPNYVAPEVL-----ANRGYDGATSDIWSCG 239
I DF L + L T CGS Y+APEV+ YD D+WS G
Sbjct: 155 ICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR-CDLWSLG 213
Query: 240 VILYVILTGYLPFDDRNLAV---------------LYQKIFRG--DFKLPKW--LSPGAQ 280
VILY++L+GY PF R + L++ I G +F W +S A+
Sbjct: 214 VILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAK 273
Query: 281 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 315
+L+ K+L + +R++ A + W Q P N
Sbjct: 274 DLISKLLVRDAKQRLSAAQVLQHPWV-QGCAPENT 307
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 7e-87
Identities = 77/313 (24%), Positives = 138/313 (44%), Gaps = 49/313 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y++ LG G FG V + +G F K + +K EI+ + L HP
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHP 108
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
++ LH+ K ++ ++LE+++GGELFD+IA++ ++ EAE +Q +G+ + H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN--IKIS 191
+ H D+K ENI+ ++K +KI
Sbjct: 169 SIVHLDIK-----------------------------------PENIMCETKKASSVKII 193
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
DFGL+ D ++ T + + APE++ T D+W+ GV+ YV+L+G P
Sbjct: 194 DFGLA---TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT-DMWAIGVLGYVLLSGLSP 249
Query: 252 FDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
F + Q + R +F + +SP A++ ++ +L+ P KR+T+ W +
Sbjct: 250 FAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309
Query: 308 QDYTPANPDDDEE 320
D++
Sbjct: 310 GDHSNLTSRIPSS 322
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 1e-85
Identities = 86/304 (28%), Positives = 140/304 (46%), Gaps = 51/304 (16%)
Query: 15 RYELGRT--LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
Y + +T LG G FG+V ++ +GL A KI++ +K +++K EI+ + L
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD 144
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCH 131
H N+++L++ SK+ I +V+EYV GGELFD+I + L E + +Q+ +G+ + H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN--IK 189
+ H DLK P ENIL ++ IK
Sbjct: 205 QMYILHLDLK---------------------------P--------ENILCVNRDAKQIK 229
Query: 190 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249
I DFGL+ + ++ L G+P ++APEV+ T D+WS GVI Y++L+G
Sbjct: 230 IIDFGLA---RRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPT-DMWSVGVIAYMLLSGL 285
Query: 250 LPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEW 305
PF N A I D + ++ +S A+ + K+L RI+ + W
Sbjct: 286 SPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPW 345
Query: 306 FEQD 309
Sbjct: 346 LSDH 349
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 1e-85
Identities = 77/307 (25%), Positives = 133/307 (43%), Gaps = 49/307 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y++ LG G FG V + +G FA K + + +++EI T+ +L+HP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHP 214
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK 133
+V LH+ +++ M+ E+++GGELF+K+A + ++ E E + +Q+ G+ + H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG--NIKIS 191
H DLK P ENI+ +K +K+
Sbjct: 275 NYVHLDLK---------------------------P--------ENIMFTTKRSNELKLI 299
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
DFGL+ H + T G+ + APEV + T D+WS GV+ Y++L+G P
Sbjct: 300 DFGLT---AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT-DMWSVGVLSYILLSGLSP 355
Query: 252 FDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
F N + + + + +S ++ +RK+L +P R+TI W
Sbjct: 356 FGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415
Query: 308 QDYTPAN 314
P
Sbjct: 416 PGNAPGR 422
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 3e-85
Identities = 85/336 (25%), Positives = 143/336 (42%), Gaps = 68/336 (20%)
Query: 15 RYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLK 72
Y+L + LG G GKV +G A+K+L + + ++E+ +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASG 80
Query: 73 HPNVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDG 126
P++V + +V K + +++E + GGELF +I +G E E ++ + +
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ + H+ + HRD+K P EN+L SK
Sbjct: 141 IQFLHSHNIAHRDVK---------------------------P--------ENLLYTSKE 165
Query: 187 ---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243
+K++DFG + L T C +P YVAPEVL YD + D+WS GVI+Y
Sbjct: 166 KDAVLKLTDFGFAK----ETTQNALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMY 220
Query: 244 VILTGYLPFDDRN----LAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRI 295
++L G+ PF + ++I G F P+W +S A+ L+R +L+ +P +R+
Sbjct: 221 ILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL 280
Query: 296 TIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEAFS 330
TI W Q P P + D + +
Sbjct: 281 TITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWD 316
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 8e-85
Identities = 84/335 (25%), Positives = 142/335 (42%), Gaps = 65/335 (19%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKHP 74
+ LG G GKV + + FA+K+L+ + +RE+ + P
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 115
Query: 75 NVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDGVS 128
++VR+ +V A + + +V+E + GGELF +I +G E E ++ + + + +
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG-- 186
Y H+ + HRD+K P EN+L SK
Sbjct: 176 YLHSINIAHRDVK---------------------------P--------ENLLYTSKRPN 200
Query: 187 -NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245
+K++DFG + + L T C +P YVAPEVL YD + D+WS GVI+Y++
Sbjct: 201 AILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYIL 256
Query: 246 LTGYLPFDDRNLAV----LYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITI 297
L GY PF + + +I G +F P+W +S + L+R +L+ P +R+TI
Sbjct: 257 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 316
Query: 298 AGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 332
W Q + +++
Sbjct: 317 TEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 351
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 1e-80
Identities = 86/307 (28%), Positives = 139/307 (45%), Gaps = 42/307 (13%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
+ R ++ G+ LGEG+F V A++L + +A+KILEK II + RE
Sbjct: 23 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 82
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
+ L HP V+L+ K+Y L Y GEL I G E R +++
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ Y H KG+ HRDLK ENILL+
Sbjct: 143 LEYLHGKGIIHRDLK-----------------------------------PENILLNEDM 167
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
+I+I+DFG + + ++ G+ YV+PE+L + +SD+W+ G I+Y ++
Sbjct: 168 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLV 226
Query: 247 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI------AGI 300
G PF N +++QKI + ++ P+ P A++L+ K+L + KR+ +
Sbjct: 227 AGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 286
Query: 301 KADEWFE 307
KA +FE
Sbjct: 287 KAHPFFE 293
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 251 bits (641), Expect = 2e-79
Identities = 57/346 (16%), Positives = 100/346 (28%), Gaps = 88/346 (25%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
+ + G R G LG+ + A D ++G F V + Q+K E+
Sbjct: 65 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEV 124
Query: 66 ATLKLLK-------------------------HPNVVRLHEVLASKSKIYMVLEY----- 95
L+LL+ ++R+ + Y
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184
Query: 96 ---VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIA 152
G L ++ L +L Q+I ++ H+ G+ H L+
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR----------- 233
Query: 153 TLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 212
+I+LD +G + ++ F DG +
Sbjct: 234 ------------------------PVDIVLDQRGGVFLTGFEHL------VRDGARVVSS 263
Query: 213 GSPNYVAPEVLANRG----------YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ 262
S + PE+ A R + D W+ G+++Y I LP +
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE 323
Query: 263 KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308
IFR K + + LL L R+ +EQ
Sbjct: 324 WIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 2e-75
Identities = 80/330 (24%), Positives = 120/330 (36%), Gaps = 84/330 (25%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
+ LG G+ G V F G P AVK + + D EI L + H
Sbjct: 16 LVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFC------DIALMEIKLLTESDDH 68
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDG 126
PNV+R + + +Y+ LE L D + SK +E L +Q+ G
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
V++ H+ + HRDLK P +NIL+ +
Sbjct: 128 VAHLHSLKIIHRDLK---------------------------P--------QNILVSTSS 152
Query: 187 -------------NIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVL-------A 224
I ISDFGL L+ G+ + APE+L
Sbjct: 153 RFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQT 212
Query: 225 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP-------KWLS 276
R + DI+S G + Y IL+ G PF D+ I RG F L + L
Sbjct: 213 KRRLTRS-IDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLI 269
Query: 277 PGAQNLLRKILEPNPVKRITIAGIKADEWF 306
A +L+ ++++ +P+KR T + F
Sbjct: 270 AEATDLISQMIDHDPLKRPTAMKVLRHPLF 299
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 238 bits (608), Expect = 5e-75
Identities = 85/343 (24%), Positives = 135/343 (39%), Gaps = 69/343 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
R + R L EG F V AQD+ SG +A+K L N + I +E+ +K L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR---AIIQEVCFMKKLSGH 85
Query: 74 PNVVRLH-------EVLASKSKIYMVLEYVTGGELFDKI---ASKGRLQEAEGRKLFQQL 123
PN+V+ E + +++L + G+L + + S+G L K+F Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 124 IDGVSYCHNKG--VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
V + H + + HRDLKV EN+L
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKV-----------------------------------ENLL 170
Query: 182 LDSKGNIKISDFGLSALPQHFRDDGLLH----------TTCGSPNYVAPEV--LANRGYD 229
L ++G IK+ DFG + H+ D T +P Y PE+ L +
Sbjct: 171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230
Query: 230 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL--SPGAQNLLRKIL 287
G DIW+ G ILY++ PF+D +I G + +P +L+R +L
Sbjct: 231 GEKQDIWALGCILYLLCFRQHPFEDGAK----LRIVNGKYSIPPHDTQYTVFHSLIRAML 286
Query: 288 EPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFS 330
+ NP +R++IA + NP ++ N +
Sbjct: 287 QVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYG 329
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 6e-75
Identities = 65/321 (20%), Positives = 112/321 (34%), Gaps = 58/321 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + LGEG F V + L G +A+K + + + + +RE +L HP
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE---EAQREADMHRLFNHP 86
Query: 75 NVVRLHEV----LASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDG 126
N++RL +K + +++L + G L+++I L E + L + G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ H KG HRDLK NILL +G
Sbjct: 147 LEAIHAKGYAHRDLKP-----------------------------------TNILLGDEG 171
Query: 187 NIKISDFGLSALPQH-------FRDDGLLHTTCGSPNYVAPEVLANRGYDGAT--SDIWS 237
+ D G + +Y APE+ + + + +D+WS
Sbjct: 172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWS 231
Query: 238 CGVILYVILTGYLPFDDRNLAV-LYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKR 294
G +LY ++ G P+D + +P+ S LL ++ +P +R
Sbjct: 232 LGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291
Query: 295 ITIAGIKADEWFEQDYTPANP 315
I + + Q P
Sbjct: 292 PHIPLLLSQLEALQPPAPGQH 312
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 6e-73
Identities = 78/309 (25%), Positives = 128/309 (41%), Gaps = 51/309 (16%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R YE+ T+G G++G+ + + G K L+ + + E+ L+ L
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLREL 62
Query: 72 KHPNVVRLHE--VLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLID 125
KHPN+VR ++ + + + +Y+V+EY GG+L I + L E ++ QL
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 126 GVSYCHNKG-----VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
+ CH + V HRDLK N+
Sbjct: 123 ALKECHRRSDGGHTVLHRDLK-----------------------------------PANV 147
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240
LD K N+K+ DFGL+ + H D T G+P Y++PE + Y+ SDIWS G
Sbjct: 148 FLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGC 204
Query: 241 ILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAG 299
+LY + PF + L KI G F ++P S ++ ++L R ++
Sbjct: 205 LLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEE 264
Query: 300 IKADEWFEQ 308
I + +
Sbjct: 265 ILENPLILE 273
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 3e-72
Identities = 78/333 (23%), Positives = 132/333 (39%), Gaps = 87/333 (26%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
+ LG G GKV + + FA+K+L+ + +RE+ + + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 71
Query: 75 NVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDGVS 128
++VR+ +V A + + +V+E + GGELF +I +G E E ++ + + + +
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG-- 186
Y H+ + HRD+K EN+L SK
Sbjct: 132 YLHSINIAHRDVK-----------------------------------PENLLYTSKRPN 156
Query: 187 -NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245
+K++DFG A E YD + D+WS GVI+Y++
Sbjct: 157 AILKLTDFGF-----------------------AKETTG-EKYDKS-CDMWSLGVIMYIL 191
Query: 246 LTGYLPFDDRNLAV----LYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITI 297
L GY PF + + +I G +F P+W +S + L+R +L+ P +R+TI
Sbjct: 192 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 251
Query: 298 AGIKADEWFEQD-YTPANPDDDEEDIFVDNEAF 329
W Q P P + D E +
Sbjct: 252 TEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERW 284
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 5e-72
Identities = 62/307 (20%), Positives = 99/307 (32%), Gaps = 59/307 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKH 73
+ LG G G + + D AVK + RE+ L+ +H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECF------SFADREVQLLRESDEH 77
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHN 132
PNV+R + Y+ +E L + + K E L QQ G+++ H+
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN----- 187
+ HRDLK P NIL+
Sbjct: 137 LNIVHRDLK---------------------------P--------HNILISMPNAHGKIK 161
Query: 188 IKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVL---ANRGYDGATSDIWSCGVILY 243
ISDFGL L G+ ++APE+L DI+S G + Y
Sbjct: 162 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT-VDIFSAGCVFY 220
Query: 244 VILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW---LSPGAQNLLRKILEPNPVKRITIAG 299
+++ G PF + A+ L+ K++ +P KR +
Sbjct: 221 YVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKH 280
Query: 300 IKADEWF 306
+ +F
Sbjct: 281 VLKHPFF 287
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 7e-72
Identities = 73/299 (24%), Positives = 136/299 (45%), Gaps = 42/299 (14%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ +Y + +GEG+FGK + + G + +K + +R+ K ++ +RE+A L +K
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMK 81
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDGVSYC 130
HPN+V+ E +Y+V++Y GG+LF +I QE + F Q+ + +
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKI 190
H++ + HRD+K +NI L G +++
Sbjct: 142 HDRKILHRDIK-----------------------------------SQNIFLTKDGTVQL 166
Query: 191 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250
DFG++ + L G+P Y++PE+ N+ Y+ SDIW+ G +LY + T
Sbjct: 167 GDFGIARVLNS--TVELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKH 223
Query: 251 PFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308
F+ ++ L KI G F + S ++L+ ++ + NP R ++ I + +
Sbjct: 224 AFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 7e-72
Identities = 91/307 (29%), Positives = 148/307 (48%), Gaps = 46/307 (14%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
Q +L +++ +TLG G+FG+V + +SG +A+KIL+K +++ LK + E
Sbjct: 32 TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L+ + P +V+L S +YMV+EYV GGE+F + GR E R Q++
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
Y H+ + +RDLK EN+L+D
Sbjct: 152 LTFEYLHSLDLIYRDLK-----------------------------------PENLLIDQ 176
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
+G I+++DFG + R G T CG+P +APE++ ++GY+ A D W+ GV++Y
Sbjct: 177 QGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAV-DWWALGVLIYE 230
Query: 245 ILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAG 299
+ GY PF +Y+KI G + P S ++LLR +L+ + KR +
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND 290
Query: 300 IKADEWF 306
IK +WF
Sbjct: 291 IKNHKWF 297
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 6e-71
Identities = 81/297 (27%), Positives = 145/297 (48%), Gaps = 46/297 (15%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+++ RTLG G+FG+V + +G +A+K+L+K ++ LK + E L ++ HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
++R+ +I+M+++Y+ GGELF + R + ++ + Y H+K +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
+RDLK ENILLD G+IKI+DFG
Sbjct: 128 IYRDLK-----------------------------------PENILLDKNGHIKITDFGF 152
Query: 196 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 255
+ + +T CG+P+Y+APEV++ + Y + D WS G+++Y +L GY PF D
Sbjct: 153 AK-----YVPDVTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDS 206
Query: 256 NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFE 307
N Y+KI + + P + + ++LL +++ + +R+ +K WF+
Sbjct: 207 NTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 2e-69
Identities = 62/312 (19%), Positives = 117/312 (37%), Gaps = 68/312 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
++ +G G FG+V A+ G + +K ++ N ++ +RE+ L L H
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHV 64
Query: 75 NVVRLHE----------------VLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEG 116
N+V + + +++ +E+ G L I +L +
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQ 176
+LF+Q+ GV Y H+K + +RDLK
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLK----------------------------------- 149
Query: 177 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 236
NI L +KI DFGL ++DG + G+ Y++PE ++++ Y D++
Sbjct: 150 PSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTRSKGTLRYMSPEQISSQDYG-KEVDLY 205
Query: 237 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 296
+ G+IL +L + + + + G + + LL+K+L P R
Sbjct: 206 ALGLILAELLHVCDTAFETS--KFFTDLRDG--IISDIFDKKEKTLLQKLLSKKPEDRPN 261
Query: 297 IAGIKADEWFEQ 308
+ I +
Sbjct: 262 TSEILRTLTVWK 273
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 2e-67
Identities = 66/296 (22%), Positives = 110/296 (37%), Gaps = 45/296 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
++ LG G++G+V + + G +AVK ++ + K+ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
VRL + +Y+ E G L + G L EA+ + + +++ H++
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
G+ H D+K NI L +G K+ DF
Sbjct: 177 GLVHLDVK-----------------------------------PANIFLGPRGRCKLGDF 201
Query: 194 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY-LPF 252
GL G G P Y+APE+L Y A +D++S G+ + + LP
Sbjct: 202 GLLV---ELGTAGAGEVQEGDPRYMAPELLQG-SYGTA-ADVFSLGLTILEVACNMELPH 256
Query: 253 DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308
L Q +F LS +++L +LEP+P R T + A Q
Sbjct: 257 GGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 3e-66
Identities = 78/297 (26%), Positives = 126/297 (42%), Gaps = 46/297 (15%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
L + + + +G G F +V A L G+P A+K ++ ++ K +EI LK L
Sbjct: 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGV 127
HPNV++ + +++ +VLE G+L I K + E K F QL +
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
+ H++ V HRD+K N+ + + G
Sbjct: 150 EHMHSRRVMHRDIK-----------------------------------PANVFITATGV 174
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
+K+ D GL H+ G+P Y++PE + GY+ SDIWS G +LY +
Sbjct: 175 VKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAA 231
Query: 248 GYLPF--DDRNLAVLYQKIFRGDFK-LPKW-LSPGAQNLLRKILEPNPVKRITIAGI 300
PF D NL L +KI + D+ LP S + L+ + P+P KR + +
Sbjct: 232 LQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 4e-65
Identities = 37/336 (11%), Positives = 82/336 (24%), Gaps = 82/336 (24%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ +L L G+ V +D++ FA+K+ +++ L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 75 NVVRLHEVL--------------------------ASKSKIYMVLEYVTG------GELF 102
+ + + + +++ + L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 103 DKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFL 162
+G L QLI + +KG+ H
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT--------------------- 221
Query: 163 LMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 222
+N+ + G + + D + + Y E
Sbjct: 222 --------------PDNLFIMPDGRLMLGDVSALW-----KVGTRGPASSVPVTYAPREF 262
Query: 223 LANRGYD-GATSDIWSCGVILYVILTGYLPFDDRNLAV--LYQKIFRG-------DFKLP 272
L + W G+ +Y + +LPF + +++ F
Sbjct: 263 LNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSC 322
Query: 273 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308
L + L+ + L + +R+ F Q
Sbjct: 323 TPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 6e-65
Identities = 61/381 (16%), Positives = 105/381 (27%), Gaps = 84/381 (22%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
G R G LG+ + A D ++G F V + Q+K E+ L+
Sbjct: 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133
Query: 70 LL----------------------KHPNVVRLHEVLASKSKIYMVLEYVT---------- 97
LL K P ++ V + ++++ +
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 98 -GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQV 156
G L ++ L +L Q+I ++ H+ G+ H L+
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR--------------- 238
Query: 157 FLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 216
+I+LD +G + ++ F + P
Sbjct: 239 --------------------PVDIVLDQRGGVFLTGFEHLVRDGASAVS-PIGRGFAPPE 277
Query: 217 YVAPEVLANRGYDGAT----SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 272
A +L + D W+ G+ +Y I LP D + IFR +P
Sbjct: 278 TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIP 337
Query: 273 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ------DYTPANPDDDEEDIFVDN 326
+ LL L R+ +EQ P D E
Sbjct: 338 ----QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGA 393
Query: 327 EAFSMHEVPSDGGRTPGSPPL 347
S P + G +
Sbjct: 394 PP-SGTSQPDEAGAAEAVTAI 413
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-64
Identities = 68/328 (20%), Positives = 117/328 (35%), Gaps = 68/328 (20%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L +E + LG G FG V A++ +A+K + + +++ RE+ L L+
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLE 61
Query: 73 HPNVVRLHEV------------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--- 117
HP +VR + K +Y+ ++ L D + + ++E E
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177
+F Q+ + V + H+KG+ HRDLK
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLK-----------------------------------P 146
Query: 178 ENILLDSKGNIKISDFGLSAL----------PQHFRDDGLLHTTCGSPNYVAPEVLANRG 227
NI +K+ DFGL G+ Y++PE +
Sbjct: 147 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206
Query: 228 YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDF-KLPKWLSPGAQNLLRK 285
Y DI+S G+IL+ +L PF + + F L P +++
Sbjct: 207 YS-HKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQD 262
Query: 286 ILEPNPVKRITIAGIKADEWFEQDYTPA 313
+L P+P++R I + FE P
Sbjct: 263 MLSPSPMERPEAINIIENAVFEDLDFPG 290
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 3e-64
Identities = 91/294 (30%), Positives = 146/294 (49%), Gaps = 42/294 (14%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRII-HLKITDQ 60
+ E +R +EL R LG+G +GKV + ++G FA+K+L+K I+ + K T
Sbjct: 8 NRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
K E L+ +KHP +V L + K+Y++LEY++GGELF ++ +G E
Sbjct: 68 TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
++ + + H KG+ +RDLK ENI
Sbjct: 128 AEISMALGHLHQKGIIYRDLK-----------------------------------PENI 152
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240
+L+ +G++K++DFGL + D + HT CG+ Y+APE+L G+ D WS G
Sbjct: 153 MLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGA 209
Query: 241 ILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
++Y +LTG PF N KI + LP +L+ A++LL+K+L+ N R
Sbjct: 210 LMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASR 263
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 4e-64
Identities = 72/297 (24%), Positives = 131/297 (44%), Gaps = 46/297 (15%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
E+ R +G+G+FGKV Q D+ +A+K + K + + + +E+ ++ L+HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
V L + ++MV++ + GG+L + +E + +L+ + Y N+ +
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 137 HRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLS 196
HRD+K +NILLD G++ I+DF ++
Sbjct: 138 HRDMK-----------------------------------PDNILLDEHGHVHITDFNIA 162
Query: 197 ALPQHFRDDGLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFD 253
A + + T G+ Y+APE+ ++R GY D WS GV Y +L G P+
Sbjct: 163 A---MLPRETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYH 218
Query: 254 DR---NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-TIAGIKADEWF 306
R + + P S +LL+K+LEPNP +R ++ ++ +
Sbjct: 219 IRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 5e-63
Identities = 88/303 (29%), Positives = 147/303 (48%), Gaps = 40/303 (13%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
Q +++ + L + LG+G+FGKV A+ + FA+K L+K+ ++ + E
Sbjct: 9 SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68
Query: 66 ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L L +HP + + +K ++ V+EY+ GG+L I S + + ++I
Sbjct: 69 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
G+ + H+KG+ +RDLK L+NILLD
Sbjct: 129 LGLQFLHSKGIVYRDLK-----------------------------------LDNILLDK 153
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
G+IKI+DFG+ ++ D +T CG+P+Y+APE+L + Y + D WS GV+LY
Sbjct: 154 DGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYE 210
Query: 245 ILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG-IKAD 303
+L G PF ++ L+ I + P+WL A++LL K+ P KR+ + G I+
Sbjct: 211 MLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270
Query: 304 EWF 306
F
Sbjct: 271 PLF 273
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 6e-63
Identities = 53/322 (16%), Positives = 106/322 (32%), Gaps = 49/322 (15%)
Query: 6 KKQEGMRLG--RYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKIT 58
K + +LG + LGEG F +V A D + F +K+ + I
Sbjct: 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG 114
Query: 59 DQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-----ASKGRLQE 113
Q+ LK ++ + ++ +V E + G L + I + + +
Sbjct: 115 TQLMER---LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 114 AEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173
+++ + H+ + H D+K F+L N
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIK------------PDNFILG------------N 207
Query: 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 233
++ D + + D G S + F + C + + E+L+N+ ++
Sbjct: 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI- 266
Query: 234 DIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPV 292
D + +Y +L G Y+ + + +FR L W +L
Sbjct: 267 DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMW-----NEFFHVMLNIPDC 321
Query: 293 KRITIAGI---KADEWFEQDYT 311
+ + K + F+Q YT
Sbjct: 322 HHLPSLDLLRQKLKKVFQQHYT 343
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 6e-63
Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 38/279 (13%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
++ + LG+G FGKV ++ +G +A+KIL K II E L+ +HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+ L + ++ V+EY GGELF ++ + E R +++ + Y H++ V
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
+RD+K LEN++LD G+IKI+DFGL
Sbjct: 127 VYRDIK-----------------------------------LENLMLDKDGHIKITDFGL 151
Query: 196 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 255
+ D + T CG+P Y+APEVL + Y G D W GV++Y ++ G LPF ++
Sbjct: 152 CK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQ 208
Query: 256 NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
+ L++ I + + P+ LSP A++LL +L+ +P +R
Sbjct: 209 DHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 8e-63
Identities = 91/309 (29%), Positives = 142/309 (45%), Gaps = 43/309 (13%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
+ + + + +G+G+FGKV A+ + +AVK+L+K I+ K I
Sbjct: 27 LGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM 86
Query: 63 REIATL-KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
E L K +KHP +V LH + K+Y VL+Y+ GGELF + + E R
Sbjct: 87 SERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA 146
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
++ + Y H+ + +RDLK ENIL
Sbjct: 147 EIASALGYLHSLNIVYRDLK-----------------------------------PENIL 171
Query: 182 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241
LDS+G+I ++DFGL ++ + T CG+P Y+APEVL + Y T D W G +
Sbjct: 172 LDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAV 228
Query: 242 LYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG-- 299
LY +L G PF RN A +Y I +L ++ A++LL +L+ + KR+
Sbjct: 229 LYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288
Query: 300 --IKADEWF 306
IK+ +F
Sbjct: 289 MEIKSHVFF 297
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-62
Identities = 86/294 (29%), Positives = 152/294 (51%), Gaps = 42/294 (14%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
++ E ++EL + LG+G+FGKV K D+ +A+K+L+K + + +
Sbjct: 14 VKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVR 72
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
K E L + HP +V+LH ++ K+Y++L+++ GG+LF +++ + E + +
Sbjct: 73 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
+L + + H+ G+ +RDLK ENI
Sbjct: 133 AELALALDHLHSLGIIYRDLK-----------------------------------PENI 157
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240
LLD +G+IK++DFGLS + + ++ CG+ Y+APEV+ RG+ ++D WS GV
Sbjct: 158 LLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGV 214
Query: 241 ILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
+++ +LTG LPF ++ I + +P++LSP AQ+LLR + + NP R
Sbjct: 215 LMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 8e-62
Identities = 88/321 (27%), Positives = 144/321 (44%), Gaps = 55/321 (17%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
I + + +E R LG+G+FGKV A+ ++G +AVK+L+K+ I+ +
Sbjct: 12 IGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM 71
Query: 63 REIATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
E L L HP + +L + +++ V+E+V GG+L I R EA R
Sbjct: 72 TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA 131
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
++I + + H+KG+ +RDLK L+N+L
Sbjct: 132 EIISALMFLHDKGIIYRDLK-----------------------------------LDNVL 156
Query: 182 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241
LD +G+ K++DFG+ + + T CG+P+Y+APE+L Y G D W+ GV+
Sbjct: 157 LDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVL 213
Query: 242 LYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301
LY +L G+ PF+ N L++ I + P WL A +L+ + NP R+ G
Sbjct: 214 LYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRL---G-- 268
Query: 302 ADEWFEQDYTPANPDDDEEDI 322
+ E I
Sbjct: 269 -----------SLTQGGEHAI 278
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-61
Identities = 86/290 (29%), Positives = 144/290 (49%), Gaps = 39/290 (13%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
++ M+L + LG+G+FGKV ++ + +AVKIL+K+ +I + E
Sbjct: 12 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK 71
Query: 66 ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L L K P + +LH + ++Y V+EYV GG+L I GR +E ++
Sbjct: 72 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
G+ + +KG+ +RDLK L+N++LDS
Sbjct: 132 IGLFFLQSKGIIYRDLK-----------------------------------LDNVMLDS 156
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
+G+IKI+DFG+ ++ D T CG+P+Y+APE++A + Y G + D W+ GV+LY
Sbjct: 157 EGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYE 213
Query: 245 ILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
+L G PF+ + L+Q I + PK +S A + + ++ +P KR
Sbjct: 214 MLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-60
Identities = 85/292 (29%), Positives = 142/292 (48%), Gaps = 39/292 (13%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
K + + + +E + LG+G FGKV ++ +G +A+KIL+K I+
Sbjct: 138 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT 197
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
E L+ +HP + L + ++ V+EY GGELF ++ + E R ++
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 257
Query: 124 IDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
+ + Y H+ K V +RDLK LEN++L
Sbjct: 258 VSALDYLHSEKNVVYRDLK-----------------------------------LENLML 282
Query: 183 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242
D G+IKI+DFGL + +D + T CG+P Y+APEVL + Y G D W GV++
Sbjct: 283 DKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVM 339
Query: 243 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
Y ++ G LPF +++ L++ I + + P+ L P A++LL +L+ +P +R
Sbjct: 340 YEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 4e-60
Identities = 82/325 (25%), Positives = 149/325 (45%), Gaps = 64/325 (19%)
Query: 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
+ + L ++L R +G G++ KV + + +A+K+++K + + D ++ E
Sbjct: 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62
Query: 68 LKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
+ HP +V LH ++S+++ V+EYV GG+L + + +L E R ++
Sbjct: 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
++Y H +G+ +RDLK L+N+LLDS+G
Sbjct: 123 LNYLHERGIIYRDLK-----------------------------------LDNVLLDSEG 147
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
+IK++D+G+ + R T CG+PNY+APE+L Y G + D W+ GV+++ ++
Sbjct: 148 HIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMM 204
Query: 247 TGYLPF---------DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI 297
G PF D L+Q I ++P+ LS A ++L+ L +P +R+
Sbjct: 205 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERL-- 262
Query: 298 AGIKADEWFEQDYTPANPDDDEEDI 322
G +P DI
Sbjct: 263 -G-------------CHPQTGFADI 273
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-59
Identities = 86/290 (29%), Positives = 144/290 (49%), Gaps = 39/290 (13%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
++ M+L + LG+G+FGKV ++ + +AVKIL+K+ +I + E
Sbjct: 333 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK 392
Query: 66 ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L L K P + +LH + ++Y V+EYV GG+L I GR +E ++
Sbjct: 393 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 452
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
G+ + +KG+ +RDLK L+N++LDS
Sbjct: 453 IGLFFLQSKGIIYRDLK-----------------------------------LDNVMLDS 477
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
+G+IKI+DFG+ ++ D T CG+P+Y+APE++A + Y G + D W+ GV+LY
Sbjct: 478 EGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYE 534
Query: 245 ILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
+L G PF+ + L+Q I + PK +S A + + ++ +P KR
Sbjct: 535 MLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-59
Identities = 82/327 (25%), Positives = 149/327 (45%), Gaps = 64/327 (19%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
K + L ++L R +G G++ KV + + +A+++++K + + D ++ E
Sbjct: 44 KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK 103
Query: 66 ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
+ HP +V LH ++S+++ V+EYV GG+L + + +L E R ++
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
++Y H +G+ +RDLK L+N+LLDS
Sbjct: 164 LALNYLHERGIIYRDLK-----------------------------------LDNVLLDS 188
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
+G+IK++D+G+ + R T CG+PNY+APE+L Y G + D W+ GV+++
Sbjct: 189 EGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFE 245
Query: 245 ILTGYLPF---------DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
++ G PF D L+Q I ++P+ LS A ++L+ L +P +R+
Sbjct: 246 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERL 305
Query: 296 TIAGIKADEWFEQDYTPANPDDDEEDI 322
G +P DI
Sbjct: 306 ---G-------------CHPQTGFADI 316
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 4e-59
Identities = 80/302 (26%), Positives = 128/302 (42%), Gaps = 50/302 (16%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ R LG+G FG+V Q +G +A K LEK RI K E L+ +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNK 133
VV L +K + +VL + GG+L I G+ E R +F ++ G+ H +
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
+ +RDLK ENILLD G+I+ISD
Sbjct: 306 RIVYRDLK-----------------------------------PENILLDDHGHIRISDL 330
Query: 194 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253
GL+ H + + G+ Y+APEV+ N Y + D W+ G +LY ++ G PF
Sbjct: 331 GLA---VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP-DWWALGCLLYEMIAGQSPFQ 386
Query: 254 DRNLAVLYQKIFRG----DFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADE 304
R + +++ R + + SP A++L ++L +P +R+ + +K
Sbjct: 387 QRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446
Query: 305 WF 306
F
Sbjct: 447 LF 448
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-58
Identities = 81/382 (21%), Positives = 140/382 (36%), Gaps = 77/382 (20%)
Query: 6 KKQEGMRLGR--YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
K E +G + R LG G FG+V Q +G +A K L K R+ K
Sbjct: 175 KWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV 234
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE--AEGRKLF- 120
E L + +V L +K+ + +V+ + GG++ I + E R +F
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 121 -QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179
Q++ G+ + H + + +RDLK EN
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLK-----------------------------------PEN 319
Query: 180 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239
+LLD GN++ISD GL+ + G+P ++APE+L YD + D ++ G
Sbjct: 320 VLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV-DYFALG 376
Query: 240 VILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 295
V LY ++ PF R V L Q++ P SP +++ +L+ +P KR+
Sbjct: 377 VTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRL 436
Query: 296 TIAG-----IKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINA 350
++ F + + PP +
Sbjct: 437 GFRDGSCDGLRTHPLFRD---------------ISWRQLEAGMLT---------PPFVPD 472
Query: 351 FQLIGMSSCLDLSGFFEKEDVS 372
+ + + D+ F + V+
Sbjct: 473 SRTVYAKNIQDVGAFSTVKGVA 494
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-58
Identities = 83/318 (26%), Positives = 137/318 (43%), Gaps = 52/318 (16%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
I + + M+ YE+ + +G G FG+V+ + + +A+K+L K +I +
Sbjct: 57 TINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF 116
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
E + P VV+L +YMV+EY+ GG+L + S + E R
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTA 175
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
+++ + H+ G HRD+K +N+L
Sbjct: 176 EVVLALDAIHSMGFIHRDVK-----------------------------------PDNML 200
Query: 182 LDSKGNIKISDFGLSALPQHFRDDGLL--HTTCGSPNYVAPEVLANRGYD---GATSDIW 236
LD G++K++DFG +G++ T G+P+Y++PEVL ++G D G D W
Sbjct: 201 LDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 257
Query: 237 SCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLPK--WLSPGAQNLLRKILEPNPV 292
S GV LY +L G PF +L Y KI + P +S A+NL+ L +
Sbjct: 258 SVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DRE 316
Query: 293 KRITIAG---IKADEWFE 307
R+ G IK +F+
Sbjct: 317 VRLGRNGVEEIKRHLFFK 334
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 5e-58
Identities = 83/301 (27%), Positives = 154/301 (51%), Gaps = 48/301 (15%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRII-HLKITDQ 60
E + + +EL + LG G +GKV + D+G +A+K+L+K I+ K T+
Sbjct: 45 TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 104
Query: 61 IKREIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
+ E L+ ++ P +V LH +++K++++L+Y+ GGELF ++ + R E E +
Sbjct: 105 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 164
Query: 120 FQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179
+++ + + H G+ +RD+K LEN
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIK-----------------------------------LEN 189
Query: 180 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRGYDGATSDIWS 237
ILLDS G++ ++DFGLS + + CG+ Y+AP+++ + G+D A D WS
Sbjct: 190 ILLDSNGHVVLTDFGLSKEFVADETERA-YDFCGTIEYMAPDIVRGGDSGHDKAV-DWWS 247
Query: 238 CGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 293
GV++Y +LTG PF + + A + ++I + + P+ +S A++L++++L +P K
Sbjct: 248 LGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKK 307
Query: 294 R 294
R
Sbjct: 308 R 308
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-56
Identities = 90/430 (20%), Positives = 164/430 (38%), Gaps = 86/430 (20%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE- 64
+ + + + + R +G G FG+V + D+G +A+K L+K RI + E
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240
Query: 65 --IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
++ + P +V + + K+ +L+ + GG+L ++ G EA+ R +
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 300
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
+I G+ + HN+ V +RDLK NILL
Sbjct: 301 IILGLEHMHNRFVVYRDLK-----------------------------------PANILL 325
Query: 183 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-NRGYDGATSDIWSCGVI 241
D G+++ISD GL+ H + G+ Y+APEVL YD + D +S G +
Sbjct: 326 DEHGHVRISDLGLACD----FSKKKPHASVGTHGYMAPEVLQKGVAYDSSA-DWFSLGCM 380
Query: 242 LYVILTGYLPFDDRN---LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI--- 295
L+ +L G+ PF + + +LP SP ++LL +L+ + +R+
Sbjct: 381 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCL 440
Query: 296 --TIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQL 353
+K +F +D + + + P PPLI
Sbjct: 441 GRGAQEVKESPFFRS---------------LDWQMVFLQKYP---------PPLIPPRGE 476
Query: 354 IGMSSCLDLSGFFEKEDVSERKI---------RFTSNHSAKDLLERIEDIVTEMGFRVQK 404
+ + D+ F++ED K+ F S + E E + + +
Sbjct: 477 VNAADAFDIG-SFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDR 535
Query: 405 KNGKLKATQE 414
+ K +
Sbjct: 536 LEARKKTKNK 545
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-56
Identities = 77/322 (23%), Positives = 134/322 (41%), Gaps = 56/322 (17%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
++ KQ + +E+ + +G G FG+V + ++ FA+KIL K ++ T
Sbjct: 62 FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACF 121
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLF 120
+ E L + LH + +Y+V++Y GG+L ++ + RL E R
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
+++ + H HRD+K +NI
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIK-----------------------------------PDNI 206
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCGSPNYVAPEVL-----ANRGYDGATS 233
L+D G+I+++DFG +DG + G+P+Y++PE+L Y G
Sbjct: 207 LMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY-GPEC 262
Query: 234 DIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLPKW---LSPGAQNLLRKILE 288
D WS GV +Y +L G PF +L Y KI + F+ P +S A++L+R+++
Sbjct: 263 DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLIC 322
Query: 289 PNPVKRITIAG---IKADEWFE 307
R+ G K +F
Sbjct: 323 SRE-HRLGQNGIEDFKKHPFFS 343
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-55
Identities = 71/323 (21%), Positives = 130/323 (40%), Gaps = 56/323 (17%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
++ K+ ++ +E+ + +G G F +V + +G +A+KI+ K ++
Sbjct: 49 IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF 108
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLF 120
+ E L + +LH ++ +Y+V+EY GG+L ++ G R+ R
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
+++ + H G HRD+K +NI
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIK-----------------------------------PDNI 193
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCGSPNYVAPEVLANRGYD------GAT 232
LLD G+I+++DFG R DG + G+P+Y++PE+L G G
Sbjct: 194 LLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE 250
Query: 233 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-----KWLSPGAQNLLRKIL 287
D W+ GV Y + G PF + A Y KI L + + A++ ++++L
Sbjct: 251 CDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL 310
Query: 288 EPNPVKRITIAG---IKADEWFE 307
P R+ G + +F
Sbjct: 311 C-PPETRLGRGGAGDFRTHPFFF 332
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-52
Identities = 60/292 (20%), Positives = 104/292 (35%), Gaps = 36/292 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ +G G FG V G +A+K +K + + ++ A L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYC 130
+VVR A + + EY GG L D I +EAE + L Q+ G+ Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 131 HNKGVFHRDLKV--ILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
H+ + H D+K I S E+ +K
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEE------------------GDEDDWASNKVMF 173
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-NRGYDGATSDIWSCGVILYVILT 247
KI D G G ++A EVL N + +DI++ + +
Sbjct: 174 KIGDLGHVTR------ISSPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAG 226
Query: 248 GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIA 298
+ + + +I +G ++P+ LS LL+ ++ P+P +R +
Sbjct: 227 AEPLPRNGD---QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAM 275
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 5e-51
Identities = 59/290 (20%), Positives = 103/290 (35%), Gaps = 53/290 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+G G+FG+V +D +G AVK + + E+ L P
Sbjct: 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSP 110
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+V L+ + + + +E + GG L I G L E Q ++G+ Y H +
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN-IKISDF 193
+ H D+K +N+LL S G+ + DF
Sbjct: 171 ILHGDVKA-----------------------------------DNVLLSSDGSRAALCDF 195
Query: 194 GLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250
G + + G+ ++APEV+ + D DIWS ++ +L G
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCH 254
Query: 251 PFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRIT 296
P+ + KI ++P +P +++ L PV R +
Sbjct: 255 PWTQYFRGPLCL-KIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS 303
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 5e-51
Identities = 77/294 (26%), Positives = 128/294 (43%), Gaps = 52/294 (17%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
LG+G +G V +DL + + A+K + + + + + EIA K LK
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ---PLHEEIALHKHLK 77
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEG--RKLFQQLIDGVSY 129
H N+V+ + I + +E V GG L + SK G L++ E +Q+++G+ Y
Sbjct: 78 HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK-GNI 188
H+ + HRD+K +N+L+++ G +
Sbjct: 138 LHDNQIVHRDIKG-----------------------------------DNVLINTYSGVL 162
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGVILYVIL 246
KISDFG S T G+ Y+APE++ RGY A +DIWS G + +
Sbjct: 163 KISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKA-ADIWSLGCTIIEMA 219
Query: 247 TGYLPFDD--RNLAVLYQKIFRGDF--KLPKWLSPGAQNLLRKILEPNPVKRIT 296
TG PF + A ++ K+ ++P+ +S A+ + K EP+P KR
Sbjct: 220 TGKPPFYELGEPQAAMF-KVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC 272
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-46
Identities = 66/307 (21%), Positives = 128/307 (41%), Gaps = 53/307 (17%)
Query: 14 GRYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
GR+ +G G+F V D ++ + A L+ ++ + + K E LK L+
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQ 83
Query: 73 HPNVVRLH----EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
HPN+VR + + K I +V E +T G L + ++ R +Q++ G+
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 129 YCHNKG--VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK- 185
+ H + + HRDLK C +NI +
Sbjct: 144 FLHTRTPPIIHRDLK-----C------------------------------DNIFITGPT 168
Query: 186 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245
G++KI D GL+ L + G+P ++APE+ YD + D+++ G+ + +
Sbjct: 169 GSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEMY-EEKYDES-VDVYAFGMCMLEM 222
Query: 246 LTGYLPFDD-RNLAVLYQKIFRGD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302
T P+ + +N A +Y+++ G K P + ++ + N +R +I +
Sbjct: 223 ATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282
Query: 303 DEWFEQD 309
+F+++
Sbjct: 283 HAFFQEE 289
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-44
Identities = 51/281 (18%), Positives = 93/281 (33%), Gaps = 52/281 (18%)
Query: 41 PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGE 100
+ + D +I + N V + + K +Y+ ++
Sbjct: 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKEN 147
Query: 101 LFDKIASKGRLQEAEG---RKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVF 157
L D + + L++ E +F Q+ + V + H+KG+ HRDLK
Sbjct: 148 LKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLK---------------- 191
Query: 158 LLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSA----------LPQHFRDDGL 207
NI +K+ DFGL +
Sbjct: 192 -------------------PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 208 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 267
G+ Y++PE + Y DI+S G+IL+ +L + +R + +
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQMER--VRIITDVRNL 289
Query: 268 DF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
F L P +++ +L P+P +R I + FE
Sbjct: 290 KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-43
Identities = 84/358 (23%), Positives = 123/358 (34%), Gaps = 111/358 (31%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--------R 63
R RYE LGEG F V A+D ++ A+K K I L + K R
Sbjct: 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK---K---IKLGHRSEAKDGINRTALR 61
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQ 121
EI L+ L HPN++ L + KS I +V +++ + + L + +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYML 119
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
+ G+ Y H + HRDLK N+L
Sbjct: 120 MTLQGLEYLHQHWILHRDLKP-----------------------------------NNLL 144
Query: 182 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVL-ANRGYD 229
LD G +K++DFGL+ + GSPN Y APE+L R Y
Sbjct: 145 LDENGVLKLADFGLA-------------KSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 191
Query: 230 GATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR-----------GDFKLP---- 272
D+W+ G IL +L +LP D +L L +IF LP
Sbjct: 192 VGV-DMWAVGCILAELLLRVPFLPGDS-DLDQLT-RIFETLGTPTEEQWPDMCSLPDYVT 248
Query: 273 -------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 317
+L++ + NP RIT ++F P
Sbjct: 249 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 306
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-41
Identities = 80/349 (22%), Positives = 127/349 (36%), Gaps = 103/349 (29%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
+YE +GEG++G V ++ D+G A+K LE +K REI LK LKH
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL--REIRMLKQLKH 61
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
PN+V L EV K ++++V EY D+ + + E + + Q + V++CH
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
HRD+K P ENIL+ IK+
Sbjct: 120 KHNCIHRDVK---------------------------P--------ENILITKHSVIKLC 144
Query: 192 DFGLSALPQHFRDDGLLHTTCGSP-----NYV------APEVL-ANRGYDGATSDIWSCG 239
DFG + R P + V +PE+L + Y D+W+ G
Sbjct: 145 DFGFA------R-------LLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPV-DVWAIG 190
Query: 240 VILYVILTG--YLPFDDRNLAVLYQKIFR-------------------GDFKLPKW---- 274
+ +L+G P ++ LY I + K+P
Sbjct: 191 CVFAELLSGVPLWPGKS-DVDQLY-LIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDME 248
Query: 275 --------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 315
+S A LL+ L +P +R+T + +FE +
Sbjct: 249 PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-41
Identities = 82/347 (23%), Positives = 134/347 (38%), Gaps = 93/347 (26%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
+YE +GEG++G V ++ D+G A+K LE + +K REI LK L+H
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKI--AMREIKLLKQLRH 83
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
N+V L EV K + Y+V E+V + + L +K Q+I+G+ +CH
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCH 141
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
+ + HRD+K P ENIL+ G +K+
Sbjct: 142 SHNIIHRDIK---------------------------P--------ENILVSQSGVVKLC 166
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYV------APEVL-ANRGYDGATSDIWSCGVILYV 244
DFG + + G ++ + V APE+L + Y A D+W+ G ++
Sbjct: 167 DFGFA---RTLAAPGEVYD-----DEVATRWYRAPELLVGDVKYGKAV-DVWAIGCLVTE 217
Query: 245 ILTG--YLPFDDRNLAVLYQKIFR-------------------GDFKLPKW--------- 274
+ G P D ++ LY I +LP+
Sbjct: 218 MFMGEPLFPGDS-DIDQLY-HIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERR 275
Query: 275 ---LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 318
LS +L +K L +P KR A + ++F+ D +
Sbjct: 276 YPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQE 322
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 82/331 (24%), Positives = 130/331 (39%), Gaps = 106/331 (32%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKL 70
+YE +GEG +G V A++ ++ A+K + R+ + REI LK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSS--ALREICLLKE 57
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
LKH N+VRLH+VL S K+ +V E+ + FD G L + QL+ G+
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLG 115
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
+CH++ V HRDLK +N+L++ G +
Sbjct: 116 FCHSRNVLHRDLKP-----------------------------------QNLLINRNGEL 140
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVL-ANRGYDGATSDIW 236
K+++FGL+ R G P Y P+VL + Y + D+W
Sbjct: 141 KLANFGLA------R-------AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI-DMW 186
Query: 237 SCGVILYVILTGYLPF--DDRNLAVLYQKIFR-----------GDFKLPKW--------- 274
S G I + P + L +IFR KLP +
Sbjct: 187 SAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT 245
Query: 275 ---------LSPGAQNLLRKILEPNPVKRIT 296
L+ ++LL+ +L+ NPV+RI+
Sbjct: 246 TSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-40
Identities = 76/359 (21%), Positives = 124/359 (34%), Gaps = 109/359 (30%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKL 70
Y LGEG + V + + A+K + I L+ + RE++ LK
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALK---E---IRLEHEEGAPCTAIREVSLLKD 56
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
LKH N+V LH+++ ++ + +V EY+ + D + + QL+ G++
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLA 114
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
YCH + V HRDLK +N+L++ +G +
Sbjct: 115 YCHRQKVLHRDLKP-----------------------------------QNLLINERGEL 139
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVL-ANRGYDGATSDIW 236
K++DFGL+ R P Y P++L + Y D+W
Sbjct: 140 KLADFGLA------R-------AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQI-DMW 185
Query: 237 SCGVILYVILTG--YLPFDDRNLAVLYQKIFR-------------------GDFKLPKW- 274
G I Y + TG P L+ IFR + PK+
Sbjct: 186 GVGCIFYEMATGRPLFPGST-VEEQLH-FIFRILGTPTEETWPGILSNEEFKTYNYPKYR 243
Query: 275 ----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIF 323
L +LL K+L+ RI+ +F + D IF
Sbjct: 244 AEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIF 302
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-40
Identities = 80/358 (22%), Positives = 135/358 (37%), Gaps = 114/358 (31%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKL 70
+++ LG G + V + +G+ A+K + L + REI+ +K
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKE------VKLDSEEGTPSTAIREISLMKE 59
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGG-----ELFDKIASKGRLQEAEGRKLFQQLID 125
LKH N+VRL++V+ +++K+ +V E++ + + L+ + QL+
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
G+++CH + HRDLK +N+L++ +
Sbjct: 120 GLAFCHENKILHRDLKP-----------------------------------QNLLINKR 144
Query: 186 GNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVL-ANRGYDGATS 233
G +K+ DFGL+ R G P Y AP+VL +R Y +
Sbjct: 145 GQLKLGDFGLA------R-------AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSI- 190
Query: 234 DIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR-----------GDFKLPKW------ 274
DIWSCG IL ++TG P + + L IF KLPK+
Sbjct: 191 DIWSCGCILAEMITGKPLFPGTN-DEEQLK-LIFDIMGTPNESLWPSVTKLPKYNPNIQQ 248
Query: 275 -----------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 315
L + L +L+ NP R++ WF + Y A+
Sbjct: 249 RPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM 306
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 75/285 (26%), Positives = 127/285 (44%), Gaps = 48/285 (16%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+ +G G+FG V A+ G AVKIL + H + ++ RE+A +K L+HPN+
Sbjct: 40 NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNI 96
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNK 133
V + + +V EY++ G L+ + G ++ + R+ D G++Y HN+
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 134 G--VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
+ HR+LK S N+L+D K +K+
Sbjct: 157 NPPIVHRNLK----S-------------------------------PNLLVDKKYTVKVC 181
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
DFGLS L + G+P ++APEVL + + SD++S GVIL+ + T P
Sbjct: 182 DFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQP 238
Query: 252 FDDRN-LAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKR 294
+ + N V+ F+ ++P+ L+P ++ P KR
Sbjct: 239 WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKR 283
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-39
Identities = 85/353 (24%), Positives = 138/353 (39%), Gaps = 126/353 (35%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
+Y +GEG +G V AQ+ LK +I+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN------------NYGETFALK---KIRLEKEDEGIPSTT 47
Query: 63 -REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKL 119
REI+ LK LKH N+V+L++V+ +K ++ +V E++ +L D +G L+ +
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSF 105
Query: 120 FQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179
QL++G++YCH++ V HRDLK +N
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKP-----------------------------------QN 130
Query: 180 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVL-ANRG 227
+L++ +G +KI+DFGL+ R G P Y AP+VL ++
Sbjct: 131 LLINREGELKIADFGLA------R-------AFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 228 YDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR-----------GDFKLPKW 274
Y DIWS G I ++ G P L +IFR +LPK+
Sbjct: 178 YSTTI-DIWSVGCIFAEMVNGTPLFPGVS-EADQLM-RIFRILGTPNSKNWPNVTELPKY 234
Query: 275 ------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309
L +LL K+L+ +P +RIT +F+++
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 83/341 (24%), Positives = 133/341 (39%), Gaps = 127/341 (37%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
+Y+ +GEG +G V A+D + RI+ LK +I+
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD------------SQGRIVALK---RIRLDAEDEGIPSTA 66
Query: 63 -REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKL 119
REI+ LK L HPN+V L +V+ S+ + +V E++ ++ D+ +K LQ+++ +
Sbjct: 67 IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIY 124
Query: 120 FQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179
QL+ GV++CH + HRDLK +N
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKP-----------------------------------QN 149
Query: 180 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVL-ANRG 227
+L++S G +K++DFGL+ R G P Y AP+VL ++
Sbjct: 150 LLINSDGALKLADFGLA------R-------AFGIPVRSYTHEVVTLWYRAPDVLMGSKK 196
Query: 228 YDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR-----------GDFKLP-- 272
Y + DIWS G I ++TG P + L KIF +LP
Sbjct: 197 YSTSV-DIWSIGCIFAEMITGKPLFPGVT-DDDQLP-KIFSILGTPNPREWPQVQELPLW 253
Query: 273 -----------------KWLSPGAQNLLRKILEPNPVKRIT 296
+LL +L +P KRI+
Sbjct: 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS 294
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-39
Identities = 87/355 (24%), Positives = 132/355 (37%), Gaps = 111/355 (31%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIAT 67
+ RY LGEG +G+V A D + A+K + R+ H + T I RE++
Sbjct: 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRLEHEEEGVPGT-AI-REVSL 86
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
LK L+H N++ L V+ +++++ EY +L + + + QLI+GV
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS--- 184
++CH++ HRDLK +N+LL
Sbjct: 146 NFCHSRRCLHRDLKP-----------------------------------QNLLLSVSDA 170
Query: 185 --KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVL-ANRGYDG 230
+KI DFGL+ R G P Y PE+L +R Y
Sbjct: 171 SETPVLKIGDFGLA------R-------AFGIPIRQFTHEIITLWYRPPEILLGSRHYST 217
Query: 231 ATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR--G--------------DFK-- 270
+ DIWS I +L P D + L+ KIF G D+K
Sbjct: 218 SV-DIWSIACIWAEMLMKTPLFPGDS-EIDQLF-KIFEVLGLPDDTTWPGVTALPDWKQS 274
Query: 271 ------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF-EQDYTP 312
L L +LL +LE +PVKRI+ +F D+ P
Sbjct: 275 FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-39
Identities = 62/290 (21%), Positives = 119/290 (41%), Gaps = 55/290 (18%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+G+ +G G+FG V K+ D+ AVK+L + K E+ L+ +H
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAP-TPQQLQAFKNEVGVLRKTRH 79
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
N++ ++ ++ +V ++ G L+ + AS+ + + + + +Q G+ Y H
Sbjct: 80 VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
K + HRDLK NI L +KI D
Sbjct: 139 KSIIHRDLKS-----------------------------------NNIFLHEDNTVKIGD 163
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT--SDIWSCGVILYVILTGYL 250
FGL+ + GS ++APEV+ + + + SD+++ G++LY ++TG L
Sbjct: 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223
Query: 251 PFDD-RNLAVLYQKIFRGDFK-----LPKWLSPGAQNLLRKILEPNPVKR 294
P+ + N + + + RG + + L+ + L+ +R
Sbjct: 224 PYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 70/290 (24%), Positives = 120/290 (41%), Gaps = 50/290 (17%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY++ LG G V A+D + A+K + + + +RE+ L H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
N+V + +V Y+V+EY+ G L + I S G L Q++DG+ + H+
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
+ HRD+K P +NIL+DS +KI DF
Sbjct: 131 RIVHRDIK---------------------------P--------QNILIDSNKTLKIFDF 155
Query: 194 GLS-ALPQHFRDDGLLHTTC--GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250
G++ AL + L T G+ Y +PE A +DI+S G++LY +L G
Sbjct: 156 GIAKAL----SETSLTQTNHVLGTVQYFSPE-QAKGEATDECTDIYSIGIVLYEMLVGEP 210
Query: 251 PFD-DRNLAVLYQKIFRGDF-----KLPKWLSPGAQNLLRKILEPNPVKR 294
PF+ + +++ + I + + K + N++ + E + R
Sbjct: 211 PFNGETAVSIAIKHI-QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 73/340 (21%), Positives = 121/340 (35%), Gaps = 80/340 (23%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
E+ +G G FG V A+ A+K +E E+ L + HPN+
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNI 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHN- 132
V+L A + + +V+EY GG L++ + L + GV+Y H+
Sbjct: 64 VKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 133 --KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN-IK 189
K + HRD LK N+LL + G +K
Sbjct: 122 QPKALIHRD----LKP-------------------------------PNLLLVAGGTVLK 146
Query: 190 ISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248
I DFG + D + GS ++APEV Y D++S G+IL+ ++T
Sbjct: 147 ICDFGTA------CDIQTHMTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITR 199
Query: 249 YLPFDDRNLAVLYQKIFRGDFK-----LPKWLSPGAQNLLRKILEPNPVKR--------- 294
PFD+ + +I L K L ++L+ + +P +R
Sbjct: 200 RKPFDE--IGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
Query: 295 -----ITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAF 329
G + ++ +D + +VD F
Sbjct: 258 MTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEF 297
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-38
Identities = 86/348 (24%), Positives = 121/348 (34%), Gaps = 107/348 (30%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKL 70
RYE +G G +G V A+D SG A+K + L I+ RE+A L+
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIS--TVREVALLRR 67
Query: 71 LK---HPNVVRLHEVLASKS-----KIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLF 120
L+ HPNVVRL +V A+ K+ +V E+V DK G L + L
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLM 126
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
+Q + G+ + H + HRDLK ENI
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKP-----------------------------------ENI 151
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----------YVAPEVLANRGYDG 230
L+ S G +K++DFGL+ R Y APEVL Y
Sbjct: 152 LVTSGGTVKLADFGLA------R-------IYSYQMALTPVVVTLWYRAPEVLLQSTYAT 198
Query: 231 ATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR-----------GDFKLPKW--- 274
D+WS G I + + L KIF D LP+
Sbjct: 199 PV-DMWSVGCIFAEMFRRKPLFCGNS-EADQLG-KIFDLIGLPPEDDWPRDVSLPRGAFP 255
Query: 275 -------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309
+ LL ++L NP KRI+ + +D
Sbjct: 256 PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 67/298 (22%), Positives = 116/298 (38%), Gaps = 56/298 (18%)
Query: 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI-----K 62
+EG + G Y L R +G G G V A+D A+K++ + L +D + +
Sbjct: 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE----TLS-SDPVFRTRMQ 82
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
RE T L+ P+VV +H+ ++Y+ + + G +L + +G L + +Q
Sbjct: 83 REARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQ 142
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
+ + H G HRD+K P ENIL+
Sbjct: 143 IGSALDAAHAAGATHRDVK---------------------------P--------ENILV 167
Query: 183 DSKGNIKISDFGLSALPQHFRDDGLLHT--TCGSPNYVAPEVLANRGYDGATSDIWSCGV 240
+ + DFG++ D+ L T G+ Y+APE + +DI++
Sbjct: 168 SADDFAYLVDFGIA---SATTDEKLTQLGNTVGTLYYMAPERFSESHATYR-ADIYALTC 223
Query: 241 ILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKR 294
+LY LTG P+ L+V+ I P + ++ + + NP R
Sbjct: 224 VLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-37
Identities = 79/316 (25%), Positives = 121/316 (38%), Gaps = 53/316 (16%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLL 71
+E LG GN G V SGL A K+ IHL+I QI RE+ L
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKL------IHLEIKPAIRNQIIRELQVLHEC 88
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
P +V + S +I + +E++ GG L + GR+ E K+ +I G++Y
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 132 NKG-VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKI 190
K + HRD+K P NIL++S+G IK+
Sbjct: 149 EKHKIMHRDVK---------------------------P--------SNILVNSRGEIKL 173
Query: 191 SDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249
DFG+S L D + ++ G+ +Y++PE L Y SDIWS G+ L + G
Sbjct: 174 CDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGR 227
Query: 250 LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309
P + L P + R + + R +A + ++ +
Sbjct: 228 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE 287
Query: 310 YTPANPDDDEEDIFVD 325
P P F D
Sbjct: 288 PPPKLPSGVFSLEFQD 303
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 7e-37
Identities = 80/304 (26%), Positives = 122/304 (40%), Gaps = 60/304 (19%)
Query: 8 QEGMRL-GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI----- 61
L RYELG LG G +V A+DL AVK+L L D
Sbjct: 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA----DLA-RDPSFYLRF 59
Query: 62 KREIATLKLLKHPNVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR 117
+RE L HP +V +++ + Y+V+EYV G L D + ++G +
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177
++ +++ H G+ HRD+K P
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVK---------------------------P-------- 144
Query: 178 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC--GSPNYVAPEVLANRGYDGATSDI 235
NI++ + +K+ DFG+ A + + T G+ Y++PE A A SD+
Sbjct: 145 ANIMISATNAVKVMDFGI-ARAIADSGNSVTQTAAVIGTAQYLSPE-QARGDSVDARSDV 202
Query: 236 WSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPN 290
+S G +LY +LTG PF D ++V YQ + R D P LS ++ K L N
Sbjct: 203 YSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDPIPPSARHEGLSADLDAVVLKALAKN 261
Query: 291 PVKR 294
P R
Sbjct: 262 PENR 265
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 81/366 (22%), Positives = 134/366 (36%), Gaps = 114/366 (31%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIAT 67
+ +YE +G+G FG+V A+ +G A+K K + + K IT REI
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITAL--REIKI 69
Query: 68 LKLLKHPNVVRLHEVLASKS--------KIYMVLEYV----TGGELFDKIASKGRLQEAE 115
L+LLKH NVV L E+ +K+ IY+V ++ G L + + +E
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSE 125
Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVL 175
+++ Q L++G+ Y H + HRD+K
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKA--------------------------------- 152
Query: 176 QLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPN------YVAPEVL-ANRG 227
N+L+ G +K++DFGL+ A +T N Y PE+L R
Sbjct: 153 --ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT-----NRVVTLWYRPPELLLGERD 205
Query: 228 YDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQ--KIFR----------------- 266
Y D+W G I+ + T + + +Q I +
Sbjct: 206 YGPPI-DLWGAGCIMAEMWTRSPIMQGNT----EQHQLALISQLCGSITPEVWPNVDNYE 260
Query: 267 --GDFKLPKW-------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311
+L K P A +L+ K+L +P +RI ++F D
Sbjct: 261 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320
Query: 312 PANPDD 317
P++
Sbjct: 321 PSDLKG 326
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 84/344 (24%), Positives = 124/344 (36%), Gaps = 127/344 (36%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
+YE +GEG +GKV A+DL +G R + LK +++
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNG----------GRFVALK---RVRVQTGEEGMPLST 58
Query: 63 -REIATLKLLK---HPNVVRLHEVL-----ASKSKIYMVLEYVTG--GELFDKIASKGRL 111
RE+A L+ L+ HPNVVRL +V ++K+ +V E+V DK+ G +
Sbjct: 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-V 117
Query: 112 QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171
+ + QL+ G+ + H+ V HRDLK
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKP----------------------------- 148
Query: 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----------YVAPE 221
+NIL+ S G IK++DFGL+ R Y APE
Sbjct: 149 ------QNILVTSSGQIKLADFGLA------R-------IYSFQMALTSVVVTLWYRAPE 189
Query: 222 VLANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR-----------GD 268
VL Y D+WS G I + ++ L KI D
Sbjct: 190 VLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSS-DVDQLG-KILDVIGLPGEEDWPRD 246
Query: 269 FKLPKW----------------LSPGAQNLLRKILEPNPVKRIT 296
LP+ + ++LL K L NP KRI+
Sbjct: 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-36
Identities = 63/297 (21%), Positives = 108/297 (36%), Gaps = 61/297 (20%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
G LG+G FG+ ++G +K L + + +E+ ++ L+HPNV
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLID---GVSYCHN 132
++ VL ++ + EY+ GG L I S + D G++Y H+
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPW---SQRVSFAKDIASGMAYLHS 126
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
+ HRDL N L+ N+ ++D
Sbjct: 127 MNIIHRDLNS-----------------------------------HNCLVRENKNVVVAD 151
Query: 193 FGLSALPQH------------FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240
FGL+ L D +T G+P ++APE++ R YD D++S G+
Sbjct: 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGI 210
Query: 241 ILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKR 294
+L I+ D + + RG P P + + + +P KR
Sbjct: 211 VLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 3e-36
Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 3/123 (2%)
Query: 343 GSPPLINAFQLIGMSSCLDLSGFFEKE-DVSERKIRFTSNHSAKDLLERIEDIVTEMGFR 401
P ++NAF++I +S L+LS F++ D +R+ RF S +++ IE + MGF+
Sbjct: 2 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 61
Query: 402 VQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSS 461
+N K + E G L+V E++E++PSL++V++RK+ G+ Y + KL S
Sbjct: 62 SHTRNFKTR--LEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCS 119
Query: 462 DLG 464
L
Sbjct: 120 KLE 122
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 67/283 (23%), Positives = 118/283 (41%), Gaps = 46/283 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
+ +G+G+FG+V D + A+KI LE+ +I D I++EI L
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIED-IQQEITVLSQCD 78
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
P V + + +K+++++EY+ GG D + G L E + + ++++ G+ Y H+
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHS 137
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
+ HRD+K N+LL G +K++D
Sbjct: 138 EKKIHRDIKA-----------------------------------ANVLLSEHGEVKLAD 162
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
FG++ Q +T G+P ++APEV+ YD +DIWS G+ + G P
Sbjct: 163 FGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPH 219
Query: 253 DDRN-LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
+ + + VL+ L S + + L P R
Sbjct: 220 SELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFR 262
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-36
Identities = 53/294 (18%), Positives = 100/294 (34%), Gaps = 67/294 (22%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L E + G++ G VK+L K R + + E L++ HPNV
Sbjct: 13 NFLTKLNENHSGELWKG--RWQGNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 77 VRLHEVLAS--KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
+ + S ++ ++ G L++ L E + Q + G
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYN------VLHEGTNFVVDQSQAVKFALDMARG 123
Query: 127 VSYCHNKG--VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
+++ H + L S ++++D
Sbjct: 124 MAFLHTLEPLIPRHALN----S-------------------------------RSVMIDE 148
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT--SDIWSCGVIL 242
+IS + +P +VAPE L + D +D+WS V+L
Sbjct: 149 DMTARISMADVK----FSFQSP---GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201
Query: 243 YVILTGYLPFDD-RNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKR 294
+ ++T +PF D N+ + + G +P +SP L++ + +P KR
Sbjct: 202 WELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-36
Identities = 67/298 (22%), Positives = 117/298 (39%), Gaps = 65/298 (21%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKLLK 72
E + +G+G FG V + + A+K L + ++ + +RE+ + L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSY 129
HPN+V+L + MV+E+V G+L+ ++ K + + ++D G+ Y
Sbjct: 82 HPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEY 137
Query: 130 CHNKG--VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG- 186
N+ + HRD L+S NI L S
Sbjct: 138 MQNQNPPIVHRD----LRS-------------------------------PNIFLQSLDE 162
Query: 187 ----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGV 240
K++DFGLS + G+ ++APE + Y +D +S +
Sbjct: 163 NAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMAPETIGAEEESYTEK-ADTYSFAM 216
Query: 241 ILYVILTGYLPFDDRN---LAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKR 294
ILY ILTG PFD+ + + + G +P+ P +N++ +P KR
Sbjct: 217 ILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 72/292 (24%), Positives = 115/292 (39%), Gaps = 57/292 (19%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-KITDQIKREIATLKLLKHPN 75
L +G G FGKV A G AVK + + + + +++E +LKHPN
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG- 134
++ L V + + +V+E+ GG L ++ K R+ Q+ G++Y H++
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 135 --VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG------ 186
+ HRDLK NIL+ K
Sbjct: 127 VPIIHRDLKS-----------------------------------SNILILQKVENGDLS 151
Query: 187 --NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
+KI+DFGL+ + G+ ++APEV+ + SD+WS GV+L+
Sbjct: 152 NKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEVIRASMFSKG-SDVWSYGVLLWE 206
Query: 245 ILTGYLPFDD-RNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKR 294
+LTG +PF LAV Y +P L+ P+P R
Sbjct: 207 LLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 59/295 (20%), Positives = 111/295 (37%), Gaps = 60/295 (20%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
E+G +G+G FG+V ++ ++ A+++++ R KRE+ + +H
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGEV------AIRLIDIERDNE-DQLKAFKREVMAYRQTRH 88
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHN 132
NVV S + ++ G L+ + K L + R++ Q+++ G+ Y H
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
KG+ H+D LKS +N+ D G + I+D
Sbjct: 149 KGILHKD----LKS-------------------------------KNVFYD-NGKVVITD 172
Query: 193 FGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT--------SDIWSCGVI 241
FGL + Q R + L G ++APE++ D SD+++ G I
Sbjct: 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232
Query: 242 LYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKR 294
Y + PF + + ++ G + ++L +R
Sbjct: 233 WYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEER 287
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-34
Identities = 72/290 (24%), Positives = 131/290 (45%), Gaps = 52/290 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+E+ LG+G FGKV A++ ++G A K++E ++ D EI L HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELED-YIVEIEILATCDHP 76
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+V+L K+++++E+ GG + + L E + + + +Q+++ +++ H+K
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
+ HRDLK N+L+ +G+I+++DF
Sbjct: 137 RIIHRDLKA-----------------------------------GNVLMTLEGDIRLADF 161
Query: 194 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSCGVILYVILTG 248
G+SA ++ + + G+P ++APEV+ YD +DIWS G+ L +
Sbjct: 162 GVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEMAQI 218
Query: 249 YLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKR 294
P + N + VL KI + D P S ++ L+ L+ NP R
Sbjct: 219 EPPHHELNPMRVLL-KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETR 267
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 68/287 (23%), Positives = 126/287 (43%), Gaps = 49/287 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+++ LGEG++G V A ++G A+K + + +I +EI+ ++ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSP 84
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+VV+ + + +++V+EY G + D I L E E + Q + G+ Y H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
HRD+K NILL+++G+ K++DF
Sbjct: 145 RKIHRDIKA-----------------------------------GNILLNTEGHAKLADF 169
Query: 194 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253
G++ Q +T G+P ++APEV+ GY+ +DIWS G+ + G P+
Sbjct: 170 GVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYA 226
Query: 254 DRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRIT 296
D + + ++ I F+ P+ S + +++ L +P +R T
Sbjct: 227 DIHPMRAIF-MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRAT 272
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 71/287 (24%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
+Y +G+G G V A D+ +G A++ L++ L I EI ++ K
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-----IINEILVMRENK 75
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+PN+V + ++++V+EY+ GG L D + ++ + E + + ++ + + + H+
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
V HRD+K +NILL G++K++D
Sbjct: 135 NQVIHRDIKS-----------------------------------DNILLGMDGSVKLTD 159
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
FG A Q + T G+P ++APEV+ + Y DIWS G++ ++ G P+
Sbjct: 160 FGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPY 216
Query: 253 DDRN-LAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRIT 296
+ N L LY G + + P+ LS ++ L + LE + KR +
Sbjct: 217 LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS 263
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 31/115 (26%), Positives = 53/115 (46%), Gaps = 5/115 (4%)
Query: 344 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 403
+NAF +I S +LSG F +R RF S +A+ ++ER+E+IV+ V
Sbjct: 2 GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVA 61
Query: 404 KKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNK 458
KK + K G+ ++ E+ +++ L ++E+RK R L
Sbjct: 62 KKETWGMKIEGQK-----GNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTD 111
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 71/288 (24%), Positives = 133/288 (46%), Gaps = 51/288 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
+ +GEG+ G V A++ SG AVK+ L K + L + E+ ++ +
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-----LFNEVVIMRDYQ 100
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H NVV +++ ++++++E++ GG L D I S+ RL E + + + ++ ++Y H
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
+GV HRD+K ++ILL G +K+SD
Sbjct: 160 QGVIHRDIKS-----------------------------------DSILLTLDGRVKLSD 184
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
FG A Q +D + G+P ++APEV++ Y DIWS G+++ ++ G P+
Sbjct: 185 FGFCA--QISKDVPKRKSLVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPY 241
Query: 253 DDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRIT 296
+ + + ++ K +SP ++ L ++L +P +R T
Sbjct: 242 FSDSPVQAMK-RLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT 288
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 62/290 (21%), Positives = 110/290 (37%), Gaps = 52/290 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
E +G G G+V + +G AVK + ++ + + +I ++ + K P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK- 133
+V+ + + +++ +E + K +G + E K+ ++ + Y K
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
GV HRD+K P NILLD +G IK+ DF
Sbjct: 145 GVIHRDVK---------------------------P--------SNILLDERGQIKLCDF 169
Query: 194 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT----SDIWSCGVILYVILTGY 249
G+S DD + G Y+APE + +D+WS G+ L + TG
Sbjct: 170 GISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
Query: 250 LPFDDRN--LAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKR 294
P+ + VL K+ + + S Q+ ++ L + KR
Sbjct: 227 FPYKNCKTDFEVL-TKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKR 275
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-33
Identities = 75/305 (24%), Positives = 121/305 (39%), Gaps = 66/305 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
YEL +G G V+ A A+K LEK + D++ +EI +
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLKEIQAMSQCH 71
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------- 124
HPN+V + K ++++V++ ++GG + D I E + L + I
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
+G+ Y H G HRD+K NILL
Sbjct: 132 EGLEYLHKNGQIHRDVKA-----------------------------------GNILLGE 156
Query: 185 KGNIKISDFGLSALPQHFRDDGLL---HTTCGSPNYVAPEVLA-NRGYDGATSDIWSCGV 240
G+++I+DFG+SA D T G+P ++APEV+ RGYD +DIWS G+
Sbjct: 157 DGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYD-FKADIWSFGI 215
Query: 241 ILYVILTGYLPFDDRN-LAVLY----------QKIFRGDFKLPKWLSPGAQNLLRKILEP 289
+ TG P+ + VL + + L K+ + ++ L+
Sbjct: 216 TAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKY-GKSFRKMISLCLQK 274
Query: 290 NPVKR 294
+P KR
Sbjct: 275 DPEKR 279
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 94/406 (23%), Positives = 136/406 (33%), Gaps = 133/406 (32%)
Query: 15 RYE-LGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+E G +G G +G V A+ D +A+K +E I REIA L+ L
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLREL 75
Query: 72 KHPNVVRLHEVLASKS--KIYMVLEYV--------TGGELFDKIASKGRLQEAEGRKLFQ 121
KHPNV+ L +V S + K++++ +Y +L + L
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
Q++DG+ Y H V HRDLK NIL
Sbjct: 136 QILDGIHYLHANWVLHRDLKP-----------------------------------ANIL 160
Query: 182 LDS----KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN--------------YVAPEVL 223
+ +G +KI+D G + R SP Y APE+L
Sbjct: 161 VMGEGPERGRVKIADMGFA------R-------LFNSPLKPLADLDPVVVTFWYRAPELL 207
Query: 224 -ANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQ-----KIFR------- 266
R Y A DIW+ G I +LT F +D + Y +IF
Sbjct: 208 LGARHYTKAI-DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPAD 266
Query: 267 ----GDFKLPKW---------------------------LSPGAQNLLRKILEPNPVKRI 295
K+P+ A +LL+K+L +P+KRI
Sbjct: 267 KDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI 326
Query: 296 TIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRT 341
T D +F +D P + I F E P D G
Sbjct: 327 TSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDK 372
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 54/265 (20%), Positives = 101/265 (38%), Gaps = 53/265 (20%)
Query: 14 GRYELGRTLGEG--NFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLK 69
G YEL +G+G + V A+ +G V+ LE + ++ E+ K
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV---TFLQGELHVSK 81
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGV 127
L HPN+V + +++++V ++ G D + E + Q ++ +
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
Y H+ G HR +K +IL+ G
Sbjct: 142 DYIHHMGYVHRSVKA-----------------------------------SHILISVDGK 166
Query: 188 IKISDFGLSA-LPQHFRDDGLLHTTC----GSPNYVAPEVLA--NRGYDGATSDIWSCGV 240
+ +S + + H + ++H +++PEVL +GYD SDI+S G+
Sbjct: 167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGI 225
Query: 241 ILYVILTGYLPFDDRN-LAVLYQKI 264
+ G++PF D +L +K+
Sbjct: 226 TACELANGHVPFKDMPATQMLLEKL 250
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 67/288 (23%), Positives = 117/288 (40%), Gaps = 53/288 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ R +G G+FG V FA+D+ + A+K + + + I +E+ L+ L+HP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N ++ + ++V+EY G K LQE E + + G++Y H+
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
+ HRD+K NILL G +K+ DFG
Sbjct: 175 MIHRDVKA-----------------------------------GNILLSEPGLVKLGDFG 199
Query: 195 LSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYL 250
++ + ++ G+P ++APEV+ YDG D+WS G+ +
Sbjct: 200 SASIMAPA-------NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKP 251
Query: 251 PFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKR 294
P + N ++ LY I + + + W S +N + L+ P R
Sbjct: 252 PLFNMNAMSALY-HIAQNESPALQSGHW-SEYFRNFVDSCLQKIPQDR 297
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-31
Identities = 64/300 (21%), Positives = 109/300 (36%), Gaps = 73/300 (24%)
Query: 8 QEGMRL-GRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQI---- 61
G + G+YE+ + G G + A D + +G P +K L + D
Sbjct: 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-------DAEAQAM 125
Query: 62 -KREIATLKLLKHPNVVRLHEV-----LASKSKIYMVLEYVTGGELFDKIASKGRLQEAE 115
E L + HP++V++ Y+V+EYV G L +L AE
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAE 183
Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVL 175
+++ +SY H+ G+ + DLK P
Sbjct: 184 AIAYLLEILPALSYLHSIGLVYNDLK---------------------------P------ 210
Query: 176 QLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234
ENI+L + +K+ D G S + G L G+P + APE++ R +D
Sbjct: 211 --ENIMLT-EEQLKLIDLGAVSRINS----FGYL---YGTPGFQAPEIV--RTGPTVATD 258
Query: 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 294
I++ G L + + R + L + LLR+ ++P+P +R
Sbjct: 259 IYTVGRTLAALTLDLPTRNGRYVDGLPEDD------PVLKTYDSYGRLLRRAIDPDPRQR 312
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-31
Identities = 67/303 (22%), Positives = 112/303 (36%), Gaps = 73/303 (24%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIAT-LKL 70
+ +G G +G V SG AVK I + + Q+ ++ ++
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVK------RIRSTVDEKEQKQLLMDLDVVMRS 77
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI------ASKGRLQEAEGRKLFQQLI 124
P +V+ + L + ++ +E ++ FDK + E K+ +
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 125 DGVSYCHNKG-VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD 183
+++ + HRD+K + NILLD
Sbjct: 136 KALNHLKENLKIIHRDIK----------PS-------------------------NILLD 160
Query: 184 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCG 239
GNIK+ DFG+S D G Y+APE + +GYD SD+WS G
Sbjct: 161 RSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYD-VRSDVWSLG 216
Query: 240 VILYVILTGYLPFDDRN--LAVLYQKIFRGD-FKLP-----KWLSPGAQNLLRKILEPNP 291
+ LY + TG P+ N L ++ +GD +L ++ SP N + L +
Sbjct: 217 ITLYELATGRFPYPKWNSVFDQL-TQVVKGDPPQLSNSEEREF-SPSFINFVNLCLTKDE 274
Query: 292 VKR 294
KR
Sbjct: 275 SKR 277
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 62/299 (20%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLK 72
G +EL +G G +G+V + + +G A+K+++ + + + IK+EI LK
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEE-IKQEINMLKKYSH 79
Query: 73 HPNVVRLHE------VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLI 124
H N+ + ++++V+E+ G + D K L+E + ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
G+S+ H V HRD+K +N+LL
Sbjct: 140 RGLSHLHQHKVIHRDIKG-----------------------------------QNVLLTE 164
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSCG 239
+K+ DFG+SA Q R G +T G+P ++APEV+A YD SD+WS G
Sbjct: 165 NAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLG 221
Query: 240 VILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKR 294
+ + G P D + + L+ I R K KW S Q+ + L N +R
Sbjct: 222 ITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLKSKKW-SKKFQSFIESCLVKNHSQR 278
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 64/312 (20%), Positives = 115/312 (36%), Gaps = 67/312 (21%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIA-TLKL 70
E LG G +G V+ + + SG AVK I + ++ ++ +++
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVK------RIRATVNSQEQKRLLMDLDISMRT 62
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLID 125
+ P V + L + +++ +E + DK + E K+ ++
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 126 GVSYCHNKG-VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
+ + H+K V HRD+K P N+L+++
Sbjct: 121 ALEHLHSKLSVIHRDVK---------------------------P--------SNVLINA 145
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGV 240
G +K+ DFG+S + DD G Y+APE + GY SDIWS G+
Sbjct: 146 LGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINPELNQKGYS-VKSDIWSLGI 201
Query: 241 ILYVILTGYLPFDDRN--LAVLYQKIFRGDFKLP--KWLSPGAQNLLRKILEPNPVKRIT 296
+ + P+D L Q + +LP K+ S + + L+ N +R T
Sbjct: 202 TMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF-SAEFVDFTSQCLKKNSKERPT 260
Query: 297 IAGIKADEWFEQ 308
+ +F
Sbjct: 261 YPELMQHPFFTL 272
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 85/388 (21%), Positives = 132/388 (34%), Gaps = 135/388 (34%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
Y + +G G+FG V A+ DSG A+K +L+ R + RE+ ++ L H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 106
Query: 74 PNVVRLHEVLASKS------KIYMVLEYVTG---GELFDKIASKGRLQEAEGRKLFQQLI 124
N+VRL S + +VL+YV +K L + QL
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
++Y H+ G+ HRD+K P +N+LLD
Sbjct: 167 RSLAYIHSFGICHRDIK---------------------------P--------QNLLLDP 191
Query: 185 K-GNIKISDFGLSALPQHFRDDGLLHTTCGSPN--YV------APEVLAN-RGYDGATSD 234
+K+ DFG + G PN Y+ APE++ Y + D
Sbjct: 192 DTAVLKLCDFGSA-----------KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSI-D 239
Query: 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------------------- 268
+WS G +L +L G Q IF GD
Sbjct: 240 VWSAGCVLAELLLG-------------QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286
Query: 269 ----FKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 312
FK P+ P A L ++LE P R+T A +F++ P
Sbjct: 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 346
Query: 313 AN--PDDDEEDIFVDNEAFSMHEVPSDG 338
P+ + + F+ E+ S+
Sbjct: 347 NVKLPNGRDTPALFN---FTTQELSSNP 371
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 74/272 (27%), Positives = 108/272 (39%), Gaps = 61/272 (22%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
L LG+G+FG V ++ + AVK L+ + + + D RE+ + L H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
N++RL+ V + MV E G L D RL++ +G L L G
Sbjct: 81 RNLIRLYGV-VLTPPMKMVTELAPLGSLLD------RLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ Y +K HRDL A R N+LL ++
Sbjct: 134 MGYLESKRFIHRDL-----------AA--------------R----------NLLLATRD 158
Query: 187 NIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVIL 242
+KI DFGL ALPQ +D APE L R + A SD W GV L
Sbjct: 159 LVKIGDFGLMRALPQ---NDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTL 214
Query: 243 YVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
+ + T G P+ N + + KI + +LP+
Sbjct: 215 WEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 74/345 (21%), Positives = 127/345 (36%), Gaps = 109/345 (31%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLK 72
Y + +G G+FG V A+ ++S A+K + +K RE+ ++++K
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKN---------RELQIMRIVK 90
Query: 73 HPNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----Q 122
HPNVV L S + +VLEYV ++ +L++ L + Q
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 123 LIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
L+ ++Y H+ G+ HRD+K P +N+LL
Sbjct: 150 LLRSLAYIHSIGICHRDIK---------------------------P--------QNLLL 174
Query: 183 DS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN--YV------APEVLAN-RGYDGAT 232
D G +K+ DFG + G PN Y+ APE++ Y
Sbjct: 175 DPPSGVLKLIDFGSA-----------KILIAGEPNVSYICSRYYRAPELIFGATNYTTNI 223
Query: 233 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-----------------GDFKLPKW- 274
DIWS G ++ ++ G F + +I + + K P+
Sbjct: 224 -DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIR 282
Query: 275 -----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308
P A +L+ ++LE P R+T +F++
Sbjct: 283 PHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 39/295 (13%), Positives = 76/295 (25%), Gaps = 78/295 (26%)
Query: 10 GMRL--GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
G R+ GRY L G + A D A+ ++ ++ + +
Sbjct: 25 GARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLR 84
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
L + P V R+ +V+ +++ +V E++ GG L + + Q L
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAA 142
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
H GV P + + G+
Sbjct: 143 DAAHRAGVALSIDH---------------------------P--------SRVRVSIDGD 167
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
+ ++ + DI G LY +L
Sbjct: 168 VVLAYPA----------------------TMPDA--------NPQDDIRGIGASLYALLV 197
Query: 248 GYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPGA----QNLLRKILEPNPVKR 294
P + LA + G P + + + ++ + R
Sbjct: 198 NRWPLPEAGVRSGLAPAERDT-AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR 251
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 81/379 (21%), Positives = 131/379 (34%), Gaps = 110/379 (29%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ + +G G G V A D A+K L + H K + RE+ +K +
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVN 82
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H N++ L V + +Y+V+E + L I + L L Q++ G
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI--QMELDHERMSYLLYQMLCG 139
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ + H+ G+ HRDLK P NI++ S
Sbjct: 140 IKHLHSAGIIHRDLK---------------------------P--------SNIVVKSDC 164
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------APEVLANRGYDGATSDIWSCGV 240
+KI DFGL+ R G YV APEV+ GY DIWS G
Sbjct: 165 TLKILDFGLA------RTAGTSFMMTP---YVVTRYYRAPEVILGMGYKENV-DIWSVGC 214
Query: 241 ILYVILTG-------------------------------------YL----PFDDRNLAV 259
I+ ++ G Y+ + +
Sbjct: 215 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK 274
Query: 260 LYQK-IFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 318
L+ +F D + K + A++LL K+L + KRI++ + Y P+ +
Sbjct: 275 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 334
Query: 319 EEDIF---VDNEAFSMHEV 334
I +D ++ E
Sbjct: 335 PPKIPDKQLDEREHTIEEW 353
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 83/379 (21%), Positives = 133/379 (35%), Gaps = 110/379 (29%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ + +G G G V A D A+K L + H K + RE+ +K +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVN 119
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H N++ L V + +Y+V+E + L I + L L Q++ G
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCG 176
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ + H+ G+ HRDLK P NI++ S
Sbjct: 177 IKHLHSAGIIHRDLK---------------------------P--------SNIVVKSDC 201
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------APEVLANRGYDGATSDIWSCGV 240
+KI DFGL+ R G T+ YV APEV+ GY DIWS G
Sbjct: 202 TLKILDFGLA------RTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGC 251
Query: 241 ILYVILTG-------------------------------------YL----PFDDRNLAV 259
I+ ++ Y+ +
Sbjct: 252 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 311
Query: 260 LYQK-IFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 318
L+ +F D + K + A++LL K+L +P KRI++ + Y PA +
Sbjct: 312 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP 371
Query: 319 EEDIF---VDNEAFSMHEV 334
I+ +D ++ E
Sbjct: 372 PPQIYDKQLDEREHTIEEW 390
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-27
Identities = 64/328 (19%), Positives = 113/328 (34%), Gaps = 87/328 (26%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L +G+G +G+V G AVKI + + + E+ +L+H N+
Sbjct: 11 TLLECVGKGRYGEVWRGSW--QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENI 64
Query: 77 VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+ S ++++++ Y G L+D + L ++ + G+++ H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 123
Query: 133 K--------GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
+ + HRDLK S +NIL+
Sbjct: 124 EIFGTQGKPAIAHRDLK----S-------------------------------KNILVKK 148
Query: 185 KGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT-----SDIWS 237
G I+D GL+ + + D + G+ Y+APEVL DIW+
Sbjct: 149 NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWA 208
Query: 238 CGVILYVILTGY----------LPFDDRN----------LAVLYQKIFRGDFKLPKWLSP 277
G++L+ + PF D V + R + +W S
Sbjct: 209 FGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ-RPNIP-NRWFSD 266
Query: 278 GAQNLLRKILE----PNPVKRITIAGIK 301
L K+++ NP R+T IK
Sbjct: 267 PTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 75/295 (25%), Positives = 115/295 (38%), Gaps = 55/295 (18%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
LG +G GNFG+V + AVK + LK + +E LK HPN+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA--KFLQEARILKQYSHPNI 174
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYCHNKGV 135
VRL V K IY+V+E V GG+ + ++G + G+ Y +K
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
HRDL A R N L+ K +KISDFG+
Sbjct: 235 IHRDL-----------AA--------------R----------NCLVTEKNVLKISDFGM 259
Query: 196 SALPQHFRD--DGLLHTTCGSPNY----VAPEVLANRGYDGATSDIWSCGVILYVILT-G 248
S R+ DG+ + G APE L Y SD+WS G++L+ + G
Sbjct: 260 S------REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLG 312
Query: 249 YLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIK 301
P+ + + + + +G +L P+ L+ + P +R + + I
Sbjct: 313 ASPYPNLSNQQTREFVEKG-GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIY 366
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 80/375 (21%), Positives = 128/375 (34%), Gaps = 98/375 (26%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD--QIKREIATLKLLK 72
++L LGEG +G V A +G A+K K K + REI LK K
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFD-KPLFALRTLREIKILKHFK 67
Query: 73 HPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
H N++ + + S +Y++ E + +L ++ S L + + Q + V
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
H V HRDLK P N+L++S +
Sbjct: 126 KVLHGSNVIHRDLK---------------------------P--------SNLLINSNCD 150
Query: 188 IKISDFGL--SALPQHFRDDGLLHTTCGSPNYV------APEV-LANRGYDGATSDIWSC 238
+K+ DFGL + G +V APEV L + Y A D+WSC
Sbjct: 151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSC 209
Query: 239 GVILYVILTG--------YL------------PFDDRNLAVL-----------YQKIFRG 267
G IL + Y P D +L +
Sbjct: 210 GCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAA 269
Query: 268 DFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP-----ANPDDDEE 320
+ P+ ++P +LL+++L +P KRIT + + + P P
Sbjct: 270 PLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSF 328
Query: 321 DIF-VDNEAFSMHEV 334
F EA + ++
Sbjct: 329 FEFDHYKEALTTKDL 343
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 67/326 (20%), Positives = 121/326 (37%), Gaps = 93/326 (28%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
Y+L R LG G + +V A ++ + VKI + +IKREI L+ L+
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKI------LKPVKKKKIKREIKILENLRGG 90
Query: 74 PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
PN++ L +++ +V E+V + + L + + R +++ + YCH
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCH 147
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK-GNIKI 190
+ G+ HRD+K P N+++D + +++
Sbjct: 148 SMGIMHRDVK---------------------------P--------HNVMIDHEHRKLRL 172
Query: 191 SDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYVILTG 248
D+GL+ F G + S + PE+L + + YD + D+WS G +L ++
Sbjct: 173 IDWGLA----EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSL-DMWSLGCMLASMIFR 227
Query: 249 YLPF--------------------DDRNLAVLYQKIFRGDFK--LPKW------------ 274
PF D + Y F L +
Sbjct: 228 KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSE 287
Query: 275 ----LSPGAQNLLRKILEPNPVKRIT 296
+SP A + L K+L + R+T
Sbjct: 288 NQHLVSPEALDFLDKLLRYDHQSRLT 313
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 60/268 (22%), Positives = 107/268 (39%), Gaps = 61/268 (22%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+ LG G +G+V L AVK L+++ + ++ +E A +K +KHPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKHPNL 278
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
V+L V + Y++ E++T G L D L+E +++ L+ +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLD------YLRECNRQEVSAVVLLYMATQISSAME 332
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
Y K HR+L N L+ +
Sbjct: 333 YLEKKNFIHRNLAA-----------------------------------RNCLVGENHLV 357
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPNY--VAPEVLANRGYDGATSDIWSCGVILYVIL 246
K++DFGLS + D APE LA + SD+W+ GV+L+ I
Sbjct: 358 KVADFGLS---RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIA 413
Query: 247 T-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
T G P+ +L+ +Y+ + + +++ +
Sbjct: 414 TYGMSPYPGIDLSQVYELLEKD-YRMER 440
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 59/272 (21%), Positives = 111/272 (40%), Gaps = 64/272 (23%)
Query: 17 ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ + LG G FG V + +P A+K L + +I E + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVD 75
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
+P+V RL + S + ++ + + G L D ++E + Q L++
Sbjct: 76 NPHVCRLLGIC-LTSTVQLITQLMPFGCLLD------YVREHKDNIGSQYLLNWCVQIAK 128
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
G++Y ++ + HRDL R N+L+ +
Sbjct: 129 GMNYLEDRRLVHRDLAA-------R----------------------------NVLVKTP 153
Query: 186 GNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGATSDIWSCGVIL 242
++KI+DFGL+ L ++ H G P ++A E + +R Y SD+WS GV +
Sbjct: 154 QHVKITDFGLAKLLGA---EEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTV 209
Query: 243 YVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
+ ++T G P+D + + + +G +LP+
Sbjct: 210 WELMTFGSKPYDGIPASEISSILEKG-ERLPQ 240
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-26
Identities = 64/270 (23%), Positives = 109/270 (40%), Gaps = 65/270 (24%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
+ LG G +G+V L AVK L+++ + + +E A +K +KHP
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHP 69
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
N+V+L V + Y++ E++T G L D L+E +++ L+
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLD------YLRECNRQEVSAVVLLYMATQISSA 123
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ Y K HRDL R N L+
Sbjct: 124 MEYLEKKNFIHRDLAA-------R----------------------------NCLVGENH 148
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGATSDIWSCGVILYV 244
+K++DFGLS L D P + APE LA + SD+W+ GV+L+
Sbjct: 149 LVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWE 204
Query: 245 ILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
I T G P+ +L+ +Y+ + + +++ +
Sbjct: 205 IATYGMSPYPGIDLSQVYELLEKD-YRMER 233
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-26
Identities = 70/320 (21%), Positives = 122/320 (38%), Gaps = 67/320 (20%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L LG+G FG+V + A+K L+ + + +E +K L+H +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 324
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
V+L+ V S+ IY+V EY++ G L D L+ G+ L QL+D G++
Sbjct: 325 VQLYAV-VSEEPIYIVTEYMSKGSLLD------FLKGETGKYLRLPQLVDMAAQIASGMA 377
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
Y HRDL+ NIL+
Sbjct: 378 YVERMNYVHRDLRA-----------------------------------ANILVGENLVC 402
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
K++DFGL+ + D+ P + APE + SD+WS G++L +
Sbjct: 403 KVADFGLA---RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELT 458
Query: 247 T-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303
T G +P+ + ++ RG +++ P +L+ + P +R T ++
Sbjct: 459 TKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ-- 515
Query: 304 EWFEQDYTPANPDDDEEDIF 323
+ E +T P +
Sbjct: 516 AFLEDYFTSTEPQYQPGENL 535
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 66/271 (24%), Positives = 109/271 (40%), Gaps = 61/271 (22%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ + +G G+ G+V + +P A+K L+ + E + + H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFDH 109
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
PN++RL V+ +V EY+ G L L+ +G+ QL+ G
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDT------FLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ Y + G HRDL A R N+L+DS
Sbjct: 164 MRYLSDLGYVHRDL-----------AA--------------R----------NVLVDSNL 188
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILY 243
K+SDFGLS + + D +TT G + APE +A R + A SD+WS GV+++
Sbjct: 189 VCKVSDFGLSRVLE--DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMW 245
Query: 244 VILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
+L G P+ + + + G ++LP
Sbjct: 246 EVLAYGERPYWNMTNRDVISSVEEG-YRLPA 275
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 70/320 (21%), Positives = 122/320 (38%), Gaps = 67/320 (20%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L LG+G FG+V + A+K L+ + + +E +K L+H +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 241
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
V+L+ V S+ IY+V EY++ G L D L+ G+ L QL+D G++
Sbjct: 242 VQLYAV-VSEEPIYIVTEYMSKGSLLD------FLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
Y HRDL+ NIL+
Sbjct: 295 YVERMNYVHRDLRA-----------------------------------ANILVGENLVC 319
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
K++DFGL+ + D+ P + APE + SD+WS G++L +
Sbjct: 320 KVADFGLA---RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELT 375
Query: 247 T-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303
T G +P+ + ++ RG +++ P +L+ + P +R T ++
Sbjct: 376 TKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ-- 432
Query: 304 EWFEQDYTPANPDDDEEDIF 323
+ E +T P +
Sbjct: 433 AFLEDYFTSTEPQYQPGENL 452
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 63/263 (23%), Positives = 101/263 (38%), Gaps = 49/263 (18%)
Query: 18 LGRTLGEGNFGKVKFA--QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG GNFG VK Q AVKIL KN + D++ E ++ L +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+VR+ + +V+E G L + +++ +L Q+ G+ Y
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
HRDL A R N+LL ++ KISDFGL
Sbjct: 139 VHRDL-----------AA--------------R----------NVLLVTQHYAKISDFGL 163
Query: 196 S-ALPQHFRDDGLLHTTCGS--P-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYL 250
S AL D+ P + APE + + SD+WS GV+++ + G
Sbjct: 164 SKALRA---DENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQK 219
Query: 251 PFDDRNLAVLYQKIFRGDFKLPK 273
P+ + + + +G ++
Sbjct: 220 PYRGMKGSEVTAMLEKG-ERMGC 241
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 90/367 (24%), Positives = 139/367 (37%), Gaps = 99/367 (26%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ +G G +G V A D +GL AVK L + IIH K + RE+ LK +K
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V +Y+V + G +L + + + +L + + L Q++ G
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRG 144
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ Y H+ + HRDLK P N+ ++
Sbjct: 145 LKYIHSADIIHRDLK---------------------------P--------SNLAVNEDC 169
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------APEV-LANRGYDGATSDIWSCG 239
+KI DFGL+ YV APE+ L Y+ DIWS G
Sbjct: 170 ELKILDFGLARHTADEMTG-----------YVATRWYRAPEIMLNWMHYNQTV-DIWSVG 217
Query: 240 VILYVILTGYLPFDDRNLAVLYQKIFR------GDF--------------KLPKW----- 274
I+ +LTG F + + I R + L +
Sbjct: 218 CIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF 277
Query: 275 ------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN-PDDDEEDIFVDNE 327
+P A +LL K+L + KRIT A A +F Q + P + P D D +++
Sbjct: 278 ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSLESR 337
Query: 328 AFSMHEV 334
+ E
Sbjct: 338 DLLIDEW 344
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 92/395 (23%), Positives = 138/395 (34%), Gaps = 115/395 (29%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
Y + +G G +G V A D +G A+K L + + K + RE+ LK ++
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMR 82
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V Y+V+ ++ G +L K+ +L E + L Q++ G
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKG 140
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ Y H G+ HRDLK P N+ ++
Sbjct: 141 LRYIHAAGIIHRDLK---------------------------P--------GNLAVNEDC 165
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------APEV-LANRGYDGATSDIWSCG 239
+KI DFGL+ R T YV APEV L Y DIWS G
Sbjct: 166 ELKILDFGLA------RQADSEMT-----GYVVTRWYRAPEVILNWMRYTQTV-DIWSVG 213
Query: 240 VILYVILTGYLPFDDRNLAVLYQKIF------------------------------RGDF 269
I+ ++TG F + ++I + DF
Sbjct: 214 CIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF 273
Query: 270 K--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA--------NPDDDE 319
L SP A NLL K+L + +R+T A +FE + + D+
Sbjct: 274 ASILTN-ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDD 332
Query: 320 EDIFVD-------NEAFSMHEVPSDGGRTPGSPPL 347
D +D E S G R PL
Sbjct: 333 VDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 367
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 66/271 (24%), Positives = 109/271 (40%), Gaps = 62/271 (22%)
Query: 18 LGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ +G G FG+V +P A+K L+ + E + H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQFSH 105
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
N++RL V++ + ++ EY+ G L L+E +G QL+ G
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDK------FLREKDGEFSVLQLVGMLRGIAAG 159
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ Y N HRDL A R NIL++S
Sbjct: 160 MKYLANMNYVHRDL-----------AA--------------R----------NILVNSNL 184
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILY 243
K+SDFGLS + + D +TT G + APE ++ R + A SD+WS G++++
Sbjct: 185 VCKVSDFGLSRVLE--DDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMW 241
Query: 244 VILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
++T G P+ + + + + I G F+LP
Sbjct: 242 EVMTYGERPYWELSNHEVMKAINDG-FRLPT 271
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 78/360 (21%), Positives = 123/360 (34%), Gaps = 108/360 (30%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD--QIKREIATLKLLK 72
RY + LG G G V A D D A+K +I+ REI ++ L
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRRLD 66
Query: 73 HPNVVRLHEVLASKSK--------------IYMVLEYVTGGELFDKIASKGRLQEAEGRK 118
H N+V++ E+L +Y+V EY+ +L + +G L E R
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLLEEHARL 124
Query: 119 LFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178
QL+ G+ Y H+ V HRDLK P
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLK---------------------------P--------A 149
Query: 179 NILLDSKG-NIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYV------APEV-LANRGYD 229
N+ ++++ +KI DFGL+ + H+ G L + +P + L+ Y
Sbjct: 150 NLFINTEDLVLKIGDFGLARIMDPHYSHKGHL------SEGLVTKWYRSPRLLLSPNNYT 203
Query: 230 GATSDIWSCGVILYVILTGYLPF-------------------DDRNLAVLYQKIFRGDFK 270
A D+W+ G I +LTG F + + L I
Sbjct: 204 KAI-DMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRN 262
Query: 271 LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 319
+S A + L +IL +P+ R+T + + P DE
Sbjct: 263 DMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP----MDE 318
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 66/275 (24%), Positives = 113/275 (41%), Gaps = 71/275 (25%)
Query: 18 LGRTLGEGNFGKV---KFAQDLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIATLK 69
+ + +G G FG+V + + A+K L EK R L E + +
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-------GEASIMG 101
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---- 125
HPN++RL V+ + +V EY+ G L L++ + + QL+
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF------LRKHDAQFTVIQLVGMLRG 155
Query: 126 ---GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
G+ Y + G HRDL A R NIL+
Sbjct: 156 IASGMKYLSDMGYVHRDL-----------AA--------------R----------NILI 180
Query: 183 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCG 239
+S K+SDFGL + + D +TT G + +PE +A R + A SD+WS G
Sbjct: 181 NSNLVCKVSDFGLGRVLE--DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYG 237
Query: 240 VILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
++L+ +++ G P+ + + + + + G ++LP
Sbjct: 238 IVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 271
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 66/273 (24%), Positives = 110/273 (40%), Gaps = 68/273 (24%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
ELGR +GEG FG V + + L A+K + ++ ++ +E T++ H
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 75
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
P++V+L V+ +++ +++++E T GEL LQ + LI
Sbjct: 76 PHIVKLIGVI-TENPVWIIMELCTLGELRS------FLQVRKYSLDLASLILYAYQLSTA 128
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
++Y +K HRD+ R N+L+ S
Sbjct: 129 LAYLESKRFVHRDIAA-------R----------------------------NVLVSSND 153
Query: 187 NIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NYVAPEVLANRGYDGATSDIWSCGVI 241
+K+ DFGLS R D + P ++APE + R + A SD+W GV
Sbjct: 154 CVKLGDFGLS------RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVC 206
Query: 242 LYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
++ IL G PF + +I G +LP
Sbjct: 207 MWEILMHGVKPFQGVKNNDVIGRIENG-ERLPM 238
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 81/367 (22%), Positives = 141/367 (38%), Gaps = 94/367 (25%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
RY +GEG +G V A D + + A+K I + + + REI L +H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ---RTLREIKILLRFRH 84
Query: 74 PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
N++ +++++ + + +Y+V + + +L+ + ++ L Q++ G+
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYFLYQILRGLK 142
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
Y H+ V HRDLK P N+LL++ ++
Sbjct: 143 YIHSANVLHRDLK---------------------------P--------SNLLLNTTCDL 167
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPNYV------APEV-LANRGYDGATSDIWSCGVI 241
KI DFGL+ + D T YV APE+ L ++GY + DIWS G I
Sbjct: 168 KICDFGLARVADPDHDHTGFLT-----EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCI 221
Query: 242 LYVILTGYLPFDDRN--------LAVL-------YQKIF---------------RGDFK- 270
L +L+ F ++ L +L I + +
Sbjct: 222 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 281
Query: 271 -LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE--DIFVDNE 327
P A +LL K+L NP KRI + A + EQ Y P++ E ++ +
Sbjct: 282 LFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELD 340
Query: 328 AFSMHEV 334
++
Sbjct: 341 DLPKEKL 347
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 77/383 (20%), Positives = 136/383 (35%), Gaps = 125/383 (32%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILE----KNRIIHLKITDQIKREIATLK 69
R+++ R G+G FG V+ ++ +G+ A+K +++ +NR + + + L
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL---------QIMQDLA 74
Query: 70 LLKHPNVVRLHEVLASKSK-------IYMVLEYV--TGGELFDKIASKGRLQEAEGRKLF 120
+L HPN+V+L + + + +V+EYV T + K+F
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 121 Q-QLIDGVSYCHNK--GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177
QLI + H V HRD+K P
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIK---------------------------P-------- 159
Query: 178 ENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGATSDI 235
N+L++ + G +K+ DFG + + + + C S Y APE++ + Y A DI
Sbjct: 160 HNVLVNEADGTLKLCDFGSAK--KLSPSEPNVAYIC-SRYYRAPELIFGNQHYTTAV-DI 215
Query: 236 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--------------------------- 268
WS G I ++ G + IFRGD
Sbjct: 216 WSVGCIFAEMMLG-------------EPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPS 262
Query: 269 ---FKLPKW---------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310
L + A +LL +L+ P +R+ +F++ +
Sbjct: 263 HTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322
Query: 311 TPANPDDDEEDIFVDNEAFSMHE 333
PA + +D+ D F +E
Sbjct: 323 DPATKLPNNKDLPEDLFRFLPNE 345
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 59/272 (21%), Positives = 107/272 (39%), Gaps = 64/272 (23%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ LG G FG V + +P +K++E + + + + L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLD 73
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
H ++VRL + S + +V +Y+ G L D +++ G Q L++
Sbjct: 74 HAHIVRLLGLC-PGSSLQLVTQYLPLGSLLD------HVRQHRGALGPQLLLNWGVQIAK 126
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
G+ Y G+ HR+L R N+LL S
Sbjct: 127 GMYYLEEHGMVHRNLAA-------R----------------------------NVLLKSP 151
Query: 186 GNIKISDFGLS-ALPQHFRDDGLLHTTCG-SP-NYVAPEVLANRGYDGATSDIWSCGVIL 242
++++DFG++ LP DD L + +P ++A E + Y SD+WS GV +
Sbjct: 152 SQVQVADFGVADLLPP---DDKQLLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTV 207
Query: 243 YVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
+ ++T G P+ LA + + +G +L +
Sbjct: 208 WELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQ 238
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 91/369 (24%), Positives = 140/369 (37%), Gaps = 103/369 (27%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
Y +G G +G V A D SG A+K L + I K + RE+ LK ++
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK---RAYRELLLLKHMQ 81
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V S Y+V+ ++ +L + + E + + L Q++ G
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKG 138
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ Y H+ GV HRDLK P N+ ++
Sbjct: 139 LKYIHSAGVVHRDLK---------------------------P--------GNLAVNEDC 163
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------APEV-LANRGYDGATSDIWSCG 239
+KI DFGL+ R T YV APEV L+ Y+ DIWS G
Sbjct: 164 ELKILDFGLA------RHADAEMT-----GYVVTRWYRAPEVILSWMHYNQTV-DIWSVG 211
Query: 240 VILYVILTGYLPFDDRNLAVLYQKIF------------------------------RGDF 269
I+ +LTG F ++ +I R DF
Sbjct: 212 CIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF 271
Query: 270 K--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE--DIFVD 325
P+ SP A +LL K+LE + KR+T A +FE P + ++ D ++
Sbjct: 272 TQLFPR-ASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLE 330
Query: 326 NEAFSMHEV 334
+E ++ E
Sbjct: 331 HEKLTVDEW 339
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 62/272 (22%), Positives = 108/272 (39%), Gaps = 71/272 (26%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
+ +G G FG V + A+K + + + E + L HP
Sbjct: 11 TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGA------MSEEDFIEEAEVMMKLSHP 63
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GV 127
+V+L+ V ++ I +V E++ G L D L+ G + L+ G+
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSD------YLRTQRGLFAAETLLGMCLDVCEGM 117
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
+Y V HRDL A R N L+
Sbjct: 118 AYLEEACVIHRDL-----------AA--------------R----------NCLVGENQV 142
Query: 188 IKISDFGLSALPQHFRD--DGLLHTTCGS--P-NYVAPEVLANRGYDGATSDIWSCGVIL 242
IK+SDFG++ R D ++ G+ P + +PEV + Y SD+WS GV++
Sbjct: 143 IKVSDFGMT------RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLM 195
Query: 243 YVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
+ + + G +P+++R+ + + + I G F+L K
Sbjct: 196 WEVFSEGKIPYENRSNSEVVEDISTG-FRLYK 226
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 59/272 (21%), Positives = 111/272 (40%), Gaps = 64/272 (23%)
Query: 17 ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ + LG G FG V + +P A+K L + +I E + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVD 75
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
+P+V RL + S + ++ + + G L D ++E + Q L++
Sbjct: 76 NPHVCRLLGIC-LTSTVQLITQLMPFGCLLD------YVREHKDNIGSQYLLNWCVQIAK 128
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
G++Y ++ + HRDL R N+L+ +
Sbjct: 129 GMNYLEDRRLVHRDLAA-------R----------------------------NVLVKTP 153
Query: 186 GNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGATSDIWSCGVIL 242
++KI+DFGL+ L ++ H G P ++A E + +R Y SD+WS GV +
Sbjct: 154 QHVKITDFGLAKLLGA---EEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTV 209
Query: 243 YVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
+ ++T G P+D + + + +G +LP+
Sbjct: 210 WELMTFGSKPYDGIPASEISSILEKG-ERLPQ 240
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 67/245 (27%), Positives = 106/245 (43%), Gaps = 59/245 (24%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ + LG+GNFG V+ ++G AVK L+ + + +REI LK L+
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ 69
Query: 73 HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
H N+V+ V S + + +++EY+ G L D LQ+ + R +L+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD------YLQKHKERIDHIKLLQYTSQI 123
Query: 126 --GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD 183
G+ Y K HRDL AT R NIL++
Sbjct: 124 CKGMEYLGTKRYIHRDL-----------AT--------------R----------NILVE 148
Query: 184 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVIL 242
++ +KI DFGL+ + ++ + SP + APE L + A SD+WS GV+L
Sbjct: 149 NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVL 207
Query: 243 YVILT 247
Y + T
Sbjct: 208 YELFT 212
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 67/268 (25%), Positives = 99/268 (36%), Gaps = 87/268 (32%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------QIKREI 65
RYE+ +G G++G V A D A+K KI +I REI
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK----------KILRVFEDLIDCKRILREI 103
Query: 66 ATLKLLKHPNVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
A L L H +VV++ +++ K ++Y+VLE + + L E + L
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL 162
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
L+ GV Y H+ G+ HRDLK P N
Sbjct: 163 YNLLVGVKYVHSAGILHRDLK---------------------------P--------ANC 187
Query: 181 LLDSKGNIKISDFGLS-----------ALPQHFRDDGLLHTTCGSPN--------YV--- 218
L++ ++K+ DFGL+ LP R+D + T +V
Sbjct: 188 LVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTR 247
Query: 219 ---APEV-LANRGYDGATSDIWSCGVIL 242
APE+ L Y A D+WS G I
Sbjct: 248 WYRAPELILLQENYTEAI-DVWSIGCIF 274
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 65/272 (23%), Positives = 112/272 (41%), Gaps = 71/272 (26%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
+ LG G FG VK+ + A+K++++ + + E + L H
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEG------SMSEDEFIEEAKVMMNLSHE 79
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GV 127
+V+L+ V + I+++ EY+ G L + L+E R QQL++ +
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
Y +K HRDL A R N L++ +G
Sbjct: 134 EYLESKQFLHRDL-----------AA--------------R----------NCLVNDQGV 158
Query: 188 IKISDFGLSALPQHFRD--DGLLHTTCGS--P-NYVAPEVLANRGYDGATSDIWSCGVIL 242
+K+SDFGLS R D ++ GS P + PEVL + SDIW+ GV++
Sbjct: 159 VKVSDFGLS------RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLM 211
Query: 243 YVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
+ I + G +P++ + + I +G +L +
Sbjct: 212 WEIYSLGKMPYERFTNSETAEHIAQG-LRLYR 242
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 63/275 (22%), Positives = 106/275 (38%), Gaps = 72/275 (26%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
L R LGEG FG+V + + AVK +K+ + K ++ E +K L H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDH 72
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
P++V+L ++ + ++++E GEL L+ + L+
Sbjct: 73 PHIVKLIGII-EEEPTWIIMELYPYGELGH------YLERNKNSLKVLTLVLYSLQICKA 125
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
++Y + HRD+ A R NIL+ S
Sbjct: 126 MAYLESINCVHRDI-----------AV--------------R----------NILVASPE 150
Query: 187 NIKISDFGLSALPQHFRD--DGLLHTTCGS--PNYV---APEVLANRGYDGATSDIWSCG 239
+K+ DFGLS R D + + P + +PE + R + A SD+W
Sbjct: 151 CVKLGDFGLS------RYIEDEDYYKASVTRLP--IKWMSPESINFRRFTTA-SDVWMFA 201
Query: 240 VILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
V ++ IL+ G PF + + +G +LPK
Sbjct: 202 VCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLPK 235
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 69/256 (26%), Positives = 104/256 (40%), Gaps = 70/256 (27%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLK 69
+ LG+GNFG V+ ++G AVK L+ + DQ + REI LK
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG------PDQQRDFQREIQILK 79
Query: 70 LLKHPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-- 125
L +V+ V + + +V+EY+ G L D LQ R +L+
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD------FLQRHRARLDASRLLLYS 133
Query: 126 -----GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
G+ Y ++ HRDL A R NI
Sbjct: 134 SQICKGMEYLGSRRCVHRDL-----------AA--------------R----------NI 158
Query: 181 LLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCG-SP-NYVAPEVLANRGYDGATSDIWS 237
L++S+ ++KI+DFGL+ LP D + G SP + APE L++ + SD+WS
Sbjct: 159 LVESEAHVKIADFGLAKLLPLD--KDYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWS 215
Query: 238 CGVILYVILT-GYLPF 252
GV+LY + T
Sbjct: 216 FGVVLYELFTYCDKSC 231
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 65/283 (22%), Positives = 102/283 (36%), Gaps = 67/283 (23%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITDQIK 62
K++ + + ELG GNFG V+ + A+K+L++ +++
Sbjct: 5 FLKRDNLLIADIELG----CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMM 58
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
RE + L +P +VRL V + +V+E GG L L
Sbjct: 59 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK------FLVGKREEIPVSN 111
Query: 123 LID-------GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVL 175
+ + G+ Y K HRDL R
Sbjct: 112 VAELLHQVSMGMKYLEEKNFVHRDLAA-------R------------------------- 139
Query: 176 QLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS--P-NYVAPEVLANRGYDGA 231
N+LL ++ KISDFGLS AL DD P + APE + R +
Sbjct: 140 ---NVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 232 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
SD+WS GV ++ L+ G P+ + I +G ++
Sbjct: 194 -SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMEC 234
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-24
Identities = 69/314 (21%), Positives = 128/314 (40%), Gaps = 79/314 (25%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHPN 75
L + LG G FG VK + AVK++++ + + +E T+ L HP
Sbjct: 12 LLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEG------SMSEDEFFQEAQTMMKLSHPK 64
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVS 128
+V+ + V + + IY+V EY++ G L + L+ QL++ G++
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLN------YLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
+ + HRDL R N L+D +
Sbjct: 119 FLESHQFIHRDLAA-------R----------------------------NCLVDRDLCV 143
Query: 189 KISDFGLSALPQHFRD--DGLLHTTCGS--P-NYVAPEVLANRGYDGATSDIWSCGVILY 243
K+SDFG++ R D ++ G+ P + APEV Y SD+W+ G++++
Sbjct: 144 KVSDFGMT------RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMW 196
Query: 244 VILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL----EPNPVKRITIA 298
+ + G +P+D + + K+ +G +L + A + + +I+ P KR T
Sbjct: 197 EVFSLGKMPYDLYTNSEVVLKVSQG-HRLYR--PHLASDTIYQIMYSCWHELPEKRPTFQ 253
Query: 299 GIKA--DEWFEQDY 310
+ + + E+D
Sbjct: 254 QLLSSIEPLREKDK 267
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 65/278 (23%), Positives = 107/278 (38%), Gaps = 83/278 (29%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L LG G FG+V + AVK L++ + D E +K L+H +
Sbjct: 16 KLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRL 70
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
VRL+ V ++ IY++ EY+ G L D L+ G KL +L+D G++
Sbjct: 71 VRLYAV-VTQEPIYIITEYMENGSLVD------FLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
+ + HRDL NIL+ +
Sbjct: 124 FIEERNYIHRDL-------------------------RAA----------NILVSDTLSC 148
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPNYV------------APEVLANRGYDGATSDIW 236
KI+DFGL+ + D+ Y APE + + SD+W
Sbjct: 149 KIADFGLA---RLIEDN----------EYTAREGAKFPIKWTAPEAINYGTFTIK-SDVW 194
Query: 237 SCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
S G++L I+T G +P+ + Q + RG +++ +
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVR 231
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 71/374 (18%), Positives = 124/374 (33%), Gaps = 101/374 (27%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL------KITD--QIKREIA 66
Y + R + G++G V D G+P A+K + ++ REI
Sbjct: 23 PYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 67 TLKLLKHPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLF 120
L HPN++ L ++ + +Y+V E + +L I + + +
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM 140
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
++ G+ H GV HRDL P NI
Sbjct: 141 YHILLGLHVLHEAGVVHRDLH---------------------------P--------GNI 165
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------APEV-LANRGYDGATS 233
LL +I I DF L+ + D +YV APE+ + +G+
Sbjct: 166 LLADNNDITICDFNLA---REDTADANK------THYVTHRWYRAPELVMQFKGFTKLV- 215
Query: 234 DIWSCGVILYVILTGYLPFDDRN--------LAVL------------------YQKIFRG 267
D+WS G ++ + F + V+ Y +
Sbjct: 216 DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLS 275
Query: 268 DFKLPKW------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN-PDDDEE 320
+ W P A +L+ K+LE NP +RI+ +FE + P + + E
Sbjct: 276 NVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSE 335
Query: 321 DIFVDNEAFSMHEV 334
D ++++
Sbjct: 336 RFHFDESVTDVYDM 349
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 67/245 (27%), Positives = 106/245 (43%), Gaps = 59/245 (24%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ + LG+GNFG V+ ++G AVK L+ + + +REI LK L+
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ 100
Query: 73 HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
H N+V+ V S + + +++EY+ G L D LQ+ + R +L+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD------YLQKHKERIDHIKLLQYTSQI 154
Query: 126 --GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD 183
G+ Y K HRDL AT R NIL++
Sbjct: 155 CKGMEYLGTKRYIHRDL-----------AT--------------R----------NILVE 179
Query: 184 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVIL 242
++ +KI DFGL+ + ++ + SP + APE L + A SD+WS GV+L
Sbjct: 180 NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVL 238
Query: 243 YVILT 247
Y + T
Sbjct: 239 YELFT 243
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 69/328 (21%), Positives = 118/328 (35%), Gaps = 87/328 (26%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L ++G+G FG+V + G AVKI + + + EI +L+H N+
Sbjct: 45 VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENI 98
Query: 77 VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH- 131
+ ++ + +++++V +Y G LFD + + KL G+++ H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 157
Query: 132 -------NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
+ HRDLK +NIL+
Sbjct: 158 EIVGTQGKPAIAHRDLK-----------------------------------SKNILVKK 182
Query: 185 KGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYDGAT-----SDIWS 237
G I+D GL+ D D + G+ Y+APEVL + +DI++
Sbjct: 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 242
Query: 238 CGVILYVILTGY----------LPFDDRN----------LAVLYQKIFRGDFKLPKWLSP 277
G++ + I LP+ D V QK+ R + +W S
Sbjct: 243 MGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL-RPNIP-NRWQSC 300
Query: 278 GAQNLLRKILE----PNPVKRITIAGIK 301
A ++ KI+ N R+T IK
Sbjct: 301 EALRVMAKIMRECWYANGAARLTALRIK 328
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 64/310 (20%), Positives = 108/310 (34%), Gaps = 78/310 (25%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
Y + +G G++G V A D ++ A+K + + +I K +I REI L LK
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK---RILREITILNRLK 83
Query: 73 HPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
++RL++++ +Y+VLE +L + L E + + L+ G
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
++ H G+ HRDLK P N LL+ +
Sbjct: 143 NFIHESGIIHRDLK---------------------------P--------ANCLLNQDCS 167
Query: 188 IKISDFGLS-----------ALPQHFRDDGLLHTTCGSP---NYV------APEV-LANR 226
+K+ DFGL+ ++ H ++V APE+ L
Sbjct: 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE 227
Query: 227 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL---- 282
Y + DIWS G I +L + +F G P ++ +
Sbjct: 228 NYTKSI-DIWSTGCIFAELLNMLQSHINDPTN--RFPLFPGSSCFPLSPDRNSKKVHEKS 284
Query: 283 ----LRKILE 288
L I
Sbjct: 285 NRDQLNIIFN 294
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 9e-24
Identities = 60/271 (22%), Positives = 102/271 (37%), Gaps = 73/271 (26%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L +T+G+G FG V G AVK ++ + E + + L+H N+
Sbjct: 24 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNL 76
Query: 77 VRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GV 127
V+L V + K +Y+V EY+ G L D L+ L L+ +
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVD------YLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
Y HRDL R N+L+
Sbjct: 131 EYLEGNNFVHRDL-------------------------AAR----------NVLVSEDNV 155
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNY----VAPEVLANRGYDGATSDIWSCGVILY 243
K+SDFGL+ ++ +T + APE L + + SD+WS G++L+
Sbjct: 156 AKVSDFGLT------KEA---SSTQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLW 205
Query: 244 VILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
I + G +P+ L + ++ +G +K+
Sbjct: 206 EIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA 235
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 58/334 (17%), Positives = 111/334 (33%), Gaps = 89/334 (26%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+ +L G FG V AQ AVKI K + Q + E+ +L +
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD----KQSWQNEYEVYSLPGM 75
Query: 72 KHPNVVRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
KH N+++ + ++++ + G L D + + E + + + G+
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGL 134
Query: 128 SYCHNK----------GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177
+Y H + HRD+K S
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIK----S------------------------------- 159
Query: 178 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT----S 233
+N+LL + I+DFGL+ + + G H G+ Y+APEVL
Sbjct: 160 KNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI 219
Query: 234 DIWSCGVILYVILTGYLP---------------------FDDRNLAVLYQKIFRGDFKLP 272
D+++ G++L+ + + +D V+++K L
Sbjct: 220 DMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK---RPVLR 276
Query: 273 K-WLSPGAQNLLRKILE----PNPVKRITIAGIK 301
W +L + +E + R++ +
Sbjct: 277 DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 65/268 (24%), Positives = 111/268 (41%), Gaps = 63/268 (23%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V A AVK ++ + + E +K L+H +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSV----EAFLAEANVMKTLQHDKL 245
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
V+LH V +K IY++ E++ G L D L+ EG K +LID G++
Sbjct: 246 VKLHAV-VTKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
+ + HRDL+ NIL+ +
Sbjct: 299 FIEQRNYIHRDLRA-----------------------------------ANILVSASLVC 323
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
KI+DFGL+ + D+ P + APE + + SD+WS G++L I+
Sbjct: 324 KIADFGLA---RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIV 379
Query: 247 T-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
T G +P+ + + + + RG +++P+
Sbjct: 380 TYGRIPYPGMSNPEVIRALERG-YRMPR 406
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 64/245 (26%), Positives = 105/245 (42%), Gaps = 58/245 (23%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ R LGEG+FGKV+ + ++G AVK L K I D +K+EI L+ L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIAD-LKKEIEILRNLY 81
Query: 73 HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
H N+V+ + I +++E++ G L + L + + + +Q +
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE------YLPKNKNKINLKQQLKYAVQI 135
Query: 126 --GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD 183
G+ Y ++ HRDL A R N+L++
Sbjct: 136 CKGMDYLGSRQYVHRDL-----------AA--------------R----------NVLVE 160
Query: 184 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVIL 242
S+ +KI DFGL+ + ++ + SP + APE L + A SD+WS GV L
Sbjct: 161 SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTL 219
Query: 243 YVILT 247
+ +LT
Sbjct: 220 HELLT 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 65/270 (24%), Positives = 110/270 (40%), Gaps = 62/270 (22%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
ELGR +GEG FG V + + + A+K + ++ ++ +E T++ H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 450
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
P++V+L V+ +++ +++++E T GEL LQ + LI
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRS------FLQVRKFSLDLASLILYAYQLSTA 503
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
++Y +K HRD+ A N+L+ S
Sbjct: 504 LAYLESKRFVHRDI----------AAR-------------------------NVLVSSND 528
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCG-SP-NYVAPEVLANRGYDGATSDIWSCGVILYV 244
+K+ DFGLS D + G P ++APE + R + A SD+W GV ++
Sbjct: 529 CVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWE 584
Query: 245 ILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
IL G PF + +I G +LP
Sbjct: 585 ILMHGVKPFQGVKNNDVIGRIENG-ERLPM 613
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 5e-23
Identities = 65/328 (19%), Positives = 119/328 (36%), Gaps = 87/328 (26%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
++ + +G+G +G+V + G AVK+ + + + EI L++H N+
Sbjct: 40 QMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFT----TEEASWFRETEIYQTVLMRHENI 93
Query: 77 VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+ + S +++Y++ +Y G L+D + S L KL + G+ + H
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHT 152
Query: 133 K--------GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
+ + HRDLK S +NIL+
Sbjct: 153 EIFSTQGKPAIAHRDLK----S-------------------------------KNILVKK 177
Query: 185 KGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT-----SDIWS 237
G I+D GL+ D +T G+ Y+ PEVL +D++S
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237
Query: 238 CGVILYVILTGYLP--------------------FDDRNLAVLYQKIFRGDFKLPKWLSP 277
G+IL+ + + ++D V +K+ R F +W S
Sbjct: 238 FGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKL-RPSFP-NRWSSD 295
Query: 278 GAQNLLRKILE----PNPVKRITIAGIK 301
+ K++ NP R+T +K
Sbjct: 296 ECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 53/328 (16%), Positives = 97/328 (29%), Gaps = 90/328 (27%)
Query: 17 ELGRTLGEGNFGKV-------KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
+LG+G F K+ +K+L+K H ++ + +
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMS 67
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---- 125
L H ++V + V + +V E+V G L L++ + ++
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY------LKKNKNCINILWKLEVAKQ 121
Query: 126 ---GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
+ + + H ++ + NILL
Sbjct: 122 LAAAMHFLEENTLIHGNV-----------CA--------------K----------NILL 146
Query: 183 DSKGN--------IKISDFGLSALPQHFRDDGLLHTTCGSPNY-------VAPEVLANRG 227
+ + IK+SD G+S + V PE + N
Sbjct: 147 IREEDRKTGNPPFIKLSDPGIS------IT-------VLPKDILQERIPWVPPECIENPK 193
Query: 228 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 286
+D WS G L+ I + G P + Q +LP + NL+
Sbjct: 194 NLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR-HQLPAPKAAELANLINNC 252
Query: 287 LEPNPVKRITIAGIKA--DEWFEQDYTP 312
++ P R + I + F D P
Sbjct: 253 MDYEPDHRPSFRAIIRDLNSLFTPDLVP 280
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 71/246 (28%), Positives = 106/246 (43%), Gaps = 62/246 (25%)
Query: 17 ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ R LGEG+FGKV + +G AVK L+ + + K+EI L+ L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY 91
Query: 73 HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
H ++++ + +V+EYV G L D + + + A+ QQ+ +G++Y
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYL 150
Query: 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKI 190
H + HRDL A R N+LLD+ +KI
Sbjct: 151 HAQHYIHRDL-----------AA--------------R----------NVLLDNDRLVKI 175
Query: 191 SDFGLS-ALPQ-----HFRDDGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVI 241
DFGL+ A+P+ R+DG P V APE L + A SD+WS GV
Sbjct: 176 GDFGLAKAVPEGHEYYRVREDGDS------P--VFWYAPECLKEYKFYYA-SDVWSFGVT 226
Query: 242 LYVILT 247
LY +LT
Sbjct: 227 LYELLT 232
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 84/395 (21%), Positives = 136/395 (34%), Gaps = 116/395 (29%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
+YEL + LG+G +G V + D +G AVK + + + REI L L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---RTFREIMILTELS 66
Query: 73 -HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
H N+V L VL + + +Y+V +Y+ +L I + L+ + + QLI + Y
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKY 124
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
H+ G+ HRD+K P NILL+++ ++K
Sbjct: 125 LHSGGLLHRDMK---------------------------P--------SNILLNAECHVK 149
Query: 190 ISDFGLS-ALPQHFRDDGLLHTTCGSPN------------YV------APEV-LANRGYD 229
++DFGLS + R + + YV APE+ L + Y
Sbjct: 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT 209
Query: 230 GATSDIWSCGVILYVILTG--------------------------------------YL- 250
D+WS G IL IL G +
Sbjct: 210 KGI-DMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIE 268
Query: 251 --------PFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302
++ K + A +LL K+L+ NP KRI+
Sbjct: 269 SLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK 328
Query: 303 DEWFEQDYTPANPDDDEEDI---FVDNEAFSMHEV 334
+ + P + + I DN S+ +
Sbjct: 329 HPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDY 363
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 67/286 (23%), Positives = 103/286 (36%), Gaps = 66/286 (23%)
Query: 5 EKKQEGMRLGRYEL---GRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITD 59
E K + + L R L LG GNFG V+ + A+K+L++ +
Sbjct: 324 ELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--E 381
Query: 60 QIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
++ RE + L +P +VRL V + +V+E GG L L
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK------FLVGKREEIP 434
Query: 120 FQQLID-------GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172
+ + G+ Y K HR+L A R
Sbjct: 435 VSNVAELLHQVSMGMKYLEEKNFVHRNL-----------AA--------------R---- 465
Query: 173 NVLQLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYV---APEVLANRGY 228
N+LL ++ KISDFGLS AL DD + APE + R +
Sbjct: 466 ------NVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 229 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
SD+WS GV ++ L+ G P+ + I +G ++
Sbjct: 517 SSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMEC 560
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 75/349 (21%), Positives = 132/349 (37%), Gaps = 85/349 (24%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
LGR LG+G FG V + Q+ S + AVK+L+ + I I + RE A +K H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-FLREAACMKEFDH 84
Query: 74 PNVVRL------HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI--- 124
P+V +L ++L ++ G+L + + R+ E Q L+
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFNLPLQTLVRFM 143
Query: 125 ----DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
G+ Y ++ HRDL A R N
Sbjct: 144 VDIACGMEYLSSRNFIHRDL-----------AA--------------R----------NC 168
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-------------VAPEVLANRG 227
+L + ++DFGLS R +++ +Y +A E LA+
Sbjct: 169 MLAEDMTVCVADFGLS------RK---IYSG----DYYRQGCASKLPVKWLALESLADNL 215
Query: 228 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRK 285
Y SD+W+ GV ++ I+T G P+ A +Y + G+ K P +L+ +
Sbjct: 216 YTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQ 274
Query: 286 ILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEED-IFVDNEAFSMHE 333
+P +R + ++ + E + +D ++++ E H
Sbjct: 275 CWSADPKQRPSFTCLRME--LENILGHLSVLSTSQDPLYINIERAHHHH 321
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 62/269 (23%), Positives = 103/269 (38%), Gaps = 69/269 (25%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-IKREIATLKLLKHPN 75
+L +T+G+G FG V G AVK ++ + T Q E + + L+H N
Sbjct: 196 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSN 247
Query: 76 VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
+V+L V + K +Y+V EY+ G L D L+ L L+
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVD------YLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ Y HRDL N+L+
Sbjct: 302 MEYLEGNNFVHRDLAA-----------------------------------RNVLVSEDN 326
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVI 245
K+SDFGL+ ++ T P + APE L + + SD+WS G++L+ I
Sbjct: 327 VAKVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEI 379
Query: 246 LT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
+ G +P+ L + ++ +G +K+
Sbjct: 380 YSFGRVPYPRIPLKDVVPRVEKG-YKMDA 407
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 6e-22
Identities = 65/281 (23%), Positives = 104/281 (37%), Gaps = 79/281 (28%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLL 71
+G G+FG V + + AVK L + I + + E +K
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDF 83
Query: 72 KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI------ 124
HPNV+ L + L S+ +VL Y+ G+L + ++ + LI
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQV 137
Query: 125 -DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD 183
G+ Y +K HRDL A R N +LD
Sbjct: 138 AKGMKYLASKKFVHRDL-----------AA--------------R----------NCMLD 162
Query: 184 SKGNIKISDFGLSAL-------PQHFRDDGLLHTTCGSPNYV---APEVLANRGYDGATS 233
K +K++DFGL+ H + L P V A E L + + S
Sbjct: 163 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKL------P--VKWMALESLQTQKFTTK-S 213
Query: 234 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
D+WS GV+L+ ++T G P+ D N + + +G +L +
Sbjct: 214 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQ 253
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 54/260 (20%), Positives = 86/260 (33%), Gaps = 72/260 (27%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE--IATLKLLKHP 74
+L +G G +G V LD P AVK+ E I + L++H
Sbjct: 16 KLLELIGRGRYGAVYKGS-LD-ERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHD 67
Query: 75 NVVRL-----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
N+ R + + +V+EY G L + S +L + G++Y
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 130 CH---------NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
H + HRDL N+
Sbjct: 127 LHTELPRGDHYKPAISHRDLN-----------------------------------SRNV 151
Query: 181 LLDSKGNIKISDFGLS------ALPQHFRDDGLLHTTCGSPNYVAPEVL------ANRGY 228
L+ + G ISDFGLS L + +D + G+ Y+APEVL +
Sbjct: 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXES 211
Query: 229 DGATSDIWSCGVILYVILTG 248
D+++ G+I + I
Sbjct: 212 ALKQVDMYALGLIYWEIFMR 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 71/378 (18%), Positives = 121/378 (32%), Gaps = 142/378 (37%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLL 71
+Y LG+TLG G+FG V D++SG FA+K K+ + RE+ +K+L
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK----------KVLQDPRYKNRELDIMKVL 57
Query: 72 KHPNVVRLHEVLASKSK--------------------------------------IYMVL 93
H N+++L + + + +++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 94 EYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHM 149
EYV L + S + QL V + H+ G+ HRD+K
Sbjct: 118 EYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIK-------- 168
Query: 150 RIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK-GNIKISDFGLSALPQHFRDDGLL 208
P +N+L++SK +K+ DFG + +
Sbjct: 169 -------------------P--------QNLLVNSKDNTLKLCDFGSA------K----- 190
Query: 209 HTTCGSPN--YV------APEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV 259
P+ Y+ APE++ Y + D+WS G + ++ G F
Sbjct: 191 KLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILGKPLFSGETSID 249
Query: 260 LYQKIF-----------------RGDFKLPKW------------LSPGAQNLLRKILEPN 290
+I + + P A +LL +IL
Sbjct: 250 QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309
Query: 291 PVKRITIAGIKADEWFEQ 308
P RI A +F+
Sbjct: 310 PDLRINPYEAMAHPFFDH 327
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 65/284 (22%), Positives = 105/284 (36%), Gaps = 85/284 (29%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+G G+FG V + + AVK L NRI + Q E +K H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 149
Query: 74 PNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------D 125
PNV+ L + L S+ +VL Y+ G+L + ++ + LI
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
G+ + +K HRDL A R N +LD K
Sbjct: 204 GMKFLASKKFVHRDL-----------AA--------------R----------NCMLDEK 228
Query: 186 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV---------------APEVLANRGYDG 230
+K++DFGL+ RD ++ + A E L + +
Sbjct: 229 FTVKVADFGLA------RD---MYDK----EFDSVHNKTGAKLPVKWMALESLQTQKFTT 275
Query: 231 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
SD+WS GV+L+ ++T G P+ D N + + +G +L +
Sbjct: 276 K-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQ 317
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 73/347 (21%), Positives = 125/347 (36%), Gaps = 87/347 (25%)
Query: 17 ELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIKREIATLKLL 71
+ R LG+G+FG V A+ + P A+K + + + +I + E + +K
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEF 85
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGRLQEAEGRKL-FQQLI---- 124
+VVRL V++ +++E +T G+L + + ++I
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 125 ---DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
DG++Y + HRDL A R N +
Sbjct: 146 EIADGMAYLNANKFVHRDL-----------AA--------------R----------NCM 170
Query: 182 LDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV---APEVLANRG 227
+ +KI DFG++ RD GLL P V +PE L +
Sbjct: 171 VAEDFTVKIGDFGMT------RDIYETDYYRKGGKGLL------P--VRWMSPESLKDGV 216
Query: 228 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLR 284
+ SD+WS GV+L+ I T P+ + + + + G L P L+R
Sbjct: 217 FTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-GLLDKPDNCPDMLFELMR 274
Query: 285 KILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDDEEDIFVDNEAF 329
+ NP R + I + E E + + EE+ + E
Sbjct: 275 MCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPEPEEL 321
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 63/297 (21%), Positives = 98/297 (32%), Gaps = 97/297 (32%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
LGE FGKV + A+K L+ ++ E
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK------AEGPLREEFRHEAML 65
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD---------KIASKGRLQEAEGRK 118
L+HPNVV L V+ + M+ Y + G+L + + S + +
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 119 LFQQLI-------DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171
+ G+ Y + V H+DL AT R
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDL-----------AT--------------R--- 157
Query: 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV-- 218
N+L+ K N+KISD GL R+ + LL P +
Sbjct: 158 -------NVLVYDKLNVKISDLGLF------REVYAADYYKLLGNSLL------P--IRW 196
Query: 219 -APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
APE + + SDIWS GV+L+ + + G P+ + + + I LP
Sbjct: 197 MAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR-QVLPC 251
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 70/285 (24%), Positives = 105/285 (36%), Gaps = 80/285 (28%)
Query: 18 LGRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLK-L 70
+GEGNFG+V A+ + A+K +++ + E+ L L
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY------ASKDDHRDFAGELEVLCKL 82
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEGRKL-FQ 121
HPN++ L + +Y+ +EY G L D + + + L Q
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 122 QLID-------GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174
QL+ G+ Y K HRDL A R
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDL-----------AA--------------R------ 171
Query: 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYV---APEVLANRGYD 229
NIL+ KI+DFGLS R + P V A E L Y
Sbjct: 172 ----NILVGENYVAKIADFGLS------RGQEVYVKKTMGRLP--VRWMAIESLNYSVYT 219
Query: 230 GATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
SD+WS GV+L+ I++ G P+ A LY+K+ +G ++L K
Sbjct: 220 TN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEK 262
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 69/348 (19%), Positives = 115/348 (33%), Gaps = 99/348 (28%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
L R LG G FG+V + S L AVK L + ++ E +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKF 90
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLI------ 124
H N+VR V ++++E + GG+L + R + ++ L L+
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHVARDI 149
Query: 125 -DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD 183
G Y HRD+ A R N LL
Sbjct: 150 ACGCQYLEENHFIHRDI-----------AA--------------R----------NCLLT 174
Query: 184 SKGN---IKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV---APEVLANR 226
G KI DFG++ RD +L P V PE
Sbjct: 175 CPGPGRVAKIGDFGMA------RDIYRASYYRKGGCAML------P--VKWMPPEAFMEG 220
Query: 227 GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLL 283
+ +D WS GV+L+ I + GY+P+ ++ + + + G ++ PK ++
Sbjct: 221 IFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-GRMDPPKNCPGPVYRIM 278
Query: 284 RKILEPNPVKRITIAGIKA------------DEWFEQDYTPANPDDDE 319
+ + P R A I + +Y P ++++
Sbjct: 279 TQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK 326
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 67/281 (23%), Positives = 100/281 (35%), Gaps = 82/281 (29%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
LG+ LGEG FG V Q+ + L AVK + K + ++ E A +K H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 74 PNVVRL-----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI---- 124
PNV+RL K ++L ++ G+L + RL+ Q L+
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMV 154
Query: 125 ---DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
G+ Y N+ HRDL A R N +
Sbjct: 155 DIALGMEYLSNRNFLHRDL-----------AA--------------R----------NCM 179
Query: 182 LDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV---APEVLANRG 227
L + ++DFGLS + + P V A E LA+R
Sbjct: 180 LRDDMTVCVADFGLS------KKIYSGDYYRQGRIAKM------P--VKWIAIESLADRV 225
Query: 228 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 267
Y SD+W+ GV ++ I T G P+ +Y + G
Sbjct: 226 YTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 63/279 (22%), Positives = 107/279 (38%), Gaps = 75/279 (26%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
R +G+G+FG V ++ + + A+K L +RI ++ + RE ++ L H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLNH 81
Query: 74 PNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
PNV+ L + L + +++L Y+ G+L ++ + + LI
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDL------LQFIRSPQRNPTVKDLISFGLQVAR 135
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
G+ Y + HRDL A R N +LD
Sbjct: 136 GMEYLAEQKFVHRDL-----------AA--------------R----------NCMLDES 160
Query: 186 GNIKISDFGLSAL-------PQHFRDDGLLHTTCGSPNYV---APEVLANRGYDGATSDI 235
+K++DFGL+ L P V A E L + SD+
Sbjct: 161 FTVKVADFGLARDILDREYYSVQQHRHARL------P--VKWTALESLQTYRFTTK-SDV 211
Query: 236 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
WS GV+L+ +LT G P+ + L + +G +LP+
Sbjct: 212 WSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-RRLPQ 249
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 66/257 (25%), Positives = 100/257 (38%), Gaps = 64/257 (24%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RYE+ + +G+G+FG+V A D A+K++ +N + Q EI L+ L+
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RN---EKRFHRQAAEEIRILEHLRK 152
Query: 74 ------PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG------RKLFQ 121
NV+ + E ++ I M E + L++ I K + Q G RK
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELI-KKNKFQ---GFSLPLVRKFAH 207
Query: 122 QLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
++ + H + H DLK P ENIL
Sbjct: 208 SILQCLDALHKNRIIHCDLK---------------------------P--------ENIL 232
Query: 182 L--DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239
L + IK+ DFG S + ++T S Y APEV+ Y D+WS G
Sbjct: 233 LKQQGRSGIKVIDFGSS-----CYEHQRVYTYIQSRFYRAPEVILGARYGMP-IDMWSLG 286
Query: 240 VILYVILTGYLPFDDRN 256
IL +LTGY +
Sbjct: 287 CILAELLTGYPLLPGED 303
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 71/352 (20%), Positives = 117/352 (33%), Gaps = 107/352 (30%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
L R LG G FG+V + S L AVK L + ++Q + E
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV------CSEQDELDFLMEALI 127
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLI-- 124
+ H N+VR V +++LE + GG+L + R + ++ L L+
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHV 186
Query: 125 -----DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179
G Y HRD+ A R N
Sbjct: 187 ARDIACGCQYLEENHFIHRDI-----------AA--------------R----------N 211
Query: 180 ILLDSKGN---IKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV---APEV 222
LL G KI DFG++ RD +L P V PE
Sbjct: 212 CLLTCPGPGRVAKIGDFGMA------RDIYRAGYYRKGGCAML------P--VKWMPPEA 257
Query: 223 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGA 279
+ +D WS GV+L+ I + GY+P+ ++ + + + G ++ PK
Sbjct: 258 FMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-GRMDPPKNCPGPV 315
Query: 280 QNLLRKILEPNPVKRITIAGIKA------------DEWFEQDYTPANPDDDE 319
++ + + P R A I + +Y P ++++
Sbjct: 316 YRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK 367
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 60/249 (24%), Positives = 105/249 (42%), Gaps = 34/249 (13%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ + R +G+G FG+V Q +D+ +AVK++ +N K T K E LK +++
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RN---IKKYTRSAKIEADILKKIQN 90
Query: 74 -----PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDG 126
N+V+ H + ++ E G L++ I + + +++
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 127 VSYCHNKGVFHRDLK---VILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD 183
++Y + H DLK ++L + + + V +T I I K
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK------------ 197
Query: 184 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243
IK+ DFG A + + + Y APEV+ N G+D + SD+WS G +L
Sbjct: 198 -STGIKLIDFG-CATFKSDY----HGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLA 250
Query: 244 VILTGYLPF 252
+ TG L F
Sbjct: 251 ELYTGSLLF 259
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 78/366 (21%), Positives = 136/366 (37%), Gaps = 107/366 (29%)
Query: 17 ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
LG+ LGEG FG+V A + AVK+L+ + T++ E+
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD------ATEKDLSDLISEM 125
Query: 66 ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
+K++ KH N++ L +Y+++EY + G L + +
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 117 RKL-FQQLID-------GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168
+L + L+ G+ Y +K HRDL A R
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDL-----------AA--------------R 220
Query: 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTCGSPNY 217
N+L+ +KI+DFGL+ RD +G L P
Sbjct: 221 ----------NVLVTEDNVMKIADFGLA------RDIHHIDYYKKTTNGRL------P-- 256
Query: 218 V---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL-- 271
V APE L +R Y SD+WS GV+L+ I T G P+ + L++ + G ++
Sbjct: 257 VKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDK 314
Query: 272 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSM 331
P + ++R P +R T + E ++ ++E + +
Sbjct: 315 PSNCTNELYMMMRDCWHAVPSQRPTFKQLV--EDLDRIVALT---SNQEMGYYHHHHHHD 369
Query: 332 HEVPSD 337
+++P+
Sbjct: 370 YDIPTT 375
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 74/297 (24%), Positives = 107/297 (36%), Gaps = 100/297 (33%)
Query: 17 ELGRTLGEGNFGKVK--FAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
LG+TLGEG FGKV A L + AVK+L++N + E
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN------ASPSELRDLLSEFNV 79
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL----------------FDKIASKGRL 111
LK + HP+V++L+ + + +++EY G L + L
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 112 QEAEGRKL-FQQLI-------DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLL 163
+ R L LI G+ Y + HRDL A
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL-----------AA---------- 178
Query: 164 MIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV----- 218
R NIL+ +KISDFGLS RD ++ +YV
Sbjct: 179 ----R----------NILVAEGRKMKISDFGLS------RD---VYEE---DSYVKRSQG 212
Query: 219 -------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 267
A E L + Y SD+WS GV+L+ I+T G P+ L+ + G
Sbjct: 213 RIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG 268
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 64/299 (21%), Positives = 107/299 (35%), Gaps = 104/299 (34%)
Query: 17 ELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
E R +GEG FG+V A L PF AVK+L++ + ++ RE A
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE------ASADMQADFQREAAL 103
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL----------------FDKIASKGRL 111
+ +PN+V+L V A + ++ EY+ G+L ++++ R+
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 112 QEAEGRKL-FQQLI-------DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLL 163
L + + G++Y + HRDL AT
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL-----------AT---------- 202
Query: 164 MIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTC 212
R N L+ +KI+DFGLS R+ + +
Sbjct: 203 ----R----------NCLVGENMVVKIADFGLS------RNIYSADYYKADGNDAI---- 238
Query: 213 GSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 267
P + PE + Y SD+W+ GV+L+ I + G P+ + + G
Sbjct: 239 --P--IRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG 292
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 65/251 (25%), Positives = 98/251 (39%), Gaps = 58/251 (23%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RYE+ +G+G+FG+V A D A+KI+ KN +Q + E+ L+L+
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KN---KKAFLNQAQIEVRLLELMNK 109
Query: 74 P------NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLID 125
+V L ++ + +V E + L+D + + + RK QQ+
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 126 GVSYCHNK--GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL- 182
+ + + H DLK P ENILL
Sbjct: 169 ALLFLATPELSIIHCDLK---------------------------P--------ENILLC 193
Query: 183 -DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241
+ IKI DFG S+ R ++ S Y +PEVL YD A D+WS G I
Sbjct: 194 NPKRSAIKIVDFG-SSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCI 247
Query: 242 LYVILTGYLPF 252
L + TG F
Sbjct: 248 LVEMHTGEPLF 258
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 69/300 (23%), Positives = 116/300 (38%), Gaps = 100/300 (33%)
Query: 17 ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
LG+ LGEG FG+V A + AVK+L+ + T++ E+
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD------ATEKDLSDLVSEM 137
Query: 66 ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
+K++ KH N++ L +Y+++EY + G L + + +
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 117 RKL-FQQLID-------GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168
++ F+ L+ G+ Y ++ HRDL A R
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDL-----------AA--------------R 232
Query: 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTCGSPNY 217
N+L+ +KI+DFGL+ RD +G L P
Sbjct: 233 ----------NVLVTENNVMKIADFGLA------RDINNIDYYKKTTNGRL------P-- 268
Query: 218 V---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
V APE L +R Y SD+WS GV+++ I T G P+ + L++ + G ++ K
Sbjct: 269 VKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDK 326
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 69/300 (23%), Positives = 116/300 (38%), Gaps = 100/300 (33%)
Query: 17 ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
LG+ LGEG FG+V A + AVK+L+ + T++ E+
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD------ATEKDLSDLVSEM 91
Query: 66 ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
+K++ KH N++ L +Y+++EY + G L + + +
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 117 RKL-FQQLI-------DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168
++ F+ L+ G+ Y ++ HRDL A R
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDL-----------AA--------------R 186
Query: 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTCGSPNY 217
N+L+ +KI+DFGL+ RD +G L P
Sbjct: 187 ----------NVLVTENNVMKIADFGLA------RDINNIDYYKKTTNGRL------P-- 222
Query: 218 V---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
V APE L +R Y SD+WS GV+++ I T G P+ + L++ + G ++ K
Sbjct: 223 VKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDK 280
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 74/403 (18%), Positives = 132/403 (32%), Gaps = 130/403 (32%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
RY L R LG G+F V A+D+ + A+KI+ ++ T+ + EI L+ +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVND 74
Query: 73 ----------HPNVVRLHEVLASKSKIY----MVLEYVTGGELFD--KIASKGRLQEAEG 116
++++L + K MV E V G L K +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYV 133
Query: 117 RKLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVL 175
+++ +QL+ G+ Y H + G+ H D+K P
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIK---------------------------P------ 160
Query: 176 QLENILLD------SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 229
EN+L++ + IKI+D G + D + + Y +PEVL +
Sbjct: 161 --ENVLMEIVDSPENLIQIKIADLGNACW-----YDEHYTNSIQTREYRSPEVLLGAPWG 213
Query: 230 GATSDIWSCGVILYVILTGYLPFDDRNLAVLY---------------------------Q 262
DIWS +++ ++TG F+ +
Sbjct: 214 CGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTR 272
Query: 263 KIF--RGDFK---------LPKWLSPGAQ----------NLLRKILEPNPVKRITIAGIK 301
F RG + L L+ + + L +L+ +P KR G+
Sbjct: 273 TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332
Query: 302 ADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGS 344
W ++ + ++ E+ G PG
Sbjct: 333 NHPWL------------KDTLGMEEIRVPDRELYGSGSDIPGW 363
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 67/272 (24%), Positives = 97/272 (35%), Gaps = 87/272 (31%)
Query: 17 ELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
G+TLG G FGKV A D+ + AVK+L+ + HL + + E+ L L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYL 83
Query: 72 -KHPNVVRLHEVLASKSKIYMVLEYVTGGEL-----------FDKIASKGRLQEAEGRKL 119
H N+V L ++ EY G+L S +++ E
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 120 FQQLID-------GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172
+ L+ G+++ +K HRDL A R
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDL-----------AA--------------R---- 174
Query: 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------------AP 220
NILL KI DFGL+ RD + NYV AP
Sbjct: 175 ------NILLTHGRITKICDFGLA------RD---IKND---SNYVVKGNARLPVKWMAP 216
Query: 221 EVLANRGYDGATSDIWSCGVILYVILT-GYLP 251
E + N Y SD+WS G+ L+ + + G P
Sbjct: 217 ESIFNCVYT-FESDVWSYGIFLWELFSLGSSP 247
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 71/296 (23%), Positives = 101/296 (34%), Gaps = 97/296 (32%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
L LGEG FGKV + AVK L++ ++ + RE
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-------SESARQDFQREAEL 96
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL--------FDKIASKGRLQEAEGRKL 119
L +L+H ++VR V + MV EY+ G+L D G A G
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 120 FQQLI-------DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172
QL+ G+ Y HRDL AT R
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDL-----------AT--------------R---- 187
Query: 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV--- 218
N L+ +KI DFG+S RD +L P +
Sbjct: 188 ------NCLVGQGLVVKIGDFGMS------RDIYSTDYYRVGGRTML------P--IRWM 227
Query: 219 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
PE + R + SD+WS GV+L+ I T G P+ + I +G +L +
Sbjct: 228 PPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-RELER 281
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 72/297 (24%), Positives = 108/297 (36%), Gaps = 98/297 (32%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
L R LGEG FGKV + AVK L+ T + RE
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-------TLAARKDFQREAEL 70
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD---------KIASKGRLQEAEGRK 118
L L+H ++V+ + V + MV EY+ G+L I G+ ++A+G
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 119 LFQQLI-------DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171
Q++ G+ Y ++ HRDL AT R
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDL-----------AT--------------R--- 162
Query: 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV-- 218
N L+ + +KI DFG+S RD +L P +
Sbjct: 163 -------NCLVGANLLVKIGDFGMS------RDVYSTDYYRVGGHTML------P--IRW 201
Query: 219 -APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 273
PE + R + SD+WS GVIL+ I T G P+ + + + I +G L +
Sbjct: 202 MPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG-RVLER 256
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 78/371 (21%), Positives = 118/371 (31%), Gaps = 90/371 (24%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
GRY + R LG G+F V + D+ A+K+++ T+ EI LK ++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRN 92
Query: 73 ----HPN---VVRLHEVLASKSK----IYMVLEYVTGGELFDKIAS--KGRLQEAEGRKL 119
PN VV+L + I MV E V G L I L +K+
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 120 FQQLIDGVSYCHNK-GVFHRDLK----------VILKSCHMRIATLQVFLLTFLLMIVIR 168
QQ++ G+ Y H K + H D+K ++ Q +
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 169 PWKFNVLQLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPN-YVAPEVL 223
L+ K +KI+D G + T Y + EVL
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265
Query: 224 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY---------------------- 261
GY+ +DIWS + + + TG F+ +
Sbjct: 266 IGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 262 -----QKIF--RGDFKLPKWLSP-------------------GAQNLLRKILEPNPVKRI 295
++ F +GD K L P G + L +LE P KR
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384
Query: 296 TIAGIKADEWF 306
T A W
Sbjct: 385 TAAECLRHPWL 395
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 60/268 (22%), Positives = 97/268 (36%), Gaps = 83/268 (30%)
Query: 17 ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+ G+TLG G FGKV A D+ L AVK+L+ H + + E+ + L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 72 -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD------KIASKGRLQEAEGRKL-FQQL 123
+H N+V L + ++ EY G+L + ++ + L
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 124 ID-------GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQ 176
+ G+++ +K HRD+ A
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDV-----------AA----------------------- 192
Query: 177 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------------APEVLA 224
N+LL + KI DFGL+ RD + NY+ APE +
Sbjct: 193 -RNVLLTNGHVAKIGDFGLA------RD---IMND---SNYIVKGNARLPVKWMAPESIF 239
Query: 225 NRGYDGATSDIWSCGVILYVILT-GYLP 251
+ Y SD+WS G++L+ I + G P
Sbjct: 240 DCVYT-VQSDVWSYGILLWEIFSLGLNP 266
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 67/276 (24%), Positives = 101/276 (36%), Gaps = 94/276 (34%)
Query: 17 ELGRTLGEGNFGKVK--FAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
+LG+ LG G FG+V A +D AVK+L++ T E+
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG------ATHSEHRALMSELKI 83
Query: 68 LKLL-KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEGR 117
L + H NVV L + +++E+ G L + K ++
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 118 KL-FQQLID-------GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169
L + LI G+ + ++ HRDL A R
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDL-----------AA--------------R- 177
Query: 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV----------- 218
NILL K +KI DFGL+ RD ++ P+YV
Sbjct: 178 ---------NILLSEKNVVKICDFGLA------RD---IYKD---PDYVRKGDARLPLKW 216
Query: 219 -APEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 252
APE + +R Y SD+WS GV+L+ I + G P+
Sbjct: 217 MAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 251
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 61/258 (23%), Positives = 99/258 (38%), Gaps = 72/258 (27%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G G FGKV + L G A+K ++ + + EI TL +HP++V L
Sbjct: 47 IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRHPHLVSLIG 102
Query: 82 VLASKSKIYMVLEYVTGGE----LFDKIASKG------RLQEAEG--RKLFQQLIDGVSY 129
++++ ++ +Y+ G L+ RL+ G R G+ Y
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR--------GLHY 154
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
H + + HRD+K + NILLD K
Sbjct: 155 LHTRAIIHRDVK----------SI-------------------------NILLDENFVPK 179
Query: 190 ISDFGLSALPQHFRDDGLLHTT---CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
I+DFG+S + H + G+ Y+ PE +G SD++S GV+L+ +L
Sbjct: 180 ITDFGISKK---GTELDQTHLSTVVKGTLGYIDPE-YFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 247 TG------YLPFDDRNLA 258
LP + NLA
Sbjct: 236 CARSAIVQSLPREMVNLA 253
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 66/277 (23%), Positives = 97/277 (35%), Gaps = 92/277 (33%)
Query: 17 ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
E G+ LG G FGKV A + AVK+L++ + + E+ + L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQL 105
Query: 72 -KHPNVVRLHEVLASKSKIYMVLEYVTGGEL---------------FDKIASKGRLQEAE 115
H N+V L IY++ EY G+L + K +E +
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 116 GRKL-FQQLI-------DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167
L F+ L+ G+ + K HRDL A
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL-----------AA-------------- 200
Query: 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--------- 218
R N+L+ +KI DFGL+ RD + + NYV
Sbjct: 201 R----------NVLVTHGKVVKICDFGLA------RD---IMSD---SNYVVRGNARLPV 238
Query: 219 ---APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 251
APE L Y SD+WS G++L+ I + G P
Sbjct: 239 KWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNP 274
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 3e-17
Identities = 64/260 (24%), Positives = 92/260 (35%), Gaps = 87/260 (33%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHPNVV 77
+GEG FG V + ++ AVK L I + ++K+ EI + +H N+V
Sbjct: 39 MGEGGFGVV-YKGYVN-NTTVAVKKLAAMVDITTE---ELKQQFDQEIKVMAKCQHENLV 93
Query: 78 RL--------HEVLASKSKIYMVLEYVTGG----ELFDKIASKG-----RLQEAEG--RK 118
L L +Y Y+ G L + R + A+G
Sbjct: 94 ELLGFSSDGDDLCL-----VY---VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN- 144
Query: 119 LFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLE 178
G+++ H HRD+K +
Sbjct: 145 -------GINFLHENHHIHRDIK----------SA------------------------- 162
Query: 179 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYVAPEVLANRGYDGATSDI 235
NILLD KISDFGL+ T G+ Y+APE L RG SDI
Sbjct: 163 NILLDEAFTAKISDFGLARA---SEKFAQTVMTSRIVGTTAYMAPEAL--RGEITPKSDI 217
Query: 236 WSCGVILYVILTGYLPFDDR 255
+S GV+L I+TG D+
Sbjct: 218 YSFGVVLLEIITGLPAVDEH 237
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 67/257 (26%), Positives = 99/257 (38%), Gaps = 54/257 (21%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPF-AVKILEKNRIIHLKITDQIKREIATLKLLK 72
RYE+ TLGEG FGKV D +G AVKI+ KN + + + EI L+ L
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KN---VDRYCEAARSEIQVLEHLN 69
Query: 73 HP------NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLI 124
V++ E I +V E + G +D I G + RK+ Q+
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 125 DGVSYCHNKGVFHRDLK---VILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
V++ H+ + H DLK ++ + + + E L
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSD-----------------YTEAYNPKIKRDERTL 171
Query: 182 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------APEVLANRGYDGATSDI 235
++ IK+ DFG SA H+T V APEV+ G+ D+
Sbjct: 172 INPD--IKVVDFG-SATYDDEH-----HST-----LVSTRHYRAPEVILALGWSQP-CDV 217
Query: 236 WSCGVILYVILTGYLPF 252
WS G IL G+ F
Sbjct: 218 WSIGCILIEYYLGFTVF 234
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 62/256 (24%), Positives = 92/256 (35%), Gaps = 52/256 (20%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
RYE+ LGEG FGKV D G A+KI+ +N K + + EI LK +K
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RN---VGKYREAARLEINVLKKIK 74
Query: 73 HP------NVVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLI 124
V + + + + E + G F+ K + R + QL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 125 DGVSYCHNKGVFHRDLKV--ILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILL 182
+ + H + H DLK I L + +N +
Sbjct: 134 HALRFLHENQLTHTDLKPENI------------------LFVNSEFETLYNEHKSCEEKS 175
Query: 183 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------APEVLANRGYDGATSDIW 236
+I+++DFG SA H HTT V PEV+ G+ D+W
Sbjct: 176 VKNTSIRVADFG-SATFDHEH-----HTT-----IVATRHYRPPEVILELGWAQP-CDVW 223
Query: 237 SCGVILYVILTGYLPF 252
S G IL+ G+ F
Sbjct: 224 SIGCILFEYYRGFTLF 239
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-15
Identities = 65/255 (25%), Positives = 101/255 (39%), Gaps = 69/255 (27%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG G FGKV + L G AVK L++ R Q + E+ + + H N++RL
Sbjct: 38 LGRGGFGKVYKGR-LADGTLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 82 VLASKSKIYMVLEYVTGG----ELFDKIASKG------RLQEAEG--RKLFQQLIDGVSY 129
+ ++ +V Y+ G L ++ S+ R + A G R G++Y
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR--------GLAY 146
Query: 130 CH---NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
H + + HRD+K A NILLD +
Sbjct: 147 LHDHCDPKIIHRDVK----------AA-------------------------NILLDEEF 171
Query: 187 NIKISDFGLSALPQHFRDDGLLHTT---CGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243
+ DFGL+ L D H T G+ ++APE + G +D++ GV+L
Sbjct: 172 EAVVGDFGLAKL----MDYKDTHVTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLL 226
Query: 244 VILTGYLPFDDRNLA 258
++TG FD LA
Sbjct: 227 ELITGQRAFDLARLA 241
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 65/287 (22%), Positives = 100/287 (34%), Gaps = 68/287 (23%)
Query: 17 ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+LG+ LG G FG+V A + AVK+L + E+ L +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 82
Query: 72 -KHPNVVRLH-EVLASKSKIYMVLEYVTGGELFD-----------------KIASKGRLQ 112
H NVV L + +++E+ G L +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV 142
Query: 113 EAEGRKLFQQLIDGVS--------YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLL- 163
A L ++L S + K + + + + + TL+ L+ +
Sbjct: 143 GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH-LICYSFQ 201
Query: 164 ----MIVIRPWKFNV--LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 217
M + K L NILL K +KI DFGL+ RD P+Y
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD------IYKDPDY 249
Query: 218 V------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 251
V APE + +R Y SD+WS GV+L+ I + G P
Sbjct: 250 VRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASP 295
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 30/136 (22%), Positives = 58/136 (42%), Gaps = 20/136 (14%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
++ LGR +G G+FG++ ++ + A+K+ E + H Q+ E ++L+
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKH----PQLLYESKIYRILQG 61
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-------LQEAEGRKLFQQLID 125
+ + +V++ + G L D R L A+ Q+I+
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD------QMIN 114
Query: 126 GVSYCHNKGVFHRDLK 141
V + H+K HRD+K
Sbjct: 115 RVEFVHSKSFLHRDIK 130
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 33/137 (24%), Positives = 57/137 (41%), Gaps = 22/137 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ +G+ +G GNFG+++ ++L + A+K LE + Q+ E K L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRA----PQLHLEYRFYKQLGS 63
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK--------LFQQLI 124
+ +++ MVLE G L D L + R + QLI
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLEL-LGPSLED-------LFDLCDRTFSLKTVLMIAIQLI 115
Query: 125 DGVSYCHNKGVFHRDLK 141
+ Y H+K + +RD+K
Sbjct: 116 SRMEYVHSKNLIYRDVK 132
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 37/136 (27%), Positives = 58/136 (42%), Gaps = 20/136 (14%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY LGR +G G+FG + D+ +G A+K+ E + H Q+ E K+++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKH----PQLHIESKIYKMMQG 63
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-------LQEAEGRKLFQQLID 125
+ + A MV+E + G L D R L A+ Q+I
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLAD------QMIS 116
Query: 126 GVSYCHNKGVFHRDLK 141
+ Y H+K HRD+K
Sbjct: 117 RIEYIHSKNFIHRDVK 132
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 34/137 (24%), Positives = 57/137 (41%), Gaps = 22/137 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
Y++GR +GEG+FG + +L + A+K E R Q++ E T KLL
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDA----PQLRDEYRTYKLLAG 64
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK--------LFQQLI 124
+ ++ +V++ G L D L + GRK +Q++
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDL-LGPSLED-------LLDLCGRKFSVKTVAMAAKQML 116
Query: 125 DGVSYCHNKGVFHRDLK 141
V H K + +RD+K
Sbjct: 117 ARVQSIHEKSLVYRDIK 133
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} PDB: 1ul7_A Length = 120 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 6e-09
Identities = 20/106 (18%), Positives = 44/106 (41%), Gaps = 8/106 (7%)
Query: 367 EKEDVSERKIRF------TSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKS 420
E +D R +RF TS+ D++ I ++ ++K L ++
Sbjct: 16 EGKDSKPRSLRFTWSMKTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQD 75
Query: 421 LGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQLCNKLSSDLGL 465
+ EV ++ SL V ++ G ++ + +K++++L L
Sbjct: 76 -SLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKL 120
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 4e-08
Identities = 34/172 (19%), Positives = 60/172 (34%), Gaps = 48/172 (27%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIATLK 69
+ + +GEG FG+V F Q + P A+KI+ + H K ++I EI K
Sbjct: 21 KLQRCEKIGEGVFGEV-F-QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 70 LL---------KHPNVVRLHEV------------------------------LASKSKIY 90
L + + L+ V +++
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLK 141
+VLE+ GG +++ +K A + + QL ++ HRDL
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLH 189
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 22/147 (14%), Positives = 53/147 (36%), Gaps = 24/147 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
++ LG+ +G G FG + A + A +++ + + E+ + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN----GPLFSELKFYQRVAK 92
Query: 74 PNVVRLHEVLASKSKI-------------------YMVLEYVTGGELFDKIASKGRLQEA 114
+ ++ + +MV+E + G +L G +++
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS 151
Query: 115 EGRKLFQQLIDGVSYCHNKGVFHRDLK 141
+L +++D + Y H H D+K
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIK 178
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 4e-07
Identities = 69/430 (16%), Positives = 127/430 (29%), Gaps = 147/430 (34%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGN--FGKV--KFAQDL----DSGLPFAVKILEKNRII 53
++ + L + + T E K QDL + P + I
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI------- 332
Query: 54 HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE 113
I + I+ +AT KH N +L ++ S L L+
Sbjct: 333 ---IAESIRDGLATWDNWKHVNCDKLTTIIESS------LNV---------------LEP 368
Query: 114 AEGRKLFQQLIDGVSYCHNKGVFHRDLKV------IL-----KSCHMRIATLQVFLLTFL 162
AE RK+F +L VF + ++ KS M + L +
Sbjct: 369 AEYRKMFDRL----------SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK---LHKYS 415
Query: 163 LMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 222
L V + K + + + +I L+ K ++ LH + +Y P
Sbjct: 416 L--VEKQPKESTISIPSIYLELK--------------VKLENEYALHRSIVD-HYNIP-- 456
Query: 223 LANRGYDG-ATSDIWSCGVILYVILTGY-LPFDDR-NLAVLYQKIFRGDFKLPKWLSPGA 279
+ +D + I G+ L + L++ +F DF ++L
Sbjct: 457 ---KTFDSDDLIPPYLDQYFYSHI--GHHLKNIEHPERMTLFRMVFL-DF---RFLE--- 504
Query: 280 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGG 339
+KI D T N + + + + +D
Sbjct: 505 ----QKI--------------------RHDSTAWNASGSILNTLQQLKFYKPYICDNDPK 540
Query: 340 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERI----EDIV 395
+L+ + F K + E I S ++ DLL ++ +
Sbjct: 541 YE----------RLVN-----AILDFLPK--IEENLIC--SKYT--DLLRIALMAEDEAI 579
Query: 396 TEMGFR-VQK 404
E + VQ+
Sbjct: 580 FEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 2e-04
Identities = 82/538 (15%), Positives = 143/538 (26%), Gaps = 198/538 (36%)
Query: 31 KFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHPNVV----RLHEVLAS 85
F + D K + + + I ++ K EI ++ + V RL L S
Sbjct: 28 AFVDNFD------CKDVQDMPKSI---LS---KEEID--HIIMSKDAVSGTLRLFWTLLS 73
Query: 86 KSKIYMVLEYVTGGE------LFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
K + MV ++V L I ++ R Q + +++ ++ + D
Sbjct: 74 KQE-EMVQKFVEEVLRINYKFLMSPIKTEQR-QPSMMTRMY-------IEQRDR--LYND 122
Query: 140 LKVILKSCHMR---IATLQVFLL------------------TFLLMIVIRPWK------F 172
+V K R L+ LL T++ + V +K F
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDF 182
Query: 173 NV---------------LQLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSP 215
+ L+ +L N S + L
Sbjct: 183 KIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR------ 236
Query: 216 NYVAPEVLANRGYDGA---TSDIWS----------CGVILYVILTGYLPFDDRNLAVLYQ 262
+L ++ Y+ ++ + C ++ + T + D A
Sbjct: 237 ------LLKSKPYENCLLVLLNVQNAKAWNAFNLSCKIL---LTTRFKQVTDFLSAATTT 287
Query: 263 KIFRGDFK-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA------DEW 305
I L K+L Q+L R++L NP ++ I W
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP---RRLSIIAESIRDGLATW 344
Query: 306 FEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGF 365
D D I E+ P++ F LS F
Sbjct: 345 ---DNWKHVNCDKLTTII---ESSLNVLEPAE---------YRKMFD--------RLSVF 381
Query: 366 FEKEDVSERKIRFTSNHSAKDLLERI---------EDIVTEMGFRVQKKNGKLKATQEHK 416
I LL I +V ++ HK
Sbjct: 382 --PPSA---HI------PTI-LLSLIWFDVIKSDVMVVVNKL----------------HK 413
Query: 417 PQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKL-------SSDLGLPP 467
SL I PS+Y+ K + ++R + + S DL P
Sbjct: 414 --YSLVEKQPKESTISI-PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPY 468
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 26/175 (14%), Positives = 58/175 (33%), Gaps = 50/175 (28%)
Query: 3 IAEKKQEGMRL-----GRYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRI 52
+AE+ G + +++G +G+G FG + A + + S P VK+ +
Sbjct: 19 LAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD-- 76
Query: 53 IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI-------------------YMVL 93
+ E+ + P ++ + +M++
Sbjct: 77 -----NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIM 131
Query: 94 EYVTGGELFDKIASKGR-------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
+ G +L + + LQ + +++D + Y H H D+K
Sbjct: 132 DRF-GSDLQKIYEANAKRFSRKTVLQLSL------RILDILEYIHEHEYVHGDIK 179
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 36/293 (12%), Positives = 84/293 (28%), Gaps = 93/293 (31%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGL--------PFAVKILEKNRIIHLKI-------- 57
+++L N G + A + F++K+ K+ + +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 58 TDQIKREIATLKLLKHPNVVRLHEVLASKSKI-YMVLEYVTGGELFDKIASKGRLQEAEG 116
Q+ + L + + K ++VL + G L +
Sbjct: 102 PLQVNKWK-KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-------ALDVSP 152
Query: 117 RKLF---------QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167
+ + +L+D + + H H ++
Sbjct: 153 KHVLSERSVLQVACRLLDALEFLHENEYVHGNVT-------------------------- 186
Query: 168 RPWKFNVLQLENILL--DSKGNIKISDFGLSALPQHFRDDG----------LLHTTCGSP 215
ENI + + + + ++ +G + + G H G
Sbjct: 187 -A--------ENIFVDPEDQSQVTLAGYGFA---FRYCPSGKHVAYVEGSRSPHE--GDL 232
Query: 216 NYVAPEVLANRGYDGA-TSDIWSCGVILYVILTGYLP---FDDRNLAVLYQKI 264
+++ + ++G + SD+ S G + L G+LP ++ QK
Sbjct: 233 EFIS--MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQ 283
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 Length = 126 | Back alignment and structure |
|---|
Score = 39.3 bits (91), Expect = 4e-04
Identities = 14/102 (13%), Positives = 37/102 (36%), Gaps = 7/102 (6%)
Query: 374 RKIRFTSNHSAK---DLLERIEDIVTEMGFRVQKKNG-KLKATQEHKPQKSLGSLSVAAE 429
S+ D++ I ++ +++ L ++L + E
Sbjct: 26 TTENLYFQGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENL--VQWEME 83
Query: 430 VFEIS-PSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQE 470
V ++ SL V ++ G ++ + +K++++L L
Sbjct: 84 VCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKLSGPSS 125
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 476 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 99.97 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.82 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.77 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.64 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.6 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.51 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.46 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.36 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.27 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.27 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 98.24 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.05 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 98.03 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 97.94 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.77 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.68 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.62 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.33 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.16 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.05 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.02 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.98 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.92 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.85 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.7 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.54 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.98 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.55 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.86 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.6 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.88 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-67 Score=523.12 Aligned_cols=262 Identities=32% Similarity=0.593 Sum_probs=243.8
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
.+.++|++++.||+|+||+||+|++..+|+.||||++.+....+.+....+.+|+.+|+.++|||||+++++|++++.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 45678999999999999999999999999999999998766545555788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
+|||||+||+|++++...+++++.+++.|+.||+.||+|||++||+||||||
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKP---------------------------- 160 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKP---------------------------- 160 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG----------------------------
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCH----------------------------
Confidence 9999999999999999888999999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+|||++.+|++||+|||+|+............+.|||+.|||||++.+..|+ .++|||||||++|+|+||+.
T Consensus 161 -------eNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~ 232 (311)
T 4aw0_A 161 -------ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLP 232 (311)
T ss_dssp -------GGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSC
T ss_pred -------HHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999876543344567788999999999999998885 89999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHH------HhcCccccc
Q 011868 251 PFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG------IKADEWFEQ 308 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~------il~~~~~~~ 308 (476)
||.+.+...++.+|.++.+.+|..+|+++++||++||+.||.+|||++| |++||||+.
T Consensus 233 PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 233 PFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred CCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 9999999999999999999999999999999999999999999999998 588999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-67 Score=515.24 Aligned_cols=263 Identities=48% Similarity=0.914 Sum_probs=224.9
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
..+..+|+|++++.||+|+||+||+|++..+|+.||||++++......+....+.+|+.+|+.++||||+++++++.+++
T Consensus 7 ~~G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 7 ADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD 86 (275)
T ss_dssp -------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 44667899999999999999999999999999999999998876655566778999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.+|+||||| +|+|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP------------------------- 140 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKP------------------------- 140 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCT-------------------------
T ss_pred EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCh-------------------------
Confidence 999999999 789999999989999999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++++|++||+|||+|+.... .....+.+||+.|||||++.+..|++.++||||+||++|+|+|
T Consensus 141 ----------~NILl~~~~~vkl~DFGla~~~~~---~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~llt 207 (275)
T 3hyh_A 141 ----------ENLLLDEHLNVKIADFGLSNIMTD---GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC 207 (275)
T ss_dssp ----------TTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHH
T ss_pred ----------HHeEECCCCCEEEeecCCCeecCC---CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHH
Confidence 999999999999999999985432 3445678999999999999999888789999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|+.||.+.+...++.++..+.+++|.++|+++.+||++||+.||++|||++|+++||||+..
T Consensus 208 g~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 208 RRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 99999999999999999999999999999999999999999999999999999999999764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-65 Score=514.05 Aligned_cols=260 Identities=28% Similarity=0.566 Sum_probs=231.1
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
.+++|+++++||+|+||+||+|++..+|+.||||++.+... .....+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 46799999999999999999999999999999999987764 34456789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|||||+||+|.++|... ..+++.+++.|+.||+.||+|||++||+||||||
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp--------------------------- 153 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKS--------------------------- 153 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCG---------------------------
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCH---------------------------
Confidence 99999999999999754 3579999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||++.+|++||+|||+|+.... ......+.|||+.|||||++.+..|+ .++|||||||++|+|+||+
T Consensus 154 --------~NILl~~~g~vKl~DFGla~~~~~--~~~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~ 222 (350)
T 4b9d_A 154 --------QNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLK 222 (350)
T ss_dssp --------GGEEECTTCCEEECSTTEESCCCH--HHHHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSS
T ss_pred --------HHEEECCCCCEEEcccccceeecC--CcccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCC
Confidence 999999999999999999986543 12234567899999999999998886 8999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 250 LPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
.||.+.+...++.++..+.+ +.+..+|+++.+||.+||+.||++|||++|+++||||.+..
T Consensus 223 ~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 223 HAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp CSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred CCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 99999999999999998876 46677999999999999999999999999999999997643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-64 Score=506.20 Aligned_cols=256 Identities=25% Similarity=0.416 Sum_probs=231.4
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
..|++.++||+|+||+||+|++..+|+.||||+++...... .+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999998654322 456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
|||+||+|.+++.. +++++.+++.|+.||+.||+|||++||+||||||
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp------------------------------- 198 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS------------------------------- 198 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG-------------------------------
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCH-------------------------------
Confidence 99999999999876 6799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+|||++.+|++||+|||+|+.... ......+.|||+.|||||++.+..|+ .++|||||||++|||++|+.||.
T Consensus 199 ----~NILl~~~g~vKl~DFGla~~~~~--~~~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~ 271 (346)
T 4fih_A 199 ----DSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYF 271 (346)
T ss_dssp ----GGEEECTTCCEEECCCTTCEECCS--SSCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTT
T ss_pred ----HHEEECCCCCEEEecCcCceecCC--CCCcccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999985433 23456678999999999999988885 89999999999999999999999
Q ss_pred CCcHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 254 DRNLAVLYQKIFRGDFK---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~~~---~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
+.+....+..+.....+ .+..+|+++.+||.+||+.||++|||++|+++||||.+...
T Consensus 272 ~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 272 NEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp TSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred CcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 99998888888776432 33458999999999999999999999999999999987543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-65 Score=502.94 Aligned_cols=259 Identities=34% Similarity=0.629 Sum_probs=229.5
Q ss_pred ccCcCEEEeceEeecCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
...++|++++.||+|+||+||+|++. .+++.||||++++...... ....+.+|+.+|++++|||||++++++.+++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 34578999999999999999999984 4688999999987653322 2346889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.+|+|||||+||+|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp------------------------- 154 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKP------------------------- 154 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCG-------------------------
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCH-------------------------
Confidence 9999999999999999999889999999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.+|++||+|||+|+.... ......+.|||+.|||||++.+..|+ .++||||+||++|+|+|
T Consensus 155 ----------~NILl~~~g~vKl~DFGla~~~~~--~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemlt 221 (304)
T 3ubd_A 155 ----------ENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLT 221 (304)
T ss_dssp ----------GGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHH
T ss_pred ----------HHeEEcCCCCEEecccccceeccC--CCccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHh
Confidence 999999999999999999985432 23455678999999999999998886 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC-----hHHHhcCccccc
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 308 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-----~~~il~~~~~~~ 308 (476)
|+.||.+.+...++.++.++.+++|..+|+++.+||++||+.||++||| ++|+++||||+.
T Consensus 222 G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 222 GTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 9999999999999999999999999999999999999999999999998 479999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-62 Score=507.07 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=231.8
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
..|+++++||+|+||+||+|++..+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999998664322 456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
|||+||+|.+++.. +++++.+++.|+.||+.||+|||++||+||||||
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp------------------------------- 275 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS------------------------------- 275 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCST-------------------------------
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCH-------------------------------
Confidence 99999999999865 5799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+|||++.+|.+||+|||+|+.... ......+.|||+.|||||++.+..|+ .++|||||||++|||++|+.||.
T Consensus 276 ----~NILl~~~g~vKl~DFGla~~~~~--~~~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~ 348 (423)
T 4fie_A 276 ----DSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYF 348 (423)
T ss_dssp ----TTEEECTTCCEEECCCTTCEECCS--SCCCBCCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTT
T ss_pred ----HHEEEcCCCCEEEecCccceECCC--CCccccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999985433 23456678999999999999988885 89999999999999999999999
Q ss_pred CCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 254 DRNLAVLYQKIFRGDF---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 254 ~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
+.+....+..+..... +.+..+|+++++||.+||+.||.+|||++|+|+||||.+...
T Consensus 349 ~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 349 NEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp TSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred CcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 9999888888877643 334568999999999999999999999999999999987543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-62 Score=483.39 Aligned_cols=256 Identities=25% Similarity=0.479 Sum_probs=223.5
Q ss_pred cCcCE-EEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----C
Q 011868 12 RLGRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----K 86 (476)
Q Consensus 12 ~~~~Y-~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~ 86 (476)
.-++| ++.++||+|+||+||+|.+..++..||+|++..... .......+.+|+.+|+.++|||||++++++.+ +
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 101 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence 34576 778899999999999999999999999999987653 33446789999999999999999999999865 3
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g--ivHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
..+|+|||||+||+|.+++...+++++.+++.++.||+.||+|||++| |+||||||
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp---------------------- 159 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC---------------------- 159 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCG----------------------
T ss_pred cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccCh----------------------
Confidence 568999999999999999998889999999999999999999999998 99999997
Q ss_pred hhccccccccCCCCceEeCC-CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~-~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ 243 (476)
+|||++. +|.+||+|||+|+.. ......+.+|||.|||||++.+ +|+ .++|||||||++|
T Consensus 160 -------------~NILl~~~~g~vKl~DFGla~~~----~~~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvily 220 (290)
T 3fpq_A 160 -------------DNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCML 220 (290)
T ss_dssp -------------GGEEESSTTSCEEECCTTGGGGC----CTTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHH
T ss_pred -------------hheeEECCCCCEEEEeCcCCEeC----CCCccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHH
Confidence 9999985 899999999999843 2345677899999999999865 575 8999999999999
Q ss_pred HHhcCCCCCCCCc-HHHHHHHHHhCCCC--CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 244 VILTGYLPFDDRN-LAVLYQKIFRGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 244 elltG~~Pf~~~~-~~~~~~~i~~~~~~--~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
+|+||+.||.+.+ ...++..+..+..+ ++...++++.+||.+||+.||++|||++|+++||||++.
T Consensus 221 elltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 221 EMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 9999999997654 55666667665433 456689999999999999999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-61 Score=505.83 Aligned_cols=411 Identities=36% Similarity=0.648 Sum_probs=314.1
Q ss_pred chhhhccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEE
Q 011868 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81 (476)
Q Consensus 2 ~~~~~~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~ 81 (476)
.......+...+++|++++.||+|+||+||+|++..+|+.||||++.+......+....+.+|+.+++.++||||+++++
T Consensus 4 ~~~~~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~ 83 (476)
T 2y94_A 4 AEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83 (476)
T ss_dssp -----CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred chhhccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 34456677889999999999999999999999999999999999998764433344678999999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
++.+.+.+|+||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 84 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp------------------- 144 (476)
T 2y94_A 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKP------------------- 144 (476)
T ss_dssp EEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSG-------------------
T ss_pred EEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccH-------------------
Confidence 9999999999999999999999998888899999999999999999999999999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+|||++.++.+||+|||++..... .....+.+||+.|+|||++.+..+.+.++|||||||+
T Consensus 145 ----------------~NIll~~~~~vkL~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi 205 (476)
T 2y94_A 145 ----------------ENVLLDAHMNAKIADFGLSNMMSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVI 205 (476)
T ss_dssp ----------------GGEEECTTCCEEECCCSSCEECCT---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHH
T ss_pred ----------------HHEEEecCCCeEEEeccchhhccc---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHH
Confidence 999999999999999999985432 3445677999999999999988887789999999999
Q ss_pred HHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCCCCC----CCC
Q 011868 242 LYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN----PDD 317 (476)
Q Consensus 242 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~~~~----~~~ 317 (476)
+|+|++|+.||.+.+....+.++..+.+..|..+++++.+||++||+.||.+|||++++++||||.+...... +..
T Consensus 206 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~ 285 (476)
T 2y94_A 206 LYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSY 285 (476)
T ss_dssp HHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCS
T ss_pred HHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999987543211 100
Q ss_pred Ccc--c------cc----c-cccccc-ccC-CCCC-----------CCC------------------------CCCCCCc
Q 011868 318 DEE--D------IF----V-DNEAFS-MHE-VPSD-----------GGR------------------------TPGSPPL 347 (476)
Q Consensus 318 ~~~--~------~~----~-~~~~~~-~~~-~~~~-----------~~~------------------------~~~~~~~ 347 (476)
... + .. . ..+... ... .+.+ ..+ ....|..
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (476)
T 2y94_A 286 SSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPER 365 (476)
T ss_dssp SCSHHHHHHHHSCCCC-------------------------------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCT
T ss_pred ccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHHHHHHHhchhhhhhhhccccccCCccccccccccccCCccc
Confidence 000 0 00 0 000000 000 0000 000 0000000
Q ss_pred ccchhhhccccccccCCCC------ccccccccceeeeecCCHHHHHHHHHHHHHhcCeEEEe-eCCceeeeeccCCCcc
Q 011868 348 INAFQLIGMSSCLDLSGFF------EKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKS 420 (476)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~ 420 (476)
.........+....++... ......++.+++.|...|.+|+..|..+++.+|+.|++ +.+.|++....+..
T Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi~s~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~-- 443 (476)
T 2y94_A 366 VPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVT-- 443 (476)
T ss_dssp TTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESEEECSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTT--
T ss_pred CCcccccCCcccccccccccccccccccccceeeecCccCCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCC--
Confidence 0000000000000000000 01123466788889999999999999999999999987 56788887643322
Q ss_pred cCceEEEEEEEEEcCceEEEEEEecCCChhhH
Q 011868 421 LGSLSVAAEVFEISPSLYVVELRKSYGDPTVY 452 (476)
Q Consensus 421 ~~~l~~~~ev~~~~~~~~lVe~~k~~Gd~lef 452 (476)
...++|.+++|++.++.+||||++..|+.++|
T Consensus 444 ~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 444 STFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp CCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred CceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 25678999999999999999999999999987
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-62 Score=488.41 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=225.4
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
.++.|++.++||+|+||+||+|+++.+|+.||||+++.+.. ..+|+.+|+.++|||||++++++.+++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45679999999999999999999999999999999986542 2469999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||||+||+|.++|...+++++.+++.|+.||+.||+|||++||+||||||
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp----------------------------- 178 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA----------------------------- 178 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCG-----------------------------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCH-----------------------------
Confidence 999999999999999888999999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCC-CEEEeccCCCCCCCcccCC---CcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 172 FNVLQLENILLDSKG-NIKISDFGLSALPQHFRDD---GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g-~vkl~DFGla~~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.+| .+||+|||+|+........ ....+.|||+.|||||++.+..|+ .++|||||||++|||+|
T Consensus 179 ------~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemlt 251 (336)
T 4g3f_A 179 ------DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLN 251 (336)
T ss_dssp ------GGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHH
T ss_pred ------HHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHH
Confidence 999999998 5999999999865432111 123456899999999999998886 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHccCCCcCCCCChHHH-------------hcCccccccC
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGAQNLLRKILEPNPVKRITIAGI-------------KADEWFEQDY 310 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~Li~~~L~~dP~~R~s~~~i-------------l~~~~~~~~~ 310 (476)
|+.||.+.+...++.++..+..+ +|+.+++++.+||.+||+.||.+|||+.|+ ++|||+.+..
T Consensus 252 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 252 GCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp SSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred CcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 99999998877778888877643 677899999999999999999999999997 5788887543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-60 Score=487.19 Aligned_cols=260 Identities=26% Similarity=0.357 Sum_probs=226.7
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------CC
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------KS 87 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------~~ 87 (476)
++|++++.||+|+||+||+|++..+|+.||||++++... .......+.+|+.+|+.++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 479999999999999999999999999999999976542 34446788999999999999999999999764 36
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.+|+|||||. |+|.+++...+++++.+++.|++||+.||+|||++||+||||||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP------------------------- 186 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKP------------------------- 186 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG-------------------------
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCc-------------------------
Confidence 7999999995 68999999888999999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcc--cCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHF--RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~--~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+|||++.+|.+||+|||+|+..... .......+.+||+.|||||++.+..+++.++||||+|||+|||
T Consensus 187 ----------~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~el 256 (398)
T 4b99_A 187 ----------SNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEM 256 (398)
T ss_dssp ----------GGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred ----------cccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHH
Confidence 9999999999999999999865332 1233456789999999999998877767999999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCCCCC-------------------------------CCCCCHHHHHHHHHccCCCcCCC
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGDFKL-------------------------------PKWLSPGAQNLLRKILEPNPVKR 294 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------p~~~s~~~~~Li~~~L~~dP~~R 294 (476)
++|++||.+.+....+.+|....... .+.+|+++.+||.+||+.||.+|
T Consensus 257 l~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R 336 (398)
T 4b99_A 257 LARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSAR 336 (398)
T ss_dssp HHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTS
T ss_pred HHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHC
Confidence 99999999999888888776432111 12368999999999999999999
Q ss_pred CChHHHhcCccccccC
Q 011868 295 ITIAGIKADEWFEQDY 310 (476)
Q Consensus 295 ~s~~~il~~~~~~~~~ 310 (476)
||++|+|+||||++..
T Consensus 337 ~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 337 ISAAAALRHPFLAKYH 352 (398)
T ss_dssp CCHHHHTTSGGGTTTC
T ss_pred cCHHHHhcCHhhCcCC
Confidence 9999999999998643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-59 Score=500.95 Aligned_cols=261 Identities=28% Similarity=0.469 Sum_probs=232.1
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHH---HHHHHHHHhCCCCCcceEEEEEE
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI---KREIATLKLLKHPNVVRLHEVLA 84 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~---~~Ei~~l~~l~HpnIv~l~~~~~ 84 (476)
...+.+++|++++.||+|+||+||+|++..+|+.||||++.+...........+ .+++.+++.++|||||+++++|.
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 457789999999999999999999999999999999999987654332223333 34466777889999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
+.+.+|+|||||+||+|+++|...+++++..++.|+.||+.||+|||++||+||||||
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKP---------------------- 320 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP---------------------- 320 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSG----------------------
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCch----------------------
Confidence 9999999999999999999999889999999999999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc-CCCCCccchhhhHhHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGATSDIWSCGVILY 243 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~sDvwSlGvil~ 243 (476)
+|||++.+|++||+|||+|+... .....+.||||.|||||++.+ .+| +.++|||||||++|
T Consensus 321 -------------eNILld~~G~vKL~DFGlA~~~~----~~~~~t~~GTp~YmAPEvl~~~~~y-~~~vDiWSLGvilY 382 (689)
T 3v5w_A 321 -------------ANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEVLQKGVAY-DSSADWFSLGCMLF 382 (689)
T ss_dssp -------------GGEEECTTSCEEECCCTTCEECS----SCCCCSCCSCGGGCCHHHHSTTCCC-CTHHHHHHHHHHHH
T ss_pred -------------HHeEEeCCCCEEecccceeeecC----CCCCCCccCCcCccCHHHHhCCCCC-CcHHHHHHHHHHHH
Confidence 99999999999999999998543 234567899999999999975 456 58999999999999
Q ss_pred HHhcCCCCCCCCc---HHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC-----hHHHhcCccccc
Q 011868 244 VILTGYLPFDDRN---LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 308 (476)
Q Consensus 244 elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-----~~~il~~~~~~~ 308 (476)
+|++|++||.+.+ ...+...+....+.+|..+|+++++||.+||+.||.+|++ +++|++||||+.
T Consensus 383 EmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 383 KLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 9999999998643 4567778888899999999999999999999999999998 799999999974
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-59 Score=463.87 Aligned_cols=257 Identities=27% Similarity=0.398 Sum_probs=224.2
Q ss_pred ccCcCEEEeceEeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 85 (476)
+.-++|.+.++||+|+||+||+|++. .++..||||+++.. +....+.|.+|+.+|++++|||||++++++.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 44568999999999999999999875 36789999999754 34456789999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhh
Q 011868 86 KSKIYMVLEYVTGGELFDKIASK-------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIA 152 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~-------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~ 152 (476)
++.+|+|||||+||+|.++|... .++++.++..++.||++||+|||+++|+||||||
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp---------- 156 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT---------- 156 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG----------
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCH----------
Confidence 99999999999999999999753 3699999999999999999999999999999997
Q ss_pred HHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCcc
Q 011868 153 TLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 232 (476)
Q Consensus 153 ~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~ 232 (476)
+|||+++++++||+|||+|+..............+||+.|||||++.+..|+ .+
T Consensus 157 -------------------------~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k 210 (299)
T 4asz_A 157 -------------------------RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TE 210 (299)
T ss_dssp -------------------------GGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HH
T ss_pred -------------------------hhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-ch
Confidence 9999999999999999999754332222233446799999999999988886 89
Q ss_pred chhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 233 SDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 233 sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+|||||||++|||+| |+.||.+.+..++...+..+. ++.|..+++++.+||.+||+.||++|||+++| ++|+++
T Consensus 211 ~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 211 SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 999999999999999 999999999989988888876 46788899999999999999999999999999 567754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-59 Score=460.41 Aligned_cols=256 Identities=25% Similarity=0.416 Sum_probs=205.1
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----- 87 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----- 87 (476)
+++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 467999999999999999999999999999999997654 3344578999999999999999999999986543
Q ss_pred -------EEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHH
Q 011868 88 -------KIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVF 157 (476)
Q Consensus 88 -------~~~lV~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~ 157 (476)
.+|+|||||+||+|.+++..... .++..++.++.||+.||+|||++||+||||||
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp--------------- 146 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKP--------------- 146 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG---------------
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcH---------------
Confidence 47999999999999999987654 44567899999999999999999999999997
Q ss_pred HHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC----------CCcccccccCCccccccccccCC
Q 011868 158 LLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD----------DGLLHTTCGSPNYVAPEVLANRG 227 (476)
Q Consensus 158 ~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~----------~~~~~~~~gt~~y~APE~l~~~~ 227 (476)
+|||++.+|.+||+|||+|+....... .....+.|||+.|||||++.+..
T Consensus 147 --------------------~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~ 206 (299)
T 4g31_A 147 --------------------SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206 (299)
T ss_dssp --------------------GGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCC
T ss_pred --------------------HHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC
Confidence 999999999999999999986543211 11234568999999999999988
Q ss_pred CCCccchhhhHhHHHHHHhcCCCCCCCCcH-HHHHHHHHhCCCC-CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcc
Q 011868 228 YDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 305 (476)
Q Consensus 228 ~~~~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~ 305 (476)
|+ .++|||||||++|||++ ||.+... ......+....++ .+...++.+.+||++||++||.+|||+.|+++|||
T Consensus 207 y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~ 282 (299)
T 4g31_A 207 YS-HKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV 282 (299)
T ss_dssp CC-THHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CC-CHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 86 89999999999999996 8875432 2333444443332 12235678899999999999999999999999999
Q ss_pred cccc
Q 011868 306 FEQD 309 (476)
Q Consensus 306 ~~~~ 309 (476)
|+.-
T Consensus 283 ~~~~ 286 (299)
T 4g31_A 283 FEDL 286 (299)
T ss_dssp GCCC
T ss_pred hCCC
Confidence 9753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-58 Score=459.07 Aligned_cols=253 Identities=28% Similarity=0.401 Sum_probs=216.1
Q ss_pred cCcCEEEeceEeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
...+|.+.++||+|+||+||+|+.. .+++.||||+++.. +....+.|.+|+.+|++++|||||++++++.+.
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 4457999999999999999999864 36889999999754 344567899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASK---------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRI 151 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~---------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~ 151 (476)
+.+|+|||||+||+|.+++... +++++.++..++.||+.||+|||+++|+||||||
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp--------- 186 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLAT--------- 186 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG---------
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccH---------
Confidence 9999999999999999999653 3599999999999999999999999999999997
Q ss_pred hHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCc
Q 011868 152 ATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 231 (476)
Q Consensus 152 ~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~ 231 (476)
+|||+++++++||+|||+|+..............+||+.|||||++.+..|+ .
T Consensus 187 --------------------------~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~ 239 (329)
T 4aoj_A 187 --------------------------RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-T 239 (329)
T ss_dssp --------------------------GGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCC-H
T ss_pred --------------------------hhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-c
Confidence 9999999999999999999865433223334567899999999999998886 8
Q ss_pred cchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 232 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 232 ~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
++|||||||++|||+| |+.||.+.+.......+..+ .++.|..+++++.+||.+||+.||++|||+++|+++
T Consensus 240 ~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 240 ESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9999999999999999 99999999988888888776 467888899999999999999999999999999765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-58 Score=457.14 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=225.3
Q ss_pred CccCcCEEEeceEeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 84 (476)
.+.++.+++.++||+|+||+||+|+.. .+++.||||+++... .....+.|.+|+.+|++++|||||++++++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 356788999999999999999999853 467899999997543 3334678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccc
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCH 148 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~ 148 (476)
+++.+|+|||||++|+|.++|... ..+++.++..++.||+.||+|||+++|+||||||
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~------ 173 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLAT------ 173 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG------
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccc------
Confidence 999999999999999999999642 3589999999999999999999999999999997
Q ss_pred hhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCC
Q 011868 149 MRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 228 (476)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 228 (476)
+|||+++++++||+|||+|+............+.+||+.|||||++.+..|
T Consensus 174 -----------------------------~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~ 224 (308)
T 4gt4_A 174 -----------------------------RNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF 224 (308)
T ss_dssp -----------------------------GGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC
T ss_pred -----------------------------cceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC
Confidence 999999999999999999986543333334566789999999999998888
Q ss_pred CCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 229 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 229 ~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+ .++|||||||+||||+| |..||.+.+...+...+..+. .+.|..+++++.+||.+||+.||++|||+.+|+++
T Consensus 225 s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 225 S-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp C-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6 89999999999999998 999999999988888888765 46788899999999999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-57 Score=462.90 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=209.3
Q ss_pred CcCEEEeceEeecCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~ 88 (476)
-++|+++++||+|+||+||+|++. .+++.||||.+.+.. ...++.+|+.+|+.+ +||||++++++|.++++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 468999999999999999999874 467899999986543 145688999999998 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
+|+|||||+||+|.+++ +++++.+++.++.||+.||+|||++||+||||||
T Consensus 95 ~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKP-------------------------- 145 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKP-------------------------- 145 (361)
T ss_dssp EEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG--------------------------
T ss_pred EEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCH--------------------------
Confidence 99999999999999998 4599999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCC-CCEEEeccCCCCCCCccc--------------------------CCCcccccccCCcccccc
Q 011868 169 PWKFNVLQLENILLDSK-GNIKISDFGLSALPQHFR--------------------------DDGLLHTTCGSPNYVAPE 221 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~-g~vkl~DFGla~~~~~~~--------------------------~~~~~~~~~gt~~y~APE 221 (476)
+|||++.+ +.+||+|||+|+...... ......+.+||+.|||||
T Consensus 146 ---------eNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE 216 (361)
T 4f9c_A 146 ---------SNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE 216 (361)
T ss_dssp ---------GGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHH
T ss_pred ---------HHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHH
Confidence 99999877 899999999997433211 112244568999999999
Q ss_pred ccccCCCCCccchhhhHhHHHHHHhcCCCCCCC-CcHHHHHHHHHh----------------------------------
Q 011868 222 VLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFR---------------------------------- 266 (476)
Q Consensus 222 ~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~---------------------------------- 266 (476)
++.+..+++.++||||+|||+|+|++|+.||.. .+....+.+|..
T Consensus 217 ~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 296 (361)
T 4f9c_A 217 VLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCE 296 (361)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHH
T ss_pred HHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHH
Confidence 998876556899999999999999999999954 344343333321
Q ss_pred ----CCC----------------CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 267 ----GDF----------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 267 ----~~~----------------~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
... +....+|+++++||++||+.||++|||++|+|+||||++
T Consensus 297 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 297 RLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 000 011337899999999999999999999999999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=487.20 Aligned_cols=261 Identities=30% Similarity=0.582 Sum_probs=237.4
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++||||++++++|.+++.+|
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 35689999999999999999999999999999999997653 333577899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+|||||+||+|+++|.. .+++++.+++.|++||+.||+|||++||+||||||
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp--------------------------- 283 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP--------------------------- 283 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCG---------------------------
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCh---------------------------
Confidence 99999999999999964 46799999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCC--CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 170 WKFNVLQLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~--g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.+ |.+||+|||+|+... ......+.|||+.|||||++.+..|+ .++|||||||++|+|++
T Consensus 284 --------~Nill~~~~~~~vKl~DFG~a~~~~---~~~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~ 351 (573)
T 3uto_A 284 --------ENIMFTTKRSNELKLIDFGLTAHLD---PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLS 351 (573)
T ss_dssp --------GGEEESSSSCCCEEECCCSSCEECC---TTSEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHH
T ss_pred --------hhccccCCCCCCEEEeeccceeEcc---CCCceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHH
Confidence 99999854 899999999998543 34456778999999999999998885 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCCCC
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 313 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~~~ 313 (476)
|+.||.+.+....+.++..+.+.++ ..+|+++++||++||+.||.+|||++|+++||||+....+.
T Consensus 352 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 352 GLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp SCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred CCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 9999999999999999998877665 45899999999999999999999999999999999866554
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=451.43 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=207.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..+++++.++||+|+||+||+|+.. ..||||+++.... +.+..+.|.+|+.+|++++|||||++++++.. +.+|+
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 3468889999999999999999853 3599999975542 44556889999999999999999999998864 56899
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
|||||+||+|.+++... +++++.++..++.||+.||+|||++||+||||||
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp---------------------------- 160 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKS---------------------------- 160 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCS----------------------------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCH----------------------------
Confidence 99999999999999754 5799999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccC---CCCCccchhhhHhHHHHHHhc
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~~~~~sDvwSlGvil~ellt 247 (476)
+|||+++++++||+|||+|+............+.+||+.|||||++.+. .| +.++|||||||+||||+|
T Consensus 161 -------~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y-~~ksDVwS~Gvvl~Ellt 232 (307)
T 3omv_A 161 -------NNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF-SFQSDVYSYGIVLYELMT 232 (307)
T ss_dssp -------SSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCC-CHHHHHHHHHHHHHHHHH
T ss_pred -------HHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCC-CcHHHhHhHHHHHHHHHH
Confidence 9999999999999999999876543334456678999999999998643 35 489999999999999999
Q ss_pred CCCCCCCCcHHHHHHH-HHhCCC-----CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcc
Q 011868 248 GYLPFDDRNLAVLYQK-IFRGDF-----KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 305 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~-i~~~~~-----~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~ 305 (476)
|+.||.+.+....... +..+.. ..+..+++++.+||.+||+.||++|||+.+|+++-.
T Consensus 233 g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 233 GELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp SSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 9999998765544444 333321 234568999999999999999999999999876643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-56 Score=444.16 Aligned_cols=265 Identities=42% Similarity=0.830 Sum_probs=243.7
Q ss_pred ccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 7 ~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
..+...+++|++.+.||+|+||+||+|++..+|+.||||++.+... +......+.+|+.+|+.++||||+++++++.+.
T Consensus 8 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 86 (328)
T 3fe3_A 8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE 86 (328)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3456678999999999999999999999999999999999987653 344567889999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
+.+|+||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp------------------------ 142 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKA------------------------ 142 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG------------------------
T ss_pred CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCH------------------------
Confidence 99999999999999999998888999999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.++.+||+|||++.... ........+||+.|+|||++.+..+++.++||||+||++|+|+
T Consensus 143 -----------~NIll~~~~~~kl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 208 (328)
T 3fe3_A 143 -----------ENLLLDADMNIKIADFGFSNEFT---VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 208 (328)
T ss_dssp -----------GGEEECTTSCEEECSTTCCGGGS---SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHH
T ss_pred -----------HHEEEcCCCCEEEeeccCceecC---CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHH
Confidence 99999999999999999997433 2344567899999999999999888778999999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
+|+.||.+.+......++..+.+.+|..+++++.+||++||+.||.+|||++++++||||....
T Consensus 209 ~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 209 SGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999999999999999999999999999999999999999999998643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-56 Score=448.85 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=218.5
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEe
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLAS 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~ 85 (476)
..++|++++.||+|+||+||+|.+..+ ++.||||++.... .....+.+.+|+.+|++++| ||||+++++|..
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 346899999999999999999997654 4679999997654 33345789999999999975 899999999866
Q ss_pred C-CEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccc
Q 011868 86 K-SKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCH 148 (476)
Q Consensus 86 ~-~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~ 148 (476)
. +.+|+|||||++|+|.++|... ..+++.++..++.||+.||+|||+++|+||||||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~------ 213 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA------ 213 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG------
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCc------
Confidence 4 5789999999999999999652 3489999999999999999999999999999997
Q ss_pred hhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCC
Q 011868 149 MRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 228 (476)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 228 (476)
+|||+++++.+||+|||+|+............+.+||+.|||||++.+..|
T Consensus 214 -----------------------------~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y 264 (353)
T 4ase_A 214 -----------------------------RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 264 (353)
T ss_dssp -----------------------------GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred -----------------------------cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC
Confidence 999999999999999999986543222223456789999999999999888
Q ss_pred CCccchhhhHhHHHHHHhc-CCCCCCCCcH-HHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 229 DGATSDIWSCGVILYVILT-GYLPFDDRNL-AVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 229 ~~~~sDvwSlGvil~ellt-G~~Pf~~~~~-~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+ .++|||||||++|||+| |+.||.+.+. ..+...+..+ .++.|..+++++.+||.+||+.||.+|||+++|++|
T Consensus 265 ~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 265 T-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp C-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 6 89999999999999998 9999998764 4455555554 467788899999999999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-55 Score=441.42 Aligned_cols=262 Identities=32% Similarity=0.622 Sum_probs=233.2
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~ 87 (476)
..+.+++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|..+++.+ +||||+++++++.+.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 356788999999999999999999999999999999999876544445567889999999988 6999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.+|+||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp------------------------- 152 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKL------------------------- 152 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG-------------------------
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCH-------------------------
Confidence 9999999999999999998888999999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.+|++||+|||+|+.... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++
T Consensus 153 ----------~NILl~~~g~ikL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~ 219 (353)
T 3txo_A 153 ----------DNVLLDHEGHCKLADFGMCKEGIC--NGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLC 219 (353)
T ss_dssp ----------GGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHH
T ss_pred ----------HHEEECCCCCEEEccccceeeccc--CCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHh
Confidence 999999999999999999985322 23345677999999999999888775 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh------HHHhcCccccc
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI------AGIKADEWFEQ 308 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~------~~il~~~~~~~ 308 (476)
|+.||.+.+...++.++..+...+|.++++++.+||++||+.||.+||++ +++++||||+.
T Consensus 220 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 220 GHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 99999999999999999999999999999999999999999999999999 89999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-54 Score=434.11 Aligned_cols=260 Identities=32% Similarity=0.619 Sum_probs=239.3
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
+.+++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 46789999999999999999999999999999999998764333344678899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp---------------------------- 133 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL---------------------------- 133 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG----------------------------
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCH----------------------------
Confidence 9999999999999998888999999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+|||++.+|.+||+|||+++.... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.
T Consensus 134 -------~NIll~~~g~vkL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~ 203 (337)
T 1o6l_A 134 -------ENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRL 203 (337)
T ss_dssp -------GGEEECTTSCEEECCCTTCBCSCC--TTCCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSC
T ss_pred -------HHEEECCCCCEEEeeccchhhccc--CCCcccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCC
Confidence 999999999999999999985322 23345678999999999999888875 89999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 251 PFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
||.+.+...++..+......+|..+++++.+||.+||+.||.+|| +++++++||||..
T Consensus 204 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 204 PFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 999999999999999999999999999999999999999999999 9999999999964
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=427.38 Aligned_cols=258 Identities=32% Similarity=0.689 Sum_probs=238.4
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
...+++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp -CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred CCChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence 35688999999999999999999999999999999999876443334467888999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp--------------------------- 134 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP--------------------------- 134 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCG---------------------------
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCh---------------------------
Confidence 99999999999999999888999999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||++.+|.+||+|||+++... ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+
T Consensus 135 --------~NIll~~~g~~kL~Dfg~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~ 200 (318)
T 1fot_A 135 --------ENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGY 200 (318)
T ss_dssp --------GGEEECTTSCEEECCCSSCEECS-----SCBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSS
T ss_pred --------heEEEcCCCCEEEeecCcceecC-----CccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCC
Confidence 99999999999999999998532 234567899999999999888875 8999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 250 LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
.||.+.+....+.++......+|..+++++.+||++||+.||.+|| +++++++||||+.
T Consensus 201 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 201 TPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp CTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 9999999999999999999999999999999999999999999999 9999999999974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-55 Score=439.64 Aligned_cols=262 Identities=45% Similarity=0.871 Sum_probs=237.3
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
...+++|++.+.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 45789999999999999999999999999999999999865433333356789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||+ +|+|.+++...+++++.+++.++.||+.||.|||++||+||||||
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp--------------------------- 136 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKP--------------------------- 136 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCST---------------------------
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCch---------------------------
Confidence 9999999 789999998888999999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||++.++.+||+|||++..... .....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|+
T Consensus 137 --------~NIll~~~~~~kl~DFG~s~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 205 (336)
T 3h4j_B 137 --------ENLLLDDNLNVKIADFGLSNIMTD---GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205 (336)
T ss_dssp --------TTEEECTTCCEEECCSSCTBTTTT---SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSS
T ss_pred --------hhEEEcCCCCEEEEEeccceeccC---CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCC
Confidence 999999999999999999986432 344567789999999999998888778999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 250 LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
.||.+.+....+.++..+.+.+|..+++++.+||++||+.||.+|||++++++||||+...
T Consensus 206 ~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 206 LPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp CSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred CCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence 9999887766666666677788999999999999999999999999999999999998643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-54 Score=433.92 Aligned_cols=262 Identities=32% Similarity=0.599 Sum_probs=237.4
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~ 87 (476)
....+++|++.+.||+|+||+||+|++..+|+.||||++++...........+.+|..+++.+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 357789999999999999999999999999999999999876433334467788999999877 8999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.+|+||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp------------------------- 146 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKL------------------------- 146 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG-------------------------
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCh-------------------------
Confidence 9999999999999999998888999999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.+|.+||+|||+++.... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++
T Consensus 147 ----------~NIll~~~g~vkL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~ 213 (345)
T 1xjd_A 147 ----------DNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLI 213 (345)
T ss_dssp ----------GGEEECTTSCEEECCCTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHH
T ss_pred ----------hhEEECCCCCEEEeEChhhhhccc--CCCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhc
Confidence 999999999999999999985322 23345678999999999999988875 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChH-HHhcCccccc
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIA-GIKADEWFEQ 308 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~-~il~~~~~~~ 308 (476)
|+.||.+.+...++.++..+...+|.++++++.+||.+||+.||.+||++. ++++||||..
T Consensus 214 g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 214 GQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 999999999999999999999999999999999999999999999999998 9999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=431.19 Aligned_cols=265 Identities=33% Similarity=0.598 Sum_probs=237.3
Q ss_pred hccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 011868 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (476)
Q Consensus 6 ~~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~ 84 (476)
.....+.+++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|..+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 91 (353)
T 2i0e_A 12 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 91 (353)
T ss_dssp -------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred CCcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence 344567899999999999999999999999999999999999876543344467788999999988 7999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
+.+.+|+||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 92 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp---------------------- 149 (353)
T 2i0e_A 92 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKL---------------------- 149 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG----------------------
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCH----------------------
Confidence 9999999999999999999998888999999999999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+|||++.+|.+||+|||+++.... ......+.+||+.|+|||++.+..|+ .++|||||||++|+
T Consensus 150 -------------~NIll~~~g~vkL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~e 213 (353)
T 2i0e_A 150 -------------DNVMLDSEGHIKIADFGMCKENIW--DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYE 213 (353)
T ss_dssp -------------GGEEECTTSCEEECCCTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHH
T ss_pred -------------HHEEEcCCCcEEEEeCCccccccc--CCcccccccCCccccChhhhcCCCcC-CcccccchHHHHHH
Confidence 999999999999999999985322 23345678999999999999888885 89999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC-----hHHHhcCccccc
Q 011868 245 ILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 308 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-----~~~il~~~~~~~ 308 (476)
|++|+.||.+.+...++.++......+|..+++++.+||.+||+.||.+||+ +++|++||||+.
T Consensus 214 ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 214 MLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 9999999999999999999999999999999999999999999999999995 699999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=426.09 Aligned_cols=262 Identities=30% Similarity=0.595 Sum_probs=237.4
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~ 87 (476)
..+.+++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 456789999999999999999999999999999999999887665666678899999999988 8999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp------------------------- 138 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL------------------------- 138 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG-------------------------
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCH-------------------------
Confidence 9999999999999999998888999999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.+|++||+|||+++.... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++
T Consensus 139 ----------~NIll~~~g~~kL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~ 205 (345)
T 3a8x_A 139 ----------DNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMA 205 (345)
T ss_dssp ----------GGEEECTTSCEEECCGGGCBCSCC--TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHH
T ss_pred ----------HHEEECCCCCEEEEeccccccccC--CCCcccccCCCccccCccccCCCCCC-hHHhHHHHHHHHHHHHh
Confidence 999999999999999999985322 23345677999999999999988875 89999999999999999
Q ss_pred CCCCCCC---------CcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh------HHHhcCccccc
Q 011868 248 GYLPFDD---------RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI------AGIKADEWFEQ 308 (476)
Q Consensus 248 G~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~------~~il~~~~~~~ 308 (476)
|+.||.. .+...++..+......+|..+++++.+||.+||+.||.+||++ +++++||||..
T Consensus 206 g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 206 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp SSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 9999975 3445677788888889999999999999999999999999996 79999999964
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=436.59 Aligned_cols=263 Identities=29% Similarity=0.589 Sum_probs=233.5
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~ 86 (476)
...+.+++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|..+++++ +||||+++++++.+.
T Consensus 46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 125 (396)
T 4dc2_A 46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 125 (396)
T ss_dssp ---CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence 3456788999999999999999999999999999999999887655555556788999999887 899999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
+.+|+||||++||+|.+++...+++++..++.++.||+.||+|||++||+||||||
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp------------------------ 181 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL------------------------ 181 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG------------------------
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCH------------------------
Confidence 99999999999999999999888999999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.+|.+||+|||+++.... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|+
T Consensus 182 -----------~NILl~~~g~ikL~DFGla~~~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell 247 (396)
T 4dc2_A 182 -----------DNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMM 247 (396)
T ss_dssp -----------GGEEECTTSCEEECCCTTCBCCCC--TTCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHH
T ss_pred -----------HHEEECCCCCEEEeecceeeeccc--CCCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHH
Confidence 999999999999999999985322 23456678999999999999988885 8999999999999999
Q ss_pred cCCCCCCCC---------cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh------HHHhcCccccc
Q 011868 247 TGYLPFDDR---------NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI------AGIKADEWFEQ 308 (476)
Q Consensus 247 tG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~------~~il~~~~~~~ 308 (476)
+|+.||.+. ....+++.+......+|..+++++.+||++||+.||.+||++ ++|++||||+.
T Consensus 248 ~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 248 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp HSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred hCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 999999642 334577888889999999999999999999999999999995 79999999964
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=429.20 Aligned_cols=260 Identities=34% Similarity=0.679 Sum_probs=240.5
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
.....+++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+..
T Consensus 35 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 114 (350)
T 1rdq_E 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34567899999999999999999999999999999999998765444445678899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.+|+||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp------------------------- 169 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP------------------------- 169 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG-------------------------
T ss_pred EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCcc-------------------------
Confidence 9999999999999999999888999999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.+|.+||+|||+++... ....+.+||+.|+|||++.+..++ .++|||||||++|+|++
T Consensus 170 ----------~NIll~~~g~~kL~DFg~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~ 233 (350)
T 1rdq_E 170 ----------ENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAA 233 (350)
T ss_dssp ----------GGEEECTTSCEEECCCTTCEECS-----SCBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHH
T ss_pred ----------ceEEECCCCCEEEcccccceecc-----CCcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhh
Confidence 99999999999999999998532 224567899999999999988875 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC-----hHHHhcCccccc
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 308 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-----~~~il~~~~~~~ 308 (476)
|+.||.+.+...++.++..+...+|..+++++.+||.+||+.||.+||+ +++|++||||..
T Consensus 234 g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 234 GYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 9999999999999999999999999999999999999999999999998 999999999974
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=425.43 Aligned_cols=260 Identities=33% Similarity=0.582 Sum_probs=234.5
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
....++|++++.||+|+||+||+|++..+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 3445689999999999999999999999999999999987643221 1357899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
..+|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp------------------------ 143 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKP------------------------ 143 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSG------------------------
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH------------------------
Confidence 99999999999999999998888899999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCC----CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHH
Q 011868 167 IRPWKFNVLQLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g----~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil 242 (476)
+|||++.++ .+||+|||++..... .......+||+.|+|||++.+..|+ .++|||||||++
T Consensus 144 -----------~NIll~~~~~~~~~vkl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil 208 (361)
T 2yab_A 144 -----------ENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVIT 208 (361)
T ss_dssp -----------GGEEESCTTSSSCCEEECCCSSCEECCT---TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHH
T ss_pred -----------HHEEEeCCCCCccCEEEEecCCceEcCC---CCccccCCCCccEECchHHcCCCCC-ccccHHHHHHHH
Confidence 999998877 799999999985432 3345567899999999999887775 899999999999
Q ss_pred HHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 243 YVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 243 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
|+|++|..||.+.+....+..+..+.+.++ ..+++.+.+||.+||..||.+|||++++++||||..
T Consensus 209 ~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 209 YILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 999999999999999999999998887765 468999999999999999999999999999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=426.62 Aligned_cols=263 Identities=27% Similarity=0.527 Sum_probs=237.2
Q ss_pred ccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 7 ~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
..+.+.+++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+.
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 45677899999999999999999999999999999999999876544444567899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
+.+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp------------------------ 143 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKP------------------------ 143 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG------------------------
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcH------------------------
Confidence 99999999999999999999888999999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc---CCCCCccchhhhHhHHHH
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILY 243 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~sDvwSlGvil~ 243 (476)
+|||++.+|.+||+|||++.... ......+.+||+.|+|||++.+ .+| +.++|||||||++|
T Consensus 144 -----------~NIll~~~g~vkL~DFG~a~~~~---~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~ 208 (384)
T 4fr4_A 144 -----------DNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAY 208 (384)
T ss_dssp -----------GGEEECTTSCEEECCCTTCEECC---TTCCBCCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHH
T ss_pred -----------HHeEECCCCCEEEeccceeeecc---CCCceeccCCCccccCCeeeccCCCCCC-CccceeechHHHHH
Confidence 99999999999999999998543 2344567899999999999874 335 48899999999999
Q ss_pred HHhcCCCCCCC---CcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC-hHHHhcCccccc
Q 011868 244 VILTGYLPFDD---RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-IAGIKADEWFEQ 308 (476)
Q Consensus 244 elltG~~Pf~~---~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-~~~il~~~~~~~ 308 (476)
+|++|+.||.+ .........+......+|..+++.+.+||.+||+.||.+||+ ++++++||||..
T Consensus 209 elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 209 ELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 99999999974 345567777778888899999999999999999999999998 899999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=426.41 Aligned_cols=262 Identities=35% Similarity=0.606 Sum_probs=229.8
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCC
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~-l~~l~HpnIv~l~~~~~~~~ 87 (476)
.....++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|..+ ++.++||||+++++++.+.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 45678899999999999999999999999999999999988765554555667778776 57789999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp------------------------- 167 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKP------------------------- 167 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG-------------------------
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCH-------------------------
Confidence 9999999999999999998888999999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.+|++||+|||+++.... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++
T Consensus 168 ----------~NIll~~~g~ikL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~ 234 (373)
T 2r5t_A 168 ----------ENILLDSQGHIVLTDFGLCKENIE--HNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLY 234 (373)
T ss_dssp ----------GGEEECTTSCEEECCCCBCGGGBC--CCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHH
T ss_pred ----------HHEEECCCCCEEEeeCcccccccc--CCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHc
Confidence 999999999999999999974221 23345678999999999999988875 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh----HHHhcCccccc
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI----AGIKADEWFEQ 308 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~----~~il~~~~~~~ 308 (476)
|..||.+.+...++.++......+|..+++.+.+||.+||+.||.+||++ +++++||||..
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 235 GLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp SSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 99999999999999999999999999999999999999999999999997 68999999964
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=405.48 Aligned_cols=263 Identities=32% Similarity=0.658 Sum_probs=237.2
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
...+.+++|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp -CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 45778999999999999999999999999999999999997765444444678999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
..|+||||+++|+|.+.+....++++..++.++.||+.||+|||++||+||||||
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp------------------------- 137 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP------------------------- 137 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCG-------------------------
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCCh-------------------------
Confidence 9999999999999999998888899999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++.+||+|||++..... ......+||+.|+|||++.+..++ .++||||+||++|+|++
T Consensus 138 ----------~Nili~~~~~~~l~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~ 202 (279)
T 3fdn_A 138 ----------ENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLV 202 (279)
T ss_dssp ----------GGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHH
T ss_pred ----------HhEEEcCCCCEEEEeccccccCCc----ccccccCCCCCccCHhHhccCCCC-ccchhHhHHHHHHHHHH
Confidence 999999999999999999864322 233456899999999999887664 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
|..||.+.+.......+......+|..+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus 203 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 203 GKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp SSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 999999999999999999999999999999999999999999999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=431.98 Aligned_cols=259 Identities=36% Similarity=0.695 Sum_probs=232.4
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++++.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+++..|+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34689999999999999999999999999999999987653 33446779999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||+.||+|.+.+...+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp----------------------------- 138 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKP----------------------------- 138 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSS-----------------------------
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCH-----------------------------
Confidence 999999999999999888999999999999999999999999999999997
Q ss_pred cccCCCCceEeC---CCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 172 FNVLQLENILLD---SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 172 ~~~~~~~NiLl~---~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+|||++ .++.+||+|||++..... ........+||+.|+|||++.+..|+ .++||||+||++|+|++|
T Consensus 139 ------~NIll~~~~~~~~vkL~DFG~a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G 209 (444)
T 3soa_A 139 ------ENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVG 209 (444)
T ss_dssp ------TTEEESBSSTTCCEEECCCSSCBCCCT--TCCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHS
T ss_pred ------HHEEEeccCCCCcEEEccCceeEEecC--CCceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhC
Confidence 999998 468899999999986543 22334567899999999999888775 899999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
..||.+.+....+..+..+.+.+|. .+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 210 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 210 YPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp SCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred CCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 9999999999999999988776553 479999999999999999999999999999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=417.30 Aligned_cols=262 Identities=39% Similarity=0.673 Sum_probs=225.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
-+++|++++.||+|+||+||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 46899999999999999999999999999999999976542 2234678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||++||+|.+++.....+++.+++.++.||+.||+|||++||+||||||
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp----------------------------- 133 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP----------------------------- 133 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG-----------------------------
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccch-----------------------------
Confidence 999999999999998878899999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+|||++.++.+||+|||++...............+||+.|+|||++.+..+.+.++|||||||++|+|++|+.|
T Consensus 134 ------~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 207 (323)
T 3tki_A 134 ------ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207 (323)
T ss_dssp ------GGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ------HHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence 99999999999999999998654322333445678999999999998888766889999999999999999999
Q ss_pred CCCCcHH-HHHHHHHhCCCCCC--CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 252 FDDRNLA-VLYQKIFRGDFKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 252 f~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
|.+.+.. ..+..........+ ..+++.+.+||.+||+.||.+|||++|+++||||.+..
T Consensus 208 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 208 WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp CSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 9876653 33333333333333 44899999999999999999999999999999998654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=405.21 Aligned_cols=259 Identities=29% Similarity=0.467 Sum_probs=220.4
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 5789999999999999999999999999999999986653 344467889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||+.+ +|.+.+.. .+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp----------------------------- 129 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKP----------------------------- 129 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG-----------------------------
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH-----------------------------
Confidence 999965 66665544 67899999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+|||++.++.+||+|||++..... ........+||+.|+|||++.+....+.++||||+||++|+|++|..|
T Consensus 130 ------~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p 201 (292)
T 3o0g_A 130 ------QNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_dssp ------GGEEECTTSCEEECCCTTCEECCS--CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCC
T ss_pred ------HHEEEcCCCCEEEeecccceecCC--ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCC
Confidence 999999999999999999975432 223345668999999999998877556899999999999999987777
Q ss_pred -CCCCcHHHHHHHHHhCCC-----------------------------CCCCCCCHHHHHHHHHccCCCcCCCCChHHHh
Q 011868 252 -FDDRNLAVLYQKIFRGDF-----------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301 (476)
Q Consensus 252 -f~~~~~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il 301 (476)
|.+.+.......+..... ..++.+++++.+||++||+.||.+|||+++++
T Consensus 202 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 202 LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 666666666666543110 11234688999999999999999999999999
Q ss_pred cCccccccC
Q 011868 302 ADEWFEQDY 310 (476)
Q Consensus 302 ~~~~~~~~~ 310 (476)
+||||....
T Consensus 282 ~hp~f~~~~ 290 (292)
T 3o0g_A 282 QHPYFSDFC 290 (292)
T ss_dssp TSGGGTTC-
T ss_pred cCcccccCC
Confidence 999998643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=435.17 Aligned_cols=262 Identities=32% Similarity=0.616 Sum_probs=228.4
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
....+++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++...+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 34567899999999999999999999999999999999987644344445678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||+ .||+||||||
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp------------------------- 277 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL------------------------- 277 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCG-------------------------
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCH-------------------------
Confidence 99999999999999999888899999999999999999999998 9999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.+|.+||+|||+|+.... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++
T Consensus 278 ----------~NIll~~~~~~kl~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~ 344 (446)
T 4ejn_A 278 ----------ENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMC 344 (446)
T ss_dssp ----------GGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHH
T ss_pred ----------HHEEECCCCCEEEccCCCceeccC--CCcccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhh
Confidence 999999999999999999985322 23345667899999999999888875 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
|+.||.+.+....+..+......+|..+++++.+||.+||+.||.+|| |++++++||||..
T Consensus 345 g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 345 GRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 999999999999999999999999999999999999999999999999 9999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=407.81 Aligned_cols=258 Identities=26% Similarity=0.457 Sum_probs=228.0
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
+-..++|++.+.||+|+||+||+|.+..+|+.||||++....... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 345678999999999999999999999999999999997654322 46789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||+.||+|.+++.. ..+++.+++.++.|++.||+|||++||+||||||
T Consensus 93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp--------------------------- 144 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS--------------------------- 144 (297)
T ss_dssp EEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG---------------------------
T ss_pred EEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCH---------------------------
Confidence 999999999999999976 4799999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||++.++.+||+|||++..... ........+||+.|+|||++.+..++ .++||||+||++|+|++|+
T Consensus 145 --------~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~ 213 (297)
T 3fxz_A 145 --------DNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGE 213 (297)
T ss_dssp --------GGEEECTTCCEEECCCTTCEECCS--TTCCBCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSS
T ss_pred --------HHEEECCCCCEEEeeCCCceecCC--cccccCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999875433 22334567899999999999888875 8999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhC---CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 250 LPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
.||.+.+.......+... ....|..+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 214 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 214 PPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp CTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 999988876665555443 234466789999999999999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-52 Score=414.43 Aligned_cols=263 Identities=36% Similarity=0.636 Sum_probs=226.2
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 83 (476)
...+..++|++.+.||+|+||+||+|++. .+|+.||+|++.+.... .......+.+|+.+|+.++||||+++++++
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 44677889999999999999999999985 68999999999865422 223346688999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHH
Q 011868 84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLL 163 (476)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~ 163 (476)
...+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp--------------------- 149 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKP--------------------- 149 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCT---------------------
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCH---------------------
Confidence 99999999999999999999998888899999999999999999999999999999997
Q ss_pred hhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHH
Q 011868 164 MIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243 (476)
Q Consensus 164 ~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ 243 (476)
+|||++.+|.+||+|||+++.... ........+||+.|+|||++.+..++ .++|||||||++|
T Consensus 150 --------------~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ 212 (327)
T 3a62_A 150 --------------ENIMLNHQGHVKLTDFGLCKESIH--DGTVTHTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMY 212 (327)
T ss_dssp --------------TTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHH
T ss_pred --------------HHeEECCCCcEEEEeCCccccccc--CCccccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHH
Confidence 999999999999999999974322 22334567899999999999887775 8999999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 244 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 244 elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
+|++|+.||.+.+......++......+|..+++++.+||.+||+.||.+|| +++++++||||..
T Consensus 213 el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 213 DMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 9999999999999999999999999999999999999999999999999999 8899999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=404.01 Aligned_cols=269 Identities=32% Similarity=0.681 Sum_probs=239.5
Q ss_pred hhhhccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEE
Q 011868 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV 82 (476)
Q Consensus 3 ~~~~~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~ 82 (476)
+++-+.....+++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||++++++
T Consensus 3 l~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 82 (284)
T 2vgo_A 3 LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY 82 (284)
T ss_dssp -------CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhCCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEE
Confidence 45667788899999999999999999999999999999999999976543333445789999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHH
Q 011868 83 LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFL 162 (476)
Q Consensus 83 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~ 162 (476)
+...+..|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||
T Consensus 83 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p-------------------- 142 (284)
T 2vgo_A 83 FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKP-------------------- 142 (284)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSG--------------------
T ss_pred EEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCH--------------------
Confidence 999999999999999999999998888899999999999999999999999999999997
Q ss_pred HhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHH
Q 011868 163 LMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242 (476)
Q Consensus 163 ~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil 242 (476)
+||+++.++.+||+|||++..... ......+||+.|+|||++.+..++ .++|||||||++
T Consensus 143 ---------------~Nil~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il 202 (284)
T 2vgo_A 143 ---------------ENLLMGYKGELKIADFGWSVHAPS----LRRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLC 202 (284)
T ss_dssp ---------------GGEEECTTCCEEECCCTTCEECSS----SCBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHH
T ss_pred ---------------HHEEEcCCCCEEEecccccccCcc----cccccccCCCCcCCHHHhccCCCC-cccchhhHHHHH
Confidence 999999999999999999864322 223456899999999999887775 899999999999
Q ss_pred HHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 243 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 243 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
|+|++|..||...+.......+......+|..+++++.+||.+||+.||.+|||++++++||||+....
T Consensus 203 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 203 YEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 999999999999998888888888888999999999999999999999999999999999999986543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=413.21 Aligned_cols=256 Identities=25% Similarity=0.477 Sum_probs=231.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++++.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 3579999999999999999999999999999999996542 234678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
||||++||+|.+++... ..+++.+++.++.||+.||.|||++||+||||||
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp---------------------------- 130 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP---------------------------- 130 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG----------------------------
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCH----------------------------
Confidence 99999999999999765 4799999999999999999999999999999997
Q ss_pred ccccCCCCceEeCC--CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 171 KFNVLQLENILLDS--KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 171 ~~~~~~~~NiLl~~--~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+|||++. ++.+||+|||++..... .......+||+.|+|||++.+..++ .++|||||||++|+|++|
T Consensus 131 -------~NIl~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g 199 (321)
T 1tki_A 131 -------ENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSG 199 (321)
T ss_dssp -------GGEEESSSSCCCEEECCCTTCEECCT---TCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHS
T ss_pred -------HHEEEccCCCCCEEEEECCCCeECCC---CCccccccCChhhcCcHHhcCCCCC-chhhHHHHHHHHHHHHhC
Confidence 9999997 78999999999985432 3345567899999999999877664 899999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
..||.+.+.......+..+.+.++ ..+++++.+||.+||..||.+|||+.++++||||.+..
T Consensus 200 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 200 INPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp SCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred CCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 999999999999999988887766 36899999999999999999999999999999998653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=418.98 Aligned_cols=256 Identities=38% Similarity=0.719 Sum_probs=231.7
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3579999999999999999999999999999999987653 334467899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|||+.||+|.+.+.....+++.+++.++.||+.||+|||++||+||||||
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp------------------------------ 156 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKP------------------------------ 156 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSG------------------------------
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCch------------------------------
Confidence 99999999999998888899999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCC---CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 173 NVLQLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 173 ~~~~~~NiLl~~~g---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||++.++ .+||+|||++..... .......+||+.|+|||++.+..|+ .++|||||||++|+|++|+
T Consensus 157 -----~NIll~~~~~~~~~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~ 227 (362)
T 2bdw_A 157 -----ENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGY 227 (362)
T ss_dssp -----GGEEESCSSTTCCEEECCCTTCBCCTT---CCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSS
T ss_pred -----HHEEEecCCCCCCEEEeecCcceEecC---CcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCC
Confidence 999998654 599999999986442 2334567899999999999888775 8999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 250 LPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
.||.+.+....+..+..+.+.+|. .+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 228 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 228 PPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 999999998999999888776653 37999999999999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=400.66 Aligned_cols=266 Identities=49% Similarity=0.906 Sum_probs=231.7
Q ss_pred ccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 7 ~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
..+.+..++|++++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 45667889999999999999999999999999999999999765433334467899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
+..|+||||+++++|.+++...+++++.+++.++.||+.||.|||++||+||||||
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p------------------------ 139 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKP------------------------ 139 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCG------------------------
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCh------------------------
Confidence 99999999999999999998888899999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+||+++.++.+||+|||++..... .......+||+.|+|||++.+..+.+.++|||||||++|+|+
T Consensus 140 -----------~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 205 (276)
T 2h6d_A 140 -----------ENVLLDAHMNAKIADFGLSNMMSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL 205 (276)
T ss_dssp -----------GGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred -----------hhEEECCCCCEEEeecccccccCC---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 999999999999999999985432 223445689999999999988777668899999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
+|..||.+.+....+..+..+....|..+++.+.+||.+||+.||.+|||++++++||||++..
T Consensus 206 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 206 CGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 9999999999888888898888888999999999999999999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=413.75 Aligned_cols=247 Identities=24% Similarity=0.329 Sum_probs=194.0
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI 89 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----~~ 89 (476)
.+|.+.++||+|+||+||+|++ +|+.||||+++... ........|+..+.+++||||+++++++..++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999986 68999999996542 11233445677777889999999999997653 68
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~--------givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
|||||||+||+|.+++.. .++++.++.+++.|++.||+|||++ +|+||||||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp------------------- 136 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS------------------- 136 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCG-------------------
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCc-------------------
Confidence 999999999999999976 5799999999999999999999987 999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC--CCcccccccCCccccccccccCC------CCCccc
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANRG------YDGATS 233 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~------~~~~~s 233 (476)
+|||++.++++||+|||+|+....... .....+.+||+.|||||++.+.. | +.++
T Consensus 137 ----------------~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~-~~k~ 199 (303)
T 3hmm_A 137 ----------------KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES-FKRA 199 (303)
T ss_dssp ----------------GGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHH-HHHH
T ss_pred ----------------ccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCcc-ChhH
Confidence 999999999999999999985433211 11234568999999999987642 3 4789
Q ss_pred hhhhHhHHHHHHhcCCCCCCCC---------------cHHHHHHHHHhCCC--CCCCC-----CCHHHHHHHHHccCCCc
Q 011868 234 DIWSCGVILYVILTGYLPFDDR---------------NLAVLYQKIFRGDF--KLPKW-----LSPGAQNLLRKILEPNP 291 (476)
Q Consensus 234 DvwSlGvil~elltG~~Pf~~~---------------~~~~~~~~i~~~~~--~~p~~-----~s~~~~~Li~~~L~~dP 291 (476)
|||||||+||||+||..||... ....+...+..... ++|.. .++.+.+||.+||+.||
T Consensus 200 DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP 279 (303)
T 3hmm_A 200 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279 (303)
T ss_dssp HHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSG
T ss_pred hhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCH
Confidence 9999999999999997765321 22334444443332 33432 22468899999999999
Q ss_pred CCCCChHHHhcC
Q 011868 292 VKRITIAGIKAD 303 (476)
Q Consensus 292 ~~R~s~~~il~~ 303 (476)
++|||+.+|++.
T Consensus 280 ~~RPt~~ei~~~ 291 (303)
T 3hmm_A 280 AARLTALRIKKT 291 (303)
T ss_dssp GGSCCHHHHHHH
T ss_pred hHCcCHHHHHHH
Confidence 999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=409.84 Aligned_cols=258 Identities=34% Similarity=0.604 Sum_probs=231.2
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
..++|++.+.||+|+||+||+|.+..+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.....
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34679999999999999999999999999999999986543221 135779999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
.|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp-------------------------- 142 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKP-------------------------- 142 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCG--------------------------
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCH--------------------------
Confidence 999999999999999998888899999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCC----CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 169 PWKFNVLQLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g----~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+|||++.++ .+||+|||++..... .......+||+.|+|||++.+..++ .++|||||||++|+
T Consensus 143 ---------~NIll~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ 209 (326)
T 2y0a_A 143 ---------ENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYI 209 (326)
T ss_dssp ---------GGEEESCSSSSSCCEEECCCTTCEECCT---TSCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHH
T ss_pred ---------HHEEEecCCCCCCCEEEEECCCCeECCC---CCccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHH
Confidence 999999888 899999999985432 2334567899999999999887775 89999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 245 ILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
|++|..||.+.+.......+......++ ..+++.+.+||++||+.||.+|||++++++||||..
T Consensus 210 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 210 LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp HHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 9999999999988888888887776654 458999999999999999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=428.67 Aligned_cols=262 Identities=31% Similarity=0.529 Sum_probs=229.8
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
....++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 45678999999999999999999999999999999999764432222345588999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||++||+|.+++.. .++++..++.++.||+.||+|||++||+||||||
T Consensus 145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp--------------------------- 196 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP--------------------------- 196 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG---------------------------
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCH---------------------------
Confidence 999999999999999875 5799999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC---CCCccchhhhHhHHHHHHh
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~sDvwSlGvil~ell 246 (476)
+|||++.+|++||+|||+++..... ......+.+||+.|+|||++.+.+ +.+.++|||||||++|+|+
T Consensus 197 --------~NILl~~~g~ikL~DFG~a~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell 267 (410)
T 3v8s_A 197 --------DNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267 (410)
T ss_dssp --------GGEEECTTSCEEECCCTTCEECCTT-SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHH
T ss_pred --------HHeeECCCCCEEEeccceeEeeccC-CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHH
Confidence 9999999999999999999754321 111344679999999999998755 1348999999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCC--CCCC--CCCCHHHHHHHHHccCCCcCC--CCChHHHhcCccccc
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGD--FKLP--KWLSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 308 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~Li~~~L~~dP~~--R~s~~~il~~~~~~~ 308 (476)
+|+.||.+.+....+.++..+. +.+| ..+++++.+||++||+.+|.+ |+++++|++||||+.
T Consensus 268 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 268 VGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred hCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 9999999999999999887653 4444 469999999999999999998 999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=428.40 Aligned_cols=262 Identities=27% Similarity=0.506 Sum_probs=228.8
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
....++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 34567999999999999999999999999999999999865432323334588999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp-------------------------- 203 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKP-------------------------- 203 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG--------------------------
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCH--------------------------
Confidence 999999999999999987 56899999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccc-----cCCCCCccchhhhHhHHHH
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILY 243 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~sDvwSlGvil~ 243 (476)
+|||++.+|.+||+|||+|+..... ........+||+.|+|||++. ...| +.++|||||||++|
T Consensus 204 ---------~NILl~~~g~vkL~DFGla~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~ 272 (437)
T 4aw2_A 204 ---------DNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMY 272 (437)
T ss_dssp ---------GGEEECTTSCEEECCCTTCEECCTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHH
T ss_pred ---------HHeeEcCCCCEEEcchhhhhhcccC-CCcccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHH
Confidence 9999999999999999999754321 112234568999999999987 3345 58999999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHHhC--CCCCCCC---CCHHHHHHHHHccCCCcCC--CCChHHHhcCccccc
Q 011868 244 VILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW---LSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 308 (476)
Q Consensus 244 elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~---~s~~~~~Li~~~L~~dP~~--R~s~~~il~~~~~~~ 308 (476)
||++|+.||.+.+....+.++... .+.+|.. +++++.+||++||..+|++ |++++++++||||..
T Consensus 273 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 273 EMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred HHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 999999999999999888888753 3555544 8999999999999999988 999999999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=405.94 Aligned_cols=262 Identities=36% Similarity=0.647 Sum_probs=222.5
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccc-----------------------hhHHHHHHHH
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----------------------LKITDQIKRE 64 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~-----------------------~~~~~~~~~E 64 (476)
.....+++|++.+.||+|+||+||+|++..+++.||||++....... ....+.+.+|
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 34567899999999999999999999999999999999997654211 1123568999
Q ss_pred HHHHHhCCCCCcceEEEEEEe--CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCc
Q 011868 65 IATLKLLKHPNVVRLHEVLAS--KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKV 142 (476)
Q Consensus 65 i~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp 142 (476)
+.+++.++||||+++++++.. ...+|+||||+++++|.+++. ..++++.+++.++.||+.||+|||++||+||||||
T Consensus 87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 165 (298)
T 2zv2_A 87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165 (298)
T ss_dssp HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 999999999999999999986 678999999999999988653 45799999999999999999999999999999997
Q ss_pred chhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccc
Q 011868 143 ILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 222 (476)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~ 222 (476)
+|||++.+|.+||+|||++..... ........+||+.|+|||+
T Consensus 166 -----------------------------------~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~ 208 (298)
T 2zv2_A 166 -----------------------------------SNLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPES 208 (298)
T ss_dssp -----------------------------------GGEEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGG
T ss_pred -----------------------------------HHEEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhh
Confidence 999999999999999999985432 2223455689999999999
Q ss_pred cccCCC--CCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHccCCCcCCCCChH
Q 011868 223 LANRGY--DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--KWLSPGAQNLLRKILEPNPVKRITIA 298 (476)
Q Consensus 223 l~~~~~--~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~Li~~~L~~dP~~R~s~~ 298 (476)
+.+... .+.++|||||||++|+|++|+.||.+.+.......+......+| ..+++++.+||.+||+.||.+|||+.
T Consensus 209 ~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~ 288 (298)
T 2zv2_A 209 LSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVP 288 (298)
T ss_dssp CCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHH
Confidence 876542 35789999999999999999999999988888888877766655 45899999999999999999999999
Q ss_pred HHhcCcccc
Q 011868 299 GIKADEWFE 307 (476)
Q Consensus 299 ~il~~~~~~ 307 (476)
++++||||.
T Consensus 289 e~l~hp~~~ 297 (298)
T 2zv2_A 289 EIKLHPWVT 297 (298)
T ss_dssp HHTTCHHHH
T ss_pred HHhcCcccc
Confidence 999999996
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=416.86 Aligned_cols=259 Identities=40% Similarity=0.769 Sum_probs=218.8
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
...++|++++.||+|+||+||+|++..+++.||||++...... ...+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 4567999999999999999999999999999999999765422 356889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
+||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp---------------------------- 144 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKL---------------------------- 144 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCG----------------------------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH----------------------------
Confidence 9999999999999998888999999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCC--EEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 171 KFNVLQLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~--vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+|||++.++. +||+|||+++... ........+||+.|+|||++.+..+++.++|||||||++|+|++|
T Consensus 145 -------~Nill~~~~~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 214 (361)
T 3uc3_A 145 -------ENTLLDGSPAPRLKICDFGYSKSSV---LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214 (361)
T ss_dssp -------GGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHS
T ss_pred -------HHEEEcCCCCceEEEeecCcccccc---ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhC
Confidence 9999987765 9999999997422 223345568999999999999888876669999999999999999
Q ss_pred CCCCCCCc----HHHHHHHHHhCCCCCCC--CCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 249 YLPFDDRN----LAVLYQKIFRGDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 249 ~~Pf~~~~----~~~~~~~i~~~~~~~p~--~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
+.||.+.+ .......+......+|. .+++++.+||++||+.||.+|||++++++||||.+...
T Consensus 215 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 215 AYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp SCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred CCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 99998754 34555666666666665 47999999999999999999999999999999987543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=397.71 Aligned_cols=266 Identities=34% Similarity=0.605 Sum_probs=242.2
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
....++|++.+.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 45678999999999999999999999999999999999877655556678899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||+.+++|.+++...+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p--------------------------- 143 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL--------------------------- 143 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG---------------------------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCh---------------------------
Confidence 99999999999999998888899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+||+++.++.+||+|||++..... ........+||+.|+|||++.+..++ .++||||+||++|+|++|+
T Consensus 144 --------~Nil~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~ 212 (294)
T 2rku_A 144 --------GNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGK 212 (294)
T ss_dssp --------GGEEECTTCCEEECCCTTCEECCS--TTCCBCCCCSCCSSCCHHHHTTSCBC-THHHHHHHHHHHHHHHHSS
T ss_pred --------HhEEEcCCCCEEEEeccCceeccc--CccccccccCCCCcCCcchhccCCCC-chhhHHHHHHHHHHHHhCC
Confidence 999999999999999999975432 12234456799999999999887774 8999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCCCC
Q 011868 250 LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 313 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~~~ 313 (476)
.||.+.+....+..+......+|..+++.+.+||.+||+.||.+|||++++++||||.....+.
T Consensus 213 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 213 PPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp CTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred CCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 9999999888888888888889999999999999999999999999999999999998766543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=412.93 Aligned_cols=258 Identities=32% Similarity=0.641 Sum_probs=224.2
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
.-++|++.+.||+|+||+||+|.+..+|+.||||++....... ....+.+.+|+.+++.++||||+++++++..++.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3468999999999999999999999999999999997543211 11257799999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 90 YMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
|+||||++||+|.+.+... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp----------------------- 158 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKP----------------------- 158 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG-----------------------
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCh-----------------------
Confidence 9999999999999888542 3589999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCC---EEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~---vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil 242 (476)
+|||++.++. +||+|||++..... ........+||+.|+|||++.+..|+ .++|||||||++
T Consensus 159 ------------~NIl~~~~~~~~~vkl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il 223 (351)
T 3c0i_A 159 ------------HCVLLASKENSAPVKLGGFGVAIQLGE--SGLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVIL 223 (351)
T ss_dssp ------------GGEEECSSSTTCCEEECCCTTCEECCT--TSCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHH
T ss_pred ------------HHeEEecCCCCCcEEEecCcceeEecC--CCeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHH
Confidence 9999987665 99999999975433 12234567899999999999888775 899999999999
Q ss_pred HHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 243 YVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 243 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
|+|++|+.||.+.+ ...+..+..+.+..+ ..+++++.+||++||+.||.+|||+.++++||||..
T Consensus 224 ~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 224 FILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 99999999998854 456677777776654 458999999999999999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=405.47 Aligned_cols=265 Identities=34% Similarity=0.609 Sum_probs=242.1
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
...++|++++.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 45678999999999999999999999999999999998776555566788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
+||||+.+++|.+++.....+++.+++.++.||+.||+|||++||+||||||
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp---------------------------- 169 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL---------------------------- 169 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG----------------------------
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCc----------------------------
Confidence 9999999999999998888899999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+||+++.++.+||+|||++..... ........+||+.|+|||++.+..+. .++|||||||++|+|++|+.
T Consensus 170 -------~NIl~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~ 239 (335)
T 2owb_A 170 -------GNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKP 239 (335)
T ss_dssp -------GGEEECTTCCEEECCCTTCEECCS--TTCCBCCCCSCCSSCCHHHHHTSCBC-THHHHHHHHHHHHHHHHSSC
T ss_pred -------hhEEEcCCCCEEEeeccCceeccc--CcccccccCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHHHCcC
Confidence 999999999999999999985432 12234456799999999999887774 89999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCCCC
Q 011868 251 PFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 313 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~~~ 313 (476)
||.+.+....+..+....+.+|..+++.+.+||.+||+.||.+|||++++++||||...+.+.
T Consensus 240 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 240 PFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp TTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred CCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence 999998888888888888899999999999999999999999999999999999998876553
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=407.18 Aligned_cols=262 Identities=27% Similarity=0.438 Sum_probs=209.1
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++++.||+|+||+||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++..++..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 46789999999999999999999999999999999976542 2234678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 92 VLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
||||+. |+|.+++... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp----------------------- 136 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKP----------------------- 136 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG-----------------------
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCh-----------------------
Confidence 999997 5999998653 3599999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+|||++.+|.+||+|||++..... ........+||+.|+|||++.+....+.++|||||||++|+|
T Consensus 137 ------------~NIl~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 202 (317)
T 2pmi_A 137 ------------QNLLINKRGQLKLGDFGLARAFGI--PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEM 202 (317)
T ss_dssp ------------GGEEECTTCCEEECCCSSCEETTS--CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred ------------HHeEEcCCCCEEECcCccceecCC--CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999999985432 122344568999999999998754445899999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCC--C--------------------------------CCCCCCCHHHHHHHHHccCCCc
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGD--F--------------------------------KLPKWLSPGAQNLLRKILEPNP 291 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~--~--------------------------------~~p~~~s~~~~~Li~~~L~~dP 291 (476)
++|+.||.+.+.......+.... . ..+..+++++.+||.+||+.||
T Consensus 203 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 282 (317)
T 2pmi_A 203 ITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNP 282 (317)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSG
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCc
Confidence 99999999988877766654310 0 0122478899999999999999
Q ss_pred CCCCChHHHhcCccccccCCCC
Q 011868 292 VKRITIAGIKADEWFEQDYTPA 313 (476)
Q Consensus 292 ~~R~s~~~il~~~~~~~~~~~~ 313 (476)
.+|||++++++||||.+.+.++
T Consensus 283 ~~Rpt~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 283 DMRLSAKQALHHPWFAEYYHHA 304 (317)
T ss_dssp GGSCCHHHHTTSGGGGGGCC--
T ss_pred ccCCCHHHHhCChhhhcccchh
Confidence 9999999999999999876554
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=447.39 Aligned_cols=262 Identities=33% Similarity=0.606 Sum_probs=238.3
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~ 87 (476)
..+.+++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|..++..+ +||||+++++++.+.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 346788999999999999999999999999999999999876443344457788999999988 6999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.+|+||||++||+|.+++...+++++.+++.|+.||+.||+|||++||+||||||
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp------------------------- 470 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKL------------------------- 470 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCS-------------------------
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCCh-------------------------
Confidence 9999999999999999999888999999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.+|++||+|||+|+.... ......+.+||+.|+|||++.+..|+ .++|||||||++|||++
T Consensus 471 ----------~NILl~~~g~ikL~DFGla~~~~~--~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyellt 537 (674)
T 3pfq_A 471 ----------DNVMLDSEGHIKIADFGMCKENIW--DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLA 537 (674)
T ss_dssp ----------TTEEECSSSCEEECCCTTCEECCC--TTCCBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHH
T ss_pred ----------hhEEEcCCCcEEEeecceeecccc--CCcccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHc
Confidence 999999999999999999984322 23345678999999999999888885 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCCh-----HHHhcCccccc
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI-----AGIKADEWFEQ 308 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~-----~~il~~~~~~~ 308 (476)
|+.||.+.+...++.+|......+|..+++++.+||++||+.||.+||++ ++|++||||+.
T Consensus 538 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 538 GQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp SSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 99999999999999999999999999999999999999999999999998 99999999974
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=398.81 Aligned_cols=262 Identities=30% Similarity=0.632 Sum_probs=209.0
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
+..+++|++.+.||+|+||+||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++...+..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 45678999999999999999999999999999999999765433334457899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||+++++|.+++... .++++.+++.++.||+.||+|||++||+||||||
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p-------------------------- 140 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTL-------------------------- 140 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCG--------------------------
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH--------------------------
Confidence 9999999999999999865 5799999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+||+++.++.+||+|||++...... .......+||+.|+|||++.+..+. .++||||+||++|+|++|
T Consensus 141 ---------~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g 208 (278)
T 3cok_A 141 ---------SNLLLTRNMNIKIADFGLATQLKMP--HEKHYTLCGTPNYISPEIATRSAHG-LESDVWSLGCMFYTLLIG 208 (278)
T ss_dssp ---------GGEEECTTCCEEECCCTTCEECC-------------------------------CTHHHHHHHHHHHHHHS
T ss_pred ---------HHEEEcCCCCEEEEeecceeeccCC--CCcceeccCCCCcCCcchhcCCCCC-chhhHHHHHHHHHHHHhC
Confidence 9999999999999999999754321 2223456799999999999877664 899999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
+.||...+......++....+..|..+++++.+||.+||+.||.+|||++++++||||...
T Consensus 209 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 209 RPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp SCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred CCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 9999987766666666666777888899999999999999999999999999999999764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=422.59 Aligned_cols=261 Identities=25% Similarity=0.465 Sum_probs=227.4
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
....++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|..+++.++||||+++++++.+.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999865433333345688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp-------------------------- 190 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP-------------------------- 190 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG--------------------------
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCH--------------------------
Confidence 9999999999999999864 4799999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc-------CCCCCccchhhhHhHH
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-------RGYDGATSDIWSCGVI 241 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-------~~~~~~~sDvwSlGvi 241 (476)
+|||++.+|++||+|||+++..... ........+||+.|+|||++.. ..| +.++|||||||+
T Consensus 191 ---------~NILld~~g~vkL~DFGla~~~~~~-~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvi 259 (412)
T 2vd5_A 191 ---------DNILLDRCGHIRLADFGSCLKLRAD-GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVF 259 (412)
T ss_dssp ---------GGEEECTTSCEEECCCTTCEECCTT-SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHH
T ss_pred ---------HHeeecCCCCEEEeechhheeccCC-CccccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHH
Confidence 9999999999999999999754321 1112345689999999999873 345 589999999999
Q ss_pred HHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCC---CCCCHHHHHHHHHccCCCcCCC---CChHHHhcCccccc
Q 011868 242 LYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP---KWLSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQ 308 (476)
Q Consensus 242 l~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~~~~Li~~~L~~dP~~R---~s~~~il~~~~~~~ 308 (476)
+|+|++|+.||.+.+....+.++.... ..+| ..+++++.+||++||. +|.+| ++++++++||||..
T Consensus 260 lyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 260 AYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp HHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 999999999999999988888887532 3444 5799999999999999 99998 59999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=414.28 Aligned_cols=263 Identities=22% Similarity=0.382 Sum_probs=220.8
Q ss_pred ccCcCEEEeceEeec--CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 11 MRLGRYELGRTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G--~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
...++|++++.||+| +||+||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 456799999999999 999999999999999999999987653 34556889999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 89 IYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp------------------------ 156 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKA------------------------ 156 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG------------------------
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH------------------------
Confidence 99999999999999999775 6799999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCccc-----CCCcccccccCCcccccccccc--CCCCCccchhhhHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFR-----DDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCG 239 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~APE~l~~--~~~~~~~sDvwSlG 239 (476)
+|||++.+|.+||+|||++....... ........+||+.|+|||++.+ ..| +.++||||||
T Consensus 157 -----------~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG 224 (389)
T 3gni_B 157 -----------SHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVG 224 (389)
T ss_dssp -----------GGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHH
T ss_pred -----------HHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHH
Confidence 99999999999999999886432211 1122334589999999999987 455 4899999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHHhCC----------------------------------------------CCCCC
Q 011868 240 VILYVILTGYLPFDDRNLAVLYQKIFRGD----------------------------------------------FKLPK 273 (476)
Q Consensus 240 vil~elltG~~Pf~~~~~~~~~~~i~~~~----------------------------------------------~~~p~ 273 (476)
|++|+|++|+.||.+.+.......+..+. .+.+.
T Consensus 225 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (389)
T 3gni_B 225 ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHR 304 (389)
T ss_dssp HHHHHHHHSSCTTTTCCSTTHHHHC-------------------------------------------------------
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcccc
Confidence 99999999999998765443333322211 12345
Q ss_pred CCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 274 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 274 ~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
.+++++.+||++||+.||.+|||++++++||||+...
T Consensus 305 ~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 305 TFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp -CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 5789999999999999999999999999999998643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=403.65 Aligned_cols=259 Identities=29% Similarity=0.417 Sum_probs=215.5
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
....++|++++.||+|+||+||+|++. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.++...
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence 345789999999999999999999984 699999999976542 333457889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||+. |+|.+.+... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 95 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp-------------------------- 147 (311)
T 3niz_A 95 TLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKP-------------------------- 147 (311)
T ss_dssp EEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG--------------------------
T ss_pred EEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCch--------------------------
Confidence 99999996 5888888654 4699999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+|||++.++.+||+|||+++.... ........+||+.|+|||++.+....+.++||||+||++|+|++|
T Consensus 148 ---------~NIl~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 216 (311)
T 3niz_A 148 ---------QNLLINSDGALKLADFGLARAFGI--PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216 (311)
T ss_dssp ---------GGEEECTTCCEEECCCTTCEETTS--CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred ---------HhEEECCCCCEEEccCcCceecCC--CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhC
Confidence 999999999999999999985432 223344568999999999998755445899999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhC--CCC----------------------------CCCCCCHHHHHHHHHccCCCcCCCCChH
Q 011868 249 YLPFDDRNLAVLYQKIFRG--DFK----------------------------LPKWLSPGAQNLLRKILEPNPVKRITIA 298 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~--~~~----------------------------~p~~~s~~~~~Li~~~L~~dP~~R~s~~ 298 (476)
+.||.+.+......++... ... ..+.+++++.+||.+||+.||.+|||++
T Consensus 217 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 296 (311)
T 3niz_A 217 KPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISAR 296 (311)
T ss_dssp SCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred CCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHH
Confidence 9999887765555544321 000 1123678999999999999999999999
Q ss_pred HHhcCccccc
Q 011868 299 GIKADEWFEQ 308 (476)
Q Consensus 299 ~il~~~~~~~ 308 (476)
++++||||+.
T Consensus 297 ell~hp~f~~ 306 (311)
T 3niz_A 297 DAMNHPYFKD 306 (311)
T ss_dssp HHHTSGGGTT
T ss_pred HHhcCccccc
Confidence 9999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=390.32 Aligned_cols=259 Identities=37% Similarity=0.704 Sum_probs=232.5
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 45789999999999999999999999999999999987653 34446789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||++|++|.+.+.....+++.+++.++.||+.||+|||++||+||||||
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp----------------------------- 133 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKP----------------------------- 133 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG-----------------------------
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCH-----------------------------
Confidence 999999999999998888899999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCC---EEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 172 FNVLQLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~---vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+||+++.++. +||+|||++..... ........||+.|+|||++.+..++ .++||||+||++|+|++|
T Consensus 134 ------~Nil~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g 203 (284)
T 3kk8_A 134 ------ENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVG 203 (284)
T ss_dssp ------GGEEESSSSTTCCEEECCCTTCEECCS---SCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHS
T ss_pred ------HHEEEecCCCCCcEEEeeceeeEEccc---CccccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHC
Confidence 9999987665 99999999975432 2334456899999999999888775 899999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
+.||.+.+.......+..+....| ..+++++.+||.+||+.||.+|||++++++||||....
T Consensus 204 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 204 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred CCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 999999998888888888776554 35799999999999999999999999999999997643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=399.16 Aligned_cols=256 Identities=32% Similarity=0.496 Sum_probs=215.3
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+++|++++.||+|+||+||+|++ .+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 47899999999999999999998 7899999999976542 233346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||+.+ +|.+.+... +.+++.+++.++.||+.||+|||++||+||||||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp----------------------------- 128 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKP----------------------------- 128 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG-----------------------------
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH-----------------------------
Confidence 999965 999988764 6799999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||+++.+|.+||+|||++..... ........+||+.|+|||++.+....+.++||||+||++|+|++|+.|
T Consensus 129 ------~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 200 (288)
T 1ob3_A 129 ------QNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200 (288)
T ss_dssp ------GGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ------HHEEEcCCCCEEEeECccccccCc--cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999874322 122334567999999999997755445899999999999999999999
Q ss_pred CCCCcHHHHHHHHHhC--CC---------------------------CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 252 FDDRNLAVLYQKIFRG--DF---------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~--~~---------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|.+.+......++... .. .++..+++++.+||++||+.||.+|||++++++
T Consensus 201 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 9998877666655431 00 012347889999999999999999999999999
Q ss_pred Cccccc
Q 011868 303 DEWFEQ 308 (476)
Q Consensus 303 ~~~~~~ 308 (476)
||||++
T Consensus 281 hp~f~~ 286 (288)
T 1ob3_A 281 HAYFKE 286 (288)
T ss_dssp SGGGGC
T ss_pred Ccchhh
Confidence 999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=411.78 Aligned_cols=254 Identities=37% Similarity=0.642 Sum_probs=224.2
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~ 89 (476)
...++|++.+.||+|+||+||+|.+..+|+.||||++.+... ...+|+.++.++ +||||+++++++.+....
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 345689999999999999999999999999999999977642 234688888887 799999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||++||+|.+.+...+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp--------------------------- 144 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKP--------------------------- 144 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG---------------------------
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCH---------------------------
Confidence 99999999999999999888899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCC-C---CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 170 WKFNVLQLENILLDSK-G---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~-g---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+|||+..+ + .+||+|||++..... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|
T Consensus 145 --------~NIl~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el 213 (342)
T 2qr7_A 145 --------SNILYVDESGNPESIRICDFGFAKQLRA--ENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTM 213 (342)
T ss_dssp --------GGEEESSSSCSGGGEEECCCTTCEECBC--TTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHH
T ss_pred --------HHEEEecCCCCcCeEEEEECCCcccCcC--CCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHH
Confidence 99998543 3 499999999985432 23345677999999999999887775 899999999999999
Q ss_pred hcCCCCCCC---CcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 246 LTGYLPFDD---RNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 246 ltG~~Pf~~---~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
++|..||.+ .+...++..+..+.+.++ ..+++++.+||++||+.||.+|||+.++++||||..+
T Consensus 214 l~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 214 LTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp HHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred hcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 999999986 456778888888877655 4589999999999999999999999999999999753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=411.55 Aligned_cols=260 Identities=29% Similarity=0.565 Sum_probs=230.9
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
+...++|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+|+.+|+.++||||+++++++......
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 455689999999999999999999999999999999997653 22346789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||+.||+|.+++... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp-------------------------- 177 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP-------------------------- 177 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG--------------------------
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccch--------------------------
Confidence 9999999999999999764 3799999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCC--CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 169 PWKFNVLQLENILLDS--KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~--~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++. ++.+||+|||+++.... .......+||+.|+|||++.+..++ .++|||||||++|+|+
T Consensus 178 ---------~NIll~~~~~~~vkL~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell 244 (387)
T 1kob_A 178 ---------ENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLL 244 (387)
T ss_dssp ---------GGEEESSTTCCCEEECCCTTCEECCT---TSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHH
T ss_pred ---------HHeEEecCCCCceEEEecccceecCC---CcceeeeccCCCccCchhccCCCCC-CcccEeeHhHHHHHHH
Confidence 9999984 47899999999985432 3344566899999999999887775 8999999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCC
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
+|..||.+.+.......+......++ ..+++++.+||.+||+.||.+|||++++++||||.....
T Consensus 245 tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 245 SGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 99999999998888888887765544 357999999999999999999999999999999987543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=432.97 Aligned_cols=261 Identities=30% Similarity=0.446 Sum_probs=234.3
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
..+..++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 34677899999999999999999999999999999999987654334445778999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 89 IYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKP------------------------ 314 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP------------------------ 314 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG------------------------
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCch------------------------
Confidence 999999999999999997654 499999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.+|.+||+|||+++.... .....+.+||+.|+|||++.+..|+ .++|||||||++|+|+
T Consensus 315 -----------eNILld~~g~vKL~DFGla~~~~~---~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLl 379 (576)
T 2acx_A 315 -----------ENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMI 379 (576)
T ss_dssp -----------GGEEECTTSCEEECCCTTCEECCT---TCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHH
T ss_pred -----------heEEEeCCCCeEEEecccceeccc---CccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHH
Confidence 999999999999999999985432 3334567999999999999888775 8999999999999999
Q ss_pred cCCCCCCCCc----HHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 247 TGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 247 tG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
+|+.||.+.+ ...+...+......+|..+++++.+||++||+.||.+|| +++++++||||+.
T Consensus 380 tG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 380 AGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred hCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 9999998753 456777777788888999999999999999999999999 7899999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=398.11 Aligned_cols=259 Identities=28% Similarity=0.420 Sum_probs=217.4
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+++|++++.||+|+||+||+|++..+|+.||||++.... ........+.+|+.+++.++||||+++++++...+..|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 579999999999999999999999999999999987654 2344467788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|||+++++|.+++...+.+++..++.++.|++.||+|||++||+||||||
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp------------------------------ 130 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKP------------------------------ 130 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG------------------------------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCh------------------------------
Confidence 99999999999988888899999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||+++.++.+||+|||++..... ........+||+.|+|||++.+....+.++||||+||++|+|++|..||
T Consensus 131 -----~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 203 (311)
T 4agu_A 131 -----ENILITKHSVIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW 203 (311)
T ss_dssp -----GGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred -----hhEEEcCCCCEEEeeCCCchhccC--cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 999999999999999999975432 2223455689999999999987554468999999999999999999999
Q ss_pred CCCcHHHHHHHHHhC---------------------CCCCC----------CCCCHHHHHHHHHccCCCcCCCCChHHHh
Q 011868 253 DDRNLAVLYQKIFRG---------------------DFKLP----------KWLSPGAQNLLRKILEPNPVKRITIAGIK 301 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~---------------------~~~~p----------~~~s~~~~~Li~~~L~~dP~~R~s~~~il 301 (476)
.+.+.......+... ..+.+ +.+++++.+||.+||+.||.+|||+++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 283 (311)
T 4agu_A 204 PGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283 (311)
T ss_dssp CCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred CCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHh
Confidence 988776555443321 01111 34788899999999999999999999999
Q ss_pred cCcccccc
Q 011868 302 ADEWFEQD 309 (476)
Q Consensus 302 ~~~~~~~~ 309 (476)
+||||+.-
T Consensus 284 ~hp~f~~~ 291 (311)
T 4agu_A 284 HHPYFENI 291 (311)
T ss_dssp TSGGGTTC
T ss_pred cChHHHhc
Confidence 99999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=429.94 Aligned_cols=262 Identities=28% Similarity=0.447 Sum_probs=235.1
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
..+..++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+...
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 46778999999999999999999999999999999999987654444446788999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 89 IYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP---------------------- 317 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKP---------------------- 317 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG----------------------
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCCh----------------------
Confidence 99999999999999999763 3699999999999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+|||++.+|++||+|||+++.... ......+.+||+.|+|||++.+..|+ .++|||||||++|+
T Consensus 318 -------------~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilye 381 (543)
T 3c4z_A 318 -------------ENVLLDDDGNVRISDLGLAVELKA--GQTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYE 381 (543)
T ss_dssp -------------GGEEECTTSCEEECCCTTCEECCT--TCCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHH
T ss_pred -------------HHEEEeCCCCEEEeecceeeeccC--CCcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHH
Confidence 999999999999999999985432 12234456999999999999988885 89999999999999
Q ss_pred HhcCCCCCCCC----cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC-----hHHHhcCccccc
Q 011868 245 ILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 308 (476)
Q Consensus 245 lltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-----~~~il~~~~~~~ 308 (476)
|++|+.||.+. +...+...+......+|..+++.+.+||++||+.||.+||+ +++|++||||..
T Consensus 382 lltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 382 MIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 99999999875 35677888888888999999999999999999999999996 489999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=390.68 Aligned_cols=257 Identities=37% Similarity=0.688 Sum_probs=232.4
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
...++|++.+.||+|+||+||+|.+..++..||+|++...... ..+.+.+|+.+++.++||||+++++++...+..|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 3457899999999999999999999999999999999765432 2578899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
+||||++|++|.+++.....+++.+++.++.|++.||+|||++||+||||||
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp---------------------------- 134 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKP---------------------------- 134 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG----------------------------
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCH----------------------------
Confidence 9999999999999998888899999999999999999999999999999997
Q ss_pred ccccCCCCceEe---CCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 171 KFNVLQLENILL---DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 171 ~~~~~~~~NiLl---~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||++ +.++.+||+|||++..... .......+||+.|+|||++.+. + +.++|||||||++|+|++
T Consensus 135 -------~Nil~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~ 202 (277)
T 3f3z_A 135 -------ENFLFLTDSPDSPLKLIDFGLAARFKP---GKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLC 202 (277)
T ss_dssp -------GGEEESSSSTTCCEEECCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHH
T ss_pred -------HHEEEecCCCCCcEEEEecccceeccC---ccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHH
Confidence 99999 7889999999999975432 3344567899999999998654 5 589999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
|+.||.+.+......++..+...+|. .+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus 203 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 203 GYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 99999999998888899888877774 5899999999999999999999999999999998654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=414.43 Aligned_cols=262 Identities=31% Similarity=0.410 Sum_probs=211.6
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC--
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS-- 87 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~-- 87 (476)
..+++|++++.||+|+||+||+|.+..+|+.||||++.+.. ........+.+|+.+++.+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 35689999999999999999999999999999999996543 33445677889999999997 999999999997544
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.+|+||||+. ++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp------------------------- 137 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKP------------------------- 137 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG-------------------------
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCH-------------------------
Confidence 7999999996 689998876 5799999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcc-------------------cCCCcccccccCCccccccccccCCC
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHF-------------------RDDGLLHTTCGSPNYVAPEVLANRGY 228 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~-------------------~~~~~~~~~~gt~~y~APE~l~~~~~ 228 (476)
+|||++.++.+||+|||+|+..... .........+||+.|+|||++.+...
T Consensus 138 ----------~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 207 (388)
T 3oz6_A 138 ----------SNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTK 207 (388)
T ss_dssp ----------GGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCC
T ss_pred ----------HHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCC
Confidence 9999999999999999999754321 01223455689999999999987444
Q ss_pred CCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-C--------------------------------------
Q 011868 229 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-F-------------------------------------- 269 (476)
Q Consensus 229 ~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~-------------------------------------- 269 (476)
.+.++||||+||++|+|++|+.||.+.+....+.++...- .
T Consensus 208 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (388)
T 3oz6_A 208 YTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTK 287 (388)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHH
T ss_pred CCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcc
Confidence 4589999999999999999999999988877766664210 0
Q ss_pred --------CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 270 --------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 270 --------~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
..+..+++++.+||.+||+.||.+|||++++++||||....
T Consensus 288 ~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 288 WKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred hhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence 01125788999999999999999999999999999997643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=405.57 Aligned_cols=253 Identities=39% Similarity=0.736 Sum_probs=205.0
Q ss_pred CcCEEEe---ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE
Q 011868 13 LGRYELG---RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK 88 (476)
Q Consensus 13 ~~~Y~i~---~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~ 88 (476)
..+|++. +.||+|+||+||+|.+..+++.||||++.+.. ...+.+|+.+++.+. ||||+++++++.+...
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~ 80 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLH 80 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence 4678886 78999999999999999999999999996542 467789999999997 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
.|+||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp-------------------------- 134 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP-------------------------- 134 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG--------------------------
T ss_pred EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCH--------------------------
Confidence 999999999999999999888999999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCC---CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 169 PWKFNVLQLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+|||++.++ .+||+|||+++.... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|
T Consensus 135 ---------~NIll~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~l 202 (325)
T 3kn6_A 135 ---------ENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTM 202 (325)
T ss_dssp ---------GGEEEEC----CEEEECCCTTCEECCC------------------------CCCC-HHHHHHHHHHHHHHH
T ss_pred ---------HHEEEecCCCcccEEEeccccceecCC--CCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHH
Confidence 999998766 799999999975432 23345567899999999999888885 899999999999999
Q ss_pred hcCCCCCCCCc-------HHHHHHHHHhCCCCCCC----CCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 246 LTGYLPFDDRN-------LAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 246 ltG~~Pf~~~~-------~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
++|+.||.+.+ ......++..+.+.++. .+++++.+||++||+.||.+|||++++++||||+..
T Consensus 203 l~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 203 LSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred HhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 99999998644 34667778777776653 489999999999999999999999999999999763
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=424.22 Aligned_cols=264 Identities=35% Similarity=0.650 Sum_probs=231.8
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccch----------hHHHHHHHHHHHHHhCCCCCcc
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL----------KITDQIKREIATLKLLKHPNVV 77 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~----------~~~~~~~~Ei~~l~~l~HpnIv 77 (476)
..+...++|++++.||+|+||+||+|++..+++.||+|++.+...... ...+.+.+|+.+++.++||||+
T Consensus 30 ~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 109 (504)
T 3q5i_A 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109 (504)
T ss_dssp ECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred cCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence 344566789999999999999999999999999999999986543221 3357799999999999999999
Q ss_pred eEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHH
Q 011868 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVF 157 (476)
Q Consensus 78 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~ 157 (476)
++++++.+...+|+||||++||+|.+.+...+++++..++.++.||+.||+|||++||+||||||
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp--------------- 174 (504)
T 3q5i_A 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKP--------------- 174 (504)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG---------------
T ss_pred eEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcH---------------
Confidence 99999999999999999999999999998888999999999999999999999999999999997
Q ss_pred HHHHHHhhhccccccccCCCCceEeCCCC---CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccch
Q 011868 158 LLTFLLMIVIRPWKFNVLQLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234 (476)
Q Consensus 158 ~~~~~~~~~~~p~~~~~~~~~NiLl~~~g---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sD 234 (476)
+|||++.++ .+||+|||++..... .......+||+.|+|||++.+ .| +.++|
T Consensus 175 --------------------~Nil~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~D 229 (504)
T 3q5i_A 175 --------------------ENILLENKNSLLNIKIVDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCD 229 (504)
T ss_dssp --------------------GGEEESSTTCCSSEEECCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHH
T ss_pred --------------------HHEEEecCCCCccEEEEECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHH
Confidence 999999876 699999999985432 334566789999999999864 46 48999
Q ss_pred hhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 235 vwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
|||+||++|+|++|..||.+.+...+...+..+.+.++ ..+++++.+||++||+.||.+|||++++++||||+...
T Consensus 230 iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 230 VWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 99999999999999999999999999999998887665 56899999999999999999999999999999998754
Q ss_pred C
Q 011868 311 T 311 (476)
Q Consensus 311 ~ 311 (476)
.
T Consensus 310 ~ 310 (504)
T 3q5i_A 310 N 310 (504)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=398.27 Aligned_cols=258 Identities=34% Similarity=0.581 Sum_probs=231.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
..++|++.+.||+|+||.||+|++..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 45689999999999999999999999999999999986543221 135779999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
.|+||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp-------------------------- 143 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKP-------------------------- 143 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSG--------------------------
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCh--------------------------
Confidence 999999999999999998888899999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCC----CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 169 PWKFNVLQLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g----~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+||+++.++ .+||+|||++..... .......+||+.|+|||++.+..++ .++|||||||++|+
T Consensus 144 ---------~NIl~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~ 210 (321)
T 2a2a_A 144 ---------ENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYI 210 (321)
T ss_dssp ---------GGEEESCTTSSSCCEEECCCTTCEECCT---TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHH
T ss_pred ---------HHEEEecCCCCcCCEEEccCccceecCc---cccccccCCCCCccCcccccCCCCC-CccccHHHHHHHHH
Confidence 999999888 799999999975432 2234556799999999999887775 89999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 245 ILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
|++|..||.+.+.......+......++ ..+++.+.+||.+||+.||.+|||++++++||||..
T Consensus 211 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 211 LLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp HHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred HHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 9999999999988888888887776655 568999999999999999999999999999999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=427.42 Aligned_cols=260 Identities=37% Similarity=0.663 Sum_probs=233.5
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
...++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++...+.+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34568999999999999999999999999999999998765444445688999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
+||||+.||+|.+.+...+++++.+++.++.||+.||.|||++||+||||||
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp---------------------------- 154 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKP---------------------------- 154 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG----------------------------
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCH----------------------------
Confidence 9999999999999999888999999999999999999999999999999997
Q ss_pred ccccCCCCceEe---CCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 171 KFNVLQLENILL---DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 171 ~~~~~~~~NiLl---~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||+ +.++.+||+|||++.... ........+||+.|+|||++.+ .|+ .++||||+||++|+|++
T Consensus 155 -------~Nil~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~ 222 (484)
T 3nyv_A 155 -------ENLLLESKSKDANIRIIDFGLSTHFE---ASKKMKDKIGTAYYIAPEVLHG-TYD-EKCDVWSTGVILYILLS 222 (484)
T ss_dssp -------GGEEESSSSTTCCEEECCTTHHHHBC---CCCSHHHHTTGGGTCCHHHHHT-CCC-THHHHHHHHHHHHHHHH
T ss_pred -------HHEEEecCCCCCcEEEEeeeeeEEcc---cccccccCCCCccccCceeecC-CCC-CcceeHHHHHHHHHHHH
Confidence 99999 567899999999997433 2334556789999999999876 464 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
|+.||.+.+......++..+.+.++ ..+++++.+||++||+.||.+|||++++++||||+...
T Consensus 223 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 223 GCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 9999999999999999988876543 34899999999999999999999999999999998653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=405.78 Aligned_cols=264 Identities=27% Similarity=0.404 Sum_probs=213.5
Q ss_pred ccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 7 ~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
......+++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++..+
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 3456778999999999999999999999999999999999976542 333456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
+.+|+||||+. |+|.+++.....+++.+++.++.||+.||+|||++||+||||||
T Consensus 106 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp------------------------ 160 (329)
T 3gbz_A 106 HRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKP------------------------ 160 (329)
T ss_dssp TEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG------------------------
T ss_pred CEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCH------------------------
Confidence 99999999996 59999999888899999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeC-----CCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 167 IRPWKFNVLQLENILLD-----SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~-----~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+|||++ .++.+||+|||++..... ........+||+.|+|||++.+....+.++|||||||+
T Consensus 161 -----------~NIll~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 227 (329)
T 3gbz_A 161 -----------QNLLLSVSDASETPVLKIGDFGLARAFGI--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACI 227 (329)
T ss_dssp -----------GGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred -----------HHEEEecCCCCccceEEECcCCCccccCC--cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHH
Confidence 999994 455699999999974322 12234456789999999999876544689999999999
Q ss_pred HHHHhcCCCCCCCCcHHHHHHHHHhCC--CC---------CCC-------------------CCCHHHHHHHHHccCCCc
Q 011868 242 LYVILTGYLPFDDRNLAVLYQKIFRGD--FK---------LPK-------------------WLSPGAQNLLRKILEPNP 291 (476)
Q Consensus 242 l~elltG~~Pf~~~~~~~~~~~i~~~~--~~---------~p~-------------------~~s~~~~~Li~~~L~~dP 291 (476)
+|+|++|..||.+.+......++.... .. .+. .+++++.+||.+||+.||
T Consensus 228 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 307 (329)
T 3gbz_A 228 WAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDP 307 (329)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSG
T ss_pred HHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCCh
Confidence 999999999999988777666655321 00 011 167899999999999999
Q ss_pred CCCCChHHHhcCcccccc
Q 011868 292 VKRITIAGIKADEWFEQD 309 (476)
Q Consensus 292 ~~R~s~~~il~~~~~~~~ 309 (476)
.+|||++++++||||+..
T Consensus 308 ~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 308 VKRISAKNALEHPYFSHN 325 (329)
T ss_dssp GGSCCHHHHHTSGGGSSS
T ss_pred hhCCCHHHHhCCcccCCC
Confidence 999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=389.78 Aligned_cols=261 Identities=39% Similarity=0.680 Sum_probs=226.4
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+++|++++.||+|+||+||+|.+..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 5789999999999999999999999999999999976542 23457899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|||+++++|.+++.....+++.+++.++.||+.||+|||++||+||||||
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p------------------------------ 133 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP------------------------------ 133 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG------------------------------
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCh------------------------------
Confidence 99999999999998777899999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||+++.++.+||+|||++...............+||+.|+|||++.+..+.+.++||||+||++|+|++|..||
T Consensus 134 -----~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 208 (276)
T 2yex_A 134 -----ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208 (276)
T ss_dssp -----GGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred -----HHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999975433222233456789999999999988777668899999999999999999999
Q ss_pred CCCcHH-HHHHHHHhCCCCCC--CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 253 DDRNLA-VLYQKIFRGDFKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 253 ~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
.+.+.. ..+..+.......+ ..+++.+.+||.+||+.||.+|||++++++||||++..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 209 DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp SCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 876543 33344443333322 45899999999999999999999999999999998654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=396.60 Aligned_cols=261 Identities=31% Similarity=0.402 Sum_probs=215.9
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhCC---CCCcceEEEEE
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLK---HPNVVRLHEVL 83 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~ 83 (476)
+.+..++|++++.||+|+||+||+|++..+|+.||||++...... .......+.+|+.+++.++ ||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 345678999999999999999999999999999999999754321 1122346677888877775 99999999999
Q ss_pred EeCC-----EEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHH
Q 011868 84 ASKS-----KIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQV 156 (476)
Q Consensus 84 ~~~~-----~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~ 156 (476)
.... ..|+||||+. ++|.+++..... +++.+++.++.||+.||+|||++||+||||||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp-------------- 148 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKP-------------- 148 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCT--------------
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH--------------
Confidence 8765 5899999995 699999987543 99999999999999999999999999999997
Q ss_pred HHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhh
Q 011868 157 FLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 236 (476)
Q Consensus 157 ~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvw 236 (476)
+|||++.++.+||+|||++..... .......+||+.|+|||++.+..++ .++|||
T Consensus 149 ---------------------~Nil~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Diw 203 (308)
T 3g33_A 149 ---------------------ENILVTSGGTVKLADFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMW 203 (308)
T ss_dssp ---------------------TTEEECTTSCEEECSCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCC-STHHHH
T ss_pred ---------------------HHEEEcCCCCEEEeeCccccccCC---CcccCCccccccccCchHHcCCCCC-chHHHH
Confidence 999999999999999999986432 3344567899999999999888875 899999
Q ss_pred hHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC---------------------------CCCCCCHHHHHHHHHccCC
Q 011868 237 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---------------------------LPKWLSPGAQNLLRKILEP 289 (476)
Q Consensus 237 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------~p~~~s~~~~~Li~~~L~~ 289 (476)
||||++|+|++|+.||.+.+......++...... ..+.+++.+.+||.+||+.
T Consensus 204 slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 283 (308)
T 3g33_A 204 SVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTF 283 (308)
T ss_dssp HHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCS
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcC
Confidence 9999999999999999998887777766542100 1134788999999999999
Q ss_pred CcCCCCChHHHhcCcccccc
Q 011868 290 NPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 290 dP~~R~s~~~il~~~~~~~~ 309 (476)
||.+|||+.++++||||.+.
T Consensus 284 dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 284 NPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp STTTSCCHHHHHTSTTC---
T ss_pred CCccCCCHHHHhcCccccCC
Confidence 99999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=389.90 Aligned_cols=257 Identities=37% Similarity=0.632 Sum_probs=221.1
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
+...++|++.+.||+|+||+||+|.+..++..||+|++..... ....+.+.+|+.+++.++||||+++++++......
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence 3455789999999999999999999999999999999987652 22357899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 90 YMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
|+||||++||+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp----------------------- 152 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKP----------------------- 152 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG-----------------------
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCH-----------------------
Confidence 999999999999998854 36799999999999999999999999999999997
Q ss_pred hccccccccCCCCceEe---CCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHH
Q 011868 166 VIRPWKFNVLQLENILL---DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl---~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil 242 (476)
+||++ +.++.+||+|||++..... .......+||+.|+|||++.+ .+ +.++|||||||++
T Consensus 153 ------------~NIl~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il 215 (285)
T 3is5_A 153 ------------ENILFQDTSPHSPIKIIDFGLAELFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVM 215 (285)
T ss_dssp ------------GGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHH
T ss_pred ------------HHEEEecCCCCCCEEEEeeecceecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHH
Confidence 99999 4568899999999985433 233456689999999999754 45 4899999999999
Q ss_pred HHHhcCCCCCCCCcHHHHHHHHHhCCCCCC---CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 243 YVILTGYLPFDDRNLAVLYQKIFRGDFKLP---KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 243 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
|+|++|+.||.+.+.......+.......+ ..+++++.+||.+||+.||.+|||+.++++||||++
T Consensus 216 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 216 YFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999988887777766655443 337899999999999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=422.82 Aligned_cols=260 Identities=38% Similarity=0.656 Sum_probs=229.5
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
+...++|++++.||+|+||+||+|++..+++.||||++.+..... .....+.+|+.+++.++||||+++++++.....+
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 445678999999999999999999999999999999997654222 2357889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||+.||+|.+.+...+++++.+++.++.||+.||.|||++||+||||||
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp--------------------------- 149 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP--------------------------- 149 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG---------------------------
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCch---------------------------
Confidence 99999999999999998888999999999999999999999999999999997
Q ss_pred cccccCCCCceEeC---CCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 170 WKFNVLQLENILLD---SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 170 ~~~~~~~~~NiLl~---~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++ .++.+||+|||+++.... .......+||+.|+|||++.+. | +.++||||+||++|+|+
T Consensus 150 --------~Nil~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll 216 (486)
T 3mwu_A 150 --------ENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILL 216 (486)
T ss_dssp --------GGEEESSSSTTCCEEECSCSCTTTBCC---C----CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHH
T ss_pred --------HHEEEecCCCCCCEEEEECCcCeECCC---CCccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHH
Confidence 999995 456799999999985432 3345567899999999998763 6 48999999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
+|+.||.+.+......++..+.+.++ ..+|+++.+||++||+.||.+|||+.++++||||+...
T Consensus 217 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 217 SGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 99999999999999999888776543 33899999999999999999999999999999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=402.14 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=213.0
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+++|++++.||+|+||+||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 5789999999999999999999999999999999975431 11122456799999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||+. |+|.+++... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp----------------------------- 128 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKP----------------------------- 128 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCG-----------------------------
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCH-----------------------------
Confidence 99996 5999988764 4699999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+|||++.+|.+||+|||++..... ........+||+.|+|||++.+....+.++||||+||++|+|++|+.|
T Consensus 129 ------~NIl~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 200 (324)
T 3mtl_A 129 ------QNLLINERGELKLADFGLARAKSI--PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPL 200 (324)
T ss_dssp ------GGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ------HHEEECCCCCEEEccCcccccccC--CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999975432 223344568999999999998755445899999999999999999999
Q ss_pred CCCCcHHHHHHHHHhCCC-------------------C-----------CCCCCCHHHHHHHHHccCCCcCCCCChHHHh
Q 011868 252 FDDRNLAVLYQKIFRGDF-------------------K-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~~~-------------------~-----------~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il 301 (476)
|.+.+.......+..... . .+..+++++.+||.+||+.||.+|||++|++
T Consensus 201 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 280 (324)
T 3mtl_A 201 FPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280 (324)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence 999888777666544210 0 0123678999999999999999999999999
Q ss_pred cCccccccCC
Q 011868 302 ADEWFEQDYT 311 (476)
Q Consensus 302 ~~~~~~~~~~ 311 (476)
+||||.....
T Consensus 281 ~hp~f~~~~~ 290 (324)
T 3mtl_A 281 KHPFFLSLGE 290 (324)
T ss_dssp TSGGGGGGCS
T ss_pred cChhhhhccc
Confidence 9999987543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=423.01 Aligned_cols=257 Identities=28% Similarity=0.425 Sum_probs=214.6
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~----- 86 (476)
..++|++++.||+|+||+||+|.+..+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 3578999999999999999999999999999999997653 3444567899999999999999999999999654
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 87 -~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
..+|+||||+.+ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp----------------------- 192 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP----------------------- 192 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG-----------------------
T ss_pred CCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCh-----------------------
Confidence 468999999965 5777764 3599999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+|||++.++.+||+|||+|+.... .......+||+.|+|||++.+..|+ .++|||||||++|+|
T Consensus 193 ------------~NIll~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el 256 (464)
T 3ttj_A 193 ------------SNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEM 256 (464)
T ss_dssp ------------GGEEECTTSCEEECCCCCC--------CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHH
T ss_pred ------------HhEEEeCCCCEEEEEEEeeeecCC---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHH
Confidence 999999999999999999985432 3345667899999999999998886 899999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCCC---------------------------CC----CCC-----------CCHHHHHHH
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGDF---------------------------KL----PKW-----------LSPGAQNLL 283 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~~---------------------------~~----p~~-----------~s~~~~~Li 283 (476)
++|+.||.+.+....+.++..... .+ |.. .++++.+||
T Consensus 257 l~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 336 (464)
T 3ttj_A 257 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 336 (464)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHH
Confidence 999999999988777766654210 00 110 156799999
Q ss_pred HHccCCCcCCCCChHHHhcCccccccCC
Q 011868 284 RKILEPNPVKRITIAGIKADEWFEQDYT 311 (476)
Q Consensus 284 ~~~L~~dP~~R~s~~~il~~~~~~~~~~ 311 (476)
++||+.||.+|||++|+++||||...+.
T Consensus 337 ~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 337 SKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred HHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 9999999999999999999999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=403.41 Aligned_cols=254 Identities=35% Similarity=0.665 Sum_probs=209.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 3467999999999999999999999999999999997643 13568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp----------------------------- 176 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKP----------------------------- 176 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG-----------------------------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCc-----------------------------
Confidence 999999999999998888899999999999999999999999999999997
Q ss_pred cccCCCCceEeCC---CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 172 FNVLQLENILLDS---KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 172 ~~~~~~~NiLl~~---~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+|||++. ++.+||+|||+++.... .......+||+.|+|||++.+..++ .++|||||||++|+|++|
T Consensus 177 ------~NIll~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g 246 (349)
T 2w4o_A 177 ------ENLLYATPAPDAPLKIADFGLSKIVEH---QVLMKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCG 246 (349)
T ss_dssp ------GGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHS
T ss_pred ------ccEEEecCCCCCCEEEccCccccccCc---ccccccccCCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhC
Confidence 9999975 89999999999985432 2334567899999999999887775 899999999999999999
Q ss_pred CCCCCCCcHH-HHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 249 YLPFDDRNLA-VLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 249 ~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
..||.+.+.. ..+..+......++ ..+++++.+||++||+.||.+|||+.++++||||...
T Consensus 247 ~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 247 FEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp SCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred CCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 9999776544 46677777665443 4578999999999999999999999999999999764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=417.89 Aligned_cols=261 Identities=30% Similarity=0.399 Sum_probs=201.0
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----CC
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-----KS 87 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~~ 87 (476)
.++|++++.||+|+||+||+|++..+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 478999999999999999999999999999999997643 344456789999999999999999999999843 35
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.+|+||||+ +++|.+++.....+++..++.++.||+.||+|||++||+||||||
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp------------------------- 184 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKP------------------------- 184 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG-------------------------
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCCh-------------------------
Confidence 799999998 679999998888899999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC-------------------------CcccccccCCccccccc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD-------------------------GLLHTTCGSPNYVAPEV 222 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~-------------------------~~~~~~~gt~~y~APE~ 222 (476)
+|||++.++.+||+|||+|+........ ......+||+.|+|||+
T Consensus 185 ----------~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~ 254 (458)
T 3rp9_A 185 ----------ANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL 254 (458)
T ss_dssp ----------GGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHH
T ss_pred ----------hhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHH
Confidence 9999999999999999999865422110 13455689999999998
Q ss_pred cccCCCCCccchhhhHhHHHHHHhc-----------CCCCCCCCcH--------------------HHHHHHHHh--CC-
Q 011868 223 LANRGYDGATSDIWSCGVILYVILT-----------GYLPFDDRNL--------------------AVLYQKIFR--GD- 268 (476)
Q Consensus 223 l~~~~~~~~~sDvwSlGvil~ellt-----------G~~Pf~~~~~--------------------~~~~~~i~~--~~- 268 (476)
+......+.++||||||||+|||++ |++||.+.+. ...+..+.. +.
T Consensus 255 ~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p 334 (458)
T 3rp9_A 255 ILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTP 334 (458)
T ss_dssp HTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCC
T ss_pred hhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCC
Confidence 7544433589999999999999999 7888876542 111111211 00
Q ss_pred -------------------C---------CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 269 -------------------F---------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 269 -------------------~---------~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
+ ...+..++++.+||++||+.||.+|||++|+++||||+...
T Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 335 SEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 0 01133689999999999999999999999999999998653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=421.68 Aligned_cols=256 Identities=35% Similarity=0.671 Sum_probs=224.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++++.||+|+||+||+|++..++..||+|++.+..... .....+.+|+.+++.++||||+++++++...+.+|+
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3457999999999999999999999999999999998764322 225678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||++||+|.+.+....++++.+++.++.||+.||.|||++||+||||||
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp----------------------------- 164 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKP----------------------------- 164 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG-----------------------------
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCh-----------------------------
Confidence 999999999999998888999999999999999999999999999999997
Q ss_pred cccCCCCceEeCCC---CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 172 FNVLQLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 172 ~~~~~~~NiLl~~~---g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+|||++.+ +.+||+|||++..... .......+||+.|+|||++.+ .|+ .++||||+||++|+|++|
T Consensus 165 ------~Nil~~~~~~~~~~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~-~~~DiwslG~il~~ll~g 233 (494)
T 3lij_A 165 ------ENLLLESKEKDALIKIVDFGLSAVFEN---QKKMKERLGTAYYIAPEVLRK-KYD-EKCDVWSIGVILFILLAG 233 (494)
T ss_dssp ------GGEEESCSSTTCCEEECCCTTCEECBT---TBCBCCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHS
T ss_pred ------hhEEEeCCCCCCcEEEEECCCCeECCC---CccccccCCCcCeeCHHHHcc-cCC-CchhHHHHHHHHHHHHhC
Confidence 99999764 4599999999985432 334556789999999999864 464 899999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+.||.+.+...+..++..+.+.++ ..+++.+.+||++||+.||.+|||+.++++||||+.
T Consensus 234 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 234 YPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 999999999999999988876654 348999999999999999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=402.47 Aligned_cols=265 Identities=26% Similarity=0.388 Sum_probs=222.5
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----- 85 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----- 85 (476)
-.+++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 467899999999999999999999999999999999976543 22334677899999999999999999999976
Q ss_pred ---CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 86 ---KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 86 ---~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
.+.+|+||||+.+ +|.+.+... .++++.+++.++.||+.||+|||++||+||||||
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp------------------- 152 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKA------------------- 152 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG-------------------
T ss_pred ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCH-------------------
Confidence 4578999999964 787777653 5799999999999999999999999999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCccc--CCCcccccccCCccccccccccCCCCCccchhhhHh
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlG 239 (476)
+|||++.++.+||+|||++....... ........+||+.|+|||++.+....+.++||||||
T Consensus 153 ----------------~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 216 (351)
T 3mi9_A 153 ----------------ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 216 (351)
T ss_dssp ----------------GGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHH
T ss_pred ----------------HHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHH
Confidence 99999999999999999997544221 223345668999999999998755446899999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCC--------------------------------CCHHHHHHHHHcc
Q 011868 240 VILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--------------------------------LSPGAQNLLRKIL 287 (476)
Q Consensus 240 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--------------------------------~s~~~~~Li~~~L 287 (476)
|++|+|++|..||.+.+.......+.......+.. .++.+.+||.+||
T Consensus 217 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 296 (351)
T 3mi9_A 217 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 296 (351)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHS
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHh
Confidence 99999999999999988877776665432222111 2677999999999
Q ss_pred CCCcCCCCChHHHhcCccccccCCC
Q 011868 288 EPNPVKRITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 288 ~~dP~~R~s~~~il~~~~~~~~~~~ 312 (476)
+.||.+|||++++++||||.....+
T Consensus 297 ~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 297 VLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp CSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred cCChhhCCCHHHHhCCCCcCCCCCc
Confidence 9999999999999999999875544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=410.47 Aligned_cols=254 Identities=31% Similarity=0.603 Sum_probs=212.2
Q ss_pred CCccCcCEEEe-ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCcceEEEEEEe-
Q 011868 9 EGMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLAS- 85 (476)
Q Consensus 9 ~~~~~~~Y~i~-~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l-~~l~HpnIv~l~~~~~~- 85 (476)
.+..+++|.+. +.||+|+||+||+|.+..+|+.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 56 ~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 34567889987 6899999999999999999999999999642 3567888887 45589999999999876
Q ss_pred ---CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 86 ---KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 86 ---~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
...+|+||||++||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp------------------ 189 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP------------------ 189 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCG------------------
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCc------------------
Confidence 567999999999999999998643 599999999999999999999999999999997
Q ss_pred HHHhhhccccccccCCCCceEeCC---CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhh
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDS---KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 237 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~---~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwS 237 (476)
+|||++. ++.+||+|||+++.... .....+.+||+.|+|||++.+..|+ .++||||
T Consensus 190 -----------------~Nill~~~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Diws 248 (400)
T 1nxk_A 190 -----------------ENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWS 248 (400)
T ss_dssp -----------------GGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSS-SHHHHHH
T ss_pred -----------------ceEEEecCCCCccEEEEecccccccCC---CCccccCCCCCCccCHhhcCCCCCC-CcccHHH
Confidence 9999998 78999999999985332 2345577899999999999888885 8999999
Q ss_pred HhHHHHHHhcCCCCCCCCcHH----HHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 238 CGVILYVILTGYLPFDDRNLA----VLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 238 lGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|||++|+|++|+.||.+.+.. .....+..+.+.+| ..+++++.+||++||+.||.+|||++++++||||.+.
T Consensus 249 lG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 249 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 999999999999999876532 24556666666554 3489999999999999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=392.75 Aligned_cols=254 Identities=26% Similarity=0.453 Sum_probs=224.4
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
.|+..+.||+|+||+||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 48889999999999999999998999999999976542 225678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
|++|++|.+++.. .++++.+++.++.||+.||+|||+.||+||||||
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp-------------------------------- 169 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKS-------------------------------- 169 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG--------------------------------
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH--------------------------------
Confidence 9999999998864 5799999999999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~ 254 (476)
+|||++.++.+||+|||++..... ........+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+
T Consensus 170 ---~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 170 ---DSILLTLDGRVKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp ---GGEEECTTCCEEECCCTTCEECCS--SSCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ---HHEEECCCCcEEEeeeeeeeeccc--CccccccccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999875433 12234556899999999999887775 899999999999999999999999
Q ss_pred CcHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 255 RNLAVLYQKIFRGDFK---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 255 ~~~~~~~~~i~~~~~~---~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
.+.......+.....+ .+..+++.+.+||.+||+.||.+|||++++++||||.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 244 DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp SCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred CCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 8887777777665433 2344789999999999999999999999999999998643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=393.32 Aligned_cols=261 Identities=34% Similarity=0.589 Sum_probs=219.4
Q ss_pred CccCcCEEEe-ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011868 10 GMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (476)
Q Consensus 10 ~~~~~~Y~i~-~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~ 87 (476)
+...++|++. +.||+|+||+||+|.+..+++.||||++.... ......+.+|+.+++++ +||||+++++++...+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 3445689995 78999999999999999999999999997653 22357889999999985 7999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.+|+||||++||+|.+++.....+++.+++.++.||+.||+|||++||+||||||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp------------------------- 139 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKP------------------------- 139 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG-------------------------
T ss_pred EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCH-------------------------
Confidence 9999999999999999998888899999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCC---EEEeccCCCCCCCccc-----CCCcccccccCCcccccccccc-----CCCCCccch
Q 011868 168 RPWKFNVLQLENILLDSKGN---IKISDFGLSALPQHFR-----DDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSD 234 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~---vkl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~sD 234 (476)
+|||++.++. +||+|||++....... ........+||+.|+|||++.+ ..+ +.++|
T Consensus 140 ----------~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~D 208 (316)
T 2ac3_A 140 ----------ENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCD 208 (316)
T ss_dssp ----------GGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHH-TTTHH
T ss_pred ----------HHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCC-Ccccc
Confidence 9999998876 9999999997543211 1122345679999999999875 335 48899
Q ss_pred hhhHhHHHHHHhcCCCCCCCCc---------------HHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCC
Q 011868 235 IWSCGVILYVILTGYLPFDDRN---------------LAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRI 295 (476)
Q Consensus 235 vwSlGvil~elltG~~Pf~~~~---------------~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~ 295 (476)
||||||++|+|++|+.||.+.+ ...++..+..+.+.+| ..+++.+.+||++||+.||.+||
T Consensus 209 iwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 288 (316)
T 2ac3_A 209 LWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL 288 (316)
T ss_dssp HHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred cHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCC
Confidence 9999999999999999998754 2456677777777776 35899999999999999999999
Q ss_pred ChHHHhcCcccccc
Q 011868 296 TIAGIKADEWFEQD 309 (476)
Q Consensus 296 s~~~il~~~~~~~~ 309 (476)
|++++++||||...
T Consensus 289 s~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 289 SAAQVLQHPWVQGC 302 (316)
T ss_dssp CHHHHHHSTTCC--
T ss_pred CHHHHhcChhhcCC
Confidence 99999999999753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=392.80 Aligned_cols=265 Identities=37% Similarity=0.677 Sum_probs=229.1
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEE--EeCCE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLKHPNVVRLHEVL--ASKSK 88 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~--~~~~~ 88 (476)
.+++|++++.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++ .....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4689999999999999999999999999999999997653211 23457899999999999999999999998 44568
Q ss_pred EEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 89 IYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
.|+||||+.++ |.+.+.. ...+++..++.++.||+.||.|||++||+||||||
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp------------------------ 137 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKP------------------------ 137 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG------------------------
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCc------------------------
Confidence 99999999776 7777765 45799999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC-CCCccchhhhHhHHHHHH
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVI 245 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~sDvwSlGvil~el 245 (476)
+||+++.++.+||+|||++................||+.|+|||++.+.. +.+.++|||||||++|+|
T Consensus 138 -----------~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l 206 (305)
T 2wtk_C 138 -----------GNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNI 206 (305)
T ss_dssp -----------GGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHH
T ss_pred -----------ccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHH
Confidence 99999999999999999998654333333445667999999999987643 335789999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCCC
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~~ 312 (476)
++|..||.+.+.......+..+...+|..+++.+.+||.+||+.||.+|||++++++||||.....+
T Consensus 207 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 207 TTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred HhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 9999999999998899999999889999999999999999999999999999999999999875543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=388.65 Aligned_cols=261 Identities=25% Similarity=0.395 Sum_probs=223.7
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
....++|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++...+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 34557899999999999999999999999999999999776655666678899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||++|++|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp--------------------------- 139 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKP--------------------------- 139 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG---------------------------
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH---------------------------
Confidence 99999999999999999888999999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+||+++.++.+||+|||++....... .......+||+.|+|||++.+..++ .++||||+||++|+|++|+
T Consensus 140 --------~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~ 209 (294)
T 4eqm_A 140 --------QNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGE 209 (294)
T ss_dssp --------GGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSS
T ss_pred --------HHEEECCCCCEEEEeCCCcccccccc-ccccCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCC
Confidence 99999999999999999998654321 1223456799999999999887775 8899999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccc
Q 011868 250 LPFDDRNLAVLYQKIFRGDFK-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~ 307 (476)
.||.+.+......+......+ .+..+++.+.++|.+||+.||.+||+..+.+.+.|..
T Consensus 210 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 210 PPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp CSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred CCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 999998877766665555433 3466899999999999999999999767766776653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=389.97 Aligned_cols=255 Identities=36% Similarity=0.683 Sum_probs=227.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||+||+|++..+|+.||+|++..... .....+.+|+.+++.++||||+++++++...+..|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 44689999999999999999999999999999999986532 224578899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||++|++|.+.+...+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp----------------------------- 134 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKP----------------------------- 134 (304)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCG-----------------------------
T ss_pred EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCH-----------------------------
Confidence 999999999999998888899999999999999999999999999999997
Q ss_pred cccCCCCceEe---CCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 172 FNVLQLENILL---DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 172 ~~~~~~~NiLl---~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+||++ +.++.+||+|||++.... .......+||+.|+|||++.+..++ .++||||+||++|+|++|
T Consensus 135 ------~NIl~~~~~~~~~~kl~Dfg~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g 203 (304)
T 2jam_A 135 ------ENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCG 203 (304)
T ss_dssp ------GGCEESSSSTTCCEEBCSCSTTCCCC----CBTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHS
T ss_pred ------HHEEEecCCCCCCEEEccCCcceecC----CCccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHC
Confidence 99999 788999999999997532 2234556799999999999887775 899999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
..||.+.+.......+..+...++ ..+++.+.+||.+||+.||.+|||++++++||||...
T Consensus 204 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 204 YPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp SCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 999999988888888888765543 4588999999999999999999999999999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=404.71 Aligned_cols=256 Identities=30% Similarity=0.516 Sum_probs=224.8
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----KITDQIKREIATLKLLKHPNVVRLHEVLA 84 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 84 (476)
+...++|++.+.||+|+||+||+|++..+++.||||++........ .....+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3445689999999999999999999999999999999987643221 12346778999999999999999999999
Q ss_pred eCCEEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHH
Q 011868 85 SKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLL 163 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg-~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~ 163 (476)
..+..|+||||+.+| +|.+++....++++..++.++.||+.||+|||++||+||||||
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp--------------------- 158 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKD--------------------- 158 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG---------------------
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCH---------------------
Confidence 999999999999766 9999999888999999999999999999999999999999997
Q ss_pred hhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHH
Q 011868 164 MIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243 (476)
Q Consensus 164 ~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ 243 (476)
+|||++.++.+||+|||++..... .....+.+||+.|+|||++.+..+.+.++|||||||++|
T Consensus 159 --------------~NIll~~~~~~kL~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 221 (335)
T 3dls_A 159 --------------ENIVIAEDFTIKLIDFGSAAYLER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLY 221 (335)
T ss_dssp --------------GGEEECTTSCEEECCCTTCEECCT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHH
T ss_pred --------------HHEEEcCCCcEEEeecccceECCC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHH
Confidence 999999999999999999985432 334456789999999999998888678999999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 244 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 244 elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
+|++|..||.+... ........|..+++++.+||.+||+.||.+|||++++++||||.+.
T Consensus 222 el~~g~~pf~~~~~------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 222 TLVFEENPFCELEE------TVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHSSCSCSSGGG------GTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHhCCCchhhHHH------HHhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 99999999976432 2334456677799999999999999999999999999999999764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=399.63 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=218.4
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCcceEEEEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----HPNVVRLHEVLA 84 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-----HpnIv~l~~~~~ 84 (476)
...-++|++++.||+|+||+||+|++..+++.||||++... ......+.+|+.+++.+. ||||+++++++.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 34457999999999999999999999999999999999643 233567888999999996 999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHH
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFL 162 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~ 162 (476)
..+..|+||||+ +++|.+++.... .+++.+++.++.||+.||+|||++||+||||||
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp-------------------- 165 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKP-------------------- 165 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG--------------------
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCc--------------------
Confidence 999999999999 999999998654 599999999999999999999999999999997
Q ss_pred HhhhccccccccCCCCceEeCC-------------------------CCCEEEeccCCCCCCCcccCCCcccccccCCcc
Q 011868 163 LMIVIRPWKFNVLQLENILLDS-------------------------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 217 (476)
Q Consensus 163 ~~~~~~p~~~~~~~~~NiLl~~-------------------------~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y 217 (476)
+|||++. ++.+||+|||++.... ......+||+.|
T Consensus 166 ---------------~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~-----~~~~~~~gt~~y 225 (360)
T 3llt_A 166 ---------------ENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS-----DYHGSIINTRQY 225 (360)
T ss_dssp ---------------GGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT-----SCCCSCCSCGGG
T ss_pred ---------------ccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecC-----CCCcCccCcccc
Confidence 9999975 7899999999997532 223456899999
Q ss_pred ccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC------------------------
Q 011868 218 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK------------------------ 273 (476)
Q Consensus 218 ~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~------------------------ 273 (476)
+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+.....++|.
T Consensus 226 ~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (360)
T 3llt_A 226 RAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAW 304 (360)
T ss_dssp CCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECT
T ss_pred cCcHHHcCCCCC-CccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecC
Confidence 999999988875 8999999999999999999999988877666655443322221
Q ss_pred ----------------------CCCHHHHHHHHHccCCCcCCCCChHHHhcCcccc
Q 011868 274 ----------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307 (476)
Q Consensus 274 ----------------------~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~ 307 (476)
..++.+.+||.+||+.||.+|||++++++||||+
T Consensus 305 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 305 PENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp TTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred cccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 1236788999999999999999999999999995
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=409.04 Aligned_cols=262 Identities=27% Similarity=0.396 Sum_probs=211.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~----- 86 (476)
..++|++++.||+|+||+||+|++..+++.||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 3468999999999999999999999999999999997643 3444567899999999999999999999999766
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
..+|+||||+. |+|.+++.....+++..++.++.||+.||+|||++||+||||||
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp------------------------ 157 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKP------------------------ 157 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG------------------------
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCH------------------------
Confidence 57999999995 69999998888899999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC--------------------CcccccccCCccccccccccC
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD--------------------GLLHTTCGSPNYVAPEVLANR 226 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~--------------------~~~~~~~gt~~y~APE~l~~~ 226 (476)
+|||++.++.+||+|||+|+........ ......+||+.|+|||++...
T Consensus 158 -----------~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~ 226 (432)
T 3n9x_A 158 -----------ANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ 226 (432)
T ss_dssp -----------GGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTC
T ss_pred -----------HHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC
Confidence 9999999999999999999865332111 234677899999999997554
Q ss_pred CCCCccchhhhHhHHHHHHhc-----------CCCCCCCCcH-----------------HHHHHHHH-------------
Q 011868 227 GYDGATSDIWSCGVILYVILT-----------GYLPFDDRNL-----------------AVLYQKIF------------- 265 (476)
Q Consensus 227 ~~~~~~sDvwSlGvil~ellt-----------G~~Pf~~~~~-----------------~~~~~~i~------------- 265 (476)
...+.++||||+|||+|+|++ |+++|.+.+. ......+.
T Consensus 227 ~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~ 306 (432)
T 3n9x_A 227 ENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKN 306 (432)
T ss_dssp SCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHh
Confidence 444589999999999999998 4555554321 11111111
Q ss_pred -----------hCCCCCC-------CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 266 -----------RGDFKLP-------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 266 -----------~~~~~~p-------~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
......+ +.+++++.+||++||+.||.+|||++++++||||....
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 307 INKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred ccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 1111111 34799999999999999999999999999999998753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=397.64 Aligned_cols=262 Identities=29% Similarity=0.419 Sum_probs=221.1
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
-..+++|++++.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+++.++||||+++++++...+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 457889999999999999999999999999999999997654 2344457788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||+.+++|.+++....++++..++.++.||+.||+|||++||+||||||
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp--------------------------- 152 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKP--------------------------- 152 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG---------------------------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcCh---------------------------
Confidence 99999999999988887778899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+||+++.++.+||+|||++..... ........+||+.|+|||++.+....+.++|||||||++|+|++|+
T Consensus 153 --------~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 222 (331)
T 4aaa_A 153 --------ENILVSQSGVVKLCDFGFARTLAA--PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222 (331)
T ss_dssp --------GGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSS
T ss_pred --------heEEEcCCCcEEEEeCCCceeecC--CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999975433 2233455689999999999987644468999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhC-------------------CCCCC------------CCCCHHHHHHHHHccCCCcCCCCChH
Q 011868 250 LPFDDRNLAVLYQKIFRG-------------------DFKLP------------KWLSPGAQNLLRKILEPNPVKRITIA 298 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~-------------------~~~~p------------~~~s~~~~~Li~~~L~~dP~~R~s~~ 298 (476)
.||.+.+.......+... ....| +.+++.+.+||.+||+.||.+|||++
T Consensus 223 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 302 (331)
T 4aaa_A 223 PLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCA 302 (331)
T ss_dssp CSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGG
T ss_pred CCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHH
Confidence 999988766555444321 01111 24689999999999999999999999
Q ss_pred HHhcCcccccc
Q 011868 299 GIKADEWFEQD 309 (476)
Q Consensus 299 ~il~~~~~~~~ 309 (476)
++++||||+..
T Consensus 303 ell~hp~f~~~ 313 (331)
T 4aaa_A 303 ELLHHDFFQMD 313 (331)
T ss_dssp GGGGSHHHHGG
T ss_pred HHhcCchhccC
Confidence 99999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=384.21 Aligned_cols=258 Identities=33% Similarity=0.620 Sum_probs=226.6
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
.++|++.+.||+|+||+||+|++..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 4679999999999999999999999999999999986543221 1357899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p--------------------------- 136 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKP--------------------------- 136 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG---------------------------
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCh---------------------------
Confidence 99999999999999998888899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCC----CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 170 WKFNVLQLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g----~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||+++.++ .+||+|||++..... ........||+.|+|||++.+..++ .++|||||||++|+|
T Consensus 137 --------~Nil~~~~~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l 204 (283)
T 3bhy_A 137 --------ENIMLLDKNVPNPRIKLIDFGIAHKIEA---GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYIL 204 (283)
T ss_dssp --------GGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHH
T ss_pred --------HHEEEecCCCCCCceEEEecccceeccC---CCcccccCCCcCccCcceecCCCCC-cchhhhhHHHHHHHH
Confidence 999999887 899999999975432 2233456799999999999877775 899999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
++|..||.+.+.......+......++ ..+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 205 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 205 LSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 999999999988888888877666554 5688999999999999999999999999999999763
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=398.18 Aligned_cols=264 Identities=27% Similarity=0.419 Sum_probs=223.9
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-- 87 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-- 87 (476)
....++|++.+.||+|+||+||+|++..+++.||||++.............+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 445689999999999999999999999999999999998776556666788999999999999999999999986543
Q ss_pred --EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 88 --KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 88 --~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
..|+||||++|++|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp----------------------- 144 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP----------------------- 144 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG-----------------------
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCH-----------------------
Confidence 3599999999999999998888999999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+|||++.++.+||+|||++........ .......+||+.|+|||++.+..++ .++|||||||++|+
T Consensus 145 ------------~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ 211 (311)
T 3ork_A 145 ------------ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYE 211 (311)
T ss_dssp ------------GGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHH
T ss_pred ------------HHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHH
Confidence 999999999999999999986443211 1223456799999999999888775 89999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHHhCCCCC----CCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 245 ILTGYLPFDDRNLAVLYQKIFRGDFKL----PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|++|+.||.+.+.......+....... +..+++++.+||.+||+.||.+||+..+++.|+|+...
T Consensus 212 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 212 VLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 999999999988877766666655443 24589999999999999999999999999999999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=403.30 Aligned_cols=255 Identities=29% Similarity=0.405 Sum_probs=214.5
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------ 86 (476)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 468999999999999999999999999999999996543 3445567899999999999999999999999765
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
..+|+||||+ |++|.+++.. .++++..++.++.||+.||+|||++||+||||||
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp------------------------ 156 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKP------------------------ 156 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG------------------------
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCH------------------------
Confidence 3569999999 8899999876 6799999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.+|.+||+|||+++... ......+||+.|+|||++.+....+.++||||+||++|+|+
T Consensus 157 -----------~NIll~~~~~~kl~Dfg~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 220 (367)
T 1cm8_A 157 -----------GNLAVNEDCELKILDFGLARQAD-----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220 (367)
T ss_dssp -----------GGEEECTTCCEEECCCTTCEECC-----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHH
T ss_pred -----------HHEEEcCCCCEEEEeeecccccc-----cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHH
Confidence 99999999999999999998532 22445689999999999987433458999999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCCC-------------------------------CCCCCCCHHHHHHHHHccCCCcCCCC
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGDF-------------------------------KLPKWLSPGAQNLLRKILEPNPVKRI 295 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~~-------------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~ 295 (476)
+|+.||.+.+....+..+..... ..+...++.+.+||.+||+.||.+||
T Consensus 221 ~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~ 300 (367)
T 1cm8_A 221 TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300 (367)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCC
Confidence 99999999887766665543111 12234689999999999999999999
Q ss_pred ChHHHhcCccccccC
Q 011868 296 TIAGIKADEWFEQDY 310 (476)
Q Consensus 296 s~~~il~~~~~~~~~ 310 (476)
|++++++||||....
T Consensus 301 t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 301 TAGEALAHPYFESLH 315 (367)
T ss_dssp CHHHHHHSGGGTTTC
T ss_pred CHHHHhcChHHHhhc
Confidence 999999999998643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=398.78 Aligned_cols=256 Identities=33% Similarity=0.626 Sum_probs=227.2
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~ 87 (476)
++|++.+.||+|+||.||+|++..+|+.||||++...... .......+.+|+.+++.+ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999999989999999999765311 122346788999999999 7999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
..|+||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp------------------------- 228 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKP------------------------- 228 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG-------------------------
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH-------------------------
Confidence 9999999999999999998888899999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccC------CCCCccchhhhHhHH
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR------GYDGATSDIWSCGVI 241 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~------~~~~~~sDvwSlGvi 241 (476)
+||+++.+|.+||+|||++..... .......+||+.|+|||++.+. .+ +.++|||||||+
T Consensus 229 ----------~NIl~~~~~~ikl~DfG~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~i 294 (365)
T 2y7j_A 229 ----------ENILLDDNMQIRLSDFGFSCHLEP---GEKLRELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVI 294 (365)
T ss_dssp ----------GGEEECTTCCEEECCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCB-CTTHHHHHHHHH
T ss_pred ----------HHEEECCCCCEEEEecCcccccCC---CcccccCCCCCCccChhhccccccccCcCC-CchhhHHhHHHH
Confidence 999999999999999999975432 2344567899999999998632 34 488999999999
Q ss_pred HHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 242 LYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 242 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+|+|++|..||.+.+.......+..+...++ ..+++.+.+||.+||+.||.+|||++++++||||++
T Consensus 295 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 295 LFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 9999999999999888888888887776554 458899999999999999999999999999999963
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=403.29 Aligned_cols=254 Identities=33% Similarity=0.556 Sum_probs=220.2
Q ss_pred cCEEE--eceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 14 GRYEL--GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 14 ~~Y~i--~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
+.|++ .+.||+|+||+||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 34655 678999999999999999999999999997653 2335789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
||||++|++|.+++... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp---------------------------- 215 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKP---------------------------- 215 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG----------------------------
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCH----------------------------
Confidence 99999999999988654 4699999999999999999999999999999997
Q ss_pred ccccCCCCceEe--CCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 171 KFNVLQLENILL--DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 171 ~~~~~~~~NiLl--~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+|||+ +.++.+||+|||+++.... .......+||+.|+|||++.+..++ .++|||||||++|+|++|
T Consensus 216 -------~NIll~~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg 284 (373)
T 2x4f_A 216 -------ENILCVNRDAKQIKIIDFGLARRYKP---REKLKVNFGTPEFLAPEVVNYDFVS-FPTDMWSVGVIAYMLLSG 284 (373)
T ss_dssp -------GGEEEEETTTTEEEECCCSSCEECCT---TCBCCCCCSSCTTCCHHHHTTCBCC-HHHHHHHHHHHHHHHHHS
T ss_pred -------HHEEEecCCCCcEEEEeCCCceecCC---ccccccccCCCcEeChhhccCCCCC-cHHhHHHHHHHHHHHHhC
Confidence 99999 6678999999999985432 2334556899999999999877664 899999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
..||.+.+....+..+......++ ..+++++.+||.+||+.||.+|||++++++||||...
T Consensus 285 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 285 LSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp SCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred CCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999998888888888766554 4589999999999999999999999999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=399.56 Aligned_cols=260 Identities=34% Similarity=0.558 Sum_probs=220.6
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
++|++.+.||+|+||+||+|.+..+++.||+|++.+.... .......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 5899999999999999999999999999999999765321 23446789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 011868 92 VLEYVTGGELFDKIAS----------------------------------------KGRLQEAEGRKLFQQLIDGVSYCH 131 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~----------------------------------------~~~l~~~~~~~~~~qi~~al~yLH 131 (476)
||||++||+|.+++.. ...+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998842 112467889999999999999999
Q ss_pred hcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCC--CEEEeccCCCCCCCcccCC--Cc
Q 011868 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG--NIKISDFGLSALPQHFRDD--GL 207 (476)
Q Consensus 132 ~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g--~vkl~DFGla~~~~~~~~~--~~ 207 (476)
++||+|||||| +||+++.++ .+||+|||++......... ..
T Consensus 186 ~~~ivH~Dlkp-----------------------------------~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 230 (345)
T 3hko_A 186 NQGICHRDIKP-----------------------------------ENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230 (345)
T ss_dssp HTTEECCCCCG-----------------------------------GGEEESCSSSCCEEECCCTTCEEGGGTTCC----
T ss_pred HCCccccCCCh-----------------------------------hhEEEecCCCceEEEeeccccccccccCcccccc
Confidence 99999999997 999998777 8999999999754322111 12
Q ss_pred ccccccCCcccccccccc--CCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHH
Q 011868 208 LHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQN 281 (476)
Q Consensus 208 ~~~~~gt~~y~APE~l~~--~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 281 (476)
....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.......+......++. .+++.+.+
T Consensus 231 ~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (345)
T 3hko_A 231 MTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARD 309 (345)
T ss_dssp ----CCCGGGCCHHHHTCSSSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHH
T ss_pred ccccCCCccccCchhhccCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHH
Confidence 456689999999999875 444 58999999999999999999999999988888888877655432 37899999
Q ss_pred HHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 282 LLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 282 Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
||.+||+.||.+|||+.++++||||++.
T Consensus 310 li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 310 LLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 9999999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=383.61 Aligned_cols=262 Identities=32% Similarity=0.554 Sum_probs=229.5
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc------chhHHHHHHHHHHHHHhCC-CCCcceEEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII------HLKITDQIKREIATLKLLK-HPNVVRLHEV 82 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~ 82 (476)
....++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+.+|+.+++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 34578999999999999999999999999999999999765311 1233567889999999996 9999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHH
Q 011868 83 LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFL 162 (476)
Q Consensus 83 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~ 162 (476)
+...+..|+||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p-------------------- 152 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKP-------------------- 152 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG--------------------
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCc--------------------
Confidence 999999999999999999999998888899999999999999999999999999999997
Q ss_pred HhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccc------cCCCCCccchhh
Q 011868 163 LMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA------NRGYDGATSDIW 236 (476)
Q Consensus 163 ~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~~~~~sDvw 236 (476)
+||+++.++.+||+|||++..... .......+||+.|+|||++. ...+ +.++|||
T Consensus 153 ---------------~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~ 213 (298)
T 1phk_A 153 ---------------ENILLDDDMNIKLTDFGFSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMW 213 (298)
T ss_dssp ---------------GGEEECTTCCEEECCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHH
T ss_pred ---------------ceEEEcCCCcEEEecccchhhcCC---CcccccccCCccccCHHHhccccccccccC-CcccccH
Confidence 999999999999999999975432 23345668999999999985 2334 4889999
Q ss_pred hHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 237 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 237 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
||||++|+|++|..||.+.+.......+..+...++ ..+++.+.+||.+||+.||.+|||++++++||||++..
T Consensus 214 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 214 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred hHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 999999999999999999888888888887766544 24789999999999999999999999999999998643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=396.38 Aligned_cols=254 Identities=25% Similarity=0.400 Sum_probs=223.3
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
.+|++.+.||+|+||+||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++..++..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999998765445555678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 94 EYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 94 E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
||+. |+|.+.+. ...++++.+++.++.|++.||+|||++||+||||||
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp------------------------------ 182 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA------------------------------ 182 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSG------------------------------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH------------------------------
Confidence 9996 68888875 456899999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccc---cCCCCCccchhhhHhHHHHHHhcCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||++.+|.+||+|||++..... ....+||+.|+|||++. ...+ +.++|||||||++|+|++|+
T Consensus 183 -----~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~ 250 (348)
T 1u5q_A 183 -----GNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERK 250 (348)
T ss_dssp -----GGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSS
T ss_pred -----HHEEECCCCCEEEeeccCceecCC------CCcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999985432 23568999999999985 3445 48899999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 250 LPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
.||.+.+.......+..+..+ .+..+++.+.+||.+||+.||.+|||++++++||||....
T Consensus 251 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 251 PPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp CTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred CCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 999988877766666665433 2456899999999999999999999999999999997643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=395.78 Aligned_cols=261 Identities=25% Similarity=0.421 Sum_probs=216.5
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKI 89 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~~~ 89 (476)
.-++|++++.||+|+||+||+|.+ .+++.||||++..... .....+.+.+|+.+|+.++| |||+++++++..++.+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 445799999999999999999998 5689999999986643 34446789999999999986 9999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+|||+ .+++|.+++...+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp--------------------------- 136 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP--------------------------- 136 (343)
T ss_dssp EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG---------------------------
T ss_pred EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc---------------------------
Confidence 999995 4889999999888999999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc-----------CCCCCccchhhhH
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-----------RGYDGATSDIWSC 238 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----------~~~~~~~sDvwSl 238 (476)
+|||++ ++.+||+|||+++..............+||+.|+|||++.+ ..+ +.++|||||
T Consensus 137 --------~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~Diwsl 206 (343)
T 3dbq_A 137 --------ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSL 206 (343)
T ss_dssp --------GGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------C-CHHHHHHHH
T ss_pred --------ceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCC-CchhhHHHH
Confidence 999997 68899999999986544322223456789999999999864 334 588999999
Q ss_pred hHHHHHHhcCCCCCCCCc-HHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCCC
Q 011868 239 GVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 239 Gvil~elltG~~Pf~~~~-~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~~ 312 (476)
||++|+|++|+.||.+.. .......+... ...+|...++++.+||.+||+.||.+|||+.++++||||.....+
T Consensus 207 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~ 283 (343)
T 3dbq_A 207 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283 (343)
T ss_dssp HHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred HHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence 999999999999998743 33344444433 345777788999999999999999999999999999999875544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=381.21 Aligned_cols=254 Identities=24% Similarity=0.458 Sum_probs=219.3
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKI 89 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~ 89 (476)
..|++.+.||+|+||+||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 358999999999999999999999999999999986553 34446789999999999999999999999865 4668
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g--ivHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
|+||||+++++|.+++...+.+++..++.++.||+.||.|||++| |+||||||
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp------------------------- 159 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC------------------------- 159 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCG-------------------------
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCH-------------------------
Confidence 999999999999999988888999999999999999999999999 99999997
Q ss_pred cccccccCCCCceEeC-CCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 168 RPWKFNVLQLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~-~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+||+++ .++.+||+|||++.... .......+||+.|+|||++.+ .+ +.++||||+||++|+|+
T Consensus 160 ----------~Nil~~~~~~~~kl~Dfg~~~~~~----~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~ 223 (290)
T 1t4h_A 160 ----------DNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMA 223 (290)
T ss_dssp ----------GGEEESSTTSCEEECCTTGGGGCC----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHH
T ss_pred ----------HHEEEECCCCCEEEeeCCCccccc----ccccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHH
Confidence 999998 78999999999997432 233456689999999998864 35 48999999999999999
Q ss_pred cCCCCCCCCc-HHHHHHHHHhCCC--CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 247 TGYLPFDDRN-LAVLYQKIFRGDF--KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 247 tG~~Pf~~~~-~~~~~~~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
+|+.||.+.. ....+..+..+.. .++...++++.+||.+||+.||.+|||++++++||||++.
T Consensus 224 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 224 TSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred hCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 9999998854 4455555554432 2455678999999999999999999999999999999763
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=398.39 Aligned_cols=265 Identities=27% Similarity=0.354 Sum_probs=216.5
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
+.+.++|++++.||+|+||+||+|++..+|+.||||++....... ......+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 346789999999999999999999999999999999997543221 112346889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
..|+||||+.+ +|.+.+... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp------------------------ 140 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP------------------------ 140 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCG------------------------
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCH------------------------
Confidence 99999999975 898888654 4699999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.+|.+||+|||+++.... ........+||+.|+|||++.+....+.++|||||||++|+|+
T Consensus 141 -----------~Nil~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 207 (346)
T 1ua2_A 141 -----------NNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207 (346)
T ss_dssp -----------GGEEECTTCCEEECCCGGGSTTTS--CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHH
T ss_pred -----------HHEEEcCCCCEEEEecccceeccC--CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHH
Confidence 999999999999999999986533 2234456789999999999977554458999999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCC--CC---C-----------------------CCCCCHHHHHHHHHccCCCcCCCCChH
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGD--FK---L-----------------------PKWLSPGAQNLLRKILEPNPVKRITIA 298 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~--~~---~-----------------------p~~~s~~~~~Li~~~L~~dP~~R~s~~ 298 (476)
+|..||.+.+....+.++.... .. + ...+++++.+||++||+.||.+|||++
T Consensus 208 ~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 287 (346)
T 1ua2_A 208 LRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT 287 (346)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHH
Confidence 9999999988877777665421 00 0 133578999999999999999999999
Q ss_pred HHhcCccccccCCC
Q 011868 299 GIKADEWFEQDYTP 312 (476)
Q Consensus 299 ~il~~~~~~~~~~~ 312 (476)
|+++||||.....+
T Consensus 288 ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 288 QALKMKYFSNRPGP 301 (346)
T ss_dssp HHHTSGGGTSSSCC
T ss_pred HHhcChhhhcCCCC
Confidence 99999999875443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=397.26 Aligned_cols=259 Identities=29% Similarity=0.443 Sum_probs=219.9
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK 88 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~ 88 (476)
++|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 48999999999999999999999999999999997543 344457899999999999999999999999654 47
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
.|+||||+. |+|.+++.. .++++.+++.++.||+.||+|||++||+||||||
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp-------------------------- 156 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKP-------------------------- 156 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG--------------------------
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCh--------------------------
Confidence 899999995 599998876 5799999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.++.+||+|||++........ .......+||+.|+|||++.+....+.++|||||||++|+|++
T Consensus 157 ---------~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 227 (364)
T 3qyz_A 157 ---------SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227 (364)
T ss_dssp ---------GGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHH
T ss_pred ---------HhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHH
Confidence 999999999999999999986543221 2234556899999999997765544589999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCC----------------------C----C-----CCCCCCHHHHHHHHHccCCCcCCCCC
Q 011868 248 GYLPFDDRNLAVLYQKIFRGD----------------------F----K-----LPKWLSPGAQNLLRKILEPNPVKRIT 296 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~----------------------~----~-----~p~~~s~~~~~Li~~~L~~dP~~R~s 296 (476)
|+.||.+.+.......+.... . . .+..+++++.+||.+||+.||.+|||
T Consensus 228 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 307 (364)
T 3qyz_A 228 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307 (364)
T ss_dssp SSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC
Confidence 999999887665555543210 0 0 12447899999999999999999999
Q ss_pred hHHHhcCccccccCC
Q 011868 297 IAGIKADEWFEQDYT 311 (476)
Q Consensus 297 ~~~il~~~~~~~~~~ 311 (476)
++++++||||.+.+.
T Consensus 308 ~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 308 VEQALAHPYLEQYYD 322 (364)
T ss_dssp HHHHHTSGGGTTTCC
T ss_pred HHHHhcCcchhhccC
Confidence 999999999987643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=379.31 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=215.8
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~ 90 (476)
..++|++.+.||+|+||+||+|.+..+++.||||++....... .....+.+|+..+..+ +||||+++++++...+..|
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 3568999999999999999999999999999999998654333 3357788999999999 8999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 91 MVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
+||||++|++|.+++... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp------------------------ 143 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKP------------------------ 143 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG------------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCH------------------------
Confidence 999999999999999764 6799999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCC-------------------CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC
Q 011868 167 IRPWKFNVLQLENILLDSK-------------------GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 227 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~-------------------g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 227 (476)
+||+++.+ ..+||+|||++..... .....||+.|+|||++.+..
T Consensus 144 -----------~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~ 206 (289)
T 1x8b_A 144 -----------SNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENY 206 (289)
T ss_dssp -----------GGEEEC--------------------CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCC
T ss_pred -----------HHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCC
Confidence 99999854 4799999999975332 22346999999999998764
Q ss_pred CCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 228 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 228 ~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
..+.++|||||||++|+|++|..|+..... ...+..+. ..+|..+++++.+||.+||+.||.+|||+.++++||||
T Consensus 207 ~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 283 (289)
T 1x8b_A 207 THLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283 (289)
T ss_dssp TTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred CCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence 545799999999999999999988765432 33444443 35677899999999999999999999999999999999
Q ss_pred ccc
Q 011868 307 EQD 309 (476)
Q Consensus 307 ~~~ 309 (476)
...
T Consensus 284 ~~~ 286 (289)
T 1x8b_A 284 LSA 286 (289)
T ss_dssp ---
T ss_pred hhh
Confidence 864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=393.06 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=211.6
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---- 87 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~---- 87 (476)
.+++|++++.||+|+||+||+|++..+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 4678999999999999999999999999999999997654 3334678999999999999999999999985543
Q ss_pred -----------------------------------------------------EEEEEEeccCCCChHHHHHhcC---CC
Q 011868 88 -----------------------------------------------------KIYMVLEYVTGGELFDKIASKG---RL 111 (476)
Q Consensus 88 -----------------------------------------------------~~~lV~E~~~gg~L~~~l~~~~---~l 111 (476)
..|+||||++||+|.+++.... ..
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 3899999999999999998754 35
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEe
Q 011868 112 QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191 (476)
Q Consensus 112 ~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~ 191 (476)
++..++.++.||+.||+|||++||+|||||| +|||++.++.+||+
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp-----------------------------------~NIll~~~~~~kL~ 206 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP-----------------------------------SNIFFTMDDVVKVG 206 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCG-----------------------------------GGEEECTTCCEEEC
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCc-----------------------------------ccEEEeCCCCEEEe
Confidence 6667899999999999999999999999997 99999999999999
Q ss_pred ccCCCCCCCcccC----------CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHH
Q 011868 192 DFGLSALPQHFRD----------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 261 (476)
Q Consensus 192 DFGla~~~~~~~~----------~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~ 261 (476)
|||+++....... .......+||+.|+|||++.+..++ .++||||+||++|+|++|..|+.. .....
T Consensus 207 DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~--~~~~~ 283 (332)
T 3qd2_B 207 DFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQME--RVRII 283 (332)
T ss_dssp CCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHH--HHHHH
T ss_pred ecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhH--HHHHH
Confidence 9999986543211 1223456799999999999888775 899999999999999999877532 22333
Q ss_pred HHHHhCCCCC-CCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 262 QKIFRGDFKL-PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 262 ~~i~~~~~~~-p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
..+.....+. +...++++.+||.+||+.||.+|||++++++||||++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 284 TDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 3343333221 1335788999999999999999999999999999974
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=388.98 Aligned_cols=258 Identities=29% Similarity=0.489 Sum_probs=216.4
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
.+..++|++.+.||+|+||+||+|++ +|+.||||++..... .......+.+|+.++++++||||+++++++...+..
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 45678999999999999999999986 688999999976643 344467899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcC--cEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 90 YMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~al~yLH~~g--ivHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
|+||||++||+|.+++...+. +++..++.++.||+.||+|||++| |+||||||
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp---------------------- 167 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKS---------------------- 167 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCG----------------------
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCCh----------------------
Confidence 999999999999999986543 999999999999999999999999 99999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+|||++.++.+||+|||+++.... ........+||+.|+|||++.+..++ .++|||||||++|+
T Consensus 168 -------------~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~e 231 (309)
T 3p86_A 168 -------------PNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWE 231 (309)
T ss_dssp -------------GGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCC-TTHHHHHHHHHHHH
T ss_pred -------------hhEEEeCCCcEEECCCCCCccccc--cccccccCCCCccccChhhhcCCCCC-chhhHHHHHHHHHH
Confidence 999999999999999999975332 12234456899999999999888775 89999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc--Cccccc
Q 011868 245 ILTGYLPFDDRNLAVLYQKIF--RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQ 308 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~--~~~~~~ 308 (476)
|++|+.||.+.+.......+. .....+|..+++++.+||.+||+.||.+|||++++++ ++|++.
T Consensus 232 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 232 LATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999988877776664 3345678889999999999999999999999999987 455544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=401.03 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=217.5
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~~~~~l 91 (476)
.+|++++.||+|+||+||+|.+.. ++.||||++..... .......+.+|+.+|+.++ ||||+++++++...+.+|+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 459999999999999999999854 99999999987653 3445688999999999996 5999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||| +.+++|.+++.....+++.+++.++.||+.||.|||++||+||||||
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp----------------------------- 183 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP----------------------------- 183 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCG-----------------------------
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCH-----------------------------
Confidence 999 45889999999888999999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccC----------CCCCccchhhhHhHH
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR----------GYDGATSDIWSCGVI 241 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----------~~~~~~sDvwSlGvi 241 (476)
+|||++ ++.+||+|||+++..............+||+.|+|||++.+. ...+.++|||||||+
T Consensus 184 ------~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvi 256 (390)
T 2zmd_A 184 ------ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256 (390)
T ss_dssp ------GGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHH
T ss_pred ------HHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHH
Confidence 999995 689999999999865432222234567899999999998652 223589999999999
Q ss_pred HHHHhcCCCCCCCCc-HHHHHHHHHhCC--CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCCC
Q 011868 242 LYVILTGYLPFDDRN-LAVLYQKIFRGD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 242 l~elltG~~Pf~~~~-~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~~ 312 (476)
+|+|++|+.||.+.. ....+..+.... ..+|.+.++++.+||.+||+.||.+|||+.++++||||.....+
T Consensus 257 l~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 330 (390)
T 2zmd_A 257 LYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330 (390)
T ss_dssp HHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred HHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence 999999999998753 334455555443 45678889999999999999999999999999999999865433
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-49 Score=389.48 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=206.8
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV 92 (476)
++|++.++||+|+||+||+|++..+|+.||||++........ ......+|+..+..+ +||||+++++++...+..|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH-HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 679999999999999999999999999999999866543223 334445555555444 899999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||+ +++|.+.+... .++++..++.++.||+.||+|||++||+||||||
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp----------------------------- 185 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKP----------------------------- 185 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG-----------------------------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH-----------------------------
Confidence 9999 77999988764 4699999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+|||++.++.+||+|||++..... .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..|
T Consensus 186 ------~NIll~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~ 254 (311)
T 3p1a_A 186 ------ANIFLGPRGRCKLGDFGLLVELGT---AGAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMEL 254 (311)
T ss_dssp ------GGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCC
T ss_pred ------HHEEECCCCCEEEccceeeeeccc---CCCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999875432 233445679999999999876 56 4899999999999999999777
Q ss_pred CCCCcHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 252 FDDRNLAVLYQKIFRGDF--KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
|.+... ...+..+.. .++..+++++.+||.+||+.||.+|||++++++||||++
T Consensus 255 ~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 255 PHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred CCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 655432 233333322 234668999999999999999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=382.97 Aligned_cols=261 Identities=30% Similarity=0.522 Sum_probs=228.1
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSK 88 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~--~~~~ 88 (476)
.+.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++. ....
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 467899999999999999999999999999999999987653 3344678999999999999999999999874 4678
Q ss_pred EEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC-----cEeccCCcchhccchhhhHHHHHHH
Q 011868 89 IYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKG-----VFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~al~yLH~~g-----ivHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
.|+||||++|++|.+++... ..+++..++.++.||+.||+|||++| |+||||||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p----------------- 144 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKP----------------- 144 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSG-----------------
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccch-----------------
Confidence 99999999999999999753 34999999999999999999999999 99999997
Q ss_pred HHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHh
Q 011868 160 TFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlG 239 (476)
+||+++.++.+||+|||++..... .........||+.|+|||++.+..++ .++||||||
T Consensus 145 ------------------~NIl~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG 203 (279)
T 2w5a_A 145 ------------------ANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLG 203 (279)
T ss_dssp ------------------GGEEECSSSCEEECCCCHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHH
T ss_pred ------------------hhEEEcCCCCEEEecCchheeecc--ccccccccCCCccccChHHhccCCCC-chhhHHHHH
Confidence 999999999999999999875332 11223456799999999999887775 899999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 240 VILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 240 vil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
|++|+|++|+.||.+.+.......+..+.. .+|..+++++.++|.+||+.||.+|||++++++|+|+....
T Consensus 204 ~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 204 CLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred HHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 999999999999999888888888877765 56778999999999999999999999999999999998653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=390.45 Aligned_cols=257 Identities=35% Similarity=0.554 Sum_probs=222.5
Q ss_pred cCEEEe-ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 011868 14 GRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 14 ~~Y~i~-~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~l 91 (476)
++|.+. +.||+|+||+||+|++..+++.||+|++...... ......+.+|+.+++.+. ||||+++++++...+..|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 468887 8899999999999999999999999999865432 233578899999999995 6999999999999999999
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
||||+.||+|.+++... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp--------------------------- 159 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKP--------------------------- 159 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG---------------------------
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCh---------------------------
Confidence 99999999999998543 6799999999999999999999999999999997
Q ss_pred cccccCCCCceEeCC---CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 170 WKFNVLQLENILLDS---KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~---~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++. ++.+||+|||++..... .......+||+.|+|||++.+..++ .++|||||||++|+|+
T Consensus 160 --------~NIl~~~~~~~~~~kL~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll 227 (327)
T 3lm5_A 160 --------QNILLSSIYPLGDIKIVDFGMSRKIGH---ACELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLL 227 (327)
T ss_dssp --------GGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHH
T ss_pred --------HHEEEecCCCCCcEEEeeCccccccCC---ccccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHH
Confidence 9999998 78999999999985432 2234556899999999999888775 8999999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
+|+.||.+.+....+..+.......+ ..+++.+.+||.+||+.||.+|||++++++||||+...
T Consensus 228 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 228 THTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred hCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 99999999988888877777655443 45889999999999999999999999999999998643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=407.07 Aligned_cols=256 Identities=37% Similarity=0.671 Sum_probs=210.6
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
.++|++.+.||+|+||+||+|.+..+++.||||++.+.... .......+.+|+.+|++++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 46899999999999999999999999999999999865422 11122358899999999999999999999864 5
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
..|+||||+++|+|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp------------------------- 267 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP------------------------- 267 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG-------------------------
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCh-------------------------
Confidence 6899999999999999998888999999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCC---CEEEeccCCCCCCCcccCCCcccccccCCcccccccccc---CCCCCccchhhhHhHH
Q 011868 168 RPWKFNVLQLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVI 241 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~sDvwSlGvi 241 (476)
+|||++.++ .+||+|||+++.... .....+.+||+.|+|||++.+ ..| +.++|||||||+
T Consensus 268 ----------~NIll~~~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~i 333 (419)
T 3i6u_A 268 ----------ENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVI 333 (419)
T ss_dssp ----------GGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTT-HHHHHHHHHHHH
T ss_pred ----------HhEEEecCCCcceEEEeecccceecCC---CccccccCCCCCccCceeeecCCCCCC-CchhhhHhHHHH
Confidence 999997654 599999999986432 334566789999999999864 344 478999999999
Q ss_pred HHHHhcCCCCCCCCcH-HHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 242 LYVILTGYLPFDDRNL-AVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 242 l~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+|+|++|+.||.+... ......+..+...++ ..+++.+.+||.+||+.||.+|||++++++||||+.
T Consensus 334 l~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 334 LFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 9999999999987543 344555666655543 458999999999999999999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=399.35 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=210.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---- 87 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~---- 87 (476)
..++|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 4679999999999999999999999999999999997654 23445678899999999999999999999997654
Q ss_pred --EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 88 --KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 88 --~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
..|+||||+. |+|.+.+. ..+++..++.++.||+.||+|||++||+||||||
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp----------------------- 155 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP----------------------- 155 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG-----------------------
T ss_pred ccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCH-----------------------
Confidence 7899999996 57888885 4699999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++ .++|||||||++|+|
T Consensus 156 ------------~NIl~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el 219 (371)
T 2xrw_A 156 ------------SNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEM 219 (371)
T ss_dssp ------------GGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHH
T ss_pred ------------HHEEEcCCCCEEEEEeeccccccc---ccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHH
Confidence 999999999999999999985432 2234456899999999999988775 899999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCCCC----------------------C--------------CCC------CCHHHHHHH
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGDFK----------------------L--------------PKW------LSPGAQNLL 283 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~~~----------------------~--------------p~~------~s~~~~~Li 283 (476)
++|+.||.+.+....+.++...... + |.. .++++.+||
T Consensus 220 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 299 (371)
T 2xrw_A 220 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 299 (371)
T ss_dssp HHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHH
Confidence 9999999998887776666542111 0 000 156789999
Q ss_pred HHccCCCcCCCCChHHHhcCccccccC
Q 011868 284 RKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 284 ~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
++||+.||.+|||++++++||||...+
T Consensus 300 ~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 300 SKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 999999999999999999999998654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=401.41 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=212.6
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------ 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------ 85 (476)
..++|++++.||+|+||+||+|++..+|+.||||++..+.. ...+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 45689999999999999999999999999999999976531 23479999999999999999999843
Q ss_pred --------------------------------CCEEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Q 011868 86 --------------------------------KSKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSY 129 (476)
Q Consensus 86 --------------------------------~~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~al~y 129 (476)
...+|+||||++ |+|.+.+. ....+++..++.++.||+.||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 345899999997 57776664 35689999999999999999999
Q ss_pred HHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeC-CCCCEEEeccCCCCCCCcccCCCcc
Q 011868 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD-SKGNIKISDFGLSALPQHFRDDGLL 208 (476)
Q Consensus 130 LH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~-~~g~vkl~DFGla~~~~~~~~~~~~ 208 (476)
||++||+|||||| +|||++ .++.+||+|||+|+.... ....
T Consensus 157 LH~~gi~H~Dikp-----------------------------------~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~ 198 (383)
T 3eb0_A 157 IHSLGICHRDIKP-----------------------------------QNLLVNSKDNTLKLCDFGSAKKLIP---SEPS 198 (383)
T ss_dssp HHTTTEECSCCCG-----------------------------------GGEEEETTTTEEEECCCTTCEECCT---TSCC
T ss_pred HHHCcCccCccCH-----------------------------------HHEEEcCCCCcEEEEECCCCcccCC---CCCC
Confidence 9999999999997 999998 688999999999985432 2334
Q ss_pred cccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhC-----------------CCC-
Q 011868 209 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-----------------DFK- 270 (476)
Q Consensus 209 ~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-----------------~~~- 270 (476)
...+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+.+. ...
T Consensus 199 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 278 (383)
T 3eb0_A 199 VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF 278 (383)
T ss_dssp CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCC
T ss_pred cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccC
Confidence 55688999999999887664458999999999999999999999998877766665431 011
Q ss_pred -----------CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 271 -----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 271 -----------~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
+|..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 279 PTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp CCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred CccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 345578999999999999999999999999999999763
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=396.16 Aligned_cols=262 Identities=30% Similarity=0.441 Sum_probs=224.1
Q ss_pred ccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 7 ~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
+...+..++|++.+.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++..+
T Consensus 26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 344567789999999999999999999999999999999998653 344567899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~-givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
+..|+||||++|++|.+++...+.+++..++.++.|++.||+|||+. ||+||||||
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp----------------------- 160 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP----------------------- 160 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSG-----------------------
T ss_pred CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccH-----------------------
Confidence 99999999999999999998888999999999999999999999996 999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||+++.++.+||+|||++.... .......+||+.|+|||++.+..++ .++|||||||++|+|
T Consensus 161 ------------~Nil~~~~~~~kl~Dfg~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l 223 (360)
T 3eqc_A 161 ------------SNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEM 223 (360)
T ss_dssp ------------GGEEECTTCCEEECCCCCCHHHH----HHC----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHH
T ss_pred ------------HHEEECCCCCEEEEECCCCcccc----cccccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHH
Confidence 99999999999999999986322 1223456899999999999888775 899999999999999
Q ss_pred hcCCCCCCCCcHHHHHH------------------------------------------HHHhCCC-CCC-CCCCHHHHH
Q 011868 246 LTGYLPFDDRNLAVLYQ------------------------------------------KIFRGDF-KLP-KWLSPGAQN 281 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~------------------------------------------~i~~~~~-~~p-~~~s~~~~~ 281 (476)
++|+.||...+...... .+..... ..+ ..+++++.+
T Consensus 224 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (360)
T 3eqc_A 224 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 303 (360)
T ss_dssp HHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHH
Confidence 99999998766543322 1222221 122 337889999
Q ss_pred HHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 282 LLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 282 Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
||++||+.||.+|||++++++||||+...
T Consensus 304 li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 304 FVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 99999999999999999999999998643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=397.96 Aligned_cols=263 Identities=31% Similarity=0.580 Sum_probs=226.6
Q ss_pred CccCcCEEEeceEeecCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~ 84 (476)
...+++|++.+.||+|+||+||+|++. .+++.||||++++.... .......+.+|+.+++.+ .||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 456689999999999999999999985 48999999999754321 122245677899999999 6999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
....+|+||||+++|+|.+++....++++.+++.++.||+.||.|||++||+||||||
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp---------------------- 187 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL---------------------- 187 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG----------------------
T ss_pred eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH----------------------
Confidence 9999999999999999999998888999999999999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccC-CCCCccchhhhHhHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILY 243 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~sDvwSlGvil~ 243 (476)
+|||++.++.+||+|||+++..... ........+||+.|+|||++.+. ...+.++|||||||++|
T Consensus 188 -------------~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ 253 (355)
T 1vzo_A 188 -------------ENILLDSNGHVVLTDFGLSKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY 253 (355)
T ss_dssp -------------GGEEECTTSCEEESCSSEEEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHH
T ss_pred -------------HHEEECCCCcEEEeeCCCCeecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHH
Confidence 9999999999999999999754321 12234456899999999998753 22358899999999999
Q ss_pred HHhcCCCCCCCC----cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 244 VILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 244 elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
+|++|+.||... ....+...+.....++|..+++.+.+||.+||+.||.+|| |++++++||||..
T Consensus 254 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 254 ELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp HHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 999999999743 3456666777778888999999999999999999999999 9999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=396.10 Aligned_cols=260 Identities=27% Similarity=0.516 Sum_probs=228.3
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchh--------------HHHHHHHHHHHHHhCCC
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--------------ITDQIKREIATLKLLKH 73 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~--------------~~~~~~~Ei~~l~~l~H 73 (476)
.....+++|++++.||+|+||.||+|.+ +|+.||||++......... ....+.+|+.+++.++|
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 3455678999999999999999999998 8999999999765432211 12789999999999999
Q ss_pred CCcceEEEEEEeCCEEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcch
Q 011868 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDK------IAS--KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVIL 144 (476)
Q Consensus 74 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~------l~~--~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~ 144 (476)
|||+++++++...+..|+||||++||+|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p-- 180 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP-- 180 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG--
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh--
Confidence 9999999999999999999999999999998 655 5679999999999999999999999 9999999997
Q ss_pred hccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccc
Q 011868 145 KSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 224 (476)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 224 (476)
+||+++.++.+||+|||++..... .......||+.|+|||++.
T Consensus 181 ---------------------------------~Nil~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~ 223 (348)
T 2pml_X 181 ---------------------------------SNILMDKNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFS 223 (348)
T ss_dssp ---------------------------------GGEEECTTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGS
T ss_pred ---------------------------------HhEEEcCCCcEEEecccccccccc----ccccCCCCCcCccCchhhc
Confidence 999999999999999999975432 2345567999999999998
Q ss_pred cC-CCCCccchhhhHhHHHHHHhcCCCCCCCCcH-HHHHHHHHhCCCCCC-------------------CCCCHHHHHHH
Q 011868 225 NR-GYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKLP-------------------KWLSPGAQNLL 283 (476)
Q Consensus 225 ~~-~~~~~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p-------------------~~~s~~~~~Li 283 (476)
+. .+++.++||||+||++|+|++|..||.+.+. ......+..+...+| ..+++++.+||
T Consensus 224 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 303 (348)
T 2pml_X 224 NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFL 303 (348)
T ss_dssp SCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHH
T ss_pred CCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHH
Confidence 77 5553489999999999999999999998776 777888887777766 56899999999
Q ss_pred HHccCCCcCCCCChHHHhcCccccc
Q 011868 284 RKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 284 ~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
.+||+.||.+|||++++++||||..
T Consensus 304 ~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 304 KLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHccCChhhCCCHHHHhcCccccC
Confidence 9999999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=403.79 Aligned_cols=253 Identities=28% Similarity=0.389 Sum_probs=215.4
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC------CCCCcceEEEEEEe
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL------KHPNVVRLHEVLAS 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l------~HpnIv~l~~~~~~ 85 (476)
..++|++++.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.+ +|+||+++++++..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 346899999999999999999999999999999999654 23356788899888887 57799999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHH
Q 011868 86 KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLL 163 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~ 163 (476)
.+.+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp--------------------- 228 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKP--------------------- 228 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSG---------------------
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH---------------------
Confidence 999999999994 69999997653 599999999999999999999999999999997
Q ss_pred hhhccccccccCCCCceEeCCCCC--EEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 164 MIVIRPWKFNVLQLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 164 ~~~~~p~~~~~~~~~NiLl~~~g~--vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+|||++.++. +||+|||+|+.. .....+.+||+.|+|||++.+..|+ .++|||||||+
T Consensus 229 --------------~NILl~~~~~~~vkL~DFG~a~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~i 288 (429)
T 3kvw_A 229 --------------ENILLKQQGRSGIKVIDFGSSCYE-----HQRVYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCI 288 (429)
T ss_dssp --------------GGEEESSTTSCCEEECCCTTCEET-----TCCCCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHH
T ss_pred --------------HHeEEccCCCcceEEeecccceec-----CCcccccCCCCCccChHHHhCCCCC-chHHHHhHHHH
Confidence 9999999987 999999999742 2234567899999999999988885 89999999999
Q ss_pred HHHHhcCCCCCCCCcHHHHHHHHHhCCCC---------------------------------------------------
Q 011868 242 LYVILTGYLPFDDRNLAVLYQKIFRGDFK--------------------------------------------------- 270 (476)
Q Consensus 242 l~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------------------------------------------- 270 (476)
+|+|++|+.||.+.+....+..+......
T Consensus 289 l~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (429)
T 3kvw_A 289 LAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPP 368 (429)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECST
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCc
Confidence 99999999999998877666554421000
Q ss_pred --------CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 271 --------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 271 --------~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
++...++.+.+||++||+.||.+|||++|+++||||++..
T Consensus 369 ~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 369 ESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp TCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred cchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence 1112378899999999999999999999999999998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=398.05 Aligned_cols=255 Identities=31% Similarity=0.428 Sum_probs=202.1
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------ 86 (476)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 368999999999999999999999999999999997543 2344567889999999999999999999999654
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
...|+||||+ +++|.+++.. .++++..++.++.||+.||+|||++||+||||||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp------------------------ 160 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKP------------------------ 160 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG------------------------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCH------------------------
Confidence 5689999999 8899998865 6799999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.++.+||+|||+++.... .....+||+.|+|||++.+....+.++||||+||++|+|+
T Consensus 161 -----------~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 224 (367)
T 2fst_X 161 -----------SNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224 (367)
T ss_dssp -----------GGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHH
T ss_pred -----------hhEEECCCCCEEEeeccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999985322 2345689999999999987444458999999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCC-----------------------CCC--------CCCCCHHHHHHHHHccCCCcCCCC
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGD-----------------------FKL--------PKWLSPGAQNLLRKILEPNPVKRI 295 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~-----------------------~~~--------p~~~s~~~~~Li~~~L~~dP~~R~ 295 (476)
+|+.||.+.+....+..+.+.. ... ....++.+.+||++||+.||.+||
T Consensus 225 ~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~ 304 (367)
T 2fst_X 225 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304 (367)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCc
Confidence 9999999988776666554310 001 123688999999999999999999
Q ss_pred ChHHHhcCccccccC
Q 011868 296 TIAGIKADEWFEQDY 310 (476)
Q Consensus 296 s~~~il~~~~~~~~~ 310 (476)
|++++++||||....
T Consensus 305 t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 305 TAAQALAHAYFAQYH 319 (367)
T ss_dssp CHHHHHTSGGGTTTC
T ss_pred CHHHHhcChhhhhcc
Confidence 999999999998654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=379.59 Aligned_cols=258 Identities=22% Similarity=0.346 Sum_probs=204.5
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
+..++|++++.||+|+||+||+|++..+|+.||+|++..... .......+.++...++.++||||+++++++..++..|
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 467899999999999999999999999999999999976532 2233445566666688899999999999999999999
Q ss_pred EEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 91 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~-givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
+||||++ |+|.+.+.. ...+++..++.++.||+.||+|||++ ||+||||||
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp----------------------- 138 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP----------------------- 138 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSG-----------------------
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCH-----------------------
Confidence 9999996 588777643 46899999999999999999999998 999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccc----ccCCCCCccchhhhHhHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL----ANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l----~~~~~~~~~sDvwSlGvi 241 (476)
+||+++.++.+||+|||++..... .......+||+.|+|||++ .+..+ +.++||||+||+
T Consensus 139 ------------~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~i 202 (290)
T 3fme_A 139 ------------SNVLINALGQVKMCDFGISGYLVD---DVAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGIT 202 (290)
T ss_dssp ------------GGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHH
T ss_pred ------------HHEEECCCCCEEEeecCCcccccc---cccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHH
Confidence 999999999999999999985432 2233445799999999996 33444 589999999999
Q ss_pred HHHHhcCCCCCCCC-cHHHHHHH-HHhCCCCCC-CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 242 LYVILTGYLPFDDR-NLAVLYQK-IFRGDFKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 242 l~elltG~~Pf~~~-~~~~~~~~-i~~~~~~~p-~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
+|+|++|+.||... ........ +.......+ ..+++++.+||.+||+.||.+|||++++++||||...
T Consensus 203 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 203 MIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 99999999999863 33333333 333333333 4589999999999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=386.10 Aligned_cols=252 Identities=25% Similarity=0.418 Sum_probs=212.0
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe--CC
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS--KS 87 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~--~~ 87 (476)
...++|++++.||+|+||+||+|++..+++.||||++.... ...+.+|+.+++.++ ||||+++++++.. ..
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 34578999999999999999999999999999999996543 467899999999997 9999999999987 67
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
..|+||||+.+++|.+++. .+++.+++.++.||+.||+|||++||+||||||
T Consensus 107 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp------------------------- 158 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKP------------------------- 158 (330)
T ss_dssp CEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG-------------------------
T ss_pred ceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH-------------------------
Confidence 8999999999999998874 499999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCC-CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 168 RPWKFNVLQLENILLDSKG-NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g-~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.++ .+||+|||+++.... .......+||+.|+|||++.+....+.++|||||||++|+|+
T Consensus 159 ----------~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 225 (330)
T 3nsz_A 159 ----------HNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 225 (330)
T ss_dssp ----------GGEEEETTTTEEEECCCTTCEECCT---TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred ----------HHEEEcCCCCEEEEEeCCCceEcCC---CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHH
Confidence 999999777 899999999975432 233456689999999999987444458999999999999999
Q ss_pred cCCCCCCCC-cHHHHHHH-------------HHhCCCCC------------------------CCCCCHHHHHHHHHccC
Q 011868 247 TGYLPFDDR-NLAVLYQK-------------IFRGDFKL------------------------PKWLSPGAQNLLRKILE 288 (476)
Q Consensus 247 tG~~Pf~~~-~~~~~~~~-------------i~~~~~~~------------------------p~~~s~~~~~Li~~~L~ 288 (476)
+|+.||... +....... +....... +..+++++.+||.+||+
T Consensus 226 ~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 305 (330)
T 3nsz_A 226 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 305 (330)
T ss_dssp HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSC
T ss_pred hCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhc
Confidence 999999433 22222211 11111111 12278999999999999
Q ss_pred CCcCCCCChHHHhcCcccccc
Q 011868 289 PNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 289 ~dP~~R~s~~~il~~~~~~~~ 309 (476)
.||.+|||++++++||||+.-
T Consensus 306 ~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 306 YDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp SSGGGSCCHHHHHTSGGGTTC
T ss_pred CCcccCCCHHHHhcCccHhhh
Confidence 999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=378.64 Aligned_cols=259 Identities=39% Similarity=0.661 Sum_probs=228.7
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
+...++|++++.||+|+||+||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++...+..
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 34567899999999999999999999999999999999765432 23357899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||+++++|.+.+....++++.+++.++.||+.||.|||++||+||||||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p--------------------------- 149 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP--------------------------- 149 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG---------------------------
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCh---------------------------
Confidence 99999999999999998878899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCC---CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 170 WKFNVLQLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~---g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+||+++.+ +.+||+|||++..... ........||+.|+|||++.+. + +.++|||||||++|+|+
T Consensus 150 --------~NIlv~~~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~ 216 (287)
T 2wei_A 150 --------ENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILL 216 (287)
T ss_dssp --------GGEEESCSSTTCCEEECSTTGGGTBCC---CSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHH
T ss_pred --------hhEEEecCCCcccEEEeccCcceeecC---CCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHH
Confidence 99999764 4799999999985432 2233455789999999998764 5 48999999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
+|..||.+.+.......+..+...++ ..+++++.+||++||+.||.+|||++++++||||.+.
T Consensus 217 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 217 SGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 99999999988888888887765543 4589999999999999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=378.92 Aligned_cols=257 Identities=24% Similarity=0.430 Sum_probs=227.7
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
-.+|++++.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++......|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 3569999999999999999999999999999999986643 23367899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|||++|++|.+++.. +++++.+++.++.||+.||.|||++||+||||||
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p------------------------------ 147 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKA------------------------------ 147 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG------------------------------
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCh------------------------------
Confidence 999999999998865 6799999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+||+++.++.+||+|||++...... ........||+.|+|||++.+..++ .++|||||||++|+|++|..||
T Consensus 148 -----~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~ 219 (303)
T 3a7i_A 148 -----ANVLLSEHGEVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPH 219 (303)
T ss_dssp -----GGEEECTTSCEEECCCTTCEECBTT--BCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTT
T ss_pred -----heEEECCCCCEEEeecccceecCcc--ccccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCC
Confidence 9999999999999999999754321 1223456799999999999887775 8999999999999999999999
Q ss_pred CCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 253 DDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
...+.......+..... .++..+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 220 SELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp TTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred CCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 98887777666665543 45677899999999999999999999999999999997653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=394.50 Aligned_cols=256 Identities=26% Similarity=0.447 Sum_probs=222.4
Q ss_pred CccCcCEEEeceEeecCceEEEEEEEC-------CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE 81 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~ 81 (476)
....++|++++.||+|+||+||+|++. .++..||||++.... .......+.+|+.+++.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 345679999999999999999999974 345679999997653 344567899999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchh
Q 011868 82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILK 145 (476)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~ 145 (476)
++...+.+|+||||++||+|.+++.... .+++.+++.++.||+.||+|||++||+||||||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp--- 231 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA--- 231 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG---
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch---
Confidence 9999999999999999999999997643 489999999999999999999999999999997
Q ss_pred ccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc
Q 011868 146 SCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 225 (476)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 225 (476)
+|||++.+|.+||+|||+++...............||+.|+|||++.+
T Consensus 232 --------------------------------~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 279 (370)
T 2psq_A 232 --------------------------------RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 279 (370)
T ss_dssp --------------------------------GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT
T ss_pred --------------------------------hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC
Confidence 999999999999999999985433222223344567899999999988
Q ss_pred CCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 226 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 226 ~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
..|+ .++|||||||++|+|++ |..||.+.+....+..+..+. ...|..+++++.+||.+||+.||.+|||+.+++++
T Consensus 280 ~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 280 RVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8775 89999999999999999 999999988877777776654 45677899999999999999999999999999875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=408.38 Aligned_cols=249 Identities=19% Similarity=0.223 Sum_probs=207.4
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH---HHHhCCCCCcceEE-------EE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA---TLKLLKHPNVVRLH-------EV 82 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~---~l~~l~HpnIv~l~-------~~ 82 (476)
.++|++.+.||+|+||+||+|++..+|+.||||++...........+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 478999999999999999999998999999999998765445556788999995 45555799999998 77
Q ss_pred EEeCCE-----------------EEEEEeccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhcCcEec
Q 011868 83 LASKSK-----------------IYMVLEYVTGGELFDKIASKGRLQE-------AEGRKLFQQLIDGVSYCHNKGVFHR 138 (476)
Q Consensus 83 ~~~~~~-----------------~~lV~E~~~gg~L~~~l~~~~~l~~-------~~~~~~~~qi~~al~yLH~~givHr 138 (476)
+...+. .|+||||+ +|+|.+++...+.+++ ..++.++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 776643 89999999 7899999987555665 7888899999999999999999999
Q ss_pred cCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccc
Q 011868 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 218 (476)
Q Consensus 139 DiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 218 (476)
|||| +|||++.+|.+||+|||+|+.. .......+| +.|+
T Consensus 231 Dikp-----------------------------------~NIll~~~~~~kL~DFG~a~~~-----~~~~~~~~g-~~y~ 269 (377)
T 3byv_A 231 YLRP-----------------------------------VDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVS-RGFE 269 (377)
T ss_dssp CCCG-----------------------------------GGEEECTTCCEEECCGGGCEET-----TCEEECCCC-TTCC
T ss_pred CCCH-----------------------------------HHEEEcCCCCEEEEechhheec-----CCcccCCCC-cCcc
Confidence 9997 9999999999999999999842 234456778 9999
Q ss_pred cccccccC-----------CCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcc
Q 011868 219 APEVLANR-----------GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 287 (476)
Q Consensus 219 APE~l~~~-----------~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L 287 (476)
|||++.+. .|+ .++|||||||++|+|++|+.||.+.+.......+. ..+..+++++.+||.+||
T Consensus 270 aPE~~~~~~~~~~~~~~~~~~~-~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L 344 (377)
T 3byv_A 270 PPELEARRATISYHRDRRTLMT-FSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFL 344 (377)
T ss_dssp CHHHHHHHTSTHHHHCCEEECC-HHHHHHHHHHHHHHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHT
T ss_pred ChhhhcccccccccccccccCC-hhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHc
Confidence 99999877 664 89999999999999999999998766443333332 234568999999999999
Q ss_pred CCCcCCCCChHHHhcCccccc
Q 011868 288 EPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 288 ~~dP~~R~s~~~il~~~~~~~ 308 (476)
+.||.+|||+.++++||||+.
T Consensus 345 ~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 345 RYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp CSSGGGCCCHHHHHTSHHHHH
T ss_pred CCCchhCCCHHHHhhChHHHH
Confidence 999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=385.49 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=217.3
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK---- 86 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~---- 86 (476)
...++|++.+.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 34578999999999999999999999999999999996543 344567788999999999999999999988654
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 87 -~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
...|+||||+. ++|.+.+.. +.+++..++.++.||+.||+|||++||+||||||
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp----------------------- 140 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKP----------------------- 140 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG-----------------------
T ss_pred cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH-----------------------
Confidence 67999999996 699998876 5799999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC--------CcccccccCCccccccccccCCCCCccchhhh
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD--------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 237 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwS 237 (476)
+|||++.++.+||+|||++......... ......+||+.|+|||++.+....+.++||||
T Consensus 141 ------------~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~s 208 (353)
T 2b9h_A 141 ------------SNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWS 208 (353)
T ss_dssp ------------GGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHH
T ss_pred ------------HHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHH
Confidence 9999999999999999999854321111 11234579999999999876444458999999
Q ss_pred HhHHHHHHhcCCCCCCCCcHHHHHHHHHhC--C----------------------CC--------CCCCCCHHHHHHHHH
Q 011868 238 CGVILYVILTGYLPFDDRNLAVLYQKIFRG--D----------------------FK--------LPKWLSPGAQNLLRK 285 (476)
Q Consensus 238 lGvil~elltG~~Pf~~~~~~~~~~~i~~~--~----------------------~~--------~p~~~s~~~~~Li~~ 285 (476)
|||++|+|++|+.||.+.+.......+... . .. .++.+++++.+||.+
T Consensus 209 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 288 (353)
T 2b9h_A 209 CGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288 (353)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHH
Confidence 999999999999999998866555443321 0 00 113578999999999
Q ss_pred ccCCCcCCCCChHHHhcCccccccC
Q 011868 286 ILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 286 ~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
||+.||.+|||++++++||||+...
T Consensus 289 ~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 289 MLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hcCcCcccCCCHHHHhcCccccccC
Confidence 9999999999999999999998643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=385.62 Aligned_cols=256 Identities=37% Similarity=0.677 Sum_probs=214.5
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
.++|++.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46899999999999999999999999999999999764321 1122345889999999999999999999997665
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.|+||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp------------------------- 142 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP------------------------- 142 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG-------------------------
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH-------------------------
Confidence 899999999999999998888999999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCC---EEEeccCCCCCCCcccCCCcccccccCCccccccccc---cCCCCCccchhhhHhHH
Q 011868 168 RPWKFNVLQLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVI 241 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~---vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~sDvwSlGvi 241 (476)
+|||++.++. +||+|||++..... .......+||+.|+|||++. ...+ +.++|||||||+
T Consensus 143 ----------~NIl~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~i 208 (322)
T 2ycf_A 143 ----------ENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVI 208 (322)
T ss_dssp ----------GGEEESSSSSSCCEEECCCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTC-TTHHHHHHHHHH
T ss_pred ----------HHEEEecCCCCCeEEEccCccceeccc---ccccccccCCcCccCchhhccCCCCCC-CchhhHHHHHHH
Confidence 9999987664 99999999975432 22344567999999999974 3444 489999999999
Q ss_pred HHHHhcCCCCCCCCcHH-HHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 242 LYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 242 l~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+|+|++|..||.+.... .....+..+...++ ..+++.+.+||.+||+.||.+|||++++++||||..
T Consensus 209 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 209 LFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 99999999999865432 34445555554432 458999999999999999999999999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=385.95 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=211.9
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--E
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--K 88 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--~ 88 (476)
..-++|++.+.||+|+||+||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 456789999999999999999999999999999999976542 223577889999999999999999999998655 7
Q ss_pred EEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 89 IYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
.|+||||++|++|.+++.... .+++.+++.++.||+.||+|||++||+||||||
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp----------------------- 140 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP----------------------- 140 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG-----------------------
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH-----------------------
Confidence 899999999999999997643 399999999999999999999999999999997
Q ss_pred hccccccccCCCCceEe----CCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccc--------cCCCCCccc
Q 011868 166 VIRPWKFNVLQLENILL----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA--------NRGYDGATS 233 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl----~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~--------~~~~~~~~s 233 (476)
+|||+ +.++.+||+|||+++.... .......+||+.|+|||++. +..+ +.++
T Consensus 141 ------------~NIll~~~~~~~~~~kL~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~ 204 (319)
T 4euu_A 141 ------------GNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATV 204 (319)
T ss_dssp ------------GGEEEEECTTSCEEEEECCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTH
T ss_pred ------------HHEEEeccCCCCceEEEccCCCceecCC---CCceeecccCCCccCHHHhhhccccccccCCC-CcHH
Confidence 99999 7888899999999985432 33345568999999999986 3445 5899
Q ss_pred hhhhHhHHHHHHhcCCCCCCCC----cHHHHHHHHHhCCC---------------------CC----CCCCCHHHHHHHH
Q 011868 234 DIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDF---------------------KL----PKWLSPGAQNLLR 284 (476)
Q Consensus 234 DvwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~---------------------~~----p~~~s~~~~~Li~ 284 (476)
|||||||++|+|++|+.||... .......++..+.+ +. +..+++.+.+||+
T Consensus 205 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 284 (319)
T 4euu_A 205 DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284 (319)
T ss_dssp HHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHH
Confidence 9999999999999999999642 23444555554332 11 1123457899999
Q ss_pred HccCCCcCCCCChHHHhcCc
Q 011868 285 KILEPNPVKRITIAGIKADE 304 (476)
Q Consensus 285 ~~L~~dP~~R~s~~~il~~~ 304 (476)
+||+.||++|||++|+++||
T Consensus 285 ~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 285 NILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHSCCCTTTSCCHHHHHHHH
T ss_pred HhccCChhhhccHHHhhhcc
Confidence 99999999999999999997
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=378.99 Aligned_cols=256 Identities=26% Similarity=0.442 Sum_probs=218.2
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+|+.+++.++||||+++++++...+..|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 34568999999999999999999999999999999997653 1367889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+||||+.+++|.+++. ....+++.+++.++.||+.||.|||+.||+||||||
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p--------------------------- 153 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKA--------------------------- 153 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG---------------------------
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCH---------------------------
Confidence 9999999999999997 456899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+||+++.++.+||+|||++...... ........||+.|+|||++.+..++ .++|||||||++|+|++|.
T Consensus 154 --------~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~ 222 (314)
T 3com_A 154 --------GNILLNTEGHAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGK 222 (314)
T ss_dssp --------GGEEECTTCCEEECCCTTCEECBTT--BSCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSS
T ss_pred --------HHEEECCCCCEEEeecccchhhhhh--ccccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999754321 1233456799999999999887775 8899999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 250 LPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
.||.+.+.......+.... +..|..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus 223 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 223 PPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp CTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred CCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 9999887765555544433 23355689999999999999999999999999999999753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=399.08 Aligned_cols=252 Identities=28% Similarity=0.390 Sum_probs=209.4
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------ 86 (476)
..+|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 447999999999999999999999999999999997543 1234799999999999999999998532
Q ss_pred CEEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHH
Q 011868 87 SKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFL 162 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~ 162 (476)
..+++||||+.+ +|.+.+. ....+++..++.++.||+.||+|||++||+||||||
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp-------------------- 184 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKP-------------------- 184 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSG--------------------
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCh--------------------
Confidence 247799999965 6666654 346799999999999999999999999999999997
Q ss_pred HhhhccccccccCCCCceEeCCC-CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 163 LMIVIRPWKFNVLQLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 163 ~~~~~~p~~~~~~~~~NiLl~~~-g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.+....+.++|||||||+
T Consensus 185 ---------------~NILl~~~~~~~kl~DFG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~i 246 (420)
T 1j1b_A 185 ---------------QNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 246 (420)
T ss_dssp ---------------GGEEEETTTTEEEECCCTTCEECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred ---------------hhEEEeCCCCeEEeccchhhhhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHH
Confidence 99999965 5689999999985432 2233456899999999999776434589999999999
Q ss_pred HHHHhcCCCCCCCCcHHHHHHHHHhC-----------------CCC------------CCCCCCHHHHHHHHHccCCCcC
Q 011868 242 LYVILTGYLPFDDRNLAVLYQKIFRG-----------------DFK------------LPKWLSPGAQNLLRKILEPNPV 292 (476)
Q Consensus 242 l~elltG~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~Li~~~L~~dP~ 292 (476)
+|+|++|+.||.+.+....+.++.+. .+. ++..+++++.+||++||+.||.
T Consensus 247 l~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~ 326 (420)
T 1j1b_A 247 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 326 (420)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChh
Confidence 99999999999998876665555431 111 2334689999999999999999
Q ss_pred CCCChHHHhcCccccccC
Q 011868 293 KRITIAGIKADEWFEQDY 310 (476)
Q Consensus 293 ~R~s~~~il~~~~~~~~~ 310 (476)
+|||+.++++||||....
T Consensus 327 ~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 327 ARLTPLEACAHSFFDELR 344 (420)
T ss_dssp GSCCHHHHHTSGGGGGGG
T ss_pred HCCCHHHHhCCHhhcccc
Confidence 999999999999997643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=379.83 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=215.9
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS---- 85 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~---- 85 (476)
...++|++++.||+|+||+||+|++..+|+.||||++..... ....+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 356799999999999999999999999999999999976532 246788999999999 79999999999976
Q ss_pred --CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 86 --KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 86 --~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
....|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp------------------- 157 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKG------------------- 157 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG-------------------
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcH-------------------
Confidence 56899999999999999999764 5799999999999999999999999999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccc-----cCCCCCccchhh
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIW 236 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~sDvw 236 (476)
+||+++.++.+||+|||++..... ........+||+.|+|||++. +..+ +.++|||
T Consensus 158 ----------------~NIl~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~ 218 (326)
T 2x7f_A 158 ----------------QNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLW 218 (326)
T ss_dssp ----------------GGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------C-CTTHHHH
T ss_pred ----------------HHEEEcCCCCEEEeeCcCceecCc--CccccccccCCccccChhhhccccccCcCC-CccchHH
Confidence 999999999999999999985432 122334567999999999986 3344 4889999
Q ss_pred hHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 237 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 237 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
||||++|+|++|..||.+.+.......+.....+ .+..+++.+.+||.+||..||.+|||++++++||||...
T Consensus 219 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 219 SLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred HHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 9999999999999999988877666666554432 245689999999999999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=390.03 Aligned_cols=252 Identities=31% Similarity=0.429 Sum_probs=213.8
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE----
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI---- 89 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~---- 89 (476)
++|++.+.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 68999999999999999999999999999999997654 3444567899999999999999999999999877654
Q ss_pred --EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 90 --YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 90 --~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
|+||||+. ++|.+.+. ..+++..++.++.||+.||+|||++||+||||||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp------------------------- 172 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKP------------------------- 172 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG-------------------------
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCH-------------------------
Confidence 99999996 68888763 4599999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.++.+||+|||+++... ......+||+.|+|||++.+....+.++|||||||++|+|++
T Consensus 173 ----------~NIll~~~~~~kL~Dfg~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 237 (371)
T 4exu_A 173 ----------GNLAVNEDCELKILDFGLARHAD-----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 237 (371)
T ss_dssp ----------GGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHH
T ss_pred ----------HHeEECCCCCEEEEecCcccccc-----cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHh
Confidence 99999999999999999998532 223456899999999999874444589999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCC-------------------------------CCCCCCCHHHHHHHHHccCCCcCCCCC
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDF-------------------------------KLPKWLSPGAQNLLRKILEPNPVKRIT 296 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~-------------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~s 296 (476)
|+.||.+.+.......+..... ..++.+++.+.+||.+||+.||.+|||
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 317 (371)
T 4exu_A 238 GKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 317 (371)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC
Confidence 9999999887766665543110 012346899999999999999999999
Q ss_pred hHHHhcCcccccc
Q 011868 297 IAGIKADEWFEQD 309 (476)
Q Consensus 297 ~~~il~~~~~~~~ 309 (476)
++++++||||...
T Consensus 318 ~~ell~hp~f~~~ 330 (371)
T 4exu_A 318 AAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHTSGGGTTT
T ss_pred HHHHhcCcccccC
Confidence 9999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=398.79 Aligned_cols=261 Identities=31% Similarity=0.437 Sum_probs=198.1
Q ss_pred cCcCEEE-eceEeecCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--C
Q 011868 12 RLGRYEL-GRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--K 86 (476)
Q Consensus 12 ~~~~Y~i-~~~LG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~ 86 (476)
.-+.|++ +++||+|+||+||+|++. .+++.||||++..... ...+.+|+.+|+.++||||+++++++.. .
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 3456888 558999999999999965 5789999999975532 3467899999999999999999999954 6
Q ss_pred CEEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHH
Q 011868 87 SKIYMVLEYVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVF 157 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~---------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~ 157 (476)
..+|+||||+. |+|.+.+... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp--------------- 156 (405)
T 3rgf_A 93 RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKP--------------- 156 (405)
T ss_dssp TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG---------------
T ss_pred CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCH---------------
Confidence 78999999995 5888887532 2499999999999999999999999999999997
Q ss_pred HHHHHHhhhccccccccCCCCceEe----CCCCCEEEeccCCCCCCCccc-CCCcccccccCCccccccccccCCCCCcc
Q 011868 158 LLTFLLMIVIRPWKFNVLQLENILL----DSKGNIKISDFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGAT 232 (476)
Q Consensus 158 ~~~~~~~~~~~p~~~~~~~~~NiLl----~~~g~vkl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~ 232 (476)
+|||+ +.++.+||+|||+|+...... ........+||+.|+|||++.+....+.+
T Consensus 157 --------------------~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 216 (405)
T 3rgf_A 157 --------------------ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA 216 (405)
T ss_dssp --------------------GGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHH
T ss_pred --------------------HHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccch
Confidence 99999 778999999999998654321 12334567899999999999886645689
Q ss_pred chhhhHhHHHHHHhcCCCCCCCCcHH---------HHHHHHHhC--CCCC------------------------------
Q 011868 233 SDIWSCGVILYVILTGYLPFDDRNLA---------VLYQKIFRG--DFKL------------------------------ 271 (476)
Q Consensus 233 sDvwSlGvil~elltG~~Pf~~~~~~---------~~~~~i~~~--~~~~------------------------------ 271 (476)
+|||||||++|+|++|+.||.+.+.. .....+... .+..
T Consensus 217 ~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (405)
T 3rgf_A 217 IDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLI 296 (405)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHH
T ss_pred hhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhh
Confidence 99999999999999999999765532 233333221 1000
Q ss_pred ------CCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCCCC
Q 011868 272 ------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 313 (476)
Q Consensus 272 ------p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~~~ 313 (476)
....++.+.+||++||+.||.+|||++|+++||||.....+.
T Consensus 297 ~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 297 KYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT 344 (405)
T ss_dssp HHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCC
T ss_pred hhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCCc
Confidence 011277899999999999999999999999999998765543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=379.71 Aligned_cols=261 Identities=28% Similarity=0.394 Sum_probs=213.2
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-------
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA------- 84 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~------- 84 (476)
.-++|++++.||+|+||.||+|.+..+|+.||+|++... +....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 457899999999999999999999999999999999754 3444678999999999999999999999873
Q ss_pred -------eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHH
Q 011868 85 -------SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVF 157 (476)
Q Consensus 85 -------~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~ 157 (476)
.....|+||||+. |+|.+++.. +++++..++.++.||+.||+|||++||+||||||
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp--------------- 148 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKP--------------- 148 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSG---------------
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCH---------------
Confidence 4468999999996 699998864 6799999999999999999999999999999997
Q ss_pred HHHHHHhhhccccccccCCCCceEeC-CCCCEEEeccCCCCCCCccc-CCCcccccccCCccccccccccCCCCCccchh
Q 011868 158 LLTFLLMIVIRPWKFNVLQLENILLD-SKGNIKISDFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 235 (476)
Q Consensus 158 ~~~~~~~~~~~p~~~~~~~~~NiLl~-~~g~vkl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDv 235 (476)
+||+++ +++.+||+|||++....... .........||+.|+|||++.+....+.++||
T Consensus 149 --------------------~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 208 (320)
T 2i6l_A 149 --------------------ANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDM 208 (320)
T ss_dssp --------------------GGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHH
T ss_pred --------------------HHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhh
Confidence 999997 56799999999998653321 12234456789999999998764444589999
Q ss_pred hhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC------------------------------CCCCCCHHHHHHHHH
Q 011868 236 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------------------------------LPKWLSPGAQNLLRK 285 (476)
Q Consensus 236 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------------------~p~~~s~~~~~Li~~ 285 (476)
|||||++|+|++|+.||.+.+.......+...... .++.+++++.+||.+
T Consensus 209 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 288 (320)
T 2i6l_A 209 WAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQ 288 (320)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHT
T ss_pred HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHH
Confidence 99999999999999999998877666655432211 124579999999999
Q ss_pred ccCCCcCCCCChHHHhcCccccccCCC
Q 011868 286 ILEPNPVKRITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 286 ~L~~dP~~R~s~~~il~~~~~~~~~~~ 312 (476)
||+.||.+|||++++++||||.....|
T Consensus 289 ~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 289 ILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp TSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred HcCCCccccCCHHHHhCCcccccccCc
Confidence 999999999999999999999865444
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=382.50 Aligned_cols=256 Identities=24% Similarity=0.380 Sum_probs=220.9
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
.+..++|++.+.||+|+||+||+|.+..+++ .||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 4567899999999999999999999986665 49999997653 344467899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
+..|+||||++||+|.+++... +.+++.+++.++.||+.||+|||++||+||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp----------------------- 179 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAA----------------------- 179 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG-----------------------
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCc-----------------------
Confidence 9999999999999999999754 5799999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC-CcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+|||++.++.+||+|||+++........ .......+|+.|+|||++.+..++ .++|||||||++|+
T Consensus 180 ------------~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~e 246 (325)
T 3kul_A 180 ------------RNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWE 246 (325)
T ss_dssp ------------GGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHH
T ss_pred ------------ceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHH
Confidence 9999999999999999999865432111 122234567899999999887775 89999999999999
Q ss_pred Hhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 245 ILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 245 llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|++ |..||.+.+.......+..+ ..+.|..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 247 ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 247 VLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999 99999999888888877765 456677899999999999999999999999998763
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=380.75 Aligned_cols=258 Identities=27% Similarity=0.430 Sum_probs=218.6
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
...++|++++.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 34568999999999999999999999999999999997543 223578899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp--------------------------- 145 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKA--------------------------- 145 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG---------------------------
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCH---------------------------
Confidence 99999999999998865 46799999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccc-----cCCCCCccchhhhHhHHHHH
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~sDvwSlGvil~e 244 (476)
+||+++.++.+||+|||++..... .........||+.|+|||++. +..+ +.++|||||||++|+
T Consensus 146 --------~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~ 214 (302)
T 2j7t_A 146 --------GNVLMTLEGDIRLADFGVSAKNLK--TLQKRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIE 214 (302)
T ss_dssp --------GGEEECTTSCEEECCCHHHHHHHH--HHHC-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHH
T ss_pred --------HHEEECCCCCEEEEECCCCccccc--cccccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHH
Confidence 999999999999999998752111 111223457999999999984 3444 489999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 245 ILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|++|..||...+.......+.....+ .+..+++.+.+||.+||+.||.+|||++++++||||...
T Consensus 215 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 215 MAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred HhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 99999999998887777777665533 345688999999999999999999999999999999753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=395.84 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=224.8
Q ss_pred CccCcCEEEeceEeecCceEEEEEE-----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 84 (476)
....++|++++.||+|+||+||+|+ +..+++.||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3456789999999999999999999 45578899999996543 3344567899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHH
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVF 157 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~ 157 (476)
.....|+||||++||+|.+++... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp--------------- 209 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA--------------- 209 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG---------------
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh---------------
Confidence 999999999999999999999764 3599999999999999999999999999999997
Q ss_pred HHHHHHhhhccccccccCCCCceEeCCCC---CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccch
Q 011868 158 LLTFLLMIVIRPWKFNVLQLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234 (476)
Q Consensus 158 ~~~~~~~~~~~p~~~~~~~~~NiLl~~~g---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sD 234 (476)
+|||++.+| .+||+|||+++...............||+.|+|||++.+..++ .++|
T Consensus 210 --------------------~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~D 268 (367)
T 3l9p_A 210 --------------------RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTD 268 (367)
T ss_dssp --------------------GGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHH
T ss_pred --------------------hhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHH
Confidence 999999665 4999999999743222222334456789999999999888775 8999
Q ss_pred hhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 235 IWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 235 vwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
||||||++|+|++ |..||.+.+.......+..+. ...|..+++.+.+||.+||+.||.+|||+++++++.|+..
T Consensus 269 vwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 269 TWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 9999999999998 999999999888888877764 4567779999999999999999999999999999988754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=382.87 Aligned_cols=254 Identities=30% Similarity=0.440 Sum_probs=215.4
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEE-CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC------cceEEE
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQD-LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN------VVRLHE 81 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn------Iv~l~~ 81 (476)
+....++|++.+.||+|+||+||+|.+ ..+++.||||++... ......+.+|+.+++.++|++ |+++++
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence 344567999999999999999999998 568899999999643 234577889999999987654 999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHH
Q 011868 82 VLASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
++...+..|+||||+ +++|.+++...+ ++++.+++.++.||+.||+|||++||+||||||
T Consensus 85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp----------------- 146 (339)
T 1z57_A 85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKP----------------- 146 (339)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG-----------------
T ss_pred ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCH-----------------
Confidence 999999999999999 899999998765 689999999999999999999999999999997
Q ss_pred HHHHhhhccccccccCCCCceEeCC-------------------CCCEEEeccCCCCCCCcccCCCcccccccCCccccc
Q 011868 160 TFLLMIVIRPWKFNVLQLENILLDS-------------------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 220 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl~~-------------------~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 220 (476)
+|||++. ++.+||+|||++.... ......+||+.|+||
T Consensus 147 ------------------~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aP 203 (339)
T 1z57_A 147 ------------------ENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD-----EHHSTLVSTRHYRAP 203 (339)
T ss_dssp ------------------GGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETT-----SCCCSSCSCGGGCCH
T ss_pred ------------------HHEEEeccccccccCCccccccccccCCCceEeeCcccccCc-----cccccccCCccccCh
Confidence 9999987 6789999999997432 223456899999999
Q ss_pred cccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC----------------------------
Q 011868 221 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP---------------------------- 272 (476)
Q Consensus 221 E~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p---------------------------- 272 (476)
|++.+..++ .++|||||||++|+|++|..||.+.+.......+.....+.|
T Consensus 204 E~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
T 1z57_A 204 EVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGR 282 (339)
T ss_dssp HHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHH
T ss_pred HHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccc
Confidence 999888775 899999999999999999999998876655444332111111
Q ss_pred ----------------CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 273 ----------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 273 ----------------~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
...++++.+||.+||+.||.+|||++++++||||+.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 283 YVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp HHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred hhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 112467899999999999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=383.29 Aligned_cols=262 Identities=25% Similarity=0.367 Sum_probs=203.3
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
...++|++++.||+|+||+||+|++..++. .||||++...... ....+.+.+|+.+++.++||||+++++++....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 456789999999999999999999877665 8999999765432 334678999999999999999999999998776
Q ss_pred EE------EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHH
Q 011868 88 KI------YMVLEYVTGGELFDKIASKG------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQ 155 (476)
Q Consensus 88 ~~------~lV~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~ 155 (476)
.. |+||||+.+|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp------------- 165 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAA------------- 165 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG-------------
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCc-------------
Confidence 55 99999999999999996432 599999999999999999999999999999997
Q ss_pred HHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchh
Q 011868 156 VFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 235 (476)
Q Consensus 156 ~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDv 235 (476)
+|||++.++.+||+|||+++...............+|+.|+|||++.+..++ .++||
T Consensus 166 ----------------------~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di 222 (323)
T 3qup_A 166 ----------------------RNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDV 222 (323)
T ss_dssp ----------------------GGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCC-HHHHH
T ss_pred ----------------------ceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCC-Cccch
Confidence 9999999999999999999864332222223344578899999999888775 89999
Q ss_pred hhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCC-------hHHHhcCccc
Q 011868 236 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRIT-------IAGIKADEWF 306 (476)
Q Consensus 236 wSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s-------~~~il~~~~~ 306 (476)
|||||++|+|++ |..||.+.+.......+..+. ...|..+++++.+||.+||+.||.+||| +++++.|+|+
T Consensus 223 ~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 223 WAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred hhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 999999999999 999999988877777776654 5667789999999999999999999999 7888999998
Q ss_pred ccc
Q 011868 307 EQD 309 (476)
Q Consensus 307 ~~~ 309 (476)
...
T Consensus 303 ~~~ 305 (323)
T 3qup_A 303 LST 305 (323)
T ss_dssp ---
T ss_pred cCC
Confidence 753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=377.31 Aligned_cols=262 Identities=24% Similarity=0.386 Sum_probs=211.6
Q ss_pred hhhccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 011868 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (476)
Q Consensus 4 ~~~~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 83 (476)
+.....+..+++|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++
T Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 24 TAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp ----------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 34556788899999999999999999999999999999999999876554555568899999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHH
Q 011868 84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLL 163 (476)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~ 163 (476)
..++..|+||||++|++|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp--------------------- 162 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKP--------------------- 162 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG---------------------
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCCh---------------------
Confidence 99999999999999999999998888899999999999999999999999999999997
Q ss_pred hhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHH
Q 011868 164 MIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243 (476)
Q Consensus 164 ~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ 243 (476)
+||+++.++.+||+|||++....... ........||+.|+|||++.+..++ .++|||||||++|
T Consensus 163 --------------~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ 226 (309)
T 2h34_A 163 --------------ENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLY 226 (309)
T ss_dssp --------------GGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHH
T ss_pred --------------HHEEEcCCCCEEEecCccCccccccc-cccccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHH
Confidence 99999999999999999997543311 1223456799999999999887775 8999999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHccCCCcCCCC-ChHHHhc
Q 011868 244 VILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQNLLRKILEPNPVKRI-TIAGIKA 302 (476)
Q Consensus 244 elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~~L~~dP~~R~-s~~~il~ 302 (476)
+|++|+.||.+.+...+...+..... ..+..+++.+.++|.+||+.||.+|| |++++++
T Consensus 227 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 227 ECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 99999999998877655544443322 24567899999999999999999999 7777765
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=394.05 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=209.8
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-- 87 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-- 87 (476)
....++|++.+.||+|+||+||+|++..+++ ||+|.+..... ...+|+.+++.++||||+++++++...+
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 4456689999999999999999999977766 88888765431 2237999999999999999999995443
Q ss_pred ----EEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHH
Q 011868 88 ----KIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 88 ----~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
.+|+||||+.+ ++.+.+. ....+++..++.++.||+.||+|||++||+||||||
T Consensus 108 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp----------------- 169 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKP----------------- 169 (394)
T ss_dssp SSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG-----------------
T ss_pred CCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCH-----------------
Confidence 38899999976 4444332 256799999999999999999999999999999997
Q ss_pred HHHHhhhccccccccCCCCceEeC-CCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhH
Q 011868 160 TFLLMIVIRPWKFNVLQLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 238 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl~-~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSl 238 (476)
+|||++ .++.+||+|||+|+.... .......+||+.|+|||++.+....+.++||||+
T Consensus 170 ------------------~Nill~~~~~~~kL~DFG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 228 (394)
T 4e7w_A 170 ------------------QNLLLDPPSGVLKLIDFGSAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWST 228 (394)
T ss_dssp ------------------GGEEEETTTTEEEECCCTTCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred ------------------HHEEEcCCCCcEEEeeCCCcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHH
Confidence 999999 799999999999985432 2234456789999999999876544589999999
Q ss_pred hHHHHHHhcCCCCCCCCcHHHHHHHHHhC-----------------CCC------------CCCCCCHHHHHHHHHccCC
Q 011868 239 GVILYVILTGYLPFDDRNLAVLYQKIFRG-----------------DFK------------LPKWLSPGAQNLLRKILEP 289 (476)
Q Consensus 239 Gvil~elltG~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~Li~~~L~~ 289 (476)
||++|+|++|+.||.+.+....+..+.+. ... ++..+++++.+||.+||+.
T Consensus 229 G~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (394)
T 4e7w_A 229 GCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEY 308 (394)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCC
Confidence 99999999999999998877666655431 011 2344789999999999999
Q ss_pred CcCCCCChHHHhcCccccccC
Q 011868 290 NPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 290 dP~~R~s~~~il~~~~~~~~~ 310 (476)
||.+|||+.++++||||+...
T Consensus 309 dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 309 TPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp SGGGSCCHHHHHTSGGGSTTT
T ss_pred ChhhCCCHHHHhcChhhhhhc
Confidence 999999999999999998643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=389.58 Aligned_cols=255 Identities=26% Similarity=0.395 Sum_probs=217.1
Q ss_pred ccCcCEEEeceEeecCceEEEEEE-----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~ 84 (476)
...++|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 456799999999999999999998 55677999999997653 334457899999999999 7999999999997
Q ss_pred eCC-EEEEEEeccCCCChHHHHHhcCC-----------------------------------------------------
Q 011868 85 SKS-KIYMVLEYVTGGELFDKIASKGR----------------------------------------------------- 110 (476)
Q Consensus 85 ~~~-~~~lV~E~~~gg~L~~~l~~~~~----------------------------------------------------- 110 (476)
..+ .+|+||||++||+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 754 48999999999999999976432
Q ss_pred -------------CCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCC
Q 011868 111 -------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177 (476)
Q Consensus 111 -------------l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 177 (476)
+++..++.++.||+.||+|||++||+||||||
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp----------------------------------- 221 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA----------------------------------- 221 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG-----------------------------------
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCCh-----------------------------------
Confidence 89999999999999999999999999999997
Q ss_pred CceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCCCCCCCc
Q 011868 178 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 256 (476)
Q Consensus 178 ~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~ 256 (476)
+|||++.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+
T Consensus 222 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 222 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 9999999999999999999865432222334556789999999999888775 89999999999999998 999998876
Q ss_pred HHH-HHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 257 LAV-LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 257 ~~~-~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
... ....+..+ ....|..+++++.++|.+||+.||.+|||+.++++|
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 301 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 443 33333333 456778899999999999999999999999999886
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=383.40 Aligned_cols=262 Identities=27% Similarity=0.491 Sum_probs=199.0
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
....++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 4567899999999999999999999988999999999875532 23356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 90 YMVLEYVTGGELFDKIAS--------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~--------~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
|+||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p------------------- 149 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKA------------------- 149 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG-------------------
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCCh-------------------
Confidence 999999999999999864 35699999999999999999999999999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCccc---CCCcccccccCCcccccccccc-CCCCCccchhhh
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFR---DDGLLHTTCGSPNYVAPEVLAN-RGYDGATSDIWS 237 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~---~~~~~~~~~gt~~y~APE~l~~-~~~~~~~sDvwS 237 (476)
+||+++.++.+||+|||++....... ........+||+.|+|||++.+ ..+ +.++||||
T Consensus 150 ----------------~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~Di~s 212 (303)
T 2vwi_A 150 ----------------GNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWS 212 (303)
T ss_dssp ----------------GGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCC-CTHHHHHH
T ss_pred ----------------hhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCC-CchhhHHH
Confidence 99999999999999999987443211 1122345679999999999876 344 58999999
Q ss_pred HhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCC----------CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccc
Q 011868 238 CGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307 (476)
Q Consensus 238 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----------~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~ 307 (476)
|||++|+|++|+.||.+.+.............+ .+..+++++.+||.+||+.||.+|||+.++++||||.
T Consensus 213 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 292 (303)
T 2vwi_A 213 FGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292 (303)
T ss_dssp HHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-
T ss_pred HHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhh
Confidence 999999999999999887765555444443321 2345788999999999999999999999999999997
Q ss_pred cc
Q 011868 308 QD 309 (476)
Q Consensus 308 ~~ 309 (476)
+.
T Consensus 293 ~~ 294 (303)
T 2vwi_A 293 KA 294 (303)
T ss_dssp --
T ss_pred cC
Confidence 64
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=386.04 Aligned_cols=260 Identities=24% Similarity=0.359 Sum_probs=205.6
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK- 88 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~- 88 (476)
...+++|++.+.||+|+||+||+|++..+|+.||||++...... .....+|+..++.++||||+++++++...+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 45678999999999999999999999999999999998665322 2456678888899999999999999865433
Q ss_pred ------EEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hcCcEeccCCcchhccchhhhHHHH
Q 011868 89 ------IYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCH--NKGVFHRDLKVILKSCHMRIATLQV 156 (476)
Q Consensus 89 ------~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~al~yLH--~~givHrDiKp~~~~~~~~~~~~~~ 156 (476)
+|+||||+.+ +|.+.+. ....+++..++.++.||+.||.||| ++||+||||||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp-------------- 159 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKP-------------- 159 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCG--------------
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCH--------------
Confidence 8999999976 5544443 4567999999999999999999999 99999999997
Q ss_pred HHHHHHHhhhccccccccCCCCceEeCC-CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchh
Q 011868 157 FLLTFLLMIVIRPWKFNVLQLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 235 (476)
Q Consensus 157 ~~~~~~~~~~~~p~~~~~~~~~NiLl~~-~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDv 235 (476)
+|||++. ++.+||+|||++..... .......+||+.|+|||++.+....+.++||
T Consensus 160 ---------------------~NIll~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 215 (360)
T 3e3p_A 160 ---------------------HNVLVNEADGTLKLCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDI 215 (360)
T ss_dssp ---------------------GGEEEETTTTEEEECCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHH
T ss_pred ---------------------HHEEEeCCCCcEEEeeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHH
Confidence 9999997 89999999999986543 2334456799999999999776644689999
Q ss_pred hhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCC--------------------------------CCCCCCCHHHHHHH
Q 011868 236 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--------------------------------KLPKWLSPGAQNLL 283 (476)
Q Consensus 236 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------------------------------~~p~~~s~~~~~Li 283 (476)
|||||++|+|++|+.||.+.+....+..+..... ..+...++++.+||
T Consensus 216 ~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 295 (360)
T 3e3p_A 216 WSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLL 295 (360)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHH
Confidence 9999999999999999999887776666543110 11122567899999
Q ss_pred HHccCCCcCCCCChHHHhcCccccccCCC
Q 011868 284 RKILEPNPVKRITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 284 ~~~L~~dP~~R~s~~~il~~~~~~~~~~~ 312 (476)
.+||+.||.+|||+.++++||||+....+
T Consensus 296 ~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 296 SALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp HHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred HHHhccCccccCCHHHHhcCccccccCCc
Confidence 99999999999999999999999875543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=379.92 Aligned_cols=259 Identities=28% Similarity=0.379 Sum_probs=223.5
Q ss_pred ccCCccCcCEEEeceEeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEE
Q 011868 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81 (476)
Q Consensus 7 ~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~ 81 (476)
..-....++|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 334556689999999999999999999983 456899999997553 3445678999999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhcCcEe
Q 011868 82 VLASKSKIYMVLEYVTGGELFDKIASKGR------------------------LQEAEGRKLFQQLIDGVSYCHNKGVFH 137 (476)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~------------------------l~~~~~~~~~~qi~~al~yLH~~givH 137 (476)
++...+..|+||||++||+|.+++..... +++.+++.++.||+.||+|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999976433 899999999999999999999999999
Q ss_pred ccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcc
Q 011868 138 RDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 217 (476)
Q Consensus 138 rDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y 217 (476)
||||| +||+++.++.+||+|||++................||+.|
T Consensus 174 ~dikp-----------------------------------~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y 218 (314)
T 2ivs_A 174 RDLAA-----------------------------------RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKW 218 (314)
T ss_dssp CCCSG-----------------------------------GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGG
T ss_pred cccch-----------------------------------heEEEcCCCCEEEccccccccccccccceeccCCCCcccc
Confidence 99997 9999999999999999999754332211223345678899
Q ss_pred ccccccccCCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCC
Q 011868 218 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRI 295 (476)
Q Consensus 218 ~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~ 295 (476)
+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+. ...|..+++++.+||.+||+.||.+||
T Consensus 219 ~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 297 (314)
T 2ivs_A 219 MAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRP 297 (314)
T ss_dssp CCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCc
Confidence 999999887775 89999999999999999 999999988777777766653 456778999999999999999999999
Q ss_pred ChHHHhcC
Q 011868 296 TIAGIKAD 303 (476)
Q Consensus 296 s~~~il~~ 303 (476)
|+.+++++
T Consensus 298 s~~~l~~~ 305 (314)
T 2ivs_A 298 VFADISKD 305 (314)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=387.27 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=224.9
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCC-------CceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDS-------GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE 81 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~ 81 (476)
.+..++|++++.||+|+||+||+|++..+ +..||||++.... .......+.+|+.+++.+ +||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 44567999999999999999999997543 3579999997653 344567899999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchh
Q 011868 82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILK 145 (476)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~ 145 (476)
++...+..|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp--- 219 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA--- 219 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG---
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc---
Confidence 9999999999999999999999997643 499999999999999999999999999999997
Q ss_pred ccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc
Q 011868 146 SCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 225 (476)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 225 (476)
+|||++.++.+||+|||+++...............||+.|+|||++.+
T Consensus 220 --------------------------------~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 267 (382)
T 3tt0_A 220 --------------------------------RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 267 (382)
T ss_dssp --------------------------------GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS
T ss_pred --------------------------------ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC
Confidence 999999999999999999986544322233445568899999999988
Q ss_pred CCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 226 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 226 ~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
..++ .++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++++.+||.+||+.||.+|||+.+++++
T Consensus 268 ~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 268 RIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7775 89999999999999999 99999999888888877766 445677899999999999999999999999999886
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=384.25 Aligned_cols=256 Identities=26% Similarity=0.365 Sum_probs=222.8
Q ss_pred CccCcCEEEeceEeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 84 (476)
....++|++++.||+|+||+||+|++. .+++.||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 445679999999999999999999986 355899999997653 3445678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccC
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASK------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDi 140 (476)
..+..|+||||+++|+|.+++... .++++.+++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999763 56999999999999999999999999999999
Q ss_pred CcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccc
Q 011868 141 KVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 220 (476)
Q Consensus 141 Kp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 220 (476)
|| +|||++.++.+||+|||++................||+.|+||
T Consensus 201 kp-----------------------------------~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 245 (343)
T 1luf_A 201 AT-----------------------------------RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 245 (343)
T ss_dssp SG-----------------------------------GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred Cc-----------------------------------ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecCh
Confidence 97 9999999999999999998743322111233456789999999
Q ss_pred cccccCCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChH
Q 011868 221 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIA 298 (476)
Q Consensus 221 E~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~ 298 (476)
|++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+.. ..|..+++.+.+||.+||+.||.+|||+.
T Consensus 246 E~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 324 (343)
T 1luf_A 246 ESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC 324 (343)
T ss_dssp HHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence 999887775 89999999999999999 9999999988888888777654 56788999999999999999999999999
Q ss_pred HHhcC
Q 011868 299 GIKAD 303 (476)
Q Consensus 299 ~il~~ 303 (476)
+++++
T Consensus 325 ~~~~~ 329 (343)
T 1luf_A 325 SIHRI 329 (343)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=383.40 Aligned_cols=253 Identities=30% Similarity=0.425 Sum_probs=213.5
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE----
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK---- 88 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~---- 88 (476)
.++|++.+.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 368999999999999999999999999999999997653 344456789999999999999999999999987653
Q ss_pred --EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 89 --IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 89 --~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
+|+||||+. ++|.+.+. .++++.+++.++.||+.||+|||++||+||||||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp------------------------ 154 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKP------------------------ 154 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCG------------------------
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH------------------------
Confidence 599999996 68888764 3599999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+||+++.++.+||+|||++..... .....+||+.|+|||++.+....+.++||||+||++|+|+
T Consensus 155 -----------~NIl~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 218 (353)
T 3coi_A 155 -----------GNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218 (353)
T ss_dssp -----------GGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHH
T ss_pred -----------HHEeECCCCcEEEeecccccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999985322 2345679999999999887444458999999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhC----------------------------C---CCCCCCCCHHHHHHHHHccCCCcCCCC
Q 011868 247 TGYLPFDDRNLAVLYQKIFRG----------------------------D---FKLPKWLSPGAQNLLRKILEPNPVKRI 295 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~----------------------------~---~~~p~~~s~~~~~Li~~~L~~dP~~R~ 295 (476)
+|+.||.+.+.......+... . ...+..+++++.+||.+||+.||.+||
T Consensus 219 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp 298 (353)
T 3coi_A 219 TGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298 (353)
T ss_dssp HSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCC
Confidence 999999998876655554321 0 112345789999999999999999999
Q ss_pred ChHHHhcCcccccc
Q 011868 296 TIAGIKADEWFEQD 309 (476)
Q Consensus 296 s~~~il~~~~~~~~ 309 (476)
|++++++||||...
T Consensus 299 t~~e~l~hp~f~~~ 312 (353)
T 3coi_A 299 TAAQALTHPFFEPF 312 (353)
T ss_dssp CHHHHHTSGGGTTT
T ss_pred CHHHHhcCcchhhc
Confidence 99999999999754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=391.44 Aligned_cols=251 Identities=29% Similarity=0.441 Sum_probs=208.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC--------CCCcceEEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--------HPNVVRLHEVL 83 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~--------HpnIv~l~~~~ 83 (476)
..++|++.+.||+|+||+||+|++..+++.||||++... ......+.+|+.+++.++ ||||+++++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 357899999999999999999999999999999999654 234577899999999996 78899999998
Q ss_pred E----eCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CcEeccCCcchhccchhhhHHHH
Q 011868 84 A----SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMRIATLQV 156 (476)
Q Consensus 84 ~----~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~-givHrDiKp~~~~~~~~~~~~~~ 156 (476)
. ....+|+||||+ +++|.+.+... .++++.+++.++.||+.||+|||++ ||+||||||
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp-------------- 175 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKP-------------- 175 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSG--------------
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCH--------------
Confidence 7 556899999999 77887777654 4699999999999999999999998 999999997
Q ss_pred HHHHHHHhhhccccccccCCCCceEeCCCC-------------------------------------------------C
Q 011868 157 FLLTFLLMIVIRPWKFNVLQLENILLDSKG-------------------------------------------------N 187 (476)
Q Consensus 157 ~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g-------------------------------------------------~ 187 (476)
+|||++.++ .
T Consensus 176 ---------------------~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (397)
T 1wak_A 176 ---------------------ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLK 234 (397)
T ss_dssp ---------------------GGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCC
T ss_pred ---------------------HHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccc
Confidence 999999776 8
Q ss_pred EEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCc------HHHHH
Q 011868 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN------LAVLY 261 (476)
Q Consensus 188 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~------~~~~~ 261 (476)
+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+ .....
T Consensus 235 ~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 308 (397)
T 1wak_A 235 VKIADLGNACWVHK-----HFTEDIQTRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308 (397)
T ss_dssp EEECCGGGCEETTB-----CSCSCCSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHH
T ss_pred eEeccccccccccc-----cCccCCCCCcccCChhhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHH
Confidence 99999999975432 23456899999999999988875 89999999999999999999997644 12222
Q ss_pred HHHHh--CC----------------------------------------CCCCCCCCHHHHHHHHHccCCCcCCCCChHH
Q 011868 262 QKIFR--GD----------------------------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAG 299 (476)
Q Consensus 262 ~~i~~--~~----------------------------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~ 299 (476)
..+.. +. ...+...++.+.+||.+||+.||.+|||+++
T Consensus 309 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 388 (397)
T 1wak_A 309 ALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388 (397)
T ss_dssp HHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHH
T ss_pred HHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHH
Confidence 22211 10 1112223467899999999999999999999
Q ss_pred HhcCccccc
Q 011868 300 IKADEWFEQ 308 (476)
Q Consensus 300 il~~~~~~~ 308 (476)
+++||||+.
T Consensus 389 ~l~hp~~~~ 397 (397)
T 1wak_A 389 CLRHPWLNS 397 (397)
T ss_dssp HHTSGGGGC
T ss_pred HhhCccccC
Confidence 999999963
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=371.25 Aligned_cols=254 Identities=29% Similarity=0.472 Sum_probs=208.6
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-------
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------- 85 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------- 85 (476)
.++|++++.||+|+||.||+|++..+|+.||||++... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 36799999999999999999999999999999999653 2345789999999999999999999998854
Q ss_pred ------CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHH
Q 011868 86 ------KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFL 158 (476)
Q Consensus 86 ------~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~ 158 (476)
....|+||||++||+|.+++... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp---------------- 144 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKP---------------- 144 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG----------------
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCH----------------
Confidence 45789999999999999999754 3688999999999999999999999999999997
Q ss_pred HHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCccc------------CCCcccccccCCccccccccccC
Q 011868 159 LTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFR------------DDGLLHTTCGSPNYVAPEVLANR 226 (476)
Q Consensus 159 ~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~------------~~~~~~~~~gt~~y~APE~l~~~ 226 (476)
+||+++.++.+||+|||++....... ........+||+.|+|||++.+.
T Consensus 145 -------------------~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 205 (303)
T 1zy4_A 145 -------------------MNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT 205 (303)
T ss_dssp -------------------GGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSC
T ss_pred -------------------HhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC
Confidence 99999999999999999998653211 01233456799999999999876
Q ss_pred CCCCccchhhhHhHHHHHHhcCCCCCCC-CcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHccCCCcCCCCChHHHh
Q 011868 227 GYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIK 301 (476)
Q Consensus 227 ~~~~~~sDvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~R~s~~~il 301 (476)
+..+.++||||+||++|+|++ ||.. .+.......+......+|. ..++.+.+||++||+.||.+|||+++++
T Consensus 206 ~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 282 (303)
T 1zy4_A 206 GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282 (303)
T ss_dssp SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHh
Confidence 444589999999999999998 6643 3344555666665555443 4567799999999999999999999999
Q ss_pred cCccccc
Q 011868 302 ADEWFEQ 308 (476)
Q Consensus 302 ~~~~~~~ 308 (476)
+||||..
T Consensus 283 ~h~~~~~ 289 (303)
T 1zy4_A 283 NSGWLPV 289 (303)
T ss_dssp HSSCSCC
T ss_pred CCCCcCC
Confidence 9999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=377.43 Aligned_cols=252 Identities=24% Similarity=0.397 Sum_probs=214.0
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
....++|++++.||+|+||+||+|.+..+++.||+|++... +......+.+|+.+++.++||||+++++++..++..
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 45678999999999999999999999999999999998543 344568899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||++||+|.+++.. ...+++.++..++.||+.||+|||++||+||||||
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp-------------------------- 136 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNS-------------------------- 136 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCST--------------------------
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCc--------------------------
Confidence 999999999999999987 56799999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC------------CcccccccCCccccccccccCCCCCccchhh
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIW 236 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~------------~~~~~~~gt~~y~APE~l~~~~~~~~~sDvw 236 (476)
+|||++.++.+||+|||++......... ....+.+||+.|+|||++.+..++ .++|||
T Consensus 137 ---------~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~ 206 (310)
T 3s95_A 137 ---------HNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVF 206 (310)
T ss_dssp ---------TSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCC-THHHHH
T ss_pred ---------CeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHH
Confidence 9999999999999999999754322111 112256899999999999888775 899999
Q ss_pred hHhHHHHHHhcCCCCCCCCcHHH-----HHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 237 SCGVILYVILTGYLPFDDRNLAV-----LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 237 SlGvil~elltG~~Pf~~~~~~~-----~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
||||++|+|++|..||....... ...... ....|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 207 slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 207 SFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999986532110 011111 12346778999999999999999999999999976
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=376.01 Aligned_cols=258 Identities=31% Similarity=0.419 Sum_probs=217.1
Q ss_pred ccCcCEEEeceEeecCceEEEEEEEC-CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEE--
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLA-- 84 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~-- 84 (476)
...++|++.+.||+|+||+||+|++. .+|+.||+|++...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 34489999999999999999999995 67899999999755422 11223566787777766 8999999999987
Q ss_pred ---eCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHH
Q 011868 85 ---SKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 85 ---~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
.....|+||||+. |+|.+++.... .+++.+++.++.||+.||.|||++||+||||||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp----------------- 148 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP----------------- 148 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG-----------------
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCH-----------------
Confidence 5568999999996 69999997643 499999999999999999999999999999997
Q ss_pred HHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHh
Q 011868 160 TFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlG 239 (476)
+||+++.+|.+||+|||++..... .......+||+.|+|||++.+..++ .++||||||
T Consensus 149 ------------------~Nili~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG 206 (326)
T 1blx_A 149 ------------------QNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVG 206 (326)
T ss_dssp ------------------GGEEECTTCCEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHH
T ss_pred ------------------HHeEEcCCCCEEEecCcccccccC---CCCccccccccceeCHHHHhcCCCC-cchhHHHHH
Confidence 999999999999999999986442 2234456799999999999887775 899999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHHhCC---------------------------CCCCCCCCHHHHHHHHHccCCCcC
Q 011868 240 VILYVILTGYLPFDDRNLAVLYQKIFRGD---------------------------FKLPKWLSPGAQNLLRKILEPNPV 292 (476)
Q Consensus 240 vil~elltG~~Pf~~~~~~~~~~~i~~~~---------------------------~~~p~~~s~~~~~Li~~~L~~dP~ 292 (476)
|++|+|++|+.||.+.+......++.... ..++..+++.+.+||.+||+.||.
T Consensus 207 ~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 286 (326)
T 1blx_A 207 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 286 (326)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTT
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcc
Confidence 99999999999999988777766665310 012345788999999999999999
Q ss_pred CCCChHHHhcCcccccc
Q 011868 293 KRITIAGIKADEWFEQD 309 (476)
Q Consensus 293 ~R~s~~~il~~~~~~~~ 309 (476)
+|||+.++++||||...
T Consensus 287 ~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 287 KRISAYSALSHPYFQDL 303 (326)
T ss_dssp TSCCHHHHHTSGGGTTC
T ss_pred cCCCHHHHhcCcccccc
Confidence 99999999999999754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=390.75 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=219.2
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||+||+|++..+++.||||++.... .......+.+|+.+|+.++||||+++++++...+.+|+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 4468999999999999999999999899999999997543 33445678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
||||++||+|.+++... ..+++.++..++.||+.||+|||++||+||||||
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp---------------------------- 241 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAA---------------------------- 241 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG----------------------------
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCH----------------------------
Confidence 99999999999999764 4699999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GY 249 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~ 249 (476)
+|||++.++.+||+|||+++...............+++.|+|||++.+..++ .++|||||||++|||++ |.
T Consensus 242 -------~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~ 313 (377)
T 3cbl_A 242 -------RNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGA 313 (377)
T ss_dssp -------GGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSC
T ss_pred -------HHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999743221111111223457789999999877775 89999999999999998 99
Q ss_pred CCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 250 LPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
.||.+.+.......+..+ ..+.|..+++++.+||.+||+.||.+|||++++++
T Consensus 314 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 314 SPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999998887777766655 45677889999999999999999999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=383.38 Aligned_cols=256 Identities=33% Similarity=0.584 Sum_probs=223.7
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCC--CCCcceEEEEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLK--HPNVVRLHEVLA 84 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~ 84 (476)
....++|++++.||+|+||+||+|++..+++.||||++........ .....+.+|+.+++.++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 4456789999999999999999999999999999999986643221 11245678999999996 599999999999
Q ss_pred eCCEEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHH
Q 011868 85 SKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLL 163 (476)
Q Consensus 85 ~~~~~~lV~E~~~g-g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~ 163 (476)
..+..|+|||++.+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp--------------------- 177 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKD--------------------- 177 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG---------------------
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCH---------------------
Confidence 99999999999976 89999998888999999999999999999999999999999997
Q ss_pred hhhccccccccCCCCceEeC-CCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHH
Q 011868 164 MIVIRPWKFNVLQLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242 (476)
Q Consensus 164 ~~~~~p~~~~~~~~~NiLl~-~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil 242 (476)
+|||++ +++.+||+|||++..... .......||+.|+|||++.+..+.+.++|||||||++
T Consensus 178 --------------~NIll~~~~~~~kL~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 239 (320)
T 3a99_A 178 --------------ENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239 (320)
T ss_dssp --------------GGEEEETTTTEEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHH
T ss_pred --------------HHEEEeCCCCCEEEeeCcccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHH
Confidence 999999 789999999999985432 2344567999999999998877766889999999999
Q ss_pred HHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 243 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 243 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
|+|++|+.||...+ .+......++..+++++.+||.+||+.||.+|||++++++||||....
T Consensus 240 ~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 240 YDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHCCCCCCChh------hhhcccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 99999999997643 344566677888999999999999999999999999999999998654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=385.89 Aligned_cols=261 Identities=25% Similarity=0.373 Sum_probs=210.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc--------chhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--------HLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--------~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 83 (476)
..++|++++.||+|+||.||+|.+. +|+.||||++...... .....+.+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 4578999999999999999999985 4999999998654321 223357899999999999999999999998
Q ss_pred Ee-----CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHH
Q 011868 84 AS-----KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVF 157 (476)
Q Consensus 84 ~~-----~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~ 157 (476)
.. ...+|+||||+. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp--------------- 162 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHP--------------- 162 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG---------------
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCCh---------------
Confidence 43 347899999996 6888888754 4799999999999999999999999999999997
Q ss_pred HHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhh
Q 011868 158 LLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 237 (476)
Q Consensus 158 ~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwS 237 (476)
+||+++.++.+||+|||++..... .......+||+.|+|||++.+....+.++||||
T Consensus 163 --------------------~NIl~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 219 (362)
T 3pg1_A 163 --------------------GNILLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWS 219 (362)
T ss_dssp --------------------GGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHH
T ss_pred --------------------HHEEEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHh
Confidence 999999999999999999974322 233445689999999999887444458999999
Q ss_pred HhHHHHHHhcCCCCCCCCcHHHHHHHHHhCC------------------------CC--------CCCCCCHHHHHHHHH
Q 011868 238 CGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------------------FK--------LPKWLSPGAQNLLRK 285 (476)
Q Consensus 238 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------------~~--------~p~~~s~~~~~Li~~ 285 (476)
+||++|+|++|+.||.+.+......++.... .. .++..++.+.+||.+
T Consensus 220 lG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 299 (362)
T 3pg1_A 220 AGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAK 299 (362)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHH
Confidence 9999999999999999988776666554210 00 123468899999999
Q ss_pred ccCCCcCCCCChHHHhcCccccccCCC
Q 011868 286 ILEPNPVKRITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 286 ~L~~dP~~R~s~~~il~~~~~~~~~~~ 312 (476)
||+.||.+|||+.++++||||+..+.+
T Consensus 300 ~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 300 MLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp HTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred HhcCChhhCCCHHHHHcCchhhhccCc
Confidence 999999999999999999999876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=368.28 Aligned_cols=251 Identities=23% Similarity=0.410 Sum_probs=220.0
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
+..++|++.+.||+|+||+||+|.+. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..|
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence 45578999999999999999999985 5778999999765422 357899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp--------------------------- 134 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAA--------------------------- 134 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG---------------------------
T ss_pred EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcch---------------------------
Confidence 999999999999999653 4699999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
+||+++.++.+||+|||++....... ........||+.|+|||++.+..++ .++||||+||++|+|++ |
T Consensus 135 --------~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g 204 (269)
T 4hcu_A 135 --------RNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEG 204 (269)
T ss_dssp --------GGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTS
T ss_pred --------heEEEcCCCCEEeccccccccccccc-cccccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCC
Confidence 99999999999999999997533211 1122344578899999999887775 89999999999999999 9
Q ss_pred CCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 249 YLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+.||.+.+.......+..+ ....|...++.+.++|.+||+.||.+|||+.+++++
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 205 KIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999988888887776 345667789999999999999999999999999876
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=393.14 Aligned_cols=254 Identities=15% Similarity=0.173 Sum_probs=196.4
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCcceEE-------EEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--KHPNVVRLH-------EVL 83 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l--~HpnIv~l~-------~~~ 83 (476)
..+|++.+.||+|+||+||+|++..+|+.||||++.............+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34599999999999999999999999999999999887654555567788886555544 699988755 565
Q ss_pred EeC-----------------CEEEEEEeccCCCChHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhcCcEecc
Q 011868 84 ASK-----------------SKIYMVLEYVTGGELFDKIASK-GRLQEAEG------RKLFQQLIDGVSYCHNKGVFHRD 139 (476)
Q Consensus 84 ~~~-----------------~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~------~~~~~qi~~al~yLH~~givHrD 139 (476)
... ..+|+||||+. |+|.+++... ..+++... ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 543 34899999997 8999999763 34444444 56679999999999999999999
Q ss_pred CCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccc
Q 011868 140 LKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 219 (476)
Q Consensus 140 iKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 219 (476)
||| +|||++.+|.+||+|||+|+... .......||+.|+|
T Consensus 220 ikp-----------------------------------~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~a 259 (371)
T 3q60_A 220 FTP-----------------------------------DNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAP 259 (371)
T ss_dssp CSG-----------------------------------GGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCC
T ss_pred CCH-----------------------------------HHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcC
Confidence 997 99999999999999999998432 22224567799999
Q ss_pred cccccc--CCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHH--HHH-----HHhCCCCCC--CCCCHHHHHHHHHccC
Q 011868 220 PEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL--YQK-----IFRGDFKLP--KWLSPGAQNLLRKILE 288 (476)
Q Consensus 220 PE~l~~--~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~-----i~~~~~~~p--~~~s~~~~~Li~~~L~ 288 (476)
||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.... +.. .....+.+| ..+++.+.+||.+||+
T Consensus 260 PE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 338 (371)
T 3q60_A 260 REFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLN 338 (371)
T ss_dssp HHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTC
T ss_pred hhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcC
Confidence 999976 556 4899999999999999999999987643211 100 011122233 4689999999999999
Q ss_pred CCcCCCCChHHHhcCccccc
Q 011868 289 PNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 289 ~dP~~R~s~~~il~~~~~~~ 308 (476)
.||.+|||+.++++||||.+
T Consensus 339 ~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 339 FDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp SSTTTCCCHHHHTTSHHHHH
T ss_pred CChhhCCCHHHHhcCHHHHH
Confidence 99999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=369.65 Aligned_cols=256 Identities=29% Similarity=0.469 Sum_probs=212.9
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
++|.....||+|+||+||+|.+..+++.||||.+.... ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 33444458999999999999999999999999997653 233577999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 94 EYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 94 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p---------------------------- 150 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKG---------------------------- 150 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG----------------------------
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCCh----------------------------
Confidence 999999999999764 2567999999999999999999999999999997
Q ss_pred ccccCCCCceEeCC-CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC-CCCccchhhhHhHHHHHHhcC
Q 011868 171 KFNVLQLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 171 ~~~~~~~~NiLl~~-~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~sDvwSlGvil~elltG 248 (476)
+||+++. ++.+||+|||++...... ........||+.|+|||++.+.. ..+.++|||||||++|+|++|
T Consensus 151 -------~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 221 (295)
T 2clq_A 151 -------DNVLINTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221 (295)
T ss_dssp -------GGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHT
T ss_pred -------hhEEEECCCCCEEEeecccccccCCC--CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9999987 899999999999754321 22234567999999999987643 124889999999999999999
Q ss_pred CCCCCCCcHH--HHHH-HHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 249 YLPFDDRNLA--VLYQ-KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 249 ~~Pf~~~~~~--~~~~-~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
+.||.+.+.. .... ........+|..+++++.+||.+||+.||.+|||++++++||||...
T Consensus 222 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 222 KPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp SCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred CCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 9999764322 2222 22334556778899999999999999999999999999999999754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=364.55 Aligned_cols=251 Identities=20% Similarity=0.338 Sum_probs=219.4
Q ss_pred ccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 7 ~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
+..+..+++|++.+.||+|+||+||+|++ +++.||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 3 KHSGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp -CCCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred CcCCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 34577899999999999999999999997 488999999976543 344467899999999999999999999999877
Q ss_pred --CEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC--cEeccCCcchhccchhhhHHHHHHHH
Q 011868 87 --SKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 87 --~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~g--ivHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
+..|+||||++||+|.+++.... .+++.+++.++.||+.||+|||++| |+||||||
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp------------------ 141 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNS------------------ 141 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSG------------------
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCcc------------------
Confidence 78999999999999999998755 4899999999999999999999999 99999997
Q ss_pred HHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCC--ccchhhhH
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG--ATSDIWSC 238 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~--~~sDvwSl 238 (476)
+||+++.+|.++|+|||++.... .....||+.|+|||++.+..+.. .++|||||
T Consensus 142 -----------------~Nil~~~~~~~~l~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~sl 197 (271)
T 3kmu_A 142 -----------------RSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSF 197 (271)
T ss_dssp -----------------GGEEECTTSCEEEEGGGSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHH
T ss_pred -----------------ceEEEcCCcceeEEeccceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHH
Confidence 99999999999999999876322 23457899999999998765542 27999999
Q ss_pred hHHHHHHhcCCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 239 GVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 239 Gvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
||++|+|++|+.||.+.+.......+... ....|..+++++.++|.+||+.||.+|||++++++
T Consensus 198 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 198 AVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999998887776666654 34567789999999999999999999999999976
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=364.24 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=219.0
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
+..++|++.+.||+|+||+||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++...+..|
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 45679999999999999999999874 6778999999765422 367899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+||||+++++|.+++...+ .+++.+++.++.|++.||+|||++||+||||||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp--------------------------- 132 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAA--------------------------- 132 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSG---------------------------
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCc---------------------------
Confidence 9999999999999997654 599999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
+||+++.++.+||+|||++....... ........||+.|+|||++.+..++ .++||||+||++|+|++ |
T Consensus 133 --------~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g 202 (268)
T 3sxs_A 133 --------RNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLG 202 (268)
T ss_dssp --------GGEEECTTCCEEECCTTCEEECCTTC-EEECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTT
T ss_pred --------ceEEECCCCCEEEccCccceecchhh-hhcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCC
Confidence 99999999999999999997543211 1122334567789999999887775 89999999999999999 9
Q ss_pred CCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 249 YLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
..||.+.+.......+..+. ...|...++.+.++|.+||+.||.+|||+.+++++
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 203 KMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999988888877777664 34567789999999999999999999999999886
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=379.95 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=213.8
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCC-ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC------cceEEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN------VVRLHEV 82 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn------Iv~l~~~ 82 (476)
....++|++.+.||+|+||+||+|.+..++ +.||+|++... ......+.+|+.+++.++|++ ++.++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 445679999999999999999999998777 68999999653 234577889999999997766 9999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 83 LASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 83 ~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
+...+..|+||||+ +++|.+.+... .++++.+++.++.||+.||+|||++||+||||||
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp------------------ 151 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKP------------------ 151 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCG------------------
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH------------------
Confidence 99999999999999 77888887654 3699999999999999999999999999999997
Q ss_pred HHHhhhccccccccCCCCceEe-------------------CCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccc
Q 011868 161 FLLMIVIRPWKFNVLQLENILL-------------------DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 221 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl-------------------~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 221 (476)
+|||+ +.++.+||+|||+++... ......+||+.|+|||
T Consensus 152 -----------------~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE 209 (355)
T 2eu9_A 152 -----------------ENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH-----EHHTTIVATRHYRPPE 209 (355)
T ss_dssp -----------------GGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETT-----SCCCSSCSCGGGCCHH
T ss_pred -----------------HHEEEecccccccccccccccccccCCCcEEEeecCcccccc-----ccccCCcCCCcccCCe
Confidence 99999 567899999999997432 2234568999999999
Q ss_pred ccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCC-----------------------------
Q 011868 222 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----------------------------- 272 (476)
Q Consensus 222 ~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----------------------------- 272 (476)
++.+..++ .++|||||||++|+|++|+.||.+.+.......+.....+.|
T Consensus 210 ~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (355)
T 2eu9_A 210 VILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRY 288 (355)
T ss_dssp HHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHH
T ss_pred eeecCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhcc
Confidence 99888775 899999999999999999999998876655444332211111
Q ss_pred ---------------CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 273 ---------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 273 ---------------~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
...++++.+||.+||+.||.+|||++++++||||...
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 289 VKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp HHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred ccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence 1123578899999999999999999999999999863
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=371.41 Aligned_cols=249 Identities=21% Similarity=0.285 Sum_probs=214.1
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCC-------ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSG-------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV 82 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~ 82 (476)
.+..++|++.+.||+|+||+||+|++..++ ..||+|++.... ....+.+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 356789999999999999999999998777 469999996543 3346789999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 83 LASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 83 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
+...+..|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp------------------- 141 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCA------------------- 141 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG-------------------
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCc-------------------
Confidence 9999999999999999999999987544 99999999999999999999999999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCC--------EEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccc
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGN--------IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 233 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~--------vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~s 233 (476)
+|||++.++. +||+|||++.... ......||+.|+|||++.+....+.++
T Consensus 142 ----------------~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~ 199 (289)
T 4fvq_A 142 ----------------KNILLIREEDRKTGNPPFIKLSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLAT 199 (289)
T ss_dssp ----------------GGEEEEECCBGGGTBCCEEEECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHH
T ss_pred ----------------ceEEEecCCcccccccceeeeccCccccccc------CccccCCcCcccCHHHhCCCCCCCchh
Confidence 9999998887 9999999987432 223456899999999998744445899
Q ss_pred hhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 234 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 234 DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|||||||++|+|++ |..||...+... ...........|...++++.+||.+||+.||.+|||+.+++++
T Consensus 200 DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 200 DKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999 455565555443 3344455667777789999999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=385.57 Aligned_cols=253 Identities=28% Similarity=0.364 Sum_probs=213.7
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CC-----CcceEEEEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HP-----NVVRLHEVLA 84 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-Hp-----nIv~l~~~~~ 84 (476)
...++|++.+.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.++ |+ +|+++++++.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 3468999999999999999999999999999999999743 234577888999998885 55 4999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH--NKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH--~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
..+..|+||||+. |+|.+++... ..+++..++.++.||+.||.||| +.||+||||||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp------------------ 187 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKP------------------ 187 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSG------------------
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCc------------------
Confidence 9999999999995 5999999765 46999999999999999999999 47999999997
Q ss_pred HHHhhhccccccccCCCCceEeC--CCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhH
Q 011868 161 FLLMIVIRPWKFNVLQLENILLD--SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 238 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~--~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSl 238 (476)
+|||++ .++.+||+|||+++... ......+||+.|+|||++.+..++ .++|||||
T Consensus 188 -----------------~NIll~~~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSl 244 (382)
T 2vx3_A 188 -----------------ENILLCNPKRSAIKIVDFGSSCQLG-----QRIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSL 244 (382)
T ss_dssp -----------------GGEEESSTTSCCEEECCCTTCEETT-----CCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHH
T ss_pred -----------------ccEEEecCCCCcEEEEeccCceecc-----cccccccCCccccChHHHcCCCCC-cHHHHHHH
Confidence 999995 57889999999997542 234467899999999999988875 89999999
Q ss_pred hHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC------------------C-------------------CC-------
Q 011868 239 GVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL------------------P-------------------KW------- 274 (476)
Q Consensus 239 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------p-------------------~~------- 274 (476)
||++|+|++|+.||.+.+......++....... | ..
T Consensus 245 G~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 324 (382)
T 2vx3_A 245 GCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNIL 324 (382)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHh
Confidence 999999999999999988777766655421100 0 00
Q ss_pred --------------------CCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 275 --------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 275 --------------------~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
.++++.+||.+||+.||.+|||++|+++||||++.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 325 GVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred hccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 01378999999999999999999999999999764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=379.82 Aligned_cols=255 Identities=30% Similarity=0.567 Sum_probs=186.5
Q ss_pred cCCccCcCEEEec-eEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-
Q 011868 8 QEGMRLGRYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS- 85 (476)
Q Consensus 8 ~~~~~~~~Y~i~~-~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~- 85 (476)
......++|++.+ .||+|+||+||+|.+..+|+.||||++.... ....+....++.++||||+++++++..
T Consensus 22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 3445678999965 5999999999999999999999999996532 122233344677799999999999976
Q ss_pred ---CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 86 ---KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 86 ---~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
...+|+||||++||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp------------------ 156 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKP------------------ 156 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSG------------------
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH------------------
Confidence 456899999999999999998653 699999999999999999999999999999997
Q ss_pred HHHhhhccccccccCCCCceEeCC---CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhh
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDS---KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 237 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~---~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwS 237 (476)
+|||++. ++.+||+|||++.... .......+||+.|+|||++.+..++ .++||||
T Consensus 157 -----------------~NIll~~~~~~~~~kl~Dfg~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~s 214 (336)
T 3fhr_A 157 -----------------ENLLYTSKEKDAVLKLTDFGFAKETT----QNALQTPCYTPYYVAPEVLGPEKYD-KSCDMWS 214 (336)
T ss_dssp -----------------GGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHH-HHHHHHH
T ss_pred -----------------HHEEEEecCCCceEEEeccccceecc----ccccccCCCCcCccChhhhCCCCCC-chhhHHH
Confidence 9999986 4559999999997432 2334567899999999999777775 8999999
Q ss_pred HhHHHHHHhcCCCCCCCCcHHHH----HHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 238 CGVILYVILTGYLPFDDRNLAVL----YQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 238 lGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|||++|+|++|+.||.+.+.... ...+......+| ..+++++.+||.+||+.||.+|||++++++||||.+.
T Consensus 215 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 215 LGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp HHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred HHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 99999999999999987654433 223333333333 4589999999999999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=378.79 Aligned_cols=255 Identities=33% Similarity=0.609 Sum_probs=213.8
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhC----CCCCcceEEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLL----KHPNVVRLHEV 82 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~~l~~l----~HpnIv~l~~~ 82 (476)
....++|++.+.||+|+||.||+|++..+++.||||++........ .....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 4456789999999999999999999999999999999976543221 1223466799999998 89999999999
Q ss_pred EEeCCEEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 83 LASKSKIYMVLEY-VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 83 ~~~~~~~~lV~E~-~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
+...+..|+|||| +.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp------------------- 167 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKD------------------- 167 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSG-------------------
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCh-------------------
Confidence 9999999999999 78999999998888899999999999999999999999999999997
Q ss_pred HHhhhccccccccCCCCceEeC-CCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhH
Q 011868 162 LLMIVIRPWKFNVLQLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~-~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGv 240 (476)
+||+++ .++.+||+|||++..... .......||+.|+|||++.+..+.+.++|||||||
T Consensus 168 ----------------~Nil~~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 227 (312)
T 2iwi_A 168 ----------------ENILIDLRRGCAKLIDFGSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGI 227 (312)
T ss_dssp ----------------GGEEEETTTTEEEECCCSSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHH
T ss_pred ----------------hhEEEeCCCCeEEEEEcchhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHH
Confidence 999999 889999999999985432 23445679999999999988777666899999999
Q ss_pred HHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 241 ILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 241 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
++|+|++|+.||.+.. .+......++..+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 228 il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 228 LLYDMVCGDIPFERDQ------EILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp HHHHHHHSSCSCCSHH------HHHHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHCCCCCCChH------HHhhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 9999999999997643 34456677888899999999999999999999999999999999764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=380.43 Aligned_cols=257 Identities=24% Similarity=0.372 Sum_probs=216.3
Q ss_pred ccCcCEEEeceEeecCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~ 84 (476)
...++|++.+.||+|+||+||+|.+ ..++..||||++.... .......+.+|+.+++++ +||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3457899999999999999999997 3466789999997543 233357899999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCC
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASKG-----------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~~-----------------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiK 141 (476)
..+..|+||||++||+|.+++.... .+++.+++.++.||+.||+|||++||+|||||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 9999999999999999999997643 37999999999999999999999999999999
Q ss_pred cchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccc
Q 011868 142 VILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 221 (476)
Q Consensus 142 p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 221 (476)
| +||+++.++.+||+|||++................||+.|+|||
T Consensus 200 p-----------------------------------~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 244 (344)
T 1rjb_A 200 A-----------------------------------RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 244 (344)
T ss_dssp G-----------------------------------GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred h-----------------------------------hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHH
Confidence 7 99999999999999999998654322222334566889999999
Q ss_pred ccccCCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChH
Q 011868 222 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIA 298 (476)
Q Consensus 222 ~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~ 298 (476)
++.+..++ .++|||||||++|+|++ |..||.+.+.......+... ..+.|..+++++.+||.+||+.||.+|||+.
T Consensus 245 ~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 323 (344)
T 1rjb_A 245 SLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 323 (344)
T ss_dssp HHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 99887775 89999999999999998 99999887654444444433 3456777999999999999999999999999
Q ss_pred HHhcCcc
Q 011868 299 GIKADEW 305 (476)
Q Consensus 299 ~il~~~~ 305 (476)
+++++..
T Consensus 324 ~l~~~l~ 330 (344)
T 1rjb_A 324 NLTSFLG 330 (344)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998744
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=368.71 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=210.0
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 84 (476)
.-....++|++.+.||+|+||+||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 3455678999999999999999999998654 4579999986543 3445678999999999999999999999984
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHH
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLL 163 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~ 163 (476)
++..|+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp--------------------- 144 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAA--------------------- 144 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG---------------------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccH---------------------
Confidence 567899999999999999997654 699999999999999999999999999999997
Q ss_pred hhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHH
Q 011868 164 MIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243 (476)
Q Consensus 164 ~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ 243 (476)
+|||++.++.+||+|||++....... ........+|+.|+|||++.+..++ .++|||||||++|
T Consensus 145 --------------~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ 208 (281)
T 1mp8_A 145 --------------RNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMW 208 (281)
T ss_dssp --------------GGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHH
T ss_pred --------------HHEEECCCCCEEECccccccccCccc-ccccccCCCcccccChhhcccCCCC-CccCchHHHHHHH
Confidence 99999999999999999998643311 1122344578899999999887775 8999999999999
Q ss_pred HHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 244 VILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 244 ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+|++ |..||.+.+.......+..+. .+.|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 209 ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 209 EILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9997 999999888777777776654 55778899999999999999999999999999865
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=380.98 Aligned_cols=256 Identities=22% Similarity=0.348 Sum_probs=217.2
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCce----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 84 (476)
..+..++|++++.||+|+||+||+|.+..+++. ||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 345678999999999999999999999888876 6777664332 1222356778999999999999999999986
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHH
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLL 163 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~ 163 (476)
.+..|+||||+.+|+|.+++... +.+++..++.++.||+.||+|||++||+||||||
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp--------------------- 143 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAA--------------------- 143 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSS---------------------
T ss_pred -CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccch---------------------
Confidence 45689999999999999999764 5799999999999999999999999999999997
Q ss_pred hhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHH
Q 011868 164 MIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243 (476)
Q Consensus 164 ~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ 243 (476)
+|||++.++.+||+|||+++...............||+.|+|||++.+..++ .++|||||||++|
T Consensus 144 --------------~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ 208 (325)
T 3kex_A 144 --------------RNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVW 208 (325)
T ss_dssp --------------TTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHH
T ss_pred --------------heEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHH
Confidence 9999999999999999999865443333344556788899999999887775 8999999999999
Q ss_pred HHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 244 VILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 244 ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+|++ |..||.+.+.......+..+ ....|..+++++.+||.+||+.||.+|||+.+++++
T Consensus 209 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 209 ELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999 99999998877777777665 455677789999999999999999999999999887
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=371.74 Aligned_cols=263 Identities=25% Similarity=0.414 Sum_probs=213.4
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASKSKI 89 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~~~~ 89 (476)
.-++|++.+.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+++.++ ||||+++++++...+..
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3457999999999999999999984 588999999976543 3445678999999999997 59999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+|||+ .+++|.+++.....+++.+++.++.||+.||.|||++||+||||||
T Consensus 104 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp--------------------------- 155 (313)
T 3cek_A 104 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP--------------------------- 155 (313)
T ss_dssp EEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG---------------------------
T ss_pred EEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCc---------------------------
Confidence 999994 5889999999888999999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc-----------CCCCCccchhhhH
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-----------RGYDGATSDIWSC 238 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----------~~~~~~~sDvwSl 238 (476)
+||+++ ++.+||+|||++...............+||+.|+|||++.+ ..+ +.++|||||
T Consensus 156 --------~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~Di~sl 225 (313)
T 3cek_A 156 --------ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSL 225 (313)
T ss_dssp --------GGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CC-CHHHHHHHH
T ss_pred --------ccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccC-CchHHHHHH
Confidence 999996 48999999999986543222223345679999999999875 234 488999999
Q ss_pred hHHHHHHhcCCCCCCCCc-HHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCCCCC
Q 011868 239 GVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 314 (476)
Q Consensus 239 Gvil~elltG~~Pf~~~~-~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~~~~ 314 (476)
||++|+|++|..||.+.. .......+... ...+|...++++.+||.+||+.||.+|||++++++||||.....+.+
T Consensus 226 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~ 304 (313)
T 3cek_A 226 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304 (313)
T ss_dssp HHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-----
T ss_pred HHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchh
Confidence 999999999999998754 33334444443 34567778999999999999999999999999999999987655443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=379.31 Aligned_cols=255 Identities=22% Similarity=0.334 Sum_probs=210.7
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceE----EEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF----AVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 85 (476)
.+..++|++.+.||+|+||+||+|++..+++.+ |+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 456788999999999999999999998887755 777765432 23345789999999999999999999999987
Q ss_pred CCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 86 KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
.. .++||||+.+|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp---------------------- 145 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA---------------------- 145 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG----------------------
T ss_pred CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCh----------------------
Confidence 65 7899999999999999976 45799999999999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+|||++.++.+||+|||+++...............||+.|+|||++.+..++ .++|||||||++|+
T Consensus 146 -------------~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~e 211 (327)
T 3poz_A 146 -------------RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWE 211 (327)
T ss_dssp -------------GGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHH
T ss_pred -------------heEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHH
Confidence 9999999999999999999754332222233345678899999999888775 89999999999999
Q ss_pred Hhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 245 ILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 245 llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|++ |+.||.+.+.......+..+. .+.|..+++++.++|.+||+.||.+|||+.+++++
T Consensus 212 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 212 LMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999 999999888777766666553 56677899999999999999999999999999876
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=375.56 Aligned_cols=256 Identities=26% Similarity=0.449 Sum_probs=220.7
Q ss_pred CccCcCEEEeceEeecCceEEEEEEEC-------CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE 81 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~ 81 (476)
....++|++++.||+|+||+||+|.+. .++..||||++.... .......+.+|+.+++.+ +||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 445589999999999999999999986 467789999997653 344467899999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchh
Q 011868 82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILK 145 (476)
Q Consensus 82 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~ 145 (476)
++...+..|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp--- 185 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA--- 185 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG---
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc---
Confidence 9999999999999999999999997643 389999999999999999999999999999997
Q ss_pred ccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc
Q 011868 146 SCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 225 (476)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 225 (476)
+||+++.++.+||+|||++................+|+.|+|||++.+
T Consensus 186 --------------------------------~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 233 (334)
T 2pvf_A 186 --------------------------------RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 233 (334)
T ss_dssp --------------------------------GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH
T ss_pred --------------------------------ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC
Confidence 999999999999999999975433211122334467889999999988
Q ss_pred CCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 226 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 226 ~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
..++ .++|||||||++|+|++ |..||.+.+.......+..+. ...|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 234 ~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 234 RVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7775 89999999999999999 999999988888877776654 45677799999999999999999999999999876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=363.01 Aligned_cols=250 Identities=27% Similarity=0.441 Sum_probs=206.4
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
..+++|++.+.||+|+||.||+|.+ +++.||||++....... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 4678999999999999999999997 48899999987654222 23357799999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---cEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG---VFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g---ivHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
|+||||++|++|.+++. ..++++..++.++.|++.||+|||++| |+||||||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp------------------------ 136 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKS------------------------ 136 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSG------------------------
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCch------------------------
Confidence 99999999999999885 468999999999999999999999999 99999997
Q ss_pred ccccccccCCCCceEeCC--------CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhH
Q 011868 167 IRPWKFNVLQLENILLDS--------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 238 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~--------~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSl 238 (476)
+||+++. ++.+||+|||++..... .......||+.|+|||++.+..++ .++||||+
T Consensus 137 -----------~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~sl 200 (271)
T 3dtc_A 137 -----------SNILILQKVENGDLSNKILKITDFGLAREWHR----TTKMSAAGAYAWMAPEVIRASMFS-KGSDVWSY 200 (271)
T ss_dssp -----------GGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCS-HHHHHHHH
T ss_pred -----------HHEEEecccccccccCcceEEccCCccccccc----ccccCCCCccceeCHHHhccCCCC-chhhHHHH
Confidence 9999986 78899999999975432 223356799999999999887775 89999999
Q ss_pred hHHHHHHhcCCCCCCCCcHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 239 GVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 239 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
||++|+|++|+.||.+.+.......+.... .+.|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 201 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 201 GVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 999999999999999988777766666554 45667799999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=366.41 Aligned_cols=251 Identities=23% Similarity=0.396 Sum_probs=216.9
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
...++|++++.||+|+||+||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++...+..|
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 34569999999999999999999875 6778999999765422 367889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+||||+++++|.+++.. ..++++.+++.++.||+.||+|||++||+||||||
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp--------------------------- 148 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAA--------------------------- 148 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSG---------------------------
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCcc---------------------------
Confidence 99999999999999976 46799999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
+||+++.++.+||+|||++....... ........||+.|+|||++.+..++ .++||||+||++|+|++ |
T Consensus 149 --------~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g 218 (283)
T 3gen_A 149 --------RNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLG 218 (283)
T ss_dssp --------GGEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTT
T ss_pred --------ceEEEcCCCCEEEccccccccccccc-cccccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCC
Confidence 99999999999999999997543211 1122334578899999999887775 89999999999999998 9
Q ss_pred CCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 249 YLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+.||.+.+.......+..+. ...|...++.+.+||.+||+.||.+|||++++++|
T Consensus 219 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 219 KMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99999988888888877764 44567789999999999999999999999999886
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=373.39 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=218.2
Q ss_pred ccCcCEEEeceEeecCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~ 84 (476)
...++|++++.||+|+||+||+|.+ ..+++.||||++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 4457999999999999999999985 4578899999997654 334467899999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhc
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASKG------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKS 146 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~~------------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~ 146 (476)
..+..|+||||+++|+|.+++.... .+++.+++.++.||+.||.|||++||+||||||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp---- 173 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA---- 173 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG----
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc----
Confidence 9999999999999999999997643 489999999999999999999999999999997
Q ss_pred cchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccC
Q 011868 147 CHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 226 (476)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 226 (476)
+||+++.++.+||+|||++................||+.|+|||++.+.
T Consensus 174 -------------------------------~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 222 (313)
T 1t46_A 174 -------------------------------RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 222 (313)
T ss_dssp -------------------------------GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC
T ss_pred -------------------------------ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC
Confidence 9999999999999999999865443222233455688999999999887
Q ss_pred CCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 227 GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 227 ~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
.++ .++|||||||++|+|++ |..||.+.+........... ....+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 223 ~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 223 VYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 775 89999999999999999 99999887654444433333 234467789999999999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=383.66 Aligned_cols=255 Identities=25% Similarity=0.450 Sum_probs=210.1
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-----------CCCcce
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----------HPNVVR 78 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-----------HpnIv~ 78 (476)
....++|++.+.||+|+||+||+|++..+++.||||++.... .....+.+|+.++++++ ||||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 345689999999999999999999999999999999997542 23567889999999886 899999
Q ss_pred EEEEEEeCC----EEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CcEeccCCcchhccchhh
Q 011868 79 LHEVLASKS----KIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMRI 151 (476)
Q Consensus 79 l~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~-givHrDiKp~~~~~~~~~ 151 (476)
+++++...+ .+++||||+ +++|.+++... .++++..++.++.||+.||+|||++ ||+||||||
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp--------- 160 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP--------- 160 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSG---------
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCCh---------
Confidence 999997654 789999999 99999999763 4699999999999999999999998 999999997
Q ss_pred hHHHHHHHHHHHhhhccccccccCCCCceEeC------CCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc
Q 011868 152 ATLQVFLLTFLLMIVIRPWKFNVLQLENILLD------SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 225 (476)
Q Consensus 152 ~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~------~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 225 (476)
+|||++ ..+.+||+|||++..... .....+||+.|+|||++.+
T Consensus 161 --------------------------~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~ 209 (373)
T 1q8y_A 161 --------------------------ENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLG 209 (373)
T ss_dssp --------------------------GGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHT
T ss_pred --------------------------HHeEEeccCCCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhC
Confidence 999994 445899999999975432 2345689999999999988
Q ss_pred CCCCCccchhhhHhHHHHHHhcCCCCCCCCcH------HHHHHHHH----------------------------------
Q 011868 226 RGYDGATSDIWSCGVILYVILTGYLPFDDRNL------AVLYQKIF---------------------------------- 265 (476)
Q Consensus 226 ~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~------~~~~~~i~---------------------------------- 265 (476)
..++ .++|||||||++|+|++|+.||.+.+. ......+.
T Consensus 210 ~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (373)
T 1q8y_A 210 APWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK 288 (373)
T ss_dssp CCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCC
T ss_pred CCCC-chHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhccccccc
Confidence 8775 899999999999999999999986542 12222221
Q ss_pred --------hCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 266 --------RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 266 --------~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
.....++...++++.+||.+||+.||.+|||++++++||||+...
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 289 FWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp BCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred ccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 112233344567899999999999999999999999999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=374.85 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=219.6
Q ss_pred ccCCccCcCEEEeceEeecCceEEEEEEECCCCceE--EEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 011868 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF--AVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL 83 (476)
Q Consensus 7 ~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~v--AvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~ 83 (476)
....+.+++|++.+.||+|+||.||+|++..++..+ |+|.+.... .......+.+|+.+++++ +||||+++++++
T Consensus 18 ~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 18 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp CSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred ccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 344577899999999999999999999998888865 999987543 233456789999999999 899999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhcc
Q 011868 84 ASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSC 147 (476)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~ 147 (476)
...+..|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp----- 170 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA----- 170 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG-----
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCcc-----
Confidence 99999999999999999999997643 699999999999999999999999999999997
Q ss_pred chhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC
Q 011868 148 HMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 227 (476)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 227 (476)
+||+++.++.+||+|||+++.... ........+|+.|+|||++.+..
T Consensus 171 ------------------------------~NIl~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~ 217 (327)
T 1fvr_A 171 ------------------------------RNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSV 217 (327)
T ss_dssp ------------------------------GGEEECGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCE
T ss_pred ------------------------------ceEEEcCCCeEEEcccCcCccccc---cccccCCCCCccccChhhhcccc
Confidence 999999999999999999874322 11223446788999999998777
Q ss_pred CCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 228 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 228 ~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
++ .++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++.+.+||.+||+.||.+|||+++++++
T Consensus 218 ~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 218 YT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp EC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 75 89999999999999998 99999999888888777665 345677789999999999999999999999999886
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=372.69 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=221.4
Q ss_pred ccCcCEEEeceEeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 85 (476)
...++|++.+.||+|+||+||+|.+. .+++.||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 34568999999999999999999876 367889999997553 33445678999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHH
Q 011868 86 KSKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQ 155 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~ 155 (476)
.+..|+||||++||+|.+++... .++++..++.++.||+.||.|||++||+||||||
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp------------- 166 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA------------- 166 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSG-------------
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCcc-------------
Confidence 99999999999999999998652 4579999999999999999999999999999997
Q ss_pred HHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchh
Q 011868 156 VFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 235 (476)
Q Consensus 156 ~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDv 235 (476)
+||+++.++.+||+|||++................||+.|+|||++.+..++ .++||
T Consensus 167 ----------------------~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di 223 (322)
T 1p4o_A 167 ----------------------RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDV 223 (322)
T ss_dssp ----------------------GGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHH
T ss_pred ----------------------ceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCC-chhhH
Confidence 9999999999999999999754322211223345678999999999887775 89999
Q ss_pred hhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 236 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 236 wSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|||||++|+|++ |..||.+.+.......+..+.. ..|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 224 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 224 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999 9999999988888877776653 4677899999999999999999999999999886
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=368.21 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=210.4
Q ss_pred CCccCcCEEEeceEeecCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 84 (476)
..+..++|++++.||+|+||+||+|+ +..+++.||||++... .......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45677899999999999999999998 5678999999999754 3444678999999999999999999999985
Q ss_pred e--CCEEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 85 S--KSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 85 ~--~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
. ...+|+||||+++|+|.+++.... ++++.+++.++.||+.||+|||++||+||||||
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp------------------- 142 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLAT------------------- 142 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG-------------------
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCH-------------------
Confidence 4 356899999999999999997643 599999999999999999999999999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC-CcccccccCCccccccccccCCCCCccchhhhHhH
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGv 240 (476)
+|||++.++.+||+|||++......... .......||+.|+|||++.+..++ .++||||+||
T Consensus 143 ----------------~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~ 205 (295)
T 3ugc_A 143 ----------------RNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGV 205 (295)
T ss_dssp ----------------GGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHH
T ss_pred ----------------hhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHH
Confidence 9999999999999999999865432111 123344578889999999888775 8999999999
Q ss_pred HHHHHhcCCCCCCCCcHH----------------HHHHHHHh-CCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 241 ILYVILTGYLPFDDRNLA----------------VLYQKIFR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 241 il~elltG~~Pf~~~~~~----------------~~~~~i~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
++|+|++|..||...... .....+.. ...+.|..+++++.+||.+||+.||.+|||+.++++.
T Consensus 206 ~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 206 VLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999998754322 11222222 2456678899999999999999999999999998763
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=364.84 Aligned_cols=256 Identities=29% Similarity=0.481 Sum_probs=209.3
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
...+++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 45678999999999999999999999999999999999865544556678899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 90 YMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p----------------------- 164 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKP----------------------- 164 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG-----------------------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcH-----------------------
Confidence 999999999999999864 45699999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||+++.+|.+||+|||++..... .........||+.|+|||++.+..++ .++|||||||++|+|
T Consensus 165 ------------~NIl~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l 229 (310)
T 2wqm_A 165 ------------ANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEM 229 (310)
T ss_dssp ------------GGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHH
T ss_pred ------------HHEEEcCCCCEEEEeccceeeecC--CCccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHH
Confidence 999999999999999999975433 12233456799999999999887775 899999999999999
Q ss_pred hcCCCCCCCCc--HHHHHHHHHhCCCCC--CCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 246 LTGYLPFDDRN--LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 246 ltG~~Pf~~~~--~~~~~~~i~~~~~~~--p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
++|..||.+.. .......+.....+. +..+++++.+||.+||+.||.+|||+.+++++
T Consensus 230 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 230 AALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999997643 345555665554432 25589999999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=366.99 Aligned_cols=259 Identities=24% Similarity=0.370 Sum_probs=202.4
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
...+++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.++..+++.++||||+++++++...+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 4567899999999999999999999999999999999986642 223334555666678888999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~-givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
|+||||+ ++.+..+... ...+++..++.++.||+.||.|||++ ||+||||||
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp------------------------- 153 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKP------------------------- 153 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCG-------------------------
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCH-------------------------
Confidence 9999999 5555555443 46799999999999999999999995 999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccc-----cCCCCCccchhhhHhHHH
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVIL 242 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~sDvwSlGvil 242 (476)
+||+++.++.+||+|||++..... ........||+.|+|||++. ...+ +.++|||||||++
T Consensus 154 ----------~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il 219 (318)
T 2dyl_A 154 ----------SNILLDERGQIKLCDFGISGRLVD---DKAKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISL 219 (318)
T ss_dssp ----------GGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------C-CTHHHHHHHHHHH
T ss_pred ----------HHEEECCCCCEEEEECCCchhccC---CccccccCCCccccChhhcccccccccCC-ccccchhhHHHHH
Confidence 999999999999999999975432 22334567999999999985 3344 4889999999999
Q ss_pred HHHhcCCCCCCCC-cHHHHHHHHHhCCCC-CC--CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 243 YVILTGYLPFDDR-NLAVLYQKIFRGDFK-LP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 243 ~elltG~~Pf~~~-~~~~~~~~i~~~~~~-~p--~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|+|++|+.||.+. +.......+..+..+ +| ..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 220 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 220 VELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 9999999999873 455556666655433 33 3479999999999999999999999999999999764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=364.33 Aligned_cols=253 Identities=18% Similarity=0.219 Sum_probs=214.1
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~ 87 (476)
....-++|++.+.||+|+||+||+|.+..+|+.||||++..... ...+.+|+.+++.+ +|+|++++++++....
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 34556789999999999999999999999999999999865432 24578899999999 7999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
..|+||||+ +++|.+++... .++++.+++.++.||+.||+|||++||+||||||
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp------------------------ 134 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKP------------------------ 134 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCG------------------------
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCH------------------------
Confidence 999999999 99999999864 4699999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCC-----EEEeccCCCCCCCcccCC-----CcccccccCCccccccccccCCCCCccchhh
Q 011868 167 IRPWKFNVLQLENILLDSKGN-----IKISDFGLSALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIW 236 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~-----vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~sDvw 236 (476)
+||+++.++. +||+|||++......... ......+||+.|+|||++.+..++ .++|||
T Consensus 135 -----------~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~ 202 (298)
T 1csn_A 135 -----------DNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLE 202 (298)
T ss_dssp -----------GGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHH
T ss_pred -----------HHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCC-hHHHHH
Confidence 9999988776 999999999855432111 123566899999999999887775 899999
Q ss_pred hHhHHHHHHhcCCCCCCCC---cHHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 237 SCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFK-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 237 SlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~-----~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
||||++|+|++|+.||.+. +....+..+...... .+..+++++.+||.+||+.||.+|||++++++.
T Consensus 203 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 203 ALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 9999999999999999874 344444444433221 234689999999999999999999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=373.84 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=211.9
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceE----EEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF----AVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 85 (476)
.+..++|++++.||+|+||+||+|++..+++.| |+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 456789999999999999999999998888766 555554332 23346789999999999999999999999987
Q ss_pred CCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 86 KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
.. .++||+|+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp---------------------- 145 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA---------------------- 145 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG----------------------
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCH----------------------
Confidence 65 8899999999999999976 45799999999999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+|||++.++.+||+|||+++...............||+.|+|||++.+..++ .++|||||||++|+
T Consensus 146 -------------~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~e 211 (327)
T 3lzb_A 146 -------------RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWE 211 (327)
T ss_dssp -------------GGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHH
T ss_pred -------------HHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHH
Confidence 9999999999999999999865433222333445678899999999888775 89999999999999
Q ss_pred Hhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 245 ILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 245 llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|++ |..||.+.+.......+..+. .+.|..+++++.+||++||+.||.+|||+.++++.
T Consensus 212 ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 212 LMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999 999999988777777666554 56677899999999999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=376.68 Aligned_cols=248 Identities=23% Similarity=0.289 Sum_probs=211.5
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~ 90 (476)
.-++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.+ +||||+++++++......|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 34689999999999999999999999999999999975532 24578999999999 8999999999999999999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+||||+ +++|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp--------------------------- 133 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKP--------------------------- 133 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG---------------------------
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH---------------------------
Confidence 999999 9999999986 46899999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCC-----EEEeccCCCCCCCcccCC-----CcccccccCCccccccccccCCCCCccchhhhHh
Q 011868 170 WKFNVLQLENILLDSKGN-----IKISDFGLSALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~-----vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlG 239 (476)
+|||++.++. +||+|||+++........ ......+||+.|+|||++.+..++ .++||||||
T Consensus 134 --------~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG 204 (330)
T 2izr_A 134 --------ENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALG 204 (330)
T ss_dssp --------GGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHH
T ss_pred --------HHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHH
Confidence 9999999887 999999999854332111 123467899999999999988775 899999999
Q ss_pred HHHHHHhcCCCCCCCC---cHHHHHHHHHhCCCCCC-----CCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 240 VILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 240 vil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~p-----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|++|+|++|+.||.+. +....+.++.......| ..+ +++.++|.+||+.||.+||++++|++
T Consensus 205 ~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 205 HMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENF-PEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 9999999999999874 44555666654443333 223 49999999999999999999999876
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=371.65 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=217.1
Q ss_pred ccCcCEEEeceEeecCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~ 84 (476)
...++|++++.||+|+||+||+|.+ ..+++.||||++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 4567999999999999999999985 3577899999997654 334457899999999999 6999999999987
Q ss_pred eCC-EEEEEEeccCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhcc
Q 011868 85 SKS-KIYMVLEYVTGGELFDKIASKGR----------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSC 147 (476)
Q Consensus 85 ~~~-~~~lV~E~~~gg~L~~~l~~~~~----------------l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~ 147 (476)
..+ .+|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp----- 176 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA----- 176 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG-----
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc-----
Confidence 654 59999999999999999987543 89999999999999999999999999999997
Q ss_pred chhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC
Q 011868 148 HMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 227 (476)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 227 (476)
+||+++.++.+||+|||++................||+.|+|||++.+..
T Consensus 177 ------------------------------~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 226 (316)
T 2xir_A 177 ------------------------------RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 226 (316)
T ss_dssp ------------------------------GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred ------------------------------ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc
Confidence 99999999999999999998654322222334567899999999998877
Q ss_pred CCCccchhhhHhHHHHHHhc-CCCCCCCCcHH-HHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 228 YDGATSDIWSCGVILYVILT-GYLPFDDRNLA-VLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 228 ~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
++ .++|||||||++|+|++ |..||.+.+.. .....+..+ ....|..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 227 ~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 227 YT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 75 89999999999999998 99999886643 334444443 355678899999999999999999999999999887
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=373.09 Aligned_cols=260 Identities=23% Similarity=0.356 Sum_probs=195.4
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeC
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~ 86 (476)
......++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+. +++.++||||+++++++...
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 34567789999999999999999999999999999999997653 2233455556665 77888999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeccCCcchhccchhhhHHHHHHHH
Q 011868 87 SKIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~yLH~~-givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
+..|+||||+.+ +|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp------------------ 154 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKP------------------ 154 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCG------------------
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCH------------------
Confidence 999999999965 88887763 56799999999999999999999999 999999997
Q ss_pred HHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccc----cCCCCCccchhh
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIW 236 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~----~~~~~~~~sDvw 236 (476)
+||+++.++.+||+|||++..... ........||+.|+|||++. +..+ +.++|||
T Consensus 155 -----------------~NIll~~~~~~kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~ 213 (327)
T 3aln_A 155 -----------------SNILLDRSGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVW 213 (327)
T ss_dssp -----------------GGEEEETTTEEEECCCSSSCC---------------------------------C-CSHHHHH
T ss_pred -----------------HHEEEcCCCCEEEccCCCceeccc---ccccccCCCCccccCceeeccccCcCCC-CchhhHH
Confidence 999999999999999999985432 22233457999999999983 4445 4899999
Q ss_pred hHhHHHHHHhcCCCCCCCCcHH-HHHHHHHhCCCC-CC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 237 SCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFK-LP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 237 SlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~-~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
||||++|+|++|+.||.+.+.. .....+..+..+ ++ ..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus 214 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 214 SLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp HHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 9999999999999999875432 222223332221 22 3588999999999999999999999999999999754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=373.82 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=217.4
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCc-----eEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL-----PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~ 84 (476)
...++|++.+.||+|+||+||+|.+..+++ .||+|++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 445789999999999999999999977664 79999997654 334467899999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchh
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASK--------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMR 150 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~--------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~ 150 (476)
..+..|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp-------- 192 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAA-------- 192 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG--------
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCccc--------
Confidence 999999999999999999998642 3589999999999999999999999999999997
Q ss_pred hhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCC
Q 011868 151 IATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 230 (476)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 230 (476)
+|||++.++.+||+|||++................||+.|+|||++.+..++
T Consensus 193 ---------------------------~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~- 244 (333)
T 2i1m_A 193 ---------------------------RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT- 244 (333)
T ss_dssp ---------------------------GGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-
T ss_pred ---------------------------ceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-
Confidence 9999999999999999999854332222223455678899999999887775
Q ss_pred ccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 231 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 231 ~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
.++|||||||++|+|++ |..||.+.........+... ....|...++.+.+||.+||+.||.+|||+.+++++
T Consensus 245 ~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 245 VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 89999999999999998 99999887654444444333 334567789999999999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=360.83 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=212.5
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhH----HHHHHHHHHHHHhCCCCCcceEEEEE
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI----TDQIKREIATLKLLKHPNVVRLHEVL 83 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~----~~~~~~Ei~~l~~l~HpnIv~l~~~~ 83 (476)
...+..++|++.+.||+|+||+||+|++..+++.||+|++.......... ...+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 34566789999999999999999999999999999999997654332221 16789999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcC--cEeccCCcchhccchhhhHHHHHHHH
Q 011868 84 ASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~g--ivHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
.+.. ++||||+++|+|.+.+... .++++..++.++.|++.||+|||++| |+||||||
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp------------------ 152 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRS------------------ 152 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSG------------------
T ss_pred cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCc------------------
Confidence 7665 7999999999999988654 47999999999999999999999999 99999997
Q ss_pred HHHhhhccccccccCCCCceEeCCCCC-----EEEeccCCCCCCCcccCCCcccccccCCcccccccccc--CCCCCccc
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSKGN-----IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATS 233 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~g~-----vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~s 233 (476)
+||+++.++. +||+|||+++... .......||+.|+|||++.. ..+ +.++
T Consensus 153 -----------------~Nil~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~-~~~~ 209 (287)
T 4f0f_A 153 -----------------PNIFLQSLDENAPVCAKVADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESY-TEKA 209 (287)
T ss_dssp -----------------GGEEESCCCTTCSCCEEECCCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEE-CHHH
T ss_pred -----------------ceEEEeccCCCCceeEEeCCCCcccccc-----ccccccCCCccccCchhhccCCCCc-Cchh
Confidence 9999998876 9999999997432 23455689999999999843 334 5889
Q ss_pred hhhhHhHHHHHHhcCCCCCCCCcHH--HHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 234 DIWSCGVILYVILTGYLPFDDRNLA--VLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 234 DvwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
||||+||++|+|++|+.||.+.+.. .....+... ....|..+++.+.+||.+||+.||.+|||++++++
T Consensus 210 Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 210 DTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999876533 223444433 34567789999999999999999999999999976
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=374.80 Aligned_cols=262 Identities=22% Similarity=0.301 Sum_probs=219.3
Q ss_pred CCccCcCEEEeceEeecCceEEEEEE-----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 83 (476)
..+..++|++++.||+|+||+||+|+ +..+++.||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS 102 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 34567899999999999999999999 55688899999996543 334456889999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHH
Q 011868 84 ASKSKIYMVLEYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQV 156 (476)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~ 156 (476)
......|+||||++|++|.+++... ..+++.+++.++.||+.||.|||++||+||||||
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp-------------- 168 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA-------------- 168 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG--------------
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCH--------------
Confidence 9999999999999999999999865 3489999999999999999999999999999997
Q ss_pred HHHHHHHhhhccccccccCCCCceEeCCC---CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccc
Q 011868 157 FLLTFLLMIVIRPWKFNVLQLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 233 (476)
Q Consensus 157 ~~~~~~~~~~~~p~~~~~~~~~NiLl~~~---g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~s 233 (476)
+|||++.+ +.+||+|||++................||+.|+|||++.+..++ .++
T Consensus 169 ---------------------~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~ 226 (327)
T 2yfx_A 169 ---------------------RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKT 226 (327)
T ss_dssp ---------------------GGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHH
T ss_pred ---------------------hHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chh
Confidence 99999954 46999999998633221112223455689999999999887775 899
Q ss_pred hhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 234 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 234 DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
|||||||++|+|++ |..||.+.+.......+..+. ...+..+++.+.+||.+||+.||.+|||+.+++++.|+..
T Consensus 227 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 227 DTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 99999999999998 999999988887777777654 4567779999999999999999999999999999988754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=364.88 Aligned_cols=253 Identities=27% Similarity=0.403 Sum_probs=222.2
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
.+..++|++.+.||+|+||+||+|.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 356678999999999999999999999999999999997543 2357889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 90 YMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
|+||||+.|++|.+++... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp------------------------- 139 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA------------------------- 139 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSG-------------------------
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCc-------------------------
Confidence 9999999999999999763 4599999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++.+||+|||++....... ........||+.|+|||++.+..++ .++|||||||++|+|++
T Consensus 140 ----------~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~ 207 (288)
T 3kfa_A 140 ----------RNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIAT 207 (288)
T ss_dssp ----------GGEEECGGGCEEECCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHT
T ss_pred ----------ceEEEcCCCCEEEccCccceeccCCc-cccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHh
Confidence 99999999999999999998654311 1223345678899999999888775 89999999999999999
Q ss_pred -CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 248 -GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 248 -G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|..||.+.+.......+... ....|..+++.+.+||.+||+.||.+|||++++++.
T Consensus 208 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 208 YGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp TSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence 99999988877776666655 455677899999999999999999999999999763
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=363.54 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=215.2
Q ss_pred cCcCEEEec-eEeecCceEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 12 RLGRYELGR-TLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 12 ~~~~Y~i~~-~LG~G~fg~V~~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
..++|++.+ .||+|+||+||+|.+ ..+++.||||++.... ......+.+.+|+.+++.++||||+++++++ ..+.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 346899998 999999999999954 5678899999997654 2334467899999999999999999999999 5677
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
.|+||||+++++|.+++...+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp-------------------------- 145 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAA-------------------------- 145 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG--------------------------
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCc--------------------------
Confidence 899999999999999999888899999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC-CcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++.+||+|||++......... .......||+.|+|||++.+..++ .++|||||||++|+|++
T Consensus 146 ---------~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~ 215 (291)
T 1xbb_A 146 ---------RNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFS 215 (291)
T ss_dssp ---------GGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHT
T ss_pred ---------ceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHh
Confidence 9999999999999999999754331111 112234567899999999877775 89999999999999999
Q ss_pred -CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 248 -GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 248 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|+.||.+.+.......+..+. ...|..+++.+.++|.+||+.||.+|||+.++++
T Consensus 216 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 216 YGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999988888777776654 4567889999999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=367.48 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=208.9
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
...++|++.+.||+|+||+||+|.+.. ++..||+|++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 445789999999999999999998765 556899999976543 3344678999999999999999999999997654
Q ss_pred -----EEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHH
Q 011868 88 -----KIYMVLEYVTGGELFDKIAS------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQV 156 (476)
Q Consensus 88 -----~~~lV~E~~~gg~L~~~l~~------~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~ 156 (476)
..|+||||+++|+|.+++.. ...+++.+++.++.||+.||.|||++||+||||||
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp-------------- 175 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAA-------------- 175 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSG--------------
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCc--------------
Confidence 35999999999999999842 35699999999999999999999999999999997
Q ss_pred HHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhh
Q 011868 157 FLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 236 (476)
Q Consensus 157 ~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvw 236 (476)
+||+++.++.+||+|||++................+++.|+|||++.+..++ .++|||
T Consensus 176 ---------------------~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~ 233 (313)
T 3brb_A 176 ---------------------RNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVW 233 (313)
T ss_dssp ---------------------GGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCC-HHHHHH
T ss_pred ---------------------ceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhH
Confidence 9999999999999999999864332212223345678899999999887775 899999
Q ss_pred hHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 237 SCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 237 SlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
||||++|+|++ |..||.+.+.......+..+ ....|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 234 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 234 AFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999 99999988877777777665 355677899999999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=361.95 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=219.5
Q ss_pred ccCcCEEEec-eEeecCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 11 MRLGRYELGR-TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 11 ~~~~~Y~i~~-~LG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
...++|.+.+ .||+|+||+||+|.+. .++..||||++.... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 4457888887 9999999999999864 468889999997653 344567899999999999999999999999 456
Q ss_pred EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
..|+||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp------------------------ 138 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAA------------------------ 138 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG------------------------
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCch------------------------
Confidence 799999999999999999653 5699999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||+++.++.+||+|||++........ ........||+.|+|||++.+..++ .++|||||||++|+|
T Consensus 139 -----------~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el 206 (287)
T 1u59_A 139 -----------RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEA 206 (287)
T ss_dssp -----------GGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHH
T ss_pred -----------heEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHH
Confidence 999999999999999999985432111 1122334578999999999877775 899999999999999
Q ss_pred hc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcc
Q 011868 246 LT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 305 (476)
Q Consensus 246 lt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~ 305 (476)
++ |+.||.+.+.......+..+. ...|..+++++.+||.+||+.||.+|||+.+++++.|
T Consensus 207 lt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 207 LSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 98 999999988877777777654 5577889999999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=371.41 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=203.4
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--- 87 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--- 87 (476)
+..++|++.+.||+|+||+||+|++. ++.||||++.... .......+|+.+++.++||||+++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 55679999999999999999999874 7999999996543 22456677999999999999999999997643
Q ss_pred -EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc----------CcEeccCCcchhccchhhhHHHH
Q 011868 88 -KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK----------GVFHRDLKVILKSCHMRIATLQV 156 (476)
Q Consensus 88 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~----------givHrDiKp~~~~~~~~~~~~~~ 156 (476)
.+|+||||+++|+|.+++.. .++++..++.++.||+.||+|||+. ||+||||||
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp-------------- 159 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS-------------- 159 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSG--------------
T ss_pred ceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCCh--------------
Confidence 57999999999999999976 5699999999999999999999999 999999997
Q ss_pred HHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC----CCCcc
Q 011868 157 FLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----YDGAT 232 (476)
Q Consensus 157 ~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~~~ 232 (476)
+|||++.++.+||+|||+++..............+||+.|+|||++.+.. ..+.+
T Consensus 160 ---------------------~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 218 (322)
T 3soc_A 160 ---------------------KNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR 218 (322)
T ss_dssp ---------------------GGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHH
T ss_pred ---------------------HhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCcc
Confidence 99999999999999999997544332333345568999999999987632 22367
Q ss_pred chhhhHhHHHHHHhcCCCCCCCCc----------------HHHHHHHHHhCCCC--CCCC-----CCHHHHHHHHHccCC
Q 011868 233 SDIWSCGVILYVILTGYLPFDDRN----------------LAVLYQKIFRGDFK--LPKW-----LSPGAQNLLRKILEP 289 (476)
Q Consensus 233 sDvwSlGvil~elltG~~Pf~~~~----------------~~~~~~~i~~~~~~--~p~~-----~s~~~~~Li~~~L~~ 289 (476)
+|||||||++|+|++|+.||.+.. .......+...... ++.. .++++.+||.+||+.
T Consensus 219 ~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (322)
T 3soc_A 219 IDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298 (322)
T ss_dssp HHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCS
T ss_pred chhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccC
Confidence 899999999999999999997642 22222223222211 1211 234599999999999
Q ss_pred CcCCCCChHHHhcC
Q 011868 290 NPVKRITIAGIKAD 303 (476)
Q Consensus 290 dP~~R~s~~~il~~ 303 (476)
||++|||+.++++.
T Consensus 299 dP~~Rps~~ell~~ 312 (322)
T 3soc_A 299 DAEARLSAGCVGER 312 (322)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999763
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=380.04 Aligned_cols=256 Identities=21% Similarity=0.361 Sum_probs=209.3
Q ss_pred CccCcCEEEeceEeecCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
.+..++|++.+.||+|+||+||+|++. .++..||||+++... .......+.+|+.++++++||||+++++++...
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 345668999999999999999999976 467789999997653 344567899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
+..|+||||++||+|.+++... ..+++.++..++.||+.||+|||++||+||||||
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp----------------------- 175 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAA----------------------- 175 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG-----------------------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCc-----------------------
Confidence 9999999999999999999764 3799999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC-CcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+|||++.++.+||+|||+++........ .......+|+.|+|||++.+..++ .++|||||||++|+
T Consensus 176 ------------~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~e 242 (373)
T 2qol_A 176 ------------RNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWE 242 (373)
T ss_dssp ------------GGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHH
T ss_pred ------------ceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHH
Confidence 9999999999999999999865432111 111223457889999999888775 89999999999999
Q ss_pred Hhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 245 ILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 245 llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|++ |+.||.+.+.......+..+ ..+.|..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 243 llt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 243 VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp HHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHH
Confidence 998 99999998888777777665 345566789999999999999999999999998763
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=357.89 Aligned_cols=251 Identities=23% Similarity=0.400 Sum_probs=219.1
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
+..++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++...+..|
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 34578999999999999999999985 6788999999765421 367899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p--------------------------- 132 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAA--------------------------- 132 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCG---------------------------
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCch---------------------------
Confidence 999999999999999764 5699999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
+||+++.++.+||+|||++....... ........||+.|+|||++.+..++ .++||||+||++|+|++ |
T Consensus 133 --------~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g 202 (267)
T 3t9t_A 133 --------RNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEG 202 (267)
T ss_dssp --------GGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTS
T ss_pred --------heEEECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccC
Confidence 99999999999999999997532211 1122344678899999999877775 89999999999999999 9
Q ss_pred CCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 249 YLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+.||.+.+.......+..+. ...|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 203 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 203 KIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp CCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999988888888777663 44567789999999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=384.19 Aligned_cols=244 Identities=26% Similarity=0.483 Sum_probs=213.3
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-KI 89 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-~~ 89 (476)
+..++|++.+.||+|+||+||+|.+ +|+.||||+++... ..+.+.+|+.+|++++||||+++++++.... .+
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 4567899999999999999999987 47899999997543 2467899999999999999999999987655 79
Q ss_pred EEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 90 YMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
|+||||+++|+|.+++...+. +++..+..++.||+.||+|||++||+||||||
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp------------------------- 317 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA------------------------- 317 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG-------------------------
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCH-------------------------
Confidence 999999999999999987543 79999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.++.+||+|||+++.... ......+|+.|+|||++.+..++ .++|||||||++|+|++
T Consensus 318 ----------~Nill~~~~~~kl~DfG~a~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t 381 (450)
T 1k9a_A 318 ----------RNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYS 381 (450)
T ss_dssp ----------GGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHT
T ss_pred ----------hhEEECCCCCEEEeeCCCcccccc-----cccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHh
Confidence 999999999999999999974322 12234678999999999888775 89999999999999998
Q ss_pred -CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 248 -GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 248 -G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|..||.+.+.......+..+ ..+.|..+++.+.+||.+||+.||.+|||+.+++.
T Consensus 382 ~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 382 FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp TTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999988877777777665 45678889999999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=363.57 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=210.4
Q ss_pred CccCcCEEEeceEeecCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 85 (476)
.....+|++++.||+|+||+||+|+ +..+++.||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 3445679999999999999999999 56789999999997654 23335789999999999999999999999987
Q ss_pred C--CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHH
Q 011868 86 K--SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFL 162 (476)
Q Consensus 86 ~--~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~ 162 (476)
. ..+|+||||+++|+|.+++.. ...+++.+++.++.||+.||+|||++||+||||||
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp-------------------- 154 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAA-------------------- 154 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG--------------------
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCch--------------------
Confidence 6 678999999999999999954 46799999999999999999999999999999997
Q ss_pred HhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 163 LMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 163 ~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+||+++.++.+||+|||++........ ........||+.|+|||++.+..++ .++||||+||+
T Consensus 155 ---------------~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~i 218 (302)
T 4e5w_A 155 ---------------RNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVT 218 (302)
T ss_dssp ---------------GGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHH
T ss_pred ---------------heEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHH
Confidence 999999999999999999985443211 1223456788999999999888775 89999999999
Q ss_pred HHHHhcCCCCCCCCc--------------H-HHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 242 LYVILTGYLPFDDRN--------------L-AVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 242 l~elltG~~Pf~~~~--------------~-~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+|+|++|..|+.... . ......+..+ ..+.|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 219 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 219 LHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 999999999864321 1 1222223222 34567789999999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=366.66 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=213.9
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 85 (476)
....++|++.+.||+|+||+||+|.+..++ ..||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 345578999999999999999999976553 459999997653 33445679999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 86 KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
.+..|+||||+++|+|.+++... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp---------------------- 175 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA---------------------- 175 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG----------------------
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh----------------------
Confidence 99999999999999999999764 5799999999999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC-CcccccccCCccccccccccCCCCCccchhhhHhHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ 243 (476)
+||+++.++.+||+|||++......... .......+|+.|+|||++.+..++ .++|||||||++|
T Consensus 176 -------------~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ 241 (333)
T 1mqb_A 176 -------------RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMW 241 (333)
T ss_dssp -------------GGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHH
T ss_pred -------------heEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHH
Confidence 9999999999999999999865432111 112233467899999999887775 8999999999999
Q ss_pred HHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 244 VILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 244 ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+|++ |..||.+.+.......+..+ ..+.|..+++.+.+||.+||+.||.+||++.+++++
T Consensus 242 ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 242 EVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999 99999988888877777765 455677789999999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=359.77 Aligned_cols=257 Identities=25% Similarity=0.350 Sum_probs=216.2
Q ss_pred ccCCccCcCEEEeceEeecCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 011868 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (476)
Q Consensus 7 ~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 83 (476)
+.-++..++|++.+.||+|+||+||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 82 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGII 82 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 3456778899999999999999999998654 34569999997653 334467899999999999999999999998
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHH
Q 011868 84 ASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFL 162 (476)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~ 162 (476)
..+ ..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 83 ~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp-------------------- 141 (281)
T 3cc6_A 83 EEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAV-------------------- 141 (281)
T ss_dssp CSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG--------------------
T ss_pred cCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCcc--------------------
Confidence 654 568999999999999999764 4699999999999999999999999999999997
Q ss_pred HhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHH
Q 011868 163 LMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242 (476)
Q Consensus 163 ~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil 242 (476)
+||+++.++.+||+|||++....... ........||+.|+|||++.+..++ .++|||||||++
T Consensus 142 ---------------~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il 204 (281)
T 3cc6_A 142 ---------------RNILVASPECVKLGDFGLSRYIEDED-YYKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCM 204 (281)
T ss_dssp ---------------GGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHH
T ss_pred ---------------ceEEECCCCcEEeCccCCCccccccc-ccccccCCCCcceeCchhhccCCCC-chhccHHHHHHH
Confidence 99999999999999999998643311 1123345678899999999877775 899999999999
Q ss_pred HHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 243 YVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 243 ~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|+|++ |+.||...+.......+..+ ..+.|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 205 ~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 205 WEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 99998 99999877766666665554 455677799999999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=361.25 Aligned_cols=255 Identities=24% Similarity=0.431 Sum_probs=200.2
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
...+.-++|++.+.||+|+||+||+|++. ..||+|++..... .......+.+|+.+++.++||||++++++. ...
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 33556679999999999999999999853 3599999976542 444567899999999999999999999965 556
Q ss_pred EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
..++||||+.|++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp------------------------ 148 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKS------------------------ 148 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG------------------------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCcc------------------------
Confidence 78999999999999999954 45799999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccc---cCCCCCccchhhhHhHHHH
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILY 243 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~sDvwSlGvil~ 243 (476)
+||+++.++.+||+|||++................||+.|+|||++. +..+ +.++|||||||++|
T Consensus 149 -----------~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~ 216 (289)
T 3og7_A 149 -----------NNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLY 216 (289)
T ss_dssp -----------GGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHH
T ss_pred -----------ceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHH
Confidence 99999999999999999998654333333445668999999999986 3444 47899999999999
Q ss_pred HHhcCCCCCCCCcHH-HHHHHHHhCCCC-----CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 244 VILTGYLPFDDRNLA-VLYQKIFRGDFK-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 244 elltG~~Pf~~~~~~-~~~~~i~~~~~~-----~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+|++|+.||.+.+.. .....+..+... .+..+++.+.+||.+||+.||.+|||++++++.
T Consensus 217 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 217 ELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp HHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 999999999886544 444444444332 234578999999999999999999999999763
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=357.83 Aligned_cols=247 Identities=25% Similarity=0.419 Sum_probs=212.8
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-------
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------- 85 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------- 85 (476)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 368999999999999999999999899999999997653 346789999999999999999998854
Q ss_pred ---------CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHH
Q 011868 86 ---------KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATL 154 (476)
Q Consensus 86 ---------~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~ 154 (476)
...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp------------ 150 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKP------------ 150 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG------------
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCH------------
Confidence 45689999999999999999753 5799999999999999999999999999999997
Q ss_pred HHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccch
Q 011868 155 QVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 234 (476)
Q Consensus 155 ~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sD 234 (476)
+||+++.++.+||+|||++..... ........||+.|+|||++.+..++ .++|
T Consensus 151 -----------------------~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~D 203 (284)
T 2a19_B 151 -----------------------SNIFLVDTKQVKIGDFGLVTSLKN---DGKRTRSKGTLRYMSPEQISSQDYG-KEVD 203 (284)
T ss_dssp -----------------------GGEEEEETTEEEECCCTTCEESSC---CSCCCCCCSCCTTSCHHHHHCSCCC-THHH
T ss_pred -----------------------HHEEEcCCCCEEECcchhheeccc---cccccccCCcccccChhhhccCCCc-chhh
Confidence 999999999999999999875432 2234456799999999999887775 8999
Q ss_pred hhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 235 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 235 vwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
||||||++|+|++|..||... ......+..+ .++..+++.+.+||.+||+.||.+|||+.+++++.|.-..
T Consensus 204 i~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 204 LYALGLILAELLHVCDTAFET--SKFFTDLRDG--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred hHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 999999999999999997532 2333334333 3567789999999999999999999999999999887543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=357.19 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=213.8
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE-
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI- 89 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~- 89 (476)
-.|++.+.||+|+||+||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 367888999999999999999765554 79999986543 444567899999999999999999999999766554
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||+.+|+|.+++.. ...+++.+++.++.|++.||+|||++||+||||||
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp-------------------------- 152 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAA-------------------------- 152 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG--------------------------
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCc--------------------------
Confidence 999999999999999976 45799999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCccc--CCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+||+++.++.+||+|||++....... .........||+.|+|||++.+..++ .++||||+||++|+|+
T Consensus 153 ---------~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~ 222 (298)
T 3pls_A 153 ---------RNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELL 222 (298)
T ss_dssp ---------GGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHH
T ss_pred ---------ceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHh
Confidence 99999999999999999998543321 12233456789999999999887775 8999999999999999
Q ss_pred c-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 247 T-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 247 t-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+ |.+||.+.+.......+..+. .+.|..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 223 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 223 TRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9 666677777666666666554 45677799999999999999999999999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=358.59 Aligned_cols=256 Identities=25% Similarity=0.339 Sum_probs=213.7
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE-Ee
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-AS 85 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-~~ 85 (476)
+....+|++.+.||+|+||+||+|.+..+ +..||+|.+.... .......+.+|+.++++++||||+++++++ ..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 34456899999999999999999997543 3468999987543 444567899999999999999999999985 55
Q ss_pred CCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 86 KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
++..|+||||+.+|+|.+++.. ...+++.+++.++.||+.||+|||++||+||||||
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp---------------------- 156 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAA---------------------- 156 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG----------------------
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCch----------------------
Confidence 6788999999999999999975 35689999999999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCccc--CCCcccccccCCccccccccccCCCCCccchhhhHhHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil 242 (476)
+||+++.++.+||+|||++....... .........||+.|+|||++.+..++ .++||||+||++
T Consensus 157 -------------~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il 222 (298)
T 3f66_A 157 -------------RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLL 222 (298)
T ss_dssp -------------GGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHH
T ss_pred -------------heEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHH
Confidence 99999999999999999998654322 11223445688999999999887775 899999999999
Q ss_pred HHHhc-CCCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 243 YVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 243 ~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|+|++ |.+||.+.+.......+..+.. ..|..+++.+.++|.+||+.||.+|||+.++++.
T Consensus 223 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 223 WELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999 7888888777666666666554 4567789999999999999999999999998763
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=382.66 Aligned_cols=248 Identities=25% Similarity=0.423 Sum_probs=214.8
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||+||+|.+. ++..||||+++.... ..+.+.+|+.+|+.++||||+++++++. ....|+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3468999999999999999999984 577899999976532 2578999999999999999999999986 567899
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp--------------------------- 312 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA--------------------------- 312 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSG---------------------------
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCH---------------------------
Confidence 99999999999999753 3689999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
+|||++.++.+||+|||+++...... ........+|+.|+|||++....++ .++|||||||++|+|++ |
T Consensus 313 --------~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g 382 (454)
T 1qcf_A 313 --------ANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYG 382 (454)
T ss_dssp --------GGEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTS
T ss_pred --------HHEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCC
Confidence 99999999999999999998543211 0112234567899999999877775 89999999999999999 9
Q ss_pred CCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 249 YLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+.||.+.+.......+..+ ..+.|..+++++.+||.+||+.||.+|||+++|+.
T Consensus 383 ~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 383 RIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp CCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 9999998888877777665 45667889999999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=357.96 Aligned_cols=250 Identities=22% Similarity=0.254 Sum_probs=207.6
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEE-EEeCCEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV-LASKSKIY 90 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~-~~~~~~~~ 90 (476)
..++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.++|++++..+.. .......|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 45789999999999999999999999999999999876542 2458899999999998876655554 46778899
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+||||+ +++|.+++.. ..++++.+++.++.||+.||+|||++||+||||||
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp--------------------------- 133 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKP--------------------------- 133 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG---------------------------
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH---------------------------
Confidence 999999 9999999974 45799999999999999999999999999999997
Q ss_pred cccccCCCCceEe---CCCCCEEEeccCCCCCCCcccCC-----CcccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 170 WKFNVLQLENILL---DSKGNIKISDFGLSALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 170 ~~~~~~~~~NiLl---~~~g~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+|||+ +.++.+||+|||++......... ......+||+.|+|||++.+..++ .++|||||||+
T Consensus 134 --------~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~i 204 (296)
T 3uzp_A 134 --------DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYV 204 (296)
T ss_dssp --------GGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHH
T ss_pred --------HHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCC-cchhhHHHHHH
Confidence 99999 48899999999999854432111 123456899999999999887775 89999999999
Q ss_pred HHHHhcCCCCCCCCc---HHHHHHHHHhCCCCC-----CCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 242 LYVILTGYLPFDDRN---LAVLYQKIFRGDFKL-----PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 242 l~elltG~~Pf~~~~---~~~~~~~i~~~~~~~-----p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+|+|++|+.||.+.+ ....+..+....... +..+++++.+||.+||+.||.+|||++++++.
T Consensus 205 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 205 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred HHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 999999999998743 223333333333222 36789999999999999999999999998763
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=356.99 Aligned_cols=245 Identities=25% Similarity=0.468 Sum_probs=207.5
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-CE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-SK 88 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-~~ 88 (476)
....++|++.+.||+|+||+||+|.+ +|+.||||++.... ..+.+.+|+.+++.++||||+++++++... +.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 45678999999999999999999987 48899999997543 256789999999999999999999987544 57
Q ss_pred EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 89 IYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
.|+||||+++++|.+++...+ .+++..++.++.|++.||+|||++||+||||||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp------------------------ 145 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA------------------------ 145 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG------------------------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCc------------------------
Confidence 899999999999999997654 389999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+||+++.++.+||+|||++..... ......+++.|+|||++.+..++ .++|||||||++|+|+
T Consensus 146 -----------~Nil~~~~~~~~l~Dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~ 208 (278)
T 1byg_A 146 -----------RNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIY 208 (278)
T ss_dssp -----------GGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHH
T ss_pred -----------ceEEEeCCCcEEEeeccccccccc-----cccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHH
Confidence 999999999999999999874332 22344688999999999887775 8999999999999999
Q ss_pred c-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 247 T-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 247 t-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+ |..||...+.......+..+ ....|..+++.+.++|.+||+.||.+|||+.++++
T Consensus 209 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 209 SFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 8 99999988877777766655 35567789999999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=388.76 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=219.0
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
...+|++.+.||+|+||+||+|.+..++..||||++..... ..+.+.+|+.+|++++||||+++++++.....+|+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 34579999999999999999999988899999999976532 25779999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp--------------------------- 346 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAA--------------------------- 346 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG---------------------------
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh---------------------------
Confidence 99999999999999763 4599999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
+|||++.++.+||+|||+++...... ........+|+.|+|||++.+..++ .++|||||||++|+|++ |
T Consensus 347 --------~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g 416 (495)
T 1opk_A 347 --------RNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYG 416 (495)
T ss_dssp --------GGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTS
T ss_pred --------hhEEECCCCcEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCC
Confidence 99999999999999999998643211 1112234567899999999887775 89999999999999999 9
Q ss_pred CCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 249 YLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
..||.+.+.......+..+ ..+.|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 417 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 417 MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 9999998877777666554 35567889999999999999999999999999976
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=365.39 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=215.7
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 83 (476)
..-+..++|++.+.||+|+||+||+|+ +..+++.||||++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 344556799999999999999999999 56789999999997653 34467799999999999999999999988
Q ss_pred E--eCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 84 A--SKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 84 ~--~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
. .....|+||||++|++|.+++.. ..++++.+++.++.||+.||+|||++||+||||||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp------------------ 155 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAA------------------ 155 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG------------------
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCh------------------
Confidence 6 55679999999999999999976 45699999999999999999999999999999997
Q ss_pred HHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhhHh
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlG 239 (476)
+||+++.++.+||+|||++........ ........||+.|+|||++.+..++ .++||||||
T Consensus 156 -----------------~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG 217 (327)
T 3lxl_A 156 -----------------RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS-RQSDVWSFG 217 (327)
T ss_dssp -----------------GGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEE-HHHHHHHHH
T ss_pred -----------------hhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCC-hHHhHHHHH
Confidence 999999999999999999985433211 1123345688899999999887774 899999999
Q ss_pred HHHHHHhcCCCCCCCCcHH---------------HHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 240 VILYVILTGYLPFDDRNLA---------------VLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 240 vil~elltG~~Pf~~~~~~---------------~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|++|+|++|..||...... .....+..+ ..+.|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 218 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 218 VVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999664432 222222222 345677899999999999999999999999999765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=353.28 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=213.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++++.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.. +..|+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 4478999999999999999999974 677899999976532 24678999999999999999999999864 46899
Q ss_pred EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 92 VLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
||||++|++|.+++.... .+++.+++.++.|++.||+|||++||+||||||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp--------------------------- 137 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRA--------------------------- 137 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG---------------------------
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH---------------------------
Confidence 999999999999986533 699999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
+||+++.++.+||+|||++....... ........+|+.|+|||++.+..++ .++|||||||++|+|++ |
T Consensus 138 --------~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g 207 (279)
T 1qpc_A 138 --------ANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHG 207 (279)
T ss_dssp --------GGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTT
T ss_pred --------hhEEEcCCCCEEECCCcccccccCcc-cccccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCC
Confidence 99999999999999999998543211 1122334578899999999877775 89999999999999999 9
Q ss_pred CCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 249 YLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+.||.+.+.......+..+ ....|..+++.+.+||.+||+.||.+|||++++++
T Consensus 208 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 208 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999998888777777665 34566778999999999999999999999999876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=380.55 Aligned_cols=252 Identities=27% Similarity=0.444 Sum_probs=208.9
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--E
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--K 88 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--~ 88 (476)
..-++|++.+.||+|+||+||+|++..+|+.||||++..... ....+.+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 456789999999999999999999999999999999976542 223577889999999999999999999998655 7
Q ss_pred EEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 89 IYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
.|+||||++||+|.+++.... .+++.+++.++.||+.||+|||++||+||||||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp----------------------- 140 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP----------------------- 140 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG-----------------------
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCH-----------------------
Confidence 899999999999999997543 399999999999999999999999999999997
Q ss_pred hccccccccCCCCceEe----CCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc--------CCCCCccc
Q 011868 166 VIRPWKFNVLQLENILL----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--------RGYDGATS 233 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl----~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~~s 233 (476)
+|||+ +.++.+||+|||+++.... .......+||+.|+|||++.+ ..+ +.++
T Consensus 141 ------------~NIll~~~~~~~~~~kL~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~ 204 (396)
T 4eut_A 141 ------------GNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATV 204 (396)
T ss_dssp ------------GGEEEEECTTSCEEEEECCGGGCEECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHH
T ss_pred ------------HHEEEeecCCCceeEEEecCCCceEccC---CCccccccCCccccCHHHhhccccccccccCC-CcHH
Confidence 99999 7788899999999985432 223445689999999999865 334 4789
Q ss_pred hhhhHhHHHHHHhcCCCCCCCC----cHHHHHHHHHhCCCC-------------------CC------CCCCHHHHHHHH
Q 011868 234 DIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFK-------------------LP------KWLSPGAQNLLR 284 (476)
Q Consensus 234 DvwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~-------------------~p------~~~s~~~~~Li~ 284 (476)
|||||||++|+|++|+.||... .......++..+.++ +| ..+++.+.++|+
T Consensus 205 DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~ 284 (396)
T 4eut_A 205 DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284 (396)
T ss_dssp HHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHH
Confidence 9999999999999999999642 233445555544321 11 113457889999
Q ss_pred HccCCCcCCCCChHHHhcC
Q 011868 285 KILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 285 ~~L~~dP~~R~s~~~il~~ 303 (476)
+||+.||++|||+++++++
T Consensus 285 ~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 285 NILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHSCCCTTTSCCHHHHHHH
T ss_pred HhhccChhhhccHHHHHHH
Confidence 9999999999999998654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=362.75 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=206.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE----eCC
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA----SKS 87 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~----~~~ 87 (476)
..++|++.+.||+|+||.||+|.+..+|+.||||++... .......+.+|+.+++.++||||+++++++. ...
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 346899999999999999999999999999999998664 2344678999999999999999999999986 334
Q ss_pred EEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHH
Q 011868 88 KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLL 163 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~ 163 (476)
..|+||||+.+|+|.+++.. ...+++.+++.++.||+.||+|||++||+||||||
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp--------------------- 162 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKP--------------------- 162 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG---------------------
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH---------------------
Confidence 78999999999999999875 46799999999999999999999999999999997
Q ss_pred hhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCC-------cccccccCCccccccccccCCC--CCccch
Q 011868 164 MIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDG-------LLHTTCGSPNYVAPEVLANRGY--DGATSD 234 (476)
Q Consensus 164 ~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~--~~~~sD 234 (476)
+||+++.++.+||+|||++.......... ......||+.|+|||++.+... .+.++|
T Consensus 163 --------------~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D 228 (317)
T 2buj_A 163 --------------TNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTD 228 (317)
T ss_dssp --------------GGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHH
T ss_pred --------------HHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhh
Confidence 99999999999999999987432211110 1123467999999999876542 247999
Q ss_pred hhhHhHHHHHHhcCCCCCCCCcHH--HHHHHHHh-CCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCc
Q 011868 235 IWSCGVILYVILTGYLPFDDRNLA--VLYQKIFR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304 (476)
Q Consensus 235 vwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~ 304 (476)
||||||++|+|++|+.||...... .....+.. ...+.+..+++.+.+||.+||+.||.+|||+++++++-
T Consensus 229 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 229 VWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 999999999999999999642111 11111211 22334456899999999999999999999999999873
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=372.00 Aligned_cols=254 Identities=21% Similarity=0.307 Sum_probs=210.1
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||+||+|++ .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 457899999999999999999996 578999999987653 2336789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 92 VLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
||||++||+|.+++.... ++++.+++.++.||+.||+|||++||+||||||
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp------------------------- 167 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKS------------------------- 167 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCS-------------------------
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCH-------------------------
Confidence 999999999999986542 599999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+||+++.++.+||+|||++...............+||+.|+|||++.+..++ .++|||||||++|+|++
T Consensus 168 ----------~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~ 236 (321)
T 2qkw_B 168 ----------INILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLC 236 (321)
T ss_dssp ----------TTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHH
T ss_pred ----------HHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHh
Confidence 9999999999999999999754332233334456799999999999887775 89999999999999999
Q ss_pred CCCCCCCCcHHHH------H-HHHHhCCC------C----CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcc
Q 011868 248 GYLPFDDRNLAVL------Y-QKIFRGDF------K----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 305 (476)
Q Consensus 248 G~~Pf~~~~~~~~------~-~~i~~~~~------~----~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~ 305 (476)
|+.||.+...... . .....+.. . .+...++.+.+++.+||+.||.+|||+.+++++..
T Consensus 237 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 237 ARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp CCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 9999976442211 1 11111111 1 11223567899999999999999999999998743
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=369.35 Aligned_cols=256 Identities=18% Similarity=0.203 Sum_probs=203.1
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECC---CCceEEEEEeecccccchh--------HHHHHHHHHHHHHhCCCCCcceE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLK--------ITDQIKREIATLKLLKHPNVVRL 79 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~~~~~~--------~~~~~~~Ei~~l~~l~HpnIv~l 79 (476)
..-++|++++.||+|+||+||+|.+.. ++..||||++......... ....+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 344689999999999999999999987 8889999999765321111 11246688999999999999999
Q ss_pred EEEEEe----CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHH
Q 011868 80 HEVLAS----KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQ 155 (476)
Q Consensus 80 ~~~~~~----~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~ 155 (476)
++++.. ....|+||||+ |++|.+++...+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp------------- 179 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKA------------- 179 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG-------------
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCH-------------
Confidence 999987 78899999999 999999998777899999999999999999999999999999997
Q ss_pred HHHHHHHHhhhccccccccCCCCceEeCCCC--CEEEeccCCCCCCCcccC-----CCcccccccCCccccccccccCCC
Q 011868 156 VFLLTFLLMIVIRPWKFNVLQLENILLDSKG--NIKISDFGLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANRGY 228 (476)
Q Consensus 156 ~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g--~vkl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~ 228 (476)
+|||++.++ .+||+|||+++....... .......+||+.|+|||++.+..+
T Consensus 180 ----------------------~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 237 (345)
T 2v62_A 180 ----------------------ANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL 237 (345)
T ss_dssp ----------------------GGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC
T ss_pred ----------------------HHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC
Confidence 999999887 999999999975533211 112245689999999999988777
Q ss_pred CCccchhhhHhHHHHHHhcCCCCCCCC--cHHHHHHHHHhCCCCCC---------CCCCHHHHHHHHHccCCCcCCCCCh
Q 011868 229 DGATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKIFRGDFKLP---------KWLSPGAQNLLRKILEPNPVKRITI 297 (476)
Q Consensus 229 ~~~~sDvwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~p---------~~~s~~~~~Li~~~L~~dP~~R~s~ 297 (476)
+ .++|||||||++|+|++|+.||.+. +..............+| ..+++++.+||.+||+.||.+|||+
T Consensus 238 ~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 316 (345)
T 2v62_A 238 S-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNY 316 (345)
T ss_dssp C-HHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred C-chhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCH
Confidence 5 8999999999999999999999653 22222222111111222 2688999999999999999999999
Q ss_pred HHHhcC
Q 011868 298 AGIKAD 303 (476)
Q Consensus 298 ~~il~~ 303 (476)
+++++.
T Consensus 317 ~~l~~~ 322 (345)
T 2v62_A 317 QALKKI 322 (345)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999774
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=358.42 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=208.0
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECC-CCc--eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLD-SGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
...++|++.+.||+|+||+||+|++.. +++ .||||++...........+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 445689999999999999999998643 333 69999997665444455788999999999999999999999998765
Q ss_pred EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
.++||||+++++|.+++... +.+++.+++.++.||+.||.|||++||+||||||
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp------------------------ 149 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAA------------------------ 149 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG------------------------
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCch------------------------
Confidence 89999999999999999763 5799999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC-CcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+||+++.++.+||+|||++......... .......+|+.|+|||++.+..++ .++|||||||++|+|
T Consensus 150 -----------~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l 217 (291)
T 1u46_A 150 -----------RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEM 217 (291)
T ss_dssp -----------GGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHH
T ss_pred -----------heEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHH
Confidence 9999999999999999999754332111 122345678899999999887775 899999999999999
Q ss_pred hc-CCCCCCCCcHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 246 LT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 246 lt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
++ |+.||.+.+.......+.... .+.+..+++++.++|.+||+.||.+|||+.+++++
T Consensus 218 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 218 FTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99 999999998888888877654 34556789999999999999999999999999873
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=357.14 Aligned_cols=249 Identities=22% Similarity=0.276 Sum_probs=203.5
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEE-EEeCCEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV-LASKSKIY 90 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~-~~~~~~~~ 90 (476)
.-++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.++|++++..+.. +......|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 34689999999999999999999999999999998765432 2357889999999998776665554 47788899
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+||||+ +++|.+++.. ..++++.+++.++.||+.||.|||++||+||||||
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp--------------------------- 133 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKP--------------------------- 133 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG---------------------------
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH---------------------------
Confidence 999999 9999999974 46799999999999999999999999999999997
Q ss_pred cccccCCCCceEe---CCCCCEEEeccCCCCCCCcccCC-----CcccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 170 WKFNVLQLENILL---DSKGNIKISDFGLSALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 170 ~~~~~~~~~NiLl---~~~g~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+|||+ +.++.+||+|||++......... .......||+.|+|||++.+..++ .++||||+||+
T Consensus 134 --------~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~i 204 (296)
T 4hgt_A 134 --------DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYV 204 (296)
T ss_dssp --------GGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC-HHHHHHHHHHH
T ss_pred --------HHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCC-chhHHHHHHHH
Confidence 99999 78899999999999865432211 123456899999999999888775 89999999999
Q ss_pred HHHHhcCCCCCCCCcH---HHHHHHHHhCCCCCC-----CCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 242 LYVILTGYLPFDDRNL---AVLYQKIFRGDFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 242 l~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p-----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+|+|++|+.||.+.+. ...+.++.......| ..+++++.+||.+||+.||.+|||++++++
T Consensus 205 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 205 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 9999999999987432 223333333332222 568999999999999999999999999876
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=377.09 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=210.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||+||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||+++++++.. +..|+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 34679999999999999999999854 56799999976542 14678999999999999999999999876 67899
Q ss_pred EEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 92 VLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
||||+++|+|.+++.. ...+++.++..++.||+.||+|||++||+||||||
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp--------------------------- 308 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA--------------------------- 308 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG---------------------------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh---------------------------
Confidence 9999999999999964 35699999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
+|||++.++.+||+|||+++...... ........+|+.|+|||++.+..++ .++|||||||++|+|++ |
T Consensus 309 --------~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g 378 (452)
T 1fmk_A 309 --------ANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKG 378 (452)
T ss_dssp --------GGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTT
T ss_pred --------hhEEECCCCCEEECCCccceecCCCc-eecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCC
Confidence 99999999999999999998643211 1122334578899999999887775 89999999999999999 9
Q ss_pred CCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 249 YLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+.||.+.+.......+..+ ..+.|..+++.+.+||.+||+.||.+|||++++++
T Consensus 379 ~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 379 RVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp CCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999998888887777665 45667889999999999999999999999999876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=369.15 Aligned_cols=253 Identities=17% Similarity=0.208 Sum_probs=201.2
Q ss_pred CcCEEEeceEeecCceEEEEEEECCC-----CceEEEEEeecccccchhH--------HHHHHHHHHHHHhCCCCCcceE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKI--------TDQIKREIATLKLLKHPNVVRL 79 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~--------~~~~~~Ei~~l~~l~HpnIv~l 79 (476)
.++|++++.||+|+||+||+|.+..+ ++.||||++.......... ...+.+|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34899999999999999999998764 5889999987653111100 0124456677888899999999
Q ss_pred EEEEEeC----CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHH
Q 011868 80 HEVLASK----SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATL 154 (476)
Q Consensus 80 ~~~~~~~----~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~ 154 (476)
++++... ...|+||||+ |++|.+++... +++++.+++.++.||+.||+|||++||+||||||
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp------------ 180 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKA------------ 180 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG------------
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCH------------
Confidence 9998764 5689999999 99999999775 6799999999999999999999999999999997
Q ss_pred HHHHHHHHHhhhccccccccCCCCceEeC--CCCCEEEeccCCCCCCCcccC-----CCcccccccCCccccccccccCC
Q 011868 155 QVFLLTFLLMIVIRPWKFNVLQLENILLD--SKGNIKISDFGLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANRG 227 (476)
Q Consensus 155 ~~~~~~~~~~~~~~p~~~~~~~~~NiLl~--~~g~vkl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~ 227 (476)
+|||++ .++.+||+|||+++....... .......+||+.|+|||++.+..
T Consensus 181 -----------------------~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 237 (364)
T 3op5_A 181 -----------------------SNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA 237 (364)
T ss_dssp -----------------------GGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC
T ss_pred -----------------------HHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC
Confidence 999999 889999999999975543211 11224456999999999998887
Q ss_pred CCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHH----hCCC-------CCCCCCCHHHHHHHHHccCCCcCCCCC
Q 011868 228 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF----RGDF-------KLPKWLSPGAQNLLRKILEPNPVKRIT 296 (476)
Q Consensus 228 ~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~----~~~~-------~~p~~~s~~~~~Li~~~L~~dP~~R~s 296 (476)
++ .++|||||||++|+|++|+.||.+......+.... .... -.+..+++++.++|..||+.||.+||+
T Consensus 238 ~~-~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~ 316 (364)
T 3op5_A 238 PS-RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPL 316 (364)
T ss_dssp CC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCC
T ss_pred CC-chhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCC
Confidence 75 89999999999999999999998643221111111 0010 012567899999999999999999999
Q ss_pred hHHHhc
Q 011868 297 IAGIKA 302 (476)
Q Consensus 297 ~~~il~ 302 (476)
+++|++
T Consensus 317 ~~~l~~ 322 (364)
T 3op5_A 317 YENLRD 322 (364)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=361.35 Aligned_cols=251 Identities=31% Similarity=0.454 Sum_probs=190.2
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEE--------
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLA-------- 84 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~-------- 84 (476)
.+|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|+.+++++. ||||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 48999999999999999999999999999999986553 344577899999999996 999999999984
Q ss_pred eCCEEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeccCCcchhccchhhhHHHHHHH
Q 011868 85 SKSKIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~al~yLH~~g--ivHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
....+|+||||+. |+|.+++.. .+++++.+++.++.||+.||+|||++| |+||||||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp----------------- 166 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKV----------------- 166 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCG-----------------
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCc-----------------
Confidence 3456899999995 799998864 467999999999999999999999999 99999997
Q ss_pred HHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC----------CcccccccCCcccccccc---ccC
Q 011868 160 TFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD----------GLLHTTCGSPNYVAPEVL---ANR 226 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~----------~~~~~~~gt~~y~APE~l---~~~ 226 (476)
+|||++.++.+||+|||++......... ......+||+.|+|||++ .+.
T Consensus 167 ------------------~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 228 (337)
T 3ll6_A 167 ------------------ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF 228 (337)
T ss_dssp ------------------GGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTS
T ss_pred ------------------ccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccC
Confidence 9999999999999999999865432111 112255799999999998 344
Q ss_pred CCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 227 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 227 ~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
.+ +.++|||||||++|+|++|+.||.+.......... ...+.+...++.+.+||.+||+.||.+|||+.+++++-+-
T Consensus 229 ~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 229 PI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp CS-SHHHHHHHHHHHHHHHHHSSCCC--------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 44 48999999999999999999999876544332221 1233445678899999999999999999999999998553
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=370.64 Aligned_cols=245 Identities=15% Similarity=0.187 Sum_probs=202.5
Q ss_pred cCcCEEEeceEeecCceEEEEE-----EECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVL 83 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a-----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~ 83 (476)
.-++|++.+.||+|+||+||+| .+..+++.||||++.... ...+.+|+.+++.++ |+||+++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 3467999999999999999999 467789999999996543 456788888888887 99999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHH
Q 011868 84 ASKSKIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFL 158 (476)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~ 158 (476)
...+..|+||||++||+|.+++.. ...+++.+++.++.||+.||+|||++||+||||||
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp---------------- 200 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKP---------------- 200 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSG----------------
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCH----------------
Confidence 999999999999999999999973 45799999999999999999999999999999997
Q ss_pred HHHHHhhhccccccccCCCCceEeCC-----------CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC
Q 011868 159 LTFLLMIVIRPWKFNVLQLENILLDS-----------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 227 (476)
Q Consensus 159 ~~~~~~~~~~p~~~~~~~~~NiLl~~-----------~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 227 (476)
+|||++. ++.+||+|||+|+..............+||+.|+|||++.+..
T Consensus 201 -------------------~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 261 (365)
T 3e7e_A 201 -------------------DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP 261 (365)
T ss_dssp -------------------GGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC
T ss_pred -------------------HHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC
Confidence 9999998 8999999999997543333344556778999999999999888
Q ss_pred CCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC-CCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 228 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL-PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 228 ~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|+ .++|||||||++|+|++|+.||........ .....+ ..+.++.+.+++.+||+.+|.+|++..+.+.+
T Consensus 262 ~~-~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 262 WN-YQIDYFGVAATVYCMLFGTYMKVKNEGGEC-----KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp BS-THHHHHHHHHHHHHHHHSSCCCEEEETTEE-----EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred CC-ccccHHHHHHHHHHHHhCCCccccCCCCce-----eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 75 899999999999999999999965432110 001111 12456789999999999999999766555444
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=354.61 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=198.4
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCcceEEEEEEe--
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLAS-- 85 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~~~~~~-- 85 (476)
....++|++.+.||+|+||+||+|++ +++.||||++.... ...+.+|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34567999999999999999999987 68999999986542 3455667777766 789999999998654
Q ss_pred --CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCcEeccCCcchhccchhhhHHH
Q 011868 86 --KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH--------NKGVFHRDLKVILKSCHMRIATLQ 155 (476)
Q Consensus 86 --~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH--------~~givHrDiKp~~~~~~~~~~~~~ 155 (476)
....|+||||+++|+|.+++.. ..+++..++.++.||+.||+||| ++||+||||||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp------------- 141 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKS------------- 141 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCG-------------
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCCh-------------
Confidence 3568999999999999999954 57999999999999999999999 99999999997
Q ss_pred HHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC--CCcccccccCCccccccccccCCCC----
Q 011868 156 VFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYD---- 229 (476)
Q Consensus 156 ~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~---- 229 (476)
+|||++.++.+||+|||++........ .......+||+.|+|||++.+....
T Consensus 142 ----------------------~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 199 (301)
T 3q4u_A 142 ----------------------KNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFD 199 (301)
T ss_dssp ----------------------GGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHH
T ss_pred ----------------------HhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCccc
Confidence 999999999999999999974332111 1112345899999999999876321
Q ss_pred -CccchhhhHhHHHHHHhcC----------CCCCCCCc----HHHHHHHHHhCC---CCCCCC-----CCHHHHHHHHHc
Q 011868 230 -GATSDIWSCGVILYVILTG----------YLPFDDRN----LAVLYQKIFRGD---FKLPKW-----LSPGAQNLLRKI 286 (476)
Q Consensus 230 -~~~sDvwSlGvil~elltG----------~~Pf~~~~----~~~~~~~i~~~~---~~~p~~-----~s~~~~~Li~~~ 286 (476)
+.++|||||||++|+|++| ..||.+.. ............ ...|.. .++.+.+||.+|
T Consensus 200 ~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 279 (301)
T 3q4u_A 200 SYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKEC 279 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHH
Confidence 2689999999999999999 88986532 122223322222 222221 346799999999
Q ss_pred cCCCcCCCCChHHHhcC
Q 011868 287 LEPNPVKRITIAGIKAD 303 (476)
Q Consensus 287 L~~dP~~R~s~~~il~~ 303 (476)
|+.||.+|||+.++++.
T Consensus 280 l~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 280 WYQNPSARLTALRIKKT 296 (301)
T ss_dssp CCSSGGGSCCHHHHHHH
T ss_pred hhcChhhCCCHHHHHHH
Confidence 99999999999999763
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=373.23 Aligned_cols=250 Identities=32% Similarity=0.427 Sum_probs=195.3
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~l 91 (476)
-+.|.+.+.||+|+||+||.+. ..+|+.||||++..+. .+.+.+|+.+|+.+ +||||+++++++.+.+.+|+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 3456667889999999998764 4689999999986542 45678999999876 89999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 92 VLEYVTGGELFDKIASKGRL-------QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l-------~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
||||+. |+|.+++...... ++..++.++.||+.||+|||++||+||||||
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp---------------------- 143 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKP---------------------- 143 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSG----------------------
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCCh----------------------
Confidence 999995 6999999765432 2334578999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCC-------------CCEEEeccCCCCCCCcccCC--CcccccccCCcccccccccc----
Q 011868 165 IVIRPWKFNVLQLENILLDSK-------------GNIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLAN---- 225 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~-------------g~vkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~---- 225 (476)
+|||++.+ +.+||+|||+++........ ......+||+.|+|||++.+
T Consensus 144 -------------~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 210 (434)
T 2rio_A 144 -------------QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL 210 (434)
T ss_dssp -------------GGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTT
T ss_pred -------------HhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccc
Confidence 99999754 48999999999865432111 12345689999999999875
Q ss_pred ---CCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCCCCCCC-------CCCHHHHHHHHHccCCCcCCC
Q 011868 226 ---RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK-------WLSPGAQNLLRKILEPNPVKR 294 (476)
Q Consensus 226 ---~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~-------~~s~~~~~Li~~~L~~dP~~R 294 (476)
..+ +.++|||||||++|+|++ |..||.+..... ..+..+....+. .+++++.+||.+||+.||.+|
T Consensus 211 ~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 287 (434)
T 2rio_A 211 QTKRRL-TRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR 287 (434)
T ss_dssp SCCCCC-CTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGS
T ss_pred ccccCc-chhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhC
Confidence 334 589999999999999999 999998765433 334444443332 135789999999999999999
Q ss_pred CChHHHhcCccccc
Q 011868 295 ITIAGIKADEWFEQ 308 (476)
Q Consensus 295 ~s~~~il~~~~~~~ 308 (476)
||+.++++||||..
T Consensus 288 ps~~eil~hp~f~~ 301 (434)
T 2rio_A 288 PTAMKVLRHPLFWP 301 (434)
T ss_dssp CCHHHHHTSGGGSC
T ss_pred CCHHHHHhCCccCC
Confidence 99999999999964
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=358.59 Aligned_cols=251 Identities=28% Similarity=0.389 Sum_probs=207.7
Q ss_pred CcCE-EEeceEeecCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--
Q 011868 13 LGRY-ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-- 85 (476)
Q Consensus 13 ~~~Y-~i~~~LG~G~fg~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-- 85 (476)
-++| ++++.||+|+||+||++. +..+++.||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 3455 999999999999998775 34588999999997653 34456789999999999999999999999987
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
...+|+||||+++|+|.+++.. .++++.+++.++.||+.||+|||++||+||||||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp----------------------- 162 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAA----------------------- 162 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG-----------------------
T ss_pred CceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCch-----------------------
Confidence 4689999999999999999876 4599999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+||+++.++.+||+|||++........ ........||+.|+|||++.+..++ .++|||||||++|+
T Consensus 163 ------------~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ 229 (318)
T 3lxp_A 163 ------------RNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYE 229 (318)
T ss_dssp ------------GGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHH
T ss_pred ------------heEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHH
Confidence 999999999999999999986543211 1123445688899999999887775 89999999999999
Q ss_pred HhcCCCCCCCCcHH---------------HHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 245 ILTGYLPFDDRNLA---------------VLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 245 lltG~~Pf~~~~~~---------------~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|++|..||...... .....+..+ ..+.|..+++++.+||.+||+.||.+|||++++++
T Consensus 230 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 230 LLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999764322 111222222 34567789999999999999999999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=352.50 Aligned_cols=236 Identities=29% Similarity=0.572 Sum_probs=196.9
Q ss_pred ccCCccCcCEEEe-ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCcceEEEEEE
Q 011868 7 KQEGMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLA 84 (476)
Q Consensus 7 ~~~~~~~~~Y~i~-~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l-~~l~HpnIv~l~~~~~ 84 (476)
-..+..+++|.+. +.||+|+||.||+|.+..+++.||+|++... ..+.+|+.++ +..+||||+++++++.
T Consensus 10 ~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~ 81 (299)
T 3m2w_A 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYE 81 (299)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred CcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhh
Confidence 3456778899998 7799999999999999999999999999642 3567888888 6668999999999998
Q ss_pred e----CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHH
Q 011868 85 S----KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFL 158 (476)
Q Consensus 85 ~----~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~ 158 (476)
. ...+|+||||++||+|.+++.... .+++.+++.++.||+.||+|||++||+||||||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp---------------- 145 (299)
T 3m2w_A 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP---------------- 145 (299)
T ss_dssp EEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSG----------------
T ss_pred hhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH----------------
Confidence 7 678999999999999999998754 699999999999999999999999999999997
Q ss_pred HHHHHhhhccccccccCCCCceEeCC---CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchh
Q 011868 159 LTFLLMIVIRPWKFNVLQLENILLDS---KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 235 (476)
Q Consensus 159 ~~~~~~~~~~p~~~~~~~~~NiLl~~---~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDv 235 (476)
+||+++. ++.+||+|||++.... +..+ +.++||
T Consensus 146 -------------------~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~-~~~~Di 181 (299)
T 3m2w_A 146 -------------------ENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKY-DKSCDM 181 (299)
T ss_dssp -------------------GGEEESSSSTTCCEEECCCTTCEECT------------------------TCGG-GGHHHH
T ss_pred -------------------HHEEEecCCCCCcEEEeccccccccc------------------------cccC-CchhhH
Confidence 9999998 7899999999986321 1234 378999
Q ss_pred hhHhHHHHHHhcCCCCCCCCcHHHHHH----HHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccc
Q 011868 236 WSCGVILYVILTGYLPFDDRNLAVLYQ----KIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307 (476)
Q Consensus 236 wSlGvil~elltG~~Pf~~~~~~~~~~----~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~ 307 (476)
||+||++|+|++|+.||.+.+...... .+..+...+| ..+++++.+||.+||+.||.+|||++++++||||.
T Consensus 182 wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~ 261 (299)
T 3m2w_A 182 WSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261 (299)
T ss_dssp HHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence 999999999999999998765543321 1222233334 45899999999999999999999999999999998
Q ss_pred ccC
Q 011868 308 QDY 310 (476)
Q Consensus 308 ~~~ 310 (476)
+..
T Consensus 262 ~~~ 264 (299)
T 3m2w_A 262 QST 264 (299)
T ss_dssp TGG
T ss_pred ccc
Confidence 643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=355.23 Aligned_cols=243 Identities=28% Similarity=0.456 Sum_probs=201.2
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
...++|++.+.||+|+||+||+|++ +++.||||++... .....+.+|+.++++++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 4567999999999999999999997 4788999998643 235778999999999999999999998864 479
Q ss_pred EEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---cCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 91 MVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHN---KGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~al~yLH~---~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
+||||++||+|.+++.... .+++..+..++.|++.||+|||+ +||+||||||
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp---------------------- 133 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP---------------------- 133 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSG----------------------
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCCh----------------------
Confidence 9999999999999998654 47899999999999999999999 8999999997
Q ss_pred hhccccccccCCCCceEeCCCCC-EEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~-vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ 243 (476)
+||+++.++. +||+|||++..... ......||+.|+|||++.+..++ .++|||||||++|
T Consensus 134 -------------~NIll~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ 194 (307)
T 2eva_A 134 -------------PNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILW 194 (307)
T ss_dssp -------------GGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHH
T ss_pred -------------hHEEEeCCCCEEEEccccccccccc-----ccccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHH
Confidence 9999999887 79999999974322 23345799999999999887775 8999999999999
Q ss_pred HHhcCCCCCCCCc--HHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 244 VILTGYLPFDDRN--LAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 244 elltG~~Pf~~~~--~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+|++|+.||.... .......+..+ ..+.+..+++.+.+||.+||+.||.+|||+++++++
T Consensus 195 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 195 EVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999998543 22333333333 345667799999999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=364.44 Aligned_cols=245 Identities=16% Similarity=0.216 Sum_probs=204.1
Q ss_pred cCEEEeceEeecCceEEEEEEECCC--------CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcce-------
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDS--------GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR------- 78 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~--------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~------- 78 (476)
++|++.+.||+|+||+||+|++..+ ++.||||++... ..+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 7999999999999999999999874 889999999754 35778999999999999887
Q ss_pred --------EEEEEEe-CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhcc
Q 011868 79 --------LHEVLAS-KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSC 147 (476)
Q Consensus 79 --------l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~ 147 (476)
+++++.. +...|+||||+ +++|.+++... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp----- 187 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTA----- 187 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCG-----
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCH-----
Confidence 6777766 78899999999 99999999875 6899999999999999999999999999999997
Q ss_pred chhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCC--CEEEeccCCCCCCCcccC-----CCcccccccCCccccc
Q 011868 148 HMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG--NIKISDFGLSALPQHFRD-----DGLLHTTCGSPNYVAP 220 (476)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g--~vkl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~AP 220 (476)
+|||++.++ .+||+|||+++....... ........||+.|+||
T Consensus 188 ------------------------------~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 237 (352)
T 2jii_A 188 ------------------------------ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISM 237 (352)
T ss_dssp ------------------------------GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCH
T ss_pred ------------------------------HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCH
Confidence 999999998 999999999986543221 1122445899999999
Q ss_pred cccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCc--HHHHHHHH---HhCCCCCC------CCCCHHHHHHHHHccCC
Q 011868 221 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKI---FRGDFKLP------KWLSPGAQNLLRKILEP 289 (476)
Q Consensus 221 E~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~--~~~~~~~i---~~~~~~~p------~~~s~~~~~Li~~~L~~ 289 (476)
|++.+..++ .++|||||||++|+|++|+.||.+.. ...+.... ......++ ..+++++.+||.+||+.
T Consensus 238 E~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 316 (352)
T 2jii_A 238 DLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMAL 316 (352)
T ss_dssp HHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTC
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhC
Confidence 999887775 89999999999999999999998753 33332222 22222222 24689999999999999
Q ss_pred CcCCCCChHHHhcC
Q 011868 290 NPVKRITIAGIKAD 303 (476)
Q Consensus 290 dP~~R~s~~~il~~ 303 (476)
||.+|||++++++.
T Consensus 317 dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 317 TYEEKPPYAMLRNN 330 (352)
T ss_dssp CTTCCCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999998764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=361.16 Aligned_cols=262 Identities=22% Similarity=0.341 Sum_probs=195.2
Q ss_pred hhhccCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHH--HHhCCCCCcceEEE
Q 011868 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT--LKLLKHPNVVRLHE 81 (476)
Q Consensus 4 ~~~~~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~--l~~l~HpnIv~l~~ 81 (476)
+......+.+++|++++.||+|+||+||+|++ +++.||||++.... ...+..|..+ ++.++||||+++++
T Consensus 3 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~ 74 (336)
T 3g2f_A 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIV 74 (336)
T ss_dssp ------CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred CcccCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhhee
Confidence 44456678999999999999999999999986 78999999997543 2333444444 45689999999998
Q ss_pred EEEe-----CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---------CcEeccCCcchhcc
Q 011868 82 VLAS-----KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---------GVFHRDLKVILKSC 147 (476)
Q Consensus 82 ~~~~-----~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~---------givHrDiKp~~~~~ 147 (476)
.+.. ...+|+||||+++|+|.+++.. ...++..++.++.||+.||+|||+. ||+||||||
T Consensus 75 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp----- 148 (336)
T 3g2f_A 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNS----- 148 (336)
T ss_dssp EEEEECTTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSG-----
T ss_pred cccccccCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeeccccc-----
Confidence 6542 3367999999999999999976 4569999999999999999999999 999999997
Q ss_pred chhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCccc------CCCcccccccCCcccccc
Q 011868 148 HMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFR------DDGLLHTTCGSPNYVAPE 221 (476)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~------~~~~~~~~~gt~~y~APE 221 (476)
+|||++.++.+||+|||++....... ........+||+.|+|||
T Consensus 149 ------------------------------~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 198 (336)
T 3g2f_A 149 ------------------------------RNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE 198 (336)
T ss_dssp ------------------------------GGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHH
T ss_pred ------------------------------ceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCch
Confidence 99999999999999999997543211 122233567999999999
Q ss_pred ccccC-------CCCCccchhhhHhHHHHHHhcCCCCCC-CCc-----------------HHHHHHHHHhC--CCCCCCC
Q 011868 222 VLANR-------GYDGATSDIWSCGVILYVILTGYLPFD-DRN-----------------LAVLYQKIFRG--DFKLPKW 274 (476)
Q Consensus 222 ~l~~~-------~~~~~~sDvwSlGvil~elltG~~Pf~-~~~-----------------~~~~~~~i~~~--~~~~p~~ 274 (476)
++.+. .+ +.++|||||||++|+|++|..||. +.. .......+... ...+|..
T Consensus 199 ~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (336)
T 3g2f_A 199 VLEGAVNLRDXESA-LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA 277 (336)
T ss_dssp HHTTCCCGGGHHHH-HHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT
T ss_pred hhcCCccccccccc-ccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc
Confidence 98762 33 368999999999999999977653 211 11111111111 2233333
Q ss_pred ------CCHHHHHHHHHccCCCcCCCCChHHHh------cCccccccC
Q 011868 275 ------LSPGAQNLLRKILEPNPVKRITIAGIK------ADEWFEQDY 310 (476)
Q Consensus 275 ------~s~~~~~Li~~~L~~dP~~R~s~~~il------~~~~~~~~~ 310 (476)
.++++.+||.+||+.||.+|||+.+++ .++|-++..
T Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~ 325 (336)
T 3g2f_A 278 WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKS 325 (336)
T ss_dssp CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC---
T ss_pred cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhccc
Confidence 334799999999999999999999994 456665543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=369.40 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=204.2
Q ss_pred cCEEEeceEeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SKSKI 89 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-~~~~~ 89 (476)
.+|++.+.||+|+||+||+|.+..+ +..||+|.+.... .......+.+|+.+++.++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 4689999999999999999997543 2468999986543 3445688999999999999999999999864 45688
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||+++|+|.+++... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp-------------------------- 220 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAA-------------------------- 220 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG--------------------------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccch--------------------------
Confidence 9999999999999999764 4689999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC--CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.++.+||+|||+++....... ........||+.|+|||++.+..++ .++|||||||++|+|+
T Consensus 221 ---------~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ell 290 (373)
T 3c1x_A 221 ---------RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELM 290 (373)
T ss_dssp ---------GGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHH
T ss_pred ---------heEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHH
Confidence 999999999999999999985432111 1122344678899999999887775 8999999999999999
Q ss_pred c-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 247 T-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 247 t-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+ |.+||.+.+.......+..+. ...|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 291 t~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 291 TRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9 889998877666666666554 34567799999999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=363.36 Aligned_cols=254 Identities=23% Similarity=0.339 Sum_probs=205.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||+||+|++ .+|+.||||++....... ....+.+|+.+++.++||||+++++++...+..|+
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence 457899999999999999999985 578999999997654221 12368999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhc---CcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 92 VLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNK---GVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~al~yLH~~---givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
||||+.+|+|.+++.... ++++..++.++.|++.||+|||++ ||+||||||
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp---------------------- 162 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA---------------------- 162 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSG----------------------
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCch----------------------
Confidence 999999999999997643 499999999999999999999999 999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+|||++.++.+||+|||++...... ........+||+.|+|||++.+..++ .++||||+||++|+
T Consensus 163 -------------~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~ 227 (326)
T 3uim_A 163 -------------ANILLDEEFEAVVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLE 227 (326)
T ss_dssp -------------GGEEECTTCCEEECCCSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEEC-HHHHHHHHHHHHHH
T ss_pred -------------hhEEECCCCCEEeccCccccccCcc-cccccccccCCcCccCHHHhccCCCC-ccccchhHHHHHHH
Confidence 9999999999999999999854321 22234456699999999999877774 89999999999999
Q ss_pred HhcCCCCCCCCcH----HHHHHHHHhCCC---------------CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcc
Q 011868 245 ILTGYLPFDDRNL----AVLYQKIFRGDF---------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 305 (476)
Q Consensus 245 lltG~~Pf~~~~~----~~~~~~i~~~~~---------------~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~ 305 (476)
|++|+.||+.... ............ ..+...++.+.+++.+||+.||.+|||+.++++|-+
T Consensus 228 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 228 LITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp HHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 9999999963211 001111111100 011113467999999999999999999999998854
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=357.19 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=204.6
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeecccc-cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
|..++.||+|+||+||+|.+ +++.||||++..... ........+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44568999999999999985 688999999975432 233456789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 95 YVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 95 ~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|+++++|.+++.. ..++++..++.++.||+.||+|||++||+||||||
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp----------------------------- 161 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKS----------------------------- 161 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG-----------------------------
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCH-----------------------------
Confidence 9999999999974 34699999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+||+++.++.+||+|||++...............+||+.|+|||++.+. + +.++|||||||++|+|++|..|
T Consensus 162 ------~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p 233 (307)
T 2nru_A 162 ------ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPA 233 (307)
T ss_dssp ------GGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCS
T ss_pred ------HHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCC
Confidence 9999999999999999999855433222234456799999999998654 5 4899999999999999999999
Q ss_pred CCCCcHH----HHHHHHHhCCC-----------CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 252 FDDRNLA----VLYQKIFRGDF-----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 252 f~~~~~~----~~~~~i~~~~~-----------~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|.+.+.. .+...+..... ..+...++.+.++|.+||+.||.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp BCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9875432 22222222211 1122245678999999999999999999999865
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=376.10 Aligned_cols=250 Identities=25% Similarity=0.334 Sum_probs=196.3
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
+|++.+.||+|+||+||. ....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++.+....|+||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 499999999999999764 3447899999999966532 2356899999999 7999999999999999999999
Q ss_pred eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 94 EYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
||+. |+|.+++.... .+++.+++.++.||+.||+|||++||+||||||
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp------------------------------ 146 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKP------------------------------ 146 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCST------------------------------
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCH------------------------------
Confidence 9995 69999997653 466667889999999999999999999999997
Q ss_pred ccCCCCceEeCC-----CCCEEEeccCCCCCCCcccC-CCcccccccCCcccccccccc---CCCCCccchhhhHhHHHH
Q 011868 173 NVLQLENILLDS-----KGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILY 243 (476)
Q Consensus 173 ~~~~~~NiLl~~-----~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~---~~~~~~~sDvwSlGvil~ 243 (476)
+|||++. ...+||+|||+|+....... .......+||+.|+|||++.+ ..+ +.++|||||||++|
T Consensus 147 -----~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-t~~~DiwSlG~il~ 220 (432)
T 3p23_A 147 -----HNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP-TYTVDIFSAGCVFY 220 (432)
T ss_dssp -----TSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CC-CTHHHHHHHHHHHH
T ss_pred -----HHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCC-CcHHHHHHHHHHHH
Confidence 9999953 23688999999986543211 123455789999999999874 333 47899999999999
Q ss_pred HHhc-CCCCCCCCcHHHHHHHHHhCCCCC---CCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 244 VILT-GYLPFDDRNLAVLYQKIFRGDFKL---PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 244 ellt-G~~Pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+|++ |..||...........+....... +...++.+.+||.+||+.||.+|||++++++||||..
T Consensus 221 ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 221 YVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred HHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 9999 999997665444332222222211 2224566899999999999999999999999999964
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=388.35 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=211.4
Q ss_pred EEEe-ceEeecCceEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 16 YELG-RTLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 16 Y~i~-~~LG~G~fg~V~~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+.+. +.||+|+||+||+|.+ ..+++.||||+++... ......+.+.+|+.+|+.++||||+++++++.. ...|+|
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence 4443 4799999999999954 4567899999997653 234456889999999999999999999999975 458999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|||+++|+|.+++.....+++.+++.++.||+.||+|||++||+||||||
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp------------------------------ 497 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAA------------------------------ 497 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG------------------------------
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCCh------------------------------
Confidence 99999999999999888899999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYL 250 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~ 250 (476)
+|||++.++.+||+|||+++....... ........||+.|+|||++.+..++ .++|||||||++|+|++ |+.
T Consensus 498 -----~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~ 571 (635)
T 4fl3_A 498 -----RNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQK 571 (635)
T ss_dssp -----GGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCC
T ss_pred -----HhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999975433211 1122334578899999999888775 89999999999999998 999
Q ss_pred CCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 251 PFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
||.+.+.......+..+. ...|..+++++.+||.+||+.||.+|||++++++
T Consensus 572 Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 572 PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp SSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999888888877764 5578889999999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=385.04 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=210.3
Q ss_pred cCEEEec-eEeecCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 14 GRYELGR-TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 14 ~~Y~i~~-~LG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
++|.+.+ .||+|+||+||+|.+. .++..||||+++... .....+.+.+|+.+|+.++||||+++++++.. +.+|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 4566666 8999999999999875 356679999997653 23346789999999999999999999999976 5699
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+||||+.+|+|.+++... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp--------------------------- 464 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAA--------------------------- 464 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG---------------------------
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCH---------------------------
Confidence 999999999999999654 4699999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT- 247 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt- 247 (476)
+|||++.++.+||+|||+++....... ........+|+.|+|||++.+..++ .++|||||||++|||++
T Consensus 465 --------~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~ 535 (613)
T 2ozo_A 465 --------RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSY 535 (613)
T ss_dssp --------GGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTT
T ss_pred --------HHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHC
Confidence 999999999999999999986533211 1112233467899999999888775 89999999999999998
Q ss_pred CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 248 GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|+.||.+.+.......+..+. .+.|..+++++.+||.+||+.||.+|||+.++++
T Consensus 536 G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 536 GQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp SCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999988888888887764 5678889999999999999999999999999743
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=355.84 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=211.2
Q ss_pred ccCCccCcCEEEeceEeecCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEE
Q 011868 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV 82 (476)
Q Consensus 7 ~~~~~~~~~Y~i~~~LG~G~fg~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~ 82 (476)
.......++|++++.||+|+||.||+|+ +..+++.||||++... .......+.+|+.+++.++||||++++++
T Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp ---CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 3455677889999999999999999998 4568999999999764 23446789999999999999999999999
Q ss_pred EEeCC--EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHH
Q 011868 83 LASKS--KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 83 ~~~~~--~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
+...+ .+|+||||+++++|.+++... .++++.+++.++.||+.||+|||++||+||||||
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp----------------- 173 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLAT----------------- 173 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG-----------------
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCc-----------------
Confidence 86543 789999999999999999875 4699999999999999999999999999999997
Q ss_pred HHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC-CcccccccCCccccccccccCCCCCccchhhhH
Q 011868 160 TFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 238 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSl 238 (476)
+||+++.++.+||+|||++......... .......+++.|+|||++.+..++ .++|||||
T Consensus 174 ------------------~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~sl 234 (326)
T 2w1i_A 174 ------------------RNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSF 234 (326)
T ss_dssp ------------------GGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHH
T ss_pred ------------------ceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCC-chhhHHHH
Confidence 9999999999999999999865432111 112334578889999999887775 89999999
Q ss_pred hHHHHHHhcCCCCCCCCcHH----------------HHHHHHHh-CCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHh
Q 011868 239 GVILYVILTGYLPFDDRNLA----------------VLYQKIFR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301 (476)
Q Consensus 239 Gvil~elltG~~Pf~~~~~~----------------~~~~~i~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il 301 (476)
||++|+|++|..||...... .+...+.. ...+.|..+++++.+||.+||+.||.+|||+.+++
T Consensus 235 G~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 314 (326)
T 2w1i_A 235 GVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 314 (326)
T ss_dssp HHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 99999999999998653211 11122222 23556778999999999999999999999999987
Q ss_pred c
Q 011868 302 A 302 (476)
Q Consensus 302 ~ 302 (476)
+
T Consensus 315 ~ 315 (326)
T 2w1i_A 315 L 315 (326)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=379.78 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=215.2
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||+||+|.+.. +..||||+++.... ..+.+.+|+.+|+.++||||+++++++.. +.+|+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 44679999999999999999999854 56799999976542 14678999999999999999999999876 67899
Q ss_pred EEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 92 VLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
||||+.+|+|.+++.. ...+++.++..++.||+.||+|||++||+||||||
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp--------------------------- 391 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA--------------------------- 391 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG---------------------------
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCH---------------------------
Confidence 9999999999999964 35699999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-C
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-G 248 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G 248 (476)
+|||++.++.+||+|||+++...... ........++..|+|||++....++ .++|||||||++|+|++ |
T Consensus 392 --------~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g 461 (535)
T 2h8h_A 392 --------ANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKG 461 (535)
T ss_dssp --------GGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTT
T ss_pred --------hhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCC
Confidence 99999999999999999998643211 0112234577899999999887775 89999999999999999 9
Q ss_pred CCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 249 YLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+.||.+.+.......+..+ ..+.|..+++.+.+||.+||+.||++|||+++|++.
T Consensus 462 ~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 462 RVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp CCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999998888888777665 356678899999999999999999999999998763
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=354.58 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=197.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCcceEEEEEEeC---
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--KHPNVVRLHEVLASK--- 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l--~HpnIv~l~~~~~~~--- 86 (476)
..++|++++.||+|+||+||+|++. ++.||||++.... .....+|.+++... +||||+++++++...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 4468999999999999999999974 8999999996542 23445566666554 899999999999877
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CcEeccCCcchhccchhhhHHHHH
Q 011868 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKVILKSCHMRIATLQVF 157 (476)
Q Consensus 87 -~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~--------givHrDiKp~~~~~~~~~~~~~~~ 157 (476)
...|+||||+++|+|.+++.. .++++..++.++.|++.||+|||++ ||+||||||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp--------------- 170 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS--------------- 170 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCG---------------
T ss_pred CCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccch---------------
Confidence 789999999999999999966 4799999999999999999999998 999999997
Q ss_pred HHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC--CcccccccCCccccccccccCCCCCc----
Q 011868 158 LLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGA---- 231 (476)
Q Consensus 158 ~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~---- 231 (476)
+|||++.++.+||+|||++......... ....+.+||+.|+|||++.+..+...
T Consensus 171 --------------------~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 230 (337)
T 3mdy_A 171 --------------------KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230 (337)
T ss_dssp --------------------GGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHH
T ss_pred --------------------HHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCc
Confidence 9999999999999999999754322111 11235689999999999987665422
Q ss_pred -cchhhhHhHHHHHHhcC----------CCCCCCCc-----HHHHHHHHHhC--CCCCCC-----CCCHHHHHHHHHccC
Q 011868 232 -TSDIWSCGVILYVILTG----------YLPFDDRN-----LAVLYQKIFRG--DFKLPK-----WLSPGAQNLLRKILE 288 (476)
Q Consensus 232 -~sDvwSlGvil~elltG----------~~Pf~~~~-----~~~~~~~i~~~--~~~~p~-----~~s~~~~~Li~~~L~ 288 (476)
++|||||||++|+|++| ..||.... .......+... ...+|. .+++++.+||.+||+
T Consensus 231 ~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 310 (337)
T 3mdy_A 231 IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310 (337)
T ss_dssp HHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSC
T ss_pred cccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhh
Confidence 39999999999999999 77776532 22222222222 222332 245679999999999
Q ss_pred CCcCCCCChHHHhcC
Q 011868 289 PNPVKRITIAGIKAD 303 (476)
Q Consensus 289 ~dP~~R~s~~~il~~ 303 (476)
.||.+|||+.+++++
T Consensus 311 ~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 311 HNPASRLTALRVKKT 325 (337)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred hChhhCCCHHHHHHH
Confidence 999999999999886
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=382.84 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=215.4
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
...++|++.+.||+|+||+||+|.+..+ +..||||.+.... .....+.+.+|+.+++.++||||+++++++. ++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 4457899999999999999999998654 4579999986543 3445678999999999999999999999985 46
Q ss_pred EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
..|+||||+++|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp------------------------ 519 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAA------------------------ 519 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG------------------------
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccch------------------------
Confidence 6899999999999999997643 699999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.+|.+||+|||+++...... ........||+.|+|||++.+..++ .++|||||||++|+|+
T Consensus 520 -----------~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell 586 (656)
T 2j0j_A 520 -----------RNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEIL 586 (656)
T ss_dssp -----------GGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHH
T ss_pred -----------HhEEEeCCCCEEEEecCCCeecCCCc-ceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHH
Confidence 99999999999999999998653321 1122344678899999999887775 8999999999999999
Q ss_pred c-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 247 T-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 247 t-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+ |..||.+.+.......+..+. .+.|..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 587 t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 587 MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp TTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7 999999998888887777654 56788899999999999999999999999998764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=355.78 Aligned_cols=256 Identities=21% Similarity=0.356 Sum_probs=211.9
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
......++|++.+.||+|+||.||+|.+.. .||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 335667899999999999999999999743 499999976542 2223456788999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
..|+||||++|++|.+++...+ .+++.+++.++.||+.||+|||++||+||||||
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp------------------------ 158 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKS------------------------ 158 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCS------------------------
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCh------------------------
Confidence 9999999999999999997654 699999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCccc---CCCcccccccCCccccccccccC--------CCCCccchh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFR---DDGLLHTTCGSPNYVAPEVLANR--------GYDGATSDI 235 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~---~~~~~~~~~gt~~y~APE~l~~~--------~~~~~~sDv 235 (476)
+||+++ ++.+||+|||++....... .........||+.|+|||++.+. ...+.++||
T Consensus 159 -----------~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di 226 (319)
T 2y4i_B 159 -----------KNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDV 226 (319)
T ss_dssp -----------TTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHH
T ss_pred -----------hhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhH
Confidence 999998 7899999999987543211 12234455799999999998752 223588999
Q ss_pred hhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCC--CCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 236 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 236 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|||||++|+|++|..||.+.+.......+..+..+. +..+++++.++|.+||+.||.+|||+.++++.
T Consensus 227 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 227 FALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp HHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999988888777776664432 23578999999999999999999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=392.22 Aligned_cols=259 Identities=29% Similarity=0.405 Sum_probs=208.4
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe---
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--- 85 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--- 85 (476)
.+..+++|++.+.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 9 pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 3556799999999999999999999999999999999987653 34456789999999999999999999999765
Q ss_pred ---CCEEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHH
Q 011868 86 ---KSKIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 86 ---~~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
.+..|+||||++||+|.+++.... ++++..++.++.||+.||+|||+.||+||||||
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP----------------- 149 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKP----------------- 149 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCS-----------------
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCH-----------------
Confidence 677899999999999999998643 699999999999999999999999999999997
Q ss_pred HHHHhhhccccccccCCCCceEeCCCCC---EEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhh
Q 011868 160 TFLLMIVIRPWKFNVLQLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 236 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl~~~g~---vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvw 236 (476)
+||+++.++. +||+|||++..... .......+||+.|+|||++.+..++ .++|||
T Consensus 150 ------------------~NILl~~~g~~~~vKL~DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIw 207 (676)
T 3qa8_A 150 ------------------ENIVLQPGPQRLIHKIIDLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKYT-VTVDYW 207 (676)
T ss_dssp ------------------TTEEEECCSSSCEEEECSCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCCS-TTHHHH
T ss_pred ------------------HHeEeecCCCceeEEEccccccccccc---ccccccccCCcccCChHHhccCCCC-chhHHH
Confidence 9999998775 99999999985432 2334567899999999999888775 899999
Q ss_pred hHhHHHHHHhcCCCCCCCCcHHHHHHH--------------HHhCCC------CCC----CCCCHHHHHHHHHccCCCcC
Q 011868 237 SCGVILYVILTGYLPFDDRNLAVLYQK--------------IFRGDF------KLP----KWLSPGAQNLLRKILEPNPV 292 (476)
Q Consensus 237 SlGvil~elltG~~Pf~~~~~~~~~~~--------------i~~~~~------~~p----~~~s~~~~~Li~~~L~~dP~ 292 (476)
|+||++|+|++|..||.+......... ...+.. +.| ..+++.+.+||.+||..||.
T Consensus 208 SLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~ 287 (676)
T 3qa8_A 208 SFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQR 287 (676)
T ss_dssp HHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC
T ss_pred HHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHh
Confidence 999999999999999976543221100 001111 112 22467899999999999999
Q ss_pred CCCChHHHhcCccccc
Q 011868 293 KRITIAGIKADEWFEQ 308 (476)
Q Consensus 293 ~R~s~~~il~~~~~~~ 308 (476)
+|||+++++.||||..
T Consensus 288 kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 288 QRGTDPQNPNVGCFQA 303 (676)
T ss_dssp ---CCTTCCCCTTHHH
T ss_pred hCcCHHHHhcCHHHHH
Confidence 9999999999999854
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=366.59 Aligned_cols=250 Identities=20% Similarity=0.275 Sum_probs=209.2
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLASKSKI 89 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~ 89 (476)
...++|++++.||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.++| ++|..+..++......
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 345789999999999999999999999999999999876542 2357889999999986 5666777777888999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||+ +++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP-------------------------- 131 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP-------------------------- 131 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG--------------------------
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCc--------------------------
Confidence 9999999 9999999975 46799999999999999999999999999999997
Q ss_pred ccccccCCCCceEe---CCCCCEEEeccCCCCCCCcccCC-----CcccccccCCccccccccccCCCCCccchhhhHhH
Q 011868 169 PWKFNVLQLENILL---DSKGNIKISDFGLSALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240 (476)
Q Consensus 169 p~~~~~~~~~NiLl---~~~g~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGv 240 (476)
+|||+ +.++.+||+|||+++........ ......+||+.|+|||++.+..++ .++|||||||
T Consensus 132 ---------~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGv 201 (483)
T 3sv0_A 132 ---------DNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGY 201 (483)
T ss_dssp ---------GGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHH
T ss_pred ---------ceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHH
Confidence 99999 68899999999999865432211 122367899999999999888775 8999999999
Q ss_pred HHHHHhcCCCCCCCCc---HHHHHHHHHhCCC-----CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 241 ILYVILTGYLPFDDRN---LAVLYQKIFRGDF-----KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 241 il~elltG~~Pf~~~~---~~~~~~~i~~~~~-----~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
++|+|++|+.||.+.. ....+.++..... .++..+++++.+||.+||+.||.+||++++|++
T Consensus 202 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 202 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999998743 3344444433322 223568899999999999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=348.51 Aligned_cols=246 Identities=25% Similarity=0.364 Sum_probs=202.0
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC----
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLASKS---- 87 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~~~~~~~~---- 87 (476)
++|++.+.||+|+||+||+|++ +|+.||||++.... ...+.+|+++++. ++||||+++++++....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 6899999999999999999997 58999999996432 4567789999887 78999999999998776
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCcEeccCCcchhccchhhhHHHHHHH
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH--------NKGVFHRDLKVILKSCHMRIATLQVFLL 159 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH--------~~givHrDiKp~~~~~~~~~~~~~~~~~ 159 (476)
..|+||||+++|+|.+++.. .++++.+++.++.||+.||+||| +.||+||||||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp----------------- 175 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS----------------- 175 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSG-----------------
T ss_pred eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCH-----------------
Confidence 89999999999999999976 57999999999999999999999 89999999997
Q ss_pred HHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC--CcccccccCCccccccccccCCCC-----Ccc
Q 011868 160 TFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYD-----GAT 232 (476)
Q Consensus 160 ~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~-----~~~ 232 (476)
+|||++.++.+||+|||++......... ......+||+.|+|||++.+.... +.+
T Consensus 176 ------------------~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 237 (342)
T 1b6c_B 176 ------------------KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 237 (342)
T ss_dssp ------------------GGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHH
T ss_pred ------------------HHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCc
Confidence 9999999999999999999753321110 023456799999999998765322 267
Q ss_pred chhhhHhHHHHHHhcC----------CCCCCCCc-----HHHHHHHHHhCCC--CCCCC-----CCHHHHHHHHHccCCC
Q 011868 233 SDIWSCGVILYVILTG----------YLPFDDRN-----LAVLYQKIFRGDF--KLPKW-----LSPGAQNLLRKILEPN 290 (476)
Q Consensus 233 sDvwSlGvil~elltG----------~~Pf~~~~-----~~~~~~~i~~~~~--~~p~~-----~s~~~~~Li~~~L~~d 290 (476)
+|||||||++|+|++| ..||.+.. ...+...+..... .+|.. .++.+.+||.+||+.|
T Consensus 238 ~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 317 (342)
T 1b6c_B 238 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 317 (342)
T ss_dssp HHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSS
T ss_pred ccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccC
Confidence 9999999999999999 88997642 3344444433322 23321 2357899999999999
Q ss_pred cCCCCChHHHhcC
Q 011868 291 PVKRITIAGIKAD 303 (476)
Q Consensus 291 P~~R~s~~~il~~ 303 (476)
|.+|||+.+++++
T Consensus 318 p~~Rps~~~i~~~ 330 (342)
T 1b6c_B 318 GAARLTALRIKKT 330 (342)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCCCHHHHHHH
Confidence 9999999999876
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=369.38 Aligned_cols=249 Identities=20% Similarity=0.205 Sum_probs=197.5
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCc---------ce----
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNV---------VR---- 78 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnI---------v~---- 78 (476)
..+|.+.+.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.++| +|. +.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3458999999999999999999999999999999975443333445789999999999987 321 11
Q ss_pred --------EEEEEEe-----CCEEEEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEec
Q 011868 79 --------LHEVLAS-----KSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138 (476)
Q Consensus 79 --------l~~~~~~-----~~~~~lV~E~~~gg~L~~~l~~-------~~~l~~~~~~~~~~qi~~al~yLH~~givHr 138 (476)
+.+++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111111 23467888877 7899998841 2357888999999999999999999999999
Q ss_pred cCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccc
Q 011868 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 218 (476)
Q Consensus 139 DiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 218 (476)
|||| +|||++.+|.+||+|||+++.... ...+.+| +.|+
T Consensus 236 DiKp-----------------------------------~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~ 274 (413)
T 3dzo_A 236 YLRP-----------------------------------VDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFA 274 (413)
T ss_dssp CCCG-----------------------------------GGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTC
T ss_pred Cccc-----------------------------------ceEEEecCCeEEEEeccceeecCC-----ccccCCC-Ccee
Confidence 9997 999999999999999999874322 2556788 9999
Q ss_pred ccccc----------ccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccC
Q 011868 219 APEVL----------ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 288 (476)
Q Consensus 219 APE~l----------~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 288 (476)
|||++ .+..+ +.++|||||||++|+|++|+.||.+.+.......+.. ....+++.+.+||.+||+
T Consensus 275 aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~ 349 (413)
T 3dzo_A 275 PPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLR 349 (413)
T ss_dssp CHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTC
T ss_pred CchhhhccccccccccCcCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHcc
Confidence 99999 33445 4799999999999999999999988765544333332 224578999999999999
Q ss_pred CCcCCCCChHHHhcCccccc
Q 011868 289 PNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 289 ~dP~~R~s~~~il~~~~~~~ 308 (476)
.||.+|||+.++++||||+.
T Consensus 350 ~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 350 YPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp SSGGGSCCHHHHTTSHHHHH
T ss_pred CChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=363.14 Aligned_cols=244 Identities=22% Similarity=0.300 Sum_probs=197.6
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhCC---------CCCcc
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLK---------HPNVV 77 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~~l~~l~---------HpnIv 77 (476)
..++|++++.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357899999999999999999997 7899999999876421 2233478889999999886 88888
Q ss_pred eEEEEEE------------------------------eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 011868 78 RLHEVLA------------------------------SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127 (476)
Q Consensus 78 ~l~~~~~------------------------------~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al 127 (476)
++.+++. ..+.+|+||||+++|++.+.+.. +.+++.+++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 8877653 26789999999999988777744 6799999999999999999
Q ss_pred HHHH-hcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCC--------------------
Q 011868 128 SYCH-NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG-------------------- 186 (476)
Q Consensus 128 ~yLH-~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g-------------------- 186 (476)
+||| ++||+|||||| +|||++.+|
T Consensus 175 ~~lH~~~~ivHrDlKp-----------------------------------~NILl~~~~~~~~~~~~~~~~~~~~~~~~ 219 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHW-----------------------------------GNVLLKKTSLKKLHYTLNGKSSTIPSCGL 219 (336)
T ss_dssp HHHHHHHCCBCSCCCG-----------------------------------GGEEEEECSCSEEEEEETTEEEEEECTTE
T ss_pred HHHHHhCCEeECCCCH-----------------------------------HHEEEeccCCcceeeeccCccccccCCCc
Confidence 9999 99999999997 999999887
Q ss_pred CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHH-HHHHhcCCCCCCCCcH-HHHHHHH
Q 011868 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI-LYVILTGYLPFDDRNL-AVLYQKI 264 (476)
Q Consensus 187 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi-l~elltG~~Pf~~~~~-~~~~~~i 264 (476)
.+||+|||+|+.... ...+||+.|+|||++.+.. +.++||||+|++ .+++++|..||.+... ......+
T Consensus 220 ~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~ 290 (336)
T 2vuw_A 220 QVSIIDYTLSRLERD-------GIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM 290 (336)
T ss_dssp EEEECCCTTCBEEET-------TEEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHH
T ss_pred eEEEeeccccEecCC-------CcEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhh
Confidence 899999999984321 2458999999999998765 489999998777 7889999999965322 2233333
Q ss_pred HhC-CCC--C----CCCCCHHHHHHHHHccCCCcCCCCChHHHh-cCcccc
Q 011868 265 FRG-DFK--L----PKWLSPGAQNLLRKILEPNPVKRITIAGIK-ADEWFE 307 (476)
Q Consensus 265 ~~~-~~~--~----p~~~s~~~~~Li~~~L~~dP~~R~s~~~il-~~~~~~ 307 (476)
... ... . +..+++++.+||++||+.| |++|++ +||||+
T Consensus 291 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 291 LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 321 111 1 1236789999999999977 999999 999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=336.23 Aligned_cols=225 Identities=15% Similarity=0.172 Sum_probs=191.4
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
+.-++|++.+.||+|+||.||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++...+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 34478999999999999999999999999999999998776555566788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
+||||++|++|.+++.. .....++..++.||+.||+|||++||+||||||
T Consensus 108 lv~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp---------------------------- 157 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHP---------------------------- 157 (286)
T ss_dssp EEEECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG----------------------------
T ss_pred EEEEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCc----------------------------
Confidence 99999999999999854 346678899999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+|||++.+|.+||+++| |++| + +.++|||||||++|+|++|+.
T Consensus 158 -------~NIll~~~g~~kl~~~~----------------------~~~~-------~-~~~~Di~slG~il~elltg~~ 200 (286)
T 3uqc_A 158 -------SRVRVSIDGDVVLAYPA----------------------TMPD-------A-NPQDDIRGIGASLYALLVNRW 200 (286)
T ss_dssp -------GGEEEETTSCEEECSCC----------------------CCTT-------C-CHHHHHHHHHHHHHHHHHSEE
T ss_pred -------ccEEEcCCCCEEEEecc----------------------ccCC-------C-CchhHHHHHHHHHHHHHHCCC
Confidence 99999999999998554 2332 3 488999999999999999999
Q ss_pred CCCCCcHHHHH---HHHHhCCCC----CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 251 PFDDRNLAVLY---QKIFRGDFK----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 251 Pf~~~~~~~~~---~~i~~~~~~----~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
||.+.+..... .+...+... .+..+++++.+||.+||+.||.+| |+.++++.
T Consensus 201 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 201 PLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 99876543211 011122222 235689999999999999999999 99999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=373.65 Aligned_cols=243 Identities=24% Similarity=0.376 Sum_probs=201.4
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK- 88 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~- 88 (476)
...++|++.+.||+|+||+||+|.+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 344899999999999999999999976 78999999986543 34456788999999999999999999999987654
Q ss_pred ----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 89 ----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 89 ----~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
.|+||||++|++|.+.+.. ++++.+++.++.||+.||.|||++||+||||||
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp---------------------- 210 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKP---------------------- 210 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG----------------------
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccCh----------------------
Confidence 7999999999999988754 799999999999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+|||++.+ .+||+|||+++.... ....+||+.|+|||++.+. + +.++|||||||++|+
T Consensus 211 -------------~NIll~~~-~~kl~DFG~a~~~~~------~~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~ 268 (681)
T 2pzi_A 211 -------------ENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAA 268 (681)
T ss_dssp -------------GGEEECSS-CEEECCCTTCEETTC------CSCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHH
T ss_pred -------------HHeEEeCC-cEEEEecccchhccc------CCccCCCccccCHHHHcCC-C-CCceehhhhHHHHHH
Confidence 99999885 999999999985332 2456799999999998764 4 589999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccc
Q 011868 245 ILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~ 307 (476)
|++|..||.+....... ........++.+.+||.+||+.||.+||+..+.+.|+|+.
T Consensus 269 l~~g~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 269 LTLDLPTRNGRYVDGLP------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHSCCCEETTEECSSCC------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHhCCCCCccccccccc------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 99999998764211000 0000011467899999999999999999999999999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=319.59 Aligned_cols=232 Identities=14% Similarity=0.128 Sum_probs=163.9
Q ss_pred eEeecCceEEEEEEECCCCceEEEEEeeccccc-------chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 011868 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-------HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 21 ~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV 92 (476)
.++.|++|.+..++....|+.||+|++.+.... .....+++.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 467788888887777778999999999765321 122346799999999999 699999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|||++|++|.++|...+++++. .|+.||+.||+|||++||+||||||
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKP------------------------------ 367 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRP------------------------------ 367 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCG------------------------------
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCch------------------------------
Confidence 9999999999999998888865 4899999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+|||++.+|++||+|||+|+.... ......+.+||+.|||||++.+. + ..++|+||+|+++++|.++..||
T Consensus 368 -----eNILL~~dg~vKL~DFGlAr~~~~--~~~~~~t~vGTp~YmAPE~l~g~-~-~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 368 -----WNVMVDARQHARLIDFGSIVTTPQ--DCSWPTNLVQSFFVFVNELFAEN-K-SWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -----GGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHHH
T ss_pred -----HhEEECCCCCEEEeecccCeeCCC--CCccccCceechhhccHHHhCCC-C-CCcccccccccchhhhccccchh
Confidence 999999999999999999986543 23446678999999999998765 3 36799999999999988776543
Q ss_pred CCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccc
Q 011868 253 DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~ 307 (476)
....... |.. ...+..+...++..+|..|+.......++|..
T Consensus 439 --------~~~l~~~----~~~-~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 439 --------LYAVWQE----PVE-RWNFVLLLALFEKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp --------HHHHHTS----CGG-GCSHHHHHHHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred --------HHHhhcC----CCC-CCcHHHHHHHHhCCCCCCCCChhhhccchhHH
Confidence 1111111 111 11245677777888888888877777777754
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=224.45 Aligned_cols=125 Identities=30% Similarity=0.568 Sum_probs=116.7
Q ss_pred CCCcccchhhhccccccccCCCCccccc-cccceeeeecCCHHHHHHHHHHHHHhcCeEEEeeCCceeeeeccCCCcccC
Q 011868 344 SPPLINAFQLIGMSSCLDLSGFFEKEDV-SERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLG 422 (476)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 422 (476)
.|+.+|||++|++|+|+|||++|+.... .++++||+|..++++|+++||++|+.+|++|+++++++++++..+|++ |
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grk--G 80 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKA--G 80 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGG--G
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCc--c
Confidence 4677999999999999999999976432 578999999999999999999999999999999888999999999999 9
Q ss_pred ceEEEEEEEEEcCceEEEEEEecCCChhhHHHHHHHHHhhcCCCCccc
Q 011868 423 SLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQE 470 (476)
Q Consensus 423 ~l~~~~ev~~~~~~~~lVe~~k~~Gd~lef~~~~~~l~~~L~~~~~~~ 470 (476)
.|++.+||||++|+++||||+|++||++||++||++|+++|+|++++.
T Consensus 81 ~l~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~Lr~~L~diV~~~ 128 (143)
T 2ehb_D 81 QLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLENIIWRA 128 (143)
T ss_dssp CCEEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHHHHHHSTTTBCC-
T ss_pred eEEEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHhhcceecC
Confidence 999999999999999999999999999999999999999999999874
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=215.83 Aligned_cols=121 Identities=27% Similarity=0.378 Sum_probs=105.2
Q ss_pred CCCcccchhhhccccccccCCCCccccccccceeeeecCCHHHHHHHHHHHHHhcCeEEEeeCCceeeeeccCCCcccCc
Q 011868 344 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGS 423 (476)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 423 (476)
.|..+|||++|++|+|+|||++|+.+...++++||+|..+|++|+++||++|+++||+|++++++ ++..++++ |.
T Consensus 2 ~~~~lNAFdiIs~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~k--G~ 76 (123)
T 2zfd_B 2 GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQK--GN 76 (123)
T ss_dssp --CCCCHHHHHHTSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGG--GT
T ss_pred CcccccHHHHHHHCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCC--cc
Confidence 45679999999999999999999754334678999999999999999999999999999988775 66667888 99
Q ss_pred eEEEEEEEEEcCceEEEEEEecCCChhhHHHHHH-HHHhhcCCCCcc
Q 011868 424 LSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCN-KLSSDLGLPPSQ 469 (476)
Q Consensus 424 l~~~~ev~~~~~~~~lVe~~k~~Gd~lef~~~~~-~l~~~L~~~~~~ 469 (476)
|.+.+||||++|+++||||+|++||++||++||. +|+++|+|++++
T Consensus 77 l~v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~ 123 (123)
T 2zfd_B 77 FAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE 123 (123)
T ss_dssp EEEEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred EEEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence 9999999999999999999999999999999776 899999999863
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-29 Score=267.23 Aligned_cols=189 Identities=18% Similarity=0.213 Sum_probs=145.7
Q ss_pred EEeceEeecCceEEEEEEECCCCceEEEEEeecccccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
...+.||+|+||+||+|. ..+..+|+|........... ..+.+.+|+.+|++++||||+++..++......|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 345689999999999994 57888999987654332222 23568999999999999999955555556677799
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||++|++|.+++.. +..++.||+.||+|||++||+||||||
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp----------------------------- 459 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTT----------------------------- 459 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCT-----------------------------
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCH-----------------------------
Confidence 9999999999999865 668999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCC-----cccccccCCcccccccccc--CCCCCccchhhhHhHHHHH
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDG-----LLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~--~~~~~~~sDvwSlGvil~e 244 (476)
+|||++. .+||+|||+|+......... ...+.+||+.|||||++.. .+|. ..+|+||..+-..+
T Consensus 460 ------~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~ 530 (540)
T 3en9_A 460 ------SNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMK 530 (540)
T ss_dssp ------TSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHH
T ss_pred ------HHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHH
Confidence 9999999 99999999998654321111 1246789999999999987 6675 77899999988888
Q ss_pred HhcCCCCCC
Q 011868 245 ILTGYLPFD 253 (476)
Q Consensus 245 lltG~~Pf~ 253 (476)
.+.++-+|.
T Consensus 531 ~v~~r~rY~ 539 (540)
T 3en9_A 531 DVERRARYV 539 (540)
T ss_dssp HHHTCSCCC
T ss_pred HHHhccccC
Confidence 877776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-26 Score=222.72 Aligned_cols=143 Identities=20% Similarity=0.242 Sum_probs=115.8
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccch---------------hHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---------------KITDQIKREIATLKLLKHPNVVRLHEVLA 84 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---------------~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 84 (476)
+.||+|+||.||+|.+ .+|+.||||+++....... .....+.+|+.+|+.++| +++.+++.
T Consensus 96 ~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~~ 171 (282)
T 1zar_A 96 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVYA 171 (282)
T ss_dssp EEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEEE
T ss_pred CEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEEe
Confidence 9999999999999999 8899999999965432110 134678999999999994 55555554
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHh
Q 011868 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLM 164 (476)
Q Consensus 85 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~ 164 (476)
. +..|+||||++|++|.+ +. ..+...++.|++.||.|||++||+||||||
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp---------------------- 221 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQ---------------------- 221 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCST----------------------
T ss_pred c-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCH----------------------
Confidence 4 45699999999999988 42 134567999999999999999999999997
Q ss_pred hhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc
Q 011868 165 IVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 225 (476)
Q Consensus 165 ~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 225 (476)
+|||++ +|.+||+|||+|+ .+..|+|||.+.+
T Consensus 222 -------------~NILl~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 222 -------------YNVLVS-EEGIWIIDFPQSV---------------EVGEEGWREILER 253 (282)
T ss_dssp -------------TSEEEE-TTEEEECCCTTCE---------------ETTSTTHHHHHHH
T ss_pred -------------HHEEEE-CCcEEEEECCCCe---------------ECCCCCHHHHHHH
Confidence 999999 9999999999986 3456789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.8e-21 Score=188.09 Aligned_cols=139 Identities=21% Similarity=0.282 Sum_probs=109.5
Q ss_pred EEEeceEeecCceEEEEEEECCCCce--EEEEEeecccccc---------------------hhHHHHHHHHHHHHHhCC
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIH---------------------LKITDQIKREIATLKLLK 72 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~--vAvK~i~~~~~~~---------------------~~~~~~~~~Ei~~l~~l~ 72 (476)
|++.+.||+|+||.||+|.+..+|+. ||||+++.....- ......+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998778999 9999976432110 011246889999999998
Q ss_pred CCCc--ceEEEEEEeCCEEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hcCcEeccCCcch
Q 011868 73 HPNV--VRLHEVLASKSKIYMVLEYVTG-G----ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKVIL 144 (476)
Q Consensus 73 HpnI--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH-~~givHrDiKp~~ 144 (476)
|+++ +.+++. ...|+||||+.+ | +|.+.... .++..+..++.||+.||.||| +.||+||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp-- 199 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE-- 199 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST--
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH--
Confidence 8764 445543 246899999932 3 66655432 345678899999999999999 99999999997
Q ss_pred hccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCC
Q 011868 145 KSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSAL 198 (476)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~ 198 (476)
+|||++. .++|+|||+|..
T Consensus 200 ---------------------------------~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 200 ---------------------------------YNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp ---------------------------------TSEEESS--SEEECCCTTCEE
T ss_pred ---------------------------------HHEEEcC--cEEEEECccccc
Confidence 9999998 999999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=2.7e-18 Score=174.16 Aligned_cols=136 Identities=21% Similarity=0.235 Sum_probs=102.2
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc---------------chhH----HHHHHHHHHHHHhCCCCCc
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---------------HLKI----TDQIKREIATLKLLKHPNV 76 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~---------------~~~~----~~~~~~Ei~~l~~l~HpnI 76 (476)
|++++.||.|+||.||+|.+ .+|+.||||+++..... .... .-...+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999998 57999999998643210 0000 0123567888888865554
Q ss_pred c--eEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHH
Q 011868 77 V--RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATL 154 (476)
Q Consensus 77 v--~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~ 154 (476)
. ..++. .. .+|||||+.|++|.+.. ....+..++.||+.+|.|||++||+||||||
T Consensus 176 ~vp~p~~~--~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp------------ 233 (397)
T 4gyi_A 176 PVPEPIAQ--SR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNE------------ 233 (397)
T ss_dssp SCCCEEEE--ET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCST------------
T ss_pred CCCeeeec--cC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCH------------
Confidence 3 33332 22 37999999998886542 2234567899999999999999999999997
Q ss_pred HHHHHHHHHhhhccccccccCCCCceEeCCCCC----------EEEeccCCCC
Q 011868 155 QVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN----------IKISDFGLSA 197 (476)
Q Consensus 155 ~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~----------vkl~DFGla~ 197 (476)
.|||++++|. +.|+||+-+.
T Consensus 234 -----------------------~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 234 -----------------------FNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp -----------------------TSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred -----------------------HHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 9999998773 8999999665
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=8.7e-13 Score=126.62 Aligned_cols=111 Identities=12% Similarity=0.085 Sum_probs=89.4
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~ 90 (476)
.++.|++...+|.|+.+.||++.. .+..+++|+........ ...+.+|+.+++.+. +..+.++++++...+..|
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 467899999999999999999874 47889999986532111 246889999999985 678889999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~ 132 (476)
+||||++|.+|.+.+. +......++.+++.++..||+
T Consensus 87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhC
Confidence 9999999999876531 223345788999999999998
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.1e-11 Score=118.08 Aligned_cols=108 Identities=17% Similarity=0.168 Sum_probs=78.9
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEVLASKSKI 89 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~~~~~~~~ 89 (476)
.+..|.+....+.|..+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++++....+..
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 456677765555667799999864 567889999975431 245788999999986544 56689988888889
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g 134 (476)
|+||||++|.+|. . ...+ ...++.+++..+..||+..
T Consensus 91 ~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~ 127 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLD 127 (264)
T ss_dssp EEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSC
T ss_pred EEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCC
Confidence 9999999998883 2 1122 2356778888888888753
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.21 E-value=1.1e-10 Score=98.43 Aligned_cols=86 Identities=17% Similarity=0.290 Sum_probs=75.9
Q ss_pred eeeecCCHHHHHHHHHHHHHhcCeEEEeeC-CceeeeeccCCCcccCceEEEEEEEEEc-CceEEEEEEecCCChhhHHH
Q 011868 377 RFTSNHSAKDLLERIEDIVTEMGFRVQKKN-GKLKATQEHKPQKSLGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQ 454 (476)
Q Consensus 377 rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~-~~i~~~~~~~~~~~~~~l~~~~ev~~~~-~~~~lVe~~k~~Gd~lef~~ 454 (476)
..+|..+|++|+.+|++++..+|+.|++++ +.+++........ +.++|.+||+++. +++++|+|+|.+||.+.|++
T Consensus 32 ~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~--~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~ 109 (120)
T 3ose_A 32 KTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQD--SLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKN 109 (120)
T ss_dssp CCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTT--CCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHH
T ss_pred cCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCC--ccEEEEEEEEEecCCCceeEEEEecCCCHHHHHH
Confidence 356889999999999999999999998765 7888877544444 7899999999996 89999999999999999999
Q ss_pred HHHHHHhhcC
Q 011868 455 LCNKLSSDLG 464 (476)
Q Consensus 455 ~~~~l~~~L~ 464 (476)
+|.+|..+|+
T Consensus 110 lc~~il~~L~ 119 (120)
T 3ose_A 110 IASKIANELK 119 (120)
T ss_dssp HHHHHHHHCC
T ss_pred HHHHHHHHhc
Confidence 9999999886
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.1e-10 Score=117.35 Aligned_cols=109 Identities=16% Similarity=0.299 Sum_probs=81.1
Q ss_pred EeceEeecCceEEEEEEECCCCceEEEEEee--cccccchhHHHHHHHHHHHHHhCC--CCCcceEEEEEEeC---CEEE
Q 011868 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILE--KNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASK---SKIY 90 (476)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~--~~~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~---~~~~ 90 (476)
-++.|+.|.++.||+... .+..+++|+.. .... ......+.+|+.+++.+. +..+.+++.++.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 467899999999999874 35678899875 3321 112357889999999997 45688999988766 4589
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~ 132 (476)
+||||++|..+.+.. ...+++.+...++.+++..|..||+
T Consensus 118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhC
Confidence 999999998875422 2347888899999999999999997
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=1.4e-10 Score=113.97 Aligned_cols=216 Identities=19% Similarity=0.146 Sum_probs=125.2
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCC--cceEEEEEEeCC---EEEEE
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPN--VVRLHEVLASKS---KIYMV 92 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-Hpn--Iv~l~~~~~~~~---~~~lV 92 (476)
++.++.|....||+.. ..+++|+-... .....+.+|+.+|+.+. +.. +.+++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4569999999999753 46899986432 33578999999998884 333 445555543333 35899
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhh------------------HH
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIA------------------TL 154 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~------------------~~ 154 (476)
|++++|.+|.+... ..++..+...++.|++..++.||+...- ....... ...... ..
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINIS--GFKSNLV-LDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCT--TSCGGGB-CCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCC--CCCccch-hhHHHHHHHHHHHHHHHhcccCCccc
Confidence 99999998876443 3588899999999999999999974321 0100000 000000 00
Q ss_pred HHHHHHHHHh-hh-c------cccccccCCCCceEeCC--CCCEEEeccCCCCCCCcccCCCccccc---ccC-------
Q 011868 155 QVFLLTFLLM-IV-I------RPWKFNVLQLENILLDS--KGNIKISDFGLSALPQHFRDDGLLHTT---CGS------- 214 (476)
Q Consensus 155 ~~~~~~~~~~-~~-~------~p~~~~~~~~~NiLl~~--~g~vkl~DFGla~~~~~~~~~~~~~~~---~gt------- 214 (476)
.......... .. . +-.-+..+.+.||+++. .+.+.|+||+.+..-....+-...... .+.
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHH
Confidence 0000000000 00 0 11245667789999998 456889999988642211000000000 000
Q ss_pred --Ccccc-ccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 215 --PNYVA-PEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 215 --~~y~A-PE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
..+.. |+...... ...+.|++|.++|.+.+|..+|
T Consensus 250 ~~Y~~~~~~~~~~r~~---~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYR---MKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHH---HHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHH---HHHHHHHHHHHHHHHHcCCHHH
Confidence 01111 22221111 1268999999999999999776
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.82 E-value=8.9e-09 Score=86.68 Aligned_cols=86 Identities=16% Similarity=0.255 Sum_probs=73.5
Q ss_pred eeecCCHHHHHHHHHHHHHhcCeEEEe-eCCceeeeeccCCCcccCceEEEEEEEEEc-CceEEEEEEecCCChhhHHHH
Q 011868 378 FTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQL 455 (476)
Q Consensus 378 f~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~l~~~~ev~~~~-~~~~lVe~~k~~Gd~lef~~~ 455 (476)
.+|..+|++|+..|..+++.+|+.|+. +.+.+++........ ..++|.+||+++. .+++.|+|+|.+||.+.|+++
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~--~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~l 110 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAE--NLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNI 110 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTT--TCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHH
T ss_pred eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCC--ceEEEEEEEEEecCCCceeEEEeeccCchhHHHHH
Confidence 346789999999999999999999986 557777766433323 7899999999995 789999999999999999999
Q ss_pred HHHHHhhcCC
Q 011868 456 CNKLSSDLGL 465 (476)
Q Consensus 456 ~~~l~~~L~~ 465 (476)
|.+|...|+.
T Consensus 111 c~~IL~eLkL 120 (126)
T 1v5s_A 111 ASKIANELKL 120 (126)
T ss_dssp HHHHHHHTTC
T ss_pred HHHHHHHHhc
Confidence 9999998874
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=3.3e-07 Score=74.54 Aligned_cols=88 Identities=9% Similarity=0.278 Sum_probs=74.4
Q ss_pred ceeeeecCCHHHHHHHHHHHHHhcCeEEEe-eCCceeeeeccCCCcccCceEEEEEEEEEcCceEEEEEEecCCC-----
Q 011868 375 KIRFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGD----- 448 (476)
Q Consensus 375 ~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~l~~~~ev~~~~~~~~lVe~~k~~Gd----- 448 (476)
.....|...|.+|+..|..+++.+|+.|+. +.+.+++........ ..+.+.+++|++.++.+|+||++..||
T Consensus 9 ~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~--~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~ 86 (106)
T 4eai_A 9 HLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGG 86 (106)
T ss_dssp EESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEECCSSCCCSS
T ss_pred eEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCC--ceeEEEEEEEEecCCcEEEEEEeccCCCCCCC
Confidence 344567888999999999999999999987 568888876433222 568999999999999999999999994
Q ss_pred ---hhhHHHHHHHHHhhcC
Q 011868 449 ---PTVYRQLCNKLSSDLG 464 (476)
Q Consensus 449 ---~lef~~~~~~l~~~L~ 464 (476)
.++|-++|.++..+|.
T Consensus 87 ~~~~~~F~d~ca~li~~la 105 (106)
T 4eai_A 87 GSHTIEFFEMCANLIKILA 105 (106)
T ss_dssp SCHHHHHHHHHHHHHHHCC
T ss_pred CcCcEeHHHHHHHHHHHHh
Confidence 8999999999887774
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=1.1e-06 Score=86.18 Aligned_cols=104 Identities=18% Similarity=0.136 Sum_probs=80.4
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC---CcceEEEEEE-eCCEEEEEEe
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP---NVVRLHEVLA-SKSKIYMVLE 94 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hp---nIv~l~~~~~-~~~~~~lV~E 94 (476)
++.++.|....||+. |..+++|+-. .......+.+|..+|+.+.+. .+.+++.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 346889999999987 5678999842 123357899999999999753 3567777664 4566889999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011868 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g 134 (476)
+++|.++.+... ..++..+...+..|+...|..||+..
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~ 131 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFP 131 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSC
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 999988877432 34788888999999999999999864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=1.4e-06 Score=83.39 Aligned_cols=103 Identities=11% Similarity=0.170 Sum_probs=78.0
Q ss_pred eEeecCce-EEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCC
Q 011868 21 TLGEGNFG-KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYVTG 98 (476)
Q Consensus 21 ~LG~G~fg-~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~g 98 (476)
.+..|..+ .||+......+..+.+|+-... ....+.+|...|+.+. +--+.+++.++...+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445544 7998887667788999986433 2567889999999885 33477899999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 011868 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133 (476)
Q Consensus 99 g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~ 133 (476)
.++.+.... .......+..++...|.-||+.
T Consensus 105 ~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~ 135 (272)
T 4gkh_A 105 KTAFQVLEE----YPDSGENIVDALAVFLRRLHSI 135 (272)
T ss_dssp EEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTS
T ss_pred ccccccccC----CHHHHHHHHHHHHHHHHHhcCC
Confidence 888776543 2234456788899999999975
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.46 E-value=2.2e-06 Score=73.84 Aligned_cols=74 Identities=7% Similarity=0.237 Sum_probs=60.6
Q ss_pred cceeeeecCCHHHHHHHHHHHHHhcCeEEEe-eCCceeeeeccCCCcccCceEEEEEEEEEcCceEEEEEEecCCCh
Q 011868 374 RKIRFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDP 449 (476)
Q Consensus 374 ~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~l~~~~ev~~~~~~~~lVe~~k~~Gd~ 449 (476)
.....-|...|.+|+..|..+++.+|+.|++ +.+.|++........ ..+.|.+++|++.++.|||||++..||+
T Consensus 5 WhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~--~~vKm~LQLYkv~~~~YLLDFk~l~g~~ 79 (157)
T 2v8q_A 5 WHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEI 79 (157)
T ss_dssp EEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC-
T ss_pred ceeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCC--ceEEEEEEEEEecCCCEEEEEEecCCCc
Confidence 3445567889999999999999999999997 568888876533221 4689999999999999999999999986
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=9.9e-06 Score=70.62 Aligned_cols=77 Identities=8% Similarity=0.221 Sum_probs=61.9
Q ss_pred ccceeeeecCCHHHHHHHHHHHHHhcCeEEEe-eCCceeeeeccCCCcccCceEEEEEEEEEcCceEEEEEEecCCChhh
Q 011868 373 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTV 451 (476)
Q Consensus 373 ~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~l~~~~ev~~~~~~~~lVe~~k~~Gd~le 451 (476)
+.....-|...|.+|+..|..+++.+|+.|++ +.+.|++....... ...++|.+++|++.++.|||||++..||+.|
T Consensus 18 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~--~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e 95 (173)
T 2y8l_A 18 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVT--STFSKMSLQLYQVDSRTYLLDFRSIDDEITE 95 (173)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTT--CCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCC--CeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence 45556678889999999999999999999997 56888887643221 1468999999999999999999999998744
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=98.24 E-value=1e-05 Score=67.48 Aligned_cols=71 Identities=6% Similarity=0.224 Sum_probs=57.1
Q ss_pred eeeecCCHHHHHHHHHHHHHhcCeEEEe-eCCceeeeeccCCCcccCceEEEEEEEEEcCceEEEEEEecCCCh
Q 011868 377 RFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDP 449 (476)
Q Consensus 377 rf~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~l~~~~ev~~~~~~~~lVe~~k~~Gd~ 449 (476)
..-|...|.+|+..|..+++.+|+.|+. +.+.+++........ ..+.+.+++|++.++.||+||++..||.
T Consensus 11 GIrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~--~~vKm~LQLYqv~~~~YLLDfk~~~~~~ 82 (130)
T 4eag_A 11 GIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTG--KFSKMSLQLYQVDAKSYLLDFKSLTNDE 82 (130)
T ss_dssp SBCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEESSSSCEEEEEEECC---
T ss_pred eeecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCC--ceeEEEEEEEEecCCcEEEEeccCCcch
Confidence 3446778999999999999999999987 568888876443332 5688999999999999999999999994
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=2.9e-06 Score=86.14 Aligned_cols=106 Identities=16% Similarity=0.118 Sum_probs=61.4
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecccc-cch---hHHHHHHHHHHHHHhCCC--C-CcceEEEEEEeCCEEEE
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHL---KITDQIKREIATLKLLKH--P-NVVRLHEVLASKSKIYM 91 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~---~~~~~~~~Ei~~l~~l~H--p-nIv~l~~~~~~~~~~~l 91 (476)
.+.||.|.++.||++.+..+++.++||....... ... .....+..|..+++.+.. | .+.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 5689999999999997655678899998653210 000 113456789999988742 3 34466654 3445689
Q ss_pred EEeccCCCChH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 011868 92 VLEYVTGGELF-DKIASKGRLQEAEGRKLFQQLIDGVSYCH 131 (476)
Q Consensus 92 V~E~~~gg~L~-~~l~~~~~l~~~~~~~~~~qi~~al~yLH 131 (476)
|||+++|.... ..+.. +..... .+.++...|+-+|
T Consensus 113 vmE~l~g~~~~~~~l~~-~~~~~~----~~~~l~~~La~lH 148 (397)
T 2olc_A 113 VMEDLSHLKIARKGLIE-GENYPH----LSQHIGEFLGKTL 148 (397)
T ss_dssp EECCCTTSEEHHHHHHT-TCCCTT----HHHHHHHHHHHHH
T ss_pred EEEeCCCcchHHHHHhc-CCcCHH----HHHHHHHHHHHHh
Confidence 99999775443 22222 111211 2345555666666
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=2.8e-06 Score=84.78 Aligned_cols=118 Identities=11% Similarity=0.152 Sum_probs=79.7
Q ss_pred EEeceE-eecCceEEEEEEEC---C---CCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-C--CCcceEEEEEEeC
Q 011868 17 ELGRTL-GEGNFGKVKFAQDL---D---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H--PNVVRLHEVLASK 86 (476)
Q Consensus 17 ~i~~~L-G~G~fg~V~~a~~~---~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-H--pnIv~l~~~~~~~ 86 (476)
...+.| +.|....+|+.... . ++..+++|+..............+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345678 88999999987642 0 26678999865432000000145778999998884 3 3577888887655
Q ss_pred ---CEEEEEEeccCCCChHHHHHh---c---CCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011868 87 ---SKIYMVLEYVTGGELFDKIAS---K---GRLQEAEGRKLFQQLIDGVSYCHNKG 134 (476)
Q Consensus 87 ---~~~~lV~E~~~gg~L~~~l~~---~---~~l~~~~~~~~~~qi~~al~yLH~~g 134 (476)
+..|+|||+++|..+.+.+.. . ..++..+...++.+++..|.-||+..
T Consensus 103 ~~~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~ 159 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIP 159 (357)
T ss_dssp TTTSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCS
T ss_pred CccCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 457899999999877653210 0 13567777788999999999999754
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=9.7e-06 Score=69.16 Aligned_cols=92 Identities=12% Similarity=0.177 Sum_probs=71.7
Q ss_pred ccceeeeecCCHHHHHHHHHHHHHhcCeEEEee---------C-CceeeeeccCCC---cccCceEEEEEEEEEcCceEE
Q 011868 373 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK---------N-GKLKATQEHKPQ---KSLGSLSVAAEVFEISPSLYV 439 (476)
Q Consensus 373 ~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~---------~-~~i~~~~~~~~~---~~~~~l~~~~ev~~~~~~~~l 439 (476)
+.....-|...|.+|+..|..|++.+|+.|+.. + +.|++....+.. .....+.|.+++|++.++.+|
T Consensus 12 kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YL 91 (137)
T 2qrd_A 12 KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFM 91 (137)
T ss_dssp CCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEE
T ss_pred ccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEE
Confidence 344555688899999999999999999999865 3 557776532210 001358899999999999999
Q ss_pred EEEEecCCC---------------h----hhHHHHHHHHHhhcC
Q 011868 440 VELRKSYGD---------------P----TVYRQLCNKLSSDLG 464 (476)
Q Consensus 440 Ve~~k~~Gd---------------~----lef~~~~~~l~~~L~ 464 (476)
|||++..|+ . ++|-.+|.+|..+|.
T Consensus 92 lDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~Li~eLa 135 (137)
T 2qrd_A 92 LDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF 135 (137)
T ss_dssp EEEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred EEEEecCCccccccCccccccCCccccccccHHHHHHHHHHHHh
Confidence 999999999 5 899999998877664
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=4e-05 Score=75.35 Aligned_cols=73 Identities=15% Similarity=0.244 Sum_probs=42.4
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCcceEE-E--EEEeCCEEEE
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----HPNVVRLH-E--VLASKSKIYM 91 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-----HpnIv~l~-~--~~~~~~~~~l 91 (476)
+.|+.|..+.||+... .+| .+++|+.... ...+..|..+++.+. .|.++... + +....+..|+
T Consensus 38 ~~l~gG~~n~~~~v~~-~~~-~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHT-DSG-AVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEE-TTE-EEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeccccccCcEEEEEe-CCC-CEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 4567778899999875 333 5899998652 133445556665553 24444310 0 1234678899
Q ss_pred EEeccCCCCh
Q 011868 92 VLEYVTGGEL 101 (476)
Q Consensus 92 V~E~~~gg~L 101 (476)
+|+|++|.++
T Consensus 109 l~~~i~G~~~ 118 (346)
T 2q83_A 109 VYDWIEGRPF 118 (346)
T ss_dssp EEECCCCBCC
T ss_pred EEEeecCccC
Confidence 9999998654
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=97.94 E-value=6.3e-05 Score=66.22 Aligned_cols=93 Identities=17% Similarity=0.215 Sum_probs=72.6
Q ss_pred ccceeeeecCCHHHHHHHHHHHHHhcCeEEEee----CCceeeeeccCCC-------cccCceEEEEEEEEEcCceEEEE
Q 011868 373 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK----NGKLKATQEHKPQ-------KSLGSLSVAAEVFEISPSLYVVE 441 (476)
Q Consensus 373 ~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~----~~~i~~~~~~~~~-------~~~~~l~~~~ev~~~~~~~~lVe 441 (476)
+.....-|...|.+|+..|..+++.+|+.|++. .|.|++....... +....+.|.+++|++.++.||||
T Consensus 50 kW~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLD 129 (179)
T 3t4n_A 50 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 129 (179)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEE
T ss_pred eeeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEE
Confidence 444556688999999999999999999999873 5778887532110 11145899999999999999999
Q ss_pred EEecCC----------------------ChhhHHHHHHHHHhhcCCC
Q 011868 442 LRKSYG----------------------DPTVYRQLCNKLSSDLGLP 466 (476)
Q Consensus 442 ~~k~~G----------------------d~lef~~~~~~l~~~L~~~ 466 (476)
|+ ..| ....|-.+|.+|.-+|...
T Consensus 130 fk-~~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~LI~eLa~~ 175 (179)
T 3t4n_A 130 FK-FDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMELAVN 175 (179)
T ss_dssp EE-EEEEECC----------------CCCCHHHHHHHHHHHHHHHHT
T ss_pred EE-eccccccccccccccccccccccccCCccHHHHHHHHHHHHHhc
Confidence 99 778 7789999999887777543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00025 Score=69.67 Aligned_cols=75 Identities=21% Similarity=0.247 Sum_probs=61.0
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEec
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~lV~E~ 95 (476)
.+.|+.|....+|+... ++..+++|+-... ....+.+|...|+.+. ...+.+++.+....+..|+||||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 46789999999999873 5678899987543 2567889999999884 35688899988888899999999
Q ss_pred cCCCCh
Q 011868 96 VTGGEL 101 (476)
Q Consensus 96 ~~gg~L 101 (476)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.68 E-value=0.0003 Score=64.88 Aligned_cols=124 Identities=17% Similarity=0.139 Sum_probs=80.7
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCC
Q 011868 99 GELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177 (476)
Q Consensus 99 g~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 177 (476)
-+|.+.|.. +.+++|+++|.++.|.+.+|.-+-...--|..|.. |
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~----------------------------------~ 78 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRS----------------------------------A 78 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCS----------------------------------G
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecC----------------------------------C
Confidence 368888875 56899999999999999998765211111333433 6
Q ss_pred CceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCCcH
Q 011868 178 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL 257 (476)
Q Consensus 178 ~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~~~ 257 (476)
..|++..+|+|-..+ +.+. .....+.|||... ...+.+.=|||||+++|..+--..|=
T Consensus 79 ~~i~l~~dG~V~f~~-~~s~--------------~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e----- 136 (229)
T 2yle_A 79 AQIRVWRDGAVTLAP-AADD--------------AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE----- 136 (229)
T ss_dssp GGEEEETTSCEEECC-C--------------------------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----
T ss_pred cceEEecCCceeccc-cccc--------------ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----
Confidence 899999999987763 2111 1233566888753 22247789999999999888533331
Q ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCC
Q 011868 258 AVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 290 (476)
Q Consensus 258 ~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 290 (476)
.-+..+|+++.+||..|..-.
T Consensus 137 ------------~eE~eLS~~LE~LL~~Mt~~~ 157 (229)
T 2yle_A 137 ------------NEERELSPPLEQLIDHMANTV 157 (229)
T ss_dssp ------------TEEECCCHHHHHHHHHHTTCC
T ss_pred ------------ccchhhCHHHHHHHHHHHhcc
Confidence 123559999999999998763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.0003 Score=71.81 Aligned_cols=77 Identities=13% Similarity=0.069 Sum_probs=45.9
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecccc-cchh-----HHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCEEEE
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHLK-----ITDQIKREIATLK-LLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~-----~~~~~~~Ei~~l~-~l~HpnIv~l~~~~~~~~~~~l 91 (476)
.+.||.|..+.||++. .++..++||....... .... ....+..|+..+. ...+..+.+++.+. .+..++
T Consensus 39 i~~l~~G~~n~vyrv~--~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVV--GSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEECCCSSSCEEEEEE--CSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEccCCCcEEEEEEE--cCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 5678999999999986 3567899994321100 0000 1223333333322 12234567777765 566799
Q ss_pred EEecc-CCC
Q 011868 92 VLEYV-TGG 99 (476)
Q Consensus 92 V~E~~-~gg 99 (476)
|||++ +|.
T Consensus 115 v~e~l~~g~ 123 (420)
T 2pyw_A 115 GMRYLEPPH 123 (420)
T ss_dssp EECCCCTTC
T ss_pred EEeecCCcc
Confidence 99999 873
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0005 Score=66.75 Aligned_cols=97 Identities=13% Similarity=-0.015 Sum_probs=59.3
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEecc-
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYV- 96 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E~~- 96 (476)
++.|+.|....+|+. ..+++|+..... .. .....+|+.+++.+...++ .+++.+. ...-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---EE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc---cc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 788999999999988 568999875431 11 1123568888887753233 4666543 33347899999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011868 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (476)
Q Consensus 97 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g 134 (476)
+|.++....... ...++.+++..|+-||+.+
T Consensus 91 ~g~~l~~~~~~~-------~~~~~~~~~~~La~lH~~~ 121 (301)
T 3dxq_A 91 GAQTMSPEKFKT-------RPGSPARAGEAFRKLHGSG 121 (301)
T ss_dssp TCEECCHHHHHH-------STTHHHHHHHHHHHHHTSC
T ss_pred CCccCCHhhHhh-------hHHHHHHHHHHHHHHhCCC
Confidence 665553211000 0125667777778888754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00066 Score=66.26 Aligned_cols=81 Identities=11% Similarity=0.108 Sum_probs=47.9
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEE------EEe
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEV------LAS 85 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~------~~~ 85 (476)
+...-.+.|+.|....+|+... .+| .+++|+..... . ...+..|+.+++.+...+ +.+++.. ...
T Consensus 22 ~~~~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 22 GSLTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp CCEEEEEEECC---EEEEEEEE-SSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred CcceEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 3444456788899999999875 334 68899986531 1 234566777777764212 2333311 123
Q ss_pred CCEEEEEEeccCCCCh
Q 011868 86 KSKIYMVLEYVTGGEL 101 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L 101 (476)
.+..+++|+|++|..+
T Consensus 95 ~g~~~~l~~~l~G~~~ 110 (322)
T 2ppq_A 95 SGRPAALISFLEGMWL 110 (322)
T ss_dssp TTEEEEEEECCCCBCC
T ss_pred CCEEEEEEEeCCCcCC
Confidence 4678999999998664
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0018 Score=63.56 Aligned_cols=103 Identities=10% Similarity=0.109 Sum_probs=57.4
Q ss_pred eceEeecCceE-EEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEec
Q 011868 19 GRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 19 ~~~LG~G~fg~-V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~~~~lV~E~ 95 (476)
.+.|+.|+... +|+... .+|..+++|...... ...+..|+.+++.+.. -.+.+++.+....+ +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 34566665554 666652 236677777654321 0234567777777742 23556776644444 789999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011868 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (476)
Q Consensus 96 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g 134 (476)
+.+..+.+.+... ...+ ...+.+++..|.-||...
T Consensus 94 l~~~~l~~~l~~~-~~~~---~~~~~~~~~~La~lH~~~ 128 (333)
T 3csv_A 94 LGDALFTEVINND-PAQE---MPLYRAAVDLLIHLHDAQ 128 (333)
T ss_dssp CCSCBHHHHHHHC-GGGH---HHHHHHHHHHHHHHHTSC
T ss_pred CCCcchHHHhcCC-CccH---HHHHHHHHHHHHHHhcCC
Confidence 9777777766532 2221 356678888888888753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0054 Score=58.88 Aligned_cols=79 Identities=15% Similarity=0.109 Sum_probs=56.4
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-C--CCcceEEEEEEeCCEEEE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H--PNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-H--pnIv~l~~~~~~~~~~~l 91 (476)
+..-++.+|.|..+.||+.+. .+|+.|.+|+-..... .....+.+|+..|+.+. . --+.+++.+. . -++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceE
Confidence 355678899999999999985 6789999998654321 11346788999999884 2 2355565542 2 378
Q ss_pred EEeccCCCCh
Q 011868 92 VLEYVTGGEL 101 (476)
Q Consensus 92 V~E~~~gg~L 101 (476)
||||+.++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0018 Score=66.41 Aligned_cols=99 Identities=10% Similarity=0.108 Sum_probs=64.7
Q ss_pred eceEeecCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEE
Q 011868 19 GRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIY 90 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~ 90 (476)
++.|+.|....||++.... .+..+.+|+..... . ...+.+|..+++.+...++ .++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 4678889999999998643 25789999884321 1 1345579999988853333 677776542 3
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g 134 (476)
+||||++|.+|... .+. -...+.+++..|+-||...
T Consensus 149 ~v~e~l~G~~l~~~-----~l~---~~~~~~~ia~~La~LH~~~ 184 (429)
T 1nw1_A 149 RLEEYIPSRPLSCH-----EIS---LAHMSTKIAKRVAKVHQLE 184 (429)
T ss_dssp EEECCCCEEECCTT-----GGG---SHHHHHHHHHHHHHHTTCC
T ss_pred EEEEEeCCcccChh-----hcC---CHHHHHHHHHHHHHHhCCc
Confidence 89999987555321 011 1134677888888888754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0056 Score=59.69 Aligned_cols=76 Identities=24% Similarity=0.224 Sum_probs=48.9
Q ss_pred ceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEE-----EEeCCEEEEE
Q 011868 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEV-----LASKSKIYMV 92 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~-----~~~~~~~~lV 92 (476)
+.|+ |....||+... .+|+.+++|+...... . ...+..|..+++.+...+ +++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 3566 88889998763 4566899999864321 1 356677888888774222 3333332 2335677899
Q ss_pred EeccCCCCh
Q 011868 93 LEYVTGGEL 101 (476)
Q Consensus 93 ~E~~~gg~L 101 (476)
|++++|.++
T Consensus 106 ~~~i~G~~~ 114 (328)
T 1zyl_A 106 FPSVGGRQF 114 (328)
T ss_dssp EECCCCEEC
T ss_pred EEecCCCCC
Confidence 999987543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.002 Score=64.90 Aligned_cols=100 Identities=14% Similarity=0.081 Sum_probs=59.8
Q ss_pred eceEeecCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 011868 19 GRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~ 90 (476)
++.|..|-...+|+..... +++.+.+|+.... ......+.+|..+++.+. +.-..++++.+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3567778888899887532 3578999986321 112456679999998885 3334667776643 2
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g 134 (476)
+||||++|..|... .+.. ..+..+++..|+-||+..
T Consensus 127 ~v~e~i~G~~l~~~-----~l~~---p~~~~~ia~~La~LH~~~ 162 (379)
T 3feg_A 127 RLEQYIPSRPLKTQ-----ELRE---PVLSAAIATKMAQFHGME 162 (379)
T ss_dssp EEEECCSEEECCGG-----GGGC---HHHHHHHHHHHHHHHTCC
T ss_pred cEEEEecCccCChh-----HhCC---HHHHHHHHHHHHHHhCCC
Confidence 89999998665321 1111 134567777888888754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0032 Score=62.86 Aligned_cols=99 Identities=10% Similarity=0.015 Sum_probs=58.0
Q ss_pred eceEeecCceEEEEEEECC--------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEE
Q 011868 19 GRTLGEGNFGKVKFAQDLD--------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKI 89 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~~~ 89 (476)
.+.|+.|....+|+..... .+..+++|+..... .. ......|..+++.+...+ +.++++.. .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 4578888889999988643 13678999875431 11 112467888888885333 45676554 22
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~ 133 (476)
++||||++|.++...-. .+ ...+.+++..|+-||+.
T Consensus 110 ~~v~e~i~G~~l~~~~~----~~----~~~~~~~a~~La~lH~~ 145 (369)
T 3c5i_A 110 GRIEEWLYGDPLRIDDL----KN----PTILIGIANVLGKFHTL 145 (369)
T ss_dssp EEEEECCCSEECCGGGG----GC----HHHHHHHHHHHHHHHTH
T ss_pred cEEEEEecCCcCChhhc----CC----hHHHHHHHHHHHHHHcC
Confidence 68999998865421100 01 12456777888888863
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.54 E-value=0.013 Score=57.84 Aligned_cols=92 Identities=13% Similarity=0.147 Sum_probs=56.5
Q ss_pred eecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEE------EEeCCEEEEEE
Q 011868 23 GEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEV------LASKSKIYMVL 93 (476)
Q Consensus 23 G~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~------~~~~~~~~lV~ 93 (476)
|.|....||+... .+| .+++|+...... .+|+.+++.+. -|++++.+.. ....+..|++|
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~ 100 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAY 100 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEE
Confidence 3444689998874 345 899998765431 34555565553 2224444322 23457889999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g 134 (476)
+|++|..+.+ ..++..+ +.++...|+-||...
T Consensus 101 ~~i~G~~~~~-----~~~~~~~----~~~lg~~La~LH~~~ 132 (339)
T 3i1a_A 101 PFIHAPNGFT-----QNLTGKQ----WKQLGKVLRQIHETS 132 (339)
T ss_dssp ECCCCCBTTT-----SCCCHHH----HHHHHHHHHHHHTCC
T ss_pred eccCCCcCcc-----cCCCHHH----HHHHHHHHHHHhCcC
Confidence 9999877631 2244433 356777788888764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.98 E-value=0.078 Score=54.62 Aligned_cols=100 Identities=11% Similarity=0.147 Sum_probs=62.6
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccC
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYVT 97 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~ 97 (476)
++.|+.|-...+|+......+..+++|+..... .. .-...+|..+++.+...++ .++++.+. + .+||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 467888999999999875445789999874321 11 1112589999999975444 56777763 2 24999998
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011868 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (476)
Q Consensus 98 gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g 134 (476)
|.+|.. ..+.. ..++.+++..|+-||+..
T Consensus 185 G~~l~~-----~~l~~---~~~~~~ia~~La~LH~~~ 213 (458)
T 2qg7_A 185 GYALSR-----EDIKN---PKFQKLIAKNLKLLHDIK 213 (458)
T ss_dssp SEECCT-----TTTTS---HHHHHHHHHHHHHHHTCC
T ss_pred CccCCh-----hhcCC---HHHHHHHHHHHHHHhcCC
Confidence 855531 11111 134566777777888654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.86 E-value=0.059 Score=54.95 Aligned_cols=101 Identities=13% Similarity=0.095 Sum_probs=63.2
Q ss_pred eceEeecCceEEEEEEECCC-------CceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 011868 19 GRTLGEGNFGKVKFAQDLDS-------GLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~ 90 (476)
++.|..|-...+|+...... +..+++++..... ...-...+|..+++.+. +.-..++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 45677888889999886421 5789999864321 11123467888888885 33345666543 22 7
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~gi 135 (476)
+||||++|..|... .+.. ..+..+++..|+-||+..+
T Consensus 147 ~I~efI~G~~l~~~-----~l~~---~~~~~~ia~~La~LH~~~~ 183 (424)
T 3mes_A 147 RIEEFIDGEPLTTK-----QLQL---THICVEVAKNMGSLHIINS 183 (424)
T ss_dssp EEEECCCSEECCTG-----GGGS---HHHHHHHHHHHHHHHTHHH
T ss_pred EEEEEeCCccCChh-----hcCC---HHHHHHHHHHHHHHhcCch
Confidence 89999998654221 0111 1356678888888887544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.60 E-value=1.1 Score=44.76 Aligned_cols=108 Identities=7% Similarity=0.074 Sum_probs=57.4
Q ss_pred cCEEEeceEeecCceEEEEEEECC-------CCceEEEEEeeccccc---ch---hH---------HHHHHHHHHHHHhC
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRII---HL---KI---------TDQIKREIATLKLL 71 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~-------~~~~vAvK~i~~~~~~---~~---~~---------~~~~~~Ei~~l~~l 71 (476)
+..+ ++.|+.|-.-.+|++.... ....|.+++....... .. .. ......|..++..+
T Consensus 53 ~~l~-v~~lsGG~SN~~y~v~~~~~~~~~~~~~~~~llRi~g~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~e~~~~~~l 131 (401)
T 3g15_A 53 DEFH-ISVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLYGAILQMRSCNKEGSEQAQKENEFQGAEAMVLESVMFAIL 131 (401)
T ss_dssp GGCE-EEEEECSSEEEEEEEECCTTCCCSSSCCSEEEEEEEEC-----------------------CHHHHHHHHHHHHH
T ss_pred CCEE-EEEeCCccccceEEEEECCCCcccccCCCeEEEEeCCCCccchhhhhHHHHHHHHHHhccCCCCCcchhHHHHHH
Confidence 4455 4577778888899987543 2356888875322100 00 00 01122455555555
Q ss_pred CCCCc-ceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011868 72 KHPNV-VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (476)
Q Consensus 72 ~HpnI-v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g 134 (476)
.-.++ .++++.+.. ..+++|++|..|... +.....+..+|+..|+-||+..
T Consensus 132 s~~g~~p~l~~~f~~----g~i~e~i~g~~l~~~--------~~~~~~~~~~ia~~La~lH~~~ 183 (401)
T 3g15_A 132 AERSLGPKLYGIFPQ----GRLEQFIPSRRLDTE--------ELSLPDISAEIAEKMATFHGMK 183 (401)
T ss_dssp HHTTSSCCEEEEETT----EEEEECCCEEECCGG--------GGGSHHHHHHHHHHHHHHHTCC
T ss_pred HhCCCCCEEEEEECC----cEEEEecCCCcCChh--------hhcCHHHHHHHHHHHHHHhccc
Confidence 43333 356666542 357888877544211 1112345667788888888653
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.88 E-value=0.069 Score=55.12 Aligned_cols=64 Identities=9% Similarity=0.153 Sum_probs=18.9
Q ss_pred EEeceEeecCceEEEEEEECCCCceEEE------EEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011868 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAV------KILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (476)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~~~~~vAv------K~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 84 (476)
.+.+.|| ||.||.|....+..+||+ |....... ..+....+.+|..+++.++|||+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEE
Confidence 4456776 999999987655568999 76543322 2233456788999999999999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 476 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-82 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-79 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-78 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-75 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-75 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-73 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-73 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-72 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-71 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-71 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-69 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-69 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-68 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-67 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-67 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-67 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-67 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-66 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-66 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-64 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-63 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-63 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-62 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-60 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-58 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-57 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-57 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-54 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-54 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-54 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-54 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-54 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-52 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-52 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-49 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-46 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-41 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-34 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-17 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 2e-15 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (646), Expect = 4e-82
Identities = 85/297 (28%), Positives = 145/297 (48%), Gaps = 40/297 (13%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L +E+GR LG+G FG V A++ S A+K+L K ++ + Q++RE+ L+
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HPN++RL+ +++Y++LEY G ++ ++ + E +L + +SYCH+
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
K V HRD+K EN+LL S G +KI+D
Sbjct: 125 KRVIHRDIK-----------------------------------PENLLLGSAGELKIAD 149
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
FG S T CG+ +Y+ PE++ R +D D+WS GV+ Y L G PF
Sbjct: 150 FGWSV----HAPSSRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPF 204
Query: 253 DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309
+ Y++I R +F P +++ GA++L+ ++L+ NP +R + + W +
Sbjct: 205 EANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (625), Expect = 8e-79
Identities = 101/301 (33%), Positives = 150/301 (49%), Gaps = 40/301 (13%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ ++L +TLGEG +G+V+ A + + AVKI++ R + + IK+EI K+L
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H NVV+ + + Y+ LEY +GGELFD+I + E + ++ F QL+ GV Y H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
G+ HRD+K EN+LLD + N+KISD
Sbjct: 122 IGITHRDIK-----------------------------------PENLLLDERDNLKISD 146
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
FGL+ + ++ + LL+ CG+ YVAPE+L R + D+WSCG++L +L G LP+
Sbjct: 147 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 206
Query: 253 D-DRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309
D + Y L W + LL KIL NP RITI IK D W+ +
Sbjct: 207 DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266
Query: 310 Y 310
Sbjct: 267 L 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 9e-78
Identities = 82/298 (27%), Positives = 135/298 (45%), Gaps = 36/298 (12%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
R ++ G+ LGEG+F V A++L + +A+KILEK II + RE +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
L HP V+L+ K+Y L Y GEL I G E R +++ + Y
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKI 190
H KG+ HRDLK ENILL+ +I+I
Sbjct: 125 HGKGIIHRDLK-----------------------------------PENILLNEDMHIQI 149
Query: 191 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250
+DFG + + ++ G+ YV+PE+L + + SD+W+ G I+Y ++ G
Sbjct: 150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLP 208
Query: 251 PFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308
PF N +++QKI + ++ P+ P A++L+ K+L + KR+ ++ +
Sbjct: 209 PFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 239 bits (610), Expect = 2e-75
Identities = 76/310 (24%), Positives = 143/310 (46%), Gaps = 49/310 (15%)
Query: 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
++G Y++ LG G FG V + +G F K + + +K EI+
Sbjct: 23 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISI 79
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDG 126
+ L HP ++ LH+ K ++ ++LE+++GGELFD+IA++ ++ EAE +Q +G
Sbjct: 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK- 185
+ + H + H D ++ ENI+ ++K
Sbjct: 140 LKHMHEHSIVHLD-----------------------------------IKPENIMCETKK 164
Query: 186 -GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
++KI DFGL+ D ++ T + + APE++ +D+W+ GV+ YV
Sbjct: 165 ASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYV 220
Query: 245 ILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGI 300
+L+G PF + Q + R D++ + +SP A++ ++ +L+ P KR+T+
Sbjct: 221 LLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
Query: 301 KADEWFEQDY 310
W + D+
Sbjct: 281 LEHPWLKGDH 290
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 237 bits (606), Expect = 5e-75
Identities = 79/315 (25%), Positives = 137/315 (43%), Gaps = 49/315 (15%)
Query: 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
+ L Y++ LG G FG V + +G FA K + H + +++EI T
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQT 76
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDG 126
+ +L+HP +V LH+ +++ M+ E+++GGELF+K+A + ++ E E + +Q+ G
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK- 185
+ + H H DLK ENI+ +K
Sbjct: 137 LCHMHENNYVHLDLK-----------------------------------PENIMFTTKR 161
Query: 186 -GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
+K+ DFGL+A H + T G+ + APEV + +D+WS GV+ Y+
Sbjct: 162 SNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYI 217
Query: 245 ILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGI 300
+L+G PF N + + D+ + +S ++ +RK+L +P R+TI
Sbjct: 218 LLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277
Query: 301 KADEWFEQDYTPANP 315
W P
Sbjct: 278 LEHPWLTPGNAPGRD 292
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 231 bits (591), Expect = 3e-73
Identities = 99/305 (32%), Positives = 146/305 (47%), Gaps = 42/305 (13%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y+ LG G F +V A+D + A+K + K + ++ EIA L +KHP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHP 67
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+V L ++ S +Y++++ V+GGELFD+I KG E + +L Q++D V Y H+ G
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
+ HRDL N+L LD I ISDFG
Sbjct: 128 IVHRDL-----------------------------KPENLL---YYSLDEDSKIMISDFG 155
Query: 195 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254
LS + +L T CG+P YVAPEVLA + Y A D WS GVI Y++L GY PF D
Sbjct: 156 LSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYD 211
Query: 255 RNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310
N A L+++I + +++ +S A++ +R ++E +P KR T W D
Sbjct: 212 ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271
Query: 311 TPANP 315
Sbjct: 272 ALDKN 276
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 5e-73
Identities = 73/304 (24%), Positives = 132/304 (43%), Gaps = 48/304 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+E+ LG+G FGKV AQ+ ++ + A K+++ L+ EI L HP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE---DYMVEIDILASCDHP 69
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNK 133
N+V+L + ++ +++++E+ GG + + R L E++ + + +Q +D ++Y H+
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
+ HRDLK NIL G+IK++DF
Sbjct: 130 KIIHRDLK-----------------------------------AGNILFTLDGDIKLADF 154
Query: 194 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD----GATSDIWSCGVILYVILTGY 249
G+SA ++ R + G+P ++APEV+ +D+WS G+ L +
Sbjct: 155 GVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212
Query: 250 LPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
P + N + KI + + P S ++ L+K LE N R T + + +
Sbjct: 213 PPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
Query: 307 EQDY 310
D
Sbjct: 273 TVDS 276
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 229 bits (585), Expect = 2e-72
Identities = 64/307 (20%), Positives = 114/307 (37%), Gaps = 45/307 (14%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ R +G G+FG V FA+D+ + A+K + + + I +E+ L+ L+HP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N ++ + ++V+EY G K LQE E + + G++Y H+
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
+ HRD+K NILL G +K+ DFG
Sbjct: 136 MIHRDVK-----------------------------------AGNILLSEPGLVKLGDFG 160
Query: 195 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT--SDIWSCGVILYVILTGYLPF 252
+ ++ G+P ++APEV+ D+WS G+ + P
Sbjct: 161 SA------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
Query: 253 DDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310
+ N I + + + S +N + L+ P R T + + ++
Sbjct: 215 FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274
Query: 311 TPANPDD 317
P D
Sbjct: 275 PPTVIMD 281
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 225 bits (575), Expect = 2e-71
Identities = 84/310 (27%), Positives = 136/310 (43%), Gaps = 54/310 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL------KITDQIKREIATL 68
YE LG G V+ + +AVKI++ ++ + +E+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 69 KLLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
+ + HPN+++L + + + ++V + + GELFD + K L E E RK+ + L++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
H + HRDLK ENILLD N
Sbjct: 124 CALHKLNIVHRDLK-----------------------------------PENILLDDDMN 148
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVIL 242
IK++DFG S L CG+P+Y+APE++ N G D+WS GVI+
Sbjct: 149 IKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 205
Query: 243 YVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW--LSPGAQNLLRKILEPNPVKRITIA 298
Y +L G PF R ++ + I G+++ P+W S ++L+ + L P KR T
Sbjct: 206 YTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 265
Query: 299 GIKADEWFEQ 308
A +F+Q
Sbjct: 266 EALAHPFFQQ 275
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 3e-71
Identities = 64/296 (21%), Positives = 127/296 (42%), Gaps = 45/296 (15%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+Y +G+G G V A D+ +G A++ + + + I EI ++ K+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---LIINEILVMRENKN 76
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
PN+V + ++++V+EY+ GG L D + ++ + E + + ++ + + + H+
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
V HRD+K +NILL G++K++DF
Sbjct: 136 QVIHRDIK-----------------------------------SDNILLGMDGSVKLTDF 160
Query: 194 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253
G A + T G+P ++APEV+ + Y DIWS G++ ++ G P+
Sbjct: 161 GFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYL 217
Query: 254 DRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
+ N I + + P+ LS ++ L + L+ + KR + + ++
Sbjct: 218 NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 1e-69
Identities = 65/309 (21%), Positives = 126/309 (40%), Gaps = 50/309 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y + LG G FG V + S + K ++ +K+EI+ L + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
N++ LHE S ++ M+ E+++G ++F++I + L E E Q+ + + + H+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN--IKIS 191
+ H D ++ ENI+ ++ + IKI
Sbjct: 122 NIGHFD-----------------------------------IRPENIIYQTRRSSTIKII 146
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251
+FG + + + +P Y APEV + A +D+WS G ++YV+L+G P
Sbjct: 147 EFGQA---RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINP 202
Query: 252 FDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
F + + I ++ K +S A + + ++L R+T + W +
Sbjct: 203 FLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262
Query: 308 QDYTPANPD 316
Q +
Sbjct: 263 QKIERVSTK 271
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 3e-69
Identities = 86/296 (29%), Positives = 145/296 (48%), Gaps = 40/296 (13%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKH 73
+ L + LG+G+FGKV A+ + FA+K L+K+ ++ + E L L +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
P + + +K ++ V+EY+ GG+L I S + + ++I G+ + H+K
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
G+ +RDLK+ +NILLD G+IKI+DF
Sbjct: 123 GIVYRDLKL-----------------------------------DNILLDKDGHIKIADF 147
Query: 194 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253
G+ ++ D +T CG+P+Y+APE+L + Y+ + D WS GV+LY +L G PF
Sbjct: 148 GMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFH 204
Query: 254 DRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG-IKADEWFEQ 308
++ L+ I + P+WL A++LL K+ P KR+ + G I+ F +
Sbjct: 205 GQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 1e-68
Identities = 77/306 (25%), Positives = 127/306 (41%), Gaps = 51/306 (16%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R YE+ T+G G++G+ + + G K L+ + + + E+ L+ L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLREL 60
Query: 72 KHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLID 125
KHPN+VR ++ + ++ +Y+V+EY GG+L I + L E ++ QL
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 126 GVSYCHNKG-----VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
+ CH + V HRDLK N+
Sbjct: 121 ALKECHRRSDGGHTVLHRDLK-----------------------------------PANV 145
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240
LD K N+K+ DFGL+ + H D G+P Y++PE + Y+ SDIWS G
Sbjct: 146 FLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGC 202
Query: 241 ILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAG 299
+LY + PF + L KI G F ++P S ++ ++L R ++
Sbjct: 203 LLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEE 262
Query: 300 IKADEW 305
I +
Sbjct: 263 ILENPL 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 217 bits (553), Expect = 1e-67
Identities = 81/298 (27%), Positives = 147/298 (49%), Gaps = 46/298 (15%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+++ RTLG G+FG+V + +G +A+K+L+K ++ LK + E L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
++R+ +I+M+++Y+ GGELF + R + ++ + Y H+K +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 136 FHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGL 195
+RDLK ENILLD G+IKI+DFG
Sbjct: 126 IYRDLK-----------------------------------PENILLDKNGHIKITDFGF 150
Query: 196 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 255
+ + +T CG+P+Y+APEV++ + Y+ + D WS G+++Y +L GY PF D
Sbjct: 151 AK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDS 204
Query: 256 NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308
N Y+KI + + P + + ++LL +++ + +R+ +K WF++
Sbjct: 205 NTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-67
Identities = 84/309 (27%), Positives = 131/309 (42%), Gaps = 52/309 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKL 70
+Y++G LG G FG V + LP A+K +EK+RI L ++ E+ LK
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 71 LK--HPNVVRLHEVLASKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGV 127
+ V+RL + ++LE +LFD I +G LQE R F Q+++ V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD-SKG 186
+CHN GV HRD+ + ENIL+D ++G
Sbjct: 124 RHCHNCGVLHRDI-----------------------------------KDENILIDLNRG 148
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
+K+ DFG D + G+ Y PE + Y G ++ +WS G++LY ++
Sbjct: 149 ELKLIDFGSG----ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204
Query: 247 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
G +PF+ +I RG + +S Q+L+R L P R T I+ W
Sbjct: 205 CGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
Query: 307 EQDYTPANP 315
+ P
Sbjct: 259 QDVLLPQET 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 218 bits (555), Expect = 2e-67
Identities = 95/427 (22%), Positives = 170/427 (39%), Gaps = 79/427 (18%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
+ + + + R +G G FG+V + D+G +A+K L+K RI + E L L
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 71 LK---HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
+ P +V + + K+ +L+ + GG+L ++ G EA+ R ++I G+
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 128 SYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN 187
+ HN+ V +RDLK NILLD G+
Sbjct: 121 EHMHNRFVVYRDLK-----------------------------------PANILLDEHGH 145
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
++ISD GL+ H + G+ Y+APEVL +++D +S G +L+ +L
Sbjct: 146 VRISDLGLAC----DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 201
Query: 248 GYLPFDD---RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304
G+ PF ++ + + +LP SP ++LL +L+ + +R+ G A E
Sbjct: 202 GHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 261
Query: 305 -----WFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSC 359
+F +D + + + P PPLI + +
Sbjct: 262 VKESPFFRS---------------LDWQMVFLQKYP---------PPLIPPRGEVNAADA 297
Query: 360 LDLSGFFEKEDVSERKIRFTSNHSAKD----LLERIEDIVTEMGFRVQKKNGKLKATQEH 415
D+ F++ED K+ + ++ + ER + V E F ++
Sbjct: 298 FDIG-SFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEARKK 356
Query: 416 KPQKSLG 422
K LG
Sbjct: 357 TKNKQLG 363
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 8e-67
Identities = 65/305 (21%), Positives = 125/305 (40%), Gaps = 53/305 (17%)
Query: 14 GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
GR+ + +G G+F V D ++ + A L+ ++ + K E LK L+
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQ 66
Query: 73 HPNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
HPN+VR ++ S K I +V E +T G L + ++ R +Q++ G+
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 129 YCHNKG--VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK- 185
+ H + + HRDLK +NI +
Sbjct: 127 FLHTRTPPIIHRDLK-----------------------------------CDNIFITGPT 151
Query: 186 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245
G++KI D GL+ + G+P ++APE+ YD + D+++ G+ + +
Sbjct: 152 GSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEMY-EEKYDES-VDVYAFGMCMLEM 205
Query: 246 LTGYLPFDD-RNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302
T P+ + +N A +Y+++ G K P + ++ + N +R +I +
Sbjct: 206 ATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
Query: 303 DEWFE 307
+F+
Sbjct: 266 HAFFQ 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 1e-66
Identities = 77/343 (22%), Positives = 125/343 (36%), Gaps = 87/343 (25%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
++ +E LG GN G V SGL A K++ I I +QI RE+ L
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHE 60
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
P +V + S +I + +E++ GG L + GR+ E K+ +I G++Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 131 HNK-GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
K + HRD+K NIL++S+G IK
Sbjct: 121 REKHKIMHRDVK-----------------------------------PSNILVNSRGEIK 145
Query: 190 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249
+ DFG+S D + ++ G+ +Y++PE L Y SDIWS G+ L + G
Sbjct: 146 LCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGR 200
Query: 250 LPF---DDRNLAVLYQKIFRGDFKL----------------------------------- 271
P D + L +++ GD
Sbjct: 201 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE 260
Query: 272 ------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308
S Q+ + K L NP +R + + + ++
Sbjct: 261 PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 3e-66
Identities = 88/305 (28%), Positives = 141/305 (46%), Gaps = 50/305 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLL 71
Y+ G LG G F VK ++ +GL +A K ++K R + + I+RE++ LK +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPNV+ LHEV +K+ + ++LE V GGELFD +A K L E E + +Q+++GV Y H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG----N 187
+ + H D L+ ENI+L +
Sbjct: 131 SLQIAHFD-----------------------------------LKPENIMLLDRNVPKPR 155
Query: 188 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
IKI DFGL+ G+P +VAPE++ +D+WS GVI Y++L+
Sbjct: 156 IKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLS 211
Query: 248 GYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303
G PF + +++ S A++ +R++L +P KR+TI
Sbjct: 212 GASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271
Query: 304 EWFEQ 308
W +
Sbjct: 272 PWIKP 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 4e-64
Identities = 86/299 (28%), Positives = 142/299 (47%), Gaps = 43/299 (14%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ ++ + LG+G FGKV ++ +G +A+KIL K II E L+ +
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HP + L + ++ V+EY GGELF ++ + E R +++ + Y H+
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
+ V +RD+K LEN++LD G+IKI+D
Sbjct: 124 RDVVYRDIK-----------------------------------LENLMLDKDGHIKITD 148
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252
FGL D + T CG+P Y+APEVL + Y A D W GV++Y ++ G LPF
Sbjct: 149 FGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPF 205
Query: 253 DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE-----WF 306
+++ L++ I + + P+ LSP A++LL +L+ +P +R+ A E +F
Sbjct: 206 YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 4e-63
Identities = 59/296 (19%), Positives = 116/296 (39%), Gaps = 49/296 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
G+ +G+ +G G+FG V + AVK+L + K E+ L+ +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRH 63
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
N++ ++ ++ +V ++ G L+ + + + + + + +Q G+ Y H
Sbjct: 64 VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
K + HRDLK NI L +KI D
Sbjct: 123 KSIIHRDLK-----------------------------------SNNIFLHEDLTVKIGD 147
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT--SDIWSCGVILYVILTGYL 250
FGL+ + + GS ++APEV+ + + + SD+++ G++LY ++TG L
Sbjct: 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207
Query: 251 PFDDRNLAVLYQKIFRGDF------KLPKWLSPGAQNLLRKILEPNPVKRITIAGI 300
P+ + N + + K+ + L+ + L+ +R I
Sbjct: 208 PYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 203 bits (518), Expect = 5e-63
Identities = 70/301 (23%), Positives = 118/301 (39%), Gaps = 45/301 (14%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RYELG LG G +V A+DL AVK+L + + +RE L H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 74 PNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
P +V +++ +++ Y+V+EYV G L D + ++G + ++ +++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
H G+ HRD+K NI++ + +K
Sbjct: 127 SHQNGIIHRDVK-----------------------------------PANIMISATNAVK 151
Query: 190 ISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248
+ DFG++ + G+ Y++PE D SD++S G +LY +LTG
Sbjct: 152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTG 210
Query: 249 YLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304
PF + + + R D P + LS ++ K L NP R A +
Sbjct: 211 EPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
Query: 305 W 305
Sbjct: 271 L 271
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (519), Expect = 3e-62
Identities = 89/307 (28%), Positives = 147/307 (47%), Gaps = 46/307 (14%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
Q +L +++ +TLG G+FG+V + +SG +A+KIL+K +++ LK + E
Sbjct: 33 PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
L+ + P +V+L S +YMV+EYV GGE+F + GR E R Q++
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
Y H+ + +RDLK EN+L+D +
Sbjct: 153 TFEYLHSLDLIYRDLK-----------------------------------PENLLIDQQ 177
Query: 186 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245
G I+++DFG + + T CG+P +APE++ ++GY+ A D W+ GV++Y +
Sbjct: 178 GYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEM 231
Query: 246 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGI 300
GY PF +Y+KI G + P S ++LLR +L+ + KR + I
Sbjct: 232 AAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291
Query: 301 KADEWFE 307
K +WF
Sbjct: 292 KNHKWFA 298
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-60
Identities = 79/336 (23%), Positives = 138/336 (41%), Gaps = 60/336 (17%)
Query: 8 QEGMRLGRYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
++ + Y+ + LG G GKV + + FA+K+L+ + +RE+
Sbjct: 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVE 56
Query: 67 TL-KLLKHPNVVRLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKL 119
+ + P++VR+ +V A + + +V+E + GGELF +I +G E E ++
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 120 FQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179
+ + + + Y H+ + HRD+K EN
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVK-----------------------------------PEN 141
Query: 180 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239
+L SK I + L T C +P YVAPEVL YD + D+WS G
Sbjct: 142 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLG 200
Query: 240 VILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNP 291
VI+Y++L GY PF + + +I G ++ P +S + L+R +L+ P
Sbjct: 201 VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEP 260
Query: 292 VKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNE 327
+R+TI W Q + +++
Sbjct: 261 TQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDK 296
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 4e-58
Identities = 67/346 (19%), Positives = 115/346 (33%), Gaps = 78/346 (22%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+ +YE +G+G FG+V A+ +G A+K + REI L+LL
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLL 66
Query: 72 KHPNVVRLHEVLAS--------KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
KH NVV L E+ + K IY+V ++ + +E +++ Q L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 124 IDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLD 183
++G+ Y H + HRD+ + N+L+
Sbjct: 127 LNGLYYIHRNKILHRDM-----------------------------------KAANVLIT 151
Query: 184 SKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241
G +K++DFGL+ + Y PE+L G D+W G I
Sbjct: 152 RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 211
Query: 242 LYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK---------------------------- 273
+ + T I + +
Sbjct: 212 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDR 271
Query: 274 ----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 315
P A +L+ K+L +P +RI ++F D P++
Sbjct: 272 LKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL 317
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-57
Identities = 77/350 (22%), Positives = 127/350 (36%), Gaps = 74/350 (21%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY +GEG +G V A D + + A+K + H + REI L +H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 74 PNVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
N++ +++++ + + K ++ ++ G +L+ + L Q++ G+ Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
H+ V HRDLK N+LL++ ++K
Sbjct: 125 IHSANVLHRDLK-----------------------------------PSNLLLNTTCDLK 149
Query: 190 ISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248
I DFGL+ + D T + Y APE++ N + DIWS G IL +L+
Sbjct: 150 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209
Query: 249 YLPFDDRNLAVLYQKIFRGDF-------------------------------KLPKWLSP 277
F ++ I +L
Sbjct: 210 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADS 269
Query: 278 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNE 327
A +LL K+L NP KRI + A + EQ Y P++ E D E
Sbjct: 270 KALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDME 319
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-57
Identities = 69/329 (20%), Positives = 109/329 (33%), Gaps = 67/329 (20%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKLLKHP 74
E LGEG F V A+D ++ A+K ++ K I REI L+ L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N++ L + KS I +V +++ + L + + + G+ Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
+ HRDLK N+LLD G +K++DFG
Sbjct: 121 ILHRDLK-----------------------------------PNNLLLDENGVLKLADFG 145
Query: 195 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254
L+ + + Y APE+L G D+W+ G IL +L
Sbjct: 146 LAK--SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203
Query: 255 RNLAVLYQKIFR--GDFKLPKW--------------------------LSPGAQNLLRKI 286
+ +IF G +W +L++ +
Sbjct: 204 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGL 263
Query: 287 LEPNPVKRITIAGIKADEWFEQDYTPANP 315
NP RIT ++F P
Sbjct: 264 FLFNPCARITATQALKMKYFSNRPGPTPG 292
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 4e-57
Identities = 64/292 (21%), Positives = 111/292 (38%), Gaps = 53/292 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+L +T+G+G FG V G AVK ++ + E + + L+H
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60
Query: 75 NVVRLHEVLA-SKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCH 131
N+V+L V+ K +Y+V EY+ G L D + S+GR L K + + + Y
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKIS 191
HRDL N+L+ K+S
Sbjct: 121 GNNFVHRDLAA-----------------------------------RNVLVSEDNVAKVS 145
Query: 192 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYL 250
DFGL+ +D T + APE L + + SD+WS G++L+ I + G +
Sbjct: 146 DFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRV 199
Query: 251 PFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301
P+ L + ++ +G P P +++ + R + ++
Sbjct: 200 PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 185 bits (470), Expect = 9e-56
Identities = 80/323 (24%), Positives = 131/323 (40%), Gaps = 68/323 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y +GEG +G V AQ+ + G FA+K + + I REI+ LK LKH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHS 60
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+V+L++V+ +K ++ +V E++ +G L+ + QL++G++YCH++
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
V HRDLK +N+L++ +G +KI+DFG
Sbjct: 121 VLHRDLK-----------------------------------PQNLLINREGELKIADFG 145
Query: 195 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 254
L+ + Y AP+VL T DIWS G I ++ G F
Sbjct: 146 LARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203
Query: 255 RNLAVLYQKIFRGDF-----------------------------KLPKWLSPGAQNLLRK 285
+ A +IFR K L +LL K
Sbjct: 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK 263
Query: 286 ILEPNPVKRITIAGIKADEWFEQ 308
+L+ +P +RIT +F++
Sbjct: 264 MLKLDPNQRITAKQALEHAYFKE 286
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-55
Identities = 64/294 (21%), Positives = 107/294 (36%), Gaps = 43/294 (14%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
L LG+G+FG V+ + + AVK L+ + + + D RE+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYC 130
H N++RL+ V+ + + MV E G L D++ G + Q+ +G+ Y
Sbjct: 69 DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 131 HNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKI 190
+K HRDL N+LL ++ +KI
Sbjct: 128 ESKRFIHRDLA-----------------------------------ARNLLLATRDLVKI 152
Query: 191 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GY 249
DFGL D ++ P SD W GV L+ + T G
Sbjct: 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
Query: 250 LPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIK 301
P+ N + + KI + +LP+ N++ + P R T ++
Sbjct: 213 EPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 4e-55
Identities = 63/296 (21%), Positives = 106/296 (35%), Gaps = 45/296 (15%)
Query: 20 RTLGEGNFGKVKFA--QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
+ LG GNFG VK Q AVKIL KN + D++ E ++ L +P +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
R+ + +V+E G L + +++ +L Q+ G+ Y H
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 138 RDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLS- 196
RDL N+LL ++ KISDFGLS
Sbjct: 131 RDLA-----------------------------------ARNVLLVTQHYAKISDFGLSK 155
Query: 197 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR 255
AL + APE + + SD+WS GV+++ + G P+
Sbjct: 156 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGM 214
Query: 256 NLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQ 308
+ + + +G+ P +L+ + R A ++ ++
Sbjct: 215 KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-54
Identities = 60/288 (20%), Positives = 114/288 (39%), Gaps = 49/288 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG G FG VK+ + A+K++++ + D+ E + L H
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+V+L+ V + I+++ EY+ G L + + + R Q + ++ + + + + Y +K
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 135 VFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFG 194
HRDL N L++ +G +K+SDFG
Sbjct: 121 FLHRDLA-----------------------------------ARNCLVNDQGVVKVSDFG 145
Query: 195 LSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLP 251
LS ++ DD + + PEVL + SDIW+ GV+++ I + G +P
Sbjct: 146 LS---RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMP 201
Query: 252 FDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIA 298
++ + + I +G P S ++ +R T
Sbjct: 202 YERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFK 249
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 2e-54
Identities = 79/317 (24%), Positives = 146/317 (46%), Gaps = 49/317 (15%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQI 61
E + + +EL + LG G +GKV + + D+G +A+K+L+K I+ K T+
Sbjct: 16 GHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 75
Query: 62 KREIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
+ E L+ ++ P +V LH +++K++++L+Y+ GGELF ++ + R E E +
Sbjct: 76 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 135
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
+++ + + H G+ +RD ++LENI
Sbjct: 136 GEIVLALEHLHKLGIIYRD-----------------------------------IKLENI 160
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240
LLDS G++ ++DFGLS + V D WS GV
Sbjct: 161 LLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 220
Query: 241 ILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 296
++Y +LTG PF A + ++I + + P+ +S A++L++++L +P KR+
Sbjct: 221 LMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLG 280
Query: 297 IAGIKADE-----WFEQ 308
ADE +F++
Sbjct: 281 CGPRDADEIKEHLFFQK 297
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-54
Identities = 72/337 (21%), Positives = 121/337 (35%), Gaps = 84/337 (24%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + +G G+FG V A+ DSG A+K + +++ RE+ ++ L H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHC 73
Query: 75 NVVRLHEVLASKSK------IYMVLEYVTGG---ELFDKIASKGRLQEAEGRKLFQQLID 125
N+VRL S + + +VL+YV +K L + QL
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 126 GVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK 185
++Y H+ G+ HRD+K +N+LLD
Sbjct: 134 SLAYIHSFGICHRDIK-----------------------------------PQNLLLDPD 158
Query: 186 GN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
+K+ DFG + + + S Y APE++ ++ D+WS G +L
Sbjct: 159 TAVLKLCDFGSA---KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 215
Query: 245 ILTGYLPFDDRNLAVLYQKIFR-----------------GDFKLPKW------------L 275
+L G F + +I + +FK P+
Sbjct: 216 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT 275
Query: 276 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 312
P A L ++LE P R+T A +F++ P
Sbjct: 276 PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-54
Identities = 77/328 (23%), Positives = 133/328 (40%), Gaps = 68/328 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
++ +GEG +G V A++ +G A+K + + + REI+ LK L HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61
Query: 75 NVVRLHEVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
N+V+L +V+ +++K+Y+V E++ + F ++ + + QL+ G+++CH+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
V HRDLK +N+L++++G IK++DF
Sbjct: 122 RVLHRDLK-----------------------------------PQNLLINTEGAIKLADF 146
Query: 194 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253
GL+ + Y APE+L Y DIWS G I ++T F
Sbjct: 147 GLA--RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204
Query: 254 DRNLAVLYQKIFRG------------------DFKLPKW-----------LSPGAQNLLR 284
+ +IFR PKW L ++LL
Sbjct: 205 GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLS 264
Query: 285 KILEPNPVKRITIAGIKADEWFEQDYTP 312
++L +P KRI+ A +F+ P
Sbjct: 265 QMLHYDPNKRISAKAALAHPFFQDVTKP 292
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-54
Identities = 73/331 (22%), Positives = 114/331 (34%), Gaps = 60/331 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
+ +GEGNFG+V A+ GL I E+ L KL H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----------------ASKGRLQEAEGR 117
PN++ L + +Y+ +EY G L D + ++ L +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177
+ G+ Y K HRDL
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLA-----------------------------------A 155
Query: 178 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 237
NIL+ KI+DFGLS + ++A E L N SD+WS
Sbjct: 156 RNILVGENYVAKIADFGLS---RGQEVYVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWS 211
Query: 238 CGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRI 295
GV+L+ I++ G P+ A LY+K+ +G + P +L+R+ P +R
Sbjct: 212 YGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERP 271
Query: 296 TIAGIKA--DEWFEQDYTPANPDDDEEDIFV 324
+ A I + E+ T N E+ +
Sbjct: 272 SFAQILVSLNRMLEERKTYVNTTLYEKFTYA 302
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 4e-54
Identities = 64/318 (20%), Positives = 111/318 (34%), Gaps = 70/318 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSG-----LPFAVKILEKNRIIHLKITDQIKREIATL- 68
E G+ LG G FGKV A + AVK+L++ + + E+ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-------------------- 108
+L H N+V L IY++ EY G+L + + SK
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 109 ---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165
L + Q+ G+ + K HRDL
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA------------------------ 191
Query: 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 225
N+L+ +KI DFGL+ + + ++APE L
Sbjct: 192 -----------ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 240
Query: 226 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNL 282
Y SD+WS G++L+ I + G P+ + + K+ + FK+ P + + +
Sbjct: 241 GIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYII 299
Query: 283 LRKILEPNPVKRITIAGI 300
++ + KR + +
Sbjct: 300 MQSCWAFDSRKRPSFPNL 317
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (458), Expect = 5e-54
Identities = 72/310 (23%), Positives = 123/310 (39%), Gaps = 47/310 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ LG G +G+V L AVK L+++ + ++ +E A +K +KHP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHP 73
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHN 132
N+V+L V + Y++ E++T G L D + R + + Q+ + Y
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
K HRDL N L+ +K++D
Sbjct: 134 KNFIHRDLAA-----------------------------------RNCLVGENHLVKVAD 158
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLP 251
FGLS L + APE LA + SD+W+ GV+L+ I T G P
Sbjct: 159 FGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSP 216
Query: 252 FDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310
+ +L+ +Y+ + + + P+ L+R + NP R + A I + FE +
Sbjct: 217 YPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH--QAFETMF 274
Query: 311 TPANPDDDEE 320
++ D+ E
Sbjct: 275 QESSISDEVE 284
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 6e-54
Identities = 77/338 (22%), Positives = 123/338 (36%), Gaps = 80/338 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + +G G +G V A D +G A+K L + + RE+ LK ++H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRHE 77
Query: 75 NVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
NV+ L +V L + Y+V+ ++ G K+ +L E + L Q++ G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
Y H G+ HRDLK N+ ++ +
Sbjct: 136 YIHAAGIIHRDLK-----------------------------------PGNLAVNEDCEL 160
Query: 189 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248
KI DFGL+ D + + Y APEV+ N T DIWS G I+ ++TG
Sbjct: 161 KILDFGLARQA-----DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215
Query: 249 YLPFDDRNLAVLYQKIFRGDFKLPKW-------------------------------LSP 277
F + ++I + P SP
Sbjct: 216 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 275
Query: 278 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 315
A NLL K+L + +R+T A +FE + +
Sbjct: 276 LAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE 313
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 9e-54
Identities = 75/330 (22%), Positives = 128/330 (38%), Gaps = 69/330 (20%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ +YE +GEG +G V A++ ++ A+K + + + REI LK LK
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELK 59
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H N+VRLH+VL S K+ +V E+ + G L + QL+ G+ +CH+
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
+ V HRDLK +N+L++ G +K+++
Sbjct: 120 RNVLHRDLK-----------------------------------PQNLLINRNGELKLAN 144
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP- 251
FGL+ + Y P+VL + D+WS G I + P
Sbjct: 145 FGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
Query: 252 FDDRNLAVLYQKIFRGDF-----------------------------KLPKWLSPGAQNL 282
F ++ ++IFR + L+ ++L
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262
Query: 283 LRKILEPNPVKRITIAGIKADEWFEQDYTP 312
L+ +L+ NPV+RI+ +F D+ P
Sbjct: 263 LQNLLKCNPVQRISAEEALQHPYF-SDFCP 291
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-53
Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 49/298 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+L LG G FG+V + AVK L++ + D E +K L+H
Sbjct: 14 TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHN 132
+VRL+ V+ ++ IY++ EY+ G L D + + +L + + Q+ +G+++
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
+ HRDL+ NIL+ + KI+D
Sbjct: 128 RNYIHRDLRA-----------------------------------ANILVSDTLSCKIAD 152
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLP 251
FGL+ L + + APE + N G SD+WS G++L I+T G +P
Sbjct: 153 FGLARL-IEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIP 210
Query: 252 FDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWF 306
+ + Q + RG P L+R + P R T +++ +++F
Sbjct: 211 YPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 3e-53
Identities = 65/310 (20%), Positives = 120/310 (38%), Gaps = 49/310 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
L LG+G FG+V + A+K L+ + + +E +K L+H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHN 132
+V+L+ V+ S+ IY+V EY++ G L D + + L+ + + Q+ G++Y
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
HRDL+ NIL+ K++D
Sbjct: 132 MNYVHRDLR-----------------------------------AANILVGENLVCKVAD 156
Query: 193 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLP 251
FGL+ L + + + APE + SD+WS G++L + T G +P
Sbjct: 157 FGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVP 214
Query: 252 FDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQ 308
+ + ++ RG P +L+ + P +R T ++A +++F
Sbjct: 215 YPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
Query: 309 DYTPANPDDD 318
P ++
Sbjct: 275 TEPQYQPGEN 284
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-53
Identities = 66/285 (23%), Positives = 103/285 (36%), Gaps = 45/285 (15%)
Query: 22 LGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
LG GNFG V+ + A+K+L++ T+++ RE + L +P +VRL
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
V + +V+E GG L + K + + +L Q+ G+ Y K HR
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 139 DLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLS-A 197
DL N+LL ++ KISDFGLS A
Sbjct: 134 DLAA-----------------------------------RNVLLVNRHYAKISDFGLSKA 158
Query: 198 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 256
L + APE + R + SD+WS GV ++ L+ G P+
Sbjct: 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMK 217
Query: 257 LAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 300
+ I +G + P P L+ R +
Sbjct: 218 GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-52
Identities = 71/295 (24%), Positives = 120/295 (40%), Gaps = 46/295 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
R ELGR +GEG FG V + P AV I + ++ +E T++ H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHN 132
P++V+L V+ +++ +++++E T GEL + + L A QL ++Y +
Sbjct: 68 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISD 192
K HRD+ N+L+ S +K+ D
Sbjct: 127 KRFVHRDIA-----------------------------------ARNVLVSSNDCVKLGD 151
Query: 193 FGLSALPQHFRDDGLLHTTC--GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GY 249
FGLS ++ D + ++APE + R + A SD+W GV ++ IL G
Sbjct: 152 FGLS---RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGV 207
Query: 250 LPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303
PF + +I G+ +P P +L+ K +P +R +KA
Sbjct: 208 KPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-52
Identities = 57/287 (19%), Positives = 108/287 (37%), Gaps = 45/287 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ +G G FG V L+ A+K + + + + E + L HP
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ-EAEGRKLFQQLIDGVSYCHNK 133
+V+L+ V ++ I +V E++ G L D + ++ L + + +G++Y
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
V HRDL N L+ IK+SDF
Sbjct: 121 CVIHRDLA-----------------------------------ARNCLVGENQVIKVSDF 145
Query: 194 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 252
G++ T + +PEV + Y SD+WS GV+++ + + G +P+
Sbjct: 146 GMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPY 203
Query: 253 DDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIA 298
++R+ + + + I G P+ S ++ + P R +
Sbjct: 204 ENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFS 250
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 5e-52
Identities = 78/330 (23%), Positives = 124/330 (37%), Gaps = 77/330 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
+YE +GEG +GKV A+DL + G A+K + + + + RE+A L+ L+
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 66
Query: 73 --HPNVVRLHEVLAS-----KSKIYMVLEYVTGGEL-FDKIASKGRLQEAEGRKLFQQLI 124
HPNVVRL +V ++K+ +V E+V + + + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 125 DGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDS 184
G+ + H+ V HRDLK +NIL+ S
Sbjct: 127 RGLDFLHSHRVVHRDLK-----------------------------------PQNILVTS 151
Query: 185 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244
G IK++DFGL+ + + + Y APEVL Y D+WS G I
Sbjct: 152 SGQIKLADFGLARIYSFQMAL---TSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAE 207
Query: 245 ILTGYLPFDDRNLAVLYQKIFRG---------------------------DFKLPKWLSP 277
+ F + KI K +
Sbjct: 208 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE 267
Query: 278 GAQNLLRKILEPNPVKRITIAGIKADEWFE 307
++LL K L NP KRI+ + +F+
Sbjct: 268 LGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-51
Identities = 80/356 (22%), Positives = 128/356 (35%), Gaps = 86/356 (24%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY+ +G G +G V A D +GL AVK L + + + RE+ LK +KH
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHE 77
Query: 75 NVVRLHEVLASKSKI-----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
NV+ L +V + ++ ++ G + I +L + + L Q++ G+ Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
H+ + HRDLK N+ ++ +K
Sbjct: 137 IHSADIIHRDLK-----------------------------------PSNLAVNEDCELK 161
Query: 190 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249
I DFGL+ + Y APE++ N + T DIWS G I+ +LTG
Sbjct: 162 ILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
Query: 250 LPFDDRNLAVLYQKIFRGDFKLPKWL-------------------------------SPG 278
F + + I R L +P
Sbjct: 217 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL 276
Query: 279 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA--------NPDDDEEDIFVDN 326
A +LL K+L + KRIT A A +F Q + P + + D+ +D
Sbjct: 277 AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDE 332
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (437), Expect = 9e-51
Identities = 57/297 (19%), Positives = 106/297 (35%), Gaps = 47/297 (15%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLK 69
+ ++ + +G G FG+V G + A+K L+ K E + +
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMG 82
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVS 128
HPNV+ L V+ + + ++ E++ G L + G+ + + + + G+
Sbjct: 83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNI 188
Y + HRDL NIL++S
Sbjct: 143 YLADMNYVHRDLA-----------------------------------ARNILVNSNLVC 167
Query: 189 KISDFGLSALPQHFRDDGLLHTT---CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245
K+SDFGLS + D + + APE + R + A SD+WS G++++ +
Sbjct: 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEV 226
Query: 246 LT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 300
++ G P+ D + I + P L+ + + R I
Sbjct: 227 MSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-50
Identities = 55/320 (17%), Positives = 111/320 (34%), Gaps = 41/320 (12%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKH 73
++ + LG G FG V + G + + K K +I E + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
P+V RL + + + + G L K + Q+ G++Y ++
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 134 GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDF 193
+ HRDL N+L+ + ++KI+DF
Sbjct: 131 RLVHRDLA-----------------------------------ARNVLVKTPQHVKITDF 155
Query: 194 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 252
GL+ L + ++A E + +R Y SD+WS GV ++ ++T G P+
Sbjct: 156 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPY 214
Query: 253 DDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD-EWFEQDY 310
D + + + +G+ P + ++ K + R + + +D
Sbjct: 215 DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
Query: 311 TPANPDDDEEDIFVDNEAFS 330
+E + + + S
Sbjct: 275 QRYLVIQGDERMHLPSPTDS 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (432), Expect = 4e-50
Identities = 58/328 (17%), Positives = 100/328 (30%), Gaps = 62/328 (18%)
Query: 11 MRLG-RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
+R+G RY LGR +G G+FG + D+ +G A+K+ Q+ E K
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYK 57
Query: 70 LLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
+++ + + A MV+E + + L Q+I +
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 129 YCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG-- 186
Y H+K HRD ++ +N L+
Sbjct: 118 YIHSKNFIHRD-----------------------------------VKPDNFLMGLGKKG 142
Query: 187 -NIKISDFGLSALPQHFRDDGLLH-----TTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240
+ I DFGL+ + R + G+ Y + D+ S G
Sbjct: 143 NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGY 201
Query: 241 ILYVILTGYLPFDDRNLAVLYQKIFRGDFK--------LPKWLSPGAQNLLRKILEPNPV 292
+L G LP+ A QK R K L K L
Sbjct: 202 VLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFD 261
Query: 293 KRITIAGIKA---DEWFEQDYTPANPDD 317
+ + ++ + + Q ++ D
Sbjct: 262 DKPDYSYLRQLFRNLFHRQGFSYDYVFD 289
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (429), Expect = 1e-49
Identities = 65/317 (20%), Positives = 109/317 (34%), Gaps = 69/317 (21%)
Query: 15 RYELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
E R +GEG FG+V + AVK+L++ ++ +RE A +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALMA 71
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR------------------- 110
+PN+V+L V A + ++ EY+ G+L + + S
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 111 -----LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165
L AE + +Q+ G++Y + HRDL
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA------------------------ 167
Query: 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 225
N L+ +KI+DFGLS ++ PE +
Sbjct: 168 -----------TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216
Query: 226 RGYDGATSDIWSCGVILYVILTGYL-PFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLL 283
Y SD+W+ GV+L+ I + L P+ + + G+ P+ NL+
Sbjct: 217 NRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLM 275
Query: 284 RKILEPNPVKRITIAGI 300
R P R + I
Sbjct: 276 RLCWSKLPADRPSFCSI 292
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 169 bits (428), Expect = 3e-49
Identities = 64/334 (19%), Positives = 122/334 (36%), Gaps = 89/334 (26%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
Y+L R LG G + +V A ++ + VKIL+ + +IKREI L+ L+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGG 89
Query: 74 PNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
PN++ L +++ +V E+V + L + + R +++ + YCH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146
Query: 132 NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN-IKI 190
+ G+ HRD+K N+++D + +++
Sbjct: 147 SMGIMHRDVK-----------------------------------PHNVMIDHEHRKLRL 171
Query: 191 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250
D+GL+ + + + S + PE+L + + D+WS G +L ++
Sbjct: 172 IDWGLA---EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
Query: 251 PFDDRNLAV--------------LYQKIFRGDFKLPKW---------------------- 274
PF + LY I + + +L
Sbjct: 229 PFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQ 288
Query: 275 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306
+SP A + L K+L + R+T +F
Sbjct: 289 HLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-48
Identities = 68/313 (21%), Positives = 117/313 (37%), Gaps = 65/313 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
R G+TLG G FGKV A D+ + AVK+L+ + HL + + E+ L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 81
Query: 70 LLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG------------------R 110
L H N+V L ++ EY G+L + + K
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170
L + Q+ G+++ +K HRDL
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA---------------------------- 173
Query: 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 230
NILL KI DFGL+ ++ + + ++APE + N
Sbjct: 174 -------RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYT 225
Query: 231 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKIL 287
SD+WS G+ L+ + + G P+ + + K+ + F++ P+ ++++
Sbjct: 226 FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCW 285
Query: 288 EPNPVKRITIAGI 300
+ +P+KR T I
Sbjct: 286 DADPLKRPTFKQI 298
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-47
Identities = 70/315 (22%), Positives = 118/315 (37%), Gaps = 64/315 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
R LG+ LGEG FG+V A+ + + AVK+L+ + K + E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71
Query: 68 LK-LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----------------ASKGR 110
+K + KH N++ L +Y+++EY + G L + + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170
L + Q+ G+ Y +K HRDL
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLA----------------------------- 162
Query: 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 230
N+L+ +KI+DFGL+ H ++APE L +R Y
Sbjct: 163 ------ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 216
Query: 231 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILE 288
SD+WS GV+L+ I T G P+ + L++ + G P + ++R
Sbjct: 217 Q-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWH 275
Query: 289 PNPVKRITIAGIKAD 303
P +R T + D
Sbjct: 276 AVPSQRPTFKQLVED 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 162 bits (410), Expect = 5e-47
Identities = 50/325 (15%), Positives = 93/325 (28%), Gaps = 62/325 (19%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
Y++GR +GEG+FG + +L + A+K + Q++ E T KLL
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAG 59
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+ ++ +V++ + + +Q++ V H
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 133 KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSK-----GN 187
K + +RD+K +N L+
Sbjct: 120 KSLVYRDIK-----------------------------------PDNFLIGRPNSKNANM 144
Query: 188 IKISDFGLSALPQHFRDDGLLH-----TTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 242
I + DFG+ + + G+ Y++ R D+ + G +
Sbjct: 145 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVF 203
Query: 243 YVILTGYLPFDDRNLAVLYQKIFRGDFK--------LPKWLSPGAQNLLRKILEPNPVKR 294
L G LP+ A QK R K L +
Sbjct: 204 MYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
Query: 295 ITIAGIKADEWFEQDYTPANPDDDE 319
++ F + N +DE
Sbjct: 264 PDYDYLQ--GLFSKVLERLNTTEDE 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-46
Identities = 61/294 (20%), Positives = 107/294 (36%), Gaps = 46/294 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKL 70
+ +G G FG+V S +P A+K L+ ++ E +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQ 65
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSY 129
H N++RL V++ + ++ EY+ G L + K G + + + + G+ Y
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
N HRDL NIL++S K
Sbjct: 126 LANMNYVHRDLAA-----------------------------------RNILVNSNLVCK 150
Query: 190 ISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT- 247
+SDFGLS L + APE ++ R + A SD+WS G++++ ++T
Sbjct: 151 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTY 209
Query: 248 GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 300
G P+ + + + + I G P L+ + + +R A I
Sbjct: 210 GERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 3e-46
Identities = 69/316 (21%), Positives = 117/316 (37%), Gaps = 53/316 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+G G+FG V LD+ + AVK L NRI + Q E +K
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF 85
Query: 72 KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSY 129
HPNV+ L + L S+ +VL Y+ G+L + + Q+ G+ +
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 130 CHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIK 189
+K HRDL N +LD K +K
Sbjct: 146 LASKKFVHRDLAA-----------------------------------RNCMLDEKFTVK 170
Query: 190 ISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247
++DFGL+ D + + T ++A E L + + SD+WS GV+L+ ++T
Sbjct: 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMT 229
Query: 248 -GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA--- 302
G P+ D N + + +G P++ ++ K P R + + + +
Sbjct: 230 RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
Query: 303 ---DEWFEQDYTPANP 315
+ + Y N
Sbjct: 290 AIFSTFIGEHYVHVNA 305
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-45
Identities = 75/373 (20%), Positives = 129/373 (34%), Gaps = 94/373 (25%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L RY+ + +G G G V A D A+K L + + + RE+ +K +
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H N++ L V + +Y+V+E + + L L Q++ G
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCG 131
Query: 127 VSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKG 186
+ + H+ G+ HRDLK NI++ S
Sbjct: 132 IKHLHSAGIIHRDLK-----------------------------------PSNIVVKSDC 156
Query: 187 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246
+KI DFGL+ + ++ + Y APEV+ GY DIWS G I+ ++
Sbjct: 157 TLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMV 212
Query: 247 TGYLPFDDRNLAVLYQKIFRG--------------------------------------- 267
+ F R+ + K+
Sbjct: 213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL 272
Query: 268 ---DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIF- 323
D + K + A++LL K+L +P KRI++ + Y PA + I+
Sbjct: 273 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYD 332
Query: 324 --VDNEAFSMHEV 334
+D ++ E
Sbjct: 333 KQLDEREHTIEEW 345
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-43
Identities = 59/326 (18%), Positives = 116/326 (35%), Gaps = 57/326 (17%)
Query: 15 RYELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
+ + R LG+G+FG V K + A+K + + ++ + E + +K
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMK 78
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----------LQEAEGRKL 119
+VVRL V++ +++E +T G+L + S ++ ++
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 120 FQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLEN 179
++ DG++Y + HRDL N
Sbjct: 139 AGEIADGMAYLNANKFVHRDLA-----------------------------------ARN 163
Query: 180 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 239
++ +KI DFG++ +++PE L + + + D+WS G
Sbjct: 164 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS-DVWSFG 222
Query: 240 VILYVILTG-YLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITI 297
V+L+ I T P+ + + + + G P L+R + NP R +
Sbjct: 223 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 282
Query: 298 AGIKA--DEWFEQDYTPANPDDDEED 321
I + E E + + EE+
Sbjct: 283 LEIISSIKEEMEPGFREVSFYYSEEN 308
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 5e-42
Identities = 62/329 (18%), Positives = 111/329 (33%), Gaps = 83/329 (25%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
L ++G+G FG+V + G AVKI + EI +L+H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSW----FREAEIYQTVMLRH 56
Query: 74 PNVVRLHEVL----ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
N++ + +++++V +Y G LFD + ++ + KL G+++
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAH 115
Query: 130 CH--------NKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENIL 181
H + HRDLK +NIL
Sbjct: 116 LHMEIVGTQGKPAIAHRDLK-----------------------------------SKNIL 140
Query: 182 LDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVL-----ANRGYDGATSD 234
+ G I+D GL+ D D + G+ Y+APEVL +D
Sbjct: 141 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 200
Query: 235 IWSCGVILYVILTGYLPFD---------------DRNLAVLYQKIFRGDFKLP---KWLS 276
I++ G++ + I D ++ + + + + +W S
Sbjct: 201 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS 260
Query: 277 PGA----QNLLRKILEPNPVKRITIAGIK 301
A ++R+ N R+T IK
Sbjct: 261 CEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 4e-41
Identities = 63/311 (20%), Positives = 107/311 (34%), Gaps = 62/311 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
R +LG+ LG G FG+V A + AVK+L++ H + + +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIH 72
Query: 70 LLKHPNVVRLHEVLASK-SKIYMVLEYVTGGELFDKIASKGR----------------LQ 112
+ H NVV L + +++E+ G L + SK L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 113 EAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172
Q+ G+ + ++ HRDL
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLA------------------------------- 161
Query: 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 232
NILL K +KI DFGL+ D ++APE + +R Y
Sbjct: 162 ----ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQ 216
Query: 233 SDIWSCGVILYVILTGY-LPFDDRNLAVLYQKIFRGD--FKLPKWLSPGAQNLLRKILEP 289
SD+WS GV+L+ I + P+ + + + + + P + +P +
Sbjct: 217 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 276
Query: 290 NPVKRITIAGI 300
P +R T + +
Sbjct: 277 EPSQRPTFSEL 287
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (328), Expect = 1e-34
Identities = 58/368 (15%), Positives = 117/368 (31%), Gaps = 107/368 (29%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY L R LG G+F V A+D+ + A+KI+ +++ T+ + EI L+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVND 68
Query: 74 PNVVRL-------------HEVLASKSKIYMVLEYVTGG---ELFDKIASKGRLQEAEGR 117
+ + H + +++V+ + G K + +
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 118 KLFQQLIDGVSYCHNK-GVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQ 176
++ +QL+ G+ Y H + G+ H D+K
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIK----------------------------------- 153
Query: 177 LENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 235
EN+L++ + + ++ L D + + Y +PEVL + +DI
Sbjct: 154 PENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCG-ADI 212
Query: 236 WSCGVILYVILTGYLPFDDRNLAVLY---------------------------------- 261
WS +++ ++TG F+
Sbjct: 213 WSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSR 272
Query: 262 --------------QKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307
+ + +K K + + L +L+ +P KR G+ W
Sbjct: 273 GLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL- 331
Query: 308 QDYTPANP 315
+D
Sbjct: 332 KDTLGMEE 339
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.4 bits (187), Expect = 7e-17
Identities = 34/245 (13%), Positives = 70/245 (28%), Gaps = 71/245 (28%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------------Q 60
+G+ +GEG V VK + K+ +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
+ E L+ L+ V +++ +++E + EL+ + ++
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRV-------RVENPDEVL 109
Query: 121 QQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENI 180
+++ V+ +++G+ H DL +
Sbjct: 110 DMILEEVAKFYHRGIVHGDLS------------------------------------QYN 133
Query: 181 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240
+L S+ I I DF S +L + +R Y DI S
Sbjct: 134 VLVSEEGIWIIDFPQSVEVGEEGWREILERDVRNIIT-----YFSRTY-RTEKDINS--A 185
Query: 241 ILYVI 245
I ++
Sbjct: 186 IDRIL 190
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 69.4 bits (170), Expect = 2e-15
Identities = 16/99 (16%), Positives = 38/99 (38%), Gaps = 8/99 (8%)
Query: 374 RKIRF------TSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVA 427
RF TS+ D++ I ++ ++ + H + +
Sbjct: 5 SSGRFTWSMKTTSSMDPSDMMREIRKVLGANNCDY-EQRERFLLFCVHGDGHAENLVQWE 63
Query: 428 AEVFEI-SPSLYVVELRKSYGDPTVYRQLCNKLSSDLGL 465
EV ++ SL V ++ G ++ + +K++++L L
Sbjct: 64 MEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKL 102
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 476 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.4 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.47 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 98.24 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.95 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.93 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 97.67 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 97.31 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.74 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.61 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.4 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-64 Score=491.40 Aligned_cols=260 Identities=33% Similarity=0.669 Sum_probs=242.2
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
.+.+++|++++.||+|+||+||+|++..+|+.||+|++.+....+......+.+|+.+++.++||||+++++++.+++.+
T Consensus 2 ~~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 81 (263)
T d2j4za1 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 81 (263)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CcchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence 45689999999999999999999999999999999999876554555567899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+|||||+||+|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp--------------------------- 134 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP--------------------------- 134 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG---------------------------
T ss_pred EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecc---------------------------
Confidence 99999999999999999888999999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||++.+|.+||+|||+|+... .......+||+.|||||++.+..|+ .++|||||||++|+|++|+
T Consensus 135 --------~Nill~~~~~~kl~DFG~a~~~~----~~~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~ 201 (263)
T d2j4za1 135 --------ENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGK 201 (263)
T ss_dssp --------GGEEECTTSCEEECCCCSCSCCC----CCCCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSS
T ss_pred --------ccceecCCCCEeecccceeeecC----CCcccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCC
Confidence 99999999999999999998543 2345667899999999999998885 8999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 250 LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
.||.+.+....+.++.+..+.+|+.+|+++.+||.+||++||++|||++|+++||||...
T Consensus 202 ~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 202 PPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp CTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 999999999999999999999999999999999999999999999999999999999753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-63 Score=489.34 Aligned_cols=263 Identities=33% Similarity=0.590 Sum_probs=236.4
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
..+.++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|++++||||+++++++.+++.+
T Consensus 4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 34557899999999999999999999999999999999876544445567899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp--------------------------- 136 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKP--------------------------- 136 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG---------------------------
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCc---------------------------
Confidence 99999999999999999889999999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||++++|.+||+|||+|+............+.+||+.|+|||++.+..|+ .++||||+||++|+|++|+
T Consensus 137 --------~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~ 207 (288)
T d1uu3a_ 137 --------ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGL 207 (288)
T ss_dssp --------GGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSS
T ss_pred --------cccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCC
Confidence 9999999999999999999866543344455677899999999999988885 8999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHH------HhcCccccc
Q 011868 250 LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG------IKADEWFEQ 308 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~------il~~~~~~~ 308 (476)
.||.+.+...++.++.++.+.+|..+++++.+||++||+.||.+|||++| +++||||+.
T Consensus 208 ~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 208 PPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp CSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred CCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 99999999999999999999999999999999999999999999999998 477888854
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-64 Score=486.66 Aligned_cols=261 Identities=39% Similarity=0.680 Sum_probs=226.6
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+++|++++.||+|+||+||+|+++.+|+.||||++.+... .+..+.+.+|+.+|++++||||+++++++.+++.+|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 5789999999999999999999999999999999987642 22346789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
||||+||+|.+++...+++++.+++.++.||++||+|||++||+||||||
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp------------------------------ 131 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP------------------------------ 131 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG------------------------------
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccH------------------------------
Confidence 99999999999998888899999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+|||++++|.+||+|||+|+............+.+||+.|||||++.+..+++.++||||+||++|+|++|+.||
T Consensus 132 -----~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf 206 (271)
T d1nvra_ 132 -----ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 206 (271)
T ss_dssp -----GGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred -----HHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCC
Confidence 999999999999999999986544333344567899999999999998888778899999999999999999999
Q ss_pred CCCcHH-HHHHHHHhCCCCCC--CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 253 DDRNLA-VLYQKIFRGDFKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 253 ~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
.+.+.. ..+..+.......+ ..+|+++.+||.+||+.||++|||++|+++||||++..
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 207 DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp SSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 876543 33334433333322 45899999999999999999999999999999998643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-62 Score=488.97 Aligned_cols=260 Identities=32% Similarity=0.617 Sum_probs=242.4
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
+.+++|++++.||+|+||+||+|++..+|+.||||++++......+....+.+|+.+|+.++||||+++++++.++..+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 46889999999999999999999999999999999998765444455688999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP---------------------------- 133 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL---------------------------- 133 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG----------------------------
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCH----------------------------
Confidence 9999999999999999989999999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+|||++.+|.+||+|||+|+.... ......+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|++
T Consensus 134 -------~NILl~~~g~vkl~DFG~a~~~~~--~~~~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~ 203 (337)
T d1o6la_ 134 -------ENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRL 203 (337)
T ss_dssp -------GGEEECTTSCEEECCCTTCBCSCC--TTCCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSC
T ss_pred -------HHeEecCCCCEEEeeccccccccc--CCcccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCC
Confidence 999999999999999999985432 23456678999999999999999885 89999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC-----hHHHhcCccccc
Q 011868 251 PFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 308 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-----~~~il~~~~~~~ 308 (476)
||.+.+...++.++..+.+++|..+|+++.+||++||++||.+|++ ++++++||||..
T Consensus 204 pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 204 PFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 9999999999999999999999999999999999999999999995 899999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-61 Score=475.34 Aligned_cols=253 Identities=25% Similarity=0.464 Sum_probs=226.8
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
.+|++.+.||+|+||+||+|++..+|+.||||++....... .+.+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 47999999999999999999999999999999998654322 467999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccc
Q 011868 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFN 173 (476)
Q Consensus 94 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 173 (476)
|||+||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp------------------------------- 144 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS------------------------------- 144 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG-------------------------------
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcH-------------------------------
Confidence 99999999998765 5799999999999999999999999999999997
Q ss_pred cCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCC
Q 011868 174 VLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 253 (476)
Q Consensus 174 ~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~ 253 (476)
+|||++.+|++||+|||+|+.... ........+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.
T Consensus 145 ----~NILl~~~~~vkl~DFG~a~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~ 217 (293)
T d1yhwa1 145 ----DNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYL 217 (293)
T ss_dssp ----GGEEECTTCCEEECCCTTCEECCS--TTCCBCCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTT
T ss_pred ----HHeEECCCCcEeeccchhheeecc--ccccccccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCC
Confidence 999999999999999999985433 23345667899999999999988885 89999999999999999999999
Q ss_pred CCcHHHHHHHHHhC---CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 254 DRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 254 ~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
+.+.......+... .++.|..+|+++++||.+||++||.+|||++|+++||||+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 218 NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp TSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 98877666655544 23456779999999999999999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.3e-61 Score=478.16 Aligned_cols=256 Identities=32% Similarity=0.696 Sum_probs=239.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 57889999999999999999999999999999999987654444556889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||||.||+|..++.....+++.+++.++.||+.||+|||++||+||||||
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp----------------------------- 132 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP----------------------------- 132 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCG-----------------------------
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCc-----------------------------
Confidence 999999999999999989999999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+|||++.+|.+||+|||+|+... ....+.+||+.|||||++.+..|+ .++||||+||++|+|++|+.|
T Consensus 133 ------~NILl~~~g~vkL~DFG~a~~~~-----~~~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~P 200 (316)
T d1fota_ 133 ------ENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTP 200 (316)
T ss_dssp ------GGEEECTTSCEEECCCSSCEECS-----SCBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCT
T ss_pred ------hheeEcCCCCEEEecCccceEec-----cccccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCC
Confidence 99999999999999999998543 234567999999999999988886 899999999999999999999
Q ss_pred CCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 252 FDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
|.+.+....+.++..+...+|+.+++++.++|.+||+.||.+|+ |++++++||||+.
T Consensus 201 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 201 FYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp TCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred CCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 99999999999999999999999999999999999999999996 9999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-61 Score=475.03 Aligned_cols=256 Identities=38% Similarity=0.711 Sum_probs=215.4
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
-++|++++.||+|+||+||+|++..+|+.||||++.+..... ....+.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 356999999999999999999999999999999998765322 246788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
||||+||+|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp------------------------------ 135 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKP------------------------------ 135 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG------------------------------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecc------------------------------
Confidence 99999999999999888999999999999999999999999999999997
Q ss_pred ccCCCCceEeC---CCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 173 NVLQLENILLD---SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 173 ~~~~~~NiLl~---~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||++ ++|.+||+|||+|+.... .....+.+||+.|||||++.+..|+ .++|||||||++|+|++|+
T Consensus 136 -----~Nil~~~~~~~~~vkl~DFG~a~~~~~---~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~ 206 (307)
T d1a06a_ 136 -----ENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGY 206 (307)
T ss_dssp -----GGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSS
T ss_pred -----cceeecccCCCceEEEeccceeEEccC---CCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCC
Confidence 999995 578999999999985432 3445678899999999999988885 8999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 250 LPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
.||.+.+......++.++..+++ ..+|+++.+||.+||+.||++|||++|+++||||...
T Consensus 207 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 207 PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp CSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred CCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999988876543 4589999999999999999999999999999999753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-61 Score=467.79 Aligned_cols=256 Identities=30% Similarity=0.539 Sum_probs=218.9
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKI 89 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~ 89 (476)
+.++|++++.||+|+||+||+|+++.+|+.||||++..... +....+.+.+|+.+|++++||||+++++++.+ ++.+
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 46789999999999999999999999999999999987654 34446789999999999999999999999854 5678
Q ss_pred EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC-----cEeccCCcchhccchhhhHHHHHHHH
Q 011868 90 YMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKG-----VFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~al~yLH~~g-----ivHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
|+|||||+||+|.+++.. ...+++.+++.++.||+.||+|||++| |+||||||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp------------------ 142 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKP------------------ 142 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCG------------------
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCch------------------
Confidence 999999999999999853 457999999999999999999999976 99999997
Q ss_pred HHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhH
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGv 240 (476)
+|||++.+|.+||+|||+|+.... ......+.+||+.|||||++.+..|+ .++|||||||
T Consensus 143 -----------------~NIll~~~~~vkl~DFG~a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGv 202 (269)
T d2java1 143 -----------------ANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGC 202 (269)
T ss_dssp -----------------GGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCC-HHHHHHHHHH
T ss_pred -----------------hhcCcCCCCcEEEeeccceeeccc--CCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCH
Confidence 999999999999999999986543 23345678999999999999888885 8999999999
Q ss_pred HHHHHhcCCCCCCCCcHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccc
Q 011868 241 ILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 306 (476)
Q Consensus 241 il~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~ 306 (476)
++|+|+||+.||.+.+...+..++..+.++ +|..+|+++.+||++||+.||.+|||++|+++|||+
T Consensus 203 ilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 203 LLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 999999999999999999999999888764 677899999999999999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-61 Score=470.31 Aligned_cols=254 Identities=28% Similarity=0.460 Sum_probs=226.0
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 93 (476)
+.|++++.||+|+||+||+|++..+|+.||||++++.. .+..+.+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 46999999999999999999999999999999997653 233567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 94 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|||+||+|.+++.. .+++++.+++.++.||+.||.|||++||+||||||
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp------------------------------ 138 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKA------------------------------ 138 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG------------------------------
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecCh------------------------------
Confidence 99999999999765 45799999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccc-----cCCCCCccchhhhHhHHHHHHhc
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.+|.+||+|||+|+.... ......+.+||+.|+|||++. +..| +.++|||||||++|+|++
T Consensus 139 -----~NIll~~~~~~Kl~DFG~a~~~~~--~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemlt 210 (288)
T d2jfla1 139 -----GNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAE 210 (288)
T ss_dssp -----GGEEECTTSCEEECCCTTCEECHH--HHHHHTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHH
T ss_pred -----hheeECCCCCEEEEechhhhccCC--CcccccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhh
Confidence 999999999999999999974322 112345678999999999984 3345 489999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
|+.||.+.+....+.++..+..+ .|..+|+++.+||++||+.||.+|||++|+++||||+.
T Consensus 211 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 211 IEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp SSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999888888888877543 35668999999999999999999999999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-60 Score=478.37 Aligned_cols=258 Identities=34% Similarity=0.680 Sum_probs=240.2
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
...+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.....+
T Consensus 37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 45679999999999999999999999999999999999876544445567899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+||||+.||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP--------------------------- 169 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP--------------------------- 169 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG---------------------------
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCH---------------------------
Confidence 99999999999999999888999999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||++.+|++||+|||+|+... ....+.+||+.|||||++.+..|+ .++|||||||++|+|+||+
T Consensus 170 --------~NILl~~~g~ikL~DFG~a~~~~-----~~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~ 235 (350)
T d1rdqe_ 170 --------ENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGY 235 (350)
T ss_dssp --------GGEEECTTSCEEECCCTTCEECS-----SCBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSS
T ss_pred --------HHcccCCCCCEEeeeceeeeecc-----cccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCC
Confidence 99999999999999999998543 234567899999999999998886 8999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 250 LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
.||.+.+....+.++..+.+.+|..+++++.+||++||+.||.+|+ |++++++||||+.
T Consensus 236 ~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 236 PPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred CCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 9999999999999999999999999999999999999999999995 9999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-60 Score=470.25 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=229.3
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 94 (476)
+|+++++||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 59999999999999999999999999999999987765555666789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccccc
Q 011868 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNV 174 (476)
Q Consensus 95 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 174 (476)
||.||+|..++...+++++.+++.++.||+.||.|||++||+||||||
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp-------------------------------- 143 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA-------------------------------- 143 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSG--------------------------------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCc--------------------------------
Confidence 999999988887778999999999999999999999999999999997
Q ss_pred CCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccccc---CCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 175 LQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 175 ~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+|||++.+|.+||+|||+|..... ....+||+.|||||++.+ ..| +.++|||||||++|+|++|+.|
T Consensus 144 ---~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y-~~~~DiwSlGvilyel~~g~~P 213 (309)
T d1u5ra_ 144 ---GNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPP 213 (309)
T ss_dssp ---GGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCB-CTHHHHHHHHHHHHHHHHSSCT
T ss_pred ---ceEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCCCc-CchhhhhhHHHHHHHHHHCCCC
Confidence 999999999999999999985332 345689999999999864 335 4899999999999999999999
Q ss_pred CCCCcHHHHHHHHHhCCCCC--CCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 252 FDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
|.+.+......++..+..+. +..+|+++.+||++||+.||.+|||++++++||||....
T Consensus 214 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 214 LFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp TTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred CCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 99988888888877766543 345899999999999999999999999999999997643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-60 Score=463.65 Aligned_cols=257 Identities=35% Similarity=0.609 Sum_probs=233.3
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
-++|++++.||+|+||+||+|++..+|+.||||++.+...... ...+.+.+|+.+|++++||||+++++++.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3679999999999999999999999999999999986643322 2357899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|+|||||+||+|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp--------------------------- 141 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKP--------------------------- 141 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG---------------------------
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeeccccc---------------------------
Confidence 99999999999999998888999999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCC----CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 170 WKFNVLQLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g----~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+|||++.+| .+||+|||+|..... .....+.+||+.|+|||++.+..|+ .++||||+||++|+|
T Consensus 142 --------~Nill~~~~~~~~~vkl~DfG~a~~~~~---~~~~~~~~~t~~y~APE~~~~~~~~-~~~DiwSlGvilyel 209 (293)
T d1jksa_ 142 --------ENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYIL 209 (293)
T ss_dssp --------GGEEESCSSSSSCCEEECCCTTCEECTT---SCBCSCCCCCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHH
T ss_pred --------ceEEEecCCCcccceEecchhhhhhcCC---CccccccCCCCcccCHHHHcCCCCC-CcccchhhhHHHHHH
Confidence 999999877 599999999985432 3345667899999999999887775 899999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
++|+.||.+.+....+..+......++ ..+|+++.+||++||+.||.+|||++|+++||||+.
T Consensus 210 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 210 LSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred HcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999988877654 568999999999999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.8e-60 Score=474.95 Aligned_cols=261 Identities=29% Similarity=0.578 Sum_probs=235.2
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
-.+++|++++.||+|+||+||+|++..+|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++.+++.+|
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45789999999999999999999999999999999997653 233578899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+|||||+||+|.+++.. .+++++.+++.++.||+.||+|||++||+||||||
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp--------------------------- 152 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP--------------------------- 152 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG---------------------------
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeech---------------------------
Confidence 99999999999999954 46799999999999999999999999999999997
Q ss_pred cccccCCCCceEeCC--CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 170 WKFNVLQLENILLDS--KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~--~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++. +|.+||+|||+|+... ......+.+||+.|||||++.+..|+ .++|||||||++|+|++
T Consensus 153 --------~NIll~~~~~~~vkL~DFG~a~~~~---~~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~ 220 (350)
T d1koaa2 153 --------ENIMFTTKRSNELKLIDFGLTAHLD---PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLS 220 (350)
T ss_dssp --------GGEEESSTTSCCEEECCCTTCEECC---TTSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHH
T ss_pred --------hHeeeccCCCCeEEEeecchheecc---cccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHh
Confidence 9999964 6889999999998543 23445678999999999999988885 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccCCCC
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 313 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~~~~ 313 (476)
|+.||.+.+....+.++..+.+.++ ..+|+++++||++||+.||.+|||++|+++||||.....+.
T Consensus 221 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 221 GLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 290 (350)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence 9999999999999999998877655 34899999999999999999999999999999998765443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-60 Score=470.86 Aligned_cols=258 Identities=33% Similarity=0.600 Sum_probs=235.4
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~-~l~HpnIv~l~~~~~~~~~~~l 91 (476)
+++|++++.||+|+||+||+|++..+|+.||||++++......+....+.+|+.++. .++||||+++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 578999999999999999999999999999999998765433344566677777665 6899999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp----------------------------- 131 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKL----------------------------- 131 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG-----------------------------
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcc-----------------------------
Confidence 999999999999999888999999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP 251 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~P 251 (476)
+|||++++|++||+|||+|+.... ........+||+.|+|||++.+..|+ .++||||+||++|+|++|+.|
T Consensus 132 ------~NiL~~~~~~~kl~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~P 202 (320)
T d1xjda_ 132 ------DNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSP 202 (320)
T ss_dssp ------GGEEECTTSCEEECCCTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCS
T ss_pred ------cceeecCCCceeccccchhhhccc--ccccccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCC
Confidence 999999999999999999985443 23345567899999999999998886 899999999999999999999
Q ss_pred CCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChH-HHhcCccccc
Q 011868 252 FDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIA-GIKADEWFEQ 308 (476)
Q Consensus 252 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~-~il~~~~~~~ 308 (476)
|.+.+...++.++..+.+.+|..+|+++.+||++||+.||.+|||+. ++++||||++
T Consensus 203 F~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 203 FHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred CCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 99999999999999999999999999999999999999999999996 8999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-59 Score=456.85 Aligned_cols=253 Identities=26% Similarity=0.481 Sum_probs=221.2
Q ss_pred CcCE-EEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CC
Q 011868 13 LGRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KS 87 (476)
Q Consensus 13 ~~~Y-~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~ 87 (476)
-+|| ++.++||+|+||+||+|++..+++.||+|.+..... .....+.+.+|+.+|++++||||+++++++.+ +.
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 4566 778899999999999999999999999999987653 33446789999999999999999999999865 45
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g--ivHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
.+|+||||++||+|.+++.....+++.+++.++.||+.||+|||++| |+||||||
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp----------------------- 142 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC----------------------- 142 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCG-----------------------
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcCh-----------------------
Confidence 68999999999999999998889999999999999999999999998 99999997
Q ss_pred hccccccccCCCCceEeC-CCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 166 VIRPWKFNVLQLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~-~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+|||++ .++.+||+|||+|+... .....+.+||+.|||||++.+ +|+ .++||||+||++|+
T Consensus 143 ------------~NILl~~~~~~~Kl~DFGla~~~~----~~~~~~~~GT~~Y~aPE~~~~-~~~-~~~DIwSlGvilye 204 (270)
T d1t4ha_ 143 ------------DNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLE 204 (270)
T ss_dssp ------------GGEEESSTTSCEEECCTTGGGGCC----TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHH
T ss_pred ------------hhceeeCCCCCEEEeecCcceecc----CCccCCcccCccccCHHHhCC-CCC-CcCchhhHHHHHHH
Confidence 999997 57999999999998432 334567899999999999865 465 89999999999999
Q ss_pred HhcCCCCCCCCc-HHHHHHHHHhCCCC--CCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccc
Q 011868 245 ILTGYLPFDDRN-LAVLYQKIFRGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307 (476)
Q Consensus 245 lltG~~Pf~~~~-~~~~~~~i~~~~~~--~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~ 307 (476)
|++|+.||.+.+ ...++..+..+..+ ++...++++.+||.+||++||++|||++|+++||||+
T Consensus 205 l~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 205 MATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999997654 55666677665432 4566899999999999999999999999999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-59 Score=473.17 Aligned_cols=259 Identities=29% Similarity=0.564 Sum_probs=234.7
Q ss_pred CccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 10 ~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
+...++|++++.||+|+||+||+|++..+|+.||||++.+.. ......+.+|+.+|++++||||+++++++.+++.+
T Consensus 25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 445688999999999999999999999999999999998654 22346788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+|||||+||+|.+.+... .++++.+++.++.||+.||+|||++||+||||||
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp-------------------------- 155 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP-------------------------- 155 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG--------------------------
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccc--------------------------
Confidence 9999999999999987654 4799999999999999999999999999999997
Q ss_pred ccccccCCCCceEeC--CCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 169 PWKFNVLQLENILLD--SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 169 p~~~~~~~~~NiLl~--~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++ .+|.+||+|||+|+... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|+
T Consensus 156 ---------~NILl~~~~~~~vkL~DFGla~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell 222 (352)
T d1koba_ 156 ---------ENIMCETKKASSVKIIDFGLATKLN---PDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLL 222 (352)
T ss_dssp ---------GGEEESSTTCCCEEECCCTTCEECC---TTSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHH
T ss_pred ---------ccccccccCCCeEEEeecccceecC---CCCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHH
Confidence 999998 67899999999998543 34456678999999999999988885 8999999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
||+.||.+.+....+.++..+.+++| ..+|+++.+||.+||+.||.+|||++|+++||||+...
T Consensus 223 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 223 SGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 99999999999999999998877655 45899999999999999999999999999999998654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-60 Score=471.78 Aligned_cols=257 Identities=30% Similarity=0.453 Sum_probs=219.9
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
+.-++|++++.||+|+||+||+|++..+|+.||+|++++.. .......+.+|+.+|+.++||||++++++|.+++.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34578999999999999999999999999999999998654 3344678999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
+||||++||+|.+++...+++++.+++.++.||+.||.|||+ +||+||||||
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP--------------------------- 133 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP--------------------------- 133 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSG---------------------------
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCH---------------------------
Confidence 999999999999999988899999999999999999999997 5999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||++.+|++||+|||+|+... .....+.+||+.|+|||++.+..|+ .++||||+||++|||++|+
T Consensus 134 --------~NILl~~~~~vkl~DFGla~~~~----~~~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~ 200 (322)
T d1s9ja_ 134 --------SNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGR 200 (322)
T ss_dssp --------GGEEECTTCCEEECCCCCCHHHH----HHTC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSS
T ss_pred --------HHeeECCCCCEEEeeCCCccccC----CCccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCC
Confidence 99999999999999999998432 2234567999999999999998886 8999999999999999999
Q ss_pred CCCCCCcHHHHH------------------------------------------HHHHhCC-CCCC-CCCCHHHHHHHHH
Q 011868 250 LPFDDRNLAVLY------------------------------------------QKIFRGD-FKLP-KWLSPGAQNLLRK 285 (476)
Q Consensus 250 ~Pf~~~~~~~~~------------------------------------------~~i~~~~-~~~p-~~~s~~~~~Li~~ 285 (476)
.||.+.+..... ..+.... ...| ..+|+++.+||.+
T Consensus 201 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 280 (322)
T d1s9ja_ 201 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 280 (322)
T ss_dssp CCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHH
Confidence 999775432110 0111111 1122 2268899999999
Q ss_pred ccCCCcCCCCChHHHhcCcccccc
Q 011868 286 ILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 286 ~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
||+.||.+|||++|+++||||++.
T Consensus 281 ~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 281 CLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp HTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred HcCCChhHCcCHHHHhhCHhhCcC
Confidence 999999999999999999999763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.3e-59 Score=471.78 Aligned_cols=259 Identities=27% Similarity=0.452 Sum_probs=225.7
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHH---HHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~---~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
+++++|++++.||+|+||+||+|++..+|+.||||++.+...........+. +|+.+++.++||||+++++++.+.+
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 4688999999999999999999999999999999999865433322233344 4477778888999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.+|+||||++||+|.+++.....+++.+++.++.||+.||+|||++||+||||||
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP------------------------- 135 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP------------------------- 135 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG-------------------------
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeecc-------------------------
Confidence 9999999999999999999888999999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.+|.+||+|||+|+.... ......+||+.|+|||++.+....+.++|||||||++|+|+|
T Consensus 136 ----------~NILl~~~g~iKl~DFGla~~~~~----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemlt 201 (364)
T d1omwa3 136 ----------ANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 201 (364)
T ss_dssp ----------GGEEECSSSCEEECCCTTCEECSS----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ----------ceeEEcCCCcEEEeeeceeeecCC----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHh
Confidence 999999999999999999985432 345567899999999999765444589999999999999999
Q ss_pred CCCCCCCCcH---HHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCC-----hHHHhcCccccc
Q 011868 248 GYLPFDDRNL---AVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 308 (476)
Q Consensus 248 G~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s-----~~~il~~~~~~~ 308 (476)
|+.||.+.+. ..+...+......+|..+|+++.+||.+||+.||.+||| ++++++||||+.
T Consensus 202 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 202 GHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp SSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 9999987543 344455556667788889999999999999999999999 799999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-58 Score=451.24 Aligned_cols=258 Identities=31% Similarity=0.548 Sum_probs=230.8
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccc------hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH------LKITDQIKREIATLKLLK-HPNVVRLHEVLAS 85 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~ 85 (476)
.++|++.+.||+|+||+||+|++..+|+.||||++.+..... ....+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999999999999999998764322 223456889999999997 9999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
++.+|+||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp----------------------- 138 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKP----------------------- 138 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG-----------------------
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCccccccc-----------------------
Confidence 999999999999999999999888999999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccC-----CCCCccchhhhHhH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSCGV 240 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~sDvwSlGv 240 (476)
+|||++.++.+||+|||+++.... .......+||+.|+|||++.+. ...+.++||||+||
T Consensus 139 ------------~Nill~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGv 203 (277)
T d1phka_ 139 ------------ENILLDDDMNIKLTDFGFSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 203 (277)
T ss_dssp ------------GGEEECTTCCEEECCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHH
T ss_pred ------------ceEEEcCCCCeEEccchheeEccC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccch
Confidence 999999999999999999986433 3344567899999999998642 22357899999999
Q ss_pred HHHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHccCCCcCCCCChHHHhcCccccc
Q 011868 241 ILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 241 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~ 308 (476)
++|+|++|+.||.+.+.......+..+...++. .+|+++++||.+||++||.+|||++|+++||||++
T Consensus 204 ilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 204 IMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred hhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 999999999999999999999988888765443 58999999999999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-58 Score=461.07 Aligned_cols=255 Identities=25% Similarity=0.488 Sum_probs=232.1
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
.+++|++++.||+|+||+||+|++..+|+.||||++++... ....+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999999999999999999976531 23568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
|||||+||+|.+++...+ ++++.+++.++.||+.||+|||++||+||||||
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp---------------------------- 130 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP---------------------------- 130 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG----------------------------
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccc----------------------------
Confidence 999999999999997654 799999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCC--CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 171 KFNVLQLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~--g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+|||++.+ +.+||+|||+++... ......+.+||+.|+|||++.+..|+ .++||||+||++|+|++|
T Consensus 131 -------~NIll~~~~~~~ikl~DFG~~~~~~---~~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G 199 (321)
T d1tkia_ 131 -------ENIIYQTRRSSTIKIIEFGQARQLK---PGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSG 199 (321)
T ss_dssp -------GGEEESSSSCCCEEECCCTTCEECC---TTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHS
T ss_pred -------cceeecCCCceEEEEcccchhhccc---cCCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhC
Confidence 99999854 589999999998543 23445677899999999999888775 899999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
..||.+.+....+.++..+.+.+|. .+|+++.+||++||+.||.+|||++|+++||||++.
T Consensus 200 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 200 INPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp SCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999998887763 689999999999999999999999999999999764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-58 Score=450.68 Aligned_cols=253 Identities=34% Similarity=0.596 Sum_probs=224.3
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchh---HHHHHHHHHHHHHhCC--CCCcceEEEEEEeCC
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK--HPNVVRLHEVLASKS 87 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~~ 87 (476)
-++|++++.||+|+||+||+|++..+|+.||||++.+....... ...++.+|+.+|++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999999999999999999876433221 1234678999999996 899999999999999
Q ss_pred EEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 88 KIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 88 ~~~lV~E~~~g-g~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
..|+||||+.+ +++.+++.....+++.+++.++.||+.||+|||++||+||||||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp------------------------ 138 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKD------------------------ 138 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG------------------------
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcc------------------------
Confidence 99999999976 68888888888999999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCC-CCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 167 IRPWKFNVLQLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~-g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+|||++.+ +.+||+|||+|+... .....+.+||+.|+|||++.+..+++.++||||+||++|+|
T Consensus 139 -----------~NIll~~~~~~vkl~DFG~a~~~~----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyel 203 (273)
T d1xwsa_ 139 -----------ENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 203 (273)
T ss_dssp -----------GGEEEETTTTEEEECCCTTCEECC----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred -----------cceEEecCCCeEEECccccceecc----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhH
Confidence 99999854 799999999998533 23455678999999999999888877889999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCccccccC
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
++|+.||.+.+ .+.++...++..+|+++.+||++||+.||++|||++|+++||||++-.
T Consensus 204 l~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 204 VCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHSSCSCCSHH------HHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred hhCCCCCCCch------HHhhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 99999998643 466778888999999999999999999999999999999999997643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-58 Score=451.42 Aligned_cols=258 Identities=25% Similarity=0.325 Sum_probs=217.7
Q ss_pred EeceEeecCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011868 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (476)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 95 (476)
.++.||+|+||+||+|++..+|+.||||+++...... ......+.+|+.+|+.++||||+++++++..++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4678999999999999999999999999997654322 12235688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccC
Q 011868 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVL 175 (476)
Q Consensus 96 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 175 (476)
+.|+++..+......+++.+++.++.||+.||+|||++||+||||||
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp--------------------------------- 128 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP--------------------------------- 128 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCG---------------------------------
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCc---------------------------------
Confidence 98888777766667899999999999999999999999999999997
Q ss_pred CCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCCCCC
Q 011868 176 QLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 255 (476)
Q Consensus 176 ~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf~~~ 255 (476)
+|||++.+|.+||+|||+|+.... ......+.+||+.|+|||++.+..+++.++||||+||++|+|++|..||.+.
T Consensus 129 --~NIli~~~~~~KL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 129 --NNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp --GGEEECTTCCEEECCCGGGSTTTS--CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --ceEEecCCCccccccCccccccCC--CcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 999999999999999999986443 2334456789999999999877665568999999999999999999999999
Q ss_pred cHHHHHHHHHhCCCC--------------------C--------CCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccc
Q 011868 256 NLAVLYQKIFRGDFK--------------------L--------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307 (476)
Q Consensus 256 ~~~~~~~~i~~~~~~--------------------~--------p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~ 307 (476)
+..+...++.+.... . .+.+++++.+||.+||+.||++|||++|+++||||+
T Consensus 205 ~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 284 (299)
T d1ua2a_ 205 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284 (299)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred CHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence 888777776542100 0 123688999999999999999999999999999998
Q ss_pred ccCCC
Q 011868 308 QDYTP 312 (476)
Q Consensus 308 ~~~~~ 312 (476)
+...|
T Consensus 285 ~~p~p 289 (299)
T d1ua2a_ 285 NRPGP 289 (299)
T ss_dssp SSSCC
T ss_pred CCCCC
Confidence 65443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-57 Score=453.69 Aligned_cols=254 Identities=31% Similarity=0.587 Sum_probs=217.0
Q ss_pred CCccCcCEEEec-eEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCcceEEEEEEe-
Q 011868 9 EGMRLGRYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEVLAS- 85 (476)
Q Consensus 9 ~~~~~~~Y~i~~-~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~-l~HpnIv~l~~~~~~- 85 (476)
....+++|++.. .||+|+||+||+|++..+|+.||||++++. ..+.+|+.++.+ .+||||++++++|.+
T Consensus 6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 345678999875 599999999999999999999999999643 457789998654 589999999999975
Q ss_pred ---CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 86 ---KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 86 ---~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
+..+|+|||||+||+|.+++... .++++.+++.++.||+.||+|||++||+||||||
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp------------------ 139 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP------------------ 139 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSG------------------
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccc------------------
Confidence 46799999999999999999764 3699999999999999999999999999999997
Q ss_pred HHHhhhccccccccCCCCceEeCC---CCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhh
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDS---KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 237 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~---~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwS 237 (476)
+|||++. ++.+||+|||+|+.... .....+.+||+.|||||++.+..|+ .++||||
T Consensus 140 -----------------~NIll~~~~~~~~~Kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwS 198 (335)
T d2ozaa1 140 -----------------ENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWS 198 (335)
T ss_dssp -----------------GGEEESCSSTTCCEEECCCTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHH
T ss_pred -----------------cccccccccccccccccccceeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHh
Confidence 9999985 56799999999985432 3445677899999999999988886 8999999
Q ss_pred HhHHHHHHhcCCCCCCCCcHHHH----HHHHHhCCCCCCC----CCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 238 CGVILYVILTGYLPFDDRNLAVL----YQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 238 lGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
|||++|+|+||+.||.+.+.... ..++..+.+.+|. .+|+++.+||++||+.||++|||++|+++||||.+.
T Consensus 199 lGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 199 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred hchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 99999999999999987764333 3344445555553 379999999999999999999999999999999754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=442.46 Aligned_cols=261 Identities=29% Similarity=0.458 Sum_probs=220.3
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+++|+++++||+|+||+||+|++..+|+.||||+++.... ......++.+|+.+|++++||||+++++++.+++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 5789999999999999999999999999999999976542 333457899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 93 LEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
|||+.+ .+.+.+.. ..++++.+++.++.||+.||+|||++||+||||||
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKp---------------------------- 130 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP---------------------------- 130 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG----------------------------
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCc----------------------------
Confidence 999965 55555533 45799999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 250 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~ 250 (476)
+|||++.++.+||+|||+|+.... ........+||+.|+|||++....+.+.++||||+||++|+|++|+.
T Consensus 131 -------eNIl~~~~~~~kl~DFG~a~~~~~--~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~ 201 (298)
T d1gz8a_ 131 -------QNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201 (298)
T ss_dssp -------GGEEECTTSCEEECSTTHHHHHCC--CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------hheeecccCcceeccCCcceeccC--CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCC
Confidence 999999999999999999975332 23345567899999999999888887899999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhCCC------------------CCC-----------CCCCHHHHHHHHHccCCCcCCCCChHHHh
Q 011868 251 PFDDRNLAVLYQKIFRGDF------------------KLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIK 301 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~~------------------~~p-----------~~~s~~~~~Li~~~L~~dP~~R~s~~~il 301 (476)
||.+.+......++.+... ..+ ..+|+++.+||++||+.||.+|||++|++
T Consensus 202 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell 281 (298)
T d1gz8a_ 202 LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281 (298)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 9999887766655543110 011 23578899999999999999999999999
Q ss_pred cCccccccCCC
Q 011868 302 ADEWFEQDYTP 312 (476)
Q Consensus 302 ~~~~~~~~~~~ 312 (476)
+||||++-..|
T Consensus 282 ~H~ff~~~~~p 292 (298)
T d1gz8a_ 282 AHPFFQDVTKP 292 (298)
T ss_dssp TSGGGTTCCCC
T ss_pred CCHhhccCCCC
Confidence 99999865444
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.7e-56 Score=434.36 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=219.8
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----E
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----K 88 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----~ 88 (476)
-++|++.+.||+|+||+||+|++..+|+.||||++.++...+......+.+|+.+|+.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999998876666666788999999999999999999999997643 4
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
+|+||||++|++|.+++...+++++.+++.++.||+.||+|||++||+||||||
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP-------------------------- 139 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP-------------------------- 139 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG--------------------------
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccC--------------------------
Confidence 899999999999999999888999999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCccc-CCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.++.++|+|||++....... ......+.+||+.|+|||++.+..|+ .++||||+||++|+|+|
T Consensus 140 ---------~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyellt 209 (277)
T d1o6ya_ 140 ---------ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLT 209 (277)
T ss_dssp ---------GGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHH
T ss_pred ---------cccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHh
Confidence 99999999999999999987543321 22345567899999999999888785 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhCCCCC----CCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccc
Q 011868 248 GYLPFDDRNLAVLYQKIFRGDFKL----PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 307 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~ 307 (476)
|+.||.+.+......++....... +..+|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 210 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 210 GEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp SSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 999999999888888777766543 355899999999999999999999555555677764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.5e-56 Score=436.28 Aligned_cols=257 Identities=31% Similarity=0.458 Sum_probs=219.6
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+++|+++++||+|+||+||+|++. +|+.||||++..... +......+.+|+.+|++++||||+++++++..++..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 579999999999999999999984 889999999976643 333457899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|||+.++.+..+....+.+++.+++.++.||+.||+|||++||+||||||
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp------------------------------ 128 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKP------------------------------ 128 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG------------------------------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCC------------------------------
Confidence 99998877777777678899999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+|||++.++.+||+|||+|..... .........|++.|+|||++.+..+.+.++||||+||++|+|++|+.||
T Consensus 129 -----~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf 201 (286)
T d1ob3a_ 129 -----QNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201 (286)
T ss_dssp -----GGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred -----ceeeEcCCCCEEecccccceeccc--CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC
Confidence 999999999999999999875332 2223455679999999999988777779999999999999999999999
Q ss_pred CCCcHHHHHHHHHhCCC-----------------------------CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 253 DDRNLAVLYQKIFRGDF-----------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 253 ~~~~~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
.+.+..+.+.++..... ..+..+++++.+||++||+.||++|||++|+++|
T Consensus 202 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 202 PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99887777666543100 1223468899999999999999999999999999
Q ss_pred ccccc
Q 011868 304 EWFEQ 308 (476)
Q Consensus 304 ~~~~~ 308 (476)
|||++
T Consensus 282 p~f~~ 286 (286)
T d1ob3a_ 282 AYFKE 286 (286)
T ss_dssp GGGGC
T ss_pred cccCc
Confidence 99974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=437.05 Aligned_cols=265 Identities=26% Similarity=0.359 Sum_probs=218.8
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------ 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------ 85 (476)
.+++|+++++||+|+||+||+|++..+|+.||||++.+... ......++.+|+.+|+.++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 47999999999999999999999999999999999976643 33345778899999999999999999999854
Q ss_pred --CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHH
Q 011868 86 --KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLL 163 (476)
Q Consensus 86 --~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~ 163 (476)
++.+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp--------------------- 145 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKA--------------------- 145 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG---------------------
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCc---------------------
Confidence 456899999998776665555667899999999999999999999999999999997
Q ss_pred hhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCccc--CCCcccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 164 MIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 164 ~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+|||++.++.+||+|||+++...... ......+.+||+.|+|||++.+...++.++||||+||+
T Consensus 146 --------------~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvi 211 (318)
T d3blha1 146 --------------ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 211 (318)
T ss_dssp --------------GGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred --------------hheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCce
Confidence 99999999999999999997544321 22344556899999999999876555689999999999
Q ss_pred HHHHhcCCCCCCCCcHHHHHHHHHhCCCCCCCC--------------------------------CCHHHHHHHHHccCC
Q 011868 242 LYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--------------------------------LSPGAQNLLRKILEP 289 (476)
Q Consensus 242 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--------------------------------~s~~~~~Li~~~L~~ 289 (476)
+|+|++|+.||.+.+.......+.+....++.. .++++.+||.+||+.
T Consensus 212 l~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~ 291 (318)
T d3blha1 212 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 291 (318)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred eeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcC
Confidence 999999999999988777666654422111100 267889999999999
Q ss_pred CcCCCCChHHHhcCccccccCCC
Q 011868 290 NPVKRITIAGIKADEWFEQDYTP 312 (476)
Q Consensus 290 dP~~R~s~~~il~~~~~~~~~~~ 312 (476)
||++|||++|++.||||...+.|
T Consensus 292 dP~~R~sa~elL~Hpff~~~p~p 314 (318)
T d3blha1 292 DPAQRIDSDDALNHDFFWSDPMP 314 (318)
T ss_dssp STTTSCCHHHHHHSGGGSSSSCC
T ss_pred ChhHCcCHHHHHcChhhccCCCC
Confidence 99999999999999999865443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=441.16 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=216.3
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCc-----eEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL-----PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~ 86 (476)
.++|++++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|+++ +|||||++++++.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 3689999999999999999999876554 69999986543 233356789999999998 899999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcc
Q 011868 87 SKIYMVLEYVTGGELFDKIASK-----------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVI 143 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~-----------------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~ 143 (476)
+.+|+|||||+||+|.++|... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp- 192 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA- 192 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG-
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch-
Confidence 9999999999999999999754 2489999999999999999999999999999997
Q ss_pred hhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccc
Q 011868 144 LKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 223 (476)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 223 (476)
+|||++.++++||+|||+|+............+.+||+.|||||++
T Consensus 193 ----------------------------------~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l 238 (325)
T d1rjba_ 193 ----------------------------------RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238 (325)
T ss_dssp ----------------------------------GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred ----------------------------------hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH
Confidence 9999999999999999999865443333334567899999999999
Q ss_pred ccCCCCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHccCCCcCCCCChHHH
Q 011868 224 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 300 (476)
Q Consensus 224 ~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~i 300 (476)
.+..|+ .++|||||||++|||+| |+.||.+.+....+.++.... ++.|..+|+++.+||.+||+.||++|||+++|
T Consensus 239 ~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei 317 (325)
T d1rjba_ 239 FEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317 (325)
T ss_dssp HHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 888885 89999999999999998 999999877655555555543 45678899999999999999999999999999
Q ss_pred hcC
Q 011868 301 KAD 303 (476)
Q Consensus 301 l~~ 303 (476)
++|
T Consensus 318 ~~~ 320 (325)
T d1rjba_ 318 TSF 320 (325)
T ss_dssp HHH
T ss_pred HHH
Confidence 876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-55 Score=431.10 Aligned_cols=255 Identities=22% Similarity=0.355 Sum_probs=211.8
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
...++|++.+.||+|+||+||+|++..+++ .||||.+.... .....+.+.+|+.+|++++||||+++++++..++
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 456789999999999999999999987665 58899886554 3444678999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
.+|+|||||+||+|.+++... +.+++.++..++.||+.||+|||++||+||||||
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp------------------------ 156 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAA------------------------ 156 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG------------------------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCcccc------------------------
Confidence 999999999999999988764 5799999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCC---cccccccCCccccccccccCCCCCccchhhhHhHHHH
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 243 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ 243 (476)
+|||++.++.+||+|||+|+......... ......||+.|||||++.+..|+ .++|||||||++|
T Consensus 157 -----------~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~ 224 (299)
T d1jpaa_ 157 -----------RNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMW 224 (299)
T ss_dssp -----------GGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHH
T ss_pred -----------ceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHH
Confidence 99999999999999999998654322111 12224589999999999888785 8999999999999
Q ss_pred HHhc-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 244 VILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 244 ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
||+| |+.||.+.+...+...+..+. ++.|..+++++.+||.+||+.||.+|||+.+|+++
T Consensus 225 el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 225 EVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9998 899999999888888887664 56777899999999999999999999999998875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=430.13 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=207.8
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++++.||+|+||+||+|+. +..||||+++.... +....+.+.+|+.+|++++||||+++++++. ++.+|+
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence 457899999999999999999974 23599999976543 3345688999999999999999999999875 456899
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
|||||+||+|.+++... .++++.++..++.||+.||+|||++||+||||||
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp---------------------------- 132 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKS---------------------------- 132 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG----------------------------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCH----------------------------
Confidence 99999999999999754 5799999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccC---CCCCccchhhhHhHHHHHHhc
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.++.+||+|||+|+............+.+||+.|||||++.+. .| +.++|||||||++|||+|
T Consensus 133 -------~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-~~~sDiwS~Gv~l~el~t 204 (276)
T d1uwha_ 133 -------NNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY-SFQSDVYAFGIVLYELMT 204 (276)
T ss_dssp -------GGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCC-CHHHHHHHHHHHHHHHHH
T ss_pred -------HHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCC-CchhhhhhhHHHHHHHHH
Confidence 9999999999999999999876543334455677899999999998653 34 489999999999999999
Q ss_pred CCCCCCCCcHHHH-HHHHHhCCC-----CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCc
Q 011868 248 GYLPFDDRNLAVL-YQKIFRGDF-----KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304 (476)
Q Consensus 248 G~~Pf~~~~~~~~-~~~i~~~~~-----~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~ 304 (476)
|+.||.+.+.... ...+.++.. ..+..+++++.+||.+||+.||.+|||+++|+++-
T Consensus 205 g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 205 GQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp SSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9999998765444 344444322 24566899999999999999999999999999873
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-55 Score=432.82 Aligned_cols=257 Identities=31% Similarity=0.403 Sum_probs=215.6
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCC-CceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEe--
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLAS-- 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~-- 85 (476)
..++|+++++||+|+||+||+|++..+ ++.||||+++..... ......+.+|+.+|+.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 347999999999999999999999765 677999999765432 22234566788887766 79999999999853
Q ss_pred ---CCEEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 86 ---KSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 86 ---~~~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
...+|++|||+.++.+..... ....+++..++.++.||+.||+|||++||+||||||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp------------------- 144 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP------------------- 144 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG-------------------
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCc-------------------
Confidence 357899999998876654443 345799999999999999999999999999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+|||++.+|.+||+|||+++.... .....+.+||+.|+|||++.+..|+ .++||||+||+
T Consensus 145 ----------------~NILi~~~~~~kl~dfg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~i 204 (305)
T d1blxa_ 145 ----------------QNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCI 204 (305)
T ss_dssp ----------------GGEEECTTCCEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHH
T ss_pred ----------------cEEEEcCCCCeeecchhhhhhhcc---cccCCCcccChhhcCcchhcCCCCC-hhehhhchHHH
Confidence 999999999999999999986433 3345678899999999999998886 89999999999
Q ss_pred HHHHhcCCCCCCCCcHHHHHHHHHhCC---------------------------CCCCCCCCHHHHHHHHHccCCCcCCC
Q 011868 242 LYVILTGYLPFDDRNLAVLYQKIFRGD---------------------------FKLPKWLSPGAQNLLRKILEPNPVKR 294 (476)
Q Consensus 242 l~elltG~~Pf~~~~~~~~~~~i~~~~---------------------------~~~p~~~s~~~~~Li~~~L~~dP~~R 294 (476)
+|+|++|+.||.+.+....+.++.... ..++..+++.+.+||++||++||++|
T Consensus 205 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R 284 (305)
T d1blxa_ 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 284 (305)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTS
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHC
Confidence 999999999999998877777664310 01234578999999999999999999
Q ss_pred CChHHHhcCccccc
Q 011868 295 ITIAGIKADEWFEQ 308 (476)
Q Consensus 295 ~s~~~il~~~~~~~ 308 (476)
||++|+++||||++
T Consensus 285 ~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 285 ISAYSALSHPYFQD 298 (305)
T ss_dssp CCHHHHHTSGGGTT
T ss_pred cCHHHHhcChhhcC
Confidence 99999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=429.00 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=212.7
Q ss_pred ceEeecCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011868 20 RTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (476)
Q Consensus 20 ~~LG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 97 (476)
++||+|+||+||+|.+. .+++.||||+++... .+....+.+.+|+.+|++++||||+++++++.++ ..|+||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 47999999999999864 356789999997654 2344567899999999999999999999999754 5789999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccccccCCC
Q 011868 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQL 177 (476)
Q Consensus 98 gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 177 (476)
+|+|.+++....++++.++..++.||+.||+|||++||+||||||
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp----------------------------------- 135 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAA----------------------------------- 135 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG-----------------------------------
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcc-----------------------------------
Confidence 999999999888999999999999999999999999999999997
Q ss_pred CceEeCCCCCEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCCCCCCC
Q 011868 178 ENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR 255 (476)
Q Consensus 178 ~NiLl~~~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~Pf~~~ 255 (476)
+|||++.+|.+||+|||+|+....... ........||+.|||||++.+..|+ .++|||||||++|||+| |+.||.+.
T Consensus 136 ~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~ 214 (277)
T d1xbba_ 136 RNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGM 214 (277)
T ss_dssp GGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred hhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCC
Confidence 999999999999999999986543221 1123345799999999999888775 89999999999999998 99999999
Q ss_pred cHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHH---hcCccc
Q 011868 256 NLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI---KADEWF 306 (476)
Q Consensus 256 ~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~i---l~~~~~ 306 (476)
+...+...+.++. ++.|..+++++.+||.+||+.||.+|||+++| |+|+|+
T Consensus 215 ~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 215 KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 8888888887764 56788899999999999999999999999998 456554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-54 Score=421.23 Aligned_cols=259 Identities=28% Similarity=0.434 Sum_probs=225.1
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
+++|+++++||+|+||+||+|++..+|+.||||+++.... ......++.+|+.+|+.++||||+++++++......++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 5799999999999999999999999999999999977653 445578899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccccc
Q 011868 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWKF 172 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 172 (476)
|+++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP------------------------------ 129 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKP------------------------------ 129 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG------------------------------
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccC------------------------------
Confidence 99999999999888888999999999999999999999999999999997
Q ss_pred ccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCCCCC
Q 011868 173 NVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 252 (476)
Q Consensus 173 ~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~~Pf 252 (476)
+|||++.++.+||+|||.|+.... .........+++.|+|||++.+..+.+.++||||+||++|+|++|+.||
T Consensus 130 -----~NIli~~~~~~kl~DFG~a~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 202 (292)
T d1unla_ 130 -----QNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp -----GGEEECTTCCEEECCCTTCEECCS--CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred -----cccccccCCceeeeecchhhcccC--CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCC
Confidence 999999999999999999985433 2233444567899999999988776679999999999999999999885
Q ss_pred -CCCcHHHHHHHHHhCCC-----------------------------CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 253 -DDRNLAVLYQKIFRGDF-----------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 253 -~~~~~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
.+.+......++..... ..+..+++.+.+||++||+.||.+|||++|+|+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 203 FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 55566665555432100 122346889999999999999999999999999
Q ss_pred Ccccccc
Q 011868 303 DEWFEQD 309 (476)
Q Consensus 303 ~~~~~~~ 309 (476)
||||++-
T Consensus 283 Hp~f~~~ 289 (292)
T d1unla_ 283 HPYFSDF 289 (292)
T ss_dssp SGGGSSC
T ss_pred ChhhcCC
Confidence 9999753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-55 Score=421.80 Aligned_cols=249 Identities=23% Similarity=0.406 Sum_probs=210.6
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
-++|+++++||+|+||+||+|++. +++.||||+++..... .+.+.+|+.++++++||||+++++++..++..|+|
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 358999999999999999999985 6778999999765422 36789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp----------------------------- 129 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAA----------------------------- 129 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSG-----------------------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccch-----------------------------
Confidence 9999999999998754 5689999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYL 250 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~ 250 (476)
+|||+++++++||+|||+|+...... ........||+.|+|||++.+..|+ .++|||||||++|||+| |.+
T Consensus 130 ------~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~ 201 (263)
T d1sm2a_ 130 ------RNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKI 201 (263)
T ss_dssp ------GGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCC
T ss_pred ------hheeecCCCCeEecccchheeccCCC-ceeecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCC
Confidence 99999999999999999998654321 2223456799999999999988886 89999999999999999 688
Q ss_pred CCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 251 PFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
||.+.+...+...+..+. ...|..+++++.+||.+||+.||++|||+++|++|
T Consensus 202 ~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 202 PYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp TTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 888888888888887764 45677889999999999999999999999999886
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.6e-55 Score=428.92 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=218.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 91 (476)
..++|++.+.||+|+||+||+|++..+|+.||||+++.+.. ..+++.+|+.+|++++||||+++++++.+++.+|+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 34589999999999999999999999999999999976542 24679999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccc
Q 011868 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRP 169 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p 169 (476)
|||||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp--------------------------- 143 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA--------------------------- 143 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG---------------------------
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCcccc---------------------------
Confidence 99999999999999753 5789999999999999999999999999999997
Q ss_pred cccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 170 WKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 170 ~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||+++++.+||+|||+|+...... ........||+.|+|||++.+..|+ .++|||||||++|||++|.
T Consensus 144 --------~NILl~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~ 213 (287)
T d1opja_ 144 --------RNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYG 213 (287)
T ss_dssp --------GGEEECGGGCEEECCCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTS
T ss_pred --------CeEEECCCCcEEEccccceeecCCCC-ceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCC
Confidence 99999999999999999998654311 1223345689999999999988885 8999999999999999955
Q ss_pred -CCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 250 -LPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 250 -~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+||.+.+...++..+..+ .++.|..+++++.+||.+||+.||.+|||++++++
T Consensus 214 ~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 214 MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 456666777776666554 45677889999999999999999999999999965
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=425.47 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=221.0
Q ss_pred CcCEEEece-EeecCceEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 13 LGRYELGRT-LGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 13 ~~~Y~i~~~-LG~G~fg~V~~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
-++|.+... ||+|+||+||+|.+.. ++..||||+++... .....+.+.+|+.+|++++||||+++++++.++ .+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-AL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eE
Confidence 356888884 9999999999998754 45579999997653 344567899999999999999999999999754 58
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||++||+|.+++.. +..+++.++..++.||+.||+|||++||+||||||
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp-------------------------- 137 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAA-------------------------- 137 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG--------------------------
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCch--------------------------
Confidence 999999999999999865 45799999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.++.+||+|||+|+....... .......+||+.|+|||++.+..++ .++|||||||++|||+|
T Consensus 138 ---------~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt 207 (285)
T d1u59a_ 138 ---------RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALS 207 (285)
T ss_dssp ---------GGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHT
T ss_pred ---------hheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHh
Confidence 999999999999999999986543221 1223456799999999999888775 89999999999999998
Q ss_pred -CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHH---hcCcccc
Q 011868 248 -GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI---KADEWFE 307 (476)
Q Consensus 248 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~i---l~~~~~~ 307 (476)
|+.||.+.+..++...+..+. ++.|+.+++++.+||.+||+.||++|||+.+| |+|+|+.
T Consensus 208 ~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 208 YGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999999988888888887764 56788999999999999999999999999987 6677764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=422.55 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=218.4
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
.++|++++.||+|+||+||+|++. ++..||||+++.... ..+.+.+|+.+|++++||||+++++++.+ +..|+|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 368999999999999999999974 678899999976542 24679999999999999999999998754 567999
Q ss_pred EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcccc
Q 011868 93 LEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPW 170 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 170 (476)
|||+++|+|.+++... .++++.++..++.||+.||.|||++||+||||||
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp---------------------------- 137 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRA---------------------------- 137 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG----------------------------
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccch----------------------------
Confidence 9999999999977543 3699999999999999999999999999999997
Q ss_pred ccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CC
Q 011868 171 KFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GY 249 (476)
Q Consensus 171 ~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~ 249 (476)
+|||+++++.+||+|||+|+..... .........||+.|+|||++.+..|+ .++|||||||++|||+| |.
T Consensus 138 -------~NIll~~~~~~Kl~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~ 208 (272)
T d1qpca_ 138 -------ANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGR 208 (272)
T ss_dssp -------GGEEECTTSCEEECCCTTCEECSSS-CEECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTC
T ss_pred -------hheeeecccceeeccccceEEccCC-ccccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCC
Confidence 9999999999999999999865431 11233456799999999999887775 89999999999999999 56
Q ss_pred CCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc--Ccccc
Q 011868 250 LPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFE 307 (476)
Q Consensus 250 ~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~--~~~~~ 307 (476)
+||...+.......+..+ ....|..+++++.+||.+||+.||++|||++++++ |+||.
T Consensus 209 ~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 209 IPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 677777788888887765 35577889999999999999999999999999988 78875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=416.07 Aligned_cols=249 Identities=23% Similarity=0.402 Sum_probs=222.7
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV 92 (476)
-++|+++++||+|+||+||+|++ .+++.||||++++.... .+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 46899999999999999999998 57889999999876532 46789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||+++|+|.+++.. ...+++..+++++.||++||+|||+.||+||||||
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~----------------------------- 128 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAA----------------------------- 128 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSG-----------------------------
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccc-----------------------------
Confidence 999999999999765 45799999999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-CCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYL 250 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt-G~~ 250 (476)
+|||+++++.+||+|||+|+..... ........+||+.|+|||++.+..|+ .++|||||||++|||+| |+.
T Consensus 129 ------~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~ 200 (258)
T d1k2pa_ 129 ------RNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKM 200 (258)
T ss_dssp ------GGEEECTTCCEEECCCSSCCBCSSS-SCCCCCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCC
T ss_pred ------eeEEEcCCCcEEECcchhheeccCC-CceeecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCC
Confidence 9999999999999999999855432 22233446799999999999988886 89999999999999998 899
Q ss_pred CCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 251 PFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 251 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
||.+.+..++..++..+. .+.|...++++.+||++||+.||++|||+++|++|
T Consensus 201 Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 201 PYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 999999988888888763 45678899999999999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=433.44 Aligned_cols=254 Identities=29% Similarity=0.409 Sum_probs=213.6
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----- 87 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----- 87 (476)
-++|+++++||+|+||+||+|++..+|+.||||++++.. .+....+.+.+|+.+|+.++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 468999999999999999999999999999999997654 34455678999999999999999999999997654
Q ss_pred -EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 88 -KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 88 -~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
.+|+||||+ |.+|...+. .+++++..++.++.||+.||+|||++||+||||||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp------------------------ 149 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKP------------------------ 149 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG------------------------
T ss_pred ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCc------------------------
Confidence 579999999 667776664 46899999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.++.+|++|||+|+... ......+||+.|+|||++.+..+.+.++||||+||++|+|+
T Consensus 150 -----------~NIL~~~~~~~kl~Dfg~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell 213 (346)
T d1cm8a_ 150 -----------GNLAVNEDCELKILDFGLARQAD-----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 213 (346)
T ss_dssp -----------GGEEECTTCCEEECCCTTCEECC-----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHH
T ss_pred -----------chhhcccccccccccccceeccC-----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHH
Confidence 99999999999999999998532 23456789999999999988777679999999999999999
Q ss_pred cCCCCCCCCcHHHHHHHHHhCCC-------------------------------CCCCCCCHHHHHHHHHccCCCcCCCC
Q 011868 247 TGYLPFDDRNLAVLYQKIFRGDF-------------------------------KLPKWLSPGAQNLLRKILEPNPVKRI 295 (476)
Q Consensus 247 tG~~Pf~~~~~~~~~~~i~~~~~-------------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~ 295 (476)
+|+.||.+.+....+..+..... ..+..+++++.+||++||+.||.+||
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 293 (346)
T d1cm8a_ 214 TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293 (346)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred HCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCc
Confidence 99999998876655544332110 12345789999999999999999999
Q ss_pred ChHHHhcCcccccc
Q 011868 296 TIAGIKADEWFEQD 309 (476)
Q Consensus 296 s~~~il~~~~~~~~ 309 (476)
|++|+|+||||+.-
T Consensus 294 ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 294 TAGEALAHPYFESL 307 (346)
T ss_dssp CHHHHHHSGGGTTT
T ss_pred CHHHHhcChhhCcC
Confidence 99999999999753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=430.68 Aligned_cols=265 Identities=31% Similarity=0.581 Sum_probs=228.7
Q ss_pred cCCccCcCEEEeceEeecCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhCCC-CCcceEEEE
Q 011868 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKH-PNVVRLHEV 82 (476)
Q Consensus 8 ~~~~~~~~Y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~ 82 (476)
.+.+.+++|++++.||+|+||+||+|++. .+|+.||||++++.... +....+.+.+|+.+|++++| |||++++++
T Consensus 18 ~~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 18 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp CCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred CcccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 34467899999999999999999999974 47899999999765432 22335678899999999976 899999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHH
Q 011868 83 LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFL 162 (476)
Q Consensus 83 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~ 162 (476)
+.+...+|++|||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp-------------------- 157 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL-------------------- 157 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG--------------------
T ss_pred eccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCc--------------------
Confidence 999999999999999999999999988999999999999999999999999999999997
Q ss_pred HhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC-CCCccchhhhHhHH
Q 011868 163 LMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVI 241 (476)
Q Consensus 163 ~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~sDvwSlGvi 241 (476)
+|||++.+|.+||+|||+|+..... ......+.+||+.|+|||.+.+.. +.+.++|||||||+
T Consensus 158 ---------------~Nill~~~~~vkL~DFG~a~~~~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~i 221 (322)
T d1vzoa_ 158 ---------------ENILLDSNGHVVLTDFGLSKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 221 (322)
T ss_dssp ---------------GGEEECTTSCEEESCSSEEEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHH
T ss_pred ---------------cceeecCCCCEEEeeccchhhhccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHH
Confidence 9999999999999999999754332 233455678999999999997643 34578999999999
Q ss_pred HHHHhcCCCCCCCCcH----HHHHHHHHhCCCCCCCCCCHHHHHHHHHccCCCcCCCC-----ChHHHhcCccccc
Q 011868 242 LYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 308 (476)
Q Consensus 242 l~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~-----s~~~il~~~~~~~ 308 (476)
||+|++|+.||.+.+. ..+.........++|..+|+++.+||.+||++||.+|| |++|+++||||++
T Consensus 222 LyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 222 MYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999987653 34455555667788889999999999999999999999 4899999999964
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=429.99 Aligned_cols=260 Identities=29% Similarity=0.459 Sum_probs=215.2
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----E
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----K 88 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----~ 88 (476)
++|++++.||+|+||+||+|++..+|+.||||++++.. .....+.+.+|+.+|+.++||||+++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 47999999999999999999999999999999997654 3445678899999999999999999999996543 3
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
+|++| |+.||+|.+++.. .++++..++.++.||+.||+|||++||+||||||
T Consensus 86 ~~l~~-~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp-------------------------- 137 (345)
T d1pmea_ 86 VYLVT-HLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKP-------------------------- 137 (345)
T ss_dssp EEEEE-ECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG--------------------------
T ss_pred EEEEE-eecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCc--------------------------
Confidence 55554 5569999999976 5799999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCccc-CCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.+|.+||+|||+|+...... ........+||+.|+|||++.....++.++||||+||++|+|++
T Consensus 138 ---------~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~ 208 (345)
T d1pmea_ 138 ---------SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 208 (345)
T ss_dssp ---------GGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHH
T ss_pred ---------ceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhh
Confidence 99999999999999999998544322 22345667899999999998776666689999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhC--C--------------------C---------CCCCCCCHHHHHHHHHccCCCcCCCCC
Q 011868 248 GYLPFDDRNLAVLYQKIFRG--D--------------------F---------KLPKWLSPGAQNLLRKILEPNPVKRIT 296 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~--~--------------------~---------~~p~~~s~~~~~Li~~~L~~dP~~R~s 296 (476)
|+.||.+.+........... . . ...+.+|+++.+||.+||+.||.+|||
T Consensus 209 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 288 (345)
T d1pmea_ 209 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 288 (345)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred CCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC
Confidence 99999988765554443211 0 0 012347889999999999999999999
Q ss_pred hHHHhcCccccccCCC
Q 011868 297 IAGIKADEWFEQDYTP 312 (476)
Q Consensus 297 ~~~il~~~~~~~~~~~ 312 (476)
++++++||||++...+
T Consensus 289 a~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 289 VEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHTSGGGTTTCCG
T ss_pred HHHHhcCHhhccCCCC
Confidence 9999999999865443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-54 Score=431.39 Aligned_cols=251 Identities=28% Similarity=0.376 Sum_probs=211.0
Q ss_pred CEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------CCE
Q 011868 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------KSK 88 (476)
Q Consensus 15 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------~~~ 88 (476)
+|+.++.||+|+||+||+|++..+|+.||||++.++.. ...+|+.+|++++||||++++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 69999999999999999999999999999999976542 23479999999999999999999853 346
Q ss_pred EEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 89 IYMVLEYVTGGELFDK---IASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~---l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
+|+||||+.++.+... .....++++.+++.++.||+.||+|||++||+||||||
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp----------------------- 150 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKP----------------------- 150 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCG-----------------------
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCc-----------------------
Confidence 8999999976533332 23456799999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCC-CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKG-NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 244 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g-~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~e 244 (476)
+|||++.++ .+||+|||+++.... .....+.+||+.|+|||++.+....+.++||||+||++||
T Consensus 151 ------------~NILl~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~e 215 (350)
T d1q5ka_ 151 ------------QNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 215 (350)
T ss_dssp ------------GGEEECTTTCCEEECCCTTCEECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred ------------ceEEEecCCCceeEecccchhhccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEe
Confidence 999999875 899999999985432 3345667899999999998876555699999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHHhC-----------------CCCC------------CCCCCHHHHHHHHHccCCCcCCCC
Q 011868 245 ILTGYLPFDDRNLAVLYQKIFRG-----------------DFKL------------PKWLSPGAQNLLRKILEPNPVKRI 295 (476)
Q Consensus 245 lltG~~Pf~~~~~~~~~~~i~~~-----------------~~~~------------p~~~s~~~~~Li~~~L~~dP~~R~ 295 (476)
|++|+.||.+.+....+.++.+. ...+ ....++++.+||.+||+.||.+||
T Consensus 216 l~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 295 (350)
T d1q5ka_ 216 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295 (350)
T ss_dssp HHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred hhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCc
Confidence 99999999988877766665431 0111 234789999999999999999999
Q ss_pred ChHHHhcCccccccC
Q 011868 296 TIAGIKADEWFEQDY 310 (476)
Q Consensus 296 s~~~il~~~~~~~~~ 310 (476)
|++|+++||||++-.
T Consensus 296 ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 296 TPLEACAHSFFDELR 310 (350)
T ss_dssp CHHHHHTSGGGGGGG
T ss_pred CHHHHhcCHhhcccc
Confidence 999999999998643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-54 Score=416.76 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=209.0
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 89 (476)
.++|++++.||+|+||+||+|++..++ ..||||.++... .....+.+.+|+.+|++++||||+++++++. ++.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 468999999999999999999987543 468888885443 4445678999999999999999999999985 5678
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||+++|+|.+++.. ..++++.+++.++.||+.||.|||++||+||||||
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp-------------------------- 136 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAA-------------------------- 136 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG--------------------------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccch--------------------------
Confidence 999999999999998765 45799999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT- 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt- 247 (476)
+||++++++.+||+|||+|+..... ........+||+.|+|||++.+..|+ .++|||||||++|||+|
T Consensus 137 ---------~NIll~~~~~~Kl~DfG~a~~~~~~-~~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~ 205 (273)
T d1mp8a_ 137 ---------RNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMH 205 (273)
T ss_dssp ---------GGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTT
T ss_pred ---------hheeecCCCcEEEccchhheeccCC-cceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhc
Confidence 9999999999999999999865432 22234456789999999999888885 89999999999999998
Q ss_pred CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 248 GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|.+||.+.+...++.++..+. .+.|+.+|+++.+||.+||+.||.+|||+++|++|
T Consensus 206 g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 206 GVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp SCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999888888888765 56788899999999999999999999999999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=414.53 Aligned_cols=256 Identities=25% Similarity=0.404 Sum_probs=214.9
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 90 (476)
+..++|++++.||+|+||+||+|++..+ +.||||+++.... . .+.+.+|+.++++++||||+++++++.+ +.+|
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~-~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS-C---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC-C---HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence 3458999999999999999999998654 5799999976542 1 4679999999999999999999999854 5689
Q ss_pred EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
+||||+++|+|..++.. ...+++.++..++.||+.||+|||++||+||||||
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp-------------------------- 141 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA-------------------------- 141 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG--------------------------
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccc--------------------------
Confidence 99999999999988854 35799999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc-
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT- 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt- 247 (476)
+|||++.++.+||+|||+|+..... ........+||+.|+|||++.+..++ .++|||||||++|||++
T Consensus 142 ---------~NIll~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~ 210 (285)
T d1fmka3 142 ---------ANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTK 210 (285)
T ss_dssp ---------GGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTT
T ss_pred ---------eEEEECCCCcEEEcccchhhhccCC-CceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhC
Confidence 9999999999999999999865332 12233456799999999999888885 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc--Ccccccc
Q 011868 248 GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQD 309 (476)
Q Consensus 248 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~--~~~~~~~ 309 (476)
|.+||.+.+...++..+..+ ..+.|..+++++.+||.+||+.||++|||+++|++ ++||...
T Consensus 211 ~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 211 GRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp TCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 56667777788788877765 45678889999999999999999999999999987 7777543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=428.88 Aligned_cols=256 Identities=30% Similarity=0.387 Sum_probs=217.1
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK 88 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~ 88 (476)
+||+++++||+|+||+||+|++..+|+.||||++.+... +....+.+.+|+.+|+.++||||+++++++... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 589999999999999999999999999999999986543 344467889999999999999999999998633 33
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
.+++|+|+.||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp-------------------------- 149 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKP-------------------------- 149 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG--------------------------
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCC--------------------------
Confidence 4566677789999998855 5799999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcC
Q 011868 169 PWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 248 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG 248 (476)
+|||++.+|.+|++|||+|.... ....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|
T Consensus 150 ---------~NILi~~~~~~kl~dfg~a~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g 215 (348)
T d2gfsa1 150 ---------SNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215 (348)
T ss_dssp ---------GGEEECTTCCEEECCC----CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred ---------ccccccccccccccccchhcccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhC
Confidence 99999999999999999997532 3345678999999999988877777999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhCCCCC-------------------------------CCCCCHHHHHHHHHccCCCcCCCCCh
Q 011868 249 YLPFDDRNLAVLYQKIFRGDFKL-------------------------------PKWLSPGAQNLLRKILEPNPVKRITI 297 (476)
Q Consensus 249 ~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------p~~~s~~~~~Li~~~L~~dP~~R~s~ 297 (476)
+.||.+.+.......+....... ...+++++.+||++||+.||.+|||+
T Consensus 216 ~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta 295 (348)
T d2gfsa1 216 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295 (348)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCH
Confidence 99999988777666665422111 12468999999999999999999999
Q ss_pred HHHhcCccccccCC
Q 011868 298 AGIKADEWFEQDYT 311 (476)
Q Consensus 298 ~~il~~~~~~~~~~ 311 (476)
+|+|+||||++...
T Consensus 296 ~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 296 AQALAHAYFAQYHD 309 (348)
T ss_dssp HHHHTSGGGTTTCC
T ss_pred HHHhcCHhhCCCCC
Confidence 99999999987543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=422.52 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=213.5
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
+-..|++++.||+|+||+||+|.+..+|+ .||+|.++... +....+.+.+|+.+|++++||||+++++++.++
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 33579999999999999999999988876 57888876443 334467899999999999999999999999865
Q ss_pred EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
..+++|||+.+|+|.+.+... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp------------------------ 139 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA------------------------ 139 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG------------------------
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchh------------------------
Confidence 567888999999999988754 5799999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.++++||+|||+|+...............||+.|+|||++.+..|+ .++|||||||++|||+
T Consensus 140 -----------~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~ 207 (317)
T d1xkka_ 140 -----------RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELM 207 (317)
T ss_dssp -----------GGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHH
T ss_pred -----------hcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHH
Confidence 9999999999999999999865443223334455789999999999988885 8999999999999999
Q ss_pred c-CCCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCc
Q 011868 247 T-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 304 (476)
Q Consensus 247 t-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~ 304 (476)
| |..||.+.+...+...+..+. ++.|+.+++++.+||.+||+.||.+|||+.+|+.|.
T Consensus 208 t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 208 TFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp TTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 8 899999988877777777765 567888999999999999999999999999999884
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=410.07 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=210.2
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
..+.|++.+.||+|+||+||+|.+..++ ..||||++.... .......+.+|+.+|++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 3467999999999999999999976654 479999997654 3344567899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhh
Q 011868 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIV 166 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~ 166 (476)
..|+||||+.+|++.+.+... ..+++.++..++.||+.||+|||++||+||||||
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp------------------------ 138 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA------------------------ 138 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG------------------------
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCcccc------------------------
Confidence 999999999999999988654 5799999999999999999999999999999997
Q ss_pred ccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC-CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 167 IRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 167 ~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+|||++.++.+||+|||+|+....... ........||+.|||||++.+..|+ .++|||||||++|||
T Consensus 139 -----------~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el 206 (283)
T d1mqba_ 139 -----------RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEV 206 (283)
T ss_dssp -----------GGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHH
T ss_pred -----------ceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHH
Confidence 999999999999999999986543221 1223345789999999999888886 899999999999999
Q ss_pred hc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 246 LT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 246 lt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
++ |.+||.+.+...++..+..+ ..+.|..+++++.+||.+||+.||++|||+.+|++
T Consensus 207 ~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 207 MTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 99 56666777777777777665 35677789999999999999999999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1e-52 Score=419.51 Aligned_cols=250 Identities=24% Similarity=0.420 Sum_probs=209.9
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe--CCE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS--KSK 88 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~--~~~ 88 (476)
..++|+++++||+|+||+||+|++..+|+.||||++++.. .+++.+|+.+|+.++ ||||+++++++.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 4578999999999999999999999999999999997543 467889999999995 9999999999974 457
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
+|+||||+.+++|.... +++++.+++.++.||+.||+|||++||+||||||
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp-------------------------- 157 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKP-------------------------- 157 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG--------------------------
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccc--------------------------
Confidence 99999999999997763 5699999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCCCC-CEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 169 PWKFNVLQLENILLDSKG-NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~~g-~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.++ .+||+|||+|+.... .......+||+.|+|||++.+....+.++||||+||++|+|++
T Consensus 158 ---------~NILi~~~~~~vkl~DFG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~ 225 (328)
T d3bqca1 158 ---------HNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225 (328)
T ss_dssp ---------GGEEEETTTTEEEECCGGGCEECCT---TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred ---------cceEEcCCCCeeeecccccceeccC---CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhcc
Confidence 999999765 599999999985432 3345667899999999998876655689999999999999999
Q ss_pred CCCCCCCCcH-HHHHHHHHh-------------CCCC------------------------CCCCCCHHHHHHHHHccCC
Q 011868 248 GYLPFDDRNL-AVLYQKIFR-------------GDFK------------------------LPKWLSPGAQNLLRKILEP 289 (476)
Q Consensus 248 G~~Pf~~~~~-~~~~~~i~~-------------~~~~------------------------~p~~~s~~~~~Li~~~L~~ 289 (476)
|+.||...+. ......+.. .... ....+++++.+||++||+.
T Consensus 226 g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~ 305 (328)
T d3bqca1 226 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 305 (328)
T ss_dssp TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCS
T ss_pred CCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccC
Confidence 9999976442 222111110 0000 1122688999999999999
Q ss_pred CcCCCCChHHHhcCccccc
Q 011868 290 NPVKRITIAGIKADEWFEQ 308 (476)
Q Consensus 290 dP~~R~s~~~il~~~~~~~ 308 (476)
||.+|||++|+|+||||+.
T Consensus 306 dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 306 DHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp SGGGSCCHHHHHTSGGGTT
T ss_pred ChhHCcCHHHHhcCcccCC
Confidence 9999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-53 Score=415.75 Aligned_cols=252 Identities=26% Similarity=0.367 Sum_probs=220.4
Q ss_pred CcCEEEeceEeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 87 (476)
.++|++++.||+|+||+||+|+.. .+++.||||+++... ..+...++.+|+.+|+.++||||+++++++...+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 357999999999999999999975 356789999997654 3445678999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcc
Q 011868 88 KIYMVLEYVTGGELFDKIASKG------------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVI 143 (476)
Q Consensus 88 ~~~lV~E~~~gg~L~~~l~~~~------------------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~ 143 (476)
..++||||+++|+|.+++.... .+++.++..++.||+.||+|||++||+||||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp- 168 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT- 168 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG-
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc-
Confidence 9999999999999999996432 488999999999999999999999999999997
Q ss_pred hhccchhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCcccccccc
Q 011868 144 LKSCHMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 223 (476)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 223 (476)
+|||+|.++++||+|||+|+............+.+||+.|+|||++
T Consensus 169 ----------------------------------~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~ 214 (301)
T d1lufa_ 169 ----------------------------------RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 214 (301)
T ss_dssp ----------------------------------GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred ----------------------------------cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHH
Confidence 9999999999999999999754433333345567899999999999
Q ss_pred ccCCCCCccchhhhHhHHHHHHhcC-CCCCCCCcHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHccCCCcCCCCChHHHh
Q 011868 224 ANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301 (476)
Q Consensus 224 ~~~~~~~~~sDvwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il 301 (476)
.+..|+ .++|||||||++|||++| .+||.+.+..++...+..+.. +.|..+++++.+||.+||+.||++|||+.||+
T Consensus 215 ~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~ 293 (301)
T d1lufa_ 215 FYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293 (301)
T ss_dssp HHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 988886 899999999999999998 578999999998888888764 46778999999999999999999999999995
Q ss_pred c
Q 011868 302 A 302 (476)
Q Consensus 302 ~ 302 (476)
+
T Consensus 294 ~ 294 (301)
T d1lufa_ 294 R 294 (301)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-53 Score=424.72 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=207.0
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------ 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------ 85 (476)
.+.+|+++++||+|+||+||+|++..+|+.||||++.+... +......+.+|+.+|+.++||||++++++|..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 34789999999999999999999999999999999987653 44456789999999999999999999999953
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhh
Q 011868 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMI 165 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~ 165 (476)
...+|+|||||.| ++.+.+. ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 94 ~~~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP----------------------- 147 (355)
T d2b1pa1 94 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP----------------------- 147 (355)
T ss_dssp CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG-----------------------
T ss_pred CceeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCc-----------------------
Confidence 4689999999965 5555553 5699999999999999999999999999999997
Q ss_pred hccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHH
Q 011868 166 VIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 245 (476)
Q Consensus 166 ~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~el 245 (476)
+|||++.++.+|++|||+++.... .......+||+.|+|||++.+..++ .++||||+||++|+|
T Consensus 148 ------------~Nil~~~~~~~kl~df~~~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~el 211 (355)
T d2b1pa1 148 ------------SNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEM 211 (355)
T ss_dssp ------------GGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHH
T ss_pred ------------cccccccccceeeechhhhhcccc---ccccccccccccccChhhhcCCCCC-CCcccccccchHHHH
Confidence 999999999999999999885433 3344566899999999999988775 899999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHhCC----------------------CCC--------------C------CCCCHHHHHHH
Q 011868 246 LTGYLPFDDRNLAVLYQKIFRGD----------------------FKL--------------P------KWLSPGAQNLL 283 (476)
Q Consensus 246 ltG~~Pf~~~~~~~~~~~i~~~~----------------------~~~--------------p------~~~s~~~~~Li 283 (476)
++|++||.+.+......++.... ... + ...++++.+||
T Consensus 212 l~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll 291 (355)
T d2b1pa1 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291 (355)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHH
T ss_pred hhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHH
Confidence 99999999888776665543211 000 0 01356789999
Q ss_pred HHccCCCcCCCCChHHHhcCccccccC
Q 011868 284 RKILEPNPVKRITIAGIKADEWFEQDY 310 (476)
Q Consensus 284 ~~~L~~dP~~R~s~~~il~~~~~~~~~ 310 (476)
++||+.||++|||++|+|+||||+...
T Consensus 292 ~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 292 SKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred HHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999998754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=413.19 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=205.7
Q ss_pred cCcCEEEeceEeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~ 85 (476)
..++|++++.||+|+||+||+|++.. +++.||||+++... .....+.+.+|+.++.++ +|+||+.+++++..
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 34789999999999999999999754 45789999997554 233356777888887776 68999999998865
Q ss_pred C-CEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccc
Q 011868 86 K-SKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCH 148 (476)
Q Consensus 86 ~-~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~ 148 (476)
. ..+|+|||||+||+|.+++... ..+++.++..++.||++||+|||++||+||||||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp------ 162 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA------ 162 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG------
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCc------
Confidence 4 5689999999999999999643 2489999999999999999999999999999997
Q ss_pred hhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCC
Q 011868 149 MRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 228 (476)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 228 (476)
+|||+++++++||+|||+|+............+.+||+.|+|||++.+..|
T Consensus 163 -----------------------------~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 213 (299)
T d1ywna1 163 -----------------------------RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 213 (299)
T ss_dssp -----------------------------GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC
T ss_pred -----------------------------cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC
Confidence 999999999999999999986554333344556789999999999998877
Q ss_pred CCccchhhhHhHHHHHHhcC-CCCCCCCcHHH-HHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 229 DGATSDIWSCGVILYVILTG-YLPFDDRNLAV-LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 229 ~~~~sDvwSlGvil~elltG-~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
+ .++|||||||++|||+|| ..||.+.+... ....+..+ .++.|..+++++.+||.+||+.||.+|||+++|++|
T Consensus 214 ~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 214 T-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp C-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-cccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5 899999999999999986 67898766443 34444443 456778899999999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=411.16 Aligned_cols=253 Identities=27% Similarity=0.453 Sum_probs=219.0
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCC-------ceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSG-------LPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL 83 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~ 83 (476)
..++|++++.||+|+||.||+|++..++ ..||||+++++. .......+.+|+..+.++ +||||+++++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 4589999999999999999999976554 479999997764 334467788899988888 799999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhcc
Q 011868 84 ASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSC 147 (476)
Q Consensus 84 ~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~ 147 (476)
.+++.+|+||||+++|+|.++|... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp----- 163 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA----- 163 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG-----
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc-----
Confidence 9999999999999999999999754 3589999999999999999999999999999997
Q ss_pred chhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC
Q 011868 148 HMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 227 (476)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 227 (476)
+|||++.++.+||+|||+++..............+||+.|+|||++.+..
T Consensus 164 ------------------------------~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~ 213 (299)
T d1fgka_ 164 ------------------------------RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 213 (299)
T ss_dssp ------------------------------GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC
T ss_pred ------------------------------cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC
Confidence 99999999999999999999765544444456678999999999999888
Q ss_pred CCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 228 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 228 ~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
|+ .++|||||||++|||++ |.+||.+.+...++..+..+ .++.|.++++++.+||.+||+.||.+|||+.+|++
T Consensus 214 y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 214 YT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 86 89999999999999998 79999999988888887765 45678889999999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=414.47 Aligned_cols=254 Identities=27% Similarity=0.391 Sum_probs=219.0
Q ss_pred CCccCcCEEEeceEeecCceEEEEEEECCCCce--EEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 011868 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (476)
Q Consensus 9 ~~~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~ 85 (476)
.-+.+++|++.+.||+|+||+||+|++..+|.. ||||.+.... ..+..+.+.+|+.+|+++ +||||+++++++.+
T Consensus 5 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 5 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred CccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 346778999999999999999999999888874 6777775443 233456799999999999 79999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccch
Q 011868 86 KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHM 149 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~ 149 (476)
++.+|+||||++||+|.+++... ..+++.++..++.||+.||.|||++||+||||||
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp------- 155 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA------- 155 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG-------
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCcccccccc-------
Confidence 99999999999999999999643 5799999999999999999999999999999997
Q ss_pred hhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCC
Q 011868 150 RIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 229 (476)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 229 (476)
+|||++.++.+||+|||+|+.... .......+||+.|+|||.+.+..|+
T Consensus 156 ----------------------------~NIL~~~~~~~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~ 204 (309)
T d1fvra_ 156 ----------------------------RNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYT 204 (309)
T ss_dssp ----------------------------GGEEECGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEEC
T ss_pred ----------------------------ceEEEcCCCceEEccccccccccc---cccccceecCCcccchHHhccCCCC
Confidence 999999999999999999985433 2233456799999999999888885
Q ss_pred CccchhhhHhHHHHHHhcC-CCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 230 GATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 230 ~~~sDvwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
.++|||||||++|||++| .+||.+.+...++..+.++ .++.|..+++++.+||.+||+.||++|||+++|+++
T Consensus 205 -~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 205 -TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp -HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 899999999999999996 5689999999998888775 456778899999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=405.11 Aligned_cols=245 Identities=25% Similarity=0.464 Sum_probs=209.3
Q ss_pred ccCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEE
Q 011868 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SKSKI 89 (476)
Q Consensus 11 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-~~~~~ 89 (476)
+..++|++++.||+|+||.||+|++ +|..||||+++++. ..+.+.+|+.++++++||||+++++++. ..+.+
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 3567899999999999999999997 57889999997543 2467899999999999999999999885 45678
Q ss_pred EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 90 YMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
|+||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+|+||||||
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp------------------------- 131 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA------------------------- 131 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG-------------------------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccch-------------------------
Confidence 9999999999999999654 3599999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhc
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 247 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ellt 247 (476)
+|||++.+|.+||+|||+++... ....+.++|+.|+|||++.+..++ .++|||||||++|||+|
T Consensus 132 ----------~Nil~~~~~~~kl~dfg~s~~~~-----~~~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t 195 (262)
T d1byga_ 132 ----------RNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYS 195 (262)
T ss_dssp ----------GGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHT
T ss_pred ----------HhheecCCCCEeecccccceecC-----CCCccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHH
Confidence 99999999999999999998532 233456789999999999888775 89999999999999998
Q ss_pred -CCCCCCCCcHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 248 -GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 248 -G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
|++||.+.+...+...+..+ .+++|..+++++.+||++||+.||.+|||+.+++++
T Consensus 196 ~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 196 FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp TSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 89999998888888888764 467888899999999999999999999999999774
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=407.58 Aligned_cols=253 Identities=27% Similarity=0.404 Sum_probs=207.4
Q ss_pred cCcCEEEeceEeecCceEEEEEEECC-CC--ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLD-SG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~-~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 88 (476)
...+|++.+.||+|+||+||+|+... ++ ..||||++.+....+.+..+.+.+|+.+|++++||||+++++++.+ ..
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 34679999999999999999998643 33 3689999987765556667889999999999999999999999975 46
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhc
Q 011868 89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVI 167 (476)
Q Consensus 89 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (476)
.|+||||+++|++.+++.. .+.+++..+..++.||+.||.|||++||+||||||
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp------------------------- 139 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAA------------------------- 139 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG-------------------------
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecH-------------------------
Confidence 7899999999999998765 35799999999999999999999999999999997
Q ss_pred cccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCC-CcccccccCCccccccccccCCCCCccchhhhHhHHHHHHh
Q 011868 168 RPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 246 (476)
Q Consensus 168 ~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~ell 246 (476)
+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++ .++|||||||++|||+
T Consensus 140 ----------~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~eml 208 (273)
T d1u46a_ 140 ----------RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMF 208 (273)
T ss_dssp ----------GGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHH
T ss_pred ----------HHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHH
Confidence 9999999999999999999865432221 123345688899999999987775 8899999999999999
Q ss_pred c-CCCCCCCCcHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHccCCCcCCCCChHHHh
Q 011868 247 T-GYLPFDDRNLAVLYQKIFRGDF--KLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 301 (476)
Q Consensus 247 t-G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il 301 (476)
| |..||.+.+......++.+... +.|..+++++.+||.+||+.||.+|||+++|+
T Consensus 209 t~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 209 TYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp TTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 8 8999999999999888877754 45677899999999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=407.33 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=222.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 86 (476)
..++|++++.||+|+||+||+|.+.. +++.||||+++... .......+.+|+.++++++||||+++++++..+
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 34899999999999999999998752 45789999997654 334456799999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHH
Q 011868 87 SKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQV 156 (476)
Q Consensus 87 ~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~ 156 (476)
...++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~-------------- 161 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA-------------- 161 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSG--------------
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcC--------------
Confidence 9999999999999999988642 2478999999999999999999999999999997
Q ss_pred HHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCCCCCccchhh
Q 011868 157 FLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 236 (476)
Q Consensus 157 ~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvw 236 (476)
+|||+++++++||+|||+|+..............+||+.|+|||.+.+..++ .++|||
T Consensus 162 ---------------------~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~ 219 (308)
T d1p4oa_ 162 ---------------------RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVW 219 (308)
T ss_dssp ---------------------GGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHH
T ss_pred ---------------------CceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccc
Confidence 9999999999999999999865443333334555799999999999988886 899999
Q ss_pred hHhHHHHHHhcC-CCCCCCCcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 237 SCGVILYVILTG-YLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 237 SlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
||||++|||+|| ..||.+.+....+..+.++. ++.|..+++.+.+||.+||+.||.+|||+++|++
T Consensus 220 S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 220 SFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999997 68999999998888887765 4567889999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=405.77 Aligned_cols=253 Identities=27% Similarity=0.430 Sum_probs=217.9
Q ss_pred cCcCEEEeceEeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~ 85 (476)
..++|++++.||+|+||+||+|+.. .+++.||||+++... .......+.+|+.+++.+ +||||+++++++.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 3479999999999999999999863 467799999997654 334467899999999999 69999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhcc
Q 011868 86 KSKIYMVLEYVTGGELFDKIASKG------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSC 147 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~~------------------~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~ 147 (476)
....|+|||||++|+|.+++.... .+++.++..++.||+.||+|||++||+||||||
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp----- 173 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA----- 173 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG-----
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc-----
Confidence 999999999999999999986532 589999999999999999999999999999997
Q ss_pred chhhhHHHHHHHHHHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccCCCcccccccCCccccccccccCC
Q 011868 148 HMRIATLQVFLLTFLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 227 (476)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 227 (476)
+|||++.++.+|++|||+++..............+||+.|+|||++.+..
T Consensus 174 ------------------------------~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 223 (311)
T d1t46a_ 174 ------------------------------RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV 223 (311)
T ss_dssp ------------------------------GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred ------------------------------ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC
Confidence 99999999999999999999765433333445578999999999998877
Q ss_pred CCCccchhhhHhHHHHHHhc-CCCCCCCCcHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 228 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 228 ~~~~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
++ .++|||||||++|||+| |.+||.+.+....+.++... ....|..+++.+.+||.+||+.||.+|||+++|++
T Consensus 224 ~~-~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 224 YT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-CcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 75 89999999999999998 77778777765555554443 33456778999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=390.63 Aligned_cols=249 Identities=24% Similarity=0.319 Sum_probs=206.7
Q ss_pred EEeceEeecCceEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEE
Q 011868 17 ELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIYMV 92 (476)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lV 92 (476)
...++||+|+||+||+|++..++ ..||||.+++.. +......+.+|+.+|++++||||+++++++.. ++..|+|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34678999999999999986643 368999997543 45556889999999999999999999999765 5689999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
||||++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~----------------------------- 158 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAA----------------------------- 158 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG-----------------------------
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccH-----------------------------
Confidence 9999999999988754 4578889999999999999999999999999997
Q ss_pred cccCCCCceEeCCCCCEEEeccCCCCCCCcccC--CCcccccccCCccccccccccCCCCCccchhhhHhHHHHHHhcCC
Q 011868 172 FNVLQLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 249 (476)
Q Consensus 172 ~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvil~elltG~ 249 (476)
+|||+++++.+||+|||+++....... ........||+.|+|||++.+..++ .++|||||||++|||+||.
T Consensus 159 ------~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~ 231 (311)
T d1r0pa_ 159 ------RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRG 231 (311)
T ss_dssp ------GGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTS
T ss_pred ------HhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCC
Confidence 999999999999999999986543221 1223345789999999999888775 8999999999999999976
Q ss_pred CCCCC-CcHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcC
Q 011868 250 LPFDD-RNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 303 (476)
Q Consensus 250 ~Pf~~-~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~ 303 (476)
.||.. .+.......+..+. +..|..+++++.+||.+||+.||.+|||+.||++|
T Consensus 232 ~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 232 APPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 66654 44455566666654 45678899999999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-48 Score=385.38 Aligned_cols=259 Identities=22% Similarity=0.263 Sum_probs=207.0
Q ss_pred cC-cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEE
Q 011868 12 RL-GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKI 89 (476)
Q Consensus 12 ~~-~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~~~ 89 (476)
++ ++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.++|+| |+.+.+++...+..
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 44 479999999999999999999999999999999876532 235788999999998766 55566677888999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhcc
Q 011868 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIR 168 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (476)
|+||||+ +++|.+.+.. .+++++.++..++.|++.||+|||++||+||||||
T Consensus 79 ~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp-------------------------- 131 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKP-------------------------- 131 (299)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG--------------------------
T ss_pred EEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCH--------------------------
Confidence 9999999 6677666654 56899999999999999999999999999999997
Q ss_pred ccccccCCCCceEeCC---CCCEEEeccCCCCCCCcccC-----CCcccccccCCccccccccccCCCCCccchhhhHhH
Q 011868 169 PWKFNVLQLENILLDS---KGNIKISDFGLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 240 (476)
Q Consensus 169 p~~~~~~~~~NiLl~~---~g~vkl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGv 240 (476)
+|||++. +..+||+|||+|+....... .....+.+||+.|||||++.+..++ .++|||||||
T Consensus 132 ---------~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~ 201 (299)
T d1ckia_ 132 ---------DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGY 201 (299)
T ss_dssp ---------GGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHH
T ss_pred ---------hhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCH
Confidence 9999864 45799999999986543221 1223456899999999999988885 8999999999
Q ss_pred HHHHHhcCCCCCCCCcHHHHHHHH---HhCC--C---CCCCCCCHHHHHHHHHccCCCcCCCCChHH---HhcCcccccc
Q 011868 241 ILYVILTGYLPFDDRNLAVLYQKI---FRGD--F---KLPKWLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFEQD 309 (476)
Q Consensus 241 il~elltG~~Pf~~~~~~~~~~~i---~~~~--~---~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~---il~~~~~~~~ 309 (476)
++|||++|+.||.+.........+ .... . ..+..+|+++.+||.+||+.||.+||++++ +++|+|.+..
T Consensus 202 ~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 202 VLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred HHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 999999999999876544332222 1111 1 134568999999999999999999999875 5788877665
Q ss_pred CCC
Q 011868 310 YTP 312 (476)
Q Consensus 310 ~~~ 312 (476)
+..
T Consensus 282 ~~~ 284 (299)
T d1ckia_ 282 FSY 284 (299)
T ss_dssp CCC
T ss_pred CCC
Confidence 544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.9e-48 Score=377.61 Aligned_cols=247 Identities=19% Similarity=0.228 Sum_probs=207.9
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEEEEE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLASKSKIYMV 92 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~lV 92 (476)
++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+..++.++| +||+.+++++......|+|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 689999999999999999999999999999999866432 2457789999999975 8999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHHHHHhhhccccc
Q 011868 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLTFLLMIVIRPWK 171 (476)
Q Consensus 93 ~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 171 (476)
|||+ |++|.+.+... ..+++.++..++.|++.||+|||++||+||||||
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp----------------------------- 129 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKP----------------------------- 129 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCG-----------------------------
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCc-----------------------------
Confidence 9999 88999998764 4799999999999999999999999999999997
Q ss_pred cccCCCCceEeCC-----CCCEEEeccCCCCCCCcccC-----CCcccccccCCccccccccccCCCCCccchhhhHhHH
Q 011868 172 FNVLQLENILLDS-----KGNIKISDFGLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 241 (476)
Q Consensus 172 ~~~~~~~NiLl~~-----~g~vkl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~sDvwSlGvi 241 (476)
+|||++. ++.+||+|||+|+....... .....+.+||+.|||||++.+..++ .++|||||||+
T Consensus 130 ------~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~ 202 (293)
T d1csna_ 130 ------DNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHV 202 (293)
T ss_dssp ------GGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHH
T ss_pred ------cceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHH
Confidence 9999974 57899999999986543211 1234466899999999999988775 89999999999
Q ss_pred HHHHhcCCCCCCCCc---HHHHHHHHHhCCC-----CCCCCCCHHHHHHHHHccCCCcCCCCChHHHhc
Q 011868 242 LYVILTGYLPFDDRN---LAVLYQKIFRGDF-----KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 302 (476)
Q Consensus 242 l~elltG~~Pf~~~~---~~~~~~~i~~~~~-----~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~ 302 (476)
+|+|++|..||.+.+ ....+.++..... .++..+++++.+++..|+..+|++||+.+.+.+
T Consensus 203 l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 203 FMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 999999999997643 3333444332221 133568899999999999999999999887644
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=376.25 Aligned_cols=248 Identities=24% Similarity=0.328 Sum_probs=192.7
Q ss_pred cCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EE
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI 89 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----~~ 89 (476)
.+|.+.+.||+|+||+||+|+. +|+.||||+++... ........|+..++.++||||+++++++..++ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4689999999999999999985 68999999996542 11222344555666789999999999997653 68
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------cCcEeccCCcchhccchhhhHHHHHHHHH
Q 011868 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN--------KGVFHRDLKVILKSCHMRIATLQVFLLTF 161 (476)
Q Consensus 90 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~--------~givHrDiKp~~~~~~~~~~~~~~~~~~~ 161 (476)
|+||||+++|+|.+++.. .++++.+...++.|++.||+|||+ +||+||||||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp------------------- 136 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS------------------- 136 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCG-------------------
T ss_pred EEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCc-------------------
Confidence 999999999999999976 469999999999999999999996 5999999997
Q ss_pred HHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCCCcccC--CCcccccccCCccccccccccCCC-----CCccch
Q 011868 162 LLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGY-----DGATSD 234 (476)
Q Consensus 162 ~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~-----~~~~sD 234 (476)
+|||++.+|.+||+|||+++....... .......+||+.|+|||++.+... .+.++|
T Consensus 137 ----------------~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~D 200 (303)
T d1vjya_ 137 ----------------KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 200 (303)
T ss_dssp ----------------GGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHH
T ss_pred ----------------cceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchh
Confidence 999999999999999999985433211 123445789999999999876431 236899
Q ss_pred hhhHhHHHHHHhcCCCCCCCC---------------cHHHHHHHHHhCCC--CCCCCC-----CHHHHHHHHHccCCCcC
Q 011868 235 IWSCGVILYVILTGYLPFDDR---------------NLAVLYQKIFRGDF--KLPKWL-----SPGAQNLLRKILEPNPV 292 (476)
Q Consensus 235 vwSlGvil~elltG~~Pf~~~---------------~~~~~~~~i~~~~~--~~p~~~-----s~~~~~Li~~~L~~dP~ 292 (476)
||||||+||||+||..||... +............. .+|... ...+.+|+.+||+.||.
T Consensus 201 i~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~ 280 (303)
T d1vjya_ 201 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 280 (303)
T ss_dssp HHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGG
T ss_pred hhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHh
Confidence 999999999999999887431 22233333333332 223221 23588999999999999
Q ss_pred CCCChHHHhcC
Q 011868 293 KRITIAGIKAD 303 (476)
Q Consensus 293 ~R~s~~~il~~ 303 (476)
+|||+.||+++
T Consensus 281 ~Rps~~ei~~~ 291 (303)
T d1vjya_ 281 ARLTALRIKKT 291 (303)
T ss_dssp GSCCHHHHHHH
T ss_pred HCcCHHHHHHH
Confidence 99999999764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.6e-46 Score=375.37 Aligned_cols=253 Identities=25% Similarity=0.435 Sum_probs=198.5
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-----------CCCcceEE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----------HPNVVRLH 80 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-----------HpnIv~l~ 80 (476)
.-+||+++++||+|+||+||+|++..+|+.||||+++++. ...+.+.+|+.+++.++ |+||++++
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 3467999999999999999999999999999999997653 23467788999988875 57899999
Q ss_pred EEEEe--CCEEEEEEeccCCCChHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeccCCcchhccchhhhHH
Q 011868 81 EVLAS--KSKIYMVLEYVTGGELFDKIA---SKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKVILKSCHMRIATL 154 (476)
Q Consensus 81 ~~~~~--~~~~~lV~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~al~yLH~-~givHrDiKp~~~~~~~~~~~~ 154 (476)
+++.. ....+++|+++.++....... ....+++..++.++.||+.||+|||+ .||+||||||
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp------------ 154 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP------------ 154 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSG------------
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCCh------------
Confidence 98754 456777777776655433332 23579999999999999999999998 8999999997
Q ss_pred HHHHHHHHHhhhccccccccCCCCceEeCCCCC------EEEeccCCCCCCCcccCCCcccccccCCccccccccccCCC
Q 011868 155 QVFLLTFLLMIVIRPWKFNVLQLENILLDSKGN------IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 228 (476)
Q Consensus 155 ~~~~~~~~~~~~~~p~~~~~~~~~NiLl~~~g~------vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 228 (476)
+|||++.++. +|++|||.|.... ......+||+.|+|||++.+..|
T Consensus 155 -----------------------~NIll~~~~~~~~~~~~kl~dfg~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~ 206 (362)
T d1q8ya_ 155 -----------------------ENVLMEIVDSPENLIQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPW 206 (362)
T ss_dssp -----------------------GGEEEEEEETTTTEEEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCC
T ss_pred -----------------------hHeeeeccCcccccceeeEeecccccccc-----cccccccccccccChhhccccCC
Confidence 9999987664 9999999997432 23456789999999999998888
Q ss_pred CCccchhhhHhHHHHHHhcCCCCCCCCcHH------HHHHHHHh--C---------------------------------
Q 011868 229 DGATSDIWSCGVILYVILTGYLPFDDRNLA------VLYQKIFR--G--------------------------------- 267 (476)
Q Consensus 229 ~~~~sDvwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~--~--------------------------------- 267 (476)
+ .++||||+||++++|++|+.||...+.. ........ +
T Consensus 207 ~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
T d1q8ya_ 207 G-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 285 (362)
T ss_dssp C-THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC
T ss_pred C-ccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCc
Confidence 6 8999999999999999999999754321 11111100 0
Q ss_pred -------CCCCCCCCCHHHHHHHHHccCCCcCCCCChHHHhcCcccccc
Q 011868 268 -------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 309 (476)
Q Consensus 268 -------~~~~p~~~s~~~~~Li~~~L~~dP~~R~s~~~il~~~~~~~~ 309 (476)
....+...++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 286 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 001112245789999999999999999999999999999843
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=7.7e-26 Score=206.66 Aligned_cols=136 Identities=21% Similarity=0.285 Sum_probs=108.9
Q ss_pred EEEeceEeecCceEEEEEEECCCCceEEEEEeeccccc---------------chhHHHHHHHHHHHHHhCCCCCcceEE
Q 011868 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---------------HLKITDQIKREIATLKLLKHPNVVRLH 80 (476)
Q Consensus 16 Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~---------------~~~~~~~~~~Ei~~l~~l~HpnIv~l~ 80 (476)
|.++++||+|+||+||+|++ .+|+.||||+++..... .........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 56899999999999999998 57899999987642210 011123456789999999999999988
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeccCCcchhccchhhhHHHHHHHH
Q 011868 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKVILKSCHMRIATLQVFLLT 160 (476)
Q Consensus 81 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~givHrDiKp~~~~~~~~~~~~~~~~~~ 160 (476)
++.. .+++|||+++..+. .++...+..++.|++.|++|||++||+||||||
T Consensus 81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP------------------ 131 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQ------------------ 131 (191)
T ss_dssp EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCST------------------
T ss_pred EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCCh------------------
Confidence 7642 27999999876553 256667788999999999999999999999997
Q ss_pred HHHhhhccccccccCCCCceEeCCCCCEEEeccCCCCCC
Q 011868 161 FLLMIVIRPWKFNVLQLENILLDSKGNIKISDFGLSALP 199 (476)
Q Consensus 161 ~~~~~~~~p~~~~~~~~~NiLl~~~g~vkl~DFGla~~~ 199 (476)
+|||+++++ ++|+|||+|...
T Consensus 132 -----------------~NILv~~~~-~~liDFG~a~~~ 152 (191)
T d1zara2 132 -----------------YNVLVSEEG-IWIIDFPQSVEV 152 (191)
T ss_dssp -----------------TSEEEETTE-EEECCCTTCEET
T ss_pred -----------------hheeeeCCC-EEEEECCCcccC
Confidence 999999655 899999999743
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.40 E-value=9e-13 Score=105.69 Aligned_cols=87 Identities=15% Similarity=0.273 Sum_probs=79.1
Q ss_pred eeeeecCCHHHHHHHHHHHHHhcCeEEEee-CCceeeeeccCCCcccCceEEEEEEEEEc-CceEEEEEEecCCChhhHH
Q 011868 376 IRFTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKLKATQEHKPQKSLGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYR 453 (476)
Q Consensus 376 ~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~l~~~~ev~~~~-~~~~lVe~~k~~Gd~lef~ 453 (476)
...+|..+|++|+.+|+++++.+|+.|+++ ++.+++...+++++ +.++|.+||+++. +++++|+|+|.+||+++|+
T Consensus 13 v~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~--~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk 90 (102)
T d1ul7a_ 13 MKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAE--NLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFK 90 (102)
T ss_dssp CCCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGG--GCEEEEEEEEECSSSSSEEEEEEEEESCHHHHH
T ss_pred eecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCC--ceEEEEEEEEEcCCCceEEEEEEEccCCHHHHH
Confidence 345689999999999999999999999765 58899998877777 8999999999996 7999999999999999999
Q ss_pred HHHHHHHhhcC
Q 011868 454 QLCNKLSSDLG 464 (476)
Q Consensus 454 ~~~~~l~~~L~ 464 (476)
++|.+|...|+
T Consensus 91 ~l~~~il~~l~ 101 (102)
T d1ul7a_ 91 NIASKIANELK 101 (102)
T ss_dssp HHHHHHHHHCC
T ss_pred HHHHHHHHhcc
Confidence 99999998876
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.47 E-value=3.1e-07 Score=85.16 Aligned_cols=112 Identities=12% Similarity=0.084 Sum_probs=81.0
Q ss_pred CcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 011868 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 13 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~l 91 (476)
+..|++++..+.++.+.||+.. ..+..+.+|+....... ....+.+|...++.+. +--+.+++.+...++..|+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 5678888876666678999876 56667888987654321 1345778888888774 4446788888888999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011868 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (476)
Q Consensus 92 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~g 134 (476)
||++++|.++.+... +......+..++...++.||+..
T Consensus 88 v~~~l~G~~~~~~~~-----~~~~~~~~~~~l~~~l~~lH~~~ 125 (263)
T d1j7la_ 88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSID 125 (263)
T ss_dssp EEECCSSEEHHHHTT-----TCSCHHHHHHHHHHHHHHHHTSC
T ss_pred EEEeccccccccccc-----ccccHHHHHHHHHHHHHHHhccC
Confidence 999999988766442 22234456778888899999754
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.24 E-value=6e-06 Score=68.43 Aligned_cols=72 Identities=8% Similarity=0.243 Sum_probs=59.9
Q ss_pred eeecCCHHHHHHHHHHHHHhcCeEEEe-eCCceeeeeccCCCcccCceEEEEEEEEEcCceEEEEEEecCCChhh
Q 011868 378 FTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTV 451 (476)
Q Consensus 378 f~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~l~~~~ev~~~~~~~~lVe~~k~~Gd~le 451 (476)
+-|...|.+|+..|..+++.+|+.|++ +.|.|++........ ..+++..++|++.++.|||||++..|+-.|
T Consensus 5 IrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~--~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 5 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCC--ceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 456789999999999999999999987 568888887544433 678999999999999999999999887433
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.95 E-value=1.1e-05 Score=73.85 Aligned_cols=104 Identities=17% Similarity=0.173 Sum_probs=68.8
Q ss_pred cCEEEeceEeecC-ceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEE
Q 011868 14 GRYELGRTLGEGN-FGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKIY 90 (476)
Q Consensus 14 ~~Y~i~~~LG~G~-fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~~~~ 90 (476)
..++.. .+..|. -+.||+... .++..+.+|.-.... ...+.+|...|+.+.. -.+.+++.+..+.+..|
T Consensus 11 ~g~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~ 82 (255)
T d1nd4a_ 11 FGYDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 82 (255)
T ss_dssp TTCEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceE
Confidence 345543 334444 468998874 567778999865442 2357788888887743 33677888888888999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 011868 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133 (476)
Q Consensus 91 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~ 133 (476)
+||++++|.++.+. ..+.. ....++...|+-||+.
T Consensus 83 ~v~~~i~G~~~~~~-----~~~~~---~~~~~l~~~la~LH~~ 117 (255)
T d1nd4a_ 83 LLLGEVPGQDLLSS-----HLAPA---EKVSIMADAMRRLHTL 117 (255)
T ss_dssp EEEECCSSEETTTS-----CCCHH---HHHHHHHHHHHHHTTS
T ss_pred EEEEeeeccccccc-----cccHH---HHHHHHHHHHHHHccC
Confidence 99999988766431 12222 2345677777788864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.93 E-value=1.5e-05 Score=78.60 Aligned_cols=82 Identities=17% Similarity=0.170 Sum_probs=51.4
Q ss_pred eceEeecCceEEEEEEECCCCceEEEEEeecc-cccc---hhHHHHHHHHHHHHHhCC-C--CCcceEEEEEEeCCEEEE
Q 011868 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN-RIIH---LKITDQIKREIATLKLLK-H--PNVVRLHEVLASKSKIYM 91 (476)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~---~~~~~~~~~Ei~~l~~l~-H--pnIv~l~~~~~~~~~~~l 91 (476)
.+.||.|....||+..+..+++.|+||.-... +... .-..++...|...|+.+. + ..+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999998777889999975321 1000 011345667888888773 2 346666654 3445578
Q ss_pred EEeccCCCChH
Q 011868 92 VLEYVTGGELF 102 (476)
Q Consensus 92 V~E~~~gg~L~ 102 (476)
|||++.+..+.
T Consensus 109 vmE~L~~~~~~ 119 (392)
T d2pula1 109 VMEDLSHLKIA 119 (392)
T ss_dssp EECCCTTSEEH
T ss_pred EEeccCCcccc
Confidence 99999776543
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=97.67 E-value=0.0001 Score=59.61 Aligned_cols=90 Identities=13% Similarity=0.248 Sum_probs=65.2
Q ss_pred ceeeeecCCHHHHHHHHHHHHHhcCeEEEeeC----------CceeeeeccCC---CcccCceEEEEEEEEEcCceEEEE
Q 011868 375 KIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN----------GKLKATQEHKP---QKSLGSLSVAAEVFEISPSLYVVE 441 (476)
Q Consensus 375 ~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~----------~~i~~~~~~~~---~~~~~~l~~~~ev~~~~~~~~lVe 441 (476)
....-|...|-+|+..|..|++++|+.|++-+ +.|+++...+. ......+.+.+++|++.++.+|||
T Consensus 4 hfGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLlD 83 (127)
T d2qrda1 4 HFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLD 83 (127)
T ss_dssp EESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEE
T ss_pred eeccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEEE
Confidence 33455789999999999999999999998633 45777632110 111145788999999999999999
Q ss_pred EE-----ecCC--------------ChhhHHHHHHHHHhhcC
Q 011868 442 LR-----KSYG--------------DPTVYRQLCNKLSSDLG 464 (476)
Q Consensus 442 ~~-----k~~G--------------d~lef~~~~~~l~~~L~ 464 (476)
|+ .+.| .+.+|-.+|.+|.-+|.
T Consensus 84 FK~dg~e~~~~~~~~~~~~~~~~~~s~~pFldl~a~LI~qL~ 125 (127)
T d2qrda1 84 VKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF 125 (127)
T ss_dssp EEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred EccCCcccccCCccccccCccccccCCccHHHHHHHHHHHHh
Confidence 98 2222 24679999998776653
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=97.31 E-value=0.0004 Score=59.01 Aligned_cols=91 Identities=20% Similarity=0.289 Sum_probs=62.2
Q ss_pred ccceeeeecCCHHHHHHHHHHHHHhcCeEEEeeC----CceeeeeccC-------CCcccCceEEEEEEEEEcCceEEEE
Q 011868 373 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN----GKLKATQEHK-------PQKSLGSLSVAAEVFEISPSLYVVE 441 (476)
Q Consensus 373 ~~~~rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~----~~i~~~~~~~-------~~~~~~~l~~~~ev~~~~~~~~lVe 441 (476)
+.....-|...|-+|+..|..|++++|+.|++.+ +.|++....+ .......+.+.+++|++.++.||||
T Consensus 45 kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlD 124 (171)
T d2qlva1 45 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 124 (171)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEE
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEE
Confidence 3455566899999999999999999999997643 5677764211 1111245789999999999999999
Q ss_pred EEe-----cCC----------------ChhhHHHHHHHHHhhc
Q 011868 442 LRK-----SYG----------------DPTVYRQLCNKLSSDL 463 (476)
Q Consensus 442 ~~k-----~~G----------------d~lef~~~~~~l~~~L 463 (476)
|+- +.| .+.+|-.+|.+|.-+|
T Consensus 125 FK~~g~e~~~~~~~~~~~~~~~e~~~~Sp~pFldlca~LI~qL 167 (171)
T d2qlva1 125 FKFDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMEL 167 (171)
T ss_dssp EEEEEEEC--------------CHHHHTSHHHHHHHHHHHHHH
T ss_pred EecCCccccccccccccccCCCcccCcCCccHHHHHHHHHHHH
Confidence 973 222 2367888888776655
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.74 E-value=0.002 Score=60.99 Aligned_cols=68 Identities=25% Similarity=0.240 Sum_probs=45.8
Q ss_pred eEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc--eEE-----EEEEeCCEEEEEEeccCCCC
Q 011868 28 GKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV--RLH-----EVLASKSKIYMVLEYVTGGE 100 (476)
Q Consensus 28 g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv--~l~-----~~~~~~~~~~lV~E~~~gg~ 100 (476)
-.||+++. .+|..|++|+.+.... ..+++..|...+..|...+|. ... ..+...+..+.+++++.|..
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 58999885 6788999999876532 146678888888877432221 111 12345678899999997743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.61 E-value=0.0048 Score=59.88 Aligned_cols=104 Identities=12% Similarity=0.107 Sum_probs=67.1
Q ss_pred cCEEEeceEeecCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe
Q 011868 14 GRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS 85 (476)
Q Consensus 14 ~~Y~i~~~LG~G~fg~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~ 85 (476)
+..++ +.|+.|-.-.+|++.... ..+.|.+++.-... . .....+|..+++.+. +.-..++++++.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 34554 578889999999998653 23567777764221 1 235668999999885 4444578887743
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCc
Q 011868 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135 (476)
Q Consensus 86 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~al~yLH~~gi 135 (476)
.+||||++|..|... +..-..+..+++..|+-+|+..+
T Consensus 117 ----g~I~efi~g~~l~~~--------d~~~~~~~~~iA~~La~lH~~~~ 154 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPLSCH--------EISLAHMSTKIAKRVAKVHQLEV 154 (395)
T ss_dssp ----EEEECCCCEEECCTT--------GGGSHHHHHHHHHHHHHHTTCCC
T ss_pred ----ceEEEEeccccCChh--------hccchhhhHHHHHHHHHHhhccc
Confidence 679999987554321 11112356677777888887543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.40 E-value=0.055 Score=49.95 Aligned_cols=82 Identities=10% Similarity=0.148 Sum_probs=44.3
Q ss_pred cCcCEEEeceEeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-----cceEEE---EE
Q 011868 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-----VVRLHE---VL 83 (476)
Q Consensus 12 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-----Iv~l~~---~~ 83 (476)
.+|+..-.+.|..|---+.|+... .+| .+++|+..... + .+.+..|+.++..+.+.+ .+...+ +.
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~--~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~ 88 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG 88 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEE-SSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred CCCCceEeecCCCCcccCeEEEEE-CCC-cEEEEEcCCCC--C---HHHHHHHHHHHHhhhhccccccccceecCCCcce
Confidence 345555556667777788998874 344 58999986542 1 234556777777764222 221100 12
Q ss_pred EeCCEEEEEEeccCCCC
Q 011868 84 ASKSKIYMVLEYVTGGE 100 (476)
Q Consensus 84 ~~~~~~~lV~E~~~gg~ 100 (476)
...+..+.++.+..|..
T Consensus 89 ~~~~~~~~~~~~~~g~~ 105 (316)
T d2ppqa1 89 ELSGRPAALISFLEGMW 105 (316)
T ss_dssp EETTEEEEEEECCCCBC
T ss_pred eeecccceeeeeccccc
Confidence 33456677777776644
|